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BLUE LIVER SYNDROME INCREASES MORBIDITY AFTER
MAJOR HEPATECTOMY IN PATIENTS WITH COLORECTAL
LIVER METASTASES RECEIVING PREOPERATIVE CHE-
MOTHERAPY
Nakano, Hiroshi1; Oussoutzoglou, Elie2; Rosso, Edoardo2; Giraudo,
Giorgio2; Otsubo, Takehito3; Bachellier, Philippe2; Jaeck, Daniel2
1Hopital de Hautepierre, Chirurgie Viscerale et de Transplantation, Uni-
versite Louis Pasteur, Strasbourg, France; 2Hopital de Hautepierre, Chir-
urgie Viscerale et de transplantation, Strasbourg, France; 3St Marianna
Univer sity Hospital, Gastroenterological Surgery, Kawasaki, Japan
Background. Sinusoidal obstruction & congestion, i.e., blue liver syndrome
(BLS), is shown to be associated with oxaliplatin-based chemotherapy
(OBC) before hepatectomy in patients with colorectal cancer liver metastases
(CRCLM). However, it is still unclear whether BLS Results in a worse
outcome after hepatectomy in patients with CRCLM.
Patients and Methods. Between 2003 and 2005, 90 patients with CRLM
who underwent an elective hepatectomy following preoperative chemothera-
pies were included. Diagnosis of BLS was established pathologically in the
non-tumoral liver parenchyma of the resected specimens, and perioperative
data were assessed in these patients.
Results. Preoperative indocyanine green retention rate at 15 minutes (ICG-
R15) and postoperative value of total bilirubin were significantly higher, and
hospital stay was significantly longer in patients presenting with BLS.
Multivariate analysis showed that female gender, administration of 6 cycles
or more of OBC, abnormal value of preoperative aspartate aminotransferase
(AST36 IU/L), or abnormal value of preoperative ICG-R15 (more than
10%) were preoperative factors significantly associated with BLS. Among
patients undergoing a major hepatectomy, BLS was significantly associated
with higher morbidity (Dindo & Clavien: Grade III and IV) and longer
hospital stay.
Conclusion. Blue liver syndrome resulted in a poorer liver functional reserve
and in a higher complication rate after major hepatectomy. Therefore, female
patients who received 6 cycles or more of OBC, or presenting with abnormal
preoperative AST and ICG-R15 values should be carefully selected before
deciding to undertake a major hepatectomy.
PL 1.02
LAPAROSCOPIC RADIOFREQUENCY ABLATION OF UNRE-
SECTABLE HEPATOCELLULAR CARCINOMA: LONG-TERM
FOLLOW UP
Siperstein, Allan; Berber, Eren; Ballem, Naveen
Cleveland Clinic, Department of Surgery, Cleveland, United States
Background. Hepatocellular Carcinoma (HCC) has seen a dramatic rise in
the United States over the last 30 years. Unresectable disease is present in
8090% of patients, for which Laparoscopic Radiofrequency Abla-
tion(LRFA) is a proven option. The aim of this study is to report the long
term survival after LRFA.
Methods. This is a prospective analysis of 104 patients undergoing LRFA
from April 1997 to October 2006. Overall survival (OS) and Disease Free
Survival (DFS) were estimated using Kaplan-Meier analysis. Univariate and
Multivariate Cox Proportional Hazard Models were used to evaluate various
demographic and clinical parameters with respect to survival. Patients were
classified according to the Barcelona Clinic Liver Cancer (BCLC) staging
system and subgroup analysis of OS and DFS were evaluated.
Results. Median (range )data: age 63 yrs (4181), lesion size 3.5 cm (110),
number of lesions 1(15), AFP 26.45 (3.743588.5) and time from diagnosis
to RFA 2 months (mos) (142). The median Kaplan-Meier survival for all
patients was 26 mos (OS) while DFS was 14 mos. Univariate analysis
demonstrated improved OS for the absence vs presence of ascites (28 vs 6
mos, p0.003), Bilirubin B2 vs 2 (27 vs 19 mos, p0.01), AFP B400 vs
400(34 vs 11 mos, pB0.0001) and Child-Pugh Grade (A28, B15,
C5 mos, p0.01). Significant factors for improved DFS: absence vs
presence of ascites (16 vs 5 mos, p0.02), Bilirubin B2 vs 2 (14 vs
5 mos, p0.0278), AFP B400 vs 400(15 vs 4 mos, p0.0025) and
Child-Pugh Grade (A38, B12, C3 mos, p0.03). Patient age, tumor
size, number of lesions, INR and albumin did not reach clinical significance.
All other clinical variables evaluated did not reach statistical significance.
BCLC staging was not found to have prognostic significance for OS or DFS
(OS, p0.11 and DFS, p0.07). 3 and 5 yr actual survival rates are 21%
and 8.3% respectively.
Conclusions. Our study suggests that LRFA may have a positive impact on
survival for unresectable HCC. It also determines which patients fare best
after LRFA, by determining predictive factors that improve survival.
PL 1.03
HEME OXYGENASE-1 GENOTYPE OF THE DONOR IS ASSO-
CIATED WITH GRAFT SURVIVAL AFTER LIVER TRANSPLAN-
TATION
Buis, Carlijn I1; van der Steege, Gerrit2; Visser, Dorien S3; Nolte,
Ilja M2; Hepkema, Bouke G4; Nijsten, Maarten5; Slooff, Maarten JH1;
Porte, Robert J1
1University Medical Center Groningen, Hepatobiliary Surgery and Liver
Transplantation, Groningen, Netherlands; 2University Medical Center
Groningen, Medical Biology, Groningen, Netherlands; 3University Medical
Center Groningen, Surgical Research Laboratory, Groningen, Netherlands;
4University Medical Center Groningen, Transplantation Immunology, Gro-
ningen, Netherlands; 5University Medical Center Groningen, Surgical
Intensive Care Unit, Groningen, Netherlands
The heme oxygenase 1 (HO-1)/carbon monoxide (CO) pathway has been
shown to provide cytoprotection during liver ischemia and reperfusion.
Inducibility of HO-1 is modulated by a (GT)n polymorphism and a single
nucleotide polymorphism (SNP) A(-413)T in the promoter. Both a short
(GT)n allele and the A-allele are associated with increased HO-1 promoter
activity, compared to the long (GT)n repeat and the T-allele. In 308
liver transplantations we performed HO-1 genotyping in donor genomic
DNA. For (GT)n genotype, livers were divided into two classes: short alleles
(B25 repeats; class-S) and long alleles (¡Y´ 25 repeats; class-L). [For the SNP
A(-413)T, recipients of livers with at least one A-allele (A-receivers) were
compared with the TT-variant.] In a subset of patients, HO-1 mRNA
expression was correlated with genotype and haplotypes. Graft survival at 1
year was significantly better for A-receivers compared to TT-receivers (84%
versus 63%, p0.004). Graft loss due to primary dysfunction was observed
more frequently in TT-receivers compared to A-receivers (p0.03). Re-
cipients of a liver with TT genotype had significantly higher serum levels of
alanine aminotransferase and aspartate aminotransferase in the first two
weeks after liver transplantation. HO-1 mRNA in liver biopsies, retrieved at
the end of the cold storage period, was significantly lower in TT genotype
livers compared to the A-allele livers (p0.03). Haplotype association
suggested a greater importance of the A(-413)T SNP over the (GT)n
polymorphism. No differences were found between class S-receivers and LL-
receivers. In conclusion, HO-1 genotype is associated with graft survival after
liver transplantation. This is at least partially explained by a higher rate of
primary dysfunction in TT-genotype livers. The functional relevance of the
A(-413)T SNP was confirmed by differences in HO-1 mRNA expression.
These findings provide additional evidence that the HO-1/CO pathway
mediates graft survival after clinical liver transplantation
PL 1.04
EFFICACY OF HUMAN UMBILICAL CORD-DERIVED MULTI-
POTENT STEM CELL IN LIVER CIRRHOSIS OF RATS AND
HUMAN
Park, Hwon Kyum1; Lee, Kwang Soo2; Lim, Sung Vin3; Han, Hoon4; Han,
Hoon4
1Hanyang University Guri Hospital, Department of Surgery, College of
Medicine, Hanyang University, Guri-Si, Korea, Republic of; 2College of
Medicine, Hanyang University, Department of Surgery, Seoul, Korea,
Republic of; 3College of Medicine, Kyung Hee University; 4Seoul Cord
Bank, Histostem, Seoul, Korea, Republic of
Background. Liver transplantation is the accepted method of treatment for
end stage liver disease. Development of various immunosuppressive drugs
and advances in the surgical techniques have led to the improvement in
patient and graft survival. However, cell-based therapies are emerging as an
alternative to whole-organ transplantation because whole liver transplanta-
tions in human beings far outweighs the supply.
Aims. We want to find out the efficacy of human umbilical cord-blood
derived multipotent stem cells (HUCB MSCs) in the liver cirrhosis of rats
induced with CCl4 and 6 patients.
Methods. We already demonstrated in vitro differentiation of HUCB MSCs
into hepatocyte-like cells. We made the animal model of cirrhosis with CCl4
in Sprague-Dawley rats for 8 weeks. We transplanted HUCB MSCs into the
cirrhotic rats at 8 weeks in amount of one million cells labled with CM-Dil, a
fluorescent lipophilic probe. We had clinical trial of 6 cirrhotic patients, 3
hepatitis B, 1 hepatitis C, 1 biliary cirrhosis and 1 ¥a´1-antitrypsin deficiency.
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We transplanted HUCB MSCs more than one million cells under the
laparoscopy.
Results. HUCB MSCs infusion ameliorated various biochemical markers
related with liver function. In immunohistochemistry, RT-PCR, and Western
blot, fibrosis markers, such as TGF-¥aˆ1, collagen type I, and a-SMA, were
also decreased by HUCB-derived MSCs infusion. Early results of 6 cases of
HUCB MSCs transplantation in Liver Cirrhosis were very promising.
Conclusion. These results suggest that HUCB MSCs infusion could not
only inhibit the fibrosis formation but also halt the progression of CCl4-
induced liver cirrhosis in rats. There has not been any side effect in these
patients. HUCB MSCs transplantation in Liver Cirrhosis is not the only
curative Treatment method at present but can be one of effective Treatment
modalities in patients with acute & chronic liver disease.
PL 1.05
CARBON DIOXIDE ENHANCED VIRTUAL CHOLANGIO-
PANCREATOGRAPHY: THE CLINICAL BENEFITS IN 100 CON-
SECUTIVE PERFORMANCES WITHOUT COMPLICATIONS
Sugimoto, Maki; Yasuda, Hideki; Koda, Keiji; Yamazaki, Masato; Tezuka,
Tohru; Kosugi, Chhiro; Higuchi, Ryota; Yagawa, Yousuke; Suzuki, Masato
Teikyo University Chiba Medical Center, Department of surgery, 3426-3
Anesaki Ichihara Chiba, Japan
Background/Aim. The recent imaging of cholangio-pancreatography has
dramatically advanced, requiring accurate diagnosis and selection of appro-
priate surgical procedures. We evaluate the clinical benefits of our new
technique of carbon dioxide enhanced virtual MDCT cholangio-pancreato-
graphy (CMCP) in surgical strategy for HPB surgery.
Methods. One hundred cases were performed MDCT under trans-papillary
infusion of carbon dioxide, synchronously intravenous contrast material were
applied for virtual angiography, 3-D reconstructions were incorporated using
OsiriX (CMCPA). Feasibility of as an operative virtual navigation for surgical
procedure in HPB surgery was evaluated.
Results/Discussions. One hundred consecutive performances were applied
without any complications including pancreatitis, cholangitis, or hepatic
dysfunction. This procedure enabled to facilitate the detection of multiple
small cystic lesions of the IPMN preoperatively and provided feasible surgical
procedure, to evaluate distal additional segments of the occluded bile duct in
bile duct cancer patient and post stenting patency, and to visualize detailed
gallbladder mucosa without intervention into the gallbladder. Virtual
endoscopy using CMCP revealed excellent endoluminal visualization to
detect stenosis, obstruction, protruding, and cystic lesions. CMCPA enabled
synchronous visualization of HPB and abdominal vessels to provide accurate
information for localizing HPB malignancies with its relationship to the
vessels. It was feasible for planning operation and image-guided navigated
surgery in resection the tumors, dissection lymph nodes, and preserving
organic function.
Conclusions. Our results indicate that CMCPA provided accurate visualiza-
tion of HPB disorder and detailed preoperative reconstruction of HPB
anatomy in safety. Newer software developments may further enhance its
accuracy, so that CMCP might challenge or replace more invasive diagnostic
measures in the near future.
PL 1.06
GLUTATHIONE-PRODUCING PROBIOTICS AMELIORATE OXI-
DATIVE STRESS AND THE SEVERITY OF EXPERIMENTAL
ACUTE PANCREATITIS
Lutgendorff, Femke1; Sandstro¨m, Per A1; Trulsson, Lena1; Timmerman,
Harro M2; van Minnen, Leo P2; Rijkers, Ger T2; Gooszen, Hein G2;
Akkermans, Louis MA2; So¨derholm, Johan D1
1University Hospital Linko¨ping, Surgery, Linko¨ping, Sweden; 2University
Medical Center Utrecht, Surgery, Utrecht, Netherlands
Background. During acute pancreatitis (AP) oxidative stress contributes to
the severity of the disease.
Aim. We tested the effects of multispecies probiotics on oxidative stress and
markers of severity in experimental AP.
Material and Methods. 53 Male Spraque-Dawley rats were randomly
allocated into five groups: 1) controls, non-operated, 2) sham-operated, 3)
AP, 4) APprobiotic mixture of six strains and 5) APplacebo. AP was
induced by intraductal glycodeoxycholate infusion and intravenous cerulein
(6 h). Probiotics or placebo were administered intragastrically on a daily
basis, starting five days prior to induction of AP. After cerulein infusion, ileal
mucosa was collected for permeability measurements in using chambers, and
tight junctions (TJs) were assessed by immunofluorescence. Histological
damage and inflammatory markers were determined in pancreas and liver
samples. In all tissues oxidative status was assessed and intracellular
glutathione contents of the administered probiotic strains were determined.
Results. Probiotics reduced AP-induced increase in ileal permeability to
E.coli K12 and 51Cr-EDTA. Disruption of the TJ proteins occludin and
claudin-1 and upregulation of the pore-forming protein claudin-2 was
prevented by probiotics. Moreover, probiotics ameliorated AP-induced tissue
damage and reduced the activity of IL-1b-converting-enzyme (ICE) and NF-
kB in pancreas and liver. In all tissues, lipid peroxidation was attenuated by
probiotics. The AP-induced decrease in glutathione was prevented in the
probiotics group, and probiotics increased the intestinal, pancreatic and liver
glutathione contents, even compared with sham operated rats. Of the
administered strains B. bifidum, B. infantis and L. acidophilus contained
high levels of glutathione.
Conclusion. Multispecies probiotics reduced AP-induced intestinal barrier
dysfunction and disruption of TJ proteins and decreased the tissue damage
and activation of inflammatory markers in liver and pancreas. These effects
may be mediated by enhancement of intestinal, pancreatic and liver
glutathione content.
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AP 1.01
IMPACT OF TUMOR EXTENT AND LYMPH NODE INVOLVE-
MENT ON SURVIVAL IN GALLBLADDER ADENOCARCINOMA
Zaydfudim, Victor1; Feurer, Irene D.2; Pinson, C. Wright2
1Vanderbilt University Medical Center, Hepatobiliary Surgery and Liver
Transplantation, 801 Oxford House, Nashville, TN, United States; 2Van-
derbilt University Medical Center, Hepatobiliary Surgery and Liver Trans-
plantation, Nashville, TN, United States
Background. Gallbladder adenocarcinoma is an aggressive malignancy with
surgical resection as the primary treatment option. The combination of
tumor extent (T stage) and lymph node involvement (N stage) significantly
impacts survival in patients with gallbladder adenocarcinoma.
Objectives. We investigated whether T stage and N stage are independent
predictors of survival in patients with gallbladder adenocarcinoma.
Methods. We conducted a retrospective, population-based cohort analysis of
the Surveillance Epidemiology and End Results (SEER) database for patients
who underwent surgical resection for gallbladder adenocarcinoma between
1988 and 2004. Kaplan-Meier and Cox proportional hazard regression
methods were used to test univariate effects of demographic and clinical
covariates and develop multivariate models of survival. Summary data are
presented as mean9SD or percentages.
Results. 3824 patients with complete staging data who survived the
immediate perioperative period (age70.9912.5, 26.0% male, 81.2%
Caucasian) were identified. Age, gender, race, radiation treatment, tumor
grade, tumor extent and lymph node status had significant independent
effects on survival (all pB0.05). Overall survival differed by stage
(pB0.001). Patient survival (1- and 5- year rates indicated) was better for:
T1N0  Stage IA (74% & 37%), T2N0  Stage IB (67% & 28%), T1N1 
Stage IIB (60% & 19%), and T2N1  Stage IIB (68% & 21%) disease; than
for: T3N0  Stage IIA (43% & 10%), T3N1  Stage IIB (45% & 7%), Stage
III (24% & 0%) and Stage IV (14% & 0%) disease (all Log-rank pB0.05).
SEER defined extent of surgical resection did not affect survival in the
multivariate model (p0.69), or in patients with T3 disease (all Log-rank
p]0.10).
Conclusions. Presence of T3 and N1 disease confers independent increased
risk of death in patients with gallbladder adenocarcinoma. Survival in
patients with node positive disease is significantly improved if their tumor
does not violate the serosal layer.
AP 1.02
HMOX-1 promoter polymorphism is associated with neuroendocrine
pancreatic carcinomas and correlates with recurrence and poor
outcome
Vashist, Yogesh; Schurr, Paulus; Uzunoglu, Guentac; Bogoevski, Dean;
Mann, Oliver; Gawad, Karim; Liebl, Lena; Izbicki, Jackob R.; Yekebas,
Emre F.
University Clinic Hamburg-Eppendorf, General, Visceral- and Thoracic
Surgery, Hamburg, Germany
There is a paucity of molecular markers to distinguish between benign and
malignant neuroendocrine pancreatic tumors (NEPT) and /or predict out-
come. Heme oxygenase-1 promoter polymorphism has been reported to
correlate with clinicopathological parameters and be associated with outcome
in several malignancies. The polymorphism is characterized by short (B25)
and long (]25) GT repeats in the promoter. The aim of the following study
was to analyze the role of HMOX-1 promoter polymorphism in NEPT.
Tumor, corresponding healthy tissue and also lymph node metastasis DNA of
46 patients that underwent surgical resection of NEPT was analyzed for
HMOX-1 promoter polymorphism by PCR, capillary electrophoresis and
DNA-sequencing. The findings were correlated with clinicopathological
characteristics and outcome. No difference in repeat pattern was found
between tumor, healthy tissue and lymph node DNA. Higher frequency of
short allele carriers was found in carcinoma and poorly-differentiated
carcinoma patients. HMOX-1 polymorphism strongly correlated in the
univariate analysis with sex, tumor grading, tumor recurrence and WHO
classification of NEPT (pB0.05, ANOVA). Furthermore disease-free and
overall survival were also strongly associated with HMOX-1 polymorphism
with short allele carriers having a highly significant shorter disease-free and
overall survival compared to long allele carriers (pB0.005, log rank test).
However in the multivariate analysis HMOX-1 was not identified as an
independent prognostic marker. WHO classification was the only prognostic
independent marker for survival. These findings suggest that the repeat
pattern distinguishes between benign and malignant NEPT. Short repeat of
HMOX-1 gene promoter is associated with higher frequency of carcinomas
6 Abstracts
and strongly correlates with tumor recurrence, disease-free and overall
survival in NEPT patients. Studies with larger number of patients are
required to evaluate the prognostic value of HMOX-1 promoter polymorph-
ism in NEPT.
AP 1.03
THE DONOR RISK INDEX INDEPENDENTLY PREDICTS PRI-
MARY NON-FUNCTION: AN ANALYSIS OF OVER 600 LIVER
TRANPLANTS
Bonney, Glenn K1; Kalyanaraman, Aarti2; Aldersley, Mark A2; Toogood,
Giles J2; Pollard, Stephen G2; Lodge, J Peter A2; Prasad, K Rajendra2
1St James’ University Hospital, Department of Hepatobiliary and Trans-
plantation, Beckett Street, Leeds, United Kingdom; 2St James’ University
Hospital, Department of Hepatobiliary and Transplantation, Leeds, United
Kingdom
Background. Primary non-function remains the most adverse outcome in
liver transplantation. Pretransplant factors that can predict its occurrence
may prove crucial to organ allocation and utilisation. Here we assess donor
and recipient factors that may result in primary non-function.
Methods. A prospectively collected database of 660 liver transplant
recipients at one centre between 19982005 was analysed. The Donor Risk
Index was used to score donor variables and calculated using the published
formula. Recipient variables included age, gender, ethnicity, diagnosis, ABO
incompatibility, intra-operative cardiac arrest, hypotension, hypoxia, chronic
renal failure, ALT on Day 13 and MELD score at transplantation. IPF was
defined as ALT1500 within the first three days of transplantation.
Results. The PNF rate in this cohort was 2.9%. None of the recipient factors
including demographics, MELD at transplantation, ABO incompatibility,
hypotension and chronic renal failure predicted the occurrence of PNF.
Furthermore, the day 1 to 3 ALT as well as the occurrence of IPF was not
associated with PNF. The Donor Risk Index was the only significant
predictor of PNF (pB0.0001).
Conclusion. Donor variables, as evaluated here by the Donor Risk Index
independently predict primary non-function following liver transplantation.
AP 1.04
EFFECT OF S-NITROSO-N-ACETYLCYSTEINE ON ISCHEMIA/
REPERFUSION LESION IN STEATOTIC LIVERS OF RATS
Andraus, Wellington; Haddad, Luciana B P; Coelho, Ana Maria M;
Sampietre, Sandra N; Oliveira, Marcelo G; Machado, Marcel C C; Bachella,
Tele´sforo
University of Sa˜o Paulo School of Medicine, Department of Gastroenterol-
ogy, Sa˜o Paulo, Brazil
Background. Steatosis is the most frequent chronic liver disease in general
population. Steatosis can make ischemia/reperfusion (I/R) lesions worse in
liver transplants and hepatic surgeries. Several antioxidant drugs have been
already used in steatotic and I/R experimental models, and showed better
outcome in treated groups. The S-nitroso-N-acetylcysteine (SNAC) releases
NAC and NO. It ameliorated oxidative stress in experimental models of
steatosis and skeletal muscle I/R. In contrast, this drug has never been used in
steatotic liver I/R.
Objective. Evaluate the effect of SNAC on I/R lesion on steatotic livers of
rats.
Methods. Thirty four male Wistar rats were studied and divided in four
groups: group I (n8)  without steatosis and treated with saline solution;
group II (n8)  without steatosis and treated with SNAC; group III (n9)
 with steatosis and treated with saline solution; group IV (n9)  with
steatosis treated with SNAC. Aproteic diet was used for steatosis induction.
The animals underwent a partial hepatic ischemia (70%) for 1 hour and
reperfusion for 4 hours.
Results. There were no difference between groups I and II in all parameters
evaluated (histology, mithocondrial function (RCR and ADPO), transami-
nasis (AST and ALT), pulmonary Evans blue extravasation and mieloperox-
idasis), and it showed only tendency of less oxidative stress (MDA) (p0.07)
in ischemic liver of treated group (group II). Groups III and IV didn’t show
any difference in transaminasis (AST and ALT), pulmonary Evans blue and
mieloperoxidasis. Group IV (steatosis and SNAC) showed in the ischemic
liver lower intraparenchymatous hemorrhage (p0.02), better mitochondrial
function (RCR (p0.01) and ADPO (p0.01)), and less oxidative stress
MDA (p0.007) when compared with untreated group (group III).
Conclusions. SNAC treatment shows no benefit in non steatotic I/R lesion,
however, in steatotic rats, SNAC ameliorates hepatic lesions post I/R.
AP 1.05
SINUSOIDAL SHEAR STRESS IS NOT A SUFFICIENT STIMULUS
FOR LIVER GROWTH
Mortensen, Kim Erlend1; Conley, Lene2; Bendixen, Christian2; Sorensen,
Peter2; Nygaard, Ingvild1; Revhaug, Arthur1
1University Hospital of Northern Norway, Gastrointestinal Surgery, Tromsø,
Norway; 2Research Centre Foulum, University of Aarhus, Department of
Genetics and Biotechnology, Aarhus, Denmark
Background. Increased sinusoidal flow and shear stress following partial
hepatectomy has been suggested to be a primary stimulus in triggering liver
regeneration. Shear stress results in the production of Nitric Oxide (NO) and
liver regeneration is inhibited by administration of NO synthase antagonists
and restored by NO donors. Portal vein branch ligation results in atrophy of
the segments supplied by the ligated vein and compensatory hyperplasia
within the residual segments. The same hemodynamic condition is created
upon hepatectomy. We hypothesized that it is the increased sinusoidal flow
per se and hence shear-stress stimulus on the endothelial surface within the
liver remnant which is the main stimulus to regeneration/hyperplasia.
Aims. To study the acute and chronic effects of selective regional portal
hyperperfusion.
Methods. Segments II, III and IV in pigs were hyperperfused by creating an
aortoportal shunt to the left portal vein resulting in a four fold increase in flow
to these segments. The impact of this manipulation was studied in an acute
model (6 animals, 9 hours) with a global porcine cDNA microarray chip and
in a chronic model (8 animals, 3 weeks).
Results. Gene expression profiling does not suggest that hyperperfusion per
se results in activation of known cell cycle genes. Chronic regional
hyperperfusion over three weeks results in the whole liver gaining a
supranormal weight of 3.6% of the total body weight (versus the normal
2,5%). Contrary to our hypothesis, the weight gain was observed on the non-
shunted side, an observation corroborated by histological examination
showing dilated lobuli.
Conclusion. Increased sinusoidal flow of isolated liver segments does not
result in the activation of cell cycle genes controlling liver regeneration nor
does it result in hyperplasia over time.
AP 1.06
ANATOMICAL VARIATIONS IN ARTERIAL SUPPLY TO SEG-
MENT IV OF THE LIVER: AN ANALYSIS OF 116 POTENTIAL
LIVER DONORS BY CT ANGIOGRAPHY
Nagpal, Anish; Kumaran, Vinay; Kakodkar, Rahul; Nundy, Samiran; Soin,
Arvinder
Sir Gangaram Hospital, Surgical Gastroenterology & Liver Transplantation,
Delhi, India
Background. Preservation of segment IV arterial supply is essential to
ensure adequate remnant and its regeneration after right hepatectomy for
tumors and transplantation. This may also be vital to prevent cut surface and
bile duct stump leaks. Conventionally, segment IV receives its supply from
left hepatic artery (LHA) but variations are common which may occasionally
result in rejection of prospective donors or postoperative complications if
ignored. There is paucity of data regarding these variations.
Aim. To study the arterial supply of segment IV in 116 consecutive potential
liver donors who were evaluated by CT angiography.
Methods. Of 116 donors tested, 12 were excluded due to aberrations in
venous or biliary anatomy. Segment IV arterial supply was assessed in the
remaining 104 in relation to its origin, distance of its origin from the proper
hepatic artery (PHA) and in case of right hepatic origin, the availability of
right hepatic artery (RHA) length for anastomosis in right lobe grafts.
Results. Of 104 potential donors, segment IV arterial supply was predomi-
nantly from LHA in 74, RHA in 21, both in 4, PHA in 3, anterior RHA in 1,
and superior mesenteric artery in 1. In cases with RHA origin, mean length of
RHA proximal to it was 10.1 mm (range 225 mm). The distal length of
RHA was less than 10 mm in 2 (0.5, 4.1 mm) and more in the remaining 19.
The patient with anterior RHA origin and the one with 0.5 mm distal stump
of RHA were excluded from right lobe donation. Two with segment IV artery
separate from the LHA were excluded from left lobe donation. The
remaining 100 donors uneventfully donated their right or left lobe.
Conclusion. Segment 4 artery has an anomalous origin in 30% cases that
may result in exclusion of 4% of potential liver donors. In those arising close
to bifurcation of the RHA, care must be taken to preserve both the segment
IV artery and the RHA trunk for anastomosis. This study provides the first
detailed insight into anatomical variations of the segment IV hepatic artery.
AP 2.01
LIVER TRANSPLANTATION FROM DONATION AFTER CAR-
DIAC DEATH: A WAY TO INCREASE THE DONOR POOL
Nezakatgoo, Nosratollah1; Rai, Rakesh1; Vera, Santiago1; Vanatta, Jayson1;
Hubbard, Lynn2; Gilly, Kim3; Eason, James1
1Methodist University hospital, Transplant surgery, Memphis, United States;
2Transplant Institute, Memphis, United States; 3Midsouth Transplant
foundation, Memphis, United States
Background. The disparity between the waiting list and available donors has
contributed to the mortality of patients on the waiting list. There has been
reluctance to use donation after cardiac death (DCD) grafts because of
concern over viability of these grafts.
Aim. To evaluate our experience of liver transplantation using DCD livers
and to maximize the donor pool by using more than 10% of DCD grafts.
Methods. From September 1, 2006 to August 31, 2007 100 liver transplants
were performed in our center. Twelve transplants were performed using
DCD livers. All patients received steroid free immunosuppression. Review of
donor and recipient characteristics and results of transplantation were
evaluated.
Results. Donor age varied from 15 to 51 (mean 36.4 years). Eight were
males 4 females. Cause of brain injury included 10 head injuries, 1
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cerebrovascular accident and 1 drug overdose. Total warm ischaemic time in
donors varied from 6 to 27 minutes (mean 14.6 minutes). Cannulation time
was 1 to 2 minutes in 11 patients, 6 minutes in 1 patient procured by another
team. Recipients were 40 to 73 (mean 57.25 years). Ten males and 2 females.
Etiology of liver disease was Hepatitis C (HCV) (6), HCV & alcoholic liver
disease (ALD) (1), HCV and hepatocellular cancer (HCC) (1), ALD (1),
Nonalcoholic steatohepatitis (1), biliary cyst (1) and primary sclerosing
cholangitis (1). Anastomotic time ranged 27 to 68 (mean 37.41 minutes).
Cold ischaemic time 2 hrs 30 minutes to 8 hours (mean 5 hrs 26 minutes).
Model for end-stage liver disease (MELD) score of recipients were 1422
(mean 16). One patient developed biliary stricture at 3 months following
transplant and was treated by endoscopic stent insertion and 1 patient died
within 30 days of transplantation. Hospital stay varied from 6 days to 58 days
with mean of 12.83 days. Three months actuarial survival was 91%.
Conclusion. DCD can be an excellent source of liver grafts with above
average graft and patient survival and low morbidity. They can contribute to
more than 10% of liver grafts.
AP 2.02
IS HEPATIC RESECTION JUSTIFIED IN PATIENTS WITH
COLORECTAL LIVER METASTASES AND LYMPH NODE
INVOLVEMENT?
de Haas, Robbert J; Wicherts, Dennis A; Aloia, Thomas; Delvart, Vale´rie;
Azoulay, Daniel; Castaing, Denis; Bismuth, Henri; Adam, Rene´
Hoˆpital Paul Brousse, Centre He´pato-Biliaire, Villejuif, France
Background. For patients with colorectal liver metastases (CLM), lymph
node (LN) involvement is one of the worst prognostic factors. However, only
small patient series are described, which renders the role of surgery in these
patients highly controversial. Furthermore, increasingly effective chemother-
apy may have changed the spectrum of this metastatic disease.
Aim. To define the role of surgical treatment in patients with CLM and LN
involvement treated by preoperative chemotherapy.
Methods. All consecutive patients resected at our institution for CLM and
simultaneous LN involvement were included in the study. If LN involvement
was diagnosed prior to hepatic resection, lymphadenectomy was only
performed if LN disease responded to or was stabilized by chemotherapy.
When diagnosed intraoperatively, surgery only proceeded when resection of
both LN disease and CLM could be complete. Overall survival (OS) and
disease-free survival (DFS) were calculated and prognostic factors were
identified.
Results. Of the 775 patients resected for CLM between June 1992 and July
2006, 47 (6%), all treated by preoperative chemotherapy, were simulta-
neously resected for LN involvement. Five-year OS for patients with and
without LN involvement were 18% and 53%, respectively (PB0.001). Five-
year DFS were 11% and 23%, respectively (P0.004). Localization of
metastatic LN strongly influenced survival, with an OS at 5 years of 25% for
pedicular, 0% for celiac, and 0% for para-aortic LN (P0.001). Multivariate
analysis identified 2 independent poor prognostic factors: celiac LN involve-
ment and age at surgery ] 40 years.
Conclusion. Liver resection combined to lymphadenectomy is justified
when lymph node metastases respond to or are stabilized by preoperative
chemotherapy and involve pedicular sites, especially in young patients. By
contrast, this approach could not be recommended to patients with celiac
and/or para-aortic LN involvement, even when responding to preoperative
chemotherapy.
AP 2.03
LASER THERMOTHERAPY OF RAT LIVER CARCINOMA IN-
CREASES ANTI-TUMOUR LYMPHOCYTE REPONSIVENESS
IN TUMOUR-DRAINING AND SYSTEMIC LYMPH NODES AND
IN SPLEEN
Tranberg, Karl-Go¨ran1; Ivarsson, Kjell1; Sjo¨gren, Hans Olov2; Stenram,
Unne3
1Lund University Hospital, Department of Surgery, Lund, Sweden; 2Lund
University, Department of Cellular and Molecular Biology, Lund, Sweden;
3Lund University, Department of Pathology, Lund, Sweden
Introduction. We have shown that interstitial laser thermotherapy (ILT)
induces an immunologic anti-tumour effect, but the mechanisms are unclear.
Aim. The aim of this study was to investigate ILT-induced effects on the
anti-tumour proliferative responsiveness and the cytokine profile of lympho-
cytes in lymph nodes and spleen.
Methods. A dimethylhydrazine-induced adenocarcinoma (H1D2) was
implanted into the liver of syngeneic rats. Intraperitoneal injection of
irradiated, IL-18 transfected H1D2 tumour cells was performed 7 days later.
Rats were allocated to treatment with ILT or sham ILTresection of the
tumour-bearing lobe, 9 days after tumour implantation. Spleen and lymph
node anti-tumour lymphocyte proliferation and cytokine production in
response to wild-type and IL-18 transfected tumour stimulator cells was
studied 11, 30 and 50 days after treatment.
Results. ILT increased the proliferative lymphocyte response in tumour-
draining lymph nodes at 1150 days after treatment, as compared to sham
ILTresection. The proliferative lymphocyte response was increased also in
systemic lymph nodes and spleen 3050 days after ILT. Following ILT,
tumour stimulation increased the release of IFN-g and IL-10 from
lymphocytes in tumour-draining lymph nodes and lowered the release of
IL-10 from lymphocytes in the spleen. There were no differences in the
lymphocyte release of IL-12 or TGF-b between ILT and sham ILT
resection. Results were similar after stimulation with wild-type and IL-18
transfected H1D2 tumour.
Conclusions. Laser thermotherapy induced an anti-tumour lymphocyte
proliferative response that started in tumour-draining lymph nodes and
subsequently developed in other lymph nodes and in the spleen. The main
effects on lymphocyte cytokine production were an increased release of IFN-
g and IL-10 from tumour-draining lymph nodes and a decreased splenic
release of IL-10.
AP 2.04
D-DIMER CAN PREDICT DEVELOPMENT OF ORGAN FAILURE
IN ACUTE PANCREATITIS
Radenkovic, Dejan; Bajec, Djordje; Ivancevic, Nenad; Jeremic, Vasilije;
Gregoric, Pavle; Djukic, Vladimir; Stefanovic, Branislav
Clinical Center of Serbia and School of Medicine, University of Belgrade,
Serbia., Belgrade, Serbia and Montenegro
Background. Despite the fact that increasing experimental evidence
suggests an important role of the coagulation system in acute pancreatitis
(AP), meaningful studies on the clinical value of parameters of the
coagulation system in predicting pancreatitis-associated complications are
still scarce.
Aim. We aimed to address this issue in a clinically and morphologically well
defined series of patients with AP.
Methods. In this prospective study 91 consecutive patients with AP were
included. In all patients coagulation, anticoagulation and fibrinolysis para-
meters: prothrombin time, activated partial thromboplastin time, fibrinogen,
antithrombin III, protein C, plasminogen activator inhibitor-1, D-dimer, and
plasminogen were measured in plasma within the first 24 hours of admission
and 24 hours thereafter. Two study groups comprising 24 patients with organ
failure (OF) and 67 patients without organ failure (NOF) were compared.
Results. On admission, the mean d-dimer concentration was 903.5 ı`g/l
(sd.174.5) for OF group and 220 ı`g/l (sd. 80.5) for NOF group (pB0,001).
On first day after admission respective values were 317.00 ı`g/l (sd. 269.25)
and 1139.50 ı`g/l (sd. 672.75), pB0,001. The sensitivity, specificity, positive
predictive, and negative predictive values of the test to predict development of
OF on admission (cut off 414.00 ı`g/l), were 90%, 89%, 75%, and 96%
respectively, and 24 h after admission (cut off 525.50 ı`g/l), were 90%, 81%,
62%, and 95%. The levels of all other measured parameters were significantly
different between the compared groups, but all values were within physio-
logical limits.
Conclusion. Prediction of development of OF is already possible on patients
admission to the hospital with very high sensitivity and specificity. D-dimer as
single test parameter significantly contributes to an improved stratification of
patients at risk to develop most serious complications during the course of AP
and deserves routine clinical application.
AP 2.05
ADDITIONAL RESECTION OF MARGIN-POSITIVE PROXIMAL
BILE DUCT DOES NOT IMPROVE SURVIVAL IN PATIENTS
WITH HILAR CHOLANGIOCARCINOMA.
Shingu, Yuji; Koji, Oda; Hideki, Nishio; Tomoki, Ebata; Yukihiro, Yo-
koyama; Tetsuya, Abe; Tsuyoshi, Igami; Masato, Nagino
Nagoya University Graduate School of Medicine, Division of Surgical
Oncology, Dept. of Surgery, Nagoya, Japan
Background. The aim of the present study was to elucidate whether
additional resection of margin-positive proximal bile duct can improve
survival.
Methods. From January, 1977 to December, 2005, 291 patients with hilar
cholangiocarcinoma underwent surgical resection with curative intent.
Excluding 25 patients who died in hospital, the remaining 266 patients
formed a cohort of this study. Surgical procedure performed comprised of
hepatobiliary resection in 258 patients and bile duct resection in 8 patients.
The proximal ductal margin status was classified into three: negative, positive
with carcinoma in situ (CIS), or positive with invasive carcinoma.
Result. Five-year survival rate of 240 patients with negative margin
and 26 patients with positive margin (CIS: n10, and invasive: n16)
was 38% and 16%, respectively (p0.060). When the 26 patients were
divided into CIS or invasive, the 2-year survival rate was 67% and 63%,
respectively (p0.144). Among 108 patients whose proximal ductal margins
were intraoperatively assessed with frozen section examination, positive
margin was present in 21 patients, 13 of whom (61.9%) were positive with
invasive carcinoma. After additional resection of the intrahepatic bile duct, 6
of the 13 patients achieved negative margin. There was not significantly
different between the survival of the 6 patients whose ductal margin status
became negative by additional resection and that of 16 patients whose ductal
margin was positive with invasive carcinoma (p0.798), with 2-year
survival rate of 67% and 63%, respectively. Multivariate Cox proportional
hazard model identified histologic type and nodal status as independent
predictors.
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Conclusion. The proximal ductal margin status was not a prognostic factor
in patients with hilar cholangiocarcinoma. Even when involved ductal margin
was cleaned with additional resection, long-term survival was not improved.
Our results may lead that routine use of frozen section examination is not
necessary for confirmation of the ductal margin status.
AP 2.06
RESPONSE OF THE DIMERIC FORM OF M2-PYRUVATE KI-
NASE TO ALTERED MICROENVIRONMENT IN PANCREATIC
CANCER CELLS.
Kumar, Yogesh1; Yang, Shiyu2; Fuller, Barry3; Davidson, Brian1
1Royal Free and University College Medical School, HPB and Liver
Transplant Surgery, London, United Kingdom; 2Royal Free and University
College Medical School, Department of Surgery, London, United Kingdom;
3Royal Free and University College Medical School, Academic Department
of Surgery, London, United Kingdom
Background. Hypoxic and nutritionally deprived areas are thought to confer
pancreatic cancer cells resistance to apoptosis. Tumour M2-pyruvate kinase,
a tumour associated isoenzyme of pyruvate kinase, is elevated in patients with
pancreatic cancer.
Aim. This study aimed to observe the effect of altered tumor microenviron-
ment on levels of tumor M2-pyruvate kinase in relation to resistance of
pancreatic cancer cell lines to apoptosis.
Materials and Methods. The dimeric form of M2-pyruvate kinase was
measured in cell homogenate supernatant of Panc 1 (ductal cancer origin)
and Colo357 (metastatic lymph node origin) human pancreatic cancer cell
lines, exposed to acidic pH (6.5), hypoxic (1% O2) and glucose deprived
culture conditions for 24, 48, 72 and 96 hrs, using sandwich type ELISA
(ScheBo† Tumour M2-PKTM) based on monoclonal antibodies specific for
it. Total M2-pyruvate kinase protein expression was measured semiquanta-
tively by western blotting. Apoptosis in these conditions was measured by
FITC Annexin V and Propium Iodide FACS analysis and Active Caspase 3
and 8 assay.
Results. Tumor M2-PK level was significantly enhanced in Colo357 cells
(pB0.05) at acidic pH compared to normal, hypoxic or glucose deprived
culture condition without any change in total M2-PK protein expression. No
significant difference was seen between normal and altered microenviron-
ment condition in terms of cell viability and apoptosis in both cell lines.
Conclusion. High levels of tumor M2-pyruvate kinase levels in metastatic
cancer cell lines exposed to acidic environment may indicate a survival
strategy of cancer cells in altered tumor microenvironment.
AP 2.07
RENIN ANGIOTENSIN SYSTEM AND COLORECTAL LIVER
METASTASES
Neo, Jaclyn H1; Zhu, Jin1; Herath, Chandana2; Muralidharan, Vijayaraga-
van1; Angus, Peter W2; Christophi, Christopher1
1Austin Health, University of Melbourne, Surgery, Heidelberg, Australia;
2Austin Health, University of Melbourne, Medicine, Heidelberg, Australia
Background. The Renin Angiotensin System (RAS) appears to be an
important mediator of tumour growth and metastasis in several malignancies.
Pharmacological blockade of this system may, therefore, provide an
alternative strategy in the management of liver metastases.
Aims. This study established the expression of components of the RAS in
CRC liver metastases and after RAS blockade.
Methods. CRC liver metastasis was induced in male inbred mice by
intrasplenic injection of murine colon cancer cells. Animals were killed at
5, 10, 16 and 21 days after tumour induction (spanning lag, exponential and
plateau phases of tumour growth). The expression and cellular localisation of
components of the RAS in normal and tumour-induced liver were assessed by
quantitative RT-PCR and immunohistochemistry. The effects of blockade of
the RAS on expression were also examined.
Results. Components of the RAS were expressed in normal liver, tumour-
induced normal liver, and in tumours and the angiotensin converting enzyme
(ACE) protein localised to the hepatic endothelial cells. ACE expression
significantly increased at day 16 (pB0.003) and Mas receptor
expression increased at days 16 and 21 (p0.01 and p0.03, respectively)
in tumours compared to normal liver from sham operated animals. However,
expression of angiotensinogen was significantly lower in tumours (p0.01)
compared to shams. Captopril, an ACE inhibitor, decreased ACE2 expres-
sion in tumours at day 16 compared to shams (p0.0294), while ACE
expression increased in Captopril treated tumours at day 21 compared to
shams (p0.0001).
Conclusion. These results provide important and novel information
regarding the expression and localisation of key components of the RAS in
CRC liver metastases. Elucidation of the role of the hepatic RAS in the
development of liver metastases may have implications for the treatment of
patients with unresectable liver metastases and may potentially provide a
novel therapeutic strategy to be used alone or as an adjuvant with other
conventional therapies.
AP 2.08
MODIFIED ENDOCYSTECTOMY VERSUS PERICYSTECTOMY
IN ECHINOCOCCUS GRANULOSUS LIVER CYSTS: A RANDO-
MIZED CONTROLLED STUDY
Elsebae, Magdy1; Elsebaie, Sameh1; Esmat, Emad1; Nasr, Maged1; Kamel,
Manal2
1Theodor Bilharz Medical Research Institute, General Surgery, Cairo, Egypt;
2Theodor Bilharz Medical Research Institute, Immunology, Cairo, Egypt
The evidence based data of hydatid liver disease indicate that the level of
evidence was too low to help decide between radical or conservative surgeries.
So, there is a need for accurately designed randomized trials with precise
goals to compare pericystectomy versus a specific modified endocystectomy
technique for the treatment of hepatic hydatid cysts 8 cm or less in diameter
in Egyptian patients, regarding the operative time, intra-operative blood loss,
complications and long-term recurrence 60 patients with 131 liver cysts of E.
granulosus fulfilling the study criteria were randomly divided to two groups.
GI: 32 patients with 69 cysts treated by modified endocystectomy and GII:
28 patients with 62 cysts treated by closed total pericystectomy. Preoperative
evaluation included history taking, clinical examination, blood tests, specific
anti-hydatid IgG4, abdominal sonography and CT scan. The operative time
for dealing with each cyst was in minutes. Operative blood loss and need for
blood transfusion were estimated for each patient. Specific anti-hydatid IgG4
by ELISA was used to diagnose and to detect early recurrence. Patients were
followed up clinically and by ultrasonography every 3 months and for anti-
hydatid IgG4 every 6 months for 2490 months. The mean maximum
operative time was in GIIa followed by GIa, GIb, then GIIb. The operative
time was significantly lower in GIIb than Ib and in GIa than IIa. Seven
patients (GII) had blood transfusion. The intraoperative bleeding in GI was
B500 ml/patient, and 18 patients (GII) each bled 500 ml. No intraper-
itoneal seedling during the follow up. 5 of 55 patients (9%) were serologically
suspected of relapse or incomplete cure. One (GII) showed early recurrence
at 3 months. High IgG4 antibodies were detected in patients which decreased
gradually after surgery and normal after 18 months post-operation.
AP 2.09
LONG TERM SURVIVAL AND DISEASE RECURRENCE AFTER
PREOPERATIVE PORTAL VEIN EMBOLISATION PRIOR TO
MAJOR HEPATECTOMY FOR COLORECTAL CANCER LIVER
METASTESE
Pamecha, Viniyendra1; Glantzounis, George1; Biswas, Atin1; Fusai, Kitu1;
Sharma, Dinesh1; Davies, Niel2; Davidson, Brian1
1Royal Free Hospital, University College Medical School, Hpb and Liver
Transplantation; 2Royal Free Hospital, University College Medical School,
Department of Radiology, LONDON, United Kingdom
Background. Portal vein embolisation (PVE) can be used to increase the
remnant liver parenchyma volume before major hepatectomy. Embolisation is
known to influence tumour growth yet few studies have addressed the disease
progression, recurrence and long term survival in patients with PVE before
major resection for colorectal cancer liver metastases.
Objective. To assess the effect of preoperative PVE on disease progression,
recurrence and long term survival in patients undergoing major resection for
colorectal cancer liver metastases.
Methods. Thirty six patients underwent preoperative PVE before resection
of four or more liver segments. PVE was performed when the future liver
remnant (FLR) assessed by MRI scan volumetry was less than 30%. Disease
free and overall survival was compared with a control group of patients
undergoing major resection (four or more segments) for CRC metastases
without PVE.
Results. PVE was successful in all patients. PVE significantly increased the
FLR volume (pre PVE 295 mls, post PVE 404 mls pB0.0001). Liver
resection was performed after PVE in 22 patients (61%), twelve patients
(33%) developed disease progression. The 5 year actual survival after liver
resection with PVE was 25% with a median follow up of 46 months. The 5
year survival after liver resection of the control group was 50%. The 5 year
disease free survival was 30% post PVE (median 12 months) and 50%
without PVE (median 22 months).
Conclusion. PVE allows patients with previously unresectable liver metas-
tases to benefit from resection. A significant proportion of patients have
disease progression post PVE. Actual long term and disease free survival is
inferior to when compared with patients requiring major resection without
PVE.
AP 2.10
THE ROLE OF NEO-ADJUVANT CHEMOTHERAPY FOR COL-
ORECTAL LIVER METASTASES: A CASE CONTROLLED STUDY
Malik, Hassan; Shahid, Farid; Al-Mukhtar, Ahmed; Toogood, Giles; Lodge,
Peter; Prasad, Raj
St James University Hospital, Leeds, United Kingdom
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Background. The aim of this study was to analyse the outcome of patients
that received neo-adjuvant chemotherapy prior to resection for colorectal
liver metastases (CRLM) and compare them with a matched cohort of
patients that underwent resection followed by adjuvant chemotherapy.
Methods. 687 patients have undergone curative resection between January
1993 and January 2006. In this period, 84 patients received neo-adjuvant
chemotherapy and 71 of this group went on to resection. A control group was
chosen, matched with these patients, made up of patients who underwent
resection followed by adjuvant chemotherapy.
Results. There was no difference in clinico-pathological features between the
neo-adjuvant and the control group. However patients in the control group
had more extended resections and had longer hospital stays compared to
those in the neo-adjuvant group, p0.015. Patients in the control group had
an increased incidence of ‘‘early’’ recurrences, pB0.001. Despite this, there
was no significant difference in either the cancer-specific or the disease-free
survival between the two groups of patients.
Conclusion. Neo-adjuvant chemotherapy has a role in the management of
patients with disease that is considered initially unresectable as a ‘‘down
sizing’’ technique. In patients with resectable disease, a ‘‘test of time’’ that
neo-adjuvant therapy offers is yet to be proven.
AP 3.01
HYPERBARIC OXYGEN THERAPY AND ISCHAEMIA PRESER-
VATION AND REPERFUSION INJURY IN LIVER TRANSPLANTA-
TION
Tran, Nhut Quang; Christophi, Christopher; Muralidharan, Vijayaragavan
Austin Health, The University of Melbourne, Surgery, Heidelberg, Australia
Background. Ischaemia, preservation and reperfusion injury (IPRI) is a
major cause for suboptimal donor organ function after liver transplantation.
Accumulating evidence suggests that hyperbaric oxygen therapy (HBO) may
improve IPRI. This study investigates the effect of HBO on a rat model of
liver transplantation.
Methods. Syngeneic liver transplantation was performed on male inbred
Lewis rats. Donor organs were stored for 24 hours at 48C for severe IPRI.
HBO was administered twice daily. The animals were killed and the livers
were removed at 48 hours after transplantation. Effect of HBO on IPRI was
assessed by quantification of hepatocyte necrosis, apoptosis and proliferation.
Techniques used include histopathology, quantitative stereology and immu-
nohistochemistry.
Results. After 48 hours of treatment, HBO therapy significantly reduced
hepatic necrosis in the median (0.7690.54% vs. 5.8791.62%, PB0.001)
and right liver lobes (2.190.92% vs. 6.0791.55%, PB0.001) and neared
significance (4.5991.5% vs. 9.4692.56%, P0.07) in the left lobe when
compared to controls. Concurrently, HBO therapy reduced apoptosis in all
liver lobes; including the left (1.3290.16% vs. 2.7890.37%, PB0.001),
median (1.0290.12% vs. 2.1390.31, PB0.05) and right liver lobes (0.749
0.11% vs. 2.0490.212%, PB0.05). By day seven, recovery was near
complete with minimal necrosis or apoptosis in both treatment and control
groups. HBO therapy stimulated early hepatocyte proliferation in all lobes
(the median: 19.6791.18% vs. 11.391.13%, pB0.0001, left: 16.5191.55%
vs. 4.94%90.51%, PB0.001 and the right: 19.3191.55% vs. 9.7590.81%,
PB0.05).
Conclusion. The application HBO therapy post transplantation significantly
reduces IPRI induced necrosis and apoptosis while stimulating increased
proliferation of hepatocytes leading to faster recovery.
AP 3.02
EFFECT OF PREOPERATIVE PORTAL VEIN EMBOLISATION
ON TUMOUR MORPHOLOGY OF COLORECTAL CANCER
LIVER METASTASES
Pamecha, Viniyendra1; Levene, Adam2; Woodward, Nick3; Dhillon, Amar-
pal2; Davidson, Brian4
1Royal Free Hospital, University College Medical School, Hpb and Liver
Transplantation, Pond Street, Hampstead, London, United Kingdom;
2Royal Free Hospital, University College Medical School, Department of
Histopathology, London, United Kingdom; 3Royal Free Hospital, University
College Medical School, Department of Radiology, London, United King-
dom; 4Royal Free Hospital, University College Medical School, Hpb and
Liver Transplantation, London, United Kingdom
Background. Portal vein embolisation (PVE) has now become an estab-
lished technique to increase remnant liver volume prior to major liver
resection for colorectal metastases. The resection rate after PVE in the
published series is 6070%. This is mainly influenced by disease progression
following PVE. The effect of PVE on tumour morphology has not been
previously been investigated.
Objective. To compare the morphology of resected colorectal liver metas-
tases in patients who had undergone pre-operative PVE with matched
controls who had not undergone PVE.
Methods. Tumour growth rate was calculated by change in tumour volume
from the time of diagnosis (CT/MRI volumetric assessment) to volume at the
time of resection in 20 patients undergone PVE and compared with 20
matched controls (non PVE). Resected histological specimens were exam-
ined for cell differentiation; percentage of necrosis, mitotic rate. Immuno-
chemical staining with Ki-67 was performed using the MIB-1 monoclonal
antibody and quantified using a Glasgow cell counting graticule. The number
of tumour cells was counted in the ten bold squares over 10 fields.
Results. The groups were comparable in demographics, stage of primary
disease, adjuvant chemotherapy and volume of liver metastases. The tumour
growth rate was rapid in PVE group compared with controls (control 
0.010¡O´0.46, PVE-1.6¡O´0.85, p0.084). In the resected specimen there was
no significant difference in the resection margins (control-20.2¡O´3.7, PVE-
14.7¡O´4.25, p0.3382), tumour volume (control-229¡O´6.8, PVE-
99.4¡O´50.4, p0.1365), degree of differentiation, cell necrosis (control-
39.50¡O´4.9, PVE-46¡O´5.6, p0.390) and mitotic index (controls-
10.50¡O´1.07, PVE-12.0¡O´1.14, p0.346). The proliferation index
Ki67 was significantly higher post PVE (control-27 b10%, PVE 37,
b17%, pB0.05).
Conclusion. PVE causes increase in tumour growth and cancer cell
proliferation.
AP 3.03
MODE OF HEPATIC SPREAD FROM CARCINOMA OF THE
GALLBLADDER
Wakai, Toshifumi1; Shirai, Yoshio1; Sakata, Jun1; Korita, Pavel1; Ajioka,
Yoichi2; Hatakeyama, Katsuyoshi1
1Niigata University Graduate School of Medical and Dental Sciences,
Division of Digestive and General Surgery, Niigata City, Japan; 2Niigata
University Graduate School of Medical and Dental Sciences, Division of
Molecular and Diagnostic Pathology, Niigata City, Japan
Background. The aims of this study were to analyze the mode of hepatic
spread from gallbladder carcinoma and to elucidate its prognostic value.
Methods. Of 162 consecutive patients undergoing radical cholecystectomy
for gallbladder carcinoma, 40 had hepatic involvement. The mode of hepatic
metastasis was examined grossly and histologically in the resected specimens.
Intrahepatic lymphatic invasion was declared when either single tumor cells
or cell clusters were clearly visible within vessels that showed immunor-
eactivity for D240 monoclonal antibody. The median follow-up time was
172 months.
Results. Twenty-four patients had evidence of microscopic angiolymphatic
portal tract invasion, in whom 16 had intrahepatic lymphatic invasion and 2
had venous invasion. Nine had distant hepatic metastatic nodules and 7 had
direct invasion alone. The gross depth of direct invasion of the liver showed a
linear correlation with the distance of angiolymphatic spread by simple linear
regression analysis (correlation coefficient [r]0.52361; P0.0086; for-
mula, y1.9720.137x). The mode of hepatic spread (PB0.001) and
residual tumor status (PB0.001) were independent prognostic factors. The
type of hepatectomy procedure (nonanatomic vs. anatomic) did not influence
survival after resection (P0.9033). All 9 patients who had tumors with
distant hepatic metastatic nodules expired within 11 months of undergoing
surgical resection.
Conclusions. Angiolymphatic invasion within the portal tracts is the main
mode of hepatic spread from gallbladder carcinoma. The correlation between
the extent of angiolymphatic invasion and the gross depth of direct invasion
may be useful for estimating adequate hepatectomy margins.
AP 3.04
HIGH AFFINITY PEPTIDES MODULATE CHEMOTHERAPY IN-
DUCED DRUG-RESISTANCE IN PANCREATIC CANCER
Hoffmann, Katrin; Schmidt, Jan; Buechler, Markus W; Maerten, Angela
Ruprecht-Karls-University of Heidelberg, Department of General Surgery,
Heidelberg, Germany
Background. Pancreatic cancer is highly resistant to chemotherapy.
Decreased survival rates are associated with acquired over-expression and
increased activity of drug extruding resistance proteins. The high affinity
peptide R121 modulates the activity of drug-resistance proteins and restores
the up-take of cytotoxic agents in cancer cells. An interaction of high affinity
peptides and drug-resistance proteins in pancreatic cancer has not yet been
investigated.
Methods R121 was tested in an orthotopic ultrasound guided pancreatic
cancer mouse model. Animals were either treated with monotherapy of 5-
Fluorouracil, cisplatin and gemcitabine or combination of these agents with
R121. The drug-resistance proteins P-Glycoprotein, MRP1 and MRP3 were
quantified by multicolor flowcytometry and protein function was evaluated in
vitro and in vivo.
Results Chemotherapy significantly up-regulated the expression of drug-
resistance proteins in vitro and in vivo. The cellular drug efflux activity
increased significantly compared to the untreated control. Combinative
treatment with 5-Fluorouracil or gemcitabine plus R121 significantly
down-regulated P-Glycoprotein, MRP1 and MRP3 expression. The protein
activity decreased significantly. Tumor size and prevalence of liver and lung
metastases were significantly reduced by combination therapy.
Conclusion. Acquired multi-drug resistance is inducible by standard
chemotherapy in pancreatic cancer. The high affinity peptide R121 inhibits
the activity of multi-drug resistance proteins and restores the chemosensitiv-
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ity. The improved outcome after combinative therapy implicates a potential
role of R121 as chemosensitizer.
AP 3.05
PROPHYLACTIC ANTIBIOTICS ARE NOT USEFUL IN PRE-
VENTING INFECTION IN SEVERE PANCREATITIS WITH PAN-
CREATIC NECROSIS. SINGLE CENTER, DOUBLE BLIND
STUDY
Borobia, Francisco G.1; Garcia Barrasa, Arantxa1; Jorba, Rosa2; Busquets,
Juli2; Ramos, Emilio2; Torras, Jaume2; Llado, Laura2; Rafecas, Antonio2;
Poves, Ignasi3; Fabregat, Joan2
1Hospital Universitari de Bellvitge, General Surgery, L’Hospitalet de
Llobregat. Barcelona, Spain; 2Hospital Universitari de Bellvitge, Hepatobili-
ary and pancreatic surgery, L’Hospitalet de Llobregat. Barcelona, Spain;
3Hospital del Mar, Hepatobiliary and pancreatic surgery, L’Hospitalet de
Llobregat. Barcelona, Spain
Use of prophylactic antibiotics in acute severe necrotizing pancreatitis is
controversial, and only two previous studies with double blind design had
been published.
Methods. This is a prospective, randomized, placebo-controlled, double
blind study carried out at one tertiary European Hospital during 5 years.
Among 798 patients with acute pancreatitis, 229 were diagnosed of severe
acute pancreatitis, and 80 of them had evidence of necrotizing pancreatitis
(34 of the 80 patients were not included in the randomization protocol
because of previously establish reasons). Then, 46 patients without previous
antibiotic treatment and with pancreatic necrosis in a contrast-enhanced CT
scan, were randomly assigned to receive either intravenous ciprofloxacin or
placebo. Five patients were secondarily excluded, and the remaining 41
patients were finally included in the study protocol (22 patients received
intravenous ciprofloxacin and 19 patients received placebo). Ciprofloxacin
was chosen by the infectious Committee of our Center because its broad
antibacterial spectrum and safety.
Results. Comparing the 22 patients received intravenous ciprofloxacin and
19 received placebo, infected pancreatic necrosis was detected in 36% and
42% respectively (p0.707), and the mortality rate was 18% and 11%,
respectively (p0.668). In addition, no significant differences between both
treatment groups were observed with respect to several variables such as:
non-pancreatic infections, surgical treatment, timing and the re-operation
rate, development of organ failure, and length of hospital and IUC stays.
Conclusion. In the present double blind study, the prophylactic use of
ciprofloxacin in patients with severe necrotizing pancreatitis did not
significantly reduce the risk of developing pancreatic infection nor decrease
the mortality rate. However, it should be considered the small number of
patients that could be finally included.
AP 3.06
FAST TRACK MAJOR LIVER SURGERY; AN UPDATE ON AN
ENHANCED RECOVERY PROGRAMME
Van Dam, Ronald M.1; Stoot, Jan H.M.B.1; Hendry, Paul O.2; Jippes,
Marie¨lle1; Bemelmans, Marc H.A.1; Fearon, Ken C.H.2; Garden, O. James2;
Dejong, Cornelis H.C.1
1University Hospital Maastricht, Department of Surgery, Maastricht, Neth-
erlands; 2Royal Infirmary, Department of Surgery, Edinburgh, United
Kingdom
Background. Optimising peri-operative care using a fast track programme
has been shown to improve convalescence following major abdominal
surgery. Recovery is accelerated through continuous thoracic epidural pain
control, stimulation of gut motility, early physical re-activation and limited
use of catheters, tubes and drains.
Objective. An international two centre study was conducted to assess
feasibility, efficacy and safety of an enhanced recovery programme after major
liver resection (MLR).
Methods. A consecutive series of 44 patients undergoing MLR from 1 march
2005, was studied (Group I). The Enhanced Recovery After Surgery (ERAS)
multimodal core protocol was used perioperatively. Data on nasogastric
drainage, resumption of normal food after surgery, length of postoperative
hospital stay (LOS), readmissions, pre-operative chemotherapy, morbidity
and mortality were collected prospectively and compared with historical data
from a prospectively collected data base of all MLR in our units in 2004
(group II, n66).
Results. In 93% of patients de NG tube was removed and oral intake
restarted within 4 hours after surgery. The median day of normal food intake
after MLR was 1 (range 03) day in group I vs 4 (014) days in group II, (pB
0.001, Mann-Whitney). Readmission rate was 18.2% in group I and 9.1% in
group II (ns). Complication rate was 50.0% in group I and 30.3% in group II
(pB0.04, chi square). Pre-operative chemotherapy was used more widely in
group I (65.9% vs 37.9%, pB 0.004). The median LOS was 6.5 (range 3
82) days in group I and 8.0 (555) days in group II pB0,002. Mortality for
the subgroups was 0% and 3%, group I and II respectively (ns).
Conclusion. An enhanced recovery programme after liver resection is safe
and can accelerate postoperative recovery. Normal food intake can be
restarted on the first day after surgery. Median length of postoperative
hospital stay is reduced from 8.0 to 6.5 days.
AP 4.01
INHIBITION OF MULTI-DRUG RESISTANCE IN PANCREATIC
CARCINOMA BY INTERFERON ALPHA
Hoffmann, Katrin; Schmidt, Jan; Buechler, Marcus W; Maerten, Angela
Ruprecht-Karls University of Heidelberg, Department of General Surgery,
Heidelberg, Germany
Background. Recent studies indicate a correlation between Interferon alpha
(IFN-alpha) based immunotherapy and improved survival in pancreatic
cancer. Over-expression of multi-drug resistance proteins and consecutive
response rates B15% to chemotherapy are important prognosis limiting
factors. Drug-resistance modulation by IFN-alpha has not yet been exam-
ined.
Methods. Pancreatic cancer was induced orthotopically by ultra-sound
guided implantation of syngenic PANC02 cells in mice. Animals were either
treated with monotherapy of 5-Fluorouracil, cisplatin and gemcitabine or
combination of these agents with IFN-alpha. Multicolor flowcytometry was
used for quantification of drug-resistance proteins P-Glycoprotein, MRP1
and MRP3 and analysis of intratumoral immunological phenotyping,
cytotoxic activity and T-cell activation status. Function of drug-resistance
proteins was investigated in vitro.
Results. Expression of resistance proteins and drug efflux activity of cancer
cells were significantly increased by chemotherapy in vitro and in vivo
compared to the untreated control. Addition of IFN-alpha to cytotoxic
regimes significantly down-regulated P-Glycoprotein, MRP1 and MRP3 as
well as protein activity. Compared to single agent therapy tumor size and
metastatic seeding decreased significantly and survival was prolonged. A
significantly higher proportion of activated and cytotoxically active CD8
tumor infiltrating lymphocytes was detectable after up-regulation of drug
resistance proteins. Immuno-chemotherapy induced a decrease of naive
T-cells and increased central as well as effector memory cells within the
tumor.
Conclusion. Reconstitution of chemosensitivity and improvement of out-
come by addition of IFN-alpha to chemotherapy were demonstrated in
experimental pancreatic cancer for the first time. Our data support immuno-
chemotherapy as a new encouraging approach and suggest clinical signifi-
cance of tumor-specific immune response in pancreatic cancer.
AP 4.02
INTERACTION OF CD44 AND ITS LIGAND HYALURONAN
PLAYS A CRITICAL ROLE IN THE DEVELOPMENT OF BILE
DUCT PROLIFERATION IN CHOLESTATIC LIVERS
Wu, Gordon; He, Yao; Sadahiro, Tomohito; Noh, Sang-Ik; Klein, Andrew
Cedars-Sinai Medical Center, Comprehensive Transplant Center, Los
Angeles, United States
Introduction. Previously we have demonstrated high levels of CD44
expression in proliferative bile ducts in cholestatic livers.
Objective. The current study was carried out to further investigate the
pathophysiology of CD44 expression by biliary epithelia.
Methods. Rat cholestatic livers were induced by bile duct ligation (BDL).
Histological distribution of CD44-expressing cells and disposition of extra-
cellular hyaluronic acid (HA) were examined in cryostat sections of the livers
with immunofluorescence or histochemistry. Biliary epithelial cells (BEC),
hepatic stellate cells (HSC), CD31 hepatic endothelial cells (HEC) and
ED2 Kupffer cells (KC) were isolated and examined for expression of
CD44 standard (s) and variant (v) isoforms with quantitative real time PCR.
The effect of CD44-HA interaction in biliary epithelial proliferation was
studied in cultures.
Results. Metamorphic analysis of the liver sections stained with HA binding
protein demonstrated strikingly increased HA synthesis in the portal triads of
the BDL livers when compared with those of sham operated controls.
Immunofluorescent staining confirmed that cell surface CD44 proteins were
intensively present in intrahepatic bile ducts which exhibited vigorous
proliferation. BEC isolated from BDL livers displayed high levels of CD44
mRNA expression, which was 3-fold greater than that expressed by HEC
(PB0.05), 22-fold greater than KC (PB0.05) and 25-fold greater than HSC
(PB0.01). CD44 species expressed in the cholestatic livers were predomi-
nantly variant isoforms. In cultures, BEC significantly increased expression of
CD44 and the cell proliferation maker ki-67 in responses to hyaluronan
stimulation.
Conclusion. Extracellular HA accumulated in the portal triads can stimulate
biliary epithelia to proliferate and to express high levels of CD44. The results
suggest that the CD44-HA pathway plays a critical role in the development of
bile duct proliferation in cholestatic livers.
AP 4.03
CAUDATE LOBE INVOLVEMENT BY COLORECTAL METAS-
TASES TRANSLATES INTO REDUCED SURVIVAL FOLLOWING
HEPATIC RESECTION
Khan, Aamir Z; Wong, Vincent; Malik, Hassan; Morris-Stiff, Gareth; Prasad,
Raj; Lodge, J Peter A; Toogood, Giles J
St James University Hospital, Leeds, United Kingdom
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Aims. To analyze operative and oncological outcomes following hepatic
resection for colorectal metastases involving the caudate lobe.
Patients and Methods. Six hundred and eighty seven consecutive patients
undergoing hepatic resection for colorectal metastases from 1993 to 2006.
Data were analyzed from a prospectively collected database, operative and
oncological outcomes including disease free and overall survival were used as
outcome measures. Patients were analyzed as those having caudate lobe
involvement (CLM) or no caudate lobe involvement (NCLM).
Results. Fifty two of 687 patients had metastases involving the caudate lobe
(7.5%). Patients with caudate lobe involvement were more likely to require an
extended hepatic resection (75% vs 27%, P0.001), perioperative blood
transfusion (29% vs 14%, P0.002), have a positive resection margin (57%
vs 32%, P0.001) and stay longer in hospital (12 vs 8 days, P0.001).
There was no difference in the in the proportion of patients requiring hepatic
pedicle clamping (29% vs 31%, P0.424), complication rate (37% vs 29%
P0.321) or 30-day mortality between the two groups (1.12% vs 1.19% P
0.446). Thirty one percent of patients in the CLM group exhibited a raised
inflammatory ratio versus 19% in the NCLM group (P0.049). Although
the disease free survival was similar (19.9 months vs 21.2 months, P0.191),
patients in the CLM group had a reduced overall survival compared to
patients in the NCLM group (36.5 months vs 50.5 months, P0.036).
Conclusions. Although long term survival can be offered to these patients,
caudate lobe involvement should be regarded as an independent prognostic
factor for reduced survival following hepatic resection for colorectal
metastases.
AP 4.04
HEAVY METALS IN GALLBLADDER CANCER TISSUES: A PRE-
LIMINARY STUDY
Chhabra, Deepak1; Oda, Koji2; Utsunomia, H3; Bharde, Shubhada4;
Takekoshi, S5; P, Jagannath1; Nimura, Yuji2
1Lilavati Hospital and Research Centre, Dept. of Surgical Oncology,
Mumbai, India; 2Nagoya University Graduate School of Medicine, Division
of Surgical Oncology, Dept. of Surgery, Nagoya, Japan; 3Wakayama Medical
College, School of Medicine, Dept. of Pathology, Wakayama, Japan; 4S. L.
Raheja Hospital  Asian Institute of Oncology, Dept. of Pathology, Mumbai,
India; 5Tokai University School of Medicine, Dept. of Pathology, Isehara,
Japan
Background. High incidence of gallbladder cancer (GBC) is reported from
North India. High concentrations of heavy metals were detected in river
waters in areas of high incidence of GBC.
Aims and Objectives. To determine if there were increased levels of heavy
metals in Indian GBC or non-neoplastic gallbladder (GB) tissue using
spectrophotometry and electron microscopy and to compare with Japanese
GBC and non-neoplastic GB tissue. To determine if human scalp hair could
be a marker for wide scale epidemiological study in endemic areas in India.
Materials and Methods. Spectrophotometric assessment was done for 19
Indian gallbladder tissues (9 GBC, 10 non-neoplastic GB) and 9 Japanese
gallbladder tissues (5 GBC, 4 non-neoplastic GB). Transmission electron
microscopy (TEM) including thin foil element analysis was carried out in 7
Indian samples (6 GBC, 1 non-neoplastic GB) to detect tissue heavy metal
concentrations. Scalp hair metal levels were evaluated using spectrophoto-
metry in 31 samples (18 endemic, 13 non-endemic) from India.
Results. Cadmium, Chromium, Lead, Arsenic, Mercury, Iron, Zinc and
Manganese were detected by spectrophotometry in Indian GBC and some
non-neoplastic GB. A comparative study with Japanese specimens demon-
strated that Lead, Arsenic, and Zinc were specifically highly accumulated in
Indian tissues. TEM of Indian tissues demonstrated electron dense deposits
in GBC; however, thin foil TEM element analysis could not localize any
metals. Human scalp hair analysis of 18 endemic samples from India revealed
significantly high levels of Cadmium, Arsenic, Mercury, lead and Zinc.
Conclusions. We hypothesize that heavy metals: Arsenic, Mercury, Lead
and Zinc may be the potent carcinogens in Indian GBC from endemic areas.
As these metals could not be localized by thin foil TEM analysis, they may be
contained in the Indian gallbladders not as particles but in a soluble active
form with higher carcinogenic potential. The specific cause effective relation-
ship of these potential carcinogens needs further evaluation.
AP 4.05
FACTORS INVOLVED IN LIVER REGENERATION AND THEIR
ROLE IN THE STIMULATION OF TUMOUR GROWTH
Harun, Nadia; Zhu, Jin; Muralidharan, Vijayaragavan; Christophi,
Christopher
Austin Hospital, Surgery, Heidelberg, Australia
Background. Partial hepatectomy for colorectal liver metastases is asso-
ciated with a 4080% tumour recurrence rate. This recurrence may be linked
to factors involved in liver regeneration which have been shown to stimulate
occult tumour growth.
Objective. This project aims to determine factors of liver regeneration which
may contribute to the stimulation of tumour growth in an established mouse
model of colorectal liver metastases.
Methods. Male CBA mice (8 week old) were used. Five groups of animals
underwent 70% resection and were compared to sham laparotomies (0%).
Each group of animals was killed at various timepoints (day 2, 4, 6, 8 and 10)
and livers analysed using immunohistochemistry to determine the pattern of
growth factor receptor expression during regeneration. This same experiment
was again performed however livers were induced with a mouse derived colon
cancer cell line (MoCR) following resection. Growth factor receptor
expression was assessed on tumour as well as normal liver surfaces.
Results. Significant early increases in hepatocyte growth factor receptor (c-
MET), (p50.01) and epidermal growth factor receptor (EGFR), (pB0.05)
levels were observed compared to the shams. These were also found to be
highly expressed on tumour surfaces. Expression of growth factor receptors in
the liver tissue of animals which underwent tumour induction were found to
be higher and maintained for longer than in the liver tissue of animals which
had no tumours.
Conclusion. Growth factor receptors elevated during liver regeneration are
also found to have receptors on tumour surfaces which may be contributing
to the stimulation of tumour recurrence following partial hepatectomy.
AP 4.06
PHASE I STUDY OF THERMODOX (THERMALLY SENSITIVE
LIPOSOMES CONTAINING DOXORUBICIN) GIVEN PRIOR TO
RADIOFREQUENCY ABLATION FOR UNRESECTABLE LIVER
CANCERS
Poon, Ronnie1; Ng, Kelvin1; Yuen, Jimmy2; Hahne, William3; Prabhakar,
Raj3; Eugeni, Michelle4; Locklin, Julia5; Wood, Bradford5; Libutti, Steven4
1Queen Mary Hospital/The University of Hong Kong, Department of
Surgery, Hong Kong, Hong Kong; 2Queen Mary Hospital/The University
of Hong Kong, Department of Radiology, Hong Kong, Hong Kong; 3Celsion
Corp, Columbia, Colombia; 4Surgery Branch NCI, USA, United States;
5NIH, Diagnostic Radiology, USA, United States
Background. Radiofrequency ablation (RFA) for liver cancers is associated
with a high recurrence rate. Thermodox (TDox) liposomes are engineered to
release doxorubicin locally at temperature 39.5C. High local TDox
concentrations around RFA-treated area could possibly increase local tumor
control.
Aims. A completed phase I study was conducted in patients with
unresectable liver cancers undergoing RFA with a 30-min. IV infusion of
TDox starting 15 min. before RFA. The aims were to determine the
maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of TDox.
Methods. Patients with hepatocellular carcinoma (HCC) or metastatic liver
cancer (MLC) eligible for RFA were recruited. Main inclusion criteria were
lesionsB4 in number andB7 cm in greatest diameter. Dose escalation was:
cohorts of 36 pts treated with a single dose of 20, 30, 40, 50 or 60 mg/m2.
RFA was performed by percutaneous or surgical approach. Contrast CT
scans were done pre-, 1 and 3 months post-treatment and every 3 months
thereafter. Patients were assessed for safety, pharmacokinetics, and local
tumor control on CT.
Results. A total of 24 patients (9 with HCC and 15 with MLC) were treated
(3, 6, 6, 6, 3 patients at 20, 30, 40, 50 and 60 mg/m2, respectively). Median
tumor size was 3.7 cm (range 1.76.5 cm). Totally 28 tumors were treated.
Twenty (83%) patients had no evidence of local tumor control failure. Three
patients had local failure detected at 28 days post-treatment, and one had
local failure at 9 months post-treatment. Grade 3/4 toxicity (reversible
neutropenia) has been observed to be dose-dependent. Two patients at 60
mg/m2 met DLT criteria and 50 mg/m2 was considered the MTD.
Conclusions. TDox can be safely given in combination with percutaneous
or surgical RFA for liver tumors, with limited and manageable toxicity. The
MTD was 50 mg/m2 for singe-dose administration. The local control for
RFA plus TDox in relatively large tumors appears favorable, supporting a
randomized trial comparing RFA plus TDox versus RFA alone.
AP 5.01
ACUTE PANCREATITIS SEVERITY IS EXACERBATED BY IN-
TESTINAL ISCHEMIA-REPERFUSION CONDITIONED MESEN-
TERIC LYMPH
Phillips, Anthony1; Flint, Richard S2; Power, Sharleen E1; Dunbar, P. Rod1;
Brown, Caroline1; Delahunt, Brett3; Cooper, Garth JS1; Windsor, John A2
1University of Auckland, School of Biological Sciences, Auckland, New
Zealand; 2University of Auckland, Department of Surgery, Auckland, New
Zealand; 3Wellington School of Medicine, University of Otago, Department
of Pathology and Molecular Medicine, Wellington, New Zealand
Background. Intestinal ischaemia is a feature of acute pancreatitis. It is not
known whether this contributes to its severity or is a consequence of it.
Aims. To determine the effect of intestinal ischaemia-reperfusion on acute
pancreatitis and the role of mesenteric lymph in contributing to disease
severity.
Methods. Two experiments are reported using intravital microscopy and a
sodium taurocholate rodent model of mild pancreatitis. In the first study, rats
underwent intestinal ischemia-reperfusion during acute pancreatitis, pro-
duced by 30 minute occlusion of the superior mesenteric artery (as 30
minutes or 310 minutes) followed by 2 hours of reperfusion. In the second
study, rats with acute pancreatitis had an intravenous infusion of mesenteric
lymph collected from donor rats that had been subjected to a similar duration
intestinal ischemia-reperfusion injury. The pancreatic erythrocyte velocity,
functional capillary density, leukocyte adherence, histology and edema index
were measured.
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Results. Intestinal ischemia-reperfusion during acute pancreatitis caused a
decline in the pancreatic microcirculation beyond that of pancreatitis alone
(erythrocyte velocity 42% of baseline vs. 73% of baseline with pancreatitis
alone, functional capillary density 43% vs. 72%, leukocyte adherence 7-fold
increase vs. 4-fold increase). This caused an increased severity in acute
pancreatitis, evidenced by a 1.41.8 fold increase in severity indices over
acute pancreatitis alone. A very similar exacerbation of microvascular failure
and increased severity was demonstrated by the intravenous infusion of
intestinal ischemia-reperfusion-conditioned mesenteric lymph.
Conclusion. Unidentified factors released into mesenteric lymph following
intestinal ischemia-reperfusion injury are capable of exacerbating acute
pancreatitis severity. This highlights an important role for the intestine in
the pathophysiology of severe acute pancreatitis and identifies mesenteric
lymph as a significant component of this pathobiology.
AP 5.02
PREDICTORS OF SURVIVAL AFTER PERCUTANEOUS ABLA-
TION OF HEPATOCELLULAR CARCINOMA
Chen, Min-Shan1; Peng, Zhen-Wei1; Zhang, Yao-Jun1; Liang, Hui-Hong1;
Li, Jin-Qing1; Zhang, Ya-Qi1; Lau, Wan Y2
1Department of Hepatobiliary Surgery, Cancer Centre of Sun Yat-Sen
University, Guangzhou, China; 2Department of Surgery, The Chinese
University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
Aims. This study aimed to determine risk factors predicting survival in
patients with Hepatocellular carcinoma (HCC) under going percutaneous
radiofrequency ablation (PRFA).
Patients and Methods. Between August 1999 and May 2005, 281 patients,
250 males and 31 females who were 33 to 80 years old (mean 65.3 years) had
PRFA only or PRFA combined with percutaneous ethanol injection (PEI) in
our center. Patients were treated with PRFA or PEI by using a percutaneous
approach with ultrasound (US) guidance and were evaluated at regular
intervals to determine disease recurrence and survival. The survival curves
were constructed by Kaplan-Meier method and compared by log-rank test,
the relative prognostic significance of the variables in predicting overall
survival were assessed by multivariate Cox proportional hazards regression
analysis.
Results. At the end of the study, 189 patients were alive, and 92 were dead.
Median survival was 48.7 months. The overall 1-year, 3-year and 5-year
survival rates were 89%, 54% and 43%, respectively for all patients. The
overall 1-year, 3-year and 5-year survival rates for small tumor size (¡U¨ 3 cm)
were 97.8%, 65.7%, 58.6%, respectively, for medium tumor size (3.15 cm)
were 94.1%, 57.1%, 37.1% at 1 year, 3 years, 5 years, respectively and for
large tumor size (5 cm) were 62.8%, 40.3%, 0%, respectively. Survival of
patients treated with PRFA was dependent on tumor size (p0.000; Risk
Ratio [RR] 9.6, 95% CI 5.217.8), number of tumors (p0.003; RR 1.6,
95% CI 1.22.0), combination with PEI (p0.010; RR 0.6, 95% CI 0.4
0.9), Child-Pugh class (p0.002; RR 2.0, 95% CI 1.33.0) and safety
margin (p0.0026; RR 0.6, 95% CI 0.40.9).
Conclusions. PRFA is an effective treatment for HCC. This study
determined which patients with HCC do best after PRFA. Tumor size,
number of tumors, combined with PEI, safety margin, and Child class are
independent risk predictors of survival
AP 5.03
Disordered Pancreatic Inflammatory Responses and Inhibition of
Fibrosis in CD39-null mice
Kunzli, Beat1; Enjyoji, Keiichi2; Nuhn, Philipp1; Berberat, Pascal1; Friess,
Helmut1; Robson, Simon2
1Technical University Munich, Department of Surgery, Munich, Germany;
2Harvard University, Department of Gastroenterology, Boston, United States
Background and Aims. Extracellular nucleotides are released from injured
cells and bind to purinergic-type 2 receptors (P2-R) that modulate
inflammatory responses. Ectonucleotidases, such as CD39/NTPDase1,
hydrolyze extracellular nucleotides and integrate purinergic signaling re-
sponses. As the role of CD39 in mediating chronic inflammation and fibrosis
is poorly understood, we studied the impact of gene deletion in a model of
pancreatic disease.
Methods. Experimental pancreatitis was induced by cyclosporine pretreat-
ment, followed by cerulein injections (50 mg/kg, 6 i.p. injections daily, 3 times
per week) and mice were sacrificed at days 2, wk 3 and wk 6. Experimental
parameters were correlated with cytokine levels in blood, mRNA and protein
expression of purinergic and fibrotic parameters in tissues. Immunohisto-
chemistry and pancreatic morphometry of fibrosis were done in wild-type and
CD39-null mice. Proliferation of primary pancreatic stellate cells (PSC) and
effects of CD39 deletion were investigated in vitro.
Results. Wild-type mice developed morphological features of pancreatitis
with the development of parenchymal atrophy and fibrosis. CD39 and P2-R
were overexpressed in both vascular and adventitious tissues in pancreatitis.
CD39-null mice developed only minor degrees of pancreatic atrophy and
fibrosis. Interferon-g was significantly increased in tissues and plasma of
CD39-null mice. Wild-type pancreatic stellate cells (PSC) expressed high
levels of CD39 and P2-R. CD39-null PSC had impaired rates of proliferation
but differentiated well in vitro although the production of procollagen-a1 was
significantly impaired (PB0.03).
Conclusions. CD39 deletion decreases fibrogenesis in experimental pan-
creatitis. Our data implicate CD39 as a modulator of PSC proliferation and
collagen production in pancreatitis.
AP 5.04
RIGHT PORTAL VEIN LIGATION IS AS EFFICIENT AS PORTAL
VEIN EMBOLIZATION TO INDUCE HYPERTROPHY OF THE
LEFT LIVER REMNANT
Aussilhou, Beatrice1; Lesurtel, Mickael1; Dokmak, Safi1; Kianmanesh,
Reza1; Farges, Olivier1; Sauvanet, Alain1; Sibert, Annie2; Vilgrain, Vale´rie2;
Belghiti, Jacques1
1Beaujon Hospital, HepatoPancreatoBiliary Surgery, Clichy, France; 2Beau-
jon Hospital, Radiology, Clichy, France
Background. Right Portal Vein (PV) obstruction induces hypertrophy of the
future left liver remnant.
Aim. To compare Portal Vein Ligation (PVL) and Portal Vein Embolization
(PVE) before right hepatectomy in terms of efficacy for induction of left liver
hypertrophy.
Methods. Between 1998 and 2003, 35 patients with liver metastases
underwent a right portal branch obstruction before ‘‘high risk’’ right
hepatectomy because of a future remnant liver volume less than 30% of
the total liver volume or because of a postchemotherapy liver parenchyma.
PVE was performed percutaneously in 18 patients, while 17 patients
underwent a PVL during a first stage laparotomy for resection of the primary
tumor (n10) and/or resection of left liver metastases (n16).
Results. There was no complication following PVE and postoperative
hospital stay was 291 days. In group PVL, 6 patients had postoperative
complications which were related to primary tumor resection and post-
operative hospital stay was 1396 days. After PV occlusion, the increase of the
left liver volume was not significantly different between the two groups (359
38% after PVE vs. 38926% after PVL, p0.7). After PVE, 6 patients were
not eligible for right hepatectomy because of insufficient hypertrophy of the
left liver (n2) or tumor progression (n4). After PVL, 3 patients were not
eligible for resection because of tumor progression (n2) or death (n1).
Technical difficulties during right hepatectomy were similar in both groups
according to duration of procedure (6.491 hours vs. 6.791 hours, p0.7)
and transfusion rates (33% vs. 28%, p0.7). Mortality was nil in both
groups and morbidity rates were respectively 58% for the PVE group and
36% for the PVL group (p0.6).
Conclusion. Right PVL and PVE result in a comparable hypertrophy of the
left liver. During the first laparotomy of a two-step liver resection, PVL can be
efficiently and safely performed.
AP 5.05
15-YEAR EVOLUTION OF LIVER TRANSPLANTATION IN
EUROPE
Adam, Rene´1; Karam, Vincent1; Buckels, John2; O’grady, John3; Castaing,
Denis1; Klempnauer, Jurgen4; Jamieson, Neville5; Neuhaus, Peter6; Lerut,
Jan7; Pollard, Stephen8; Salizzoni, Mauro9; Rogiers, Xavier10; Garcia-
Valdecasas, Juan11; Muhlbacher, Ferdinand12; Mir, Jose13; Broelsch, Chris-
topher14; BURRA, Patrizia15
1Hoˆpital Paul Brousse, Centre He´patobiliaire, Villejuif, France; 2The Queen
Elizabeth Hospital, Queen Elisabeth Medical Center, Birmingham, United
Kingdom; 3King’s College, Liver Transplantation Unit, London, United
Kingdom; 4Medizinische Hochschule Hannover, Klinik fu¨r Viszeral-und
Transplantationschirurgie, Hannover, Germany; 5ADDENBROOKE’S Hos-
pital, Department of Surgery, Cambridge, United Kingdom; 6Charite´-
Campus  Virchow klinikum, fu¨r Allgemein-Viszeral- und Transplanta-
tionschirur, Berlin, Germany; 7Catholic University of Louvain, Cliniques
Universitaires St-Luc, Brussels, Belgium; 8St Jame’s & Seacroft University
Hospital, Transplantation Unit, Leeds, United Kingdom; 9Centro de
Trapianti di Fegato, Azienda Ospedaliera S. Giovanni Battista, Torino, Italy;
10Universitatskrankenhaus Eppendorf, Dept. of Hepatobiliary Surgery,
Hamburg, Germany; 11Hospital Clinic I Provincial de Barcelona, Gastro-
intestinal Surgery Department, Barcelona, Spain; 12Transplantationszen-
trum, Klinishe Abteilung fu¨r Transplantation, Wien, Austria; 13Hospital
Universitario LA FE, Servicio de Medicina D, Valencia, Spain; 14C. U. K.
GHs Essen, Klinik fu¨r Allgemeine und Transplantationschirurgi, Essen,
Germany; 15Universitat degli Studi di Padova, Department of Surgery &
Gastroenterological Scienc, Padova, Italy
From May 1968 to December 2005 the ELTR has accumulated data
on 68776 Liver Transplantations (LT) at 137 centers (23 countries).
We analysed the evolution of main indications, surgery techniques and
results during the last 15 years period comparing 3 era: (1) 19901995; (2)
19952000 and (3) 20002005. Evolution of indication and surgical
technique
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19901995 19952000 20002005
n11883 n17939 n26824
Indication
Fulminant hepatitis 1238 (10%) 1531 (8%) 1989 (7%)
Alcoholic cirrhosis 1841 (15%) 3561 (20%) 5402 (20%)
Virus C cirrhosis 1351 (11%) 2810 (16%) 4265 (16%)
Virus C cirrhosis 891 (7%) 1139 (6%) 1547 (6%)
Hepatocellular
carcinoma
1042 (9%) 2085 (12%) 4191 (16%)
Surgical technique
Cadaveric full-size 11094 (93%) 16174 (90%) 22840 (85%)
Split liver 211 (2%) 790 (4%) 1689 (6%)
Living donor 81 (0.7%) 299 (2%) 1484 (6%)
Patient survival
Survival
1990
1995
1995
2000
2000
2005 P value
Fulminant
hepatitis
1-yr 62% 68% 75% B0.001
5-yr 54% 61% 65%
Alcoholic
cirrhosis
1-yr 81% 86% 88% B0.001
5-yr 68% 73% 71%
Virus C cirrhosis 1-yr 81% 84% 87% 0.167
5-yr 64% 67% 62%
Virus B cirrhosis 1-yr 81% 88% 91% B0.001
5-yr 68% 79% 80%
Hepatocellular
carcinoma
1-yr 75% 84% 89% B0.001
5-yr 46% 57% 60%
Cadaveric
full-size
1-yr 78% 84% 87% B0.001
5-yr 64% 71% 69%
Split liver 1-yr 64% 77% 85% B0.001
5-yr 55% 70% 73%
Living donor 1-yr 73% 86% 86% 0.078
5-yr 69% 78% 67%
With regard to the indication, the results show an increase of alcoholic
(ALCI) and virus C cirrhosis (VCC), as of hepatocellular carcinoma (HCC).
Regarding the surgical technique, split and living donor have increased to
represent currently each one 6% of all LT. Concerning the outcome, LT is
increasingly providing a survival exceeding 80% at 1 year. Survival has
significantly improved for all indications including HCC with however the
exception of VCC. The same improvement in survival was observed in
cadaveric full-size and split transplants but not for living donor transplant. In
conclusion, improved patient management and surgical technique, and more
effective immunosuppression still lead to significant improvements in the
outcome of LT. Website: www.eltr.org
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INTERVENTIONAL RADIOLOGY IN MANAGEMENT OF COM-
PLICATIONS AFTER PANCREATIC RESECTIONS: TATA MEM-
ORIAL HOSPITAL EXPERIENCE
Nagarjan, Ganesh1; Kulkarni, Aniruddha2; Kulkarni, Suyash2; Barreto,
George1; Shukla, Parul J1; Shrikhande, Shailesh V1
1Tata Memorial Hospital, Surgical Oncology, Mumbai, India; 2Tata Memor-
ial Hospital, Radiology, Mumbai, India
Background. Major causes of morbidity and mortality after pancreatic
resections are pancreatic leaks, collections and hemorrhage. The data on
interventional radiology (IR) after pancreatic resections remains sparse from
the developing world.
Aims. Assess the impact of IR on complications after pancreatic resections.
Materials and Methods. Prospective data of 63 pancreatic resections
(January 2006-July 2007). Type of surgery, complications, IR procedures
(IRP’s), reoperations, and hospital stay were evaluated.
Results. 56 and 7 underwent pancreaticoduodenectomy (PD) and distal
pancreatectomy (DP), respectively. There were 39 males and 24 females.
Mean age was 46.5 years (1172 years). 18 had peripancreatic collections of
which 13 underwent IRP’s (20%). 4 patients had pancreatic fistula while 2
developed bile leaks. Remaining 7 had collections unrelated to leaks. 4/7 who
underwent DP (57%), required an IRP compared to only 9/56 who
underwent PD (12.5%). Of the 13 patients, two required a single aspiration,
one multiple aspirations, and eight required pigtail catheter drainage.
Percutaneous biliary drainage was required in the two bile leaks. One had
embolization for a gastrointestinal bleed in addition to aspiration of
collection. None required reoperation. Mean postoperative stay was 34.7
days in those with IRP’s and 16.2 days in those without. Mortality was 1/63
(1.5%). 7 of 13 patients who underwent IRP’s would have required resurgery
if this facility was unavailable.
Conclusion. This is perhaps the first audit highlighting IR in pancreatic
resections from the developing world. IRP’s are an asset to pancreatic surgical
teams since they avoid resurgery and associated morbidities.
FP 1.02
WHIPPLE VS PYLORUS PRESERVING PANCREATICODUODE-
NECTOMY. POSTOPERATIVE RESULTS AND SURVIVAL OF A
PROSPECTIVE-RANDOMIZED STUDY IN A SINGLE INSTITU-
TION.
Borobia, Francisco G.1; Altet, Joan1; Jorba, Rosa1; Busquets, Juli1; Torras,
Jaume1; Llado, Laura1; Ramos, Emilio1; Rafecas, Antonio1; Pelaez, Nuria1;
Martin Comin, Josep2; Valls, Carlos3; Fabregat, Joan1
1Hospital Universitari de Bellvitge, Hepatobiliary and pancreatic surgery,
L’Hospitalet de Llobregat. Barcelona, Spain; 2Hospital Universitari de
Bellvitge, Nuclear Medicine, L’Hospitalet de Llobregat. Barcelona, Spain;
3Hospital Universitari de Bellvitge, Radiology, L’Hospitalet de Llobregat.
Barcelona, Spain
Objective. A prospective randomized study was designed to compare
operative, postoperative and survival results after performing classic Whipple
pancreaticoduodenectomy (WPD) versus pilorus preserving pancreaticoduo-
denectomy (PPPD).
Methods. Patients with surgical diseases in the head of the pancreas and
periampulary region are invited to participate. The study was approved by
our Hospital ethical committee. Randomization was performed after con-
firming resectability by both techniques. Data concerning patients’ demo-
graphics, intraoperative, histology, as well as postoperative complications and
survival were analysed. Delayed gastric emptying (DGE) was evaluated
clinically and quantified by isotopic nuclear gammagraphy with oral ingestion
of Tc99m pre and postoperatively. Nutritional parameters and quality of life
test were also recorded pre and postoperatively. Seventy-five patients were
included and randomized for a WPD (36) or a PPPD (39) resection from
2003.
Results. There were no significant differences between both groups
attending demographics, histology study, blood loss and duration of surgery.
Postoperative morbidity and mortality was also similar. DGE were similar in
both groups, clinically (WPD, n10, PPPD, n16; p0,81) and measured
by Tc99m (p0,92). No differences were found in body weigh loss and
prealbumin determination. Quality of life test showed similar score. Global
morbidity was 33.3%. Hospital length of stay were 17 days without
differences between them (p0,38). Operative mortality was 6.6%.
Conclusions. Our study demonstrated that both surgical procedures are
similar to treat pancreatic head diseases, attending to postoperative results
and long-term survival. No differences were found in surgical parameters,
postoperative morbidity and a similar incidence of DGE were recorded in two
groups.
FP 1.03
A SYSTEMATIC REVIEW AND META-ANALYSIS OF PYLORUS-
PRESERVING VERSUS CLASSICAL PANCREATICODUODE-
NECTOMY FOR SURGICAL TREATMENT OF PANCREATIC
CANCER
Diener, Markus K1; Heukaufer, Christina1; Antes, Gerd2; Seiler, Christoph
M1; Bu¨chler, Markus W1
1University of Heidelberg, Department of General, Visceral and Trauma
Surgery, Heidelberg, Germany; 2University of Freiburg, German Cochrane
Centre, Freiburg, Germany
Objective. Comparison of effectiveness between the pylorus-preserving
pancreaticoduodenectomy (‘‘pylorus-preserving Whipple’’-PPW) and the
classical Whipple (CW) procedure for pancreatic and peri-ampullary
carcinoma.
Methods. A systematic literature search (Medline, Embase, The Cochrane
Library, Biosis, Science Citation Index, Ovid Journals) was performed to
identify all eligible articles. Randomized controlled trials (RCTs) comparing
PPW versus CW for periampullary and pancreatic carcinoma were eligible for
inclusion. The methodological quality of included studies was evaluated
independently by two authors. Quantitative data on peri-operative para-
meters (blood loss, transfusion, operation time and length of hospital stay),
mortality, morbidity and survival were extracted from included studies for
meta-analysis. Pooled estimates of overall treatment effect were calculated
using a random effects model.
Results. 1235 abstracts were retrieved and checked for eligibility and 6
RCTs finally included. The critical appraisal revealed varying heterogeneity
with respect to methodological quality and outcome parameters. The
comparison of overall in-hospital mortality (OR 0.49; 95% CI 0.17 to
1.40; P0.18), morbidity (OR 0.89; 95% CI 0.48 to 1.62; P0.69) and
survival (HR 0.74; 95% CI 0.52 to 1.07; P0.11) showed no significant
difference. However, operating time (WMD 68.26 min; 95% CI 105.70
to 30.83; P0.0004) and intraoperative blood loss (WMD 766 mL;
95% CI 965.25 to 566.74; P0.0001) were significantly reduced in the
PPW group.
Conclusions. Hence, in the absence of relevant differences in mortality,
morbidity and survival, the PPW seems to be as effective as the CW. Given
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obvious clinical and methodological interstudy heterogeneity, efforts should
be intensified in the future to perform high quality RCTs of complex surgical
interventions on the absis of well defined outcome parameters.
FP 1.04
COMPARISON OF SURVIVAL BETWEEN SURGICAL RESEC-
TION AND CHEMORADIATION FOR LOCALLY ADVANCED
PANCREATIC CANCER
Shinchi, Hiroyuki1; Maemura, Kosei1; Noma, Hidetoshi1; Mataki, Yukou1;
Kurahara, Hiroshi1; Maeda, Shinichi1; Aikou, Takashi1; Takao, Sonshin2
1Kagoshima University Graduate School, Department of Surgical Oncology,
Kagoshima, Japan; 2Kagoshima University, Frontier Science Research
Center, Kagoshima, Japan
Purpose. The purpose of this study was to compare the length of survival of
surgical resection with that of chemoradiation in patients with locally
advanced pancreatic cancer.
Methods. Eighty-four patients with histologically proven locally advanced
pancreatic cancer without distant metastases were evaluated in this retro-
spective study. Forty-one patients received surgical resection while 43
patients received EBRT (50.4 Gy/28/fractions) with concurrent twice-weekly
gemcitabine (40 mg/m2/day). The length of survival of the two groups were
analyzed and compared.
Results. The median survival and 1-year, 3-year, and 5-year survival rate was
12.6 months and 54%, 13%, and 6% in the resection group, while 11.3
months and 47%, 4%, and 0% in the chemoradiation group (P0.12). The
R0 resection group had a significantly longer survival than the chemoradia-
tion group. On the other hand, R1/2 group had a similar survival as compared
to the chemoradiation group.
Conclusions. Locally invasive pancreatic cancer without distant metastases
appears to be best treated by R0 surgical resection, while chemoradiation
should be recommended rather than R1/2 resection.
FP 1.05
Comparison of Pancreatic Fistula between Closed Suction Drainage
and Natural Drainage in Pancreaticojejunostomy
Lee, Seung Eun; Young-Joon, Ahn; Jang, Jin-Young; Hwang, Dae Wook;
Kim, Sun-Whe
Seoul National University College of Medicine, Department of Surgery,
Seoul, Korea, Republic of
Background. Leakage of the pancreaticojejunal anastomosis has been a
major complication after pancreaticoduodenectomy. Over the past decades,
various measures directed towards prevention of pancreatic leakage have been
studied. The purpose of this study is to find better method as comparing
closed suction drainage and natural drainage in pancreaticojejunostomy for
preventing pancreatic fistula.
Methods. During the period 2004 to 2005, a total of 120 patients who
underwent pancreaticojejunostomy was enrolled in this study and randomly
classified into two groups. 65 patients was allocated to closed suction
drainage group and 55 patients to natural drainage group. We inserted
PVC tube into remnant pancreatic duct across the duct-to-mucosa type
pancreaticojejunostomy in 2 cm depth as a totally external pancreatic stent,
which was connected with aspiration bag of Jackson-Pratt drain for
generating negative pressure or with bile bag for natural drainage. Pancreatic
fistula was defined and graded into A, B, C by ISGPF criteria.
Results. There were no differences between the two groups in age, sex,
diagnosis, texture of the pancreas, using of sandostatin and staging.
Pancreatic fistula occurred in 24 patients (43.6%) among the natural
drainage cases and in 15 (23.1%) among the closed suction drainage cases
(P0.017). In the natural drainage group, grade A occurred in 18 patients
(75%), grade B in 4 (16.7%), and grade C in 2 (8.3%). In the closed suction
drainage group, grade A occurred in 9 patients (60%), grade B in 4 (26.7%),
and grade C in 2 (13.3%) (P0.614).
Conclusion. In this randomized pilot study, temporary external drainage of
the pancreatic duct with closed suction drainage significantly reduced the
incidence of pancreatic fistula. Additional randomized prospective multi-
center study based on this study is ongoing to compare closed suction
drainage with natural drainage.
FP 1.06
INFLUENCE OF RECONSTRUCTION METHODS ON QUALITY
OF LIFE AFTER PANCREATODUODENECTOMY IN PANCREA-
TIC HEAD CANCER PATIENTS
Marcin, Musiewicz; Ciosek, Jakub; Pawel, Lampe; Mrowiec, Slawomir
Medical University of Silesia, Department of Gastrointestinal Surgery,
Katowice, Poland
Background. The most important aspect which determine the outcome and
success of the pancreatoduodenectomy (PD) procedure is pancreatic
anastomosis. The quality of life (QoL) after the surgical treatment of
pancreatic head carcinoma depends on the method of alimentary tract
reconstruction and clinical factors. The main purpose of this research is the
assessment of the QoL of patients after PD with pancreatojejunostomy (PJ)
and pancreatogastrostomy (PG) reconstruction and the influence of clinical
factors on the QoL.
Material and Methods. The study involved 68 patients with pancreatic
head carcinoma who had undergone radical PD between 2004 to 2006.
EORTC  QLQ-C30, QLQ-PAN26 questionnaires and Beck’s scale were
additionally sent to patients at least six months after PD. 37 patients were
included to the study and were divided into 2 groups: PJ group including 25
patients after Whipple, Traverso and Imanaga reconstruction; PG group
including 12 patients after Clagett and Flautner reconstruction.
Results. In PG group, there was a statistically significant reduction in
gastrointestinal symptoms (p0.04) and greater QoL in most functional,
symptoms and single item scales. The PJ group were greater only in scales:
cognitive functioning, fatigue and insomnia. No statistical differences were
found in preoperative, intraoperative factors and postoperative complica-
tions. In PJ group was no depression and mild depression in PG group was
found. Some strong correlations were found between clinical factors and
QoL. Preoperative loss of weight and pain, duration of pancreatoduodenect-
omy and duration of hospitalisation had impact on the QoL in both groups.
Conclusions. The Patients who underwent PD with PG have better quality
of life than patients after PJ reconstruction. Some of clinical factors could
deteriorate the QoL in most patients after PD. Beck’s scale can detecting
depression which was masking true results of the QoL.
FP 1.07
DRAIN FLUID AMYLASE LEVELS AFTER PANCREATICO-
DUODENECTOMY FOR CANCER: CORRELATIONS WITH
OUTCOME
Ramesh, Hariharan1; Sharma, Mohit2; Manish, Gandhi2; Manoj, Jacob2;
Ambady, Venugopal2; Bedi, Manmohan2
1Lakeshore Hospital & Research Center, GI Surgery, Cochin, India;
2Lakeshore Hospital & Research Center, Cochin, India
Background. Pancreatoenteric anastomotic leak is a major cause of
morbidity and mortality after pancreaticoduodenectomy. Drain fluid amylase
levels are used as markers for pancreatico-enteric anastomotic leak.
Aim. To record drain amylase levels after surgery, and to correlate them with
clinically significant pancreatic leak or adverse outcome.
Patients and Methods. 100 consecutive patients with pancreatic cancer
treated by pancreaticoduodenectomy (male 63, female 37, age range 17 to 74
years, mean 54.81, median 56). Anastomosis of the pancreatic remnant was
carried out by pancreaticogastrostomy in 42, and pancreaticojejunostomy in
58 cases. Drain amylase levels were measured on alternate days starting Day
1, along with drain fluid amounts, type of fluid and the same was correlated
with overall complication rate, postoperative fever, intra abdominal collec-
tions, bleed, overt leakage, and hospital stay. Sensitivity, specificity and ROC
curves were obtained using SPSS PC (version 14).
Results. There was no mortality. Complications occurred in 48 patients,
including 9 pancreaticoenteric anastomotic leaks. Hospital stay ranged
between 11 and 58 days (mean 15.65, median 14) when there was no
anastomotic leak and between 16 and 41 days (mean 29.22, median 33; p B
0.001). Re-intervention was also higher in patients with anastomotic leak (4
out of 12; 33%) versus those who did not have leak (5 out of 88; 6% P
0.009). High drain amylase on Day 1 was sensitive but not specific. High
drain amylase on Day 5 was a sensitive and specific predictor of clinically
overt pancreatic fistula and the area under the curve on the ROC curve
was 95%.
Discussion. High drain amylase on Day 5 has a higher accuracy in
predicting postoperative pancreatic fistula than the European Pancreatic
fistula study group criterion of Day 3 values.
Conclusion. High drain fluid amylase on Day 5 is a sensitive and specific
indicator of clinically significant pancreatic fistula.
FP 1.08
PROGNOSTIC ANALYSIS FOR SMALL PANCREATIC HEAD
ADENOCARCINOMA: A SINGLE INSTITUTE EXPERIENCE
Hwang, Tsann-Long; Yeh, Chun-Nan; Jan, Yi-Yin; Chen, Miin-Fu
Chang Gung Memorial Hospital, Chang Gung University, Department of
General Surgery, Taipei, Taiwan
Introduction. The prognosis of pancreatic adenocarcinoma is poor, and 5
years survival rate after resection is still around 15% to 25%. This study was
designed to analyze clinicopathological and prognostic factors to differentiate
between small and large pancreatic head adenocarinoma (PAD) patients
undergoing resection in the past 25 years from a single center in Taiwan.
Materials and Methods. Between 1983 and 2006, the clinical features of 36
small PAD patients (tumor size less than 2 cm) undergoing resection were
retrospectively reviewed and 123 large PAD patients were used for
comparison.
Results. One hundred and fifty nine patients with PAD underwent resection
from 1983 to 2006 were enrolled in this study. Among them, 36 patients
(22.6%) with PAD had tumor small than 2 cm in size classified as small PAD.
Patients with small PAD had similar clinico-pathological features to those
with large PAD. The follow-up duration of 36 patients with small PAD
underwent resection ranged from 1.0 to 122.7 months (median: 10.9
months). Patients with small PAD underwent resection had similar outcome
to that of patients with large PAD. Overall survival rates for patients with
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small PAD underwent resection at 3, and 5 years were 26.4 and 6.6 per cent,
respectively. Univariate log rank analysis identified good nutritional status as
the only favorable influence on overall survival for resectable small PAD
patients.
Conclusion. Patients with small PAD had similar clinico-pathological
features and prognosis to those with large PAD. Small PAD should not be
regarded as early PAD.
FP 1.09
ROLE OF STAGING LAPAROSCOPY/LAPAROSCOPIC ULTRA-
SOUND IN RESECTABLE PANCREATIC AND PERI-AMPUL-
LARY CANCERS
Hariharan, Deepak1; Siddeshwarappa, Madhu2; Bhattacharya, Satyajit2;
Abraham, Ajit2; Kocher, Hemant2
1Barts & the London School of Medicine & Dentistry, Institute of Cancer,
London, United Kingdom; 2The Royal London Hospital, Barts and the
London HPB centre, London, United Kingdom
Background. The role of staging laparoscopy (SL) and laparoscopic
ultrasound (LUS) remains controversial in the management of patients
with pancreatic and peri-ampullary cancers (PAC).
Aim. To determine the utility of SL/LUS in detecting unresectability in
patients with PAC who were otherwise resectable based on conventional
staging.
Method. Publications (1995-to date) examining the role of SL/LUS in
potentially resectable PAC were examined with respect to change in surgical
management. Studies indirectly assessing the role of SL/LUS without
actually performing laparoscopy as well as those where surgical outcome
could not be determined were excluded. Operative evaluation was considered
as gold standard for staging, when undertaken, while laparoscopy alone was
considered as gold standard when it detected metastatic disease. Overall test
characteristics and yield of SL/LUS in preventing unnecessary laparotomy
were determined.
Result. A total of 20 studies with 2,040 patients satisfied our inclusion
criteria. However, as the definition of resectability varied, data were re-
analysed with a specific algorithm to determine resectability. The test
characteristics of SL/LUS for different sets of patients were as follows:
Sensitivity Specificity
Positive
predictive
value
Negative
predictive
value Yield
*Locally
advanced
disease
(N316)
63.6 100 100 45.6 48.7
*Resectable
disease
(N1724)
63.4 98.6 97.6 75.7 29.2
Combined
(resectable
locally
advanced
disease)
63.4 98.7 98.2 72.1 32.3
*Metastatic disease excluded, All values in %
Conclusion. SL/LUS has a potential role in preventing unnecessary
laparotomy in patients with PAC without metastases and should be
thoroughly evaluated in a prospective multi-centre trial with pre-determined
criteria.
FP 2.01
Results of Resection and Transplantation for HCC in Cirrhosis and
non-Cirrhosis
Rayya, Fadi; Bartels, Michael; Hauss, Johann; Fangmann, Josef
University Hospital Leipzig, Clinic for Abdomen- and Transplantation
Surgery, Leipzig, Germany
Background. Hepatocellular carcinoma (HCC) is one of the most common
cancer worldwide. Both resection and transplantation are surgical treatment
options depending on the size of tumours and the presence of cirrhosis. Liver
cirrhosis is the main reason for the high early postoperative mortality after
resection. Even in the Child A stage, extensive resections are not recom-
mended.
Objectives. This study presents the results of the surgical treatment (LR or
LT) for HCC in cirrhotic- and non cirrhotic livers.
Patients and Methods. We analysed the data of 76 patients who underwent
LR or LT for HCC from January 2001 to December 2006.
Results. In non cirrhotic livers the following resections were performed: 30
right and extended right hemihepatectomies (54.5%), 11 left hemihepatec-
tomies ( 20%) and 14 mono- or bisegmentectomies (25.5%). In cirrhotic
livers were performed in Child A stage 1 right hemihepatectomy, 1 extended
right hemihepatectomy, 1 extended left hemihepatectomy and 4 mono- or
bisegmentectomies and in Child B stage 3 mono- or bisegmentectomies. In
11 patients who underwent transplantation were 2 patients with tumors
exceeding the Milan criteria and 5 patients of them (5/11) were treated with
TACE before the transplantation.
Conclusion. Liver resection for HCC in cirrhosis should be performed with
caution (no long-term survival in our data). Our study confirms that
transplantation shows good long-term survival in early HCC stages. How-
ever, this may also be true for stages above the Milan criteria. For HCC in
non-cirrhotic livers resection remains the treatment of choice, justifying an
extensive surgical approach. This achieves favourable long term survival as
demonstrated in the study presented.
FP 2.02
RESOURCE UTILIZATION AND CLINICAL OUTCOMES OF
PREOPERATIVE TRANSARTERIAL CHEMOEMBOLIZATION
FOR RESECTABLE HEPATOCELLULAR CARCINOMA
Lee, King-Teh
Kaohsiung Medical University Hospital, Department of Surgery, Kaohsiung,
Taiwan
Background. Hepatocellular carcinoma (HCC) is one of the most malig-
nant cancers in world. Transarterial chemoembolization (TACE) is an
effective treatment for HCC, although the outcome is still contradictory.
Aim. To assess the resourece utilization and clinical ouotcomes of
preoperative TACE for resectable HCC, we conducted a comparative
analysis in 347 HCC patients who underwent liver resections.
Methods. We retrospectively compared medical resource ultilization and
clinical outcomes after liver resection between those underwent preoperative
TACE (LR-TACE, n113) and who did not (LR, n234).
Results. The over-all mortality rate is 29% for LR versus 41.7% for LR-
TACE (pB0.05). The over-all recurrent rate is 51% for LR versus 48% for
LR-TACE (p0.05). The 1,3,5 year survival rate for LR is significantly
higher than that of LR-TACE (89%, 73%, 59% for LR vs. 81%, 57%, 47%
for LR-TACE, p0.02). The difference is not statistically significant,
although the dissease free survival rare is higher in LR-TACE (66%, 44%,
32% for LR vs. 60%, 49%, 40% for LR-TACE p0.96). The assessment of
resource utilization shows that the mean length of stay is 14.6998.94 for LR
versus 16.23913.83 days for LR-TACE (p0.21). The total hospital
charges is USD 380792322 for LR versus USD 431893883 for LR-
TACE (p0.23). The average re-admission days in 6-month period after
discharge from liver resection is 2.2495.11 days for LR versus 4.76910.52
days for LR-TACE. The difference is statistical significance (p0.03). The
average hospital charge for this period is USD 45991080 for LR versus USD
98392204 for LR-TACE. The difference is also statistical significance (p
0.03).
Conclusion. Preoperatvie TACE consumes more medical resource and
causes poorer long-tern survival, therefore, we suggest that preoperative
TACE should not be performed for resectable HCC.
FP 2.03
LAPAROSCOPIC VERSUS OPEN MINOR LIVER RESECTION
FOR HEPATOCELLULAR CARCINOMA
Lai, Eric C.H.; Tang, Chung Ngai; Yang, George P.C.; Tsui, David K.K.; Li,
Michael K.W.
Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Chai
Wan, Hong Kong SAR, Hong Kong
Introduction. Laparoscopic liver resection of hepatocellular carcinoma
(HCC) is a new option. The advantages of laparoscopic liver resection are
those of minimally invasive surgery, such as early recovery, shorter hospital
stay, and better cosmetic outcome. However, it is still a matter of debate
because of the uncertainty of the surgical outcome, and the fear of
compromising the oncological resection. The aim of this study was to
compare the surgical outcomes between laparoscopic and open approaches.
Methods. A retrospective non-randomized comparative study was per-
formed in a single tertiary center regarding the outcomes between laparo-
scopic and open minor liver resection of HCC from January 2001 to June
2007.
Results. During the study period, 22 and 25 patients with HCC underwent
laparoscopic minor liver resection and open minor liver resection in our
surgical unit, respectively. No differences in operation time (mean, 148.3
minutes vs. 135.6 minutes, p0.261), blood loss (mean, 389 ml vs. 575 ml,
p0.051), operative morbidity (18.1% vs. 20%, p0.083), and operative
mortality (0% vs. 4%, p0.083) were found between laparoscopic group and
open group. There was significant difference in hospital stay between
laparoscopic group and open group (mean, 7 days vs. 14.5 days, p
0.035). The 3-year disease-free survival rates of laparoscopic group and
open group were 46% and 32%, respectively (p0.98). The 3-year overall
survival rates of laparoscopic group and open group were 58% and 60%,
respectively (p0.56).
Conclusion. This study showed that, when compared with open approach,
laparoscopic minor liver resection for HCC has similar surgical outcome. In
addition, laparoscopic approach had benefit of shorter hospital stay. How-
ever, this procedure should be performed by surgical team expert in
hepatobiliary and laparoscopic surgery in properly selected patients. These
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favorable findings of laparoscopic resection for HCC certainly warranted
further investigations and studies.
FP 2.04
2250 HEPATECTOMIES FOR LIVER TUMORS: AN INVERSE
VOLUME-OUTCOME RELATIONSHIP
Azoulay, Daniel; Pascal, Gerard; Andreani, Paola; Andreani, Paola; Iacopi-
nelli, Marco; Adam, Rene´; Castaing, Denis, Aphp hopital Paul Brousse,
Villejuif, France
Objective. To assess the changes in liver resectional surgery over 20-years.
Methods. From 1985 to 2005, 2250 consecutive hepatectomies were
performed. Operative morbidity and mortality were analyzed. Trends over
the study period were analyzed.
Results. The diagnosis were colorectal metastases (n1110, 49.3%),
primary hepatic or biliary cancers (n625, 27.9%), miscellaneous malignant
disease (n355, 15.8%), and benign disease (n169, 7.1%). The liver
parenchyma was normal in 1756 cases (78.0%), cirrhotic in 237 cases (10%),
fibrotic in 106 cases (5%), steatotic in 110 cases (5%), cholestatic in 41 cases
(2%). Resections needed in 1775 cases (78.9%) some form of clamping
ranging from triad clamping to total vascular exclusion. Anatomical resec-
tions were performed in 1383 cases (61.5%). The mean blood transfusion
was mean1.74.5 blood units. Morbidity and mortality rates were 29.1%
and 2.4%. With experience, indications for liver resection were enlarged to
significantly more severe patients, and/or significantly more complex proce-
dures. This was realized at the price of significantly increased morbidity and
mortality rates (from 1985 to 1995 vs from 1995 to 2005, morbidity and
mortality rates were 21.6% vs 34.4% (pB0.0001) and 0.9% vs 2.9% (p
0.01) respectively. Mortality and morbidity rates were similar when compar-
ing patients of similar severity and/or resections of similar complexity. On
multivariate analysis, presence of cirrhosis or fibrosis, preoperative
bilirubin34 mmole/L, and transfusion were the only independent predictors
of both morbidity and mortality.
Conclusion. The present series, the largest reported so far, shows it is
possible to extend the indications for liver resection (most often the only
chance of cure) ‘‘at the price’’ of increased morbidity and mortality rates, still
acceptable. We consider this attitude as the responsibility of tertiary centers
compared to the one using experience to favor early results by a stringent
selection excluding high risk patients/and or procedures.
FP 2.05
The Survival Paradox Of Elderly Patients After Major Liver Resec-
tions
IJtsma, Alexander
University Medical Center Groningen, Surgery, Groningen, Netherlands
Objective. The objective of this study is to assess the short and long term
outcome of liver resections in the elderly in a matched control analysis.
Methods. From a prospective single center database of 628 patients
undergoing a liver resection, 132 patients were aged 60 years or over and
underwent a primary major liver resection. Of these patients, 93 could be
matched on a one-to-one basis with a control patient, aged less than 60 years,
with the same diagnosis and the same type of liver resection.
Results. The mean age difference was 16.7 years. The matched elderly
patients had a significantly higher American Society of Anesthesiologists
(ASA) grade. All other demographics and operative characteristics were not
different. In-hospital mortality was higher in the matched elderly patients (11
vs. 2%, p0.017). Morbidity rate was also higher in the matched elderly
patients (47 vs. 31%, p0.024). One, three, and five year survival rates in
the matched elderly patients were 81%, 58% and 42%, respectively
compared to 90%, 59% and 42% in the control patients (p0.558).
Conclusion. Besides achieving radical resections, the patients’ preoperative
ASA grade proved to be an independent and clinically significant predictor
regarding the outcome after major liver resection. This finding does not only
underline the obvious statement to strive for tumor free margins, but it also
urges those involved in preoperative patient selection for major liver
resections rather to consider the ASA grade than patient age as a predictive
factor for long term survival.
FP 2.06
CLINICAL SIGNIFICANCE OF THE TUMOR SIZE AS A POST-
OPERATIVE PROGNOSTIC FACTOR IN HEPATOCELLULAR
CARCINOMA PATIENTS
Kim, Dong-Goo; Lee, Kyung Keun; Kim, Sae June
Kangnam St. Mary’s hospital, Surgery, Seoul, Korea, Republic of
Introduction. In hepatocellular carcinoma, postoperative prognosis are
related to the morphologic feature such as tumor size and number and
biologic feature such as vascular invasion and tumor cell differentiation. In
preoperative state, the morphologic features of tumor could be evaluated
through the radiologic examination which is not accurate compare to
pathologic findings but the pathologic characteristic could not be revealed.
Methods. From Jan., 1995 to Sep. 2006, the 287 patient with hepatocellular
carcinoma who underwent the operations including surgical resection and
transplantation at Catholic University of Korea were evaluated. The patients
were grouped 4 categories by the tumor size and evaluated general
characteristics and tumor biology including vascular invasion and tumor
cell differentiation. The authors also evaluated the patient survival and
disease free survival according to tumor size and operative methods (resection
vs transplantation).
Results. The incidence of vascular invasion, poorly differentiation of tumor
cell and serum AFP level were increased significantly according to tumor size
(PB0.05). The survival rate and disease free survival rate after surgical
treatment were correlated to tumor size. (75.8% of less than 2 cm and 20.3%
of more than 10 cm in 5 years survival rate, PB0.05). In treatment method
including surgical resection and transplantation, the patients with smaller
tumor had more benefit by transplantation treatment in disease free survival
rate (PB0.05) but similar result in patient survival rate (P0.9). The
patients with large tumor were increased the survival and disease free survival
rate in surgical resection group.
Conclusions. The tumor sizes were closely related to tumor biology
(vascular invasion and tumor cell differentiation) and major prognostic factor
after surgical treatment in survival and disease free survival rate. Surgical
methods including resection and transplantation in patients with hepatocel-
lular carcinoma could be selected according to tumor size.
FP 2.07
THE NEED FOR HEPATIC VEIN RECONSTRUCTION IN PAR-
TIAL PROXIMAL HEPATECTOMY FOR LIVER TUMOR
Wu, Cheng-Chung; Cheng, Shao-Bin; Yeh, Dah-Cherng
Taichung Veterans General Hospital, Department of Surgery, Taichung,
Taiwan
Introduction. The need for hepatic vein reconstruction in partial proximal
hepatectomy (Couinaud¡js segment II, IVa, VII and VIII) with major hepatic
vein resection is controversial.
Methods. Among 1427 hepatectomies which were performed between 1991
and June 2007, 54 patients underwent partial proximal hepatectomies. Of
these 54 patients, 18 patients underwent hepatic vein reconstruction (group
A). During operation, the preserved distal part of the liver showed congestive
discoloration in all 18 patients. Of the remaining 36 patients without
undergoing hepatic vien reconstruction, the area of congestive discoloration
in 9 patients (group B) was1 Couinaud¡js segment, that of the other 27
patients (Group C) wasB1 Couinaud¡js segment.
Results. No patients died after hepatectomies, postoperative AST, ALT and
total bilirubin level was significantly higher in group B than group A and C.
No differences were found between group A and C. Postoperative ascites
complication occurred in all group B patients, while only 2 and 3 patients in
group A and C developed this complication. The postoperative hospital stay
and hospital costs in patients with morbidity is higher.
Conclusion. Hepatic vein reconstruction is needed in partial proximal
hepatectomy with resection of major hepatic vein when area of congestive
discoloration of distal liver is1 Couindaud¡us segment.
FP 2.08
Prognostic impact of anatomical and non-anatomical resection for
the hepatocellular carcinoma
Kang, Koo Jeong; Kim, Yong Hoon; Lim, Tae Jin
Keimyung University Dong-San Medical Center, Surgery, Daegu, Korea,
Republic of
Introduction. Anatomical resection of the liver including the tumor is
reasonable treatment option for better outcome than non-anatomical
resection in patients who have hepatocellular carcinoma.
Aim. We analyzed the surgically resected 147 HCC patients. Our point of
view in this study stands on the prognostic impact between types of surgical
resection or whether the patient factors are more important rather than the
type of surgical resection or not.
Method. Of one hundred and forty seven hepatectomies performed at
Keimyung University DSMC during 2000 to 2006, ruptured, laparoscopi-
cally resected, non-operatively treated patients(preoperatively) were ex-
cluded. One hundred and twenty nine patients were included in this study.
Survival analysis was performed to look at two different scopes of prognostic
factors, patients¡* factors including cirrhosis, ICG R15, tumor staging, and
surgical factors including anatomical or non-anatomical resection, amount of
bleeding, resection margin and ischemic time etc.
Result. Eighty anatomical resections, a sectionectomy or more hemihepa-
tectomy in 52 patients and systematic segmentectomy stained by injection of
methylene bule dye in the portal tributary in 28 cases, non anatomical
resection in 49 patients were performed. Significant prognostic factors in
univariate analyses include cirrhotics, ICG R15, tumor size and stage,
however only cirrhotics and tumor size were significant in multivariate
analysis. The type of resection was not appeared in the significant prognostic
factors.
Conclusion. Segmental resection is safe and allows complete resection of
liver tumors with more preservation of normal liver parenchyma, but the
patient and tumor factors are significantly important prognostic factors.
Anatomical resection including systematic segmentectomy was no survival
benefit in comparison to the non-anatomical resection.
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FP 2.09
PROGNOSTIC FACTORS AFFECTING SURVIVAL AFTER RE-
CURRENCE IN PATIENTS WHO UNDERWENT LIVER TRANS-
PLANTATION FOR HEPATOCELLULAR CARCINOMA
Shin, Woo Young; Suh, Kyung-Suk; Lee, Hae Won; Kim, Joohyun; Yi, Nam-
Joon; Lee, Kuhn Uk
Seoul National University College of Medicine, Department of Surgery,
Seoul, Korea, Republic of
Background. Liver transplantation is regarded as good treatment for early
hepatocellular carcinoma (HCC). However, some patients experience
recurrence and show rapid progression of disease. In present study, we
investigated prognostic factors affecting survival after recurrence in patients
who underwent liver transplantation for HCC.
Methods. From October 1992 to December 2005, 105 patients underwent
liver transplantation for HCC. Among these 23 (21.9%) recurred patients
were retrospectively reviewed. Mean age was 54.6 years. There were 18 men
and 5 women. All patients had past history of hepatitis B virus infection.
There were 4 deceased donor liver transplantations and 19 living donor liver
transplantations. Univariate and multivariate analyses were performed to
analyze factors affecting survival after recurrence.
Results. Mean recurrence time was 8.9 months. Mean survival time after
recurrence was 13.1 months and 1- and 3-year survival rates after recurrence
were 43.5% and 7.2% respectively. Initially, 4 patients showed multi-organ
involvement, however in the follow up 18 patients had multi-organ involve-
ment. On univariate analysis, preoperative AFP400 ng/ml, maximal size of
tumor5 cm, beyond pathologic UCSF criteria, major vessel invasion,
Edmondson-Steiner grade III and IV, 6th AJCC T3 and T4, recurrence
within 4 postoperative months, AFP400 ng/ml at recurrence, and extra-
hepatic recurrences were related with shorter survival after recurrence. On
Multivariate analysis, recurrence within 4 postoperative months (HR18.3,
p0.004), Edmondson-Steiner grade III and IV (HR8.4, p0.001) and
preoperative AFP400 ng/ml (HR3.5, p0.025) were identified on
independent prognostic factors of survival after recurrence.
Conclusion. After transplantation, recurred HCC has a tendency to involve
multi-organs, and prognosis is very poor. Hence, adjuvant treatment may be
considered in patients with preoperative AFP400 ng/ml and/or high grade
tumor.
FP 3.01
RAPID PROGRESSION OF AFP IN THE WAITING TIME OF
TRANSPLANTION FOR HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC PATIENTS: A POOR PROGNOSTIC FACTOR
Vibert, Eric1; Iacopinelli, Salvatore Marco2; Salloum, Chady2; Azoulay,
Daniel2; KARAM, Vincent2; Castaing, Denis2; Samuel, Didier2; Adam,
Rene´2
1Paul Brousse hospital (AP/HP), Centre Hepato Biliaire, Villejuif, France;
2Paul Brousse hospital (AP/HP), Centre Hepato-Biliaire, Villejuif, France
Introduction. Despite selective criteria, liver transplantation (LT) for
hepatocellular carcinoma (HCC) on cirrhosis is still associated with reduced
survival in patients with poor histological features. Rather than AFP static
level, AFP dynamic assessment on waiting list may be more relevant to
predict patient outcome after LT in Milan Criteria.
Objective. Assessment of the prognostic value of AFP rapid progression
before LT.
Methods. AFP progression was defined according to preliminary results as a
slope of AFP15 ng/ml by month. From 1987 to 2005, among 252 cirrhotic
patients transplanted for HCC, 153 primarily transplanted patients for AFP
secreting HCC were analysed: 26 (16%) were transplanted with AFP
progression and 126 (82%) were transplanted during a period of low increase
or decline of AFP level. The two groups were compared with regards to
preoperative and histological data. A uni- and multivariate analysis of
prognostic factors of overall survival (OS) and disease-free survival (DFS)
was made.
Results. Preoperatively, both groups were similar except for the rate of AFP
higher in the progression group (p0.0001). After median follow-up of 45
months, 5-year OS and DFS was 72% and 69% respectively, in the total
cohort. In the progression group, 5-year survival was significantly lower to
those of the no progression group (OS 77% versus 54%, p0.02 DFS 74%
versus 47%, p0.01). In multivariate analysis, AFP progression was a
preoperative factor independently associated with OS and DFS decrease
with, respectively, a preoperative number of nodule3 for OS and an age60
years for DFS. With regard to pathological analysis, satellite nodules (p0.02)
and vascular invasion (p0.01) were more frequent in the progression group.
Conclusion. As a surrogate marker of poor tumoral pathological features,
AFP progression is the more relevant preoperative prognostic factor for OS
and DFS after LT. Hence, a reappraisal of therapeutic strategy should be
done in case of rapid progression of AFP on waiting list.
FP 3.02
LIVER TRANSPLANTATION AND MORBID OBESITY: A MULTI-
CENTER STUDY
Shokouh-Amiri, Hosein1; Santiago, Vera2; Gaber, Osama3; Mehrazin, Reza4;
Nezakatgoo, Nostratollah4; McMillan, Robert5; Mook, Julie5; LaRoux,
Sarah5; Cataldo, Doria3; Ranjan, Dinesh6; Zibari, Gazi5
1Louisiana State University Health Sciences Center, Surgery, 1501 Kings
Highway, Shreveport, United States; 2Methodist University Hospital, Sur-
gery, Memphis, United States; 3Methodist Hospital, Surgery, Houston,
United States; 4Methodist University Hospital Transplant Institute, Surgery,
Memphis, United States; 5Louisiana State University Health Sciences
Center, Surgery, Shreveport, United States; 6University of Kentucky Medical
Center, Surgery, Lexington, United States
Background. Severe obesity has increased to more than 35% in the U.S.
Patients with morbid obesity (BMI40 kg/m2) are being referred for liver
transplantation. Reports have suggested increased early morbidity and
mortality for obese patients undergoing liver transplantation.
Purpose. To evaluate several centers experiences transplanting livers into
patients with morbid obesity (BMI40 kg/m2).
Method. A retrospective, IRB approved, chart review of first transplant,
deceased donor liver transplantation at four centers (1 & 2 actively
transplanting, and 3 & 4 sporadically transplanting morbidly obese patients)
from 1992 to 2006 was undertaken. There were a total of 633 patients in
centers 1 and 2. There were 34 patients identified with BMI40 (Group I),
48 patients with BMI 35B40 (II), 123 patients with BMI30B35 (III)
and 428 patients with BMI B30 (IV). Demographic data were gathered.
Outcomes measured include perioperative mortality, length of stay, 1 and 5
years patient and graft survival. In centers 3 and 4, there were 8 patients with
BMI 40 kg/m2 among 980 liver transplants.
Results. Demographic data were similar in all groups, as well as distribution
of MELD. One perioperative mortality was encountered in Group I. Five
patients from Group I died within 3 months, all with high MELD. Similar 3
month mortality was found in all groups (14.7% vs 12.5% vs 13.8% vs 14.9%
respectively). Length of stay was similar in all. There was a correlation
between MELD and length of stay independent of BMI. One and five year
patient survival were similar in all, independent of their BMI (83% and 77%
vs 81% and 73% vs 84% and 74% vs 84% and 74% respectively in Groups I,
II, III and IV). In center 3 and 4, no preoperative mortality was encountered
and their long term survival was similar to the rest of their patient population.
Conclusion. Outcomes of liver transplantation are not adversely affected by
severe morbid obesity, therefore; morbid obesity alone should not be
considered a contraindication for liver transplantation.
FP 3.03
A SYSTEMATIC REVIEW OF COST OF LIVER TRANSPLANTA-
TION
Van der Hilst, Christian1; IJtsma, Sander2; Slooff, Maarten2; TenVergert,
Elisabeth2
1University Medical Center Groningen, University of Groningen, Gronin-
gen, Netherlands; 2University Medical Center Groningen, University of
Groningen, Hepatobiliary Surgery and Liver Transplantation, Groningen,
Netherlands
Background. Studies concerning costs of liver transplantation (LTx) are
heterogenous regarding included patients, methods of assessing costs,
inclusion of procedural phases, health systems, and year of publication.
Consequently, a large variation in costs is observed.
Aim. The aim of this study was to improve insight into the differences in cost
of LTx by performing a systematic review.
Methods. Eight databases were searched without language restriction
(MeSH and full text). In total, 2000 citations were identified of articles
published between 1990 and 2006. Thirtyfour articles were found eligible for
data extraction. Information on clinical admission for LTx until discharge
were extracted and compared. All costs were expressed in US$ (pricelevel:
2005). Differences between health care systems, changes in cost for LTx over
time, different methods of assessing costs, and differences between adult and
pediatric recipients were assessed.
Results. In total, 6107 LTx were included in the review. The reported
inflation-corrected mean cost per LTx was $159,517. Mean cost of studies
varied from $18,891 to $434,129. LTx performed in the US were most
expensive, followed by Japan, Europe, and South-America. The difference
between the US, Japanese, European, and South-American health care
systems was the most important factor explaining cost differences. Cost
differences did not depend on the method of assessment. The inflation
corrected mean costs were stable over time. No important differences in costs
between pediatric and adult LTx were observed.
Conclusion. Important differences in costs were observed between different
health care systems. Differences were independent of methods of cost
assessment. The higher cost of LTx in the US was in line with the higher
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cost of the US health care system compared to other health care systems.
Costs remained stable over time indicating that in view of the improved
results of LTx and the increase in numbers of LTx performed over the years,
cost effectiveness has improved.
FP 3.04
FINANCIAL COMPARISON OF ADULT-TO-ADULT LIVER
TRANSPLANTATION FROM LIVING- VS DECEASED-DONORS
Mohanka, Ravi; Kayler, Liise; Tom, Kusum; Fontes, Paulo; Dvorchik, Igor;
DeVera, Michael; Soltys, Kyle; Blisard, Deanna; Sharma, Vivek; Starzl,
Thomas; Marcos, Amadeo
University of Pittsburgh Medical Center, Thomas E Starzl Transplantation
Institute, Pittsburgh, United States
Background and Objective. Liver transplantation is one of the most costly
surgical procedures performed today. Live-donor liver transplantation
(LDLT) may be more financially advantageous over deceased-donor liver
transplantation (DDLT) due to the opportunity to select patients who are less
ill and to operate in an elective manner; however, few studies have addressed
this issue.
Methods. Between January 2001 and December 2004, 833 consecutive
adult liver transplants (LDLT 74, DDLT 758) were analyzed. Charges were
recorded for the following time periods: (1) pretransplant, 90 days before
transplantation, (2) the transplant hospitalization, and (3) posttransplant,
365 days after the transplant hospitalization. Charges were expressed as an
arbitrary charge unit (ChU) that is a value between $5,000 and $15,000.
Results. Compared with DDLT, the average ChU for LDLT was threefold
lower for pretransplant care (pB0.0001), 22% lower for the transplant
admission (p0.0316), and 8% lower for post-hospitalization medical care
(p0.2113). Baseline characteristics indicated a healthier status of the
LDLT group who exhibited significantly lower MELD scores ( pB0.0001),
shorter average 90-day pretransplant hospital length of stays (p0.0091),
shorter average time on the liver transplant waiting list ( pB0.0001), and
proportionately less requirement for pretransplant mechanical ventilation
(p0.0320], compared to DDLT recipients.
Conclusion. The magnitude of the cost advantage for living- over deceased-
donor transplantation depends greatly on recipient health.
FP 3.05
LIVER TRANSPLANTATIONS WITH DONORS OVER 60 YEARS
OLD COULD HAVE THE SAME OUTCOME AS WITH YOUNGER
DONORS
Ravaioli, Matteo; Grazi, Gian Luca; Cescon, Matteo; Cucchetti, Alessandro;
Ercolani, Giorgio; Del Gaudio, Massimo; Vetrone, Gaetano; Zanello,
Matteo; Lauro, Augusto; Tuci, Francesco; Dazzi, Alessandro; La Barba,
Giuliano; Zanfi, Chiara; Bertuzzo, Valentina; Di Gioia, Paolo; Vivarelli,
Marco; Pinna, Antonio Daniele
S. Orsola-Malpighi Hospital; University of Bologna, Liver and Multi-organ
Transplantation, Bologna, Italy
Background. According to liver transplant registries, the survival of grafts
from older donors is lower than with younger donors. We sought to
determine whether donor selection by liver biopsy would positively influence
the outcome.
Methods. from a prospectively collected database in the period 19992005
we retrospectively reviewed the outcomes of 89 patients who received a liver
from a donor ] 60 years after a histologically evaluated liver biopsy and with
the shortest possible ischemia time (group D]60). These outcomes were
compared with the outcomes in 198 matched recipients, whose livers were
not histologically evaluated. Their donors wereB60 years in 89 cases (group
DB60-, positive-reference who were expected to have an optimal outcome)
and ] 60 years in 89 cases (group D]60-, negative-reference, expected to
have a worse outcome).
Results. In terms of study design, the recipient features were comparable
among the three groups according to age, sex, viral infection (HCV vs. no-
HCV) and MELD score, but group D]60 had a lower ischemia time than
the other groups: mean value 4159106 minutes vs. 4659111 (DB60-), pB
0.05 and vs. 476994 (D]60), pB0.05. After a median follow-up of 3
years, the 1 and 3 year graft survival of group D]60 (84% and 76%) was
comparable to group DB60 ( 89% and 76%) and was significantly higher
than group D]60 (71% and 54%), pB0.005.
Conclusions. histological selection and low ischemia time allow equivalent
graft outcome after liver transplantation between grafts from older and
younger donors.
FP 3.06
Societal reintegration and Economic implications following orthoto-
pic liver transplant
Molinari, Michele; Gillis, Amy; Walsh, Mark
Dalhousie University, Surgery, Halifax, Canada
Background. Data on the impact of OLTon the patients’ integration in their
communities and its financial consequences at a personal and familiar level
are lacking. Primary aims of this study were to assess employment rate,
productivity and activity index of patients after OLT in Atlantic Canada.
Methods. From September 2006 to January 2007 a cross sectional study was
performed using validated Work Productivity and Societal Reintegration
Questionnaires. Participants were interviewed by phone or during follow-up
visits and were adults at least 3 years post OLT, without communication
impairments. All data were prospectively collected. Categorical data were
analyzed by Chi-Square and Student’s t test for continuous variables; P
values less than 0.05 with two tail distribution were considered significant.
Results. Among eligible 158 patients, 47 were randomly selected. 45 (95%)
participated and 2 declined for personal reasons. 15 patients (33%) were full
time employed and 12 (52%) were employed in the same position as before
OLT. 13 individuals (28%) were on disability while the remaining were
students or housekeepers. 11 patients (24%) had retired. After OLT, 19
patients (42%) experienced financial restrictions preventing access to care or
necessary medications due to significant reduction in their annual personal
($28,300 vs 26,500, PB0.005) and household income (44,000 vs 43,700,
PB0.05). Overall, 77% patients reported that OLTx had a negative impact
on their financial status in comparison to their pre-OLT status (PB0.005).
However, productivity and activity index showed overall acceptance of
current societal role and sequlae of OLTx had little impact on activities of
daily life at this time.
Conclusion. In Atlantic Canada, patients undergoing OLTx for end stage
liver disease have an employment rate of 33%, consistent with available
literature. Socially, 84% of patients are satisfied with their current role in
society and are able to perform most daily activities without difficulty.
FP 4.01
ISOLATED SEGMENTAL BILE DUCT INJURY AFTER LAPARO-
SCOPIC CHOLECYSTECTOMY. CLINICAL PRESENTATION, DI-
AGNOSIS, TREATMENT AND LONG TERM OUTCOME
de Reuver, Philip1; Grossmann, Irene1; Rauws, Erik2; Busch, Olivier1; van
Gulik, Thomas1; Gouma, Dirk1
1Academic Medical Centre, Surgery, Amsterdam, Netherlands; 2Academic
medical centre, Gastroenterology, Amsterdam, Netherlands
Background. Isolated segmental bile duct injury (ISBDI) is a distinct type
of bile duct injury seen after laparoscopic cholecystectomy. The aim of this
study was to determine the prevalence, clinical characteristics, diagnostic
modalities and treatment outcome in ISBDI patients.
Patients and Methods. ISBDI patient data, obtained from a consecutive
series of 500 bile duct injury patients referred to a tertiary centre, were
analyzed. Patient characteristics, diagnostic modalities and treatment out-
come were determined.
Results. Forty-two patients (8%) were identified among 500 bile duct injury
patients having ISBDI. In only 5 patients (12%) ISBDI was diagnosed before
referral to a tertiary centre. Postoperative symptoms in ISBDI patients are
not different from overall bile duct injury patients. The mean interval
between referral and accurate diagnosis was 1269361 days. Eighteen
patients (31%) underwent surgery, 16 patients underwent endoscopy
(38%) and 6 patients (14%) were treated by percutaneous radiological
intervention. Surgical and endoscopic therapy of ISBDI patients is associated
with higher morbidity compared to BDI patients. Postoperative abscesses
occurred in 22% (4/18) in ISBDI patients vs. 7% (10/133) in BDI patients,
p0.044; endoscopic failure 25% (2/8) in ISBDI patients vs. 4% (3/85) in
BDI patients, p0.057).
Conclusion. ISBDI is a rare complication, difficult to diagnose, and
associated with more treatment related morbidity compared to general bile
duct injury patients.
FP 4.02
COMMON BILE DUCT INJURIES DURING CHOLECYSTECT-
OMY IN A POPULATION-BASED COHORT OF 1171 PATIENTS
Sandblom, Gabriel1; Videhult, Per2; Ljungdahl, Mikael3; Wollert, Staffan3;
Darkahi, Bahman4; Karlson, Britt-Marie3; Rasmussen, Ib Chirstian3
1University Hospital, Department of surgery, Lund, Sweden; 2Ersta Hospi-
tal, Department of surgery, Stockholm, Sweden; 3University Hospital,
Department of surgery, Uppsala, Sweden; 4Enko¨ping Hospital, Department
of surgery, Enko¨ping, Sweden
Background. Although common bile duct injury (CBDI) is considered one
the most feared complication during cholecystectomy, it is so rare that in
order to understand the epidemiology of CBDI we have to rely on large
register studies.
Objective. The purpose was to assess the frequency and outcome of CBDI
as a complication to cholecystectomy in a population-based setting.
Method. All patients operated on for gallstone disease between 2003 and
2005 in the county of Uppsala, a county with 303 000 citizens in Sweden,
were registered prospectively.
Result. 1171 operations were registered. IOC was performed in 95% of the
operations. The indication for surgery was ongoing cholecystitis in 114
(12%) patients, history of conservatively treated cholecystitis in 235 (20%)
patients, and biliary colic in 813 (63%) patients. The operation was
performed as a laparoscopic procedure in 79%. Nine cases of significant
anatomical variants were recorded. In four cases these anatomical variants
included an unusually short cystic duct, predisposing to CBDI in two of the
operations. Four cases of CBDI (0.3%) were recorded. The CBDI included
one perforation of the common bile duct (CBD) caused by the cholangio-
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graphy catheter and one accidental application of a clip on the common bile
duct (CBD) followed by CBD incision. Both these CBDI were treated
successfully with a T tube In the third case an accidental CBD incision was
repaired with a direct suture. In the last case total ligation and division of the
right hepatic duct necessitated a reoperation and a bile duct reconstruction.
Conclusion. Common bile injuries are rare (0,3%) even in routine
cholecystectomies. The injuries do not necessarily occur in complicated
cases. Only one case needed more extensive surgery whereas the other three
could be handled during the cholecystectomy. All patients performed well
during follow-up. A prospective registration may help to improve quality and
identify the reasons for serious complications.
FP 4.03
TYPE ‘‘C’’ EXTRAHEPATIC BILIARY ANATOMY  THE SUR-
GEON’S PITFALL?
Rohatgi, Sanjeev1; Shivathirthan, Nairuthya1; Sheik, Vasim3; Kamat, Di-
nesh1; Haldar, Premashish1; Mathur, Surendra Kumar1
1Jagjivan Ram Hospital, Western Railway Hospital, Dept of G.I. Surgery,
Maratha Mandir marg, Mumbai Central, Mumbai, India; 2Jagjivan Ram
Hospital, Western Railway Hospital, Dept of Surgery, Mumbai, India
Introduction. Bile Duct Injury (BDI) following Cholecystectomy is a
catastrophe.
Aims and Objectives. This retrospective study analyses 40 BDI patients in
last 6 years admitted in this hospital, with aims to identify certain parameters
which probably contributed to their injury. The study attempts to correlate
the type of injury incurred based on the anatomy of the Extrahepatic Bile
Duct & the patient parameters.
Materials and Methods. Patient’s parameters studied were Sex, Body Mass
Index (BMI), and history of Acute Cholecystitis and Cholangitis. Extra-
hepatic Biliary Anatomy was mainly studied by MRCP. Selectively ERCP,
TTube Cholangiograms, PTBD & Fistulo grams were used.
Results. The study revealed that the commonest type of BDI was Strasberg’s
Type-E (25/40 patients 62.5%) with E-2 being the maximum (11/40 patients
27.5%). Variation of Extrahepatic Biliary Anatomy was seen in 31/40
(77.5%) the commonest variant was C-Type where the Right posterior
Sectoral duct joins the Common hepatic Duct or the Left Hepatic Duct (16/
40 patients 40.0%) Comparison of the type of the biliary anatomy with the
type of BDI revealed that the Type-E BDI were more common with Type-C
anatomy. Other factors like Male Sex, BMI 30, episodes of acute
cholecystitis and cholangitis individually showed statistical significance at
5% levels with P values of 0.011, 0.004, 0.001 and 0.011 respectively.
Maximum female patients were seen in Type C and E-2 injury.
Conclusion. Anatomical variation of the extrahepatic bile duct is one of the
very important factors which determined the Bile Duct Injury in this study.
The study showed assosciation of type of injury and anatomical parameters
highly significant at 5% level (P value0.002) Anatomical variation of the
C1 & C2 type had the maximum number of the bile duct injury and the
higher level of injury. Patient (Male Sex & Obesity) & Inflammatory (Acute
Cholecystitis & Cholangitis) parameters are additional contributory factors.
An awareness of the dangerous Type-C anatomy is highlighted in this study.
FP 4.04
LONG TERM FOLLOW UP FOLLOWING REPAIR OF BILE DUCT
INJURY  COMPARATIVE DATA ON IMMEDIATE AND EARLY
REPAIR VERSUS LATE; A SINGLE UK CENTRE EXPERIENCE
Silva, Michael A; Perera, Thamara; Hegab, Bassem; Mayer, David; Bram-
hall, Simon R; Buckels, John A C; Mirza, Darius F
University Hopsital Birmingham NHS Trust -Queen Elizabeth, The Liver
Unit, Birmingham, United Kingdom
Background. The incidence of iatrogenic bile duct injuries (BDI) during
laparoscopic cholecystectomy is 0.30.6%. We present our experience in the
management of BDI.
Method. Data was collected prospectively between 1991 and 2007. Long
term outcome in terms of reintervention and morbidity were recorded in
immediate ‘on-table’ repair (group 1), early (within 21 days) (group 2) and
late repair (group 3). Strasberg’s classification was used to stage BDI.
Results. There were 163 patients referred with bile duct injury related
problems, 53 (33%) male, median age 53 years (20  83). Median days to
referral was 20 (0  241 months) following injury. Seventy five percent (122)
were type E injuries, with 15% type D while type C, B and A accounted for 8
(5%), 2 (1%) and 6 (4%) respectively. Median follow-up after initial BDI was
75 (1  355) months. Ninety nine of 135 (99/135; 73%) surgically managed
patients underwent repair at our centre {19 (19%), 37 (37%) and 43 (44%)
in each group respectively}. Four patients (4/37; 11%) in group 2 needed
revision compared to none (0/19) and 01 (1/43; 2%) in group 1 and 3
respectively (p0.12). There was no difference in the need for non-surgical
intervention (13%, 18% and 11% respectively; p0.86), incidence of
recurrent cholangitis (13%, 16% and 5% respectively; p0.19) and biliary
stricture (17%, 11% and 21% respectively; p0.4) among the three groups.
No difference was observed in each group in terms of morbidity free long
term follow up (Long term morbidity; 11, 29 and 20 patients respectively:
p0.97).
Conclusion. On table and early repair of BDI has a good out come with long
term results in terms of morbidity being comparable with that of late.
FP 4.05
BILE DUCT INJURIES FOLLOWING CHOLECYSTECTOMY FOR
GALL STONE DISEASE: SURGICAL AUDIT FROM A TERTIARY
CARE CENTER IN NORTH INDIA
Ranjit, Hari V; Anand, Prakash; Biju, Pottakkat; Anu, Behari; RK, Singh;
Ashok, Kumar; Rajan, Saxena; VK, Kapoor
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Department of
Surgical Gastroenterology, Lucknow, India
Background. There have been few reports of bile duct injury (BDI)
following cholecystectomy (Ccx) from tertiary care institutions.
Objectives. To study the incidence, management and outcome of BDI
following Ccx.
Methods. Retrospective analysis of data of BDIs sustained during about
5700 Ccxs performed for gall stone disease between January 1989 and June
2007.
Results. Laparoscopic cholecystectomy (LC) was attempted in about 4300
and completed laparoscopically in about 4000 patients; open cholecystect-
omy (OC) was done in about 1400. There were 57 BDIs  47 in attempted
LC and 10 in OC. Major BDIs (25/57) included bile duct transection (type
E) in 8, lateral CBD injury (type D) in 14 and injury to aberrant duct (type
C) in 3 patients; minor BDIs (8/57) included injury to subvescical duct (type
A) in 3 and cystic duct leak (type A) in 5 patients; BDIs could not be
classified in 24/57(43%) patients. 22/57(38%) injuries were detected intra
operatively and definitive repair was done in 21 (RYHJ-7, CBD repair with T
tube drainage -5 and primary repair  9). 35/57 (62%) injuries were detected
post operatively; they presented as biloma in 15, bile leak in 16 and biliary
peritonitis in 4. Of 35 patients with injury detected post operatively, 15
underwent endoscopic stenting and 9 had percutaneous drainage (8 of these
had combined endoscopic and percutaneous management and 7 required
surgical re-exploration) and 11 were managed conservatively. 5/57 (9%)
patients with BDI died-4 had biliary peritonitis and 1 had biloma; one patient
who died had associated vascular injury also. The cause of death was sepsis in
all cases. On follow up, one patient developed bile duct stricture, which was
managed endoscopically.
Conclusion. BDIs can occur even in experienced hands at tertiary centres.
Incidence of major BDI was 0.4% in 5700 Ccx performed by us. Early
detection of BDI and the judicious management with a combination of
endoscopic, percutaneous and surgical methods can reduce the morbidity
and mortality.
FP 4.06
SURGICAL MANAGEMENT OF PORTAL BILIOPATHY IN EHPVO
Ponnambathayil, Shaji; Dhar, Puneet; Surendran, Sudhindran; OV, Sudheer
Amrita Institute of Medical Sciences, GI and HPB Surgery, Cochin, India
Background. In portal hypertension particularly in extra hepatic portal
venous obstruction (EHPVO) functional or structural biliary changes may
result in extensive porto-venous collaterals which is termed portal biliopathy.
We review our experience in surgical management in patients of symptomatic
portal biliopathy.
Methods. Over the last 8 years 93 patients presented with EHPVO of whom
23 required surgical management. Of these, 7 had features of portal
biliopathy. We present a review of these EHPVO patients with portal
biliopathy from a prospectively maintained computerised database.
Results. Presenting features were jaundice in 5 (cholangitis in 4); Gastro-
intestinal bleeding in 3 and symptomatic hypersplenism in one. Commonest
structural change observed was combined involvement of extrahepatic and
bilateral intrahepatic biliary system (Type III b, n5). Five patients had
Common bile duct calculi and 2 had gall bladder calculi. Three patients
underwent portosystemic shunting and 4 patients had hepaticojejunostomy
(without severe portal hypertension or manifest GI bleed), although they
were prepared for a shunt as well. One patient each in shunt and bypass
groups developed recurrent cholangitis but responded to conservative
management. A patient with hepaticojejunostomy required a subsequent
shunt for ectopic variceal bleed. Follow-up serum Bilirubin reduced faster
(Range 457 weeks) than alkaline phosphatase levels (Range 4208 weeks).
Conclusions. EHPVO is not very rare in South India. Jaundice is the
commonest presentation, and Type III b is the most frequently encountered
anatomical anomaly. Surgery can relieve most symptomatic patients. Direct
hepaticojejunostomy is possible in selected patients without severe portal
Hypertension.
FP 5.01
PROPOSAL OF NEW CLASSIFICATION FOR CYSTIC DUCT
CARCINOMA
Yokoyama, Yukihiro; Nishio, Hideki; Ebata, Tomoki; Abe, Tetsuya; Igami,
Tsuyoshi; Oda, Koji; Nimura, Yuji; Nagino, Masato
Nagoya University Graduate School of Medicine, Surgery, Nagoya, Japan
Background. Farrarfs criteria for cystic duct carcinoma (histopathologic
diagnosis of a carcinoma strictly limited to the cystic duct) are impractical
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especially when making diagnosis of primary cystic duct carcinoma in its
advanced stage. Therefore, in our previous study, we proposed a new
definition of cystic duct carcinoma: a gallbladder tumor, the center of which
is located in the cystic duct. In this study, we further propose a new
classification for cystic duct carcinomas diagnosed by our definition.
Methods. This study included 44 surgical patients with cystic duct
carcinoma diagnosed by our criteria. These patients were further classified
into two groups: hepatic hilum type (HH, n29) in which the tumor mainly
invades the hepatic hilum, and cystic confluence type (CC, n15) in which
the tumor mainly involves the confluence of the cystic duct. The clinico-
pathologic features of these two groups were retrospectively analyzed.
Results. There was more papillary or well differentiated adenocarcinoma in
CC type as compared with HH type. The perineural and vascular invasion
were more common in HH type than in CC type. The survival rate tends to
be higher in CC type than in HH type (P0.064). Moreover, we found a
significantly different gender ratio between these two groups (female was
predominant in HH type, whereas male was predominant in CC type).
Conclusion. Our new classification showed two distinct types of cystic duct
carcinoma, which may help in making diagnosis and planning treatment
strategy for an advanced biliary carcinoma originated in the cystic duct.
FP 5.02
ADJUVANT THERAPY AFTER SURGICAL RESECTION IN
STAGE III GALLBLADDER CANCER
Dulla, K V Prasad1; Behari, Anu1; Rastogi, Neeraj2; Singh, Rajneesh K1;
Kumar, Ashok1; Saxena, Rajan1; Kapoor, Vinay K1
1SanjayGandhi PostGraduate Institute of Medical Sciences, Gastrosurgery,
Lucknow, India; 2SanjayGandhi PostGraduate Institute of Medical Sciences,
Radiotherapy, Lucknow, India
Background. Surgical resection is the treatment of choice for gallbladder
cancer (GBC). A large number of patients, however, have recurrence after
surgical resection.
Aim. This study is aimed to know the effect of adjuvant therapy on overall
survival after surgical resection in patients with loco-regionally advanced
GBC.
Methods. Between 1989 and 2005, 108 patients with stage III GBC
underwent resection [simple cholecystectomy (SC) n66 or extended
cholecystectomy (EC) n42] with or without adjuvant therapy. 63 patients
who received post-operative adjuvant therapy (Group A) were compared with
45 patients who did not receive any adjuvant therapy (Group B). Adjuvant
therapy included external radiotherapy and chemotherapy with 5-flurouracil.
Results. Age, sex, clinical presentation and surgical procedures were
comparable between the two groups. Group A included 37 (59%) patients
who underwent SC and 26 (41%) patients who underwent EC. Group B
included 28 (62%) patients who underwent SC and 17 (38%) patients who
underwent EC. Median survival in Group A was 19 (mean38) months
compared to 11 (mean17) months in group B (p0.001). 12 of 13
patients who survived beyond 5 years had received adjuvant therapy. Median
survival of patients undergoing SC alone, SC with adjuvant therapy, EC
alone and EC with adjuvant therapy was 10, 17, 17 and 25 months,
respectively, with no statistical difference in survival between the last three
groups.
Conclusions. In patients with stage III GBC adjuvant therapy improved
survival. Patients who underwent simple cholecystectomy with adjuvant
therapy had similar survival as those who underwent extended cholecystect-
omy.
FP 5.03
THE RECENT CHANGING PATTERN OF SURGICAL TREAT-
MENT AND OUTCOMES IN PATIENTS WITH GALLBLADDER
CANCER: 18 YEAR SURGICAL EXPERIENCE
Yang, Sung Hoon
Seoul National University College of Medicine, Surgery, Seoul, Korea,
Republic of
Methods. From 1987 to 2004, 368 consecutive patients surgically treated for
GB cancer were included in this single?center analysis. We divided the 18 year
study period into Period I (19871995) and Period II (19962004). Clinical
characteristics, changing patterns of surgical treatment and outcomes were
compared between two periods.
Results. The incidental detection without symptoms was increased more
than twice (p0.015). The patients with stage 0 and I was similar between
two periods (p0.410). The patients with stage II was significantly increased
than previous period I (p0.037), but the patients with stage III and IV was
significantly decreased (p0.045). In the patients with T1 or T2 disease,
there were no significant differences according to the surgical procedures
between two periods (p0.05, all). In the patients with T3 and T4 disease,
the proportion of SC decreased significantly (pB0.001), but that of
aggressive surgery including major hepatectomy and/or pancreaticoduode-
nectomy (PD) increased significantly (p0.002). The operative mortality
and curative resection rate were not significantly different between the two
periods (p0.256 and p0.154, respectively). The overall 5-year survival
for patients underwent surgical treatment was improved (21.1%?41.5%) and
5-year survival for patients underwent curative resection was improved
(42.9%-67.8%). The 5-year survival for the patients underwent major
hepatectomy and/or PD were improved (0%-35.6%).
Conclusions. The improved surgical outcome compared with the previous
period is may be due to the increase of the detection for early stages, the
increase of aggressive surgery including major hepatectomy and/or PD for the
advanced stage.
FP 5.04
FIVE-YEAR SURVIVORS AFTER SURGERY FOR GALLBLAD-
DER CANCER INVOLVING THE EXTRAHEPATIC BILE DUCT
Nishio, Hideki; Ebata, Tomoki; Igami, Tsuyoshi; Yokoyama, Yukihiro;
Uehara, Keisuke; Abe, Tetsuya; Oda, Koji; Nagino, Masato
Nagoya University Graduate School of Medicine, Division of Surgical
Oncology, Nagoya, Japan
Background. Outcome of surgery for gallbladder cancer (GBC) involving
the extrahepatic bile duct (EHBD) is dismal and five-year survivors have been
rarely reported.
Aim. To clarify clinical features of the long-term survivors.
Methods. One hundred three patients who underwent surgery for GBC
involving EHBD between August 1978 and July 2002 were surveyed for more
than 5 years after surgery and were enrolled in the study. Clinical and
histological features were analyzed.
Results. The study patients consisted of 33 men and 70 women with an
average age of 63 years. There were eleven 5-year survivors (5-year group)
with 12% of 5-year survival rate, consisting of 6 men and 5 women.
Gallbladder cancer was located at the neck in 5, both the body and the neck
in 2, and the cystic duct in 4. Various hepatic resections were performed in 8
patients (major resection, n7), whereas, the remaining 3 underwent
cholecystectomy with EHBD resection. Although all patients underwent
R0 resection for M0 disease, regional lymph node metastasis was found in 3
patients. The 5-year group was compared with 33 patients who underwent
R0 resection for M0 disease but did not survive for 5 years after the surgery
(non 5-year group). Univariate analyses using 13 variables revealed that
Igperineural invasionIh (p0.096) and Iglymph node metastasisIh
(p0.078) tended to be associated with the non 5-year group.
Conclusions. There was no significant difference between the 5-year and the
non 5-year groups. GBC involving EHBD should be aggressively resected as
only curative resection can offer long-term survival for patients with the
advanced tumor.
FP 5.05
IS RESECTION OF EXTRAHEPATIC BILE DUCTS AN ESSEN-
TIAL COMPONENT OF RADICAL SURGERY FOR GALLBLAD-
DER CANCER IN NONJAUNDICED PATIENTS?
Singhal, Dinesh; Chaudhary, Adarsh
Sir Ganga Ram Hospital, Surgical Gastroenterology, New Delhi, India
Background. Gallbladder cancer (GBC) without jaundice is an uncommon
clinical entity. The role of routine extrahepatic bile duct (EHBD) resection in
such patients during radical cholecystectomy (RC) remains to be elucidated.
We resect EHBD for specific indications only and have prospectively
evaluated the oncologic validity of our policy.
Patients and Methods. Thirty consecutive non-jaundiced GBC patients
(Group I, EHBD resection, n12 and Group II, EHBD preserved, n18)
underwent RC between 20032007. The main outcome measures were
perioperative complications, microscopic R0 resection, medium term disease
free survival (DFS).
Results. There were 15 males and 15 females, median age of 51 (range 30 
72) years. The two groups were comparable for demographic data, post-
operative complications, hospital stay and histopathological stage. At Kaplan
Mier analysis, the median DFS was significantly associated with T stage (P
0.004), N stage (P0.003) and TNM stage (P0.005) but not with EHBD
resection (P0.802). Cox regression analysis showed that only the TNM
stage (P0.04) was the independent predictor of DFS.
Conclusions. Following RC for non-jaundiced GBC patients, DFS is
determined by TNM stage and not EHBD resection. Hence extrahepatic
bile duct resection may be performed for specific indications only.
FP 5.06
GALLBLADDER POLYP: CRITICAL APPRAISAL
Aldouri, Amer; Malik, Hassan; Lodge, Peter; Prasad, K R; Wyatt, Judi;
Dexter, Simon; Toogood, Giles
St james’s university hospital, Leeds, United Kingdom
Gallbladder polypoid lesions (GBP) are relatively common findings on US
examinations (4%), in the majority of cases they are benign; however
gallbladder cancer (GBC) could present as GBP or arise from adenomatous
GBP, especial in high-risk patients. Researchers from Mayo clinic advocated
cholecystectomy for GBP in patients with primary sclerosing cholangitis. We
retrospectively analysed all patients who had US examinations in Leeds
Teaching Hospitals NHS Trust (LTH) aiming to find whether GBP in
patients who migrates from high risk area (India) are more likely to be
malignant compared to that in White people. Between January 1998 and July
2006, 137655 abdominal US examinations performed in LTH. All reports of
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these US have been retrieved from our radiology department database and
reviewed retrospectively. After exclusion of follow-up that and US performed
for renal or pelvic organs, 71431 US reports were included in this analysis.
All pathology reports of gallbladders removed during the same period (5780)
have been included in the analysis. Single GBP detected in 2% (No. 1431) of
all examined patients, stratification of data according to ethnic background
revealed that 1.9% (1341) of white patients had single GBP, 2.2% (26) of
Indian and 1.8% (64) of others ethnic subgroups. GBC diagnosed in 28
patients, four had GBP diagnosed by US. The prevalence of GBC in White
patients with GBP was 0.1% (2/1341) compared to 7.6% (2 /26) among
patients with Indian Background. Regression analysis revealed that age 60
years, Indian ethnic background, GB wall thickness, single GBP and
GBP10 mm in size are significant risk factor for GBC. This analysis
suggests that solitary GBP in patients with Indian background should be
considered to be highly suspicious for cancer and further imaging (EUS) may
be advisable.
FP 6.01
NONINVASIVE QUANTITATIVE ASSESSMENT OF HEPATIC
STEATOSIS IN THE RAT LIVER USING 3.0 TESLA 1H-MAG-
NETIC RESONANCE SPECTROSCOPY
Marsman, Hendrik A1; van Werven, Jochem R2; Nederveen, Aart J2; ten
Kate, Fibo JW3; Stoker, Jaap2; van Gulik, Thomas M1
1Academic Medical Center, Surgery, Amsterdam, Netherlands; 2Academic
Medical Center, Radiology, Amsterdam, Netherlands; 3Academic Medical
Center, Pathology, Amsterdam, Netherlands
Background. Hepatic steatosis has been recognized as a serious risk factor
for adverse outcome after liver resection and transplantation. Gold standard
for quantitative steatosis determination is histological assessment of a needle
biopsy. However, this method is unreliable due to heterogenous parenchymal
distribution of steatosis, and is associated with complications. 1H-Magnetic
Resonance Spectroscopy (1H-MRS) using a conventional MRI scanner
allows non-invasive quantification of steatosis by measuring resonance signals
of proton containing fatty acid chains in liver tissue. This modality has never
been validated as a diagnostic tool for quantitative steatosis determination.
Objective. To validate 1H-MRS measurements in a rat steatosis model and
to investigate a correlation with histological and biochemical steatosis
determination.
Methods. Steatosis was induced by feeding rats a methionine choline
deficient (MCD) diet for 0, 1, 3 or 5 weeks (n5 per group). 3.0 Tesla
1H-MRS measurements of rat livers, using a scanning voxel size of 1510
8 mm (1200 mm3), were compared to histological steatosis as assessed by a
blinded pathologist, triglyceride content and total fatty acids measured by gas
chromatography.
Results. Histological steatosis ranged from 10% to 95% after 1 to 5 weeks
MCD diet, respectively. A significant correlation was observed between 1H-
MRS and histopathological macrovesicular steatosis (R0,931, pB0.0001).
Also, 1H-MRS correlated significantly with triglycerides content (R0,956,
pB0.0001) and total fatty acids assessed by gas chromatography (R0,943,
pB0.0001).
Conclusion. 3.0 Tesla 1H-MRS measurements in a rat steatosis model is
strongly correlated with morphological and biochemical assessment of
parenchymal fat content. These results encourage clinical application of
1H-MRS for non-invasive pre-operative measurement of steatosis during risk
assessment of patients requiring liver resection.
FP 6.02
CONTRAST-ENHANCED INTRAOPERATIVE ULTRASONOGRA-
PHY IN STAGING BEFORE HEPATECTOMY
Jersenius, Ulf1; Isaksson, Bengt2; Lundell, Lars2; Mihocsa, Laszlo3
1Karolinska University Hospital Huddinge, GastroCentrum Kirurgi, Stock-
holm, Sweden; 2Karolinska Universitetssjukhuset Huddinge, Surgery, Stock-
holm, Sweden; 3Karolinska Universitetssjukhuset Huddinge, Radiology,
Stockholm, Sweden
Introduction. Intraoperative Ultrasonography is the most accurate method
to stage malignant lesions in the liver. Using contrast-enhanced intraoperative
ultrasonography the staging becomes even more accurate. The method is
routine in many centres. An optimal pre operative staging is essential in
hepatic surgery for malignant liver lesions to obtain complete tumour
clearance, increase the safety for the patients and possible prolong survival
for the group of patients.
Objective. To evaluate the diagnostic yield of contrast-enhanced intrao-
perative ultrasonography compared to pre operative imaging techniques with
clinical consequences in terms of changes in operative strategy.
Methods. The contrast agent SonoVue† was used in all patients. One
hundred consecutive patients, 48 women and 52 men, median age 65 year
(1784), with hepatic malignancies were examined with contrast-enhanced
intraoperative ultrasonography. The examinatrion of one radiologist well
experienced with contrast-enhanced intraoperative ultrasonography. All
patients were examined within two weeks before the hepatectomy. Sixty
patients were diagnosed with liver metastases from colo-rectal cancer
metastases, 31 with hepatocellular cancer and nine for other malignant
tumours.
Results. When comparing the per operative imaging with contrast-enhanced
intraoperative ultrasonography and the routine staging, new information was
revealed in 25 of the 100 patients (25%), leading to changed operative
strategy. Fourteen patients had colo-rectal cancer metastases, six hepatocel-
lular cancer and five other malignanat tumours. In 21 of the cases the new
information implemented larger resections, in two cases less resections and
two patients were found to be not resectable.
Conclusion. Contrast-enhanced intraoperative ultrasonography is a valuable
tool in order to optimize the surgical treatment of hepatic malignancies.
Contrast-enhanced intraoperative ultrasonography acquire a central role in
an updated per operative staging of patients with hepatic malignancies.
FP 6.03
ETIOLOGY, DIAGNOSIS AND INTERVENTIONAL RADIOLOGI-
CAL MANAGEMENT OF SPLANCHNIC ARTERY ANEURYSMS: A
REVIEW OF 32 CASES
Moses, Vinu1; Kumar NK, Shyam1; Babu, Surendra1; Mammen, Thomas1;
Venkatramani, Sitaram2
1Christian Medical College, Vellore, Department of Radiology, Vellore,
India; 2Christian Medical College, Vellore, Department of Hepatobiliary
Surgery, Vellore, India
Background. Although diagnosed splanchnic artery aneurysms are rare,
autopsy studies suggest that they are more frequent than abdominal aortic
aneurysms. Splanchnic artrery aneurysms are important to diagnose because
over 25% rupture with a mortality of 5070%.
Objective. To assess etiology, presenting symptoms, diagnosis and manage-
ment of splanchnic aneurysms in a tertiary care hospital in South India.
Methods. Records of 32 cases with splanchnic aneurysms (200007)
diagnosed and treated by endovascular embolization in Radiodiagnosis
Department were analyzed.
Results. Etiology included post-inflammatory, post-traumatic, iatrogenic,
infection, atherosclerotic and idiopathic. Pseudoaneurysm secondary to
pancreatitis (34%) was the most common identifiable etiology. The most
common presentation was hematemesis and melena. The common sites of
aneurysm were hepatic artery pseudoaneurysms (31%) and splenic artery
pseudoaneurysms (31%). Endovascular treatment was attempted in all cases,
with a success rate of 81%. Three cases (9%) had re-bleeds after
endovascular treatment, two (6%) of which underwent endovascular re-
embolization and one (3%) underwent surgical ligation. Two cases (6%) who
underwent successful endovascular embolization, died due to co-morbid
conditions.
Conclusion. Splanchnic aneurysms have high mortality and morbidity. This
warrants their prompt diagnosis and management. Although CT and MR
angiography are slowly replacing conventional angiography in the diagnosis of
splanchnic aneurysms, conventional angiography offers a therapeutic option.
Endovascular repair of splanchnic aneurysms is preferred as it avoids the
morbidity and mortality associated with surgical repair, and provides good
outcome.
FP 6.04
CLINICAL VALUE OF CONTRAST-ENHANCED (SONOVUE†)
INTRAOPERATIVE ULTRASOUND FOR CHARACTERIZATION
OF FOCAL LIVER LESIONS
Tan, Felicia1; Tan, Yu-Meng1; Low, Albert2; Chung, Alexander3; Cheow,
Peng Chung3; Ooi, London1; Lo, Richard2
1National Cancer Centre, Department of Surgical Oncology, Singapore,
Singapore; 2Singapore General Hospital, Diagnostic Radiology, Singapore,
Singapore; 3Singapore General Hospital, General Surgery, Singapore,
Singapore
Objectives. The aim of the study was to assess the clinical value of contrast-
enhanced intraoperative ultrasound (CE-IOUS) as a novel tool for detection
and characterization of focal liver lesions during hepatic surgery.
Materials and Methods. Forty-one patients scheduled to undergo liver
resection were studied. Focal liver lesions were detected by preoperative
computed tomography (CT) imaging or magnetic resonance imaging (MRI)
of the liver. Following exploration, IOUS was performed using an HDI-5000
scanner (Philips) and a finger probe with pulse inversion harmonic (PIH)
capability. CE-IOUS in the PIH mode was performed in a standardized
protocol (low MI: 0.02  0.04) after intravenous injection of 2.44.8 ml of
Sonovue. All detected lesions on postcontrast scans were counted and
mapped. Any alteration in surgical management was documented. The
excised liver specimen was sent for pathological examination to ascertain its
true histology. The CE-IOUS and histopathological findings were compared
and correlated. Blinded analysis of the recorded procedure was also
performed.
Results. A total of 84 liver lesions were studied. CE-IOUS altered surgical
management in 8 patients (19.5%), and detected additional lesions in 15
patients (36.5%). CE-IOUS altered the preoperative diagnosis in 4 patients
(9.5%) and was correct in all patients (100%). Surgical management was
unchanged in 7 patients despite additional lesions detected on CE-IOUS.
Two benign lesions were wrongly diagnosed as malignant on CEIOUS (A
thrombosed haemangioma and the other a regenerative nodule). One
hepatocellular carcinoma was wrongly diagnosed as a regenerative nodule
on CE-IOUS. The sensitivity for CE-IOUS was 98.7%, positive predictive
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value 97.5% and overall accuracy 96.4%. Conclusion CE-IOUS improves
detection and characterization of focal liver lesions. This in turn led to
alteration in surgical management. CE-IOUS may represent the new gold
standard of imaging in hepatic surgery.
FP 6.05
A COMPARISON OF LESIONS PRODUCED BY RADIOFRE-
QUENCY, CRYOTHERAPY AND MICROWAVE ABLATION IN
THE LIVER
Bhardwaj, Neil1; Strickland, Andrew D2; Ahmad, Fateh2; West, Kevin3;
Lloyd, David M2
1Leicester Royal Infirmary, Hepatobiliary surgery, 6th floor Balmoral
Building, Infirmary square, Leicester, United Kingdom; 2Leicester Royal
Infirmary, Hepatobiliary surgery, Leicester, United Kingdom; 3Leicester
Royal Infirmary, Histopathology, Leicester, United Kingdom
Background. Microwave tumour ablation (MTA), radiofrequency (RF) and
cryotherapy utilise thermal energy to destroy unresectable primary or
secondary liver tumours. Adequate destruction of tumour tissue is dependent
upon uniform ablation volume and resistance to the heat sink effect.
Aims/Objectives. To compare the unablated/ablated boundary and the heat
sink effect within the ablations induced by cryotherapy, MTA and RF in the
rat liver.
Methods. A total of 84 rats underwent a laparotomy. For each of the 3
ablative modalities, 21 rats were assigned to each group and the liver was
ablated. Twenty-one rats were used as a control arm and received no
treatment other than a laparotomy. All rats were sacrificed at 48 hours and
the livers analysed with H&E.
Results All specimens demonstrated a sharply demarcated boundary
between the ablated and unablated tissue to the naked eye. Histologically,
RF and Cryotherapy demonstrated irregular boundaries, intra-lesional viable
hepatocytes, particularly cells in proximity to blood vessels and a large
inflammatory response between the two zones. Microwave produced a
histologically sharp demarcation between the two zones, no intralesional or
perivascular survival and a completely uniform ablation area.
Conclusion. RF and cryotherapy rely on conduction of thermal energy in
order to ensure cytotoxic temperatures are reached within an ablation zone.
This method can often be haphazard and subsequently be prone to the
corrupting effects of blood vessels, particularly at the peripheries of a
treatment area. Microwaves on the other hand produce uniform ablation
volumes as they exert a ‘field effect’ and are therefore less prone to the heat
sink effect. This may mean that microwave ablation may be more effective in
treating unresectable liver tumours, particularly those in close proximity to
blood vessels.
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IMPACT OF ENDOSCOPIC ULTRASOUND (EUS) ON PANCREA-
TICO-BILIARY PRACTICE IN A TERTIARY REFERRAL CEN-
TRE. A NEW BENCHMARK IN DIAGNOSTIC YIELD?
Cherian, PT; Hejmadi, RK; Tanierre, Phillipe; Wigmore, SJ; Mirza, DF;
Mayer, D; Bramhall, SR; Buckels, JAC; Mahon, Brin
University Hospital, Birmingham, United Kingdom
Aim. The reported median diagnostic yield from EUS fine needle aspiration
cytology (FNA) is 78% (range 3993%). We report a single centre experience
in the diagnostic work-up of solid pancreatic masses.
Methods. In a consecutive series of 429 EUS examinations performed over a
12-month period by a single operator, 108 were on non-cystic pancreatic or
biliary lesions. Data was collected prospectively and the accuracy of FNA was
assessed retrospectively using either surgery or repeat imaging as the
benchmark.
Results. 101 of the 108 FNAs (94%) were diagnostic, 4 were falsely negative
(FN) and 3 atypical and considered equivocal. There were 78 pancreatic
lesions, 64 were true positives (TP), 11 true negatives (TN), 1 with atypical
cytology and 2 FN (both GISTs) (96% diagnostic). In 9 sub-ampullary
lesions there were 2 TPs, 6 TNs and 1 FN (subsequent T2 N0 adenocarci-
noma) (89% diagnostic). There were 21 bile duct lesions of which 10 were
TPs, 8 TNs, 2 atypical and 1 FN (86% diagnostic). It is possible that with
longer follow up these rates might change.
Conclusion. In a high-volume practice a median diagnostic yield from EUS
and FNA of greater than 90% is achievable and should be the aim in order to
minimize patient distress, discomfort and allow early patient management
planning.
FP 7.01
PREOPERATIVE PREDICTION OF COMMON BILE DUCT
STONES
Videhult, Per1; Sandblom, Gabriel2; Ljungdahl, Mikael3; Wollert, Staffan3;
Darkahi, Bahman4; Liljeholm, Ha˚kan4; Karlson, Britt-Marie3; Rasmussen,
Ib Christian3
1Ersta Hospital, Department of surgery, Stockholm, Sweden; 2University
Hospital, Department of surgery, Lund, Sweden; 3University Hospital,
Department of surgery, Uppsala, Sweden; 4Enko¨ping Hospital, Department
of surgery, Enko¨ping, Sweden
Background. Optimal planning of a cholecystectomy requires reliable
prediction of the risk of encountering common bile duct stones (CBDS)
since this calls for more resources and experienced surgeons and personel.
Objective. To explore how ALP, bilirubin and available preoperative clinical
variables can be used to predict the presence of common bile duct stones in a
large population-based setting.
Methods. All operations in the Uppsala county, Sweden, with a population
of 303 000, were registered prospectively 20032005. Data included indica-
tion for surgery, preoperative liver tests (alkaline phosphatate (ALP) and
bilirubin), age, gender and findings at intraoperative cholangiography.
Results 1199 patients, including 794 women (66%), underwent cholecys-
tectomy 20032005. Mean age was 48 years, standard deviation 15 years.
Intraoperative cholangiography was successfully performed in 1119 (95%) of
the patients. In 152 cases a pathological cholangiography was achieved. In a
multivariate logistic regression analysis, elevated liver function markers
(bilirubin 50 mmol/l and/or ALP5 microkat/l) and age above median
were found to significantly and independently predict the presence of
common bile duct stones, whereas history of acute pancreatitis, cholecystitis
or gender did not. The positive predictive value (PPV) and negative
predictive values (NPV) for the liver function markers were 40% and 94%.
The PPV and NPV for age were 12% and 92%.
Conclusion. Liver function markers are the single most reliable predictors of
CBDS. The only variable besides the liver function markers that predict
CBDS is age, whereas a history of cholecystitis or acute pancreatitis does not.
FP 7.02
ACCURACY OF INTRAOPERATIVE CHOLANGIOGRAPHY
Videhult, Per1; Sandblom, Gabriel2; Ljungdahl, Mikael3; Wollert, Staffan3;
Darkahi, Bahman4; Liljeholm, Ha˚kan4; Karlson, Britt-Marie3; Rasmussen,
Ib Christian3
1Ersta Hospital, Department of surgery, Stockholm, Sweden; 2University
Hospital, Department of surgery, Lund, Sweden; 3University Hospital,
Department of surgery, Uppsala, Sweden; 4Enko¨ping Hospital, Department
of surgery, Enko¨ping, Sweden
Background. Although intraoperative cholangiography (IOC) is a widely
used method for detecting common bile duct stones (CBDS), its accuracy
has not been fully evaluated in large non-selected patient samples.
Objective. The purpose of this study was to assess the sensitivity, specificity
and predictive value of dynamic IOC regarding its ability to diagnose CBDS
in a population-based setting, and to assess the morbidity associated with the
investigation.
Method. All patients operated on for gallstone disease between 2003 and
2005 in the county of Uppsala, Sweden, with a population of 303 000, were
registered prospectively. The outcome of cholangiography was validated
against the postoperative clinical course.
Result. Altogether 1171 patients operations were performed 20032005.
IOC was performed in 1117 patients (95%). Common bile duct stones were
found in 134 patients (11%). One perforation of the common bile duct
caused by the IOC catheter was recorded. Sensitivity was 97%, specificity
99%, negative predictive value 99%, positive predictive value 95%, and
overall accuracy 99%. In 7 of the 134 cases where IOC indicated CBDS, no
stones could be verified on exploration. In 4 of the 979 cases where IOC was
normal, the clinical course indicated overlooked CBDS.
Conclusion. Intraoperative cholangiography is a safe and accurate method
for detecting common bile duct stones with 5% false positive findings and
0,1% false negative findings.
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LONG-TERM RESULTS AFTER LAPAROSCOPIC TRANSVERSE
CHOLEDOCHOTOMY FOR COMMON BILE DUCT STONES
Lezoche, Emanuele1; Paganini, Alessandro M.1; Sarnari, Jlenia2; Guerrieri,
Mario2; De Sanctis, Angelo2; Rotundo, Adriana1
1Policlinico Umberto I, Department of Surgery "P. Stefanini", Rome, Italy;
2Azienda Ospedaliera Umberto I, Clinica di Chirurgia Generale e Metodo-
logia Chirur, Ancona, Italy
Background. Transverse rather than longitudinal choledochotomy reduces
the risk of CBD ischemia and long-term stricture. Aim was to evaluate the
long-term results of laparoscopic transverse choledochotomy (TC) during
laparoscopic cholecystectomy (LC) in a consecutive series of unselected
patients.
Methods. From April 1991 to February 2007, CBD stones were present in
363 out of 3455 patients (pts) (10.5%) (139 males, 224 females, mean age
57.6 years, range 1296 years) who underwent LC. The indications for
laparoscopic TC were multiple ductal stones ( 5), larger stones ( 8 mm),
stones in the common hepatic duct, narrow cystic duct, failure of a trans-
cystic duct approach. A pre-requisite was the presence of a dilated CBD ( 8
mm). After discharge, the follow-up study was conducted by yearly
ambulatory visits, laboratory exams, telephone contacts with the patient or
family doctor, ultrasound or Cholangio-MRI. The procedure was completed
laparoscopically in 348 patients (95.9%), with a TC in 144 patients (41.4%),
who are the object of this study, or a trans-cystic duct approach in 204
(58.6%).
Results. Biliary drainage was employed in 122 of 144 cases (84.7%). Major
complications occurred in 8 cases (5.6%) and mortality in one high risk
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patient (0.7%). Retained and recurrent ductal stones occurred in 11 (7.6%)
and in 5 patients (3.5%), respectively. No patient was lost to follow-up (mean
113.1 months, range 40.0188.9). No signs of bile stasis and no biliary
stricture were observed. One-hundred-eighteen patients are alive with no
biliary symptoms; 25 elderly patients have died from unrelated reasons.
Conclusions. This experience confirms the long-term safety of laparoscopic
TC with no long-term stricture. It reduces the need for endoscopic
sphinterotomy in most patients with CBD stones, with a reduction in the
diagnostic and therapeutic burden for the patient and a reduction in hospital
stay.
FP 7.04
Clinical epidemiological analysis of 309 ERCPs performed in Nova
Scotia in 2006 for choledocholithiasis and gallstone pancreatitis.
Molinari, Michele1; Walsh, Mark1; Nason, Amy2
1Dalhousie University, Surgery, Halifax, Canada; 2Dalhousie University,
Halifax, Cameroon
The ideal management of choledocholithiasis and gallstone pancreatitis is
controversial. With the advancement of diagnostic modalities, endoscopic
retrograde cholangiopancreatography (ERCP) should be performed only
when intervention is needed. Referral patterns for ERCP, and patients’
management are influenced by resources and location. Limited information is
available for the clinical use and outcomes of ERCP in Atlantic Canada. Aim
of this study was to assess the diagnostic, therapeutic and success rates of
ERCP performed in a high volume tertiary medical center in Nova Scotia.
Methods. A retrospective observational study was performed over one year
period (January 1 to December 31, 2006) at the QEII hospital. ERCP data of
565 procedures were reviewed by two independent investigators. All data
discrepancies were analyzed and resolved. Demographic characteristics,
indications for ERCP, interventions, diagnosis and outcomes were captured.
Procedures were then divided into 2 groups: therapeutic or diagnostic.
Therapeutic ERCPs were defined when successful stone extraction or
sphincterotomy for sphincter dysfunction were obtained.
Results. Within the 12 month period, 309 ERCPs were carried out for
presumed choledocholithiasis (No 273, 88.3%) or gall stone pancreatitis (No
36, 21.7%) on a population with mean age of 62 (SD17.9). Therapeutic
ERCP was performed in 175 (64.1%) patients with choledocholithiasis and
in 12 (33.4%) individuals with pre-ERCP diagnosis of pancreatitis. Inability
to cannulate the papilla was observed in 8 (2.9%) patients with choledocho-
lithiasis and 4 (11.1%) individuals with pre-ERCP diagnosis of pancreatitis.
Conclusion. As ERCP is invasive, ideally it should be indicated only as a
therapeutic modality. Our findings suggest that in Atlantic Canada, diag-
nostic ERCPs are still performed in 35.9% of choledocholithiasis and 66.6%
of gall stones pancreatitis. Implementing better referral patterns and patient
selection would optimize resources and decrease complications.
FP 7.05
TREATMENT OF COMPLICATED HEPATOLITHIASIS AND IN-
TRAHEPATIC BILIARY STRICTURES BY TRANSPARIETAL
CHOLANGIOSCOPY
Fiocca, Fausto1; Salvatori, Filippo M2; Santagati, Alessio3; Ceci, Vincenzo3;
Donatelli, Gianfranco3; Cereatti, Fabrizio3; Bruni, Antonio4; Bezzi, Mario5
1Policlinico Umberto IUniversity "La Sapienza", Emergency Endoscopic
Surgery, Roma, Italy; 2Policlinico Umberto IUniversity "La Sapienza",
Radiology, Roma, Italy; 3Policlinico Umberto IUniversity, Emergency
Endoscopic Surgery, Roma, Italy; 4Policlinico Umberto IUniversity Roma,
Rdiology, Roma, Italy; 5Policlinico Umberto I-University Roma, Radiology,
Roma, Italy
Background. Percutaneous cholangioscopy (PCS) is an endoscopic tool
complementary to percutaneous cholangiography (PTC) to find small biliary
stones and for differential diagnosis of ductal lesions of uncertain aspect. Its
advantages include the direct approach to areas where stones are difficult to
locate, to perform associated procedures such as balloon dilatation of biliary
strictures, crushing of intractable stones by electrohydraulic lithotripsy
(EHL).
Patients and Methods. From 1990 to 2006 492 pts were admitted for
management of biliary disease. PCS were performed with a 3 mm or a 4.9
mm scope after a matured (47 days) PTC; 22 cases through a biliary fistula
of a previously surgically inserted T tube. 349 pts (71%) had intractable
stones in the biliary tree: failure of ERCP, stones more than 1.5 cm or for not
accesible CBD at ERCP for previous surgery. 143 pts (29%) had strictures of
the biliary tree of uncertain origin. Stones were crushed with EHL (Olympus
Walz 2) with 3 and 4.5 F probes under direct endoscopic vision and
fragments flushed with saline injection. Direct biopsy of visible lesions were
performed.
Results. All 349 pts were successfully treated with stones’ clearance after a
mean of 1.8 sessions: 229 (65%) of them with EHL after ballon dilatation of
stenosis if present. No related mortality; major complications were 8 (2.3%)
massive bleeding that required embolization and 2 (0.6%) perforations of the
main bile duct that were treated conservatively. Minor complications were 37
(10.6%) pts who experienced nausea and vomiting for fluid overload, minor
bleeding and cholangitis. 41 (11.8%) pts had stones recurrences after 860
months and were successfully retreated.
Conclusions. PCS with a PTC approach and EHL is a feasible and easy
miniinvasive procedure for treatment of complicated retained or recurrent
biliary stones, they require a team of skilled radiologist and endoscopist. PCS
and EHL when conducted with sufficient care and decision is effective in all
the cases.
FP 7.06
A 24-YEAR FOLLOW-UP OF PATIENTS WITH SILENT GALL-
STONES SHOWED A SIMILAR LONG-TERM RISK OF CHOLE-
CYSTECTOMY AS IN THE GENERAL PUBLIC
Malte, Schmidt1; Søndenaa, Karl1; Christoph, Schleer2; Trygve, Hausken3
1Haraldsplass Deaconal Hospital, Department of Surgery, Bergen, Norway;
2Haraldsplass Deaconal Hospital, Department of Radiology, Bergen, Nor-
way; 3University of Bergen, Department of Medicine, Bergen, Norway
Introduction. We examined the risk of getting symptomatic gallstone disease
(GSD) or having a cholecystectomy (C) with silent gallstones (GS).
Objective. In 1983, 259 persons (145 women (56%), 114 men, mean age
51.4 years) from a random population were found by ultrasonography (US)
to have GS. In 2007, a follow-up study with US and clinical consultation was
done. Eighty-nine persons consented to an examination (Group 149
women, 40 men), 45 answered a letter or telephone questionnaire (Group
217 women, 28 men), together 134. The rest had either died (n98),
refused follow up (n12), or were not traced (n15). One thousand and
thirty-two persons (531 women (51.5%), 501 men, mean age 44 years)
constituted a Control Group (CG). Interim cholecystectomy and overall
mortality rates were confirmed through hospital and official public records.
Reuslts. A total of 10.4% (27/259) in the study population had had a
cholecystectomy, i.e. Groups 12: 9 persons (6.7%), deceased: 11 (11.2%),
the rest: 7 (25.9%). In Group 1, 30.5% (25/82) had gallstones at US. Of
these, 11 (44%) had had abdominal pain at one stage. 31.6% of the rest (18/
57) also had had abdominal pain. In Group 2, another 11.6% (5/43) had had
abdominal pain. In CG, 20.3% (209/1032) had died, compared with 37.1%
(equal portion men and women) in the gallstone group.
Conclusion. The incidence of C in persons with asymptomatic gallstones
was slightly different than that of the general public (6.6%) which may be age
and gender dependent. The increased mortality rate was not caused by GSD.
We have at present no obvious explanation for the lower incidence of
gallstones in 2007 compared with 1983.
FP 8.01
PLATELET TRANSFUSIONS DURING LIVER TRANSPLANTA-
TION ARE ASSOCIATED WITH POST-OPERATIVE MORTALITY
DUE TO ACUTE LUNG INJURY
Pereboom, Ilona TA; de Boer, Marieke T; Lisman, Ton; Porte, Robert J
University Medical Center Groningen, Hepatobiliary Surgery and Liver
Transplantation, Groningen, Netherlands
Background and Objective. Platelet transfusions have been shown to be a
strong independent risk factor for graft failure and patient mortality after
orthotopic liver transplantation (OLT). No previous studies investigated the
mechanisms of patient death and graft failure as a result of platelet
transfusions during OLT. In this study these mechanisms were evaluated.
Methods. A series of 449 adult patients undergoing a first OLT between
1989 and 2005 in our center were included in this study. Reasons for
postoperative graft failure and patient death were assessed in patients who did
or did not receive perioperative platelet transfusions.
Results. 90-days graft survival was significantly reduced in patients who
received platelet transfusions during OLT (75% versus 90%, pB0.001). The
main reason for graft failure in these patients was patient death (20% versus
5%, pB0.001). 90-days patient survival was also significantly reduced in
patients who received platelet transfusions during OLT (79% versus 94%,
pB0.001). This increased mortality could be attributed to an increased
occurrence of acute lung injury, which was more frequent in patients
receiving platelet transfusions during OLT (p0.004). Surprisingly, liver-
related thrombotic complications were equally distributed between patients
receiving platelet transfusions and patients who were not transfused.
Conclusions. This study confirms the detrimental effect of platelet transfu-
sions in patients undergoing OLT. Patient death is the main reason for graft
failure in patients who received platelet transfusions during OLT. Acute lung
injury is the main reason for patient death in these patients. These findings
support previous calls for a cautious use of platelet transfusions in patients
undergoing liver transplantation, because of serious adverse events and
increased mortality due to acute lung injury.
FP 8.02
HIGH PRIMARY NON FUCNTION AND RETRANSPLANTATION
RATE IN NON HEART-BEATING DONOR (NHBD) LIVER TRANS-
PLANTATION UNDER PATIENT DRIVEN ALLOCATION
Sainz Barriga, Mauricio; Dezza, Maria Clara; Berrevoet, Frederik; Haent-
jens, Ivo; Rosetto, Anna; Colenbie, Luc; Rogiers, Xavier; de Hemptinne,
Bernard; Troisi, Roberto
Ghent University Hospital Medical School, Hepatobiliary and Liver Trans-
plant Service, Ghent, Belgium
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Introduction. The non heart-beating-donor (NHBD) has reemerged as a
tentative to expand the donor pool. We reviewed a single center experience
comparing liver transplantation (LT) with controlled NHBD vs. brain death
donor (BDD) under patient driven allocation.
Methods. Between October 2003 and August 2007, 512 LTwere performed.
Sixteen NHBD were compared with 118 BDD primary LT. Fisher and T-
Test were used when appropriate. Survival was analyzed by Kaplan-Meier
and Long Rang test.
Results. Sixty-three percent of BDD were extended criteria donors. Fifty
percent of NHBD grafts were shipped from abroad. Recipient mean MELD
was 1595 and 1897 respectively for NHBD and BDD (p0,03). Mean
CIT was 391.6 hours and 992.3 hours respectively for NHBD and BDD
(pB0.001). Biliary complications rate was 31.5% and 17% respectively
for NHBD and BDD (p0.1). Cholestasis was significantly lower in BDD
(pB0,001). Primary non function incidence was 12% and 1%; and
retransplantation rate was 31% vs. 6%, (pB0,001) respectively for NHBD
and BDD (pB0,01). Seventy-one percent of NHBD failed grafts were
shipped from other centers. Graft survival was 55% and 82% respectively for
NHBD and BDD recipients at 4 years (p0,007), while graft survival was
56% and 69% respectively for NHBD and BDD (p0.38) when compared
only with extended criteria donor.
Conclusion. In our experience, LT with NHBD is characterized by a higher
retransplantation rate and cholestatic evolution respect to BDD, specially
when shipped from abroad. Graft survival is comparable to extended criteria
donors.
FP 8.03
PRE-TRANSPLANT SCORING IN PREDICTING IN-HOSPITAL
MORTALITY FOLLOWING LIVER TRANSPLANTATION
Bonney, Glenn1; Stuart, Murdoch2; Attia, Magdy2; Aldersley, Mark A2;
Toogood, Giles J2; Pollard, Stephen G2; Lodge, J Peter A2; Prasad, K
Rajendra2; Prasad, K Rajendra2
1St James University Hospital, Hepatobiliary and Transplantation, Beckett
Street, Leeds, United Kingdom; 2St James University Hospital, Hepatobili-
ary and Transplantation, Leeds, United Kingdom
Background. In recent years, much research has been carried out into
factors that effect short and long term outcomes in liver transplantation. As a
scoring system, MELD has been shown to predict outcomes in liver
transplantation. Here we assess MELD and other physiological scores in
predicting in-hospital mortality.
Methods. A prospectively collected database of 696 recipients of liver
transplants performed at one centre from 19982005 was analysed. The
physiological scores analysed included Donor Risk Index, MELD at
transplantation, Acute Physiological and Chronic Health Evaluation
(APACHE) II and III score and Simplified Acute Physiological Score
(SAPS) II.
Results Recipient demographics including age, diagnosis, ethnicity and ABO
mismatch did not significantly affect in-hospital mortality. On univariate
analysis, APACHE II APACHE III, SAPS II and MELD significantly
predicted in-hospital mortality (pB0.0001, pB0.0001, pB0.0001, p
0.03 respectively). On multivariate analysis SAPS II was the only indepen-
dent predictor of in-hospital mortality (pB0.0001 with a odds ratio of 3.149.
Conclusion. SAPS II independently predicts in-hospital mortality in liver
transplant recipients and may be useful in resource utilisation in these
patients.
FP 8.04
EXTRACORPOREAL PORTAL BLOOD ARTERIALIZATION
WITH A NEW DEVICE TO TREAT TOXIC ACUTE LIVER FAIL-
URE IN THE SWINE MODEL
Nardo, Bruno; Tsivian, Matvey; Neri, Flavia; Bianchi, Elisa; Piras, Gian-
Luca; Puviani, Lorenza; Cavallari, Giuseppe; Bertelli, Riccardo; Vincenzo,
Pacile
S. Orsola Hospital, University of Bologna, Bologna
Background. The present study aimed to determine whether the portal
blood arterialization by a new liver extracorporeal device (L.E.D.) is effective
in treating swine with toxic administration leading to acute liver failure
(ALF).
Methods. Eight swine with ALF induced by intraperitoneal injection of
carbon tetrachloride in oil solution at a dose of 450 mg/Kg of body weight
were randomly divided into two groups: four animals received L.E.D.
treatment 24 hours after the intoxication. and four swine were not-treated
(control group). Blood was withdrawn from the iliac artery and reversed in
the portal venous system. An extracorporeal device was interposed between
the outflow and the inflow in order to monitoring the hemodynamic
parameters. Each treatment lasted 6 hours. Serum and liver samples were
collected in both groups. The survival was assessed at 1 week.
Results. L.E.D. treatment yielded beneficial effects for carbon tetrachloride
induced-ALF swine with decreased serum ammonia, transaminases and total
bilirubin as compared with the untreated group. INR recovered rapidly in the
L.E.D. group remaining significantly lower than in untreated animals. The 7-
day survival of L.E.D. group swine was significantly higher than that of
untreated animals, with a statistically significant difference (pB0.05). Three
swine in the L.E.D. group survived at 1 week while none of the swine in the
control group were alive at that time.
Conclusions. Arterial blood supply in the portal system through the L.E.D.
is easily applicable, efficacious, safe and cost effective and may represent a
novel approach for ALF swine induced by carbon tetrachloride intoxication.
FP 8.05
NEW INSIGHTS INTO PROTECTION OF HEPATIC FUNCTION
BY REMOTE ISCHEMIC LIMB PRECONDITIONING IN THE
LATE PHASE OF HEPATIC ISCHEMIA REPERFUSION INJURY
Tapuria, Niteen; Junnarkar, Sameer; Fuller, Barry; Seifalian, Alexander M;
Davidson, Brian R
Royal Free Hospital, HPB & Liver transplant surgery, London, United
Kingdom
Background. Ischemia reperfusion injury (IRI) may lead to nonfunction or
dysfunction of transplanted liver grafts. At the Royal Free (UK) experimental
studies by intravital microscopy have demonstrated that remote ischemic
limb preconditioning (RIPC) modulates hepatic microcirculation by increas-
ing RBC velocity, sinusoidal flow, sinusoidal perfusion and decreasing
neutrophil adhesion as well as apoptosis to protect liver function in the early
phase of hepatic reperfusion injury. This is the first study to focus on the role
of RIPC in protection of hepatic function in the late phase of reperfusion
injury.
Aim. To investigate the effect of RIPC on late phase of reperfusion injury in
an animal model of 24 hour hepatic ischemia reperfusion injury.
Material and Methods. A rat model of IRI with 45 minutes of partial liver
ischemia (70%) followed by 24 hours of reperfusion was used for this study.
Two animal groups studied included IRI-24 and RIPCIR-24. The animals
were preconditioned by 4 cycles of right hind limb ischemia (5minutes),
reperfusion (5 minutes) prior to ischemia. Hepatic microcirculation was
assessed by studying velocity of RBC flow, sinusoidal perfusion, sinusoidal
flow and sinusoidal diameter under intravital microscopy. The number of
neutrophils adherent to endothelium/mm2 and the numbers of stained
apoptotic cells/HPF were assessed by intravital microscopy. Liver functions
were assessed.
Results. There was no significant difference in the RBC velocity, sinusoidal
flow or sinusoidal diameter between the IR-24 and RIPCIR-24 groups.
Sinusoidal perfusion was significantly better in the RIPCIR-24 group.
Neutrophil adhesion and apoptosis were significantly reduced and liver
functions were significantly better in the RIPC group.
Conclusion. Modulation of hepatic microcirculation and neutrophil activa-
tion by RIPC in the late phase of hepatic IR is a key mechanism in protection
of liver function. The role of modulation of neutrophil activation to prolong
graft survival needs further investigation.
FP 8.06
OXYGENATED PERFUSION: RESUSCITATION OF CELLULAR
ENERGY METABOLISM AND MITOCHONDRIAL FUNCTION
DURING ORGAN PRESERVATION
Roy, Debabrata1; Morten, Karl2; Ashley, Neil2; Elker, Doruk1; Southerland,
Andrew1; Guerriero, Dino1; Coussios, Constantin1; Friend, Peter J1
1John Radcliffe Hospital, Nuffield Department of Surgery, Oxford, United
Kingdom; 2John Radcliffe Hospital, Nuffield Department of Obstetric and
Gynaecology, oxford, United Kingdom
Introduction. Livers from non-heart-beating-donors (NHBD) may be
important in alleviating the donor organ shortage. However, the liver does
not tolerate prolonged warm ischaemia followed by cold preservation and, as
a result, the application of non-heart-beating-donors has had limited impact
in clinical liver transplantation to date. We have investigated whether addition
of normothermic recirculation prior to retrieval complements the already
proven benefit of normothermic preservation.
Methods. After 60 minutes of warm ischaemia, porcine livers were treated by
normothermic recirculation (n5, NR), by in situ oxygenated perfusion for
1 hour followed by normothermic preservation for 23 hours. Group C
(Control, n5) did not receive NR, but were otherwise treated in the same
way. We assessed liver function during preservation and during 24 hours of
subsequent reperfusion (a surrogate for transplantation). The apoptotic and
necrotic changes after reperfusion were examined by TUNEL and haema-
toxylin staining.
Results. Cellular ATP levels declined sharply during 60 minutes of warm
ischaemia (by 90% of the basal level, pB0.01). NR improved mitochondrial
function (mitochondrial respiratory control ratio, pB0.05) and ATP levels
significantly (pB 0.01). This effect was maintained throughout the period of
warm preservation and associated with greater functional recovery of the NR
livers with superior bile production (pB0.05), base deficit (pB0.05) and
reduced hepatocellular (pB0.01) damage. Both apoptosis and necrosis were
attenuated in the NR group with significantly greater destruction of
architecture on histology in group C livers.
Conclusions. NHBD livers are resuscitated by a combination of normother-
mic recirculation and normothermic preservation. This may have important
clinical implications.
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NECESSITY OF ADVANCED TRAINING IN HEPATO-PAN-
CREATO-BILIARY SURGERY
Chang, Yeon-Jeen; Jaocbs, Michael; Mittal, Vijay
Providence Hospital and Medical Centers, Department of Surgery, South-
field, United States
Background. Hepato-Pancreato-Biliary (HPB) surgeries require compre-
hensive knowledge, meticulous surgical technique and a good institutional
support system. Advanced training in HPB surgery is available at select
centers, however, no approved fellowship has been established yet.
Objective. Determine the level of training in HPB surgery received during
General Surgery Residency (GSR) and assess whether additional training is
needed in order to focus practice in HPB surgery.
Method. All GSR Programs (GSRP) in the US were invited to participate in
a survey of attitudes and experience in HPB surgery. Results were compared
to the requirements established by the Resident Regulation Committee, the
2006 General Surgery Log Database, and the training criteria suggested by
the International Hepato-Pancreato-Biliary Association (IHPBA).
Results. Eighty of 250 GSRP (32%) responded to the survey. 80% of GSRP
feel that their graduating residents have sufficient training in HPB surgery.
However, 38% of the programs refer 50% of their biliary cases to an HPB
surgeon, 28% have an independent HPB service, and 35% have transplant
centers that perform 50% of the hepatic surgeries. The average number of
pancreatic cases per graduating resident in 2006, as reported by Accredita-
tion Council for Graduate Medical Education (ACGME), was 10.297.3
(mean9SD), with Whipple and distal pancreatectomies compromising
B50% of those cases (4.794.6). The average number of hepatic resections
was 8.695.1, and 5.391.3 for complex biliary cases. All these numbers fulfill
the minimal number of index cases required by ACGME, though they fall
short of the 25 cases in each category suggested by the IHPBA.
Conclusion. Though HPB Surgery is an essential part of GSR training, a
significant portion of HPB surgery is done at transplant centers or by HPB
surgeons. Therefore, guidelines must be established to assure adequate
training. Furthermore, when HPB surgery is the main focus of the future
practice, residents should seek additional training.
FP 9.02
THE ROLE OF SURGICAL APPRENTICESHIP IN MODERN HPB
TRAINING
Gilmour, Jeff
The Royal Infirmiry of Edinburgh, Edinburgh, United Kingdom
Introduction. Surgical training has often been considered as an apprentic-
ship. Decision making skills are passed on from trainer to trainee as both
work together through a long series of problematic situations. This and other
apprenticeship like aspects of training have been eroded in recent years by
changes to working practice and other constraints. This is of particular
concern in HPB training where so many advanced techniques and complex
clinical decision making skills are required.
Objective. To estimate the proportion of surgical decision making that is
evidence or experience based and to explore apprenticeship like mechanisms
of training.
Methods. A combination of qualitative and quantitative methods namely;
questionnaire, reflective practice exercises and observational techniques were
employed to study the basis of clinical decision making of over 20 HPB/
general surgeons and trainees in 400 operations/OPD consultations focusing
on the interaction between trainer and trainee and how this facilitates such
decision making.
Results. 29% of decisions were evidence based (22% for trainees and 40%
for trainers). 54% of trainee decisions were influenced by trainer interaction
(past or present). Effective clinical decision making skills were observed to be
transferred from trainer to trainee but this required time and a good rapport.
All subjects acknowledged that this apprenticeship like interaction facilitated
experience based practice which was an important supplement to evidence
based practice.
Conclusion. Whenever possible clinical decision making should be evidence
based however good evidence is often unavailable and consequently many
decisions are experience based. In order to optimise the training of HPB
surgeons attention should be paid to the underlying mechanisms by which
clinical skills such as decision making, are acquired. A greater effort should be
made to preserve and enhance some of the traditional apprenticeship like
aspects of training.
FP 9.03
KEEPING IT TOGETHER: WHAT MAKES A DIFFERENCE TO
CARERS IN ACUTE HPB CANCER SERVICES
Byrne, Clare1; Poston, Graeme J2; Griffin, Andrea2
1University Hospital Aintree NHS Foundation Trust, HPB (Liver) Unit,
Digestive Diseases Centre, Lower Lane, Liverpool, United Kingdom; 2
Background. Meeting the needs of carers as an integral part of managing
those affected by HPB cancer is increasingly being recognised. However, the
emphasis tends to be on care delivered in the community. This paper reports
on a study which identified the key aspects of carer involement in acute HPB
cancer care.Method.: 27carers, and 17 bereaved carers affected by HPB
cancer were interviewed and completed measures of psychological well-being
(HADS and GHQ12).
Results. Fisher’s exact was significant for psychological distress and
information in carers (.029). Key issues influencing access to information,
sensitive communication, carer inclusion/exclusion at disclosure, coordina-
tion of care and carers other social responsibilities were identifie. Fisher’s
exact was almost significant for fatigue and anxiety in carers (0.74), which
was not associated with burden of care, but with the emotional strain
associated with healthcare professional’s failure to acknowledge their role as
carer with information and support needs, their emotional relationship to the
patient and their personal loss.
Discussion. There is indication that during the acute phases of investigation,
diagnosis, or at recurrence and transition to incurable disease, carers have
specific needs which need to be addressed in conjunction with the needs of
the patient. Delay in including carers has consequences for psychological well
being both when caring and for adjustment when bereaved. The importance
of the role of a key source of information and support in HPB cancer, and the
potential to coordinate, mediate and manage inclusion of carers in together-
ness with the patient and partnership with health professionals is explored.
FP 9.04
CAN THE RISK OF POSTOPERATVE INFECTIOUS COMPLICA-
TIONS BE REDUCED BY PROPHYLACTIC PEROPERATIVE
ANTIBIOTICS?
Videhult, Per1; Sandblom, Gabriel2; Ljungdahl, Mikael3; Wollert, Staffan3;
Darkahi, Bahman4; Liljeholm, Ha˚kan4; Karlson, Britt-Marie3; Rasmussen,
Ib Christian3
1Ersta Hospital, Department of surgery, Stockholm, Sweden; 2University
Hospital, Department of surgery, Lund, Sweden; 3University Hospital,
Department of surgery, Uppsala, Sweden; 4Enko¨ping Hospital, Department
of surgery, Enko¨ping, Sweden
Introduction. The benefit from prophylactic treatment with antibiotics
during routine cholecystectomy is controversial.
Objective. To explore the risk of postoperative infections in a population-
based cohort of patients operated for gallstone disease and to compare the
infection rate between patients who received antibiotic prophylaxis with those
who did not.
Methods. All operations in the Uppsala county, a county with 320 000
citizens in Sweden, were registered prospectively 20032005. Data included
indication for surgery, open/laparoscopic approach, prophylactic treatment
with antibiotics and postoperative adverse events, readmittance due to
postoperative complications. Complicated procedures were defined as
operations for which acute cholecystitis, exploration of the common bile
duct or gallbladder perforation were recorded.
Results. Altogether 1199 patients underwent cholecystectomy. Prophylactic
antibiotic treatment was given to 755 patients (63%). Minor infections were
recorded in 12 patients (1.0%) and major infections, including intra-
abdominal abscesses, pneumonia and urosepsis, were recorded in 7 patients
(0.6%). Infections were recorded for 4 (0.5%) of the patients receiving
antibiotics and 15 (4.3%) of those who did not (pB0.05). None of the
patients receiving antibiotics had any major infection. In patients undergoing
complicated procedures infections were recorded for 1/54 (1.9%) of the
patients receiving antibiotics and 12/194 (6.2%) of those who did not (no
significance).
Conclusion. The risk of postoperative infection is influenced not only by the
use of prophylactic antibiotics. Although antibiotics slightly reduce the risk of
infections, the incidence of serious infections is so low that the benefit from
prophylactic treatment with antibiotics should be questioned. The reduced
risk for infections has to be weighed against the risk of the risk of drug
resistance.
FP 9.05
BIOCHEMICAL STRESS IN MAJOR SURGERY  WHIPPLE’S VS
HEPATECTOMY/ANTERIOR RESECTION
Kan, Yuk-Man; Paulvannan, Subramanian; Jah, Asif; Sadat, Umar; Huguet,
Emmanuel L; Jamieson, Neville V; Praseedom, Raaj K
Addenbrooke’s Hospital, Hepatobiliary & Transplant Surgery, Cambridge,
United Kingdom
Introduction. Biochemical markers predicting morbidity and mortality in
patients undergoing major surgical procedures have been studied with
varying degrees of sensitivity. Albumin is a precursor of the acute phase
reaction and significant drops can be used as an indicator of stress/sepsis. The
aim of this study was to use albumin as a marker to determine the severity of
operative stress from major surgical procedures and its consequence on
morbidity and mortality.
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Methods. Between 2002 & 2007, at our institution, 125 pancreaticoduode-
nectomy were performed. Albumin levels were taken pre-operatively, on day
1, day 3, day 5 and day 7. ASA grade, operative time, blood loss and
complications were recorded prospectively. Twenty patients undergoing
hepatectomy for metastatic disease and 20 patients with anterior resection
for rectal carcinoma were used as controls.
Results. In all patients, albumins levels dropped markedly on day 1 to 50%
for pancreaticoduodenectomy, 57% in hepatectomy and 65% in anterior
resection (all, pB0.05). The albumin level remained persistent low with
minimal recovery in patients with pancreaticoduodenectomy throughout the
post operative period with a median value of 58% of baseline levels by day 7
(p0.5). In contrast, there was a steady recovery in albumin levels for those
who had had hepatectomy or anterior resection and by day 7, albumin had
recovered to 73% & 85% of the baseline levels respectively (pB0.05).
Conclusions. Albumin levels are markedly reduced and remain low in the
early post operative period in patients having major surgical procedures and
this was most marked in pancreaticoduodenectomy. Recovery of albumin
levels occurs within the first week of major surgery but this is noticeably
absent in Whipple’s procedure. This reflects the severity of biochemical and
operative stress in this procedure and persists significantly post-operatively.
Nutritional support must be maximised and careful assessment is necessary
in this period.
FP 10.01
ARE ROUTINE MEASUREMENTS OF SERUM AMYLASE AND
LIPASE HELPFUL IN THE DIAGNOSIS OF ACUTE ABDOMINAL
PAIN? A PROSPECTIVE STUDY
Sutton, Paul A1; Purcell, Gemma2; Whiting, Frances1; Wright, Tom J1;
Smith, Janette1; Humes, David J1; Lobo, Dileep N1; Morgan, Linda2
1Nottingham University Hospitals, Wolfson Digestive Diseases Centre,
Nottingham, United Kingdom; 2Nottingham University Hospitals, Depart-
ment of Clinical Chemistry, Nottingham, United Kingdom
Background. The routine measurement of serum lipase and amylase in
patients with acute abdominal pain has become standard practice for many
Emergency Departments in the United Kingdom as a response to 4 hour
admission targets. The biochemical diagnosis of acute pancreatitis is made in
our unit with an amylase 1000 U/l and 600 U/l for lipase.
Aim. To identify the role of amylase and lipase in the screening of patients
presenting with acute abdominal pain.
Methods. All adult patients presenting to the Emergency Department having
serum amylase and lipase measured within a six week period were identified,
and a prospective review of their case notes was undertaken.
Results. A total of 542 patients were studied; 52% female, mean (SD) age 47
(22) years. 510 patients had routinely requested enzymes measured, whilst
only 32 had them measured on clinical suspicion of pancreatitis. In only 7
(1.3%) was acute pancreatitis diagnosed using our biochemical threshold for
lipase, with 3 of these being identified on routine screening. In addition to
those with pancreatitis, 11 patients had a raised lipase attributable to other
upper GI pathology. Only 1 patient had a raised amylase (with a normal
lipase), which was attributable to a perforated duodenal ulcer. Where no
clinical suspicion of pancreatitis exists, 170 patients will need to be screened
to identify one case resulting in an excess cost of £754.80 (US$ 1509.60).
Discussion. The routine testing of serum amylase and lipase in all patients
presenting with acute abdominal pain is costly and requests should be guided
by clinical suspicion.
FP 10.02
DESCRIBING CT FINDINGS IN SEVERE ACUTE PANCREATITIS
USING MORPHOLOGIC TERMS: AN INTERNATIONAL INTER-
OBSERVER STUDY
Van Santvoort, Hjalmar C1; Bollen, Thomas L2; Besselink, Marc1; Banks,
Peter A3; Boermeester, Marja A4; Van Eijck, Casper H5; Evans, Jonathan6;
Freeny, Patrick C7; Grenacher, Lars8; Hermans, John J9; Horvath, Karen
D10; Hough, David11; Lameris, Johan S12; van Leeuwen, Maarten S13;
Mortele, Koenraad J14; Neoptolemos, John P15; Micheal G, Sarr16; Vege,
Santhi Swaroop17; Werner, Jens18; Gooszen, Hein G1
1University Medical Center Utrecht, Surgery, Utrecht, Netherlands; 2St
Antonius, Radiology, Nieuwegein, Netherlands; 3Brigham’s and Womans
Hospital, Harvard Medical School, Gastroenterology, Boston, United States;
4Academic Medical Center, Surgery, Amsterdam, Netherlands; 5Erasmus
Medical Center, Surgery, Rotterdam, Netherlands; 6Royal Liverpool Uni-
versity Hospital, Radiology, Liverpool, United Kingdom; 7University of
Washington Medical Center, Radiology, Seattle, United States; 8University
of Heidelberg, Radiology, Heidelberg, Germany; 9Erasmus Medical Center,
Radiology, Rotterdam, Netherlands; 10University of Washington Medical
Center, Surgery, Seattle, United States; 11Mayo Clinic, Radiology, Roche-
ster, United States; 12Academic Medical Center, Radiology, Amsterdam,
Netherlands; 13University Medical Center Utrecht, Radiology, Utrecht,
Netherlands; 14Brigham and Women’s Hospital, Harvard Medical School,
Radiology, Boston, United States; 15Royal Liverpool University Hospital,
Surgery, Liverpool, United Kingdom; 16Mayo Clinic, Surgery, Rochester,
United States; 17Mayo Clinic, Gastroenterology, Rochester, United States;
18University of Heidelberg, Surgery, Heidelberg, Germany
Background. Clear communication regarding CT findings in severe acute
pancreatitis (SAP) is essential for proper treatment decisions and clinical
research. The current terminology from the Atlanta Symposium (e.g.
pseudocyst, pancreatic abscess) has recently shown very poor interobserver
agreement, creating the potential for patient mismanagement (Besselink
Pancreas 2006). Objective, descriptive terminology might be a valuable
alternative.
Aim. The aim of this study was to determine the interobserver agreement for
a new set of descriptive, morphologic terms for CT findings in SAP.
Methods. 17 reviewers (8 radiologists, 7 HPB surgeons and 2 gastroenter-
ologists) in 3 US and 5 European centres renowned for their experience in
pancreatic disease independently reviewed 55 digital CTs of patients with
SAP. Percentage agreement (PA) (median, interquartile range [IQR]) for 9
descriptive, morphologic terms was calculated among all reviewers and
separately among the 8 radiologists and 9 clinicians. PA was defined as poor
(B0.50), moderate (0.510.70), good (0.710.90), and excellent (0.91
1.00).
Results. Overall agreement was good to excellent for the terms’collection’
(PA1; IQR 0.68-1),’relation with pancreas’ (1; 0.681),’content’ (0.88;
0.871), ‘shape’ (1; 0.781), ‘mass effect’ (0.78; 0.621)’loculated gas
bubbles’ (1; 11) and’air-fluid level’ (1; 11). Overall agreement was
moderate for’extent of pancreatic nonenhancement’ (0.60; 0.460.88)
and’encapsulation of collection’ (0.56; 0.480.69). PA was greater among
radiologists than clinicians for’extent of pancreatic nonenhancement’ (PA
0.75 versus 0.57, P0.008),’encapsulation’ (0.67 versus 0.46, P0.001),
and’content’ (1 versus 0.78, P0.008).
Conclusion. Interobserver agreement for the new set of descriptive,
morphologic terms is good to excellent. Therefore, we recommend that
subjective (interpretative) definitions to describe CT findings in SAP (e.g.
pseudocyst) should no longer be used in radiologic reports.
FP 10.03
GABESATE MESYLATE AND EARLY DISOBSTRUCTION OF
PAPILLA IMPROVE THE COURSE OF SEVERE ACUTE PAN-
CREATITIS
Bassi, Nicolo`
Regional Hospital, IV Dpt Surgery, Treviso, Italy
Purpose. Gallstones is the more frequent cause of acute pancreatitis in Italy.
It is well known that severe pancreatitis occurs for longer time obstruction of
the papilla. Mortality rate is around 6%. In this study we analysed 1026
patients with acute pancreatitis. We verified that the course of severe
pancreatitis could be improved by medical treatment with gabesate mesilate
and the early disobstruction of the papilla.
Methods. From January 1993 until December 2006, 1026 patients were
admitted in our Department with diagnosis of acute pancreatitis. In 599
patients aetiology was related to gallstones. 195 had severe pancreatitis.
Diagnosis was confirmed by laboratory tests if Amilasy and Lipasi level was
twice the normal range with associated increasing of Bilirubin, Alkaline
phoshatase and a˜gt levels. Abdominal ultrasonography were carried out on
each patient. CT scan or ColangioWirsungMRI were performed in the
majority of patients, while ERCP only when necessary.
Results. 195 patients with severe pancreatitis were evaluated. 158 of 195
patients with severe pancreatitis were treated with gabesate mesylate from the
day of admission (period 19952006, group A). In 92 patients of 158 early
disobstruction of the papilla occurred (within 48 hours), spontaneously or by
ERCP. 37 pts. (period 19931995, group B) did not received gabesate
mesylate and disobstruction occurred in 18 pts. In group A only 37% of pts
underwent surgical operation vs 70% in group B (pB 0.05).
Conclusion. our study conducted in a cohort of patients with documented
gallstone severe pancreatitis, provided further evidence that prompt treat-
ment with gabesate mesilate with early disobstruction of the papilla could
improve the course of severe pancreatitis.
FP 10.04
FULMINANT ACUTE PANCREATITIS: 10 YEARS AFTER OUR
DEFINITION AND FIRST REPORT
Secchi, Mario; Quadrelli, Lisandro; Rossi, Leonardo; Serra, F; Forte, J
IUNIR and HIG, Surgery, Rosario, Argentina
In 1992, a clinically-based classification system for Acute Pancreatitis (AP)
was proposed at the Atlanta Symposium. Fulminant Pancreatitis (FP) is a
non- agreed definition, but some patients with severe AP progress to an early
fulminant and lethal disease. We first defined FAP in 1998. We proposed
those cases of severe AP which showed failure or dysfunction of three or more
organs (multisystemic organ failure: MOF) within 48 hours after onset of
symptoms: British Journal of Surgery Vol.85 Suppl.2 (July): 8081, 1998.
Methods. 1132 patients having AP of any etiology were prospectively studied
in four surgical centers over the last 20 years. Our aim was to analyze
fulminant cases of severe AP and detect incidence, etiology, organ involve-
ment in MOF and mortality impact. Severity was determined by APACHE
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II (severe cases: 15 points) and by our Original INDEX (severe cases:
0.40). Mortality referred to those hospitalized cases.
Results. 150 severe cases were detected; 19 of these cases (12%) were
fulminant. The following causes were identified: lithiasis (11 patients
[4 alcohol-associated]), alcohol abuse (3 patients), dyslipimia (2 patients),
post-ERCP (2 patients), and post-papillotomy (1 patient). All cases of FP
showed MOF with some organ functions involved: lung and kidney in all 19,
heart in 9, liver in 8, endocrine pancreas in 8, brain in 6 and hemostasia in 4.
The mean APACHE II was 2998 and the INDEX was 0.5890.9. All
patients were treated in ICUs with a multidisciplinary approach (early TEN,
ATB treatment and systemic support), and 15 patients of 19 (78%) died after
early systemic complications (n10) and late local complications (n5)
while on treatment. The mortality rate for non-fulminant severe cases was
14% (6 cases of 131) (X2: p0.018).
Conclusion. Fulminant pancreatitis is a special entity in cases of severe AP
with MOF detected within 48 hours after onset of symptoms, with 78% of
mortality. Our definition and prospective study provides a new approach for
the early treatment of severe AP.
FP 10.05
DIFFERENT PATTERNS OF THE CYTOKINE EXPRESSION IN
PERIPHERAL WHITE BLOOD CELLS OF PATIENTS WITH
ACUTE NECROTIZING AND EDEMATOUS PANCREATITIS
Dambrauskas, Zilvinas1; Gulbinas, Antanas2; Berberat, Pascal O3; Giese,
Nathalia3; Giese, Thomas4; Barauskas, Giedrius5; Pundzius, Juozas5; Friess,
Helmut3
1Institute for Biomedical Research, Kaunas University of Medicine, Kaunas,
Lithuania; 2Institute for Biomedical Research, Kaunas, Lithuania; 3Heidel-
berg University, Department of Surgery, Heidelberg, Germany; 4Heidelberg
University, Institute of Immunology, Heidelberg, Germany; 5Kaunas Uni-
versity of Medicine, Department of Surgery, Kaunas
Background. Acute pancreatitis (AP) is an inflammatory disorder associated
with a complex cascade of immunological events. Analysis of the local and
systemic immune status and inflammatory response might contribute to the
better understanding of underlying pathophysiological mechanisms and
introduction of novel treatment methods.
Methods. The total of 30 patients with edematous (n17) and necrotizing
(n13) acute pancreatitis were prospectively entered into the study. The
EDTA samples of peripheral blood were drawn within 2472 hours after
onset of AP, and white blood cells (WBC’s) were isolated using the
erythrocyte lysis buffer immediately after collection. The mRNA expression
of 30 different cytokines and adhesion molecules was determined in blood
WBC’s by quantitative reverse transcriptase-polymerase chain reaction
(QRT-PCR). Clinical data related to the severity of the disease and
accompanying complications was also collected for each patient for further
statistical analysis.
Results. Disease severity scores (APACHE II, Imrie and MODS) were
significantly higher in the group of patients with necrotizing AP compared to
those with edematous AP. There was a statistically significant correlation
between these severity scores and expression of certain cytokines in the
peripheral blood WBC’s. A marked increase in the expression of IL-10 and
CD-11b was observed in circulating WBC’s of patients with necrotizing AP,
while expression of IL-4, IL-8, IFN-g and CD25 was downregulated in the
same group of patients when compared with edematous AP patient group.
Expression of IL-1b was also significantly lower in the group of patients who
developed systemic inflammatory response syndrome (SIRS), multiple organ
dysfunction syndrome (MODS) and died within the first two weeks.
Conclusion. Consequent infiltration of peripheral organs by aberrantly
activated inflammatory cells might be a detrimental event leading to the
development of severe necrotizing AP and MODS.
FP 10.06
SELECTIVE EMBOLISATION FOR BLEEDING VISCERAL AR-
TERY PSEUDOANEURYSMS IN PANCREATITIS
Sethi, Harsheet1; Peddu, Praveen2; Prachalias, Andreas3; Kane, Pauline2;
Karani, John2; Heaton, Nigel4; Rela, Mohamed4
1Kings College Hospital, HPB Surgery, London, United Kingdom; 2Kings
College Hospital, Radiology, London, United Kingdom; 3Kings College
Hospital, General Surgery, London, United Kingdom; 4Kings College
Hospital, HPB Surgery and Liver Transplantation, London, United King-
dom
Background. Pancreatitis is associated with arterial complications in 410%
of patients, with untreated mortality approaching 90%. Timely intervention
at a specialist centre can reduce the mortality to 15%. We present a single
institution experience of selective embolisation as first line management of
bleeding pseudoaneurysms in pancreatitis.
Methods. A retrospective analysis of all patients admitted to our centre with
acute and chronic pancreatitis from January 2000 till June 2007 identified 16
patients with visceral artery pseudoaneurysms. 69% of these were male and
63% were smokers. In 50% of the patients, bleeding complicated initial
presentation of pancreatitis. Alcohol was the offending agent in 10 patients,
gallstones in 3, trauma, drug induced and idiopathic pancreatitis in one each.
All patients had a contrast CT scan and 15 of the 16 patients underwent
coeliac axis angiography through a femoral approach.
Results. The pseudoaneurysms ranging from 0.9 to 9.0cm affected the
Splenic artery in 7, Hepatic in 3, Gastroduodenal and Right gastric in 2 each,
and Left gastric and Pancreaticoduodenal in 1 each. One patient developed
spontaneous thrombosis of the pseudoaneurysm. 14 patients had effective
coil embolisation of the pseudoaneurysm. One patient needed surgical
exclusion of the pseudoaneurysm following difficulty in accessing the coeliac
axis radiologically. There were no episodes of rebleeding and no in-hospital
mortality.
Conclusion. Pseudoaneurysms are unrelated to the severity of pancreatitis
and major haemorrhage can occur irrespective of their size. Co-existent
portal hypertension and sepsis increase the risk of surgery. Angiography and
selective coil embolisation is a safe and effective way to arrest the
haemorrhage.
FP 11.01
SYMPTOMATIC POLYCYSTIC LIVER DISEASE: SURGICAL
MANAGEMENT AND LONG-TERM QUALITY OF LIFE OUT-
COMES
Russell, Robert1; Feurer, Irene D.2; Wisawatapnimit, Panarut3; Pinson, C.
Wright1
1Vanderbilt University Medical Center, Hepatobiliary Surgery and Liver
Transplantation, Nashville, TN, United States; 2Vanderbilt University
Medical Center, Surgery and Biostatistics, Nashville, TN, United States;
3Vanderbilt University Medical Center, College of Nursing, Nashville, TN,
United States
Background/Aims. Surgical management is the mainstay of treatment for
patients with symptomatic polycystic liver disease (PCLD). The aim of this
study was to analyze immediate and long-term outcomes along with post-
operative health-related quality of life (HRQOL) in patients undergoing
operation for symptomatic PCLD.
Methods. A retrospective analysis of clinical, operative, and follow-up data
was carried out for patients with symptomatic PCLD undergoing surgery
from May 1991 to March 2007. The primary outcome measures assessed
were mortality, recurrence of symptoms, and HRQOL. HRQOL data was
obtained by mailed questionnaire using the SF-36† Health Survey (SF-36).
Data are reported as mean9SD.
Results. 20 patients (age52911 years) underwent surgery for sympto-
matic PCLD. Comorbidities included polycystic kidney disease in 50% and
cerebral aneurysms in 5%. Thirteen patients had fenestration and resection,
six patients had fenestration only, and one patient underwent liver trans-
plantation. There was no operative mortality and the overall morbidity rate
was 35%. The mean follow-up was 74959 months. Six patients reported
recurrence of symptoms at a mean of six years, but none required repeat
operative intervention. Fifteen patients returned SF-36 health surveys (mean
follow-up92956 months). Overall, physical HRQOL scores (39914) were
one standard deviation below the general population mean while mental
HRQOL scores (4699) approximated the general population mean (50910
for PCS and MCS).
Conclusions. Fenestration, fenestration with resection and, much less
frequently, liver transplantation are acceptable management strategies
depending on the extent and distribution of the cysts. These twenty patients
had no operative mortality, reasonable morbidity, and good long term relief of
symptoms. Nevertheless, this disease process has a significant effect on
patients’ physical HRQOL. Mental HRQOL is maintained.
FP 11.02
CLOSTRIDIUM DIFFICILE INFECTION IN HPB AND TRANS-
PLANT SURGERY: INCREASING CONCERNS?
Bhati, Chandra S1; Gills, Martin2; Bramhall, Simon R1; Mayer, David A1;
Buckels, John AC1; Mirza, Darius F1
1Queen Elizabeth Hospital, Liver Unit, Birmingham, United Kingdom;
2Queen Elizabeth Hospital, Department of Microbiology, Birmingham,
United Kingdom
Background. With the increasing use of broad-spectrum antibiotics in
surgical patients, antibiotic-associated diarrhoea is becoming more common.
Clostridium Difficile Infection (CDI), can range in severity from asympto-
matic to severe and life threatening, and this increases the morbidity as well
cost to health services.
Objectives. The aim of this study was to identify the patients with C. difficile
infection associated diarrhoea (CDAD) in HPB and liver transplant patients
and associated risk factors.
Methods. All patients between 1/06/2004 to 30/05/2007 period who had
positive C difficile toxin in stool were entered into a database retrospectively
using the hospital based microbiology database and computer system.
Supplementary information including demographic information, past med-
ical history, operative details and complications were obtained from HPB and
transplant database as well as local medical records. Risk factors in the form
of exposure to antibiotics, type of antibiotics, previous history of any
operation, GI intervention, associated co morbid factors and complications
were noted.
Results. During this period 371 liver transplants and 1832 HPB cases were
performed in the unit and 83 (3.7%) patients were positive for C difficile
toxin.
28 Abstracts
HPB Transplant
No of patients 57 (3.1%) 26 (7%)
Mean age 61.7 yrs (SEM1.989) 49.9yrs(SEM 2.76)
Medan age 63.1 (17.285 years) 55 (18 69 years)
Age ]65 year 34 (60%) 7 (27%)
No. exposed to antibiotic/
multiple antibiotic at time of
CDAD or within 14 days
45*/26 *N/A8 23/10
Leucocytosis on day of CDAD 43 (75.4%) 16 (62%)
Hospital stay(Median) 22 days(7132) 40 days(7255)
30 days mortality after CDI 8 (14%) 2 (0.8%)
Co morbid factors found in HPB patients were diabetes mellitus (8.8%),
history of previous operation (52.6%), previous GI surgery (17.5%) and
more then one previous surgery (14%). Ciprofloxacin and co-amoxiclav were
found to be commonly associated with CDI in HPB patients while
piperacillin in transplant patients. Two patients had positive evidence that
CDI contributed to sepsis and death in HPB cohort while none in transplant
cohort. No evidence of fulminate colitis were found.
Conclusion. CDI is increasing with the use of antibiotics in HPB and
transplant patients. It increases the morbidity and health cost. Old age,
previous history of operation and exposure to multiple antibiotics remains
major co factors for CDI.
FP 11.03
SURGICAL TREATMENT OF HYDATID LIVER DISEASE. STUDY
BASED ON THE DATA OF LITHUANIAN ECHINOCOCCUS
REGISTER.
Prof. Strupas, Kestutis1; Sokolovas, Vitalijus1; Jurgaitis, Jonas1; Paskonis,
Marius1; Brimas, Gintautas1; Marcinkute, Audrone2; Barakauskiene, Ausr-
ine3
1Vilnius University Hospital Santariðkiø Klinikos, Vilnius, Lithuania; 2Na-
tional Tuberculiosis and Infectious disease University Hospital, Vilnius,
Lithuania; 3National Pathology Center, Vilnius, Lithuania
Background. Surgery remains the main treatment modality for hydatid liver
disease. There are still debate about the best approach. Conservative surgery
has opposed to radical surgery were the cyst is totally removed, including the
pericyst, by total pericystectomy or partial hepatectomy. The short pre-
operative chemotherapy with mebendazol/abendazol as well, as the post-
operative chemotherapy treatment according to the guidelines of European
Echinococcosis Register, is very important for prophylaxis of recurrences of
hydatid disease.
Objective. This study is based on the data of Lithuanian Echinococcosis
Register. Register was founded in 2003 and have tide relations with European
Echinococcosis Register. Study results shows that radical resection of hepatic
hydatid disease is a safe and effective treatment.
Methods. In prospective study data from 2003/06 were collected until 2007/
01. Totally 76 patients were included in Lithuanian Echinococcosis Register.
18 cases of Echinococcus granuliosus (hydatid disease) and 58 cases of
Echinococcus multilocularis (alveolar hytadid disease). In all cases diagnosis
was obtained using serology test (ELISA), radiological modalities (US, ST,
MRB), and in rare cases  biopsy. Chemotherapy with mebendazol/abendazol
received all patients. Patients suitable for operation chemotherapy received
preoperatively and postoperatively.
Results. From entire series, 25 patients (34%) were feasible for radical
operation. Two types of radical operations were performed- pericystectomy
or partial hepatectomy. Others 51 (66%) received only palliative treatment
and chemotherapy. In the radically operated group there were no operative
and postoperative mortality. There were no complications and recurrence of
disease in 36 month of follow up.
Conclusion. Results shows that radical surgery with preoperative and
postoperative chemotherapy is the first choice treatment for hydatid liver
disease.
FP 11.04
DETERMINATION OF THE RIGHT-SIDED BORDER OF THE
CAUDATE LOBE IN HUMAN LIVERS
Kogure, Kimitaka1; Ishizaki, Masatoshi1; Suehiro, Taketoshi1; Shimura,
Tatsuo1; Kuwano, Hiroyuki1; Yorifuji, Hiroshi2; Takata, Kuniaki3; Makuu-
chi, Masatoshi4
1Gunma University, Graduate School of Medicine, Department of General
Surgical Science (Surgery I), Maebashi, Japan; 2Gunma University, Gradu-
ate School of Medicine, Department of Neuromuscular and Developmental
Anat, Maebashi, Japan; 3Gunma University, Graduate School of Medicine,
Department of Anatomy and Cell Biology, Maebashi, Japan; 4Japanese Red
Cross Medical Center, Tokyo, Japan
Background. Resection of malignant liver tumors should encompass the
anatomical segment that includes the tumor-bearing region. Combined
resection of the tumor-bearing segment and the caudate lobe is convention-
ally performed for hilar cholangiocarcinoma. However, the right-sided border
of the caudate lobe has been a matter of controversy.
Objective. This study was conducted to clarify the real dissection line in
performing the complete resection of the caudate lobe.
Materials and Methods. The thirty-four adult cadaveric livers were
submitted for the study. By identifying both feeding areas of the caudate
lobe portal veins and the posterior superior portal branches the border
between the caudate lobe and the right liver was determined.
Results. The caudate lobe consisted of three subsegments, i.e. Spiegel lobe,
paracaval portion and caudate processus. Each subsegment had its own
specific portal vein branches ramifying from the left and right portal veins,
and rarely from the portal vein. The number of the portal vein branches of the
caudate lobe was variable in each case. In our 34 cases, their number ranged
from one to six and each number of cadaver was 3, 9, 11, 7, 2 and 2,
respectively. There were two types of the right-sided border between the
caudate lobe and the right liver. In 23 cases the border did not exceed the line
coinciding with the right-sided wall of the IVC. In another 11 cases,
the border removed to the right side from the right-sided wall of the IVC.
In these cases the thickness of the hepatic tissue of the caudate lobe exceeding
the right-sided wall of the IVC was between 220 mm.
Conclusion. The study revealed that the caudate lobe is completely resected
if dissection line was situated on at least 20 mm right side from the right-sided
wall of the IVC.
FP 11.05
A SINGLE INSTITUTIONAL EXPERIENCE IN THE MANAGE-
MENT OF AMOEBIC LIVER ABSCESS
Rajasekar, Arthanari1; Rajasekaran, Rasapan2
1Sri Gokulam Hospital, Surgical Gastroenterology, 3/60 Meyyanur Road,
Salem, India; 2Sri Gokulam Hospital, Radiology, Salem, India
Introduction. Liver abscess, particularly amoebic is a major health problem
in India. We report our experience in the management of amoebic liver
abscess.
Patients and Methods. From April 2001 to August 2006, a total of 124
patients with liver abscess were treated. Patients with abscess size of 5 cm in
ultrasound were treated with medical therapy, abscess size 5 cm to 10 cm
with ultrasound guided aspiration of the abscess and abscess size more than
10cm with ultrasound guided percutaneous insertion of catheter.
Results. Mean age was 43 years. Male: Female ratio was 98: 26. Sixty seven
patients (54%) consumed toddy an extract from the palm tree and 38
patients (30.5%) consumed liquor. Seventy three (59%) patients had one
abscess the remaining patients had more than one abscesses. In 70% of the
patients right lobe of the liver was predominantly affected. Forty three
patients (35%) were managed conservatively, 6 patients latter required
percuatenous ultrasound guided aspiration due to persistent pain. Fifty three
patients (43%) underwent percutaneous ultrasound guided aspiration.
Seventeen patients (14%) required percuatneous catheter insertions. Eleven
patients (9%) presented with ruptured liver abscess, 1 patient with loculated
collection percutaneous insertion of drainage tube was done, 9 patients
underwent laparoscopic drainage of abscess and 1 patient required lapar-
otomy There was no mortality. Two patients developed bleeding per rectum.,
colonoscopy revealed amoebic granuloma in the caecum in both this patients.
Conclusion. Amoebic liver abscess is common in males who drink toddy and
is more common in the right lobe. Small sized abscess can be managed
conservatively and abscess more than 5 cm will require percutaneous
aspiration or insertion of a drain. Patients presenting with intraperitoneal
rupture can be managed by laparoscopic technique.
FP 11.06
HAS INCIDENCE OF HEMOBILIA INCREASED WITH INCREAS-
ING CONSERVATIVE MANAGEMENT OF BLUNT LIVER INJU-
RIES?
Thumma, Venu Madhav1; Varma, Vibha2; Nagari, Bheerappa2; Regula-
gadda, Adikesava Sastry2
1Nizams Institute Of Medical Sciences, Surgical Gastroenterology, Punja-
gutta, Hyderabad, India; 2Nizams Institute Of Medical Sciences, Surgical
Gastroenterology, Hyderabad, India
Background. Hemobilia is described after percutaneous interventions or
following blunt trauma with varying frequencies.
Aim. To observe whether the trend toward conservative management of
major liver trauma has resulted in an increased incidence of hemobilia and to
evaluate the role of selective hepatic artery angiography in timing, diagnosis
and management.
Methods. The study period was divided into two halves. During the initial
half (19972001) 40 cases and during the later half (200206) 55 cases of
blunt liver trauma were managed.
Results. During the initial half 10 (25%) were managed conservatively (8
grade I and 2 grade II injuries). All the grade III injuries were operated. There
was no incidence of hemobilia in the initial group. During the latter half 20
cases (36%) were managed conservatively (8 grade I, 6 grade II and 6 grade
III injuries). Three of them (1 grade I and 2 grade III) developed hemobilia.
Another patient with grade III injury who was managed surgically also
developed hemobilia. The mean interval between the initial injury and the
diagnosis of hemobilia was 2 months. Selective angiography was done in all
and it successfully localized the bleed in only two patients who were actively
bleeding. In the remaining two patients the bleeding lesions were successfully
Abstracts 29
localized when the procedure was repeated during the active bleed.
Pseudoaneurysm of a branch of right hepatic artery was found in all the
four patients and was treated successfully with selective embolisation. There
were no deaths and no complications.
Conclusion. Increased frequency of hemobilia in liver injuries in the latter
half of the study especially in grade III injuries throws a suspicion whether
predominant conservative initial management is responsible. Selective
arterial embolisation is the treatment of choice with a substantial rate of
success and a low incidence of serious complications in treatment of
traumatic hemobilia
FP 11.07
SURGICAL EXPERIENCE WITH ECHINOCOCCOSIS IN A SIN-
GLE CENTER IN THE NETHERLANDS
Stoot, Jan1; Jongsma, Kees2; Terpstra, Onno3; Breslau, Paul4
1University Hospital Maastricht, Department of Surgery, maastricht, Nether-
lands; 2Harbor Hospital Rotterdam, department of Surgery, Rotterdam,
Netherlands; 3Leiden University Medical Center, Department of Surgery,
Leiden, Netherlands; 4
Background. Hydatid disease of the liver remains endemic in the world and
is an import disease in the Netherlands. Although PAIR(Puncture Aspiration
Injection and reaspiration) has been investigated by several groups, there is
still no consensus about the best treatment.
Objective. We performed a single center retrospective study to evaluate
clinical presentation, treatment and outcome of surgically treated patients for
echinococcosis.
Methods. Records of hundred consecutive surgically treated patients were
analysed retrospectively on relapse of disease, infection, complications and
mortality. In this study the frozen seal technique was used for radical
surgery.
Results. At clinical presentation the majority of complains consisted of
abdominal pain(n80), abdominal mass, (n40), fever(n18) and
urticaria(n10). Also, cardiac decompensation, anaphylaxis and jaundice
were seen at presentation. Serology(ELISA, IMF) confirmed diagnosis in
85% and liverfunction-tests were only disturbed with envolvement of hepatic
ducts. In all cases echinococcosis was diagnosed by Computed Tomography
or ultrasound. The majority of the cysts was seen only in the liver. Surgery
was performed in all cases(n103) with the frozen seal technique. Mean age
was 36(770). Eleven complications were recorded in total: 7 minor
complications(6 infections and one pneumonia) and 4 moderate/major
complications(two biliary fistula, abces and peritonitis). With a mean
follow-up of 24 months, relapse of disease was seen in 5 cases, of whom 4
needed surgical treatment. No mortality was observed in this study. This is in
contrast with the mortality rate found in literature.
Conclusion. This method of surgery is safe and effective. Future studies
have to prove its position in the treatment of hydatic disease as new
developments show promising results.
FP 11.08
COAGULATION STATUS IN EXTRAHEPATIC PORTAL VENOUS
OBSTRUCTION IN INDIAN POPULATION: PRE AND POST
SHUNT EVALUATION
Dash, Nihar Ranjan; Pal, Sujoy; Sahni, Peush; Chattopadhyay, Tushar Kanti;
Sharma, Aribam D
AIIMS, New Delhi, GI Surgery, Delhi, India
Background. The etiology of extra hepatic portal venous obstruction
(EHO) remains unsubstantiated. Hypercoagulable state is one strongly
implicated in western studies. However the demographic and clinical features
of EHO in Indian population are different.
Objective. To evaluate the coagulation status in Indian patients with EHO
both before and after proximal splenorenal shunt (PSRS).
Material And Method. Between Nov.03 and Nov.05 all cases of EHO with
bleed and/or hypersplenism, who underwent PSRS, were prospectively
studied. Whole blood samples on day 0,5 and 180 were tested for coagulation
status by using Thromboelastograph (TEG). The results were compared with
141 historical controls of the TEG reference manual. The shunt patency was
assessed by ultrasound Doppler findings and endoscopic evaluation of
varices. Attempt was made to find correlation among the coagulation
spectrum and other parameters.
Results. 37 patients (16 females) were studied. Mean age was21.8yrs (12
45). Mean platelet count was 74000/cumm (25196). Post operatively one
patient had transient ascitis and one had intraperitoneal bleed requiring
surgical hemostasis. Shunt block was detected in only one case. Day 0 values
showed hypercoagulable state in 18.9% cases and hypocoagulable state in
10.8% cases (significant changes in R, K, MA, Angle, TEG index in
comparison to control). A hyper coagulable state was observed on the Day
5. 23(62%) cases could be followed up. The Values were near normal by day
180. There was no significant correlation between TEG parameters with
platelet count, bilirubin or prothombin time. The TEG index remained high
at more than 2.5 in the only case of shunt block.
Conclusion. Significant number (29.7%) of EHO patients had coagulation
disorder. A reversal in the hypercoagulability occurs following PSRS even
though there is occurrence of hypercoagulability in the immediate post-
operative period. Persistence of hypercoagulability may predict shunt
thrombosis. A larger comparative study is needed.
FP 11.09
REVIEW OF PANCREATIC TRAUMA AT ALFRED HOSPITAL,
MELBOURNE
Choi, Julian1; Warwick, Andrea1; Burton, Paul2; Usatoff, Val2; Hassen,
Sayed2; Evans, Peter2
1Alfred Hospital, Surgery, Melbourne, Australia; 2Alfred Hospital, Mel-
bourne, Australia
Backgrounds. Pancreatic injury is relatively uncommon in patients with
abdominal trauma. However, it is associated with significant morbidity and
mortality.
Aims. The aims of this review are; to examine mechanism of pancreatic
injury and to grade its severity; to study its management and outcomes at
Alfred hospital.
Methods. A review of trauma database was performed to identify patients
with pancreatic trauma, admitted to Alfred hospital between January 2002
and July 2007 and their charts were reviewed.
Results. Between 2002 and 2007, 53 patients were admitted to Alfred
hospital with pancreatic trauma. The mean age and mean ISS (injury severity
score) was 34.8 years old and 27.1 respectively. 45 patients (85%) had a blunt
and 8 (15%) had a penetrating injury to pancreas. 36 patients (68%) had a
minor (grade 12: pancreatic contusion or minor laceration) and 17 (32%)
had a major pancreatic injury (grade 35: pancreatic ductal injury, transec-
tion or massive disruption of pancreatic head). The grading of pancreatic
trauma was based on findings at laparotomy or on abdominal CT. ISS for
minor and major pancreatic injury groups were 48.8 and 32.9 respectively.
45% of patients with minor pancreatic injuries were successfully managed
with conservative treatment. 20 patients in this group required laparotomy
including 7 splenectomies, 4 bowel resections, and 1 distal pancreatectomy.
Amongst 17 patients with the major pancreatic injury, 8 patients underwent
distal pancreatectomy and splenectomy; 4 pancreatico-duodenectomy; 1
spleen preserving distal pancreatectomy; 1 bile duct repair; 1 uncinate
process resection and 1 duodenal repair. There were 8 deaths in this series
with mortality rate of 15%. 7 deaths in the minor pancreatic injury group
were due to severe head injuries.
Conclusion. 53 pancreatic trauma patients were admitted over 5 years with
32% having major pancreatic injuries. The mortality rate from pancreatic
injury was 1.9%. The pancreatic trauma is uncommon and its management
demonstrtates an excellent outcomes.
FP 12.01
EIGHT YEARS EXPERIENCE ON RADIOFREQUENCY ABLA-
TION FOR LIVER MALIGNACIES  A REPORT OF 803 CASES
Chen, Min-Shan1; Zhang, Yao-Jun1; Li, Jin-Qing1; Liang, Hui-Hong1;
Zhang, Ya-Qi1; Lin, Xiao-Jun1; Lau, Wan Y2
1Department of Hepatobiliary Surgery, Cancer Centre of Sun Yat-Sen
University, Guangzhou, China; 2Department of Surgery, The Chinese
University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
Objective. To summarize the 8-year experience on radiofrequency ablation
(RFA) for liver malignancies and explore the effect and prognostic factors.
Methods. Between August 1999 and February 2007, 803 patients with liver
malignancies, [672 with primary liver cancer (PLC) and 131 with liver
metastasis] were treated with RFA. 781 cases were performed percutaneously
under the guidance of ultrasound, 8 cases percutaneously under the guidance
of CT, 9 with laparoscopy and 5 with laparotomy. 117 cases were treated by
RFA combined with percutaneous ethanol injection and 108 cases by RFA
combined with transcathetal arterial chemoembolization. The mortality,
morbidity, complete ablative rates, loco-recurrence rates and survival rates
were calculated.
Results. For 803 liver malignancies, the mortality was 0.25%, the morbidity
was 0.37%, the complete ablative rate was 92.49%, the loco-recurrence rate
was 13.80% and the 1, 2, 3, 4, 5-year survivals were 95.05%, 85.62%,
75.70%, 60.67% and 47.47%, respectively. According to the tumor size, the
1, 2, 3, 4, 5-year survivals for tumors ¡U¨3.0cm were 97.20%, 90.1%,
84.76%, 76.93% and 60.37%, respectively, for tumors 3.15.0cm 94.85%,
84.52%, 70.37%, 45.78% and 41.53%, respectively, and for tumors £345.0cm
85.44%, 67.33%, 46.40%, 14.30% and 0%, respectively (P£¼0.001). For
the 672 PLCs, the 1, 2, 3, 4, 5-year survivals for stage ¢n˜a (Chinese staging
system) were 97.84%, 91.53%, 84.58%, 77.10% and 61.92%, respectively,
for stage ¢n˜b 93.86%, 83.67%, 69.82%, 45.12% and 42.20%, respectively,
for stage ¢o`86.17%, 67.33%, 47.28%, 17.19% and 0%, respectively, and the
1, 2-year survivals for stage ¢o´ were 67.84% and 0%, respectively
(P£¼0.001).
Conclusions. RFA is a safe and effective method for liver malignancy, and
the tumor size and stage are important prognostic factors.
FP 12.02
LIVER SURGERY FOR COLORECTAL METASTASES: RESULTS
AFTER 10 YEARS OF FOLLOW-UP
Vigano’, Luca; Ferrero, Alessandro; Lo Tesoriere, Roberto; Sgotto, Enrico;
Russolillo, Nadia; Capussotti, Lorenzo
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Ospedale Mauriziano ‘‘Umberto I’’, Surgery, Torino, Italy
Background. Liver surgery is the gold standard treatment of colorectal liver
metastases with five-year survival rates of 3040%. Anyway after 5 years some
patients are alive with recurrence and metastases can occur later on. Longer
follow-up data are needed.
Aim. To analyze survival results, late recurrence rate and prognostic factors
of survival in patients with at least 10 years of follow-up.
Methods. 125 patients undergoing liver resection for colorectal liver
metastases between 1985 and 1996. Patients with postoperative mortality
(4 cases) or dead before 10 years of follow-up without any evidence of tumor
recurrence (7) were excluded. The analysis was performed on 114 patients.
Results. Actual 5- and 10-year survival rates were 21.1% and 15.8%.
Eighteen patients were alive 10 years after liver resection, 16 were disease free
(5 cases after reresection). Actual 5- and 10-year disease-free survival rates
were 16.7% and 14.0%. In patients with recurrence, reresection significan-
tively improved survival (pB0.001). More than 90% of recurrences occurred
before 5 years of follow-up, but 28.6% of patients disease-free at 5 years
developed recurrence. Multivariate analysis evidenced 4 independent nega-
tive prognostic factors of survival: synchronous metastases (p0.038),
3 metastases (pB0.001), metastatic infiltration of nearby structures
(pB0.001) and postoperative morbidity (p0.001). Thirty-nine patients
without negative prognostic factors had 10-year overall and disease-free
survival rates of 33.3% and 30.8%.
Conclusions. Patients with 1 to 3 metachronous metastases without
infiltration of nearby structures have the best long-term results and about
one third of them are alive 10 years after liver resection. Postoperative
morbidity worsens long-term outcomes. Risk of recurrence is high even later
than 5 years of follow-up. Reresection should be performed whenever
possible.
FP 12.03
OUTCOMES FOLLOWING INTENSIVE SURVEILLANCE FOL-
LOW-UP FOLLOWING HEPATIC RESECTION FOR COLOREC-
TAL METASTASES
Gomez, Dhanwant; Sangha, Vicky K; Morris-Stiff, Gareth; Malik, Hassan Z;
Toogood, Giles J; Lodge, J. Peter A.; Prasad, Rajendra
Leeds Teaching Hospital NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom
Background. With the increase in hepatic resection being performed in
patients with colorectal liver metastasis (CRLM), hepatobiliary units have
follow-up protocols which mainly consist of computer tomography of the
thorax and abdomen (CT). However, the appropriate interval follow-up
period is still controversial. The aim of the study was to determine the
number of patients identified with recurrence in 3 monthly intervals and
determine whether there is a difference in survival.
Methods. Patients undergoing resection for CRLM from January 1993 to
March 2007 were identified from the hepatobiliary database.
Results. 705 primary resections were performed during the study period.
There were 434 (62%) patients that developed recurrence during the follow-
up period, of which 398 (56%) patients developed recurrence within the first
two years of follow-up. Disease recurrence was detected at 3, 6, 9, 12, 15, 18,
21 and 24 months on surveillance CT follow-up in 112 (28%), 86 (22%), 40
(10%), 61 (15%), 33 (8%), 29 (7%), 13 (3%) and 24 (6%) patients,
respectively. Patients who did developed recurrence during these time points
were treated with resection in 29 (26%), 20 (23%), 13 (33%), 24 (39%), 8
(24%), 7 (24%), 5 (38%) and 16 (67%) patients, respectively. Patients with
disease recurrence at 3 (pB0.001), 6 (p0.002), 9 (pB0.001) and 12 (pB
0.001) months that were treated with liver and/or lung resection had a
significantly better overall survival compared to patients treated with
chemotherapy. If 3-monthly CT scanning is performed within the first 2
years as our unit’s protocol, the additional patients with recurrence detected
were 198 (50%) patients. In addition, patients with recurrence within the first
year of follow-up managed with surgery have a significantly better long-term
outcome.
Conclusion. Intensive 3 monthly surveillance follow-up detect CRLM
recurrence which is treatable by means of further resection. Patients with
recurrence treated with re-resection have improved long-term survival.
FP 12.04
PERIOPERATIVE CEA MEASUREMENTS TO PREDICT CUR-
ABILITY AFTER LIVER RESECTION FOR COLORECTAL
METASTASES
Jaeck, Daniel; Oussoultzoglou, Elie; Rosso, Edoardo; Pessaux, Patrick;
Bachellier, Philippe
Hopital de Hautepierre, Centre de Chirurgie Visce´rale et Transplantation,
Strasbourg, France
Background. Despite various multimodality treatments, definitive cure
remains still elusive for a majority of patients with resected colorectal liver
metastases (CLM). Better tools for appropriate patient selection are needed
to identify those who most likely will benefit from radical resection and
adjuvant therapy. The aim of this study is to prospectively evaluate peri-
operative carcinoembryonic antigen (CEA) blood levels as a predictor of
outcome after curative intent resection of CLM.
Patients and Methods. From January 2000 to December 2004, 213
patients received CLM resection with curative intent out of 233 patients
operated for CLM. The CEA blood level was routinely measured one week
before and 6 weeks after liver resection. The 213 patients were divided into
three groups: A) patients with normal pre- and post-operative CEA blood
levels (n69); B) patients with elevated preoperative and normal post-
operative CEA blood levels (n111); C) patients with elevated pre- and
post-operative CEA blood levels (n33). The ability of peri-operative CEA
levels to predict outcome after curative intent resection was investigated.
Results. The overall 1-, 3- and 5-year survival rates were 92.0%, 66.3% and
35.8% respectively with a median survival of 32.2 months. The 5-year overall
and disease-free survival in group A was 50.2% and 21.9%, group B 38.5%
and 18.3% and group C 0% and 0% (PB0.0001). The multivariate analysis,
only peri-operative CEA blood level, hepatic pedicle lymph node involvement
and number and size of liver metastases were independent prognostic factors
for overall survival.
Conclusion. This study could demonstrate the predictive value of peri-
operative CEA levels. Moreover these CEA levels showed better predictive
value than available clinical scores and biological characteristics of the
primary tumor and of liver metastases. CEA levels as early as 6 weeks
postoperatively may be helpful in selecting patients for adjuvant chemother-
apy after surgical resection of CLM.
FP 12.05
INTRAHEPATIC LYMPHATIC INVASION INDEPENDENTLY
PREDICTS POOR OUTCOMES AFTER HEPATECTOMY IN PA-
TIENTS WITH COLORECTAL CARCINOMA LIVER METAS-
TASES
Korita, Pavel1; Wakai, Toshifumi1; Shirai, Yoshio1; Sakata, Jun1; Takizawa,
Kazuyasu1; Cruz, Pauldion1; Ajioka, Yoichi2; Hatakeyama, Katsuyoshi1
1Niigata University Graduate School of Medical and Dental Sciences,
Division of Digestive and General Surgery, Niigata City, Japan; 2Niigata
University Graduate School of Medical and Dental Sciences, Division of
Molecular and Diagnostic Pathology, Niigata City, Japan
Background. D240 monoclonal antibody immunoreactivity is specific for
lymphatic endothelium and therefore provides a marker of lymphatic
invasion. We hypothesized that intrahepatic lymphatic invasion reflects the
nodal status of colorectal carcinoma liver metastases and may function as an
adverse prognostic factor.
Methods. A retrospective analysis of 105 consecutive patients who under-
went resection for colorectal carcinoma liver metastases was conducted.
Intrahepatic lymphatic invasion was declared when either single tumor cells
or cell clusters were clearly visible within vessels that showed immunor-
eactivity for D240 monoclonal antibody. The median follow-up time was
124 months.
Results. Of 105 patients, 13 were classified as having intrahepatic lymphatic
invasion. All tumor foci of intrahepatic lymphatic invasion were detected
within the portal tracts. Intrahepatic lymphatic invasion was significantly
associated with hepatic lymph node involvement (P0.039). Survival after
resection was significantly worse in patients with intrahepatic lymphatic
invasion (median survival time of 13 months; cumulative 5-year survival rate
of 0%) than in patients without (median survival time of 40 months;
cumulative 5-year survival rate of 41%; PB0.0001). Patients with intrahe-
patic lymphatic invasion also showed decreased disease-free survival rates
(PB0.0001). Intrahepatic lymphatic invasion thus independently affected
both survival (relative risk, 7.666; 95% confidence interval, 3.73215.748;
PB0.001) and disease-free survival (relative risk, 4.112; 95% confidence
interval, 2.1857.738; PB0.001).
Conclusions. Intrahepatic lymphatic invasion is associated with hepatic
lymph node involvement and is an adverse prognostic factor in patients with
colorectal carcinoma liver metastases.
FP 12.06
ADRENAL METASTASES IN PATIENTS WITH COLORECTAL
LIVER METASTASES
de Haas, Robbert J; Rahy Martin, Aida C; Wicherts, Dennis A; Azoulay,
Daniel; Castaing, Denis; Bismuth, Henri; Adam, Rene´
Hoˆpital Paul Brousse, Centre He´pato-Biliaire, Villejuif, France
Background. Within the literature, only few cases exist describing adrenal
metastases (AM) from colorectal cancer. Furthermore, adrenal involvement
by colorectal cancer is generally considered as incurable systemic disease.
Aim. To evaluate if this patient group should still be considered as having a
dismal prognosis, we reviewed our experience in treating patients with AM,
initially referred for colorectal liver metastases (CLM).
Methods. Patients resected for CLM at our hospital between January 1993
and December 2006 who developed AM were included in this study.
Comparison regarding long-term outcome was made to all other patients
resected for CLM but without AM during the same period.
Results. Hepatectomy (HR) was performed in 795 patients, of whom 13
(2%) developed AM, after a mean of 26 months after first CLM diagnosis.
The remaining 782 patients (98%) were without AM. Four patients (31%)
presented with solitary AM, while in 9 patients (69%) other organs were also
involved. Nine patients (69%) underwent adrenalectomy, the other 4 (31%)
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were treated by systemic chemotherapy. Median survival after first HR was
45 months (95% confidence interval (CI) 3358) in the AM group,
compared to 59 months (95% CI 5068; P0.20) in patients without
AM. After AM diagnosis, median survival was 23 months (95% CI 1928).
Median survival after adrenalectomy (N9) was 23 months (95% CI 13
31), versus 30 months (95% CI 1942) after chemotherapy (N4) (P
0.12). If adrenalectomy was combined to HR (N3), median survival after
AM diagnosis was 23 months, vs. 20 months in case of metachronous
adrenalectomy (N6). At last follow-up, 9 patients died of disease
progression (69%), and 4 were alive with recurrence (31%).
Conclusion. Adrenal involvement in patients with metastatic colorectal
cancer has a dismal prognosis, but does not reduce significantly the survival
of patients resected from liver metastases. Prolonged survival can be achieved
by an aggressive treatment including liver resection, adrenalectomy, and
systemic chemotherapy.
FP 12.07
EXPRESSION PATTERNS OF RAS COMPONENTS: NOVEL FAC-
TORS INVOLVED IN LIVER REGENERATION AND TUMOUR
STIMULATION
Zhu, Jin; Harun, Nadia; Malcontenti-Wilson, Cathy; Fifis, Theodora;
Muralidharan, Vijayaragavan; Christophi, Chris
Austin Hospital/University of Melbourne, Department of Surgery, Heidel-
berg, Australia
Background. Partial hepatectomy is the standard treatment for patients with
colorectal cancer liver metastasis. Liver regeneration following hepatectomy
has been correlated with increased tumour growth and metastases due to
upregulation of growth factors and cytokines. Key components of the Renin-
Angiotensin System (RAS) are novel growth regulatory factors possessing
angiogenic and mitogenic activity and have been shown to contribute to
tumour growth.
Objective. This study investigates the local expression pattern of the RAS
components in a mouse model of liver regeneration.
Methods. CBA mice were divided into two groups: 70% partial hepatectomy
and sham controls. Tissues and serum were collected at days: 1, 2, 4, 6, 8 and
10 post hepatectomy. Liver regeneration was quantitated by evaluation of
hepatocyte proliferation using Ki67 IHC. Expression of local RAS compo-
nents was detected by real-time PCR, IHC and RIA methods. Serum levels of
HGF and TGF-b1 were determined by ELISA.
Results. Hepatectomy significantly increased hepatocyte proliferation with a
peak at Day2 post-operation. Among the RAS components, the expression of
Angiotensinogen, Angiotensin converting enzyme (ACE), and MAS receptor
were significantly up-regulated after hepatectomy, and peaked at Day1,
Day4, and Day10 respectively. AngiotensinII type I receptor (AT1) expres-
sion was found to be the same in both groups. In normal and sham livers, the
expression of AngiotensinII type II receptor (AT2) was negative, but positive
expression of AT2 appeared at late phase during liver regeneration.
Additionally, Serum HGF and TGF-b1 levels peaked at Day6 and Day8
after hepatectomy, respectively.
Conclusion. This is the first study to show upregulation of RAS components
which are closely related to tumor growth and metastasis during different
stages of liver regeneration. These components may provide new intervention
targets for prevention of tumour recurrence after liver resection, and
contribute to overall improvement in patient outcomes.
FP 12.08
ASSESSMENT OF REGIONAL HEPATIC LYMPH NODE METAS-
TASES IN PATIENTS UNDERGOING HEPATECTOMY
Jersenius, Ulf1; Isaksson, Bengt2; Kylander, Christian3; Lundell, Lars3;
Dlugosz, Rafal4; So¨derdahl, Gunnar4; Bjo¨rnstedt, Mikael5
1GastroCentrum Kirurgi, Karolinska Universitetssjukhuset Huddinge,
Stockholm, Sweden; 2Karolinska University Hospital Huddinge, Suregry,
Stockholm, Sweden; 3Karolinska University Hospital Huddinge, Surgery,
Stockholm, Sweden; 4Karolinska University Hospital Huddinge, Transplan-
tation surgery, Stockholm, Sweden; 5Karolinska University Hospital Hud-
dinge, Pathology, Stockholm, Sweden
Introduction. Metastases from colorectal cancer to regional hepatic lymph
nodes may indicate an aggressive disease and are considered to be a negative
prognostic factor for survival. Macroscopic nodular involvement is usually
judged as a contraindication for a hepatectomy. The prevalence of micro-
scopic lymph node metastases, systematically explored in the regional lymph
node stations, is scarcely assessed in prospective studies.
Objective. The aim in this study was to assess the number of patients with
regional hepatic microscopic lymph node metastases at the time for hepatic
resection due to colo rectal cancer secondaries.
Methods. In 57 consecutive patients, at the time for hepatic resection,
systematic lymph node clearance were performed in three regional hepatic
lymph node stations: the hepato-duodenal ligament, the celiac trunc and
retropancreatically between the aorta and the inferior caval vein. The first 44
patients were evaluated only with routine staining. To further evaluate
micrometastatic disease the last 13 patients were also evaluated with
immunohistochemistry using cytokeratin 20 and MNF 116.
Results. Among the 57 patients 290 regional hepatic lymph nodes were
examined with routine stain. Metastases were found in 15 nodes collected
from 5 patients. In one of the 13 patients examined with immunohistochem-
istry 2 micrometastases were found. These metastases were not seen in
routine staining.
Conclusion. Regional hepatic lymph node metastases were found in 9% of
the patients with liver metastases from colorectal cancer at the first
hepatectomy. Additional metastases are possible to detect with immunohis-
tochemistry. The impact of micrometastases on survival and the need for
changed onco-surgical strategies in the treatment of these patients have to be
addressed.
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IMMUNE RESPONSES FOLLOWING THERMAL ABLATION IN A
MURINE MODEL OF COLORECTAL LIVER METASTASES
Lin, Wen Xu; Fifis, Theodora; Nikfarjam, Mehrdad; Malcontenti-Wilson,
Caterina; Muralidharan, Vijayaragavan; Christophi, Christopher
University of Melbourne, Austin Health, Department of Surgery, Heidelberg
3084, Australia
Background. Thermal ablation is a recommended treatment for selected
patients with unresectable colorectal cancer liver metastases. Some studies
report lower recurrence after TA compared to liver resection, however
recurrence still occurs. Experimental studies suggest that destruction of
tumor tissue in situ may stimulate host immunity against cancer.
Aim. To investigate the induction of immune responses after thermal
ablation and to determine the temporal & spatial distribution of T cells;
Kupffer cells and the expression of IFNg.
Methods. A murine liver metastatic tumor model was used. Thermal
ablation of selected tumors was performed 21 days after tumor induction.
Tissues were collected from ablated and sham treated livers and tumors at the
time of treatment and at several time points, up to 7 days after treatment.
Localisation of CD3 T cells, Kupffer cells and IFNg levels were assessed
using immunohistochemistry. Livers of un-induced mice were used as
controls.
Results. CD3T cells and Kupffer cell numbers were significantly elevated
in tumor bearing livers compared to un-induced livers and were found to
accumulate at the tumor-host interface and around tumour vessels. Thermal
ablation treatment caused an immediate and significant increase in CD3T
cells and Kupffer cell frequencies and levels of IFNg in the ablated tumors
compared to shams. High levels persisted for all the time points tested. At 24
hours post treatment, there was a decrease from initial high levels followed by
a progressive increase reaching a maximum between days 57. Similar
increases were observed in tumors distant to the ablation site suggesting a
systemic immune response.
Conclusion. Thermal ablation induces immune responses which may be
anti tumor, and may account for lower tumour recurrence compared to liver
resection. Understanding the immunological mechanisms associated with
thermal ablation may enable manipulation of the response for more effective
treatment of colorectal liver metastases.
FP 13.01
RESECTION FOR HEPATOCELLULAR CARCINOMA: PRE-
OPERATIVE BIOPSY INCREASES TUMOUR RECURRENCE
Young, Alastair L; Malik, Hassan Z; Abu-Hilal, Mohammed; Guthrie, J
Ashley; Wyatt, Judy I; Prasad, K Raj; Toogood, Giles J; Lodge, J Peter A
St James’s University Hospital, Hepatobiliary and Transplant Surgery, Leeds,
United Kingdom
Background. In Western countries Hepatocellular Carcinoma tends to
present at a larger size, which can be a contraindication to transplantation
and often resection. Although diagnosis by imaging and alpha-fetoprotein is
usually straightforward, non-specialist units continue to use biopsy to prove
the diagnosis before transfer for specialist surgical opinion.
Aims/Objectives. We have looked at the impact of pre-operative biopsy on
our post-resection results for Hepatocellular Carcinoma.
Methods. We retrospectively analyzed all Hepatocellular Carcinomas
resected in our unit over the last 14 years. Survival data were calculated
and univariate and multivariate analyses was carried out to determine impact
of pre-operative, operative and histological factors affecting outcome.
Results. We identified 101 patients who had resection for Hepatocellular
Carcinoma. Of these 48 were classified as giant (10cm). Overall survival
at 1, 3 and 5 years was 78%, 56% and 50%. Size did not influence
survival, although more complex surgical techniques were required for giant
tumors. Predictors of poorer disease free survival were positive resection
margin (p0.001), multiple tumors (p0.001), pre-operative biopsy
(p0.002) and macroscopic vascular invasion (p0.015). On multivariate
analysis only pre-operative biopsy and multiple tumours remained
significant.
Conclusion. Our data shows excellent outcomes following resection for
Hepatocellular Carcinoma in a Western Centre with a preponderance of large
tumors. This supports the management of such patients in large volume units
which are fully equipped and experienced in the management of these
complex patients. Pre-operative biopsy should be avoided as this unnecessary
manoeuvre appears to have worsened our long term results.
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IS FATTY LIVER DISEASE AN IMPORTANT RISK FACOR IN THE
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA?
Morris-Stiff, Gareth1; Khan, Aamir1; Gomez, Dharwant1; Davies, John1;
Treanor, Darren2; Wyatt, Judy2; Toogood, Giles J1; Prasad, K Raj1
1St James University Hospital, Hepatobiliary and Transplant Surgery, Leeds,
United Kingdom; 2St James University Hospital, Histopathology, Leeds,
United Kingdom
Background. HCC is a relatively uncommon tumour in the United
Kingdom, but when diagnosed, it is frequently seen in the absence of viral
hepatitis or chronic liver disease (CLD), however the presence of fatty liver
disease is frequently noted. The aim of this study was to investigate whether
these steatotic changes may be important in the pathogenesis of HCC in this
setting.
Methods. All patients undergoing resection of a HCC were included. In
addition to patient demographics, and a history of liver disease, details of
alcohol consumption and risk factors for fatty liver disease were collected
including: diabetes mellitus; hypertension; and hyperlipidaemia. Patient c-
reactive protein and fibrinogen levels were also collated as were viral screen
Results. Pathology specimens were reviewed to determine the presence of
liver pathology other than HCC, including cirrhosis and fatty liver disease.
Results. 87 patients undergoing resection of HCC were assessed including
63 males and 24 females with a median age of 58 years. 40 patients had a
history of chronic liver disease including: HBV (n15); non-viral cirrhosis
(n12); HCV (n6); haemochromatosis (n4); and other (n3). 47
patients had no known predisposing factors of which 18 had fatty changes
noted on the biopsies including: mild (n8); moderate (n9) and severe
(n1) although none had cirrhosis. Only 5 patients with CLD had steatosis.
All patients with steatosis alone had 2 or more diagnostic factors for non-
alcoholic fatty liver disease (NAFLD) and none consumed large volumes of
alcohol.
Conclusions. In this Western series of HCCs, a large proportion of patients
had no underlying CLD identified pre-or post-resection. Importantly, 18/86
(20.9%) had steatosis as the only finding other than HCC, all of whom fitted
criteria for NAFLD. The data would suggest that NAFLD may be an
important risk factor for HCC and further studies are required to determine
the pathogenesis of HCC in this setting.
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THE CLINICAL SIGNIFICANCE OF DIHYDRO-PYRIMIDINE
DEHYDROGENASE AND THYMIDYLATE SYNTHASE MESSEN-
GER-RNA EXPRESSIONS IN HEPATOCELLULAR CARCINOMA
Nii, Akira1; Shimada, Mitsuo2; Ikegami, Toru2; Imura, Satoru2; Morine,
Yuji2; Kanemura, Hirohumi2; Arakawa, Yusuke2; Sugimoto, Koji2
1Department of Surgery, the University of Tokushima, Tokushima, Japan;
2Department of Surgery, the University of Tokushima, Tokushima, Japan
Backgrounds. Dihydro-Pyrimidine Dehydrogenase (DPD) and Thymidy-
late Synthase (TS) are considered to be key enzymes that work during
metabolizing 5FU system. Recently, it has been also known as a key factor for
forecasting the prognosis of patients with cancers. However, little has been
known regarding its significance in hepatocellular carcinoma.
Aims. The clinical significance of DPD mRNA and TS mRNA of
hepatocellular carcinomas was investigated.
Methods. Seventy-nine patients, who underwent hepatic resection for
hepatocellular carcinomas, were involved in this retrospective study. The
mRNA levels of the resected specimens were evaluated in quantative fashion
using real-time RT-PCR. The clinical impacts of these levels were evaluated,
in relation to prognosis and various clinicopathological variables. The RNA
levels were classified in high expression () or low expression (-) by a mean
value.
Results. Four groups were classified, DPD-/TS-group (n27), DPD-/TS
groups (n13), DPD/TS-groups (n13), and DPD/TSgroups (n
26). There was no significant difference in their background data. The 3-year
and 5-year survival rates were 72% and 55% in DPD/TSgroups, and
42% and 29% in DPD-/TS- group. The survival rate was significantly higher
in DPD/TSgroups than in DPD-/TS-group (pB0.05). On the other
hand, recurrence free survival rate did not show a significant difference
between the groups. The higher DPD group had significantly more cases with
positive micro-metastasis, clinical Stage IV and AFP400 ng/ml. The higher
TS group had significantly less cases with ICG15min 20%.
Conclusions. The combination of DPD and TS mRNA expression might be
a useful diagnostic tool for expecting the post-surgical prognosis of
hepatocellular carcinoma, both from tumor-related and hepatic function-
related aspects. Further investigations, regarding their relationship with
chronic liver disease associated hepatocellular carcinomas, are required.
FP 13.04
PREDICTION OF MICROSCOPIC PORTAL VEIN INVASION OF
HEPATOCELLULAR CARCINOMA: PERFUSION DEFECT AREA
RATIO ON CT DURING ARTERIAL PORTOGRAPHY
Shirabe, Ken1; Kajiyama, Kiyoshi2; Tsujita, Eiji2; Abe, Tomoyuki2
1Aso-Iizuka Hospital, department of hepato-gastroenterological surgery,
Iizuka city, Japan; 2Aso-Iizuka Hospital, Department of Surgery, Iizuka,
Japan
Backgrounds. Microscopic portal invasion (mpi) of cancer cells in
hepatocellular carcinoma (HCC) is poor prognostic predictor after hepatic
resection.
Aim. To predict mpi preoperatively, we propose the perfusion defect area
ratio (PPDAR) on CTAP. We clarify whether PPDAR can predict mpi of
HCCs. PATIENTS: Forty-six patients with HCC, who underwent hepa-
tectomy, were enrolled into this study, on condition that (1) no preoperative
therapy was performed, (2) the patients underwent CTAP, MRI and/or CT,
(3) HCC less than 5cm in diameter, (4) no diagnosis of portal vein
invasion on preoperative ultrasonography, CT, MRI, hepatic angiography
and CTAP.
Methods. (1) Definition of PPDAR: We measured the maximum area of
HCC nodule on CT or MRI (maximum area). Maximum portal perfusion
defect area on CTAP was measured. The perfusion defect ratio is calculated
as follows: maximum portal perfusion defect is divided by maximum area. (2)
To evaluate the portal perfusion defect ratio in prediction of mpi, forty-six
patients were divided into two groups; group I: the patients with HCC, of
which the portal perfusion defect ratio was less than 1.6 (n36), and group
II: the patients with HCC, of which PPDAR was no less than 1.6 (n10).
The cliniopatological backgrounds were compared between two groups.
Results. The mean PPDAR was 1.4 (0.75.8) and median was 1.3. In
group II, the incidence of mpi was seven of ten patients (70%) and five of 36
(14%) in group I. The incidence of mpi in group II was significantly higher
than in group I (P0.0012). There was no difference between group I and II
in size of HCC. Poorly differentiated HCC in group I was significantly more
common than in group II (P0.04).
Conclusion. The portal perfusion defect ratio is a good preoperative
predictor for mpi of HCC. In HCCs with high PPDAR no less than 1.6,
the occult portal vein invasion of cancer cells is predicted. Then, we would
design the anatomic hepatic resection rather than wedge resection in HCC
with high PPDAR no less than 1.6.
FP 13.05
COMPARISON OF NONINVASIVE DIAGNOSIS OF HEPATIC
FIBROSIS AND PORTAL VEIN PRESSURE: SERUM PIIIP VS
CDS VS APRI
Ueno, Shinichi; Sakoda, Masahiko; Kubo, Fumitake; Hiwatashi, Kiyokazu;
Tateno, Taro; Kurahara, Hiroshi; Mataki, Yuko; Shinchi, Hiroyuki; Natsu-
goe, Shoji; Aikou, Takashi
Kagoshima University, Department of Surgical Oncology, Kagoshima, Japan
Background. In hepatic tumor resection, the grade of hepatic inflammation
and fibrosis and the elevation of portal vein pressure are risk factors. When
fibrosis progresses, Type III collagen increases compared with Type I
collagen, and it is known that the serum concentration of N-terminal peptide
of type III procollagen (PIIIP), the precusor of type III collagen, rises.
Comparison of preoperative PIIIP level with the conventional liver functional
parameters: the liver cirrhosis discrimination score (CDS, Bonacini et al.)
and AST to platelet ratio index (APRI, Wai et al.) was performed.
Methods. All patients with hepatic tumor underwent hepatic resection
between 1998 and 2002 were analyzed. PIIIP was measured at the time of
hospitalization and made 0.30.8U/ml the normal range. The degree of liver
fibrosis was estimated by quantification at F0-4 using biopsy-specimen of the
non-cancerous region of the liver preoperatively. Portal vein pressure was
measured immediately after the skin incision.
Results. 1) There was a significant correlation between CDS and APRI (r
0.6), however, no correlation was seen between PIIIP and the other 2 indices.
2) Serum PIIIP, CDS and APRI were correlated with the degree of fibrosis
and portal vein pressure, respectively. Correlation coefficient values of APRI
were more higher (0.62, 0.55 respectively) than those of PIIIP or CDS. 3)
The average values of PIIP and APRI were 0.8890.29 and 1.7991.0 in F34
group, whereas 0.7090.31 and 0.919.69 in F02 groups. Most patients with
advanced fibrosis (F34) showed both PIIIP0.8 and APRI1.5.
Conclusion. The APRI is most reliable of the progress of fibrosis and high
portal vein pressure among the 3 parameters for the patients undergoing
hepatic resection. If the levels of APRI and PIIIP are high, the liver is
accompanied by advanced fibrosis with a high possibility.
FP 13.06
ASSESSMENT OF PERIOPERATIVE PERIOD USING BTR
AFTER RESECTION OF HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC PATIENTS
Abe, Akihito; Kubota, Keiichi
Dokkyo University Hospital, Department of Gastroenterological Surgery,
Tochigi, Japan9
Aim. Examination of liver function by use of indocyanine green (ICG)
enables to determine the extent of possible resection and contributes
to lowering postoperative morbidity and mortality. However, patients
with normal level of ICG sometime had complications after operation.
We evaluated the clinical usefulness of BTRIiBranched-chain amino
acids and Tyrosine RatioIjin patients after liver resection for HCC
patients.
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Material and Methods. During the period from April 2005 to August 2007,
a total of 111 liver resections for HCC were performed at the 2nd
Department of Surgery at Dokkyo University school of Medicine. BTR
was measured in 40 cases including in this study. We divided them into two
groups, group A with ICG I$20% and group B with ICGI . . .19%. The risk
factors selected in the univariate setting included serum liver function test
(LFT), serum coaglating factors (CF) and post operative stay (POS).
Results. BTR value was significantly lower in the group A (3.2) than in
group B (4.7) (PB0.05). Also, LFT, CF and POS tended to be better in the
group B than group A. However, in group B, some patients had low BTR
(less than 3.0). Those patients had prolonged POS more than 50 days and
suffered from uncontrollable sever effusion and ascites.
Conclusion. Preoperative BTR value is a good indicator of perioperative
period morbidity. Even if ICG-R15 value is good, a case with low BTR value
should be paid attention after hepatectomy.
FP 13.07
ELEVATED NEUTROPHIL-LYMPHOCYTE RATIO PREDICTS
POORER OVERALL AND DISEASE-FREE SURVIVAL FOLLOW-
ING RESECTION FOR HEPATOCELLULAR CARCINOMA
Gomez, Dhanwant1; Malik, Hassan2; Farid, Shahid2; Toogood, Giles2;
Lodge, J Peter A2; Prasad, K Rajendra2
1St. James’s University Hospital, Department of Hepatobiliary Surgery and
Transplant, Beckett Street, Leeds, United Kingdom; 2St. James’s University
Hospital, Department of Hepatobiliary Surgery and Transplant, Leeds,
United Kingdom
Aims. To analyse the impact of an elevated neutrophil to lymphocyte ratio
(NLR) on the overall and disease-free survival following curative resection for
Hepatocellular carcinoma (HCC).
Patient and Methods. Patients undergoing curative resection for HCC
from January 1996 to December 2006 were identified from the Hepatobiliary
database. Data analysed included demographics, laboratory analyses and
histopathology data.
Results. Seventy-three patients were identified with a median age of 65 years
(range: 15  85 years) and median follow-up of 16 months (range: 12  120
months). The 1-, 3- and 5-year overall survival rates were 76%, 56% and
56% respectively. An elevated NLR was the only adverse predictor of overall
survival. On univariable analysis, multiple tumours within the liver, nodal
disease, large tumour size, involved resection margin, vascular invasion, pre-
operative biopsy and an elevated NLR were predictors of poorer disease-free
survival. Multiple tumours within the liver and an elevated NLR were
independent predictors of poorer disease-free survival. The median disease-
free survival of patients with an elevated NLR was 8 months compared to 72
months for those with a low ratio.
Conclusion. The presence of an elevated pre-operative NLR is an
independent predictor of poorer overall and disease-free survival following
curative resection for HCC.
FP 13.08
LONG TERM OUTCOME OF LIVER RESECTION FOR HEPATO-
CELLULAR CARCINOMA IN NON-CIRRHOTIC NON-FIBROTIC
LIVER WITHOUT VIRAL HEPATITIS OR ALCOHOL ABUSE
LUBRANO, Jean; Huet, Emmanuel; Tsivildis, Basile; Franc¸ois, Arnaud;
Goria, Odile; Riachi, Ghassan; Scotte´, Michel
Rouen University Hospital, Rouen, France
Background. Hepatocellular carcinoma (HCC) occurs mostly in cirrhotic
liver. Less than 10% of HCC arise in normal liver parenchyma.
Aims. The aims of our study was to analyse clinical presentation, surgical
outcome and prognosis factors in our series of patients operated for HCC
arising in strictly normal liver parenchyma without cirrhosis, fibrosis,
steatosis and underlying viral hepatitis or alcohol abuse.
Methods. Between January 1986 and 2005, 321 patients were referred to our
institution for HCC. Among them, 20 patients (6.2%) were operated for
HCC arising in non-cirrhotic non-fibrotic liver parenchyma. Pathological
examinations were reviewed according to Chevallier fibrosis and Metavir viral
score. Pre-, per- and postoperative data were reviewed to analyse their
influence on tumor recurrence and survival.
Results. Median age was 57 years (3580). Morbidity and morality rate were
10% and 5% respectively. 1, 3 and 5-year survival rate were 85, 70 and 64%
respectively and disease free survival at 1, 3 and 5 years were 84%, 66% and
58% respectively. In univariate analysis, survival was influenced by a
preoperative cytolysis, R0 resection, recurrence and recurrence within 1
year. In multivariate analysis, recurrence and recurrence within 1 year
significantly decreased survival. In 8 patients, recurrence occurred in a
median delay of 15 months (270). Within patients with recurrence, survival
was not influenced by reoperation (P0.65). Overall survival rates at 1, 3
and 5 years were 75%, 37% and 25% respectively. In case of recurrence,
death occurred with a median delay of 12 months.
Conclusions. These results for HCC arising in normal liver parenchyma
justify liver resection and underline the strong differences with HCC in
cirrhotic liver. With a median survival of 12 months, in front of recurrence
after curative resection of HCC in noncirrhotic liver, orthotopic liver
transplantation should be discussed as salvage treatment rather than
rehepatectomy.
FP 13.09
LIVER RESECTION VS TRANSPLANTATION FOR HEPATOCEL-
LULAR CARCINOMA ON CIRRHOSIS: AN INTENTION TO
TREAT ANALYSIS
Ercolani, Giorgio; Ravaioli, Matteo; Grazi, Gian Luca; Dazzi, Alessandro; Di
Gioia, Paolo; Bertuzzo, Valentina; Cescon, Matteo; Del Gaudio, Massimo;
Vetrone, Gaetano; Zanello, Matteo; Tuci, Francesco; Pinna, Antonio daniele
Hospital Sant’Orsola-Malpighi, University of Bologna, Department of
Surgery and Transplantation, Bologna, Italy
Background. Optimal treatment with liver resection (LR) or liver trans-
plantation (OLT) for patients with hepatocellular carcinoma (HCC) on
cirrhosis remains still controversial.
Methods. From 1999 to 2005, we treated 316 cirrhotic patients with HCC:
78 LRs and 238 were listed for LTs. The outcome of LT for HCC was
compared with that of resected patients. A further step was to analyze the
outcome in the group of patients with MELD score less than 12 and single
nodule inferior to 6 cm. Finally, an intention to treat analysis was done
including patients lost during waiting time in the LT group: patient survival
was analyzed from the time that patients were resected or listed for OLT.
Results. Median age was higher in the LR compared to the LT group (65
year old vs 57, pB0.05); median MELD score was lower in the LR group (9
vs 14, pB0.05). Mean number of nodules was inferior in the LR group
(1.290.6 vs 1.891, pB0.05); mean tumor diameter was higher in the LR
group (3.992.5 cm vs 2.791.2 cm, pB0.05). Among the 238 listed patients,
165 (69%) were transplanted, 32 (13.4%) died during the waiting time and
21 (8.8%) were excluded for tumor progression. The overall 3-year survival
was 55% in the resected group and 78% in the transplanted group (pB0.05).
The overall recurrence rate was 39.7% in the LR group and 12.3% in the LT
group (pB0.05). However, by selecting patients with MELD score less than
12 and single tumor with maximum diameter less than 6 cm, the overall 3-
year survival was 62% in the resected group (46 patients) and 73% in the
transplanted group (20 patients) (pn.s.). In the intention to treat analysis,
3-year survival remained 61% for the LR group and was 61% for LT group
(pn.s.).
Conclusions. LR remains an effective treatment for single HCC in well
compensated patients; in this set of patients LR may be preferable than OLT
in particular if waiting list is expected to be quite long.
FP 14.01
PORTAL VEIN RESECTION IN COMBINATION WITH HEPA-
TECTOMY FOR HILAR CHOLANGIOCARCINOMA: AUDIT OF
51 CASES
Gi-Won, Song; Lee, Sung-Gyu; Lee, Young-Joo; Park, Kwang-Min; Hwang,
Shin; Kim, Ki-Hun; Ahn, Chul-Soo; Moon, Deok-Bog; Ha, Tae-Yong; Jung,
Dong-Hwan
Asan Medical Center, Surgery, Seoul, Korea, Republic of
Background. Although portal vein resection (PVR) can increase the chance
for curative resection, there are controversies in regard to the balance between
risk and effect on survival of patients with hilar cholangiocarcinoma(CCC)
Therefore, we performed retrospective study to elucidate the safety and
survival impact of PVR for hilar cholangiocarcinoma.
Patients and Method. Between June 1989 and June 2005, surgical
interventions with curative intent were performed on 301 patients and 259
patients underwent resection. Among them, 51 patients underwent combine
PVR. We analyzed survival data of 259 patients and compare the survival and
clinicopathological factors between group with PVR and without PVR.
Results. The 1-, 3-,5- year survival rate of 186 patients underwent curative
resection were 83.3, 42.0 and 29.3%, respectively. And 7 patients have been
survived more than 5 years. Surgical mortality was occurred in 11(4.3%)
patients. When we compared the differences of clinicopathological character-
istics between PVR() and PVR() groups, Bisthmus-Corlette type IV,
infiltrative type, presence of perineural invasion, lymphovasculr tumor emboli
and LN metastasis were more frequent in PVR() group. Survival rate was
significantly lower in PVR() group (18.8% vs 26.7%). Total 5 mortalities
were occurred but, mortality directly related with PVR was occurred in only 1
case. Surgical morbidity and postoperative liver function profile were not
different between two groups. In PVR group, actual tumor invasion into
portal vein was observed in 28 patients. And tumor invasion on pathological
exam did not affect survival within PVR() group.
Conclusion. Although mortality rate of hepatectomy combined with PVR is
higher, incidence of mortality directly related to PVR is low. Therefore,
combined liver and PV resection can be performed with acceptable mortality.
Although PV resection has negative impact on survival, combined liver and
PVR can offer long-term survival to some patients with advanced hilar CCC.
FP 14.02
NODAL METASTASIS IN DISTAL BILE DUCT CANCER: MODE
OF SPREAD AND PROGNOSIS
Matsubara, Hideo; Ebata, Tomoki; Nishio, Hideki; Igami, Tsuyoshi; Nagino,
Masato
Nagoya University Graduate School of Medicine, Division of Surgical
Oncology, Nagoya, Japan
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Background. Although nodal involvement is widely accepted as an
important prognostic factor in distal bile duct cancer, correlation between
the mode of nodal involvement and prognosis has not fully addressed.
Methods. A total of 104 patients with distal bile duct cancer who underwent
pancreatoduodenectomy were retrospectively reviewed. Lymph nodes in the
hepatoduodenal ligament (No. 12), adjacent to the pancreas head (No. 13),
along the common hepatic artery, and along the superior mesenteric artery
(No.14) were routinely dissected as regional nodes. The former two and the
latter two were classified n1 and n2, respectively, based on the Japanese
classification.
Results. Nodal metastasis was observed in 33 of 104 (32%) study patients.
The number of involved node was single in 11 patients, two in 11, three in 2,
and more than three in 9 patients, while n1 and n2 (or more) metastasis was
present in 28 and 6 patients, respectively. No.13 was most frequently involved
(n17), followed by No 12 (n16) and No 14 (n14). The survival for the
patients with nodal metastasis was significantly lower than that without (5-
year survival rate: 13% vs 31%, respectively, p0.014); the survival was not
different between the patients with n1 metastasis and those with n2 or more
metastasis. The number of metastatic nodes was associated with survival: 5
year survival rate of 33% in single, 9.1% in two, 14% of 3 or more (p0.04).
The survival for patients with No 12 metastasis was significantly lower than
those without (5-year survival rate 16% vs 27%, respectively, p0.024). No
significant difference in survival was seen between the patients with or
without nodal metastasis in the other location.
Conclusion. Two or more involved nodes strikingly worsen the survival in
distal bile duct cancer. In addition, No 12 is a key prognostic when involved.
FP 14.03
POPULATION TRENDS IN HILAR/EXTRAHEPATIC CHOLAN-
GIOCARCINOMA.
Chan, Anthony; Sheen, Aali; Siriwardena, Ajith
Manchester Royal Infirmary, Hepatobiliary Surgery Unit, Manchester,
United Kingdom
Aims. Hilar and extrahepatic cholangiocarcinoma (EHC) is a rare, and
usually rapidly fatal cancer. Obtaining long-term epidemiological trends is
difficult for such an uncommon cancer. This study utilises the Surveillance,
Epidemiology and End Results (SEER) Program to provide a detailed
longitudinal epidemiological overview of the management of EHC.
Methods. Data were extracted on malignant EHC including demographic
profile, stage and survival. The frequency and incidence data query were
limited to the original SEER 9 registries (1973 through 2004), to the primary
site of extrahepatic bile duct (code C24.0) and to cholangiocarcinoma
histology (codes 81608162) as defined by the International Classification of
Disease for Oncology. Trends in incidence were adjusted to age and evaluated
using a Percentage Change (PC) between 1973 and 2004 and Annual
Percentage Change (APC) calculated using weighted least-squares. Survival
data were set to observed 5-year survival and queried using the actuarial
method.
Results There were 805 cases of EHC, constituting 0.03% of all cancer
registrations in SEER between 1973 and 2004. The overall incidence of EHC
between 1973 and 2004 is 1.24 per million, increasing from 0.14 cases per
million in 1973 to 4.54 cases per million in 2004; this annual increase of
12.23% per year is statistically significant (pB0.01). The majority of EHC
are diagnosed with regional (32.7%) spread. While 29.4% have unknown
staging, only 16.6% have localized disease. Most EHC have unknown
histological grading (75.7%), 4.3% are well differentiated, 11.1% moderately
differentiated, 8.3% are poorly differentiated and 0.6% anaplastic. Overall
observed 5-year survival rate of 6.2%.
Conclusion. EHC is a rare cancer. Although the number of registrations is
increasing suggesting an increase in incidence, factors such as greater access
to imaging and lower thresholds for diagnosis may be contributory. The
majority of patients have regional disease at the time of diagnosis and that 5-
year survival is dismal.
FP 14.04
PROGNOSIS AFTER SURGERY FOR BILE DUCT CANCER WITH
A POSITIVE DUCTAL RESECTION MARGIN
Higuchi, Ryota1; Ota, Takehiro2; Furukawa, Toru3; Araida, Tatsuo4;
Hamano, Mie2; Takesita, Nobuhiro2; Yazawa, Takehisa5; Tezuka, Tohru6;
Yagawa, Yohsuke2; Yasuda, Hideki6; Yamamoto, Masakazu2
1Institute of Gastroenterology, Tokyo Women’s Medical University and
Teikyo University Chiba Medical Center, Surgery, Tokyo, Japan; 2Depart-
ment of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical
University, Tokyo, Japan; 3International Research and Educational Institute
for Integrated Medical Science, Tokyo WomenIfs Medical University,
Tokyo, Japan; 4Tokyo WomenIfs Medical University Yachiyo Medical
Center, Tokyo, Japan; 5Department of Surgery, Institute of Gastroenterol-
ogy, Tokyo WomenIfs Medical University, Tokyo, Japan; 6Teikyo University
Chiba Medical Center, Department of Surgery, Chiba, Japan
Background. In patients with positive ductal resection margins after
resection for bile duct cancer, the prognosis may be different between
patients with residual carcinoma in situ and those with residual invasive
carcinoma.
Aim. We investigated the prognosis after resection for bile duct cancer with a
positive ductal resection margin.
Methods. We retrospectively analyzed 306 patients with bile duct cancer
who underwent resection. We measured prognosis in patients who underwent
curative resection, non-curative resection according to the status of the ductal
margin and other factors for bile duct cancer.
Results. Hilar and superior bile duct cancer were seen in 116 cases, and
middle and inferior bile duct cancer in 190 cases. The curative and non-
curative resection rates were 67% (204/306) and 33% (102/306), respec-
tively. 36 patients had non-curative resection according to the status of the
ductal margin (carcinoma in situ in 13 cases, invasive carcinoma in 23 cases).
The 5-year survival rate of patients with curative resection, those with positive
ductal margins in carcinoma in situ, those with residual invasive carcinoma
and those with non-curative resection (according to other factors) were 44,
47, 23 and 11%, respectively. There was a significant difference between the
5-year survival rates of patients with curative resection and those with non-
curative resection (PB0.0001), and those with curative resection and those
with positive ductal margins with residual invasive carcinoma (P0.0058).
Conclusion. The prognosis in patients with positive ductal margins in
carcinoma in situ was as long as in those with curative resection. On the other
hand, The prognosis in patients with positive ductal margins with residual
invasive carcinoma was poor, so appropriate additional resection should
performed in cases with positive ductal margins with residual invasive
carcinoma according to the clinical classification of the tumor and the
patient’s condition.
FP 14.05
RESULTS AND PROGNOSTIC PREDICTORS FOLLOWING RE-
SECTION FOR INTRAHEPATIC CHOLANGICARCINOMA
Gomez, Dhanwant1; Morris-Stiff, Gareth2; Bonney, Glenn K2; Toogood,
Giles J2; Lodge, J Peter A2; Prasad, K Rajendra2
1Leeds Teaching Hospital NHS Trust, HPB and Transplantation Unit,
Beckett Street, Leeds, United Kingdom; 2Leeds Teaching Hospital NHS
Trust, HPB and Transplantation Unit, Leeds, United Kingdom
Aims. To analyse the results and prognostic predictors affecting the overall
and disease-free survival following potentially curative resection for intrahe-
patic cholangiocarcinoma (IHCC).
Patient and Methods. Patients undergoing curative resection for IHCC
during the period from January 1996 to December 2006 were identified from
the hepatobiliary database. Data analyzed included demographics, laboratory
analyses and histopathology data.
Results. Twenty-seven patients were identified with a median age of 57 years
(range: 32  84 years). The 1-, 3- and 5-year overall and disease-free survival
rates were 74%, 16% and 16%, and 44%, 15% and 15%, respectively. On
univariate analysis, age (B65 years), female gender, neutrophil to lympho-
cyte ratio (NLR) 5, vascular invasion and lymph node involvement were
predictors of poorer overall survival. Multivariable analysis did not identify
any independent predictors of overall survival. A NLR 5 was the only
adverse predictor of disease-free survival. The median disease-free survival of
patients with NLR 5 was 6 months compared to 18 months for those with
NLR B5. There was a significant association between patients with a NLR
5 and satellite lesions, vascular invasion and lymph node involvement.
Conclusion. Long-term outcome following curative resection of IHCC is
poor. However, the presence of a pre-operative NLR 5 is a predictor of
poorer overall and disease-free survival and may have a role in selection of
patients for aggressive resection.
FP 14.06
IS INTENSIVE RADIOLOGICAL FOLLOW-UP OF CHOLANGIO-
CARCINOMA WORTHWHILE?
Murphy, Laura; Morris-Stiff, Gareth; Gomez, Dhanwant; Toogood, Giles J.;
Lodge, J. Peter A.; Prasad, Rajendra
Leeds Teaching Hospitals NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom
Background. There is now accumulating evidence as to the benefits of
screening for recurrences following resection of colorectal metastases, since
the results of resection of these recurrences provides similar survival as
surgery for first time metastases.
Aims. To evaluate the efficacy of intensive CT-based radiological follow-up
in relation to the diagnosis and treatment of recurrence following resection of
cholangiocarcinoma.
Patients and Methods. All patients achieving an R0 resection of either
intrahepatic (IHC) or hilar (HC) cholangiocarcinoma were identified from a
prospectively maintained database. Protocol CT scans were performed at 3,
6, 9, 12, 18 and 24 months following resection. All CT scans were reviewed
to determine the timing and distribution of recurrences and the database was
interrogated to determine the management and outcome of recurrent disease.
Results. During the period of the study 46 patients (26 IHC and 20 HC)
were deemed suitable candidates for recruitment to the screening program.
To-date, protocol CT scanning has identified recurrences in 21 of 26 (88.5%)
undergoing resection of IHC and 11 of 20 (55%) of patients with HC.
Despite pre-clinical recognition of recurrences, none of the patients were
suitable for re-resection due to widespread dissemination or inadequate
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hepatic reserve. Following recurrence, death occurred within a median of 3.5
months in both groups.
Conclusions. Despite close radiological follow-up, cross-sectional imaging
with CT following curative resection of IHC and HC did not show any
benefit in terms of identification of recurrences suitable for re-resection and
cannot therefore be justified.
FP 14.07
MALIGNANCY COMPLICATING CHOLEDOCHAL CYST
Singh, Shivendra1; Bora, Giri Raj1; Mandal, Sanjoy1; Gondal, Ranjana2;
Agarwal, Anil1
1G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India; 2G. B. Pant Hospital and Maulana Azad Medical
College, Pathology, New Delhi, India
Background and Aim. Malignancy is a recognized complication of long
standing Choledochal cyst (CDC), Malignancy is more commonly seen in
the cyst itself, however the entire hepato-pancratic-biliary region is at risk. We
herein report our experience of malignancy associated with CDC.
Material & Method. Of the 204 patients admitted with diagnosis of
Choledochal cyst between January 2001 to June 2007, there were fifteen
cases (7.35%) of malignancy. Clinical presentation, management and follow
up of these patients were analyzed in detail.
Results. A total of 15 patients of CDC with malignancy were diagnosed over
the period. 11 patients (5.39%) were found to have Carcinoma Gall bladder
and 4 patients (1.96%) had Cholangiocarcinoma. There were 14 females and
1 male with a mean age of 44.5 years (range 20 to 72 years). Eleven had type I
and 4 type IVa CDC. Of the 11 GBC pts. 1 had metastatic disease on preop.
work-up Of the remaining 10 taken up for surgery, resection was not possible
in 2 patients, one due to detection of metastasis and in the other due to locally
advanced disease. Resection was performed in 8 patients. Radical Cholecys-
tectomy with excision of Choledochal cyst was performed in 5 and additional
resection of adjacent organs was required in 3 patients. In Cholangiocarci-
noma group, metastatic disease on preoperative work up in 1 and intra-
operative findings in another 2 patients. One patient underwent Whipple’s
PD with cyst excision. Resection was R0 in all patients treated with curative
intent. Carcinoma Gall bladder had resectability rate of 72.72% while
Cholangiocarcinoma had 25%. Overall resectability was 60%. Overall
mortality in surgical group was 1/13 (7.96%). This patient had postoperative
pancreatitis and developed multiorgan failure. Major Perioperative morbidity
was 2/13 (15.38%).
Conclusion. Choledochal Cyst has a definite risk of Malignancy, which was
7.35% in the current series. Therefore all CDC should be excised upon
diagnosis.
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PATENCY OF PERCUTANEOUSLY INSERTED METAL STENTS
IN PATIENTS WITH MALIGNANT BILE DUCT OBSTRUCTION
Sandblom, Gabriel1; Dahlstrand, Ursula2; Nyman, Rickard3; Ericsson, Lars-
Go¨ran3; Rasmussen, Ib Christian2
1University Hospital, Department od Surgery, Lund, Sweden; 2University
Hospital, Department of Surgery, Uppsala, Sweden; 3University Hospital,
Department of radiology, Uppsala, Sweden
Background. An effective bile duct drainage is crucial for the quality of life
in patients with jaundice due to obstruction of the bile ducts by non-operable
tumours. This can be achieved by percutaneous stenting, although the stents
will inevitably clog, dislocate or fracture if the patient lives long enough.
Objective. To assess the patency of metal stents inserted percutaneously and
to explore risk factors for stent failure, in particular type of stent and how its
localisation is in relation to the obstruction.
Methods. All patients who were treated at the Uppsala University Hospital,
Sweden, with percutaneous stenting for malignant bile duct obstruction
20002005 were identified retrospectively. From the patient histories, data on
the localisation of the obstruction and type of stent used, date and cause of
death and date of stent failure were extracted. Stent patency was defined as
the duration from the insertion of the stent until the date of failure. In case
cause of death was directly related to failure of the stent, the date of death was
defined as patency endpoint.
Results. Altogether 64 patients, 34 women and 30 men, were identified.
Mean age was 71 years, standard deviation 11 years. The median patency was
estimated to 347 days, the first quartile 103 days and the third quartile 492
days. Stent diameter more than 10 millimeter and distal localisation of the
stricture were found to be associated with significantly longer patency in
univariate Cox proportional hazard analysis. In multivariate Cox propor-
tional hazard analysis, only the localisation of the stricture was found to be
independently and significantly associated with patency.
Conclusion. Percutaneous inserted metal stent is a good alternative
for patients with obstructive jaundice and a life expectancy not exceeding
one year. It may give an instant relief from the symptoms associated with
the jaundice. The patency is, however, poor for Klatskin tumours. By
using metal stents with a diameter of at least 10 mm the patency may be
prolonge.
FP 14.09
A PROSPECTIVE LONGITUDINAL STUDY OF QUALITY OF
LIFE FOLLOWING LIVER RESECTION FOR HEPATOBILIARY
MALIGNANCIES
Dasgupta, Dowmitra1; Smith, Adam B2; Hamilton-Burke, Werbena3; Pra-
sad, KRajendra2; Toogood, Giles J2; Velikova, Galina2; Lodge, J Peter A2
1St. James’s University Hospital, HPB and Transplant Surgery, Beckett
Street, Leeds, United Kingdom; 2St. James’s University Hospital, HPB and
Transplant Surgery, Leeds, United Kingdom; 3St James’s University Hospi-
tal, HPB and Transplant Surgery, Leeds, United Kingdom
Introduction. Quality of life assessment is an important indicator of
treatment efficacy. No prospective longitudinal studies using a validated
quality of life (QOL) instrument assessing short and long term quality of life in
those patients undergoing liver resections for hepatobiliary malignancies exist.
Methods. Patients undergoing liver resections for hepatobiliary malignancies
in a 1 year period from July 2002 were enrolled. They completed the
European Organization for Research and Treatment of Cancer Core
questionnaire (EORTC QLQ- C30), pre operatively, 6 months, 12 months
and between 36 and 48 months post operatively. Quality of life over time and
its relation to several clinical factors was analysed.
Results. 103 patients were enrolled in this study, predominantly with
metastatic colorectal cancer (n74). Patient compliance with completion
of QOL data at each time point was 99%, 97%, 97% and 77.2% respectively.
Most functional scales and the global QOL scale showed a non-significant
trend to deterioration at 6 months and return to pre-operative level at 12
months. Physical functioning deteriorated significantly at 6 months (t2.36,
p0.02) and did not return to baseline at 12 months (t3.19, p0.002).
Pain and dyspnoea showed a moderate increase at 6 months (t2.13, p
0.036 and t2.96, p0.004 respectively) and 12 months (t2.29, p
0.024 and t3.66 pB0.0001 respectively). Fatigue was worse at 6 months
(t2.22, p0.029), but returned to pre-operative levels at 12 months (t
0.96, p0.34). No difference in symptoms or functional scales was observed
between patients undergoing major or minor liver resection. Survivors
without recurrence at 3648 months show better QOL than patients with
recurrent disease.
Conclusion. Generally QOL deteriorates in the first 6 months and then
improves to baseline levels. There is no difference in QOL between patients
undergoing major and minor resections. Recurrence free survivors continue
to improve their QOL in the long term. Further studies on QOL and cost
effectiveness required.
FP 15.01
CAN WE TREAT PATIENTS WITH CHRONIC PANCREATITIS
SUCCESFULLY?  NEW ASPECTS BY IMMUNOLOGICAL BACK-
GROUND
Farkas, Gyula Jr.1; Takacs, Tamas2; Farkas, Gyula1; Ma´ndi, Yvette3
1Department of Surgery, University of Szeged, Szeged, Hungary; 2Ist
Department of Internal Medicine, University of Szeged, Szeged, Hungary;
3University of Szeged, Department of Medical Microbiology and Immunol-
ogy, Szeged, Hungary
Introduction. Cytokine regulation may be important as concerns the
susceptibility to the development of chronic pancreatitis; transforming
growth factor-b1 (TGF-b1) plays a central role in the pathogenesis of
pancreatic fibrogenesis.
Aims. The aim of our study was to analyse the relevance of TGF-b1
polymorphisms in patients with chronic pancreatitis.
Methods. Of the 83 patients enrolled in the study, 43 were treated medically
and 40 patients underwent surgical intervention. Healthy blood donors (n
75) served as controls. The polymorphisms of TGF-b1 were determined by
the ARMS method, serum TGF-b1 levels were detected by ELISA.
Results. No correlation was found between the genotipes and the histolo-
gical varietes of chronic pancreatitis. There was a higher frequency (50%) of
the TT genotype of TGF-b1 with a concomitant higher TGF-b1 level in the
plasma (5.291.7 ng/ml) in patients with chronic pancreatitis than in healthy
blood donors ( 28%, and 2.890.9 ng/ml respectively). The number of TT
homozygotes differed significantly between the patients who underwent
surgical intervention and the controls, and even between the operated and
the non operated patients. Those patients who had TT genotipe with high
serum levels of TGF-b1 were rehospitalized or underwent further operations.
The frequency of the T/C genotype was significantly higher in both groups of
patients than in the controls (58%, and 58% vs 40%). Successfully treated
patients were found only with T/C or C/C genotipes and low serum levels of
TGF-b1.
Conclusion. The correlations of the TGF-b1 with chronic pancreatitis
underline the importance of these cytokines in the pathomechanism of
the disease. Moreover, it seems that the TT genotype of TGF-b1 might
be a risk factor for the development of a severe form of chronic pancrea-
titis, as a prognostic sign for a future surgical intervention or even
reoperation.
36 Abstracts
FP 15.02
EVIDENCE Of VARIATIONS IN INDICATION FOR ELECTIVE
SURGERY FOR SYMPTOMATIC CHRONIC PANCREATITIS
Shah, Nehal; Siriwardena, Ajith
Manchester Royal Infirmary, Hepatobiliary Surgical Unit, Manchester,
United Kingdom
Background. Surgical treatment can provide good relief of symptoms in
symptomatic chronic pancreatitis (CP) with procedures being categorised
broadly as main duct drainage, duodenum-preserving pancreatic head
resection (DPPHR) or Whipple-type pancreaticoduodenectomy. Although
many reports describe good outcome after surgery, there is little information
on the starting point for intervention, namely, the indications for surgery; and
thus this study examines contemporary indications for elective surgical
intervention in CP.
Methods. A computerised search of the National Library of Medicine’s
‘‘PUBMED’’, ‘‘EMBASE’’ & ‘‘COCHRANE’’ database was undertaken for
the period January 1997 to March 2007 using the keywords ‘‘surgery’’ and
‘‘chronic pancreatitis’’. Of the 1232 resulting hits, exclusions of reports that
gave no original data provided a final study sample of 38 reports providing
outcome data on 3518 elective operative procedures for CP. Data were then
extracted on indication, type and outcome of surgery.
Results. Data were available on 3518 patients undergoing surgery for CP.
Abdominal pain was the principal indication for surgery in 85%, suspicion of
underlying cancer in 15%, weight loss in 14% and other indications in 8%.
DPPHR was the most commonly performed with Puestow’s (lateral
pancreaticojejunostomy, LPJ) being second and Whipple or pylorus preser-
ving third. Most reports did not give information on relation between type of
surgery and defined indication and the choice of procedure is dictated by unit
preference.
Conclusions. Although abdominal pain is the commonest indication for
surgery in CP, there is no evidence of standardisation of pain symptoms
across units and elective procedures appear to be selected principally by unit
preference. This study highlights for the first time, the need for standardisa-
tion of indications for surgery in CP. In turn, only this standardisation will
allow meaningful comparison of results across units.
FP 15.03
Salvage after primary treatment failure of surgery for treatment of
chronic pancreatitis
Vashist, Yogesh K.1; Bogoevski, Dean2; Liebl, Lena2; Cataldegirmen,
Guellue2; Gawad, Karim2; Schneider, Claus2; Mann, Oliver2; Izbicki, Jakob
R.2; Yekebas, Emre F.2
1University Clinic Hamburg-Eppendorf, General, Visceral- and Thoracic
Surgery, Martinistrasse 52, Hamburg, Germany; 2University Clinic Ham-
burg-Eppendorf, General, Visceral- and Thoracic Surgery, Hamburg,
Germany
Pain relief is the primary goal of surgery for chronic pancreatitis (CP).
Salvage in case of pain after surgical treatment include both ‘redo’-surgery
and non-surgical interventions. Here, we report on our institutional
experience with respect to surgical salvage after primary treatment failure.
Among 702 patients treated surgically for CP, 45 presented with pain
recurrence and subsequently underwent different redo-procedures. For
measurement of quality of life, a validated EORTC-questionnaire including
a pain score was used. The number of re-operations varied between 2 and 5
operations. Follow-up ranged from 12 to 126 months after the redo-
operations. The entire cohort of 45 patients had primarily undergone
duodenum-preserving pancreas head resection in different modifications.
After primary surgery, median global pain score did not adequately decrease.
Imaging evaluation showed at least one of the following pathologies:
recurrence of inflammatory mass in the pancreatic head, stenosis or stones
in the pancreatic duct remnant, and parenchymal calcifications and pseudo-
cysts. In 37 patients organ preserving pancreatic redo-resections preserving
adjacent organs were carried out, while in 2 patients classical resectional
procedures and in 3 patients stepwise near subtotal pancreatectomy had to be
performed. No perioperative mortality was registered. Following redo-
operation, surgical morbidity accounted for 24.4%. No statistical difference
in morbidity was detected between the index and redo-procedures. Median
pain score decreased significantly after redo-procedures from 86 median
(range: 62100) to 25 (range1046; p0.0001; t-test) compared to the status
after the index operation. Therapeutic nihilism after failure of primary
surgical treatment in CP patients is not justifiable. Based on the individual
complaints and morphological findings in imaging investigations, surgical
salvage procedures offer reasonable chances to achieve pain relief as the
eventual success parameter of any treatment for CP.
FP 15.04
RESECTION OF PANCREATIC CANCER IN CHRONIC PAN-
CREATITIS IMPROVES OUTCOME
Bedi, MMS; Sharma, Mohit; Gandhi, Manish; Hariharan, Ramesh
Lakeshore Hospital & Research Center, GI Surgery, Cochin, India
Background. Cancer superimposed on chronic pancreatitis has a poor
prognosis and earlier reports had described a dismal outcome with resection.
Aim. to analyse the results of resectional surgery to determine survival, and
quality of life. Type of study: Retrospective analysis of prospectively compiled
data and prospective record of QOL after surgery Patients: 33 patients with
pancreatic cancer superimposed on chronic pancreatitis underwent resec-
tional surgery during the period 1998 to 2006. There were 15 males and 18
females. All patients were diabetic (11 oral hypoglycemic agents, and
remainder on insulin). All patients had intractable pain, and 21 were
jaundiced. 26 patients underwent radical Whipple’s pancreaticoduodenect-
omy, and 7 distal pancreatectomy with splenectomy. Additional organ
resections were performed in 7 (colon in 5, small bowel in 1, liver nodule
excision in 1).
Results. there was no mortality. Hospital stay ranged between 11 and 29
days (median 17). 32 complications occurred in 17 patients (morbidity 55%).
Over a median follow up of 44 months (3 to 73), 17 patients had died over
periods ranging from 7 to 28 months. 16 patients were alive over a maximum
follow up of 73 months. QOL studies revealed excellent or good quality of life
in 73% of patients.
Conclusion. resection of pancreatic cancer in chronic pancreatitis may
improve survival, and quality of life with the potential for long term survival.
FP 15.05
SURGERY FOR CHRONIC PANCREATITIS WITH PORTAL HY-
PERTENSION  IS IT ANY DIFFERENT
Singh, Rajneesh Kumar; Behari, Anu; Kumar, Ashok; Saxena, Rajan;
Kapoor, Vinay
Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS),
Dept of Surgical Gastroenterology, Luycknow, India
Background. Surgery for chronic pancreatitis in the presence of portal
hypertension is associated with high morbidity and mortality. We present our
experience of surgery with and without portal hypertension.
Methods. Of the 170 patients operated for chronic pancreatitis, 147 did not
have (Group A) and 23 had portal hypertension (Group B). Surgical
procedures were-pancreatic resection (distal pancreatectomy or pancreatico-
duodenectomy) or combined resection/ drainage in 24, drainage alone
(longitudinal pancreatico-jejunostomy) in 128. The additional procedures
were Freys’ head coring (23), biliary surgery (42), gastro-jejunostomy (6) and
splenectomy (19). The two groups (A & B) were compared for patients’
characteristics and the results of surgery.
Results. The patients with chronic pancreatitis and portal hypertension
(group B) had a larger number of male patients, pseudocysts, hemorrhage
and a lower mean hemoglobin, while other preoperative patient character-
istics were comparable. During surgery the group with portal hypertension
(group B) had a larger proportion of splenectomies, required more blood
transfusion and had greater postoperative morbidity. Overall 3 patients
required re-operation for complications and there was only one postoperative
mortality (0.7%). The duration of surgery, re-operation and postoperative
mortality were similar in the two groups. At a mean follow-up of 598 days (9
654), 74.7% patients were pain free or had mild pain (similar in the two
groups). Subset analysis showed that portal hypertension lead to increased
postoperative morbidity (pB0.01) in patients undergoing pancreatic resec-
tion but not in patients undergoing drainage alone.
Conclusion. It can be concluded that although surgery for chronic
pancreatitis with portal hypertension is associated with increased blood loss
and morbidity, more so with resectional surgery, but with adequate manage-
ment the re-operation rate and mortality are low and long term relief of pain
is similar to the patients without portal hypertension.
FP 15.06
REOPERATION AFTER SURGERY FOR CHRONIC PANCREATI-
TIS
Van der Gaag, Niels A; Boermeester, Marja A; Busch, Olivier RC; Van Gulik,
Thomas M; Gouma, Dirk J
Academic Medical Center, Surgery, Amsterdam, Netherlands
Background. The main indication for surgery for chronic pancreatitis (CP)
is intractable pain, for which, depending on location/extent of disease,
different options exist: drainage alone (pancreaticojejunostomy), drainage/
(limited) resection (Frey/Beger) or pure resection (pancreatoduodenectomy-
PD; tail resection). Although excellent outcomes after surgery have been
reported, reoperation for recurrent pain or local symptoms (cholestasis;
gastric outlet obstruction (GOO); pseudocyst) is required for a minority of
patients, mainly due to progression of disease.
Aim. To evaluate reoperation rates for pain or local symptoms after different
surgical procedures for CP.
Methods. Records of 235 patients (146 drainage; 46 drainage/resection; 38
tail resection; 5 PD), operated between Jan-1992 and Sep-2006 for pain due
to CP, were reviewed.
Results. Two patients died postoperatively, 3 patients were lost to follow-up.
Median follow-up was 60 months. Overall reoperation rate was 12% (27/
230), with a break down according to procedure of 8% (11/144) for drainage,
11% (4/38) for tail resection, 20% (1/5) for PD and 24% (11/45) for
drainage/resection (P0.02). Overall reoperation rate for recurrent pain was
4% (9/230), however was significantly higher after drainage/resection than
when compared to drainage alone: 11% (4/45) vs. 3% (4/144)(P0.036),
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respectively. Reoperation rates for local symptoms were: cholestasis 4% (12/
230), pseudocyst 2% (5/230), GOO 2% (5/230) and malignancy 1% (3/230).
Conclusion. Overall reoperation rate following surgery for CP was 12%.
Although some consider drainage alone as an incomplete surgical interven-
tion for CP, because of a higher risk of recurrence of pain or local symptoms,
this could not be confirmed in this study in terms of reoperation. A higher
reoperation rate was found for pain after drainage/resection as compared to
drainage alone. This higher rate likely reflects the presence of more extensive
and/or progressive disease.
FP 15.07
CYSTIC PANCREATIC NEOPLASMS: A SINGLE CENTER EX-
PERIENCE
Joseph, Philip1; Vyas, Frederick2; Sanghi, Ravish2; Eapen, Anu3; Thomas,
Susanna4; Sitaram, Venkatramani2
1Christian Medical College Hospital, Department of General Surgery,
Ida Scudder road, vELLORE, India; 2Christian Medical College Hospital,
Department of General Surgery, vELLORE, India; 3Christian
Medical College Hospital, Department of Radiodiagnosis, Vellore, India;
4Christian Medical College Hospital, Department of Pathology, Vellore,
India
Background. Cystic neoplasms of the pancreas are rare. With proper
surgical treatment, cystic neoplasms are one of the few curable tumors of the
pancreas.
Objective. To review our experience with cystic neoplasms of the pancreas
over a 5 year period from 20022007.
Methods. Medical records of patients diagnosed with cystic neoplasm of
pancreas were retrospectively examined.
Results. A total of 27 patients (24 females, 3 males) underwent operative
therapy for cystic neoplasms of the pancreas. Their mean age was 32 years.
The presenting symptoms were abdominal pain (15), vomiting and abdom-
inal mass (3); jaundice (2); pancreatic fistula following laparotomy and
biopsy and percutaneous drainage of cyst elsewhere (1 each) and acute
abdomen following intra-abdominal rupture of the neoplasm (1). Six patients
were asymptomatic. Abdominal mass was palpable in 12 patients. All patients
underwent computed tomography of the abdomen. The location of the tumor
was in the head (6), body (8) and tail of pancreas (13). Surgical management
consisted of 6 pancreatico-duodenectomies, 20 distal pancreatectomies (2
spleen sparing) and 1 subtotal pancreatectomy with resection of portal vein.
Two patients underwent simultaneous resection for co-existent renal cell
carcinoma. The histological diagnosis included solid cystic pseudo-papillary
neoplasm (13), mucinous cystadenoma (8), neuroendocrine carcinoma (2),
and one each of serous cystadenoma, mucinous cystadenocarcinoma, islet
cell tumor and Von-Hippel-Lindau syndrome. Post operative complications
included pancreatic leak (4), wound dehiscence with enterocutaneous fistula
(1), thrombosis of superior mesenteric vein (1). There was no mortality. At a
median follow up of 20 months, none of the patients had evidence of
recurrent disease.
Conclusion. Cystic neoplasms are being diagnosed with improvements in
imaging. Preoperative FNAC is not required. Since survival of patients with
cystic neoplasm is better than adenocarcinoma, an aggressive approach for
surgical resection is advocated.
FP 15.08
SOLID CYSTIC PSEUDO-PAPILLARY TUMOR OF THE PAN-
CREAS: A SINGLE CENTER EXPERIENCE
Vyas, Frederick1; Joseph, Philip2; Sanghi, Ravish3; Eapen, Anu4; Sitaram,
Venkatramani3
1Christian Medical College Hospital, Department of General Surgery,
Vellore, India; 2Christian Medical College Hospital, Department of General
Surgery, Vellore 632004, India; 3Christian Medical College Hospital,
Department of General Surgery Unit 4, Vellore, India; 4Christian Medical
College Hospital, Department of Radiology, Vellore, India
Background. Solid cystic pseudo-papillary tumor of the pancreas is a rare
exocrine neoplasm, which tends to affect young females. Surgical resection
remains the treatment of choice as it offers excellent prognosis. Aims and
Objectives: We present our experience in the management of these rare
neoplasms highlighting their varied presentation and surgical management.
Methods. Medical records of all patients diagnosed with solid cystic pseudo-
papillary neoplasm at our institution over a 5 year period from 20022007
were reviewed.
Results. There were 13 females ranging in age from 10 to 51 years (mean 25
years). Nine patients presented with abdominal pain, three with abdominal
mass, one was asymptomatic, one had nonspecific symptoms and one
presented with pancreatic fistula following biopsy of the mass. A palpable
mass was found on examination in 9 patients. The mean transverse diameter
of the mass on CT scan was 9.38 cms. Preoperative histological diagnosis was
available in 4 patients; 2 patients underwent open biopsy in another hospital
and 2 patients had diagnosis confirmed by FNAC. The tumor was located in
the head of the pancreas in 4 patients, in the body in 3 and in the tail of
pancreas in 6 patients. Surgical procedures included distal pancreatectomy
with splenectomy (8), pancreatico-duodenectomy (4) and subtotal pancrea-
tectomy with portal vein excision and splenectomy (1). Negative margins of
resection were achieved in all. There is no recurrence till date over a median
follow up of 25 months (range 360).
Conclusion. Solid cystic pseudo-papillary tumors vary considerably in their
presentation and location in pancreas. Pre-operative histological/cytological
confirmation of diagnosis is not necessary. Distant metastasis is uncommon.
Surgical resection offers excellent prognosis; the operation should be tailored
according to the location of the tumor in the pancreas.
FP 15.09
OUTCOMES OF CONSERVATIVE, ENDOSCOPIC AND SURGI-
CAL TREATMENT IN THE MANAGEMENT OF PANCREATIC
PSEUDOCYST
Akolekar, Deepika; Oniscu, Gabriel C; Hidalgo, Ernest; Powell, James;
Ravindran, Ravi; Wigmore, Steve J; Garden, O James; Parks, Rowan W
Royal Infirmary of Edinburgh, Department of Clinical and Surgical Sciences,
Edinburgh, United Kingdom
Background. Pancreatic pseudocyst is a common complication following
acute and chronic pancreatitis.
Aims. The aim of this study was to compare the outcome of conservative,
endoscopic and surgical treatment of pancreatic pseudocysts (PPC) in a
specialist hepatobiliary centre.
Methods. All patients who were treated for PPC between 1995 and 2006
were identified from Lothian Surgical Audit database and details regarding
their presentation, treatment and outcome were analysed.
Results 190 patients (102 males, 88 females) were treated for PPC over this
period. Pseudocyst formation was a consequence of acute pancreatitis in 128
patients, chronic pancreatitis in 47 and acute on chronic pancreatitis in 15
patients. The commonest etiology was alcohol (49%) followed by gallstone
disease. Primary treatment was conservative in 27 patients, percutaneous in
5, endoscopic in 60, and surgical in 98 patients with a median pseudocyst size
of 5 cms, 6.5 cms, 7.8 cms and 10 cms respectively. Primary treatment was
successful in 68 surgical patients (87.7%) and only in 18 patients (30%)
treated by endoscopic drainage. Secondary intervention was frequently
required following endoscopic procedures. The overall success rate of
surgical treatment was 93%. The surgical morbidity rate was 15%. Median
follow up was 52 months (571 months). Outcomes of the various treatment
procedures are shown in the table below.
Procedure n Resolution Failure Recurrence
Endoscopic transgastric
drainage
35 9 (25.7%) 23 (65.7%) 3 (8.5%)
Endoscopic transpapillary
drainage
24 9 (37.5%) 15 (62.5%) 
Combined transgastric and
transpapillary
2 1 (50%) 1 (50%) 
Percutaneous drainage 5 3 (60%)  2 (40%)
Cystgastrostomy 55 51 (92.7%)  4 (7.2%)
Cystjejunostomy 38 36 (94.7%)  2 (5.2%)
Laparoscopic cystgastrostomy 2 2 (100%)  
Distal Pancreatectomy 18 17 (94.4%)  1 (5.5%)
External drainage 6 5 (83.3%)  1 (16.6%)
Cystduodenostomy 1 1 (100%)  
Conclusion. Surgical drainage of pancreatic pseudocysts is associated with a
good success rate and low morbidity. Although minimally invasive techniques
are indicated in selected patients, open surgical drainage remains an effective
treatment option.
FP 16.01
PREDICTIVE VALUE OF INVERSE RELATIONSHIP BETWEEN
SERUM BILIRUBIN AND ALKALINE PHOSPHATASE LEVELS
FOR HEPATIC RECOVERY AFTER LIVER RESECTION
Jah, Asif; Sadat, Umar; Kan, Yuk-Man; Drage, Martin; Paulvannan,
Subramanian; Gibbs, Paul; Praseedom, Raaj K; Jamieson, Neville V; Huguet,
Emmanuel L
Addenbrooke’s Hospital, Hepatobiliary and Transplant Surgery, Cambridge,
United Kingdom
Background. Hepatic insufficiency is a serious complication of major liver
resection. Early prediction of insufficiency would allow early initiation of
appropriate care. Previous studies have discussed the post-operative changes
in liver function tests (LFTs) but insufficient data exist regarding their value
in predicting hepatic insufficiency.
Aim. To study the trends of LFTs after liver resection with a view to
predicting hepatic insufficiency, cholestasis and protracted post-operative
recovery.
Methods. A total of 122 non-cirrhotic patients who underwent liver
resections for colorectal liver metastases between September 2002 and
October 2006 were evaluated. LFTs were noted pre-operatively and on
post-operative days 1, 3, 7, 14 and 28. Patients were divided into 2 groups on
the basis of their post-operative course. Group I (112 patients) had an
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uneventful hepatic recovery while Group II (10 patients) had prolonged
cholestasis and/or liver failure. Pattern of changes in serum bilirubin (SB),
alkaline phosphatase (ALP), bilirubin to alkaline phosphatase (SB/ALP) ratio
and alanine transaminase (ALT) were compared using a 2-sided, paired t-
test.
Results. There was a significant peak in SB and SB/ALP ratio on day 1 (pB
0.001) in those patients who had an uneventful recovery (Group I). SB and
SB/ALP ratio diminished by day 3 and returned to normal by day 7. In
contrast, patients who developed hepatic insufficiency (Group II), SB and
SB/ALP ratio continued to rise beyond day 1, peaking on day 3 (pB0.004)
and remained significantly raised on day 7 and beyond (pB0.004). In both
groups, ALT peaked on day 1 and thereafter continued to fall irrespective of
SB and ALP levels.
Conclusion. An inverse relationship exists between trends of SB and ALP
levels after liver resection. SB and SB/ALP ratio which continue to rise at day
3 may be useful in the early identification of patients who are likely to develop
hepatic insufficiency.
FP 16.02
HYPERBARIC OXYGENATION DECREASES THE HEPATO-
TOXICITY OF DOXORUBICIN AND INDUCES LIVER REGEN-
ERATION
Firat, Ozgur1; Kirdok, Ozgur1; Makay, Ozer1; Gurcu, Baris1; Uguz, Alper1;
Ilgezdi, Savas2; Karabulut, Bulent3; Yilmaz, Funda4; Zeytunlu, Murat1;
Coker, Ahmet1
1Ege University Hospital, General Surgery, Izmir, Turkey; 2Neoks Hyperba-
ric Oxygen Cure Center, Izmir, Turkey; 3Ege University Hospital, Medical
Oncology, Izmir, Turkey; 4Ege University Hospital, Pathology, Izmir, Turkey
Background. Portal vein embolisation (PVE) is a technique to enhance
resectability based on liver’s capability of regeneration. In the chemother-
apeutically injured livers regeneration is restricted secondary to hepatocel-
lular injury. We aimed to investigate whether hyperbaric oxygenation (HBO)
can alleviate the hepatotoxicity of chemotherapy and induce regeneration in
the injured liver.
Methods. Forty rats were allocated to four groups (n10 for each) and
subjected to either right portal vein ligation (RPVL  groups I, II, III) or
sham operation (group IV) under sterile conditions. Rats in group II and III
were administered 2 ı`gr/gr doxorubicin seven days before laparotomy. Rats in
group III were exposed to HBO sessions at 24th, 48th and 72nd hour
postoperatively. On postoperative 7th day rats were sacrified. Degree of liver
injury was assessed by AST, ALT and albumin levels. Liver regeneration was
assessed by mitotic index (MI).
Results. Highest values of serum AST, ALT and the lowest values of serum
albumin were seen in group II (DOXORPVL). HBO showed a tendency to
correct these alterations. A significant increase was seen in AST and ALT of
group II when compared with group I (RPVL only) (pB0.008). In group III
(DOXORPVLHBO), these values were decreased to nonsignificant
values according to group I (p0.05). Levels of serum albumin were
statistically decreased in all RPVL groups. Changes with doxorubicin
administration and HBO showed slightly but not significant differences in
albumin levels (p0.05). However, a notable increase in group III elevated
serum albumin levels almost equal to group I, which doxorubicin was not
administrated. The MI values were significantly increased in the left lobes of
all RPVL groups when compared with group IV (pB0.008). Furthermore,
MI levels of group III were significantly higher than those of group I (pB
0.008).
Conclusion. HBO decreases the injury secondary to chemotherapy and
induces liver regeneration, therefore has potential to contribute to the
treatment of HCC.
FP 16.03
LIVER REGENERATION INCREASED BY PORTAL VEIN ARTER-
IALIZATION IN TWO ACUTE LIVER FAILURE MODELS IN THE
RAT.
Nardo, Bruno1; Tsivian, Matvey1; Neri, Flavia1; Bianchi, Elisa1; Piras,
Gianluca1; Puviani, Lorenza1; Cavallari, Giuseppe1; Pariali, Milena2
1S. Orsola Hospital, University of Bologna, Bologna; 2S. Orsola Hospital,
University of Bologna, Biomedical Research Center
Background/Aim. We aimed to determine whether an additional supply of
oxygenated blood achieved by portal vein arterialization (PVA) is protective
in rat ALF caused by hepatectomy or toxin administration.
Methods. ALF was induced in SD rats by performing an extended
hepatectomy or by giving i.p. 1 ml/kg CCl4. Afterwards, rats were divided
to receive PVA, by connecting the left renal artery to the splenic vein with a
stent following left nephrectomy and splenectomy, or to left nephrectomy and
splenectomy only (control rats). Hepatocyte regeneration was assessed by
calculating the mitotic index, the bromodeoxy uridine (BrdU) incorporation
and the ratio liver/body weights. Liver injury was evaluated by the serum ALT
level and necrotic cell count. The 10-day survival was assessed in separate
groups of rats.
Results. As expected, the PVA procedure significantly increased pO2 and
oxygen saturation in the portal blood compared to controls (pO2: 6391.6 vs
3992.9 mmHg; O2 sat.%: 93.190.7 vs 67.090.5). PVA significantly
improved survival compared to controls in both ALF models (90%
hepatectomy: 90vs30%; CCl4: 100vs40%). Accordingly, in the toxic ALF,
serum ALT levels and cell necrosis were significantly reduced by PVA (at
24h: 8439344 vs 14939562U/L and 3297 vs 64915%). The BrdU
staining was significantly greater in PVA than control rats in both experi-
mental models. Similar results were obtained when the mitotic index was
measured. The ratio liver/body weight after hepatectomy recovered signifi-
cantly faster in arterialized rats. Finally, when PVA was performed in healthy
rats, all the parameters studied were not significantly affected.
Conclusions. These data indicate that the additional supply of arterial
oxygenated blood through PVA promotes a rapid and extensive regeneration
leading to a faster restoration of liver mass after partial hepatectomy and
resolution of toxic-induced massive liver necrosis in rats. Thus, this technique
may represent a novel tool for optimizing hepatocyte regeneration during
acute liver failure.
FP 16.04
HBV DNA LOAD DOES NOT CORRELATE WITH HEPATIC
HISTOLOGY IN CHRONIC HEPATITIS B
Mahtab, Mamun1; Rahman, Salimur1; Khan, Mobin1; Kamal, Mohammad2;
Karim, Fazal3; Ahmed, Faroque1; Hussain, Fawaz1; Podder, Provat1
1Bangabandhu Sheikh Mujib Medical University, Department of Hepatol-
ogy, Dhaka, Bangladesh; 2Bangabandhu Sheikh Mujib Medical University,
Department of Pathology, Dhaka, Bangladesh; 3Dhaka Mahanagar Hospital,
Department of Medicine, Dhaka, Bangladesh
Background. Compare correlation between HBV DNA and grade and stage
of histopathology in chronic hepatitis B (CHB).
Methods. Liver biopsies done in 159 patients. 62.9% had wild type HBV
infection and rest 37.1% pre-core/core-promoter mutant (PC/PCM) infec-
tion. DNA was measured by PCR.
Results. In wild type CHB, 97% had moderate-high DNA and 3% had low-
moderate. In PC/PCM CHB, 74.6% had moderate-high DNA and rest
25.4% had low-moderate. In wild type CHB, in moderate-high DNA group
78.4% had minimal-mild chronic hepatitis (CH) (HAI-NI 08) and 21.6%
had moderate-severe CH (HAI-NI 918). 66.6% and 33.3% patients with
low-moderate DNA had minimal-mild and moderate-severe CH respectively.
In moderate-high DNA group, 77.3% patients had minimal-moderate
fibrosis (HAI-F 02) and 22.7% had severe fibrosis-cirrhosis (HAI-F 34).
Figures were 33.3% and 66.6% respectively in patients with low-modaerate
DNA. In PC/CPM patients, in moderate-high DNA group 79.5% had
minimal-mild CH and 20.5% had moderate-severe CH. 93.3% and 6.7%
patients with low-moderate DNA load had minimal-mild and moderate-
severe CH respectively. In moderate-high DNA group, 68.2% patients had
minimal-moderate fibrosis and 31.8% had severe fibrosis-cirrhosis. These
figures were 86.7% and 13.3% respectively in patients with low-moderate
DNA.
Conclusion. Study shows that high HBV DNA does not correlate with
necro-inflammation and fibrosis in liver either wild type or PC/CPM CHB.
FP 16.05
IN VIVO INDUCTION OF SPECIFIC IMMUNITY AGAINST HE-
PATOCELLULAR CARCINOMA(HCC) BY FUSION OF HCC PA-
TIENT-DERIVED DENDRITIC CELLS AND HCC CELLS
Yin, Xiaoyu1; Wang, Liang2; Lu, Mingde3; Huang, Jiefu3; Liang, Lijian3
1The First Affiliated Hospital/Sun Yat-Sen University, Department of
Hepatobiliary Surgery, Guangzhou, China; 2The First Affiliated Hospital/
Zhejiang University, Department of Surgery, Hanzhou, China; 3The First
Affiliated Hospital, Department of Hepatobiliary Surgery, Guangzhou,
China
Background. It has been shown that fusion of dendritic cells(DCs) and
tumor cells is able to activate autologous T lymophocytes to generate specific
cytotoxic T lymphocytes in vitro. However, its efficacy in inducing specific
anti-tumoral immunity in vivo has not been well-documented.
Aims. Using severe combined immunodeficiency(SCID) murine model of
reconstructed human immune system, the ability of fusion of HCC patient-
derived DCs and HCC cells to induce specific immunity against HCC in vivo
was evaluated.
Methods. Human immune system was reconstructed on SCID mice by
intra-peritoneal injection of peripheral blood lymphocytes from HCC
patients, ie, hPBL-SCID murine model. Fusion of HCC patient-derived
DCs and Co60-irradiated HepG2 cells (DCs/HepG2) was achieved by 50%
polythyleneglycol. hPBL-SCID mice were vaccinated with DCs/HepG2,
Co60-irradiated HepG2, DCsCo60-irradiated HepG2 and DCs, respec-
tively, and then challenged with subcutaneous inoculation of HepG2. Tumor
growth in SCID mice was monitored. Serum levels of human IL-2, IL-12, jA˜-
INF and AFP in SCID mice were detected. Cytotoxicity of SCID mice-
derived splenocytes against HepG2 was evaluated.
Results. Fusion of DCs and HepG2 cells was confirmed by fluorescence
microscopic examination. HepG2 Tumor growth on SCID mice was
dramatically inhibited in DCs/HepG2 group, compared with HepG2 group,
HepG2DCs group and DCs group (pB0.01). Serum levels of human IL-2,
IL-12 and jA˜-INF in mice were significantly greater in DCs/HepG2 group as
compared with HepG2 group, HepG2DCs group and DCs group (pB
0.05). DCs/HepG2 group has a markedly lower serum AFP level than
HepG2 group, HepG2DCs group and DCs group (all pB0.05). Spleno-
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cytes from DCs/HepG2 group had significantly greater cytotoxicity against
HepG2 as compared with HepG2 group, HepG2DCs group and DCs
group (all pB0.05).
Conclusions. Fusion of HCC patient-derived DCs and HCC cells was
capable of inducing specific antitumoral immunity in vivo, and represented as
a promising approach for HCC immunotherapy.
FP 16.06
ISOLATION AND CHARACTERIZATION OF A NOVEL SUBSET
OF ED2 (CD163)dim HEPATIC MACROPHAGES DISTINGUISH-
ABLE FROM CONVENTIONAL KUPFFER CELLS IN RAT LIVERS
Wu, Gordon; He, Yao; Sadahiro, Tomohito; Klein, Andrew
Cesars-Sinai Medical Center, Comprehensive Transplant Center, Los
Angeles, United States
Introduction. We previously identified 2 subsets of ED2 cells from rat
livers using flow cytometry.
Objective. The current study was designed to define the phenotypic and
functional properties of these 2 macrophage subsets.
Methods. An ED2high and ED2dim subgroup of hepatic macrophages were
isolated from normal and cholestatic livers by FACS and subjected to
phenotypic and functional characterization. Expression of genes relating to
myeloid lineage differentiation, inflammatory cytokines and ECM remodel-
ing enzymes was studied using quantitative real time PCR.
Results. The ED2high cells in culture exhibited morphology, growth pattern
and phagocytic activity consistent with the general description of Kupffer
cells. The ED2dim cells were smaller in size, monocyte-like in cellular
morphology and weak in phagocytosis. Transmission electron microscopy
demonstrated that both subsets of ED2 cells are characteristic of mono-
cyte/macrophage origin. In addition to expression of low levels of macro-
phage-related surface markers such as CD14, CD68, and CD163, the
ED2dim cells expressed mRNA encoding for myeloid lineage differentiation
markers ERMP12 and ERMP20 but not markers for T (CD3), B (CD19)
and NK (CD94) cells. ED2dim cells isolated from cholestatic livers induced
by bile duct ligation expressed higher levels of, when compared with ED2high
cells, TNFa(3-foldED2high, p0.02), IFNg (11-fold, p0.018),
RANTES (7-fold, p0.02), TIMP1 (3-fold, p0.004) and MMP9 (2-
fold, p0.037), but lower levels of IL1b (1/4-fold that of ED2high, p0.003)
and Fucose receptor ( 1/3 fold, p0.04).
Conclusion. The ED2dim cells appear to be a novel subset of hepatic
macrophages which exhibits morphology, phenotype and function distin-
guishable from classic Kupffer cells. The fact that the ED2dim cells expressed
high levels of inflammatory cytokines (TNFa, INFg and RANTES) and
ECM remodeling enzymes (TIMP1 and MMP9) suggests that these cells
may play an important role in liver inflammation and tissue repair.
FP 16.07
CHOLESTASIS ENHANCES COAGULATION DISTURBANCES
DUE TO ISCHEMIA REPERFUSION INJURY
Kloek, Jaap1; Levi, Marcel2; Heger, Michal1; Gouma, Dirk1; van Gulik,
Thomas1
1Academic Medical Center, Department of Surgery, Amsterdam, Nether-
lands; 2Academic Medical Center, Department of Internal Medicine,
Amsterdam, Netherlands
Background. Cholestasis is associated with increased morbidity and
mortality in patients undergoing major liver surgery. An additional risk is
induced when vascular inflow occlusion is applied giving rise to liver ischemia
reperfusion (I/R) injury. I/R injury ultimately leads to microcirculatory
perfusion failure. The role of the coagulation system in this type of injury
is relatively underexposed.
Objective. The aim of this study is to determine the effects of hepatic I/R
injury on the coagulation system in cholestatic rats.
Methods. Wistar rats were randomized into 2 groups: The 1st group (n24)
was subjected to 30m partial liver ischemia 7 days after bile duct ligation
(BDL); the 2nd (control) group (n24), was subjected to ischemia without
preceding BDL (sham laparotomy). Animals were sacrificed pre-I/R and after
6, 24, and 48h reperfusion. Liver damage parameters, activation of
coagulation and fibrinolysis were assessed before and after I/R.
Results. Serum AST and ALT levels were higher after 6 and 24h of
reperfusion in cholestatic rats (PB0.05). Hepatic necrosis, wet/dry ratios of
liver tissue and neutrophil influx measured by myeloperoxidase activity were
increased in the cholestatic group after up to 48h reperfusion (PB0.05).
Liver synthetic function was decreased in the cholestatic group as reflected by
prolonged prothrombin time at 6 and 24h reperfusion (PB0.05). Further-
more, cholestasis resulted in a significant augmentation of ischemia-induced
activation of coagulation. I/R in cholestatic rats resulted in a 12fold vs. 7fold
(PB0.01) increase in markers for thrombin generation, (thrombin-antith-
rombin (TAT) complex levels) and a 6fold vs. 2fold (PB0.01) increase in
fibrin degradation products (FDP), (cholestatic vs. control, resp.). In
addition, the cholestatic rats showed significantly increased levels of
plasminogen activator inhibitor (PAI-1) after 6 and 24h reperfusion.
Conclusions. Liver I/R injury including disturbance of the coagulation
system is severly enhanced in the presence of cholestasis.
FP 16.08
BUCILLAMINE INHIBITS NEUTROPHIL ACTIVATION AND DE-
CREASES LIVER WARM ISCHAEMIA REPERFUSION INJURY
Junnarkar, Sameer1; Tapuria, Niteen2; Mani, Ali Reza3; Fuller, Barry2;
Seifalian, Alexander2; Davidson, Brian2
1Royal Free And University College Medical Schooll, Academic Department
of Surgery, London, United Kingdom; 2Royal Free Hospital, London,
United Kingdom; 3Royal Free And Universdity Hospital Medical school,
Academic Department of Medicine, London, United Kingdom
Introduction. Liver transplantation and resection surgery involve a period of
ischaemia and reperfusion to the liver which initiates an inflammatory
cascade resulting in liver and remote organ injury. Bucillamine is a low
molecular weight thiol antioxidant that is capable of rapidly entering cells.
Our previous studies have shown that bucillamine reduces warm ischaemia
reperfusion injury in liver. Hypothesis- Bucillamine may reduce warm
ischaemia reperfusion injury by reducing neutrophil activation.
Aim. To use a well described model of liver ischaemia reperfusion to
determine the effect of Bucillamine administration on neutrophil adhesions
and cytokine production. Neutrophil activation is explored as possible
mechanism.
Materials and Methods. Effect of bucillamine was studied in a rat model of
liver ischaemia- reperfusion injury with 45 minutes partial (70%) ischaemia
and 3 hours reperfusion. Liver injury was assessed by serum transaminases
(AST and ALT) and propidium iodide staining of apoptotic hepatocytes on
intravital microscopy. Leukocyte adhesions were assessed on Intravital
microscopy. Cytokine response was assessed by measuring serum CINC-1
levels. Results- The model produced a significant liver injury with elevated
Transaminases and an acute inflammatory response. Bucillamine reduced the
liver injury as indicated by a reduced AST (9329200.8 vs. 2072.59511.79,
pB0.05) and ALT (861.49262.63 vs. 2079.259322.33, pB0.05). The
number of apoptotic cells at the end of 3 hours of reperfusion was also
significantly lesser in the Bucillamine group (p 0.001). Serum CINC-1
levels were found to be lesser in animals given Bucillamine with a very
significant difference at 24 hours post reperfusion (pB0.001). There also was
significantly lesser neutrophil adhesion in the Bucillamine group at the end of
3hours of reperfusion.
Conclusions. Bucillamine therapy reduces the deranging effects of warm
ischaemia reperfusion y inhibiting neutrophil activation.
FP 16.09
METHOXYPOLYETHYLENE GLYCOL MODIFIED-ALBUMIN
(PEG-ALB) ENHANCED THE COLD PRESERVATION PROPER-
TIES OF UW SOLUTION IN RAT LIVER GRAFTS
Sanabria, Juan1; Abbas, Rime1; Dingam, David2; Malholtra, Deepak2;
Brunengraber, Henry1
1University Hospital-Case Medical Center, Surgery, Cleveland, United
States; 2University of Toledo Medical Center, Biochemistry, Toledo, United
States
Background. Liver grafts preserved in cold undergo changes mainly
manifested by morphological changes of the sinusoidal endothelium. Swollen
and fragmented cytoplasm translates into poor portal blood flow, increase
release of liver enzymes and low bile production upon liver reperfusion.
Aim. To determine if the addition of higher molecular weight polyethylene
glycol modified albumin to the University of Wisconsin (UW) preservation
solution ameliorates the cold preservation injury of liver grafts.
Methods. Mehtoxypolyethylene glycol 5000 activated with cyanuric chloride
was covalently coupled to human albumin (Peg-Alb) at multiple sites. The
Isolated Perfused Rat Liver model was used (IPRL). Human and Rat
hepatocytes cell lines were preserved in cold under similar preservation
solutions. Effects were studied after rewarming of cells on Glutathione turn
over by mass spectrometry. Apoptosis of SLC’s on liver tissue and cell lines
were evaluated by Tunel assay and flowcytometer techniques. Table 1. IPRL
results of grafts preserved with UW solution and UW solution plus PEG- Alb.
Group (n4) Portal Blood flow AST Bile production ml/g of liver/minute U/
g of liver ul/g of liver Control neg UW (1h) 0.930.033** 2.11.08**
10.55.97 Control pos UW (30h) 0.190.010 14.40.34 00 PEG-Alb &
UW (30h) 0.980.005** 28.41.03 3.57.54 Alb & UW (30h) 0.05
0.007 26.92.45 00 ** pB0.05 by ANOVA Preliminary results showed
Gluthatione turnover was significantly decreased in all groups compared to
negative controls. In contrast, apoptosis of SLC was similar in the PEG-Alb
group when compared to the negative control group but significantly
decreased in the PEG-Alb group when compared to other groups.
Conclusions. The addition of high molecular albumin to UW preservation
solution appears to ameliorate endothelial injury of cold preserved liver grafts
as judged by better portal vein blood flow, increased bile production and
decreased SLC apoptosis in well preserved hepatocytes.
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SURGICAL AMPULLECTOMY: A SAFE AND COMPLETE
TREATMENT OF PRESUMED BENIGN AMPULLOMAS
Sauvanet, Alain1; Lesurtel, Mickae¨l1; Goasguen, Nicolas1; Ponsot, Philippe2;
Couvelard, Anne3; Palazzo, Laurent2; Ruszniewski, Philippe2; Belghiti,
Jacques1
1Hospital Beaujon, HPB Surgery, Clichy, France; 2Hospital Beaujon,
Gastroenterology, Clichy, France; 3Hospital Beaujon, Pathology, Clichy,
France
Aims. Presumed benign ampullomas (PBA) can be treated by pancreatico-
duodenectomy (PD), or endoscopic/surgical ampullectomy (SA). SA needs
to exclude preoperatively invasive carcinoma (Ca.) and aims to obtain tumor-
free margins to avoid the need for subsequent PD. This study evaluated both
feasibility and results of SA.
Methods. From 1995 to June 2007, 34 patients (age: 3879 yrs) underwent
SA for PBA revealed by pain/cholangitis (n11), pancreatitis (n5),
fortuitously (n17) or during follow-up after SA. All 34 patients underwent
side-viewing duodenoscopy with biopsies and endoscopic ultrasound (EUS).
Preoperative biopsies revealed low-grade (LGD; n22) or high-grade
(HGD; n6) dysplasia adenoma, or inflammatory/normal mucosa (n6).
EUS staging was uT1N0 in all cases. Intraoperative frozen section (FS) was
done routinely on resection margins. Patients were informed of the need for
PD in case of invasive Ca. on definitive pathologic examination.
Results. One patient (3%) had immediate conversion into PD (gross aspect
suggestive of invasive Ca. confirmed by FS). Four intraoperative complica-
tions (3 duodenal disinsertions, one pancreas divisum unrecognized pre-
operatively) were successfully treated. At FS, 6 biliary sections and 3
pancreatic ductal margins were tumor-positive, that led to perform 9
additional ductal resections (all tumor-free at FS). Size of PBA ranged
from 8 to 65mm (mean: 20 mm). There was no mortality and postoperative
course was uneventful in 25 patients (76%). Definitive pathologic examina-
tion revealed R0 resection (n33) including 22 adenomas (14 LGD, 8
HGD), 5 micro-invasive Ca. (T1NOD0), one invasive Ca. (T1NOD1,
general condition precluding PD), and 5 others benign lesions. With a
median 24 months follow-up (range: 372), 3 (9%) patients had symptoms.
Tumor recurrence occurred in 3 (9%) (no reoperation).
Conclusions. SA with routine FS can treat PBA with no mortality, less
morbidity than PD and tumor-free margins. After complete endoscopic
work-up, probability of subsequent PD is very low.
FP 17.02
OUTCOMES OF PANCREATIC SURGERY IMPROVE AFTER
ESTABLISHING A HEPATO-PANCREATO-BILIARY SERVICE IN
A COMMUNITY HOSPITAL
Mittal, Vijay; Kansakar, Erina; Chang, Yeon-Jeen; Jacobs, Michael; Silapas-
wan, Sumet; Ferguson, Lorenzo A.; Kestenberg, William; Mittal, Vijay
Providence Hospital and Medical Centers, Surgery, Southfield, United States
Background. Hepato-Pancreato-Biliary (HPB) surgeries are complex pro-
cedures with high rates of complications, which require a good institutional
system that can effectively minimize the morbidity and mortality of these
patients. A HPB service comprises a team of surgeons, fellows, nurse
practitioners, medical oncologists, radiation oncologists, interventional radi-
ologists, gastroenterologists and operating room staff.
Objective. To assess the patient and institutional advantages of establishing a
HPB service for pancreatic cancer patients.Method.: Patients undergoing
pancreatoduodenectomy at Providence Hospital and Medical Centers were
included in the study. Length of stay (LOS), institutional costs, morbidity
and mortality, and patient satisfaction were compared between 19901999
and 20002007 when a HPB service was implemented.
Results. A total of 217 pancreatic carcinomas were diagnosed during 1990
1999, as compared to 330 cases during 20002007. The total number of
pancreatoduodenectomies increased from 32 cases (15% of total) during
19901999 to 103 (31% of total) in 20002007. Average Whipple’s
procedure increased from 3.5 cases to 14 cases per year. The LOS decreased
40% from an average of 21 days to 12 days. Mortality rate decreased from
3.1% to 0%. Morbidity decreased from 62.5% to 25%. Institutional costs
decreased from $35,500 to $ 28,000 per patient. Overall patient satisfaction
had increased during 20002007.
Conclusions. Establishing a HPB service has improved the cost-effective-
ness of our institution in treating patients with pancreatic disease. Due to this
HPB service, patients receive focused and efficient care. Such a service
should be implemented in all community hospitals.
FP 17.03
THE ANALYSIS OF AGE STANDARDIZED MORTALITY RATES
FOR PANCREATIC CANCER ACROSS THE WORLD
Saied, Abdouslam1; Hariharan, Deepak1; Patel, Bijendra1; Kocher, Hemant2
1Barts & the London School of Medicine & Dentistry, Institute of Cancer,
London, United Kingdom; 2The Royal London Hospital, Barts and the
London HPB centre, London, United Kingdom
Background. Pancreas cancer is the fourth commonest cause of cancer
related mortality across the world, with incidence equalling mortality.
Method. Age-Standardized (world) mortality Rate [ASR (W)] for pancreatic
cancer were extracted separately for males and females from a data base
maintained by International Agency for Research on Cancer for 51 countries
across the world (Europe-33 countries, Americas-8 countries and Asia-10
countries) and trends analysed for the period 1960 2002; as well as the last
decade available (19922002).
Results. From 19602002, the ASR (W) due to pancreatic cancer showed a
steady increase across all the countries studied with more male deaths than
female deaths. North America [ASR range (W) 68] and countries in central
Europe [ASR (W) range 812] showed highest mortality for both sexes.
However, the period 19922002, the ASR (W) remained static across most
countries for both sexes. The highest mortality rates (for both sexes) were seen
in Central Europe [range: men (812), women (4.57)] while Canada was the
only country that showed a decline [men (7.5 to 6.4), women (5.9 to 5)].
Conclusion. Our results indicate that though there was an initial increase in
ASR (W) for pancreatic cancer, the change has not been seen in the last
decade. This probably reflects standardisation and consolidation of diag-
nostic tests for pancreatic cancer.
FP 17.04
PANCREATIC LEAK: WHAT HAVE WE LEARNT?
Bhange, Snehal; Patil, Bhushan; Singh, Rajinder; Adhikari, Devbrata; Shetty,
Tilakdas; Joshi, Rajeev
T. N. Medical College & B.Y.L. Nair Ch. Hospital, General Surgery,
Mumbai, India
Background. ‘‘God put the pancreas in the back, because he did not
want surgeons messing with it’’- Harold Ellis. Pancreatic surgeries are
associated with high operative morbidity and mortality mostly due to
pancreatic leak.
Objective. Compare the leak rates following pancreatic surgeries and look
for an association between local recurrence and pancreatic leak in malig-
nancy. Is occurrence of a leak an independent predictor of disease free
survival (DFS) after curative resection?
Method. Records of 261 patients (126 pancreatico-duodenectomies and 135
cases of surgeries for benign pancreatic disorders) were analysed from
February 1999 to July 2007.
Result. Clinically significant leak was present in 22 patients. 20 cases were
following pancreatico-duodenectomy, 1 each were following enucleation of
insulinoma and necrosectomy. Trivial leaks were seen in 18 cases, 14
following pancreatico-duodenectomy, 3 following distal pancreatectomies
and 1 following a Puestow’s procedure. Of the 22 significant leak cases, 2 had
to be re- explored, 5 succumbed while the rest were successfully managed
conservatively as were the trivial leaks. Leak rate following pancreatico-
duodenectomy was 26.98% (34/126) and mortality was 7.93%(10/126) while
for benign pathologies it was 4.44%(6/135) and 1.48% (2/135) respectively
which was statistically significant. Of 34 patients with leak following
pancreatico-duodenectomy, 26 had DFS of 1 year or less (76.47%) and on
imaging and biopsy they were found to have local recurrence. Of the
remaining 92 patients only 8 (8.69%) had recurrence at 1 year or less and
this too was statistically significant.
Conclusion. Leak rate is significantly higher following surgeries for
malignancies and is associated with higher mortality. Based on our small
cohort it was also seen that leaks are associated with a lower DFS. We
postulate that the occurrence of a leak could be an independent predictor of
diminished DFS and this needs to be validated by larger study groups.
FP 17.05
A SIMPLE INFLAMMATION BASED PROGNOSTIC SCORE IS
AN INDEPENDENT PREDICTOR OF SURVIVAL IN AN UNSE-
LECTED SEQUENCE OF 252 PATIENTS WITH PANCREATIC
CANCER
McMillan, DC; Jamieson, NB; Glen, P.; Carter, R; McKay, C.J.; Imrie, Clem
Glasgow Royal Infirmary, Lister Department of Surgery, Glasgow, Scotland,
United Kingdom
Background. The outlook for patients with ductal adenocarcinoma of the
head of the pancreas remains poor, having the lowest 5-year survival rate of
any cancer. Selection of patients for either surgery, palliative chemotherapy or
supportive care is of crucial importance. There is increasing evidence that the
presence of a systemic inflammatory response plays an important role in
predicting survival in patients with cancer. This has recently been formalised
in an inflammation based prognostic score, modified Glasgow Prognostic
Score (mGPS, 0C-reactive protein B10 mg/l, 1C-reactive protein 10
mg/l and 2C-reactive protein 10 mg/l and albuminB35g/l)1. The aim of
the present study was examine the value of the mGPS in an unselected cohort
of patients with pancreatic cancer. Study: Of our 252 patients; 65 underwent
potentially curative resection, 59 had a palliative bypass procedure and 128
palliative treatment only. On follow-up 241 (96%) patients died of their
cancer. On univariate survival analysis age (pB0.05), clinical TNM stage
(pB0.001), mGPS (pB0.001) and treatment (pB0.001), were associated
with cancer specific survival. On multivariate survival analysis of the
significant variable only age (HR 1.28, 95% CI 0.991.65, p0.062),
clinical TNM stage (HR 1.62, 95% CI 1.341.97, pB0.001) and the mGPS
(HR 1.54, 95% CI 1.321.80, pB0.001) were independently associated with
cancer specific survival.
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Conclusion. These results support the inclusion of the assessment of the
systemic inflammatory response, the mGPS, in the routine pre-treatment
assessment of patients with pancreatic cancer. The mGPS may impact future
treatment algorithms.
FP 17.06
THE USE OF A WOUND PROTECTOR LOWERS SURGICAL SITE
INFECTION RATES AFTER PANCREATICODUODENECTOMY
Stokes, Jayme B; Swenson, Brian R; Bauer, Todd W; Adams, Reid A
University of Virginia, Department of Surgery, Charlottesville, VA, United
States
Background. Surgical site infections remain the third most common
complication of pancreaticoduodenectomies.
Objective. To evaluate the effects of a wound edge protector on surgical site
infection rates following pancreaticoduodenectomy.
Methods. Wound edge protectors were implemented at our institution on all
PDs occurring after September 2004. Patients undergoing pancreaticoduo-
denectomy 30 months prior to and after this date were identified. A
retrospective review of prospectively collected database was performed, and
demographic, medical history and 30 day surgical outcomes data were
recorded. Surgical site infections were defined in accordance with the Centers
for Disease Control guidelines.
Results. Ninety-seven pancreaticoduodenectomies were performed between
June 2002 and March 2007. Forty-six patients underwent surgery without a
wound protector (control group), while 51 patients protectors placed. Both
groups were similar with regards to demographics, medical and social history,
previous radiotherapy and chronic steroid use. Preoperative skin prep and
perioperative antibiotic use was the same in both groups. Patients in the
control group were more likely to have an ASA greater than 2 (p0.02). The
SSI rate was 28% in the control group and 11.7% in the wound protector
group (pB0.05). Patients with wound protectors were less likely to develop
superficial wound infections (5.9% vs. 19.6%; pB0.05). There was an
absolute reduction in deep wound and organ space infections; however, these
did not reach statistical significance due to the small sample size. There was
no correlation between demographic or perioperative characteristics that
were more likely in the SSI group.
Discussion. In our study, the addition of wound protectors reduced SSI
rates after pancreaticoduodenectomy by more than 50% suggesting that
intraoperative contamination of the wound edge plays a large role in the
development of SSI. Additional prospective studies are needed to further
evaluate these findings.
FP 18.01
LIVING LIVER DONOR MORTALITY UPDATE  TIME FOR A
REGISTRY
Ringe, Burckhardt1; Strong, Russell2
1Drexel University College of Medicine, Center for Liver, Biliary and
Pancreas Disease, Philadelphia, United States; 2University of Queensland,
Princess Alexandra Hospital, Brisbane, Australia
Living donation has become a life saving option for end stage liver disease
patients who have no chance of receiving a deceased donor organ. Although
donor safety has always been the major concern, there is no accurate
information on donor deaths. The authors reviewed the medical literature, to
update the worldwide living liver donor mortality rate. To verify the accuracy
of the information a certainty (C) level was assigned to each source: C1,
direct report by member representing the transplant program where the
fatality occurred; C2, indirect publication by author not involved in the care;
and C3, information based on verbal presentation or personal communica-
tion. A total of 33 living liver donor deaths could be identified. 12 cases were
classified as C1: donor deaths and programs identified, and details of the
complications published. There were 8 C2 fatalities, and 13 cases were
considered C3. During the International Liver Transplantation Society
Meeting held in June 2007, four more deaths could be added to the cases
collected previously by the authors. 8 deaths occurred in Europe, 8 in North
America, 5 in South America, 10 in Asia, and 2 in Africa. Based on estimated
13,700 living donor liver transplants performed, the donor death rate is at
least 0.10.3%. Only C1 cases allowed to characterize donor risk factors:
preoperative medical conditions, psychosocial abnormalities, right lobe
donation, and postoperative surgical complications. In order to maintain
informed consent and confidence in this procedure, it is imperative to report
all living donor deaths. Unfortunately, the discrepancy between published
and unpublished cases has not changed, and the dilemma of rumor versus
facts prevails. As long as the information available is incomplete, it seems
justified to publish reviews like this, however, the only way to get accurate
information is direct reporting by the transplant program where the fatality
occurred. It is time for an international living donor mortality registry.
FP 18.02
ROLE OF INTRAOPERATIVE CONTINUOUS RENAL REPLACE-
MENT THERAPY IN LIVING DONOR LIVER TRANSPLANTA-
TION
R, Anand1; Kakodkar, Rahul1; Kumaran, Vinay1; Saigal, Sanjiv2; Saraf,
Neeraj2; Nundy, Samiran1; Soin, Arvinder S1
1Sir Ganga Ram Hospital, Surgical Gastroenterology & Liver Transplanta-
tion, New Delhi, India; 2Sir Ganga Ram Hospital, Gastroenterology, New
Delhi, India
Background. Renal dysfunction in patients with end-stage liver disease has
been traditionally associated with a grim prognosis, sometimes even
precluding liver transplantation. Recent studies have suggested that patients
with pretransplant renal dysfunction requiring perioperative renal replace-
ment therapy can be managed effectively and achieve reasonable survival.
However, the impact of increased metabolic demand caused by renal failure
on a partial graft and eventual outcome in patients undergoing living donor
liver transplant (LDLT) is not clear.
Aim. To evaluate the role of intraoperative continuous renal replacement
therapy (CRRT) in the outcome of patients with preoperative renal
dysfunction undergoing living donor liver transplantation.
Methods. Prospectively maintained database of 150 consecutive patients
undergoing LDLT at a single center between January 2005 and May 2007
was reviewed. Patients with pre-operative renal dysfunction (serum
creatinine2 mg/dl) and/or oliguria due to hepatorenal syndrome were
given elective intraoperative CRRT by continuous veno-venous hemofiltra-
tion (CVVH). Patients developing renal failure in the postoperative period
requiring renal support were excluded. Indications for liver transplant and
renal support, operative details and postoperative course were studied.
Results. Five patients (4 chronic liver disease, 1 acute liver failure) required
CVVH. Median MELD score was 16 (1436). CVVH was discontinued in all
patients postoperatively by 48 hours, as adequate urine output was
established. There was no postoperative mortality. At a median follow-up
of 222 days (119287), all patients have satisfactory liver graft and kidney
function.
Conclusion. Intraoperative CRRT is a feasible and well-tolerated modality
which allows otherwise high-risk patients with renal dysfunction to undergo
live donor liver transplant without additional morbidity or mortality.
FP 18.03
LIVING DONOR LIVER TRANSPLANTATION: A EUROPEAN
LIVER TRANSPLANT REGISTRY (ELTR) REPORT ON 2043
CASES
Adam, Rene´1; Karam, Vincent1; Rogiers, Xavier2; Tokat, Yaman3; Lerut,
Jan4; Broelsch, Christopher5; Neuhaus, Peter6; De Hemptine, Bernard7;
Castaing, Denis1; O’grady, John8; Kalicinski, Piotr9; Boillot, Olivier10;
Klempnauer, Jurgen11; Revillon, Yann12; Belghiti, Jacques13; Garcia-Valde-
casas, Juan14; Burra, Patrizia15
1Hoˆpital Paul Brousse, Centre He´patobiliaire, Villejuif, France; 2Universi-
tatskrankenhaus Eppendorf, Dept of Hepatobiliary Surgery, Hamburg,
Germany; 3Ege University Medical School, 4Department of Surgery-Divi-
sion of Hepatobiliary, Izmir, Turkey; 4Catholic University of Louvain,
Cliniques Universitaires Saint Luc, Brussels, Belgium; 5C. U. K. GHs Essen,
Klinik fu¨r Allgemeine und Transplantationschirurgi, Essen, Germany;
6Charite´- Campus-Virchow klinikum, Klinik fu¨r Allgemein-Viszeral- und
Transplantation, Berlin, Germany; 7Universitair Ziekenhuis, Dienst voor
Levertransplantatie en Digestieve Heel, Ghent, Belgium; 8King’s College
Hospital, Transplantation Unit, London, United Kingdom; 9Children’s
Memorial Health Institute, Department of Pediatric Surgery and Organ
Transpla, Warsaw, Poland; 10Hoˆpital Edouard HERRIOT, Unite´ de trans-
plantation he´patique, Lyon, France; 11Medizinische Hochschule Hannover,
Klinik fu¨r Viszeral-und Transplantationschirurgie, Hannover, Germany;
12CHU Necker Enfants Malades, Sce de Chirurgie Infantile, Paris, France;
Table 1
Control
(n46)
Wound Protector
(n51) p-value
Female Gender 21 (45.7%) 31 (60.8%) 0.14
Age (years) 62.9 (12.3) 61.6 (13.4)
Minority Race 7 (15.2%) 3 (5.9%) 0.18
Past Medical History
Diabetes 11 (23.9%) 12 (26.1%) 0.81
Smoking 32 (69.6%) 32 (62.8%) 0.88
Alcohol Use 1 (2.2%) 2 (4.4%) 1.00
COPD 5 (10.9%) 2 (4.4%) 0.23
Recent Weight Loss 5 (10.9%) 6 (13%) 0.75
Chronic Steroid Use 2 (4.4%) 3 (6.5%) 1.00
Previous Radiotherapy 1 (2.2%) 0 (0%) 0.49
Body Mass Index25 23 (50.0%) 21 (40.4%) 0.45
ASA 2 24 (52.2%) 15 (29.4%) 0.02
Elevated Creatinine 1 (2.2%) 0 (0%) 0.51
Decreased Albumin 2 (4.4%) 7 (13.7%) 0.16
Malignant Pathology 42 (91.3%) 44 (86.3%) 0.44
OUTCOMES
Surgical Site Infection 13 (28%) 6 (11.7%) 0.04
Superficial 9 (19.6%) 3 (5.9%) 0.041
Deep Space 3 (6.5%) 0 (0%) 0.064
Organ Space 1 (2.2%) 3 (5.9%) 0.359
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13Hoˆpital BEAUJON, Sce de Chirurgie Digestive, Paris, France; 14Hospital
Clinic I Provincial de Barcelona, Barcelona, 16Gastrointestinal Surgery
Department, Barcelona, Spain; 15Universitat degli Studi di Padova, Depart-
ment of Surgery & Gastroenterological Scienc, Padova
Living Donor Liver Transplantation (LDLT) is increasingly used in Europe
but results concerning donor and recipient outcome have not been
extensively evaluated. From October 1991 to June 2006, LDLT accounted
for 2043 of the 63552 (3%) transplants performed in 71 centers. We
compared the outcome of LDLT to that of Full Size Cadaveric Liver
Transplantion (FSCLT). LDLT that was initially reserved for pediatrics is
now used mainly in adults (71% of cases in 2005). The right liver was
donated to 91% of adults and the left lobe was donated to 85% of children.
Overall 5-yr graft and patient survivals were 67% and 73%, and were better in
children (76% and 83%) than in adults (55% and 63%-pB0.01). At a range
from 232 days following LDLT, mortality occurred in 4 of the 2043 donors
(0.2%) due to pulmonary embolism (1), sepsis (2) and cardiac failure (1).
Early donor morbidity (3 months) was 21%. As compared to FSCLT
performed during the same period, LDLT was used more often for cancers
(23% vs 13%, pB0.01) and less often for fulminant hepatitis (3% vs 7%, pB
0.01) and retransplantation (2% vs 10%, pB0.01). In children, 5-yr graft
and patient survivals were better with LDLT than with FSCLT, (76 and 83%
vs 69% and 81%pB0.01). By contrast, in adults, survivals were lower than
those of the FSCLT (55% and 64% vs 62% and 69%-pB0.01). In
conclusion, although LDLT represents only 3% of all transplants, it has
significantly performed over time. Donor mortality is 0.2% with an early
morbidity of 21%. Disparities in graft and patient survivals are likely due to
differences in the indications for transplantation, including more frequent
application of LDLT to adult patients with cancer. Website: www.eltr.org
FP 18.04
BILIARY COMPICATIONS AFTER LIVING DONOR LIVER
TRANSPLANTATION -CAUSE AND TREATMENT
Tashiro, Hirotaka; Itamoto, Toshiyuki; Amano, Hironobu; Ohdan, Hideki;
Oshita, Akihiko; Ishiyama, Kohei; Asahara, Toshimasa
Hiroshima University, Surgery, Hiroshima, Japan
Background. In living-donor liver transplantation (LDLT), biliary compli-
cations are recognized as a significant cause of post-transplantation morbid-
ity.
Methods. Ninety patients who underwent LDLT with duct-to-duct biliary
reconstruction at Hiroshima University Hospital were enrolled in this study.
The mean follow-up was 24 months (range, 376 months). 24 patients
underwent the basiliximab-based immunosuppressive therapy and 66
patients underwent non-basiliximab-based immunosuppressive therapy.
The development of biliary complications after LDLT was retrospectively
analyzed. Biliary complications were initially treated by endoscopic or
radiological modalities.
Results. Biliary leakages and strictures occurred in 13 (14%) and 26 (29%)
of the 90 patients, respectively. Stepwise multivariate analysis demonstrated
bile leakage to be an independent risk factor for the development of biliary
stricture (p0.001) and basiliximab-based immunosuppressive therapy to be
an independent protective factor for postoperative biliary leakage (p0.005).
The total one-week total doses of steroids were significantly lower in
basiliximab-based immunosuppressive regimes (mean dose, 545mg) than in
non-basiliximab-based ones (mean dose, 1060mg) (p0.01). All patients
with biliary leakage were successfully treated with endoscopic or radiological
modalities except two patient who was treated by surgical treatment.
Endoscopic or radiological modalities were successful as primary treatment
modalities in 17 (65%) of 26 patients with biliary strictures. Lastly, 7 patients
were treated surgically with long-term success, except for one patient with
chronic cholangitis who died after 16 months.
Conclusions. Steroid-sparing basiliximab-based immunosuppressive ther-
apy reduced the incidence of biliary leakage and biliary leakage was the
independent factor for biliary stricture. The non-surgical and surgical
treatments for biliary complications were satisfactory.
FP 18.05
REFINED PROCEDURES FOR LEFT LOBE GRAFT PROCURE-
MENT FROM LIVING DONORS
Shimada, Mitsuo; Ikegami, Toru; Imura, Satoru; Morine, Yuji; Kanemura,
Hirofumi; Arakawa, Yusuke
The University of Tokushima, Department of Surgery, Tokushima, Japan
Introduction. Major obstacle in adult-to-adult living donor liver transplan-
tation (LDLT) is requirement of larger grafts, which may jeopardize the
donor safety. We have reported the feasibility of a left lobe graft including
middle hepatic vein (MHV) and a left caudate lobe even in adult-to-adult
LDLT (Arch Surg 2002, Transplant Int 2004, and Am J Transplant 2006).
Our refinements both in donor evaluation and in donor surgery are
introduced. Method: The donor was fully evaluated by 3D-liver image
software, which calculates volume distribution of all the intrahepatic vessel
branches. A part of the anterior segment, which is drained by the tributaries
of MHV, was added to the left lobe graft. Surgical techniques were as follows:
after minimal separation of the hilar structures, the first Glissonian pedicles
were taped. After taping the infrahepatic inferior vena cava (IVC), a cotton
tape was passed between the right and middle/left hepatic veins through on
the IVC to the cranial side of the hilar plate, all enabling the hanging
maneuver. aDivision of the hepatic parenchyma was performed just on the
left side of the right anterior pedicle. After in situ bile leakage test, the cutting
point of the left hepatic duct was secured by intraoperative cholangiography.
Five living donors underwent left hepatic lobectomy by these techniques.
Results. The mean graft volume (GV) and the GV/standard liver volume
ratio (GV/SLV) were 474g and 42.6%, respectively. A mean additional
volume gain and its ratio to the standard left lobe volume were 42ml and
7.6%. Immediate graft function of these three patients was excellent. The CT
scan performed on the 7th post-operative day confirmed excellent blood
perfusion in the whole graft including the additional segment. Neither
complication attributable to small-for-size graft nor this technique was
observed.
Conclusions. Our refined method for the left lobe graft procurement from
living donors is a promising approach to overcome the small graft and make
further improvements in LDLT.
FP 18.06
OPEN DOOR POLICY OF LIVING DONOR LIVER TRANSPLAN-
TATION FOR LIVER TUMOURS: PANACEA OR OVERKILL?
Soin, Arvinder S1; R, Anand1; Kakodkar, Rahul1; Kumaran, Vinay1; Saigal,
Sanjiv2; Saraf, Neeraj2; Nundy, Samiran1
1Sir Ganga Ram Hospital, Surgical Gastroenterology & Liver Transplanta-
tion, New Delhi, India; 2Sir Ganga Ram Hospital, Gastroenterology, New
Delhi, India
Background. While live donor liver transplantation (LDLT) is ideal for
cirrhosis with small unresectable hepatomas without extrahepatic or gross
vascular spread, its role is controversial in benign or metastatic liver tumours,
resectable or large hepatomas, or HCC with segmental vascular spread.
Aim. To see if recipient/donor outcomes justify a liberal policy in accepting
tumour patients for LDLT.
Methods. Of 179 liver tumour referrals for LDLT since 2004, 128 were not
transplanted due to extrahepatic/gross vascular spread or lack of donors. 14
(12 HCCs, 2 hepatoblastomas) underwent resection (Group R). 37 patients
had LDLT including 30 right and 7 left lobes. 14 were within Milan (Group
M), 10 within UCSF (Group U), and 10 beyond these criteria (Group B). 3
non-cirrhotics had tumors (HCC, neuroendocrine metastases and heman-
gioendothelioma) replacing most of the liver. Posttransplant immunosup-
pression was Tacrolimus-based. 16 randomly selected patients were
converted to Sirolimus at 2 months.
Results. Of 34 cirrhotics, 1 had Child’s A, 9 Child’s B and 24 Child’s C
disease. 11 had HBV, 21 HCV, 1 alcoholic, 1 tyrosinemia and 1 cryptogenic
cirrhosis. One patient each had tumour thrombosis of segment 5 portal vein
and segment 7 hepatic vein. Overall/disease free survival at a mean follow up
of 16 months (140) were 91% (34/37) and 90% (33/37). Mortality was due
to myocardial infarction on day 9 in 1 (Group M), pulmonary metastases
at 4 months in 1 (Group B), and hepatic vein obstruction on day 27 in 1
(Group U). One Group U patient with seg 5 portal vein recurrence is alive at
40 months with scar recurrence. There was no recurrence/death in the
Sirolimus group. In Group R, operative mortality was zero but HCC recurred
in 4 (33%). The 2 hepatoblastoma patients are well at 4,27 months. All
donors did well.
Conclusions. LDLT is worth doing for all HCC patients without extra-
hepatic/gross vascular invasion, and in those with large neuroendocrine
secondaries and benign tumours replacing the liver. Resected HCCs often
recur.
FP 19.01
DETERMINANTS OF OUTCOME AFTER PANCREATIC NECRO-
SECTOMY
Kudari, Ashwinikumar; Doley, Rudraprasad; GSB, Kishore; Yadav, Thakur
Deen; Gupta, Rajesh; Wig, Jai Dev
PGIMER, General Surgery, Chandigarh, India
Background. The aim of this study was to identify factors associated with
outcome after pancreatic necrosectomy.
Methods. One hundred patients who underwent pancreatic necrosectomy
from July 2002 to June 2007 were studied. Patients were divided into two
groups, group A  patients who died after pancreatic necrosectomy and
Group B- patients who survived after pancreatic necrosectomy. Various
factors like age, sex, etiology, mean APACHE II score at admission, CTSI,
pre operative percutaneous drainage of peripancreatic fluid collection, organ
failure and the presence of infected pancreatic necrosis between two groups
were studied.
Results. There were 28 patients in group A and 72 patients in Group B. The
mean age of patients in group A and B 34.21 and 36.28 respectively. The
initial median Acute Physiology and Chronic Health Evaluation (APACHE)
II score was 8.5 and 7.79 in group A and B respectively. Patients who died
had higher APACHE II scores at presentation. Survivors had significantly
longer times to surgery than those who died (P0.038). 15 patients in group
A and 47 patients in group B underwent pre operative percutaneous drainage
of infected peripancreatic collection and its effect on the outcome was not
statistically significant (p0.279). 26 patients in group A and 70 patients in
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group B had infected pancreatic necrosis and the effect on outcome was not
statistically significant (p0.317). All patients in group A and 9 patients in
group B had multi organ failure. Presence of multiorgan failure was
associated with increased mortality (p0.000). Logistic regression analysis
showed that only postoperative APACHE II score and multiorgan failure
were an independent predictor of increased mortality.
Conclusion. Increasing APACHE II score and presence of postoperative
multiorgan failure were the most important predictors of outcome after
pancreatic necrosectomy.
FP 19.02
GADOLINIUM CHLORIDE BUT NOT GLYCINE REDUCES HE-
PATIC AND PANCREATIC ORGAN INJURY IN ACUTE ALCO-
HOLTOXIC PANCREATITIS.
Schneider, Lutz1; Hartwig, Werner1; Longerich, Thomas2; Hackert, Thilo1;
Fritz, Stefan1; Krych, Ralf1; Gebhard, Martha-Maria3; Buchler, Markus W1;
Werner, Jens1
1University of Heidelberg, General Surgery, Heidelberg, Germany; 2Uni-
versity of Heidelberg, Department of Pathology, Heidelberg, Germany;
3University of Heidelberg, Department of Experimental Surgery, Heidelberg,
Germany
Background. Alcoholic pancreatitis is associated with a high incidence of
systemic complications. Hepatic Kupffer cells seem to mediate systemic
complications in acute necrotizing pancreatitis. Destruction or blockade of
Kupffer cells by GdCl3 or glycine are known to be hepato-protective in liver
transplantation. The aim of our study was to evaluate the protective effects of
Kupffer cell blockade in a model of acute necrotizing pancreatitis after
chronic alcohol exposure.
Methods. Rats were feed for 6 weeks prior to induction of acute necrotizing
pancreatitis with either alcohol or control diet without alcohol. Necrotizing
pancreatitis was induced using intraductal GDOC and intravenous caerulein
infusion. In the therapy group animals received either gadolinium chloride
(10mg/kgKG) or glycine (1.5mmol/kgKG) prior to induction of acute
necrotizing pancreatitis. Hepatic microcirculatory disturbances regarding
leukocyte-endothelial-interaction and microperfusion as well as histomor-
phologic changes of the pancreas and liver were determined at 6 hours after
induction of disease.
Results. Alcohol feeding leads to increased pancreatic and hepatic injury in
acute necrotizing pancreatitis with high amounts of sticking leukocytes in
hepatic venuoles and sinusoids. Gadolinium chloride and glycine reduced
leukocyte sticking and improved microcirculatory perfusion of the liver.
Hepatic and pancreatic organ damage was reduced by gadolinium chloride
whereas glycine had no effects on histomorphologic changes.
Conclusions. Alcohol exposure aggravates pancreatic and hepatic injury in
acute pancreatitis. Destruction of Kupffer cells by gadolinium chloride is
effective in attenuating microcirculatory as well as histomorphologically
derangements whereas Kupffer Cell inhibition by glycine does not reduce
morphologic injury.
FP 19.03
GALANIN TYPE 2 RECEPTORS ARE INVOLVED IN CAERULEIN-
INDUCED ACUTE PANCREATITIS IN THE MOUSE
Saccone, Gino1; Zotti, Mario TG1; Bhandari, Mayank1; Schloithe, Ann C1;
Carati, Colin J2; Toouli, James1
1Flinders Medical Centre, Surgery, Bedford Park, Australia; 2Flinders
Medical Centre, Anatomy and Histology, Bedford Park, Australia
Background. Acute pancreatitis (AP) is a common clinical condition and
can be fatal. The mechanisms underlying the onset and progression of AP are
incompletely understood. Our recent studies have implicated the neuro-
transmitter galanin in AP in a possum model. Galanin has 3 receptors (types
1, 2 and 3) however the receptor(s) involved in AP are unknown.
Objectives. Determine if galanin receptor 2 is involved in AP by treatment
with a selective chimeric peptide antagonist, M871.
Methods. AP was induced in mice by 7 hourly intraperitoneal injections of
caerulein (50mg/kg). For comparison, the non-selective galanin antagonist
galantide (GT) was also tested. GT (40nmol/kg) or M871 (20 or 40nmol/kg)
was administered with each caerulein injection. Control mice received GT
(40nmol/kg) or M40 (40nmol/kg) or saline. Pancreata were harvested at 12
hours to measure myeloperoxidase activity, a marker of inflammation. Pre-
and post-AP blood was collected to measure plasma amylase and lipase
activities. M8971 was generously provided by U Sollenberg, Stockholm
University. Statistically analysis utilised the Mann-Whitney test.
Results. M871 treatment did not alter the AP-induced plasma amylase or
lipase activities, but the 40nmol/kg dose reduced myeloperoxidase by 54%
(pB0.05). GT treatment suppressed the AP-induced plasma amylase and
lipase activity by 65% and 66% respectively and myeloperoxidase activity by
78% (all pB0.05).
Conclusion. M871 reduced the AP-induced pancreatic myeloperoxidase
activity suggesting that the galanin receptor 2 is involved. Treatment with GT
was more effective in ameliorating AP implying that other galanin receptors
are involved. Supported by BioInnovation SA, Flinders Technologies and the
FMC Foundation.
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A SIMPLIFIED PROGNOSTIC SYSTEM FOR ACUTE PANCREA-
TITIS. A 20-YEARS COMPARATIVE STUDY.
Secchi, Mario1; Rossi, Leonardo1; Quadrelli, Lisandro1; Serra, Fernando2;
Forte, Jose3
1IUNIR-Medical School and HIG, Surgery, Rosario; 2Hospital Provincial,
Surgery, Rosario, Argentina; 3HECA, Surgery, Rosario, Argentina
Introduction. In 1987 we proposed a new Prognostic System (Index) for
predicting severity of AP. In 1992 a clinically-based classification system for
Acute Pancreatitis (AP) was proposed at the Atlanta Symposium: severe cases
were defined on the basis of an APACHE II and Ranson criteria.
Methods. 1132 patients having AP of any etiology were prospectively studied
in four surgical centers over the last 20 years. Our original prognostic system
(Index) included clinical and serological parameters: abdominal pain, ileus,
ascitis, shock, creatininemia, calcemia, lipasemia, amylasemia, bilirubin,
glycemia, and leukocytosis: a point from 0 to 2 or 3 given for each parameter
according to its category; thus a healthy or cured patient was given 0 point,
while a very seriously ill patient was given 20 points. The resulting sum is
always divided by the maximum possible: 20; and so healthy or cured patients
will average 0.00 and the most seriously ill patients 1.00. (severe cases:
0.40). 300 consecutive cases were prospectively studied to compare the new
system with two standard score systems: APACHE II (equal or more than 8
points) (at day 1 and 2) and Ranson (equal or more than 3 points)(within two
days after admission). We compared sensibility and specificity to predict a
severe attack within two days of admission.
Results. 44 (14%) severe cases were confirmed when major organ failure
occurred (complicated), and 258 (86%) cases were mild (uncomplicated).
Etiology was lithiasic for 85% of cases. Sensibility to detect severe cases was
95% for our Index, 78% for APACHE II and 88% for Ranson. Specificity was
97% for Our index, 86% for APACHE II and 95% for Ranson. Positive
Predictive Value was 0.95, 0.78 and 0.88, respectively. Kappa: 0.3224(NS)
Ji2: 0.07(NS).
Conclusion. Our INDEX is a simple method with a high sensibility and
specificity to predict severe attacks of AP as well as the other methods are, but
provides daily clinical follow-up information for all patients with AP.
FP 19.05
THE EFFECTS OF HYPERBARIC OXYGEN THERAPY ON LIPID
PEROXIDATION IN A RAT MODEL OF SEVERE ACUTE PAN-
CREATITIS
Koh, Shir Lin1; Muralidharan, Vijayaragavan2; Christophi, Christopher2
1The University of Melbourne, Surgery, Austin Health, Heidelberg, Aus-
tralia; 2The University of Melbourne, Surgery, Heidelberg, Australia
Background. The annual incidence of acute pancreatitis is 3040 per
100 000 population. Severe acute pancreatitis occurs in 1520% of patients
and is associated with significant tissue necrosis. There is evidence that
ischemia-reperfusion plays a critical role in the pathogenesis of severe acute
pancreatitis. During ischemia-reperfusion, there is an excessive release of
radical oxygen species. This leads to lipid peroxidation of the acinar cells
membranes. Hyperbaric oxygen has been shown to improve the survival rate
of rats with severe acute pancreatitis.
Aim. This study investigates the effects of hyperbaric oxygen on lipid
peroxidation in a rat model of severe acute pancreatitis.
Methods. Thirty male albino Wistar rats (250300 g) were induced with the
disease by biliopancreatic infusion of 0.1ml/100g of 4% sodium taurocholate
at a constant pressure of 20mmHg. Rats were randomized for hyperbaric
oxygen treatment. Endpoints were at days 1, 2 and 3 post-induction.
Pancreas was macroscopically scored and collected for analysis at the
endpoints. The level of malondialdehyde, an end product of lipid peroxida-
tion, of the pancreas was measured by thiobarbituric acid reactive substances
assay. The level of antioxidant enzyme, superoxide dismutase, in the rat
serum was measured. Statistical analysis was performed with 2-independent
sample T-test or Mann-Whitney test.
Results. Hyperbaric oxygen decreases the level of malondialdehyde on days
1 and 2. On day 3, the treated group shows a higher level of malondialdehyde.
There is a trend of reduction in the level of malondialdehyde in the treated
groups at earlier endpoints. However, there is no statistical difference
between any groups. The level of superoxide dismutase was lower in the
treated groups, showing a statistical significance on day 1 (p0.016).
Conclusion. Hyperbaric oxygen may improve the condition of severe acute
pancreatitis by reducing the extent of lipid peroxidation.
FP 19.06
OUTCOMES FROM PERCUTANEOUS PANCREATIC NECRO-
SECTOMY
Lochan, Rajiv1; French, Jeremy J1; Scott, John2; Rose, John2; Jackson,
Ralph2; White, Steve A1; Charnley, Richard M1
1Freeman Hospital, Hepato-Pancreato-Biliary Unit, Dept of Surgery, New-
castle upon Tyne, United Kingdom; 2Freeman Hospital, Dept of Radiology,
Newcastle upon Tyne, United Kingdom
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Introduction. Open pancreatic necrosectomy procedures are associated
with significant morbidity and mortality. We have sought to increase
alternative methods of necrosectomy. Percutaneous necrosectomy (following
CT guided access of the necrosis cavity) is an effective, minimally invasive
technique for treatment of necrosis associated with the body and tail of the
pancreas.
Aim. Evaluation of the results of percutaneous necrosectomy.
Methods. All patients who underwent this procedure were identified and
then patient and disease characteristics including outcome were identified.
Results. Between 1999 and 2007, 39 patients (19 with multi-organ failure)
underwent percutaneous necrosectomy as the primary means of treatment.
The median (range) APACHE2 disease severity score at presentation was 16
(334). There was no difference (p0.108) in the APACHE2 scores before
[16 (334)] and immediately after [15 (935)] percutaneous drainage. The
total number of necrosectomy procedures performed was 138 and the median
(range) was 3 (111). There were 6 major procedure related complications
(4.3%)  colonic perforations in 3, portal vein thrombosis in 23 and retro-
peritoneal haemorrhage (early in the experience and treated by packing) in 1
patient. Two patients needed multiple open necrosectomies (20 and 22
procedures each) to control necrosis. Of the remaining 37 patients, 8 needed
additional [median (range)] 1(18) open necrosectomies; 3 other patients
underwent endoscopic neecrosectomy. Twenty-eight patients recovered from
the illness, 3 of these needing long-term renal support. Eleven patients died
(28%).
Conclusion. Percutaneous necrosectomy is an effective minimally invasive
technique in the treatment of necrostizing pancreatitis
FP 20.01
ENDOSCOPIC GALLBLADDER STENTING EGBS FOR LAPARO-
SCOPIC CHOLECYSTECTOMY IN ACUTE CHOLECYSTITIS
Yagawa, Yohsuke; Sugimoto, Maki; Yasuda, Hideki; Koda, Keij; Yamazaki,
Masato; Tezuka, Tohru; Kosugi, Chihiro; Higuchi, Ryota
Teikyo University Chiba Medical Center, Department of surgery, 34263
Anesaki Ichihara Chiba, Japan
Background. Impacted cholecystolithiasis and occluded cholesystitis have
an increased risk of complications associated with cholecystectomy. Percu-
taneous or transpapillary naso-gallbladder drainage (PTGBD, ENGBD)
were usually accomplished preoperatively in such situation, but involved the
risk for deviation of the drain followed recurrence of symptoms. The aim of
this study was to evaluate the safety and usefulness of endoscopic gallbladder
stenting (EGBS) for the treatment for acute cholecystitis.
Methods. Seven patients with acute cholecystitis who underwent endoscopic
retrograde cholangiography with gallbladder stent placement were subjected
in this retrospective study. EGBS entailed placement of a single-pigtail
polyethylene stent between the gallbladder and the duodenum at ERCP. The
advantages and techniques of EGBS were described.
Results. Benefits of such stenting could be the disimpaction of gallstones and
the drainage of obstructed gallbladder. Drainage is expected to achieve after
being pushed back the obstructing stone into the gallbladder. No procedure-
associated morbidity or mortality was found. EGBS resulted effective bile
drainage and resolution of their symptoms immediately in all patients,
adjusting adequate preoperative period. During Lap-Chole, EGBS enabled
to clarify inflamed cystic duct, thereby made operative dissection easier.
There were no bile duct injuries or mortalities. No intraoperative or
postoperative complications occurred. There were no stent deviations.
Conclusion. EGBS is a beneficial procedure to perform safer laparoscopic
cholecystectomy for inflamed occluded cholecystitis. This approach is
noninvasive, safe, and effective in preventing tube deviation from the
gallbladder, potential morbidity and mortality.
FP 20.02
MANAGEMENT OF POSTTRAUMATIC BILE DUCT STRIC-
TURES
Vishnevsky, Vladimir; Kubyshkin, Valery; Ikramov, Ravshan; Shevchenko,
Tatjana; Olesov, Oleg; Efanov, Mikhail
Vishnevsky Institute of surgery, abdominal surgery, Moscow, Russian
Federation
Background. The management of patients with posttraumatic biliary
stricture is a challenging problem. This study reports the short and long-
term outcome of patients undergoing surgical procedures for posttraumatic
stricture of extrahepatic bile ducts.
Materials and Methods. From 1986 to January 2005, 150 patients
underwent surgical procedures for posttraumatic stricture of extrahepatic
bile ducts. The main cause of trauma was cholecystectomy (92.7%) including
laparoscopic procedure (30.2%). The most effective diagnostic techniques to
identify the type of stricture were magnetic resonance cholangiopancreato-
graphy (sensitivity93.3%). According to H. Bismuth (2000) there were
following types of strictures: III-80 (53,4%), IV-36 (24%), V- 14 (9,3%).
Only 20 (13,3%) patients underwent biliary reconstruction for type II
stricture. The main type of operation was a Roux-en-Y hepaticojejunostomy.
The overwhelming factors that affect outcome were width of anastomosis
(¡Y´15 mm) and complete excision of fibrotic tissue. We could perform it in all
patients with type II stricture, in 92.5%-with type III; 70%-IV; 57%-V (§aˆB
0.05).
Results. Mortality and morbidity was 1,3% and 38%, respectively. 86
patients have median follow-up of 6.4 ¡A` 0.5 years (range, 1 C20 years). The
poor outcome has been reported in 14 (16,3%) patients who had relapse of
stricture. All those patients underwent biliary reconstruction for type IV
stricture primarily. The main causes that significantly affected poor outcome
were narrow anastomosis and incomplete removing of fibrotic tissue. All
patients with recurrent stricture underwent biliary reconstruction again.
Satisfactory result was obtained in 10 patients.
Conclusion. The best choice for posttraumatic biliary stricture is the
surgical reconstructive procedure that provides acceptable results in majority
of patients. Significantly high risk of recurrence is connected with type IV
stricture, incomplete removing of fibrotic tissue and narrow anastomosis.
FP 20.03
LAPAROSCOPIC EXCISION OF CHOLEDOCHAL CYSTS
Chinnuswamy, Palanivelu; Palanisamy, Senthilnathan; Ramakrishnan, Patha-
sarathi; Gs, Maheshkumaar; Rangaswamy, Senthilkumar; Subbiah, Rajapan-
dian
GEM HOSPITAL, GI SURGERY, COIMBATORE, India
Background. Choledochal cysts are congenital dilatations of the extra
hepatic biliary system that typically affect the pediatric population. The
currently accepted mode of treatment for choledochal cysts is total excision
with hepatico jejuonostomy by conventional approach.
Methods and Results. We performed our first laparoscopic choledochal cyst
excision in 1996 and have successfully performed 31 surgeries in our
institute. We report our experience in the laparoscopic management of
choledochal cyst from 1996. We analyzed the data of thirty one patients who
had undergone choledochal cyst excision in our institute from 1996 to 2007.
Twenty two patients were males and nine patients were females. The mean
age of the patients was 26.5 years (8  48). All the patients underwent
ultrasound examination, liver function tests and CT scan of the abdomen or
MRCP. The choledochal cyst was Type 1 in 25 patients (83%) and Type IV A
in 6 patients (17%). Twenty four (77.41%) patients had anomalous
pancreato biliary junction. The mean operative time was 220 minutes
(160320 mts). The patients were extubated immediately after the surgery
and sent to ICU. The mean ICU stay for these patients was 1.3 days. The
patients were allowed to take liquids on the 2nd post operative day, after the
passage of flatus. The mean duration for starting oral fluids was also 1.3 days.
The patients were discharged on 5 th post operative day. The mean duration
of hospital stay was 5.6 (4 to 21 days). Laparoscopic excision of choledochal
cyst offer the additional advantages of the minimal access surgery
such as better cosmesis; quicker recovery and decreased wound related
complications, this gains more importance as this disease involves younger
age group patients active, and highly motivated individuals who
seek a cosmetically and functionally appealing result after surgery and would
aspire to return to work as soon as possible. These procedures have the
potential to replace the conventional approach in the near future as the
standard of care.
FP 20.04
A SURGEON AS FIRST ASSISTANT REDUCES THE INCIDENCE
OF CBD INJURIES DURING LAPAROSCOPIC CHOLECYSTECT-
OMY
Martin, Matt1; Earle, Kristen2
1Central Carolina Surgery, PA, Greensboro, North Carolina, United States;
2Moses Cone Hospital Systems, Central Carolina Surgery, PA, Greensboro,
North Carolina, United States
Background. This retrospective review supports the hypothesis that a
surgeon acting as first assistant during laparoscopic cholecystectomy will
reduce the incidence of significant CBD injuries. This is important at a time
when payers seek to reduce payment for this member of the team and this can
place a solo surgeon in a difficult situation when trying to recruit a surgeon to
assist.
Methods. Central Carolina Surgery, PA is a single specialty general surgery
group of 19 surgeons that have performed 9,056 laparoscopic cholecystec-
tomies since merging in October 1999. In those cases, 81% of the cases had
surgeons as first assistants and 66% of the cases were performed with
intraoperative cholangiography. Six cases of CBD injury that required bile
duct enterostomy for reconstruction occurred during this period for an
incidence of 0.06625%. Only three of these injuries were occurred with the
laparoscopic method alone. The other three injuries occurred after the
procedure had been converted to open for another reason.
Discussion. When this same group of surgeons learned to perform
laparoscopic cholecystectomy in 1990 their published series [Surgical
Endoscopy: (1993) 7: 300303] of 762 cases had 98% of cases performed
with a surgeon as first assistant and no CBD injuries. Only 27% of those 762
cases had intraoperative cholangiograms.
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Conclusions. This single practice experience supports the use of a surgeon
as first assistant to lower the incidence of CBD injures.
FP 20.05
QUALITY CONTROL IN A POPULATION-BASED COHORT OF
PATIENTS UNDERGOING CHOLECYSTECTOMY
Sandblom, Gabriel1; Videhult, Per2; Ljungdahl, Mikael3; Wollert, Staffan3;
Darkahi, Bahman4; Liljeholm, Ha˚kan4; Karlson, Britt-Marie3; Rasmussen,
Ib Christian3
1University Hospital, Department of surgery, Lund, Sweden; 2Ersta Hospi-
tal, Department of surgery, Stockholm, Sweden; 3University Hospital,
Department of surgery, Uppsala, Sweden; 4Enko¨ping Hospital, Department
of surgery, Enko¨ping, Sweden
Background. Although the introduction of the laparoscopic technique has
stimulated quality improvement in specialised centres, the outcome as it is
practised in the community at large is less well known.
Objective. To assess the complication rate and outcome of cholecystectomy
in a population-based cohort.
Methods. All patients undergoing cholecystectomy in the county of
Uppsala, which has a population of 303 000, have been registered
prospectively.
Results. Altogether 1199 patients underwent cholecystectomy 20032005.
The indication for surgery was ongoing cholecystitis in 114 (12%) cases,
history of conservatively treated cholecystitis in 235 (20%) cases and other
reasons in 813 (63%) cases. The risk for bleeding exceeding 100 millilitres
assessed in a multivariate logistic analysis was found to significantly
associated with male gender (Odds Ratio [OR] 1.5), age above median
(OR 1.7), open approach (OR 12.6), ongoing cholecystitis (OR 3.0) and
previous history of cholecystitis (OR 1.7). The risk for conversion from
laparoscopic to open surgery was found to be significantly associated with
operation for ongoing cholecystitis (OR 3.0) and history of previous
cholecsytitis (OR 2.4). The risk for operation time exceeding 120 minutes
was significantly associated with male gender (OR 1.3), age above median
(OR 1.3), ongoing cholecystitis (OR 2.4) and previous cholecystitis (OR 2.1).
Conclusion. Ongoing cholecystitis and history previous of cholecystitis
were associated with increased risk of bleeding, conversion to open surgery,
long operation time and long postoperative stay. Although conservative
treatment and delayed operation may lead to less risk of bleeding and
postoperative complications than surgery during ongoing cholecystitis, this
has to be traded off with the inconvenience of repeated admission and risk of
recurrence.
FP 20.06
LAPAROSCOPIC CHOLECYSTECTOMY BENCHMARKS USA
Voyles, Carl
Surgical Clinic Assoicates, Department of Surgery, University of Mississippi,
Jackson, Mississippi, United States
Introduction. Laparoscopic cholecystectomy is a common operation world-
wide.
Objective. To outline cost-effective quality benchmarks essential for inter-
national comparison and improvement.
Methods. From a single-surgeon series of 4500 LCs, the most recent
experience of 100 LC’s in a free-standing ambulatory surgery center (ASC)
was compared to a corresponding in-hospital experience of 218 patients (16
months; same surgeon).
OR setting ASC Hospital
Number 100 218
Age 41 60
Female 79% 61%
Mean OR time 22 minutes 29 minutes
Median OR time 21 minutes 24 minutes
% operative cholangiogram 24% 46%
Same day discharge 92% 31%
Next am discharge 8% 53%
2nd day or later discharge 0 16%
Transfusion 0 0.5%
Readmission 1% 3%
Results. The ambulatory patients were younger and more likely to be female
with less severe disease than the hospital population (reflected by # of
operative cholangiograms). In the hospital group, there were 2 primary open
operations and 2 conversions to open operation. Only one of 152 same day
discharges from ASC or hospital was readmitted to the hospital (CMV
hepatitis). Same day discharge was by nursing protocol (208 minutes after
operation); postoperative follow-up was by telephone only in 36% of patients.
There were no adverse events associated with early discharge or avoidance of
operative cholangiogram. In the hospital group, 4 of 6 subsequent read-
missions were related to age or underlying disease; 2 complications were from
surgical intervention (intra-abdominal hematoma and small bowel obstruc-
tion).
Conclusions. Given appropriate patient selection and team coordination,
elective outpatient LC can be performed very safely in the ASC or hospital.
Outcomes from the ASC provide useful benchmarks for the elective
cholecystectomy.
FP 21.01
RESULTS OF LIVER TRANSPLANTATION FOR HEPATOCELLU-
LAR CARCINOMA IN CIRRHOTIC PATIENTS INFECTED WITH
HIV
Vibert, Eric; Duclos-Vallee, Jean-Charles; Azoulay, Daniel; Adam, Rene´;
Samuel, Didier; Castaing, Denis
Paul Brousse hospital (AP/HP), Centre Hepato Biliaire, VILLEJUIF
Introduction. Antiretroviral therapy (ART) for human immunodefiency
virus (HIV) has improved survival of patients. End-stage liver disease due to
hepatitis B virus (HBV) and hepatitis C virus (HCV) have been successfully
treated by liver transplantation (LT) in HIV patient. Hence, LT for
hepatocellular carcinoma (HCC) in HIV patients was possible with usual
selective criteria (Milan criteria).
Objective. Assessment of intent-to-treat survival results of LT in HIV
patients.
Methods. From 1999 to 2007, among 118 cirrhotic HIV patients listed for
LT, 20(16%) patients presented HCC. Cause of cirrhosis was HCV(n15),
HBV(n2) and HCV/HBV (n2). Excepted one patient, HCC was the
main reason of listing. When feasible, chemoembolization (TACE) and/or
radiofrequency (RF) was performed before listing or during waiting-time
(WT). Rate and cause of drop-out (DO), overall survival and recurrence were
analyzed.
Results. At listing, mean MELD was 1596, mean number of nodules and
diameter wer 1.691 and 2798 mm respectively with 18/20(90%) patients
within Milan criteria. Except one, all patients have been treated by RF (n7)
and/or TACE (n14). The rate of DO was 7/20 (35%) due to malignant
progression (n5) and HIV progression (n2). One living-related and 12
cadaveric LT were made. Mean delay of WT was 7 months. One patient died
postoperatively due to hepatic arterial rupture. ART discontinued after LT
during a median of 24 days. On specimen, 5/13(38%) patients were outside
Milan criteria. Poor differentiation and vascular invasion were found in 4/
13(30%) and 5/13(38%) patients, respectively. Mean follow-up was 1893
months. Hepatic recurrence have occurred in 3/13(23%) at 2, 3 and 37
months after LT. These 3 patients were died and others (n10) are alive
without recurrence. Intent-to-treat survival at 2-year was 65% (5 patients at
risk).
Conclusion. LT in infected HIV patient with HCC is reasonable but the
high rate of DO due to tumor progression required a cautious management
on WT list.
FP 21.02
LIVER TRANSPLANTATION FOR HEPATITIS C (HCV): 10 YEAR
REVIEW
Doyle, M B Majella1; Anderson, Christopher, D2; Vachharajani, Neeta2;
Lowell, Jeffery A2; Chapman, William C2
1Washington University, Transplant and HPB, St Louis, United States;
2Washington University, Department of Surgery, Section of Transplant, St
Louis, United States
Background. Hepatitis C (HCV) remains the leading indication for liver
transplantation in adults in the U.S., but is associated with near universal
HCV recurrence, increased graft loss, and reduced long-term survival. Older
donors in HCV recipients are reported to result in an accelerated rate of
recurrence.
Aim. This study was undertaken to investigate the results of liver
transplantation over a 10 year period at a single, large volume transplant
center.
Methods. From 1997 to 2006, 579 liver transplants were performed at our
institution. Pediatric recipients (n90) (15.5%), were excluded from
analysis. In the remaining 489 (84.4%) adult patients 187 (39%) had HCV
and 302 (61%) had other indications. A prospectively maintained database
was utilized for the current analysis.
Results. The median follow up was 55 months. Overall patient survival at 1,
3, and 5 years was 88.13%, 77.4% and 67.5% and graft survival was 85.48%,
74.83% and 63.85% in patients with HCV. There was no significant
difference in patient or graft survival between HCV and non-HCV patients
at 1 and 3 or 5 years. Recurrent HCV not requiring transplant but with
clinically significant disease (grade II fibrosis) was 20% at 1 year but 62% by
8 years. Sixty-six patients received transplants using donors 65 years (15/
187 HCV (8%), 41/302 (13.5%) non-HCV). No difference was demon-
strated in short or long-term patient or graft survival comparing patients who
received grafts from older vs. younger donors, or when older donors were
used in HCV recipients.
Conclusion. HCV recurrence remains a significant cause of graft and patient
loss following liver transplantation. The increasing use of marginal donors,
including elderly grafts, does not appear to adversely affect long-term results
and may be a source of additional organs for expanding liver transplant
waiting lists.
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INTER-LABORATORY VARIABILITY IN ASSESSMENT OF THE
MODEL OF END-STAGE LIVER DISEASE (MELD) SCORE
Lisman, Ton1; van Leeuwen, Yvonne2; Adelmeijer, Jelle3; Pereboom, Ilona
T.A.3; Haagsma, Elizabeth B.4; van den Berg, Aad P.4; Porte, Robert J.3
1University Medical Center Groningen, Dept. of Surgery, CMC V, Y2144,
Groningen, Netherlands; 2Leiden University Medical Center, Dept. of
Clinical Epidemiology, Leiden, Netherlands; 3University Medical Center
Groningen, Dept. of Surgery, Groningen, Netherlands; 4University Medical
Center Groningen, Dept. of Gastroenterology and Hepatology, Groningen,
Netherlands
Background. The model of end-stage liver disease (MELD) score is
nowadays widely used to prioritise patients for liver transplantation. How-
ever, the lab-to-lab variation in MELD score in a single patient appears
substantial.
Objective. To investigate the contribution of each individual MELD
component (creatinine, bilirubin, and INR) to the inter-laboratory variation.
Methods. We sent 15 samples from patients listed for liver transplantation to
seven different European laboratories who were asked to measure all three
variables. In addition, 10 samples from patients on oral anticoagulant
treatment were sent to the same labs for INR measurement.
Results. In all 15 samples, a substantial and clinically relevant variation
in the calculated MELD score was observed between laboratories. The
difference in MELD score between the highest and lowest scoring lab
varied between 2 and 11 points (mean difference 4.8). The individual
components of the MELD score all showed substantial lab-to-lab variability,
with coefficients of variation of approximately 10%. The variation in
creatinine measurements resulted in differences of up to three MELD
points in a single patient when comparing the highest and lowest scoring
lab. The variation in bilirubin measurements only accounted for a difference
of 1 point between the highest and lowest scoring laboratory, but the variation
in INRs resulted in differences of 2 to 12 MELD points. MELD scores or
INR values were not substantially different in laboratories that used
the Owren instead of the more widely used Quick methodology for
determination of the INR. The variability in the INR in patients on oral
anticoagulants was substantially less as compared to the variability in patients
with liver disease.
Conclusion. We observed a large inter-laboratory variation in the
MELD score. This variation in MELD score is primarily caused by the
INR and to a lesser degree by serum creatinine levels. Variation in serum
bilirubin levels has a minor impact on the inter-laboratory variations in
MELD score.
FP 21.04
ADULT SPLIT LIVER TRANSPLANTATION  AN ANALYSIS OF
BLOOD LOSS, COAGULATION TRENDS AND TRANSFUSION
REQUIREMENTS.
Cherian, P Thomas; Pissanou, T; Tsourouflis, G; Gunson, B; Mayer, D;
Wigmore, SJ; Mirza, DF; Buckels, JAC; Bramhall, SR
University Hosptial, Birmingham
Background. As one of several possible mechanisms to expand the organ
pool, split deceased donor transplantation is increasingly being performed.
Although more recently graft survival has become comparable to those of
whole liver grafts (WLT), precise blood loss and transfusion requirements are
still unknown.
Methods. Between Sept 1994 and April 2007, there were 1553 WLT (233
SLTs) performed. Of these 104 were adult, cadaveric, ex vivo SLTs, all of
whom were included in our study. We reviewed our prospectively collected
database, clinical case notes and hospital records.
Results. Of the 104 patients 41were male and median age at transplant was
50 years. The indications for transplant were alcoholic cirrhosis(12), primary
biliary cirrhosis(33), primary sclerosing cholangitis(16), viral hepatitis(16),
and others(26). In 96 patients an 5,6,7,8,4 (trisegment) graft and in 7
patients a 5,6,7,8 segment graft was used. The mean drop in haemoglobin
from the transplant was 3.1 gms(range 1.7 to 9.2). The median intra-
operative transfusion requirements were studied. Apoprotinin when used (29
patients), significantly decreased transfusion requirements [from 5 RBC units
to 3 (median) PB 0.05]. The source of bleeding after implantation was the
liver capsule(5), cut surface(52), reteroperitoneal(18) and perianastamotic(9)
where documented. Intra-operative Hb drop was significantly higher in the
alcoholic compared to biliary cirrhosis group (4.5gms versus 3gms). Trends
in blood product requirements and clotting was studied, which showed 23%
patients needed blood products even after day 5.
Conclusions. The mean drop in haemoglobin from a SLT transplant was
3.1 gms (range 1.7 to 9.2). Apoprotinin when used made a significant
decrease in transfusion requirements. The source of bleeding was the cut
surface in the majority after implantation. However the higher intra-operative
Hb drops in certain subgroups suggests that the explantation still accounts
for most of the overall blood loss.
FP 21.05
HYPERNATREMIA IN DECEASED DONORS AND ITS EFFECT
IN LIVER TRANSPLANTATION-INDIAN EXPERIENCE
Kanchustambam, Subba rao; Gottimukkala,
Apollo health city, HPB & Liver transplant surgery, Hyderabad, India
Abstract. Deceased donor hypernatremia has been reported that it may have
an effect on the graft recovery in Liver transplantation. As the donors in India
are scarce; we have used all livers including donor hypernatemia170 meq/
dl with good success.
Aim. The aim of the study is to see if this has any effect over the graft
function from Indian experience of Deceased donor liver transplants.
Methods. From Feb 2003 to Aug 2006, 32 Liver transplants were performed
of which 24 were Deceased donor liver transplants. The donors divided into
two groups group A NaB155(13) and group B 155(11) (2 had175). All
procured with UW solution preserved at 4 c. Mean Cold ischemic time were
11 .5 hrs and 10.3 hrs (highest 15.5hrs). Hospitals ICU stay varied from 4
days to 7days. The age of donors was 10 to 65 yrs.
Results There is no difference in the blood transfusion requirement. There is
no primary non function in either group. The AST and ALT after 24hrs were
higher in group 1 but did not affect the graft function. There is no difference
in the prothrombin time. The 2 year survival was 86%.
Conclusion. The so called Marginal donors with Na155meq/dl did not
effect either the early post operative period or the long term survival. Though
the present study is a retrospective and involves a small number of donors, we
might conclude that one should not refuse Livers based on any single
marginal donor criteria.
FP 21.06
MANAGEMENT OF BILIARY COMPLICATIONS IN LIVER
TRANSPLANTATION FROM DONATION AFTER CARDIAC
DEATH (DCD)
El Sarrag, Ibrahim; Khan, Abdaal; Abdullah, Khalid; Ohali, Wael; Nafea,
Osama; Abdulkareem, Abdulmajeed
King Abdulaziz Medical City, Hepato-biliary Sciences, Riyadh, Saudi Arabia
Introduction. A higher incidence of biliary complications after liver
transplant has been noted in DCD livers.
Material and Methods. A retrospective review of biliary complications in
DCD liver transplants managed at our center was performed over 2 year
period (Jan, 2005 to Feb, 2007).
Results. 51 consecutive patients who had DCD liver transplants abroad were
managed at our institution during this period. One immediate postoperative
mortality was excluded. 50 charts were reviewed. There were 39 males and
11 females. The mean age was 57.1 yrs (9.84). The indication for transplant
was HCV, 18 patients (including 2 with HCC), HBV, 14 patients (including
2 with HCC), HCVHBV 5 patients, cryptogenic 12 (including 2 with
HCC), one patient schistosoma and one patient with PSC. 17 patients had
T-tubes placed after duct to duct reconstruction. Biliary complications
occurred in 13 patients (26%). There were 6 leaks of which 4 were minor
following T-tube removals, which were managed by ERCPstent in 2
patients and percutaneous aspiration of collection in one patient. Only one
patient required operative intervention with Roux-en-Y hepatico-jejunost-
omy. There were 8 strictures (16%) including one of left hepatic duct, 5
anastomotic and 2 multiple intra and extrahepatic strictures. All, except the
left hepatic duct stricture were managed by interventional radiology9ERCP
with stenting and balloon dilatations. The mean follow up was 16.2 months
(8.4).
Conclusion. While DCD liver transplants have a higher biliary stricture rate,
most can managed by non-operative means.
FP 22.01
CAN IMMUNOTHERAPY PREVENT RELAPSE OF TUMOR
AFTER CURATIVE OPERATION FOR HCC?
Kotera, Yoshihito; Katagiri, Satoshi; Ariizumi, Shunniti; Takahasi, Yutaka;
Masakazu, Yamamoto; Takasaki, Ken
Tokyo Women’s Medical University, Surgery, Tokyo, Japan
Background. The cases of Hepatocelluler Carcinoma (HCC) with vesicular
invasion or intra-hepatic metastasis are often relapsed tumor even
after curative operation. To prevent recurrence of tumor, additional therapy
is needed like chemotherapy or immunotherapy. In this study, we tried
to predict the existence of vascular invasion or intrahepatic metastasis
using conventional CTscan. Then we performed additional therapy such
cases.
Patients and Methods. we chose 146 consecutive cases which performed
hepatectomy in 2002 to 2005. Before the operation, we diagnosed whether
simple nodule type HCC or simple nodule with extranodular growth type
HCC on CT-scan. Then the patients who given the diagnosis of simple
nodule with extranodular growth type HCC received immunotherapy or
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Trans arterial chemo embolization (TACE). Dendritic cell vaccine and
CD3 activated T-lymphocyte were recruited for immunotherapy. Result: 62
cases out of 146 cases (42%) had whether vascular invasion or intrahepatic
metastasis. 22 cases received immunotherapy (IT),22 cases received
TACE and 24 cases received no additional therapy (NT). In these three
groups, any differences were seen in background of the patients. Accuracy of
diagnosis of gross finding was over 70%. 24 months Disease free survival
(DFS24) for IT group and TACE group and NT group were 43%, 23%,
12% respectively. And there were significant difference in these groups.
(pB0.05).
Conclusion. Immunotherapy could prevent relapse of tumor with vascular
invasion or intrahepatic metastasis.
FP 22.02
INTRA-LYMPHATIC IMMUNOTHERAPY OF INOPERABLE PA-
TIENTS AFFECTED BY HEPATOCARCINOMA: Results OF A
PILOT STUDY
Nardo, Bruno1; Bertelli, Riccardo1; Beltempo, Paolo1; Puviani, Lorenza1;
Cavallari, Giuseppe1; Tsivian, Matvey1; Neri, Flavia1; De Vinci, Caterina2;
Pizza, Giancarlo2
1University of Bologna, Bologna; 2University of Bologna, Immunotherapy
Module-Operative Unit of Urology, D, Bologna
Background/Aim. Intra-lymphatic injections of interleukin-2-activated
(IL2) autologous peripheral lymphocytes (LAK), were offered on compas-
sionate basis, to patients affected by inoperable hepatocarcinoma.
Methods. From January 2003 to March 2005, 31 patients were treated by
monthly intra-lymphatic injections of LAK and 250 IU IL2. The lymphatic
vessels of the foot were localized according to the technique for lympho-
graphy, and cannulated with a fine needle connected to a syringe containing
LAK and IL2. The duration of a treatment-cycle was intended initially for six
months, with restaging at three and six months with abdominal TC or
ultrasonography, a´-fetoprotein and liver function tests. Fifteen patients
underwent at least three cycles of intra-lymphatic immunotherapy, with a
mean follow-up of 7.2 months, among them 9 had a virus-related cirrhosis (3
HCV, 4 HBV, 2 HCV and HBV positive). In order to evaluate the efficacy of
the treatment, the following parameters were considered: vascular infiltration
or thrombosis, Child-Pugh classification, histological grading, lymphoade-
nopaty, viral status, levels of a´-fetoprotein.
Results. No clinical adverse side effects were reported in the early and late
period. A stabilization or relevant recovery in liver function tests was observed
in 7 patients who underwent at least 6 cycles of intra-lymphatic immu-
notherapy (46.6%). The survival of patients who underwent 12 cycles of
treatment resulted significantly higher as compared to those patients with less
than 12 cycles. Both group had an higher survival as compared with an
untreated control group.
Conclusions. The intra-lymphatic immunotherapy is a safe procedure and
allow to ameliorate the liver function tests and to improve survival of patients
with inoperable HCC. This preliminary clinical experience may encourage a
clinical trials in order to establish the effective impact on patient survival as
well as the enrolment criteria.
FP 22.03
TREATMENT OF MEDIUM AND LARGE HEPATOCELLULAR
CARCINOMA USING PERCUTANEOUS COMPOSITE THERMAL
ABLATION TECHNIQUE: AN ANALYSIS OF LONG-TERM SUR-
VIVAL
Yin, Xiaoyu1; Lu, Mingde2; Xie, Xiaoyan3; Xu, Huixiong3; Xu, Zuofeng3;
Kuang, Ming4; Liang, Jinyu3
1The First Affiliated Hospital, Department of Hepatobiliary Surgery, Sun
Yat-Sen University, Guangzhou, China; 2The First Affiliated Hospital/Sun
Yat-Sen University, Department of Hepatobiliary Surgery, Guangzhou,
China; 3The First Affiliated Hospital, Department of Medical Ultrasonics,
Guangzhou, China; 4The First Affiliated Hospital, Department of Hepato-
biliary Surgery, Guangzhou, China
Background. Thermal ablation using radiofrequency(RFA) or microwa-
ve(MWA) is effective in curing hepatocellular carcinoma(HCC) B3 cm.
However, its efficacy in treating medium- and big-sized HCC still needs to be
improved.
Aims. To evaluate therapeutic efficacy of percutaneous composite thermal
ablation technique for HCC between 3.0 cm and 7.0 cm.
Methods. By using multiple-needle insertion and multi-point energy
application technique, percutaneous RFA or MWA was adopted to treat
109 HCC patients with at least one tumor between 3.0cm and 7.0cm. Fifty-
eight patients were first-treated cases (no previous treatment), and 51 were
recurrent cases after hepatectomy. Seventy patients had single tumor, and 39
had multiple tumors. There were 158 tumors, with a diameter B3.0cm in
34£3.0¡«5.0cm in 105, and 5.0¡«7.0cm in 19. Local therapeutic efficacy
and long-term outcome were analyzed.
Results. Mortality and major complications incidence were 0% and 9.2%,
respectively. Complete ablation rate was greater in tumors B3.0cm and
3.0¡«5.0cm than those 5.0¡«7.0cm, being 100% and 94.3% vs 78.9%,
respectively (pB0.05). With mean follow-up of 22.08 418.5 months, local
tumor progression was more common in tumors with diameter of 3.0¡«5.0cm
and 5.0¡«7.0cm than those B3.0cm(pB0.05). Distant recurrence developed
in 53.2% patients. 1-,3-,5- year survival rate was 75.8%,30.9%,15.4%,
respectively. Univariate analysis showed that first-treated patients had a
significantly better long-term survival than post-hepatectomy recurrent
patients (pB0.05), and patients with pre-ablation AFPB200ug/L had a
markedly greater long-term survival than those AFP200ug/L (pB0.05).
Cox regression analysis demonstrated that both no previous treatment and
pre-ablation AFPB200ug/L were independent favorable prognostic factors
(pB0.05).
Conclusion. By using composite ablation technique, percutaneous thermal
ablation was effective in treating HCC B7cm, especially B5cm. No previous
treatment and pre-ablation AFPB200ug/L were independent favorable
prognostic factors.
FP 22.04
ETHANOL ABLATION OF HEPATOCELLULAR CARCINOMA
SIZED UP TO 5 CM BY USING A MULTIPRONGED NEEDLE
WITH SINGLE TREATMENT SESSION
Kuang, Ming1; Lu, Ming D2; Xu, Zuo F3; Xie, Xiao Y4; Xie, Xiao Y3; Xu,
Hui X3; Liu, Guang J3
1The First Affiliated Hospital of, Department of Hepatobiliary Surgery, Sun
Yat-Sen University, Guangzhou, China; 2The First Affiliated Hospital of Sun
Yat-Sen University, Department of Hepatobiliary Surgery, Guangzhou,
China; 3The First Affiliated Hospital of Sun Yat-Sen University, Department
of Meical Ultrasonics, Guangzhou; 4
Objective. To investigate the initial efficacy of ethanol ablation (EA) in
patients with hepatocellular carcinoma (HCC) sized up tp 5 cm by using a
multi-pronged injection needle with single treatment session.
Methods. The study was performed with approval of the ethic committee,
and written informed consent was obtained for all patients. A total of 100
patients with primary or recurrent HCC 5 cm or less in size were treated.
Single tumors were seen in 85 patients, and 2 or 3 nodules seen in 15
patients. Primary HCC was observed in 57 patients and recurrent tumors
were in 43 patients. Follow-up ranged from 3 to 28 months (mean, 15
months96). Patients were observed for progression of the treated tumors and
for appearance of new lesions in the liver. Risk factors to the local
effectiveness, disease-free survival and overall survival were assessed with
Chi-square test, univariate and multivariate analysis.
Results. Mean treatment session was 1.1. Primary effectiveness rate was
94% and was significantly related to tumor stage (P.008) (? 3 cm, 100%;
3.15.0 cm, 87%), tumor pattern (P.017) (encapsulated, 97%; noncapsu-
lated, 81%), and existence of portal hypertension (P.017). At the end of
follow-up, local tumor progression rate was 12%. The 1-, and 2-year disease-
free survival (DFS) rates in patients with primary or recurrent HCC were
81% and 62%, 47% and 36%, respectively. The independent predictors of
DFS were tumor location (P.0018), and occurrence of complication (P
.0016). The 1-, and 2-year overall survival (OS) rates in patients with primary
or recurrent HCC were 96% and 82%, 84% and 46%, respectively. The
independent predictors of OS were alpha-fetoprotein level (P.0032),
and recurrence (P.0000) in all patients, and primary effectiveness rate
(P.003) in patients with primary tumors. Complication rate was 7%. No
ablation-related death was observed.
Conclusions. The use of a multi-pronged injection needle may improve
treatment efficacy of EA of HCC up to 5 cm in diameter within less
FP 22.05
PERCUTANEOUS RADIOFREQUENCY ABLATION FOR THE
TREATMENT OF HEPATOCELLULAR CARCINOMA IN THE
CAUDATE LOBE
Peng, Zhen-Wei1; Chen, Min-Shan1; Liang, Hui-Hong1; Zhang, Yao-Jun1;
Li, Jin-Qing1; Zhang, Ya-Qi1; Lau, Wan Y2
1Department of Hepatobiliary Surgery, Cancer Centre of Sun Yat-Sen
University, Guangzhou, China; 2Department of Surgery, The Chinese
University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
Aims. This study aimed to evaluate the efficacy and safety of Percutaneous
radiofrequency ablation (PRFA) for hepatocellular carcinoma (HCC) in the
caudate lobe.
Patients and Methods. Between January 2001 and December 2006, 17
patients, twelve males and five females who were 33 to 68 years old (mean
54.3), with the caudate lobe HCCs [2.06.5cm in diameter (mean 3.1)] were
treated with either PRFA alone (n14), or PRFA with percutaneous ethanol
injection (n3) under ultrasound guidance. The right or anterior approach
was used in 12 and 5 patients respectively.
Results. All procedures were performed successfully. There was no motility
and major complication due to PRFA. 14 tumors (82.4%) were completely
ablated after one to two sessions of treatment. During follow-up (range 3 to
60, mean 29.1 months), two (14.3%) developed local recurrence. Intrahe-
patic metastasis developed in 9 of 17 patients (52.9£¥). No distant metastasis
was found. 4 patients died (23.5£¥), 3 from tumor progression and one from
hepatic failure. The 1-, 2-, and 4-year overall survivals were 88.2%, 80.2%,
and 72.2% respectively, and the progress free survivals were 47.1%, 20.2%,
and 10.1% respectively.
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Conclusions. PRFA is efficacious and safe for patients with HCC in the
caudate lobe.
FP 23.01
DETERMINANTS OF OUTCOME FOLLOWING NECROSECT-
OMY AND CLOSED DRAINAGE FOR NECROTIZING PANCREA-
TITIS
Singhal, Dinesh1; Chaudhary, Adarsh1; Pervaiz, Azhar1; Puri, Rajesh2;
Kumar, Mandhir2; Sud, Randhir2
1Sir Ganga Ram Hospital, Surgical Gastroenterology, New Delhi, India; 2Sir
Ganga Ram Hospital, Gastroenterology, New Delhi, India
Introduction. Necrosectomy is the currently accepted treatment for infected
pancreatic necrosis and some patients with sterile necrosis. This study was
conducted to identify factors determining outcome after necrosectomy.
Patients and Methods. Forty-six patients (38 infected and 8 sterile)
underwent necrosectomy and closed drainage of the lesser sac between
20032007. The impact of patient, disease and postoperative factors on
complications and mortality was analyzed.
Results. There were 37 males and 9 females with a median age of 38 (range
15  67) years. Thirty (65%) had major complications and 9 (19.5%) died.
The causes of death include delayed massive hemorrhage (4), persistent
multiorgan failure (4) and pulmonary embolism (1). At stepwise logistic
regression analysis, independent predictors of mortality were preoperative
multiorgan failure (MOF), extrapancreatic necrosis and isolation of Candida
in the drained pus. The latter was significantly associated with preoperative
MOF and delayed massive hemorrhage. Prophylactic use of carbapenams
emerged as an independent predictor for the presence of Candida.
Conclusions. The systemic and local severity of necrotizing pancreatitis
determines the outcome following necrosectomy. Prophylactic use of
carbapenams results in an increased isolation of Candida from the pus which
is associated with major pre and postoperative complications.
FP 23.02
ORGAN FAILURE ASSOCIATED WITH SEVERE ACUTE PAN-
CREATITIS
Wig, Jaidev1; Kochhar, Rakesh2; Bharathy, Kishore GS1; Kudari, Ashwini
K3; Doley, Rudraprasad3; Yadav, Thakur D3; Gupta, Rajesh3
1PGIMER, Chandigarh, India, General Surgery, Chandigarh, India; 2PGI-
MER, Chandigarh, India, Gastroenterology, Chandigarh, India; 3PGIMER,
Chandigarh, India, Chandigarh, India
Background. The clinical course of severe acute pancreatitis may be
complicated by the evolution of organ failure which is associated with
increased mortality.
Aim. To study the incidence of organ failure in severe acute pancreatitis,
contributing factors and their effect on outcome.
Methods. One hundred and sixty one patients with severe acute pancreatitis
over a 4 year period were studied at a tertiary level university hospital. The
effect of age, etiology, presence of bacterial infection, APACHE II scores and
extent of necrosis on computed tomography on the occurrence of organ
failure and mortality were analyzed.
Results. Organ failure was present in 52% of patients. Single, two and three
organ failure was seen in 48.8%, 33.3%, and 17.8% respectively. Corre-
sponding mean APACHE II scores were 10.24, 9.61, and 17.32. APACHE II
score and extent of pancreatic necrosis on computed tomography correlated
with number of organs failing (pB.001 and .003 respectively). Presence of
infective necrosis however was not associated with increased incidence of
organ failure (p.462). 77.9% of patients without organ failure survived
while mortality rate increased with increasing number of organs failing.
Conclusions. Organ failure in patients with severe acute pancreatitis
predicted poor outcome. APACHE II score and extent of necrosis on
computed tomography correlated with organ failure.
FP 23.03
A NEW NON-INVASIVE MODEL OF SEVERE ACUTE PANCREA-
TITIS IN MICE
Hartwig, Werner1; Schimmel, Eik1; Hackert, Thilo1; Bergmann, Frank2;
Strobel, Oliver1; Schneider, Lutz1; Bu¨chler, Markus W.1; Werner, Jens1
1University of Heidelberg, Dept. of General, Visceral, and Transplant
Surgery, Heidelberg, Germany; 2University of Heidelberg, Dept. of Pathol-
ogy, Heidelberg, Germany
Background. A non-invasive model of necro-hemorrhagic pancreatitis
induced by simultaneous cerulein/enterokinase (EK) infusion has recently
been established in rats. Since the only presently available non-invasive model
of severe pancreatitis in mice (CDE-diet) is associated with several short-
comings, the aim of the present study was to establish and characterize this
new model in mice.
Methods. Male Bulb-C mice (2025 mg) were used for experiments.
Pancreatitis was induced by simultaneous infusion of cerulein (100 mg/kg/h)
and EK (4001600 U/kg/h). Controls were infused with saline, cerulein, or
EK only. Animals were sacrificed six hours after start of infusions. Pancreatic
and pulmonary injury were assessed by histology, wet-to-dry weight ratio,
and myeloperoxidase activity in tissue. Systemic cytokine-, amylase-, and
LDH-levels in blood were measured to assess the inflammatory reaction and
cell injury. Long-term experiments were performed to determine survival in
this model.
Results. Animals developed marked local and systemic organ injury with
simultaneous cerulein/EK infusions. Pancreatic edema increased with high
cerulein/EK infusions as compared to cerulein or EK alone. Likewise,
pancreatic as well as pulmonary leukocyte sequestration was significantly
higher with combined cerulein/EK infusions. Importantly, survival decreased
in these animals. Pancreata showed cell necrosis, but not as strong as known
from the rat model. Increased LDH and IL 1b-levels in serum reflected cell
damage and the systemic inflammatory response in cerulein/EK infused
animals.
Conclusions. Applying intravenous cerulein/EK infusions, a new model of
lethal acute pancreatitis with associated systemic inflammatory response has
been established. This easily reproducible and non-invasive model appears
valuable for future investigations in genetically altered mice.
FP 23.04
THE GALANIN ANTAGONISTS GALANTIDE AND M35 BUT NOT
C7 AND M40 AMELIORATE CAERULEIN-INDUCED ACUTE
PANCREATITIS IN MICE
Bhandari, Mayank1; Kawamoto, Masahiko1; Thomas, Anthony2; Carati,
Colin J3; Schloithe, Ann C1; Toouli, James1; Saccone, Gino TP1
1Flinders Medical Centre, Surgery, Bedford Park, Australia; 2Flinders
Medical Centre, Anatomical Pathology, Bedford Park, Australia; 3Flinders
Medical Centre, Anatomy and Histology, Bedford Park, Australia
Background and Aims. We have shown that the galanin antagonist
galantide ameliorates acute pancreatitis (AP) in a possum model. We
evaluated several galanin antagonists; C7, M35, M40 and galantide, for
their ability to ameliorate AP in a cerulein mouse model.
Methods. AP was induced in male Swiss mice by 7 hourly intraperitoneal
(i.p.) injections of caerulein (50 mg/kg). Galantide (40 nmol/kg), C7, M35 or
M40 (20 or 40 nmol/kg) were administered i.p. with each caerulein injection.
Control mice received galantide, C7, M35 or M40 (40 nmol/kg) alone or
saline. Pancreata were harvested at 12 hours for histological examination and
estimation of myeloperoxidase (MPO) activity. Plasma amylase and lipase
activity were measured pre- and post-treatment. Data were analyzed using
ANOVA or the Mann  Whitney test.
Results. Treatment with galantide, M35 and C7 (at 40 nmol/kg) reduced
plasma amylase and lipase activities in AP mice by 5575% (pB0.05).
Administration of M40 (20 and 40nmol/kg) did not significantly alter plasma
enzymemia when compared to the AP alone group. None of the antagonist
alone or saline altered plasma enzyme activity above pre-treatment levels.
Galantide, M35 and M40 significantly reduced the pancreatic MPO activity
(by 7583%) compared to the AP alone group (pB0.05), whereas C7
increased MPO activity. C7 alone also increased MPO activity. Galantide and
M35 (40 nmol/kg) but not C7 or M40 treatment significantly reduced the
AP-induced necrosis score by 3150% compared to the AP alone group (pB
0.05). C7 alone increased the necrosis score compared with saline treatment
alone.
Conclusion. Galantide and M35 ameliorated the severity of AP, but M40
and C7 had mixed effects, with C7 exacerbating some indices of AP. These
data suggest that complex galanin pathways may be involved in this model of
AP. Supported by BioInnovation SA, Flinders Technologies and the FMC
Foundation.
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TRENDS IN THE MINIMALLY INVASIVE MANAGEMENT OF
NECROTIZING PANCREATITIS: A SURVEY OF AUSTRALIAN
AND NEW ZEALAND SURGEONS
Loveday, Benjamin PT1; Rossaak, Jeremy I2; Mittal, Anubhav1; Phillips,
Anthony3; Windsor, John A1
1University of Auckland, Department of Surgery, Auckland, New Zealand;
2Auckland City Hospital, Department of Surgery, Auckland, New Zealand;
3University of Auckland, School of Biological Sciences, Auckland, New
Zealand
Background. While there is consensus in published guidelines on the
diagnosis and early management of acute pancreatitis, there is less agreement
on how to manage infected pancreatic necrosis and its local complications.
Aims. The aim of this survey was to determine the trends in the minimally
invasive management of necrotizing pancreatitis in Australia and
New Zealand, and to identify barriers to the use of minimally invasive
techniques.
Methods. In early 2007, members of the Australian and New Zealand
Hepatic Pancreatic and Biliary Association were invited to complete an
anonymous web-based survey. Following questions concerning demographics
and pancreatitis caseload, a 5-point Likert scale was used to score the
perceived role of percutaneous drainage and minimally invasive techniques in
the management of infected pancreatic necrosis, pancreatic abscess, and
pancreatic pseudocyst. A comparison was made between current manage-
ment and that before 2002. Barriers to minimally invasive necrosectomy were
identified and scored.
Results. Forty-four consultant surgeons completed the survey. Minimally
invasive necrosectomy is considered to be increasingly important as a
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primary treatment for infected pancreatic necrosis (p0.0004) and percu-
taneous drainage as a secondary treatment for pancreatic abscess (p0.001).
The complexity and anatomical location of the necrotic tissue were identified
as major barriers to the use of minimally invasive necrosectomy by 24/42
(56%) and 20/42 (47%) participants, respectively. Conversely, lack of
support from the intensive care unit and hospital managers were not
considered a barrier by 39/42 (91%) and 35/42 (81%) participants,
respectively.
Conclusion. Over the last 5 years the trend has been toward percutaneous
drainage and minimally invasive necrosectomy for the management of
necrotizing pancreatitis. Further research is required to determine the
appropriate indications and techniques for these interventions.
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THE EFFECTS OF HYPERBARIC OXYGEN THERAPY ON APOP-
TOSIS AND PROLIFERATION IN A RAT MODEL OF SEVERE
ACUTE PANCREATITIS
Koh, Shir Lin1; Tan, Joon Win2; Muralidharan, Vijayaragavan2; Christophi,
Christopher2
1The University of Melbourne, Surgery, Austin Health, Heidelberg, Victoria,
Australia; 2The University of Melbourne, Surgery, Heidelberg, Victoria,
Australia
Background. The annual incidence of acute pancreatitis is 3040 per 100
000 population. Severe acute pancreatitis occurs in 1520% of patients and is
associated with significant tissue necrosis. Apoptosis predominates in the
milder form of pancreatitis. Hyperbaric oxygen has been shown to improve
the survival rate of rats with severe acute pancreatitis. Hyperbaric oxygen acts
through several mechanisms, possibly through the alteration of apoptosis and
proliferation.
Aim. This study investigates the effects of hyperbaric oxygen on apoptosis
and proliferation in a rat model of severe acute pancreatitis.
Methods. Forty male albino Wistar rats (250300g) were induced with
severe acute pancreatitis by biliopancreatic infusion of 0.1ml/100g of 4%
sodium taurocholate at a constant pressure of 20mmHg. Rats were
randomized for hyperbaric oxygen treatment with endpoints of days 1, 2
and 3 post-induction. Pancreas of rats was macroscopically scored at the
endpoints. Sections of formalin-fixed pancreas were stained for apoptosis and
proliferation with antibodies anti-caspase3 and anti-Ki67 respectively. Image-
proplus software was used to quantify the percentage of apoptosis and
proliferation in acinar cells. Statistical analysis was performed with 2-
independent sample T-test or Mann-Whitney test.
Results. The rate of apoptosis in this disease is higher than that of a normal
rat (p0.008 on day 1). Hyperbaric oxygen further increase the rate of
apoptosis, reaching a statistical significance on day 1 (p0.04). The rate of
proliferation is increased in the disease compared to normal, and hyperbaric
oxygen therapy further increased the level of proliferation on days 2 and 3.
There was no statistical significance between any groups.
Conclusion. Hyperbaric oxygen may improve the condition of severe acute
pancreatitis by increasing the rate of apoptosis in acinar cells.
FP 24.01
CUMULATIVE SUM (CUSUM) PROVIDES AN OBJECTIVE MEA-
SURE OF COMPETENCY IN ENDOSCOPIC RETROGRADE
CHOLANGIO-PANCREATOGRAPHY (ERCP) TRAINING
Connor, Saxon
Christchurch Hospital, Surgery, Christchurch, New Zealand
Introduction. Endoscopic retrograde cholangio-pancreaography (ERCP) is
a complex and technically challenging procedure with a risk of significant
complications. Recommendations exist as to how many ERCP’s should be
performed before a trainee is deemed competent however these are not
individualised to the trainee. Cumulative sum (CUSUM) allows continuous
monitoring of a proceduralists performance to identify acceptable outcomes.
The aim of this study was to assess a trainees progress with ERCP (learning
curve) by CUSUM analysis.
Method. A single trainee performed one supervised ERCP list per week
between 06/0507/07. Data was collected prospectively. Data was analysed
by intention to treat. The Binary outcome measure was successful cannula-
tion in patients with an intact sphincter of Oddi. Cumulative failure charting
and sequential probability ratio testing was performed. Acceptable cannula-
tion failure rates were set at 20%. Unacceptable cannulation failure rates were
set at 35%. Type I and II error rates were set at 0.10.
Results. 208 ERCP’s were performed. Median (range) age was 72 (2194)
years. Choledocholithiasis was the indication in 114 (55%) patients.
Successful cannulation was achieved in 114 of 170 (67%) patients with intact
biliary sphincters. Sphincterotomy was completed in 85 of the 89 (96%)
patients in whom it was indicated. A therapeutic procedure was completed in
95 (95%) of 100 patients in whom it was indicated. Although cumulative
failure charting suggested the trainee had not yet achieved satisfactory
performance sequential probability ratio testing indicated that an acceptable
outcome had been achieved for the last 105 consecutive ERCP’s.
Conclusion. CUSUM enables sensitive and continuous monitoring of a
trainees performance to objectively determine competence. Wider and
systematic use would enable appropriate benchmarks to be identified and
more objective assessment of a trainee’s experience.
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LAPAROSCOPIC CHOLECYSTECTOMY AND ERCP: TREAT-
MENT OF BILIARY STONES DISEASES
Fiocca, Fausto1; Santagati, Alessio2; Ceci, Vincenzo2; Donatelli, Gian-
franco2; Cereatti, Fabrizio2
1Policlinico Umberto I-Universita` ‘‘La Sapienza’’, Endoscopic Emergency
Surgery, Roma, Italy; 2Policlinico Umberto I-University ‘‘La Sapienza’’,
Endoscopic Emergency Surgery, Roma, Italy
Introduction. Laparoscopic cholecystectomy (LC) is the gold standard
technique for cholelithiasis, while common bile duct (CBD) stone treatment
is still controversial. Our experience in pre-, intra-, and post-operative ERCP
in pts undergoing LC in the last 5 years will be evaluated.
Patients, Methods and Results. 835 pts were referred to us from different
Institutions. Pre-operative ERCP was performed in 674 pts with confirmed
diagnosis of CBD stones at US or Magnetic Resonance or recurrent biliary
pancreatitis. Endoscopic sphincterotomy (ES) was successfull in 658 (97.6%)
while CBD clearance was successfull in 625 (92.7%). 49 pts were treated
with transhepatic lithotripsy or surgically. Mortality was none, major
complications 2, minor complications 6.8%, mean hospital stay 4.5 days.
Intra-operative ERCP was performed in 75 pts in which an intra-operative
cholangiography (IOC) showed CBD stones. ES was performed in all pts,
some times with the help of the cholangiographic catheter, and CBD
clearance was obtained in 68 pts (90.7%). 7 pts were successfully treated
the day after with a new ERCP. Mortality was none, major complication 1,
minor complications 4.9%, mean hospital stay 3.9 days. Post-operative
ERCP was performed in 86 pts in which IOC was positive for stones: they
were successfully treated 4872 hours after LC with ES and CBD stones’
clearance. In three cases a catheter had been left through the cystic duct by
the surgeon. No mortality or major complications, minor complications 5,3%
and mean hospital stay 6.8 days.
Conclusions. Selective IOC is an important tool in doubt cases for better
diagnosis of CBD stones that can be safely treated intraoperatively or
postoperatively. Intraoperative ERCP may be preferred by the pt but it needs
an expert endoscopist on duty while the postoperative approach offers
optimal.
Results. The risk of failures of the endoscopic postoperative approach, which
may impose further treatments, is related to complex CBD pathologies that
must be ruled out preoperatively.
FP 24.03
SAFETY AND EFFECTIVENESS OF DAY-CASE LAPAROSCOPIC
CHOLECYSTECTOMY-A META-ANALYSIS OF RANDOMISED
CONTROLLED TRIALS
Junnarkar, Sameer1; Gurusamy, Kurinchi1; Faroukh, Marwan2; Davidson,
Brian Ritchie1
1Royal Free Hospital, Academic Department of Surgery, London, United
Kingdom; 2Stoke Mandeville Hospital, Department of Surgery, Aylesbury,
United Kingdom
Objective. To assess the advantages and disadvantages of day-case surgery
compared to overnight stay in patients undergoing elective laparoscopic
cholecystectomy. Design: Systematic review and meta-analysis. Data
Sources: Cochrane library trials register, Medline, Embase, Science Citation
Index Expanded and reference lists.
Review Methods. Randomised clinical trials comparing day-case and
overnight stay in elective laparoscopic cholecystectomy were identified and
data was extracted from these trials by two independent reviewers. For each
outcome the relative risk, weighted mean difference or standardised mean
difference was calculated with 95% confidence intervals based on available
case-analysis.
Results. Five trials with 429 patients randomised to the day-case group
(215) and overnight stay group (214) were included for the review. Four of
the five trials were of low risk of bias. 49.1% of patients undergoing elective
laparoscopic cholecystectomy during the period of the trials were recruited
into the three trials which reported this. The withdrawal/ drop-out rate after
randomisation varied between 6.5% and 12.7% in the different trials. There
was no statistically significant difference between the two groups for
morbidity, morbidity after discharge, prolongation of hospital stay, re-
admission, proportion reviewed by doctor without being admitted, pain
scores, patient quality of life, patient satisfaction, patient preference of
treatment, return to normal activity, or return to work. 81.4% of day case
patients were discharged on the day of surgery. There were no serious medical
complications after discharge in the day-case group.
Conclusions. Day-case surgery is safe and can be planned in nearly half of
the patients undergoing elective laparoscopic cholecystectomy. It can be
completed successfully in more than four-fifths of these patients.
FP 24.04
RANDOMISED CLINICAL TRIAL OF LONGITUDINAL VERSUS
TORSIONAL MODE ULTRASONIC SHEARS FOR LAPARO-
SCOPIC CHOLECYSTECTOMY
Ching, Siok Song; Sarela, Abeezar I; McMahon, Michael J
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dom
Background. Ultrasonic shears are increasingly used in surgery for haemo-
static cutting. Conventional ultrasonic shears such as the UltraCision
Harmonic Scalpel† (Ethicon Endo-Surgery) use longitudinal mode (LM)
vibration. The recently developed LOTUSTM system (S.R.A. Developments
Ltd.) uses torsional mode (TM) vibration, which may provide theoretical
advantages for faster cutting and better haemostasis.
Aims. To compare TM with LM shears for laparoscopic cholecystectomy.
Methods. During 20032007, 141 patients undergoing elective laparoscopic
cholecystectomy were randomised to either TM or LM shears. Intra-
operative events such as failure in haemostasis and time taken for dissecting
the gallbladder off the liver bed were recorded. Post-operatively, a sample of
suctioned fluid was analysed for haemoglobin concentration, [Hb]. Intra-
operative blood loss was estimated by volume of suctioned fluid[Hb]fluid/
[Hb]blood. Mann-Whitney U Test and Chi-square Test were used for
statistical analyses.
Results. There were 30 men and 111 women, median age 48 years (range
1681). Seventy-one patients were randomised to TM shears and 70 patients
to LM shears. Median intra-operative blood loss was 5.0 ml (IQR 1.015.9)
with TM shears and 10.2 ml (IQR 2.518.6) with LM shears, p0.09.
Median gallbladder dissection time was similar in both groups (16 min, IQR
1028 vs 20 min, IQR 1229, p0.16). Gallbladder perforation rates were
24% for TM shears and 33% for LM shears, p0.33. Other modalities of
haemostasis (Surgicel† or electrosurgery) were required on 13 patients
(18%) in the TM group compared with 21 patients (30%) in the LM group,
p0.11. One patient in the LM group developed post-operative haemoper-
itoneum that required urgent laparoscopic exploration.
Conclusions. TM ultrasonic shears appear to be as effective as shears that
utilise LM vibration. The results support the theoretical advantages of TM
shears although statistical significance was not reach.
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CHOLEDOCHAL CYST: 13 YEARS EXPERIENCE OF A TER-
TIARY REFERRAL CENTRE IN INDIA, ANALYSIS OF 287 CASES
OF BILE DUCT CYSTS
Bora, Giri Raj; Singh, Shivendra; Mishra, PK; Sachdev, AK; Chaudhary, A;
Aranya, RC; Gondal, Ranjan; Agarwal, Anil
G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India
Background and Aim. Choledochal cyst (CDC) or Congenital Bile duct
cyst is a rare disorder affecting biliary system. Due to recent improvement in
imaging techniques and increased awareness more cases are being diagnosed
and referred to for definitive surgical treatment.
Material and Methods. We present retrospective analysis of our prospective
collected data over a period of 13 years at a tertiary referral centre in India.
Results. A total of 287 cases of Choledochal cyst were managed between Jan
1995 to July 2007. There were 67 (23.34%) pediatric and 220(76.66%) adult
patients. Male to female ratio was 1: 3.28. Pain abdomen was most common
presenting feature followed by jaundice, cholangitis, abdominal lump and
pancreatitis. A history of prior biliary surgery was found in 53 (18.46%)
patients. One hundred and sixty five patients had type I CDC, 116 type IVa,
3 type V and there was 1 patient each who had type II, type III and Type IVb
CDC. Cystolithiasis was found in 32.69%. Patients with Type I, II and IV
CDC underwent excision of extrahepatic portion of Choledochal cyst with
Roux-en-Y Hepaticojejunostomy. Three patients of type V CDC underwent
left hepatectomy. Thirty day mortality was 1.05% ( 1 patient had cerebral
infarct, one patient due to postoperative pancreatitis following radical
Cholecystectomy for associated gallbladder malignancy).
Conclusion. Study represents a large single centre experience dealing with
Choledochal cyst. Malignancy and portal hypertension are complication
associated with long standing Choledochal cyst. Choledochal Cyst excision
with bilioenteric is safe procedure with accepted morbidity and mortality.
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PREOPERATIVE PORTAL VEIN EMBOLIZATION BEFORE MA-
JOR HEPATIC RESECTION IS A SAFE AND EFFICIENT PROCE-
DURE. A LARGE SINGLE INSTITUTION EXPERIENCE
JAECK, Daniel; GIRAUDO, Giorgio; OUSSOULTZOGLOU, Elie;
ROSSO, Edoardo; PESSAUX, Patrick; BACHELLIER, Philippe
Hopital de Hautepierre, Centre de Chirurgie Visce´rale et Transplantation,
Strasbourg, France
Background. The aim of this study was to report the results of preoperative
portal vein embolization (PVE) performed in a single institution.
Methods. Between January 1997 and March 2006, 146 patients requiring a
right or extended right hepatectomy for primary or secondary liver tumors
underwent PVE when the future remnant liver volume (FRL) was less than
30% of total liver. Liver volumes and hepatic function were evaluated before
and after PVE.
Results. PVE was performed successfully in 145 patients. In one patient the
catheterization of the portal branch failed. Complications occurred in 14
patients (10%) including a transitory fever (n9), a parenchymal hematoma
(n1), a mild hemoperitoneum (n1), a mesenterico-portal venous
thrombosis (n1), a pulmonary embolism (n1) and a systemic sepsis
(n1). The prothrombine ratio and the platelet count were significantly
lower 3 days after PVE. Insufficient hypertrophy of the FRL was observed in
12 patients and malignant disease progression in 19. The hypertrophy rate of
the FRL 4 to 8 weeks after PVE was 47.7931.9%. Pathological type of the
liver tumor, cirrhosis, diabetes mellitus and chemotherapy did not affect the
volume of the left liver hypertrophy. However, the time required to achieve an
adequate liver hypertrophy was significantly shorter in patients with normal
liver. One-hundred-fourteen patients (78.6%) subsequently underwent
hepatic resection.
Conclusions. The results suggest that PVE is a safe and efficient procedure
inducing adequate hypertrophy of the FRL before major liver resection.
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LIVER RESECTION WITH AND WITHOUT PRINGLE MANEU-
VER: A MATCHED PAIR ANALYSIS
Scho¨n, Michael R.1; Zaatar, Mohamed1; Kaps, Maria2; Hauss, Johann P.2;
Scholz, Markus3; Wiegel, Natalie1
1Klinikum Karlsruhe, Surgery, Karlsruhe, Germany; 2Universtiy of Leipzig,
Surgery, Leipzig, Germany; 3Universtiy of Leipzig, Medical Informatics and
Statistics, Leipzig, Germany
Introduction. Several vascular occlusion techniques during liver resection
have been discussed recently. Hepatic vascular inflow occlusion (Pringle
maneuver) is associated with lower blood loss and a reduction of operative
time. However ischemia-/reperfusion injury may play an important role in
morbidity.
Methods. Out of 200 elective liver resections in 38 patients liver resection
was carried out without Pringle maneuver (group A). Out of the remaining
patients 38 patients were selected in a matched pair analysis in which liver
resection was carried out with Pringle maneuver (group B). The two groups
were well matched for age, gender, tumor size and resection extent, diagnosis,
diabetes mellitus, simultaneous procedures, fibrosis/cirrhosis, ASA classifica-
tion, and preoperative laboratory values. For statistical analysis the Mann-
Whitney U-test was applied. A value of pB0.05 was considered statistically
significant.
Results. The postoperative outcome of both groups in means of blood
transfusion, ICU- and hospital stay, complications, mortality rate and
postoperative liver function tests was similar (p0,05). Further stratification
for resection extent (small resection: 12 segments, and large resection: 35
segments) revealed no differences. Yet, applying the pringle manoeuvre in
livers with fibrosis/cirrhosis was associated with significantly higher post-
operative levels of transaminases (ALAT/ASAT, pB0,03) when compared to
resections without pringle maneuver.
Conclusion. Most cases of liver resection can be performed safely with or
without pringle maneuver. However, fibrotic/cirrhotic livers which are known
to be particularly susceptible for ischemia/reperfusion injury may benefit
from omitting the pringle maneuver.
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TOTAL VASCULAR EXCLUSION (TVE): A USEFUL TECHNIQUE
DURING COMPLEX HEPATIC RESECTIONS
Smith, Katherine; Morris-Stiff, Gareth; Gomez, Dhanwant; Toogood, Giles
J; Lodge, J. Peter A.; Prasad, Rajendra
Leeds Teaching Hospital NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom
Background. Acquisition of vascular control is imperative during extensive
during complex hepatic resections. Whilst the Pringle manoeuvre may suffice
in many cases, additional control of hepatic outflow may be required, this
being termed total vascular exclusion (TVE).
Aims. To evaluate the indications and outcomes of TVE during complex
hepatic resections.
Patients and Methods. The hepatobiliary database was interrogated to
identify all cases in which TVE had been utilised. Those in which subsequent
veno-venous bypass or an ex-vivo resection were subsequently used were
excluded. Analysis included: demographic factors; operative data; and
outcome in terms of postoperative complication rate and perioperative
mortality.
Results. 40 cases were identified (27 males, 13 females with a median age of
56 years. The most common indications for surgery were: colorectal
metastases (52.5%); cholangiocarcinoma (22.5%); and hepatocellular carci-
noma (12.5%). The median number of Couinaud segments excised was 6
(range: 27). In 77.5% of cases a Pringle was used prior to TVE. The median
duration of TVE was 27.5 minutes (range: 2180). The median perioperative
blood transfusion was 5 units (range: 042) and median plasma transfusion
was 4 (range: 015). Additional procedures included: portal vein reconstruc-
tion (17.5%); IVC reconstruction (15%); and biliary reconstruction (42.5%).
The morbidity rate was 55%, the 30-day mortality rate was 12.5%, and the
median hospital stay was 14 days (range: 653).
Conclusions. Whilst the morbidity and mortality of complex resections is
high, the use of TVE may facilitate resection of technically challenging
lesions.
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A COMPARATIVE ANALYSIS OF CRUSH/CLAMP, STAPLER,
AND DISSECTING SEALER HEPATIC TRANSECTION METH-
ODS
Castaldo, Eric T.; Earl, T. Mark; Feurer, Irene D.; Pinson, C. Wright
Vanderbilt University Medical Center, Nashville, United States
Introduction. Several methods for hepatic parenchymal division exist. The
primary aim of this study was to assess differences in post operative bile leaks
and operative blood loss between 3 transection methods crush/clamp (CC),
stapler (SP), or dissecting sealer (DS; TissueLink).
Methods. A single institution, retrospective cohort study was performed on
data collected over a 3-year period in patients undergoing elective liver
resection using the CC, SP, or DS. Patients were excluded if multiple
methods of transection were used or if intraoperative death occurred. A bile
leak was defined as 1) bile drainage for 7 days after surgery 2) post
operative imaging demonstrating a fluid collection confirmed to be bile with
percutaneous drainage and/or 3) reoperation in which a bile leak was
identified. Blood loss was characterized as minor if B1000 mL and major
if 1000 mL. The association of bile leak with transection type was
assessed with a chi-squared test. A multiple logistic regression model
was used to assess whether major blood loss was associated with transection
method (reference group CC), vascular isolation, extent of liver resection
(B2 Couinaud segments or 2 segments), and other concurrent major
operations as covariates.
Results. Analyses included 141 patients (51 CC, 66 SP, and 24 DS). The
overall rate of bile leaks was B3%. The risk of bile leak was no different
between CC, SP, and DS (p0.23). The risk of major blood loss was
increased with DS when compared to CC (OR3.09, p0.04), with no
difference between SP and CC (p0.18). Major blood loss was not
associated with extent of liver resection (p0.21) and a concurrent other
major operation (p0.30) but was associated with vascular isolation (OR
3.53, p0.03).
Conclusion. The risk of post operative bile leak is no different for
hepatectomies using CC, SP, and DS. However, hepatectomy using DS is
associated with an increased risk of major operative blood loss when
compared to CC.
FP 25.05
TECHNIQUES FOR PARANCHYMAL TRANSECTION IN LIVER
SSURGERY: A META-ANALYSIS OF RANDOMISED CON-
TROLLED TRIALS
Pamecha, Viniyendra1; Guruswamy, Kurunchi2; Junnankar, Sameer2;
Sharma, Dinesh2; Davidson, Brian2
1Royal Free Hospital, University College Medical School, Hpb and Liver
Transplantation, Pond Street, Hampstead, LONDON, United Kingdom;
2Royal Free Hospital, University College Medical School, Hpb and Liver
Transplantation, London, United Kingdom
Background. Blood loss is one of the main factors affecting the outcome of
liver surgery. Different parenchymal transection techniques have been
described to decrease blood loss.
Objectives. To assess the benefits and risks of the different techniques of
parenchymal transection during liver resections by review and meta-analysis
of randomised controlled trials.
Methods. The Cochrane Library, MEDLINE, EMBASE, and Science
Citation Index were searched until September 2006. The inclusion criteria
were all randomised clinical trials comparing different methods of parench-
ymal dissection. Data was collected on population characteristics, methodo-
logical quality, mortality, morbidity, blood loss, transection speed and
hospital stays. Analysis was done using the fixed-effect model RevMan. If
there was statistical heterogeneity, random-effects model was used. For each
outcome the odds ratio (OR), weighted mean difference (WMD) or
standardised mean difference (SMD) with 95% confidence intervals was
calculated.
Results. Seven trials with 565 patients were included. The comparisons
include CUSA vs clamp-crush (2 trials); RFDS (Radio Frequency Dissecting
Sealer) vs clamp-crush (1 trial); sharp dissection vs clamp-crush technique (1
trial); and hydrojet vs CUSA (2 trials). One trial compared CUSA, RFDS,
hydrojet and clamp crush technique. There was no significant difference
between the techniques in mortality, morbidity, liver dysfunction, ITU and
hospital stays. The blood transfusion requirements were lower in the clamp-
crush technique than CUSA and hydrojet (OR 11.29, 95% CI 1.29 to
98.89). There was a tendency for lower transfusion requirements in the
clamp-crush technique than with RFDS (OR 5.73, 95% 0.94 to 34.77).
Clamp-crush technique was quicker than CUSA, hydrojet and RFDS
(WMD 1.50, 95% CI 2.33 to 0.67).
Conclusions. The Clamp-crush technique is more rapid and associated with
lower blood loss than other methods of parenchymal transaction and remains
the gold standard for comparison of new Methods.
FP 25.06
IS ROUTINE PRINGLE MANEUVER NECESSARY IN MODERN
LIVER RESECTION? AN ANALYSIS OF 248 CONSECUTIVE
CASES OF NO-CLAMP HEPATECTOMY
Lee, Kit Fai; Wong, John; Ng, Wilson WC; Ling, Eva; Fok, Ka-Lun; Ng,
Nancy; Lo, Xina; Mak, Nerissa OS; Lai, Paul BS
Prince of Wales Hospital, Surgery, Hong Kong, China
Background. Although Pringle maneuvre helps to cut down blood loss
during hepatectomy, the ischaemic insult brought to remnant liver cannot be
under-estimated.
Objective. To evaluate the feasibility and possible benefits by abandoning
routine Pringle maneuvre in liver resection.
Methods. Between June 2003 and May 2007, 248 consecutive liver
resections (including 28 laparoscopic resections) were performed in our
institute without using Pringle maneuvre. Extrahepatic dissection of porta
structures and hepatic veins were done if possible. Liver was then transected
with CUSA and haemostasis achieved by TissueLink dissecting sealer,
ligatures and staples.
Results. There were 152 males and 96 females with median age of 54 years
(range 2280). Commonest indication was hepatocellular carcinoma (52.4%)
and 31% of pateints had cirrhosis. Around 30% of cases were major
hepatectomy. All liver resections were accomplished without Pringle man-
euvre except in 6 cases, in which 2 were for extraction of portal vein tumor
thrombus and 4 for control of bleeding. There were two in-hospital mortality
(0.8%). One patient died of myocardial infarction and the other died of liver
failure. Complications occurred in 63 patients (25.4%), of which one patient
needed reoperation for bleeding from right adrenal gland. Median blood loss
was 300ml (range 202700) and 19 patients (7.7%) required transfusion.
Median operation time was 240min (range 70490). The median post-
operative hospital stay was 7 days (range 247).
Conclusion. Low blood loss can equally be achieved in hepatectomy without
Pringle maneuvre. Furthermore, recovery is hastened by avoiding ischaemic
insult to liver as denoted by low operative mortality and morbidity, and short
post-operative hospital stay.
FP 25.07
RISK FACTORS FOR LIVER FAILURE AND MORTALITY AFTER
MAJOR HEPATECTOMY ASSOCIATED WITH PORTAL VEIN
RESECTION
Jaeck, Daniel; Rosso, Edoardo; PESSAUX, Patrick; Oussoultzoglou, Elie;
Bachellier, Philippe
Hopital de Hautepierre, Centre de Chirurgie Visce´rale et Transplantation,
Strasbourg, France
Objective. To report the postoperative outcome of hepatectomy associated
with portal vein resection (PVR) and to identify risk factors of clinical value
for predicting liver failure and mortality. Summary Background Data: Partial
resection of the portal vein during hepatectomy allows to increase the number
of patients who may benefit from a potentially curative operation. However
this procedure may increase postoperative morbidity and mortality. Little is
known about risk factors for liver failure (LF) and mortality after such
procedure.
Methods. Between July 1996 and February 2007, a total of 1348 patients
were operated for liver disease in our institution. Among them 44 patients
underwent liver resection associated with PVS. Medical records of these
patients were prospectively collected and retrospectively analyzed.
Results. Ninety-three percent of the patients underwent a major hepatect-
omy. Overall morbidity was 57%, fifty-two percent of all complications were
of grade III or IV according to Clavien’s classification. Overall mortality was
9%. Irreversible LF was the only cause of death. Univariate analysis showed
that male gender (P0.013), preoperative portal vein embolization (PVE)
(P0.002), extent of liver resection (P0.009) were significantly associated
with an increased risk of postoperative LF. Moreover, PVE (P0.024),
extent of liver resection (P0.028), presence of steatosis (P0.021),
occurrence of LF (P0.026) and re-laparotomy (P0.026) were signifi-
cantly associated with increased risk of postoperative mortality.
Conclusion. The present study confirmed that major hepatic resection with
PVS can be performed with acceptable overall morbidity and mortality.
However preoperative selection of the patients should take in consideration
gender, need for PVE, and the extent of hepatic resections to avoid
irreversible LF and death.
FP 25.08
ANALGESIC EFFICACY OF CONTINUOUS WOUND INSTILLA-
TION OF ROPIVACAINE FOLLOWING LIVER SURGERY IV A
RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROL STUDY
Lai, Bo San Paul1; Chan, Simon K C2; Li, Peggy T Y2; Wong, John3;
Karmakar, M J4; Lee, K F3
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1Prince of Wales Hospital, Chinese University of Hong Kong, Surgery, Hong
Kong, Hong Kong; 2Prince of Wales Hospital, Anaesthesia and Intensive
Care, Hong Kong; 3Prince of Wales Hospital, Surgery, Hong Kong; 4Prince
of Wales Hospital, Chinese University of Hong Kong, Anaesthesia and
Intensive Care, Hong Kong
Introduction. Because of post-operative hepatic dysfunction and its
associated coagulopathy, effective pain management modalities including
epidural analgesia and NSAID drugs have to be avoided after liver surgery.
Objective. This study aims to investigate the efficacy of continuous wound
instillation of local anaesthetics over the subcostal wounds after liver surgery.
Method. 49 patients undergoing elective liver surgery were recruited. All
patients received standardized general anaesthesia and right subcostal
incision. Two multi-orifices 16-gauge indwelling catheters were subcutaneous
tunneled and buried within the musculo-fascial layer before skin closure.
Patients were randomized to receive either ropivacaine 0.25% (R group) or
saline (S group) infused at 4 ml/hour via an elastometric balloon pump (On-
Q PainBuster, I-Flow Corp, California) for 3 days. Supplemental analgesia
was provided by intravenous morphine patient-control analgesia (PCA).
Results. 43 patients completed the trial and 6 patients were excluded from
study (2 laparoscopic procedure; 2 opened and closed; 1 developed cardiac
complication intraoperatively and 1 developed TIA on day 2). There is no
difference between the groups in age, ASA status and demographic data.
Patients in ropivacaine group had significantly less pain at rest and after
spirometry in 4, 12, 24, 48 and 72 hours post-operatively (PB0.01). The
total morphine consumption was significantly reduced (58 ¡O´ 30 vs. 86 ¡O´
44mg, PB0.05). Forced vital capacity was reduced post-operatively in both
groups, but the reduction was more significant in control group at 12 and 24
hours (PB0.05); but not in 4, 48 and 72 hours. There is no significant
difference in extubation time, ICU and hospital length between the groups.
Conclusion. Continuous wound instillation of ropivacaine is more effective
to reduce pain compared with placebo after major liver surgery.
FP 25.09
LAPAROSCOPIC SEGMENT VI LIVER RESECTION USING A
LEFT LATERAL DECUBITUS POSITION: A MORE APPROPRI-
ATE LAPAROSCOPIC TECHNIQUE
Belli, Giulio; Fantini, Corrado; D’Agostino, Alberto; Cioffi, Luigi; Limon-
gelli, Paolo; Russo, Gianluca; Belli, Andrea
S. M. Loreto Nuovo Hospital, Department of General and HPB Surgery,
Naples, Italy
Background. Although the laparoscopic technique for left-sided lesions,
such as left lateral hepatic sectionectomy is well described in the literature,
the best laparoscopic approach to segment VI resection is still debated.
Objective. We describe a laparoscopic technique for segment VI resection
using a left decubitus position with the right side up of the patient facilitated
by some personal tricks.
Methods. From January 2000 to December 2006 ten patients ( 6 men, 4
women; mean age, 61.3 years) underwent laparoscopic segmentectomy of the
segment VI at our department. Eight patients presented with hepatocellular
carcinoma on cirrhosis, and two had a liver metastases from colon cancer. We
used a left decubitus position with the right side up in eight patients. Two
early patients were operated on utilizing a more common supine position.
Results. The mean operative time was 125 min ( range 80165 min) The
average size of the lesions was 2.9 cm. (range 1.3  3.1). The laparoscopic
procedure was carried out successfully in all cases. There were no deaths and
no intraoperative or postoperative complications. Blood transfusions were not
required. The main postoperative hospital stay was 7.6 days (range 512).
Conclusions. The key points of the technique are: patient in left decubitus
position (right side up) with the surgeon facing the patient’s abdomen; early
and easier mobilization of the right liver cutting the triangular and the right
coronary ligament but not the round and the falciform ligaments; the use of
an esophageal retractor to facilitate the Pringle manoeuvre; the use of a tape
passed around the right mobilized liver hanging and handling the segment VI;
the liver transection performed in an ideal laparoscopic orthogonal position
(908) with the instruments in a more precise triangular position. The
technique described may be a good option for patients with lesions in the
segments VI with the advantage to perform a safer liver transection in a more
appropriate laparoscopic position.
FP 26.01
LIVER TRANSPLANTATION FOR UNRESECTABLE HEPATO-
BLASTOMA: 20-YEAR EXPERIENCE IN A SINGLE CENTER
Mohanka, Ravi1; Cruz, Ruy1; Talukdar, Anjan2; Ranganathan, Sarangar-
ajan3; Bond, Geoffrey2; Soltys, Kyle2; Mazariegos, George2; Marsh, Wallis1;
Marcos, Amadeo1; Sindhi, Rakesh2
1University of Pittsburgh Medical Center, Thomas E Starzl Transplantation
Institute, Pittsburgh, United States; 2University of Pittsburgh Medical
Center, Children’s Hospital of Pittsburgh, Pittsburgh, United States;
3University of Pittsburgh Medical Center, Children’s Hospital of Pittsbrugh,
Pittsburgh, United States
Background. Hepatoblastoma is a rare but highly malignant liver tumor.
Complete surgical resection after chemotherapy is the definitive treatment for
hepatoblastoma; however, orthotopic or reduced-sized liver transplant can be
an acceptable treatment strategy for patients with unresectable liver tumor.
Objective. The aim of this study was to present a single center’s experience
of liver transplant for hepatoblastoma in children.
Study Design. A retrospective analysis of 23 patients with unresectable
hepatoblastoma who were referred for liver transplantation between March
1987 and August 2006 was conducted.
Results. The patient assessed had an age range from 15 to 77 months at time
of diagnosis; median 32 months (12 girls/ 11 boys). Seventeen patients
received whole grafts and 6 reduced sized. The time from the diagnosis to the
transplant ranged from 3 to 39 months (median 7 months). Five patients
present early rejection treated adequately with steroids. Twelve out of 23
patients were on chemotherapy after the transplant; the chemotherapy
protocol varies but usually includes cisplatin, ifosfamide, vincristine and/or
5-fluoracil. Posttransplantation survival rate were 91% and 86% for 1 and 5
years respectively.
Conclusion. Total hepatectomy and liver transplantation is a potentially
curative treatment option for unresectable hepatoblastoma with low recur-
rence rate. Posttransplant chemotherapy is recommended in selected cases.
FP 26.02
DE NOVO MALIGNANCIES AFTER LIVER TRANSPLANTATION
Bilbao, Itxarone1; Sapisochin, Gonzalo1; Dopazo, Cristina1; Lazaro, Jose
Luis1; Castells, Luis2; Lopez, In˜igo1; Balsells, Joaquin1
1Hospital Vall d?Hebron, Surgery Department, Barcelona, Spain; 2Hospital
Vall d?Hebron, Hepatology Department, Barcelona, Spain
Introduction. De novo malignancy after transplantation, has been attrib-
uted to prolonged immunosuppression status, oncovirus activation and a
direct oncogenic effect of immunosuppressive drugs.
Aims. To determine risk factors, clinical characteristics and outcomes of de
novo tumors after liver transplant (LT) from a large single-center series.
Material. From 1988 to 2007, 783 LT were performed in 725 patients. 59
patients (8.1%) developed de novo malignancy. Type of malignancies, clinical
characteristics and outcomes have been analysed. In order to determine risk
factors for malignancy a case-control study were done. Controls were
matched by age910 years, sex, diagnosis leading to LT and time from LT
to diagnosis of tumour.
Results. Most of the tumours were solid 61% (lung, esophago-gastric, colo-
rectal, prostata-bladder, oropharynge, etc), followed by skin tumors 34% and
lymphoid cancer 5%. Mean time from LT to diagnosis was 54932 months
(r:4130). Immunosuppression at induction was based on FK 506 59%
(cases) vs 52% (controls) and CyA 41% (cases) vs 48% (controls), pns.
After tumour diagnosis, CNI were decreased to half levels in 93%, completely
stopped in 2%, and converted to m-TOR in 5%. All tumours except 3 were
treated with surgery (45), radiotherapy (19), chimiotherapy (19), etc, as in
non-transplanted population. Steroids withdrawal was achieved in 87% of
cases vs 93% of controls (pns). Risk factors for malignancy were:
intraoperative multitransfusion of RBC (p0.02) and the presence of portal
thrombosis (p0.03). Recipient age over 65 years and previous intake of
alcohol and smoking showed a tendency. (pns). Actuarial survival post-
diagnosis for solid and haematological malignancies was poor: 69%, 36% and
3% at 123 years.
Conclusion. De novo malignancies is a real problem after liver transplanta-
tion, specially in aged candidates with previous history of alcohol and
smoking with sever hepatopaty at time of transplant. Minimal immunosup-
pression must be administered in this high risk patients.
FP 26.03
METHODS OF BILIARY RECONSTRUCTION IN LIVER TRANS-
PLANTATION: A META-ANALYSIS OF RANDOMISED CON-
TROL TRIALS
Mehta, Naimish1; Guruswamy, Kurinchi2; Davidson, Brian2
1Royal Free Hospital, Dept of HPB and Liver Transplant Surgery,
Hampstead, London, United Kingdom; 2Royal Free Hospital, Dept of
HPB and Liver Transplant Surgery, London, United Kingdom
Backgroud. Biliary complications have been reported in range of 20%40%
and remain a significant cause of morbidity following liver transplantation.
Aim. To determine the optimal method of biliary reconstruction during liver
transplantation from literature review and meta-analysis.
Method. Evidence was evaluated from six randomised trials (until July 2007)
related to the different techniques of biliary reconstruction during liver
transplantation. We collected the data on the characteristics, methodological
quality, mortality, biliary complications, operating time and hospital stay. 3
trials compared primary anastomosis with or without t-tube (n324); 1 trial
compared primary anastomosis with or without biliary stent (n37); 1 trial
compared side-to-side vs end-to-end biliary anastomosis (n100); and 1
trial compared duct-to-duct anastomosis with hepaticojejunostomy in right
lobe living donor liver transplant recipients (n53). Two of the six trials were
of low risk of bias.
Results. Primary anastomosis versus T-tube (n324): biliary complications
were significantly higher in the t-tube group 44/148 vs 23/147. (RR 0.09,
95% CI 0.02 to 0.48). Similar proportion of patients required surgical
treatment in both the groups. In primary anastomosis with or without stent
group (n37): biliary complications were significantly lower in the primary
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closure (1/19 vs 9/18) group. In side-to-side vs end-to-end biliary anasto-
mosis group (n100) and primary anastomosis vs hepaticojejunostomy
group (n53): biliary complications were similar.
Conclusions. Duct to duct primary biliary reconstruction is associated with
low risk of biliary complications. Alternative methods of reconstruction have
either shown no impact (side to side biliary anastomosis, hepaticojejunost-
omy) or an increased risk of complications (with t-tube or stent).
FP 26.04
DOES HIGH RISK GRAFTS COMPROMISE OUTCOMES IN
PATIENTS WITH CHOLESTATIC LIVER DISEASE?
Bonney, Glenn K; Attia, Magdy; Milson, Charlie E; Davies, Mervyn; Pollard,
Stephen G; Toogood, Giles J; Lodge, J Peter A; Prasad, K Rajendra
St James’ University Hospital, Department of Hepatobiliary and Tranpslan-
tation, Leeds, United Kingdom
Background. The current organ shortage necessitates the use of marginal
grafts in low risk liver transplant recipients, such as those with cholestatic
liver disease. This will allow good grafts to be utilised in higher risk patients,
such as those with alcohol and viral induced cirrhosis, to achieve good
outcomes. However, there is a concern whether this allocation will adversely
impact outcome in low risk recipients. The aim of this study was to analyse
patient and graft survival following transplantation of low and high risk grafts
into cholestatic, alcohol and viral induced cirrhotics.
Methods. A prospectively collected database of donors and recipients of liver
transplants performed at one centre from 19982005 was analysed. The
recipients were divided into cholestatic (n207), alcohol (n149) and viral-
induced (n200) cirrhosis categories with diagnoses of primary biliary
cirrhosis/primary sclerosing cholangitis, alcoholic cirrhosis and Hepatitis B/C
induced cirrhosis respectively. The donor grafts were split into low- and high-
risk categories based on the Donor Risk Index B1.8 and greater or equal to
1.8 respectively.
Results. There was no significant difference between the groups with respect
to recipient age, gender, ethnicity, MELD score, year of transplantation and
Donor Risk Index. There was no significant difference in patient and graft
survival transplanted with low and high DRI grafts in the cholestatic group
(p0.473). In comparison, there was a significantly poorer patient and graft
survival in the alcoholic group receiving high DRI grafts (p0.05 and 0.04
respectively). There was similarly a poorer patient and graft survival in the
viral induced cirrhosis group receiving high DRI grafts (p0.04 and 0.02
respectively).
Conclusion. High risk grafts, as evaluated here by the Donor Risk Index,
can be transplanted into cholestatic liver disease without significantly
compromising patient and graft survival when compared to low risk grafts.
FP 26.05
STENTING FOR VENOUS OUTFLOW PROBLEMS POST-LIVER
TRANSPLANTATION
Oniscu, Gabriel C1; Perera, Thamara1; Gunson, Bridget1; Buckles, John1;
Mirza, Darius1; Brahmall, Simon1; Mayer, David1; Olliff, Simon2
1The Queen Elizabeth Hospital, The Liver and Hepatobiliary Unit,
Birmingham, United Kingdom; 2The Queen Elizabeth Hospital, Departmetn
of Radiology, Birmingham, United Kingdom
Background. Venous outflow obstruction is a rare but serious complication
post liver transplantation.
Aim. This study reviews the management and outcome of venous outflow
problems following liver transplantation in a large single centre experience.
Methods. 31 patients with venous outflow problems were identified among
3000 patients who had a liver transplant between 19822007. Demographic,
transplant and interventional data were retrieved from the prospective unit’s
database as well as radiology records.
Results. The incidence of venous outflow obstruction after liver transplanta-
tion is low (1.1%). 25 cases occurred following the first transplant and 6
occurred after re-transplants. All grafts were from heart beating donors and
30/31 were whole size grafts. 13 livers were implanted using a classic
technique, whilst 18 cases had a piggyback technique (2 Brisbane). The mean
time interval between transplantation and stenting was 210 days (range: 34 
4178 days). 17 patients underwent TIPSS, 8 had hepatic vein stenting, 7 IVC
stenting and 7 underwent PV stenting. 9 patients required a combination
procedure (TIPSSvenous stenting or hepatic vein stentingportal/IVC
stenting). TIPSS was performed more often after classic OLT. The median
survival post-stenting was 510 days (range:15232 days) and the main causes
of death were sepsis (7), bleeding (2) and cerebral dysfunction (3). The 30-
days mortality was 16.12% and the overall mortality was 51.6%. The failure
rate was 48.38%. Two patients were re-transplanted post stenting. Survival
post stenting was worse in patients that had a classic OLT compared to those
that had a piggyback technique (Log Rank, p0.02). Survival was
significantly worse after TIPSS compared to IVC or hepatic veins stenting
(Log Rank, p0.02).
Conclusion. Venous stenting for outflow obstruction after liver transplanta-
tion should be attempted as the first line of treatment, despite the high risk of
complications. TIPSS are associated with a worse outcome compared to
other venous stenting procedures.
FP 26.06
INFLUENCE OF THE LENGTH OF THE ANHEPATIC PHASE ON
OUTCOME AFTER PRIMARY LIVER TRANSPLANTATION
IJtsma, Alexander J.C.1; Hilst, Christian S. van der2; TenVergert, Elisabeth
M.2; Boer, Marieke T. de1; Jong, Koert P. de1; Peeters, Paul M.J.G.1; Porte,
Robert J.1; Slooff, Maarten J.H.1
1University Medical Center Groningen, HPB Surgery and Liver Transplan-
tation, Groningen, Netherlands; 2University Medical Center Groningen,
Medical Technology Assessment, Groningen, Netherlands
The aim of this study was to assess the relation between the duration of the
anhepatic phase and the outcome after liver transplantation (LT) in terms of
patient and graft survival and graft dysfunction. A single center cohort of
consecutive adult primary LT recipients transplanted with the piggyback
technique using heart-beating donors without veno-venous bypass between
1994 and 2004 was analysed. The study group consisted of 182 patients.
Study variables were donor age and BMI, recipient age, diagnosis and MELD
score and peroperative RBC transfusions, blood loss and the duration of the
cold and warm ischemia time and of the anhepatic phase. The functional
anhepatic phase (FAHP, from clamping of native liver blood supply until
recirculation) and anatomical anhepatic phase (AAHP, from removal of the
native liver until recirculation) were separately analysed. ROC curves were
constructed to determine optimal cut-off values. Initial poor function (IPF)
was defined as ASAT2000 U/l and PT16 secs on days 27. Median
AAHP was 76 mins (37321). Median FAHP was 98 mins (45321). IPF
occurred in 21 patients (12%). In patients with an AAHP below 100 mins,
the incidence of IPF was 11 out of 131 (8.4%) while in patients with an
AAHP over 100 mins this was 10 out of 38 (26%) (pB0.004). In patients
with an FAHP below 120 mins, the incidence of IPF was 10 out of 115
(8.7%) while in patients with an FAHP over 120 mins this was 11 out of 55
(20%) (pB0.04). The occurrence of IPF was the only study variable
independently associated with patient survival. One year patient survival in
patients without IPF was 91% versus 67% in patients with IPF (pB0.001). A
direct relation between the AAHP or FAHP duration and patient or graft
survival could not be established. In conclusion, this study shows that LT
patients with a prolonged functional (over 120 minutes) or anatomical (over
100 minutes) anhepatic phase have a two to threefold higher incidence of
IPF. Patients with IPF had a significantly worse patient survival.
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MULTICENTER STUDY TO VALIDATE PREVIOUS PUBLISHED
FORMULAS TO ASSESS RIGHT LOBE LIVER VOLUME
Gondolesi, Gabriel1; Ghirardo, Silvio2; Tokat, Yaman3; Baris, Akim3;
Makuuchi, Masatoshi4; Sugawara, Yasuhiko4; Mulligan, David5; Russell,
Lyndsay5; Soejima, Yuji6; Yoshizumi, Tomoharu6; Belghiti, Jacques7; Don-
dero, Federica7; Pinna, Antonio8; Maseti, Michele9; Rogiers, Xavier10;
Wilms, Christian10; de Santiban˜es, Eduardo11; Gadano, Adrian11; Podesta,
Luis G.12; Andriani, Oscar12; Facciuto, Marcelo13; Emre, Sukru14
1RMTI/Mount Sinai School of Medicine, New York, Liver Unit, Fundacion
Favaloro, Buenos Aires, Argentina; 2Mount Sinai School of Medicine,
Recanati/Miller Transplantation Institute, New York, United States; 3Ege
University Medical School, Department of Organ Transplantation, Izmir,
Turkey; 4University of Tokyo, HPB Surgery Division, Transplantation
Division, Tokyo, Japan; 5Mayo Clinic Hospital, Transplantation Surgery,
Phoenix, Arizona, United States; 6Kyushu University, Department of
Surgery and Science, Fukuoka, Japan; 7Hospital Beaujon, Digestive Surgery,
Clichy, France; 8Sant’Orsola-Malpighi Hospital, Department of Liver and
Solid Organ Transplantatio, Bologna, Italy; 9Policlinico di Modena, Centro
Trapianti de Fegato e Multiviscerale, Modena, Italy; 10University Hospital
Hamburg Eppendorf, Department of Hepatobiliary Surgery, Hamburgo,
Germany; 11Hospital Italiano, Transplante Hepatico, Buenos Aires, Argen-
tina; 12Fundacion Favaloro, Unidad de Cirugia HPB y Transplante
Hepatico, Buenos Aires, Argentina; 13Westchester Medical Center, Depart-
ment of Hepatobiliary Surgery and Liver Tran, Valhalla, New York, United
States; 14Mount Sinai School of Medicine, New York, Department of
Surgery, Yale School of Medicine, United States
Background. A simple formula for clinical estimation of whole liver weight
was proposed (SLW772*BSA), right lobe liver weight (RLW) was
estimated as 57% (R-57) of the SLW and applied in right lobe living donor
liver transplant (RLLDLT).
Aim. To validate the accuracy and worldwide applicability of R-57, to
compare it with images obtained volumes and with other formulas (OF) (De
Land, North, Heineman, Mount Sinai, Urata), and in case of negative results
to build a new formula (NewF) based on the collected data.
Material and Methods. From 1/02 to 7/05, 376 RLLDLT from 11 centers
from Asia (2), North (3) and South America (2) and Europe (4) were
enrolled. Data collected: Donor: weight(kg), height (cm), age, sex and race;
Recipient: weight, age, sex; Right lobe: actual liver weight (ARLW) at the end
of the back table flushing (grs), and estimated volume/weight according to
CT, MRI or US. SLW and RLW were reported as mean and SD; mean
ARLW and graft to recipient weight ratio (GRWR) were compared with the
means of each estimation method using Bland-Altman (BA). Estimation
methods were considered acceptable if results were within 20% of the true
value, McNemar’s test was used for comparison between them. Linear
regression was used to develop the NewF.
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Results. Donors: 45% males; age: 37911 years; weight: 71.5911.8 kgs;
BSA: 1.8190.18; Recipients: 35% males; age: 49912 years; weight: 70.09
15 kgs; Right lobe: ARLW: 757.19180.7; CT(n325):827.69206.2;
MRI(n31): 961.39157.3; US(n20):726.59155.9 grs; R-57: 799.69
81.1 (pB0.05); NewF (BSA*474): 757.59142 grs (pB.5). GRWR:
ARLW: 1.190.29; CT(n325):1.2290.34; MRI (n31): 1.3090.39;
US(n20):1.1190.29 grs; R-57: 1.1890.24 (pB0.05); NewF: 1.119
0.25 grs (pB.5). NewF estimates right lobe weight and GRWR (BA:
0.14%, disagreement: 17%) better than CT, US, R-57, and OF (pB.001).
Conclusions. R-57 was less accurate to predict RLW in the multicenter
study than in the initial study. The new proposed formula allowed adequate
estimation with worldwide applicability.
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CLINICAL SITUATION OF VHC () LIVER TRANSPLANT PA-
TIENTS AFTER 10-YEAR OF SURVIVAL
Bilbao, Itxarone1; Dopazo, Cristina1; Lazaro, Jose Luis1; Castells, Luis2;
Sapisochin, Gonzalo1; Lopez, In˜igo1; Escartin, Alfredo1; Balsells, Joaquin1
1Hospital Vall d?Hebron, Surgery Department, Barcelona, Spain; 2Hospital
Vall d?Hebron, Hepatology Department, Barcelona, Spain
Objectives. To analyze the clinical situation of HCV () liver transplant
patients with a survival of 10 years and to compare them with HCV ()
patients that have not survived this period.
Materials and Methods. From 1988 to 1997, 127 HCV () patients had a
liver transplant with ¡Y´10-year follow-up. Of these, 43 are alive and 84 are
dead. The average age was 57 years. The immunosuppressive induction was
82% CyA, and 18% FK. Both groups have been compared regarding
demographic characteristics of recipient, donor and surgery, and short and
long term complications. Causes of mortality in the group with B10 years
survival have been also analyzed.
Results. The main causes of mortality were: relapse of HCV 26% and HCC
14%, sepsis-infection 16%, and medical causes 13%. Concerning recipient
characteristics (univariant analyses), patients with short survival were older,
and had higher incidence of pre-LT renal failure. There were no differences
in donors or surgery, although older donors showed a tendency toward higher
mortality in the recipient. In the group with long term survival, steroids were
removed in greater percentage (100% vs. 51%). Patients with ¡Y´10 years
survival showed lower incidence of rejection (43% vs 58%), infection (34% vs
42%) and renal failure (29% vs 60%), at one year post-LT. Alive HCV ()
patients 10 years after LT showed: 45% chronic renal failure, 79% arterial
hypertension, 26% IDDM, 17% dyslipidemia, 66% HCV relapse in the graft
as acute hepatitis.
Conclusion. In HCV () patients, age over 60 years, HCC indication for LT,
and pre-LT renal failure are risk factors of lower survival on the long term. To
achieve long survival after LT is essential to apply early agressive immuno-
suppressive regimens that could avoid rejection and the use of steroids, but
late inmunosupression regimens avoiding CNI as much as possible.
FP 26.09
FEASIBILITY STUDY OF HEPATECTOMY WITH EXTENSIVE
USE OF RFA FOR TREATING PATIENTS WITH MORE THAN 15
ENDOCRINE METASTASES TO THE LIVER
Elias, Dominique1; Goe´re´, Diane1; Leroux, Guillaume1; Lo Dico, Rea1;
Ducreux, Michel2; Baudin, Eric2
1Institut Gustave Roussy, Surgical Oncology, Villejuif, France; 2Institut
Gustave Roussy, Medical Oncology, Villejuif, France
Aim. The aim of this study was to report the feasibility of a complete
cytoreductive surgery combined with radiofrequency ablation (RFA) during
one step, in patients with more than 15 liver metastases (LM) from well
differenciated endocrine tumors.
Methods. A combination of anatomical bloodless hepatectomy to treat large
or contiguous LM was done with an extensive use of RFA (with cooling of the
bile duct, and trans-LM hepatectomy passing through LM preliminary
ablated with RFA) to treat the remaining small LM (B25 mm). During
surgery, the primary tumor, if present, was also resected.
Results. From January 2002 to May 2007, 16 patients underwent complete
resection and/or ablation of mulptiple and bilobar LM from endocrine tumor,
mostly originating from the duodeno-pancreas (n10/16). Liver resection
consisted in 12 extended hepatectomy. The mean number of LM treated per
patient was 25.7917 (median, 20[16  89]). Resection of the primary was
associated in 9 patients, resulting in 5 left pancreatectomy, 2 duodenopan-
createctomy, 1 partial duodenectomy, 1 right colectomy. The mean duration
of surgery was 332971 min, and median intra-operative blood loss was
5709348 ml. There was no mortality. Morbidity was observed in 11 patients
(69%). Two patients were reoperated. Other specific complications were 2
transient liver insufficiency, 1 caval thrombosis, 4 pleural effusions, 3
pancreatic fistulas.
Conclusion. This new approach allows to propose resection to a greater
number of patients and to abandon the two-stage hepatectomy.
FP 27.01
ONE-STAGE ULTRASOUND-GUIDED HEPATECTOMY FOR
MULTIPLE BILOBAR COLORECTAL METASTASES: AN ALTER-
NATIVE TO TWO-STAGE HEPATECTOMY
Del Fabbro, Daniele; Botea, Florin; Marconi, Matteo; Palmisano, Angela;
Procopio, Fabio; Spinelli, Antonino; Donadon, Matteo; Montorsi, Marco;
Torzilli, Guido
University of Milan, Istituto Clinico Humanitas IRCCS, Third Department
of General Surgery, Rozzano (MI), Italy
Background. Two-stage hepatectomy with or without portal vein emboliza-
tion allows to treat multiple bilobar metastases expanding surgical indications
for these patients. However, it has some related drawbacks: two operations
are needed, and some patients do not complete the treatment strategy for
disease progression. Taking profit from our ultrasound guided resection
policy we explored the safety and effectiveness of one-stage surgical
procedures in patients otherwise recommended for the two-stage approach.
Methods. Eighteen (25%) patients with bilobar and more than 4 colorectal
cancer liver metastases (CLM) among 73 consecutive patients who under-
went surgery for that were selected. Total number of CLM preoperatively was
103 (median 5; mean 5.7; range 411). Surgical strategy was based on tumor-
vessels relationship at intraoperative ultrasonography (IOUS) and on findings
at color-Doppler IOUS.
Results. In-hospital mortality was nil. Tumor clearance was feasible at one
stage in all patients but 2 who had explorative laparotomy. The overall
morbidity rate was 25% (4/16). Major morbidity occurred in 1 patient (6%):
not even one patient was reoperated. Blood transfusions were done in 2
(12.5%) patients. After a mean follow-up of 16 months (median 15; range 6
42), 3 patients are died for systemic recurrence, 7 patients are alive without
disease, and 6 are alive with disease. No cut-edge local recurrence were
observed.
Conclusions. IOUS-guided resection based on strict criteria allows surgical
treatment at one stage in patients carrier of multiple, bilobar CLM. This
strategy limits drastically the need for two stage hepatectomy, and with that
overcome their drawbacks.
FP 27.02
EFFECTS OF PREOERATIVE TREATMENT WITH CYTOSTATIC
AGENTS ON SHORT AND LONG TERM EFFECTS OF LIVER
SURGERY FOR METASTASES FROM COLO-RECTAL CANCER
Haglund, Ulf; Duraj, Frans; Nore´n, Agneta; Urdzik, Jozef
University Hospital, Department of Surgery, Uppsala, Sweden
Background. Surgery is the only treatment of liver metastases from colo-
rectal cancer with a potential to cure. There are evidence supporting that pre-
and postoperative treatment with cytostatic agents may enhance the curative
potential on liver surgery in these patients. On the other hand, increased risks
of liver surgery following preoperative chemotherapy treatment have been
reported.
Objective. To further evaluate this we investigated patients undergoing liver
surgery for colo-rectal metastases in our institution.
Methods. We retrospectively investigated patients undergoing liver resection
for colo-rectal metastases 1999  2006 using data collected prospectively in
our liver surgery register.
Results. In total 179 patients had liver surgery for colo-rectal metastases
during this period. Of them 83 (46%) had preoperative treatment with
cytostatic agents most often including oxiliplatin or irinotecan. 96 (54%) had
no such preoperative treatment. Age and sex distribution was similar in the
two groups. There was no significant difference in operating time (157960 vs
148960 min; ns) or blood loss between the groups. Hospital or 30 day
mortality was similar in the two groups (1.2% vs. 1.0%). Severe postoperative
complications were few and did not differ in this material. Neither did the
total number of postoperative complicatio#ns (10.8% vs. 10.4%). Long
term survival tended to be longer in the group treated preoperatively with
cytostatic agents. Observed 3 and 5 years survival as of January 2007 was
62% and 50%, respectively, with cytostatics. Corresponding data for patients
without preoperative cytostatics was 59% and 43%, respectively (ns; n35).
Conclusion. Preoperative treatment prior to liver surgery for metastases
from colo-rectal cancer did not significantly influence operating time, length
of stay, or survival. Only a tendency towards improvment was seen in survival
which may be due to a limited number of patients included early with other
agents than commonly used today.
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PROGNOSIS FOLLOWING LAPAROSCOPIC LIVER RESECTION
OF COLORECTAL METASTASES  IS IT COMPARABLE TO
OPEN RESECTION?
Hatzifotis, Michael1; Patel, Bhavik1; Bryant, Richard1; Shaw, Ian2; Martin,
Ian3; Hopkins, George1; Fielding, George1; Nathanson, Leslie4; O’Rourke,
Nicholas1
1Royal Brisbane Hospital, HPB Surgery, Brisbane, Australia; 2Prince Charles
Hospital, Surgery, Brisbane; 3Wesley, HPB Surgery, Brisbane; 4Royal
Brisbane Hospital, HPB Surgery, Brisbane
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Introduction. It is well established in the published literature that 5 year
survival following liver resection for colorectal metastases is improved by 40 
60%.
Methods. We examined our last 230 laparoscopic liver resections between
Jan 1998 and Jan 2007.
Results. Thirty eight percent (87/230) of resections were for colorectal
metastases. There were 23 right hemihepatectomies, 7 left hemihepatec-
tomies, 16 left lateral sectionectomies, 12 segmentectomies, 29 non-
anatomical resections. The median duration of surgery was 120 minutes.
The median blood loss was 300mls. There were 6 conversions to open. The
average length of hospital stay was 6 days. The overall morbidity was 22%.
The 30 day mortality was zero. The resection margins were positive in 4
patients. The average follow up duration was 40 months.
Discussion. The survival of patients in our series seems comparable to large
open series of liver resections.
FP 27.04
SEVERE SINUSOIDAL OBSTRUCTION SYNDROME CORRE-
LATES WITH WORSE POSTOPERATIVE OUTCOME AFTER
MAJOR LIVER RESECTION AND COULD BE PREDICTED PRE-
OPERATIVELY
Brouquet, Antoine1; Scatton, Olivier1; Zalinski, Stefane1; Terris, Benoit2;
Brezault, Catherine3; Mallet, Vincent1; Goldwasser, Francois3; Soubrane,
Olivier1
1Hospital Cochin, Liver Diseases, Paris, France; 2Hospital Cochin, Pathol-
ogy, Paris, France; 3Hospital Cochin, Oncology, Paris, France
Background. Oxaliplatin-based chemotherapy (OBC) may induce sinusoi-
dal obstruction syndrome (SOS) lesions in the non tumoral liver parenchyma
(NTLP). The impact of these lesions on postoperative outcome
following hepatic resection for colorectal liver metastases (CLM) is still
debated.Aim. To define the risk of major hepatectomy according to
severity of SOS syndrome, and determine predictive factors of SOS
occurrence.
Methods. Between 1998 and 2006, 51 patients received preoperative OBC
and underwent major liver resection for CLM. A detailed analysis and
grading of steatosis and SOS in the NTLP was obtained for these patients. 90
day mortality and morbidity were studied according to SOS severity (no or
mild lesionsSOS 1/2 vs moderate or severe lesionsSOS 2/3). We assessed
preoperative factors that could predict SOS occurrence. Finally, the APRI
scoring system was evaluated in this setting.
Results. 38 patients (74%) had SOS 2/3 lesions. Postoperative mortality
(4%) was not correlated to the severity of SOS lesions (2 in SOS 2/3 group vs
0 in SOS 0/1 group). Severe SOS lesions were significantly associated with
postoperative hepatic insufficiency (26/38 in SOS 2/3 vs 3/13 in SOS 0/1; p
0.004) and ascitis (p0.03). All patients with severe liver failure had severe
SOS lesions. On POD 5, serum bilirubin level was higher (54.8 vs 26.7; p
0.03) and prothrombin rate was lower in patients with SOS 2/3 lesions (69.1
vs 79.1%; p0.04). Number of OBC cycles was not predictive of severe SOS
occurrence. Preoperative elevation of AST and ALT levels (1.5 fold increase)
(p0.03 and 0.04 respectively) and a low platelet count (B170000) were
associated with SOS 2/3 (p0.002). Finally, ROC analysis revealed cut-off
that predicts severe SOS lesions occurrence is APRI score 0.6 (AUC 0.852;
sensibility 69%; specificity 90%).
Conclusion. Severe SOS lesions related to OBC significantly increased the
risk of major liver resection. Occurrence of severe SOS lesions could be
preoperatively predicted by the use of APRI score.
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HIGH PORTAL PRESSURE PREDICTS OF LIVER FAILURE
AFTER MAJOR HEPATECTOMY COMBINED WITH PORTAL
VEIN EMBOLIZATION FOR COLORECTAL LIVER METASTASES
Jaeck, Daniel; Rosso, Edoardo; Oussoultzoglou, Elie; Pessaux, Patrick;
Giraudo, Giorgio; Bachellier, Philippe
Hopital de Hautepierre, Centre de Chirurgie Ge´ne´rale et Transplantation,
Strasbourg, France
Objective. The aim of the present study was to identify risk factors for liver
failure (LF) in patients who underwent major hepatectomy combined with
portal vein embolization (PVE) for colorectal liver metastases (CLM).
Background. Liver failure still remains one of the most serious complication
after major liver resection due to an increased risk of postoperative morbidity
and mortality. Preoperative PVE is recommended to prevent LF after major
hepatectomy particularly in case of injured liver.
Patients and Methods. Between January 1997 and April 2006, a total of 76
patients underwent right or extended right hepatectomy combined with PVE
for CLM in our department. LF was defined as following: serum bilirubin ]
50 mmol/L and/or prothrombin timeB50% at postoperative day five, and/or
the presence of ascites requiring treatment with diuretics and/or percuta-
neous drainage. Portal venous pressure was measured at the time of PVE just
before embolization.
Results. No patients died within 2 months after hepatectomy. Overall
morbidity rate was 42.1%. Transitory LF occurred in 18 patients (24%). Age,
gender, delay between PVE and liver resection, ICGR-15, extent of liver
resection, steatosis, sinusoidal injury, degree of future remnant liver
hypertrophy and the ratio (future remnant liver/body weight) were not found
to be associated with an increased risk of postoperative LF. However, an
increased portal pressure measured at the time of PVE procedure was
significantly associated with an increased risk of postoperative LF (16.894.6
mmH2O versus 13.594.4 mmH2O, P0.0182).
Conclusions. The present study suggests that LF still occurs after major
hepatectomy for CLM even in patients who underwent preoperative PVE,
and seems predictable by a high preoperative portal pressure. Treatment of
portal pressure by medical treatment may reduce the rate of post-operative
LF.
FP 27.06
LONG TERM OUTCOME OF LIVER RESECTION FOR SYNCH-
ONOUS COLORECTAL LIVER METASTASIS
Lubrano, Jean; Huet, Emmanuel; Xiao, Yquing; Michel, Pierre; Scotte´,
Michel
Rouen university hospital, Rouen, France
Background. Synchronous liver metastasis (LM) occurred in about 15 to
20% of colorectal cancers.
Aims. The aims of our study were to analyse surgical outcome, survival and
prognosis factors in our series of patients operated for synchronous colorectal
LM.
Methods. Between January 1990 and July 2006, 50 patients were operated
for synchronous colorectal LM. Pre-, peri- and postoperative data were
reviewed to analyse their influence on overall and disease free survival.
Subgroup analysis was made to assess the influence of chemotherapy and the
timing of surgery (simultaneous versus delayed liver resection) on overall and
disease free survival.
Results. Median age was 64 years (3389). Primary tumour was colon in 37
patients (18 right colon cancers) and rectal in 13 patients. 34 patients
received preoperative chemotherapy with a median of 8 cycles (324) and 16
were operated without neoadjuvant treatment. 19 patients underwent
simultaneous liver and colorectal resection and 31 patients a delayed liver
resection. Morbidity and mortality rates were 30% and 2% respectively. 1, 3
and 5-year survival rates were 94, 61 and 25%, respectively and disease free
survival at 1, 3 and 5 years were 62%, 30% and 15%, respectively. In
multivariate analysis, recurrence and symptomatic primary tumour (obstruc-
tion or haemorrhage) significantly decreased overall survival. Disease free
survival was strongly influenced by performing a R0 liver resection and by
postoperative complications. Recurrence occurred in 36 patients with a
median delay of 9 months (354). In these patients, survival was increased by
second resection (p0.03). Morbidity, mortality, overall and disease free
survival were not influenced by the timing of liver surgery (synchronous or
delayed resection) or by preoperative chemotherapy.
Conclusions. Our results highlight the pejorative prognosis of synchronous
colorectal LM. They confirm the safety of simultaneous liver and colorectal
resection and the need for an aggressive surgical approach in case of liver
recurrence.
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HEPATIC RESECTION FOLLOWING RESCUE CETUXIMAB
TREATMENT FOR COLORECTAL LIVER METASTASES PRE-
VIOUSLY REFRACTORY TO CONVENTIONAL SYSTEMIC
THERAPY
Adam, Rene´; Aloia, Thomas; Le´vi, Francis; Wicherts, Dennis A; de Haas,
Robbert J; Paule, Bernard; Bralet, Marie-Pierre; Bouchahda, Mohamed;
Machover, David; Ducreux, Michel; Castagne, Vincent; Azoulay, Daniel;
Castaing, Denis
Hoˆpital Paul Brousse, Centre He´pato-Biliaire, Villejuif, France
Background. The value of cetuximab-containing chemotherapy in patients
with irresectable colorectal liver metastases (CLM) resistant to first-line
chemotherapy, is unknown.
Aim. This study aimed to determine the post-cetuximab outcomes after
hepatic resection (HR) of heavily pretreated patients.
Methods. Between February 2004 and August 2007, 10 out of 198 patients
(5%) with irresectable CLM resistant to initial chemotherapy were treated
with cetuximab-containing regimens at our institution, and reconsidered for
HR after response of CLM. During the same period, 22 patients from
elsewhere were referred for HR while receiving cetuximab-containing regi-
mens in the same clinical setting. Short-term and long-term outcomes were
assessed.
Results. From the 32 patients switched to potential resectability after
cetuximab-based therapy, 27 (84%) ultimately were submitted to HR during
laparotomy. Twenty-one (66%) had failed at least 2 lines of pre-cetuximab
chemotherapy. A median of 6 cycles of cetuximabirinotecan (24/32),
oxaliplatin (5/32), or both (1/32) was given. Postoperative mortality was 3%
(1/32) with a complication rate of 44% (14/32). Complete tumor necrosis
was observed in 2 patients (7%). After a median follow-up of 25 months after
CLM diagnosis and 12 months after HR, 24 of the 27 resected patients
(89%) were alive, 8 of whom (30%) were disease-free. Median overall (OS)
and progression-free survival (PFS) from initiation of cetuximab therapy
were 24 and 14 months, respectively. After HR, OS and PFS were 24 and 10
months, respectively.
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Conclusion. Cetuximab allows to increase the resectability of patients with
unresectable CLM refractory to conventional chemotherapy. In case of
response, rescue surgery allows to reach median OS and PFS of 24 and 14
months from the onset of cetuximab therapy. Compared to the usual poor
prognosis of patients resistant to initial chemotherapy (median OS around 12
months), this novel oncosurgical strategy could significantly benefit these
advanced patients.
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REPEAT HEPATECTOMY IS SAFE AND EFFECTIVE FOR RE-
CURRENT COLORECTAL LIVER METASTASES
Yeluri, Sashidhar1; Prasad, K Rajendra2; Gomez, Dhanwant2; Malik, HZ2;
Toogood, G J2; Lodge, J Peter A2
1St. James’s University Hospital, Department of HPB and Transplant
Surgery, Beckett Street, Leeds, United Kingdom; 2St. James’s University
Hospital, Department of HPB and Transplant Surgery, Leeds, United
Kingdom
Background. Hepatic resection represents the only potential cure for the
treatment of colorectal liver metastases (CRLM). Nevertheless, the majority
of patients develop disease recurrence following resection. The aim of this
study is to analyse the peri-operative and long-term outcomes of patients who
undergo repeat hepatic resection for CRLM.
Methods. A prospectively maintained database was used to identify 687
patients who underwent resection for CRLM between 1993 and 2006. 105 of
these patients underwent 119 attempts at re-resection (100 second, 10 third,
2 fourth and 3 unsuccessful). Records for these patients were reviewed
retrospectively.
Results. There were 76 men and 29 women with a median age of 61 years.
Of the repeat resections, 84 were minor resections (less than 3 segments).
There were 5 postoperative deaths. Morbidity was 21.5% for repeat
resections. The overall 1-, 3- and 5- year survivals were 90%, 46% and
24% respectively. On multivariate analysis CEA 10mg/L (p0.022) and
tumour involvement at the resection margin (pB0.001) were independent
predictors of poor disease free survival. Tumour involvement at the resection
margin was the only adverse prognostic factor for overall survival (pB0.001).
Conclusion. Repeat liver resection for colorectal liver metastases is safe and
in selected cases can provide long term survival.
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THE UTILITY OF CONTRAST ENHANCED INTRA-OPERATIVE
ULTRASOUND FOR THE DETECTION OF LIVER METASTASES
DURING SURGERY FOR PRIMARY COLORECTAL CANCER
Shah, Ankur1; Callaway, Mark2; Pope, IM3; Thomas, Michael G4; Finch-
Jones, Meg D5
1Bristol Royal Infirmary, HPB and Colo-rectal Surgery, Bristol, United
Kingdom; 2Bristol Royal Infirmary, Radiology, Bristol, United Kingdom;
3Bristol Royal Infirmary, HPB Surgery, Bristol, United Kingdom; 4Bristol
Royal Infirmary, Colo-rectal Surgery, Bristol, United Kingdom; 5Bristol
Royal Infirmary, HPB Surgery, Bristol, United Kingdom
Background. CT scan is the most commonly used staging investigation for
the detection of liver metastasis in colorectal cancer. Up to 2025% of
patients with colorectal cancer (CRC) have previously undetected liver
metastases diagnosed when intraoperative ultrasound (IOUS) is used at the
time of bowel resection. However, occult liver metastases (OLM) are still
missed where IOUS is used routinely.
Aims. To assess the ability of IOUS to detect additional liver lesions/
metastases at primary bowel surgery and to evaluate whether contrast
enhanced IOUS (CE-IOUS) helps in the detection and characterization of
OLM over and above non-contrast IOUS.
Methods. This is a single centre prospective study. Following multislice CT
for staging, patients with a CRC were consented for IOUS followed by CE-
IOUS. After surgical exploration, patients underwent IOUS of the liver.
Contrast (Sulphur hexafluoride microbubbles/Sonovue†-4.8 ml) was in-
jected and the IOUS repeated. The findings of CT, non-enhanced IOUS and
CE-IOUS were compared. Changes in the staging or management were
noted. If additional lesions were found, these were confirmed post-opera-
tively with Iron oxide MRI of the liver.
Results. Over a 4month period in this ongoing study, eleven patients have
been recruited. IOUS demonstrated additional lesions in 4 patients but
changed staging or management in only 1 patient. However, contrast
confirmed the benign or malignant nature of lesions in all of these 4 patients
and changed management in 3 patients, and altered the staging in the fourth
patient. Thus, CE-IOUS changed the management in 27% of patients
compared to 10% of patients with non-enhanced IOUS.
Conclusion. In this pilot study, early results show the ability of IOUS to
detect additional metastases is improved by CE-IOUS and this has led to an
impact on the surgical staging and management.
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GASTRIN RECEPTOR EXPRESSION IS INCREASED IN HUMAN
PANCREATIC CANCER AND IN ENDOTHELIAL CELLS OF
PANCREATIC CANCER AND PANCREATITIS
Tobias, Amanda1; Aloysius, Mark M2; Zaitoun, Abed M3; Bates, Timothy
E4; Lobo, Dileep N2; Watson, Sue A1
1University of Nottingham, Division of Preclinical Oncology, Nottingham,
United Kingdom; 2Nottingham University Hospitals, Division of Gastro-
intestinal Surgery, Nottingham, United Kingdom; 3Nottingham University
Hospitals, Division of Pathology, Nottingham, United Kingdom; 4Notting-
ham University Hospitals, Division of Community Health Sciences, Notting-
ham, United Kingdom
Background. The gastrointestinal peptide gastrin has been shown to be an
important growth factor in several gastrointestinal cancers and also pancrea-
tic cancer, through the gastrin receptor, cholecystokinin-2 (CCK-2R).
Increased gastrin secretion is also linked to angiogenesis.
Aims. To examine the correlation between CCK-2R expression and
pancreatic cancer.
Methods. Tissue micro arrays of human pancreatic samples including cancer
(n98), pancreatitis (n106), positive (n48) and negative (n59) lymph
nodes and normal (n31) tissue as classified by a pathologist, were
prepared. These were then stained with a specific CCK-2R antibody using
an antigen retrieval method and visualisation with AEC. Staining was
assessed by two people and scored according to area and intensity, 0B5%,
1low, 2medium, 3high. Sections were also scored positive or negative
for CCK-2R staining in endothelial cells.
Results. Compared to normal tissue both cancer and positive lymph
nodes had significantly higher CCK-2R expression (pB0.001). Positive
correlation was observed between CCK-2R expression in the tumour,
peritumoural pancreatitis and corresponding endothelium. However, there
was selective lack of expression in chronic pancreatitis and corresponding
endothelium.
Conclusions. Expression of the gastrin receptor is increased in pancreatic
cancer cells compared to normal. There is also an increase in endothelial cells
expressing CCK-2R in pancreatic cancer compared to normal.
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DEREGULATION OF POTASSIUM CHANNELS EXPRESSION IN
PANCREATIC ADENOCARCINOMAS
Brevet, marie1; Ouadid-Ahidouch, halima2; Fuks, david3; Delcenserie,
richard4; Bartoli, eric4; Regimbeau, Jean-Marc3; Chatelain, denis1
1hospitalo-universitary hospital, pathology, Amiens, France; 2hospitalo-uni-
versitary hospital, Laboratory of cellular and molecular physiology, Amiens,
France; 3hospitalo-universitary hospital, digestive surgery, Amiens, France;
4hospitalo-universitary hospital, gastroenterology, Amiens, France
Carcinogenesis of pancreatic adenocarcinomas is still unknown. Potassium
channels are plasmic membrane proteins involved in ions exchange between
intra and extra cellular compartments. They are involved in proliferation and
apoptosis mechanisms. A deregulation of their expression has already been
shown in breast, lung and prostatic adenocarcinomas. The aim of this study
was to compare the immunohistochemical expression of potassium channels
in pancreatic adenocarcinomas and normal pancreas specimens.
Material and Methods. 20 specimens of pancreatic adenocarcinomas and
20 specimens of normal pancreatic tissue were included in the study.
Immunohistochemistry with potassium channels antibodies (GIRK1,
BKCa, Kv1.3, Kv1.1, ERG1 and TASK2) was realized on paraffin
embedded specimens. Staining was evaluated by two pathologists and
divided in 4 groups related to the intensity of the staining (, , , 
).
Results. A high cytoplasmic expression of GIRK1 and ERG1 ( or 
) was observed in 87% and 96% of pancreatic adenocarcinomas whereas
this intensity of expression was observed in only 50 and 75% of normal
pancreas. For Kv 1.3, high expression was less frequent in adenocarcinomas
compared to normal pancreas (4% versus 25%). No difference was observed
for the three other channels (BKCa, Kv1.1 and TASK2).
Conclusion. For the first time, we show the deregulation of potassium
channels expression in pancreatic adenocarcinomas. We show an over
expression of GIRK and ERG1, involved in cellular proliferation and an
under expression of Kv1.3 involved in apoptosis. These data have to be
confirmed by real time PCR but these potassium channels are probably
involved in the carcinogenesis of pancreatic adenocarcinomas and may be
new targets for future therapeutics against this dramatical cancer.
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PROGNOSTIC SIGNIFICANCE OF PINCH SIGNALING IN HU-
MAN PANCREATIC ADENOCARCINOMA
Scaife, Courtney1; Firpo, Matt1; Emerson, Lyska2; Shea, Jill1; Boucher,
Kenneth3; Beckerle, Mary1; Mulvihill, Sean1
Abstracts 57
1University of Utah, Surgery, Salt Lake City, United States; 2University of
Utah, Pathology, Salt Lake City, United States; 3University of Utah,
Biostatistics, Salt Lake City, United States
Introduction. Pancreatic adenocarcinoma remains one of the most poorly
controlled solid organ malignancies in the United States. Prognostic markers
for pancreatic cancer have failed to accurately predict patient prognosis.
Recent interest has developed in the integrin-associated PINCH protein
expression in human cancers to predict tumor invasiveness and aggressive-
ness. [8, 9 please delete] The goal of this study is to define the expression of
PINCH protein in pancreatic adenocarcinoma which may predict poorer
patient survival.
Methods. 20 cases of were randomly identified and the charts were reviewed
for stage, nodal involvement, margin status, and disease-free and overall
survival. PINCH expression was evaluated from parrafin-embedded blocks
stained for PINCH expression in the tumor and the tumor-associated (TA)
stroma. The comparison of PINCH expression to prognosis was evaluated by
dividing the data into two groups near the median, and performing a
likelihood ratio test using the Cox proportional hazards model.
Results. Preliminary data from 20 pancreatic cancer patients indicates a
higher expression of PINCH protein in pancreatic adenocarcinoma versus
normal pancreatic tissue. Additionally, high PINCH expression in the TA
stroma is associated with decreased overall survival. The median survival was
884 days in subjects with low pinch compared to 337 days in 13 subjects with
high pinch, for a hazard ratio of 2.3. There was no significant correlation
between tumor tissue PINCH expression and survival.
Conclusions. In this study, the expression of the integrin-associated protein,
PINCH, may predict tumor aggressiveness and patient survival. As has been
demonstrated in breast cancer previously, the expression of PINCH in the
peri-tumoral stroma is the most significant predictor of a poor outcome.
PINCH expression may be a marker of an invasive leading edge of tumor or
microscopically postive margins following resection.
FP 28.04
ALEMTUZUMAB INDUCTION AND STEROID-FREE IMMUNO-
SUPPRESSION IN PANCREAS TRANSPLANTATION
Rathnasamy Muthusamy, Anand Sivaprakash1; Roy, Debabrata2; Elker,
Doruk E2; Quiroga, Isabel2; Sinha, Sanjay2; Vaidya, Anil C2; Friend, Peter J2
1Oxford Transplant Centre, Transplant Surgery, Churchill Hospital, Oxford,
United Kingdom; 2Oxford Transplant Centre, Transplant Surgery, Oxford,
United Kingdom
Background. Alemtuzumab (Campath) is a humanised anti-CD52 anti-
body, which depletes T & B lymphocytes and is known to be clinically
effective in many lymphocyte-mediated conditions. The impact of Campath
induction immunosuppression in pancreas transplantation was evaluated,
with particular reference to the ability to minimise the use of steroids.
Methods. 126 transplants were performed in 122 patients; these included
patients undergoing simultaneous pancreas kidney (SPK), pancreas after
kidney (PAK) or a pancreas transplant alone (PTA). 30 mg of Campath was
given IV on day 0 & 1with tacrolimus (trough levels of 812ng/ml) and
mycophenolate mofetil for maintenance immunosuppression. Methyl Pre-
dnisolone was given IV before reperfusion of the grafts (pancreas-500mg,
kidney-250mg). No steroids were used in the maintenance regimen. Patient
and graft survival, rejection rate and adverse events were obtained retro-
spectively.
Results. There were 76 males and 46 females in the group with a median age
of 42 (range 2767). 97 patients underwent SPK, 23 patients had PAK while
6 had PTA. The median hospital stay was 15 days and median length of
follow-up 10 months (range 036 months). Overall thirty-day mortality was
0.8%; overall patient survival was 97%. 98% of the patients are currently off
dialysis and 94% have a functioning pancreatic allograft. 22 patients received
anti-rejection therapy for 27 episodes (21.5%). 4 patients (3%) have had
significant BK viruria, but still have functioning renal grafts. 7 patients
(5.5%) have had positive CMV antigenemia resulting in antiviral therapy. 31
patients (25%) had re-operations. 86% have received no steroids post
transplant, and 7 patients (6%) are currently on steroids. 1 patient developed
post-transplant lymphoproliferative disorder at 10 months post SPK but has
functional grafts.
Conclusion. Campath is safe and enables pancreas transplantation to be
carried out without the need for maintenance steroids in 86% of cases and
with an acceptable rejection rate.
FP 28.05
CELLULAR PROLIFERATION (CP), NFkB AND GENE MICRO-
ARRAY ANALYSIS OF OMEGA-3 FATTY ACID TREATED GEM-
CITABINE (GEM) RESISTANT PANCREATIC CANCER
Saied, Abdul; Razzak, Anthony; Hering, Justin; Trevino, Jose; Somasundar,
P; Espat, Joseph
Roger Williams Hospital, Surgical Oncology, Providence, United States
Pancreatic cancer (PC) is a malignancy with high mortality. Patients are often
treated with gemcitabine (GEM) chemotherapy; but chemoresistance is
common. In the present experiments, the effects of omega-3 fatty acids (n-3
FA), GEM and combination treatment on CP in two PC cell lines, L3.6pl an
intrinsically GEM sensitive cell line and L3.6 clone (L3.6 GEM RES), an
experimentally created GEM resistant clone, were examined.
Methods. L3.6pl cells were cultured using standard protocol. GEM
resistance was induced by exposure to 500 ng/ml of GEM, 5x greater than
the IC50, for 48 hours, and increased to 3000 ng/ml in 500 ng/ml increments.
Cells were treated with DMEM, 100M n-3FA emulsion, 100mM GEM or
combination of 100mM n-3 FA and 100mM GEM for 12 hrs. n-6 FA
emulsion was used as a lipid control. CP was measured with WST-1 assay.
NFkB was assayed using EMSA. Genetic expression was evaluated using
microarray, significance in differential expression denoted as ] 2x-change
relative to media-only (control).
Results. In L3.6pl, a significant decrease in CP was observed in n-3 FAs
compared to lipid control. In GEM alone, a 70% decrease in CP was
observed, with no difference in n-3 FA or n-6 FA combo treatment, likely due
to the GEM sensitivity of L3.6pl. In L3.6 GEM RES, GEM treatment alone
did not significantly affect proliferation. However, proliferation was signifi-
cantly decreased using n-3 FA alone or in combo with GEM. EMSA revealed
a significant decrease in NFkB expression in all cells treated with n-3 FAs.
Genetic data revealed significant alterations in genes responsible for CP,
including: GADD45A, CDKN1A, CDKN1C and TP53.
Conclusion. Comparison of GEM sensitive PC versus GEM resistant PC
clones reveals a significant decrease in CP with n-3 FA compared to media-
only controls. In both PC cell lines, effects are optimized with combo n-
3FAGEM treatments. NFkB, an intracellular marker for chemoresistance,
was decreased in cells treated with n-3 FAs; findings supported by genetic
analysis.
FP 28.06
LYMPHATIC CONNECTIONS BETWEEN THE PANCREAS AND
INTESTINE
Loveday, Benjamin PT1; Mittal, Anubhav1; Phillips, Anthony2; Windsor,
John A1
1University of Auckland, Department of Surgery, Auckland, New Zealand;
2University of Auckland, School of Biological Sciences, Auckland, New
Zealand
Background. Mesenteric lymph, conditioned by intestinal ischemia-reper-
fusion injury, has been shown to exacerbate the severity of acute pancreatitis
(unpublished). It is not known how mesenteric lymph exerts its influence on
the pancreas, whether via the peripheral circulation or direct lymphatic
connections.
Aims. The aim of this study was to determine the nature of the lymphatic
connections between the pancreas and intestine.
Methods. Under general anaesthetic, the mesenteric ducts of adult male
Wistar rats were cannulated either antegrade near the caecum or inserted
retrograde from the thoracic duct. Colloidal carbon, Evans blue dye or
polyurethane-based resin was perfused into the lymphatics under direct
visualisation to identify connections between the mesenteric duct and
pancreas. Using the same cannulation techniques, gadolinium contrast
medium was perfused into the lymphatics and images obtained using a 4.7
Teslar magnetic resonance imaging (MRI) scanner.
Results. Lymphatics were well-visualised with the dyes and resin. A
dominant lymphatic connection was consistently noted, in all dye and resin
studies, between the mesenteric duct and a lymph node located in the head of
the pancreas. Other smaller connections were identified parallel and in close
proximity to this dominant connection. Both dye and resin were seen to
traverse the lymph node and backfill lymphatics that ran into the parenchyma
of the pancreas. Contrast enhancement of the mesenteric duct was seen on
MRI, with possible enhancement of parts of the pancreas.
Conclusion. For the first time, consistent and direct lymphatic connections
were identified between the mesenteric duct and the pancreas through a
lymph node in the head of the pancreas. Further research is required to
determine whether this is the route by which mesenteric lymph exacerbates
acute pancreatitis, and the role of these connections in other critical illnesses.
FP 28.07
BONNET MONKEY MODELS FOR MALNUTRITION-RELATED
PANCREATIC DISEASES
Sandhyamani, Samavedam
Sree Chitra Tirunal Institute for Medical Sciences and Technology, Depart-
ment of Pathology, Trivandrum, India
Introduction. Malnutrition-related pancreatic diseases are common, parti-
cularly in developing countries. Their etiology is uncertain owing to lack of
definite animal models.
Aims. To conduct histopathological study of diet-induced pancreatic
degenerative lesions in bonnet monkeys (Macaca radiata).
Methods. 42 sub-adult monkeys were fed tapioca-starch or cornstarch-based
low-protein normal-carbohydrate (LPNC) or low-protein high-carbohydrate
(LPHC) or control (normal protein, carbohydrate) diets for 3 or 5 months’
periods.
Results. The pancreas was normal in all the 12 Controls, while 13 animals
fed LPNC diets showed marked to severe lobular and acinar cell atrophy. In
17 animals fed LPHC diets the pancreas showed moderate to marked acinar
cell atrophy, marked islet hyperplasia or nesidioblastosis with hypertrophy
and mucoid metaplasia of duct epithelium with inspissated secretions within
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ducts and ductules. Generalized mucoid vasculopathic arteriosclerosis, also
affecting the pancreatic vasculature, was seen in all the test animals, more
pronounced in those fed LPHC diets for a longer duration.
Conclusions. A primate model of diet-induced pancreatic lesions was
established. LPNC diets induce lesions resembling human pancreatic atrophy
in certain diabetics. LPHC diets induce lesions similar to chronic pancreatitis
(Tropical Chronic Calculus Pancreatopathy with diabetes mellitus). Toxic
factors from tapioca were excluded in initiating the lesions, since identical
changes were seen with both starches. Future work: The long-term effects of
mucoid vasculopathy on the exocrine and endocrine pancreas need to be
explored. More importantly, the differential damage and regenerative
functions of a (alpha) versus b (beta) cells of pancreatic islets need to be
studied in the above experimental models. Appropriate Immuno-histochem-
ical and Biochemical techniques to track insulin  glucagon interactions will
help in a better understanding of the pathogenesis of diabetes mellitus.
FP 28.08
TUMOUR GROWTH ASSESSMENT USING MINIMUM SPAN-
NING TREE ANALYSIS IN PANCREATIC, AMPULLARY AND
DISTAL BILE DUCT CANCER
Verbeke, Caroline S1; Menon, Krishna V2; Knapp, Johannes3
1The Leeds Teaching Hospitals NHS Trust, Department of Histopathology,
Leeds, United Kingdom; 2The Leeds Teaching Hospitals NHS Trust,
Department of Surgery, Leeds, United Kingdom; 3University of Leeds,
School of Physics and Astronomy, Leeds, United Kingdom
Background. The definition of microscopic resection margin involvement
(R1) in large bowel cancer (LBC) has been established as tumour cellsB1
mm to the margin. This R1 definition is also used for the reporting of
pancreatic head cancer specimens, but has never been validated. The
Minimum Spanning Tree algorithm (MSTA) is a computer generated
method that analyzes the topology of cancer growth patterns by determining
the minimum distance between tumour cells.
Aim. To determine, using the MSTA, whether a similar growth pattern in
LBC and cancer arising in the pancreatic head justifies the current R1
definition for reporting of the latter.
Methods. In 10 cases of each LBC, pancreatic (PC), ampullary (AC) and
distal bile duct cancer (DBC) a 200x picture was taken in the centre and
periphery (at the invasive front) of the tumour as well as half way between
both. For each picture, the distances between cancer cells were determined
using the MSTA. The average minimum distance was compared between the
3 zones in the 4 cancer groups, as was the tumour cell density.
Results. In all cancer groups, the distance between cancer cells was
comparable in the central zone, and larger in the periphery than in the
centre of the tumour (p50.02). However, this difference between centre and
periphery was smaller in LBC than in PC, DBC and AC (p50.03). Results
were similar for PC and DBC, but differed from those of AC (p50.03). On
average, the tumour cell density dropped in the periphery of PC to 30% of
that in the tumour centre, and only to 83% in LBC (pB.0001), 62% in AC
and 40% in DBC (p50.01).
Conclusion. Tumour cell growth in PC, DBC and * to a lesser extent *
AC is less dense than in LBC. Particularly in the periphery, tumour growth is
more dispersed in PC, DBC and AD, and tumour cell density drops to as
little as 30% at the invasive tumour front. This difference in tumour growth
demands revision of the R1 definition for pancreatic head cancer. The MST
algorithm is a useful tool to assess the topology of cancer growth patterns.
FP 28.09
INCIDENCE AND CHARACTERISTICS OF CHRONIC AND LYM-
PHOPLASMACYTIC SCLEROSING PANCREATITIS IN PA-
TIENTS SCHEDULED TO UNDERGO PANCREATODUO-
DENECTOMY
de Castro, Steve1; de Nes, Lindsey1; Nio, Yung2; Velseboer, Daan3; Ten
Kate, Fiebo3; Olivier, Busch1; van Gulik, Thomas1; Gouma, Dirk1
1Academic Medical Center, Surgery, Amsterdam, Netherlands; 2Academic
Medical Center, Radiology, Amsterdam, Netherlands; 3Academic Medical
Center, Pathology, Amsterdam, Netherlands
Background. The determination of the nature of a pancreatic head mass
scheduled to undergo pancreatoduodenectomy can be very difficult. This is
important since patients who suffer from pancreatitis do not always require
surgery. The aim of the present study was to analyze the incidence of
pancreatitis and the signs and symptoms associated with the disease and
diagnostic procedures performed.
Methods. A consecutive group of patients who underwent a pancreatoduo-
denectomy between 1992 and 2005 with histopathologically proven pan-
creatic adenocarcinoma (PCA) and pancreatitis were analysed.
Results. The incidence of pancreatitis after pancreatoduodenectomy is 63
out of 639 patients who underwent a pancreatioduodenectomy (9.9%). Of
these patients, 24 patients (38%) had lymphoplasmacytic sclerosing pan-
creatitis (LPSP) and 31 patients (49%) had focal chronic pancreatitis. Eight
patients (13%) had an intermediate form with characteristics of both.
Pancreatic adenocarcinoma occurred in 227 patients (36%). The presence
of pancreatitis without a discrete mass on endoscopic ultrasonography (EUS)
seemed to have clinical relevance with a positive likelihood ratio of 5.1.
Mortality after resection was nil in both groups.
Conclusion. The incidence of pancreatitis is 9.9% for patients scheduled to
undergo a pancreatoduodenectomy. Of these patients 38% had LPSP, 13%
had a intermediate form and 49% had focal chronic pancreatitis. The
determination of the exact nature of a pancreatic head mass remains difficult.
FP 29.01
RELIABILITY OF PREOPERATIVE 3D CT VOLUMETRY AND
EFFECT OF MHV INCLUSION ON REMNANT VOLUME IN
RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION
R, Anand; Kakodkar, Rahul; Kumaran, Vinay; Nundy, Samiran; Soin,
Arvinder S
Sir Ganga Ram Hospital, Surgical Gastroenterology & Liver Transplantation,
New Delhi, India
Background. Inclusion of the middle hepatic vein (MHV) in right lobe
living donor liver transplantation (LDLT) is regarded by many as essential to
ensure optimum graft function. However, concern remains regarding
increased donor risk. Volumetry by current imaging techniques is associated
with an error of 536% when compared to intraoperative graft weight. Hence,
there is a potential for leaving behind an inadequate left lobe remnant based
on preoperative volumetry.
Aim. To study the reliability of preoperative three-dimensional computed
tomography (3DCT) volumetry in the prediction of graft weight in LDLT
and the effect of inclusion of MHV with the right lobe graft on remnant liver
volume.
Method. 23 consecutive right lobe donors were prospectively studied
between March and August 2007. All donors underwent preoperative
triphasic CT. Graft and remnant volume was estimated to the right and left
of a plane passing along the right margin of the MHV. Postoperatively, 20
stable patients underwent a repeat CT scan within 16 hours of surgery for
estimation of remnant left lobe volume. The MHV was included with the
graft in all cases, ‘coring out’ the MHV from the left side, preserving any
significant segment 4a drainage into the MHV.
Results. Median graft weight was 750g (520969), and GRWR 1 (0.661.7).
Median preoperative estimated remnant volume was 37% (2745) of the total
liver volume. Preoperative CT volumetry underestimated graft weight in 10
cases (43.5%), overestimated it in 10 (43.5%) and was identical in 3 cases
(13%). The mean error ratio was 8.76.17. Postoperative predicted remnant
volume was greater than the preoperative volume in 12 cases (60%), less in 6
cases (30%) and identical in 2 (10%) cases. All donors except 1(5%) had a
remnant volume over 30%.
Conclusion. 3DCT volumetry predicts graft volume with reasonable
accuracy. Based on the error ratios obtained, inclusion of the MHV with
right lobe grafts did not compromise the remnant liver volume estimated to
the right of MHV on preoperative CT volumetry.
FP 29.02
PULMONARY AND BLOOD STREAM INFECTIONS IN ADULT
LIVER TRANSPLANT RECIPIENTS
van den Broek, Maartje1; Saner, Fuat2; Olde Damink, Steven W.M.1; Rath,
Paul3; Paul, Andreas2; Nadalin, Silvio2; Broelsch, Christoph E.2; Malago´,
Massimo4
1University hospital Maastricht, Department of Surgery, Maastricht, Nether-
lands; 2University hospital Essen, Dept. of General, Visceral and Transplant
Surgery, Essen, Germany; 3University hospital Essen, Institute of Medical
Microbiology, Essen, Germany; 4University College London, Department of
Surgery, London, United Kingdom
Background. Infectious complications occur in approximately 50% of
cadaveric liver transplant (CLTx) recipients and confer a major risk of
mortality after liver transplantation. Theoretically, living donor liver trans-
plant (LDLTx) recipients have lower infection rates as they are better
prepared and have shorter ischemic times.
Objective. To assess whether the incidence of pulmonary and blood stream
infections in LDLTx recipients differed from their CLTx counterparts.
Methods. To detect the expected difference of 50 percent in the incidence of
pulmonary and blood stream infections in favour of the LDLTx recipients
(i.e. incidence of 25% in the LDLTx versus 50% in the CLTx group), a
minimum number of 55 patients had to be included in each arm of this
cohort study. Consequently, the clinical course of 55 LDLTx recipients
transplanted between December 2002 and December 2006 was analysed.
The 173 CLTx recipients who were transplanted in the same period served as
a control group. Patients were treated in a single ICU receiving triple
immunosuppression and antimicrobial prophylaxis. Differences in infectious
complications were calculated by means of Fisher’s exact test. PB0.05 was
considered significant.
Results. Mean MELD-score did not differ between LDLTx and CLTx
recipients (14.2 versus 13.3, p0.4). Pulmonary infections were experienced
by 18% of LDLTx versus 5% of CLTx recipients (p0.005) and blood
stream infections occurred in 33% of LDLTx versus 21% of CLTx recipients
(p0.1). One year survival was significantly higher for all recipients who did
not experience a pulmonary infection (85% versus 42%, pB0.001).
Conclusion. LDLTx recipients experienced significantly more pulmonary
infections when compared with their CLTx counterparts. There was a trend
towards a higher incidence of blood stream infections in the LDLTx group.
These differences might be explained by the smaller graft body weight ratio in
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the LDLTx recipients reflecting the important role of the liver in the innate
immune defence.
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ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANTATION
USING EXTENDED RIGHT LOBE GRAFTS
Kim, Ki Hun1; Lee, Sung Gyu2; Lee, Young Joo2; Park, Kwang Min2;
Hwang, Shin2; Ahn, Chul Soo2; Moon, Deok Bog2; Ha, Tae Yong2; Song, Gi
Won2; Jung, Dong Hwan2; Ryu, Je Ho2; Park, Jung Ik2; Lee, Hyo Jun2; Ko,
Kyung Hoon2; Kim, Kwan Woo2; Choi, Nam Kyu2
1Asan Medical Center, Department of Surgery, 388-1, Pungnap-dong,
Songpa-gu, Seoul, Korea, Republic of; 2Asan Medical Center, Department
of Surgery, Seoul, Korea, Republic of
Background. Adult-to-adult living donor liver transplantation(AALDLT)
using extended right lobe grafts has become as an treatment method to
solve the problem of graft insufficiency since Hong Kong group first
successfully performed for a 90-kg man with fulminant Wilson¡*s disease
in May 1996.
Aims. The authors report their experience with adult-to-adult living donor
liver transplantation using extended right lobe graft in a single center.
Methods. From March 1998 to June 2007, 1428 AALDLTs were performed
at the Asan Medical Center. Among them, 21 AALDLTs using extended
right lobe graft were included in this retrospective study. 3 types of techniques
for hepatic vein reconstruction have been used to enable the sufficient venous
outflow drainage of extended right lobe grafts.
Results. There were 18 male and 3 female. The median age of recipients was
47 years(range, 1962 years) and median MELD score was 20(range, 936).
Of 21 patients, 11 had HBV related LC, 7 had HBV related LC with HCC,
and 3 had acute liver failure. The median percentage of steatosis was
5%(range, 015%), the median graft weight was 605 gm (range, 400
800 gm) and the median GRWR was 0.86%(range, 0.691.16%). There
were 2 in-hospital mortalities caused by sepsis. The median age of donors was
28 years(range, 1639 years). There was no donor mortality. As for hepatic
vein reconstruction in this study, there were 3 types of techniques in the
following order: 14 quilt venoplasties make ¡8common-large opening¡9 using
GSV and PV of recipient, 4 direct RHV anastomoses and separate
reconstructions of MHV with interposition vein graft, and 3 separate RHV
and MHV anastomoses without interposition vein graft. Modification of graft
procurement technique by preserving S4b hepatic vein was performed in 2
cases.
Conclusions. The extended right lobe graft may provide an alternative
option to overcome the small-for-size graft in AALDLT if the meticulous
donor hepatectomy and complete donor selection can be performed for
donor safety.
FP 29.04
SAFETY OF THE LIVING DONOR IN LEFT PART LIVER TRANS-
PLANTATION  AN ANALYSIS OF 100 CONSECUTIVE CASES-A
SINGLE-CENTER EXPERIENCE
Paluszkiewicz, Rafal1; Zieniewicz, Krzysztof1; Grzelak, Ireneusz1; Pacho,
Ryszard2; Hevelke, Piotr1; Kalinowski, Piotr1; Krawczyk, Marek1
1Medical University of Warsaw, Dpt. of General, Transplant and Liver
Surgery, Warsaw, Poland; 2Medical University of Warsaw, 2nd Dpt. of
Radiology, Warsaw, Poland
Background. One of the most serious problems faced for living donor is a
risk of death or morbidity. The AIM of this study was to assess the risk of
harvesting the left part of the liver from the consecutive 100 living related
donors.
Methods. Between October 1999 and January 2007 liver segments II and III
were harvested from 90 donors and segments II, III and IV from 10 donors.
Blood transfusions, complications, length of hospitalization and resection
index, regeneration index and postoperative liver function tests on the 7th,
30th day and after 12 month were evaluated in donors.
Results. The strict correlation between CT volumetric assessment and the
mass of harvested graft was demonstrated by linear regression analysis (r
0.56) and Student’s t-test (pB0.04). The mean regeneration index 12 month
after resection increased significantly in donors of segments II, III and IV
(138.64%923.98%) as compared with donors of segments II and III
(109.93%918.36%) (pB0.02). Postoperatively donors manifested adverse
effects of surgery including transient elevation of bilirubin and transaminase
levels and a decreased prothrombin index. 12 month after harvesting the
mean level of all these parameters was within normal limits. No mortality or
reoperation was noted in the entire series. Postoperative complications
occurred in 7 patients (2 wound infections, 2 postoperative hernia, 2 delayed
gastric emptying, 1 bile reservoir) (7%). Blood transfusion was not necessary
in any of the procedures. Mean hospitalization time was 8.769 3.39 days
after harvesting II and III and 9.4491.42 days after harvesting II, III and IV
segments (p0.05).
Conclusion. Safety is guaranteed when the left lobe or the left lateral
segment is harvested for living related liver transplantation.
FP 29.05
RIGHT VERSUS LEFT LOBE LIVING DONOR LIVER TRANS-
PLANTATION IN ADULTS: DOES SIDE MATTER?
Kakodkar, Rahul; Kumaran, Vinay; Saigal, Sanjiv; Saraf, Neeraj; Nundy,
Samiran; Soin, Arvinder Singh
Sir Ganga Ram Hospital, Surgical Gastroenterology & Liver Transplantation,
New Delhi, India
Background. While right lobe grafts usually provide enough liver (graft to
recipient weight ratio-GRWR 0.8) for adult liver transplantation, they are
technically demanding. Left lobe grafts are simpler, but provide enough
volume only for small adults. It is not clear whether right and left liver grafts
having similar GRWR function equally well after transplantation.
Aim. To compare early outcomes of patients receiving right and left lobe
grafts with GRWR 0.8.
Methods. Since Jan 2005, 96 right lobe and 16 left lobe LDLTs with
GRWR0.8 were performed in adults. Both groups had comparable
demographics and MELD scores. Anterior sector outflow of right lobes
was routinely reconstructed by including the middle hepatic vein (n90) or
extending segmental tributaries (n6). Intra-operative Doppler confirmed
vascular patency in all cases. Warm ischaemia time, post-operative pro-
thrombin time (PT), aspartate transaminase (AST) and bilirubin on days
1,3,7; ICU stay, duration of ascitic drainage and culture-proven sepsis were
statistically compared between the two groups.
Results. Mean GRWR was 0.84 (0.81.5) for R lobes and 0.82 (0.80.92)
for left lobes (pNS). Thirty day recipient mortality was 8.3% (8/96) and
6.6% (1/16) for right and left lobes respectively (pNS). Apart from 1
patient who had partial portal vein thrombosis requiring anticoagulation and
one with RHV stenosis treated with stenting, there were no vascular
complications.
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SIMULTANEOUS ARTERIAL AND BILIARY REPAIR AFTER
LIVER TRANSPLANTATION (LT)
Sommacale, Danie`le1; Sibert, Annie2; Donde´ro, Fe´de´rica1; Francoz, Claire3;
Paugam, Catherine4; Sauvanet, Alain1; Vilgrain, Vale´rie2; Goasguen, Nico-
las1; Durand, Franc¸ois3; Belghiti, Jacques1
1Hospital Beaujon, HPB Surgery, Clichy, France; 2Hospital Beaujon,
Radiology, Clichy, France; 3Hospital Beaujon, Hepatology, Clichy, France;
4Hospital Beaujon, Anesthesia, Clichy, France
Aims. The presence of hepatic arterial (HAS) in patients with biliary
strictures (BS) following LT is common. The aim of this study is to report 7
patients with BS associated with HAS treated by simultaneous artery and
biliary surgical repair.
Method. Among 787 OLT performed from 1991 to 2005, 12 patients
(1.5%) experienced BS associated with HAS. Retransplantation was indi-
cated in 5 with intrahepatic biliary stenosis. In 7 cases, with exclusive
extrahepatic BS and HAS, simultaneous biliary and arterial repair were
considered. Patients, aged from 31 to 60 yrs. Simultaneous biliary and
arterial repair was indicated in the presence of biliary duct to duct stenosis in
6 cases and after Roux-en-Y in 1 case. Arterial stenosis were more than 50%
of the arterial diameter. Six patients had BS previously treated by plastic
prothesis and 2 had HAS previously treated by endovascular stent or
pneumatic dilatation.
Results. Arterial repair was the first step of the procedure with a complete
resection of the arterial stricture followed by a terminoterminal arterial
anastomosis. In 1 case stenosis involved only the right hepatic artery while in
the 6 other cases the stenosis was located at the site of the anastomosis. In all
cases resistance index was 0.5 on intraoperative doppler ultrasound after
reconstruction. Biliary repair included in all cases a Roux-en-Y. There was no
postoperative death and morbidity was observed only in 1 patient. No
postoperative biliary fistula was observed and the mean hospital length of stay
was 16 days. With a mean follow up of 67 months, all patients are alive
without graft loss. Recurrent arterial stenosis was discovered in 1 patient and
although successfully treated by endovascular stent, he developed biliary
stricture 13 months later and was treated by iterative Roux-en-Y.
Warm
ischaemia PT 1 PT 3 PT7 AST1 AST3 AST7 Bili 1 Bili3 Bili7 ICU stay
Septic
episodes Ascites
Left lobe 37 min 21.3 sec 20.8 sec 16.5 sec 278IU 144IU 92*IU 9.3 mg/dL 6.8 mg/dL 3.7 mg/dL 9.1*days 1.2* 13 days
Right Lobe 49 min* 20.5 sec 19.4 sec 16.1 sec 204IU 118IU 78 IU 6.7 mg/dL 4.6 mg/dL 2.8 mg/dL 6.8 days 0.8 8.1 days*
* statistically significant Conclusion: Although patients with left lobe grafts may eventually fare as well as those with size matched right lobe grafts, they are
more likely to have persistent ascites due to residual portal hypertension and require additional ICU stay due to sepsis.
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Conclusions. Results of our series demonstrated that simultaneous biliary
and arterial surgical repair is safe and efficient in patients with extrahepatic
biliary stenosis associated with arterial stenosis complicating LT.
FP 30.01
LONG-TERM SURVIVAL AFTER PANCRATICODUODENECT-
OMY FOR ENDOCRINE TUMORS OF THE AMPULLA OF VATER
AND MINOR PAPILLA
Pedicone, Roberto1; Adham, Mustapha1; HERVIEU, Vale´rie2; Scoazec,
Jean-Yves2; Partensky, Christian1
1Edouard Herriot, HPB Surgery and Transplantation, Lyon, France;
2Edouard Herriot, Pathology and Cytology, Lyon, France
Background. Endocrine tumors of the papilla of Vater and minor papilla are
exceptional. Accurate indications for surgical management are lacking.
Objective. To report our personal experience and assess the correlation
between pathological features and prognosis.
Methods. Clinical charts of 8 patients, 3 male and 5 female, mean age 47.8
years (range: 3757 years) who underwent a pancreaticoduodenectomy for
endocrine tumor of the ampulla of Vater or minor papilla by the senior author
(CP) between 1982 and 2003 were reviewed. No patient was lost to follow-
up. Mean follow-up was 88 months (range 17223 months).
Results. Two patients were diagnosed incidentally, two had a Zollinger-
Ellison syndrome, three had abdominal pain and one had jaundice. One
patient had a Recklinghausen disease. Operative mortality was nil. Mean size
of the tumor was 17.4 mm (range: 540 mm). Pathological examination of
operative specimens demonstrated 7 cases of well-differentiated and one case
of poorly differentiated endocrine carcinoma. Immunochemistry, which was
performed in 7 patients, was positive for somatostatin in two, for gastrin in
one and for calcitonin in one. Seven patients had positive lymph nodes and
one also had diffuse liver metastases. At the end of follow-up, five patients
were alive and disease-free, one was alive with stable liver metastases and two
patients were deceased: one, with undifferentiated tumor, developed diffuse
liver metastases and died 17 months postoperatively and the other one, with
gastrinoma, died twelve years after surgery from an unrelated cause.
Conclusion. This study demonstrates the frequency of the metastatic spread
to lymph nodes and the variable secretory profile of these uncommon tumors.
Pancreaticoduodenectomy may offer long term survival in patients with well
differentiated tumors, even when positive satellite lymph nodes and liver
metastases are present.
FP 30.02
SURGICAL MANAGEMENT OF NON-FUNCTIONING NEU-
ROENDOCRINE PANCREATIC TUMOURS
Spalding, Duncan1; Rajakulendran, Karthig2; Pai, Madhav2; Williamson,
Robin2
1Hammersmith Hospital, HPB Surgery, Du Cane Road, London, United
Kingdom; 2Hammersmith Hospital, HPB Surgery, London, United King-
dom
Introduction. Due to their slow growth and inability to produce hormone-
dependent symptoms, non-functioning neuroendocrine pancreatic tumours
(NFNEPTs) usually have an indolent natural history. Surgical treatment of
these tumours has become increasingly important for symptom palliation and
survival. The aim of this study was to assess the role of surgery, adjuvant
therapy and outcomes of NFNEPTs based on the experience of a single
institution.
Methods. Between 19942007, 21 patients were treated for NFNEPTs.
Their investigations, surgery, histology and clinical outcome were reviewed
retrospectively.
Results. There were 11 men and 10 women of median age 49 (range 2676)
years. Gut hormone profiles were normal in all patients. Contrast-enhanced
computed tomography localised the tumour in 20 patients and visceral
angiography in 15 of 16. The NFNEPTs were located in the head in 16
patients, body in 2 and tail in 3. Eleven patients underwent curative resection
(pancreatoduodenectomy [PD] n8, distal pancreatectomy n2 and
laparoscopic enucleation n1) and 10 palliative resection (PD n6, total
and distal pancreatectomy 2 each). Four patients had concomitant liver
resections (curative and palliative 2 each). There were no operative deaths.
Seventeen tumours were malignant, 14 expressed chromogranin, 13 neurone
specific enolase, 9 synaptophysin, 7 cytokeratin and 6 protein gene product
9.5. Ten patients received adjuvant therapy (chemotherapy n2, embolisa-
tion n2, chemotherapy and embolisation n1, a-interferon n2, targeted
radionuclide therapy n1, targeted radionuclide therapy and radiation n
1). Nine patients have died from disease a median of 43 (range 10141)
months after operation. The 12 survivors, 7 of whom had curative resections,
have been followed for a median of 46 (range 2495) months. Ten patients
are asymptomatic but only 5 are free from disease.
Conclusions. Although surgical cure is rare in NFNEPTs, long-term
palliation can be achieved with an aggressive surgical approach and adjuvant
therapy.
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NEUROENDOCRINE PANCREATIC AND DUODENAL TUMORS
Straka, Vladimı´r; Straka, Martin; Sabol, Martin; Chvalny´, Peter
St. Elisabeth Oncological Institute, Department of Oncological Surgery,
Bratislava, Slovakia
Background. Neuroendocrine tumors(NET) of pancreatic and duodenal
origin are rare. This study aimed to present surgical experience analysing the
postoperative outcome.
Patients and Methods. From 1991 to 2007 51 patients(range of age
1976 years) underwent surgery for 46 duodenal and pancreatic NET: 44
patients had functioning tumors(20 gastrinomas, 23 insulinomas and 1 VIP-
oma). 7 patients had non-functioning tumor associated with clinical
symptoms caused by tumor location and size growth(4 duodenal, 3
pancreatic).
Results. The precise topic diagnosis was achieved in only 50% of
gastrinomas, 69% of insulinomas and overall in 64% of cases before surgery.
A high portion of functioning tumors in the present study were malig-
nant:45.5% (80% duodenal gastrinomas, 40%pancreatic gastrinomas, 21%
insulinomas, 1 VIP- oma, 1 carcinoid tumor and 2 non-functioning tumors of
pancreas). Eight proximal pancreaticoduodenectomies, 23 distal pancreatec-
tomies and 20 local excisions were performed. In one female right
hepatectomy because of pancreatic gastrinoma liver metastases was done
simultaneously with distal pancreatosplenectomy. 7 patients had postopera-
tive complications (15%). Pancreatic fistula developed in 4 patients (in-
sulinoma subgroup: 1 pancreaticoduodenectomy, 2 local excisions, 1 distal
pancreatectomy) that were resolved by conservative treatment in 3 cases and
1 patient required reoperation. We observed 1 delayed gastric emptying and 2
wound infections. Perioperative mortality was 0.0%. During long follow up
period 3 patients died (related to tumor progression: 1 non-functiong
pancreatic tumor, 2 pancreatic gastrinomas).
Conclusion. Surgical resection is the only curative option for NET.
Surgery can be safely caried out in pancreatic surgery centre and good
long-term survival is reached. Our cohort of 242 patients with pancreatic
resections (175 proximal and 67 distal) include 51 patients( 21.1%) with
NET.
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Laparoscopic resection for endocrine tumors in 28 patients.
Rault, Alexandre1; SaCunha, Antonio2; Collet, Denis2; Masson, Bernard2
1CHU Bordeaux, Service de chirurgie digestive et endocrinienne, Hopital
Haut Le´ve´que, Pessac, France; 2Chu Bordeaux, Service de chirurgie
digestive et endocrinienne, Pessac, France
Introduction. These last years, advances in laparoscopic surgery allow
treating pancreatic endocrine tumors. We report a single institution experi-
ence of laparoscopic treatment of pancreatic endocrine tumors. Patients,
Method: In a 10 years period, 72 laparoscopic pancreatectomies were
performed. Indication for resection was endocrine tumors for 28 of the
patients.
Results. Median age was 48 years-old (21 women, 7 men). Indications for
resection were: 17 insulinomas(61%), 6 non functional endocrine tumors
(21%), 2 glucagonomas (7%), 1 gastrinoma (3.7%), 1 vipoma (3.7%), 1
carcinoma (3.7%). Mean size of tumors was 14mm and 18.5 mm for non
functional tumors. Six tumors were located in the pancreatic head (21.5%),
19 in the body and tail (68%). 22 operations (78%) were performed
laparoscopically: 13 enucleations, 4 spleno-pancreatectomies, 4 left pancrea-
tectomies, 1 central pancreatectomy. Six patients required a conversion to
laparotomy: 4 undetectable tumors, 1 device problem, 1 suspicion of
metastatic lesion. Mean hospital stay was 12.7 days. Morbidity rate was
23% (6 pancreatic fistulas, 1 bleeding, 1 wound abcess). Total remission rate
after surgery was 89.2% (100% in case of sporadic insulinoma): 1 endocrine
carcinoma with metatstatic disease, 1 gastrinoma, 1 nesidioblastoma.
Conclusion. Laparoscopic treatment of endocrine tumors is safe regarding
small tumors. Enucleation is feasible with few morbidity. It seems difficult to
detect by laparoscopy small tumors and pre-operative exploration is very
important.
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RADICAL SURGICAL RESECTION FOR CARCINOID TUMORS
OF THE AMPULLA
Hwang, Shin; Lee, Sung-Gyu; Lee, Young-Joo; Kim, Ki-Hun; Ahn, Chul-
Soo; Ko, Kyoung-Hoon; Choi, Nam-Kyu; Kim, Kwan-Woo
Asan Medical Center, Univerisity of Ulsan, Department of Surgery, Seoul,
Korea, Republic of
Introduction. Ampullary carcinoid tumors are extremely rare.
Patient And Method. The present study describes the clinicopathological
features and outcomes for 10 ampullary carcinoid patients who underwent
radical resection from 1998 to 2005. During this study period, 294 patients
underwent pancreatoduodenectomy for ampullary neoplasms in our institu-
tion.
Results. The mean patient age was 58.0913.4 years, and 7 were male.
Initial clinical manifestations were jaundice in 4 patients, non-specific
gastrointestinal symptoms in 5, and completely asymptomatic in 1. Standard
pancreatoduodenectomy was performed in 3 patients, and pylorus-preserving
pancreatoduodenectomy in 7, and there were no major complications. The
mean tumor size and volume were 2.191.3 cm and 4.196.9 mL,
respectively. Synaptophysin staining was positive in 10 patients, and
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chromogranin staining positive in 8. R0 resection was achieved in all 10
patients. Overall and disease-free survival rates were 90% and 80% at 1 year,
and 64% and 56% at 3 years, respectively. The liver was the most common
site of initial metastasis after curative resection. Univariate analyses revealed
that a maximal tumor diameter ]2 cm and tumor extension beyond the
ampulla were risk factors for tumor recurrence.
Conclusion. While the majority of ampullary carcinoids are indolent, this
tumor is associated with a relatively poor prognosis. We believe that radical
resection, with the aim of complete tumor removal and cure, is the treatment
of choice.
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ASSESSMENT OF THE EFFICACY AND TOXICITY OF 131I-
METAIODOBENYLGUANIDINE MIBG THERAPY FOR META-
STATIC NEUROENDOCRINE TUMOURS MNETS
Banks, Melissa1; Poston, Graeme2
1University Hospital Aintree, Centre for Digestive Diseases, Lower Lane,
Liverpool, United Kingdom; 2University Hospital Aintree, Centre for
Digestive Diseases, Liverpool, United Kingdom
Background. MIBG is a licensed palliative treatment for patients with
MNETs. However its’ role in symptom control in MNETs remains
uncertain.
Methods. We retrospectively assessed the consequences of MIBG therapy in
48 patients (30 gastroenteropancreatic, 6 pulmonary, 12 unknown primary
sites) with MNETs between 1996 and 2006.
Results. Mean age at diagnosis 57.6 years (range 34 to 81). MIBG was
administered on 88 occasions (mean 1.8 treatments, range 14). 29 patients
had biochemical markers measured before and after MIBG, and 11 (36.7%)
showed 50% reduction in levels post therapy. 40 patients had radiological
investigations performed post-MIBG, of whom 11(27.5%) showed reduction
in tumour size post therapy. 27 (56.3%) patients reported improved
symptoms post-MIBG therapy. Overall median survival from diagnosis was
79 months. Kaplan-Meier analysis showed significantly increased median
survival of 37 months (p0.01) from date of first MIBG in patients
reporting symptomatic benefit post-MIBG, but no increased survival from
diagnosis. Patients with biochemical and radiological responses didn’t show
any significant alteration in survival compared to non-responders. 11
(22.9%) patients required hospitalisation due to complications, mostly mild
bone marrow suppression.
Conclusions. MIBG improved symptoms in more than half of patients with
MNETs, and overall survival was increased in those patients who reported a
symptomatic response to therapy.
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LAPAROSCOPIC CENTRAL PANCREATECTOMY: EXPERIENCE
OF SIX PATIENTS
Sa Cunha, Antonio; Rault, Alexandre; Beau, Cedric; Masson, Bernard;
Collet, Bernard
Chu Bordeaux, Bordeaux, France
Background. Medial pancreatectomy is an alternative technique for benign
or low grade malignant tumors of the neck of the pancreas. We describe our
experience of laparoscopic central pancreatectomy.
Methods. In 1999, we started a prospective evaluation of laparoscopic
pancreatic resection. Until February 2006, 60 patients were included, 6 of
whom had a laparoscopic central pancreatectomy. Surgical procedure,
postoperative course and follow up were collected.
Results. Laparoscopic central pancreatectomy was achieved in all patients.
In one case, we had to perform a laparotomy to find the specimen which had
been lost in the cavity during the anastomosis. The median operative time
was 225 minutes (range, 180 to 365 minutes). No patient required blood
transfusion in the peri-operative period. There was no mortality. Sympto-
matic pancreatic fistula occurred in two patients (33%). No patient required
reoperation or radiological drainage. Oral feeding was resumed in a median of
11 days (range, 921 days). The median post-operative hospital stay was 18
days (range, 1525 days). With a median follow up of 15 months (range, 434
months), all patients are alive without exocrine or endocrine insufficiency.
Conclusion. Laparoscopic central pancreatectomy is feasible and safe.
Laparoscopic central pancreatectomy may become the standard approach
for resection of benign or low-grade malignant tumors of the neck of the
pancreas performed by highly skilled surgeons.
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CLINICALPATHOLOGICAL FEATURES OF INTRADUCTAL PA-
PILLARY MUCINOUS NEOPLASIA OF THE BILIARY TRACT:
EQUIVALENT TO PANCREATIC PAPILLARY MUCINOUS NEO-
PLASIA?
Kloek, Jaap1; van der Gaag, Niels2; Erdogan, Deha2; Rauws, Eric3; Busch,
Olivier2; Gouma, Dirk2; ten Kate, Fibo2; van Gulik, Thomas2
1Academic Medical Center, Amsterdam, Netherlands; 2Academic Medical
Center, Department of Surgery, Amsterdam, Netherlands; 3Academic
Medical Center, Department of Gastroenterology, Amsterdam, Netherlands
Introduction. Intraductal papillary mucinous neoplasm of the pancreas
(IPMN-P) is a rare but well-established entity, in contrast to intraductal
papillary mucinous neoplasms of the biliary tract (IPMN-B) of which
pathological features and biologic behaviour are largely undetermined. The
aim of the present study was to assess the clinicalpathological features of
IPMN-B and to compare these with IPMN-P.
Methods. The files of 19 patients who underwent resection (19912006) for
IPMN-B (7 underwent local bile duct excision, 8 combined with partial
hepatectomy and 4 PPPD) were reviewed and compared with 20 consecutive
cases resected for IPMN-P (all PPPD). Clinicalpathological characteristics of
all patients were evaluated, resection specimens were reassessed and
immunohistochemically screened for expression of a distinct set of tumor
markers.
Results. The most common presenting symptom in patients with IPMN-B
was obstructive jaundice (63%). The main symptoms in patients with IPMN-
P were abdominal pain (35%), jaundice (25%) and acute pancreatitis (20%).
Eleven IPMN-B patients (58%) had neoplasms with invasive adenocarci-
noma, compared to 4 IPMN-P patients (20%). The 3-year survival rate of
patients with IPMN-B was significantly lower than in IPMN-P patients (62%
vs. 89%, respectively; pB0.01). A high expression of MUC1 and P53 was
associated with a significantly shorter survival. CK7, CK20 and Dpc4 protein
was equally expressed in both groups (77%, 33% and 92%, respectively).
Differences in MUC1, MUC2, MUC5AC and CDX2 expression profile
distinguished 4 histologically distinct types of tumor in the IPMN-B group
(i.e. gastric, intestinal, pancreaticobiliary and oncocytic type), whereas in the
IPMN-P group, 3 different types were identified (not any oncocytic type).
Conclusions. Patients with IPMN-B presented more often with obstructive
jaundice than in IPMN-P. Pathological characteristics of IPMN-B resembled
those of IPMN-P however, IPMNB was associated with a higher malignancy
rate and therefore, worse survival.
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PRIMARY PANCREATIC LYMPHOMA: INCIDENCE, HISTO-
PATHOLOGICAL CHARACTERISTICS AND PROGNOSIS DE-
RIVED FROM A 10-YEAR EXPERIENCE
Cherian, Thomas1; Manzia, T2; Pascoe, J2; Toti, L2; Bramhall, SR2;
Wigmore, SJ2; Mayer, D2; Buckels, JAC2; Mirza, DF2
1University Hosptial, Birmingham, United Kingdom; 2
Background. Lymphoproliferative diseases induced by immunosuppressive
therapy in the gastro-intestinal tract is not infrequent. Primary pancreatic
lymphoma (PPL) however is a rare form of extra nodal lymphoma of
pancreatic parenchyma with most reports limited to single case publications.
As PPLs exhibit diverse biological behaviour and often represents disease that
may be curable even in advanced stages, we reviewed and report our
experience at a high volume tertiary HPB unit.
Method. We conducted a retrospective review of 1551 pancreatic (including
peri ampullary) malignancies from 1997 to 2007, identified from a
prospectively collected database. We present the findings of our analysis of
all cases of PPL, and discuss inducing factors if any, the clinical course,
diagnosis, and treatment of these less common neoplasms of the pancreas.
Results. In total there were 14 cases of PPL leading to an incidence of 1%
[males 10, median age of 60 years (range 2886)]. Presenting symptoms
included abdominal pain(6), jaundice(9), and weight loss(6). The median
follow-up was 23 months (range1129). In the absence of pre-operative
histological diagnosis, five patients (40%) underwent surgery-2 pancreatico-
duodenectomy and 3 palliative bypasses. Final tissue diagnosis confirmed 13
non-Hodgkin’s lymphomas (NHL10; high-grade B-cell lymphoma2;
Burkitt’s1) and one Hodgkin’s lymphoma in a patient with a past history of
nodal Hodgkin’s lymphoma. None of our cohort had had past exposure to
immunosuppression or radiation. In our institution 5-year survival was 50%,
in contrast to ductal pancreatic cancers (5%), with no survival difference
between patients who had and did not have surgery. Conclusion Primary
pancreatic lymphomas are rare, comprising 1% of pancreatic tumours.
The vast majority are non Hodgkin’s tumours. They have a good prognosis
whether they are treated with surgery or not supporting the need to
achieve histological diagnosis even in patients with irresectable pancreatic
tumours.
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SURGERY AFTER NEOADJUVANT CHEMOTHERAPY WITH
BEVACIZUMAB IN PATIENTS WITH INITIALLY UNRESECT-
ABLE COLORECTAL LIVER METASTASIS. A MATCHED PAIR
ANALYSIS
Figueras, Joan1; Albiol, Maite2; Mahfud, Mahfud2; Lopez-Ben, Santiago2;
Codina-Barreras, Antoni2; Falgueras, Laia2; Queralt, Bernardo3; Hernandez-
Yague, Xavi3; Guarden˜o, Raquel3; Ortiz, Rosa4; Soriano, Jordi5; Codina-
Cazador, Antoni2
1Trueta Hospital Girona, Surgery, Girona, Spain; 2Josep Trueta Hospital,
Surgery, Girona, Spain; 3Josep Trueta Hospital, ICO, Girona, Spain; 4Josep
Trueta Hospital, Pathology, Girona, Spain; 5Josep Trueta Hospital, IDI,
Girona, Spain
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Background. Neoadjuvant chemotherapy with Bevacizumab (Bev) has been
reported to be highly effective for initially unresectable liver metastases (LM).
However, wound healing complications and bleeding have been described.
The primary objective was to determine the development of complications,
reoperations and mortality.
Methods. Prospective study. Inclusion Criteria: Stage IV disease with
unresectable LM. 26 patients received neoadjuvant chemotherapy with Bev
before surgical resection of LM. Median time from last dose of Bev and
operation was 61 days range (31180). These patients were matched to 45
patients previously operated who also underwent neoadjuvant chemotherapy
but without Bev. Matching was performed blinded to the patients outcome
and according to the following criteria: age, gender, number and size of LM,
bilobarity and type of hepatectomy.
Results. There were no differences regarding: Gender (p0.075). Median
age (p0.11). Median CEA & Ca 19.9 levels before surgery (p0.3) & (p
0.2). Rectal cancer (p0.35). 43 (61%) patients presented bilobar LM (p
0.35). 42 (59%) underwent major hepatectomy (p0.48). 14 patients (20%)
(p0.4) underwent simultaneous resection of the primary and LM. Mean
number of LM was 5.4(p0.15). 35 (49%) patients had more 3 LM (p
0.34). Mean size was 2.9 cm(p0.63). 25 patients (35%) presented
extrahepatic resectable disease. Mean postoperative stay was 14 days (p
0.38). Only 3 patients needed intraoperative transfusion (p1). Post-
operative mortality was nil in the group of Bev vs 4 (9%) p0.15. Sixteen
(62%) vs 21(48%) patients experienced postoperative complications p
0.17. Without differences between groups except for reintervention that
was more frequent in patients with Bev 7(27%) vs 3(7%) p0.02. In the Cox
regression analysis, factor related with reoperation were presence of extra-
heptic disease (p0.01) and use of Bev (p0.053).
Conclusion. Chemotherapy with Bevacizumab is safe. Reoperations seam to
be related to other factors
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TREATMENT OF COLORECTAL LIVER METASTASES WITH
SELECTIVE INTERNAL RADIATION THERAPY: DOES PRIOR
CHEMOTHERAPY AFFECT THE RESPONSE RATE?
Stubbs, Richard; Rajekar, Harshal; Croft, Anthony; Mendis, Nishantha
Wakefield Hospital, The Wakefield Clinic, Wellington, New Zealand
Background. Selective Internal Radiation Therapy (SIRT) is a relatively
new and effective modality for treating liver tumours including CRC liver
metastases. It involves radiotherapy to the tumours as opposed to che-
motherapy.
Aim. To determine if the response rate of CRC liver metastases to SIRT is
affected by prior exposure of the patient to systemic chemotherapy.
Methods. We have demonstrated that patients in whom CEA values fall by
more than 75% in the 2 months following SIRT, have a better survival than
those in whom such a CEA fall is not seen (Boppudi S et al Australasian
Radiology 2006). We have used this criteria in those with elevated CEA, or a
reduction in tumour size on CT, in those with normal CEA, as a measure of
response to determine whether the response rate of CRC liver metastases to
SIRT is affected by prior exposure to systemic chemotherapy.
Results. 156 patients with CRC liver metastases received SIRT between
January 97 and April 2006. This included 98 males and 58 females with a
mean age of 60 years. 40 of the 156 patients had received some form of
systemic chemotherapy prior to undergoing SIRT (23 oxaliplatin/irinotecan
based regimens, 17 capecitabine/5FU based regimes). Tumour response was
assessed by CEA levels in 137 patients and by CT scan changes in 14.
Evaluation was not possible in the other 5 patients (early death 3 patients,
insufficient data 2 patients). Responses were seen in 96 of the 151 patients
(64%). Of the 111 who received no prior chemotherapy 72 responded (65%),
and of the 40 who received prior chemotherapy 24 (60%) responded. These
differences are not significant (p0.05). Of the 23 patients who received
oxaliplatin and/or irinotecan based regimens, 12 (52%) responded. This
difference is statistically significant (pB0.05).
Conclusion. Response rates of CRC liver metastases to SIRT are high, but
are reduced a little in those who have had prior oxaliplatin or irinotecan based
chemotherapy regimens.
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RESPONSE TO NEOADJUVANT CHEMOTHERAPY PREDICTS
OUTCOME AFTER RESECTION OF HEPATIC COLO-RECTAL
METASTASES BETTER THAN TRADITIONAL CLINICAL RISK
FACTORS
Ben-Haim, Menahem1; Small, Risa1; Lubezky, Nir1; Shmueli, Einat2;
Nakache, Richard1; Aderka, Dan3; Klausner, Joseph1
1Tel-Aviv Sourasky Mediacal Center, Surgery B, Tel-Aviv, Israel; 2Tel-Aviv
Sourasky Mediacal Center, Oncology, Tel-Aviv, Israel; 3Sheba Medical
Center, Oncology, Tel Hashomer, Israel
Background. The prognosis of patients following resection of CRC
metastases to the liver has traditionally been predicted by clinical risk factors,
such as the Memorial Sloan-Kettering Cancer Center Clinical Score
(MSKCC-CS, including: number of metastases, size of largest metastases,
lymph node status, CEA level and disease-free interval). However, in the era
of contemporary neoadjuvant chemotherapy, the clinical scoring system
needs re-validation and the role of treatment related factors as prognostic
indicators should also be investigated.
Methods. Retrospective study including patients with CRC liver metastases,
who received oxaliplatin or irinocetan based neoadjuvant chemotherapy and
underwent R0 resection of liver metastases. Patients followed with tumor
markers, CT and PET-CT, before, during and after chemotherapy and
surgery. The predictive value of the MSKCC-CS and degree of response to
chemotherapy (measured by CT and PET-CT), were analyzed by univariate
and multivariate analysis and COX regression.
Results. Included are 54 patients, average age, 60 (range 3086), mean
MSKCC clinical score, 2.6 (range 15). Response to chemotherapy on CT
was found to be a significant predictor of survival on both univariate (p
0.03) and multivariate analysis (p0.03), whereas the MSKCC-CS and
response to chemotherapy on PET-CT were not. Time to recurrence was
predicted by the response to chemotherapy measured on CT (p0.03; p
0.02) & PET-CT (p0.009, p0.03) on both univariate and multivariate
analysis, respectively, whereas the MSKCC-CS was not (p0.30, p0.64).
Conclusions. In this cohort of patients treated with neoadjuvant chemother-
apy, the outcome was not predicted by the traditional clinical scoring system,
but rather by response to chemotherapy as evaluated by CT and PET-CT.
This observation should be considered while designing treatment strategy
and establishing justification of surgery for patients with CRC metastases to
the liver.
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Survival after systemic chemotherapy and liver resection for color-
ectal metastases; a ten year audit
Lordan, Jeffrey; Karanjia, Nariman D.; Fawcett, William J; Quiney, Nial;
Worthington, Tim R.; Remington, Jacky
Royal Surrey County Hospital, Guildford, United Kingdom
Background. Metastatic colorectal carcinoma is a common cause of cancer
death. Hepatic resection offers the only potential cure. The aim of this study
was to audit the operative morbidity and overall and disease free mortality of
metastatic colorectal cancer in a modern tertiary referral unit.
Methodology. All patients who underwent surgical treatment for colorectal
metastases over a ten year period were included. Patients were treated with
chemotherapy preoperatively for synchronous and early (B2 years) meta-
chronous metastases. Data were collected prospectively. End points were
overall and disease free survival, peri-operative morbidity and mortality.
Univariate and multivariate analyses were used to identify mortality risk
factors.
Results. 283 patients underwent hepatic resections with curative intent.
Overall survival at 1, 3 and 5 years was 90%, 59.2% and 46.1% respectively.
Disease free survival at 1, 3 and 5 years was 68.1%, 34.8% and 27.9%
respectively. Operative mortality was 2.1% and morbidity was 23.7%.
Patients with macroscopic diaphragm invasion by tumour, CEA100,
tumour size5cm or a segmentectomy had a significantly worse long term
outcome. Dukes’ stage had no effect on overall survival.
Conclusions. Morbidity and mortality for hepatic resection for colorectal
liver metastases is improving. The 5 year survival of 46% should encourage
surgeons to adopt an ever more aggressive approach to treating/referring
hepatic colorectal metastases.
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EFFECTS OF PRE-HEPATECTOMY (HPX) OXALIPLATIN (O)
ON NORMAL LIVER ARCHITECTURE IN PATIENTS COMING
TO HPX FOR COLORECTAL LVER METASTASES (CLM)
Pathak, Samir1; Poston, Graeme J2; Verghese, Miriam E2; Foster, Christo-
pher S3
1Royal Liverpool University Hospital, Dept of Surgery, Liverpool, United
Kingdom; 2Royal Liverpool University Hospital, Surgery, Liverpool, United
Kingdom; 3Royal Liverpool University Hospital, Pathology, Liverpool,
United Kingdom
Background. Pre-HPX O is used routinely before HPX for colorectal liver
metastases. Concern has been expressed about hepatic sinusoidal obstruc-
tion, and post-operative complications in these patients OBJECTIVES-Use
of Electron (EM) and light microscopy(LM) to ascertain whether there was
any microscopic differences in chemotherapy treated (C), and chemotherapy
naive livers (NC). Additional measures such as post-operative stay and
complications were also studied.
Methods. Tru-cut biopsies were taken from normal liver at HPX and
underwent, both LM with H&E staining and EM with osmium-tetroxide
fixation. Hepatic steatosis and sinusoidal dilatation were graded on a linear
scale (03) on LM.
Results. 32 specimens were analysed in total, 16 in each arm(NC and C). All
pre-operative liver function tests were normal, there was no difference
between the two groups in post-operative stays or complication rates. LM
showed 7 C samples to demonstrate sinusoidal dilatation(grade 12) and 4 C
samples to show steatosis (grades 12). 5 NC samples showed sinusoidal
dilatation(grades12) and 7 illustrated steatosis (grades 12). No nodular
hepatic regeneration or perisinusoidal fibrosis/ veno-occlusive disease in
either group. EM showed normal intracellular hepatocyte architecture in all
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NCs, but all Cs showed development of lipofuscin cytoplasmic blebs, marked
paucity of mitochondria and loss of uniformly granulated cytoplasm which
contained fragmented membranes.
Conclusions. There were no obvious differences in LM appearances. There
were real and measurable O related changes to intracellular hepatocyte
architecture but these did not relate to biochemical liver dysfunction or
increased postoperative complications in this sample.
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MOLECULAR PROGNOSTIC MARKERS IN COLORECTAL CAN-
CER LIVER METASTASES: CD31, CD34, VEGF, PDGF AND EGFR
DO NOT PREDICT OUTCOME
Ben-Haim, Menahem1; Small, Risa1; Brazowski, Eli2; Shmueli, Einat3;
Nakache, Richard1
1Tel-Avi Sourasky Medical Center, Surgery B and Transplantation, Tel-Aviv,
Israel; 2Tel-Aviv Sourasky Medical Center, Pathology, Tel-Aviv, Japan; 3Tel-
Aviv Sourasky Medical Center, Oncology, Tel-Aviv, Israel
Background. The pathological evaluation of biochemical markers in liver
metastases can be a potential strategy to select chemotherapy and predict
outcome. We evaluated five molecular markers in resected colorectal liver
metastases from patients who received neoadjuvant chemotherapy to
determine their correlation with outcome.
Methods. Immunohistochemical staining for markers related to angiogenesis
and endothelial receptors, including vascular endothelial growth factor
(VEGF), epidermal growth factor receptor (EGFR), platelet-derived growth
factor (PDGF) and endothelial markers, CD31 and CD34. All were from
colorectal cancer liver metastases, which were treated with oxaliplatinin or
irinocetan based neoadjuvant chemotherapy and bevacizumab followed by
R0 resection. Microvessel quantification was performed for CD31 and CD34
staining, and staining intensity grading and percentages were assessed for
VEGF, EGFR, & PDGF. Clinical data (demographics, staging, response to
chemotherapy and outcome) were extracted from charts. Kaplan Meier
survival and Cox univariate and multivariate analysis were performed.
Results. Tumor specimens from 34 patients’ resected liver metastases were
examined (18 men, 16 women; mean age 60.3). Mean microvessel counts for
CD31, CD34 marginal and central epithelium were 45, 55, and 34,
respectively. EGFR stained negatively in all specimens. VEGF and PDGF
mean staining intensity were graded as 1.59 and 1.68, respectively, on a scale
of 03. Findings of the immunohistochemical staining failed to show
significance of these 5 markers in predicting disease recurrence and overall
survival. There was no difference in patients who did and did not respond to
chemotherapy.
Conclusions. These five molecular markers failed to show significance in
outcome prediction. Further evaluation of biochemical markers is warranted
in the setting of colorectal cancer and hepatic metastases in order to improve
case selection for surgery and aid in design of the most appropriate
chemotherapy regimen.
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LIVER RESECTION OF COLORECTAL METASTASES IN EL-
DERLY PATIENTS: IS IT WORTHWHILE AND IS THERE AN
AGE LIMIT?
Adam, Rene´1; Laurent, Christophe2; Poston, Graeme J3; Figueras, Juan4;
Capussotti, Lorenzo5; IJzermans, Jan NM6; Colombo, Pierre E7; Herrera,
Javier8; Ruers, Theo9; Mentha, Gilles10; Wicherts, Dennis A1; de Haas,
Robbert J1; and, LiverMetSurvey11
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Background. Elderly patients are increasingly submitted to similar treat-
ment strategies as younger patients for colorectal liver metastases (CLM), but
a question remains concerning a possible age limit for surgery. LiverMet-
Survey is an international multicentre registry that allows evaluation of large
cohorts of patients with long-term results.
Aim. To evaluate the outcome after liver resection of CLM in patients ]70
years.
Methods. From January 1986 to July 2006, among 3662 patients resected
for CLM in 36 centers from 11 countries, 729 (20%) were aged ]70 years.
Of these, 463 (13%) were 7075 years, 194 (5%) 7580 years and 72 (2%) ]
80 years. The total cohort of elderly patients was compared to the younger
population. Within the elderly group, a multivariate analysis was conducted
to determine prognostic factors of survival.
Results. Elderly patients had a higher maximum tumor size ( 50 mm: 28
vs. 23%, P0.02), but less multinodular disease (3 nodules: 11 vs. 23%,
PB0.0001). Hepatectomy was more frequently limited (B3 segments: 53 vs.
43%, P0.0002) and curative (94 vs. 91%, P0.01). Perioperative
mortality within 2 months was increased (4 vs. 2%, PB0.0001). Overall 5-
year survival was lower than that of younger patients (37 vs. 44%, P0.001).
Within the elderly group, three factors emerged as independently associated
to poor survival: synchronous metastases (P0.01), bilateral distribution
(P0.01) and presence of concomitant extrahepatic disease (P0.01). Five-
year survivals after resection were not different between patients aged 7075
years (39%), 7580 years (31%) and ]80 years (31%) (P0.83).
Conclusion. In patients ]70 years, liver resection for CLM is able to
provide a 5-year survival of 37%, with however an increased perioperative
mortality. After 70 years, there is no upper age limit to contraindicate surgery
and well selected octogenarian patients may hope for similar long-term
survival.
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TWO-STAGE HEPATECTOMY FOR IRRESECTABLE COLOR-
ECTAL CANCER LIVER METASTASES: A 14-YEAR EXPERI-
ENCE
Adam, Rene´; Wicherts, Dennis A; Miller, Rafael; de Haas, Robbert J;
Bitsakou, Georgia; Vibert, Eric; Veilhan, Luc Antoine; Azoulay, Daniel;
Bismuth, Henri; Castaing, Denis
Hoˆpital Paul Brousse, Centre He´pato-Biliaire, Villejuif, France
Background. Single curative hepatectomy for multiple bilateral colorectal
liver metastases (CLM) may be impossible for patients with an unfavorable
distribution of the disease, even in combination with preoperative che-
motherapy, portal embolization and local ablation. In a two-stage strategy,
compensatory liver regeneration after a first noncurative hepatectomy may
enable a second curative resection.
Aim. To assess feasibility, risks and outcomes of two-stage hepatectomy in a
large single center experience.
Methods. Between October 1992 and October 2006, 51 patients with
irresectable CLM were planned for two-stage hepatectomy, since single
resection could not achieve a complete treatment. Feasibility, risks and
outcomes were reviewed.
Results. Two-stage hepatectomy was feasible in 35 of 51 patients (69%).
Mean age for the 35 successfully treated patients (M/F18/17) was 57.5
years. Patients had a mean number of 9.6 metastases with a mean maximum
diameter of 50.2 mm at diagnosis. All but one patient (97%) received
preoperative chemotherapy, 27 (77%) continued chemotherapy between the
two procedures and 26 (74%) also received postoperative chemotherapy. The
mean delay between the two liver resections was 4.3 months. Postoperative
mortality within 2 months was 0% and 11% after the first and second
hepatectomy, respectively. Morbidity rates were also higher after the second
hepatectomy (63 vs. 23%, PB0.01). After a median follow-up of 26.0
months (range: 3.7130.3), overall 3- and 5-year survivals were 57% and
39%, respectively, from the time of first hepatectomy.
Conclusion. Two-stage hepatectomy can be considered an established
potentially curative strategy in the treatment of selected patients with
irresectable multiple CLM. Mortality and morbidity rates after the second
hepatectomy are however increased, in these patients concomitantly treated
by prolonged chemotherapy. Patients that can sustain this aggressive
complete strategy experience a 5-year survival of 39% and are provided
with a hope of long-term survival.
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TIMING OF LIVER SURGERY FOR SYNCHRONOUS COLOR-
ECTAL METASTASES: A CASE-MATCHED STUDY
de Haas, Robbert J; Wicherts, Dennis A; Azoulay, Daniel; Castaing, Denis;
Bismuth, Henri; Adam, Rene´
Hoˆpital Paul Brousse, Centre He´pato-Biliaire, Villejuif, France
Background. Surgery is still the only potentially curative treatment for
patients with synchronous colorectal liver metastases (CLM). However, no
clear data exists regarding the optimal surgical strategy for these patients,
mainly because groups of one- and two-stage strategy are not comparable in
terms of extent of liver disease.
Aim. To compare simultaneous colorectal and hepatic resection with a
delayed strategy in patients with a limited (B3 segments) hepatectomy.
Methods. All patients with synchronous CLM who underwent limited
hepatectomy at our hospital were included. Patients treated by a simulta-
neous colorectal and hepatic resection (S group) were compared to patients
treated with a delayed hepatectomy (D group). Subsequently, patients of
each group were matched for age, gender, number and distribution of CLM.
Short-term outcome, overall (OS) and disease-free survival (DFS), and
prognostic factors were determined.
Results. Between 1986 and 2006, 228 patients underwent hepatectomy for
synchronous CLM, of whom 55 (24%) underwent simultaneous colorectal
resection versus 173 (76%) in whom hepatectomy was delayed. Postoperative
mortality (5 2 months) was similar between both groups (0% vs. 1%, P
0.56), however, morbidity was significantly less within the S group (9% vs.
24%, P0.02). Five-year OS and DFS were 47% and 24% in the S group,
respectively, compared to 52% and 27% in the D group (P0.48 (OS) and
P0.83 (DFS)). After case-matching, 26 patients remained in each group,
similar in terms of number, size, and distribution of CLM, confirming these
Results. Multivariate analysis revealed 3 poor prognostic factors of survival:
64 Abstracts
female gender,3 CLM at diagnosis, and maximum size of CLM at
diagnosis30 mm.
Conclusion. Combining colorectal resection to a limited hepatectomy is a
safe procedure for patients with synchronous CLM, with survival rates
comparable to a delayed strategy, and even less morbidity. It can be
recommended to patients with limited hepatic disease.
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Evaluation of pull-through adhesive pancreatojejunostomy (Kaki-
taIfs method) following pancreatoduodenectomy
Kazunori, Furuta
Kitasato University, SURGERY, 2-1-1 Asamizodai Sagamihara, KANA-
GAWA, Japan
Objective. To establish the advantage of our technical procedure and
outcome of a consecutive series of pancretojejunostomies Summary Back-
ground Data: The mortality rate after pancreatoduodenectomy has been
reported to be 4% in institutions in which the number of patients is large. Of
the complications, leakage of pancreatic fluid, which could be fatal, is
important. To prevent pancreatic suture failure, various modifications have
been performed in many institutions. Among the surgical procedures,
pancreatojejunostomy, which will affect the outcome, is most important.
Therefore, a simple anastomotic method that does not cause complications,
which can be used by general surgeons, is necessary.
Methods. 343 consecutive patients who underwent pancreatojejunostomy by
our pull-through adhesive pancreatojejunostomy were reviewed.
Results. Of the 343 consecutive patients, the complication of pancreatic
fistulae was observed in 5 patients (1.46%). In all 5 patients with post-
operative pancreatic fistulae, the leakage of pancreatic fluid was reduced by
long-term indwelling of the drains, and recovery was achieved. The exocrine
function of the remaining pancreas was examined by the PFD test. The
follow-up observation period was 6120 months (mean, 31.4 months). A
PFD level of more than 70% is normal. The mean PFD level of patients was
68.3I}5.93% before and 68.1I}17.3% after surgery. There was no
significant difference in the PFD level between before and after surgery,
indicating that, following surgery, the exocrine function of the pancreas was
maintained at the same level as that before surgery. During the 5-year follow
up after discharge following the initial procedure, 10.1% of 46 survival
patients developed insulin-dependent diabetes mellitus(IDDM), and during
the 10-year follow up, 17.6% of 17 survival patients developed IDDM.
Conclusions. Our pancreatojejunostomy method is simple, safe, and useful.
We consider that it is necessary to evaluate the maintenance of pancreatic
function during a longer period after surgery.
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RESULTS OF PANCREATICODUODENECTOMY IN PATIENTS
WITH PERIAMPULLARY CARCINOMA. PERINEURAL GROWTH
MORE IMPORTANT PROGNOSTIC FACTOR THAN ORIGIN OF
TUMOR
van Roest, Margijske HG1; Gouw, Annette SH2; Peeters, Paul MJG1; Porte,
Robert J1; Slooff, Maarten JH1; Fidler, Vaclav3; de Jong, Koert P1
1University Medical Center Groningen, Hepato-Pancreato-Biliary Surgery,
Groningen, Netherlands; 2University Medical Center Groningen, Pathology,
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Background. Pancreatic head carcinoma is considered to have the worst
prognosis of the periampullary tumors (papil of Vater, distal bile duct or
duodenum carcinoma). Several other prognostic factors for periampullary
tumors have been identified, e.g. lymph node status, free resection margins,
tumor size and differentiation and vascular invasion. The impact of
perineural growth in relation to the site of origin of periampullary carcinomas
is less well known.
Objective. To study the impact of perineural growth as a prognostic factor in
the various tumor types (pancreatic head, papil of Vater, distal bile duct and
duodenum carcinoma).
Methods. 205 patients were retrieved form our prospective database of
patients with periampullary carcinomas.
Pancreaticoduodenectomy was performed in 121 patients with a periampul-
lary tumor. 64 patients were found not resectable and underwent a bypass
procedure. Clinicopathological characteristics were analyzed in a multivariate
analysis.
Results. Angioinvasion was found in 29% of the cases, perineural growth in
49% of the cases. Perineural growth was present in 37 of 51 patients with
pancreatic head carcinoma, in 7 of 30 patients with papil of Vater carcinoma,
in 7 of 19 with distal bile duct carcinoma, and in 8 of 21 with duodenum
carcinoma. Overall 5-year survival was 32.6% (median survival 20.7
months). Median survival in tumors with perineural growth was 13.1 months
as compared to 36.0 months in tumors without perineural growth. Using
multivariate analysis the following unfavorable prognostic factors were
identified: perineural growth (RR2.90), R1 resection (R2.28), positive
lymph nodes (R1.96) and angioinvasion (R1.79). Portal or superior
mesenteric vein reconstruction and tumor localization were not of statistically
significant importance.
Conclusion. Perineural growth is a more import riskfactor for survival than
the site of origin of periampullary carcinomas.
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PANCREATIC FISTULAS AFTER DUODEDOPANCREATOMY:
HOW TO PREDICT THE GRAVITY? INTEREST OF AN INTRA-
OPERATIVE CLASSIFICATION OF PANCREATIC STUMP
Ewald, Jacques; Sa Cunha, Antonio; Rault, Alexandre; Collet, Denis;
Masson, Bernard
Maison du Haut-Leveque, Department of Digestive Surgery, 33600 PES-
SAC, France
Introduction. Identify the morbidity and mortality risk factors after
duodeno-pancreatectomy and estimate the capacity of intra-operative pan-
creatic stump classification for predicting the risk and the seriousness of
pancreatic fistulae.
Methods. A retrospective study of 245 patients who underwent a duodeno-
pancreatectomy with intra-operative classification of the remaining pancreas
in three types. 97 (39,6%) patients had a type I pancreas (healthy pancreas
and Wirsung diameterB5 mm), 27 (11%) a type II (delicate IIa or
unstitchable IIb) and 121 (40,4%) a type III (sclerous IIIa or atrophic
IIIb). 32 (13%) received a neo-adjuvant treatment for pancreatic adenocar-
cinoma. Through a blind study, we have analysed the pancreas histological
characteristics (fibrosis and adipose tissue density) of 35 patients according to
the three types (12 types I, 10 types II and 13 types III). Conducting uni or
multi-variable analysis, we have looked for the predictive factors of the
pancreatic fistula occurrence, its gravity and the mortality.
Results. We have found two predictive factors of pancreatic fistula: the
pancreatic stump kind and the absence of neo-adjuvant treatment. Sixty
patients (24,5%) had pancreatic fistula. Among them 80% were type II,
25,7% type I and 10,7% type III (pB0,0001). Fistulae of type II pancreas
appeared earlier (p0,04) and were more serious: haemorrhage risk of type
II was 10 times higher than type I (p0,001) and 40 times higher than type
III (p0,001). The only predictive factor of mortality was the kind of stump:
type II mortality (25,7%) exceeded types I or III (1,1%) (pB0,0001). Only
one fistula (3,2%) occurred among the 32 patients who received pre-
operative treatment (p0,0001).
Conclusion. This classification may be a tool to predict the gravity of
pancreatic fistula. It will also enable to adapt the surgical course and the post-
operative support related to the pancreatic fistula risk.
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POST-OPERATIVE PANCREATIC FISTULA-CAN BINDING
TECHNIQUE SOLVE THE PROBLEM? THE EXPERIENCE
FROM A REGIONAL HOSPITAL IN HONG KONG
FUNG, Ting-Pong1; LAM, Siu-Ho2
1United Christian Hospital, Department of Surgery, 130 Hip Wo Street,
Kwun Tong, Hong Kong, China; 2United Christian Hospital, Department of
Surgery, Hong Kong, China
Introduction. Binding technique had been reported to have zero leakage
rates for pancreatojejunostomy. However, whether this technique is easily
reproducible is not known. The Objective of this study is to review the
incidence of pancreatic fistula, defined according to the international study
group of pancreatic fistula (ISGPF) between the end-to-side pancreatojeju-
nostomy (end-to-side PJ) and binding technique pancreatojejunostomy
(binding PJ).
Method. From 2002 to mid 2007, patients undergoing pancreatoduode-
nectomy were reviewed. The method of pancreatojejunostomy (PJ), leakage
defined by the ISGPF, mortality and re-operative rate were reviewed and
compared.
Results. There were 38 cases of pancreatoduodenectomy. 17 cases got end-
to-side PJ and 21 cases got binding PJ. According to the ISGPF definition, in
the end-to-side PJ group, there were 6 cases of Grade A(66.7%), 1 case of
Grade B(11.1%) and 2 cases of Grade C(22.2%) pancreatic fistula. In the
binding group, there were 4 cases of Grade A (36.4%), none in Grade B and
7 cases of Grade C (63.6%) pancreatic fistula. 3 cases of the end-to-side
group ( 3/17, 17.6%) and 7 cases of the binding group (7/21, 33.3%) ended
up with re-operation and total pancreatectomy. 2 out of the 17 cases in end-
to-side group and 3 out of the 21 cases in the binding group resulted in
mortality.
Conclusion. Although binding technique had been reported to have zero
leakage rates, the result seemed not so easily reproducible. In case of leakage,
it is more common to have disastrous Grade C pancreatic fistula requiring re-
operation.
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TREATMENT STRATEGY FOR PANCREATIC FISTULA AFTER
PANCREATO-DUODENECTOMY
Shimoda, Mitsugi; Kita, Junji; Katoh, Masato; Rokkaku, Kyu; Sawada,
Tokihiko; Kubota, Keiichi
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Aim. Pancreatic fistula (PF) is the most frightening and most frequent
complications after pancreaticoduodenectomy (PD). This study was under-
taken to determine which independent factors influence the development of
PF after PD.
Material and Methods. Between April 2000 and April 2007, 127con-
secutive patients underwent a PD with pancreaticojejunostomy (PJ). We
performed reconstruction after PD using modified Child.
Methods. Pancreatic duct tube was inserted and fixed by 40 TF Vicryl and
PJ was performed using 40 PDS-II. Omentum graft covered in the GDA
then 4 drains were put into the PJ from middle line incision. We diagnosed as
PF developing in patients with a 1 POD amylase value in drains of more than
10,000 U/L. We have divided patients into 2 groups, PF group and non PF
group. Patient characteristics were comparable in both groups. The predict-
ing risk factors selected in the univariate setting were amount of bleeding,
operating time, hospital stay, gender, age, with or without DM, with or
without hepatic resection or not, p-duct tube size, "soft" pancreas or not and
tumor location. Result: Thirty-four of 127 patients had PF, the overall
incidence of PF was 26.7%. There were 23 male and 11 female. Mean
operating time, bleeding and postoperative hospital stay were 587.9 min.,
729.4 ml and 46.0 days, respectively. Thirty of 34 patients were in need of
continuous lavage. Four patients had GDA bleeding, 3 had TAE and one had
operation. One of the four patients died from liver failure after TAE. PF was
more frequent high age ( 65yrs) and soft pancreas, and prolonged hospital
stay after surgery (P0.03, P0.04, P0.0001). Amount of bleeding,
operating time, gender, with or without DM, with or without hepatic
resection, p-duct tube size and tumor location were not significant difference
between two groups.
Conclusion. High age is more frequent risk for PF, and PF prolonged
hospital stay after PD.
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NO EVIDENCE FOR SUBSTANTIAL SYSTEMIC ACTIVATION OF
BLOOD PLATELETS DURING ORTHOTOPIC LIVER TRANS-
PLANTATION
Pereboom, Ilona TA1; Lisman, Ton1; Hendriks, Herman GD2; Porte,
Robert J1
1University Medical Center Groningen, Hepatobiliary Surgery and Liver
Transplantation, Groningen, Netherlands; 2University Medical Center
Groningen, Anaesthesiology, Groningen, Netherlands
Background. In hemostatically compromised patient with liver failure,
additional substantial hemostatic changes occur during orthotopic liver
transplantation (OLT). Platelet function is thought to deteriorate during
OLT, as a result of platelet activation and proteolysis of platelet receptors by
plasmin following reperfusion, but this hypothesis was never formally tested.
Objective. To study platelet function markers in samples taken during and
after OLT.
Methods. Fifteen patients undergoing OLT were included in the study.
Samples were taken at induction of anaesthesia, 15 minutes after the start of
the anhepatic phase, 15 minutes after reperfusion, at the end of surgery, and
at post-operative days 1, 5, and 10. In addition, one sample was taken directly
from the venous outflow from the liver immediately after reperfusion. Platelet
activation was assessed by measuring activation makers on platelets by flow
cytometry, and by measurement of activation products in plasma by ELISA.
Results. No increase in platelet activation as measured by P-selectin and
activated a´IIbaˆ3 expression on the platelets was observed during OLT. In
fact, these activation markers decreased post-operatively, indicating that the
platelets were in a pre-activated state at the start of surgery. No increases in
the soluble activation markers cleaved GPV, GPIba´, and a´-granule-released
beta-thromboglobulin was observed during OLT. Also at 10 days after
surgery plasma levels of these makers were comparable to the levels observed
at the start of surgery. Significant proteolysis of PAR-1, GPIb and a´IIbaˆ3 was
only observed in the sample taken directly after reperfusion, but no
proteolysis of these receptors could be observed in systemic blood samples
at all time points.
Conclusion. Using flow cytometry and measurement of soluble platelet
receptors, we found no evidence for a significant activation of circulating
blood platelets during OLT. These data suggest that platelet activation and
proteolysis of platelet receptors is not as overt as previously assumed.
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ACTIVE IMMUNIZATION IN PATIENTS WHO UNDERWENT
LIVER TRANSPLANTATION FOR HBV-RELATED LIVER DIS-
EASE
Lee, Hae Won; Suh, Kyung-Suk; Kim, Joohyun; Shin, Woo Young; Yi, Nam-
Joon; Lee, Kuhn Uk
Seoul National University College of Medicine, Department of Surgery,
Seoul, Korea, Republic of
Background. Active immunization has been tried as an alternative strategy
of HBV prophylaxis after liver transplantation for HBV-related liver disease
because of several disadvantages of conventional prophylactic methods with
hepatitis B immune globulin (HBIG) and lamivudine. We described our
experience of HBV vaccination to find its problems and future prospects.
Methods. Preliminary study was performed on eight patients who had
undergone LT for HBV-related liver disease more than two years before. All
patients showed normal liver function without HBV recurrence or other
complications before vaccination. High dose of recombinant vaccine (80¥ı`g)
were intramuscularly administered four times (0-, 5-, 10-, and 25-week
schedule). We continued HBIG administration during the study. Addition-
ally, the vaccination results of twelve random cases not included in this study
were also investigated.
Results. In only one (12.5%) of eight patients included in preliminary study,
HBIG administration could be discontinued (180IU/L). The others
continued to need HBIG to maintain proper anti-HBs level. Of twelve
non-study patients, however, six could maintain anti-HBs level without
HBIG administration and all of three patients who had received only
lamivudine and vaccination because of intolerability to HBIG could maintain
good anti-HBs level (30IU/L) without HBIG although they required
repetitive boosters.
Conclusion. High dose HBIG may disturb the production of anti-HBs
antibodies and HBV vaccination under lamivudine prophylaxis is seems to be
more effective for active immunization. More potent vaccination method
than simple high dose recombinant vaccine, such as adjuvant HBV vaccine,
may be necessary for successful active immunization.
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QUALITY IMPROVEMENT PROGRAM FOR LIVER TRANS-
PLANT ANESTHESIA REDUCES BLOOD TRANSFUSION,
NEED FOR MECHANICAL VENTILATION AND DURATION OF
HOSPITAL CARE
Hevesi, Zoltan1; Lopukhin, Sergei2; Mezrich, Joshua3; Lee, Minjung4;
Andrei, Adin-Cristian5
1University of Wisconsin, Madison, United States; 2University of Wisconsin
Hospital and Clinics, Anesthesiology, Madison, United States; 3University of
Wisconsin Hospital and Clinics, Transplant Surgery, Madison, United
States; 4University of Wisconsin, Department of Statistics, Madison, United
States; 5University of Wisconsin, Biostatistics and Medical Informatics,
Madison, United States
Background. Continuous quality improvement (CQI) is widely used in
various industries. This method is based on repeated data collection to
improve the product. Adapting CQI principles to medicine has limitations.
Liver transplantation presents a unique challenge for anesthesiology Chairs in
allocating the right level of anesthesiology expertise. Different solutions can
be found in various institutions, and the variability of care is significant.
Objective. We aimed to determine if a dedicated anesthesia team is a
worthwhile investment of resources.
Methods. We describe organizational changes such as a new dedicated liver
transplant anesthesia team, increased anesthesia involvement in the trans-
plant service-line functions, new resident rotation, regularly updated evi-
dence-based clinical guidelines and a new liver transplant anesthesia
database. We compare blood transfusion, postoperative mechanical ventila-
tion, intensive care duration and length-of-stay (LOS) for patients under-
going liver transplantation before and after implementation of our CQI
program.
Results. In 2003, we implemented an anesthesia CQI process that was based
on periodic data analysis of liver transplantation cases and sequential
enhancement of anesthesia care. During the follow-up period, patient
complexity, surgical group-composition and surgical technique were essen-
tially unchanged. We observed significant reductions of the intra-operative
blood transfusion requirement, need for postoperative mechanical ventila-
tion, intensive care duration and LOS. 20002002 (N217) 2005 (N87)
RBC 14.9 (16.9) 5.2 (5.4)* FFP 28.1 (21.2) 3.4 (4.7)* ICU (day) 4.5 (6.1)
3.0 (4.1)* Vent (day) 2.3 (4.5) 1.3 (3.3)* LOS (day) 23.1 (23.6) 14.0 (10.3)*
Mean (Std Dev) *p-valueB0.05.
Conclusions. Our CQI program was associated with an improvement of
short-term patient outcomes at a large university hospital. The quality
improvement process described here may be a useful model for other similar
hospitals attempting to improve liver transplant anesthesia care.
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SEVERITY OF HEPATIC STEATOSIS AND OUTCOME AFTER
ORTHOTOPIC LIVER TRANSPLANTATION: AN ANALYSIS OF
RISK FACTORS
Deroose, Jan1; Zondervan, Pieter2; Kazemier, Geert1; Metselaar, Herold3;
IJzermans, Jan N.M.1; Alwayn, Ian P.J.1
1Erasmus MC, Departments of Surgery, Rotterdam, Netherlands; 2Erasmus
MC, Pathology, Rotterdam, Netherlands; 3Erasmus MC, Hepatology,
Rotterdam, Netherlands
Background. Macrovesicular steatosis is thought to be an important risk
factor for initially poor function (IPF) or even dysfunction after orthotopic
liver transplantation (OLT). Due to shortage of grafts severe fatty infiltrated
livers have been used with varying results.
Aim. To evaluate the impact of steatosis in combination with other known
risk factors on the outcome of OLT in terms of IPF, survival and hospitalized
time.
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Methods. We analyzed 185 consecutive OLT’s between 2000 and 2004. The
degree of steatosis was determined by histological examination and classified
as non (M0), mild (B30%, M1), moderate (3060%, M2) or severe
macrovesicular steatosis (60%, M3). Recipients were classified as showing
primary function or IPF of the transplanted liver based on serum transami-
nases.
Results. IPF was observed in 34% of M0, 32% of M1, 58% of M2 and 88%
of M3 cases (pB0,001). In multivariate regression analysis, the grade of
steatosis, heart beating (HB) vs. non-heart beating (NHB) donor, and
duration of cold ischemia time (CIT) were significantly associated with IPF
(pB0,001, p0,003 and p0,027, resp.). Furthermore, the risk of
developing IPF is 40.3% for livers with M3 steatosis, 40.9% for NHB livers
and 33.5% for livers with long CIT (500 minutes). If none of the risk
factors are present, the risk of developing IPF is 7,2%, whereas the presence
of all risk factors increases the risk to 97,5%. Patients with IPF have a
significantly shorter patient survival than those without IPF (p0,04). Graft
survival was not influenced by IPF (p0,07).
Conclusion. Livers with severe steatosis from NHB donors with a prolonged
CIT have a risk of 97.5% for developing IPF. Patients with IPF have a shorter
survival, these livers should therefore not be used for transplantation. Livers
with severe steatosis without other risk factors have an increased risk for
developing IPF and should be used for selected recipients. Livers with mild or
moderate steatosis are not at risk for IPF and can readily be transplanted.
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LIVING DONOR LIVER TRANSPLANTATION FOR FULMINANT
HEPATIC FAILURE
Ikegami, Toru1; Shimada, Mitsuo1; Taketomi, Akinobu2; Soejima, Yuji2;
Yoshizumi, Tomoharu2; Imura, Satoru1; Morine, Yuji1; Kanemura, Hiro-
fumi1; Maehara, Yoshihiko3
1The University of Tokushima, Department of Surgery, Tokushima, Japan;
2Kyushu Univeristy, Department of Surgery and Science, Fukuoka, Japan;
3Kyushu University, Department of Surgery and Science, Fukuoka, Japan
Introduction. Living donor liver transplantation (LDLT) has become an
accepted treatment for terminal liver diseases.
Methods. Forty-four living donor liver transplantations performed for
fulminant hepatic failure (FHF) at Kyushu University Hospital and the
University of Tokushima Hospital were reviewed.
Results. The etiologies included hepatitis B (n14), hepatitis C (n1),
autoimmune hepatitis (n2), WilsonIfs disease (n3), and unknown
cause (n25). The graft types were as follows: left lobe (n34), right lobe
(n9), and lateral segment (n1). The mean graft volume to standard liver
volume ratio was 43.5 I} 9.2%. The extubation was significantly delayed in
the Grade IV encephalopathy group (73.7 I} 18.2 hours) in comparison to
the other Grades (pB0.01 to Grade I and II, pB0.05 to Grade III). All other
patients except one with a subarachnoid hemorrhage had complete neuro-
logic recovery after transplantation. The 1- and 10-year survival rate were
77.6% and 65.5% for grafts, and 80.0% and 68.2% for patients.
Conclusion. The outcome in LDLT for ALF is fairly acceptable despite
severe general conditions and emergent transplant settings. LDLT is now
among the presently accepted life-saving treatment of choice for ALF,
although new types of innovative medical treatment for this disease entity
are still anticipated.
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MODULATION OF ACUTE CELLULAR REJECTION BY HYPER-
BARIC OXYGEN THERAPY: A STUDY IN A RAT MODEL OF
ORTHOTOPIC LIVER TRANSPLANTATION
Gan, Stephanie; Muralidharan, Vijayaragavan; Christophi, Christopher
University of Melbourne Austin Health, Department of Surgery, Melbourne,
Australia
Background. Acute cellular rejection is a common cause of post-transplan-
tation morbidity. HBO therapy has been shown to favourably alter immune
responses.
Aim. This study investigates the effect of HBO therapy on rejection in a rat
model of liver transplantation.
Methods. Male inbred Dark Agouti and Lewis rats were transplanted to
create severe or mild rejection. HBO was administered twice daily for seven
days after transplantation, after which the rats were killed. Outcome was
assessed by serum biochemistry, histopathology, area of inflammatory cell
infiltrate and T cell counts. A survival study in the severe model was
conducted for 14 days with HBO and matching controls.
Results. Twice daily HBO therapy in the severe model significantly reduced
serum bilirubin (43.597.7 mmolL-1 vs 81.6911.4 mmolL-1 p0.02), peri-
central venous infiltration (118932912630 mm2 vs 5353296283 mm2 p
0.005) and conferred significant survival benefit with mean survival time of
289917.2 hours vs 23495.5 hours (p0.01). In the severe model, there was
a significant difference in both T cell number and total cell number in the
perivenous region (85.7296.32 vs 123.76910.33 cells p0.002; 197.529
11.31 vs 275.07919.18 cells p0.001). In the mild model there was a
significant difference in both T cell number and total cell number in the
periportal region (321.46920.41 vs 384.71919.56 cells p0.004; 550.689
31.62 vs 618.81926.47 cells p0.008), and in the perivenous region
(54.4793.12 vs 67.0393.02 cells p0.001; 95.7194.29 vs 113.2995.01
cells p0.007).
Conclusion. Twice daily HBO therapy after transplantation reduces
inflammatory cell infiltration, in particular T cell infiltrate, and acute
rejection with a survival benefit. This may have potential therapeutic
implications.
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CURRENT STATUS OF MINIMALLY INVASIVE NECROSECT-
OMY FOR POST-INFLAMMATORY PANCREATIC NECROSIS
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Introduction. Blunt (non-anatomical) debridement of necrotic tissue at
laparotomy is the standard method of treatment of infected post-inflamma-
tory pancreatic necrosis. Recognition that laparotomy may add to morbidity
by increasing post-operative organ dysfunction has led to the development of
alternative, minimally invasive methods for debridement. There is a need for
consensus regarding optimal approaches and this study reports the current
status of minimally invasive necrosectomy (MIN) by different approaches,
using standardised reporting methodology for comparison.
Methods. Searches of MEDLINE and EMBASE for the period 19972007
were undertaken using OVID with Boolean operators. Only studies with
original data and information on outcome were included to produce a final
population of 19 studies reporting on 253 patients undergoing MIN with the
median (range) number of patients per study being 7 (153). MIN was
categorised as retroperitoneal, endoscopic or laparoscopic and the following
datapoints were selected for comparison: delay from admission to necro-
sectomy, inpatient stay and procedure-related mortality. Data are presented
as medians (range).
Results. The retroperitoneal approach was undertaken in 139 (54.9%) with
a median delay from admission of 35 (1348) days, median in-pt stay of 74
(23100) days and overall mortality of 17.4 (827%). Endoscopic trans-
gastric ‘‘necrosectomy’’ was undertaken in 97 with a median inpatient stay of
18 (1.549.5) days. The median number of interventions per patient in both
these groups was 3. Laparoscopic necrosectomy is reported in 17 patients
(with 0% mortality).
Conclusion. These data show that MIN can be undertaken with acceptably
low mortality. The retroperitoneal approach has the most published support
of the MIN techniques. Despite these techniques being promoted
by enthusiasts, no comment for superiority of MIN over percutaneous
radiological drainage of pancreatic abscess or contemporary small-incision
necrosectomy can or should be made without formal randomised trial.
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SURGICAL TREATMENT OF NECROTIZING PANCREATITIS BY
NECROSECTOMY AND CLOSED LAVAGE: OUTCOME IN A 17-
YEAR, SINGLE-CENTER SERIES
Kudari, Ashwinikumar1; Doley, Rudraprasad1; GSB, Kishore1; Yadav,
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Background. Surgical treatment of necrotizing pancreatitis (NP) has
undergone considerable changes during the past 2 decades. In this study,
we report our experience of necrosectomy and continuous closed lavage over
the past 17 years.
Methods. During this time period 214 patients underwent pancreatic
necrosectomy. The total series was evaluated separately for treatment period
A (19901996) treatment period B (1997-June 2002) and treatment period C
(July 2002May 2007).
Results. Preoperative disease severity did not differ between the groups. The
incidence of sterile necrosis was significantly higher during the time period A.
Percutaneous drainage was more frequently used during time period B and
C. Disease onset-surgery time was more during time period B and C. The
analysis of the three treatment periods revealed that during period B and C,
there was a decrease in operatively treated patients with sterile necrosis (PB
.0005). Mortality was significantly less during treatment period B and C.
There was no significant difference in the incidence of locoregional
complications among the three groups.
Conclusions. In conclusion, PN is associated with significant morbidity and
mortality Over the long time-course of this study, there has been an evolution
in the management of patients, with a reduction in the number operated
without an objective diagnosis of infected pancreatic necrosis. We have also
found in recent years an increased use of percutaneous interventions and a
tendency towards delayed surgical intervention.
FP 34.03
ANTI-INFLAMMATORY EFFECTS OF ANTIFACTOR VII IN SE-
VERE EXPERIMENTAL PANCREATITIS IN THE RAT
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Introduction. Severe acute pancreatitis (SAP) is characterized by an early
onset of pronounced pro-inflammatory response. A crosstalk between
inflammation and coagulation exist but exactly how this system interact is
unclear. In severe sepsis, the use of activated protein C may provide outcome
benefits and this regime has also been tried with some effect in SAP in the rat.
In general, though the anti-inflammatory properties of anti-coagulation in
acute pancreatitis (AP) has not been studied.
Aim. The aim of the present study was to evaluate the effect of active site
inhibited factor VII (ASIS) in SAP in the rat and the effect on the
inflammatory response.
Method. ASIS was administered intraperitoneally 40 minutes or 3 hours
after induction of SAP. SAP was induced by infusion of taurodeoxycholate in
the biliary pancreatic duct. The effect was evaluated by measuring levels of
myeloperoxidase (MPO; reflecting neutrophil infiltration) in the lungs, ileum
and pancreas and determination of interleukin(IL)-6 levels in plasma.
Results. Comparing the treatment groups with administration given 30
minutes or 3 hours after induction of SAP, plasma levels of IL-6 (p0.001
and p0.009, respectively) as well as MPO levels in lungs (pB0.001 and
p0.04, respectively) were significantly lower in both treatment groups as
compared to SAP animals without ASIS treatment. Similar tendencies were
seen when measuring MPO levels in ileum (p0.08 and p0.023,
respectively) while MPO levels in the pancreas were not affected by ASIS
treatment.
Dscussion/Conclusion. Anti-factor VII given as treatment (early and at
fulminant onset of disease) after induction of SAP in the rat resulted in a
systemic anti-inflammatory effect, evident by decrease in MPO levels in lungs
and intestine, and increased levels of IL-6 in plasma. The role of anti-
coagulation in the modulation of the inflammatory response require further
studies, but may represent a future treatment modality.
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CONSERVATIVE APPROACH IN THE MANAGEMENT OF SAP.
EIGHT-YEAR EXPERIENCE IN SINGLE INSTITUTION
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Introduction. Colloid resuscitation, control of the intra-abdominal hyper-
tension (IAH), renal and pulmonary support, improvement of the visceral
perfusion in parallel with early enteral feeding and antibiotics on demand are
important conditions for prevention of infection and successful management
of SAP.
Objective. to review prospectively collected data and summarise our eight-
year clinical experience in the management of SAP.
Methods. Data from clinical protocols of 269 SAP patients treated in our
institution during the period from 19992006 were analysed. Success of the
conservative treatment, frequency of the ventilatory support, infection rate,
number of surgical interventions, complications and mortality were evalu-
ated, comparing periods from 1999 to 2002 (P 1) and 20032006 (P 2).
Results. Overall success rate for conservative treatment was 57%. Improve-
ment of the protocol routine resulted in more successful conservative
treatment comparing 51% in P 1 vs. 69% in the year 2006, pB0,01.
Ventilatory support was applied in 6,3% of cases with similar frequency
through the periods. Totally 142 patients underwent continuous veno-
venouse haemofiltration (CVVH) as a component of fluid resuscitation and
IAH control. Application of the CVVH increased significantly comparing P 1
and P 2 comprising 24% vs. 96%, pB 0,005 respectively. Surgical treatment
was performed in 38% of cases (P 1) comparing 22% in P 2, pB0,001.
Overall mortality was 19% with drop down to 12% in year 2006.
Conclusion. Conservative approach with colloid resuscitation, early appli-
cation of CVVH, control of the IAH, early enteral feeding, and selective
antibiotic strategy can be successfully applied in the treatment protocol of
SAP.
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SOCIAL DEPRIVATION IS A CAUSATIVE FACTOR IN ACUTE
PANCREATITIS
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Background. The aetiology and mortality of acute pancreatitis (AP) are
known to be related to lifestyle factors such as alcohol, smoking and obesity.
The role of social deprivation has however not previously been reported.
Objective. To carry out a six month prospective observational study of AP in
one geographical region covering a population of 3 million.
Methods. All patients with a clinical and biochemical diagnosis of AP were
identified. Clinical casenotes were reviewed to confirm the diagnosis,
aetiology and outcome of confirmed cases. Age standardised incidence
(ASI) and mortality (ASM) were calculated using 2001 census data and
the European standard population. To study social deprivation patients were
stratified into five quintiles of deprivation based on the index of multiple
deprivation (IMD) score.
Results. AP was confirmed in 963 episodes during the study period. ASI was
55.6 per 105 per year. Case mortality was 4.98% (48/963) for all patients and
17.16% (46/228) for patients with severe AP as defined by the Atlanta
criteria. ASM was 2.19 per 105 per year. The aetiology of AP was gallstones
for 409 (42.5%), alcohol 277 (28.8%) idiopathic for 137 (14.2%) and other
aetiology in 140 (14.5%). A significant trend was observed of increasing ASI
with increasing levels of deprivation (Pearson correlation, R0.943, p
0.012). There was also a significant trend of increasing proportion of AP
secondary to alcohol excess with increasing level of deprivation (R0.981,
p0.003).
Conclusion. A higher incidence of AP was observed than has previously
been reported in the UK. More socially deprived individuals have a
significantly increased incidence and alcohol aetiology. A moderate decline
in case based mortality is observed compared to previous studies although
patients with severe AP remain at significant risk of death.
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TIMING OF LAP CHOLE AFTER ACUTE CALCULUS PANCREA-
TITIS
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Background. The optimal time for managing cholelithiasis in acute biliary
pancreatitis(ABP) is important because of the significant incidence of
recurrent attacks during the waiting period. But it still controversial with
very few surgeons advising early cholecystectomy as against the more
common practice of interval cholecystectomy.
Aim. To analyse the feasibility of Laparoscopic cholecystectomy at the same
admission.
Methods. 62 consecutive patients of ABP were taken up for the study After
grouping by Glasgow modification of Ransons criteria 8 patients with severe
acute pancreatitis were excluded from the study. Laparoscopic cholecystec-
tomy(LC) was carried out during the same admission, within 72 hours, in all
these 54 patients and the results were then compared with 60 control group
patients undergoing elective LC for cholelithiasis.
Results. The average onset of pain to operating time was 64.6 hrs(4896
hrs), operating time was similar in both groups,16.5 mins and 14.2 mins in
the control group. Fibrous adhesions were seen in 6 patients and Calot’s
triangle dissection was difficult in 2 patients in the test group as opposed to 5
patients with fibrous adhesions and 3 with difficult Calot’s triangle in the
control group. Discharge time was not much different 3.33 days in the test
group and 2.6 days in the control group. None of the groups had any
complications.
Conclusion. Early, same admission, LC in patients with mild acute biliary
pancreatitis appears to be a viable and better alternative since it prevents the
occurrence of interval pancreatitis during the waiting period, reduces the
number of noncompliant patients and gives results comparable with those of
elective laparoscopic cholecystectomy. Patients with severe acute biliary
pancreatitis are however better treated by interval laparoscopic cholecystect-
omy.
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Backgroung. Autoimmune Pancreatitis (AP) is a rare cause of benign mass
lesion of the pancreas that may mimic that of pancreatic carcinoma and lead
to inappropriate pancreatic resection.
Aim. To analyze retrospectively presentation and outcome of patients who
underwent a laparotomy for AP.
Methods. From 1995 to 2006, 22 patients had pathologic features consistent
with AP following laparotomy including pancreaticoduodenectomy (n10),
splenopancreatectomy (n9), pancreatic biopsy (n2) and gastrojejunost-
omy (n1). The demographics, pathological and clinical features, and
outcomes of these patients were analyzed.
Results. Fourteen males and 8 females (median age: 44 years (2070))
presented with weight loss (77%), acute pancreatitis (46%), pancreatic pain
(46%) and jaundice (41%). Four (18%) patients had a history of auto-
immune disease. Preoperative abdominal CT and/or MR imaging were
performed in all patients and endoscopic ultrasound in 20 (91%) patients. In
16 (72%) patients, there was a focal enlargement of the pancreas that
mimicked pancreatic cancer. Retrospectively, a review of the imaging work up
identified features of AP (diffuse pancreatic enlargement, peripancreatic
inflammation and narrowing of pancreatic ducts) in 13 (59%) cases.
Preoperative biopsies and peroperative frozen sections were performed in 8
(36%) and 20 (91%) patients, and were suggestive of AP in 2 (10%) and 4
(20%) cases, respectively. Nineteen (86%) patients had a presumed
preoperative diagnosis of pancreatic carcinoma. Five (23%) patients devel-
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oped recurrence (median follow-up, 32 months (195)) after resection: 3
with cholangitis and 2 with pancreatitis with a median delay of recurrence of
5 months and 36 months, respectively.
Conclusion. AP mimicked pancreas carcinoma in presentation although
imaging features of AP were present in almost two third of the cases. In case
of atypical pancreatic mass, arguments for AP have to be sought (imaging
features, serum IgG4 levels, biopsy or steroid therapy test) to avoid
inappropriate laparotomy.
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PANCREATIC ADIPONECTIN RECEPTORS AND STEATOPAN-
CREATITIS
Mathur, Abhishek; Yancey, Kyle W; Wade, Terrence E; Prather, Andrew D;
Swartz-Basile, Deborah; Lu, Debao; Lillemoe, Keith D; Pitt, Henry A;
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Background. Obesity leads to fat infiltration of multiple organs, including
the pancreas. Increased adiposity is associated with an augmented secretion
of proinflammatory adipokines including IL-6 and leptin. Additionally, the
levels of the anti-inflammatory adipokine adiponectin are decreased. We have
recently shown that hyperleptinemic (Lepdb) obese mice have more
pancreatic fat, and they develop a more severe pancreatitis, nonalcoholic
steatopancreatitis (NASP) compared to lean mice. However, no data are
available on the expression of pancreatic adiponectin receptors and the
relationship between adiponectin and pancreatitis. Therefore, we hypothesize
that obesity and hypoadiponectinemia will decrease adiponectin receptor
expression and accentuate NASP.
Methods. Thirty-two lean C57, and 24 obese Lepdb female mice were
studied at 12 weeks of age. Sixteen C57 and 8 Lepdb control mice underwent
total pancreatectomy only, and pancreatic adiponectin receptor 1 expression
was analyzed via PCR. In the remaining 16 mice from each group edematous
pancreatits was induced by intraperitoneal injection of cerulein (50mg/kg
hourly for 6 hours). Three hours after the last injection, blood and pancreata
were collected. Pancreatitis severity was scored histologically using a
validated method: the degree of edema, inflammation, and vacuolization
were added for a total score. Serum adiponectin and pancreatic tissue levels
of interleukin (IL)-6 were measured by ELISA. Data were evaluated via
ANOVA and the Tukey test.
Results Results for pancreatic adiponectin receptor 1 expression in the
control mice and serum adiponectin, pancreatic IL-6 and histologic score in
pancreatitis mice are presented in the table.
Conclusions. These data suggest that obese, hyperleptinemic mice have 1)
decrease pancreatic expression of adiponectin receptor 1 and 2) more severe
cerulein-induced pancreatitis. Therefore, we conclude that decreased pan-
creatic adiponectin receptors exacerbates steatopancreatitis.
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WHAT HAPPENS TO PATIENTS WITH COLORECTAL LIVER
METASTASES WHO HAVE HAD A COMPLETE PATHOLOGICAL
RESPONSE TO CHEMOTHERAPY?
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Background. Increasing effectiveness of neoadjuvant chemotherapy for
patients with colorectal liver metastases (CRLM) has led to dramatic
radiological responses.
Aim. To report the long term outcome of resected patients who are found to
have had a complete pathological response to pre-operative chemotherapy.
Methods. Our prospectively compiled database identified 524 patients
undergoing liver resection for CRLM between 1997 and 2006. Case notes,
radiology, pathology were reviewed in these patients. 30 had no malignancy
of which 11 had benign lesions and 19 were negative/no tumor; of these 14
had chemotherapy prior to resection and form our study group.
Results. Pre-resection chemotherapy was as follows: 6 oxaliplatin based
regimes; 5 had 5-fu and folinic acid alone; 1 capcitabine only; 1 irenotecan; 1
chemo-radiotherapy. 7 patients had a right sided resection, 3 a left resection
and 5 had non-anatomical resections. Pathology reported no viable tumor or
necrotic material with no malignant cells in all 14 cases. 3 patients have died
with disease recurrence but the remaining 11 are well at follow-up (median 2
yrs).
Conclusion. This small heterogenous group suggests outcome in patients
who have chemoresponsive CRLM is good. The question remains as to
whether this could be achieved by chemotherapy alone or whether surgery
contributes to this result but in the absence of accurate non surgical
assessment of complete pathological response surgery continues to have a
role.
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RESECTED COLORECTAL LIVER METASTASES. COMPARING
THE SHORT AND THE LONG TERM SURVIVORS
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Background. Prognostic factors (PF) of colorectal liver metastases (CRLM)
resection are usually obtained through the analysis of survival curves
including all the patients submitted to resection. In this series, the
identification of PF is obtained through the analysis of two groups of selected
patients-short (STS) and long term survivors (LTS).
Objectives. Definition of two groups of STS and LTS from resection for
CRLM and retrospective identification of PF that influenced survival.
Methods. 219 patients were offered a resection for CRLM (April 1996-
March 2007). Two groups of patients were selected: STS (B18 months
survival; n32) and LTS (48 months survival; n24). PF studied by
multiple logistic regression analysis (SPSS): gender; age; primary tumor:
Dukes, TNM and Node status; adjuvant chemotherapy and duration; pre-
operative radiotherapy; colectomy-hepatectomy interval; neoadjuvant che-
motherapy: duration and response; CRLM: synchronicity, number, distribu-
tion and size; resection: lobectomy or wider; blood transfusions.
Results. Survival was significantly influenced by: rectal primaries (p
0.028), Dukes C or D (p0.067), N positive of primaries (p0.045) and
response to neoadjuvant chemotherapy (p0.003; the strongest factor).
Surgical margin B10 mm seemed to have influenced prognosis (not
statistically significant).
Conclusions. Patients with CRLM on progression under chemotherapy
should not be offered resection. Rectal origin, high Dukes and N positive are
predictive of prognosis. Margins10mm shoud be preserved.
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COMPLETE PATHOLOGICAL RESPONSE AFTER PREOPERA-
TIVE CHEMOTHERAPY FOR COLORECTAL LIVER METAS-
TASES: MYTH OR REALITY?
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Background. Complete clinical response (CCR) of colorectal liver metas-
tases (CLM) following chemotherapy treatment has recently been shown to
be of limited predictive value for complete pathological response (CPR) and
cure of the disease.
Aim. The objective of this study was to determine predictive factors of CPR
as well as its impact on long-term survival.
Methods. From January 1985 to July 2006, 767 consecutive patients with
CLM underwent liver resection after systemic chemotherapy. Patients with
CPR were compared to patients without CPR.
Results. Twenty-nine of 767 resected patients (4%) presented with CPR
(M/F16/13, mean age54 years). Prior to hepatectomy, CCR was present
in 2 of 767 patients (0.3%). None of the patients with CPR had CCR.
Patients with CPR had a mean number of 3.3 metastases with a mean
maximum size of 29.3 mm at diagnosis. Surgery consisted of 5 major
resections (17%) and 24 limited hepatectomies (83%), and had a 0%
postoperative (5 2 months) mortality rate. After a median follow-up of 52.2
months (range: 1.1 to 193.0 months), overall 3- and 5-year survivals for
patients with CPR were 91% and 76%, respectively, significantly higher
when compared to operated patients without CPR (61% and 45%,
respectively) (P0.004). Disease-free survivals at 5 years were 69% and
19%, respectively (PB0.001). Independent predictive factors for CPR were
age 560 years, maximum size of metastases 5 3 cm at diagnosis, CEA level
at diagnosis 530 ng/ml and an objective response following chemotherapy.
The probability of CPR ranged from 0.2% when all factors were absent to
30.9% when all were present.
Group Adiponectin R1 Group Adiponectin (mg/ml) IL-6 (pg/mg) Histologic Pancreatitis
C57 Control 19 0 C57 Pancreatitis 2394 7319109 490.3
Lepdb Control 0.690.1* Lepdb Pancreatitis 1292* 98679250* 790.4*
*pB0.01 vs C57
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Conclusion. The incidence of CPR is 4% in patients with CLM treated with
preoperative chemotherapy. However, CPR may occur in almost one-third of
patients aged 5 60 years with metastases smaller than 3 cm and low CEA
values, showing an objective radiological response. CPR is associated with
uncommon high survival rates.
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OUTCOME OF POSTHEPATECTOMY MISSING COLORECTAL
LIVER METASTASES AFTER COMPLETE RESPONSE TO CHE-
MOTHERAPY
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Clarisse4; Ducreux, Michel2; Elias, Dominique5
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3Institut Gustave Roussy, Pathology, Villejuif, France; 4Institut Gustave
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Oncology, Villejuif, France
Background. Dramatic responses to chemotherapy are occurring more and
more frequently in patients with multiple colorectal liver metastases (LM),
leading to resection. In a few patients, some LM vanish on imaging studies,
remain undetected during hepatectomy and are left in place, which defined
the ‘‘missing LM’’. The aim of our study was to assess the long-term outcome
of such ‘‘missing LM’’.
Patients. Between January 1999 and June 2004, among 228 patients treated
for colorectal LM, missing LM were observed in 16 patients. All the patients
were operated within 4 weeks of imaging. Hepatic arterial infusion (HAI)
with oxaliplatin was administrated in 12 patients (75%): 7 before hepatect-
omy and 5 after.
Results. Overall 69 missing LM were diagnosed and left in place. Among the
persistent LM resected, a complete pathological response was significantly
more observed in the group with preoperative HAI (6/7), than in the group
without (2/9, pB0.02). With a mean follow-up of 51 months [2490],
missing LM did not reappear in 10 patients (62%). Adjuvant HAI was
significantly correlated with the definitive eradication of missing LM (pB
0.01), as was not a complete pathological response. The overall 3-year
survival rate of these highly selected 16 patients was 94%.
Conclusion. Colorectal LM under chemotherapy that vanish on high-
quality imaging studies, remain undetected during hepatectomy and left in
place, are definitively cured in 62% of the cases. This excellent result seems to
be due to the administration of adjuvant hepatic arterial infusion of
chemotherapy and should stimulate new investigations.
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SALINE-LINKED SURFACE RF ABLATION (SLSRFA): A SAFE
EFFECTIVE METHOD OF SURFACE ABLATION OF HEPATIC
METASTATIC COLORECTAL CANCER (CRC)
Gnerlich, Jennifer1; Ritter, Jon2; Hawkins, William1; Linehan, David1;
Strasberg, Steven1
1Washington University in Saint Louis, HPB Surgery, St Louis, United
States; 2Washington University in Saint Louis, Pathology, St Louis, United
States
Backgound. We have published parameters determining safety and efficacy
of a SLSRFA device (TissueLink) in a porcine model (Ann Surg
239:518;2004). Depth of ablation was related to power, lesion size and
inflow occlusion. The purpose of this study was to determine safety and
efficacy of treatment of CRC metastases in a clinical setting.
Methods. After IRB approval the initial portion of the study was conducted
in 16 patients to determine if parameters defined in the animal model were
clinically applicable. Normal areas of liver were treated with SLSRFA using
various diameters and powers for 9 minutes with and without inflow
occlusion (1cm/10W; 2cm/15W; 4cm/45W) in patients undergoing resection.
In part two of the study, superficial hepatic CRCs were treated at 45W for 9
minutes without inflow occlusion in 7 patients. After resection ablation depth
was measured and samples obtained for NADH staining (for cell viability)
and H&E staining.
Results. In the initial 16 patients, ablation depth varied from 3mm to 20
mm. Depth was significantly dependent on power, lesion size and inflow
occlusion (all pB0.05) as in pigs. At 45W/4cm diameter, mean ablation
depths in normal liver were 10mm and 18mm without and with inflow
occlusion. NADH stains showed total cell necrosis to the full depth of
ablation. In the study continuation, large tumors showed total cell necrosis to
a mean depth of 14 mm from the surface (range 1215 mm; n5). Tumors
less than 1cm size showed complete necrosis. Strikingly normal liver tissue
was viable immediately adjacent to dead tumor in the deeper parts of the
lesions.
Conclusion. SLSRFA rapidly, completely, and safely ablates normal liver to
a depth of 12 cm. Remarkably it is even more effective in ablating CRC,
possibly because CRC metastases are less hydrated than normal liver.
SLSRFA is an effective tool for extending resection margins and for ablating
superficial small tumors or superficial parts of large tumors perhaps in
conjunction with interstitial RFA of the deeper parts.
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SMA-PIRARUBICIN INHIBITS TUMOUR GROWTH BY DIS-
RUPTING TUMOUR MICROCIRCULATION
Daruwalla, Jurstine1; Greish, Khaled2; Malcontenti-Wilson, Cathy3; Vijayar-
agavan, Muralidharan3; Maeda, Hiroshi2; Christophi, Chris3
1Dept Surgery, Austin Hospital, The University of Melbourne, Melbourne,
Australia; 2Sojo University, Biodynamics Research Lab, Kumamoto, Japan;
3Austin Hospital, Surgery, Melbourne, Australia
Background. Macromolecular drugs preferentially accumulate in tumours
due to the specific characteristics of tumour microvessels. SMA-Pirarubicin is
a macromolecular agent that specifically targets tumour blood vessels via the
EPR effect. It has been shown to significantly reduce tumour growth and
improve survival in a murine model of colorectal liver metastases. Incomplete
tumour destruction at the tumour periphery is the ongoing cause of tumour
recurrence. The role played by the tumour microcirculation in tumour
recurrence is uncertain. This study investigates the pattern of microcircula-
tory changes and alterations in the ultrastructural properties of tumour
vasculature following administration of SMA-Pirarubicin.
Methods. Liver metastases were induced in male CBA mice using a murine
derived colon cancer cell line. SMA-Pirarubicin (100 mg/kg) was adminis-
tered intravenously over three divided doses. Tumour microvasculature was
quantified using scanning electron microscopy of microvascular resin casts.
Tumour perfusion and permeability were assessed using confocal in-vivo
microscopy and evans blue.
Results. SMA-Pirarubicin reduced tumour microvascular index by almost
60% (27%93.7 compared to the control group 47%94.4, p0.003). Vessel
diameter remained unaltered (66 mm97.3 54 mm95.5, p0.3). Confocal
microscopy showed enhanced leakage and intratumoural drug localization 24
hours following treatment. Vascular occlusion beyond the tumour periphery
and central tumour necrosis were apparent 24 hours post-drug treatment.
Tumour permeability was also enhanced (p0.017) with minimal effect on
normal liver.
Conclusion. SMA-Pirarubicin selectively accumulates in tumours compared
to normal tissue and has a direct effect on tumour microvasculature. The
microcirculatory changes coupled with cytotoxicity together inhibit growth of
colorectal liver metastases. Growth of residual cells at the tumour periphery is
sustained by a rich microvascular network.
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THE ACTIVATION OF APOPTOSIS IN THE LIVER PARENCH-
YMA AFTER RADIOFREQUENCY ABLATION
Vanagas, Tomas1; Gulbinas, Antanas2; Pundzius, Juozas1; Barauskas, Gie-
drius1
1Kaunas University of Medicine Hospital, Department of General Surgery,
Kaunas, Lithuania; 2Kaunas University of Medicine, Institute for Biomedical
Research, Kaunas, Lithuania
Background. Radiofrequency ablation (RFA) of liver causes destruction of
parenchyma that is morphologically defined as the inner zone of tissue
necrosis (central zone) and surrounding hyperemic rim (transition zone). The
transition zone contains apparently undamaged tissue but exhibits signs of
subacute hemorrhage. However, apoptosis may be an ongoing process which
further would lead to cell death in transition zone. Discovery and
characterization of transition zone with on going apoptosis has important
clinical significance, therefore we conducted an experimental study aimed to
qualitatively evaluate if the hyperthermia within the transition zone induces
apoptosis in a porcine liver model.
Materials and Methods. Nine anesthetized pigs underwent RFA of liver
parenchyma. RFA was carried out for 10 minutes. Altogether eleven lesions
were produced. One hour after completion of the procedure pigs were
sacrificed and the liver with the ablation zones and surrounding normal liver
parenchyma were excised. The specimens were further investigated to
identify the apoptotic processes. Western blot analysis and immunohisto-
chemistry were used for the detection of active (cleaved) subunit of
caspase-3.
Results. Morphologic analysis of the sections of the ablated area stained with
hematoxylin and eosin revealed two zones: inner zone of tissue necrosis
(central zone) and transition zone. Necrotic tissue with damaged structure of
hepatic cells was observed in central zone, whereas the transition zone
contained apparently undamaged liver cells with signs of sub acute
hemorrhage. Western blot analysis and immunohistochemistry revealed the
caspase-3 active (cleaved) subunit immunoreactivity in the transition zone in
contrast to normal liver parenchyma.
Conclusion. Our study showed that the active 17-kDa subunit of caspase-3
was detectable in the transition zone during the early period after thermal
ablation. Activation of apoptosis in the transition zone after RFA may play a
role inducing the sub lethal injury of the liver parenchyma.
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ROLE OF PET-CT IN MANAGEMENT OF PATIENTS WITH
COLORECTAL CARCINOMA
Kumari, Saumya1; Krishna, B. A.2; Singh, Natasha2; Maitra, Riddhika2
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Background. Recurrence occurs in one third of patients with colorectal
carcinoma, within two years of curative resection. Early detection and prompt
treatment may lead to disease resolution in upto 25% of these patients while
the presence of extrahepatic disease precludes surgery. The existing diag-
nostic modalities lack the sensitivity and specificity to detect recurrence.
Aim. To evaluate the role of PET-CT imaging in the detection of recurrence,
restaging and hence guiding management.
Methods. A total of 71 patients who had earlier undergone surgical resection
of the primary colonic/rectal lesion, were included in the study. All of them
were suspected to have recurrence based on raised serum CEA levels/
symptoms/ abnormal CT scans during follow up and were subjected to PET-
CT imaging.
Results. In 36 patients with elevated serum CEA levels and positive CT
scans, the PET-CT imaging revealed additional lesions in 7 patients,
suggesting upstaging of the disease by 20%. In 15 patients with elevated
serum CEA levels and negative CT scans, the PET-CT study detected
recurrence site in 11 patients. In 20 patients who had normal serum CEA
levels with an abnormal CT scan, the PET-CT study confirmed recurrence in
16 of these patients.
Conclusions. 1. In our study, the sensitivity of PET-CT to detect recurrence
was found to be 92%, whereas that of CT alone was 71%.2. The PET-CT
study influenced the management in 35% of patients by detecting either
recurrence or additional disease sites.
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PROGNOSTIC VALUE OF KI67 AND P21 IN METASTATIC AND
NON-METASTATIC COLORECTAL CANCER
Riesener, Klaus-Peter1; Steffen, Dirk2; Tittel, Andreas2; Schumpelick,
Volker2
1Marien-Hospital Marl, Department of General and Visceral Surgery, Marl,
Germany; 2University Hospital, Department of Surgery, 52074 Aachen,
Germany
Background. Molecular markers in proliferating tumours have been widely
investigated. Nevertheless their role in metastatic spread of colorectal
carcinoma is not known. The aim of our study was to identify a possible
role of the proliferation marker Ki67 and the CDK-inhibitor p21 in the
development of hepatic metastases.
Methods. Group I consisted of 76 patients, who were operated with R0-
resections both on their primary tumour and synchronous or metachronous
hepatic metastases within five years after the primary operation (metastatic
tumour). Group II consisted of 72 patients, who were operated on their
primary colorectal carcinoma and were free of recurrence or metastatic
spread at least for the following five years (non-metastatic tumour).
Immunhistochemistry for Ki67 and p21 were performed in the primary
tumours in both groups. Ki67 was analysed quantitatively, p21 was analysed
using a score (06) based on percentage and intensity of its expression in
tumour cells.
Results. The groups were comparable concerning age and sex of the
patients. The UICC stage was I in 8 patients, II in 25 patients and III in
39 patients of Group I corresponding with 21, 29, and 16 patients of Group
II. 5092,6% of the tumour cells expressed Ki67 in Group I versus 3692,3%
in Group II (pB0,05). The expression of p21 reached a higher score in
Group II (mean 3,6 vs. 2,9, respectively). Focussing on the results of UICC
stage II only, the differences between Group I and Group II were evident as
mentioned for the entire groups.
Conclusion. Our study shows a close correlation between the expression of
the proliferation marker Ki67 and the occurence of metastases in colorectal
carcinoma. The CDK-inhibitor p21 was more likely detected in non-
metastatic tumours in our series. The combination of high expression of
Ki67 and low expression of p21 was observed in 54% of all patients in group I
and only 24% in group II indicating an influence of these markers on the
ability of metastatic spread in colorectal cancer.
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ENDOSCOPIC ULTRASOUND VERSUS LAPAROSCOPY AND
LAPAROSCOPIC ULTRASOUND TO PREDICT UNRESECTABIL-
ITY IN THE STAGING OF PANCREATIC HEAD CANCERS
Shah, Ankur1; Shah, Jayshri2; Pope, IM1; Norton, Sally3; Finch-Jones, Meg1
1Bristol Royal Infirmary, HPB Surgery, Bristol, United Kingdom; 2Frenchay
Hospital, Gastroenterology, Bristol, United Kingdom; 3Frenchay Hospital,
Upper GI surgery, Bristol, United Kingdom
Background. Pancreatic head cancers (CAHOP) have a poor prognosis,
even after a curative resection. There is no single investigation to accurately
predict unresectability(UnR). Endoscopic ultrasound (EUS) and staging
laparoscopy with laparoscopic ultrasound (LUS) have been used with CT
scan to stage CAHOP.
Objective. The aim of this study is to compare ability of EUS against LUS to
predict unresectability in CAHOP after a multislice (CT) scan.
Methods. Two studies. Study I-Retrospective review between 20012005 of
patients who had a EUS or LUS or both. Study II-A prospective blinded
study comparing the 2 investigations over 8 months. Both Investigators were
blinded to the findings of other investigation (EUS or LUS). Findings were
confirmed on histology, or laparotomy or combination of 2 investigation.
Results. Study I- Out of a total of 79 patients referred, 65 patients had LUS,
29 had EUS and 27 had both. Sensitivity, negative predictive value (NPV)
and accuracy of LUS(n65) was 74%, 72%,83% compared to 55%,50%,
and 69% respectively for EUS(n29) When both investigations were
performed in the same patient(n27); the sensitivity, NPV and accuracy
were higher for LUS compared to EUS.( 78%, 69%, 85% compared to 50%,
50%, and 66.5% respectively). Study II: 13 patients were enrolled in the
prospective study. The positive predictive value for unresectability was 100%
for both the investigations. The sensitivity, NPV and accuracy for LUS was
57%, 675, and 77% as compared to 25%, 54.5% and 61.5% respectively.
Both investigations were similar in diagnosing the tumour size, vascular
invasion and nodal status; however, LUS diagnosed more patients with liver
and peritoneal metastases.
Conclusion. As compared to EUS, LUS was more sensitive and accurate in
the overall staging of CAHOP. It was rare to pick up vascular unresectability
solely based on EUS. In our unit EUS is now selectively used to aid staging of
pancreas cancer only after LUS.
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TPS, CA 19-9, VEGF AND CEA AS TUMOUR MARKERS IN
PATIENTS WITH OBSTRUCTIVE JAUNDICE OR MASS LESIONS
IN THE PANCREATIC HEAD
Sandblom, Gabriel1; Granroth, Sofie2; Rasmussen, Ib Christian3
1University Hospital, Dept of Surgery, Lund, Sweden; 2University Hospital,
Dept of Internal Medicine, Uppsala, Sweden; 3University Hospital, Depart-
ment of Surgery, Uppsala, Sweden
Background. Although numerous tumor markers are available for periam-
pullary tumors, including pancreatic cancer, their specificity and sensitivity
have been questioned. OBJECTIVE To assess the diagnostic and prognostic
values of tissue polypeptide specific antigen (TPS), carbohydrate antigen 19-
9 (CA 19-9), vascular endothelial growth factor (VEGF), and carcinoem-
brynic antigen (CEA).
Methods. Patients with mass lesions in the pancreatic head or obstructive
jaundice of unknown etiology admitted to the department of surgery,
Uppsala University Hospital, were included in the study. In addition to the
investigations routinely undertaken for these patients, serum was obtained
and stored in a freezer for later analysis.
Results. Altogether 56 patients were included (30 men and 26 women).
Mean age was 63 years (range 3592 years, standard deviation 13 years).
Among these patients, further investigations revealed pancreatic cancer in 20
patients, other malignant diseases in 12 and benign conditions in 24. Median
CEA in all patients was 3.4 mg/L (range 0.5585.0), median CA 19-9 was105
kU/L (range 0.61 300 00), median TPS 123.5 U/L (range 15.03350) and
median VEGF 132.5 ng/L (range 60.04317). Area under the curve was
0.747, standard error (standard error [SE]0.075) for CEA, 0.716 (SE
0.078) for CA 19-9 and 0.822 (SE0.086) for TPS in ROC plots based on
the ability of the tumours to distinguish between benign and malignant
conditions. None of the markers significantly predicted survival in the
subgroup of patients with pancreatic cancer.
Conclusion. Our study thus shows that the markers may be used as fairly
reliable diagnostic tools, but cannot be used to predict survival.
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IMMUNOHISTOCHEMISTRY FOR M2-PYRUVATE KINASE IN
FORMALIN-FIXED PANCREATIC TISSUE: A NEGATIVE MAR-
KER FOR PERIAMPULLARY CANCERS?
Aloysius, Mark M1; Zaitoun, Abed M2; Bates, Timothy E3; Ilyas, Moham-
mad2; Rowlands, Brian J4; Lobo, Dileep N4
1Nottingham University Hospitals, Division of Gastrointestinal Surgery,
Wolfson’s Digestive Diseases Centre, Nottingham, United Kingdom; 2Not-
tingham University Hospitals, Division of Pathology, Nottingham, United
Kingdom; 3University of Nottingham, Division of Community Health
Sciences, Nottingham, United Kingdom; 4Nottingham University Hospitals,
Division of Gastrointestinal Surgery, Nottingham, United Kingdom
Background. Although elevated serum concentrations of M2-pyruvate
kinase (M2-PK) have been found correlate with poor prognosis in patients
with periampullary cancer, there are no published studies on tissue
expression of M2-PK in pancreatic cancer. AIMS: To characterise the
immunohistochemical expression of M2-PK in archived specimens of
periampullary cancers, chronic pancreatitis, and normal pancreatic tissue.
Methods. This was an immunohistochemical study on archived pancreatic
tissue of 126 consecutive patients undergoing pancreatic resections for cancer
and chronic pancreatitis between June 2001 and June 2006. Tissue
microarrays were constructed from formalin-fixed paraffin-embedded tissue
blocks containing periampullary cancer, chronic pancreatitis and normal
pancreatic tissue. Immunohistochemical staining was done with mouse anti-
M2-PK monoclonal antibody, (clone DF-4) at an optimal dilution of 1:25.
M2-PK expression was quantified with the immunohistochemical score
(IHS) which ranged from 0 to 12.
Results. 104 underwent pancreatic resection for cancer and 22 for chronic
pancreatitis. A further 77 specimens of chronic pancreatitis tissue were
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obtained adjacent to areas of cancers. Normal pancreatic tissue was obtained
from the resection specimens, adjacent to areas of cancer or chronic
pancreatitis in a total of 32 patients. 91 metastatic lymph nodes from 68
patients were also studied. There was a consistent lack of expression of M2-
PK (IHS0) in all periampullary tumours and metastatic lymph nodes,
irrespective of tumour type or differentiation. However, chronic pancreatitis
tissue and normal pancreatic tissue around these tumours were found to have
a variable expression of M2-PK (IHS1 in 21%, IHS23 in 39%, IHS]4
in 40%).
Conclusions. Selective lack of immunohistochemical expression of M2-PK
in periampullary cancer cells can potentially be used to confirm a diagnosis of
periampullary cancer and differentiate between cancer and chronic pancrea-
titis.
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LAPAROSCOPIC VS. OPEN RESECTION OF INTRADUCTAL
PANCREATIC MUCINOUS NEOPLASMS
Gumbs, Andrew A.1; Gayet, Prof. Brice2
1Institut Mutualiste Montsouris, Digestive Diseases, 42 Boulevard Jordan,
Paris, France; 2Institut Mutualiste Montsouris, Digestive Diseases, Paris,
France
Background. Required resection margins for noninvasive intraductal
papillary mucinous neoplasms (IPMNs) are a controversial issue. Over a
10-year period we have resected IPMNs from the entire pancreatic gland with
minimally invasive techniques and compared our survival and complication
rates with open controls to see if any difference in resection margins and
outcomes could be observed.
Methods. Data were collected retrospectively, including our first cases of
advanced laparoscopic resections. Five-year Kaplan-Meier curves were
calculated and statistical analysis was performed using the log rank and
Student’s T test for continuous variables. Chi square and Fisher’s exact tests
were used for analyzing categorical variables.
Results. From March 1997 to Febuary 2006, we operated on 22 patients
with noninvasive IPMNs, of which 9 (41%) were operated on laparoscopi-
cally and 13 (59%) using open techniques. Three patients underwent
laparoscopic duodenopancreatectomy, compared to five in the open group.
All resection margins were negative, but two patients required total
pancreatectomy, both of which were performed laparoscopically. One of
these was converted to open (11%) because of difficulty in reconstructing the
biliary anastomosis. The overall complication rates were 56% for the
laparoscopic group and 85% for the open group. Twenty-two percent of
the laparoscopic group required reoperation and 11% required percutaneous
drainage, compared to 15 and 23% in the open group, respectively. All
patients are alive after a mean of 20 months (range243) in the
laparoscopic group and 37 months (range1121) in the open one (p
0.05).
Conclusions. Laparoscopic resection of noninvasive IPMNs of the entire
pancreatic gland has similar complication and survival rates as open
procedures. As a result, the laparoscopic approach is appropriate for
noninvasive IPMNs of the entire pancreatic gland; however, larger cohorts
are needed to see if any approach has superior outcomes. Because of these
favorable results, studies are currently underway to see if the minimally
invasive approach is also appropriate for invasive IPMNs.
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RISK FACTORS OF GRADE C PANCREATIC FISTULA AMONG
PATIENTS WITH PANCREATIC FISTULA AFTER PANCREATO-
DUODENECTOMY
Fuks, david1; Piessen, Guillaume2; Huet, Emmanuel3; Tavernier, Marion4;
Nunes, Bertrand5; Zerbib, Philippe5; Mauvais, Francois6; Chiche, Laur-
ence4; Salame, Ephraim4; Segol, Philippe4; Michot, Francis7; Scotte,
Michel7; Triboulet, Jean-Pierre8; Mariette, Christophe8; Pruvot, Francois
Rene5; Verhaeghe, Pierre9; Regimbeau, Jean-Marc9
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8University Hospital C Huriez, Department of digestive and oncological
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Background. Pancreatic fistula (PF) is the most common postoperative
complication following pancreatoduodenectomy (PD). A recent definition
(ISGPF) allows grading PF according to severity. Most PF are treated
conservatively (Grade A), but in a few patients, PF can require interventional
procedures (Grade B) or be life-threatening and needs reoperation in
emergency (Grade C). The aim of this study was to evaluate the risk factors
of Grade C PF among patients with PF after PD.
Study Design. Between 20002006, 680 consecutive patients underwent a
PD in 4 Digestive Surgery Department (Lille, Amiens, Rouen, Caen). PF
was defined as drain output of any measurable volume of fluid on or after
postoperative day 3 with an amylase content greater than 3 times the serum
amylase activity (Bassi et al.). To identify possible risk factors of Grade C PF,
we reviewed records of 111 (16.3%) patients with postoperative PF and
compared patients with Grade C PF vs Grade A-Grade B PF.
Results. Median age was 59 years (2287). 50.4% PD were performed with
pancreaticogastrostomy and 55 with pancreaticojejunostomy. Overall mor-
tality was 2% (n13/680). Grade C PF occurred in 36 (32%) patients
(mortality 36.1%). Seven (19.4%) had percutaneous drainage for intra-
abdominal collection and all had reoperation. The major indication for
reoperation was haemorrhage (n18). Grade C PF increased postoperative
LOS (46 vs 29 days, pB0.001). Univariate analysis showed that peroperative
soft pancreatic parenchyma (p 0.01) and transfusion 2 blood units
(p 0.0036) were significant factors of Grade C PF. Multivariate analysis
identified only soft pancreatic parenchyma as risk factor of Grade C PF (p
0.05). The presence of a soft pancreatic parenchyma in patient with PF
increased by 5.4 the risk of Grade C PF.
Conclusion. Thirty percent of patients will have grade C PF if PF appeared
after pancreato-duodenectomy, and among them mortality was 30%. The
presence of a soft pancreatic parenchyma in patient with PF increased by 5
the risk of grade C PF.
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VALIDATION OF A NOMOGRAM FOR PREDICTING SURVIVAL
AFTER RESECTION FOR ADENOCARCINOMA OF THE PAN-
CREAS SHOWS NO EFFECT OF ADJUVANT THERAPY
de Castro, Steve; Biere, Surya; Lagarde, Sjoerd; Olivier, Busch; van Gulik,
Thomas; Gouma, Dirk
Academic Medical Center, Surgery, Amsterdam, Netherlands
Background. Nomograms are statistically based tools that provide the
overall probability of a specific outcome. They have shown better individual
discrimination than the current TNM staging system in numerous cancer
models. The pancreatic nomogram combines individual clinicopathological
and operative data to predict disease-specific survival at 1, 2, and 3 years from
initial resection. A single European institution database was used to validate a
proposed pancreatic adenocarcinoma nomogram.
Methods. The nomogram was validated by an external patient cohort from a
pancreatic adenocarcinoma database at Academical Medical Center which
included 263 consecutive patients operated on between January 1985 and
December 2004. During this period adjuvant therapy was not given regularly
but incidentally in clinical trials.
Results. Of the 263 patients, 256 (97%) had all variables documented. At
last follow-up, 35 patients (13%) were alive, with a median follow-up time of
27 months (range, 3 to 114 months). The 1-, 2-, and 3-year disease-specific
survival rates were 61%, 30%, and 16%, respectively. The nomogram
concordance index was 0.61. The calibration analysis of the model showed
that the predicted survival did not deviate significantly from the actual
survival. This nomogram was developed by the Memorial Sloan-Kettering
Cancer Center on 555 patients and validated by Massachusetts General
Hospital on 424 patients. When both centers where compared to the AMC
cohort, the patient characteristics where similar while adjuvant therapy was
used significantly less often in the AMC.
Conclusion. The pancreatic cancer nomogram provides an accurate survival
prediction when applied to an external patient cohort. The concordance
index was similar to the two major US centers while the adjuvant therapy was
used significantly less often. Thus adjuvant therepy has no impact on this
nomogram and overall survival.
FP 36.07
SYNERGISTIC EFFECTS OF ERLOTINIB IN COMBINATION
WITH GEMCITABINE IN PANCREATIC CANCER
Nagakawa, Yuichi1; Tsuchida, Akihiko1; Tohyama, Yasutaka2; Saito, Hi-
toshi1; Ozawa, Takashi1; Kasuya, Kazuhiko1; Ikeda, Takahisa1; Aoki,
Tatsuya1
1Tokyo medical university, Department of Surgery, Tokyo, Japan; 2Tokyo
University of Pharmacy and Life Science, Department of Pharmacy, Tokyo,
Japan
Background. It has been reported that the combination treatment of the
epidermal growth factor receptor (EGFR) blocker (erlotinib) and gemcita-
bine is effective as compare to gemcitabine treatment alone in pancreatic
cancer. However, the mechanism of synergistic effects of erlotinib in
combination with gemcitabine is not fully understood. In this study, we
examined the relationship between the anti-tumor effects of gemcitabine and
EGFR-related signal pathways after erlotinib treatment, and influences of cell
cycle and apoptosis by combination treatment of erlotinib and gemcitabine.
Methods. Five pancreatic cancer cell lines (AsPC-1, BxPC-3, HPAC, MIA
PaCa-2, PANC-1) were used. Activation of EGFR-related signal pathways
after erlotinib treatment were determined by Western blotting. Cell cycle was
analyzed by FACS scan.
Results. We confirmed that erlotinb arrested cells in G1 phase and increase of
expression of the p21(Waf1/CIP1) and p27(Kip1) and that gemcitabine
arrested cells in S phase. Therefore, we hypothesized that gemcitabine followed
by erlotinib would be superior to the opposite order because gemcitabine
requires entry into S phase to produce cytotoxy. The schedule of gemcitabine
followed by erlotinib caused arrest of cells in S phase. This schedule caused
decreased pAKT and pMAPK, and increased apoptosis compared with
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gemcitabine alone. The schedule of erlotinib followed by gemcitabine also
caused suppression of pAKT and pMAPK but arrested cells in G1.
Conclusions. These findings suggest that the schedule of gemcitabine
followed by erlotinib may increase the therapeutic index over gemcitabine
alone.
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NEW ABLATIVE THERAPY FOR LOCALLY ADVANCED PAN-
CREATIC MALIGNANCY
Naik, Saleem; Varshney, Subodh; Sewkani, Ajit; Purohit, Dipak; Singh,
Vikrant; Mishra, Pratik; Sharma, Sandesh
Bhopal Memorial Hospital and Research Centre, Surgical Gastroenterology,
Bhopal, India
Background. Unresectable pancreatic cancer has a dismal prognosis.
Palliative surgery and chemo-radiotherapy have not produced significant
improvement in survival. We evaluated the saftey and the efficacy of
radiofrequency ablation for cytoreduction of unresectable tumors of the
pancreas.
Material and Methods. Radiofrequency ablation was performed in six
patients with histologically proven unresectable cancer of the pancreas: Three
females (4072 years) of age (mean 60 years). The sizes of the pancreatic
tumors were 5.0 to 8.0 cm (mean 6.5 cm), respectively. Five pateints
underwent radiofrequency ablation during an open operation while one
pateint had percutaneous CT guided radiofrequency ablation. Endobiliary
stenting for obstructive jaundice was done in all the patients.
Results. Partial necrosis (up to 3 cm) of the tumour was achieved in all cases.
There was no major morbidity or mortality. Median survival post procedure
was 14 months. Self limiting minor complications occurred in two patients.
Conclusion. Radiofrequency ablation is a local ablative method used with
increasing frequency and may be used safely for cytoreduction in locally
advanced inoperable pancreatic malignancies. Further studies are required to
ascertain whether this can improve survival/quality of life alone or in
combination with other therapies.
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PHASE I STUDY OF ORAL FLUOROPYRIMIDINEl ANTICANCER
AGENT (S-1) WITH CONCURRENT RADIOTHERAPY IN PA-
TIENTS WITH UNRESECTABLE PANCREATIC CANCER
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Kubo, Fumitake1; Aikou, Takashi1; Takao, Sonshin2
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In this phase I trial, we evaluated the safety of S-1, a novel oral
fluoropyrimidine anticancer agent, combined with external-beam radio-
therapy (EBRT) to determine the maximum tolerated dose and dose-limiting
toxicity (DLT) in unresectable pancreatic cancer patients. Patients had
histologically proven unresectable locally advanced or metastatic pancreatic
cancer. S-1 was administered orally twice daily. EBRT was delivered in
fractions of 1.25 Gy2 per day, totaling 50 Gy per 40 fractions for 4 weeks.
S-1 was given at 5 dose levels: 60 mg/m2/day on days 17 and 1521 (level 1),
114 (level 2), and 121 (level 3a) and 80 mg/m2/day on days 121 (level 3b)
and 128 (level 4). We studied 17 patients: dose levels 1 (4 patients), 2 (4
patients), 3a (3 patients), 3b (3 patients), and 4 (3 patients). One patient in
level 1 (grade 3 vomiting) and two patients in level 4 (grade 4 neutropenia
and grade 3 anorexia) showed DLT. No DLT was seen for levels 2, 3a, and
3b. Clinical effects by computed tomography included 5 partial responses
(35%), 11 cases of stable disease, and 1 case of progressive disease. CA19-9
levels of less than half the starting values were observed in 8 of 16 (50%)
patients. S-1 at a dose of 80 mg/m2/day given on days 121 is safe and
recommended for phase II study in patients with locally advanced
and unresectable pancreatic cancer when given with external beam radio-
therapy.
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LAPAROSCOPIC LIVER SURGERY: LESSON LEARNED FROM A
CONSECUTIVE SERIES OF 110 PATIENTS
Belli, Giulio; Fantini, Corrado; D’Agostino, Alberto; Cioffi, Luigi; Limon-
gelli, Paolo; Russo, Gianluca; Belli, Andrea
S.M. Loreto Nuovo Hospital, Department of General and HPB Surgery,
Naples, Italy
Background. Recent reports showed that a mininvasive approach in liver
surgery could obtain reduced operative blood loss, fewer early postoperative
complications and earlier recovery with oncologic clearance and a survival
rate similar to open surgery but it is necessary a careful selection of patients
and a wide experience in both hepatic and laparoscopic advanced surgery.
Objective. The authors report their experience, the evolution of the
technique and their Results.
Methods. From 2000 to 2006 110 laparoscopic procedures for benign and
malignant hepatic diseases were carried out in 101 patients. For tumors the
selection criteria were: a small (sizeB5 cm), exophytic or subcapsular tumor
located in the left or peripheral right segments of the liver (II-VI segments,
Couinaud); a well-compensated cirrhosis (Child-Pugh A); and an ASA score
lower than 3.
Results. There were 90 malignant tumors (81.8%) and 20 benign lesions
(18.2%). HCC was the main indication for treatment (67/110) and HCV
related cirrhosis was present in all these patients. Four of the 110 procedures
(3.6%) were converted to laparotomy; a conversion to hand assisted
technique occurred in 1 patient. In 8 patients with HCC on cirrhosis a liver
resection was associated with a radiofrequency ablation (RFA). Non
anatomic (40) and anatomic (36) resections, laparoscopic RFA (22) and
marsupialitations for liver cysts (12) were done. The mean operative time was
131 min. One cirrhotic patients with HCC died in third postoperative day for
an acute distress respiratory syndrome while another cirrhotic patient with a
small HCC in VIII segment was reoperated for an uncontrollable and
persistent bleeding by laparotomy. The morbidity was 15%. No port site or
local recurrences occurred in patients with malignant lesions.
Conclusions. Our data confirm that laparoscopic liver resection, in
experienced hands, is a safe and effective technique for appropriately selected
patients.
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LESSONS LEARNT FROM 230 LAPAROSCOPIC LIVER RESEC-
TIONS
Hatzifotis, Michael1; Patel, Bhavik1; Bryant, Richard1; Shaw, Ian1; Martin,
Ian2; Hopkins, George3; Fielding, George3; Nathanson, Leslie3; O’Rourke,
Nicholas3
1Royal Brisbane Hospital, HPB Surgery, Brisbane; 2Wesley Hospital, HPB
Surgery, Brisbane; 3Royal Brisbane Hospital, HPB Surgery, Brisbane,
Australia
Introduction. Laparoscopic liver resection allows minimal access treatment,
with all its ensuing benefits, in a selected group of patients.
Methods. We would like to reflect on our experience of 230 laparoscopic
liver resections.
Results; These include 29 major resections, 60 sectionectomies, 141 minor
resections. Only very rarely are procedures hand-assisted. Forty-five percent
of resections were for benign pathology, and 55% were for malignant
pathology. The average operating time was 138 minutes. Margins were
involved in five patients, and within 1cm in 11% of patients. Average blood
loss was 482mls. The overall morbidity was 13%. The 30 day mortality was
1.3%.
Discussion. Overall approximately 20% of all of our liver resections are
attempted laparoscopically. However all left lateral sectionectomies are
performed laparoscopically. Patient selection is based upon position of the
lesion within the liver. Major hepatectomies can be attempted only if the
lesion is well clear of the plane of transection. Non-anatomic resections when
attempted laparoscopically must be done so with caution because of the risk
of positive margins as the surgeons inate fear of encountering large blood
vessels may compromise oncologic clearance. This is particularly so in dome
lesion where, because of the angles of laparoscopic approach, a large surface
area of parenchyma may have to be dissected. Encountering major bleeding
during laparoscopic liver resection often requires rapid conversion to an open
approach. We have found laparoscopic ultrasound helpful, and understand-
ing of resection planes using ultrasound guidance improves with experience.
The evolving technology for parenchymal transection and hemostasis make
laparoscopic liver surgery an exciting frontier.
FP 37.03
ONE HUNDRED LAPAROSCOPIC LIVER RESECTIONS: AN
OPTIMAL APPROACH TO AVOID BLEEDING AND TRANSFU-
SION
Haddad, Luciana B P; Scatton, Olivier; Randone, Bruto; Andraus, Well-
ington; Massault, Pierre-Philippe; Soubrane, Olivier
Cochin Hospital, Liver Department, Paris, France
Background. The laparoscopic approach has been developed for liver
resections in several centers, and many authors have confirmed the feasibility
and safety of this approach in selected patients. The purpose of the present
study was to analyze patients that underwent laparoscopic liver resections
with special concern to bleeding and transfusion.
Methods. From February 1997 to June 2007, we performed 100 liver
laparoscopic resections, including those performed for living donation.
Outcomes, perioperative bleeding, need for transfusions were studied.
Results. The resections involved 47 women and 53 men, with a mean age of
42.5913.5. Indications for hepatectomy were benign lesions in 28 patients,
malignant tumors in 33 and living donation in 39 patients. Seventy-five
resections involved 2 or more segments. The mean operative time was 2539
91.6 min (range, 60540). The mean operative blood loss was 1209127.6 ml
(range 101000ml). No transfusion was required in resections completed by
laparoscopy. The procedure was completed laparoscopically in 83 patients. In
the case of conversion, decision was not made in emergency situation or life-
threatening bleeding. Mortality was nil. Postoperative complications oc-
curred in 23 patients, more often in patients converted (p0.001). The
factors related significantly with conversion were: cirrhosis, BMI, Pringle
maneuver necessity, hospital and intensive care stay and morbidity. Perio-
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perative blood loss was significantly higher in patients converted (82.39
153.8 versus 306.39362.4, pB0.001).
Conclusion. This study confirms that liver resection by laparoscopy is
feasible and safe. Dual surgeon expertise is needed, both in hepatobiliary and
laparoscopic surgeries. Laparoscopic liver procedures should have the same
technical principles than opens liver surgeries. This policy and precocity in
conversion provide better outcome in such cases.
FP 37.04
FEASIBILITY OF LAPAROSCOPIC PORTAL VEIN LIGATION
PRIOR TO MAJOR HEPATECTOMY
Are, Chandrakanth1; Iacovitti, Simonetta2; Crafa, Francesco2
1Eppley Cancer Centre, University of Nebraska Medical Centre, Divsion of
Surgical Oncology, Dept of Surgery, Omaha, United States; 2MG Vannini
Hospital, Department of Surgery, Rome, Italy
Background. Portal vein embolization is increasingly performed as the
initial step in two-stage hepatectomy. Patients noted to have bilobar disease at
laparoscopy are considered for embolization, if suitable, at a subsequent
stage.
Aim. The aim of this study was to assess the feasibility of portal vein ligation
by the laparoscopic approach at the time of staging in suitable patients.
Materials and Methods. A retrospective review was performed to identify
patients that underwent laparoscopic portal vein ligation. The demographic,
clinical, radiographic, operative and volumetric details were collected to
determine the feasibility of portal vein ligation.
Results. A total of 9 patients underwent portal vein ligation as part of a two
stage procedure in preparation for subsequent major hepatectomy. With a
median age of 67 yrs, the diagnoses included: colorectal metastasis (5
patients), cholangiocarcinoma (3 patients) and hepatocellular carcinoma (1
patient). The ligation involved the right portal vein in all and was performed
with silk ligature (7 patients) and clips (2 patients). Volumetric data was
available in six patients which showed a mean increase from 209.1 cc997.76
to 495.83 cc9301.91 (increase by 137%) In 2 patients, inadequate
hypertrophy mandated later embolization by percutaneous technique. Five
patients underwent subsequent major hepatic resection as planned. The
remaining four patients were noted to have progression of disease that
precluded the planned procedure. There were no complications associated
with PVL.
Conclusions. Laparoscopic portal vein ligation is feasible and can be safely
performed at the time of staging. In selected patients it may be considered as
an alternative to subsequent embolization.
FP 37.06
LAPAROSCOPIC LEFT LATERAL SECTIONECTOMY WITHOUT
MOBILIZATION OF THE LIVER OR INFLOW OCCLUSION AS
ROUTINE APPROACH IN NON-CIRRHOTIC PATIENTS
Sainz Barriga, Mauricio; Dezza, Maria Clara; Berrevoet, Frederik; de
Hemptinne, Bernard; Troisi, Roberto
Ghent University Hospital Medical School, Hepatobiliary Service, Ghent,
Belgium
Introduction. Laparoscopic liver resection is increasingly performed for
benign and tumoral lesions. Surgical technique is evolving due to the
increased experience and the development of resecting devices.
Materials and Methods. Between October 2002 and August 2007, 59
(8.4%) out of 702 liver resections were performed laparoscopically and 22
(37%) were left lateral sectionectomy (LLS). In the last 18 cases, surgical
technique consisted in avoidance of mobilization of the left liver and
intermittent inflow occlusion. Linear staplers and harmonic scalpel were
routinely used.
Results. Mean patient age was 50916 years (range 2976). Surgery was
performed for 7 (39%) malignant lesions and for 11 (61%) benign tumors.
The mean operating time was 125 min (range 90210). The mean blood loss
was 120 ml (range 50230). No patient had underlying liver cirrhosis and no
conversion to laparotomy was recorded. All patients are alive after a median
follow-up of 14 months (range 359). No biliary leaks were recorded and the
total hospital stay was 3.6 days (range 36). Occurrence of a new colo-rectal
liver metastasis was noticed in 1 patient 12 month after laparoscopic LLS.
Conclusion. According to this experience, laparoscopic left lateral sectio-
nectomy without inflow occlusion and mobilization of the liver is a safe
procedure and could be considered as a routine approach in non-cirrhotic
patients.
FP 37.07
LAPAROSCOPIC RIGHT HEPATECTOMY  A SINGLE CENTRE
EXPERIENCE USING MODIFIED ANTERIOR APPROACH
Chinnusamy, Palanivelu; Palanisamy, Senthilnathan; Ramakrishnan, Partha-
sarathi; Palanivelu, Praveen Raj; Suviraj James, John; Muthukumar, Rangar-
ajan; Rangasamy, Senthikumar
Gem Hospital, Gi Surgery, Coimbatore, India
Aim. The aim of this study is to establish feasibility, safety and advantages of
laparoscopic right hepatectomy.
Material and Methods. Between March 2001 and April 2007, we operated
on 18 cases, the indications being hepatocellular carcinoma, focal nodular
hyperplasia, secondaries liver and giant hemangioma. Case selection was
based on patient and lesion characteristics. Non obese patients with no or
minimal co morbid conditions were selected and all were non cirrhotic. There
were 13 males and 5 females. Preoperative evaluation includes functional
assessment, CT scan abdomen and MRI (selected cases). General Anaes-
thesia was used in all cases. We have adopted a new technique called
laparoscopic modified anterior approach by a single surgeon. The sequence
of steps will be portal dissection and inflow control, parenchymal division and
right hepatic vein division(out flow control). We used Pringle maneuver only
in selected cases.
Results. The mean operative time was 230 minutes and blood loss 310 mls.
We used hand port in 3 cases because of bulkiness of the tumor. There were
no conversions. Blood transfusion was necessary in 9 of the cases. Post-
operatively patients were mobilized on second day and mean hospital stay was
6 days. Two patients developed bile leak postoperatively, one requiring ERCP
and stenting. Other complications include ascites (n-1) and pleural effusion
(n-1). Follow up ranges between 3 months and 4 years and two patients have
since then died of the disease.
Conclusion. Laparoscopic right hepatectomy is feasible, oncologically
sound and offers the advantages of minimal access approach, but is a major
undertaking which requires adequate skill in open and laparoscopic liver
surgery aided by varied advanced instrumentation.
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LAPAROSCOPIC LEFT LATERAL SECTIONECTOMY-IS IT THE
GOLD STANDARD YET?
Hatzifotis, Michael1; Patel, Bhavik1; Bryant, Richard1; Shaw, Ian2; Martin,
Ian3; Hopkins, George1; Fielding, George4; Nathanson, Leslie1; O’Rourke,
Nicholas1
1Royal Brisbane Hospital, HPB Surgery, Brisbane, Australia; 2Prince Charles
Hospital, HPB Surgery, Brisbane, Australia; 3Wesley Hospital, HPB Surgery,
Brisbane; 4Royal Brisbane Hospital, Hpb, Brisbane
Introduction. We describe our simplified technique which avoids any formal
dissection of inflow or outflow. The left lobe is mobilized completely and
separated from the liver using multiple firings of a linear stapler device. Our
usual preference is the EndoGIA 60mm Vascular device (Tyco) in one, two or
occasionally three layers for bulky livers.
Methods. We would like to report on our series of 60 consecutive
laparoscopic left lateral sectionectomies.
Results. The average procedure time was 93 minutes. Average blood loss was
124ml. There were 3 conversions. Final pathology revealed malignancy in
45% cases. Average length of hospital stay was 4 days. Our overall morbidity
was 10%. There was one post operative death.
Discussion. This approach offers the benefits of laparoscopic surgery. We
have adopted the laparoscopic approach as our preferred method for
resection of the left lateral section of the liver. We believe it to be the gold
standard for left lateral sectionectomy.
FP 37.09
LAPAROSCOPIC LIVER RESECTIONS: INITIAL EXPERIENCE
IN A UNIVERSITY HOSPITAL SETTING
Stoot, Jan; Van Dam, Ronald; Olde Damink, Steven; Bemelmans, Marc;
Dejong, Kees
University Hospital Maastricht, Department of Surgery, maastricht, Nether-
lands
Background. Laparoscopic liver resections are gaining popularity world
wide, but experience in the Netherlands is still limited. This study was
conducted to assess the feasibility and safety of laparoscopic liver surgery for
left sided leasions.
Methods. Patients treated with laparoscopic liver resections in the years
2003 to 2007 were included using a prospectively collected database. This
group was matched with a group of patients undergoing the same type of liver
resection as an open procedure. Primary outcomes were complications.
Secondary outcomes were conversion, blood loss, length of operation, and
length of stay. Data were analysed according to the intention to treat
principle.
Results. The laparoscopic approach for left lateral resection (bisegmentect-
omy 2 and 3) was performed in nine patients (group I, two male, seven
female) with a median age of 53 [range 2682] years. In the open group, nine
patients were matched for the same type of resection (group II, five male, four
female, median age 63 [range 3277] years). There were two minor
complications in the laparoscopic group compared with two moderate
complications in the open group. In the laparoscopic group there were 2
conversions (22.2%) due to tumour size and close relation with the liver vein.
The median blood loss was 100cc [range 50750] in the laparoscopic group
versus 500cc [range 250750] in the open group. The median operation time
in group I was 120 [range 106261] minutes compared to 167 [range 97
229] minutes in group II. The median length of stay was 7 [range 410] days
in group I versus 6 [410] days in group II.
Conclusion. Left lateral resection of liver tumours is feasible and safe using
laparoscopic approach, but does not necessarily lead to reduced hospital
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length of stay. It may be appropriate to consider this as the standard approach
in young females with benign liver tumours in the not too distant future.
FP 38.01
THE PROTEOMIC ANALYSIS OF BILE: METHODOLOGY AND
POTENTIAL APPLICATION
Bonney, Glenn K1; Craven, Rachel A2; Melcher, Alan F2; Selby, Peter J2;
Banks, Rosamonde E2; Prasad, K Rajendra3
1St James’ University Hospital, Department of Hepatobiliary and Tranp-
slantation, Beckett Street, Leeds, United Kingdom; 2St James’ University
Hospital, Cancer Research UK Clinical Centre, Leeds, United Kingdom; 3St
James’ University Hospital, Department of Hepatobiliary and Tranpslanta-
tion, Leeds, United Kingdom
Cholangiocarcnioma is a malignant tumour of the bile duct epithelium of the
liver with a rising incidence worldwide. However, there remains a lack of
sensitive and specific biomarkers for the disease. Bile, a biological fluid
directly draining the liver, may contain higher concentrations of biomarkers
than those found in the general circulation. The proteomic analysis of bile in
disease pathogenesis (i.e. malignancy and gallstone disease), drug metabo-
lism and biomarker discovery has received recent interest. However several
technical challenges arise in its analysis with its high salt content, and the
presence of bile pigments and lipids necessitating the development and
evaluation of processing Methods. Therefore there remains a need for an
accurate method to quantify proteins and process bile prior to such analyses.
Here we describe a protocol developed for standard processing of bile prior to
proteomic analysis. Modified Bradford and BCA assay failed to demonstrate
a linear trend on serial dilution. Densitometric scanning of Coomassie
stained 1D SDS PAGE gels quantified against a serial dilution of albumin-
depleted serum was the most consistent and reproducible assay for protein
quantification. For sample clean-up, TCA precipitation for desalting and
concentration was shown to give good results with near 100% protein
recovery on 1D PAGE and increased number of spots with better focussing
on 2D PAGE compared to TCA/Acetone precipitation and commercially
available 2D Clean-up kit or Zeba columns. Delipidation by fast centrifuga-
tion (18000g) also improved the focussing on 2D PAGE without loss of
protein species. Based on these results a reproducible method for protein
quantification and processing of bile for proteomic analysis has been
developed. We have generated a master map of bile and are currently
carrying out comparative analysis of bile samples from patients with benign
versus malignant disease.
FP 38.02
SEGMENTAL ISCHEMIA OF THE LIVER  A NEW MODEL IN
THE PIG
Winbladh, Anders1; Sandstro¨m, Per1; Gullstrand, Per2; Svanvik, Joar2;
Trulsson, Lena2
1University Hospital, Linko¨ping, Surgical Department, Linko¨ping, Sweden;
2Sweden
Background. Pringle?s manoeuvre used during liver surgery induces an
ischemia-reperfusion injury (IRI), which might negatively affect the liver
postoperatively. The degree of oxidative stress and apoptosis/necrosis could
possibly predict liver failure. Previous experimental models have used
clamping of the whole or half the liver, but that causes pooling of blood in
the gut which might aggravate the injury to the liver. Further, these models
depend on tissue and blood sampling and uses sham operated animals as
controls.
Objective. To avoid these problems, we have with the aid of microdialysis
(MD), developed a new model with segmental ischemia to study these
phenomena.Method.: Eight pigs received MD-catheters placed in liver
segments IV and V. After 60 minutes all circulation to segment IV was
closed with a clamp. Reperfusion was initiated by releasing the clamp after 80
minutes of ischemia. Segment V had undisturbed circulation and functioned
as control. Reperfusion was followed for 220 minutes with dialysate sampled
every 20 minutes. Blood and tissue samples were taken once an hour.
Results. The pigs were circulatory stable. Lactate/pyruvate ratio (31 to
3358), lactate (2.8 to 7.4 mM), glycerol (23 to 883 mM) and glucose (4.0 to
15.4 mM) were all significantly raised during ischemia in segment IV
compared to segment V, but these values normalized after reperfusion.
Serum levels of AST increased significantly, whereas ALT and LDH were
unchanged. Histology from segment IV shows infiltration of leukocytes in the
portal zones and swelling of cells which is not seen in segment V. Markers of
oxidative stress (e.g. glutathione levels) are under analysis.
Conclusion. Total vascular clamping of one liver segment causes minimal
systemic effects, but microdialysis technique reveals local anaerobic metabo-
lism during ischemia but no significant changes after reperfusion. This
experimental model is suited for studying IRI in vivo, and make temporal
histological correlations.
FP 38.03
ESTABLISHMENT OF ALTERED GI MOTILITY IN OBSTRUC-
TIVE JAUNDICE AND ITS MODULATION BY TINOSPORA COR-
DIFOLIA- AN IMMUNOMODULATOR
Kantharia, Chetan1; Rege, Nirmala2; Prabhu, Ramkrishna2; Bapat, Ravin-
dra2; Supe, Avinash2
1Kemh & Seth Gs Medical College, Surgical Gastroenterology, Parel,
Mumbai, India; 2 Hospital & Seth Gs Medical College, Clinical Pharmacol-
ogy, Mumbai, India
Introduction. GI dysmotility has never been considered as an important
clinical feature of OJ.
Objective. To assess GI Motility in experimental study and in patients with
OJ using objective parameters and if found altered, to evaluate the effect of
Tinospora cordifolia, an immunotherapeutic agent.
Methods. Experimental study Percentage gastric emptying (GE) following a
semisolid test meal was studied in normal (Grp1), sham operated (Grp2) and
cholestatic rats (Grp3). Duration of cholestasis was 4 weeks. Cholestatic rats
(n30) were then divided into 3 groups and given therapy for next 7 days
Group A: distilled water, Group B: aqueous extract of Tinospora cordifolia
(100 mg/kg) and Group C: metoclopramide (1.36 mg/kg). On 8th day% GE
was assessed. Clinical study This study was extended in patients with OJ (n
10) and normal volunteers (n10), and orocaecal transit time (OTT) was
measured Patients of OJ were treated with Tinospora cordifolia (1.5 gm/day)
and OTT was assessed before and after therapy.
Results. Experimental In Group1% gastric emptying was 8599.65%.
Surgical stress (Grp2) did not alter%GE. The% GE of rats with cholestasis
was significantly decreased (10.27913.22%, pB0.01). Further reduction
was seen when these animals were left untreated (-4914.23%). Therapy with
Tinospora cordifolia significantly improved%GE (59.37920.17%, pB0.01)
but not with metoclopramide. Clinical The OTT was found prolonged in
patients with OJ (8.2591.67 hrs) compared to normal volunteers (5.8591.7,
pB0.05). Therapy with Tinospora cordifolia significantly reduced the OTT
(6.592.1hrs.) compared to basal values (9.2592.36 hrs, pB0.05). Symp-
toms suggestive of GI dysmotility disappeared.
Conclusion. Gastroparesis and reduction in GI motility is observed in
cholestasis. Tinospora cordifolia is found to improve the altered motility and
thus impart better quality of life.
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ALTERED AQUAPORIN-9 (AQP9) EXPRESSION AND LOCALI-
ZATION IN HUMAN HEPATOCELLULAR CARCINOMA (HCC)
AND ADJACENT LIVER
McKillop, Iain1; Banks, Peter2; Heniford, B Todd3; Lincourt, Amy4; Russo,
Mark5; Palilonis, Molly4; Iannitti, David3
1University of North Carolina at Charlotte, Biology, Charlotte, NC, United
States; 2Carolinas Medical Center, Pathology, Charlotte, NC, United States;
3Carolinas Medical Center, Surgery, Charlotte, NC, United States; 4Car-
olinas Medical Center, Surgical research, Charlotte, NC, United States;
5Carolinas Medical Center, Medicine, Charlotte, NC, United States
Background. Aquaporins (AQPs) represent transmembrane proteins that
form channels allowing rapid water movement along an osmotic gradient.
Aquaporin 9 is expressed on the basolateral membrane of hepatocytes and
plays a role in bile production as well as cell apoptosis. This study evaluates
AQP9 expression and localization in human hepatocellular carcinoma
(HCC) and adjacent liver.
Methods. 18 human HCC specimens (14 male, 4 female) and adjacent liver
were obtained. Immuno-fluorescent histochemitry (IFHC) was performed
using an anti-AQP9 and F-488 labeled secondary antibody. DAPI staining
was included for nuclear identification and localization purposes. Samples
were blind scored the data and correlated to patient pathology.
Results. Of seven HCCs arising in ‘‘normal’’ liver, 4 had no AQP9
expression in the tumor while having strong AQP9 staining with normal
zonal distribution in the adjacent liver. In 2 of the remaining samples (both
female) equal staining was observed in the tumor and adjacent liver but no
zonal localization within the liver lobules. In the final sample, membrane
localization and zonal distribution was observed in the normal liver
and extensive staining with membrane localization was detected in the
tumor. In the micronodular cirrhosis patient group (n7), the HCCs stained
weakly for AQP 9 while the adjacent cirrhotic liver AQP 9 was detected
at the plasma membrane with loss of zonal distribution. In the remaining
samples AQP9 detection did not demonstrate a consistent pattern of staining
relative to membrane localization or zonal distribution in tumor or adjacent
liver.
Conclusions. These data demonstrate decreased AQP9 expression in HCC
cirrhotic and non-cirrhotic livers. Additionally, micronodular cirrhosis is
associated with loss of zonal distribution of AQP9. These data may improve
our understanding of how changes in AQP expression relate to HCC
progression in terms of decreased normal liver function and potentially, in
the increased resistance to apoptosis in transformed hepatic cells.
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MICROWAVE ABLATION COMBINED WITH INTRA-TUMORAL
INOCULATION OF DENDRITIC CELLS INDUCE SPECIFIC IM-
MUNITY AGAINST HEPATOCELLULAR CARCINOMA
Yin, Xiaoyu; Wang, Zhu; Lu, Mingde; Hou, Xun; Kuang, Ming; Liang,
Lijian
The First Affiliated Hospital, Department of Hepatobiliary Surgery,
Guangzhou, China
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Background. Microwave or radiofrequency ablation has been widely used
for treatment of hepatocellular carcinoma (HCC), but post-ablation recur-
rence still remains a major challenge. Induction of specific immunity may
represent a promising approach to prevent tumor recurrence.
Aims. To investigate the efficacy of microwave ablation combined with intra-
tumoral inoculation of dendritic cells (DCs) in inducing specific immunity
against HCC in vivo.
Methods. C57BL/6 bone marrow-derived DCs were grown in vitro for 6
days with use of murine recombinant GM-CSF and IL-4. C57BL/6 mice
were inoculated subcutaneously with Hepa1-6 cells to establish subcutaneous
HCC, and randomized into control group, group receiving intratumoral
inoculation of DCs (DC group), group receiving microwave ablation of
tumor (MWA group), and group receiving microwave ablation of tumor plus
intra-tumoral injection of DCs (MWADC group). Immunohistochemical
staining was employed to evaluate intra-tumoral infiltration of CD4 and
CD8 lymphocytes. Cytotoxicity of splenocytes against Hepa1-6 was
evaluated using MTT method. Tumor growth and animal survival in each
group were compared.
Results. Immunohistochemical staining illustrated that MWADCs group
had a markedly greater number of CD4 and CD8 T lymphocytes inside
tumor tissue as compared control group, DC group and MWA group (pB
0.05). Splenocytes from MWADCs group had a remarkably higher specific
cytotoxicity against Hepa1-6 at E/T ratio of 40 and 100 than those from
control group, DC group and MWA group (pB0.05). Tumor regression rate
was significantly higher in MWADCs group as compared with control
group, DC group and MWA group (pB0.05). Fifteen week survival rate was
significantly greater in MWADCs group than other three groups (pB
0.01).
Conclusions. Intra-tumoral inoculation of DCs following MWA could
effectively elicit specific anti-tumoral immunity in vivo. It represented as an
effective approach for preventing tumor recurrence after MWA.
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ASSESSMENT OF HEPATIC FUNCTION DURING LIVER RE-
GENERATION: COMPARISON BETWEEN 99mTc-GSA SCINTI-
GRAPHY AND 99mTc-MEBROFENIN HEPATOBILIARY
SCINTIGRAPHY
de Graaf, Wilmar1; Bennink, Roelof J.2; Maas, Adrie1; de Bruin, Cora2; van
Gulik, Thomas M.1
1Academic Medical Center, Department of Surgery/Surgical Laboratory,
Amsterdam, Netherlands; 2Academic Medical Center, Department of
Nuclear Medicine, Amsterdam, Netherlands
Background. In living donor liver transplantation, liver regeneration is
mandatory for the clinical outcome of donor and recipient. Reliable
assessment of liver function during regeneration is therefore crucial. 99mTc-
mebrofenin hepatobiliary scintigraphy (HBS) and 99mTc-GSA scintigraphy
with SPECT have been introduced for assessment of liver function. The
uptake of 99mTc-mebrofenin is equivalent to the uptake of indocyanine green.
99mTc-GSA scintigraphy can be combined with SPECT, enabling assessment
of both liver function and functional liver volume (FLV). There is no study
comparing these methods in a standardized model.
Aim. To compare 99mTc-GSA scintigraphy with 99mTc-mebrofenin HBS for
assessment of hepatic function in regenerating rat livers.
Methods. Rats (n60) were allocated to 2 protocols. Hepatic function was
determined by 99mTc-GSA scintigraphy with SPECT or 99mTc-mebrofenin
HBS on day 1, 3, 5 and 7 after 70% partial hepatectomy (PHX) (n6 each
timepoint). A group (n6), undergoing no resection served as controls.
Conventional liver volume (CLV), FLV, 99mTc-GSA uptake and 99mTc-
mebrofenin uptake were expressed as percentage of baseline values.
Results. CLV measured 1 day after 70% PHX was 60.3% of baseline level
and further regenerated from 71.4% at day 3 to 76.7% and 76.4% at day 5
and 7. During the regeneration process, there was no difference between
CVL and FLV. One day after 70% PHX, 99mTc-mebrofenin uptake (46.1%
from baseline) and 99mTc-GSA uptake (44.5%) were significantly lower than
CLV. At day 5 and 7, there was no difference between 99mTc-mebrofenin
uptake and CLV. 99mTc-GSA uptake however was still significantly lower
compared to CLV and 99mTc-mebrofenin uptake.
Conclusion. Functional regeneration is impaired compared to volumetric
regeneration in the early phase of regeneration. Hepatic 99mTc-GSA uptake
as a liver function test underestimates hepatic regeneration in comparison to
liver volume and 99mTc-mebrofenin uptake in the final phase of liver
regeneration.
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THE PATHOLOGICAL EXAMINATION OF GASTRIC MUCOSA
IN CHILDREN WITH H. PYLORI *POSITIVE AND *NEGATIVE
EHPVO
Prasad, Kaushal K1; Thapa, Babu R1; Sharma, Arun K1; Nain, Chander K1;
Singh, Kartar1; Negi, B2
1Postgraduate Institute of Medical Education & Research, Department of
Superspeciality of Gastroenterology, Chandigarh, India; 2Postgraduate In-
stitute of Medical Education & Research, Dept. of Radiology, Chandigarh,
India
Background. The basic histopathological finding in gastric mucosa is
chronic gastritis in patients with Helicobacter pylori-infection.
Aims. We aimed to assess the pattern of gastric mucosal lesion in children
with Helicobacter pylori-infection and extrahepatic portal venous obstruction
(EHPVO), and to determine whether EHPVO contributed to the severity of
the gastritis.
Methods. We retrospectively enrolled 70 patients with EHPVO, and
consisted of 30 children with (Group A: 18 male; 12 female; mean age,
10.3890.64 years) and 40 children without H. pylori-infection (Group B: 27
male; 13 female; mean age, 11.4390.66 years), who made up the control
group. In all patients, diagnostic upper endoscopy was performed, and gastric
biopsies were taken for histological examination and diagnosis of H. pylori.
The gastric damage was classified according to the modified Sydney System.
Results. H. pylori were not found in gastric mucosa without histological
changes. The prevalence of chronic superficial gastritis (13.33% versus 35%,
p0.04) was significantly low in group A than group B. The prevalence of
follicular gastritis (60% versus 42.50%, p0.15) and lymphocytic gastritis
(10% versus 12.50%, p0.74) was similar between the two groups. There
was a significant increase in grade of inflammation (1.6390.10 versus 1.339
0.07, pB0.02), activity (0.4790.12 versus 0.0390.02, pB0.001)
atrophy (0.2390.09 versus 0.0390.02, pB0.05) and edema (1.039
0.09 versus 0.6390.09, pB0.001) on histologic examination in group A
than group B. The number of intraepithelial lymphocytes, number of
lymphoid follicles, intestinal metaplasia and microvessel congestion was
similar between the two groups.
Conclusions. Helicobacter pylori-infection in children with EHPVO may
identify cases with chronic active gastritis. The gastric histological pattern in
children with EHPVO appears to be independent of H. pylori-infection. The
role of H. pylori-infection in the pathogenesis of congestive gastropathy
seems to be unlikely.
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BILE LEAKS REDUCTION AFTER ADULT SPLIT LIVER TRANS-
PLANTATION USING A HAEMOSTATIC SPONGE (TACHOSIL†)
Toti, Luca; Manzia, Tommaso Maria; Lenci, Ilaria; Attia, Magdy; Buckels,
John AC; Mayer, A David; Mirza, Darius F; Bramhall, Simon R; Wigmore,
Stephen J
Queen Elizabeth Hospital, Liver Unit, Birmingham, United Kingdom
Background. Bile leaks are a frequent complication of adult split liver
transplantation. We compared surgical complications in patients who had the
cut surface of the liver treated with a fibrin-collagen sponge (Tachosil) and
patients in whom the cut surface of the liver was treated with fibrin glue.
Methods. Two consecutive cohorts of 16 patients undergoing adult right
lobe split liver transplant were compared. In the first cohort the liver was
treated with fibrin glue and in the second the liver surface was treated with
Tachosil fibrinogen-thrombin-collagen sponge patches. Blood usage and post
operative complications were documented.
Results. Blood usage in both groups was equal. Patients in whom the cut
surface of the liver was treated with Tachosil had significantly fewer bile leaks
(1 of 16) compared with those where fibrin glue was used on the cut surface
(7 of 16). There were some differences in biliary anastomotic techniques used
in the two groups but 7 of 8 leaks arose from the cut surface with only 1
anastomotic leak.
Conclusions. Using a fibrinogen-thrombin-collagen sponge patch such as
Tachosil may reduce bile leaks from the cut surface of adult right lobe split
liver transplants.
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IMPACT OF RESECTION MARGIN STATUS ON SURVIVAL FOL-
LOWING RESECTION FOR PANCREATIC, AMPULLARY AND
DISTAL BILE DUCT CANCER
Gomez, Dhanwant1; Menon, Krishna V1; Smith, Andrew M1; Verbeke,
Caroline S2
1The Leeds Teaching Hospitals NHS Trust, Department of Surgery, Leeds,
United Kingdom; 2The Leeds Teaching Hospitals NHS Trust, Department
of Histopathology, Leeds, United Kingdom
Background. We have recently reported a high R1 rate (85%) for pancreatic
cancer (PC) following the use of a rigorous, fully standardized protocol (SP)
for pathological examination.
Aims. To determine whether the R1 rate is consistently high using the same
SP in a larger prospective series, and to compare clinicopathological features
and survival data between PC, ampullary (AC) and distal bile duct (BDC)
cancers.
Methods. Patients undergoing potentially curative resection (pancreatico-
duodenectomy) for PC, AC or BDC between January 2003 and April 2007
were identified from the Pathology database. Clinicopathological and survival
data were analyzed.
Results. 84 patients were identified (PC28, AC24, BDC32). PCs and
BDCs were locoregionally advanced cancers (]75% of cases pT3N1L1V1)
with a high R1 rate (PC: 82%, BDC: 72%). AC, even if T-stage corrected,
was significantly different from PC and BDC in terms of smaller tumour size,
lower R1 rate (25%) and less frequent vascular and perineural invasion (pB
0.001). There was no difference in clinicopathological factors between the R1
and R0 group in PC, whereas lymphovascular invasion and lymph node
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positivity rate were higher in the R1 group of AC (p5 0.050), and pN1-stage,
lymphatic permeation and lymph node positivity rate more common in R1
resected BDCs (p5 0.038). One and 3 year survival rates were 68% and 17%
for PC, 83% and 83% for AC, and 71% and 30% for BDC, respectively. On
univariate analysis, resection margin status was the only adverse prognostic
factor in patients with PC (p0.024), while there were no prognostic factors
that affected overall survival in AC and BDC.
Conclusion. Resection margin status is a significant prognostic factor
in PC.
FP 39.03
PANCREATIC CANCER PATIENTS SURVIVING FIVE OR MORE
YEARS AFTER SURGERY
Baba, Hiroyuki1; Honda, Goro2; Kurata, Masanao2; Tsuruta, Koji2; Oka-
moto, Atsutake2
1Shuwa General Hospital, Surgery, Kasukabe, Japan; 2Tokyo Metropolitan
Cancer and Infectious Diseases Center Komagome Hospital, Surgery, Tokyo,
Japan
Background. Although various trials of multidisciplinary treatment ap-
proach have been made, pancreatic cancer still remains to be a dismal
disease. However, we have experience some patients with good prognosis
after surgical resection. AIM We tried to define its character by retrospective
review for future treatment strategy.
Method. 140 pancreatic cancer patients, surgically treated from 1975 to
2004 at Tokyo Metropolitan Komagome Hospital, were investigated. They
were all pathologically proven as pancreatic cancer and their charts were
briefly reviewed. Patients who survived five or more years were targets for this
study.
Results Ten patients (six males, four females; average age 64.8 years old)
lived more than five years after surgical resection. Nine of them had Whipple
procedure and the other had distal pancreatectomy. Five patients received
intraoperative radiotherapy (IORT). Maximum tumor diameter averaged
23.3 mm. Only two patients were symptom free. Jaundice was the most
common symptom (six patients, 67%). Pathologically, tumor existed within
the pancreatic parenchyma. Only one patient had microscopic invasion to the
retroperitoneum. Lymph node involvement was found in six patients, two of
them being pN2. Survival of node negative patients verses positive were 121
months to 112 months. Adjuvant therapy was routine for all patients,
however, regimen varied. Gemcitabine was the first choice for patients after
1999.
Conclusion. Small tumors within the pancreatic parenchyma are candidates
for good prognosis. However, it is not sufficient. Interestingly, IORT,
adjuvant therapy and node involvement were not factors for long
survival.
FP 39.04
POST RADIOCHEMOTHERAPY LEVELS OF SERUM CA19-9
PREDICT RESECABILITY FOR PATIENTS WITH LOCALLY
ADVANCED PANCREATIC ADENOCARCINOMA.
Sa Cunha, Antonio; Wagner, Tristan; Rault, Alexandre; Collet, Denis;
Masson, Bernard
Chu Bordeaux, Bordeaux, France
Background. Locally advanced pancreatic adenocarcinoma may be down-
staged by Radiochemotherapy (RCT) to allow for surgical resection.
However restaging CT was less accurate following RCT for predict
resecability. Serum levels of CA19-9 have been shown to correlate with
both recurrence and survival in patients with pancreatic cancer.
Aim. The purpose of this study was to determine whether post RCT CA19-9
levels can predict resecability for patients with locally advanced pancreatic
adenocarcinoma.
Methods. From January 2003 to December 2006, 33 patients with radio-
graphically locally advanced pancreatic adenocarcinoma, pathologically
confirmed, have received RCT. Patients with tumor response or stabilization
at restaging CT-scan underwent a surgical exploration to determine whether
the tumor was resectable. All patients had pre and post RCT CA19-9 levels.
Data were analysed according to 2 post RCT serum CA19-9 levels: CA19-
9B200, and CA19-9200.
Results. At restaging CT-scan, six patients had tumor progression (mean
CA19-9 level of 1004 UI/ml), 23 patients had tumor stabilization (mean
CA19-9 level of 515 UI/ml) and 4 patients had tumor response (mean CA19-
9 level of 72.5 UI/ml). Twenty seven patients (23: tumor stabilization and 4:
tumor response) were surgically explored. 18 patients had CA19-9 levels
B 200 UI/ml and 9 had CA19-9 levels 200 UI/ml. Twelve patients were
found to be unresectable due to unsuspected distant metastatic disease or
persistent malignant arterial encasement on frozen. Fifteen patients under-
went pancreatic resection. Surgical margins were negative in 12 patients
(80%). Resecability rate was 72% (13/18) in patients with CA19/9 levels
B200 and 22% (2/9) in patients with CA19/9 200 (p0.035).
Conclusion. In patients with locally advanced pancreatic adenocarcinoma,
post RCT CA19-9 value of less than 200 UI/ml are strong predictor of
resecability. This study shows that CA 19-9 levels should be included in post
RCT restaging in patients with pancreatic adenocarcinoma.
FP 39.05
THE EFFECT OF CELECOXIB ON PANCREATIC CANCER IN
VITRO
Andersson, Roland; Aho, Ursula; Tingstedt, Bobby; Zhao, Xia
Lund University Hospital, Dept of Surgery, Clinical Sciences, Lund, Lund,
Sweden
Background. Among factors underlying the aggressive nature of pancreatic
cancer (PC), tissue expression of cyklooxygenase-2 (COX-2) might play a
role, as well as the transcription factor nuclear factor kappa B (NF-KappaB),
frequently activated in PC and decreasing apoptosis, as well as increased
expression of epidermal growth factor receptor (EGFR), stimulating metas-
tases development.
Aim. The aim of the present study was to evaluate the effect of a selective
COX-2 inhibitor on PC in vitro.Method.: The cell lines PANC-1, AsPC-1
and BxPC-3 were then stimulated with serum (10% fetal calf serum).
Celecoxib was used for cell incubation. The effect was evaluated by
measuring cell proliferation, apoptosis, expression of EGFR and NF-KappaB
activation.
Results. Incubation with celecoxib for 24 and 48 hours, respectively,
resulted in a significant decrease in proliferation in PANC-1 (p0.008 and
pB0.001, respectively), BxPC-3 (p0.035 and pB 0.001, respectively) and
AsPC-1 (p0.001; 48 hours). A significant increase in apoptosis was noted
in PANC-1 cells after 24 and 48 hours (p0.044 and pB0.001, respectively)
and in BxPC-3 after 24 hours (p0.002). Celecoxib resulted in significantly
decreased expression of EGFR in PANC-1 and BxPC-3 after 24 hours (p
0.007) and p0.005, respectively). A decreased expression of EGFR in
AsPC-1 cells was noted after 24 and 48 hours (p0.033 and p0.003,
respectively). Celecoxib decreased the activation of NFKappaB in all cell
lines studied.
Discussion/Conclusion. Incubation with celecoxib resulted in decreased
proliferation and increased apoptosis especially in cell lines generally
considered COX-2 positive (PANC-1 and BxPC-3). Celecoxib decreased
expression of EGFR and the activation of NF-KappaB in all cell lines. The
study implies that COX-2 might have an important role in the proliferation of
PC and the use of COX-2 inhibitors might play a potential role in future
palliative treatment.
FP 39.06
MANAGEMENT OF CELIAC ARTERY STENOSIS IN PATIENTS
ELIGIBLE FOR PANCREATODUODENECTOMY
de Nes, L.C.F.; van der Gaag, N.A.; Idu, M.M.; Busch, O.R.C.; van Gulik,
T.M.; Gouma, D. J.
Academic Medical Center, Department of Surgery, Amsterdam, Netherlands
Background. Since an increasing number of elderly patients are considered
for pancreatoduodenectomy (PD), the likelihood of encountering advanced
vascular comorbidity such as celiac artery/trunk stenosis (CAS) increases.
CAS results in retrograde perfusion of the hepatic artery via the gastro-
duodenal artery (gda) and carries a high risk of liver ischemia when, during
PD, the gda is divided.
Aim. To evaluate incidence and management of CAS in patients eligible for
pancreatoduodenectomy (PD).
Methods. Records of 1070 patients who underwent an explorative lapar-
otomy during Jan-1992/Sep-2007 on the suspicion of a pancreatic/periam-
pullary tumour, were analyzed for the occurrence of CAS. Management was
evaluated.
Results. Twelve patients with CAS were identified (1.1%, 12/1070). CAS
was diagnosed preoperatively in 3 patients on radiological imaging and in 8
patients intraoperatively [clamping of gda resulted in disappearance of
hepatic artery pulsations]. In 1 patient CAS became apparent after PD and
the development of liver abscesses. A PD was performed in 6 patients with
concomitant hepatic artery/aortic bypass and in 2 patients with sparing of the
gastroepiploic artery and postoperative radiological intervention. Resection
was deferred in 4 patients. Reperfusion of the hepatic artery was successful in
all cases. Postoperatively 1 of the patients that underwent reconstruction died
due to complicated course after pancreatojejunostomy leakage, while 1
patient underwent reoperation for anastomotic leakage and had liver
ischaemia due to an obstructed bypass.
Conclusion. CAS is a hazardous condition in patients requiring PD, since
misdiagnosis results in postoperative liver ischemia. Awareness of this risk is
mandatory in any patient assessed for PD. In patients with CAS who are
found to be resectable, PD combined with hepatic artery/aortic bypass is
advised.
FP 39.07
CLINICO-EPIDEMIOLOGICAL CHARACTERISTICS OF MU-
CIN-PRODUCING NEOPLAMS OF THE PANCREAS: ANALYSIS
OF 557 CONSECUTIVE CASES
Stefano, Crippa1; Fernandez-del Castillo, Carlos2; Bassi, Claudio1; Finkel-
stein, Dianne3; Roberto, Salvia4; Thayer, Sarah P2; Dominguez, Ismael2;
Falconi, Massimo4; Capelli, Paola5; Mino-Kenudson, Mari6; Zamboni,
Giuseppe5; Lauwers, Gregory6; Partelli, Stefano7; Pederzoli, Paolo4; War-
shaw, Andrew L2
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1University of Verona, Department of Surgery, Verona, Italy; 2Massachusetts
General Hospital, Surgery, Boston, USA Minor Outlying Islands; 3Massa-
chusetts General Hospital, Department of Biostatistics, Boston, USA Minor
Outlying Islands; 4University of Verona, Surgery, Verona, Italy; 5University of
Verona, Pathology, Verona, Italy; 6Massachusetts General Hospital, Pathol-
ogy, Boston, USA Minor Outlying Islands; 7University of Verona, Surgery,
Verona, USA Minor Outlying Islands
Background. Mucin-producing neoplasms of the pancreas (MPNPs)
include mucinous cytic neoplasms (MCNs), intraductal papillary mucinous
neoplasms involving the main pancreatic duct (MD-IPMNs) or its branch-
ducts (BD-IPMNs). In the past MCNs and BD-IPMNs were frequently
confused, and a clear distinction between BD-IPMNs and MD-IPMNs is
lacking as well.
Aim. To evaluate clinico-epidemiological characteristics and prognosis of a
large series of MPNPs.
Methods. Analysis of 577 patients with resected, histologically confirmed
MPNPs.
Results. 168 patients (30.2%) had MCNs, 159 (28.5%) BD- IPMNs, 230
(41.3) MD-IPMNs [149 (26.8%) combined IPMNs, 81 (14.5%) ‘‘pure’’
MD-IPMNs]. Patients with MCN were significantly younger than those with
BD-IPMNs (44.5 vs 66 years), were almost exclusively women (Female: 95%
in MCNs, 57% in BD-IPMNs and 44% in MD-IPMNs); the lesion
preferentially involved the distal pancreas in MCNs (97%) and the head in
BD-IPMNs (58.5%) and MD- or combined IPMNs (64% and 66%).
IPMNs were more likely to be symptomatic than MCNs. Adenoma was
found in 73% of MCNs, 44% of BD-IPMNs, 8% of combined IPMNs and
11% of MD-IPMNs. The rate of invasive cancer was 11% in MCNs and BD-
IPMNs and 42% and 48% in combined- and MD-IPMNs. MD-IPMNs and
combined IPMNs had the same sex-ratio, rate of malignancy, rate of
symptomatic patients, and tumor site, and these parameters were significantly
different when compared with BD-IPMNs. Neoplasms were incidentally
discovered in 35% of BD-IPMNs, 19% of combined IPMNs and 13% of
MD-IPMNs. 5-year disease specific survival was 100% for patients with
noninvasive MCNs, BD-IPMNs and combined-IPMNs; 95% for patients
with noninvasive MD-IPMNs; 58%, 56%, 51%, 64%, for invasive MCNs,
BD-IPMNs, MD-IPMNs, and combined-IPMNs.
Conclusions. MPNPs encompass different neoplasms with specific features.
MCNs and BD-IPMNs are two distinct diseases. BD-IPMNs show
significant differences if compared with MD- and combined-IPMNs. BD-
IPMNs should be considered a specific disease itself.
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APPLEBY OPERATION WITH PREOPERATIVE CELIAC ARTER-
IAL EMBOLIZATION FOR LOCALLY ADVANCED DISTAL PAN-
CREATIC CANCER
Miyazaki, Akinari; Cho, Akihiro; Yamamoto, Hiroshi; Nagata, Matsuo;
Takiguchi, Nobuhiro; Kainuma, Osamu; Soda, Hiroaki; Gunji, Hisashi;
Ikeda, Atsushi; Matsumoto, Ikuko; Nimura, Yoshinori; Mikami, Tomoko;
Ryu, Munemasa
Chiba Cancer Center Hospital, Gastroenterological surgery, Chiba, Japan
Background. Appleby operation consists of an en bloc resection of the
stomach, the body and tail of pancreas and the spleen with celiac artery
divided. This procedure is useful for an advanced cancer of pancreas body
and tail with celiac trunk invasion.
Objective. We report Appleby operation with preoperative celiac arterial
embolization.
Methods. A case report of 72 year-old male with a locally advanced distal
pancreatic cancer derived from intraductal papillary mucinous neoplasm.
Computed Tomography showed that the celiac trunk was involved but the
superior mesenteric artery was intact. We performed Appleby operation two
days after transcatheter celiac arterial embolization with coils.
Results. The operation time and intraoperative bleeding was 210 minutes
and 400g. There were no remarkable complications and the length of hospital
stay after operation was 14days. The surgical margin was free of tumor
pathologically.
Conclusions. We performed Appleby operation more safely due to the
preoperative celiac arterial embolization.
FV 1.02
PANCREATICODUODENECTOMY AND PORTAL VEIN RESEC-
TION WITH RECONSTRUCTION USING AN INTERPOSITION
GRAFT OF LEFT RENAL VEIN IN PDAC
Choi, Dong Wook; Paik, Kwang Yeol; Lee, Hyung Geun; Ryu, Dong Do;
Heo, Jin Seok; Choi, Seong Ho
Samsung Medical Center, Surgery, Seoul, Korea, Republic of
Introduction. For pancreatic ductal adenocarcinoma in head portion,
Pancreaticoduodenectomy is treatment of choice, although complete resec-
tion may require venous resection We experienced the technique of using the
left renal vein as a conduit for venous reconstruction during pancreatico-
duodenectomy.
Methods. 44-year old man was evaluated for abdominal pain. CT scans
demonstrated pancreas mass in uncinate process with SMV invasion at the
splenoportal junction. Under the impression of PDAC, exploratory lapar-
otomy was carried out. Dissection of the gastrocolic trunk was difficult,
because of inflammatory adhesion existed. Hepatoduodenal ligament was
dissected and multiple lymph node were enlarged. After Kocher maneuver,
paraaortic node was not enlarged and cleared. Portal vein was invaded at the
splenoportal junction level and impossible to dissect from the main tumor;
therefore, segmental resection and end-to-end anastomosis was performed.
Splenic vein was ligated and distal portal vein stump and 1st jejunal branch
opening were united for anastomosis. After end-to-end anastomosis, prox-
inmal jejunum was discolored by anastomotic site tension. We decided the
procedure that using the left renal vein as an interposition graft for venous
reconstruction. The left gonadal vein was preserved and left renal vein was
harvested about 2cm length. Then re-anastomosis was performed using graft.
Jejunal edema and discoloration was improved. Then pancreaticojejunost-
omy, choledochojejunostomy, gastrojejunostomy were proceeded in order.
Operation time was 8hr 40min and estimated blood loss was 800ml.
Postoperative 7th day, Renal DMSA scan and Doppler USG revealed
decreased left renal function. The patient was discharged on 16th post
operative day.
Results. Pathologic diagnosis was ductal adenocarcinoma with moderate
differentiation and the stage was IIB (T3N1M0).
Conclusions. The left renal vein provides an additional choice for an
autologous graft during pancreaticoduodenectomy with venous resction
FV 1.03
HANGING MANOEUVRE TO FACILITATE THE RETROPERITO-
NEAL DISSECTION DURING PANCREATICODUODENECTOMY
PESSAUX, Patrick1; ROSSO, Edoardo2; OUSSOULTZOGLOU, Elie2;
JAECK, Daniel2
1Hopital de Hautepierre, Centre de Chirurgie Visce´rale et Transplantation,
Avenue Molie`re, Strasbourg, France; 2Hopital de Hautepierre, Centre de
Chirurgie Visce´rale et Transplantation, Strasbourg, France
Background. Malignant periampullary tumours often invade into retro-
peritoneal peripancreatic tissues and a positive resection margin following
pancreaticoduodenectomy is associated with a worst survival. Among the
different steps of pancreaticoduodenectomy one of the most difficult, bloody,
and less codified is the resection of the retroperitoneal margin (RM) Aim of
the study: The aim of this video was to describe a surgical technique that
allows for a precise and reproducible identification of the RM and for an
optimal control of bleeding.
Methods. A liberal Kocherization exposes the origin of the SMA just
superior to the point at which the left renal vein crosses the aorta. A large
right-angled dissector is passed along the superior mesenteric artery from its
origin on the aorta up to its emergence in the mesentery. At tape is seized
with the right-angled and passed around the RM. The assistant lift upward
the tape exposing the RM (hanging manoeuvre) facilitating de dissection of
the RM from the superior mesenteric artery. Bleeding may be easily
controlled by further lifting of the tape leaving to the surgeon ‘‘two’’ hands
for selective and definitive hemostasis with fine sutures.
Conclusion. The hanging manoeuvre for pancreaticoduodenectomy allows
a complete, safe, and reproducible resection of the RM and may
contribute to increase the number curative resections (avoids the « point
of no return » of the classical operation and early identification of non
respectability). This method also accomplishes adequate lymphadenectomy
and easier identification and safeguarding of a replaced right hepatic
artery, if present.
FV 1.04
HEPATIC ARTERY RECONSTRUCTION IN PANCREATICO-
DUODENECTOMY BY DIRECT ANASTOMOSIS UTILIZING
PANCREATICODUODENAL ARTERY.
Hoshino, Takanobu; Ishida, Takashi; Odaka, Akio; Hashimoto, Daijo
Saitama Medical University, Medical Center, Hepato-pancreato-biliary
Surgery, Kawagoe-city, Japan
Objective. To present technical aspects and advantages of hepatic artery
(HA) reconstruction by direct anastomosis utilizing pancreaticoduodenal
artery (PDA) as a useful option in pancreaticoduodenectomy.
Methods. Pancreaticoduodenectomy was performed in a patient with
complete obstruction of celiac trunk. A 69-year-old female patient, com-
plaining of jaundice, was admitted with diagnosis of cancer of either pancreas
head or CBD. Angiography demonstrated complete obstruction of celiac
trunk, because of arteriosclerosis, and marked dilation of the arcade between
inferior and superior PDAs. Blood flow of HA turned out to be supplied only
from superior mesenteric artery (SMA) via arcades of PDAs. Therefore, it
was mandatory to perform HA reconstruction to safely complete pancrea-
ticoduodenectomy.
Operation. Intraoperative findings revealed no tumor exposure on the
surface of pancreas or CBD. There was no tumor invasion to adjacent tissue
and no lymph node swelling, either. Therefore, we decided to utilize the
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arcade of PDAs for HA reconstruction. Anterior arcade of inferior and
superior PDAs was carefully dissected and freed, first, by ligating and
dividing small branches communicating to pancreas head. Following
complete dissection of the anterior arcade of PDAs, we performed recon-
struction of HA by end-to-end anastomosis between gastroduodenal artery
and dilated anterior inferior PDA (4 mm in diameters for both arteries). After
adequate blood flow of HA (through this vascular anastomosis) was
confirmed, the rest of pancreaticoduodenal resection followed by biliary
and alimentary tract anastomoses were completed in usual fashion.
Results. Postoperative course was uneventful, and no complication, includ-
ing vascular problems such as anastomotic occlusion or leakage, was
observed. This patient is still alive, free of disease, at four years three months
following surgery.
Conclusion. HA reconstruction utilizing PDAs appears to be one of the
useful options when adequate diameters of the arteries are available.
FV 1.05
PANCREAS SPARING-DUODENECTOMY FOR LOW-GRADE
MALIGNANCY OF THE DUODENUM
Ikuko, Matsumoto1; Cho, Akihiro1; Miyazaki, Akinari1; Ikeda, Atsushi1;
Gunji, Hisashi2; Soda, Hiroaki1; Kainma, Osamu2; Takiguchi, Nobuhiro2;
Nagata, Matsuo2; Yamamoto, Hiroshi1; Ryu, Munemasa1
1Chiba Cancer Center, Gastroenterological Surgery, Chiba, Japan; 2
Introduction. Pancreas sparing- duodenectomy (PSD) is an organ-preser-
ving surgical procedure suitable for patients with pre or low-grade malig-
nanies of the duodenum. The surgical technique is challenging due to the
close anatomical relationship between the pancreatic head and the duode-
num. We herein present a case with early cancer of the papilla Vater which
was successfully resected using PSD.
Case. A 54-year-old man was referred for treatment of a tumor of the
ampulla of Vater. Although endoscopic biopsy did not confirm malignancy,
the patient underwent PSD under the presumptive diagnosis of adenoma or
cancer in adenoma of the papilla Vater. After cholecystectomy, a stenting tube
was inserted from the cystic duct into the duodenum, acting as a landmark.
The ligament of Treitz is dissected, and the proximal jejunum is transected
with the gastrointestinal stapler. Dissection between the infra-ampullary
duodenum and the pancreatic head proceeded to the major papilla. The
common duct of the bike and pancreatic ducts was encircled both extra-
duodenally and extra-pancreatically. Then, common duct and supra-ampul-
lary duodenum were divided. Reconstruction was accomplished by end-to-
end duodenojejunostomy with inplanting the bile and pancreatic ducts in the
jejunum. He had compications of bile leakage and delayed gastric emptying,
however they got well spontaneously.
FV 1.06
PANCREATOGENOUS ADULT HYPERINSULINEMIC HYPO-
GLUCEMIA SYNDROME
Pekolj, Juan1; Fernandez, Diego L2; Bregante, Mariano2; Salceda, Juan3;
Mazza, Oscar2; Ardiles, Victoria2; de Santibanes, Eduardo4
1Hospital Italiano Buenos Aires, HPB and Liver Transplant Unit, Buenos,
Argentina; 2Hospital Italiano Buenos Aires, HPB and Liver Transplant Unit,
Buenos Aires, Argentina; 3Hospital Italiano Buenos Aires, HPB and Liver
Transpant, Buenoa Aires, Argentina; 4Hospital Italiano Buenos Aires, HPB
and Liver Transplant Unit, Buenos Aires
Background. Insulinoma and Nesidioblastosis constitute an important
cause of pancreatogenous adult hyperinsulinemic hypoglucemia syndrome.
Both can be managed through miniinvasive surgery.
Objective. To show two PAHH Syndrome cases resolved by laparoscopic
approach.
Population and Methods. A 26 year-old female and a 54-year-old female
with PAHH syndrome are presented here. CT scan did not show any tumor
in either of them. Angiography showed an insulinoma on tail of pancreas in
the second case. The 48-hour fast test was positive in both cases. Calcium
stimulation was positive in splenic artery and in splenic and gastroduodenal
artery in the first? case.
Results. Both patients were approached by laparoscopy. The first case was
resolved through a laparoscopic spleen-preserving distal pancreatectomy. The
second case was resolved performing a laparoscopic distal pancreatosple-
nectomy. Patients were discharged at day 5 and 6, respectively, without
postoperative complications. Post-operative 48-hour fast test was negative.
Hypoglucemia and diabetes were not observed in the follow- up.
Conclusion. PAHH syndrome should be surgically managed. Laparoscopic
surgery allowed us to resolve both cases satisfactorily. Symptoms were
controlled without any complications and without hypoglucemia or diabetes
in the follow-up.
FV 2.01
EXTENDED LEFT HEPATECTOMY THROUGH ANTERIOR AP-
PROACH FOR HEPATOCELLULAR CARCINOMA ARISING
FROM THE CAUDATE LOBE
Kim, Hong-Jin; Lee, DS; Yun, SS
Yeunganm University Hospital, Surgery, Daegu, Korea, Republic of
Background. Hepatocellular carcinoma arising from caudate lobe is rare,
and it’s prognosis is poor. We performed extended Lt. hepatectomy through
anterior approach for huge hepatocellular carcinoma arising from caudate
lobe and would like to present it.
Method. Seventy three-year old male patient was admitted for incidental Lt.
lobe huge mass of liver. when serum hemoglobin was 13.7g/dL, platlet was
196K/uL, albumin was 3.7g/dL, Total bilirubin was 1.02mg/dL, AST 45U/L,
ALt 13U/L, PT 12.9s, and HBsAg was negative, HBeAb was positive.,
AntiHCV was negative, aFP was 18542, PIVKA-2 was above 2000U/mL.
ICG R15 was 16.6%. whole abd. CT scan shows an about 12cm-sized
heterogenous huge mass in Lt. lobe of liver. It arising from caudate lobe and
compressing the Lt. lobe of liver. Lt. hepatic vein and Lt. portal vein was not
visualized due to compression. We used anterior approach. Lt. heapatic
artery and portal vein was ligated and transsected first, and liver parenchyme
was dissected with Rt. lobe and Lt. lobe. by color demarcation line. After
anterior approach was performed, caudate lobectomy was performed care-
fully.
Results. Pathologic diagnosis was hepatocellular carcinoma, and its largest
diameter was 12cm, vascular invasion and capsule invasion was notified, thus
the stage was IVa(T4N0M0). 1 month later, his follow up CT scan and
angiography shows that there was no recur or distant metastasis. 3 months
later, serum aFP and PIVKA-2 level was normalized.
Conclusion. Anterior approach could be a good strategy for huge HCC
arising from caudate lobe.
FV 2.02
CHOLANGIOCARCINOMA IN PROXIMITY OF THE CAVO-HE-
PATIC CONFLUENCE: RIGHT HEPATECTOMY EXTENDED TO
THE POSTERIOR PORTION OF SEGMENT 4
Nuzzo, Gennaro; Giuliante, Felice; Ardito, Francesco; Vellone, Maria;
Giovannini, Ivo
Catholic University-School of Medicine, Hepato-Biliary and Digestive
Surgery Unit, Rome, Italy
Background. Intrahepatic cholangiocarcinoma accounts for about 10% of
primary liver tumours. Although there is often late diagnosis with low
resectability rate, liver resection remains the only therapeutic option. Large
resections are frequently required.
Objective. The video shows the case of a 69-yr old male patient with a 9-cm
tumour completely invading liver segments 6 and 7. CT-scan and magnetic
resonance showed close proximity of the tumour to the whole retro-hepatic
portion of the cava and caval infiltration could not be totally excluded.
Superiorly the tumour was also in close proximity of the right cavo-hepatic
confluence, and inferiorly in proximity of the right postero-lateral portal
pedicle without infiltration.
Method. A right hepatectomy extended to the posterior portion of segment 4
was performed. To achieve complete vascular control, and be prepared for a
total vascular exclusion, the supra- and infra-hepatic vena cava were isolated
and prepared, with interruption of the right adrenal vein. The posterior wall
of the tumour was progressively detached from the anterior wall of vena cava,
proceeding from below upwards, with the interruption of several dorsal veins
and of the right dorsal caval ligament, therefore obtaining an extra-
parenchymal preparation of the right hepatic vein. The parenchymal
transection was carried out by Kelly-clasia and wet bipolar forceps, without
clamping of the hepatic pedicle.
Results. The recovery was normal, with uneventful postoperative course.
FV 2.03
RE-HEPATECTOMY AFTER RIGHT HEPATECTOMY FOR COL-
ORECTAL METASTASIS
Regimbeau, jean-marc1; Fuks, david2; Degremont, raphael1; de Dominicis,
florence1; Mauvais, franc¸ois1
1hospitalo-universitary hospital, digestive surgery, Amiens, France; 2hospi-
talo-universitary hospital, digestive surgery, Amiens
Right hepatectomy for colorectal liver metastasis is, basically, the major
resection the most frequently carried out after wedge resection. It represents
30 to 45% of liver resection. Some of the patients, who have had a right
hepatectomy, will recur with new liver metastasis. They will become possible
candidates for a rehepatectomy, for it has been validated in terms of survival.
We are presenting you a video of a rehepatectomy for a metastasis recurrence
occurring in the low part of the IVth segment, after a right hepatectomy. This
localisation necessitates a hilar cholangiocarcinoma like resection, including a
main bile duct resection. We are proposing you a classification of intrahepatic
recurrence after right hepatectomy.
FV 2.04
EXTENDED LEFT LOBECTOMY WITH PRESERVATION OF THE
INFERIOR RIGHT HEPATIC VEIN FOR A CHOLANGIOCARCI-
NOMA INVOLVING THE HEPATO-CAVAL CONFLUENCE
Dalla Valle, Raffaele
University of Parma, General Surgery, Parma, Italy
Background. After an extended hemihepatectomy adequate venous drai-
nage of the remaining liver is required in order to preserve hepatic function.
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Most liver tumours involving the confluence of the hepatic veins are
considered unresectable because hepatic venous outflow after resection
would be compromised. In 1025% of people, the inferior right hepatic
vein presents large calibre. Thus the superior hepatic veins may be
sacrified and hepatic function preserved if a large inferior right hepatic vein
is present.
Technique. The video describes a case of cholangiocarcinoma involving the
dome of the liver, all the three hepatic veins and the portal pedicle to the
VIII segment. The patient was a 78 old years woman in good general
conditions and liver function. At the CT scan she had a large inferior right
hepatic vein draining the posterior liver sector. The patient was treated by
an extended left hepatic lobectomy with resection of the main right, left and
middle hepatic vein and preservation of the inferior right hepatic vein. The
video also shows the technical solution (an omental flap like an hammock
fixed to the diaphragm) adopted to preserve a good venous drainage of the
residual posterior sector hampered by the kinking of the inferior hepatic
vein. The patient is still alive after 18 months of follow-up but a recent CT
scan showed three distant liver metastasis actually treated with chemother-
apy.
Conclusions. This case confirms that a hepatic lesion involving the dome of
the liver, apparently unresectable can turn resectable if an alternative venous
drainage is present. In these cases a pre-operative search for an inferior right
hepatic vein is mandatory and is easily accomplished by ultrasound and
computerized tomography.
FV 2.05
ISOLATED COMPLETE RESECTION OF CAUDATE LOBE
MAINLY BY LEFT APPROACH
PENG, Shu You; LIU, Yiing Bin; LI, Jiang Tao
Second Affiliated hospital/zhejiang university, Department of surgery,
Hangzhou, China
Introduction. Caudate lobe resection especially isolated complete resectio-
n(ICR) is still a serious challenge to many of the HPB surgeons. The choice
of an appropriate approach is important to the success of ICR.
Objective. Among the 5 different approaches, left approach alone is seldom
used for ICR especially when the tumor is huge. This video is to demonstrate
the feasibility of left approach in such situation.
Methods. A 37-year-old lady complaint of upper abdomen discomfort for 2
mo CT scan showed a huge hemangioma 106cm. Isolated complete
resection of caudate lobe was planned.
Results. During operation a huge hemangioma was confirmed. Left lobe was
fully mobilized. Separation started from upper pole of the caudate lobe which
was detached from the IVC. With the use of a special instrument, Peng¡*s
Multifunctional Operative Dissector (PMOD) to isolate and divide several
short hepatic veins, quite a long segment of IVC was separated from the
upper part of the caudate lobe. The separation then restarted from the lower
left portion of the caudate. With all the short hepatic veins on the left side
divided, the Spiegelian lobe was completely detached from the IVC followed
by complete detachment of the paracaval portion. Dissection being carried on
from left to right, we now came to the right side of the IVC, along which all he
short hepatic veins were isolated and divided. The caudate process was then
divided and the stump was pushed to the left. The caudate portal triads
began to be dissected and divided one by one. the tumor was detached from
its base, segment VI and VII using the transection technique called Curettage
and Aspiration Dissection technique. Operation time 190 min. Blood loss
300ml.
Conclusion.1. Left approach is feasible for isolated complete resection of
caudate lobe even when the tumor is huge in size. 2 PMOD is useful in
carrying out precise and delicate dissection such as isolation of short hepatic
veins and transection of liver parenchyma as well.
FV 2.06
LIVER HANGING MANOEUVRE APPLIED IN ISOLATED COM-
PLETE RESECTION OF CAUDATE LOBE
PENG, Shu You1; LIU, Ying Bin1; CAI, Xiu Jun2
1second affiliated hospital/zhejiang university, Department of Surgery,
Hangzhou, China; 2Sir Run Run Shaw hospital/zhejiang university, Depart-
ment of Surgery, Hangzhou, China
Introduction. Liver Hanging Maneuver(LHM) has been used frequently for
right lobe resection ever since it was described by Belghiti in 2001 for right
lobe resection. It has rarely been used for caudate lobe resection.
Objective. Among 152 cases of caudate lobe resection that we performed,
LHM was applied in 5 cases. This video is to show the feasibility and
advantage of using LHM in caudate lobe resection.
Methods. A 50-year-old lady complaint of upper abdomen discomfort for 3
mo HBsAg(), AFP() CT scan showed a mass in the caudate lobe, so did
the sonography but it was unable to rule out malignancy. It was decided to
remove the tumor.
Results During exploration a large hemangioma was found occupying the
entire caudate lobe. The liver was fully mobilized and both supra and
infrahepatic IVC taped. Caudate process was raised up. An index finger was
inserted between the caudate process and the IVC to start developing the
retrohepatic tunnel toward the inter-hepatic-venous fossa which had been
dissected previously. When the finger tip appeared at the fossa, a catheter was
inserted to follow the withdrawing finger until it appeared at the lower
opening of the tunnel. The catheter then became a sling to lift the liver
forward. With a special instrument, Peng¡*s Multifunctional Operative
Dissector (PMOD), dissection becomes easy. After all the short hepatic
veins on the left side were divided the hanging catheter could be swung to the
left and became a sling to control the common trunk. Short hepatic veins on
the right were totally divided and the caudate portal triads were identified and
divided one by one. The hemangiom was then carefully detached from the
left and middle hepatic vein and gradually separated from segment VI and
VII.
Conclusion.1 LHM is feasible and useful in isolated complete resection of
caudate lobe.2 PMOD is very helpful in carrying out precise and delicate
dissection. 3 The layer of liver parenchyma encasing IVC might not
necessarily be a hindrance to caudate lobe resection
FV 2.07
APPLICATION OF LIVER HANGING MANEUVER FOR HEPATIC
RESECTION FOR HCC: REPORT OF TWO CASES
Nanashima, Atsushi; Sumida, Yorihisa; Nagayasu, Takeshi
Nagasaki University Graduate School of Biomedical Sciences, Division of
Surgical Oncology, Nagasaki, Japan
Background. Surgical factors such as blood loss, operation time and surgical
margins are significant prognostic factors in patients with HCC. The liver
hanging maneuver (LHM) proposed by Belghiti is widely used for hemi-
hepatectomy to reduce blood loss and time required for transection. We
evaluated feasibility of the procedure and its application for various anatomic
resections of the liver.
Methods. We compared surgical parameters in 9 patients who underwent
LHM (LHM group) for hemihepatectomy with those of 37 patients without
LHM (non-LHM group). We also describe two cases in whom LHM was
applied for other anatomic resections.
Results. Time required for hepatic transection was significantly shorter in
LHM group than in non-LHM group (37 vs. 48 min, p0.04).
Case 1. A 60-year-old man had two HCCs in segments 5 and 8. He was
scheduled for anatomic resection of right paramedian sectoriectomy. The
space between vena cava and infra-hepatic caudate process was dissected and
two small tubes for LHM were passed through this space. At hepatic hilum,
the space between GlissonIfs pedicle and hepatic parenchyma was dissected
and tubes were placed through (1) the space between right paramedian and
right lateral GlissonIfs pedicles, and (2) the space left to right paramedian
GlissonIfs pedicle. Hepatic transection was performed by pulling-up at two
resected planes, Cantlie line and a line along right hepatic vein simulta-
neously. This made a Igdouble LHMIh possible.
Case 2. A 72-year-old male was found to have 25 cm-in-size of HCC in the
right liver, which compressed hepatic veins and vena cava. The vena cava was
not involved by HCC and a tube could be placed. Although large tumor
compressed left lateral sector, right trisectoriectomy was easily performed
with LHM at the plane of the falciform ligament.
Conclusion. LHM can be applied for various anatomic resections. LHM is
useful for appropriate transection plane, shortening time required for hepatic
transection and reducing blood loss.
FV 2.08
MODIFIED TWO-SURGEON TECHNIQUE FOR LIVER PAR-
ENCHYMAL TRANSECTION USING ‘TISSUELINK’ AND ‘CUSA’.
Deshpande, Rahul; Efthimiou, Evangelos; Khan, Aamir; Mudan, Satvinder
Royal Marsden Hospital, Dept. of GI Surgery, London, United Kingdom
Background. Although various techniques for parenchymal transection have
been described, none has been proven to be conclusively superior to the
others.
Methods. A modified technique using precoagulation with’Tissuelink’
followed by parenchymal division with’CUSA’ was used for parenchymal
transection for 40 liver resections. The details of the technique are described
in the accompanying video presentation.
Results. The mean operating time for the hepatotomy and the blood loss
during the procedure are comparable to other techniques. No inflow
occlusion is used during the procedure. No other devices such as argon
diathermy are needed.
Discussion. This technique uses precoagulation of parenchyma and vessels,
thereby also providing a good resection margin. It can be universally used for
all kinds of liver resections. It is a good teaching tool, demonstrates the
intrahepatic anatomy clearly and can be safely performed even with an
inexperienced assisstant.
Conclusion. Our technique provides for a safe alternative method for liver
parenchymal transection.
FV 2.09
EX-VIVO HEPATIC TRISECTIONECTOMY AND LIVER AUTO-
TRANSPLANTATION IN A PATIENT WITH AN OTHERWISE
UNRESECTABLE FIBROLAMELLAR HEPATOCELLULAR CAR-
CINOMA
Gondolesi, Gabriel; Andriani, Oscar; Gonzalez-Campan˜a, Ariel; Rowe,
Carlos; Silva, Marcelo; Podesta, Luis Gustavo
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Fundacion Favaloro/Hospital Universitario Austral, Liver Unit, Buenos
Aires, Argentina
Background. Ex-vivo hepatic resection with liver auto-transplantation
(ATx) was conceived to allow treatment for otherwise unresectable malig-
nancies and to expand the role of controlled liver surgery. Giant fibrolamellar
hepatocellular carcinoma (HCC) presenting extrahepatic disease (ED) do
not qualify for chemotherapy or transplantation; when feasible, liver resection
is the only treatment option remaining in these patients.
Aim. To present a video of the surgical approach used to treat a patient with
extended fibrolamellar HCC considered unresectable and to show clinical,
radiological and surgical findings used to plan the surgical strategy.
CASE. A 28 year old female with a two year history of weight loss and non
specific abdominal discomfort. Abdominal US performed after 6 months
follow-up identified a liver tumor with a central scar. After repeated biopsies,
a fibrolamellar HCC was diagnosed and systemic chemotherapy initiated.
One year later the patient was referred to us for TACE. Re-evaluation work-
up included: aFP, chest and head CT as well as bone scintigraphy, all
negative. An MRI showed a 1614 cm right lobe lesion compressing the
retro-hepatic cava and displacing the left hepatic vein. Two extra-hepatic
lesions were identified. ED resection was followed by total hepatectomy with
preservation of the vena cava and transient porto-caval shunt. Ex-vivo
resection and engraftment were completed without the need for vascular
graft and with duct to duct biliary reconstruction over a T-tube.
Conclusion. Refinements of classical surgical procedures used for liver
transplantation allow referral centers to offer salvage procedures in advanced
cases generating challenging clinical scenarios.
FV 2.10
LESSENS LEARNED FROM 150 CASES OF LAPAROSCOPIC
LIVER RESECTIONS
Wakabayashi, Go; Nitta, Hiroyuki
Iwate Medical University, Department of Surgery, Morioka, Japan
Backgroud/Aims. Despite advances in laparoscopic techniques, laparo-
scopic liver resection has not come into widespread use yet. However we have
accumulated 150 patients since 1995, who underwent laparoscopic partial
liver resection, laparoscopic left lateral sectionectomy, and laparoscopy-
assisted major hepatectomy. Bleeding control, which is a basic element for
liver resection, needs to be better accessed by methods suitable for
laparoscopic surgery in order to perform safer laparoscopic liver resection.
The aim of this study is to establish safer technique and significance of
laparoscopic liver resection.
Methods. We analyzed initial results from the point of operative techniques
and indications for laparoscopic liver resection at our institute. Laparoscopic
liver resections have been successfully performed by application of hilar blood
flow control technique, automatic suturing devices, and radiofrequency
precoagulation method.
Results. One hundred and fifty adult patients with primary or metastatic
liver cancer and other diseases underwent laparoscopic partial liver resec-
tion(92 patients), laparoscopic left lateral segmentectomy(24), and laparo-
scopy-assisted lobectomy(34) between 1995 and 2006. Two conversions
occurred because of bleeding. There were three post-operative bile leakages,
but no post-operative bleeding, nor other major complications.
Conclusions. Laparoscopic liver resection can be safely performed and it
can be categolized into surface resection, wedge resection, left lateral
sectionectomy, and laparoscopy-assisted lobectomy, although its indications
remain restricted. For a safer laparoscopic liver resection, an efficient
bleeding control technique such as automatic suturing devices and radio-
frequency precoagulation method is needed during parenchymal transection
of the liver.
FV 3.01
RADIOFREQUENCY-ASSISTED LAPAROSCOPIC HEPATECT-
OMY IN CIRRHOTIC LIVER (PARTIAL SEGMENT V RESECTION
FOR HEPATOCELLULAR CARCINOMA)
Cugat, Esteve1; Herrero, Eric1; Garcia, Maribel1; Rivero, Joaquin1; Perez,
Noelia1; Rodriguez, Aurora2; Marco, Constancio1
1Hospital Mutua de Terrassa, General and HPB Surgery, Terrassa, Spain;
2Hospital Mutua de Terrassa, Anesthesia, Terrassa, Spain
Introduction. Laparoscopic approach for liver resection has demonstrated
to be a safe procedure in selected cases, also in cirrhotic patients, with a
comparable morbidity rate than in open resections. It represents a relatively
new option for the treatment of hepatocellular carcinoma (HCC) on
cirrhosis, probably because of the intraoperative difficulties related to the
treatment of this pathology and the problems related to the minimally
invasive approach.
Case Report. We present a 74 years-old male with liver cirrhosis, VHC
positive serology, A child. In ultrasonography control a 3 cm solid lesion in
segment V next to the gallbladder was found. MRI findings strongly
suggested the diagnosis of hepatocellular carcinoma. The patient underwent
a laparoscopic limited resection including part of the segment V using
radiofrecuency ablation device (Habib†) for the liver transection. No
postoperative complications occurred. Pathological findings were consistent
with HCC.
Discussion. Liver resection by open surgery remains the method of choice
for treatment of hepatocellular carcinoma (HCC) in cirrhotic patients. The
laparoscopic approach may enable liver resection in patients with evidence of
portal vein hypertension with controversial indication in open surgery. Lower
rate of liver decompensation has been reported after laparoscopic procedures.
We believe that a minimally invasive approach can minimize the postoperative
morbidity rate, and it may represent a new therapeutic strategy for cirrhotic
patients. A part from this the development of new techniques and
instrumentations is one of the the main factors in the evolution of the
laparoscopic liver resections. In this case the radiofrecuency assisted
laparoscopic liver resection has demonstrated to be safe in cirrhotic liver, in
terms of vascular control during the transection. More cases are needed to
determine whether the operating room time and the overall hospital stay
might be diminished with this procedure and also to determine the impact on
the overall costs.
FV 3.02
LAPAROSCOPIC LIVER RESECTION OF HEPATOCELLULAR
CARCINOMA IN CIRRHOTIC PATIENT
Herrero, Eric; Cugat, Esteve; Rivero, Joaquin; Garcı´a, Maribel; Perez,
Noelia; Marco, Constancio
Hospital Mutua de Terrassa, Terrassa, Spain
Introduction. Laparoscopic approach for liver resection has demonstrated
to be a safe procedure in selected cases, also in cirrhotic patients, with a
comparable morbidity rate than open resections. It represents a relatively new
option for the treatment of hepatocellular carcinoma (HCC) on cirrhosis,
probably because of the intraoperative difficulties related to the treatment of
this pathology and the problems related to the minimally invasive approach.
Case Report. We present a 74 years-old female with liver cirrhosis known
since March 2002, VHC positive serology, A child with portal vein
hypertension. In ultrasonography control a 2 cm subglissonian solid lesion
in segment II/III was found. MRI and CT scan findings strongly suggested
the diagnosis of hepatocellular carcinoma. The patient underwent a laparo-
scopic limited resection including part of the segment II and III. No blood
transfusions were needed. No postoperative complications occurred, neither
ascites, nor jaundice, nor encephalopathy. Definitive pathological findings
were consistent with hepatocellular carcinoma over cirrhotic liver, with a safe
resection margin.
Discussion. Liver resection by open surgery remains the method of choice
for treatment of hepatocellular carcinoma (HCC) in cirrhotic patients with
compensated liver function, and laparoscopy for surgical treatment of hepatic
diseases is at an early stage. The laparoscopic approach may enable liver
resection in patients with cirrhosis and evidence portal vein hypertension with
controversial indication in open surgery. Lower rate of liver decompensation
has been reported after laparoscopic procedures. We believe that a minimally
invasive approach can minimize the postoperative morbidity rate, which is
still too high in this group of patients, and it may represent a new therapeutic
strategy for cirrhotic patients.
FV 3.03
LAPAROSCOPIC LEFT LATERAL SECTORECTOMY FOR COL-
ORECTAL CANCER METASTASES
Herrero, Eric; Cugat, Esteve; Rivero, Joaquin; Garcia, Maribel; Marco,
Constancio
Mutua de Terrassa, Terrassa, Spain
Introduction. Laparoscopic treatment should be considered for selected
patients with benign and malignant lesions in the left lobe or frontal segments
of the right liver. The immediate benefits seem to be those of any miniinvasive
surgery: reduced trauma to the abdominal wall, early mobilization, shorter
hospital stay, and better cosmetic Results.
Case Report. We present a 76-year-old male who underwent colorrectal
resection for carcinoma 2 years before (pT3N0M0). CEA elevation was
detected. An abdominal CT scan was performed showing 2 liver metastases
in segments II and III. No extra hepatic disease was reported after complete
study with thoracic CT scan and PET. The patient underwent surgery on
May 2006. A left lateral segmentectomy (segments II and III) was performed
by laparoscopic approach. Pathological findings were consistent with
metastasic colorrectal adenocarcinoma in the 2 resected nodules with safe
resection margin.
Discussion. The recent rapid developments of innovative laparoscopic
instruments and improvements in surgical skill have made laparoscopic-
assisted liver resection possible. Extensive experience in laparoscopic and
hepatobiliary surgery is mandatory in carrying out liver resection through the
minimal access approach. In appropriately selected patients, laparoscopic
liver resection is feasible and safe, and achieves acceptable survival among
individuals with hepatic malignancy. The evolution of laparoscopic hepatec-
tomies probably will depend on the development of new techniques and
instrumentations. Finally, the use of the haemostatic and sealant materials,
widely used in open surgery, presents technical variations in its use in
laparoscopic surgery, just as is we show in this video.
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FV 3.04
TOTALLY LAPAROSCOPIC CENTRAL HEPATECTOMY
Gumbs, Andrew1; Gayet, Brice2
1Institut Mutualiste Montsouris, Digestive Diseases, 42 Boulevard Jourdan,
Paris, France; 2Institut Mutualiste Montsouris, Digestive Diseases, Paris,
France
Introduction. Since the first report of a laparoscopic liver resection in 1992,
laparoscopic resection of peripheral hepatic segments has become increas-
ingly more common in the surgical treatment of both benign and malignant
tumors. The minimally invasive approach to major hepatectomies, however,
is still only being currently performed in highly specialized centers. This is
principally because of concerns for gas embolism and difficulty in controlling
major hemorrhage via the laparoscopic approach. This video will demon-
strate the relevant technical maneuvers in the performance of a totally
laparoscopic central hepatectomy.
Method. This video will illustrate the pertinent issues regarding instrument
selection, trochar placement, intra-operative monitoring and steps necessary
to perform central hepatectomy using totally laparoscopic techniques. The
principal steps of this procedure include: control of hepatic inflow, division of
hepatic parenchyma, control of hepatic outflow, mobilization of the liver and
specimen removal.
Conclusion. Minimally invasive techniques for central hepatic resections are
feasible, and high volume centers that specialize in these procedures can have
results similar to historical open series. Totally laparoscopic central hepa-
tectomy should currently only be performed by surgeons with expertise in
laparoscopy and hepatobiliary surgery.
FV 3.05
LAPAROSCOPIC RIGHT HEMIHEPATECTOMY WITH EXTRA-
HILIAR PEDICLE DISSECTION
Jarufe, Nicolas1; Boza, Camilo2; Sanhueza, Marcel2; Guerra, Juan Fran-
cisco1; Martinez, Jorge1
1P. Universidad Cato´lica de Chile, Digestive Surgery, Santiago, Chile; 2P.
Universidad Catolica de Chile, Digestive Surgery, Santiago, Chile
The development of the laparoscopic surgery has permitted to incorporate
this technology to the surgical treatment of different pathologies. The use of
laparoscopic approach for liver resections has remained limited for selected
patients with left-sided and right-peripheral lesions requiring limited resec-
tion. This video shows a laparoscopic formal right liver resection (segments V,
VI, VII and VIII) with pedicle dissection, extrahepatic right hepatic vein
section and liver parenchymal-transection, in a 73 years old male with 2
methachronic colorectal metastases in the right lobe of the liver. He had a
laparoscopic right colectomy performed 6 moth before liver surgery.
FV 3.06
LAPAROSCOPIC RIGHT POSTERIOR SECTORECTOMY FOR
LIVER METASTASES
Herrero, Eric; Cugat, Esteve; Garcı´a, Maribel; Rivero, Joaquin; Marco,
Constancio
Hospital Mutua de Terrassa, General Surgery, Terrassa, Spain
Introduction. Laparoscopy has become an established approach for many
procedures, and its advantages are well-known. Recent developments of
innovative laparoscopic instruments and improvements in surgical skills have
made laparoscopic-assisted liver resection possible. However, it is usually
limited to selected patients in which the lesion is located in the left lobe or
peripheral right segments.
Case Report. We present a 76 years-old male who underwent a colorectal
resection for a cecum carcinoma on May 2004 (pT3N0M0). Six moths later,
a routine CT-scan showed a liver lesion about 2.5cm between segments VI
VII. A PET-scan was performed in order to discard other extrahepatic
lesions. The patient underwent surgery on January 2007, by a laparoscopic
approach. The intraoperative ultrasonography showed only one 3cm tumor
between segments VI-VII. A right posterior sectorectomy was performed.
Pathological findings were consistent with metastasic colorectal adenocarci-
noma with a safe resection margin.
Discusion. This new technical approach for liver resection is safe and
feasible, and considered as a routine procedure for some authors, but its use
in malignant tumours is still controversial. In our opinion, the procedure
should be performed by an experienced surgical team in hepatobiliary and
laparoscopic surgery, following the same oncologic rules than open resec-
tional therapy, including radical R0 resection and a free surgical margin.
Laparoscopic ultrasound should be routinely used to achieve complete
staging and an adequate margin. Acceptable morbidity and mortality rate,
with comparable results to conventional surgery have been reported.
Extensive experience in conventional liver surgery and advanced laparoscopic
surgery, and also the availability of all requested technology are indispensable
prerequisites.
FV 3.07
UTILITY OF THE RADIOFRECUENCY-ASSISTED LAPARO-
SCOPIC HEPATECTOMY IN NORMAL LIVER (LEFT LATERAL
SECTORECTOMY)
Cugat, Esteve1; Herrero, Eric1; Rivero, Joaquin1; Garcia, Maribel1; Perez,
Noelia1; Rodriguez, Aurora2; Marco, Constancio1
1Hospital Mutua de Terrassa, General and HPB Surgery, Terrassa, Spain;
2Hospital Mutua de Terrassa, Anesthesia, Terrassa, Spain
Introduction. Laparoscopic treatment should be considered for selected
patients with benign and malignant lesions in the left lobe or frontal segments
of the right liver. The immediate benefits seem to be those of any miniinvasive
surgery: reduced trauma to the abdominal wall, early mobilization, shorter
hospital stay, and better cosmetic Results.
Case Report. We present a 47-year-old male with previous history of acute
cholangitis and abnormal hepatic blood test. A cholangio-MRI was
performed showing segmentary dilatation of intrahepatic biliary ducts in
segment II and III secondary to an stenotic process without clear suspicion of
malignancy. The patient underwent surgery on March 2007. A left lateral
sectorectomy (segments II and III) and cholecistectomy was performed by
laparoscopic approach using radiofrecuency ablation device (Habib†) for the
liver transection. Pathological findings were consistent with sclerosant
cholangitis without malignancy. The postoperative course was uneventful.
Discussion. The recent rapid developments of innovative laparoscopic
instruments and improvements in surgical skill have made laparoscopic-
assisted liver resection possible. Extensive experience in laparoscopic and
hepatobiliary surgery is mandatory in carrying out liver resection through the
minimal access approach. In appropriately selected patients, laparoscopic
liver resection is feasible and safe, and achieves acceptable survival among
individuals with hepatic malignancy. The evolution of laparoscopic hepatec-
tomies will probably depend on the development of new techniques and
instrumentations. In this case the radiofrecuency assisted laparoscopic liver
resection has demonstrated to be safe and useful in normal liver, in terms of
vascular control during the transection. More cases are needed to determine
whether the operating room time and the overall hospital stay might be
diminished with this procedure and determine the impact on the overall
costs.
FV 3.08
TOTALLY LAPAROSCOPIC RIGHT POSTERIOR SECTIONECT-
OMY AND MILES’ OPERATION
Han, Sung-Sik1; Choi, Hyo Seong2; Kim, Seong Hoon1; Park, Sang-Jae1;
Park, Joong-Won1
1National Cancer Center, Center for Liver Cancer, Goyang-si, Gyeonggi-do,
Korea, Republic of; 2National Cancer Center, Center for Colorectal Cancer,
Goyang-si, Gyeonggi-do, Korea, Republic of
We describe a case of totally laparoscopic Miles¡* operation with right
posterior sectionectomy of the liver. A 60-year-old woman presented with
lower rectal cancer 1cm above anal verge and 3cm sized synchronous liver
metastasis in segment 6 and 7. After dividing the right posterior Glisson¡*s
pedicle, the liver parenchyme was transected. Using the intraoperative
ultrasonography, 1.5cm tumor free margin was obtained successfully. The
resected specimen was delivered through perineal wound after Miles¡*
operation without additional laparotomy for specimen retrieval. The patient
was discharged on postoperative day 14 without any complications.
FV 4.01
LAPAROSCOPIC LEFT LATERAL SEGMENTECTOMY IN NOR-
MAL AND CIRRHOTIC LIVERS-USE OF ENDOSTAPLERS
patel, bhavik; O’rourke, Nicholas
royal brisbane and womans hospital, brisbane, Australia
Introduction. Laparoscopic liver resection is becoming more popular and
left lateral segmentectomy is probably the simplest of all laparoscopic liver
resections. However, it is not withouth its technical difficulties.
Objectives. We aim to demonstrate our tips and techniques for this
procedure, in both normal and cirrhotic livers, by means of an edited video.
Results We have performed more than 70 laparoscopic left lateral segmen-
tectomies over a 7 year period. The experience we have gained from this has
allowed us to produce a high quality edited video, which highlights the
important aspects of this procedure. The video demonstrates important
technical considerations to avoid tumor spillage, ensure clear margins and
secure haemostasis. We have performed this procedure in patients with
cirrhotic and normal livers. We have had mortality in a patient with child B
liver cirrhosis who died of liver failure on day 14.
Conclusions. Laparoscopic left lateral segmentectomy is safe and feasible in
both normal and cirrhotic livers. Endoscopic vascular staplers provide
haemostasis and permit a controlled resection
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LAPAROSCOPIC LIVER RESECTION
de Santiban˜es, Eduardo1; Pekolj, Juan1; Salceda, Juan2; Fernandez, Diego1;
Bregante, Mariano1; Bregante, Mariano1; Ardiles, Victoria1
1Hospital Italiano de Buenos Aires, HPB & Liver Transplant Unit, Buenos
Aires, Argentina; 2Hospital Italiano de Buenos Aires, HPB & Liver
Transplant Unit, Buenos Sires, Argentina
Background. The development of laparoscopic surgery during the last years
has also reached liver resections. We present a single case of an incidental liver
tumor treated with a laparoscopic approach.
Material and Method. Our case is a 48- year- old man, with a history of
steroids oral intake, who presented a liver tumor located in left lateral
segment of the liver. The patient underwent a laparoscopic liver resection
with an uneventful 4- day post-operative course.
Conclusions. The laparoscopic approach for liver tumors has become an
important tool, being also a safe indication for lesions located in the anterior
and lateral sectors of the liver. Laparoscopic surgical techniques can
reproduce every single step of open surgery such as intra-operative
ultrasound and Pringle maneuver. Laparoscopic liver resections performed
by well- trained surgeons are safe and effective procedures for selected
patients.
FV 4.03
LAPAROSCOPIC RESECTION OF LEFT LATERAL SEGMENT
(LEFT LATERAL SECTIONECTOMY)
Alkari, Bassam; Owera, Anas; Ammori, Basil
Manchester Royal Infirmary, Department Of Surgery, Manchester, United
Kingdom
FV 4.04
LAPAROSCOPY-ASSISTED LIVER LOBECTOMY USING GLIS-
SONEAN PEDICLE TRANSECTION
Cho, Akihiro1; Yamamoto, Hiroshi2; Nagata, Matsuo2; Takiguchi, Nobu-
hiro2; Kainuma, Osamu2; Souda, Hiroaki2; Gunji, Hisashi2; Miyazaki,
Akinari2; Matsumoto, Ikuko2; Arimitu, Hidehito2; Nagao, Yoshiko2; Ryu,
Munemasa2
1Chiba Cancer Center Hospital, Chiba, Japan; 2Chiba Cancer Center
Hospital, Division of Gastroenterological Surgery, Chiba, Japan
Although many reports have described laparoscopic minor liver resections,
major hepatic resection, including right or left lobectomy, has not been widely
developed because of technical difficulties. This article describes a new
technique for performing laparoscopy-assisted right or left hepatic lobectomy
using hilar Glissonean pedicle transaction. Laparoscopic mobilization of the
right or left hepatic lobe is performed, including dissection of the round,
faliciform, triangular and coronary ligaments. The right or left Glissonean
pedicle is encircled and divided laparoscopically. A parenchymal dissection is
then performed though the upper median or right subcostal incision, through
which the resected liver is removed. We successfully performed this
procedure in 8 patients without blood transfusion or serious complications.
Laparoscopy-assisted hepatic lobectomy using hilar Glissonean pedicle
transaction can be feasible and safe in highly selected patients.
FV 4.05
TOTALLY LAPAROSCOPIC EXTENDED LEFT HEPATECTOMY
Gumbs, Andrew1; Bar-Zakai, Barak2; Gayet, Brice3
1Institut Mutualiste Montsouris, Medical and Surgical Department of
Digestive Disea, 42 Boulevard Jourdan, Paris, France; 2Institut Mutualiste
Montsouris, Department of Digestive Diseas, Paris, France; 3Institut
Mutualiste Montsouris, Medical and Surgical Department of Digestive
Disea, Paris, France
Introduction. Laparoscopic resection of peripheral hepatic segments has
become increasingly more common in the surgical treatment of both benign
and malignant tumors. The minimally invasive approach to major hepatec-
tomies is still only being currently performed in highly specialized centers.
This video will demonstrate the relevant technical maneuvers in the
performance of a totally laparoscopic extended left hepatectomy including
resection of segment I. Common pitfalls and areas of concern will also be
discussed.
Method. This video will illustrate the pertinent issues regarding pre-
operative patient selection, necessary minimally invasive equipment, trochar
placement, intra-operative monitoring and steps necessary to perform a left
hepatectomy including control and resection of the middle hepatic vein and
the left aspect of segment VIII using totally laparoscopic techniques. The
techniques for removal of segment I will also be demonstrated. The five
principal steps of this procedure include: mobilization of the liver, control of
hepatic inflow, division of hepatic parenchyma, control of hepatic outflow
and removal of the specimen.
Results. At our institution a total of 3 extended left hepatectomies have been
performed with totally laparoscopic techniques. These procedures included
left hepatectomies with the addition of resection of the middle hepatic vein
and complete or partial resection of segments V and VIII. Complications
included bile leak in one patient that responded to endoscopic placement of
biliary stents. Out short and long-term results have been similar to our open
historical controls. No mortalities have been observed.
Conclusion. Minimally invasive techniques in left hepatic resections are
feasible, and high volume centers that specialize in these procedures can have
results similar to historical open series. Totally laparoscopic extended left
hepatectomy should currently only be performed by surgeons with expertise
in laparoscopy and hepatobiliary surgery.
FV 4.06
TOTALLY LAPAROSCOPIC LEFT LATERAL HEPATIC LOBECT-
OMY USING LIGASURE† DIATHERMY FOR HYDATID LIVER
DISEASE
Efthimiadis, Christopher1; Cosmidis, Christopher1; Grigoriou, Marios1;
Anthimidis, George1; Poursalidis, John2; Fahantidis, Epaminontas2; Basda-
nis, George2
1Interbalkan Medical Center, Thessaloniki, Greece; 2Aristotle University,
Thessaloniki, Greece
Background. Treating patients with hydatid disease of the liver is an
uncommon but often difficult task for the surgeon. Surgical intervention is
considered the gold standard in the treatment of the disease either in the form
of resection or as drainage procedures. Minimally invasive techniques have
emerged allowing drainage laparoscopically or with the use of percutaneous
catheters under ultrasonographic or CT guidance. Despite the advantages of
minimally invasive techniques in some cases with complicated Hydatidosis
hepatectomy is both safer and more effective in controlling the disease.
Laparoscopic liver resection in conjunction with the use of the Ligasure†
atlasTM diathermy system minimizes the morbidity of the procedure making it
an even more attractive option in complicated cases.
Aim/Objective. We present the case of a 50 year old woman with a large
hydatid cyst involving segments II and III and communicating with the
intrahepatic billiary tree that we treated with totally laparoscopic left lateral
hepatic lobectomy using the Ligasure† atlasTM diathermy system with
excellent Results.
FV 5.01
SIMULTANEOUS PANCREATICODUODENECTOMY, RIGHT
TRISEGMENTECTOMY AND RIGHT HEMICOLECTOMY FOR
GALL BLADDER CARCINOMA
Are, Chandrakanth1; Iacovitti, Simonetta2; Crafa, Francesco2
1Eppley Cancer Centre, University of Nebraska Medical Centre, Division of
Surgical Oncology, Dept of Surgery, Omaha, United States; 2MG Vannini
Hospital, Department of Surgery, Rome, Italy
Background. Simultaneous pancreaticoduodenectomy and major hepatect-
omy is a infrequently performed procedure AIM: We report a case of
simultaneous pancreaticoduodenectomy, right trisegmentectomy and right
hemicolectomy for gall bladder carcinoma.
Materials and Methods. A 67 year female patient that presented with
abdominal pain and belching. She underwent a CT scan and MRI that
showed a mass arising from the gall bladder that involved hepatic segments
IV, V and VI, the pylorus, head of pancreas and hepatic flexure. Upper
endoscopy showed evidence of pyloric stenosis and colonoscopy revealed
evidence of infiltration of hepatic flexure. Her Ca 19-9, CEA and CA 125
were 1369 u/ml, 57.2 ng/ml and 40 u/ml respectively.
Results. The patient underwent diagnostic laparoscopy that showed no
evidence of peritoneal spread, following which she underwent placement of
pyloric stent and right portal vein embolization. Her nutritional status had
improved after four weeks and repeat imaging demonstrated hypertrophy of
left lateral segment. She was taken to the operating room for pancreatico-
duodenectomy, right trisegmentectomy and right hemicolectomy. The
proximal and distal points of transection for right hemicolectomy were
divided with Endo-GIA stapler. The portal vein and superior mesenteric vein
were dissected free following which the neck of the pancreas was divided. The
inflow and outflow to the right lobe of the liver were isolated and divided. The
patient required repair of the left portal vein and the superior mesenteric vein.
An end to end pancreaticojejunostomy and end to side hepaticojejunostomy
were performed and decompressed with internal/external stents. An ileost-
omy was fashioned and a feeding jejunostomy tube was placed. The operative
time was eight hours with an estimated blood loss of 600 cc. The final
histopathology revealed gall bladder carcinoma. (T4 N0 MO).
Conclusion. We present a case of simultaneous pancreaticoduodenectomy,
right trisegmentectomy and right hemicolectomy for advanced gall bladder
carcinoma.
FV 5.02
RIGHT HEPATECTOMY EXTENDED TO SEGMENT 1 FOR HI-
LAR CHOLANGIOCARCINOMA
Nuzzo, Gennaro; Giuliante, Felice; Ardito, Francesco; Vellone, Maria;
Giovannini, Ivo
Catholic University-School of Medicine, Hepato-Biliary and Digestive
Surgery Unit, Rome, Italy
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Background. Radical surgery for hilar cholangiocarcinoma involves resec-
tion of the biliary confluence with right or left hepatectomy according to the
extension of the tumour, and resection of the caudate lobe which is frequently
infiltrated, at least microscopically.
Objective. The video shows the case of a 57-yr old male patient who
developed obstructive jaundice one month before referral. CT-scan and
magnetic resonance demonstrated a 2-cm tumour interrupting the main and
the right secondary biliary confluence (Bismuth type 3 A), and a right
percutaneous biliary drainage was inserted. The patient was then referred in
poor condition with sepsis and persistent jaundice. With left percutaneous
biliary drainage the patient condition improved, and four weeks later he
underwent surgery.
Methods. After bilateral subcostal incision extended to the xifoid, the
hepatic pedicle was prepared, confirming in the hilum a nodular mass
infiltrating the right hepatic artery. The liver was mobilized, the retro-
hepatic vena cava was prepared interrupting several dorsal veins, from
below upwards. The caudate lobe was prepared from the right and the left
side. The right dorsal caval ligament and the Arantius ligament were
interrupted. Extraparenchymal isolation and preparation of the right hepatic
vein and common venous trunk was carried out. Right hepatic vein, right
portal branch and right hepatic artery were interrupted extraparenchymally.
The left hepatic duct, and the common bile duct just above the pancreas,
were also interrupted. A right hepatectomy was then performed, with en-
bloc resection of caudate lobe and biliary confluence, by Kelly-clasia and
wet bipolar forceps, without hepatic pedicle clamping. Frozen section on
left hepatic duct was negative, and a Roux-en-Y left hepatico-jejunostomy
was performed.
Results. Early recovery was normal. After discharge, readmission was
needed because of hemobilia from a small pseudoaneurysm of the left
hepatic artery, which was treated by embolization.
FV 5.03
HEPATIC RESECTION COULD BE APPLICABLE TREATMENT
IN KLATSKIN TUMORS INVOLVING THE SECONDARY CON-
FLUENCE ON THE RIGHT AND THE LEFT INTRAHEPATIC
DUCT
Hwang, Ho Kyoung; Kim, Jae Keun; Park, Joon Seong; Cho, Shin Il; Yoon,
Dong Sup; Chi, Hoon Sang; Kim, Byoung Ro
Yonsei University College of Medicine, surgery, Seoul, Korea, Republic of
Introduction. Hilar cholangiocarcinoma is a relatively rare tumor, Klatskin
tumors are usually categorized as by Bismuth-Corlette Classification and the
treatment options are primarily either curative or palliative bypass surgery, or
non surgical therapy or liver transplantation. A type IV tumors involving the
secondary confluence on the right and the left side generally considered
unresectalble. We recently had the patient who underwent successful radical
hepatic resection for Klatskin type IV tumor.
Methods. The 62-year old male had medical history of hypertension. He had
undergone abdominal CT scan, there was Klatskin’s tumor extending to the
bilateral 2nd order branches, type IV and multiple small lymph nodes in Left
paraaortic space and aortocaval space. We performed left hemihepatectomy
and caudate lobectomy. We took isolation technique for identifying and
dividing left portal triad. Pringle¡*s maneuver was used. Liver parenchyma
was dissected with harmonic scalpel(ethicon, USA). The left hepatic vein was
identified and divided with endo GIA 60mm (Autosuture, USA). Left bile
ductoplasty was performed after identification of negative resection margin.
Roux- en Y hepaticojejunostomy was performed. The specimen of liver,
weighing 977gram, There was periductal infiltrative lesion measuring 2
1.5cm.
Results. The operative time was 900 min. The postoperative periods were
uneventful except wound infection, with discharge on days 14. The
pathologic diagnosis was adenocarcinoma (well differentiated) at bifurcation
of right and left hepatic ducts with frequent perineural invasion and with
extension to liver parenchyma, distal portion of right hepatic duct and
common hepatic duct with clear resection margin and there was no lymph
node metastasis.
Conclusion. Hepatic resection could be considerable management option
for Klatskin tumor involving the secondary confluence on the right and the
left IHD, though further studies are needed for improving the outcome.
FV 5.04
HEPATIC RESECTION AND TRANSDUODEAL BILE DUCT RE-
SECTION AND PANCREATIC DUCTREPOSITIONING FOR BILI-
ARY PAPILLOMATOSIS
Yoon, Dong Sup; Kim, Jae Keun; Hwang, Ho Kyoung; Park, Joon Seong;
Cho, Shin Il; Chi, Hoon Sang; Kim, Byoung Ro
Yonsei University College of Medicine, surgery, Seoul, Korea, Republic of
Introduction. Biliary papillomatosis is a rare biliary pathology. Concomitant
intrahepatic and extrahepatic involvement was notified about 40%. Some
authors believe that local resection is an acceptable form of treatment with
comparable outcomes and a markedly decreased morbidity and mortality
compared with too excessive major resection for non-malignant lesion. We
recently had the patient who underwent successful radical hepatic resection
and transduodenal complete bile duct resection with pancreatic duct
repositioning for concomitant intrahepatic and extrahepatic biliary papillo-
matosis.
Methods. The 67-year old male had medical history of pulmonary
tuberculosis and pneumoconiosis. He had undergone abdominal CT scan
and MRCP, there was Intraductal papillary tumors mainly involving hilar
portion and EHD. On PTCS, there was multiple nodular papillary masses
with mucin in the left IHD and confluence of bile duct. The result of biopsy
on confluence of bile duct was adenocarcinoma, moderately differentiated
and pathology of biopsy on distal CBD was tubular adenoma with low-grade
dysplasia. The patient underwent left hemihepatectomy and caudate lobect-
omy. longitudinal duodenotomy was made. The mucosa was incised superior
to the ampulla until bile duct was encountered. The dissection was continued
until the bile duct was completely excised and pancreatic duct opening was
exposed. The pancreatic duct was identified, followed by direct mucosa-to
mucosa repositioning with absorbable 40 sutures between the orifice and the
duodenum. Roux en Y hepaticojejunostomy was performed.
Results. The postoperative periods were uneventful. The pathologic
diagnosis was adenocarcinoma at confluence of bile duct and left IHD and
tubular adenoma with high-grade dysplasia at distal CBD.
Conclusion. The hepatic resection and transduodenal complete bile duct
resection with pancreatic duct repositioning could be considerable manage-
ment option for concomitant intrahepatic and extrahepatic biliary papillo-
matosis with severe co-morbidity
FV 5.05
RIGHT TRISECTIONECTOMY WITH CAUDATE LOBECTOMY
AND PORTAL VEIN RESECTION FOR HILAR CHOLANGIOCAR-
CINOMA
Choi, Dong Wook1; Paik, Kwang Yeol1; Chung, Jun Chul2; Lee, Hyung
Geun1; Ryu, Dong Do1; Heo, Jin Seok1; Choi, Seong Ho1
1Samsung Medical Center, Surgery, Seoul, Korea, Republic of; 2Soon Chun
Hyang Bucheon Hospital, Surgery, Bucheon, Korea, Republic of
Background. Bile duct resection and major hepatectomy is considered as
standard treatment for hilar cholangiocarcinoma (HC). We performed right
trisectionectomy with caudate lobectomy and portal vein resection for HC
and would like to present it.
Methods. Sixty two-year old man was evaluated for incidental detection of
AST/ALT increase and suspicious of HC. CT scans demonstrated a type IIIa
HC with portal vein invasion at the hilar bifurcation and the volume of left
lateral section was 440 ml (32.7%). Under the impression of HC, exploratory
laparotomy was carried out. We used bilateral subcostal skin incision with
median extension. After verification of no distant metastasis, the above-
mentioned operation was planned to achieve a curative resection. Dissection
of the hepatoduodenal ligament was first initiated to ascertain vascular
invasion and to clear lymph nodes. Portal vein was invaded at the bifurcation
level and impossible to dissect from the main tumor; therefore, segmental
resection and end-to-end anastomosis was conducted after control of several
small portal vein branches to the caudate process and the Spigelian lobe.
During the mobilization of the right hemiliver, the right hepatic vein was
divided using Endo-GIA¢c¸. Through further dissection of small hepatic veins
from the caudate lobe and the Arantius duct, the whole liver was mobilized
from the vena cava. Then liver parenchymal dissection was performed using
CUSA and the middle hepatic vein was also divided with Endo-GIA¢c¸.
Finally, the left hepatic duct was divided at the peripheral level of the
confluence of B2 and B3. Hepaticojejunostomy was performed with interrupt
sutures using 5.0 Vicryl. The patient was discharged on 9th post operative
day without significant complication.
Results. Pathologic diagnosis was ductal adenocarcinoma with moderate
differentiation at the common hepatic and intrahepatic duct and the stage
was IIA (T3N0M0).
Conclusions. We believe that this technique would be helpful for HC with
portal vein invasion
FV 5.06
LEFT TRISECTIONECTOMY WITH CAUDATE LOBECTOMY
AND PANCREATODUODENECTOMY FOR HILAR CHOLANGIO-
CARCINOMA
Choi, Dong Wook1; Paik, Kwang Yeol1; Chung, Jun Chul2; Lee, Hyung
Geun1; Ryu, Dong Do1; Heo, Jin Seok1; Choi, Seong Ho1
1Samsung Medical Center, Surgery, Seoul, Korea, Republic of; 2Soon Chun
Hyang Bucheon Hospital, Surgery, Bucheon, Korea, Republic of
Background. Bile duct resection and major hepatectomy is considered as
standard treatment for hilar cholangiocarcinoma (HC). We performed left
trisectionectomy with caudate lobectomy, bile duct resection and pylorus-
preserving pancreatoduodenectomy for HC and would like to present it.
Methods. Fifty six-year old female patient was admitted for suspicious HC
with ENBD performed at an outside hospital. Preoperative radiologic
findings suggested type IIIb HC and left trisectionectomy with caudate
lobectomy was planned with intent of a curative resection. We used bilateral
subcostal incision with median extension and explored abdominal cavity to
examine distant metastasis. First of all, the hepatoduodenal ligament was
dissected to clear lymph nodes and to ascertain vascular invasion, and the
CBD was divided near the pancreas. The resection margin of the distal bile
duct was positive for tumor in frozen biopsy. After division of hepatic artery
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and portal vein to the left hemiliver and the anterior section of the right
hemiliver, several small portal vein branches to the caudate and the
Spigelian¡*s lobe were also controlled. Next the right hemiliver and the
caudate lobe were mobilized through division of small hepatic veins to the
IVC and the Arantius duct. The left hemiliver was also mobilized and the left
hepatic vein was divided using Endo-GIA¢c¸. Liver parenchyma was
transected between right anterior and posterior section along with the right
hepatic vein and bile duct was divided at the confluence level of B6 and B7.
Additional PPPD was carried out due to positive resection margin of the
distal bile duct. Hepaticojejunostomy was performed with interrupt sutures
using 5.0 Vicryl.
Results. Pathologic diagnosis was ductal adenocarcinoma (Bismuth type
IIIb) with moderate to poor differentiation at the common hepatic and
intrahepatic duct and the stage was IIB (T2N1M0).
Conclusion. We believe that this technique could be a helpful option for
HC.
FV 6.01
THREE-PORT LAPAROSCOPIC SUBTOTAL DISTAL PANCREA-
TECTOMY
Jacobs, Michael
Providence Hospital, Surgery, Wayne State University School of Medicine,
Southfield, United States
Background. Laparoscopic distal pancreatectomy and pancreatic enuclea-
tions are preferred techniques for benign diseases and cystic tumors. The
application of LDP for malignancy is debatable. In more than 400 reported
cases of LDP and Len, four or more port entry incisions were used. The three
port technique is a further advancement in minimally invasive surgery of
pancreas.
Objective. To demonstrate the feasibility of laparoscopic subtotal distal
pancreatectomy using the three-port technique.
Methods and Results. A 46-year old female was evaluated for weight loss.
Examination was unremarkable. A CT-scan showed a 4-cm mass in the tail of
the pancreas. A laparoscopic subtotal distal pancreatectomy using three-ports
was performed. The operating time was less than 3-hours, the blood loss less
than 200-mL, and length of stay was 3 days. Histopathology showed invasive
moderate- to poorly-differentiated ductal adenocarcinoma of pancreas. The
margins of resection were negative. There were no perioperative complica-
tions.
Conclusion. In addition to the usual benefits of laparoscopic distal
pancreatectomy, the three-port technique can be applied to lesions requiring
subtotal resection without compromising the oncologic principles. A shorter
recovery enables the patient to begin adjuvant therapy sooner.
FV 6.02
HAND-ASSISTED LAPAROSCOPIC WHIPPLE OPERATION FOR
AMPULLA OF VATER ADENOCARCINOMA
Tsui, David; Tang, C N; Lai, Eric; Li, Michael K W
Pamela Youde Nethersole Eastern Hospital, Surgery, Hong Kong SAR,
Hong Kong
Introduction. Whipple operation is a highly complex operation for
periampullary tumor and tumor in the head of pancreas. With the advent
of laparoscopic surgery, laparoscopic resection can be considered for selected
cases. We would like to present a case of hand-assisted laparoscopic Whipple
operation for ampulla of Vater adenocarcinoma.
Method. A 52-year old lady presented initially with anaemia. Upper
endoscopy showed ampulla tumor. Biopsy confirmed adenocarcinoma.
Computed tomography (CT) of abdomen showed ampulla tumor with
involvement of head of pancreas without evidence of vessel encasement or
dissemination. Hand-assisted laparoscopic Whipple operation was performed
using 4-port approach (including 1 handport at right upper quadrant
measuring 7.5cm long).
Result. The surgery was completed in 270 minutes with operative blood loss
of 150ml. Post operative recovery was well and the patient was discharged on
day 8. She came back at 2 weeks post operation for vomiting. No major
collection was shown on CT abdomen and upper endoscopy revealed intact
anastomosis. She was treated conservatively and discharged. There was no
tumor recurrence upon a follow up period of 14 months.
Conclusion. Laparoscopic Whipple operation is technically feasible in
selected patients. The use of hand-assistance provides a good tactile sensation
for the surgeon and thus facilitates the whole procedure.
FV 6.03
LAPAROSCOPIC DISTAL PANCREATECTOMY WITH SPLE-
NECTOMY
Herrero, Eric; Cugat, Esteve; Garcı´a, Maribel; Rivero, Joaquin; Marco,
Constancio
Hospital Mutua de Terrassa, General Surgery, Terrassa, Spain
Introduction. Laparoscopic distal pancreatectomy is a safe procedure, with
minimal morbidity, rapid recovery, and short hospital stay. In appropriate
cases, spleen preservation is feasible. The most frequent cause of post-
operative morbidity is the pancreatic leak but it could be usually managed
conservatively. We present a case of surgical treatment of a mucinous
cystadenoma of the pancreas by laparoscopic approach. The intervention
consisted in a laparoscopic distal pancreatectomy with associated splenect-
omy.
Case Report. A 45-year-old woman was admitted in emergency by upper
abdominal pain referred to the back occasionally associated with vomiting.
Abdominal CT scan reported a cystic tumour of 4.84.6 cm. in the
pancreatic body suggesting a mucinous cystadenoma of the pancreas. The
patient underwent distal pancreatectomy with splenectomy by laparoscopic
approach. The pathological findings were consistent with mucinous cysta-
denoma of the pancreas without lymph node involvement. No complications
occurred during the postoperative period.
Discussion. Surgical resection is indicated in potentially malignant pan-
creatic cystic neoplasms. Differentiating serous and mucinous cystadenoma
from pseudocysts may be difficult preoperatively, so tumours of the pancreas
that cannot be confirmed to be serous cystic neoplasm should be resected as
the possibility of pancreatic cancer, mucinous cystadenocarcinoma, or
mucinous cystadenoma with malignant potential exists. At present, laparo-
scopic surgery has proven to be beneficial in patients with cystic pancreatic
neoplasms. In experienced hands, this minimally invasive approach reduces
postoperative hospital stay and expedites recovery. However, the incidence of
pancreatic fistula following distal resection is not any less than in open
surgery. The use of sealant materials in the pancreatic resection margin may
decrease the incidence of fistula after distal pancreatectomy. Its use in
laparoscopic surgery differs technically of that in open surgery as we show in
this video.
FV 6.04
LAPAROSCOPIC WHIPPLE’S PANCREATICO-DUODENECT-
OMY
Alkari, Bassam1; Ammori, Basil2
1Manchester Royal Infirmary, Department of Surgery, Oxford Road,
Manchester, United Kingdom; 2Manchester Royal Infirmary, Department
Of Surgery, Manchester, United Kingdom
FV 6.05
SURGICAL TECHNIQUE OF DISTAL PANCREATECTOMY WITH
EN BLOC CELIAC AXIS RESECTION FOR LOCALLY ADVANCED
PANCREATIC BODY CANCER
Hirano, Satoshi1; Kondo, Satoshi2; Tanaka, Eiichi2; Shichinohe, Toshiaki2;
Suzuki, On2; Sagawa, Noriaki2; Ichimura, Tatsunosuke2; Hashida, Hideaki2;
Suzuoki, Masato2
1Hokkaido University, Surgical Oncology, Graduate School of Medicine,
Sapporo, Japan; 2Hokkaido University, Surgical Oncology, Sapporo, Japan
Introduction. Pancreatic body cancer often involves the common hepatic
artery and/or the celiac axis. Distal pancreatectomy with en bloc celiac axis
resection (DP-CAR) is a newly designed extended surgical procedure for
locally advanced cancer of the pancreatic body.
Objective. To demonstrate the surgical technique of DP-CAR and evaluate
its clinical efficacy.
Methods. Preoperative coil embolization of the common hepatic artery was
routinely used to enlarge the collateral pathways and prevent ischemia-related
complications. The procedures routinely included en bloc resection of the
celiac, common hepatic, and left gastric arteries, the celiac plexus and
ganglions, the nerve plexus around the superior mesenteric artery, a part of
the crus of the diaphragm and the GerotaIfs fascia, the left adrenal gland,
the retroperitoneal fat tissues bearing lymph nodes above the left renal vein,
the transverse mesocolon covering the body of the pancreas, and the inferior
mesenteric vein. Resection of the portal vein and the middle colic vessels was
optional.
Results. Since 1998, 23 patients underwent DP-CAR. The postoperative
morbidity rate was 48% and no hospital death was encountered. Post-
operative diarrhea was mild. Preoperative intractable abdominal and/or back
pain in 10 patients was completely alleviated immediately after surgery. The
surgical margins were histologically negative in 21 patients. The median
survival time was 21.0 months.
Conclusions. DP-CAR offers a high R0 resectability rate and may
potentially achieve complete local control in selected patients. The complete
relief from the pain contributes to excellent postoperative quality of life.
FV 6.06
SURGICAL PROCEDURE AND CLINICAL RESULTS OF LAYER-
TO-LAYER PANCREATICOJEJUNOSTOMY IN CONSECUTIVE 70
CASES.
Hayashibe, Akira; Kameyama, Masao
Bell Land General Hospital, Surgery, Sakai city, Japan
Background. Pancreatic anastomotic leakage remains a major troublesome
complication in pancreatic surgery. So various technical modifications
regarding the pancreatic anastomosis have been attempted to decrease
anastomotic leakage. We have performed Layer Cto-Layer pancreaticojeju-
nostomy and obtained extremely favorable results.
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Patients and Methods. During 19992007, 70 patients (33 female, 37
male) underwent Layer Cto-Layer Pancreaticojejunostomy. The mean age
was 65.0 years (range 3384). Surgical procedure of Layer Cto-Layer
Pancreaticojejunostomy. The jejunal serosa was resected a little smaller
than a size of the pancreatic stump. Then jejunal mucosa was exposed. The
dorsal part of the jejunal seromuscular layer and the dorsal part of the
pancreatic capsular parenchyma of the stump were sutured with seven to
eight stitches of 40 non absorbable thread to leave no dead space. A small
hole in the exposed jejunal mucosa with the same diameter as the pancreatic
duct was made. The anastomosis between the posterior wall of the pancreatic
duct (ductal mucosa) and the posterior wall of the jejunal mucosa were
performed (Layer-to-Layer anastomosis). The anterior wall of¡¡the pancreatic
duct (ductal mucosa) and the anterior wall of the jejunal mucosa were
sutured in the same manner(Layer-to-Layer anastomosis). The ventral part
of the jejunal seromuscular layer and the ventral part of the pancreatic
capsular parenchyma of the stump were sutured.
Results. Mean post-operative hospital stay was 32.3 days. Morbidity rate
due to early postoperative complication was¡¡9.0% (pneumothorax in 1,
pulmonary embolism in 1, gastric ulcer in 1, wound infection in 3), with no
pancreatic anastomotic leakage.
Conclusions. There were low complication rate and no pancreatic anasto-
motic leakage in consecutive 70 patients,¡¡who underwent Layer Cto-Layer
Pancreaticojejunostomy. We consider that Layer Cto-Layer Pancreaticojeju-
nostomy is extremely safe, reliable and favorable for pancreatic anastomosis.
FV 7.01
TYPE I CHOLEDOCAL CYST. LAPAROSCOPIC RESECTION
AND HAND SEWN LAPAROSCOPIC ROUX EN Y BILIARY
RECONSTRUCTION
Jarufe, Nicolas; Escalona, Alex; Guerra, Juan Francisco; Martinez, Jorge
Pontificia Universidad Cato´lica de Chile, Digestive Surgery, Santiago, Chile
The development of laparoscopic surgery has allowed incorporating this
technology to the surgical treatment of diverse pathologies. Todani’s type I
choledocal cyst are rare in adults. The most optimal treatment consists of its
complete resection and the drainage of the normal biliary duct to the intestine
through a Roux en Y reconstruction. This video shows a resection of a type I
choledocal cyst in a 32 years old woman with previous cholecistectomy. The
video demonstrates the procedure, technique and biliary reconstruction
in a Roux en Y loop with hand sewn laparoscopic hepatico-yeyunal
anastomosis.
FV 7.02
BILIO-ENTERIC RECONSTRUCTION ACCORDING TO HEPP-
COUINAUD TECHNIQUE
Nuzzo, Gennaro; Giuliante, Felice; Vellone, Maria; Ardito, Francesco;
D’Acapito, Fabrizio; Giovannini, Ivo
Catholic University-School of Medicine, Hepato-Biliary and Digestive
Surgery Unit, Rome, Italy
Background. Major bile duct injury at cholecystectomy may involve critical
problems, which include early diagnosis and treatment, treatment of
secondary complications, and choice of a biliary reconstruction offering the
best long-term oucome. Our preference is for the Hepp-Couinaud operation.
Objective. The video shows this type of reconstruction in a 29-yr old female
patient, referred with obstructive jaundice after laparoscopic cholecystect-
omy, with complete stenosis of the common bile duct (Bismuth type 3).
Method. The Hepp-Couinaud operation was performed at day 16 after
cholecystectomy, with a preoperatively positioned percutaneous biliary
drainage in place. The video details the main surgical steps: right subcostal
incision extended to the left; identification of structures of the hepatic
pedicle, and of surgical clips on the transected biliary stump; careful access to
the hilar plate, lowering of the hilar plate with identification and preparation
of the biliary confluence and the left hepatic duct; incision of the biliary
confluence and of the left hepatic duct to obtain a 3-cm wide anastomosis;
preparation of a 70 cm jejunal loop for Roux-en-Y bilio-enteric reconstruc-
tion; final anastomosis with a posterior and an anterior monolayer row of
interrupted reabsorbable sutures.
Results. The postoperative course was uneventful.
FV 7.03
LAPAROSCOPIC CHOLECYSTECTOMY IN TWO PATIENTS
WITH SITUS INVERSUS TOTALIS
Rajasekar, Arthanari
Sri Gokulam Hospital, Department of Surgical Gastroenterology, 3/60
Meyyanur Road, Salem, India
Background. Laparoscopic cholecystectomy is one of the commonest
laparoscopic procedure performed through out the globe. Occasionally
patient with situs inversus will require, laparoscopic cholecystectomy. We
discuss the surgical difficulties encountered and how they were overcome in
two such cases.
Case Presentation. A 34 years female patient a known case of situs inversus
presented with features of biliary colic. Ultrasonography of the abdomen
confirmed cholelithiasis and thickened gallbladder wall. Another 56 years
female patient, a known case of situs inversus presented with features of
chronic calculous cholecystitis, ultrasonography of the abdomen showed a
contracted gallbladder with gallstones. Laparoscopic cholecystectomy was
performed in both patients without any complications. All the laparoscopic
theatre equipments were placed on the left side of the patient. The ports were
inserted in the usual way on theleft side (10mm port subumblical, 10mm port
left subcoastal along midclavicular line, 5mm port left subcoastal more
laterally and 5mm epigastric port). The epigastric port was used to retract the
hartman’s pouch and the medial most subcoastal port for dissection and the
lateral most subcoastal port was used to retract the fundus.
Conclusion. Laparoscopic cholecystectomy can be performed safely in situs
inversus patients, however care must be taken to re-arrange the equipment
setup in theatre and to reorganize the mirror image anatomy.
FV 7.04
POST LAPAROSCOPIC CHOLECYSTECTOMY BILIARY STRIC-
TURE WITH PORTAL BILIOPATHY- A SURGICAL CHALLENGE!
KANCHUSTAMBAM, SUBBA RAO1; sainath, Brundavan2; samal, sub-
hash3; puppala rao, padma4
1APOLLO HEALTH CITY, HPB& LIVER TRANSPLANT SURGERY,
HYDERABAD, India; 2apollo health city, HPB and Liver transplant surgery,
hyderabad, India; 3apollo health city, gastroenterology and hepatology,
hyderabad, India; 4apollo health city, anesthesiology, hyderabad, India
Introduction. Benign biliary stricture following laparoscopic cholecystect-
omy is not an uncommon problem. Portal biliopathy is another benign entity
related to portal hypertension induced bile duct changes and presenting as
cholangitis and choledocholithiasis due to biliary obstruction. Patient
presenting with both problems is a difficult and challenging for the treating
team. Here in we present case that has portal hypertension and post
cholecystectomy biliary stricture and how we managed surgically.
Materials and Methods. 24yrs female had a Lap cholecystectomy when she
was 17yrs. She presented with cholangitis two yrs later. Since then she was
managed by placing stents (5 times) across a tight stricture at common
hepatic duct as well as right hepatic duct. Left duct stones extracted twice.
CT abdomen revealed right lobe atrophy with left lobe hypertrophy with
portal vein replaced by portal cavernoma with two stents in situ. Endoscopy
demonstrated grade 3 varices.
Operative Findings. There were dense adhesions between omentum and
porta. Multiple clips around the cystic duct and bile duct area were found
along with large collaterals. Tight stricture was found at the junction of cystic
duct and common hepatic duct along with dilated left duct and pin hole at
the opening of right duct.
Procedure. 1st stage mesocaval shunt using right internal jugular vein 2nd
stage  roux en y hepaticojejunostomy.
Conclusion. Portal biliopathy along with cholecystectomy induced biliary
stricture is a challenge to the surgeon. It can be managed safely in staged
procedure.
FV 7.05
POST CHOLECYSTECTOMY MIRIZZI SYNDROME IV LAPARO-
SCOPIC MANAGEMENT
Lo, Xina; Lee, K.F.; Ng, Wilson W.C.; Fok, K.L.; Ng, Nancy C.; Mak,
Nerissa O.S.; Wong, John; Lai, Paul B.S.
The Chinese University of Hong Kong, Department of Surgery, Hong Kong,
Hong Kong
Background. Cystic duct remnant after cholecystectomy occasionally
enlarged and have new form stones within, but this usually occur years after
the primary surgery and that most of them present as incidental findings or
pain and rarely have biliary obstruction as a feature.
Case Report. We report an unusual case of a 45 years old gentleman who
had an uneventful laparoscopic cholecystectomy elsewhere for symptomatic
gallstones two months before presentation. He was referred for further
management of persistent right upper quadrant pain and deranged liver
function of obstructive pattern after operation. He had ERCP done at the
primary hospital and was told to have impacted common bile duct stone but
could not be removed endoscopically. Subsequently further ERCP was
performed in our hospital and a 2cm stone was found to be impacted at an
enlarged cystic duct remnant, which was also compressing against the
common duct, causing Mirizzi syndrome. Stone removal failed once again
despite successful cannulation of the cystic duct remnant and a stent in
common bile duct was inserted for drainage. Laparoscopy with original aim
for cystic duct remnant excision was performed. Cystic duct remnant was
found to be relatively small. The stump was opened with the culprit stone
milked out and then repaired. Patient¡js liver function normalized soon after
the operation and his pain was much improved. He was discharged on post
operation day 2. Three weeks after operation, the stent inserted was removed
via ERCP and he had remained asymptomatic.
Conclusion. This case demonstrated that in experienced hands and
with good pre-operative assessment, laparoscopic approach is a safe and
effective way to tackle post-cholecystectomy cholelithiasis within cystic duct
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remnant, and previous surgery does not prohibit subsequent laparoscopic
intervention.
FV 7.06
Mirizzi Syndrome Laparoscopic Treatment
Pekolj, Juan; Fernandez, Diego L; Salceda, Juan; Bregante, Mariano; Pfaffen,
Guillermo; Ardiles, Victoria; de Santiban˜es, Eduardo
Hospital Italiano Buenos Aires, HPB and Liver Transplant Unit, Buenos
Aires, Argentina
Background. Mirizi?s Syndrome is a rare complication of a long standing
cholelithiasis. Many surgical approaches of varing complexity have been
advocated for treatment. Minimally invasive surgery has been used for many
other procedures and it could be feasible to resolve different types of this
syndrome. Objetive: to show two Mirizzi?s Syndrome type II cases resolved by
laparoscopic approach.
Population and methods. Case one is a female 73 year-old patient with
abdominal pain and jaundice; Ultrasound showed a cholecystitis with a
gallstone impacted at the infundibulum and intrahepatic duct dilatation.
Case 2 is a male 82 year-old with abdominal pain and jaundice; the CT scan
and MRI showed gallbladder dilatation with a gallstone and intrahepatic duct
dilatation.
Results. Both patients were approached by laparoscopy, first case was
resolved doing a subtotal cholecistectomy and laparoscopic closure; second
case II was resolved performing a laparoscopic hepaticojejunostomy; Both
patients were discharged at 3 and 4 day respectively without postoperative
complications.
Conclusion. Mirizzi?s syndrome sometimes can be anticipated on the basis
of preoperative staging, and often is diagnosed or confirmed during the
procedure. Subtotal cholecystectomy and simple closure with secure in-
traperitoneal drain appears to be a safe option for these patients, also a
hepaticojejunostomy could be performed when the closure is not safe because
the local conditions.
FV 8.01
GIANT HEPATIC HEMANGIOMA: LAPAROSCOPIC ENUCLEO-
RESECTION
Pret, Francesco; Nitti, P; Dalla Serra, G; Sebastiani, R; De Luca, R; Prete, F
University of Bari School of Medicine, Department of Surgery, Bari, Italy
Background. Hepatic hemangiomas (HH) are candidates to surgical
treatment when symptomatic, rapidly growing, suspect for malignancy or
complicated. Enucleation is an alternative option to the formal hepatic
resection. We present the laparoscopic enucleation of a giant HH.
Patient and method. The patient is a 29-year-old woman, with a 10-cm
HH of the left lobe causing subcontinuous epigastric pain exacerbated by
physical activity. By laparoscopy with four ports, after preparing for an
eventual Pringle manouver, we incise the Glisson capsule near the mass
margin, and identify the narrow cleavage between the compressed parench-
yma and the angioma capsule. An accurate dissection is performed along this
plane, up to close and section the vessels of the so-called hilum of the
angioma. When the enucleation is almost complete another small nodule
isseen posteriorly, and a small portion of hepatic parenchyma is resected.
Results. The postoperative recovery was uncomplicated and our patient
discharged in V postoperative day. Histology revealed HH and a small focus
of nodular hyperplasia.
Comment. The enucleation of HH reduces the sacrifice of liver parenchyma.
Size and location of HH influence the decision towards the most appropriate
treatment. In selected cases enucleating a large HH is feasible by laparoscopy
and well tolerated.
FV 8.02
SURGICAL TREATMENT OF RECTAL CANCER WITH BILAT-
ERAL, MULTIPLE LIVER METASTASES. STAGED HEPATECT-
OMY WITH PORTAL EMBOLIZATION
Figueras, Joan1; Codina-Barrera, Antoni1; Lopez-Ben, Santi1; Albiol, Maite1;
Farres, Ramon2; Pardina, Berta3; Codina-Cazador, Antoni2
1Department of Surgery, Division of hepato-biliary-pancreatic surgery,
Girona, Spain; 2Department of Surgery, Division of colorectal surgery,
Girona, Spain; 3Hospital Trueta, Department of anesthesiology, Girona,
Spain
Surgery represents the only chance of cure for patients with colorectal liver
metastases (CLM). However, most patients with synchronous CLM will
present with huge multiple unresectable disease. Those patients considered
unresectable can be rescued and made resectable by neo-adjuvant che-
motherapy. Synchronous CLM can be treated either simultaneous (the
primary tumor and the liver metastases in the same operation) or sequential
surgical procedures. In recent years important advances have been made in
surgical treatment of colorectal liver metastases (Portal embolization, staged
hepatectomy and thermal ablation). However, the timing of surgery and
applied strategy is still not well defined.
Clinical Case. We present a patient with obstructing rectal cancer and
synchronous 11, huge, multiple, bilateral CLM. An expandable metallic wall
stent was introduced to relieve obstruction in the primary and upfront
aggressive systemic chemotherapy (FolfiriBevacizumab) 8 cycles was
initiated. As significant radiological downsizing of CLM was achieved, we
proceed with the staged surgical treatment. Our strategy in the first stage was
metastasectomy of 3 CLM in the left liver and radiofrequency ablation of
another CLM, as well as lymphadenectomy, intraoperative right portal
embolization, and resection of the primary was also performed. Two months
later a right hepatectomy (2nd stage) was performed with the ‘‘extraglissonian
approach’’ stapling of the right pedicle and using the ‘‘hanging manoeuvre’’.
The histopathology confirmed a pT3, pN1 rectal adenocarcinoma, as well 11
CLM and one positive hilar pedicle lympha node. Adjuvant chemotherapy
was continued with the same schema used preoperatively. Eighteen months
after the 2nd staged hepatectomy the patient is alive and disease free.
Conclusion. This clinical case demonstrates that surgical R0 resection can
be achieved in patients with rectal cancer and multiple, huge, bilateral CLM
even in the presence of extrahepatic disease.
FV 8.03
LIVER RESECTION IN PATIENTS WITH UNILATERAL BILE
DUCT CYST TYPE V (CAROLI?S DISEASE)
Lendoire, Javier; Kohan, Gustavo; Quarin, Carlos; Raffin, Gabriel; Duek,
Fernando; Barros Schelotto, Pablo; Imventarza, Oscar
Hospital Dr Cosme Argerich, Liver Transplantation Unit, Buenos Aires,
Argentina
Liver resection is the best curative option for patients with unilateral
symptomatic Caroli?s disease. First case is a 71 year old male whose initial
symptom was right upper quadrant pain. CT scan and MRI cholangiography
demonstrated left dilated intrahepatic ducts with hepatolithiasis. Surgical
approach was done by a midline incision. Intraoperative ultrasound
confirmed the unilateral involvement of the biliary tree. A left lateral
sectionectomy, cholecistectomy and bile duct exploration was performed.
Patient was discharged at 7th postoperative day. Second case is a 39 year old
female that presented with episodes of cholangitis that respond to medical
treatment. A previous cholecistectomy was performed 4 years ago. Diagnostic
imaging showed dilatation of the left bile duct with hepatolithiasis. The
surgical approach was a subcostal incision with midline extension. No
differences with previous imaging were found on the intraoperative ultra-
sound. Left hepatectomy was performed. Patient was discharged at the 5th
postoperative day. No patient required blood transfusion. There was no
recurrence at follow up in both patients. Comments: In our series of 11
patients with Caroli?s Disease a predominance of males with unilateral and
left localization was found.
FV 8.04
RECONSTRUCTIO OF MIDDLE HEPATIC VEIN TRIBUTARIES
DRAINING SEGMENT V AND VIII OF RIGHT LIVER GRAFT
WITH RECIPIENT’S OWN MIDDLEHEPATIC VEIN
Tashiro, Hirotaka; Itamoto, Toshiyuki; Ohdan, Hideki; Amano, Hironobu;
Oshita, Akihiko; Ishiyama, Kohei; Asahara, Toshimasa
Hiroshima University, Surgery, Hiroshima, Japan
Background. A right liver graft lacking the middle hepatic vein can cause
congestion of the anterior segment in living donor liver transplantation.
Various solutions designed to overcome this problem have been reported,
including a right liver graft with the reconstruction of the middle hepatic vein
tributaries using various interposition vein grafts.I
Method. The recipient hepatectomy was completed with preservation of
middle hepatic vein tributaries. In the right-liver living donor transplantation,
the middle hepatic vein tributaries draining segments V (V5) and VIII (V8) of
a right lobe graft were reconstructed with the recipientIfs own middle
hepatic vein. When the recipientIfs middle hepatic vein is too short for
reconstruction of the V5, the recipientIfs right or left hepatic vein which was
harvested ex vivo from recipient liver was used as an interposition graft
between the V5 of the liver graft and the recipientIfs middle hepatic vein.
Results. These techniques were used in 11 branches of V8 and 11 branches
of V5 among 16 patients. The 2-month patency rate of the V8 and V5
reconstructed were 100% and 88%, respectively. All liver transplant patients
that underwent these operations are alive.
Conclusions. The use of the recipientIfs own middle hepatic vein is a
suitable option for reconstructing middle hepatic vein tributaries (V8 and V5)
in right-liver living donor transplantation.
FV 8.05
DISSECTION OF THE SUPERIOR MESENTERIC ARTERY (SMA)
AS THE FIRST STEP OF PANCREATICODUODENECTOMY.
Dargan, Puneet; ADHAM, Mustapha; PARTENSKY, Christian
Edouard Herriot Hospital, Department of HPB Surgery, Lyon, France
The video demonstrates dissection of the SMA as the first step of
pancreaticoduodenectomy. The patient had a space occupying lesion in the
head of the pancreas. Preoperative investigations included angio-MRI which
showed a replaced right hepatic artery originating from the SMA. After a
bilateral sub costal incision, the hepatic flexure of the colon is mobilized. The
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Kocher’s manoeuvre is performed with full mobilization of the duodenopan-
creas beyond the left margin of the aorta. The origin of the SMA is
progressively dissected free and encircled by sectioning the right nervous
mesenteric hemi-plexus. Common hepatic duct is also encircled and satellite
lymph nodes are resected and sent for frozen section. The right abnormal
hepatic artery is encircled and dissection is continued towards its origin from
the SMA with resection of lymph nodes which are also sent for frozen section.
The retropancreatic segment of SMA is progressively freed by sectioning the
pancreaticodudoenal superior and inferior arteries. The portal vein and
mesenterico-portal junction are progressively exposed by careful dissection
from the SMA. At our Institute pancreaticoduodenectomy is performed with
the SMA approach. The advantages of the technique include a radical
relevant lymphadenectomy, prevention of point of no return at any time
during the procedure and facilitation of preservation of a replaced right
hepatic artery and resection of the portal vein when indicated.
FV 8.06
ROBOTIC MICRODISSECTION OF THE HEPATIC HILUM
Jaydeep, Palep
"Misericordia" Hospital, International School Of Robotic Surgery, Via
Senese 169, Grosseto, Italy
Robotic assisted surgery overcomes the limitations of standard laparoscopy
techniques by giving us 3D stable vision, accuracy of dissection and a fixed
operating field which transforms the procedure in to a bench-like micro-
surgery. The main advantages being the improved quality of dissection of the
portal pedicle avoiding a Pringles manouver and the possibility to recognise
accurately the anatomical variants which help avoid bile duct and vascular
injuries. In this video we have shown three examples of difficult hilum
dissections dealt with robotic surgery.
FV 8.07
LAPAROSCOPIC DISTAL PANCREATECTOMY WITH SPLEEN
PRESERVATION
Jureidini, Ricardo1; penteado, sonia2; Abdo, Emilio E2; Sorbello, Mauricio2;
Cunha, Jose EM2; Cecconello, Ivan2
1University of sao Paulo, Gastroenterology, Sao Paulo, Brazil; 2
Division of pancreatic parenchima, vein and artery are difficult procedures
during laparoscopic surgery and demand the use of expensive devices.
Further, some authors attribute higher incidence of pancreatic fistulae to its
division with stapler. To avoid these problems we developed an approach to
the splenopancreatic area by dividing the short gastric vessels, the spleno-
cholic ligament and the connective tissue behind the pancreas. After this
laparoscopic dissection we perform a small median laparotomy (10 cm) to
extract from the cavity the spleen, tail and body of the pancreas. The splenic
artery and vein can be easily divided in conventional manner. The pancreatic
parenchima is also transected with a sharp blade and the pancreatic duct and
vessels can be gently ligated. This Laparoscopic assisted approach is a
technically simple procedure for the treatment of distal pancreatic lesions and
reduces its costs.
FV 8.08
SINGLE PORT LAPAROSCOPIC CHOLECYSTECTOMY
Rao, Prashant1; Rao, Sonali1; Rane, Abhay2
1Mamata Hospital, Mumbai, India; 2East Surrey Hospital, Redhill, United
Kingdom
Since the advent of Laparoscopic Surgery in the 1980’s, laparoscopic
cholecystectomy has rapidly become the gold standard for the treatment of
symptomatic cholelithiasis. In the last decade, surgeons have pushed the
frontiers of technology to apply the laparoscopic technique to various
abdominal surgeries. Standard laparoscopic techniques for cholecystectomy
have consisted of the four port technique with various modes of triangulation
in the French or the American technique. Traditionally laparoscopic ports
work on the concept of one instrument per port and this has necessitated the
use of four ports and four incisions for the completion of the procedure.
Innovative surgeons have tried reducing the ports and have reported
cholecystectomies using three and in some cases even two ports. Recently
the pressure to perform NO SCAR surgery has culminated in the reporting of
a few cases of natural orifice surgery. There has been no reported case of
transabdominal single port cholecystectomy using three standard laparo-
scopic instruments and their modifications. The development of the R port of
Advanced Surgical Concepts has made this possible. The R port is an
innovative port that allows the ingress of three instruments through a single
port. Using the single R port through the umbilicus makes this surgery almost
scarless. After all the umbilicus is an embryonic natural orifice. We present a
video of one in a series of a few single port cholecystectomies done using the
R port through the umbilicus. We used bent instruments, the Endo-eye and
modified clip appliers to prevent the chopsticks effect of three instruments
through a single port. The video depicts how the instruments were modified
to make the procedures feasible and the difficulties encountered and how they
were overcome, besides demonstrating the technique of single port surgery.
Single port laparoscopic cholecystectomy appears to be a feasible procedure
and can be done in a scarless fashion through the umbilical cicatrix without
the need for extra ports.
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JUVENILE HEPATOCELLULAR CARCINOMA ASSOCIATED
WITH FAMILIAL POLYPOSIS COLI
Oida, Takatsugu1; Mimatsu, Kenji1; Kawasaki, Atsushi1; Aramaki, Osamu1;
Kuboi, Youichi1; Kanou, Hisao1; Miyake, Hiroshi2; Amano, Sadao3
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Kasukabe Municipal Hospital, Surgery, Kasukabe, Japan; 3Nihon Univer-
sity School of Medicine, Surgery, Tokyo, Japan
Background. It is well known Familial adenomatous polyposis (FAP)
patients develop malignant tumors in colon and rectum, but also in other
organs such as thyroid grand, adrenal grand, duodenal papilla, stomach and
so on. The other hand, juvenile hepatocellular carcinoma (HCC) without
hepatitis infection is rare. Extracolonic malignancy on liver such as HCC
associated with FAP is extremely rare. Therefore, we present a case of a 23-
year-old man who had HCC after total colorectomy for FAP.
Case Report. A 23-year-old man was admitted to our hospital with hepatic
tumor. No abnormality was found by physical examination and laboratory
functioning data were within the normal range. Virological study revealed
hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (HBsAb)
and hepatitis C virus (HCV) were negative. Serum level of alpha-fetoprotein
(AFP) was normal range, and paraneoplastic syndrome (PNS) did not exsit.
He underwent total colorectomy five years ago due to FAP. Family history
were as follows. His mother underwent sigmoidectomy due to sigmoid colon
cancer and his sister also underwent total colorectomy due to FAP.
Ultrasonograpy (US) revealed hypoechoic solid mass measureing 40 mm
on the surface of segment 78 in the hepatic right lobe. Magnetic resonace
imaging (MRI) showed the tumor with a low signal intensity on a T1-
weighted image and a slightly high intensity on a T2-weighted image. Hepatic
arteriograhy revealed tumor vessels and pooling. Under Pringel maneuver,
partial hepatic resection was carried out. Pathological examination of surgical
specimen revealed a 4.0 I4.0 I3.3 cm tumor, showed moderately
differentiated hepatocellular carcinoma.
Conclusion. It is suggested that HCC is one of the manifestation of
oncogenicity in FAP.
PP 1.02
PROGNOSTIC FACTORS OF CURATIVE RESECTION IN HEPA-
TOCELLULAR CARCINOMA: AN ANALYSIS OF 163 PATIENTS
CONCERNING THE SIGNIFICANCE OF BODY MASS INDEX.
Okamura, Yukiyasu; Maeda, Atsuyuki; Ishii, Hiromichi; Kanemoto, Hide-
yuki; Matsunaga, Kazuya; Uesaka, Katsuhiko
Shizuoka Cancer Center Hospital, Hepato-Biliary-Pancreatic surgery, Sunto-
Nagaizumi, Shizuoka, Japan
Background. The incidence of obesity has been increasing in Japan as well
as Western countries. Epidemiological studies have shown that obesity is a
risk factor for carcinogenesis of hepatocellular carcinoma (HCC). Although
many reports showed some prognostic factors related to the survival of
patients following curative resection for HCC, no documentation concerning
the impact of obesity on survival have not been presented to date. In this
study we analyzed how obesity affected the survival of HCC after surgery.
Patients and Methods. One hundred sixty-three patients who underwent
curative hepatectomy for HCC in our hospital between September 2002 and
June 2007 were enrolled in this study. The twenty preoperative, operative,
and pathologic variables were analyzed retrospectively to identify the factors
that might significantly affect the disease-free survival and overall survival.
The body mass index (BMI) factor was assigned to three groups: BMI less
than 19, BMI 20 to 25, BMI more than 25.
Results. The cumulative overall three-year survival rate was 76.3% and the
disease-free rate was 31.8%. Multivariate analysis identified four independent
prognostic factors for overall survival: tumor grade (poorly differentiated),
BMI (less than 19), blood transfusion(), and satellite nodule(), and five
independent risk factors for tumor recurrence: UICC-Stage(IIIA, B),
microscopic vessel invasion(), cirrhosis(), satellite nodule(), and past
history of HCC treatment().
Conclusion. Present data showed that the cumulative overall survival rate
after curative hepatectomy for HCC, but not the disease-free survival rate,
was significantly lower in patients whose BMI were less than 19. This data
suggested that low BMI was a new prognostic factor for HCC after surgery.
Since our number of patients and follow up period are still limited, further
study is needed.
PP 1.03
TREATMENT OF RUPTURED HEPATOCELLULAR CARCINOMA
Kuboi, Youichi1; Oida, Takatsugu1; Mimatsu, Kenji1; Kawasaki, Atsushi1;
Aramaki, Osamu1; Kanou, Hisao1; Miyake, Hiroshi2; Amano, Sadao3
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1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Kasukabe Municipal Hospital, Surgery, Kasukase, Japan; 3Nihon University
School of Medicine, Surgery, Tokyo, Japan
Background and Aim. Spontaneous rupture is a life-threatening complica-
tion of hepatocellular carcinoma (HCC). Liver failure is the main cause of
death. Debates still remain on the most appropriate treatment in such
patients because of the high operative mortality of emergency surgery and the
high risk of rebleeding and less satisfying mid- and long-term results of non-
operative procedures like angiographic embolization. The objective of this
study was to evaluate the outcome of different treatment strategies.
Patients and Method. A retrospective study of 25 patients with ruptured of
HCC was conducted. Three patients underwent emergency surgery and 19
patients urgent transcatheter arterial embolization (TAE) and 3 patients
conservative therapy at the onset.
Results. Two of 3 patients of conservative therapy, chemoembolization was
performed, and these patients survived 3 and 4 months of each. The other
one was died. All cases of urgent TAE, hemorrhage was stopped, 8 of them
were performed the surgery. They tolerated the operation, 3 month, 6 month,
1-year rates of survival were 63%, 50%, 13%. Remaining 11 cases were
underwent non-surgical procedure, chemoembolization was performed in 6
patients and conservative therapy was in 5 patients. Hepatectomy was
performed in 3 cases at onset, although, one patient died from hepatic
failure after the surgery, remaining 2 cases were tolerated the surgery and
survived 6 month and 28months of each.
Conclusion. Urgent TAE is should be a first step pf procedure, after
controlling hemorrhage, only the case with good liver function should be
undergo hepatectomy with minimally invasive surgery.
PP 1.04
REDUCTION SURGERY FOR MULTIPLE HEPATOCELLULAR
CARCINOMA WITOUT SUFFICIENT HEPATIC FUNCTIONAL
RESERVE
Oida, Takatsugu1; Mimatsu, Kenji1; Kawasaki, Atsushi1; Aramaki, Osamu1;
Kuboi, Youichi1; Kanou, Hisao1; Miyake, Hiroshi2; Amano, Sadao3
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Kasukabe Municipal Hospital, Surgery, Kasukabe, Japan; 3Nihon Univer-
sity School of Medicine, Surgery, Tokyo, Japan
Background and Aim. Resection of hepatocellular carcinoma (HCC) has
become a safe operation with low operative mortality, and is the most
effective treatment of HCC. However, intrahepatic recurrence after surgical
resection for HCC is very common. Aggressive treatment of HCC increases
patientsIf survival, but frequently, patients are not suitable for surgery
because of the multifocality of the tumor. Resectability depends on the
number and location of the tumors and the volume of the functional remnant
liver. We evaluated the efficacy of the reduction surgery with intraoperative
radiofrequency ablation (RFA) for HCC patients without sufficient hepatic
functional reserve, and with multiple intrahepatic lesions including intrahe-
patic metastasis and multicentric recurrence.
Patients and Method. Ten patients were underwent surgical reduction
combined with RFA. Preoperative hepatic function reserve was evaluated by
converted the indocyanine green retention rate at 15 min (ICG R15). All of
the patientsIf ICGR15 were over 18%, and the mean IGG15 was 21%. Two
patients of them underwent resection of S67 segmentectomy with RFA, 4
patients S6 segmentectomy with RFA, 1 patient S8 segmentectomy with
RFA,1 patient S78 segmentectomy with RFA,1 patient S23 segmentect-
omy with RFA,1 patient S23 8 segmentectomy with RFA.
Results. There were no operative death. No surgical complications related to
the procedure were observed. The 1-, 2-, 3-, 5-year survival rates were 80%,
60%, 30%, 30%.
Conclusion. Rescection combined with RFA provides a surgical option for
the patients who is traditionally unresecrtable HCC, and may be increased
long-term survival. Further progresses may improved the efficacy and extend
the indications of surgical procedure in HCC.
PP 1.05
LAPARPSCOPIC HEPATECTOMY WITHOUT PRINGLE MANEU-
VER; Using LIFTING METHOD TO PREVENT PORTSITE AND
PERITONEAL METASTASIS
Aramaki, Osamu1; Oida, Takatsugu2; Kanou, Hisao2; Kuboi, Youichi2;
Amano, Sadao3; Kawasaki, Atushi2
1Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan; 2Social
Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan; 3Nihon
University School of Medicine, Surgery, Tokyo, Japan
Background/Purpose.: Laparoscopic liver resection has not become wide-
spread due to technical problems, risk of air embolism, and possible tumoral
spread, port site and peritoneal metastases. We provide a report of our
procedure for laparoscopic partial hepatectomy preventing air embolization,
port site and peritoneal metastases.
Methods. We performed laparoscopic partial hepatectomy in seven patients.
For preventing air embolization, lifting method was performed. All patients
were no required Pringl maneuver. Before parenchymal transecton of liver,
we dicided the resection line at 2cm distant from tumoral edge by
laparoscopic ultrasonography. The monopolar microwave coagulator(MC)
needle was inserted along the resection line repeatedly. The average out put
was 60W, and the duration was 40s. After the coagulation of the resection line
by MC, parenchymal transaction was perfomed by ultrasonically activated
coagulating shears(US). Left hepatic vein was sutured.
Results. Air embolism was not observed and blood infusion was no required
in all patients. No port site or peritoneal metastases were observed.
Conclusion. Laparoscopic liver resection with MC and US is useful
procedure preventing port site and peritoneal metastases without Pringl
maneuver under lifting method.
PP 1.06
HEPATOCELLULAR ADENOMA WITH MALIGNANT TRANS-
FORMATION: A CASE REPORT
Jacobs, Michael1; Malladi, Subramanyam2
1Providence Hospital, Surgery, Wayne State University School of Medicine,
Southfield, United States; 2Providence Hospital, Surgery, Southfield, United
States
Background. Liver cell adenomas are rare benign tumors. Their incidence
has increased since the introduction of oral contraceptives. The treatment of
these lesions remains controversial. Some authors believe that liver cell
adenomas are potentially premalignant lesions and could degenerate into a
hepatocellular carcinoma. There are very few documented reports of this
transformation.
Objective. We report a case of hepatocellular carcinoma arising from a
hepatocellular adenoma.
Methods and Results. A 54-years old female was referred to our institution
for the evaluation of a liver mass detected by a CT scan. The patient had
history of right upper quadrant pain for 6-months. Past medical history was
significant for osteoporosis for which she received hormonal replacement
therapy for 8 years. CT scan showed a solid mass lesion arising from right
lobe of liver. MRI showed an exophytic lesion from liver with a pseudo-
capsule and a central stellate scar. T1 weighted images showed intensity
similar to liver. T2 weighted of the mass were hyper intense except for the
scar. The alpha-fetoprotein level was normal. The patient was prepared for
surgery based on the large size of this symptomatic mass. Intra-operatively
the mass was found to be arising from the segment 5 and 6 of the liver. The
left side of the liver was unremarkable. Cholecystectomy and partial right
hepatectomy with resection of segments 5 and 6 was performed. Histo-
pathology showed a hepatocellular carcinoma arising from a hepatocellular
adenoma. The resection margins were free of tumor. Two years after the
surgery the patient is symptom free and repeat CT scan has not showed any
recurrence.
Conclusion. Malignant transformation of a hepatocellular adenoma is a rare
phenomenon but it does occur. Close and prolonged follow up is necessary
for all hepatic adenomas if a decision is made to forego surgical resection.
PP 1.07
IS THE OURCOME OF SURGICAL RESECTION OF HEPATO-
CELLULAR CARCINOMA LOCATED IN THE CAUDATE LOBE
WORSE THAN THAT IN SEGMENT IV?
Jeng, Kuo-Shyang
Mackay Memorial Hospital, Surgery, Taipei, Taiwan
Background.
Surgical resection of HCC originating from caudate lobe of the liver is known
as a challenging problem to surgeons because of the difficult anatomical
location and a worse prognosis. Centrally located HCC, especially originating
from Segment IV, is also a technique demanding in resection. The HCC in
the two locations are similar in complexity.
Aims. To compare the late outcome of our surgical patients of than two
group.
Methods. We compare a consecutive 36 patients with HCC located in
caudate lobe and 24 patients with HCC originating from segment iv and
analyze the demographic data, pathologic data, the course of operation, and
postoperation surgical morbidity and the late outcome including recurrence,
recurrence free interval, survival and death between the two groups.
Results. The significant differences of demographic data between the two
groups include gender (p0.020), hepatitis (p0.018), AFP value (p
0.009). The significant pathologic parameters include vascular invasion (p
0.018) and encapsulation (p0.042). There is no significant difference of
recurrence (p0.094) and its related death (p0.825).
Dicussion and Conclusion. From our study, the late outcome has no
statistically significant difference between two groups. We recommend
aggressive resection fro HCC located in caudate lobe is advisable if it is
feasible.
PP 1.08
PROGNOSTIC FACTORS OF 10-YEAR SURVIVORS AFTER IN-
ITIAL TREATMENT FOR HEPATOCELLULAR CARCINOMA,
DETERMINED IN 713 JAPANESE PATIENTS
TATENO, Taro1; Ueno, Shinichi2; Sakoda, Masahiko2; Kubo, Fumitake2;
Hiwatashi, Kiyokazu2; Shinchi, Hiroyuki2; Mataki, Yukou2; Kurahara,
Hiroshi2; Natsugoe, Shoji2; Aikou, Takashi2
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1Kagoshima University, Surgical Oncology and Digestive Surgery, Graduate
School of Medical and Dental Sciences, Kagoshima, Japan; 2Kagoshima
University Graduate School of Medical and Dental Sciences, Surgical
Oncology and Digestive Surgery, Kagoshima, Japan
Background. Hepatocellular carcinoma (HCC) is a relatively common
malignant tumor worldwide, accounting for almost one million deaths
annually. In the past two decades, some newly developed therapeutic options
have been applied with varying degrees of success: i.e., hepatectomy,
transcatheter arterial chemoembolization, and percutaneous ablation therapy.
In recent years, liver transplantation also has been applied to patients with
small HCC(s).
Objectives. To clarify the prognostic factors for long-term survival by
studying the clinical factors of 10-year survivors after initial treatment for
HCC and to discuss the timing of liver transplantation for HCC patients with
hepatitis C virus (HCV) infection.
Methods. 713 Japanese patients who received over 10 years observation after
initial treatment for HCC were selected. Differences in clinical factors
between 10-year survivors and the remainder were studied. The multiple
logistic regression model was used for multivariate analysis.
Results. Significant differences were noted between the groups in age, tumor
number, vascular involvement, concordance of Milan Criteria (MC),
Japanese tumor-node-metastasis stage, Child-Pugh stage (CP), HCV infec-
tion, serum a-fetoprotein level, and modality of initial treatment. Multivariate
analysis showed that older age, out of MC, CP-B or -C, and initially treated
other than by hepatectomy were independent risk factors for 10-year survival.
If patients were within MC and CP-A, the overall 10-year survival rate of the
patients initially treated by hepatectomy was 71% and 49% with HCV
infection.
Conclusions. Younger patients with HCC within MC and CP-A can expect
long-term survival, if surgically resectable. Hepatectomy should be recom-
mended especially to HCC patients with HCV infection, if in these
categories.
PP 1.09
SYSTEMATIC SUBSEGMENTECTOMY FOR HEPATOCELLU-
LAR CARCINOMA
Kubota, Keiichi; Kita, Junji
Dokkyo University Hospital, Department of Gastroenterological Surgery,
Tochigi, Japan
Systematic subsegmentectomy (anatomical resection) was developed to
extirpate the total portal area containing a hepatocellular carcinoma
(HCC) and tumor thrombi. During surgery, the portal branch bearing
HCC is punctured under ultrasound guidance and 5 ml of indigocarmine dye
is injected. The stained area is marked with electrocautery. Recently, a new
technique with a fluorescence imaging system using indocyanine green is
employed for determining the subsegment. Under PringleIfs maneuver, the
area is extirpated. This technique is applicable to patients with ICG15 less
than 30%. Between April 2000 and March 2005, 56 patients with one HCC
underwent this procedure without any mortality (Group 1), whereas 39
patients underwent non-anatomical resection (Group 2). The median
operation time, bleeding amount and Pringle time of the 2 groups were
272 min and 285 min, 354 ml and 400 ml and 45 min and 39 min,
respectively, without any significant differences. 36 of the 56 patients and 32
of the 39 patients had liver cirrhosis. Portal invasion was observed in 8 of the
54 and 7 of the 37, respectively. In Group 1, 15 of the 30 patients with
recurrence underwent re-hepatectomy, whereas 10 of 26 patients of Group 2
underwent re-hepatectomy. Overall 5-year survival rates and disease-free
survival rates of the 2 groups were 71.5% and 46.1% and 28.5% and 14.1%,
respectively. There was statistically significant difference in relapse-free
survival rate between the two groups. In addition, uni-variate analysis showed
that CLIP score, septum formation, portal invasion and defferentiation of
HCC are significant prognostic factors for relapse-free survival. Although
systematic subsegmentectomy is indicated to patients with better liver
function, this procedure is considered superior to non-anatomical resection
in terms of prolonging relapse-free survival time.
PP 1.10
APPLICATION OF MELD SCORE AND SERUM SODIUM CAN
INDICATE THE EXTENT OF HEPATECTOMY FOR HEPATO-
CELLULAR CARCINOMA ON CIRRHOSIS
Cescon, Matteo1; Cucchetti, Alessandro1; Grazi, Gian Luca1; Ferrero,
Alessandro2; Vigano`, Luca2; Ercolani, Giorgio1; Zanello, Matteo1; Ravaioli,
Matteo1; Capussotti, Lorenzo2; Pinna, Antonio Daniele1
1University of Bologna, Liver and Multiorgan Transplant Unit, Padiglione
25, Policlinico Sant’Orsola-Malpighi, Department of Surgery and Trans-
plantation, Bologna, Italy; 2Unit of Surgical Oncology, Institute for Cancer
Research and Treatment, Candiolo, Turin, Italy
Background. The usefulness of MELD in indicating the maximum extent of
hepatectomy for HCC on cirrhosis with the lowest risk of irreversible
postoperative liver failure (IPLF) is unexplored.
Objective. To elaborate a model for end-stage liver disease (MELD)-based
system to indicate the extent of hepatectomy for hepatocellular carcinoma
(HCC) on cirrhosis.
Methods. 466 hepatectomies performed at two tertiary Italian centers
between 1996 and 2006 were studied. Factors significantly affecting IPLF
were used to create a decision tree for safe liver resection.
Results. IPLF developed in 23 patients (4.9%). MELD score (categorized as
B9, between 9 and 10, and 10; PB0.05 for all comparisons) and extent of
hepatectomy were independent predictors of IPLF. In patients with MELD
B9, IPLF rate was 0.4% (1/30 major hepatectomies; 0/197 other resections).
In patients with MELD 9 to 10, IPLF rate was 1.2% (1/83) among resections
of B1 segment, 5.1% (3/56) among segmentectomies or bisegmentectomies,
and 11.1% (2/18) among major hepatectomies. In this category of MELD,
serum sodium identified a low risk group (sodium ]140 mmol/L), not
experiencing IPLF (0/80; 11 major hepatectomies), and a high risk group
(sodium B140 mmol/L), where resections of B1 segment led to an IPLF
rate of 2.5% (1/40) and resections of ]1 segment led to an IPLF rate 5%
(PB0.05). In patients with MELD 10, IPLF rate was 10% in all types of
hepatectomies.
Conclusions. A simple algorithm based on MELD score and serum sodium
can indicate the maximum tolerable extent of hepatectomy for HCC on
cirrhosis.
PP 2.01
LAPAROSCOPIC LIVER RESECTION: EARLY UK EXPERIENCE
Alkari, Bassam; Owera, Anas; Ammori, Basil
Manchester Royal Infirmary, Department Of Surgery, Manchester, United
Kingdom
Background & Aims. Advancements in surgical technique and technology
have facilitated safe laparoscopic liver resection in selected patients. The aim
of this study is to evaluate the feasibility and outcome of laparoscopic liver
resection.
Methods. Patients with lesions situated in the anterior and left lateral
segments were selected for laparoscopic resection. Data were collected
prospectively.
Results. Between 2003 and 2007, 23 patients (11 males) with a median
(range) age of 64 (3083) years underwent 23 laparoscopic hepatic resections
for colorectal metastases (n19) and other indications (n4). The
resections included left hepatic lobectomy (n14), bi-segmental resections
(n3), uni-segmental (n3) resections, and metastatectomy (n2). All
procedures were completed laparoscopically. Estimated median (range)
blood loss was 100 (25500) and one patient received a total of two units
blood transfusion. Postoperative complications were encountered in one
patient (4.3 per cent), and there were no operative deaths. The median
(range) post-operative hospital stay was 3 (114) days. The resection margins
were clear in 14 of 18 patients with malignant disease; and at a median
(range) follow up of 13.5 (536) months, 4 patients (22%) had disease
recurrence and 16 patients (89%) remain alive.
Conclusions. In selected patients with lesions in the anterior and left lateral
segments, laparoscopic liver resection is feasible, achieves adequate cancer
resection, and is associated with smooth and rapid recovery. Long-term
follow up data are required for oncological Results.
PP 2.02
LAPAROSCOPIC LIVER RESECTIONS IN A MULTIMODAL
‘FAST TRACK’ SETTING
Stoot, Jan; Van Dam, Ronald; Van De Poll, Marcel; Olde Damink, Steven;
Bemelmans, Marc; Dejong, Kees
University Hospital Maastricht, Department of Surgery, Maastricht, Nether-
lands
Background. Laparoscopic surgical procedures have been popularized
because of rapid recovery, short postoperative stay and cosmetic aspects.
More recently, so-called multimodal Enhanced Recovery After Surgery
(ERAS) programs have shown promising results in many open elective
surgical procedures with respect to improved recovery and outcome. The
added value of a fast track ERAS programme in laparoscopic liver surgery has
hitherto not been explored.
Aim. This study was conducted to evaluate the added value of an ERAS
programme for laparoscopic liver surgery for left sided lesions.
Methods. Patients treated in an ERAS programme with laparoscopic left-
sided liver resections in the years 2005 to 2007 were included. The
laparoscopic ERAS group was compared with historical data from con-
secutive patients using a prospectively collected database of laparoscopic liver
resections. Primary outcome was length of stay. Secondary outcomes were
complications, conversion, blood loss and duration of operation.
Results. Six patients were treated with laparoscopic liver resections
(bisegmentectomy 2 and 3) in the ERAS programme (group I; 1 male, 5
females, median age 54 [range 3482] years). Three laparoscopic procedures
were performed before the ERAS programme from 20032005 (group II; 1
male, 2 female, median age 37 [2670] years). Median length of stay was 6
[range 410] days in group I versus 8 [79] days in group II. There were two
minor complications in the ERAS group compared with no complications in
the historical group. There was one conversion in each group. Median blood
loss was 75cc [range 50200] in group I versus 250cc [range 50750] in
group II. Median operation time in group I was 119 [range 113149] minutes
compared to 182 [range 106261] minutes in group II. There were no deaths.
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Conclusion. This first fast track laparoscopic liver resection study ever
conducted suggests that a multimodal enhanced recovery programme for
laparoscopic liver surgery is feasible and probably reduces median length of
hospital stay.
PP 2.03
LAPAROSCOPIC LIVER RESECTIONS
Juan, Pekolj; Salceda, Juan; Fernandez, Diego L; Bregante, Mariano; Mazza,
Oscar; Ardiles, Victoria; de Santiban˜es, Eduardo
Hospital Italiano Buenos Aires, HPB and Liver Transplant Unit, Buenos
Aires, Argentina
Background. laparoscopic liver surgery had had an important development
in specialized centers, and laparoscopic liver resections are the most complex
procedures in this area. Objectivs: to value the results of an initial experience
of laparoscopic liver resections. Institution: Specialized HPB Surgery Section
in a Private Hospital. Variables to measure: age, sex, pre and postoperative
diagnosis, indications for resection, number size and localization of the
lesions, procedure performed, pedicle clamping, technique of parenquimal
section, operative and clamping time., associated procedures, conversion
rate., postoperative stay, morbidity and mortality, long term results in
malignant cases.
Results. In 24 patient we indicated laparoscopic liver resection. This is the
5.2% of all our resections in the same period. In 87,5 was by benign lesions,
and in 12.5 by malignant tumors. Two patients (8,3%) were converted. The
resections were minor in 21 cases and major in 1. Pringle maneuvere was
performed in 50% of the cases. Mean operative time was 170 min, and the
mean length of stay was 3 days. We had no mortality and only one
postoperative bile leak self limited (4.1%). In all malignant patient a safety
minimal margin of 1 cm was obtained.
Conclusions. laparoscopic liver resections performed by well trained
surgeons, are safe and effective procedures for selected patients with benign
and malignant liver lesions.
PP 2.04
SHORT-TERM AND LONG-TERM Results OF LAPAROSCOPIC
OPERATIONS ON THE LIVER AT NON-PARASITIC CYSTS
Starkov, Yury; Shishin, Kirill; Solodinina, Elena
A.V.Vishnevsky Institute of Surgery, Endoscopic Surgery, Moscow, Russian
Federation
Ninety nine patients with 169 non-parasitic liver cysts were operated from
1992 till 2007. The age varied from 32 till 78 years (middle age was 63 years).
Plural cysts were found at 32 patients and solitary-at 67. The size of liver
cysts at this group of patients varied from 4 up to 18 cm (average size-10.692
cm (9 SE). Complications occurred at 6 patients: 5 had cyst infection and 1-
intracystic bleeding. Cyst fenestration and atypical liver resections were
performed. The long liquid leakage on drainages within 57 days was marked
in the postoperative period at 11 patients. The bile leakage from 300 up to
100 cc per day occurred in one case after atypical liver resection for the big
cyst of 2, 3 and 4th segments and resolved spontaneously within 1 month.
Average duration of the postoperative period was 9 days (from 4 days till 1
month). Liquid congestions in a residual cavity were observed at 4 patients
and were successfully treated by a unitary puncture under the ultrasonic
control. Long-term results from 1 to 10 years were observed at 45 patients
with large cysts. Residual cysts at the operation cite were found in two cases
in dorsal segments of the right lobe of a liver. Considering the absence of
clinical signs the repeated intervention was not performed. Long-term
experience shows, that laparoscopic treatment of non-parasitic liver cysts
liver is accompanied by good results with small quantity postoperative
complications and low rate of recurrences. Wide excision of protruding
cystic walls with deepitelization of a residual cavity is the most widespread
and effective operation. Laparoscopic atypical liver resections with excision of
thin, partially sclerotic functionally defective sites areas of parenchyma is
indicated at big and giant liver cysts. Laparoscopic punction and punction-
drainage methods of treatment are auxiliary in addition to cystic excision.
They provide radicalism of intervention at patients with plural liver cysts with
intraparenchymal or dorsal location.
PP 2.05
METHODS of PARENHIMAL DISSECTION AND THE HEMOS-
TASIS AT LAPAROSCOPIC OPERATIONS ON THE LIVER
Starkov, Kirill; Shishin, Kirill; Solodinina, Elena
A.V.Vishnevsky Institute of Surgery, Endoscopic Surgery, Moscow, Russian
Federation
Today laparoscopic technologies are one of actively developing directions of
surgical hepatology, reflecting general tendencies of development of Surgery.
The basic real approach to increase the safety of operations is prevention of
the possible bleeding which is realized by precise manipulations with
application of consecutive or simultaneous various methods of dissection of
hepatic tissue and hemostasis on the incision line. Superficial liver areas (23
cm from a capsule) usually do not contain large vessels. Optimal tools to
incise the parenchyma are ultrasonic scissors which provide reliable hemos-
tasis. The additional hemostasis is achieved using various kinds of electro-
coagulation. Methods of contactless coagulation (argonoplasmal,
hydrothermal, spray) have obvious advantages. Safe dissection of deep liver
areas means topical diagnostics and marking of large vessels by dynamic
laparoscopic ultrasound for their pre´cised allocation and their crossing after
their clipping or sewing. The sufficient for crossing dissection of vessels from
parenchyma is performed by destructor-aspirator, water-jet dissector, instru-
ments or devices as Tissue-Link. The hemostasis is made using various
variants of contactless electrocoagulation. Large veins are crossed with
vascular staplers. Veins of moderate diameter (up to 34mm) can be crossed
after processing by the device as LigaSure or clipping. Vascular isolation of a
liver is not an obligatory stage of laparoscopic operations. Pringle method can
be applied if uncontrolled bleeding occurs at segmentary resections for a
period of maintenance of the reliable hemostasis. The experience of
laparoscopic liver resections on 29 patients shows, that the combination of
various techniques of parenchymal dissection and hemostasis allow to
perform safe laparoscopic resections even at patients with a cirrhosis.
PP 2.06
MESOHEPATECTOMY FOR METASTASIS OF COLORECTAL
CANCER
Visokai, Vladimir; Lipska, Ludmila; Levy, Miroslav
Thomayer Teaching Hospital, Surgical Department, Prague 4, Czech
Republic
The only chance of a long time survival for patients with colorectal carcinoma
is a surgical removal of all malignant tissues. TNM classification helps to
predict the prognosis, but even patients in a very advanced stage of the
disease can profit from an agressive surgical treatment. Large centrally
located liver metastases are usually indicated for major liver resection e.g.
extended right (segment 4,5,6,7,8)or left (segment 2,3,4.8) hepatectomy, or
mesohepatectomy (segment 4,5,8). Mesohepatectomy is leaving the right and
left segments in situ, preserving more functioning liver tissue. Mesohepa-
tectomy is a seldom used, technically demanding procedure. A 54year-old
woman was operated for obstructive ileus in 1996. Obstruction was caused by
a tumor of descending colon invading abdominal wall and the acute left
colectomy with lymphadenectomy was performed. Microscopically 6 lym-
phatic nodes were positive. Patient was postoperativelly treated with adjuvant
chemotherapy. Fifteen months later the patient underwent a resection of
central hepatic segments (Couinaud?s segment IV VVIII) for metachro-
nous metastasis 8cm large. At present the patient has no signs of recurrence,
she has returned back to her normal life. Despite several unfavorable
prognostic factors-obstruction, abdominal wall infiltration, number of
positive nodes and centrally located metastasis with satelite lesions- the
patient has been surviving 10 years since mesohepatectomy.
PP 2.07
AN APPROACH FOR THE SYSTEMATIC RESECTION OF
ANTERO-SUPERIOR AREA: EXPOSING GLISSONEAN PEDI-
CLES BY PRIOR DISSECTION OF THE MAJOR HEPATIC FIS-
SURE
Honda, Goro1; Baba, Hiroyuki2; Kurata, Masanao2; Tsuruta, Koji2
1Tokyo Metropolitan Cancer and Infectious Diseases Center, Surgery,
Komagome Hospital, Tokyo, Japan; 2Tokyo Metropolitan Cancer and
Infectious Diseases Center, Surgery, Tokyo, Japan
Introuduction. Most hepatocellular carcinomas (HCC) invade the portal
vein and form intrahepatic metastases at an early stage. Therefore, patients
with HCC require a systematic resection (SR) of the liver containing the
tumor. However, the antero-superior (AS) area is located in the center of the
liver and Glissonean pedicles of the AS area are not visible from the liverIfs
surface or hilum; therefore, it is difficult to ligate Glissonean pedicles of the
AS area precisely before dissection of parenchyma of the liver, though this
procedure is the most important step for the SR.
Methods. We performed the SR of the AS area with prior dissecting the
major hepatic fissure and exposing Glissonean pedicles of the AS area in 9
HCC patients (8 men, 1 woman; mean age, 58.8 years; age range, 3368
years; 4 chronic hepatitis B, 5 chronic hepatitis C) between December 1999
and December 2003. Two patients had another tumor involving another area;
1 patient also had an additional partial resection, while the other patient was
given intraoperative radio-frequency ablation. We determined operation time,
blood loss, postoperative hospital days, postoperative complications and
prognosis and investigated the effects of venous congestion (outflow block)
on antero-inferior area that are caused by transection of the drainage vein of
this area interflowing to middle hepatic vein.
Results. The mean operation time was 311 minutes. The mean blood loss
was 905 milliliters. The mean postoperative hospital days was 17 days.
Postoperative complications included 4 cases of pleural effusion or ascites;
there were no cases of bile leakage. The mean observation period was 46.4
months, and 8 patients (88.9%) had no recurrence. Atrophy of S5
parenchyma was seen on CT 6 months after operation in only 2 patients,
but they never developed postoperative hepatic failure.
Conclusion. The SR of the AS area with this approach is considered safer
and useful.
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USE OF NOVEL BIPOLAR RADIOFREQUENCY DEVICE FOR
OPEN AND LAPAROSCOPIC HEPATIC RESECTION: INITIAL
EXPERIENCE AND OUTCOME.
Espat, Joseph; Somasundar, Ponnandai
Roger Williams Cancer Center, Surgical Ocnology, 825 Chalkstone, United
States
Background. A wide range of hepatic parenchymal devices is available at
present and radiofrequency energy has been increasingly utilized in these
technologies. In the present report, hepatic parenchymal trasection per-
formed with the EnSeal device (SurgRx, Redwood, CA) was evaluated for
postoperative bile leak, hepatic necrosis, or hemmorrhage.
Methods. Data was extracted from a prospective database of hepatobiliary
surgical procedures maintained by the department; patient demographics,
procedure, postop complications(B and 30 day) were prospectively
collected. 6 total patients underwent hepatic resection with the Enseal
bipolar radiofrequency device, (3 colorectal (CRC) metastasis, 1 adenoma, 1
hemagioma and 1 HCC; of these, 2 CRC metastases and the hemangioma
were performed laparoscopically.
Results. procedures: 1 hemihepatectomy, 2 left lateral sections, and 3
atypical non-anatomic resections were performed. Estimated blood loss did
not differ from standardized instituional historical control ( data not shown).
No postoperative bile leaks were identified and no postoperative drainage was
required in any of the 6 patients. Similarly. no postoperative hemmorrhage
was observed and no patient clinically required transfusion. In the 30 day
complication category no parenchymal abscess was noted and no patient
demonstrated transection plane necrosis on routine 30 day postoperative
imaging.
Discussion. In utilizing new technologies and devices, outcomes for
common operations should be equivalent or superior to the standard
approach. When evaluated for the specific anticipated and recognized
complications of radiofrequency energy, the use of the EnSeal bipolar device
performed without evidence of bile leak, abscess formation or change inB
or30 complication rate.
Conclusion. While the use of a specific technique or device is largely
predicated on surgeon preference, in this experience, the device performs to
expected outcome standard.
PP 2.09
BILIO-JEJUNOSTOMY: AN OPTION TO TREAT NON RESPON-
SIVE CHRONIC BILIOMA FOLLOWING TRAUMA TO THE LI-
VER
Sharma, Pradeep1; Sharma, 2
1Bharati Vidyapeeth Medical College & Hospital, 2Department of Surgery,
Dhankawadi, Pune, India
Background. Biliomas are one of the sequels following trauma to the liver.
Most of the time these bilioma occur due to trauma to the minor biliary
radicles. These biliomas respond to repeated aspirations and/or therapeutic
ERCP and stenting of the common bile duct. However the biliomas can
become recurrent if they involve major biliary radicle. Such large biliomas can
also cause pressure atrophy of the liver affecting its functions.
Method. We present herewith a case of chronic recurrent bilioma following
intrahepatic transection of the left Hepatic duct which was successfully
treated with a Roux  en  Y Bilio Jejunal anastomosis. This was followed by
complete disappearance of the bilioma as well as regeneration of the liver. We
have not found any such mention in the literature.
Conclusion. Roux-en-Y Bilio Jejunal anastomosis can be a safe and easy
option to treat chronic and recurrent biliomas occurring after liver trauma.
PP 2.10
TRANSECTION OF THE LIVER WITH A NEW RF-ASSISTED
DEVICE, IN VIVO ESSAY WITH OPEN APPROACH IN A PIG
LIVER MODEL
Navarro, Ana1; Burdio, Fernando2; Berjano, Enrique3; Gu¨emes, Antonio4;
Sousa, Ramon4; Subira, Jorge5; Rufas, Maria4; Gonzalez, Ana6; Burdio, Jose
Miguel7; Castiella, Tomas8; Tejero, Eloy4; De Gregorio, Miguel Angel9;
Grande, Luis2; Lozano, Ricardo4
1Hospital Clı´nico Lozano Blesa and Fundacio´n Hospital de Calahorra,
Department of Surgery, Zaragoza and Calahorra, La Rioja, Spain; 2Hospital
del Mar, Department of Surgery, Barcelona, Spain; 3Polytechnic University
of Valencia, Department of Electronic Engineering, Valencia, Spain; 4HCU
Lozano Blesa, Department of Surgery, Zaragoza, Spain; 5HCU Lozano
Blesa, Department of Urology, Zaragoza, Spain; 6Veterinary Faculty, Uni-
versity of Zaragoza, Department of Animal Pathology and Surgery, Zaragoza,
Spain; 7University of Zaragoza, Dept of Electric Engineering and Commu-
nications, Zaragoza, Spain; 8HCU Lozano Blesa, Department of Pathology,
Zaragoza, Spain; 9HCU Lozano Blesa, Department of Interventional
Radiology, Zaragoza, Spain
Introduction. In hepatic surgery, both blood loss and transection time have
shown to be main determinants of operative outcome. Some methods have
been employed in order to reduce intraoperative blood loss. More recently,
saline-linked radiofrequency technology has been described and evaluated for
transection of the liver, main advantages being: Less blood loss during
transection and a shorter transection.
Objective. A new radiofrequency-assisted device specifically designed for
tissue thermocoagulation and division of the liver is described and compared
with an state-of-the art saline-linked instrument in an in vivo pig liver model.
Material and Methods. The new radiofrequency-assisted device is a hand-
held instrument that contains in a single embodiment: a blunt cooled-tip
Coagulation System:A blunt uninsulated cooled-tip electrode and a Cutting
System attached to the tip. Four pigs (47.6 kg) were usedto perform a total of
8 non-anatomical resections using either our new RF-assisted method
(Group A) or saline-linked dissecting sealer DS 3.0; Tissue Link Medical
(Group B). Pringle maneuver was not performed and only these instruments
were used for dissection, division and hemostasis. Transection time, Total
blood loss, Transection area, Transection speed, Blood loss per transection
area, Risk for Biliary leakage (methylene-blue test) and Tissue coagulation
depth, were main variables considered and compared between groups.
Group A Group B P*
Transection time (min) 11.9592.48 21.0296.61 0.006
Total blood loss (ml) 69.75973.93 527.009273.29 0.001
Transection area (cm2) 34.8396.54 41.0198.34 N.S.
Transection speed (cm2 /
min)
2.9790.39 2.0690.51 0.002
Blood loss per transection
area
(ml/cm2)
1.8291.b>.02/c> 12.8596.14 0.001
Tissue coagulation depth
(mm)
5.9091.61 3.3791.40 0.005
Results. All the pigs tolerated the procedures well and no relevant
complications occurred. In group A both blood loss and and blood loss per
transection area were lower (p0.001 than in group B (69.75973.93 ml,
and 1.8291.56 ml/cm2 vs. 527.009273.29 ml and 12.8596.14 ml/cm2).
Transection speed was 2.9790.39 cm2 /min in group A and 2.0690.51cm2 /
min in group B (p0.002).
Conclusions. Our new RF-assisted device has shown to address parench-
ymal division and hemostasis simultaneously, saving both blood and
transection.
PP 2.11
HOW TO PERFORM ANATOMICAL SUBSEGNENTECTOMY
USING GLISSONEAN PEDICLE APPROACH
Yamamoto, Masakazu1; Kotera, Yoshihito2; Ariizumi, Shun-ichi2; Takahashi,
Yutaka2; Imai, Kenichirou2; Katagiri, Satoshi2
1Institute of Gastroenterology, Department of Surgery, Tokyo Women’s
Medical University, Tokyo, Japan; 2Institute of Gastroenterology, Depart-
ment of Surgery, Tokyo, Japan
The liver can be divided into three segments according to the secondary
Glissonean pedicles at the hepatic hilus. One secondary pedicle has 4 to 6
tertiary branches. The area fed by a single tertiary branch does not
correspond to CouinaudIfs segment. We therefore refer to the area fed by
a tertiary branch as a cone unit of the liver. We can easily approach the
branches in the left segment because the tertiary branches can be seen along
the umbilical portion without liver dissection. However, in the right segment,
the tertiary branches can not be seen at the hepatic hilus. We therefore should
clamp the secondary pedicles at the hepatic hilus and confirm the borderline
between the segments. The tertiary branches from near the hepatic hilus can
be approached after dissecting the liver parenchyma around the secondary
pedicle. However, tertiary branches which originate from deep portions of the
secondary branches cannot be approached from the hepatic hilus. Such deep
branches can be approached after firstly dissecting the liver parenchyma on
the borderline between the segments. We have performed over 2000
anatomical liver resections at our institute since 1980. Over half of these
were anatomical resections smaller than one segment of the liver. Any type of
anatomical subsegmentectomy can be achieved using this technique.
PP 3.01
RADIOFREQUENCY-ASSISTED LIVER RESECTION: MORE LI-
VER PRESERVATION, LESS BLOOD LOSS
Kilicturgay, A.Sady´k1; Ozen, Yy´lmaz2; Kaya, Ekrem1
1Uludag Universty Medical Faculty, HPB surgey, Bursa, Turkey; 2U.Uni-
versty Medical FAculty, HPB Surgery, Bursa, Turkey
Aim. The aim of this study was to assess the feasibility and safety of a novel
concept for liver resection using a radiofrequency energy-assisted technique.
Method. Under intraoperative ultrasound (IOUS) guidance, a Cool-Tip RF
probe is inserted into the liver parenchyma surrounding the tumor. A zone of
coagulative desiccation is created around the tumor ensuring a 1-cm
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resection margin. Then, using a scalpel, the liver parenchyma is divided, and
the tumor is removed with minimal blood loss. RF works by the conversion of
RF waves into heat. Coagulative desiccation occurs and results in sealing of
blood and biliary vessels.
Results. From January 2005 to July 2007, 127 radiofrequency-assisted liver
resection (RF-ALR) (68 female, 59 male, mean age:58.6 (1578) years old)
were performed in our unit. RF-ALR was used in 53 cases with metastatic
disease (colorectal, breast, pulmonary), 19 cases with primary liver tumor, 25
cases with liver hydatidozis, 22 cases with hemangioma. 55 of these cases had
nonanatomic hepatectomies, 26 of the cases had hemihepatectomies (right or
left), and 46 cases had segmentectomies, 7 cases had resection for more than
1 metastasis and 5 cases had reresections. The mean operation time was 145
min (range, 120290 min), and only 12 (9.7%) patients needed blood
transfusion, predominantly those were receiving major hepatectomy. All
resections, except one, have been done without inflow occlusion of the liver
even in the sirotic cases. Postoperatively, only 4 patients had billiary fistula
and absess and right-sided pleural effusion was observed in 17 cases. Elevated
AST and ALT levels returned to the normal with in the 27 days. There was
no mortality.
Conclusion. The technique is safe and feasible, simplifies liver resection and
appears to be associated with minimal morbidity and blood lose and
maximum liver parenchyma preservation.
PP 3.02
RADIOFREQUENCY-ASSISTED HEPATIC PARENCHYMA RE-
SECTIONS (RFR): IS THERE ANY REAL BENEFITS?
Ribeiro Jr, Marcelo A F1; Condi, Gustavo1; Fonseca, Alexandre Z2; Saad,
William A1
1UNICID, PUC-sorocaba, Hospital Sao Luiz, Surgery, Sao Paulo, Brazil;
2Grajau Hospital, Surgery, Sao Paulo, Brazil
Introduction. Liver resections demand good surgical skills, since it is usually
associated with important blood loss, specially in cirrhotic patients with poor
coagulation parameters. It has been reported that for each blood unit
transfused the risk of disease recurrence and death was increased by 5%
and 7%, respectively. Thus, in order to reduce blood loss during surgery,
several techniques were developed, including low central venous pressure
anesthesia, continuous or intermittent hepatic pedicle clamping or total
vascular exclusion. Nowadays, RFR has been often used by offering feasibility
and efficacy in reducing those bleedings.
Objective. Analyze radiofrequency as an alternative way for hepatic
parenchyma resections.
Methods. Literature systematic review based on Medline from 1997 to
2007.
Results. The authors describe RFR as a promising technique for hepatec-
tomies in comparison to clamps, ultrasonic dissectors or stapling devices due
to its capability of reducing the operative time, the postoperative morbidity,
mortality and consequently increasing the survival rates. The main advantage
achieved was the massive reduction of blood loss at the operative time, which
contributes to the patients recover by avoiding common postoperative
complications.
Discussion. It is estimated that 20% to 60% of the patients undergoing liver
resections require blood transfusions, while the association between bleeding
versus poor short survival is well established. Although the RFR was initially
used for hepatic tumors resection in cirrhotic patients, it can be used in
healthy parenchyma, once the time of application is shortened.
Conclusions. Currently, RFR has been referred as one of the most effective
techniques for tumor resections, allowing positive impact in patients
surviving rates. Future research must be performed to evaluate the best
time of application of radiofrequency and the not totally known consequences
of the heat injuries in the intra-hepatic biliary tract.
PP 3.03
GIANT LIPOMA OF HEAD OF PANCREAS- A CASE REPORT
Malladi, S.V. Subramanyam; Malladi, S.V. Subramanyam; Chang, Yeon-
Jeen; Mittal, Vijay; Jacobs, Michael
Providence Hospital and Medical Centers, Surgery, Southfield, United States
Background. Mesenchymal tumors represent only 1 to 2% of all pancreatic
tumors. Pancreatic lipoma was first described by Bigard and since then only
five cases have been reported with histological confirmation.
Objective. We report a case of massive pancreatic head lipoma that
mimicked a liposarcoma and required a pancreaticoduodenectomy.
Methods and Results. A 59-year-old male with a history of severe sinusitis,
gastroesophageal reflux, and early satiety, was found to have an intraabdom-
inal mass on a computer tomography scan of the thorax. The patient was not
jaundiced and did not have evidence of pancreatitis. CAT scan of the
abdomen revealed a 12 cm fat containing mass replacing the pancreatic head
with areas of soft tissue density and internal striations suspicious for
liposarcoma. MRI confirmed the above findings. The patient was prepared
for surgery. Intraoperatively, a large fat containing mass was seen directly
arising from pancreatic parenchyma, effacing the duodenum, and indistin-
guishable from the pancreas proper. On the inferior aspect of the pancreatic
body a separate lipomatous mass was found, and its excision was necessary to
identify the pancreatic neck and body. Intraoperative ultrasound revealed a 6
cm area of increased density in the central aspect of the pancreatic head mass,
finding suspicious for liposarcoma. A Kausch-Whipple procedure was
performed. Histopathology showed extensive replacement of the head of
pancreas with mature adipose tissue extending into the pancreatic margins.
Clear-cut pancreatic parenchyma was not detected, suggesting a massive
lipoma of the head of pancreas.
Conclusion. Giant lipomas of the pancreas are rare tumors. Their clinical
presentation is variable, however, resection is indicated if they are sympto-
matic or if they cannot be differentiated from malignancy.
PP 3.04
INFERIOR VENA CAVA LEIOMYOSARCOMA: A SURGICAL
CHALLENGE
Andraus, Wellington1; Medeiros, Raissa2; Azevedo, Mauricio A2; Haddad,
Luciana B P1
1University of Sa˜o Paulo School of Medicine, Department of Gastroenter-
ology, Sa˜o Paulo, Brazil; 2
Background. Leiomyosarcomas of the inferior vena cava is a rare tumor.
These tumors are seen more frequently in middle-aged women and have a
favorable prognosis once completely resected.
Objective. The aim of this study is to relate a case of a patient successfully
treated for extensive leiomyosarcoma of the vena cava with pancreas invasion.
Case Report. A 40-year-old woman presented with upper abdominal pain
and progressive jaundice. Physical examination revealed only jaundice and
obesity. Laboratory tests showed bilirrubine of 12 mg/dl, alkaline phospha-
tase of 1220 mg/dl and gama glutamil transferase of 367mg/dl. Computed
tomography showed a high-density image in pancreas head and vena cava
‘‘thrombosis’’. Laparotomy was performed and a large caval mass involving
the renal veins, caudade lobe and pancreas head was seen. Vena cava, renal
veins and all liver was dissected and repaired. Pancreas and duodenum was
divided. Caudade lobe was divided of the liver. Vena cava was ligated 2 cm
under hepatic veins and 5 cm under the renal veins, that was also cutted and
all tumor was ressected in bloc. Venous reconstruction was undertaken only
for the renal veins, using a PTFE prosthesis for a reno-renal vein
anastomosis. A double loop reconstruction was used for pancreas and biliary
tree. Pathologic examination confirmed a leiomyosarcoma with free surgical
margins. The postoperative course was uneventful and the patient was
discharged on postoperative day 12. The venous flow through the renal veins
became normal, as confirmed by later Doppler ultrasound.
Conclusion. Treatment of inferior vena cava leiomyosarcoma remains a
technical challenge. When complete caval obstructin is present, caval
resection without any caval anastomosis is possible. Hepatic and pancreatic
associated resection can be performed. Colateral vessels of left renal vein are
often present in such cases, and the renal-renal vein anastomosis is an option
to preserve the right renal vein drainage.
PP 3.05
DOES THE METHOD OF CLOSURE OF THE STUMP OF
PANCREAS AFTER DISTAL PANCREATECTOMY AFFECT
POSTOPERATIVE FISTULA RATE?
Gandhi, Manish1; Bedi, Manmohan2; Ramesh, Hariharan1
1Lakeshore Hospital & Research Center, GI Surgery, Cochin, India; 2
Background. Postoperative pancreatic fistulas are common following distal
pancreatectomy regardless of technique used Aim: to analyse whether the
technique of pancreatic stump closure affected the postoperative fistula rate
Patients and Methods. 39 patients who underwent distal pancreatectomy
for neoplasms were studied. Patients with chronic pancreatitis or those where
drainage procedures were added were excluded. There were 19 males and 20
females (ages 27 to 69, median 46). Patients were grouped into three: a)
sutured closure (closure with 0000 Prolene suture with duct closure) (n
16); b) external pancreatic fistula using a 5/6 French tube (n9); and c)
stapled closure using Endo GIA 60 or Echelon 60 stapler (n14). Fistula
rates, hospital stay, readmission rate and other complications Parameter
Sutured Ext drainage Stapled (group a) (group b) (group c) P value Number
16 9 14 Duration of drain placement (median) 8 5 4 B0.05 Hospital stay
(days, median) 11 6 7 B0.05 Intra abdominal abscess 4 0 0 Readmission 2 2
0 Fistula 6 0 1 B0.05
Conclusion. Stapled closure had the lowest incidence of postoperative fistula
and the lowest hospital stay.
PP 3.06
DIAGNOSIS AND TREATMENT OF HEMOSUCCUS PANCREA-
TICUS: DEVELOPMENT OF ENDOVASCULAR MANAGEMENT
Lermite, Emilie1; REGENET, Nicolas2; TUECH, Jean-Jacques3; MUCCI,
Ste´phanie4; LADA, Paul4; Arnaud, Jean-Pierre4
1Chirurgie visce´rale. CHU, Angers, France; 2CHU nantes, chirurgie
visce´rale, Nantes, France; 3CHU, Chirurgie visce´rale, Rouen, France;
4CHU, chirurgie visce´rale, Angers, France
Objectives. The purpose of this study was to analyze the diagnostic and
therapeutic features of hemosuccus pancreaticus.
Methods. We reviewed our experience with management of 17 patients
admitted to surgery or gastroenterology units for hemosuccus pancreaticus
between 1981 and 2005. We studied symptoms, contribution of established
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morphological examinations (upper digestive endoscopy, computed tomo-
graphy, and selective digestive angiography), and treatment.
Results. Fifteen men and two women with a mean age of 57 years presented
hemosuccus pancreaticus. All the men had a history of chronic alcoholic
pancreatitis. Thirteen patients (76.5%) presented overt digestive bleeding (5
melena, 2 hematochezia, 2 melena with hematochezia, and 4 hematemesis).
The inaugural sign was anemia in 2 patients and epigastric pain another 2
patient. An upper digestive endoscopy was performed in 15 patients and
visualized hemosuccus pancreaticus directly in 9 patients. Arteriography was
performed in 16 patients (94.1%) and made the diagnosis in 14 (87.5%).
Surgery was performed in 9 patients, after embolization in 2 patients.
Embolization was performed in 9 patients and effective in 7 patients.
Therapeutic abstention proved successful in 1 patient. There were no death
and no recurrent bleeding.
Conclusions. Hemosuccus pancreaticus is a rare cause of digestive bleeding.
Upper digestive endoscopy and angiography during active bleeding can
provide the diagnosis. Most cases can be managed by angioembolization.
However, in patients with recurrent bleeding or failed embolization,
emergency surgery is required.
PP 3.07
MANAGEMENT OPTIONS IN SPLANCHNIC ARTERY PSEUDOA-
NEURYSMS-A CRITICAL ANALYSIS AT A TERTIARY CARE
REFERRAL CENTER
Johnson, Mariaantony1; Surendran, Rajagopal2
1Govt. Stanley Medical College Hospital, SURGICAL Gastroenterology,
Chennai, India; 2Govt. stanley Medical college hospital, surgical gastro-
enterology, shennai, India
Background. Haemosuccus Pancreaticus and Haemobilia are rare causes of
obscure gastrointestinal bleeding.
Objective. To evaluate the safety, efficacy and clinical outcome of non-
surgical and surgical treatment options for pseudoaneurysmal bleeding from
visceral arteries with an intent to setup management guidelines.
Methods. Retrospective analysis of 16 patients treated for bleeding visceral
artery Pseudoaneurysms (PAs) from 1998 to 2005.11 patients had bleeding
PAS complicating pancreatitis, post-traumatic in two following blunt liver
injury, and post-operative in 3 patients, following laparoscopic cholecystect-
omy in two and whipple’s Pancreatoduodenectomy in one.
Results. Computed tomography revealed the bleeding PA in 53.8% (n7/
13) patients and conventional angiography gave the correct diagnosis in
81.8% (n9/11). The mean (range) size of the P.A was 5.45 (210) cm.
Angiography was undertaken in 11(68.75%) with Transcatheter angio-
graphic embolization (TAE) attempted in 9 (81.8%) and achieving tempor-
ary hemostasis in 6(66.6%). Technical failure occurred in 3 (33.3%),
secondary intra-abdominal sepsis in one(11.1%), rebleeding in one patient,
respectively and were successfully treated by elective operation. Morbidity
and rebleeding in the angiographic intervention group were 11.1% each
respectively. Surgical morbidity was 41.6% with no rebleeding. No mortality
in either group. Follow-up data was available for 14 patients without any
recurrence of pseudoaneurysm or bleeding after a mean (range) follow-up of
26.3 (4559) months.
Conclusion. TAE should be considered as the first line treatment of choice
in all patients presenting with pseudoaneurysmal bleed after adequate
resuscitation. Surgery should be reserved only for (i)actively bleeding lesions
unsuitable for angioembolization with significant haemodynamic instabili-
ty(ii)non-availability or failure of embolization(iii)secondary complications
such as extrinsic compression or sepsis. Operation and TAE play comple-
mentary management roles.
PP 3.08
RADIO FREQUENCY ABLATION (RF) OF THE PANCREAS aˆ_‘‘
EFICIENCY AND SAFETY. AN EXPERIMENTAL STUDY IN A
PORCINE MODEL.
Felekouras, Evangelos1; Pikoulis, Emmanouil1; Papalois, Apostolis1; Agro-
giannis, Georgios2; Pavlakis, Emmanouil1; Prassas, Evangelos1; Papacon-
stantinou, Ioannis1; Petrou, Athanasios1; Geranios, Aggelos1; Bastounis,
Elias1
1Laiko General Hospital, First Department of Surgery University of Athens,
Athens, Greece; 2Laiko General Hospital, Pathology Department University
of Athens, Athens, Greece
Background. The aim of our experimental study was to investigate the
safety and efficacy of radiofrequency ablation of pancreatic tissue in a porcine
model.
Material. Two groups of 6 animals were operated under general anesthesia.
RF energy was applied to a pre-marked area of pancreatic head on the right
side of portal vein. In group A, portal vein cooling during ablation was
external, and in group B internal.
Method. Under full monitoring (PiCCOAˆ†) portal vein was catheterized via
splenic vein with a pulmonary artery catheter, the tip being positioned to the
level of the hepatic pedicle. Ablation time was 12 min, using a 2 cm intra-
cooling RF needle (TYCOAˆ†). The head of the pancreas was isolated and
the needle electrode placed in it parallel and in proximity (0,5 cm) to the right
side of the portal vein. Cooling was effective, as the intraluminal temperature
of the vein never exceeded the core temperature. Blood tests were taken prior
to operation and day 10, 20 and 30 postop. Euthanasia followed by
necrotomy was performed to all animals. The entire pancreas was excorpo-
rated and undergone pathological study. The collected data were cautiously
interpreted.
Results. All the animals suffered diarrhea and significant weight loss during
the first week postop. Three out of them died during the 3rd week; the cause
was ileus and kahexia in one, duodenum perforation in another, or general-
ized sepsis (multiple small liver abscesses) in the third. Two animals
presented portal vein thrombosis, one presented mass formation in distal
pancreas, were in another 2 a significant atrophy of the entire pancreas
observed. Formation of abscesses in the sub skin fat tissue was estimated in 8
animals. Serum tests confirmed severe pancreatitis in all animals. Pathology
of the pancreatic specimens is in process.
Conclusion. Radiofrequency ablation of the pancreas carries high post-
operative morbidity and noteworthy mortality. Our experiment did not
demonstrate safety and efficacy of the method.
PP 3.09
OUTCOME AND MANAGEMENT OF RUPTURED PANCRETICO-
DUODENAL ARTERY ANEURYSMS
Lee, Minjae1; Gerstman, Michelle1; Burton, Paul1; Lyon, Stuart2; Usatoff,
Val1; Evans, Peter1
1The Alfred Hospital, Monash University, Department of Surgery, Mel-
bourne, Australia; 2The Alfred Hospital, Department of Surgery, Melbourne,
Australia
Background. Pancreatico-duodenal artery aneurysms are an uncommon
form of splanchnic artery aneurysm. Patients frequently present after rupture
with major intra-abdominal haemorrhage or unexplained collapse and are
associated with a high mortality rate. Diagnosis and management of this
condition has proven to be challenging despite the use of advanced diagnostic
and interventional modalities.
Methods. A retrospective review was conducted on reported cases of
Pancreatico-duodenal artery aneurysm rupture at a tertiary institution.
Results. Five recent cases of pancreatico-duodenal artery aneurysm rupture
were identified. Two of the cases resulted in patient mortality due to
haemorrhage.
Conclusion. The risk of Pancreatico-duodneal artery aneurysm rupture is
not associated with the size of the aneurysm. However due to the high
resultant mortality associated with rupture, accurate diagnosis and expedient
management of this condition is crucial. Therapeutic embolisation has
evolved as the preferred management technique for most foregut aneurysms
as they are not easily amenable to surgical intervention in the emergent
setting. High-resolution Computed Tomography angiography and selective
embolisation have improved the diagnostic and therapeutic options available
for the treatment of this condition. Therefore the use of urgent Computed
Tomography angiography is advocated in all patients with unexplained
retroperitoneal or intraperitoneal haematoma. This can be followed by
targeted embolisation with concurrent intensive monitoring and resuscita-
tion. Nevertheless, should the advanced interventional radiology techniques
fail then surgical intervention is the only remaining option.
PP 3.10
NONOCCLUSIVE SMALL BOWEL NECROSIS IN ASSOCIATION
WITH FEEDING JEJUNOSTOMY AFTER ELECTIVE UPPER
GASTROINTESTINAL SURGERY
Spalding, Duncan1; Behranwala, Kasim2; Straker, Peter2; Thompson,
Jeremy2; Williamson, Robin3
1Hammersmith Hospital, HPB Surgery, Du Cane Road, London, United
Kingdom; 2Royal Marsden Hospital, Department of Surgery, London,
United Kingdom; 3Hammersmith Hospital, HPB Surgery, London, United
Kingdom
Introduction. Nonocclusive small bowel necrosis (NOSBN) has been
associated with early postoperative enteral feeding. The purpose of this
study was to determine the incidence of this complication in an elective upper
gastrointestinal (GI) surgical patient population, and the influence of both
patient selection and type of feeding jejunostomy (FJ) inserted, based on the
experience of two surgical units in affiliated hospitals.
Methods. The records were reviewed of 524 consecutive patients who
underwent elective upper GI operations with insertion of an FJ for benign or
malignant disease between 19972006. One unit routinely inserted needle
catheter jejunostomies (NCJ), whilst the other selectively inserted tube
jejunostomies (TJ).
Results. Six cases of NOSBN were identified over 120 months in 524
patients (1.15%), with no significant difference in incidence between routine
NCJ (n5, 1.16%) and selective TJ (n1, 1.06%). Median rate of feeding
at time of diagnosis was 105 (range 75125) ml/h, and diagnosis was made at
a median of 6 (range 418) postoperative days. All patients developed
abdominal distension, hypotension and tachycardia in the 24 hr before re-
exploratory laparotomy. Five patients died and one patient survived.
Conclusions. The understanding of the pathophysiology of NOSBN is too
limited to recommend that enteral nutrition be withheld from patients except
in those at high risk with an open abdomen, planned repeat laparotomies, or
significant bowel oedema. Patients should be fully resuscitated before
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initiating enteral feeding and feeding interrupted in the face of haemody-
namic instability, significant abdominal distension or feeding-related pain.
PP 3.11
NEW HIGH SPEED RADIOFREQUENCY SYSTEM IN THE LIVER
ABLATION: A PRELIMINARY REPORT
Yao, Peng; Chu, Francis; Daniel, Steve; Morris, David
University of New South Wales, Department of Surgery, Sydney, Australia
Background. Radiofrequency ablation (RFA) is a relatively safe procedure
proving local heating of the tissue and subsequent thermal necrosis of the
tested tissue. RFA has been broadly used for unresectable liver tumours,
however there are many important residual problems associated with
currently available standard RFA. Current probes are only easily able to
treat tumors of approximately 3 cm and often take over 20 minutes to
produce a single 5 cm diameter sphere of ablatable tissue. High local
recurrence and tract seeding is also the major drawback.
Aim. We have developed new high speed radiofrequency system for the liver
ablation.
Methods. Study was approved by the local authority and patients were given
consent preoperatively. 14 patients underwent tumor ablation followed by the
surgical resection. After surgery the ablated tissue was opened and analysed,
the ablation size was measured. The total ablation time was also recorded.
Results. No perioperative morbidity and mortality occurred. Three different
size ablations were studieded: 3.5 cm diameter, 5 cm diameter, and 7 cm
diameter. The average ablation size was 3.690.1 cm, 5.090.3 cm and 6.99
0.3 cm respectively, the ablation time was 3 min, 5 min and 12 min
respectively.
Conclusion. We have shown that this high speed radiofrequency system is
safe, effective, and requires only a small fraction of the time.
PP 4.01
MULTIMODALITY THERAPY FOR LARGE INOPERABLE HCC
Purohit, Dipak1; Naik, Saleem2; Varshney, Subodh2; Sewakani, Ajit2;
Sharma, Sandesh2; Singh, Vikrant2
1Bhopal Memorial Hospital and Research Centre, Surgical Gastroenterology,
Bhopal, India; 2Bhopal Memorial Hospital and Research Center, Surgical
Gastroenterology, Bhopal, India
Background. Only a small proportion of patients with HCC are able to
undergo surgical resection. Following resection, overall 5-year survival rates
range from 3550%. Even with curative resection, intrahepatic reccurence
occurs in upto 70% of cases. We report 3 year survival of four pateints for
large HCC (size 812 cms) in pateints with Child C cirrhosis and Hepatitis B
or C viral infection, treated with multimodality therapy for the HCC and
retroviral therapy for hepatitis.
Material and Methods. Four pateints (three male and one female), aged
5870 years, 3 had Hepatitis B and 1 had Hepatitis C infection, all were
Child C status and had large HCC (size 8 to 11 cms) on presentation. These
pateints were considered inoperable due to large size of tumour and large size
and poor liver function. They were managed by various multimodality
ablative techniques and supportive care. Supportive treatment were given to
improve the Child’s status in the form of FFP, Albumin and retroviral therapy
for viral hepatitis (HBV received Adefovir 10mg OD, Hep C on low dose
PegINF, 2 patients with Hep B and HCC were also given LAR Sandostatin
20mg IM every 4 weeks). The modalities used were TACE( 1 to two sessions)
followed by Radiofrequency of residual tumour. The pateints were assessed
with cross sectional imaging in pre and post procedure and were followed up
with tumor markers, USG, CECT or contrast enhanced MRI and routine
labarotory parameters.
Result. The tumour showed 60100% reduction in size and the Child’s
status improved from Child’s C to B in 3 patients and to Child’s A in one
patient. We report 100% 3 yr. survival in all four pateints (Ranging 3.0 to 5.5
yrs). Two pateints are still alive at 36 and 42 months.
Conclusion. Aggressive multimodality management by TACE/RFA and
treatment of the underlying viral hepatitits and supportive care can increase
the survival some of pateints with large inoperable HCC.
PP 4.02
ADJUVANT THERAPY FOR THE RESECTABLE HEPATOCELLU-
LAR CARCINOMA
Shen, Feng; Li, Jun
Eastern Hepatobiliary Hospital/Second Military Medical University, Shang-
hai, China
Introduction. The multiple well-selected therapies following liver resection
might yield longer survival for the HCC patients.
Aim and Method. To decrease the recurrent rate of HCC patients after liver
resection, multiple therapies were applied, including TACE and combined
therapies for portal vein tumor thrombus (PVTT).
Results. (1) The data of our 823 patients who underwent curative resection
was analyzed. Multivariate analysis suggested that adjuvant TACE was a
significant and independent negative predictor of the tumor recurrence, the
recurrence rate of patients who received this treatment (n126) was
significantly lower than that of patients who did not received it (n697).
Our data also indicated the significant role of adjuvant TACE in terms of
anti-tumor effect occurred within two years after liver resection, which might
increase the survival within two years of surgery (1st year was 81.5% vs
67.8%, 2nd year was 70.7% vs 54.4%, 3rd year was 52.3% vs 43.9% and 5th
year was 42.5% vs 35.0%). (2) In our 917 cases of HCC, 797(86.9%) had
PVTT if all portal vein system was included and 139(15.2%) had gross
PVTT. The patients with resectable HCC and gross PVTT received tumor
resection and PVTT resection or aspiration. The three years disease free
survival was better in resection (71.2%) than in aspiration (21.0%). Also
TACE, LA (laser ablation) and PPVC were performed in our hospital for
eliminating the gross PVTT. 65 cases of HCC with gross PVTT were treated
with LA, TACE and PPVC respectively. The regression of PVTT and the
reappearance of portal vein flow detected by color Doppler US were used as
evaluating criterion for the efficacy of therapy. LA showed a better role in the
elimination of gross PVTT (PB0.05).
Conclusion. The combination of adjuvant therapies might yield more
benefit for patients in terms of recurrence prevention. The further progress
depends on the well-planned combination of multiple treatments and
reasonable sequential arrangement of these strategies.
PP 4.03
RADIOFREQUENCY ABLATION OF PRIMARY AND META-
STATIC LIVER TUMORS-125 CASES EXPERIENCE
Ribeiro Jr, Marcelo A F1; Chaib, Eleazar2; Sala, Mariana3; Vulcano, Juliane
C3; Yamashita, Renato H3; Saad, William A4
1PUC- Sorocaba, UNICID and Hospital Sa˜o Luiz, Department of Surgery,
Sa˜o Paulo, Brazil; 2University of Oxford, Nuffield Department of Surgery,
Oxford, United Kingdom; 3UNICID, Department of Surgery, Sa˜o Paulo,
Brazil; 4HCFMUSP, UNICID and PUC-Sorocaba, Surgery, Sao Paulo,
Brazil
Background. Radiofrequency ablation of primary and metastatic liver
tumors has been shown to be one of the promising new modalities to treat
or to palliate liver tumors. It can be used in nodules until 34 cm of diameter,
by laparotomy, laparoscopy and percutaneouslly.
Aims. The authors will present a serie of 125 cases, 59 females and 66 males
with a mean age of 60,8 years, in which the radiofrequency ablation has been
used either by laparotomy or percutaneouslly to treat 192 lesions.
Results. In the present series the group was composed of 47 cases of
hepatocellular carcinoma, 61 metastases of colorectal cancer, 06 cases of
neuroendocrine tumors, 04 cases of breast cancer metastasis, 04 cases of
cholangiocarcinoma, 01 case of hepatic metastasis of leiomyosarcoma, 01
case of pancreas cancer metastasis and 01 case of kidney cancer metastasis.
The mean number of lesions treated were 1,5 per case with a average size of
3,69cm per lesion. The following liver segments were compromised: Seg I
(10), Seg II (7), Seg III (7), Seg IV (43), Seg V (11), Seg VI(14), Seg VII (53)
and Seg VIII (47). The morbidity was 25,6% and the mortality was 3,2%. In
13,6% of the cases we were able to find recurrence after the procedure, with a
mean time of 10,5 months. In association with RFA were performed at the
same procedure ethanol injections, nodulectomies, left lateral segmentec-
tomies and others.
Conclusion. RFA is safe, can be used in patients with a poor hepatic
function (Child B and C), as a bridge to liver transplantation, given to the
patients a chance to stay disease free or at least controlled while waiting for
the new organ. For the metastatic diseases it does not substitute surgery but
can be used in patients who do cannot be operated, can also be used
associated with other modalities like surgery, transarterial chemoemboliza-
tion and after recurrence and can give to the patient a chance to remain
disease free.
PP 4.04
REPEAT TRANS-ARTERIAL CHEMOEMBOLIZATION FOR UN-
RESECTABLE HEPATOCELLULAR CARCINOMA: INSTITU-
TIONAL EXPERIENCE
Damrah, Osama1; Pai, Madhava1; Lapenga, Alex2; Tait, Paul2; Habib,
Nagy1; Canelo, Ruben2; Jiao, Long2
1Hammersmith Hospital-Imperial College London, London, United King-
dom; 2Hammersmith Hospital, London, United Kingdom
Introduction. Trans-arterial chemoembolization is a widely used method of
treatment for patients with unresectable hepatocellular carcinoma (HCC),
but its efficacy remains debated. The aim of this study was to assess the
outcome of trans-arterial chemoembolisation (TACE) in the management of
unresectable hepatocellular carcinoma.
Methods. Between January 2002 and May 2006, patients with unresectable
hepatocellular carcinoma who had lipidol chemoembolization (lipidol plus
doxorubicin) were reviewed. Both patient and tumour characteristics, results
of chemoembolization including complications and survival were collected
for analysis.
Results. A total of 66 TACE procedures were performed in 26 patients
consisting of 2.591.5 treatment per patient. Cirrhosis was present in 22
patients (47%). Twelve patients had Okuda Score II and III (46%) with
multifocal disease present in 20 patients (77%). The mean tumour size was
6.194.2 cm (range, 1.717.5 cm). Eight patients had TACE twice (31%), 3
patients 3 (11.5%) and 4 (11.5%) times respectively, 3 patients 5 (11.5%)
and 1 patient 6 (4%) times respectively. Post embolisation syndrome was
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common (76%). Other complications included liver abscess (n1) and liver
failure (n2). The median follow-up time was 26.5 months. Four patients
(15%) died at the follow-up from tumour progression (n3) and gastro-
intestinal haemorrhage (n1). The overall median survival rate was 26.5
months. Patients who had repeated TACE had a better median survival
compared with those treated with single TACE (28.5 vs. 9.5 months).
Conclusion. Repeated TACE is an effective therapeutic option for patients
with unresectable HCC.
PP 4.05
EFFECTS OF THE SELECTIVE CYCLOOXYGENASE-2 INHIBI-
TOR ON THE INVASION OF HUMAN HEPATOCELLUAR CARCI-
NOMA CELLS
jiansheng, li1; ZhengDong, Fang2
1Anhui Provincical Hosptial, general surgery, hefei, China; 2Anhui Provinci-
cal Hosptial, Department of General Surgery, hefei, China
Abstract Introduction. Tumor cyclooxygenase-2 (COX-2) expression is
known to be associated with enhanced tumor invasiveness. Recent studies
show that up-regulation of cyclooxygenase-2 (COX-2) in human cancer cells
induces activation of matrix metalloproteinases (MMPs) and increase of
metastatic potential. In this study, we investigate the effects of nimesuli, a
selective cyclooxygenase inhibitor, on the invasion of human hepatocelluar
carcinoma cell line SMMC-7721 and on the expression and enzymatic
activity of MMPs.
Methods. SMMC-7721 cells were treated with nimesuli (25,50,100,200,
400jI`mol/L)and control group, MTT reduction assay was used to evaluate
the inhibitory rate;Transwell chamber assay was performed to determine its
effect on the invasion of SMMC-7721 cells; the expression of MMPs mRNA
and enzymatic activity of SMMC-7721 cells were evaluated by RT-PCR and
gelatin zymography, respectively.
Results. The inhibitory rate of nimesuli on SMMC-7721 cells proliferation
increased as incubated time and nimesuli concentration increasing;Com-
pared with that in control group, Nimesuli could down-regulate the
expression of MMPs mRNA and enzymatic activity(Nimesuli
25,50,100,200L, 400jI`mol/L vs control: MMP-2 mRNA 0.968£-0.545£-
0.330£-0.158£-0.083 vs 1.063£»MMP-9 mRNA 1.005£-0.758£-0.465£-
0.208£-0.103 vs 1.075 £-P£¼0.05);the inhibitory rates of SMMC-7721 cells
that penetrated polycarbonates in experiment group(7.8%£-08.0%£-35.6%£-
53.6%£-61.4%)was less than control group(P£¼0.01). CONSLUSION:
The selective cyclooxygenase inhibitor, nimesuli, can inhibit the growth
and invasion of SMMC-7721 cells. Its possible mechanism may be involved
in down-regulation of MMPs.
PP 4.06
MAJOR ANATOMICAL VARIANTS WITH SURGICAL VALUE FOR
LIVER RESECTION AND TRANSPLANT. STUDY ON CORRO-
SION CASTS
Matusz, Petru
University of Medicine and Pharmacy "Victor Babes", Department of
Anatomy, Timisoara, Romania
Introduction. The segmental character of liver parenchyma is admitted
since Rex (1888). Most descriptions are based on the intraparenchymal
distribution of afferent pedicle elements (portal hepatic vein  PHV, proper
hepatic artery  PHA, and the intrahepatic biliary ducts system  IHBDS).
Matherial and Method. On a study material of 100 liver corrosion casts we
analyzed the major anatomical variants of intraparenchymal distribution of
the afferent pedicle elements. The corrosion casts were made by injecting
with plastic the vasculo-ductal systems, followed by parenchyma corrosion
with hydrochloric acid.
Results. The PHV trunk presents variations of ramification in 4% cases (2%
trifurcations and 2% atypical bifurcations). In 9% cases there are 3 lateral
branches (in 2% cases two superior lateral branches and in 7% two inferior
lateral branches). In 1% cases the medial branch gives birth to 4 segmental
branches. In 8% cases the anterior branch is absent as a morphologic entity,
the segmental branches arising directly from the right branch. The posterior
branch has, in 22% cases, a supplemental segmental branch. The proper
hepatic artery presents, in 1% cases, only the right branch. In 16% cases, the
medial branch arises from the right branch. In 14% cases we found an
anastomotic arterial network in contact with the anterior aspect of the PHV
bifurcation. The left hepatic duct receives, in 19% cases, the lateral, medial
and posterior branch; the posterior branch crosses the plane of the main
portal fissure. In 21% cases the right hepatic duct is absent as a morphologic
entity.
Conclusions. Knowledge of these aspects of variants of intraparenchymal
distribution of the elements from the afferent pedicle is important in case of
surgical procedures of the hepatic parenchyma.
PP 4.07
RELIABILITY OF INTRAHEPATIC MICRODIALYSIS IN MONI-
TORING OF SMALL MOLECULES IN THE LIVER
Isaksson, Bengt1; Jersenius, Ulf1; Ravn, Anna2; Iwata, Takashi2; Jorns, Carl2;
Nowak, Greg2
1Karolinska University Hospital Huddinge, Division of Surgery, Stockholm,
Sweden; 2Karolinska University Hospital Huddinge, Division of Transplan-
tation Surgery, Stockholm, Sweden
Introduction. Intrahepatic microdialysis has potential of being a standard
monitoring method in surveillance of liver during and after resection and
transplantation. Four small molecules, glucose, glycerol, lactate and pyruvate
give information about the metabolic state of the liver. Today, 20kD cut off
membranes are used for collection of those molecules. However, use of
membranes with 100kD cut off would allow us to monitor bigger molecules
such as cytokines. The aim of this study was to assess whether 20kD and
100kD intrahepatic microdialysis catheters can be used equally concerning
the recovery of glucose, glycerol, lactate and pyruvate.
Methods. Six female pigs were used in the experiment. Four microdialysis
catheters were inserted in the liver of each pig, two catheters of 20kD and two
of 100kD cut off. A Ringer-like solution was pumped through the 20kD
catheters and one of the 100kD catethers at a flow rate of 0,3 ml/min. The
other 100kD was pumped with Voluven at the same flow rate. Samples were
collected at 40 minute intervals and analysed for glucose, glycerol, lactate and
pyruvate.
Results. All fours parameters were stable during the monitoring time. There
were no differences regarding intahepatic glucose and glycerol across groups.
Regarding lactate and pyruvate we observed a tendency of higher lactate and
pyruvate monitored with 100kD catheters. However, there were no differ-
ences between catheters with the same cut off.
Conclusions. Our results showed that 20kd and 100kD intrahepatic
catheters can be used equally regarding the monitoring of small molecules
such glucose and glycerol. The placement of the catheters in different liver
lobes gives the same results. Microdialysis is an easy and reproducible
method to directly monitor the liver and replacement of routinely used 20kD
catheters with 100kD catheters, could give us a chance to monitor bigger
molecules such as cytokines.
PP 4.08
EFFECTS OF PRINGLE?S MANOUVRE ON INTRAHEPATIC ME-
TABOLISM DURING LIVER RESECTION
Isaksson, Bengt1; Jersenius, Ulf1; Ungerstedt, Johan1; Lundell, Lars1;
Permert, Johan1; Nowak, Greg2
1Karolinska University Hospital Huddinge, Division of Surgery, Stockholm,
Sweden; 2Karolinska University Hospital Huddinge, Division of Transplan-
tation Surgery, Stockholm, Sweden
Introduction. Careful evaluation of liver function is vital for planning of the
surgical strategy to minimize morbidity and mortality in extensive liver
surgery. With microdialysis (MD) it is possible to continously monitor
metabolic alterations in the liver. A clinical study of intrahepatic metabolic
effects of Pringle?s manouvre (PM) during liver resection was done.
Methods. Eleven consecutive patients who underwent liver resections were
investigated. Intrahepatic placement of the MD-catheter in segment 4 was
done immediately after laparotomy. Serial samples of the dialysis fluid were
collected every 10 minutes, before, during, and after a 20-minutes period of
PM. Glucose, lactate, pyrvate (markers of ischemia), and glycerol (marker of
membrane damage or lipolysis) were alalyzed and the lactate/pyruvate-
quotient was calculated (sensitive marker of ischemia).
Results. During PM intrahepatic glucose increased from 7.190.7 to 12.99
1.7 mM. During initial reperfusion, glucose further increased to 15.7 92.5
mM, and thereafter decreased. PM also resulted in an increased lactate/
pyruvate-ratio (from 3.490.5 to 9.092.3). During reperfusion the lactate/
pyruvate-ratio was normalized. Intrahepatic pyruvate was unchanged during
PM, but increased during reperfusion (from 99918 to 151923 mM),
indicating increased perfusion. During PM, both intrahepatic glycerol and
lactate were increased (from 5096 to 139928 mM, and from 2.490.3 to
6.5908 mM, respetively): Both lactate and glycerol continued to increase
during initial reperfusion.
Conclusions. PM for 20 minutes was associated with severe intrahepatic
metabolic alterations with increased glucose (glycoenolysis), lactate/pyruvate-
ratio (anaerobic metabolism), and glycerol (cellular membrane damage).
Microdialysis enables continous monitoring of intrahepatic metabolism
during liver surgery. The method is easy to use and safe for the patient.
PP 4.09
SURGICAL EXPERIENCE WITH FUNCTIONAL AND NON-
FUNCTIONAL HPB NEUROENDOCRINE TUMORS
Chhabra, Deepak1; Joshi, Shashank2; Lad, Prashant1; Navadgi, Suresh3;
Shah, Rajiv1; P, Jagannath1
1Lilavati Hospital and Research Centre, Dept. of Surgical Oncology,
Mumbai, India; 2Lilavati Hospital and Research Centre, Dept. of Endocri-
nology, Mumbai, India; 3S. L. Raheja Hospital, Dept. of Surgical Oncology,
Mumbai, India
Background. Neuroendocrine tumors (NETs) of the gastro-entero-pan-
creatic system present with different biological behaviors. Surgery is curative
and plays an important role in palliation.Aims And Objectives. To determine
difference in surgical outcomes of functioning and non-functioning hepato-
pancreato-biliary (HPB) NETs.
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Methods. 43 patients of NETs (March 2003 to March 2007) were
retrospectively reviewed. Tumors were classified as per functional status
and WHO classification system. Factors evaluated for disease-specific
mortality were: age, sex, functional status, surgical procedure, pathologic
characteristics, disease-free and overall survival.
Results. 43 patients (19 females, 24 males) included 21 functional and 22
non-functional tumors. Mean age was 501 years. Functional tumors
included 15 Insulinomas, 3 gastrinomas, 2 glucagonoma and 1 calcitonin
secreting tumor. 23 (54%) tumors were malignant and dominated by non-
functional tumors (n19). 20(46%) tumors were benign, majority of which
were functional (n17). Biologically, 18 patients had low grade and 5
patients had high grade malignant tumors, 19 tumors were benign and 1 was
of uncertain behaviour. 84% (n16) of non-functional pancreatic tumors
were malignant. 33 patients underwent surgery: 25 pancreatic resections, 3
hepatic resections, 2 enucleations, 1 triple bypass and 1 RFA. 1 patient was
inoperable. 88% (n29) patients had curative resection. At median follow
up of 30 months, 29 surgical patients (88%) are alive and no patient with
benign tumor died because of NET. Significant difference in survival was
observed in surgical vs. non surgical patients. There was no significant
difference in the surgical outcomes for functional or non-functional tumors.
Disease free survival was 79.5% and overall survival was 72%.
Conclusions. Surgical resection should be advocated for NETs. Non-
functional tumors should be considered potentially malignant and treated
with aggressive surgery. Definitive surgical resection is a predictor of survival
in NETs.
PP 4.10
ADULT HEPATOBLASTOMA: REPORT OF A CASE.
Morales, Dieter1; Garcia de Polavieja, M2; Figols, FJ2; Casanova, D2;
Arruabarrena, A2; Madrazo, C2; Palacios, A2; Yagu¨e, E2; Naranjo, A2
1University Hospital "Marque´s de Valdecilla", Department of Surgery,
Santander, Spain; 2
Introduction. Hepatoblastoma is most common primary malignant hepatic
neoplasm in children. Median age at diagnosis is one year and mostly present
by three years. This is a rare case report of a female patient with
hepatomegaly diagnosed as hepatoblastoma.
Case Report. 28 year old female with history of A hepatitis at childhood.
She was was addressed to our hospital with upper right abdominal mass and
pain for one month. Blood samples, cultures and hepatic tests were normal.
Ct scan showed a mass of 15 cms with necrosis at left hepatic lobe (figure 1).
Magnetic resonance imaging showed a tumor at left involving segments III
IVb with necrosis. Diferencial diagnosis with adenoma and fibrolamelar
carcinoma was done. A laparotomy was performed finding a big mass at III
IV b. intraoperative ultrasonography confirmed the finds and a segmentect-
omy of II, III, IV was performed. All abdominal cavity was normal.
Postoperative period was uneventful. Histology demonstrated embrionary
Hepatoblastoma (Fig. 2,3,4,5).
Conclusions. 1.-Hepatoblastoma is an uncommon tumor in adults. 2.-
Surgery is the only effective treatment in this kind of tumors despite the use of
systemic chemotheraphy or hepatic chemoembolithation.
PP 5.01
MANAGEMENT OF NECROTISING PANCREATITIS-INFECTED
OR NONINFECTED-AN INDIAN EXPERIENCE WITH RETRO-
SPECTIVE CORELATION WITH APACHE II SCORING
Trivedi, Dilip1; Trivedi, Mayuri2; Walawalkar, Rajeev2
1Sir H N Hospital, Mumbai, India; 2Sir H.N Hospital, mumbai, India
Aim. To study the outcome of protocolised management of infected/
noninfected necrotizing pancreatitis and correlate the outcome of the
treatment with Apache II scoring for judging the prognosis in the prospective
study in future.
Method. 67 cases of infected and noninfected pancreatic necrosis were
analyzed retrospectively with the apache II scoring criteria. All the patients
were investigated as per the protocol and the decision to start the conservative
or surgical method was taken as per the protocol. Some of the patients
needed 1- 4 surgical explorations. Necrosectomy and open cholecystectomy if
the patients’ condition permitted was done as surgery of choice in patients of
gallstone pancreatitis. In pancreatitis due to other etiology Cholecystectomy
was not mandatory. The outcome and the complications like secondary
bleeding and pancreatic fistula were analyzed. Various combinations of broad
spectrum antibiotics were used depending on the culture antibiotic sensitivity
reports of the pus from pancreatic necrosectomy. All the patients were given
enteral feeding in both the groups. In persistent infection prophylactic
proximal diversion of stool was used in 8 cases. Intensive care monitoring,
respiratory support and TPN were used judiciously whenever the need arose.
The total mortality was 22%. Long term follow-up was available in 60% of
the patients and the duration of long term follow up was from 1 to 8 years.
Conclusion. Protocolised management of necrotizing pancreatitis in a
tertiary care hospital with experienced team of doctors definitely improved
the results of necrotizing pancreatitis compared to an individual surgeon
managing this kind of patients occasionally. Apache II scoring will definitely
indicate the severity of necrotizing pancreatitis and give an indication of the
likely prognosis in a given situation. Pancreatic fistula is one of the dreaded
complications which are difficult to manage. As reported in literature we also
feel that gallstone pancreatitis probably has a better prognosis and outcom
PP 5.02
HOSPITAL CASELOAD IS A RISK FACTOR FOR MORTALITY IN
PATIENTS WITH ACUTE PANCREATITIS
Ellis, Matthew P; French, Jeremy J; Charnley, Richard M
Freeman Hospital, Hepato-Pancreato-Biliary Surgery, Newcastle upon Tyne,
United Kingdom
Background. Acute pancreatitis is associated with a significant risk of
mortality. Although specialist referral for selected patients is recommended in
international guidelines there is little data on the influence of hospital-related
factors on mortality.
Objective. To conduct a comprehensive assessment of the risk factors for
mortality in an observational study of AP in 18 hospitals within a
geographical area of population 3 million.
Methods. Extensive prospective data collection of clinical, radiological and
laboratory data. Multivariate logistic regression analysis was used to assess
the independent relationship of potential patient- and hospital-related risk
factors to observed mortality.
Results. Complete data was obtained from all 963 confirmed episodes of AP
which occurred during the study period, of which 228 (23.68%) were severe
according to the Atlanta criteria. Case mortality was 4.98% (48/963) for all
patients and 17.16% (46/228) for patients with severe AP. Independent risk
factors for mortality in the adjusted model were older age (likelihood ratio,
pB0.001), iatrogenic aetiology (p0.018), and low hospital caseload (p
0.012). A bimodal distribution of mortality against time to first intervention
was observed, the optimal window of opportunity for intervention occurring
in weeks 35 of admission. A non-significant trend of higher mortality was
observed following procedures which were carried out in non-specialist
centres (36.4%, 8 fatalities) than in the specialist centre (17.6%, 3 fatalities).
Conclusion. Severe AP continues to present a significant risk of mortality.
This large population-based study has, for the first time, identified that low
hospital caseload is associated with higher mortality in acute pancreatitis.
Formulation of precise guidelines for the specialist referral of selected groups
are therefore needed.
PP 5.03
AUTOIMMUNE PANCREATITS: STILL A CHALLENGING DIAG-
NOSTIC PROBLEM
Massani, Marco1; Caratozzolo, Ezio2; Recordare, Alfonso2; Bassi, Nicolo`2
1Regional Hospital, IV Dpt surgery, Treviso, Italy; 2
Background. Acute pancreatitis is an inflammatory condition with an high
incidence of morbidity that frequently represents a life threatening problem.
Over the last few years, thanks to radiological and biochemical improvement,
the number of idiopathic pancreatitis is decreased. The diagnosis of
autoimmune pancreatitis is now day quite common and is accepted that
treatment is based on medical therapy. But some reports of unnecessary
duodenopancreatectomy are still published.
Methods. In a cohort of 1026 patients with proven acute pancreatitis we
retrospectively reviewed our experience. We have considered 4 patients
(0,38%) with autoimmune pancreatitis. Three of whom (75%) had a
complete response to steroid therapy, one pt. relapsed (33,33%), the other
one needs a duodenopancreatectomy after one month of high dose steroid
therapy due to the persistence on cephalic mass mimicking an adenocarci-
noma.
Discussion. The diagnosis of autoimmune pancreatitis is possible when we
find the typical radiological apparency, with the so called sausage pancreas
with the irregularly narrowing pancreatic duct, and with high level of IgG and
IgG4 with presence of autoantibody revealed at biochemical test. Sometime
FNAC is helpful showing interlobular fibrosis with infiltration of lymphocyte
and IgG4 positive plasmacyte. Treatment should start as early as possible
with steroid’s high dose associated with antiproteases. Sometime the
diagnosis remain unclear and surgery has to be considered, only in these
situation, an option.
Conclusion. our data suggest that even in high volume center, the correct
diagnosis of autoimmune pancreatitis could still be difficult and that
sometime is possible only after ‘‘unnecessary’’ duodenopancreatectomy.
PP 5.04
METHODOLOGICAL PROBLEMS ASSOCIATED WITH THE L-
ARGININE-INDUCED EXPERIMENTAL PANCREATITIS
MODEL: EVIDENCE FOR NON-PANCREATITIS RELATED MOR-
TALITY
Jamdar, Saurabh1; Jeziorska, Maria2; Nirmalan, Mahesh2; Siriwardena,
Ajith3
1Manchester Royal Infirmary, Manchester, United Kingdom; 2University of
Manchester, Manchester, United Kingdom; 3Manchester Royal Infirmary,
Surgery, Manchester, United Kingdom
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Background. This investigation evaluates the degree of pancreatic injury
using three commonly utilised concentrations of L-arginine administered in
the L-arginine-induced experimental pancreatitis in the rat.
Methods. Adult male rats were divided into four groups at random as
follows: control (n7); 250 mg L-arginine per 100g body weight (n6);
300mg/100g (N6), 400mg /100g(n6). Pancreatitis was induced by intra-
peritoneal injection of L-arginine in pH-buffered sterile 0.15M saline. At 48
hours, all animals were sacrificed. Plasma was taken for lipase, amylase and
haematological indices and pancreata were fixed in formalin and stained with
haematoxylin and eosin. Pancreatic injury was assessed using a histological
injury scoring system. Data are presented as median (range) with analyses
being undertaken by non-parametric Mann-Whitney U-test accepting
significance at the PB0.05 level.
Results. The serum lipase in control animals was 5.5 (38) units/ml. In
comparison, lipase was significantly elevated in animals administered both
250 mg/100g bodyweight (12 [716] units/ml) (P0.02) and 300mg/100g
bodyweight (10 [716] units/ml) (P0.03) of L-arginine. There was no
difference in lipase levels between the 250mg and the 300mg groups (P
0.79). Histological injury scores were significantly increased in animals
receiving 250mg/100g body weight and 300mg/100g body weight of L-
arginine when compared to control. Animals receiving 400mg/100g body
weight of L-arginine died several hours after administration of L-arginine,
subsequent histology demonstrated almost no features of pancreatic injury
but confirmed chemical peritonitis.
Conclusions. There is a concentration dependent increase in the degree of
pancreatic injury in the L-arginine-induced experimental pancreatitis model.
At high concentrations mortality secondary to chemical peritonitis is a
feature.
PP 5.05
UPPER ABDOMINAL COMPARTMENT SYNDROME (UACS) IN
NECROTIZING SAP. TWO DIFFERENT STRATEGIES.
Plaudis, Haralds; Zeiza, Kaspars; Pupelis, Guntars
Clinical University Hospital ‘‘Gailezers’’, Surgery, Riga, Latvia
Introduction. Inflammatory fluid collections localised above the transverse
colon can severely affect pulmonary, renal and cardiovascular function due to
UACS. However urinary bladder measurements of the IAP can be incon-
sistent with clinical picture.
Objective. To demonstrate two cases of the UACS in necrotizing SAP with
different treatment strategies.
Methods. Case report.
Results. Patient 1. Necrotizing SAP developed in 37 year old male patient
after alcohol abuse. Serum lipase 1924 U/L, SIRS, asymmetric distension
and pressure pain of the upper abdomen, liver and metabolic dysfunction
were present on admission. Pulmonary, renal and haematological dysfunction
was observed two days later. CRP reached 656 mg/L. Urinary bladder IAP
measurements reached 14 mm Hg on day 8. Fiveorgan system MODS due
to UACS persisted despite laparocenthesis, ICU support therapy and
continuous veno-venouse haemofiltration (CVVH). Surgical decompression
and necrosectomy was performed on day 12. Repeated laparotomy and
ileostomy was necessary to manage colon fistula and retroperitoneal infec-
tion. Patient recovered after 5 month treatment. Patient 2. 55 year old male
patient suffered necrotizing SAP after alcohol abuse. Serum Lipase activity
was 3000U/L on admission. Renal, liver and haematological dysfunction
developed in 24 h. CVVH was started. Maximal CRP reached 444 mg/L on
day 3. Pulmonary, neurological and metabolic dysfunctions marked progres-
sion of MODS few days later. Moderate elevation of the IAP reaching 15
mmHg was observed. Resolution of MODS was evident on day 8. Hospital
stay was 22 days without need for surgical intervention.
Conclusion. Routine urinary bladder measurements of the IAP can be
inconsistent with the magnitude of the physiologic consequences in the
presence of UACS during the course of necrotizing SAP. Timely complex
ICU treatment including early CVVH can prevent progression of UACS and
MODS.
PP 5.06
MANAGEMENT OF BLEEDING PSEUDOANEURYSMS IN COM-
PLICATED PANCREATITIS.
Ðileikis, Audrius; Beiða, Virgilijus; Zdanyte¨, Elena; Jurevie`ius, Saulius;
Strupas, Kæstutis
Vilnius University hospital Santariðkiø klinikos, Abdominal surgery, Vilnius,
Lithuania
Background. Development of pseudoaneurysms and haemorrhage in
patients with pancreatic diseases is a rare but life-threatening condition.
Methods. We presented the data of 28 patients treated at the Abdominal
Surgery Center of Vilnius University Hospital Santariðkiø Klinikos for
bleeding peri/intrapancreatic pseudoaneurysms in the period from 1995 to
2006.
Results Sonoscopic duplex scanning provided for accurate determination of
pseudoaneurysms in 6 (54.5%) of 11 patients. Spiral CT angiography
determined correct diagnosis in 13 (92.8%) of 14 patients while common
CT scan with intravenous contrasting in 5 (50%) out of 10 patients.
Transcatheter angiography was performed for 16 patients resulting in
accurate diagnosis of pseudoaneurysm for 11 patients (68.7%). Transcath-
eter embolization of the impaired blood vessel was successfully performed for
6 (54.5%) patients during angiography. Most frequently pseudoaneurysms
developed in a. lienalis 12 (42.8%) and in a. pancreatoduodenalis 11
(39.3%). Seven patients (25%) with unstable hemodynamics and continued
bleeding were operated on immediately as emergencies. 22 (78.6%) patients
had pancreas resection performed, 4 (14.2%) underwent arterial ligation with
pseudocyst drainage, 1 (3.6%) patient undervent transcatheter embolisation
and debridment afterward and another one (3.6%) underwent transcatheter
embolization only. There was one case (4.5%) of recurrent bleeding following
pancreas resection, and two patients (50%) had recurrent hemorrhage after
arterial ligation and pseudocyst drainage.
Conclusions. Spiral CT angiography is considered to be the most accurate
diagnostic method in determining peri/intrapancreatic vascular pseudoaneur-
ysms. Transcatheter angiography and embolization is not always possible. We
consider embolization alone to be insufficient in case pseudoaneurysm has
already formed in the long chronic process and ruptured since the main cause
conditioning the development of pseudoaneurysm-pancreas irreversibly
changed due to inflammation-remains not eliminated.
PP 5.07
AN IMPROVED SURGICAL PROCEDURE IN PATIENTS WITH
SMALL DUCT AND DISTAL CHRONIC PANCREATITIS
Aramaki, Osamu1; Oida, Takatugu2; Mimatsu, Kenji1; Kawasaki, Atushi1;
Kuboi, Youichi1; Kanou, Hisao1; Amano, Sadao3
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Social Insurance Yokohama Central Hospital, Suregery, Yokohama, Japan;
3Nihon University School of Medicine, Surgery, Tokyo, Japan
Introduction. Small duct chronic pancreatitis has been regarded as a
classical indication for more extensive resection. We proposed herein a new
strategy for surgical treatment of small duct chronic pancreatitis based on the
resection of the tail of the pancreas combined with a caudal pancreatojeju-
nostomy pancreaticoplasty and sphincteroplasty.
Patients and Methods. Between 1996 and 2006, patients with severe pain
who were diagnosed with small duct pancreatitis (main pancreatic ductB7
mm) underwent the procedure. There are 6 major surgical steps: (1) A
Kocher maneuver, (2) mobilizing the spleen and the tail of pancreas, (3) the
resection of the tail of the pancreas, (4) Termino-lateral pancreaticojejunost-
omy (5) transduodenal sphincteroplasty, (6) transduodenal pancreatico-
plasty.
Results. No complications or mortality associated with the surgical
procedure were observed in the immediate postoperative period. Follow-up
ranged from 6 to 100 months and complete symptom control was achieved in
all patients.
Conclusion. In small duct and distal pancreatitis, our procedure is a safe,
minimally invasive, and effective.
PP 5.08
POLYMORPHISMS OF THE MCP-1 AND HSP70-2 GENES IN
KOREAN PATIENTS WITH ALCOHOLIC CHRONIC PANCREA-
TITIS
Lee, Sang Hyub1; Kim, Yong-Tae2; Ryu, Ji Kon2; Jeong, Ji Bong2; Lee,
Kyeung-Yeup2; Yoon, Yong Bum2; Hwang, Jin-Hyeok3
1Seoul National University Bundang Hospital, Department of Internal
Medicine, Seoul National University College of Medicine, Seongnam-si,
Gyeonggi-do, Korea, Republic of; 2Seoul National University College of
Medicine, Department of Internal Medicine and Liver Research, Seoul,
Korea, Republic of; 3Seoul National University Bundang Hospital, Depart-
ment of Internal Medicine, Seongnam-si, Gyeonggi-do, Korea, Republic of
Background. Although alcohol abuse is the most common cause of chronic
pancreatitis, alcoholic chronic pancreatitis (ACP) develops in only a small
number of alcoholics. Genetic factors may influence susceptibility. Monocyte
chemotactic protein-1 (MCP-1) j¡2518 and heat shock protein 70-2 (HSP70-
2) j¡1267 G alleles have been reported to be risk factors of severe acute
pancreatitis. However, their role in ACP has not been investigated. Our aim
was to determine whether their polymorphisms affect the susceptibility and
severity to ACP.
Methods. A genetic association study for susceptibility and severity was
performed on 79 male Korean ACP patients (49.8¡3411.2 years) and 82 male
controls (52.3¡3411.2 years). MCP-1 and HSP70-2 genotypes were deter-
mined using a fluorescence polarization detection method.
Results. The distribution of the MCP-1 A/A, A/G and G/G genotypes in
ACP patients was 12.7, 49.4 and 38.0%, respectively, and for HSP70-2 they
were 22.8, 58.2 and 19.0%, respectively. Genotype distributions were not
different in patients and controls (p0.93 and 0.41, respectively). In ACP
patients, the frequencies of the MCP-1 and HSP70-2 G alleles were 62.7%
and 48.1%, respectively, which was not different from those of controls
(p0.73 and 0.91, respectively). However, MCP-1 G allele revealed the
influence on the development of severe ACP, when its frequency was
compared between mild to moderate and severe ACP (29.6% vs. 56.0%,
p0.02).
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Conclusions. The MCP-1 and HSP70-2 polymorphisms do not play a
major role in the development of ACP in Koreans. However, MCP-1
polymorphism may be associated with the severity of ACP.
PP 5.09
ANTERIOR GASTROTOMY, CYSTGASTROSTOMY, PERCUTA-
NEOUS TRANSGASTRIC RETROPERITONEAL DRAINAGE AND
COMBINATION G-J TUBE FOR COMPLEX PANCREATIC PSEU-
DOCYSTS
Espat, Joseph1; Saied, Abdul2; Somasundar, Ponnandai2; Hering, Justin2
1Roger Williams Medical Center, Hepatobiliary Surgery, 825 Chalkstone
Ave, Prior 4, Providence, RI, United States; 2Roger Williams Medical
Center, Hepatobiliary Surgery, Providence, RI, United States
Background. Various approaches have been used to achieve complete
resolution of persistent complex pancreatitis-associated pseudocysts (PAP).
Particularly challenging are those PAP located near the pancreatic head.
While in recent years endoscopic and/or radiologic drainage has been in
vogue; approximately 4060% of patients will still require an operation.
Herein we describe our open operative approach.
Methods. The prospectively maintained departmental hepatobiliary data-
base was queried for the combined procedure codes of ‘‘cystgastrostomy,
retroperitoneal drainage and combined G-J tybe placement’’. Resultant
matches were then cross referenced against the electronic medical record
for the diagnosis of ‘‘alcoholic pancreatitis’’. Additionally, the data points of
PAC anatomic location, post-operative length of stay(LOS), time to enteral
feeding and image confirmed resolution at 90 days was collected.
Results. Over the interval 20032006, 17 patients meeting the above criteria
were identified; 12 patients had pancreatic body/tail associated collections
and 5 demonstrated pancreatic head/neck anatomic location. 17/17 had
undergone ERCP with pancreatic duct decompressive stent placement, 13/17
had undergone failed percutaneous radiologic drainage. 17/17 had demon-
strated persistent PAC despite interventions. The operative procedure of
laparotomy with cystgastrostomy performed via anterior gastrotomy, with
placement of a transgrastric peritoneal drain in combination with a G-J tube
placed floroscopically past the Ligament of Treitz was performed in all
patients. Median post op LOS was 7 days (range 413), 100% of patients
initiated J-tube enteral feeding 24 hours post procedure, 15/17 patient
demonstrated complete resolution of PAC on 90 day imaging (CT).
Conclusion. The described surgical approach is useful for patients with
persistent PAP to attain rapid hospital discharge, conversion to enteral
alimentation and 85% resolution of PAP.
PP 5.10
CHRONIC PANCREATITIS FOLLOWING ALCOHOL ABUSE.
Liyanage, Chandika1; Deen, Kemal2; Ariyaratne, Jayantha2
1Faculty of Medicine, University of Kelaniya, Department of surgery, Sri
Lanka, Ragama, Sri Lanka; 2Faculty of Medicine, University of Kelaniya,
Department of surgery, Ragama, Sri Lanka
Introduction. Unlike in the west the commonest cause for pancreatitis in Sri
Lanka is alcoholism. Chronic pancreatitis is the commonest sequale of acute
pancreatitis and gives rise to chronic pain, and pancreatic pseudocysts.
Objectives. To understand the aetiology and the quality of life including the
degree of pain and the outcome of interventions on patients with chronic
pancreatitis. Methodology: 19 patients who were diagnosed of having chronic
pancreatitis were followed up.
Results. 17/19(89%) of the patients had a history of heavy alcohol
consumption. 14/17(82%) of these patients had been consuming illicit
liquor. One had a history of gallstones and common bile duct stones. One
had a history of Caroli’s disease and one was diagnosed with an idiopathic
stricture. The commonest problem was severe pain which had an average of 6
in the visual analog pain score. 11 (58%) of patients had pancreatic
pseudocysts. One spontaneously ruptured. 2 underwent operative cystgas-
trostomy and one was drained under ultrasound guidance. Others were
managed conservatively while monitoring serial ultrasounds. The pain and
discomfort significantly regressed in patients who underwent therapeutic
interventions for symptomatic psedocysts. 5 patients had intractable pain
which required referral to a pain clinic. None had complex pancreatic
surgery.
Conclusions. Majority of this cohort had a history of illicit alcohol abuse. It
is possible that due to poor standards harmful compounds may be present in
local brew. Some patients benefited by surgical interventions. However
expertise pancreatic surgical care was not available for these patients. Almost
all patients were unable to get along with their vocation which emphasizes the
need for proper management of this benign but disabling condition.
PP 6.01
THE DIAGNOSTIC USEFULNESS OF FDG-PET AND DWI-MRI
FOR PANCREAS TUMORS
Arakawa, Yusuke
Tokushima University, Tokushima, Japan
Backgrounds. Not only the FDG-PET (fluorodeoxyglicose-positron emis-
sion tomography) but also DWI-MRI (diffusion-weighted imaging magnetic
resonance imaging) has been reported to be an innovative diagnostic tool for
various types of malignancies. The purpose of this study is to evaluate the
usefulness of FDG-PET and DWI-MRI for the correct diagnosis of pancreas
tumors.
Methods. Sixteen patients who underwent surgical removal of pancreatic
tumors were enrolled in this retrospective study. The SUV-max (Maximum
standardized uptake values) in FDG-PET and the ADC (apparent diffusion
coefficient) in DWI-MRI were used the following analyses. The mean follow-
up periods was 1.8years.
Results. There were 11 patients with pancreas carcinomas: invasive ductal
carcinoma (n9), intraductal pancreas mucinous carcinoma (n2), and 5
patients with benign tumor: intraductal pancreas mucinous adenoma (n2)
and insulinoma (n2). The mean SUV-max in FDG-PET was significantly
higher in pancreatic carcinomas (10.4) than other benign lesion (4.3) (pB
0.05). The mean ADC in DWI-MRI of pancreatic carcinoma (1.97I10
3) was significantly higher than benign tumor (2.7I103) (pB0.05).
Among the 4 patients with lymph node metastases, the detectability of FDG-
PET was 0/4 (0%), whereas that of DWI-MRI was 1/4 (25%). No significant
difference was observed in the relationship between SUV-max and patient
survival or pathological factors.
Conclusions. This study showed the potential usefulness of FDG-PET and
MRI-DWI in diagnosing benign or malignant natures in pancreas tumors,
although further collection and analysis of cases might be necessary.
PP 6.02
PANCREATIC HEAD MASS: IS A PREOPERATIVE DIAGNOSIS
ALWAYS NECESSARY?
Varma, Vibha1; Thumma, Venu Madhav2; Bheerappa, Nagari2; Sastry,
Regulagadda Adikesav2
1Nizam’s Institue of Medical Sciences, Department of Surgical Gastroenter-
ology, Hyderabad, India; 2Nizam’s Institute of Medical Sciences, Depart-
ment of Surgical Gastroenterology, Hyderabad, India
Background. Despite advances in imaging, differentiating a benign and
malignant pancreatic head mass is difficult.
Aim. Retrospective clinicopathological study of pancreatic head masses to
analyze the etiology and factors influencing final management.
Methods. Pancreatic head masses operated between June 2002 and June
2007 were studied. Standard protocol of investigations included side viewing
endoscopy and biopsy where indicated, contrast enhanced computed
tomography of abdomen, estimation of Ca 19-9 and endoultrasound (select
cases). Frozen done incase of diagnostic dilemma. Good risk patients with
operable lesion underwent resection even without a definitive diagnosis.
Results. Thirty five of 75 operated patients of head masses with uncertain
diagnosis formed the study group and were divided into: Group I with
associated chronic pancreatitis (20), while Group II without chronic
pancreatitis (15). In Group I, 10 each had inflammatory head masses and
malignancy on final histopathology. Of 8 Whipple’s resection for suspected
malignancy, 4 proved malignant finally. Two of 5 patients following Frey’s
procedure were malignant, frozen being negative in both. Rest had bypass
procedures, for advanced malignancy (4) or inflammatory mass (3). Frozen
was positive in 20% (1/10) patients with malignancy. In Group II, 7 were
benign and 8 malignant on final histopathology. Eleven underwent Whipple’s
resection for adenocarcinoma (5), focal pancreatitis (1), groove pancreatitis
(1), tuberculosis (1), Non Hodgkin’s Lymphoma (1), duodenal gastrointest-
inal stromal tumor (1) and cystic neoplasm (1). Median pancreatectomy was
done for cystic neoplasm in one. Others had palliative procedures. Frozen
was positive in 43% (3/7) patients with malignancy. No major complications
encountered after Whipple’s resection.
Conclusion. Definitive diagnosis was not possible in nearly half patients of
pancreatic head mass. Inability to distinguish benign from neoplastic disease
justifies the use of pancreaticoduodenectomy in appropriate setting.
PP 6.03
CLINICALLY AGGRESSIVE SOLID PSEUDOPAPILLARY TUMOR
OF THE PANCREAS
Nagatsuka, Ryousuke; Iki, Katsumichi; Urakami, Atsushi; Saitoh, Ai; Saitoh,
Ai; Tsunoda, Tsukasa
Kawasaki Medical School, Gastroentelorogical Surgery, Kurashiki, Japan
Solid pseudopapillary tumors (SPTs) are unusual neoplasms of the pancreas
of uncertain histogenesis that occur mostly in young women. Despite its low
malignant potential, proximately 15% of patients with SPT develop meta-
static disease. Even in the presence of disseminated disease, the clinical cause
is usually protracted, and overall 5-year survival is reportedly 97%. We have
encountered a case of SPT possessing unusual pathologic features. The
patient was a 35-year-old woman who had chemotherapy for malignant
lymphoma two years ago. She complained of an increase in abdominal girth,
mild abdominal pain, and constipation for a month. Laboratory workup
demonstrated normal pancreatic enzyme levels and liver function tests, and
serum CEA and CA19-9 were within normal range. Initial imaging
evaluation revealed a 7-cm mass in the body of pancreas. No masses were
identified in the liver. There was no evidence of lymphadenopathy. Fine
needle aspiration of the pancreas was performed with endoscopic retrograde
pancreatography and revealed Igpoorly differentiated malignant neoplas-
mIh. The patient underwent a pancreatic body resection with splenectomy.
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The postoperative recovery was unremarkable and adjuvant chemotherapy
has been performed for three month after operation. The pathologic features
of the tumor, which might have been indicative of its aggressive behavior,
included a diffuse growth pattern, extensive tumor necrosis, and significant
nuclear atypia. Immunohistochemically, the tumor cells were positive for ¿-1-
antitrypsin, synaptophysin, neuron specific enolase, CD56, and P53 protein,
but were negative for CD10, AE1:AE3, CAM2, and EMA. Markedly
increased MIB-1 expression and unusually high mitotic rate (50%/50
HPF) were also detected in the case. Although precise pathologic criteria
suggesting a high risk for aggressive behavior are uncertain, recognition of
some of the unusual pathologic features displayed in this case may be useful
in the prediction of potentially more aggressive SPTs.
PP 6.04
CANCER CELL DETECTION BY FLUORESCENT IN SITU HY-
BRIDIZATION FROM PERITONEAL FLUID IN RESECTABLE
PANCREATIC CANCER
Han, Sung-Sik1; Hwang, Dae Wook2; Lee, Seung Eun2; Jang, Jin-Young2;
Lee, Dong Soon3; Kim, Sun-Whe2
1National Cancer Center, Center for Liver Cancer, Goyang-si, Gyeonggi-do,
Korea, Republic of; 2Seoul National University College of Medicine,
Department of Surgery, Seoul, Korea, Republic of; 3Seoul National
University College of Medicine, Department of Laboratory Medicine, Seoul,
Korea, Republic of
Background. Detecting free tumor cells from peritoneal fluid in patients
with pancreatic cancer can be useful for predicting prognosis and choosing
the modality of adjuvant therapy. But there are few reports about the method
of effective detection.
Objectives. To identify the free cancer cells from peritoneal fluid with
cytology and fluorescent in situ hybridization (FISH) technique and to
investigate the prognostic significance through clinical correlation.
Methods. The patients who were suspected for pancreatic ductal adeno-
carcinoma were enrolled. Peritoneal washing was performed right after
laparotomy with normal saline and collected and preserved with fixative.
Post-operative drain fluid was collected on postoperative 2 day and preserved
with fixative. Peritoneal washing fluid and drain fluid were analyzed using
Papanicolau¡*s method and FISH with p53 probe. Immunohistochemistry
for p53, CEA, CA19-9 was performed with cell block. Cancer tissue was
examined using immunohistochemistry for p53, CEA, CA19-9 and FISH for
p53 probe. DNA was extracted from cancer tissue and sequencing was done
to find out mutation. Clinico-pathologic correlation with the results of the
fluid analysis was performed.
Results. The mean age of the 35 subjects was 61.3 years with a male/female
ratio of 2.2:1(24:11). Peritoneal washing fluid was collected in 30 patients.
FISH for p53 showed positive rate of 53.3%. Post-operative drain fluid was
collected in 35 patients. FISH for p53 showed positive rate of 51.4%. The
positive rate of the control group was 0%. Immunohistochemistry and FISH
for p53 in cancer tissue showed positive rate of 41% and 89.3% respectively.
Clinicopathologic analysis showed that patients with p53 FISH () for
peritoneal fluid tend to have more metastatic diseases.
Conclusion. FISH method is very useful for detecting free cancer cells from
peritoneal fluid in patients with pancreatic cancer. However, further studies
of larger scale using various probes are required to investigate the prognostic
significance.
PP 6.05
PANCREATIC HEAD LESION: DILEMMAS AND SOLUTIONS
Adhikari, Devbrata1; Singh, Rajinder2; Patil, Bhushan2; Bhange, Snehal2;
Shetty, Tilakdas2; Joshi, Rajeev2
1T. N. Medical College & B.Y.L Nair Ch Hospital, Dept of General Surgery,
A.L Nair Road, Mumbai, India; 2T.N Medical College & B.Y.L Nair Ch
Hospital, Mumbai, Dept of Surgery, Mumbai, India
Background. Differentiation between chronic pancreatitis and cancer is
difficult in pancreatic head lesions. Focal pancreatitis around small cancers
may cause them to be missed and 3% of cases with chronic pancreatitis
harbour malignancy.
Objective. To avoid a misdiagnosis and form a diagnostic and therapeutic
algorithm.
Method. 163 cases with pancreatic head lesions were analyzed between
February 1999 to July 2007. Diagnosis was based on clinical assessment,
USG, CT, tumour markers, MRI and EUS guided FNAC in select cases.
Result: 6 cases of cystic tumours and 3 cases of metastatic deposits, all of
whom underwent curative resection after definitive diagnosis.1 case of
lymphoma underwent chemotherapy. Presumptive diagnosis of mass due to
carcinoma or chronic pancreatitis and/or inflammation was made in 123
patients and 13 and 17 patients respectively. 29 of the 123 patients were
resectable and underwent pancreatico-duodenectomy. Preoperative tissue
diagnosis of carcinoma was confirmed in 18 cases while 10 were confirmed
postoperatively.1 resected patient turned out to be chronic pancreatitis. 59
non resectable patients underwent palliative surgical bypass and intra-
operative biopsy but malignancy was confirmed in only 38 patients. Of the
30 cases of benign head mass 11 patients underwent Frey’s procedure and
histopathology confirmed chronic pancreatitis.
Discussion. No diagnostic modality can, in isolation or in combination,
accurately differentiate between chronic pancreatitis and cancer. Pre opera-
tive tissue diagnosis is desirable but not mandatory provided the clinico-
radiological co-relation is strongly indicative.11 out of 29 patients underwent
resection without a tissue diagnosis and 1 proved negative, justifying an
approach based on the above concept.
Conclusion. Good clinico-radio-pathological correlation, appropriate ag-
gressiveness and resection even without or inspite of negative tissue diagnosis
if the clinical setting and imaging is typical, is justified.
PP 6.06
CENTRAL PANCREATECTOMY WITH PANCREATICOGAS-
TROSTOMY: A TECHNIQUE FOR THE RESECTION OF PAN-
CREATIC NECK LESIONS.
Ajit, Sewkani1; Sandesh, Sharma2; Saleem, Naik3; Dipak, Purohit3; Subodh,
Varshney3
1Bhopal Memorial Hospital & Research Centre, Department of Surgical
Gastroenterology, Bhopal, Bhopal, India; 2Bhopal Memorial Hospital &
Research Centre, Department of Surgical Gastroenterology, Bhopal, India;
3Bhopal Memorial Hospital & Reseach Centre, Department of Surgical
Gastroenterology, Bhopal, India
Background. Central pancreatectomy is a segmental pancreatic resection
indicated to remove benign or low-grade malignant tumors of the neck and
proximal part of the body of the pancreas. The main advantage of this
operation compared with major resections is that it permits to spare normal
pancreatic parenchyma; moreover, spleen and upper digestive and biliary
tracts are saved. It has been used sparingly because the spectrum of
indications is quite narrow. Although historically used for traumatic
pancreatic transection and chronic pancreatitis, it currently is reserved for
selective management of pancreatic neck lesions that are benign or have low
malignant potential.
Case Summary. A 62 years female presented with pain in abdomen with
loss of appetite and weight, on routine evaluation found to have mass in body
of pancreas. On cross sectional imaging a 1.11.3 cm mass lesion in
proximal body in close proximity with main pancreatic duct was confirmed.
Her CA 19-9 and chromogranin A levels were normal. On exploration
pancreatic mass in proximal body/neck found which was anterior to superior
mesenteric vein and artery. A central pancreatectomy was performed with
suture ligation of proximal stump and distal pancreatico-gastrostomy. Frozen
section suggestive of serous cystadenoma with free margin.
Conclusion. When technically feasible, central pancreatectomy is a safe,
pancreas-preserving pancreatectomy for non-enucleable benign pancreatic
pathology confined to pancreatic neck that allows for cure of the disease
without loss of substantial amount of pancreatic parenchyma & preservation
of exocrine/endocrine functions. Caution is necessary when using central
pancreatectomy in the treatment of pancreatic neck lesions. Surgeon
experience is of utmost importance in this decision-making process as well
as the technical aspects of central pancreatectomy. The precise role of central
pancreatectomy in the management of benign or lowmalignant potential
lesions of the neck of the pancreas remains in evolution.
PP 6.07
INTRAOPERATIVE GLUCOSE MANAGEMENT IN PANCREATIC
SURGERY
van Samkar, Gan1; Stoker, Sharon2; Preckel, Benedikt1; Hollmann, Markus1
1AMC University Hospital of Amsterdam, Anesthesia, Amsterdam, Nether-
lands; 2University of Amsterdam, Amsterdam, Netherlands
Background. Poor intraoperative glucose control has been associated
with worsened hospital outcome in patients undergoing cardiac surgery
(1;2). Intensive insulin therapy in critically ill patients has shown
beneficial effects, reducing morbidity and mortality(3). Little is known about
the effect of glucose control in pancreatic surgery. We retrospectively
analyzed if patients undergoing pancreatic surgery experienced hyperglyce-
mic episodes during this procedure and the effect of insulin therapy on
glucose levels.
Methods. data were collected from the electronic database: 2004, 2005,
2006 (Whipple operations). Hyperglycemia was defined as7.0 mmol/L
(126mg/dL). Glucose management, sampling time, frequency, time delay to
sample after induction of anesthesia, therapeutic intervention and the result
of intervention were scored.
Results. In total, 156 patients underwent pancreatic surgery, from which 63
patients had a normal glucose and 89 patients (57%) were hyperglycemic. In
4 patients, no glucose levels during the operation were recorded. Of the 89
hyperglycemic patients, only 18 patients were treated with Insulin. In only 7
patients Insulin therapy resulted in normoglycemia. In the 69 untreated
hyperglycemic patients, 8 patients had glucose levels of 9.0 mmol/L. In 5%
of patients, the first glucose sample was taken within 30 minutes after
induction of anesthesia. In all others, the delay to first measurement was60
minutes. (range: 70  300 minutes).
Conclusion. Sampling of glucose levels occurred infrequently and often
delayed. The majority of hyperglycemic patients (glucose7.0 mmol/L) was
not sufficiently treated with Insulin. Only 38% of the treated patients showed
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normoglycemia. For patients at risk, such as pancreatic surgery, studies
should address whether frequent glucose sampling and sufficient treatment of
hyperglycemia might improve perioperative outcome. We should sample after
induction of anesthesia, and at least at hourly intervals in the case of
hyperglycemia or insulin therapy in patients at risk
PP 6.08
TOTAL PANCREATECTOMY FOR INTRADUCTAL PAPILLARY
MUCINOUS TUMOURS OF THE PANCREAS
Spalding, Duncan1; Behranwala, Kasim2; Alaee, Farhang2; Williamson,
Robin2
1Hammersmith Hospital, HPB Surgery, Du Cane Road, London, United
Kingdom; 2Hammersmith Hospital, HPB Surgery, London, United King-
dom
Introduction. Total pancreatectomy (TP) is rarely performed for pancreatic
ductal adenocarcinoma due to its associated morbidity and poor prognosis.
Although increasingly recognised, the correct surgical management of
intraductal papillary mucinous tumours (IPMT) of the pancreas remains
controversial. Total pancreatectomy is increasingly performed on the basis
that these tumours are characterised by extensive intraductal spread and have
a favourable outcome even when presenting at an invasive stage. The aim of
this study was to assess the role of TP in the surgical treatment of patients
with IPMT.
Methods. Pancreatic resections were performed on 10 patients with IPMT
between 20012005. Histology and the clinical outcome were reviewed.
Results. There were 6 men and 4 women of median age 68 (range 5875)
years. Five patients underwent a pylorus-preserving proximal pancreatectomy
(PPPP), one had a Whipples procedure with inclusion of the body of
pancreas and 4 had a TP depending on operative and frozen-section findings.
Histology revealed benign IPMT (n2), invasive mucinous adenocarcinoma
(n8), positive lymph nodes (n4) and positive resection margins
(pancreatic intraepithelial neoplasia [n2]). There was no operative
mortality and morbidity was equivalent between PPPP and TP (27.5% vs
25%). Six patients had adjuvant chemotherapy (gemcitabine and cisplatin).
At a median follow-up of 9 (range 780) months, one patient had died of
recurrent disease at 18 months (PPPP and positive resection margin) and 1
patient had evidence of recurrence at 11 months but was alive and well at 80
months after further chemotherapy (PPPP and negative resection margin).
Eight patients have remained disease free.
Conclusions. TP should be considered as an effective treatment for IPMT
with extensive involvement in order to achieve complete resection.
PP 6.09
SOLID PSEUDO-PAPILLARY TUMOR OF THE PANCREAS PRE-
SENTING AS HEMATEMESIS
Apostolidis, Stelios; Zatagias, Akis; Papavramidis, Theodossis S.; Michalo-
poulos, Antonis; Papadopoulos, Vassilis N.; Paramythiotis, Daniel; Harlaftis,
Nick
AHEPA University Hospital, Aristotles’ University of Thessaloniki, 1st
Propedeutic Surgical Department, Thessaloniki, Greece
Background. Solid pseudo-papillary tumors (SPTs) of the pancreas are rare
and typically present in young female patients. They are slowly growing
masses, that may attain large size, and of low malignant potential. Surgical
resection is curative in most of the cases
The present case is extremely interesting because it concerns a small SPT of
the head of pancreas which present with a episodes of hematemesis.
Case Report. The present case concerns a 71 years old female with a small
SPT of the head of the pancreas. The patient presented to the emergency
department with an episode of hematemesis but otherwise hemodynamically
stable. Emergency gastroscopy revealed a bleeding mass projecting to the
duodenum. Fluid, blood and electrolyte resuscitation followed. CT revealed a
small mass in the head of the pancreas. A typical Whipple operation was
performed. The pathological features of the tumor were compatible with an
SPT. The postoperative course of the patient was uneventful and today, a year
after the operation, no recurrence of the disease is present.
Conclusion. International literature supports the concept that complete
surgical excision offers benefits in almost all patients. SPTs are of low-grade
malignancy and are potentially curable by extended resections of the primary
tumor mass.
PP 6.10
EVALUATION OF POSTOPERATIVE COMPLICATIONS IN PA-
CREATICODUODENECTOMY AT SHIKOKU CANCER CENTER
HOSPITAL
Ohta, Koji; Tanada, Minoru; Kurita, Akira; Takashima, Shigemitsu
Shikoku Cancer Center Hospital, Mastuyama, Japan
We evaluated postoperative complications in pancreaticoduodenectomy. 41
patients underwent pancreaticoduodenectomy between 2001 and 2006 at the
Shikoku Cancer Center Hospital. The subjects were 16 pancreatic, 9 bile
duct, 4 duodenal, 4 papillary, 1 gastric cancer, and 4 benign tumors including
intraductal papillary-mucinous tumor. Pancreaticoduodenectomy(PD) was
performed in 27 cases with pancreaticojejunostomy, and pylorus preserving
pancreaticoduodenectomy(PPPD) was done in 14 cases with pancreatico-
gastrostomy. Mean intraoperative blood loss was 1180g in PD and 995g in
PPPD. The mean operative time was 441 minutes in PD and 377 minutes in
PPPD. No operative mortality was recognized during this period. The
postoperative complications in PD were recognized in 11 cases (40.7%), with
the most common complications being pancreatic fistula (n5), early
delayed gastric emptying (n2), and bowel obstruction (n2). The post-
operative complications in PPPD were recognized 9 cases (64.2%), with the
most common complications being early delayed gastric emptying (n8) and
pancreatic fistula (n3) Median postoperative length of hospital stay was 29
days in PD and 35 days at PPPD. Pancreaticoduodenectomy can be
performed safety. But many complications occurred and prolonged post-
operative length of hospital stay.
PP 6.11
EFFECTS OF WIRSUNG-PANCREATICO-GASTRIC ANASTO-
MOSIS FOLLOWING PANCREATICODUODENECTOMY: A SIN-
GLE CENTER EXPERIENCE
Prete, Francesco; Vincenti, L; Basile, R; Nitti, P; De Renzo, D; Preziosa, G;
Prete, F
University of Bari School of Medicine, Department of Surgery, Bari, Italy
Introduction. Management of the pancreatic stump following pancreatico-
duodenectomy (PD) is a source of concern among pancreatic surgeons. The
ideal choice of anastomosis remains a matter of debate. Aim of the present
study is to ascertain the effect of the wirsung-pancreatico-gastrostomy
(wPGA) after pancreaticoduodenectomy through a single surgeon’s experi-
ences.
Materials and methods. Since 1998 our model of treatment of the
pancreatic stump switched from PGA to wPGA. From January 1998 to
March 2007, 101 patients were perspectively and consecutively treated with
wPGA after PD. After opening only the seromuscular layer of the posterior
gastric wall, sparing the mucosa, the inferior border of the pancreatic stump is
sutured to the inferior border of the gastric opening. Then a small incision is
performed on the posterior aspect of the exposed gastric mucosal layer. A
small drain, the distal extremity of which is inserted in the wirsung duct, is
anchored to the nasogastric tube (retrieved through the mucosal incision),
and then retracted together with it through the stomach. The anastomosis
between the pancreatic parenchyma and the muscular layer of the stomach is
completed. The wirsung duct drain is removed on the VIIVIII postoperative
day.
Results. The overall mortality (30 days) was 2/101 (1.9%), the overall
morbidity (including late morbidity) was 5/101 (4.9%), while the anasto-
mosis-related morbidity and mortality were 0%. Since 2001 there was no
perioperative mortality. No pancreatic leakage was reported. The mean
postoperative stay was 12 days.
Conclusions. In our experience this technique was a technically reprodu-
cible and safe method to prevent complications after pancreaticoduodenect-
omy.
PP 7.01
HEPATIC TUBERCULOSIS MIMICKIN METASTASES IN A PA-
TIENT WITH COLORECTAL CANCER.
Morales, Dieter1; Garcia de Polavieja, M2; Carrasco, M2; Figols, FJ2;
Madrazo, C2; Casanova, D2; Ortega, C2; Vega, ME2; Naranjo, A2
1University Hospital "Marque´s de Valdecilla", Department of Surgery,
Santander, Spain; 2
Introduction. Hepatic tuberculosis is very uncommon and usually its
consequence of lung tuberculosis infection. We report the case of a patient
with colorectal cancer and hepatic metastases with histological diagnosis of
adenocarcinoma and hepatic tuberculosis simultaneously.
Case Report. 67 year old male with history of radical surgery for colorrectal
cancer and two liver metastases at IV, V operated in other hospital. He also
had two hepatic metastases at segments VII and VIII didn?t removed at this
moment. Histological study showed colorectal adenocarcinoma
T4N1M1(hepatic). Postoperative CEA was normal. The patient was
included in a Phase III study with chemotheraphy and the CT scan showed
two hepatic metastases at segments VII-VIII. He was admitted at our unit for
surgery of this hepatic metastases. Pre-operative CT scan showed two hepatic
injuries, one of this has decreased its size, with low density without gain of
contrast (figure 1). Right hepatectomy was performed and the histological
study showed hepatic tuberculosis, but not adenocarcinoma.
Conclusions. 1.-Coexistence of hepatic tuberculosis with colorectal cancer
metastases is very uncommon. 2.- Pain, fever and miliar spread is typical of
hepatic tuberculosis. 3.- Ultrasonography and CT scan hypoechogenic
images without contrast change are typical of hepatic tuberculosis.
PP 7.02
ARTERIAL EMBOLIZATION FOLLOWING PORTAL VEIN
OCLUSSION CAN INCREASE RESECTABILITY OF HEPATIC
METASTASES FOR COLORECTAL CANCER
Ardiles, Victoria; Bregante, Mariano; Salceda, Juan; Fernandez, Diego;
Pekolj, Juan; de Santiban˜es, Eduardo
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Background. Portal occlusion has been shown to be an effective method for
increasing the resectability of liver metastases from colorectal cancer.
However, when the liver parenchyma does not grow enough, it is possible
to embolize the ipsilateral hepatic artery in order to increase hypertrophy.
Objective. To analyze our experience in sequential ipsilateral portal and
arterial occlusion for the treatment of liver metastases from colorectal cancer.
DESIGN: Retrospective cohort study.
Materials and Method. Five men, mean age: 59, with liver metastases from
colorectal cancer initially irresectable due to small remnant liver volume.
Preoperative portal embolization and IV chemotherapy were performed. As
remnant liver volume/patient?s weight ratio wasB0.8, arterial embolization
was carried out. Right hepatic artery was selectively embolized. Follow-up
was performed with hepatic CT scan.
Results. Hypertrophy of the left lateral segment was observed in all patients.
Three patients underwent a right hepatectomy. Because two patients showed
disease progression, surgery was not performed. A patient was reoperated on
for a hemoperitoneum. Mean ICU stay and hospital stay were 2 and 6 days,
respectively. Resected patients are disease-free with a follow-up of 312
months.
Conclusions. Arterial embolization following ipsilateral portal occlusion can
increase resectability of liver metastases from colorectal cancer.
PP 7.03
HEPATIC LYMPH NODE DISSECTION PROVIDES A SURVIVAL
BENEFIT FOR PATIENTS WITH NODAL DISEASE OF COLOR-
ECTAL CARCINOMA LIVER METASTASES
Wakai, Toshifumi; Shirai, Yoshio; Sakata, Jun; Korita, Pavel; Takizawa,
Kazuyasu; Hatakeyama, Katsuyoshi
Niigata University Graduate School of Medical and Dental Sciences,
Division of Digestive and General Surgery, Niigata City, Japan
Background. The issue whether hepatic lymph node dissection is efficacious
for nodal disease of colorectal carcinoma liver metastasis is yet to be resolved.
The aim of this study was to define the role of hepatic lymph node dissection
in the surgical management of patients with resectable colorectal carcinoma
liver metastases.
Methods. Seventeen of 130 consecutive patients who had hepatectomy for
colorectal carcinoma liver metastases underwent concomitant lymphadenect-
omy for suspected nodal metastasis. A total of 217 lymph nodes were
examined histologically for metastases. The therapeutic value index of
hepatic lymph node dissection was estimated by multiplying the prevalence
of hepatic lymph node metastases by the 5-year survival rate of patients with
hepatic lymph node metastases. The median follow-up time was 98 months.
Results. Overall cumulative 5-year survival rate after resection was 24%
(median survival time, 20 months). Lymph node metastases were detected in
10 patients: hepatic lymph node metastases (four patients), distant lymph
node metastases (three patients) and both lymph node metastases (three
patients). Of the 10 patients with lymph node metastases, two patients
survived for 10 years despite the involvement hepatic lymph node. The
prevalence and 5-year survival rate for patients with hepatic lymph node
metastases were 50% and 29%, respectively. Thus, the therapeutic value
index of hepatic lymph node dissection was 14.5.
Conclusions. The application of hepatic lymph node dissection is justified
for patients with suspected nodal disease. Hepatic lymph node dissection
provides a survival benefit for some patients with nodal disease of resectable
colorectal carcinoma liver metastases.
PP 7.04
SEGMENT-ORIENTED APPROACH TO LIVER RESECTION
Kostov, Daniel; Ivanov, Valkan
Naval Hospital, Clinic of General Surgery, Varna, Bulgaria
Introduction. Aims of liver resection are to resect the liver with minimal
bleeding and leaving adequate functional liver.
Objective. We present our experience in the rationale and techniques of
segment-oriented approach to liver resection and assess the technical and
oncologic results of anatomic segmentectomies.
Methods. From 166 liver resection, 64 cases (38%) have included 1, 2 or 3
adjacent segments. There were 18 monosegmentectomies, 7 right posterior
sectionectomies (segments 6 and 7), 4 right anterior sectionectomies
(segments 5 and 8), 4 right inferior bisegmentectomies (segments 5 and 6),
12 central hepatectomies (segments 4,5 and 8 91), 2 central posterior
bisegmentectomies (segments 4a and 8), 6 central anterior bisegmentec-
tomies (segments 4b and 5) and 11 left lateral sectionectomies (segments 2
and 3). Indications were hepatocellular carcinoma (n4), Klatskin tumor
(n2), gallbladder carcinoma (n2) and liver metastases due to different
diseases: colorectal carcinoma (n49), mammary carcinoma (n2), malig-
nant melanoma (n1), gastric carcinoma (n2), pancreatic head carcinoma
(n2). Intraoperative ultrasound had been used to achieve anatomic
resection.
Results. Mortality, transfusion, and morbidity rates were 1,5%, 22%, and
24%, respectively. Mean section margin was 7mm (range 135mm). Isolated
intrahepatic recurrence occurred in 12 patients (18%), and 4 (6%) under-
went repeat hepatectomy.
Conclusion. Segment-oriented liver resection is a distinct surgical approach
and represents the complexity of hepatic surgery. This operative procedure is
a safe alternative to extensive liver resection in selected patients.
PP 7.05
RELATIONSHIP BETWEEN METACRHONOUS COLORECTAL
LIVER METASTASES AND NODE STATUS OF PRIMITIVE TU-
MOR.
La Greca, Gaetano1; Sofia, Maria2; Li Destri, Giovanni3; Mosca, Francesco3;
Lombardo, Rosario2; Zappala`, Orazio4; Fichera, Simona5; Puleo, Stefano2
1University of Catania, Dep Surg Sci Org Transp Adv Tech, Catania, Italy;
2University of Catania, catania, Italy; 3University of Catania, Italy; 4Univerity
of Catania, Catania, Italy; 5University, Catania, Italy
Background/Aims. The golden point in colorectal liver metastases should
be to establish which patient are at risk to develop liver metastases and what
we have to do to find and treat this metastases in a very early stage. Aim of
this work is to evaluate retrospectively how positive nodes in colorectal
specimen have been predictive for the development of liver metastases in our
patients.
Materials and Methods. All patients submitted to R0 resection for
colorectal cancer in the period January 1999-December 2003 were con-
sidered retrospectively. Age, sex, site of tumor and type of resection, Aster-
Coller classification, number of nodes in surgical specimen, ratio of
metastatic nodes and disease free interval were considered.The patients
were followed-up in order to evaluate the development of liver metastases, in
relation to the presence of positive node in the surgical specimen of colorectal
resection.
Results. We analysed 221 patients submitted to R0 colonic resection for
colorectal cancer: 118 were male and 103 female with a median age of 69.8
years (range 2689). According with the Aster-Coller classification the
patient were 113 in B2 stage and 108 in C stage. In the group of patients
in B2 stage 67 are alive without disease after 5 years, the remnants developed
liver metastases and/ or other recurrence. The number of examinated nodes
in this group of patients, are respectively 11.4 for patients that didn’t
developed metastases and 14.3 for patients that developed metastases. In the
group of patients in C stage 34 patients are free from disease, in this group the
positive nodes ratio was 1 N/3.6 (0.28). In the 72 patients that developed
liver metastases the nodes ratio was 1N/2.7 (0.37).
Conclusions. Our results show that also in patients in B2 stage, liver
metastases occur, so only the number of nodes is not enough to predict the
development of metastases. Other factors related to biological aspect of the
primitive tumor or to immunological status of the patients could influence
the liver recurrences.
PP 7.06
EFFECTIVENESS OF FONG’S SCORE AND LAPAROSCOPIC
EXPLORATION TO ASSESS THE RESECTABILITY OF META-
CHRONOUS COLORECTAL LIVER METASTASES.
La Greca, Gaetano1; Li Destri, Giovanni2; Sofia, Maria1; Portale, Teresa
Rosanna1; Di Benedetto, Fabrizio1; Vicari, Salvatore1; Latteri, Saverio1;
Russello, Domenico1; Puleo, Stefano1
1University of Catania, Catania, Italy; 2Uniuversity of Catania, Castania,
Italy
Background/ AIMS:The resectability of liver metastases is usually assessed
by imagine techniques, intraoperative ultrasonography or preoperative
ultrasound laparoscopic exploration, and the Fong’s clinical score can be
used to predict the prognosis of patients. Aim of this retrospective study was
to establish the effectiveness of the Fong’s risk score to predict the rate of
resectability and if laparoscopic exploration with ultrasonography can
considerably reduce the number of useless laparotomies.
Materials and Methods. in the period January 1997-January 2003 in all
patients with colorectal liver metases was calculated the Fong’s clinical score
and a statistical analysis was performed to evaluate the relation score-
resectability, the probability of unless laparotomy in related to the score and
the Fong’s factor that better predict the resectability. None of the patients was
submitted to preoperative laparoscopic exploration.
Results. we have observed 47 patients, eligible for liver resection. The Fong’s
score was calculated and the patients submitted to liver resection were: all
patients with score 0 (100%), 10/14 (76.9%) with score 1, 7/12 (58.3%) with
score 2, 4/6 (66.6%) with score 3. No patient had score 4 o 5. The statistical
analysis showed a not significant relationship between the level of the score
and the resectability (p0.4056), but the probability of useless laparotomy in
relation to the score range from 0.07 for score 0 to 29.4 for score 2. The best
parameter that influence the assessment of not resectability is the CEA. The
use of lapascopic exploration could spared 12% of unless laparotomies in the
subgroup of patients with score 01, and 39% in the subgroup with score 23.
Conclusions. our study show that a high Fong’s score, especially the CEA
positivity should be considered in the evaluation of not resection of colorectal
liver metastases. Moreover the preoperative laparoscopic exploration could
avoid useless lapatomies.
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SYNCHRONOUS EXTRAHEPATIC DISEASE DOES NOT CON-
TRAINDICATE HEPATECTOMY FOR COLORECTAL LIVER ME-
TASTASES
Yeluri, Sashidhar; Prasad, K Rajendra; Gomez, Dhanwant; Malik, HZ;
Lodge, J Peter A; Toogood, GJ
St. James’s University Hospital, Department of HPB and Transplant Surgery,
Leeds, United Kingdom
Background. The presence of extra hepatic disease (EHD) is traditionally
considered to be a contraindication for hepatic resection in patients with
colorectal hepatic metastases (CRLM). The aim of the present study is to
report the long term outcome following aggressive surgical resection in
CRLM patients with synchronous resectable EHD. The secondary aim is to
identify prognostic factors that impact on long-term outcome in these
patients.
Methods. CRLM patients with synchronous EHD were identified from a
prospectively maintained database. Data analysed included demographics,
operative and pathological factors. Irrespective of the number of metastasis,
each EHD location was counted as one lesion.
Results. 25 patients were included, of which 12 were identified intraopera-
tively as having EHD. 32 EHD sites were identified in these patients; the
most common affected sites being pulmonary and diaphragmatic involve-
ment. 16 patients with EHD underwent simultaneous resection at the time of
hepatectomy, whilst 7 patients with distal metastases underwent resection at a
later date. 2 patients underwent pulmonary resection for EHD prior to
undergoing hepatectomy. Overall morbidity was 19% and there was 1 peri-
operative death. The 1, 3 and 5 year overall survival was 83%, 34% and 14%,
respectively.
Conclusion. In selected cases, an aggressive approach in resecting EHD may
lead to prolonged disease-free and overall survival.
PP 7.08
THE RESULTS OF TREATMENT THE COLORECTAL METAS-
TASES TO THE LIVER BY USING DIFFERENT METHOD.
Musiewicz, Marcin; Ciosek, Jakub; Lampe, Pawel; Mrowiec, Slawomir
Medical University of Silesia, Department of Gastrointestinal Surgery,
Katowice, Poland
Introduction. The liver resection is still conventional but radical treatment
of metastases of colorectal cancer. In recent years, there has been observed an
increasing interest in ablation technique in treatment of nonresection
metastases.
Material and Method. 528 patients with liver tumour, who had undergone
treatment from January 1990 to June 2005, were studied. 170 patients with
colorectal cancer metastases of a liver were included in the study. There were
performed: 48 hemihepatectomies, 80 segmentectomies or cone resections,
12 ablation procedures, 13 cannulation of hepatic artery and 17 explorative
laparotomy. The final results of resection or ablation were obtained from 134
patients and they were divided into three group: I group including 48 patients
after hemihepatectomy, II group including 80 patients after segmentectomy
or cone resection, III group including 12 patients who had undergone
ablation.
Results. The intraoperative blood loss was highest in case of I group where it
was 725 ml (3003600mI) in comparison with II group with 280 ml (150
2500 mI) and III group with 150ml [0400ml]. The postoperative complica-
tions were observed more often in case of I group-20 [42%] patients than in
case of II group 24 [30%] patients and III group 1 [8%] patient. The
perioperative mortality was more frequent in case of I group -8.3% [4
patients] in comparison with II group-3,75% [1 patient] and III group-8% [1
patient]. The average duration of hospitalisation after surgery was longer in I
group [23 days] than in II group [16 days] and III group [8days]. The three-
year survival rate was 37% in case of group I and 31% in case of group II;
five-year survival rate was 21% in group I and 25% in-group II.
Conclusions. The result after surgical treatment of colorectal metastases
depends on an extent of liver resection. The ablation is a safe alternative
method of treatment in the selected group of patients who have not been
qualified to a resection procedure.
PP 7.09
MICROWAVE ABLATION IS AN EFFECTIVE METHOD OF
TREATING PATIENTS WITH UNRESECTABLE COLORECTAL
LIVER METASTASES.
Bhardwaj, Neil1; Strickland, Andrew D1; Ahmad, Fateh1; El abassy,
Moshier2; Lloyd, David M1
1Leicester Royal Infirmary, Department of Hepatobiliary Surgery, Leicester,
United Kingdom; 2Leicester Royal Infirmary, Department of Radiology,
Leicester, United Kingdom
There are many thermal methods available to treat unresectable colorectal
liver metastases. Microwave tumour ablation (MTA) is fast becoming an
acceptable method to destroy these tumours. Other modalities such as
cryoablation and radiofrequency suffer from high complication or recurrence
rates. AIMS To assess the efficacy of MTA to treat unresectable colorectal
liver metastases.
Methods. Twenty-five consecutive patients surviving greater than 1 year
post-ablation were included in this study. A total of 80 tumours (mean
21mm; range 862 mm) were ablated. All patients underwent pre- and post-
operative cross sectional imaging. The majority of patients were treated
between 24 minutes at 150W by the single insertion of the applicator.
Fifteen patients had a concomitant liver resection and MTA and ten had
MTA alone.
Results. No bile duct injury, abscess formation, bleeding or microwave
related complications were observed. Fourteen patients are alive post ablation
of whom 7 are disease free (mean f/u 27 months; range 12  41), 7 are alive
with distal intra-hepatic tumour recurrence (mean f/u 35 months; range 18
48), of whom 1 patient also has local recurrence at the treated site, probably
due to their tumour in close proximity to major hilar vessels. Of those with
recurrence, 86% of patients are alive more than 2 years post ablation. Eleven
patients died; surviving an average of 25 months (range 1241 months).
Discussion MTA is safe, efficient and an effective treatment option for
patients with unresectable colorectal liver tumours. The low local tumour
recurrence (1.25%) and complication (0%) rate are extremely encouraging
and compare favourably to other treatment options.
PP 7.10
LARGE UNRESECTABLE LIVER TUMOURS TREATED SUC-
CESSFULLY WITH MICROWAVE ABLATION.
Bhardwaj, Neil1; Strickland, Andrew D2; Ahmad, Fateh2; Elabassy, Mosh-
ier3; Lloyd, David M2
1University Hospital Leicester Royal Infirmary, HPB surgery, 6th floor
Balmoral Building, Infirmary square, Leicester, United Kingdom; 2Univer-
sity Hospital Leicester Royal Infirmary, HPB surgery, Leicester, United
Kingdom; 3University Hospital Leicester Royal Infirmary, Radiology, Leice-
ster, United Kingdom
Introduction. It has always been a challenge to treat large unresectable liver
tumours. Radiofrequency (RF) and cryoablation are often unsuccessful in
gaining local control over tumours greater than 3cm. Microwave tumour
ablation (MTA) can be a successful alternative as it may be more effective.
AIMS To assess the efficacy of MTA to treat unresectable tumours greater
than 3cm.
Methods. 17 consecutive patients with either single or multiple unresectable
tumours measuring at least 3cm or above were included. All patients
underwent pre-operative cross-sectional imaging. A total of 48 lesions were
treated, 26 of which were 3cm or greater (mean 3.9cm; range 37cm). Fifteen
patients had colorectal liver metastases, 1 patients had a HCC and 1 a
parathyroid carcinoma metastasis. Most tumours were treated with 150 Watts
of power for 2  3 minutes by a single insertion of the applicator. All
treatments were monitored in real time with IOUS and temperature
monitoring. Eight patients underwent MTA alone and nine patients under-
went a concomitant liver resection along with MTA. All patients underwent 3
monthly cross-sectional imaging post-operatively.
Results. No ablation related complications such as bile leaks, abscess
formation or bleeding were reported. Eight patients are alive of whom 4
are disease free (mean 34 months; range 1841). Four have distal intra-
hepatic recurrence of disease (mean 40 months; range 3248) of whom one
also has local tumour recurrence at the ablation site. Nine patients died
(mean 19 months; range 1242) of either hepatic or extra-hepatic disease
progression, none had evidence of local recurrence on their latest scan.
Discussion All patients treated were initially declared inoperable prior to
coming to our centre and over 60% were alive more than 2 years post-
ablation. MTA safely produces complete tumour ablation of large liver
tumours without the need for multiple insertions of the applicator. The local
tumour recurrence rate of 2% compares favorably to RF and cryoablation.
PP 8.01
INFANTILE HEPATIC VASCULAR TUMORS: TREATMENT OP-
TIONS
Kotru, Anil1; Kotru, Anil1; Chapman, William2; Lowell, Jeff3
1Geisinger Medical Center, Organ Transplantation, Danville, United States;
2Washington University in St Louis, Saint Louis, United States; 3Washington
University in Saint Louis, Organ Transplantation, Saint Louis, United States
Hepatic vascular tumors (HVT) are the most common benign liver tumors
present in infancy and childhood commonly associated with high output
cardiac failure. The most common is infantile hemangioendothelioma, a
lesion most often congenital, usually multifocal, frequently symptomatic in
infancy and may be complicated by hemodynamic and coagulation disorders.
Clinical symptoms are variable and range from asymptomatic forms detected
by chance to intractable high output cardiac failure. In addition, hepatome-
galy, consumption coagulopathy with anemia, and thrombopenia/hemor-
rhage (Kasabach-Merritt-Syndrome) as well as cutaneous/visceral
hemangiomas can occur -up. Medical treatment consists of steroids, a´
interferon, and treatment of additional clinical symptoms. Possible surgical
procedures are ligature of feeding vessels, hepatic resection, and liver
transplantation Apart from established medical and surgical options, the
endovascular approach represents an important alternative. In this report, we
present our experience with interventional coil occlusion in 3 patients
suffering from symptomatic vascular tumors of liver.
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Methods. Three patients suffering from AVM of liver (age range 30150
days) associated with cardiac failure were treated by endovascular interven-
tions between 19992006
Results. Signs of heart failure resolved in two patients within 3 weeks
intervention. These two patients after a follow up of 72 months and 36
months remain asymptomatic. Third patient who is still remains in hospital
after endovascular coil occlusion of hepatic artery has shown remarkable
improvement in cardiovascular haemodynamics and hepatic functions.
Follow up imaging in these patients showed significant regression of lesions.
Conclusion. Embolisation of hepatic artery and rest of the collateral arteries
feeding these arteriovenous malformations is a safe and effective treatment.
Liver transplantation is very rarely performed. We do not recommend
endovascular intervention in multifocal
PP 8.02
SUCCESSFUL TRANSPLANTATION OF LIVER GRAFT WITH
GRADE III TRAUMA.
Mohanka, Ravi1; Cruz, Ruy2; Fontes, Paulo2; Marsh, Wallis2; Marcos,
Amadeo2; DeVera, Michael2
1Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical
Center, Pittsburgh, United States; 2Thomas E Starzl Transplantation
Institute, Pittsburgh, United States
Background. Liver trauma is usually considered a contraindication for liver
recovering. Isolated cases of emergency transplant utilizing injured liver have
been reported. We reported a case of liver with intra-parenchymal hematoma
which was successfully harvested and transplanted in an elective procedure.
Case Report. A 28-year old man was admitted to emergency department
following a road traffic accident. A CT-scan of his abdomen showed a
11cm7cm4cm intra-parenchymal hematoma involving segments VI and
VII (grade III, AAST organ injury scale). His AST/ALT peaked 264/213 and
were 83/158 at the time of organ procurement. Forty eight hours after
admission in the hospital, the irreversible nature of his brain injury became
apparent and he was declared brain dead. A standard technique was used for
liver procurement using 10 liters of aortic and 5 liters of UW solution. The
liver was transplanted in a 49-year old patient with end stage liver disease
secondary to a hepatitis C induced cirrhosis. The cold and warm ischemia
times were 13 hrs 51 min and 28 minutes, respectively. USG was performed
on the back-table to evaluate the vessels and hematoma size. Transplant was
done using a piggyback technique with venous-venous bypass and standard
end-to-end portal vein, hepatic artery and bile duct anastomosis over a T-
tube. Solumedrol was used for induction followed by prograf monotherapy.
Five days after his transplant a ct-scan was done showing a complete
regression of the hematoma. His post-operative course was complicated by
severe bile duct stricture, DVT of upper extremities and agitation/confusion
requiring change in the immunossupression treatment. The patient was
discharged 38 days after transplant.
Conclusion. The presence of grade III liver trauma should not contra-
indicate liver harvesting and transplantation. Inclusion of this group of
patients would potentially contribute to expand the donor pool.
PP 8.03
RESULTS OF HEMI-RIGHT SPLIT LIVER TRANSPLANTATION
WITH OR WITHOUT THE MIDDLE HEPATIC VEIN
Dargan, Puneet1; ADHAM, Mustapha1; Dumortier, Je´rome2; Abdelaal,
Amr1; Sagnard, Pierre1; Boucaud, Catherine1; Boillot, Olivier1
1Edouard Herriot Hospital, Department of HPB Surgery, Lyon, France;
2Edouard Herriot Hospital, Department of Hepatology, Lyon, France
Middle hepatic vein preservation for a hemi-right split adult liver transplan-
tation is not consensuel. The aim of this study was to evaluate outcomes of
the graft and patient after right split graft with or without the middle hepatic
vein.
Methods. 33 patients received 34 cadaveric right split liver graft between 02/
2000 & 05/2006. According to the type of recipient pairs, two adults or
adultpediatric, the middle hepatic vein was kept or not with the right hemi
liver. The first group (GI, n15) had grafts with only the right hepatic vein,
the second (GII, n18) had grafts with right and middle hepatic veins. The 2
groups were similar for patients’ demographics, initial liver disease and donor
characteristics. In GI and GII, GRWR was 1.290% and 1.69.3% (pB
0.05), and cold ischemia time was 10:5592:49 hr and 10:4793:32 hr,
respectively (pNS).
Results. Post-operative death occurred in 1 patient in each group. Vascular
complications included 2 portal vein, 1 hepatic artery, and 1 right hepatic
vein anastomotic strictures, all in GI. Biliary complications occurred in 20%
and 22% of the patients, in GI and GII, respectively (pNS). There were no
differences between both groups regarding post-operative outcome and blood
tests at day 115 except for a significantly higher cholestasis in GI. At 1 and 3
years, patients’ survival was 94% for both groups and graft survival was 93%
for GI and 90% for GII (pNS).
Conclusions. Our results suggest that adult right split liver transplantation
with or without middle hepatic vein is safe and associated with similar long
term
Results. Early liver function recovered more slowly in livers without the
middle hepatic vein.
PP 8.04
ALTERNATIVE SURGICAL TECHNIQUE FOR CAVAL PRESER-
VATION IN LIVER TRANSPLANTATION
Doria, Cataldo1; Frank, Adam1; di Francesco, Fabrizio1; Spaggiari, Mario2;
Ramirez, Carlo1; Ranjan, Dinesh3; Zibari, Gazi4; Marino, Ignazio5
1Jefferson Medical College-Thomas Jefferson University Hospital, Surgery,
Philadelphia, United States; 2j, Surgery; 3University of Kentucky Medical
Center, Surgery, Lexington, KY, United States; 4Willis-Knighton/Louisiana
State University, Surgery, Shreveport, LA, United States; 5Jefferson Medical
College-Thomas Jefferson University Hospital, Surgery, Philadelphia
Introduction. The two most commonly used surgical techniques to perform
liver transplantation are: standard and piggy-back. The first replaces the
recipient’s vena cava from the diaphragm to the right renal vein. The latter
preserves the recipient’s inferior vena cava, and the donor’s IVC is
anastomosed to a combination of the recipient’s hepatic veins. Material
and method: We herein describe a modification of the piggy-back technique,
where the recipient’s hepatic veins were clumped en-bloc without pealing the
liver off the IVC. This maneuver was carried out by bluntly developing a
surgical plan between the IVC and the hepatic veins; the infrahepatic IVC
was, subsequently, tangentially clumped as shown in the figure.
Results. The operative time was reduced by two hours compared with our
mean operative time.
Conclusions. Piggy back technique, whenever possible, is considered the
technique of choice for liver transplantation, because patients remain more
hemodynamically stable. Our modification proved to be safe, effective and
allowed a shorter operating time.
PP 8.05
INFERIOR LONG TERM POST LIVER TRANSPLANTATION OUT-
COMES IN RECIPIENTS OF ASIAN ORIGIN
Bhati, Chandra; Naidu, Sudeep; Seth, Avnish; Gunson, Bridget; Bramhall,
Simon; Buckels, John; Mirza, Darius
Queen Elizabeth Hospital, Liver Unit, Birmingham, United Kingdom
Background. Outcomes in liver transplantation are dependant on donor,
operative and recipient factors. Liver disease is common in patients of Asian
origin and almost all UK cadaveric donors are Caucasian. These factors may
impact on graft availability and outcome.
Aim. We compared outcomes in matched groups of adult Asian and
Caucasian recipients of cadaveric liver grafts at a single UK centre.
Methods. Demographics, risk factors, graft availability, survival and mor-
tality data on all adult Asian patients transplanted between 1986 and October
2006 were analysed from a prospective database.
Results. For each Asian recipient (n111), one Caucasian transplant
recipient (n111), matched for age, gender, race, diagnosis, and year of
transplantation, was selected from the transplant database. Blood group
distribution, MELD, Creatinine, BMI and time on waiting list were also
recorded.
Asian Caucasian P value
No 111 111 n/s
Type of graft Full/Split 103/8 105/6 n/s
Graft failure 50 36 0.017
Total deaths 48 30 0.005
Diabetes 30 15 0.019
Cardiac co morbidity 9 2 0.05
Time on waiting list (Mean) 73 days 43 days 0.01
MELD (Mean) 12 12 n/s
BMI (Mean) 25.02 26.02 n/s
Graft failure in blood group (BAB) 20/41 9/33 0.041
Death in blood group BAB 19/41 7/33 0.016
Patient and graft survival by Kaplan-Meier analysis was better in Caucasian
patients (Patient survival: 5 and 10 years survival 60% and 50% in Asian
versus 77% and 70% in Caucasians; Graft survival: 5 and 10 years survival
was 57% and 46% in Asian versus 71% and 63% in Caucasians), with a
higher incidence of diabetes and cardiac co-morbidity in Asian patients.
Conclusion. Liver transplant recipients of Asian origin have worse long term
outcomes having waited longer for their grafts. The higher incidence of
diabetes, cardiac comorbidity and incidence of blood group B may contribute
to this
PP 8.06
LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCI-
NOMA IN PORTUGAL
Pinto Marques, Hugo1; Ribeiro, Vitor2; Oliveira, Fernando Jose´3; Costa
Maia, Jose´4; Barroso, Eduardo1
1Curry Cabral Hospital, HepatoBiliaryPancreatic and transplantation Cen-
tre, Lisbon, Portugal; 2Hospital de Santo Anto´nio, Surgery and Transplanta-
tion, Porto, Portugal; 3Hospitais da Universidade de Coimbra, Liver
Transplantation, Coimbra, Portugal; 4Hospital de Sa˜o Joa˜o, Surgery, Porto,
Portugal
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Background. Results of liver transplantation (LT) for hepatocellular
carcinoma (HCC) are comparable to those of LT for other diseases. Although
it is commonly done in the various liver transplant Centres in Portugal, until
now no study analyzed the global results of this therapeutic strategy in our
Country.
Objectives. To evaluate the global results of LT and the impact of sequential
LT for the treatment of HCC in Portugal.
Patients and Methods. A Multi-institutional retrospective sudy including
the 4 LT Centres in Portugal was done. Between 1993 and 2006, 137
patients were submitted to LT for HCC. There were 122 men and 15
women. Most frequent aetiologies were cirrhosis due to alcohol, HCV and
HBV. Forty-seven patients were submitted to preoperative therapy, most
frequently transarterial chemoembolization. Sequential LT was performed in
56 patients (41%). The median size of the largest nodule was 4,3 cm and 16
patients had more than three nodules. Eighty patients (58%) fulfilled Milan
Criteria and 95 patients (69%) fulfilled University of California  San
Francisco (UCSF) Criteria. Kaplan-Meier and Log Rank tests were used for
statistical analysis.
Results. Operative mortality was 13,1% (18 patients). Twenty-seven patients
(19,7%) relapsed, most frequently in the lung or liver. Overall 5-year survival
was 56%, and 10-year survival was 32%. Patients fulfilling Milan Criteria had
a 73% 5-year survival. Patients fulfilling UCSF Criteria had a 72% 5-year
survival. The most important factors influencing survival were number and
size of nodules, as well as the presence of vascular invasion. There was no
difference regarding overall or disease-free survival for cadaveric or sequential
LT.
Conclusion. In Portugal, results of LT for HCC respecting standard
selection criteria are similar to most international series. Expansion of those
criteria obtained satisfactory results in our Centres. Sequential LT is a valid
option for the treatment of those patients and achieves results that are
equivalent to cadaveric LT.
PP 8.07
COMPARISON OF HISTIDINE- TRYPTOPHAN- KETOGLUTA-
RATE SOLUTION (HTK) AND UNIVERSITY OF WISCONSIN
SOLUTION (UW) IN ADULT LIVER TRANSPLANTATION
Rayya, Fadi1; Schoen, Michael1; Uhlmenn, Dirk2; Hauss, Johann1; Fang-
mann, Josef1
1University Hospital Leipzig, Clinic for Abdomen and Transplant Surgery,
Leipzig, Germany; 2University Hospital Leipzig, Clinic for Abdomen and
Transplan Surgery, Leipzig, Germany
Background. A safe and effective preservation solution is a precondition for
successful liver transplantation (LTx). This study compares University of
Wisconsin (UW) and Histidine- Tryptophan- ketoglutarate HTK solutions in
liver transplantation PATIENTS/ Methods. We retrospectively reviewed
medical records of 137 primary cadaveric LTx performed between January
2003 and December 2006 at our institution. 68 grafts were harvested using
UW and 69 using HTK. Recipients were managed similarly with regard to
operative techniques and immunosuppression. Donor data including serum
transaminases, serum sodium, ICU stay and assessed macroscopic liver
quality were collected. Recipient serum transaminases were collected at
postoperative days 1, 7, 14 and 30. Biliary- and vascular complications,
patient and graft survival were compared.
Results. Mean serum transaminase levels were slightly higher in the HTK
group at day 1 (NS) but were comparable thereafter. Primary non-function
occured in 1 patient in each group. 6 patients in the UW and in 7 patients in
the HTK group, were retransplanted. Biliary complication rates were similar
in the UW and HTK groups (26.5% and 30.8%, respectively). There were 5
(7.2%) arterial complications in the HTK and 2 (2.9%) in the UW group
(pB0.05). Mean follow-up was 25 months. Graft survival at 1, 12, and 36
month was 90%, 78%, 75%, and 90%, 71%, and 71% in the UW and HTK
group, respectively. 1, 12, 36 month patient survival was 93%, 78%, 75% and
93%, 78%, 78%, in the UW and HTK group, respectively.
Conclusions. There were no significant differences in graft and patient
survival between the two groups. Biliary and arterial complication rates were
also comparable. UW and HTK solutions seem to be equally safe
PP 8.08
LIVER TRANSPLANTATION IN JEHOVAHS WITNESSES
Honore, Pierre; Detry, Olivier; Deroover, Arnaud
C.H.U. Sart Tilman(ULG), surgery, Liege, Belgium
Background. and AIM: In liver transplantation(LT), the use of blood
products(red cells, platelets, plasma components) was reduced due to better
medical and surgical management, but the interest of transfusion-free LT is
debated. The authors developed a transfusion-free LT program for Jehovah’s
witnesses(JW), and analysed its outcome to evaluate the potential interest of
bloodless strategies in LT for the JW and non-JW recipient population.
Methods. Over an 8-years period,17 selected JW underwent 18 LT in the
author’s department, including 5 right lobe living related LT and one
pediatric LT. We analysed herein the outcome of 11 adult patients(5 males,6
females, mean age:50 years) who underwent 12 cadaveric whole LT. They
received preoperative erythropoietin(EPO) therapy, with iron and folic acid
to increase preoperative haematocrit(Ht). A cell saving system was used
during the surgical procedures. No patient was lost to follow-up(mean:44
months).
Results. No blood product was used in the whole follow-up. During the
operative procedure a mean of 1,250 ml were scavenged by the cell-saving
system, allowing the reinfusion of a mean of 404 ml of concentrated red cells.
Due to preparation, Ht level rose from 37.591.6% at the first visit, to 439
1.5% just before LT(pB0.05). Postoperative day 1 mean Ht was359
1.6%,(pB0.05), and further decreased during the post transplant peri-
od(mean lowest Ht:30.791.7%, pB0.05). Mean Ht at discharge was 33.69
1.9%. One patient needed urgent retransplantation due to early hepatic
artery thrombosis. No patient experienced complication linked to anemia.
Patient and graft survival is 100% and 90% respectively, at follow-up.
Conclusions. These excellent results justify the development of bloodless
LT program. They also raise questions on the interst of prospective
evaluation of bloodless strategies in non-JW patients undergoing LT, and
on the possible protective effects of EPO against ischemia-reperfusion injury
and apoptosis
PP 8.09
THE FIRST DOMINO TRANSPLANTATION IN CZECH REPUB-
LIC
Oliverius, Martin1; Adamec, Milos1; Trunecka, Pavel2; Frankova, Sona3;
Kieslichova, Eva4
1Institute for Clinical and Experimental Medicine, Transplant Surgery
Department, Prague, Czech Republic; 2Institute for Clinical and Experi-
mental Medicine, Department of Hepatogastroenterology, Prague, Czech
Republic; 3Institute for Clinical and Experimental Medicine, Department of
Hepatogastroenterology, Prague, Czech Republic; 4Institute for Clinical and
Experimental Medicine, Department of Anestesiology and Intensive Care,
Prague, Czech Republic
Background. while there is a worldwide increase in liver transplantation the
number of cadaveric donors remains relatively stable. Several new techniques
including reduced-, split-, living donor- and non heart beating donor
transplantation have been developed to solve this problem. Domino liver
transplantation represents an uncommon alternative. AIM(S)/OBJEC-
TIVE(S): Familial amyloidotic polyneuropathy (FAP) is an inherited
disorder with the systemic deposition of amyloid fibrils containing mutant
transthyretin variants. The liver produces 95% of the mutant form of
transthyretin. Successful liver transplantation could eliminate the source of
the variant transthyretin molecule, and is now the only known curative
treatment. Sequential transplant or domino liver transplant (DLT) allows the
transplantation of a patient with chronic liver disease by implantation of a
full-size liver derived from a patient with FAP who in turn receives a
cadaveric graft. Therefore, it is possible to transplant two patients using a
single cadaveric graft.
Methods. A 40-yr-old woman with FAP underwent cadaveric liver trans-
plantation, and her liver was used as a domino graft for a 59-yr-old man with
pT2NOMO G2 hepatocellular carcinoma. The first procedure was per-
formed as a conventional ‘‘end to end cavocaval anastomosis ‘‘ while the
second one was a "piggy back" procedure.
Results. The surgical outcome was successful. Postoperative course was
uneventful with early liver function. Immunosuppression was based on
tacrolimus, MMF and steroids.
Discussion and Conclusion. domino liver transplantation is a save
procedure which may help in reducing of current organ shortage in some
particular cases in the future.
PP 9.01
A NOVEL TECHNIQUE OF MODIFIED DEVINE WITH TWO
BRAUN ANASTOMOSES FOR UNRESECTABLE PANCREATIC
CANCER
Kawasaki, Atsushi1; Oida, Takatsugu1; Mimatsu, Kenji1; Aramaki, Osamu1;
Kuboi, Youichi1; Kanou, Hisao1; Miyake, Hiroshi2; Amano, Sadao3
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Kasukabe Municipal Hospital, Surgery, Kasukabe, Japan; 3Nihon Univer-
sity School of Medicine, Surgery, Tokyo, Japan
Background/AIMS: If curative operation of pancreatic cancer is not
possible, palliation of cholestasis and eventual duodenal obstruction is
mandatory. In these cases with both duodenal and biliary obstruction, the
standard approach has been gastroenterostomy plus biliodigestive anasto-
mosis. However, in the case of conventional gastrojejunostomy, the bypass
dose not always function effectively. The other hand, with the development of
interventional insertion of a biliary stent has taken the place of surgical
bypass, but there was a higher prevalence of late complications. We
introduced and evaluated our bypass procedure for unresectable pancreatic
cancer.
Patients and Methods. Eight patients underwent modified Devine with two
BraunIfs amastomoses to treat untesectable pancreatic head carcinoma. 1)
Modified Devine Exclusion; The side of anastomosis was determined at
greater curvature of the body of the stomach. With a linear stapler, partial
ablation, a wide segment near the lesser curvature was left as a drainage route
for contents remaining in the oral of the constricted duodenum. The jejunum
was anastomosed antecolically to the oral side of the stomach. 2) Braun
anastomosis (First BraunI@anastomosis) was performed at the 20 cm
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below of the gastorojujunostomy. 3) Choledocojujunostomy was performed
without stent tube. 4) Another Braun anastomosis was performed between
the first BraunI@anastomosis and choledochojejunostomy.
Results. No complications directly related to the procedure occurred. No
suction drain was required. Mean survival, hospital stay and out of hospital
stay were 5 months, 20 days and 3.5 months.
Conclusion. Modified Devine with two BraunI@amastomoses is a simple
and effective technique for unresectable pancreatic carcinoma.
PP 9.02
DIFFERENT TECHNIQUES OF MINIMALLY INVASIVE PAN-
CREATIC NECROSECTOMY
Nagpal, Anish; Haribhakti, Sanjiv
Haribhakti Surgical Hospital, Ahmedabad
Introduction. Infection of pancreatic necrosis is one of the most morbid
complication of acute necrotizing pancreatitis. Almost all the patients of
infected necrosis of pancreas require surgical intervention. With advances in
technology, necrosectomy has become possible with minimally invasive
techniques.
Methods. 5 patients of infected pancreatic necrosis underwent necrosectomy
by minimally invasive techniques during the period between January 2004 to
December 2006. Mean APACHE II score on admission was 14.2 (range from
536). 2 patients underwent retroperitoneoscopic necrosectomy, 2 patients
underwent hand assisted and one patient underwent total laparoscopic
necrosectomy. 2 patients underwent simultaneous cholecystectomy.
Results. 2 out of 5 patients died (one on 5th post-operative day and one on
25th postoperative day just before discharge) while 3 patients developed
controlled, self healing pancreatic fistula.
Conclusion. Minimally invasive pancreatic necrosectomy is feasible techni-
que with acceptable results in carefully selected patients by experienced
surgeons.
PP 9.03
NEW SUGICAL TECHNIQUE OF LAPAROSCOPIC CYSTGAS-
TROSTOMY FOR PANCREATIC PSEUDOCYSTS; POSTERIOR
APPROACH
Aramaki, Osamu1; Oida, Tkatugu2; Oida, Tkatugu2; Mimatsu, Kenji1;
Kawasaki, Atushi1; Kuboi, Youichi1; Kanou, Hisao1; Amano, Sadao3
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan; 2;
3Nihon University School of Medicine, Surgery, Tokyo, Japan
Introduction. Internal drainage of acute pancreatic pseudocysts is indicated
6 weeks after the first documentation of pseudocyst. When pseudocysts are
located in close contact with the posterior wall of the stomach, they are best
drained by pseudocyst-gastrostomy. Laparoscopic treatment of pancreatic
pseudocysts allows for definitive drainage with faster recovery. Although,
many groups have reported their experiences with an anterior approach, only
a few have done with a posterior approach.
Patients and Methods. Five patients underwent laparoscopic cystogas-
trostomy for pancreatic pseudocysts. The posterior approach was performed
by directly visualizing the posterior gastric wall and the pseudocyst,
drainaging the cyst with a needle. After a sufficient drainage orifice is made
and the cyst contents are thoroughly debrided. The cystogastrostomy was
fashioned through an posterior approach with stapling device. Closure of the
opening wall was performed by hernia stapler.
Results. Cystogastrostomy was underwent by posterior approach with
stapling device in all patients without conversion to anterior approach nor
to open surgery. There were no operative complications. No late recurrences
have been found at a median follow-up of 49 months.
Conclusion. Laparoscopic csytogastrosotmy by posterior approach with
wide internal drainage for pancreatic pseudocyst is safe, feasible and effective
procedure, and it no requires the opening of the anterior stomach.
PP 9.04
THE LAPAROSCOPIC APPROACH TO DRAINAGE OF PAN-
CREATIC PSEUDOCYSTS: A SUITABLE APPROACH FOR’ALL
COMERS’
Hamza, Numan1; Alkari, Bassam2; Ammori, Basil J2
1Manchester Royal Infirmary, HepatoPancreatoBiliary Surgery, Oxford
Road, Manchester, United Kingdom; 2Manchester Royal Infirmary, Hepa-
toPancreatoBiliary Surgery, Manchester, United Kingdom
Introduction. Pancreatic pseudocysts (PP) are traditionally managed by
laparotomy.
Objective. Our experience with the laparoscopic approach for all comers
with PP requiring surgical drainage is presented.
Methods. Between 2001 and 2007, 15 consecutive patients underwent 16
surgical drainage procedures for PP, all of which were attempted laparosco-
pically.
Results. The median PP size was 13 (range, 6.523) cm. The procedures
included pseudocyst-gastrostomy (PCG) (n13), Roux-en-Y pseudocyst-
jejunostomy (n2), and an unplanned external drainage due to extensive
adhesions (n1). The approach to PCG was transgastric (n8), endogastric
(n3) and exogastric (n2). Pancreatic necrosis was present in 13 patients
of whom 9 required debridement. Three patients underwent a concomitant
cholecystectomy. There were no conversions to open surgery. The median
operative time was 122.5 (interquartile range, 85153.75) minutes. There
were no postoperative complications and no mortalities. The median post-
operative hospital stay was 2 (range, 14) days. At a median follow up of 13
(range 141) months one patient (6.7%) developed a recurrent PP that was
drained laparoscopically.
Conclusions. Laparoscopic drainage of PP is a feasible, safe, an effective
alternative to laparotomy for all comers with PP that require internal
drainage, and is associated with rapid recovery, short hospital stay and a
recurrence rate comparable to open surgery.
PP 9.05
A TAILORED APPROACH TO LAPAROSCOPIC SPLEEN-PRE-
SERVING DISTAL PANCREATECTOMY OUR INITIAL EXPERI-
ENCE
Das De, Soumen1; Kow, Alfred Wei-Chieh1; Lim, Khong-Hee2; Liau, Kui-
Hin2; Ho, Choon-Kiat2
1Tan Tock Seng Hospital, Digestive Disease Center, Dept of General
Surgery, Singapore; 2Tan Tock Seng Hospital, Digestive Disease Center,
Dept of General Surgery, Singapore, Singapore
Background. ¼ Laparoscopic resection for small lesions of the pancreas has
recently gained popularity. We report our initial experience with a tailored
approach to laparoscopic spleen-preserving distal pancreatectomy, indivi-
dualized to the location of the lesion.
Aim. Our aim is to show a tailored approach reduces the removal of excessive
normal pancreatric tissue without compromising margins.
Methods. Three patients underwent laparoscopic distal pancreatectomy with
spleen-preservation over a two-month period. Surgical techniques and
patient outcomes were examined.
Results. All our patients were females, with ages ranging from 31 to 47 years
old. Two patients underwent the surgery with a ‘‘medial-to-lateral’’ approach
as the lesion was close to the body or proximal tail of pancreas. The third
patient had a lesion in the distal tail of the pancreas and surgery was
performed in a ‘‘lateral-to-medial’’ manner. This latter approach allowed us
to avoid excessive sacrifice of normal pancreatic tissue for such distally
located lesions. All patients had preservation of the splenic artery and vein.
The first two patients stayed in hospital for 5 days while the third patient
stayed for 9 days. There was no significant difference between operative time
and intra-operative blood loss.
Discussion. Laparoscopic distal pancreatectomy with preservation of the
spleen is a feasible surgical technique with acceptable outcome. We practice a
tailored approach to the dissection technique based on location of the lesion.
A ‘‘medial-to-lateral’’ approach is indicated for lesions in the body of the
pancreas while a ‘‘lateral-to-medial’’ dissection has been shown to be feasible
for lesions in the distal tail of the pancreas. We have successfully performed
splenic preservation in both approaches, with preservation of splenic vessels,
with a successful surgical outcome.
PP 9.06
LAPAROSCOPIC MANAGEMENT OF CYSTIC NEOPLASMS OF
PANCREAS-MMHRC EXPERIENCE.
PALANIAPPAN, KUMAR; Chandran, Nivedita; Narashiman, Mohan;
Arthanari, Ramesh
MEENAKSHI MISSION HOSPITAL & RESEARCH CENTRE, DE-
PARTMENT OF SURGICAL GASTROENTEROLOGY, MADURAI,
India
Background. Cystic lesions of pancreas are common, and more than 80
90% are pseudo cyst of pancreas. Cystic neoplasms account for 1015% of
cystic lesions of pancreas. The most common cystic neoplasm are serous
cystadenoma & mucinous cystadenoma. Accurate pre op diagnosis is
essential for optimum surgical management.
Aim. To analyze retrospectively the outcomes of patients admitted with
cystic neoplasm of pancreas-specifically at morbidity like pancreatic fistula,
abscess etc.
Type of Study: Retrospective chart analysis. 20002007.
Results. Total of 13 patients were admitted with cystic neoplasm of
pancreas. 11 females and 2 were males. Age group varied from 1756 years
( mean 26.3years). 10 patients had serous cystadenoma, 3 cases had
mucinous cystadenoma. All underwent laparoscopic procedures. Enucleation
was done in 2 patients, distal pancreatectomy with spleenectomy was done in
5 patients, 4 patients underwent distal pancreatectomy with spleen preserva-
tion, 2 cases underwent median pancreatectomy. The average operating time
was 110160 min ( mean: 130 min). None of the patients required blood
transfusion. The average size of tumor varied from 520 cm( mean 8cm).
There was no mortality in the present series. 3 patients had post op external
pancreatic fistula, which was managed conservatively. Fistula closed sponta-
neously over a period of 3weeks. The average fistula volume was about
100ml. 2 patients had post op intra abdominal abscess, which was
percutaneously aspirated. the average hospital stay was about 6 days (517
days).
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Conclusion. Cystic neoplasms of pancreas can be managed safely by
laparoscopic techniques with accepted morbidity & mortality.
PP 9.07
LAPAROSCOPIC HAND ASSISTED NECROSECTOMY FOR SE-
VERE GALLSTONE PANCREATITIS
Yoo, Stephen; Tchanque, Catherine N; Chang, Yeon-Jeen; Jacobs, Michael J;
Mittal, Vijay K
Providence Hospital and Medical Centers, General Surgery, Southfield,
United States
Introduction. Debridement is a key principle for the management of
necrotizing pancreatitis. Traditionally, an open laparotomy has been required
to address this difficult clinical scenario. Presented here is a case of
laparoscopic hand-assisted necrosectomy as a minimally invasive approach
to managing complications from severe gallstone pancreatitis.
Objectives. To present a case of laparoscopic hand-assisted necrosectomy
for the management of severe gallstone pancreatitis
Presentation. A 28 year-old Hispanic female presented with a case of severe
gallstone pancreatits. Her initial hospital course required an ERCP with
placement of a biliary stent, as well as complications from ARDS. A
laparoscopic cholecystectomy was performed on the same admission prior
to discharge. She returned to the hospital 7 days post-discharge with a
temperature of 38.98C. CT scan revealed a retroperitoneal fluid collection
along Morrison’s pouch and the right paracolic gutter. CT-guided drainage
was unsuccessful, and aspiration was positive for Candida glabrata. With
failure of conservative means, a laparoscopic hand-assisted necrosectomy
was performed. A drainage system was created to irrigate the peritoneum
utilizing Jackson-Pratt drains and a 28-French chest tube. The patient was
eventually discharged home with the devised drainage system. Subsequent
CT scans had shown successful resolution of the infected necrotic fluid
collections.
Discussion. With the high mortality associated with necrotizing pancreatitis,
aggressive debridement is mandatory. When considering a less invasive
surgical option, it must not come at the expense of achieving substandard
outcomes. The hand port helped facilitate the necessary and adequate level of
necrosectomy, while still limiting the morbidity from a more invasive
laparotomy.
PP 9.08
LAPAROSCOPIC DISTAL PANCREATECTOMY
Slepavicius, Algirdas
Klaipeda University Hospital, Abdominal and endocrine surgery, Klaipeda,
Lithuania
Background. Laparoscopic distal pancreatectomy for benign conditions was
first described in the early 1990s, but it has not become as popular as other
laparoscopic surgeries. There are only several case reports and a handful of
small series. We present our initial experience in performing laparoscopic
distal pancreatectomies.
Methods. From June 2006 to June 2007, three patients underwent
laparoscopic distal pancreatectomy in the department of Abdominal end
Endocrine surgery of Klaipeda University Hospital. The author performed
one distal pancreatectomy with preservation of the spleen and two distal
splenopancreatectomies.
Results. Two males and one female in the age range of 6987 years
underwent operations. Splenic preservation was possible in one patient. The
tumor diameter ranged from 3.6 cm. to 6.5 cm. The mean operating time was
125 min for distal splenopancreatectomy and 210 min for distal pancrea-
tectomy. All patients were started on a liquid diet on the first postoperative
day. The median hospital stay was 6 days. The histologic report showed two
insulinomas and one mucinous cystadenoma. There were no pancreatic
leaks, deaths, nor readmisions.
Conclusions. Laparoscopic distal pancreatectomy is a safe procedure with
rapid recovery and short hospital stay. In appropriate cases, splenic
preservation is feasible.
PP 9.09
LAPAROBOTIC APPROACH TO PANCREATODUODENECT-
OMY
Yiengpruksawan, Anusak1; Carnevale, Nino2
1The Valley Cancer Center, Valley Hospital, Ridgewood, New Jersey, United
States; 2The Valley Cancer Center, Ridgewood, New Jersey, United States
Background. Pancreatoduodenectomy (PD) is a technically demanding
procedure. Although the laparoscopic approach has been performed success-
fully, technical difficulties may preclude its widespread adoption. With the
newly introduced robotic technology, some of these difficulties have been
over come.
Objective. We would like to report our recent experience applying this
technology to PD and show that the procedure and outcomes may be
improved with the laparobotic approach.Method.: We used the daVinci
robotic surgical system (Intuitive Surgical, Mountain View, CA, USA)
equipped with four arms. Pyloric sparing technique was performed in all
cases. The pancreatic remnant was anastomosed to the stomach. Technical
details of the procedure and outcomes of the patients were evaluated.
Results. Successful pyloric sparing PD was achieved in two patients with
benign pancreatic tumors using a unique approach that takes advantage of
the superior vision and dexterity-enhanced instruments inherent in the
robotic approach. The operative time were 5 and 7 hours, and the lengths of
hospital stay were 5 and 7 days, respectively. No blood transfusion was given.
There was one postoperative complication but no death.
Conclusions. Laparobotic pancreatoduodenectomy is feasible and safe in
the hands of a highly skill pancreatic surgeon with minimally invasive surgical
experience. It warrants further investigation on a large scale multiinstitutional
study.
PP 9.10
TREATMENT OF THE SMALL CYSTIC NEOPLASM OF THE
PANCREAS
Kubyshkin, Valery1; Grishankov, Sergey2
1Vishnevsky Institute of Surgery, Moscow, Russian Federation; 2Moscow,
Russian Federation
Background. Cystic neoplasm of the pancreas (CN) is demanded surgical
approach usually, but treatment policy of the small cystic tumors is
controversial.
Aim. To study clinical and morphological features of the small cystic tumors
and determine appropriate treatment one’s.
Methods. Between 1992 and 2006 we treated 52 patients with different CN
of the pancreas. 12 patients (23%) had CN less than 3cm in size. Median age
was 53 years (varied from 35 to 73). All patients were female. Tumor
localization: neck 5 (41.6%), body and tail  7 (58.4%). We analyzed clinical
dates (complains, history of disease, rate of growing), results of US, CT and
EUS. All cysts were treated surgically and undergone cross-section morpho-
logical examination.
Results. only 1 patient with small CN had clinical symptoms (moderate pain
in upper part of abdomen). Rest of the small CN was found incidentally and
long time (from 2 to 7 years) has been observed in outpatient’s clinics. All
small CN increased in size during of observation (rate was 0.51cm/per year).
Cystic septa were discovered in 10 cases, solid masses in cystic cavity were
visualized in 1 case. 1 patient had unilocular cyst. We not perform fine needle
aspiration in during EUS routinely. Surgical treatment included  7 distal
pancreatectomy, 3 medial resection and 2 enucleation of CN. Results of
cross-sectional histological examination: 7 CN were serous cystadenomas
without any malignant changes, 4 CN were mucinous cystadenovas with foci
of moderate dysplasia and 1 patient had borderline mucinous CN with severe
dysplasia. Malignant tumors we not discovered between all small CN.
Conclusion. Small CN are benign usually but has trended to increase in size
and demand constant medical observation because part of them are
mucinous with premalignant changes.
PP 10.01
PRENEOPLASTIC LESIONS IN GALLBLADDER CANCER
Saitoh, Ai1; Iki, Katsumichi1; Urakami, Atsushi1; Nagatsuka, Ryousuke1;
Tsunoda, tsukasa2
1Kawasaki Medical School, Gastroentelorogical Surgery, Kurashiki, Japan; 2
Background. Gallbladder cancer is an uncommon disease except in
countries like India, Japan and Chile. The knowledge of the etiology and
pathogenesis of this neoplasia is significantly less compared to other
malignant tumors. The epithelial lesions involved in gallbladder carcinogen-
esis are dysplasia and adenomas that represent two biologically distinct
carcinogenetic models. Both models were supported by morphological and
molecular genetic evidences. However, dysplasia associated or not to
gallbladder cancer have not been studied. We presented the possibility of
the dysplastic lesion is or not one of precancerous lesion in gallbladder
cancer.
Materials and Method. Twelve surgical specimens which histologically
diagnosed as gallbladder cancer were used. Tissues were fixed in 10%
buffered formalin, embedded in paraffin by conventional methods and
stained with hematoxylin and eosin. General rules for surgical and patholo-
gical studies on cancer of the biliary tract, 5th edition 2003 Japan, was used to
classify macroscopic types of each cases as follows: 1) papillary type, 2) flat
type, and 3) nodular type. And we counted atypical lesions, hyperplasia (H),
metaplasia (M), and dysplasia (D), which adjacent to neoplastic lesions in
each types of gallbladder cancer.
Results. Epithelial hyperplasia, metaplasia, and dysplasia are present in the
mucosa adjacent to each cancer type in 13%, 27%, and 62% in papillary
type, 25%, 20%, and 54% in flat type, and 13%, 19%, and 69% in nodular
type, respectively. And in 18%, 21%, and 61% in total gallbladder cancer
examined. The frequency of atypical epithelial lesions was not associated with
histologic types of gallbladder cancer. In all cases, dysplasia is observed in the
surrounding mucosa of the tumoral lesion.
Conclusions. From the morphological point of view, the dysplasia Ij
carcinoma sequence is the most plausible carcinogenic pathway for gall-
bladder cancer.
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PP 10.02
INCIDENTAL GALLBLADDER CANCER: RADICAL SURGERY
OFFERS LONGER SURVIVAL.
Toti, Luca; Attia, Magdy; Manzia, Tommaso Maria; Lenci, Ilaria; Buckels,
John AC; Mirza, Darius F; Mayer, A David; Taniere, Philippe; Bramhall,
Simon R
Queen Elizabeth Hospital, Liver Unit, Birmingham, United Kingdom
Background. Gallbladder cancer (GBC) is a disease with an increasing
incidence. The majority of cases present with advanced incurable disease but
increasingly GBCs are being diagnosed incidentally after routine cholecys-
tectomy. Our aim was to retrospectively evaluate our experience of incidental
GBC according to surgical approach and TNM staging.
Material and Methods. 180 patients (129 females 72% and 51 males 18%)
with GBC were treated in our unit between March 1997 and June 2007.
Incidental gallbladder cancer (iGBC) was identified in 39 (22%).
Results. In the iGBC group median age at presentation was 62.3 (range 40
79) years; there were 33 female (85%) and 6 males (15%); 38 were
adenocarcinomas, 1 adenosquamous (10 well, 18 moderately, 11 poorly
differentiated). The local pathological stage of the tumours was pT1a (1),
pT1b (8), T2 (21) and T3 (9). 9 patients had an open cholecystectomy, 14
had a gallbladder bed resection (GBR), 13 had a gallbladder bed resection
extrahepatic biliary duct excision (GBREBDE) and 3 had just a lapar-
otomy (LP). The overall 5 year survival in all 180 GBC patients was 14%: 38
patients had a resection with an overall survival of 40%. In the iGBC group
overall 5 year survival was 38%. In T1 group overall 5 years survival was
53%, in T2 was 50% and in T3 was 0% (but 1 patient is still alive). In
patients who had GBR only and patients who had GBREBDE the 5 year
survival was 33 and 62% respectively (pB0,03).
Conclusions. Radical re-operation in patients with incidental gallbladder
carcinoma appears to improve survival. Extrahepatic bile duct excision when
added to gallbladder bed resection also appears to improve survival.
PP 10.03
COMPARISON BETWEEN TWO METHODS OF PALLIATION
FOR JAUNDICE AND PRURITUS IN PATIENTS WITH UN-RE-
SECTABLE NON-METASTATIC GALLBLADDER CANCER
Jain, Sundeep1; Kalla, Mukesh2; Sharma, Jayant3; Chokrobarty, Sudipto4;
Sharma, Shyam Sunder5
1S.K. Soni Hospital, Gastrointestinal & Laparoscopic Surgery, Sector 5,
Vidhyadhar Nagar, Jaipur, India; 2S.R. Kalla Memorial Hospital, Gastro-
enterology, Jaipur, India; 3S.K. Soni Hospital, Gastroenterology, Jaipur,
India; 4S.K. Soni Hospital, Gastrointestinal & Laparoscopic Surgery, Jaipur,
India; 5S.M.S. Medical College & Hospital, Gastroenterology, Jaipur, India
Introduction. Majority of patients with gallbladder cancer (GBC) in India
have un-resectable disease with jaundice and pruritus as their main
complaint. Biliary drainage gives significant improvement in morbidity
related to cholestasis. OBJECTIVE This study was conducted to compare
the results of surgical and endoscopic biliary drainage in the selected group of
patient with un-resectable, non-metastatic GBC.
Methods. Data was collected from patients with GBC with obstructive
jaundice who underwent biliary drainage by endoscopic stenting (plastic/
SEMS) (group I) or segment III bypass (group II) during the period August
2005 to July 2007. Systematic analysis of prospective data was undertaken;
patients were analyzed for post-procedure morbidity, mortality and symptom
free survival.
Results All patients were matched for demographic features, gallbladder
stone association and stage of the disease. The fall in serum bilirubin levels to
B4mg% within one month and complete relief from pruritus with in 27days
was seen in all the patients. There was no difference in procedure related
morbidity and mortality. The median hospital stay was 1and 6 days (range of
16 and 515 days) in the respective groups. Four in group I and one in group
II patients had readmission for cholangitis and gastric outlet obstruction
respectively, for which stent replacement and gastrojejunostomy was done.
The mean symptom free survival in the two groups was 3.1 and 4.5 months
(median 2.5 and 3.5 months, range of 16 and 112 months) respectively.
Three patients in group II (30%) survived for more than 6 months with none
in group I. Five patients underwent stenting with SEMS. The cholangitis and
survival rates were similar with SEMS and plastic stents.
Conclusions. Segment III biliary-enteric bypass can be performed safely and
provides better palliation for jaundice and pruritus in patients with un-
resectable non-metastatic GBC. There is no advantage of SEMS over plastic
stents in these patients.
PP 10.04
SURGICAL MANAGEMENT OF CARCINOMA GALL BLADDER
Khandelwal, Manish1; Goyal, Ashish2; Khandelwal, Chiranjiva3
1Broomfield Hospital, Chelmsford, United Kingdom; 2Mahavir Cancer
Sansthan, Surgical Oncology, Patna, India; 3IGIMS, GI Surgery, Patna,
India
Background. Carcinoma(Ca) Gall Bladder(GB) is common in North India.
It is an aggressive disease with poor prognosis. We come across 250300 cases
of Ca GB every year. Most of these are diagnosed by Imaging Studies or
FNAC. We lack facilities for endoscopic biliary drainage in our part of the
world.
Methods. We retrospectively analysed 255 cases of Ca GB that presented to
us from Jan ‘95 to March ‘07. We reviewed the symptoms, stage at
presentation, mode of spread, treatment options & mortality.
Results. M:F ratio was 1:2.4. Average age was 47.1 for males and 46 years
for females.6 were less than 15 years of age. 25% presented with obstructive
jaundice & 20% with gastric outlet obstruction. Calculi were noted in 69%
cases. GB fundus was involved in 30%, body in 18% & neck in 16%. Entire
GB was involved in 36% cases. Spread of tumor was mainly through direct
invasion into liver, bileduct, duodenum & colon.22% cases had only wide
spread lymphadenopathy, without liver infiltration. 200(78%) underwent
resection.54% of cases were in advanced stage at presentation (36% & 18% in
Stage III & Stage IV respectively). Curative resection was done in 37% while
palliative resection was done in 63%. Curative surgery included extended
cholecystectomy in 31 cases with liver resection & radical lymphadenectomy,
5 cases with bile duct excision & and 2 had pylorus preserving pancreato-
duodenectomies. Simple Cholecystectomy done in 10(5.5%) cases (Inciden-
tal CaGB, Stage I) were also curative resections. Bypass was done in 48(19%)
cases (biliary bypass in 28 & bowel bypass in 20). 13(7.5%) cases were
inoperable. The overall mortality was 5.5%.
Conclusion. Surgical treatment is the only curative option. Resection should
be done wherever R0 resection is possible. However, debulking surgery &
aggressive surgery can have high morbidity & mortality and should be
avoided. Areas where endoscopic drainage is not available or technically not
possible; palliative resection/bypass can be done with acceptable mortality
and offers better quality of life.
PP 10.05
WHAT IS AN ADEQUATE EXTENT OF RESECTION FOR T1
GALLBLADDER CANCERS?
YOU, Dong Do; Lee, Hyung Geun; Paik, Kwang Yeol; Heo, Jin Seok; Choi,
Seong Ho; Choi, Dong Wook
samsung medical center, Seoul, Korea, Republic of
Introduction. Simple cholecystectomy offers adequate treatment for T1a
cancers, however it remains debatable whether T1b cancers should be treated
by simple cholecystectomy or by radical resection.
Objective. The purpose of this study was to analyze clinicopathologic and
surgical features and to determine what should be an adequate extent of
resection for T1 gallbladder cancers.
Methods. A retrospective analysis was conducted on 52 patients with
pathologic stage T1 (27 with T1a and 25 with T1b). Clinicopathological
features, extents of resection and survival rates were investigated retro-
spectively.
Results. No lymph node metastasis, lymphovascular or perineural infiltra-
tion was observed in those with T1a disease, but 2 of the 25 patients with
T1b disease had lymph node metastasis and one patient had lymphatic
infiltration. 21 of the 52 study subjects underwent simple cholecystectomy.
No peritoneal dissemination occurred regardless of surgical method (laparo-
scopy or open surgery). Of the 23 radically resected patients in T1b group, 6
patients underwent cholecystectomy and hepatoduodenal lymph node
dissection (CholeLN), and 17 patients underwent CholeLN combined with
wedge resection of IVb, V segment of liver, common bile duct resection, or
pancreaticoduodenectomy. No difference in locoregional recurrence, metas-
tasis or survival rate was observed regardless of combined resection of an
adjacent organ. The overall survival rate for all patients was 96.15% and for
T1a and T1b these were 96.3% and 96.0%, respectively.
Conclusion. When early gallbladder carcinoma is suspected as a result of
imaging findings, further evaluation of the depth of invasion by endoscopic
ultrasonography or intraoperative frozen biopsy is advised. Then if the disease
stage is determined to be T1a, laparoscopic or open cholecystectomy alone is
curative, and if T1b, cholecystectomy with hepatoduodenal lymph
node dissection without combined resection of an adjacent organ is
recommended.
PP 10.06
EARLY STAGES OF GALLBLADDER CARCINOMA
Frena, Antonio
Central Hospital of Bolzano, General Surgery, Bolzano, Italy
Background. carcinoma detected at histological examination of the gall-
bladder after cholecystectomy for gallstone disease or acute cholecystitis is
defined as incidental. It is a fairly rare event, but the increase in the number of
cholecystectomies performed as a result of the success of the laparoscopic
technique has led to a rise in the number of incidental carcinomas detected.
Histologically, in most cases, these are pT1 and pT2 carcinomas,
i.e., tumours that do not penetrate beyond the muscular wall of the
gallbladder.
Aims. up until the ‘nineties it was believed that these carcinomas could be
adequately treated by simple cholecystectomy, whereas today the treatment
of choice entails a radical second operation. Methodology: this study,
conducted at a single institute, constitutes a review of 20 years’ experience:
the data base consists of 3072 cholecystectomies with a 0.68% incidence of
incidental gallbladder carcinoma.
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Results. survival data are carefully calculated in relation to the evolution of
surgical treatment over the years, thus making it possible to correlate tumour
staging, patient survival and surgical therapy.
Conclusions. the contributions made by literature reports since the ‘nineties
have prompted hepatobiliary surgeons to modify their attitudes towards
incidental gallbladder carcinoma. Detection of previously unrecognised
microinfiltrations of the serosa and of neoplastic involvement of distant
lymph-node stations has led to the introduction of the concepts of radical and
extended cholecystectomy. Comparison between the historical survival
curves of patients treated with simple cholecystectomy and the distinctly
better curves of those treated with a radical second operation accounts for the
evolution of surgical treatment over the past two decades.
PP 10.07
EFFICACY OF GEMCITABINE/CISPLATIN COMBINED CHE-
MOTHERAPY FOR GALL BLADDER CANCER
Nakamura, Noriaki; Arii, Shigeki; Tanaka, Shinji; Kudo, Atsushi; Itoh, Kouji
Tokyo Medical and Dental University, Dept. Hepato-biliary pancreatic
surgery, Bunkyo-ku Yushima Tokyo, Japan
Background. Although the first treatment of gallbladder cancer is an
operation, still sufficient results are not expected. Furthermore, in unresect-
able gallbladder cancer, a prognosis is very poor. We will report the
gemcitabine/cisplatin (GEM/CDDP) combined chemotherapy we have tried
recently.
Material and method. 37cases of gall bladder cancer were treated from
April, 2000 to July, 2007 in the department of Hepato-biliary pancreatic
surgery, Tokyo medical and dental university hospital. The three weeks
protocol of the GEM/CDDP chemotherapy tried mainly for the unresected
cases was that the CDDP (50mg/mm2) was administrated intravenously on
the day 8, GEM (1000mg/mm2) was on the both day 1 and 8 and no
treatment was on the day 15. The radiological images and the tumor marker
(CEA and CA19-9) were examined.
Result.The number of resected case was 24 (64.9%) among 37 case-
s.I@The median survival time (MST) was about 12 months and the five-
year probability of survival was 31.5%. According to the treatment, although
MST of 24 cases of the resected group was about 24 months, in 13 cases of
unresected group, about 7.2 month. This difference was significant statisti-
cally. Then, the GEM/CDDP treatment was enforced as the chemotherapy
against for unresected group. The eight patients were enrolled in this
chemotherapy group from December, 2004 to July, 2007. Average age was
70.6 years old. One case was an adjuvant treatment after operation others
were clinical stage IVb. Although MST of a GEM/CDDP group is about
seven months and the significant difference was not statistically accepted to 3
months of MST in no chemotherapy group before GEM/CDDP treatment
trial, extension of MST for about 4 months was seen. In the evaluation of
efficacy, the overall response rate was 42.8% (3 out of 7 cases). Adverse
events were observed in one case of reduction of blood platelet (Grade3) and
2 cases of leukocytopenia (Grade2).
Conclusion. This combinedI@chemotherapy had few adverse events and
was good response rate(42.8%).
PP 10.08
GALLBLADDER CANCER IN A PATIENT PRESENTING WITH
MASSIVE WEIGHT LOSS
Jacobs, Michael; Ahad, Ahmad W.; Patel, Purnal; Jacobs, Michael
Providence Hospital and Medical Centers, Surgery, Southfield, United States
Background. Gallbladder (GB) cancer has an aggressive natural history and
carries a poor prognosis. Surgery offers the only possible cure in early stage
gallbladder cancer. Unfortunately, symptoms are vague and most diagnoses
are made incidentally.
Objective. We report a case of severe weight loss in a patient with GB
cancer, whose diagnosis was possibly overlooked due to confounding
symptoms.
Method and Result. A 54 year-old female presented to us with a history of
vague abdominal pain associated with a 185-pound weight loss that was
attributed to diet and exercise following an abdominoplasty. She had
intermittent symptoms of abdominal discomfort, pain, bloating and dyspep-
sia after this procedure. An ultrasound revealed cholelithiasis. A Computer
Tomography scan showed a pericholecystic collection that was compressing
the GB. Subsequent Magnetic Resonance Imaging study confirmed chole-
lithiasis, and showed eccentric, focal areas of GB wall thickening that
extended into the adjacent hepatic parenchyma and mesenteric fat. CA 19-
9 level was elevated with other labs being unremarkable. Surgery was advised.
Intraoperatively, a mass emanating from the GB was found to be penetrating
segments 4B and 5 without any other local involvement. En-bloc resection of
the GB and segments 4B and medial aspect of 5 was performed. Portocaval,
celiac, hepatic and supraduodenal lymph nodes were negative for metastasis.
Pathology revealed an invasive poorly differentiated carcinoma with focal
squamous differentiation extending to the posterior margins. Postoperative
course was unremarkable.
Conclusion. The best prognosis for GB cancer is observed in-situ
adenocarcinomas that are resected in completion. Surgically, in-situ cancers
can be treated with simple cholecystectomy while any other stage require
more extended procedures. In patients with significant weight loss, under-
lying malignancy should be ruled out with further thorough work-up to allow
these patients the best possible outcome.
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MANAGEMENT OF GALLBLADDER CANCER IN A TERTIARY
REFERRAL CENTRE
Oniscu, Gabriel C1; Cornell, Rachel1; Oniscu, Anca2; Kamel, Hassan2;
Garden, James1; Parks, Rowan W1
1University of Edinburgh, Department of Clinical and Surgical Sciences,
Edinburgh, United Kingdom; 2University of Edinburgh, Departmetn of
Pathology, Edinburgh, United Kingdom
Background. Gallbladder cancer poses a significant treatment dilemma,
especially when discovered incidentally.
Aim. This study reviews the management of gallbladder cancer and
investigates the role of further surgery after the initial cholecystectomy.
Methods. Demographic, diagnostic and procedural data were obtained from
a prospectively collected database for all patients diagnosed with gallbladder
cancer between 1996 and 2006. All histology reports and resected specimens
were reviewed to ensure uniform and up-to-date staging.
Results. A total of 116 patients were treated. Seventy one patients (61%)
were diagnosed incidentally following an initial cholecystectomy of whom 42
(60%) underwent a laparoscopic procedure and one third were tertiary
referrals. Of the 71 patients, 21 (29.5%) underwent further radical surgery
(16 central liver resection /gallbladder bed excision, 5 radical bile duct
excision) 17 (24%) underwent palliative stenting or bypass surgery and the
remaining 33 (46%) had chemo/no further treatment). The staging after
initial cholecystectomy for those patients that underwent further procedures
is shown in the table below. Only 4 of the 26 patients with positive resection
margin at the initial surgery underwent further radical surgery. The median
time interval between cholecystectomy and further radical surgery was 70
days, with no difference between local and referred patients. Radical surgery
(median survival 1002 days) did not lead to a survival benefit compared to
cholecystectomy alone (median survival 796 days) (Log Rank, p0.69) Of
the 45 patients that were not diagnosed incidentally, 50% underwent
palliative stenting, 22.5% had a cholecystectomy only and 25% had other
palliative procedures. Only one patient (stage IIB) had a subsequent radical
bile duct excision.
Conclusion. Gallbladder cancer is often an incidental finding. Further
surgery in selected cases is indicated and results in a limited survival benefit.
IA
(n4)
IB
(n20)
IIA
(n10)
IIB
(n19)
III
(n1)
IV
(n7)
ve resection
margins
1 4 3 13 0 5
Liver resection 0 4 3 4 1 1
Bile duct excision 1 1 0 2 0 0
Stenting 1 1 3 1 0 2
Other palliative
surgery
0 2 0 4 0 0
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SYSTEMATIC LITERATURE REVIEW OF NEUROENDOCRINE
TUMOURS OF THE GALL BLADDER
Mirza, Tariq A1; Iype, Satheesh2; Feakins, Roger3; Propper, David4; Kocher,
Hemant2
1Barts and the London NHS Trust, HPB Surgery, London, United King-
dom; 2Royal London Hospital, Barts and the London NHS Trust, HPB
Surgery, London, United Kingdom; 3Barts and the London NHS Trust,
Department of Pathology, London, United Kingdom; 4Barts and the London
NHS Trust, Medical Oncology, London, United Kingdom
Background. Neuroendocrine carcinoma of gall bladder is a rare condition,
often diagnosed incidentally.
Methods. Case reports on neuroendocrine tumours of gall bladder pub-
lished from 1997 till 2007 were searched on Pubmed. 34 patients of
neuroendocrine tumours of gall bladder were found in 26 articles. Primary
outcome measures of this systematic review were surgical management,
oncological management, histology of the tumour, metastasis and survival.
Results
RESECTABLE25
SURGICAL MANAGEMENT Open cholecystectomy9 Laparoscopic
cholecystectomy5 Cholecystectomy with liver resection7 Cholecystect-
omy with biliaryenteric anastamosis3 Cholecystectomy with pancreatic
resection1
ONCOLOGICAL MANAGEMENT Patients given adjuvant chemotherapy
and drugs mentioned11 Patients given adjuvant chemotherapy and drugs
not mentioned1 Patients not given adjuvant chemotherapy13
SURVIVAL Patients followed up21 Patients lost to follow up4 Survival
range3.5 months to 15 years
HISTOLOGY Small cell11 Carcinoid tumour4 Clear cell2 Large
cell0 Miscellaneous8
Abstracts 109
METASTASIS Metastasis present15 Metastasis absent7 Not
mentioned3
UN-RESECTABLE9
SURGICAL MANAGEMENT Surgery not performed5 Palliative resec-
tion and biliodigestive anastamosis2 Exploratory laparotomy open and
close2
ONCOLOGICAL MANAGEMENT Patients given palliative chemotherapy
and drugs mentioned3 Patients given palliative chemotherapy and drugs
not mentioned3 Patients not given palliative chemotherapy3
SURVIVAL Patients followed up6 Patients lost to follow up3 Survival
range5 months to 10 months
HISTOLOGY Small cell4 Carcinoid tumour0 Clear cell0 Large
cell4 Miscellaneous1
METASTASIS Metastasis present8 Metastasis absent0 Not
mentioned1
Conclusion. The response to chemotherapy is poor and at present,
resectional surgery with adjuvant chemotherapy offers the best hope.
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BOUVERET’S SYNDROME MASQUERADING AS CARCINOMA
GALL BLADDER:REPORT OF TWO CASES AND REVIEW OF
LITERATURE
Dash, Nihar Ranjan1; Kumar, Ashok2; Saxena, Rajan2
1AIIMS, GI Surgery and LTx, New Delhi, India; 2SGPGIMS, Surgical
Gastroenterology, Lucknow, India
Background. Bouveret’s syndrome (BS) is a rare condition of large gall
stone fistulating in to the gastric outlet. The varied presentations, difficulty in
diagnosis and changing trends in the management warrants a timely review.
We describe two cases of BS that presented like gall bladder cancer (GBC)
and discuss the management in the light of literature. Case1. A 75 year lady
presented with gastric outlet obstruction (GOO) for 15 days, anemia,
hypoproteinemia, and a vague lump in the right hypochondrium. Sonography
(USG) and CT showed poorly defined gall bladder (GB) outline with a
suspicion of mass lesion. Endoscopy showed an irregular bulging into first
part of duodenum with a clot over it. Biopsy was not done. Laparotomy
revealed a 544 cm stone impacted at the cholecystoduodenal fistula.
Frozen section, partial cholecystectomy (Pccx), cholangiogram, duodenost-
omy and gastrojejunostomy (GJ) were done. Case2. A 65 year lady presented
with pain abdomen and obstructive jaundice for 2 months, GOO for one
month, anaemia and hypoproteinemia. No mass was palpable. Serum
bilirubin was 6mg/dl. USG and CT gave an impression of GB neck mass
with infiltration into proximal CBD and duodenum. Endoscopy revealed an
intraduodenal bulging with old hemorrhage. Laparotomy revealed a 7mm
thick-walled GB with stones impacted at the site of a cholecysto-choledocho-
duodenal fistula. Pccx, cholangiogram, choledochostomy, duodenostomy
and GJ was done.
DISCUSSION. Both the cases had uneventful recovery. Both had xantho-
granulomatous cholecystitis. The stones were amorphous type and did not
cast any shadow on USG. Case reports of BS do appear every year since its
description. In areas common to GBC, BS might confuse the diagnosis and
lead to under or over treatment. Endoscopy, lithotripsy and surgery are the
modes of management advocated. However we suggest surgical management
because of better assessment of malignancy.
Conclusion. BS can masquerade GBC. A high index of suspicion can lead to
appropriate management.
PP 11.01
A TEN YEAR STUDY COMPARING RIGHT AND EXTENDED
RIGHT HEPATECTOMIES WITH ALL OTHER HEPATIC RESEC-
TIONS FOR COLORECTAL METASTASES.
Lordan, Jeffrey; Karanjia, Nariman; Quiney, Nail; Fawcett, William;
Worthington, Tim; Remington, Jacky
Royal Surrey County Hospital, Guildford, United Kingdom
Aims. Colorectal cancer metastasises to the liver in 50% of patients who
develop the disease. The gold standard treatment and only potential cure is
hepatic resection, often accompanied with adjuvant chemotherapy. Many
studies have examined factors that predict outcome, but none have compared
right sided resections with left or parenchymal sparing resections.
Patients and Method. 283 patients underwent hepatic resection for
colorectal metastases from September 1996 to November 2006 and were
prospectively studied. The early and late outcomes of those who had right
and extended right hepatectomies (RH) were compared with those who had
all other types of liver resection (AOLR). Adjuvant therapy and pre-operative
assessment were standardized.
Results. The 1, 3 and 5 year overall survival rates in the RH group were
84.1%, 54.3% and 38.9% respectively. The 1, 3 and 5 year overall survival
rates in the AOLR group were 95.4%, 65.4% and 53.3% respectively. The
difference was statistically significant (p0.033). The 1, 3 and 5 year
disease-free survival rates in the RH group were 69.5%, 34.4% and 25.5%
respectively and 68.4%, 34.9% and 34.9% respectively in the AOLR group
(p0.455). Operative mortality was 3.9% in the RH group and 0.65% in the
AOLR group (p0.042). Morbidity was 31.3% in the RH group and 18% in
the AOLR group.
Conclusion. Patients undergoing right and extended right hepatectomies for
colorectal metastases have a greater operative morbidity and mortality and
have a significantly worse overall survival compared to all other liver
resections for the same disease.
PP 11.02
A 10 year study of outcome following hepatic resection for colorectal
liver metastases  The effect of evaluation in a multi-disciplinary
team setting
Jeffrey, Lordan; Karanjia, Nariman; Quiney, Nail; Fawcett, William;
Worthington, Tim
Royal Surrey County Hospital, Guildford, United Kingdom
Aims. Colorectal carcinoma is the second most common cause of cancer
death in the western world and nearly 50% of patients develop liver
metastases. Many cancers are managed via a multidisciplinary team process.
This study compares the long term outcome of patients with metastatic
colorectal cancer referred via a multidisciplinary team including a liver
surgeon (MDT) with those referred directly to a tertiary hepato-biliary unit.
Patients and Method. This is a prospective study of 331 consecutive
referrals made to the Royal Surrey County Hospital over ten years out of
which 108 patients were referred via a formal MDT including a liver surgeon
while 223 were referred directly. Pre-operative assessment and management
were standardised and short and long term data were recorded.
Results. Patients referred via the MDT had 1, 3 and 5 year survival rates of
89.6%, 67.5% and 49.9% respectively and 1, 3 and 5 year disease free
survival of 65.4%, 31% and 27.2% respectively. Patients referred directly had
1, 3 and 5 year survival rates of 90.3%, 54.1% and 43.3% respectively and 1,
3 and 5 year disease free survival rates of 70.3%, 37.6% and 27.9%
respectively. The difference in overall survival was significant (p0.0001),
although the difference in disease free survival was not (p0.21).
Conclusion. Assessing, managing and referring patients with metastatic
colorectal cancer via a multidisciplinary team process including a liver
surgeon significantly improves overall survival.
PP 11.03
FAILURE OF CURATIVE SCHEDULE IN PATIENTS WITH PO-
TENTIALLY RESECTABLE COLORECTAL CARCINOMA WITH
SYNCHRONOUS METASTASES.
Cook, marie-ce´cile; Fuks, david; Bre´hant, olivier; Dumont, fre´de´ric; Chate-
lain, denis; Yzet, thierry; Joly, jean-paul; Dupas, jean-louis; Verhaeghe,
pierre; Regimbeau, jean-marc
Hospitalo-Universitary Hospital, Digestive Surgery, Amiens, France
Background. The management of patients with synchronous liver metas-
tases (SLM) depends on primary tumour, the resectability of the metastatic
disease and patient’s comorbidities. Among all patients with potentially
resectable primary colorectal carcinoma (CRC) with SLM, curative resection
will be possible in some patients although in others, surgery will never be
performed. The purpose of our study was to identify factors of failure of
curative schedule in these patients.
Methods. From January 2002 to March 2007, we reviewed over 88 patients
with CRC and SLM, data of 45 patients potentially resectable. Two groups
were defined: Group 1 when complete metastatic and primary tumour
resection was finally performed after one and more surgical stages (n31)
and Group 2 when curative resection was not possible (n14). Clinical,
pathologic and outcome data were retrospectively analysed so as preoperative
management of SLM (chemotherapy, radiofrequency, portal vein emboliza-
tion).
Results. Curative resection (Group 1) was performed in 31 (69%) patients
with 48% of major hepatic resection. The mortality rate of hepatic resection
was 0% although it was 9% for primitive tumour resection (27% of primary
tumour were located in rectum). Portal vein embolization was performed
preoperatively in 8 patients and radiofrequency ablation was realised in 13
patients. Median follow-up was 21 months. Overall survival was 86% at 1
year and 39% at 3 years. Survival in group 1 was 97% and 57% at 1 and 3
years respectively. Disease free survival was 87% and 40% at 1 and 3 years.
Tumoral recurrence occurred in 61% of resected patients. In a multivariate
analysis, number of hepatic metastases 3 and complicated initial presenta-
tion of primitive tumour were found to be significant and predictors of failure
hepatic resection.
Conclusion. Curative resection of SLM may produce a long-term survival
thanks to aggressive management. A number of SLM 3 and complicated
initial presentation of primitive tumour are predictive factor of failure of
curative schedule.
PP 11.04
DIAGNOSTIC ACCURACY OF LIVER-SPECIFIC MRI AS A PRE-
DICTOR OF CHEMOTHERAPY ASSOCIATED HEPATIC CELLU-
LAR INJURY PRIOR TO LIVER RESECTION
O’Rourke, Thomas1; Rees, Myrddinn1; Tekkis, Paris2; Lyle, Nicola3;
Mustajab, Asmat4; Welsh, Fenella1; John, Timothy G1; Peppercorn, Delia3
1North Hampshire Hospital, Department of Hepatobiliary Surgery, Basing-
stoke, United Kingdom; 2St Mary’s Hospital, Imperial College, Department
of Biosurgery and Surgical Technology, London, United Kingdom; 3North
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Hampshire Hospital, Department of Radiology, Basingstoke, United King-
dom; 4North Hampshire Hospital, Department of Pathology, Basingstoke,
United Kingdom
Background. Hepatic parenchymal injury following chemotherapy for
colorectal liver metastases (CRLM) is associated with increased surgical
morbidity and mortality. Currently there is no non-invasive preoperative
investigation available that reliably predicts this parenchymal damage.
AIM: To evaluate the diagnostic precision of preoperative magnetic reso-
nance imaging (MRI) using two contrast agents (gadolinium and ferocarbo-
tran) for hepatic parenchymal injury prior to hepatic resection for CRLM.
Methods. Preoperative MRI criteria were used to score 37 patients with
CRLM by two independent radiologists, blinded to outcomes, for steatosis
and ferocarbotran uptake and compared to blinded standardized histopatho-
logical endpoints of steatosis, steatohepatitis and sinusoidal dilatation.
Sensitivity, specificity, predictive values, diagnostic accuracy and area under
the receiver operating characteristic curve were calculated for the MRI
sequences.
Results. On histological examination, severe steatosis, steatohepatitis and
sinusoidal dilation were evident in 6 (16.2%), 4 (10.8%) and 9 (24.3%)
patients respectively. The MRI steatosis score had a diagnostic accuracy for
detection of severe steatosis (97.3%, positive predictive value (PPV)100%)
and steatohepatitis (97.3%, PPV80%) but not sinusoidal dilatation
(62.2%, PPV0). Ferocarbotran-enhanced MRI had a higher diagnostic
accuracy for the detection of severe sinusoidal dilatation (78.3%, PPV
100%).
Conclusion. The present study demonstrated that liver-specific MRI
accurately predicted the severity of steatosis and steatohepatitis and less so
for sinusoidal dilatation. Liver-specific MRI may play a crucial role in the
pre-operative setting in diagnosing chemotherapy-induced hepatotoxicity and
timing of liver surgery for colorectal liver metastases.
PP 11.05
IMATINIB MESYLATE COMBINED WITH SURGERY FOR THE
TREATMENT OF PERITONEAL AND MULTIPLE LIVER METAS-
TASES FROM GASTRIC GASTROINTESTINAL STROMAL TU-
MOR
Jain, Sundeep1; Kalla, Komal2; Maru, Anish3; Kalla, Mukesh4
1S.K. Soni Hospital, Gastrointestinal & Laparoscopic Surgery, Sector 5,
Vidhyadhar Nagar, Jaipur, India; 2S.R. Kalla Memorial Hospital, Pathology,
Jaipur, India; 3S.K. Soni Hospital, Medical Oncology, Jaipur, India; 4S.R.
Kalla Memorial Hospital, Gastroenterology, Jaipur, India
Introduction. Imatinib mesylate is the first line of treatment for metastatic
GIST. Although the evidence in favor of surgery is growing, it is still
considered experimental for the treatment of metastatic GIST.
Methods. We present a case of a middle-aged female with metastatic GIST,
treated successfully with the combination of imatinib and surgery. The
English literature on the treatment of metastatic GIST is also reviewed.
CASE A 35 years old female underwent a subtotal gastrectomy for malignant
leiyomyosarcoma in September 1999. She presented to our hospital in
November 2005, with malignant ascites, multiple liver metastases and
intolerable pain in the right hypochondrium. The presence of C-KIT protein
was confirmed in the tissue from liver secondary and imatinib mesylate (400
mg daily) was started. After 2 months of treatment ascites was completely
resolved. In February 2006, R0 liver resection was performed for secondaries
causing intolerable pain. Postoperative period was uneventful with the
hospital stay of 5 days. She was discharged on maintenance imatinib therapy
(400 mg daily).
Results Patient was completely pain free at the time of discharge. She is
asymptomatic and disease free till date (18 months) after treatment with this
combined approach.
Conclusions. The combination of imatinib mesylate and surgery can prove
to be curative in selected patients whose disease is responsive to preoperative
imatinib therapy. However, more studies with large number of cases are
necessary to further evaluate the effectiveness of combination of imatinib and
surgery for the treatment of metastatic GIST. Postoperative maintenance
imatinib therapy is important to prevent recurrence.
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SUCCESSFUL RESECTION OF HEPATICTUMOR WITH PORTAL
TUMOR THROMBI DUE TO GASTRIC CANCER
Kawasaki, Atsushi1; Oida, Takatsugu1; Aramaki, Osamu1; Kuboi, Youichi1;
Mimatsu, Kenji1; Miyake, Hiroshi2; Amano, Sadao3
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Kasukabe Municipal Hospital, Surgery, Kasukabe, Japan; 3Nihon Univer-
sity School of Medicine, Surgery, Tokyo, Japan
Background. Portal vein tumor thrombus frequently develops in advanced
hepatocellilar carcinoma. However, it is extremely rare in gastric cancer, and
the prognosis of gastric cancer with extensive tumor thrombus in the portal
vein is poor. Obstruction of the portal vein can lead to cavenous transforma-
tion of veins, intestinal bleeding and ascites. Removal of the thrombus is the
only procedure preventing such situations. We report a rare case of metastatic
hepatic tumor from gastric cancer with a tumor thrombus in the portal vein.
Case Report. The patient was a 62-year-old man who underwent
gastrectomy due to gastric cancer. At 8 months after the surgery, follow-up
ultrasonography and computed tomography revealed a hepatic tumor with a
tumor thrombus in the portal vein without metastasis to either the extra-
abdominal region or lymph nodes. To prevent cavenous transformation of the
veins, intesitinal bleeeding and ascites, we performed right hepatic lobectomy
with removal of the tumor thrombus. The pathological findings yielded a
diagnosis of metastatic liver tumor from gastric cancer. The patient died of
peritoneal carcinomatosis at 1 year after the second operation. The period of
survaival after the surgery was short, however, he had maintained a good
quality of life for a while.
Conclusion. Extended excision of the liver might be useful for improving the
prognosis of such patients with a tumor thrombus in the portal vein from
gastric cancer.
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LIVER SURGERY AND MANAGEMENT OF NEUROENDOCRINE
HEPATIC METASTASES.
Sapisochin, Gonzalo; Bilbao, Itxarone; Escartin, Alfredo; Dopazo, Cristina;
Lazaro, Jose Luis; Olsina, Jorge; Balsells, Joaquin
Hospital Vall D?Hebron, HBP Surgery and Liver Transplant, Barcelona,
Spain
Introduction. Compared with most metastatic gastrointestinal tumors,
neuroendocrine cancers have a slow clinical progression and survival is
prolonged. Liver metastases are the most important predictor of poor survival
and resection is believed to be the first-line therapy.
Aims. To asses our experience in liver surgery of neuroendocrine liver
metastases.
Results. Between 19892006, 695 hepatectomies have been performed in
our unit, 9 (1,3%) for neuroendocrine metastases. Mean patients age was
57,5 years (r 3876);(4 males,5 females). Primary tumor was pancreatic in 7
cases (78%) (4 non-functioning, 1 VIPoma, 1 glucagonoma, 1 gastrinoma);
midgut carcinoid in 1 and carcinoid syndrome of uncertain origin in 1. Liver
metastases were diffuse in 5 cases, located on the left lobe in 3 and 1 on the
right lobe. Preoperative mean size of the biggest lesion was 591,5 cm and
78% of them were well delimited. Liver surgery was synchronic with the
primary tumor in 5 cases, after the primary tumor was treated in 2 and before
the primary tumor was identified in 2. Surgical procedures were 5 minor
hepatectomies and 4 major hepatectomies. Four patients required blood
transfusion. There was no postoperative mortality or acute liver failure. Eight
patients (88%) had progression of their disease after a mean follow-up of 38
months (r 6,589). Four of these patients were retreated, with re-hepatect-
omy, RFA or TACE; 2 of them are now waiting to be retreated. Progression
was local in 4 patients, systemic in 2 and both local and systemic in the other
2. Actuarial patient survival rates at 1 and 5 years were 100% and 78% while
actuarial patient survival rates free of disease at 1 and 5 years were 89% and
44%.
Conclusions. The relatively slow growth of these tumors makes debulking
surgery the first line of treatment and can occasionally result in cure. Surgery
must be performed even after progression is diagnosed, since it can increase
survival rates. Techniques such as RFA and TACE can be useful for a better
oncologycal control of the disease.
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MANAGEMENT OF LIVER METASTASIS FROM GASTROIN-
TESTINAL STROMAL TUMOURS: MULTIMODAL APPROACH
Damrah, Osama1; Sipos, Peter2; Pai, Madhava1; Wasan, Hapreet2; Canelo,
Rubin2; Habib, Nagy1; Jiao, Long1
1Hammersmith Hospital-Imperial College London, London, United King-
dom; 2Hammersmith Hospital, London, United Kingdom
Introduction. Liver metastasis from gastrointestinal stromal tumours
(GIST) is a major determinant of survival. A treatment strategy is crucial
to achieve the best survival. A multimodal approach for treatment of GIST
liver metastasis is reported here.
Methods. Database of patients with liver metastasis from GIST (n13)
treated at our unit between January 2002 and June 2006 were reviewed.
Treatment modalities included surgical resection, radio frequency ablation
(RFA), hepatic artery chemoembilisation (TACE), imatinib mesylate, and
selective internal radiation therapy using Yttrium microsphres (SIRTEX).
Patient and primary tumour clinicopathological characteristics and the extent
of intrahepatic and extrahepatic metastatic disease were recorded.
Results. There were 6 (46%) males and 7 (54%) females with a mean age of
65.59.7 years (range 4580). The primary tumour site was the stomach in
six patients (46%), terminal ileum three patients (23%), duodenum two
patients (15%) and the pelvis in two patients (15%). The mean size of the
metastatic liver lesions was 8.03cm 4.33sd. Liver resections were
performed in 7 patients. RFAs in 4 patients. In two patients TACE was
performed and one patient was treated with SIRTEX. Five patients were
treated with imatinib. One patient received 8 therapeutic modalities, 2
patients 7 modalities and one patient received 4 treatment modalities. The
more modalities were given the longer survival time was observed. Resection
and imatinib treatment significantly improved the survival time in compar-
ison with imatinib treatment alone (p0.031). Of all patients who under-
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went hepatectomy, three patients survived more than 5 years (23%) after the
initial hepatectomy. The average survival was 35.14 month.
Conclusion. multimodal approach for patients having liver metastasis from
GIST provides better survival rates. Treatment should be patient tailored,
and well-conducted prospective studies are needed to further evaluate the
different treatment options.
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RESECTION OF A METASTATIC LESION OF LARYNGEAL CAN-
CER IN THE LIVER AFTER LARYNGECTOMY: A CASE REPORT
Yazawa, Naoki; Imaizumi, Toshihide; Furukawa, Daisuke; Fukumitsu,
Hiroshi; Okada, Kenichi; Matsuyama, Masahiro; Oida, Yasuhisa; Ishii,
Masanori; Dowaki, Shoichi; Sugio, Yoshinori; Tobita, Kosuke; Ohtani,
Yasuo; Makuuchi, Hiroyasu
Tokai University School of Medicine, Department of Surgery, Isehara, Japan
We here report a markedly rare case that laryngeal cancer metastasized to the
liver after laryngectomy. A 58-year-old male underwent total laryngectomy for
laryngeal cancer in November 2004. Pathology revealed moderately differ-
entiated squamous cell carcinoma at stage IV (T4, N2). He received
chemoradiation therapy (S-1 and 50-Gy irradiation) postoperatively. In
February 2007, abdominal CT demonstrated a low-density mass in 3 cm in
diameter in S7 of the liver. Abdominal ultrasonography revealed an iso-echoic
mass in 313027 mm with a low-echoic marginal zone. SPIO-MRI
showed a high-intensity region in S7 of the liver by T2-weighted image. Upper
gastrointestinal endoscopy and barium enema revealed no abnormal findings.
Tumor biopsy was done for differentiation from cholangiocarcinoma and liver
metastasis of laryngeal cancer was diagnosed. Tumor markers were within the
normal range (CEA, 1.9 ng/ml; CA19-9, 25.9 U/ml; and SCC, 1.1 ng/ml).
Since there was no local or lymphatic relapse for 2 years and 6 months after
laryngectomy and liver metastasis was solitary, surgical indication was
determined. Liver S7 subsegmentectomy was carried out in June 2007, and
liver metastasis of laryngeal cancer was diagnosed pathohistologically.
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HEPATIC METASTASECTOMY FOR MEDULLARY CARCINOMA
OF THYROID
Babel, Nitin; Kumar, Naveen; Chamberlain, Ronald
Saint Barnabas Medical Center, Department of Surgery, Livingston, NJ,
United States
Introduction/Aim. Metastatic medullary carcinoma of the thyroid (MTC)
is an uncommon surgical problem and usually advanced at presentation.
Hepatic metastases from MTC may impair quality of life by hypercalcitone-
mia-associated diarrhea, pain or liver failure. We report a case of 58 year old
male with liver metastases from a primary MTC. We discuss potential role of
hepatic resection in these patients with review of pertinent literature.
Methods. A 58 year old male presented with constant, right upper quadrant
pain. Laboratory workup was normal. CT scan of abdomen showed a solid
5.9 cm mass in the right lobe of the liver. CT guided biopsy revealed a
metastatic non-small cell poorly differentiated carcinoma. Further evaluation
revealed a 4.5 cm mass in the left neck. PET evaluation revealed disease
limited to the neck and right liver. Fine-needle aspiration of the neck mass
confirmed MTC and plasma calcitonin levels were elevated at5300 pg/ml
(normalB10 ng/l). MEN syndrome was excluded prior to embarking on
surgical treatment.
Results. The patient underwent an R0 total thyroidectomy and central neck
dissection, which revealed a 6 cm MTC. Repeat evaluation revealed the liver
lesion had increased to 7.5 cm. The patient underwent an R0 right
hepatectomy, and RFA of potential smaller lesion on the left lobe of liver.
Pathology revealed metastatic MTC.
Discussion. MTC is a well-defined adult neuroendocrine tumor. Currently
there are no curative therapeutic options in metastatic MTC. Palliative
systemic chemotherapy regimen or TACE, irradiation and somatostatin
analogue have been employed but are unproven. Hepatic metastasectomy for
metastatic lesions of the liver may play a role in these patients. Amidst this
clinical dilemma, and considering our patient’s good performance status with
radiographically resectable disease, we persued surgical metastasectomy in an
effort to achieve maximal tumor control locally. At six months of follow up
with calcitonin and radiologic studies there are no signs of tumor recurrence.
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EVALUATION OF HUMAN LIVER REGENERATION AFTER PAR-
TIAL HEPATECTOMY BY HEPATIC EXTRACTION FRACTION
CALCULATED WITH 99mTc-MEBROFENIN
Tralhao, Jose1; Abrantes, Ana2; Cardoso, Dulce3; Figueirinha, Rita2;
Lourenc¸o, Candida3; Ponciano, Emanuel4; Botelho, Maria F4; Castro Sousa,
Francisco1
1Coimbra University Hospitals, Surgery, Coimbra, Portugal; 2Ibili-Faculty of
Medicine, Biophysics/Biomathmatics, Coimbra, Portugal; 3Coimbra Uni-
versity Hospitals, Nuclear Medicine, Coimbra, Portugal; 4Ibili-Faculty of
Medicine, Biophysics/Biomathematics, Coimbra, Portugal
Liver regeneration after hepatectomy (Hep) is a fundamental parameter of
liver response to injury. Much of the investigation on the mechanisms and
kinetic of hepatic growth has been done only in partially hepatectomized
animals and in hepatocytes primary cultures. The study of the hepatic
extraction fraction (HEF) by radioisotopic methods gives information about
physiological mechanism of uptake, transport and allows also the excretion
quantification of the hepatobiliary system by using 99mTc-IDA derivates.
This prospective study aimed to estimate the interest of HEF in the
evaluation of human liver regeneration/function of patients with hepatic
tumoral disease underwent partial Hep. 22 patients with colorectal metas-
tases (n18), hepatocellular carcinoma (n2) and others (n2) were
included. Liver function was assessed after intravenous bolus injection of
99mTc-Mebrofenin that was uptaked by the hepatocytes and eventually
excreted via billiary pathway without any change to its chemical structure.
The HEF is calculated using deconvolution analysis of first pass curve
coming from scintigraphic data. We evaluated the pre-operative HEF and in
the 5th day and one month after the hepatic resection. We considered the
HEF values of 98.890.4% (MED9SD) as normal. For statistical analysis,
T-Student test was used. The pre-operative, 5th day or one month after the
partial Hep HEF (MED9SD) was 98.3393.36%, 98.3793.06% and
97.195.37%, respectively. There was not statistically difference between
the three evaluations of HEF (ns). These results allow us to say that the
human liver regeneration is early enough to normalize the HEF at day 5 after
partial Hep, being this evaluation of undoubtedly interest to know the
function kinetics and indirectly knowledge about human liver regeneration.
Additionally, this fast functional liver recovery has high clinical importance,
once more aggressive adjuvant chemotherapy can start much early after
surgical treatment.
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CLINICAL SIGNIFICANCE OF PORTAL VEIN EMBOLIZATION
BEFORE RIGHT HEPATECTOMY
Nanashima, Atsushi; Sumida, Yorihisa; Sawai, Terumitsu; Nagayasu, Take-
shi; Yasutake, Toru
Nagasaki University Hospital, Division of Surgical Oncology, Nagasaki,
Japan
Aim. To identify clinical significances of portal vein embolization (PVE)
prior to major hepatectomy, we examined clinical parameters and outcome
after right hepatectomy in patients who underwent PVE.
Methods. The subjects were 30 patients who underwent PVE (PVE group),
and 52 patients (non-PVE), in whom PVE was considered unnecessary,
followed by right hepatectomy for hepatobiliary cancer.
Results. Total hepatic volume after PVE (10689268 ml) tended to increase
compared with before PVE (p0.059). After PVE, the change in hemi-liver
volume was 8.996.0%. Increases in hepatic volume of non-embolized left
liver before and at 4 weeks after hepatectomy between PVE and non-PVE
groups were similar. Changes in hepatic volumes before and after PVE were
not significantly influenced by background liver disease. After PVE, the
functional liver volume (4199185 cm3) was significantly lower than
morphological volume (5649165 cm3) in the embolized liver (pB0.05).
Although preoperative liver function was worse in PVE group compared with
non-PVE, serious hepatic complications were rarely observed in PVE group.
Conclusion. Marked changes in hepatic volume were noted after PVE in
patients with impaired liver function and those who need large-volume right
hepatectomy, especially in functional volume, suggesting that PVE is a useful
procedure to prevent post-operative liver failure.
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THE YIN AND YANG OF ISCHAEMIC PRECONDITIONING IN
LIVER REGENERATION PRODUCTION OF REGENERATIVE
MEDIATORS IN HUMAN HEPATOCYTES
Gomez, Dhanwant1; Graham, Anne2; Orsi, Nicholas3; Ekbote, Uma3; Burn,
J Lance4; Homer-Vanniasinkam, Shervanthi5; Prasad, K Rajendra6
1St. James’s University Hospital, Department of Hepatobiliary Surgery &
Transplant, Beckett Street, Leeds, United Kingdom; 2University of Bradford,
Department of Biomedical Sciences, Bradford, United Kingdom; 3St.
James’s University Hospital, Leeds Institute of Molecular Medicine, Leeds,
United Kingdom; 4University of Sheffield, Section of Oncology, Sheffield,
United Kingdom; 5Leeds General Infirmary, Leeds Vascular Institute, Leeds,
United Kingdom; 6St. James’s University Hospital, Department of Hepato-
biliary Surgery & Transplant, Leeds, United Kingdom
Introduction. Liver regeneration is crucial following major liver resection
and transplantation, particularly in cases of auxiliary and split-liver
transplantation. However, the beneficial effects of ischaemic preconditioning
(IPC) on liver regeneration following surgery is inconclusive. We aimed to
assess the cytokine and growth factor production by human hepatocytes
(n5) and evaluate the effect of IPC on these mediators in an in vitro
hypoxia-reoxygenation (H-R) model mimicking ischaemia-reperfusion
injury.
Methods. Confluent culture flasks of hepatocytes were subjected to H-R (1
hour hypoxia1 hour reoxygenation), IPC with H-R (10 minutes hypoxia
10 minutes reoxygenation1 hour hypoxia1 hour reoxygenation) and
compared to untreated controls. Production of interleukin (IL)-1 beta (b),
IL-1 receptor antagonist (IL-1ra), IL-6, IL-8, tumour necrosis factor-alpha
(TNF-a), transforming growth factor (TGF)-a and granulocyte-colony
stimulating factor (G-CSF) were determined over a 48 hour period.
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Results. IL-8, G-CSF and IL-1ra were produced by hepatocytes, while IL-
1b, IL-6, TGF-a and TNF-a were undetected in all groups. IPC prior to H-R
decreased IL-8 and G-CSF production over the 48 hour period compared to
H-R alone, in particular, decreased G-CSF levels at the 36 hour time-point
(56%). IPC prior to H-R decreased IL-1ra output by 52% and
35% compared to H-R alone after 8 and 12 hours respectively. Although
there was a trend for decreased IL-8, G-CSF and IL-1ra production, this
was not statistically significant between IPC-treated and non-IPC-treated
groups.
Conclusion. Hepatocytes produced pro-regenerative mediators such as IL-
8, G-CSF and IL-1ra. Although there was a trend towards decreased
production of these mediators, the beneficial effect of IPC in liver regenera-
tion remains inconclusive. The final effect on liver regeneration would
depend on the interaction of various liver cells and studies on co-culture
models are required.
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ISCHAEMIC PRECONDITIONING VERSUS INTERMITTENT
CLAMPING ON HUMAN HEPATOCYTES: EFFECTS ON CYTO-
KINES AND GROWTH FACTORS INVOLVED IN LIVER REGEN-
ERATION
Gomez, Dhanwant1; Graham, Anne2; Orsi, Nicholas3; Ekbote, Uma3; Burn,
J Lance4; Homer-Vanniasinkam, Shervanthi5; Prasad, K Rajendra6
1St. James’s University Hospital, Department of Hepatobiliary Surgery and
Transplant, Beckett Street, Leeds, United Kingdom; 2University of Bradford,
Department of Biomedical Sciences, Bradford, United Kingdom; 3St.
James’s University Hospital, Leeds Institute of Molecular Medicine, Leeds,
United Kingdom; 4University of Sheffield, Section of Oncology, Sheffield,
United Kingdom; 5Leeds General Infirmary, Leeds Vascular Institute, Leeds,
United Kingdom; 6St. James’s University Hospital, Department of Hepato-
biliary Surgery and Transplant, Leeds, United Kingdom
Introduction. Ischaemic preconditioning (IP) with continuous clamping
and intermittent clamping (IC) of the portal triad are distinct protective
strategies against ischaemia-reperfusion injury (IRI) following liver trans-
plantation and resection. However, their effects on liver regeneration are
undetermined. We aimed to evaluate the effects of IP and IC on cytokine and
growth factor production by human hepatocytes in an in vitro hypoxia-
reoxygenation (H-R) model to mimic IRI.
Methods. Confluent culture flasks of hepatocytes were subjected to H-R (1
hour hypoxia1 hour reoxygenation), IP with H-R (10 minutes hypoxia10
minutes reoxygenation1 hour hypoxia1 hour reoxygenation), IC (15
minutes hypoxia5 minutes reoxygenation x31 hour reoxygenation) and
compared to untreated Control. Differences in production levels of inter-
leukin (IL)-1 receptor antagonist (IL-1ra), IL-6, IL-8, tumour necrosis
factor-alpha (TNF-a), transforming growth factors (TGF)-a and granulo-
cyte-colony stimulating factor (G-CSF) were determined over 48 hours.
Results. The production of IL-6, TGF-a and TNF-a was undetectable. IP
prior to H-R decreased IL-8 production over 48 hours compared to H-R
alone. In comparison, IC increased the production of IL-8 at the 8, 12, 24
and 48 hour time-points. Both IP and IC decreased the production of G-CSF
by 56% and 55% at 36 hours, and by 20% and 15% at 48 hours, respectively.
There was no significant difference in IL-8 and G-CSF production between
IP- and IC- treated groups. IP prior to H-R decreased IL-1ra output by 52%
compared to H-R alone after 8 hours. By contrast, IL-1ra production was
significantly increased (56%) by IC at 8 hours (p0.019).
Conclusion. IP and IC equally influence the expression of IL-8 and G-CSF
in hepatocytes, with IC significantly influencing the release of IL-1ra between
4 to 12 hours. These results suggest that IC could potentially affect the liver
regeneration cascade more than IP.
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SYNERJIC PROTECTIVE EFFECTS OF RECOMBINANT HUMAN
ERYTHROPOIETIN AND 2-MERCAPTOETHANE SULFONATE
ON LIVER ISCHEMIA-REPERFUSION INJURY
Tasar, Py´nar; O¨zen, Yy´lmaz; Kilicturgay, A. Sady´k
Uludag U¨niversity, Medical Faculty, HPB Surgery, Bursa, Turkey
Aim. One of the important causes on mortality and morbidity in liver surgery
and transplantation is ischemia-reperfusion injury. The protective effects of
recombinant human erythropoietin (rhEPO) and 2-Merkaptoethane sulfo-
nate(MESNA), when applied together, on the injury of ischemia- reperfusion
has been investigated in this study.
Material and Method. Female Wister- Albino rats have been applied for 30
minutes duration hepatic ischemia and after that for 2 hours long reperfusion.
5 minutes before ischemia 1000IU/kg rhEPO, and 15 minutes before
ischemia 150mg/kg MESNA alone and combined were administered
intraperitoneally. At the end of the reperfusion, for estimating liver functions,
aspartate aminotransferase(AST), alanine aminotransferase(ALT), laktate
dehydrogenase(LDH) and gama-glutamyi transferase(v-GT) serum levels
were measured. Malondialdehyde(MDA), which is the main indicative of
lipid peroxidation in ischemia-reperfusion injury, was measured. Hystological
changes in tissues samples taken from rats’ liver, were also evaluated.
Results. It is found that plasma ALT, AST, LDH and v-GT levels were very
high in control groups. AST and ALT levels -especially for rhEPO group-
were in the range of normal limits. In the combined group, which has been
given MESNA and rhEPO treatment together, parankimal alterations in liver
tissue were less significant and necrosis did not occured.
Conclusion. It is clear that rhEPO treatment is quite more effective than
MESNA treatment in order to prevent oxidative injury. The combination of
these two agents has opbvious effects biochemically, and significant tissue
protection hystologhically in ischemia-reperfusion injury.
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SYNERGEIC PROTECTIVE EFFECTS OF RECOMBINANT HU-
MAN ERYTHROPOIETIN AND 2-MERCAPTOETHANE SULFO-
NATE ON LIVER ISCHEMIA-REPERFUSION INJURY
Tasar, Py´nar; Ozen, Yy´lmaz; Kilicturgay, Sadik
Uludag Universty Medical Faculty, U.U¨. Medical Faculty General Surgery,
Bursa, Turkey
Aim. Ischemia-reperfusion injury is a very well knowm cause of morbidity
and mortality in major liver surgery. Several agents have, and are being tried
to decrease this definitely hazardous clinical problem. In this study the
protective effects of the combined application of recombinant human
erythropoietin (rhEPO) and 2-Merkaptoethane Sulfonate (MESNA) are
investigated. Material and Method. Female Wistar- Albino rats were
anesthetized with 5 mg/kg Xylazine hydrochloride (IM) and 60 mg/kg
Ketamine hydrochloride (IM). Rats were subjected to 30 minutes duration
hepatic ischemia and after that 2 hours reperfusion. The rats of Group-A
(control) had ischemia-reperfusion only. Group-B rats were given 1000IU/kg
rhEPO, and Group-C rats had 150mg/kg MESNA 5 and 15 minutes before
ischemia respectively. Group-D rats were given rhEPO and MESNA with the
same doses and timing of Groups B and C. At the end of the reperfusion,
aspartate aminotransferase (AST), alanine aminotransferase (ALT), laktate
dehydrogenase (LDH) and gama-glutamyl transferase (a˜-GT) serum levels
were measured for liver function alterations. Malondialdehyde (MDA),
which is the main indicative of lipid peroxidation in ischemia-reperfusion
injury, was also measured. Hystological changes in tissue samples taken from
rats’ livers, were also evaluated under light microscopy.
Results. Plasma ALT, AST, LDH and a˜-GT levels were very high in control
groups. AST and ALT levels were in the range of normal limits in Groups B,
C and D (especially in group B). In the combined treatment group (Group-
D) parenchymal alterations in liver tissue were less significant and necrosis
did not occured.
Conclusion. It is clear that rhEPO treatment is quite more effective than
MESNA treatment in order to prevent oxidative injury. The combination of
these two agents has obvious protective effect biochemically, and significant
tissue protection hystologically in ischemia-reperfusion injury.
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POSTOPERATIVIE MORBIDITY AND LIVER REGENERRATION
AFTER LEFT HEMIHEPATECTOMY IN DONORS HAVING
GREATER THAN 50% STEATOSIS
Moon, Deok-Bog1; Lee, Sung-Gyu1; Hwang, Shin1; Kim, Ki-Hun1; Park,
Kwan-Woo1; Ha, Tae-Yong1; Ahn, Chul-Soo1; Song, Gi-Won1; Jung, Dong-
Hwan1; Choi, Nam-Kyu1; Ko, Kyoung-Hoon1; Kim, Kwan-Woo2
1Asan Medical Center, Seoul, Hepato-Biliary Surgery & Liver Transplanta-
tion, Seoul, Korea, Republic of; 2
Background & Purpose. Parenchymal transection of steatotic liver might
result in more bleeding intraoperatively, and higher risk of liver dysfunction
and surgical complications postoperatively. Hence, person with steatotic liver
is usually not acceptable as a living liver donor. At our institute, however,
steatotic donors has been permissible only if left sided hepatectomy is
indicated for dual-graft living donor liver transplantation(LDLT) under
urgent situation. We are aim to evaluate the postoperative courses of the
steatotic donors after left sided hepatectomy for LDLT.
Methods. We compared left sided hepatectomy patients according to
steatosis (¡A˜50% vs B10%) and presence of middle hepatic vein or not
between January 2002 and June 2005.
Results. There are left lobectomy(LL) group (18 patients), left lateral
sectionectomy(LS) group (10 patients) having more than 50% steatosis in
remaining right lobe, and control LL group (20 patients) having less than
10% steatosis. In steatotic groups, body mass index, ALT and cholesterol
level were higher and liver/spleen ratio was less than 0.9. Resection rate
between steatotic LL and control LL was 30.5¡344.2%, 29.7¡
3
44.2% respec-
tively, and was not different. One patient in steatotic LL was needed
transfusion during operation and the changes of hemoglobin level between
pre- and post-hepatectomy was significantly higher in steatotic LL(3.6gm/dl)
than steatotic LS(1.6gm/dl) and control LL2.1gm/dl). Postoperatively, AST
and ALT were higher in steatotic groups, but total bilirubin level was not
different. In steatotic LL, the frequency of middle hepatic vein thrombosis
and the degree of anterior segment congestion were more common and
severe than control LL. Regeneration of steatotic liver was not impaired in
steatotic groups and liver/spleen ratio was improved to more than 1.0 within 1
week.
Conclusions. When we have to use steatotic liver graft for LDLT, left lateral
section graft is a better option than left lobe graft including middle hepatic
vein.
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CYTOKINES PLAY AN ESSENTIAL ROLE IN THE LIVER RE-
GENERATION AFTER PORTAL VEIN EMBOLISATION
Pai, Madhava; Abulkhir, Adel; Damrah, Osama; Healey, Andrew; Habib,
Nagy; Jiao, Long
Hammersmith Hospital, Imperial College, Hepatobiliary Surgery, London,
United Kingdom
Background. Cytokines such as Interleukin-6 (IL-6), interleukin -1 (IL-1)
and tumour necrosis factor-U¨ (TNF- U¨) have been shown to play an
important role in initiation and maintenance of liver regeneration in rodents.
Aim. To examine the role of inflammatory process in liver regeneration in a
human model of liver regeneration following portal vein embolisation (PVE).
Methods. Fifteen patients with malignant hepatobiliary diseases including
colorectal liver metastasis CLM (n13), hepatocellular carcinoma HCC
(n1) and carcinoid metastasis (n1) underwent right PVE to induce liver
hypertrophy on the contralateral side. Serum concentrations of IL-6, IL-1,
and TNF- U¨ together with volumetric study before and after PVE were
analysed.
Results. Serum IL-6 concentrations increased one day after PVE (mean9
SE, 69.09929.08 vs. 3359 75 pg/ml, p0.0010) and TNF- U¨ change 199
11.18 vs. 75.31930 pg/ml, p0.04). The concentrations of IL-1 remained
unchanged 0.319 0 vs. 0.339 0 pg/ml, p1.000). The other inflammatory
makers included CRP and ESR showing (mean9SE, 1996 vs. 67.29917
mg/l, p0.007; 4397 vs 46.497.2 mm/hr unit, p0.45 respectively). The
mean volume of the contralateral non-embolised lobe grew significantly from
624.649 135 cm3 to 8049 253 cm3 (p0.04) after PVE whereas the size of
embolised lobe decreased significantly from 1216.439 420.42 cm3 to 9469
337.2 cm3 (p0.006). The future liver remnant was increased by 13% after
PVE.
Conclusion. Liver regeneration is an orchestrated response induced by
specific stimuli. Cytokines would seem to play an important role in
stimulating the production of acute phase reactants from hepatocytes. IL-6
and TNF- U¨ seem to play an important role in the early signalling pathway
contributing to the proliferation of hepatocytes and leading to liver
regeneration.
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LIVER REGENERATION FOLLOWING PORTAL VEIN EMBOLI-
SATION
Pai, Madhava1; Abulkhir, Adel2; Damrah, Osama2; Healey, Andrew2; Tait,
Paul3; Jackson, James3; Graham, Alison3; Habib, Nagy2; Jiao, Long2
1Hammersmith Hospital, Imperial College, Hepatobiliary Surgery, Du Cane
Road, London, United Kingdom; 2Hammersmith Hospital, Imperial Col-
lege, Hepatobiliary Surgery, London, United Kingdom; 3Hammersmith
Hospital, Imperial College, Radiology, London, United Kingdom
Background. Portal vein embolisation (PVE) is used clinically to induce
compensatory hypertrophy of the non- embolised lobe for patients under-
going major liver resection.
Aim. To assess the effect of PVE on liver regeneration measured by
volumetry.
Methods. Between 2000 and 2007, Fifty-seven patients with malignant
hepatobiliary diseases including colorectal liver metastasis (CLM, n43),
Cholangiocarcinoma (ChC, n6), hepatocellular carcinoma (HCC, n3),
carcinoid metastasis (n1) and others (n4) underwent right PVE (n44)
and right PVE with segment IV embolisation (n13) to induce liver
hypertrophy on the contralateral side. PVE was done using polyvinyl alcohol
(PVA) and steel coils. CT scan volumetric analysis was carried out before the
surgery to asses the total liver volume and the future liver remnant (FLR).
Computed tomography volumetry was carried out 68 weeks after portal vein
embolisation to assess left lobe regeneration.
Results. All embolisation procedures were technically successful. The side
effects included mild abdominal pain (n41), fever (n45), nausea and
vomiting (n37). There were no major complications except bile leak and
subcapsular hematoma in one patient. Calculated volume of the non-
embolised left lobe increased significantly from 6409164 cm3 before PVE
to 8549246cm3 after PVE (pB0.0001). The volume of the embolised right
lobe decreased from 11359421 cm3 before PVE to 9749326 cm3 after PVE
(p0.04). The FLR increased by 11% after PVE. Forty nine patients (86%)
have successfully completed the surgical resection with only 3 (0.06%)
patients having post resection transient liver failure.
Conclusion. PVE is a safe and effective procedure for increasing the future
liver remnant before major hepatectomy and does not complicate surgical
resection
PP 13.01
UNUSUAL FEATURES OF NON-FUNCTIONING PANCREATIC
NEUROENDOCRINE TUMORS
Benini, Ba´rbara; Trivin˜o, Marcelo; Apodaca-Torrez, Franz R.; DeOliveira,
Michelle L.; Trivin˜o, Tarcisio
University Federal of Sao Paulo-UNIFESP, Surgery-Division of Gastro-
intestinal Surgery, Sao Paulo, Brazil
Background. Pancreatic neuroendocrine tumors are uncommon when
compared to ductal adenocarcinoma of the pancreas. They account for 3
5% of all pancreatic tumors while constitute 3050% of pancreatic
neuroendocrine tumors. Few cases of non-functional pancreatic endocrine
tumors associated to cystic features have been reported.
Objective. The authors present two cases of rare non-functional pancreatic
endocrine cystic tumors with pathologic correlation.
Methods. Two female patients with nonfunctional cystic neuroendocrine
tumors, presenting abdominal pain were evaluated.
Results. Patients underwent pylorus-preserving pancreatoduodenectomy.
There was no related mortality or major morbidity. Patients are alive and
without recurrence fourteen years and five months after the surgical
treatment respectively. The macroscopic examination of the surgical speci-
men in both cases showed large cystic tumor in the head of the pancreas
whereas the immunohistochemistry markers were positively stained by
chromogranin A, neuro-specific-enolase and synaptophisyn.
Conclusion. Cystic neuroendocrine tumors represent a subgroup of
pancreatic cystic and neuroendocrine tumors with difficult preoperative
diagnosis because the majority of theses tumors are nonfunctional and
radiological imaging may not differentiate these tumors from other pancreatic
cystic tumors. Survival advantage may be evident in absence of liver
metastases and radical tumor resection.
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MANAGEMENT OF PANCREATIC NEUROENDOCRINE TU-
MORS: A SINGLE CENTER EXPERIENCE.
Olsina, Jorge Juan1; Sapisochin, Gonzalo1; Dopazo, Cristina2; Ganchegui,
Amaia2; Caralt, Mireia2; Escartin, Alfredo1; Naval, Javier1; Lazaro, Jose
Luis1; Bilbao, Itxarone1; Balsells, Joaquin1
1Hospital Universitario Vall D?Hebron, HBP and Liver Transplantation Unit,
Barcelona, Spain; 2Hospital Vall D?Hebron, HBP and Liver Transplantation
Unit, Barcelona, Spain
Introduction. Pancreatic Neuroendocrine tumors (PNET) are rare tumors
with a variety of clinical behaviors. These tumors may be functional,
symptom specific and diagnosed at an earlier stage, or nonfunctional.
Most of these tumors are initially benign, usually degenerate and show an
indolent course of disease, but if they spread to the liver survival rates can
decrease. Some of these tumors may be included in a genetic syndrome
such as MEN 1. OBJETIVE: To asses our experience on PNET in the last 6
years.
Results. From 2000 to 2006, 33 patients (17 male/16 female) with a mean
age of 56,1 years (r 2482) underwent surgery for PNET in our center.
Fourteen were nonfunctioning tumors (42%); 9 glucagonoma (27%); 3
insulinoma (9%); 3 ampullary carcinoid (9%); 2 gastrinoma (6%); 1 VIPoma
(3%) and 1 Somatostatinoma (3%). Two patients had a Von-Hippel-Lindau
disease, 2 had a MEN 1 and one of them a neurofibromatosis-1. Mean size of
the tumor was 4 cm (r 0,720 cm). Surgical procedures performed were 12
distal pancreatectomies with splenectomy, 2 distal pancreatectomies, 11
cephalic pancreaticoduodectomies, 2 total pancreaticoduodectomies and 1
enucleation. Perioperative mortality was seen in one patient. Six patients
(18,2%) have died with progression of their disease, 3 of them had liver
metastases at diagnosis. Twenty-six patients (78%) are alive, 7 of them (27%)
have recurrence with a mean time of 33 months, and 19 (73%) are free of
disease.
Conclusions. This single-center experience demonstrates that PNET can be
safely resected with a low mortality and morbidity. Patients with metastatic
disease benefit of an aggressive approach with a multimodality therapy that
may include RF, chemoembolization, liver resection, that may be done at the
moment of diagnosis or when recurrence is observed. This aggressive
approach is justified to optimize palliation and survival.
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3 CASES OF ADULT TYPE NESIDIOBLASTOSIS
Park, Kwan Tae; Shin, Haengchul; Kim, Songchul; Han, Duckjong
Asan Medical Center, Surgery, Seoul, Korea, Republic of
Introduction. Adult type of nesidioblastosis which cause hyperinsulinemic
hypoglycemia is extremely rare. It is so difficult to differentiate nesidioblas-
tosis from insulinoma preoperatively, which also cause hyperinsulinemic
hypoglycemia. And its clinical feature, prognosis and disease inheritance
trend are not clearly demonstrated. So, authors are to report our experiences
of 3 cases of nesidioblastosis suffering from hyperinsulinemic hypoglycemia.
Methods. Three cases of nesidioblastosis operated in Asan Medical Center,
Seoul was reviewed retrospectively.
Results. All of them were female and all of them was suffering from
hyperinsulinemic hypoglycemia evaluated with prolonged fasting test, image
studies of pancrease and portal vein sample test. Preoperatively one patient
was diagnosed as insulinoma, other patient could not be differentiated from
insulinoma and another patient was diagnosed as nesidioblastosis preopera-
tively. Subtotal pancreatectomy was performed and two of three patients were
relieved from hypoglycemia immediately after surgery, but one patient
remained on hypoglycemia. Histologic examination revealed no tumor lesion
of insulinoma but islet cell hyperplasia with ductuloinsular complex
consistent with nesidioblastoma. One patient died after 5 years from surgery
and 2 patients remained euglycemic during follow up period (mean 18mo).
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Conclusion. It is not easy to differentiate nesidioblastosis from insulinoma
preoperatively. Careful preoperative evaluation would be necessary especially
when no definite mass lesion detected on pancreas even by thorough
radiologic imaging study. Treatment of choice is operative reduction of
nesidioblastic islet cell hyperplasia. But, it is very difficult to decide the extent
of pancreatic resection in order to acquire successful cessation of hypogly-
cemia or not to cause pancreatic endocrine insufficiency from too extensive
resection.
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PANCREATIC TUMOURS IN THE YOUNG  MANAGEMENT
DILEMMA
Amjad, Nasser1; Kassian, Junaini1; Singh, Harbahajan2
1Kulliyah of Medicine, Jalan Hospital Campus, IIUM, Department of
Surgery, Kuantan, Malaysia; 2Hospital Tengku Ampuan Afzan, Department
of Surgery, Kuantan, Pahang, Malaysia
Pancreatic cancer rarely occurs in persons younger than 50 years and
endocrine tumours are uncommon representing less than 5% of all pancreatic
tumours. Majority of the endocrine tumours are usually small tumours (B
1cm). When young patients present with large tumours and inconclusive
biochemical and imaging results, surgeons face a management dilemma. We
present two young females, patient A who was 22 yrs and the other patient B,
35 yrs old. Both of them presented with more than three week history of
progressive obstructive jaundice. These two patients did not have any
symptoms or signs of functional endocrine or carcinoid syndromes. None
of them had any history of acute pancreatitis or family history of pancreatic
neoplasms. CT scan of patient A showed a mass in the head of the pancreas
measuring more than 6 cm in diameter while patient B had mass at the same
site measuring more than 9cm in diameter. At laparotomy the tumours
appeared malignant and was deemed operable. Decision was made to carry
out Whipple’s operation in both patients. Lymph nodes were dissected out
from the celiac axis in both patients. Patient A had a non-functioning
endocrine tumour and patient B a non-functioning carcinoid tumour. Both
made excellent progress and at three years follow-up are asymptomatic.
Radical surgery is indicated even in young patients when faced with uncertain
diagnosis
PP 13.05
HEPATO-PANCREATICODUODENECTOMY (HPD) COMBINED
WITH TRANSARTERIAL EMBOLIZATION (TAE) FOR THE
TREATMENT OF MALIGNANT GLUCAGONOMA WITH LIVER
METASTASES.
Hoshino, Takanobu; Ishida, Takashi; Odaka, Akio; Hashimoto, Daijo
Saitama Medical University, Medical Center, Hepato-pancreato-biliary
Surgery, Kawagoe-city, Japan
Objective. To elucidate how best to treat malignant endocrine tumors of the
pancreas associated with multiple liver metastases.
Methods. Hepato-pancreaticoduodenectomy (HPD) combined with trans-
arterial embolization (TAE) was successfully and effectively performed in a
patient with malignant glucagonoma with multiple liver metastases. A 56-
year-old male patient, complaining of skin erosion, erythema, and body
weight loss, was admitted and diagnosed as glucagonoma based upon
markedly elevated serum glucagon level (2037 pg/ml). Abdominal CT and
ultrasonography demonstrated the existence of a hypervascular tumor of the
pancreas head (3.8 cm in diameter) and multiple liver metastases (in S3, S5,
and S8). Since medical treatment with octreotide acetate, somatostatin
analogue, was not effective in controlling the tumors and glucagon level,
surgical treatment (HPD) was performed to resect pancreas head tumor and
metastatic tumors in the liver.
Results. Immediately following HPD, serum glucagon level dropped quickly,
and skin lesions were also substantially improved. A year after the surgery,
several liver metastases appeared, which were repeatedly treated by TAE,
resulting in no rapid growth in number or sizes. This patient is still alive, free
of symptoms, with several small liver metastases at three years six months
following surgery.
Conclusion. Malignant endocrine tumors of the pancreas, such as glucago-
noma, appears to be effectively treated by combination of surgical resection
and TAE, even if associated with multiple liver metastases.
PP 13.06
VIPOMA: A RARE CASE OF PANCREATIC MASS
Cheung, Chin Cheung; Wong, Wai Man; Leung, Kam Fung
Tuen Mun Hospital, Department of Surgery, Tuen Mun, Hong Kong
Introduction. Vasoactive intestinal polypeptide secreting tumor (VIPoma) is
a rare pancreatic neuroendocrine tumor. The incidence is one in 10 million.
Patients usually present with chronic diarrhea and are diagnosed late because
it is slow growing. About 50% of patients have metastatic spread by the time
of diagnosis.
Objective. The aim is to find the result of surgical resection in one case of
VIPoma of the pancreatic neck with liver metastasis.
Method: A 44-year-old lady was diagnosed by typical symptoms (profound
watery diarrhea for two years with hypokalemia), high serum level of VIP, and
radiological findings. Abdominal ultrasonography and computed tomography
(CT scan) revealed a 34cm mass in the neck of pancreas with local invasion
to the portal vein and multiple subcentimetre hyperenhancing nodules in
liver.
Result: Patient was treated with Sandostatin (Novartis) for symptomatic
control in view of liver metastasis. Re-stage CT scan was done three months
later revealed no hyperenhancing nodules found. Spleen-sparing distal
pancreatectomy with wedge excision of portal vein was done. Intra-operative
ultrasonography revealed a subcentimetre nodule in segment IVa, wedge
excision of the liver nodule was also performed. The immunohistochemical
examination was compatible with VIPoma of pancreas with regional lymph
nodules and liver metastases. Patient was well with immediate resolving of
symptoms and normalization of VIP level. She was regularly followed up
without evidence of recurrence up to one year.
Conclusion. A case of VIPoma of the pancreas with liver metastasis was
treated successfully by aggressive surgical resection.
PP 13.07
CLINICOPATHOLOGIC FINDINGS OF SOLID-PSEUDOPAPIL-
LARY TUMORS
Oida, Yasuhisa; Imaizumi, Toshihide; Matsuyama, Masahiro; Yazawa, Naoki;
Tobita, Kosuke; Ohtani, Yasuo; Makuuchi, Hiroyasu
Tokai University School of Medicine, Digestive Surgery, Isehara kanagawa,
Japan
Background. Solid-pseudopapillary tumor of the pancreas (SPT) is a rare
disease with a low-grade malignancy. It most commonly occurs in young
women and has unique pathologic features. Despite growing interest in this
tumor, histogenesis of these tumors is unknown and still under consideration.
Aim. To evaluate the clinicopathological features of this tumor.
Methods. The clinical features of eight surgically treated cases in our
hospital between January 1994 to July 2007, were retrospectively reviewed.
Results. All patients were Asian and female. The mean age was 20 year-old
(range, 14 to 34). Four patients presented with abdominal pain at
presentation, 2 with palpable mass, 1 with nausea. Four tumors were located
in tail, 1 in body, and 3 in head. CT and MRI revealed a well demarcated
solid-cystic mass in the pancreas with slight enhancement of the cystic wall.
The maximal diameter of tumors ranged from 3.8 to 12 cm (mean, 7.5cm).
Surgical procedures included distal pancreatectomy with splenectomy in four
patients and enucleation in four patients. All tumors contained some degree
of internal hemorrhage or cystic degeneration, and were well encapsulated.
Microscopically these tumors were characterized highly cellular portion
composed of papillary arrangement of monotonous uniform polygonal cells
around delicate and often myxoid fibrovascular stalks. All of these tumors
were diffusely and strongly immunoreactive for ¿-1-antitrypsin and ¿-1-
antichymotrypsin, and negative for estrogen receptor. One patient developed
single liver metastasis 3 years after first operation, the tumor was enucleated.
All patients were alive without evidence of recurrence with a follow-up of 9 to
74 months.Conclusion. The behavior of SPT was less aggressive than other
pancreatic tumors, even in a case with metastasis. The diagnosis can be made
preoperatively with the combination of radiological and clinical features, and
minimally surgery such as enucleation is applicable.
PP 13.08
‘‘NONFUNCTIONAL’’ NEUROENDOCRINE TUMORS (NNETs)
OF THE PANCREAS: DIAGNOSTIC CRITERIA AND SURGICAL
TREATMENT.
Kubyshkin, Valery1; Kochatkov, Alexander1; Gurevich, Larisa2; Stepanova,
Yulia3
1A.V. Vishnevsky Institute of Surgery, abdominal surgery department,
Moscow, Russian Federation; 2MONIKI, Moscow, Russian Federation;
3A.V. Vishnevsky Institute of Surgery, radiology department, Moscow,
Russian Federation
Background. NNETs of the pancreas are rare lesions with better prognosis
in comparison with pancreatic adenocarcinomas (PAC). The differences in
long term survival make it necessary to preoperatively differentiate NNETs
with PAC for appropriate treatment of these patients.
Methods. Data of preoperative examination, surgical procedures and long
term survival of 62 patients with NNETs and 98 patients with PAC were
compared to find differential diagnostic criteria. All tumors were verified
morphologically and immunohistochemicaly.
Results. We did’t find specific clinical symptoms of NNETs. The main
clinical symptom of the disease was a palpable tumor in 20% of the patients.
NNETs were located in the pancreatic head, body and tail, in 54.8% (34 pts),
25.8% (16 pts) and 19.4% (12 pts). The possibility of accurate differential
diagnosis between NNETs and PAC by US and spiral CT was assessed
relying on the different grade of visualization of the solid part and
vascularization of the tumors. Whipple procedures were performed on
37.1% (23 pts) patients, distal pancreatectomies on 25.81% (16 pts), tumor
enucleations on 30.65% (19 pts), laparotomies on 3.23% (2 pts) and
laparoscopies on 3.23% (2 pts). The mean size of the removal tumors were
8.2 cm, 6.5 cm, 2.7 cm during Whipple procedures, distal pancreatectomies
and tumor enucleations, consequently. Three patients had RFA-procedures
of hepatic metastasis after tumor resections. The median survival of the
NNETs patients was 55.4936.1 months in contrast of the median survival
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patients with PAC that was 11.899.2 months. The difference between the
survivals is statistically significant (p0.01).
Conclusions. The precise preoperative differentiation of NNETs and
pancreatic adenocarcinoma and staging are the keys to correct surgical
treatment of the patients. Acceptable survival of the patients with the NNETs
makes tissue-preserving surgical procedures on patients with small NNETs as
well as surgical treatment of hepatic metastasis worthwhile.
PP 13.09
EXOCRINE FUNCTION IN THE TYPE 2 DIABETIC PANCREAS
MAY NOT BE IMPAIRED IN ALL POPULATIONS
Bodapati, Archana1; Turner, Richard2; Sinha, Ashim2
1James Cook University, Cairns, Australia; 2Cairns Base Hospital, Cairns,
Australia
Background. Published reports suggest an association between pancreatic
exocrine insufficiency (PEI) and diabetes mellitus (DM). The evidence for
this is weak, as the invasive nature of tests utilized in such studies precluded
recruitment of large non-selected samples. Recently, reduced faecal elastase-
1 concentration (FEC) has been used to screen for PEI. Evidence of reduced
FEC in type 2 DM exists; however it has not been studied in all populations.
Aim. The study aimed to define associations between FEC and type 2 DM
in a regional Australian population.
Methods. 33 type 2 diabetic patients were randomly selected from a local
hospital and individually matched for age and sex to 33 controls with no
clinical or documented history of DM.
Results. FEC was higher in diabetics compared to controls (p0.60). PEI
was found in 41% of controls and 33% of diabetics (p0.41). Increasing age,
the male sex, a high body mass index, high blood pressure, lack of exercise,
smoking, and alcohol consumption appeared to be associated with reduced
FEC; however this was not a significant association. Among diabetic subjects,
non-significant trends for low FEC were found with clinical markers (long
duration of known DM, presence of complications, insulin therapy) and
biochemical markers (poor glycaemic control) of DM severity and athero-
genic lipid profiles.
Conclusions. Overestimation of the difference to be detected may be
responsible for the lack of power and contributed to the statistically non-
significant Results. Despite this, trends identified suggest PEI in type 2 DM
may not be problematic in our population. These results do not support a
recommendation for universal screening for PEI in the diabetic population
studied. It is possible that the non-significant association reflects recruitment
of predominantly mildly affected diabetics. Thus, future studies may benefit
from staging their diabetic participants using C-peptide. Larger case-control
or cohort studies are required to further explore the relationship.
PP 13.10
SOLID PSEUDOPAPILLARY TUMOR OF THE PANCREAS: AN
UNUSUAL PRESENTATION
Tellioglu, Gurkan1; Krand, Osman1; Berber, Ibrahim1; Kilicoglu, Gamze2;
Titiz, Izzet1
1Haydarpasa Numune Research and Training Hospital, General Surgery,
Istanbul, Turkey; 2Haydarpasa Numune Research and Training Hospital,
Radiology, Istanbul, Turkey
Aim. The aim of this case report is to discuss the surgical treatment of solid
pseudopapillary neoplasm of the pancreas (SPN) in case of unusual
presentation.
Case Report. 19 year-old male patient referred to our clinic with mild
abdominal pain. Physical examination revealed normal findings. Abdominal
ultrasonography (US) revealed a solid mass located in the neck of the
pancreas, and as 6.5 cm in diameter. Contrast enhanced abdominal CT
revealed a solid mass lesion located in the panceatic neck. Body of the
pancreas was atrophic nd there was no dilatation of the pancreatic duct. The
lesion was heterogenously hypodense on noncontrast CT, while it demon-
strated significant, but heterogeneous contrast enhancement with hypodense
areas in the center and the periphery of the lesion. There was no evidence of
adjacent solid organ invasion. Preoperative US-guided fine needle aspiration
biopsy (FNAB) was not considered since perilesional dense vascularity
precluded the intervention. Laparotomy was undertaken. The tumor was
not invasive and soft in texture. Peripancreatic lymphadenopathies were
excised and frozen section analysis reported reactive hyperplasia. The lesion
was well encapsulated. Distal pancreatectomy without splenectomy was
performed. The patient was discharged after an uneventfull postoperative
course. Histopathologic examination revealed solid pseodopapillary tumor
(SPN) of pancreas with clear surgical margins including an invasive
component. Patient completed the one year follow-up without evidence of
recurrence.
Discussion. The differential diagnosis of SPN with malignant transforma-
tion is not possible unless metastatic lesions and/or local invasion detected.
Spleen preserving distal pancreatectomy is justified in the literature for the
lesions located in the tail of pancreas. Long-term follow-up of patients treated
with spleen preserving distal pancreatectomy with SPN expressing invasive
component is needed.
PP 14.01
GALL BLADDER CANCER WITH TUBERCULOSIS
Singh, R. P.1; Singh, Shivendra1; Agarwal, Shaleen1; Sakhuja, Puja2; Puri,
Sunil3; Agarwal, Anil1
1G.B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India; 2G.B. Pant Hospital and Maulana Azad Medical
College, Pathology, New Delhi, India; 3G.B. Pant Hospital and Maulana
Azad Medical College, Radiology, New Delhi, India
Background & Aim-Gall Bladder Cancer has a very high incidence in
Northern India and tuberculosis is also still common. We herein report our
experience of unusual coexistence of tuberculosis in patients with Gall
bladder cancer and its impact on the management. Methods-We present 6
cases from 20032007 who presented with a diagnosis of Gall Bladder cancer
and were also found to have evidence of tuberculosis on workup. Results-
There were 6 females, mean age 56.6 yrs. The preoperative imaging of the
patient was suggestive of mass in the GB area. 2 patients had supraclavicular
lymph nodes palpable on preoperative examination. Fine Needle aspiration
cytology (FNAC) of the cervical lymph nodes was positive for tuberculosis on
histopathological examination. In the third patient on diagnostic laparoscopy,
multiple peritoneal nodules were detected which were tubercular on HPE. 2
patients had inter-aortocaval lymph nodes frozen positive for tuberculosis. In
one patient the HPE report of the radical cholecystectomy specimen was
granulomatous lymphadenitis of hepatoduodenal ligament lymph nodes. 4
patients underwent Radical Cholecystectomy.
Conclusions. This paper presents cases in which Gall bladder cancer and
tuberculosis co-existed. It highlights the importance of confirming the
presence of distant metastasis by histopathological examination (FNAC or
biopsy) before discarding the patient for curative surgery in a patient with
locally resectable GBC on imaging.
PP 14.02
SURGICAL TREATMENT OF GALLBLADDER CARCINOMA. A
COMPARISON OF TWO PERIODS
Olivares, Gabriel1; Guerra, Juan Francisco1; Funke, Ricardo1; Jara, Jimena1;
Tapia, Grace1; Torres, Javiera2; Martı´nez, Jorge1; Guzma´n, Sergio1; Iban˜ez,
Luis1; Jarufe, Nicola´s1
1Universidad Cato´lica de Chile, Digestive Surgery, Santiago, Chile; 2Uni-
versidad Cato´lica de Chile, Pathology, Santiago, Chile
Introduction. Gallbladder carcinoma is a lethal malignancy, with poor
survival Results. Chile has one of the most highest rates of this cancer in the
world. The aim of this study is to compare two periods regarding surgical
strategy and if an aggressive approach improves survival rates.
Methods. A retrospective database of patients who underwent surgery for
gallbladder carcinoma from 1978 to 2007 was reviewed. Two time period
were defined. P1: patients operated from 1978 to 1997 (n165); and P2:
patients from 1998 to 2007 (n35) where an aggresive surgical approach
was applied
Results. A total of 200 patients were analyzed. Demographic and clinico-
pathological data were comparable in both groups. Preoperative diagnosis
moved from 34% (P1) to 54% (P2). Curative intent surgery was performed
in 46 patients of P1 (28%) and in 23 cases of P2 (65%). Radical resections
(wedge, IV and V segments, extrahepatic bile duct) varied from 8% in the first
period to 65% in the second. Morbidity and mortality rates improved from
28% and 6% for P1 to 14% and 0% for P2, respectively. Actuarial survival
rate was 7.9% for P1 and 21% for P2.
Conclussion. In our series, increase of curative intent surgery and radical
resections represents an improvement in overall and median survival rates,
with decreased perioperative morbidity and mortality
PP 14.03
ROLE OF NEOADJUVANT CHEMOTHERAPY IN LOCALLY AD-
VANCED GALLBLADDER CANCER: AN EARLY REVIEW
Chaudhari, Ashish1; Chhabra, Deepak1; Navadgi, Suresh2; Shah, Rajiv C.1;
Jagannath, Palepu1
1Lilavati Hospital And Research Center, Surgical Oncology, MUMBAI,
India; 2Asian Institute of Oncology-S. L. Raheja Hospital, Gastrointestinal
Service, MUMBAI, India
Background. Gallbladder cancer (GBC) has dismal survival due to
advanced stage at presentation. Neoadjuvant Chemotherapy for GBC is still
under evaluation.
Introduction. Majority of patients with GBC have an advanced disease
(stage III, IV) at presentation. Five year survival in stage I and II is over 80%,
however, overall five year survival is only 15%. Palliative chemotherapy has
produced 2030% response. This retrospective study analyzes response of
neoadjuvant chemotherapy in locally advanced GBC.
Patients and Methods. 15 patients with locally advanced and unresectable
GBC (February 2001 to May 2007) who received neo-adjuvant chemother-
apy were analyzed. All patients received 21 day cycle of Gemcitabine
1000mg/m2 on day 1 and day 8 and Cisplatin 100mg/m2 on days 1, 2 and
116 Abstracts
3. The response was measured on serial CT scans. Patients were categorized
as PR (partial response), SD (stable disease) or PD (progressive disease) as
per WHO guidelines. Patients with PR were offered surgery.
Results. 15 patients included 4males and 9 females. 13/15 patients (86.66%)
showed PR, while 2 patients had SD. 11 underwent radical cholecystectomy,
1 Median Hepatectomy. 3 patients (1 PR, 2 SD) had peritoneal disease on
exploration. Neoadjuvant chemotherapy increased resectability. There was
no operative mortality. One patient died of recurrence 4 months after radical
cholecystectomy. A median survival of 9 months and 4 months was noted in
the resected and unresected group respectively.
Conclusions. Neoadjuvant chemotherapy; Gemcitabine and Cisplatin, has a
promising role in downsizing locally advanced gallbladder cancer, thereby
increasing resection rate and improving median survival.
PP 14.04
FACTORS INFLUENCING THE LONG TERM SURVIVAL OF T2
AND T3 ADENOCARCINOMA OF GALL BLDDER
Chen, Miin-Fu1; Jan, Yi-Yin1; K., Dilip Chakravarty2
1Chang Gung Memorial Hospital, Department of General Surgery, Taipei,
Taiwan; 2Chang Gung Memorial Hospital, Fellow in HPB Surgery, Dept. of
General Surgery, Taipei, Taiwan
Introduction. Adenocarcinoma of gallbladder when symptomatic present as
advanced carcinoma and carries poor prognosis. With the improvement in
preoperative assessment, imaging, staging and surgical hepatobiliary resec-
tion and better survival is possible.
Objective. This is retrospective study carried out from 1996 to 2006 in
Chang Gung Memorial Hospital, Taipei, Taiwan to study the factors
influencing the long term survival in T2 and T3 adenocarcinoma of
gallbladder.
Methods. In this study only T2 and T3 adenocaricnoma of gall bladder were
included. T1 and T4 malignancies and other malignancies of gallbladder are
excluded. Total 52 cases with T2 and T3 adenocarcinoma of gall bladder
have undergone both curative and palliative surgical resection, out of which
T2 adnocarcinoma are14 in no.(26.9%) and T3 adenocarcinoma are 38 in
no.(73.1%). The factors which were taken into consideration are staging of
tumor, lymph node metastasis, tumor marker levels, liver function tests, type
of surgery offered to the patient, operative complications and post operative
chemotherapy and/or radiotherapy.
Results. The overall cumulative survival rates in T2 and T3 adenocarcinoma
of gallbladder in 1st, 3rd and 5th yr are 60.6%, 44.2% and 40.5%
respectively. In Univariate analysis of 52 patients show that significant
prognostic factors are CEA level, T staging, lymph node metastasis,
pathological stage, and type of surgery (all pB0.05). T staging hazard ratio
3.279 (1.77910.087) with a p-value of 0.053 and type of resection (curative/
palliative) has a hazard ratio of 3.984 (0.9878.929) with a p-value of 0.001
by multivariate analysis using the Cox Proportional Hazards Model.
Conclusion. T2 and T3 Adenocarcinoma of gallbladder has better long term
survival provided that the disease is diagnosed in early stage and proper
staging and curative radical surgery.
PP 14.05
AGGRESSIVE TREATMENT OF GALL BLADDER CANCER
Singh, R.P.; Singh, Shivendra; Mandal, Sanjoy; Agarwal, Shaleen; Mishra, P
K; Sakhuja, Puja; Agarwal, Anil
G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India
Background. Carcinoma of the gall bladder is a common disease in North
India and carries a poor prognosis. Here we present a Single centre
experience of the surgical management of Gall bladder cancer (GBC)
patients from 20002007.
Methods. Total of 411 patients were taken for resections, 158 with SOJ
(38.44%), 253 without SOJ (61.55%). 338 patients underwent resection with
a curative intent (104 with SOJ & 234 without SOJ).
Results. Of these patients, 164 had curative resections. Amongst these 164
curative resections 44 were in patients with SOJ & 120 in pts without SOJ.
The overall resectability was 39.90% (27.85% for SOJ group & 47.43% for
non SOJ group). In pts undergoing curative resections, Seg IVBV were
resected in 146 pts, Seg IVbVVI were resected in 3 pts & Ext. RH was
done in 15 pts (9.03%). Adjacent organ was involved in 53 pts. In these pts
with adjacent organ involvement, duodenal sleeve was resected in 17 pts,
distal GastrectomyD1 resection was done in 24 pts, colon was resected in
23 pts, pancreaticoduodenectomy was required in 2 pts, vascular reconstruc-
tion/ligation was done in 10 pts. The morbidity and mortality rates were 42%
& 12.17% respectively for pts with jaundice. The same figures were 11% &
4.3% for pts without SOJ.
Conclusion. Aggressive approach results in better resectability and im-
proved survival in Gall bladder Cancer.
PP 14.06
COMPARISON OF TREATMENT Results IN PRIMARY VS POST-
CHOLECYSTECTOMY PRESENTATION IN GALL BLADDER
CANCER: EXPERIENCE AT A TERTIARY CANCER CENTER IN
INDIA
Gupta, Vivek1; Deo, SV Suryanarayana2; Kumar, Sunil2; Kar, Madhaba-
nanda2; Shukla, Nootan K2
1Institute Rotary Cancer Hospital, Surgical Oncology, All India Institute of
Medical Sciences, New Delhi, India; 2Institute Rotary Cancer Hospital, All
India Institute of Medical Sciences, Surgical Oncology, New Delhi, India
Background. Carcinoma gall bladder is an aggressive malignancy with
dismal treatment Results. The aim of this study was to review the treatment
results of carcinoma gall bladder cases (primary vs postcholecystectomy
presentation) operated in a tertiary care centre in India and reasons for
unresectability in these patients.
Methods. A retrospective analysis of 56 patients with carcinoma gall bladder
operated between 1996 and 2006 was done. Only 56% of total outpatients
with gall bladder cancer were found suitable for surgical exploration. If
resectable, radical cholecystectomy with wedge resection of the liver with
minimum of 2 cm margin and porto-coeliac lymphadenectomy was done.
Patients with transmural infiltration of tumor or pathological node involve-
ment also received adjuvant chemoradiotherapy.
Results. Curative resection was done in 47% of the patients. Thirty patients
had undergone simple cholecystectomy previously. Rate of curative resection
was higher in postcholecystectomy group (57% vs 30%), possibly because of
incidental detection. Among postcholecystectomy patients resectability rate
was better in post laparoscopic group as compared to open (54% vs 42%).
Major nonmetastatic reasons for inoperability were extensive nodal involve-
ment/residual disease and dense periportal fibrosis. Pathologically trans-
mural/nodal involvement were present in 80% of curatively resected group.
Three year disease free and overall survival for curatively resected patients
was 54% and 64% respectively whereas 3 year overall survival for the total
patient population was 34%.
Conclusion. Gall bladder cases with primary presentation have lower
resectability rate as compared to postcholecystectomy cases. With judicious
patient selection and multimodality treatment approach reasonable survival
results can be achieved. Patient should be referred to a specialist center if
preoperative/intraoperative suspicion of gall bladder malignancy is present.
PP 14.07
AGGRESSIVE MANAGEMENT OF PATIENTS WITH GALL
BLADDER CANCER- IS IT WORTHWHILE?
Varma, Vibha1; Gupta, Subash2; Soin, Arvinder3; Nundy, Samiran4
1Nizam’s Institute of Medical Sciences, Department of Surgical Gastro-
enterology, Panjagutta, Hyderabad, India; 2Indraprastha Apollo Hospitals,
Liver Transplant and Gastrosurgery, New Delhi, India; 3Sir Ganga Ram
Hospital, Multi Organ Transplantation Unit, New Delhi, India; 4Sir Ganga
Ram Hospital, Department of Surgical Gastroenterology, New Delhi, India
Background. Gall bladder cancer (GBC) the commonest cause of malig-
nant obstructive jaundice in Northern India is considered to be an aggressive
and incurable disease. Recent data supports aggressive surgical resection even
in advanced stages of disease with improved survival statistics.
Objective. We reviewed our data on 120 operated patients of GBC to assess
whether radical surgical resection translated to better survival in GBC.
Material and Methods. Of the 129 cases of GBC admitted between July
1996 and July 2003, 120 were offered surgical treatment. There were 45
males and 75 females with a mean age of 54 (range 23 to75) years. Details of
demographic data, clinical features, preoperative staging using TNM staging
system, surgical treatment, follow up and their survival was analyzed.
Results. Pain in the right hypochondrium was the commonest symptom
(78%), followed by abdominal lump (57%) and jaundice (52%). Gallstones
were found in 62% and 17% presented with gastric outlet obstruction.
Seventy-eight of 84 patients with jaundice and, or abdominal lump had
advanced stage GBC. Four patients had stage I disease, 16 stage II, 28 stage
III and 72 had stage IV disease. Radical surgical procedures were performed
in 64 (53%) patients. Operative mortality was 7.5%. Seventy two (60%)
patients were followed up. The median overall survival after curative
procedure was 21 months (range 463 months) compared with 9 months (
range 1- 32months) for other procedures (p0.000).
Conclusion. Majority (83%) of patients with GBC have advanced stage
disease at presentation. About half of patients with GBC are amenable to
radical surgery. An aggressive surgical approach in GBC is associated with a
longer survival.
PP 14.08
ESTROGEN RECEPTOR ¥A´, ¥Aˆ AND PROGESTERON RECEP-
TOR AS A POSSIBLE PROGNOSTIC FACTOR IN RADICALLY
RESECTED PRIMARY GALLBLADDER CARCINOMA
Park, Joon Seong1; Kim, Jae Keun1; Jung, Wo Hee2; Hwang, Ho Kyoung1;
Cho, Sin Il1; Yoon, Dong Sup1; Chi, Hoon Sang1; Kim, Byong Ro1
1Yonsei University Colledge of Medicine, Surgery, Seoul, Korea, Republic of;
2Yonsei University Colledge of Medicine, Pathology, Seoul, Korea, Republic
of
Background.: Gallbladder carcinoma is a relatively rare malignancy with an
extremely poor prognosis. The pathologic staging of gallbladder carcinoma is
a key determinant of the patient¡*s prognosis and the treatment options.
However, we have often encountered patients in whom the course of their
disease differed substantially from what would be predicted based on their
clinical staging, which highlights the needs to consider additional predictive
factors. Gallbladder carcinoma occurs more frequently in women than men,
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yet expression of the estrogen receptor(ER) family and progesterone(PR)
have not been studied. We applied an immunohistochemical technique to
examine the expression of ER¥a´, ER¥aˆ and PR in radically resected
gallbladder carcinoma tissues and then compared their expression status
with several clinicopathological factors.
Methods. We immunohistochemically investigated 30 specimens of gall-
bladder adenocarcinoma tissues using ER¥a´, ER¥aˆ and PR antibodies. The
expression of ER¥a´, ER¥aˆ and PR were compared using the Chi-square test.
Survival was analyzed using the Kaplan-Meier method.
Results. The results indicated that adenocarcinoma of gallbladder are both
negative for ER¥a´ and PR, irrespective of histologic grade, TNM stage and
sex. However, twenty-two of 30 cases (73.3%) were confirmed positive for
ER¥aˆ, which was significantly correlated with poor differentiated tumor
grade. Overall survival rates of ER¥aˆ-positive and negative patients were
77.3% and 37.5%, respectively (p0.034). In multivariate analysis, only
ER¥aˆ was statistically significant (p0.033).
Conclusions. Evaluation of ER¥aˆ expression in gallbladder carcinoma may
be an important factor in identifying a poor prognostic group of gallbladder
carcinoma.
PP 14.09
MUCINOUS ADENOCARCINOMA OF GALL BLADDER AND
MUCOCELE OF GALL BLADDER: A CLINICAL DILEMMA
Navadgi, Suresh; Shah, Rajiv; P, Jagannath
S.L. Raheja Hospital-Asian Institute of Oncology, Dept. of Surgical
Oncology, Mumbai, India
Background. Impacted stone at cystic duct can lead to a mucocele of Gall
bladder (GB), which may result in massive distension of Gall Bladder. Such
enlarged Gall Bladder with symptoms of fever and pain may pose a diagnostic
dilemma between a benign mucocele of Gall Bladder and a cystic GB
malignancy. CASE SUMMARY: We report such a clinical scenario in a 65
year old female who presented with complaints of abdominal pain in right
hypochondrium. She was recently diagnosed and treated for typhoid. On
clinical examination she had a huge distended GB, which was enlarged up to
the right iliac fossa. CA 19-9 was within normal limits. Ultrasonography was
suggestive of an enlarged GB wall with thickening? Inflammatory? Neoplas-
tic. CT scan showed a distended GB due to impacted stone at neck with wall
thickening and retroperitoneal lymphadenopathy. On exploration a distended
GB mass causing displacement of Stomach, duodenum and transverse colon
was seen with infiltration of adjacent liver parenchyma. There were enlarged
periportal and retroportal lymph nodes. A radical cholecystectomy involving
wedge resection of adjacent liver parenchyma with lymphadenectomy was
done. Final histopathology showed a 16x 16 cms. GB mass which was poorly
differentiated mucin secreting adenocarcinoma involving full thickness of gall
bladder wall with positive retroportal nodes. Liver and cystic duct margins
were free.
Conclusion. Majority of GB malignancies are usually adenocarcinomas,
mucin producing tumors are relatively rare. These tumors can mimic the
benign mucocele of Gall Bladder which can follow an impacted stone at
cystic duct
PP 14.10
DOES LAPROSCOPIC CHOLECYSTECTOMY FOR UNSUS-
PECTED GALL BLADDER CANCER ADVERSELY IMPACT THE
OUTCOME?
Navadgi, Suresh1; Chhabra, Deepak2; Shah, Rajiv3; Ambulkar, I4; Advani, S
H4; P, Jagannath3
1SLRH, Surgical Oncology, Mumbai, India; 2Lilavati Hospital and Research
Centre, Surgical Oncology, Mumbai, India; 3S.L. Raheja Hospital-Asian
Institute of Oncology, Surgical Oncology, Mumbai, India; 4S.L. Raheja
Hospital-Asian Institute of Oncology, Medical Oncology, Mumbai, India
Background. Incidental Gall bladder cancer (GBC) has been reported in
approximately 1.53% of cholecystectomies, majority of which undergo
inadequate preoperative workup for diagnosis and staging prior to cholecys-
tectomy. Objective of this study was to analyze the various patterns of
presentation and recurrence of disease in patients who underwent Cholecys-
tectomy for unsuspected GBC.
Methods. Retrospective review of 93 patients over a three-year period (2004
-2007) who were diagnosed as GBC, of which 23 had undergone Cholecys-
tectomy for suspected benign disease elsewhere was carried out. Based on
histopathology reports and imaging, patients were classified as organ
confined, locally advanced and metastatic disease.
Results. 23 out of 93 patients had undergone Cholecystectomy for ‘benign’
gall bladder disorders of which 21(91%) were laparoscopic and 2 (9%) were
open. There were 8 (35%) males and 15 (65%) females. Median age was 55
years. On presentation, CT scan was done in all patients to assess residual
disease and for restaging. 8 (35%) patients were organ confined (OC) had no
residual disease, 9 (39%) patients had locally advanced (LA) disease and 6
(26%) patients presented with distant metastasis (DM). Median time of
presentation was 3 months from diagnosis. Due to delayed referral, patients
were not suitable for revision surgery. All patients received gemcitabine and
cisplatin based chemotherapy. Status at last follow up was as follows: 4(17%)
are alive and disease free (3 OC, 1 LA), 5(22%) are alive with disease (4 LA
and 1 DM), 11(49%) have expired (2 OC, 4 LA and 5 DM) and 3 patients
are lost to follow up. Median time to death was 8.5 months.
Conclusions. Inadequate preoperative workup and histopathology reports
due to lack of awareness make it difficult for the treating physician to
accurately stage the disease and plan treatment. Early referral of patients to
tertiary centres for evaluation may offer some advantages of revision surgery
PP 15.01
MAJOR HEPATECTOMIES IN ERDERLY PATIENTS
Contis, John1; Karapanos, Konstantinos2; Vassilikostas, George2; Smyrniotis,
Vassilios2; Voros, Dionysios2; Fragoulidis, George2
1Univ. of Athens School of Medicine, 2nd Dept of Surgery, Athens, Greece;
2Univ of Athens School of Medicine, 2nd Dept of Surgery, Athens, Greece
Introduction. Curative liver resection has been accepted as the only chance
of long-term survival for patients with primary and metastatic liver cancer.
Faced with an increasing number of elderly patients presented with hepatic
malignancies, we studied old age defined as 70 years or older as a prognostic
factor for the early outcome of major hepatectomies.
Methods. We performed a retrospective review of a consecutive series of
patients who underwent a major hepatectomy to study old age (70 years) as
a risk factor regarding outcome. All patients undergoing major liver resection
(defined as three segments or more) from January 2001 to December 2005
were included. Patients were studied in two groups: 70 years of age and older
(54 patients, 7090. mean 75 years) and less than 70 years old (138 patients).
Early outcomes were analyzed. From the cohort of the last 200 patients who
underwent a major hepatectomy in our center, 56 patients older than seventy
years (7090, mean 75years) and their perioperative morbidity and mortality
as well as hospital stay were compared to the outcome of 144 patients
younger than 70 years.
Results. Elderly patients had a 5,5% mortality (3 deaths due to MI,
hemorrhage and liver failure respectively) and a 15% rate of major
complications ( biliary leak 7 patients, re-operation for bleeding one patient)
while their mean hospital stay was 10,9 days (350 days). There was no
statistical difference in the incidence of perioperative complication and death
rate compared to younger patients who suffered a 4.3% mortality and 16.6%
morbidity rate. Their mean hospital stay was 11.3%, also not statistical
different.
Conclusions. Major liver resections can be safely performed in the elderly
with early results similar to those in the younger than 70 age group. Age by
itself cannot be considered as contraindication for surgery in the elderly
patients who could benefit from a liver resection.
PP 15.02
ANALYSIS OF HEPATIC RESECTIONS IN A NEWLY SET UP UK
SPECIALIST HPB CENTRE
Mukherjee, Samrat; Bhattacharya, Satyajit; Abraham, Ajit T; Hutchins,
Robert R; Kocher, Hemant M
Barts and the London HPB Centre, London, United Kingdom
Background. Advances in surgical techniques and improved perioperative
patient management make it possible to perform extensive resections with
acceptable morbidity and mortality rates.
Aims. We analysed the morbidity and mortality outcomes for all the liver
resections undertaken for various pathological lesions in a new specialist
hepatobiliary centre.
Patients and Methods. All patients undergoing a hepatic resection between
January 2004 to June 2007 were extracted from our HPB database.
Outcomes were analysed for morbidity, mortality and length of hospital stay.
Results. A total of 125 patients (Median age 60, range 2280 years; Male
64) had a hepatic resection between Jan 2004 to Jun 2007. Pathology
included colorectal liver metastasis (n73), hepatocellular carcinoma (n
11), cholangiocarcinoma (n8), carcinoid metastases (n4), neuroendo-
crine metastasis (n5), non-colorectal non-neuroendocrine (n14) and
benign (n10). The resections performed were major resections (n42),
extended resections (n14), segmental resections (n23), wedge resections
(n32), left lateral segmentectomy (n12) and laparoscopic resections (n
2). The mortality was 2.4% (n3) and the morbidity was 33.6% (n42).
The median length of hospital stay was 10 days (range 4 -392). For patients
undergoing hepatic resection for colorectal metastases (n73), mortality was
nil and morbidity was 30.1% (n22).
Conclusions. Hepatic resections can be carried out for a variety of
pathological liver lesions with acceptable mortality and morbidity in specialist
centres.
PP 15.03
INDOCYANINE GREEN CLEARANCE FOLLOWING MINOR LI-
VER RESECTION
Low, Jee K1; Mackillop, Andrew2; Clark, Debbie1; Vadeyar, Hemant1;
Sherlock, David1
1North Manchester General Hospital, Surgery, Manchester, United King-
dom; 2North Manchester General Hospital, Anaesthesia, Manchester,
United Kingdom
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Introduction. Elimination of indocyanine green (ICG) from blood can be
used to determine peri-operative hepatic function.
Aim. This technique was used to monitor the hepatic function of patients
undergoing segmentectomy and re-do hepatic resection.Method.: Twelve
consecutive patients scheduled for hepatic resection (segmentectomy and re-
do resection) were studied. We used transcutaneous pulse densitometry for
the assessment of liver function by measuring ICG plasma clearance (Limon
†). After an intravenous injection of 0.25mg/kg of ICG, we observed plasma
disappearance rate (PDR) and retention rate extrapolated to 15 minutes
(R15).
Results. Thirteen patients were studied, eight male and four female. The
mean PDR before operation of all thirteen patients was 24.8%/min (17.7
33.3), on the first post-operative day 31.2%/min (17.542.0), one week later
27.5%/min (18.934.0) and beyond six weeks 24.5%/min (17.939.1)
respectively. Of the seven patients who underwent segmentectomy, the
mean PDR was 26.6%/min, 31.5%/min, 28.0%/min and 25.0%/min respec-
tively. Three patients who had re-do hepatectomy had a mean PDR of 20.7%/
min, 25.4%/min, 24.8%/min and 19.9%/min respectively. Of the remaining
patients, one had inoperable metastatic recurrence and the other two had
large gastrointestinal stromal tumours. Their mean PDR was 24.7%/min,
36.5%/min, 29.1%/min and 28.1%/min respectively.
Conclusion. The PDR was significantly higher on the first post-operative
day when comparing it with the preoperative value. This suggests that the
hepatic clearance of ICG is increased during the early post-operative period.
PP 15.04
LIVER RESECTIONS IN A SEMIRURAL SET UP  A PERSONAL
EXPERIENCEOF 32 CASES
Desai, Sharad
Mahatma Gandhi Cancer Hospital, Miraj, India
Background. Liver resections are supramajor undertakings and requires
good infrastructure. However they can also be done safely with moderate
surgical equipment and routine postoperative support in the semirural set up.
Objectives. To know the results of Liver resections in semirural hospitals.
Material/Methods. A retrospective analysis of our series of 32 major Liver
resections done in various hospital and nursing homes in a small town in
India was done. Most hospitals had facilities for good anesthesia and
electocautery. Some of the hospitals did not have a Intensive care unit.
Results. Though none of the hospitals had sophisticated equipment, the
surgeries could be done unhindered and without difficulty. Our cases
involved  10 HCC, 6 Ca Gall Bladders, 4 Metastatic resections, 4
Hemangiomas, 1 Hepatic adenoma, 1 Hepatoblastoma, 2 Hydatid cysts, 4
Refractory Abcesses. Major Blood loss(2000 ml) occurred in 2 cases. No
Intraoperative injury occurred.17 patients did not receive any transfusions.
One patient died due to sepsis and another died due to liver failure from a
small remnant liver. A morbidity occurred due to biliary fistula which took
more than a month to heal.
Discussion. Hepatic resections can be done with safety with moderate
equipment. The use of vessel sealers and CUSA does not improve the
Results. Proper anatomical dissection and good anesthesia are important to
obtain good Results.
PP 15.05
ENDOSCOPIC SCLEROTHERAPY VERSUS LIGATION IN THE
PRIMARY PROPHYLAXIS OF ESOPHAGEAL VARICEAL
BLEEDING IN CIRRHOTIC PATIENTS
Szczepanik, Andrzej B1; Misiak, Andrzej2; Szczepanik, Anna M2; Meissner,
Alfred J2
1Institute of Hematology and Transfusion Medicine, Department of Surgery,
Warsaw, Poland; 2
The AIM of this study was to compare the efficacy and safety of injection
sclerotherapy versus variceal ligation in the prevention of the first bleeding
from high-risk varices in patients with liver cirrhosis.
Methods. Fifty two patients with esophageal varices, endoscopically judged
to be a high risk of hemorrhage (grade III or IV, red color signs), with no
previous history of bleeding, were included in the study. All patients were
randomly assigned to endoscopic sclerotherapy group (EST) (27 patients) or
endoscopic variceal ligation group (EVL) (25 patients). Mean age of patients
was 56.5 in the EST and 54.0 in the EVL group. Etiology of liver cirrhosis
was: postnecrotic 18 vs 15, alcoholic 7 vs 4, other 1 vs 6 in the EST vs EVL
group respectively. According to Child-Pugh classification (A/B/C) there
were 12/12/3 patients in the EST and 8/14/3 in the EVL group. Endoscopic
procedures were performed using endoscopes Olympus (Japan). Injection
sclerotherapy with 5% ethanolamine oleate, 1020 ml per session, was
performed every week. Variceal ligation with placing 2 to 5 elastic bands
(Endoloop, Olympus) was done every two weeks. Both procedures were
repeated until complete variceal eradication was achieved. Endoscopic
examination was then performed every 3 months in the both groups.
Recurrent varices were obliterated or ligated.
Results. Eradication of esophageal varices was achieved in 26/27 (96.3%)
patients in the EST group and in all in the EVL group. The mean number of
procedures required to obtain eradication was higher in the EST than in the
EVL group (4.9 vs 2.7). Recurrence of varices at follow-up at a median of 21
months was higher in the EVL (4/25; 16.0%) then in the EVL group (2/27;
7.4%). The complications were observed in 4/27 patients (14.8%) in the EST
and in 2/25 (8.0%) in the EVL group. One death was observed in the EVL
group and none in the EST group.
Conclusion. EST and EVL are similarly effective in the eradication of
esophageal varices and in the prevention of the first bleeding.
PP 15.06
THE DEVELOPMENT OF A SWINE MODEL OF SECONDARY
LIVER TUMORS FROM A GENETICALLY INDUCED SWINE
FIBROBLASTS CELL LINE.
Sanabria, Juan1; Abbas, Rime1; Robinson, Ann1; Adam, Stacy2; Okada, S1;
Kim, Juliam1; Christopher, Counter2
1University Hospitals-Case Medical Center, Surgery, Cleveland, United
States; 2Duke University, Pharmacology, Durham, United States
Background. Swine models of secondary liver tumors may demonstrate to
be an ideal model to study the efficacy of surgical and ablative treatment
options available for liver tumors. PURPOSE. To develop a secondary liver
tumor in a large animal model.
Methods. Fibroblasts from swine were isolated from ear lobule; cells then
were transfected with amphotrophic retroviruses encoded with human
genetic (hTERT, p5300, cyclinD-1, CDK4R24C, Myc T58A, RASG12V)
material. Transformed cell lines were inoculated into swine under tacrolimus
based immunosuppression (n4). Isolates from first pass were cultured and
then inoculated as a second pass into 1) nude immunodeficient mice (n5),
2) immune intact wild mice (n2) and, 3) porcine animals without
immunosuppression (n2).
Results. Tumor growth was evident in 75% of immunosuppressed swines.
One animal die with diarrhea and failure to thrive before the completion of
experiment (3weeks). Growth of tumors was slow in two animals while in one
animal tumor was larger with a peak growth of 42mm at three weeks. All
growths showed to be malignant on histology. Cell morphology changed from
initial cell line as compared with cell isolates after first pass. Tumor growth
was evident in 100% of the nude immunodeficient mice with a peak size of
22mm (175mm, MeanSD) at the time of sacrifice (3weeks). Tumor
growth was evident in all wild mice with a peak size of 8.9mm at the end of
the third week. Tumor growth in swine was characterized for slow growth
with a peak size of 8mm at three weeks.
Conclusions. Characterization of new mutations in cell lines after first pass
is the matter of current studies. Further changes may produce a more rapid
growth of genetically induced tumorogenic cells in the immune-intact swine
PP 15.07
MANAGEMENT OF CHOLEDOCHAL CYST WITH PORTAL HY-
PERTENSION
Bora, Giri Raj1; Singh, Shivendra1; Gondal, Ranjana2; Agarwal, Anil1
1G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India; 2G. B. Pant Hospital and Maulana Azad Medical
College, Pathology, New Delhi, India
Background & Aim. Portal hypertension is a rare complication of long
standing Choledochal cyst. We analysed our cases of Choledochal Cyst
complicated by presence of Portal hypertension.
Material and Methods. Over the study period of 6.5 years (January 2001 to
June 2007) at a tertiary care centre in India, eleven cases of Choledochal cyst
with associated portal hypertension were encountered out of 204 patients
(5.39%). Clinical presentation, management, Liver histology and hospital
course of these patients were analyzed in detail.
Results. There were 11 patients (2M,9F) with a mean age of 33.3 years(12
to 72 years). Eight patients had type IVA & 3, type I CDC. Pain abdomen
was most common presenting feature in 8 ( 72.7%), followed by jaundice 6(
54.54%), cholangitis 1 (9.09%) and abdominal mass 1 ( 9.09%). Lower end
cholangiocarcinoma (metastatic) with SBC was found in 1 patient and
palliative bilio-enteric bypass was performed. Complete excision of extra
hepatic portion of Choledochal cyst with Roux-en-Y Hepaticojejunostomy
was feasible in 8 patients (80%) where surgery was performed with intent of
excision of CDC. Cyst excision was not possible in 2 patients, one patient in
the early part of the study underwent loop cystojejunostomy with jejunoje-
junostomy on encountering collaterals. Another patient had history of
recurrent acute pancreatitis and necrosectomy. There was no post operative
mortality. Ascites requiring diuretic therapy developed in 4 (40%) patient.
Conclusion. Portal hypertension complicated choledochal cysts in 5.39%
(11 of 204) of our patients of CDC. Direct Excision of CDC can be
performed in patients with a patent portal vein. We advocate policy of
primary excision of Choledochal cyst and prior shunt surgery should
probably be reserved only for those patients with a blocked portal vein/
extensive pericholedochal collaterals.
PP 15.08
PROXIMAL LIENO- RENAL SHUNT IS THE TREATMENT OF
CHOICE FOR EXTRAHEPATIC OBSTRUCTION
Sahoo, Duryodhan; Mohapatra, M.K.; Mallick, P.K.
SCB Medical College, Cuttack, India
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Introduction. The role of surgery in portal hypertension has diminished
over the years. At present, the first line of treatment for bleeding oesophageal
varices is endoscopic sclerotherapy, variceal ligation and pharmacotherapy.
Surgery is indicated in endoscopic failures, in patient with gastric varices and
portal gastropathy. In our Institution, the practice is to offer proximal lieno-
renal shunt to patients with extrahepatic obstruction with good liver function.
Material and Methods. We had 35 case of EHO during last 8 years, 30
cases underwent shunt procedure (L.R. Shunt). 3 cases underwent devascu-
larization procedure (modified Hasaab’s procedure). All patients were within
the age range of 10 to 28 years. Maximum number of cases were referred to
us from the department of Gastroenterology, SCB Medical College, Cuttack.
Results. 1. Bleeding controlled with improvement in general health and
nutrition  32 cases. 2. Shunt block and rebleeding  1 case 3. Rebleeding
after devascularization procedure  1case 4. Abdominal pain with subacute
intestinal obstruction  1case 5. Mortality  nil.
Conclusion. 1. In our opinion  L.R. Shunt is the treatment of choice in
portal hypertension (EHO) with upper Gastrointestinal bleeding with splenic
vein diameter of 6mm or more. 2. It is an onetime procedure. 3. It is cost
effective (Rs. 70008000) in this Govt. hospital setup 4. Reasonably good
shunt patency in patients having splenic vein of 6mm & above in diameter. 5.
Therefore we recommend, for illiterate & poor patients living at remote
places, and with scarce medical facilities, L-R shunt as the primary mode of
therapy.
PP 15.09
HEPATECTOMY FOR BILOBAR LIVER METASTASIS
Vimalraj, V.; Jeswanth, S.; Rajarathinam, G.; Ravichandran, P.; Rajendran,
S.; Balachandar, T.G.; Kannan, D.; Surendran, R.
Government Stanley Medical College and Hospital, Department of Surgical
Gastroenterology, Chennai, India
Background and Aims. We reviewed our experience with resection for
bilobar liver secondaries(that included colorectal and certain other malig-
nancies) to clarify the safety and effectiveness of this treatment and also to
assess the long-term results of liver resections for bilobar liver metastasis.
Methods. Between January 1998 and January 2007, 25 patients with bilobar
liver metastasis were identified from a cohort of 312 hepatic resection
patients and data retrospectively analyzed.
Results. The mean age was 47 years [18  72 yrs]. The indications for
resection were colorectal-14/25 (56%), Neuroendocrine- 4/25(16%), meta-
static GIST  4/25(16%), renal cell carcinoma  2, wilms tumour  1. Surgery
alone was done in 14/25 patients. Combined surgery and radiofrequency
ablation was done in 6/25 patients. Resection, portal vein ligation was done in
5 patients.4/5 patients underwent second stage resection. The mean blood
loss of 320cc (range 501100 cc). Mean length of stay was 12 days (range
846 d). Complications were encountered in 3 patients, Bile leak  1,
Intra abdominal abscess  1(both were managed by percutaneous drainage)
and liver failure in 1 needed prolonged medical management. Follow-up
ranged from 6 months to 7 years. 18/ 25 patients are alive and are on
follow up.
Conclusion. Surgery alone or in combination with RFA offers both a chance
of long term survival and even cure. Our data suggests that resections alone
or in combination with newer strategies can be performed safely in these
patients with no mortality and minimal morbidity.
PP 15.10
FIRST REPORTED NEW VALVE IN INFERIOR VENA CAVA AT
DIAPHRAGMATIC LEVEL
Guo, Chenghao1; Zhang, Hui2; Agarwal, Anil3; Wang, Zhonggao4
1Institute of Pathology and Pathophysiology, School of Medicine, Shandong
University, Department of Pathology, Jinan, China; 2Second Hospital of
Shandong University, Jinan, China; 3G. B. Pant Hospital and Maulana Azad
Medical College, Department of GI Surgery, New Delhi, India; 4Beijing
Xuanwu Hospital, Beijing, China
Background & Aim: Membranous obstruction of the inferior vena cava is a
common etiology of Budd-Chiari Syndrome in developing countries. The site
is usually located at the level of the diaphragm below the right atrium.
Material and Methods. We present a case of a 38 year old Chinese man
who had a new valve located in left anterior wall of IVC at diaphragmatic level
on post mortem examination.
Results. The New valve was a crescent- shaped fold of the lining membrane
of inferior vena cava, 16mm5 mm size and transversely located 28 mm to
entry into the right atrium. Both side of new valve had endothelium lining.
The new valve location was different and lower than Eustachian valve. The
location corresponds with the site of membranous obstruction of the IVC in
cases of Budd Chiari Syndrome.
Conclusion. Our case describes an unreported new valve located in
the hepatic portion of inferior vena cava at the diaphragmatic level.
The new valve location may have an important role to explain the
pathogenesis of membrane obstruction of the inferior vena cava in Budd-
Chiari Syndrome.
PP 16.01
Effect of early antibiotic prophylaxis with ertapenem and meropenem
in experimental acute pancreatitis in rats
Catena, Fausto1; Ansaloni, Luca2; Severi, Silvia2; Gazzotti, Filippo2;
Coccolini, Federico2; D’Alessandro, Luigi2; Principe, Alfonso2; Pinna,
Antonio2
1Transplant, General and Emergency Surgery DPTSt Orsola- Malpighi
University Hospital Bologna ITALY, Bologna, Italy; 2
Background. The clinical course in acute necrotizing pancreatitis is mainly
determined by bacterial infection of pancreatic and peripancreatic necrosis.
The effect of two antibiotic regimens for early prophylaxis was investigated in
the taurocholate model of necrotizing pancreatitis in the rat.
Methods. Sixty male Sprague- Dawley rats were divided into three
pancreatitis groups (15 animals each) and a sham-operated group (15
animals). Pancreatitis was induced by intraductal infusion of 3% taurocholate
under sterile conditions. Animals received two different antibiotic regimes
(15 mg/kg ertapenem or 20 mg/kg meropenem) one shot before the induction
of pancreatitis or no antibiotics (control). Animals were examined after 24 h
for pancreatic and extrapancreatic infection.
Results Early antibiotic prophylaxis with both regimens could significantly
reduce pancreatic infection from 12/15 (control group) to 4/153/15
(antibiotic group). (pB0.05).
Conclusions. In our animal model of necrotizing pancreatitis, early
antibiotic prophylaxis with ertapenem and meropenem reduce bacterial
infection of the pancreas. The effectivity of early antibiotic prophylaxis in
the clinical setting should be subject to further investigation with improved
study design.
PP 16.02
DELAYED SINGLE STAGE NECROSECTOMY FOR INFECTED
PANCREATIC NECROSIS
Doctor, Nilesh H; Barreto, Savio G; Hussain, Maharra
Jaslok Hospital and Research Centre, Department of Gastrointestinal
Surgery, Mumbai, India
Background. Data on the indications, timing and technique of debridement
for infected pancreatic necrosis is varied. Although early versus late and single
stage versus multiple procedures have been extensively studied in Western
literature, such studies on the management of infected pancreatic necrosis in
India are few.
Objective. To analyze the feasibility and outcome of delayed single-stage
necrosectomy after an early conservative, but aggressive resuscitation of
patients with infected pancreatic necrosis.
Methods. During the time period between 1st January, 1998 and 31st May,
2006, 32 patients with severe acute pancreatitis who developed infected
pancreatic necrosis and were managed by pancreatic necrosectomy, were
analysed.
Results. Of the thirty-two pancreatic necrosectomies performed during the
period between 1st January, 1998 and 31st May, 2006, 28 patients required
only a single procedure. Thus a single-stage necrosectomy could be
performed in 28 patients (87.5%). Patients underwent surgery a median of
29 days after diagnosis of acute pancreatitis while one patient had to be
explored on the 13th day. Sepsis and multiple organ failure accounted for the
9.6% mortality rate. Enteric fistulae occurred in 18.7% of patients. The
median hospital stay was 23 days, and the interval until return to regular
activities was 150 days.
Conclusion. Delayed single-stage pancreatic necrosectomy for infected
pancreatic necrosis has been documented to be an effective treatment
strategy with reduced morbidity and mortality. Early antibiotic therapy
with carbapenems and good supportive care may help in delaying surgery.
PP 16.03
ACUTE PANCREATITIS WITH SPONTANEOUS MASSIVE
BLEEDING INTO PERITONEAL CAVITY: A CASE REPORT
Washiro, Mitsustune1; Kusashio, Kimihiko2
1Suzaka Hospital, Surjery, Suzaka, Japan; 2Chibarousai Hospital, Surjery,
Ichihara, Japan
Massive bleeding may complicate the course of acute pancreatitis. The
incidence of bleeding occurs usually after operation including necrosectomy,
and the main pathogenetic mechanism of bleeding is mediated by pseudo-
cysts or abcess. On the other hand, spontaneous bleeding due to acute
pancreatitis is a rare, but frequently fatal complication of acute pancreatitis.
Especially, Intraperitoneal hemorrhage is a distinctly less common manifesta-
tion. Severe inflammation and/or regional necrosis may cause major vessels or
peripancreatic vessels erosion, whose eventual rupture may result in massive
bleeding into peritoneal cavity. Symptoms appeared just before lethal
bleeding, too late to even hazard a diagnosis. A rapid and accurate diagnosis
is critically important. We report a case of massive intraperitoneal bleeding
owing to disruption of peripancreatic vessels in a patient recovering from
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acute pancreatitis. Diagnosis of bleeding was made by computed tomography
and ultrasound-guided blood aspiration. The source of the bleeding was
identified intraoperatively, and a distal pancreatectomy and a splenectomy
were performed. Our case confirms the necessity to add massive intraper-
itoneal venous bleeding to the list of differential diagnosis for sudden
deterioration in patients with acute pancreatitis.
PP 16.04
VASOSPASM IN EARLY SEVERE ACUTE PANCREATITIS: A
REVERSIBLE PHENOMENON!
Deshpande, AA1; Raut, AA2; Rege, SA2; Dalvi, AN2; Hardikar, JV2
1Seth G. S. Medical College & K.E.M. Hospital, Department of Surgery,
Parel, Mumbai, India; 2Seth G. S. Medical College & K.E.M. Hospital,
Department of Surgery, Mumbai, India
Background. Pancreatic ischemia due to vasospasm has been documented
in experimental and clinical severe acute pancreatitis. The degree of
reversibility of this vasospasm if any and its clinical implications have not
been tested. In a prospective observational study we tested the hypothesis
that many of the clinical and CT features of early acute pancreatitis are due to
vasospasm and they may be at least partially reversible if a standardized
treatment protocol is instituted within a critical time.
Study Design: Between January 2007 to June 2007, all the CT scans for
acute pancreatitis performed within 48 hours of admission were reviewed.
Scans showing large fluid collections, pseudocysts, emphysematous pancrea-
titis, and also acute on chronic pancreatitis were excluded. The scans showing
severe necrotizing pancreatitis were included for the study. These were
reviewed for: enhancement pattern and percentage enhancement of the
gland, the Hounsfield units of the poorly perfused areas, peripancreatic
inflammation, peripancreatic necrosis. The clinical charts were evaluated for:
1) duration of symptoms 2) probable etiology, 3) organ failure if any 4) total
duration of stay 5) outcome and 6) mortality. The follow-up scans whenever
performed were compared with the first scan.
Results. Totally 58 scans were studied, 30 were excluded. Of the 28 scans
included, pancreatic enhancement was poor in 8 and absent in 16. More than
80% of the gland was involved in 20 scans. Significant peripancreatic
inflammation was seen in 6 scans and peripancreatic necrosis was seen in
13. Superior mesenteric venous thrombosis was noted in 1 scan. Twenty
patients had presented within 48 hours of the onset of symptoms.
Standardized treatment was given to all patients including oxygenation,
proper fluid management, colloid infusion daily, antibiotic, early enteral
nutrition and supportive treatment as necessary. Etiology was gallstones in 4
and alcohol in 24. Organ failure was seen in 2 patients, (1 respiratory, 1-
renal). Average hospital stay was 12 days (range 6 to 31 days). Twenty six
patients were discharged. Surgical intervention was done in 1. There was one
readmission with infected necrosis and this patient succumbed to sepsis.
Total mortality was 12% (3/28). Follow-up scans were done in 7/28 patients.
80% of these showed partial or complete reversibility of the enhancement
pattern and peripancreatic changes.
Conclusions. Severity of clinical and radiological features in early acute
pancreatitis is in part due to associated vasospasm. Treatment instituted in
proper time is helpful in reversing the vasospasm and limiting the ischemic
insult to the pancreas thereby decreasing the severity and limiting the course
of the illness.
PP 16.05
LOCAL COMPLICATIONS OF ACUTE PANCREATITIS. LAPARO-
SCOPIC APPROACH.
Secchi, Mario
Hospital Italiano de Rosario, Surgey, Virasoro 1249, Rosario, Argentina
Authors: Mario A. Secchi MD, Lisandro Quadrelli MD and Leonardo Rossi
MD Surgical Division ‘‘B’’ Hospital Italiano de Rosario Argentina
Objective. To consider a new agreed definition for AP as well as a
laparoscopic and conventional approach of its local complications(LC) of
acute pancreatitis(AP).
Design: Retrospective (19871997) and prospective (19982007) study,
were performed at 4 surgicals centers: Hospitales Italiano, HECA, Provincial
from Rosario and Model Clinic from Rufino. (Argentina) POPULATION:
1132 patients having AP between April, 1987, and Jannuary, 2007.Method.:
Lesions and local complications were defined according to the Pancreas
Club, Repu´blica Argentina, 1998. All patients had AP of any etiology
confirmed by morphological
Methods. A CT Scan performed after the 4th. day of the onset of AP showed
an AP local involvement. The clinical therapy was to treat local lesion, and a
combination of clinical, percutaneous, laparoscopic(VLP) and/or conven-
tional surgery was performed to treat LC. 195 patients developed 263 local
lesions and complications. Local lesions: 35 had acute fluid collections5
cm. in diameter ( 8 underwent percutaneous punction and drainage), and 47
had pancreatic necrosis (with no complications at all). 173 local complica-
tions: 30 abscesses, 49 acute pseudocyst, 5 infected acute pseudocyst and 89
infected necrosis. Abscesses of any size and pseudocysts5 cm of diameter
were treated. Second surgical procedures for treating infected necrosis were
not considered.
Results of Treatment. Laparoscopic approach were used in 23 cases for
treated local complications of AP (13%), This technique is feasible, safety
and apropiate for recurrent abscesses (n6), cystograstrostomy or assisted
cystoyeyunostomy ( n10) and focal infected necrosis less than 30% of
pancreas volume (n7). L.C. mortality with multidisciplinary treatment:
was 1.4% (16/ 1132).
Conclusion. Multidisciplinary treatment, including laparoscopic, is manda-
tory to obtain better results in LC of AP.
PP 16.06
A CHOICE FOR EMPIRICAL STEROID TREATMENT IN PA-
TIENTS WITH SUSPECTED LYMPHOPLASMACYTIC SCLER-
OSING PANCREATITIS (LPSP): A DIAGNOSTIC TOOL.
Borobia, Francisco1; Jorba, Rosa2; Busquets, Juli3; Valls, Carlos4; Serrano,
Teresa5; Pelaez, Nuria3; Rafecas, Antonio3; Ramos, Emilio3; Torras, Jaume3;
Llado, Laura3; Fabregat, Joan3
1Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat (Barcelona),
Spain; 2Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat.
Barcelona, Spain; 3Hospital Universitari de Bellvitge, Hepatobiliopancreatic
surgery, L’Hospitalet de Llobregat. Barcelona, Spain; 4Hospital Universitari
de Bellvitge, Radiology, L’Hospitalet de Llobregat. Barcelona, Spain;
5Hospital Universitari de Bellvitge, Histology, L’Hospitalet de Llobregat.
Barcelona, Spain
Introduction. LPSP is an autoimmune disorder that present as obstructive
jaundince and can mimics a pancreatic adenocarcinoma (PA). Only
histologic study after resection or steroids response gives the clue for
diagnosis. OBJECTIVE To present our results and management algoritm
for LPSP.
Methods. From 1999, eleven patients (8M/3F) have been diagnosed of
LPSP. All patients had jaundice, progresive or self-limited. Four were referral
to our Hospital with biliary stents. One were considered as extended PA and
treated with biliary stent. In 4 patients LPSP was suspected, one of them was
transfered after bilioenteric by-pass for suspected advanced PA with
esclerosing cholangitis.
Results. Mean age were 56,8 years (2475). CT scan appearance are
diffusely enlarged pancreas or pseudotumour. MRCP shows irregular
narrowing of the pancreatic duct. EUS/CT-biopsies were performed to rule
out malignacy. IgG4 were elevated only in 2 patients. Six patients were
resected because inaccurate suspicion of malignancy. Patient with suspected
advanced PA with stent was reevaluated and LPSP were diagnosed. Patients
diagnosed of LPSP were treated with steroids. In 3 patients jaundice
disappeared with medical therapy, two due to LPSP and one due to sclerosing
cholangitis. Another patient did not respond and was resected. Patients
treated with steroid 2 years have better quality of life.
Conclusions. LPSP can be diagnosed by clinical suspicion and with TC and
MRCP images. EUS and/or TC-biopsy must be done before a steroid assay.
In case of no response or doubt of PA surgery must performed. A succesful
steroid treatment can be considered as diagnostic.
PP 16.07
PANCREATICOPLEURAL FISTULA  TWO PHOTOGENIC
CASES
Desai, Chirag1; Desai, Maharshi2; Shah, Viral3; Upadhyay, Swati1
1The Apollo Hospitals Internationals Ltd., Department of GI/HPB surgery,
Ahmedabad, India; 2The Apollo Hospitals Internationals Ltd., Department
of Critical Care, Ahmedabad, India; 3The Apollo Hospitals Internationals
Ltd., Department of Pulmonology, Ahmedabad, India
Chronic massive pancreatic pleural effusion is an uncommon and often
unrecognized clinical syndrome, which results from an internal pancreatic
fistula and usually presents as an effusion of unknown cause. The effusion
frequently occurs without clinical evidence of pancreatitis, but occasionally it
may be associated with a pseudocyst of the pancreas. In this report, two cases
of chronic massive pancreatic pleural effusions are presented. Both the cases
presented with dyspnoea from large pleural effusion, were treated initially for
tuberculosis and both had a history of alcohol abuse. They had high level of
amylase in the pleural fluid. MRCP, CT and ERCP showed mid pancreatic
duct stricture with tract going to the mediastinal pseudocyst which in turn
communicated well to the pleural space (One right side and other left side).
Both the patients were given conservative treatment in form of chest drainage
& nutritional support. One was also given octreotide. In both the cases
endoscopic stenting was tried but due to the tight stricture it was technically
not possible. Both the patients responded to the conservative treatment. A
high index of suspicion is necessary to be aware of the presence of
pancreaticopleural fistula. The conservative treatment with or without
endoscopic stenting is usually successful and takes 23 weeks. Surgery is
needed only in resistant and recurrent cases. Chronic massive pancreatic
pleural effusion may be recurrent. Morbidity and mortality are reduced when
a definite diagnosis is established and appropriate therapy rendered.
PP 16.08
A CASE OF XANTHOGRANULOMATOUS PANCREATITIS
Kamei, Keiko; Takeyama, Yoshifumi; Haji, Seiji; Yasuda, Takeo; Shinzaki,
Wataru; Satoi, Shunpei; Fujiwara, Shozo; Ishikawa, Hajime; Yasuda, Chikao;
Nakai, Takuya; Oyanagi, Harumasa
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Kinki University School of Medicine, Department of Surgery, Osaka-
Sayama, Japan
Background. Xanthogranulomatous inflammation is well known in the gall
bladder and kidney, but xanthogranulomatous pancreatitis is very rare and
clinicopathological features are not enough described.
Case report. A 55-year-old man with a history of hyperlipidemia was
referred to us with a complaining of back pain. Abdominal CT showed the 3-
cm-diameter low density tumor of the pancreas head. EUS revealed the high
echoic mass with surrounded by low echoic lesion. We could not deny the
malignant pancreatic tumor, so subtotal stomach-preserving pancreatico-
duodenectomy was performed. Intraoperative findings showed the mass
lesion which contained coagula. Pathological findings showed xanthogranu-
lomatous inflammation with numerous foamy histiocytes of the pancreas
head without malignant findings. His post operative course was well, and he
has remained well at 12 months after the operation. Herein we report a rare
case of xanthogranulomatous pancreatitis which was difficult to differentiate
from pancreas cancer, with a review of the literatures.
PP 16.09
BYPASS SURGERY FOR BILIARY OBSTRUCTION IN CHRONIC
PANCREATITIS
Omoshoro-Jones, Jones AO; Jeppe, Cara; Smith, Martin D
Chris Hani Baragwanath Hospital, Hepatopancreatobiliary Unit, Division of
Surgery, Johannesburg, South Africa
Introduction. Bile duct stricture occurs in 1030% of chronic pancreatitis.
Hepaticojejunostomy (HPJ) or choledochojejunostomy (CD-J) and pancrea-
ticoduodenectomy form the standard of care. Opening the intrapancreatic
bile duct with incorporation into the pancreaticojejunostomy has been
described. We present our experience with the use of HPJ or CD-J in the
treatment of distal common bile duct stenosis (DCBDS) in patients under-
going duodenal preserving pancreatic resection for chronic pancreatitis.
Method. From a prospectively studied cohort of patients undergoing local
resection of head of pancreas and pancreaticojejunostomy (LR LPJ), those
that underwent concurrent HPJ or CD-J (performed to a section of the same
Roux loop used for the LPJ) were analysed.
Results. Twenty seven patients had HPJ (5) or CD-J (22) with LRLPJ over a
14-yr period. All patients had significant pain at a median duration of 4 (0.5 
15) years. Of 22 patients with DCBDS, jaundice was present in all while 7
(31.82%) presented with cholangitis managed with pre-operative endoscopic
drainage used in all jaundiced patients. The median operative time, blood
loss and transfusion rates were 4.5 (3  8.33) hours, 0.75 (0.3  2.0) L and 1
(1  2) units respectively. Three patients (11.11%) developed pancreatobili-
ary related complications: 1 self-limiting bile leak, 1 pancreatic fistula and 1
LPJ-anastomotic leak that required re-operation. There were no death and
the median hospital stay was 16 (6  38) days. The median 7-year pain relief
rate is 95.59%. No patient has recurrent jaundice.
Conclusion. DCBDS is common in chronic pancreatitis. HPJ or CD-J at the
time of the primary LR LPJ is simple and safe with minimal morbidity and
good long term Results. This procedure is recommended as the alternative
to draining the bile duct by incorporating it into the pancreaticojejunostomy.
PP 16.10
AUTOIMMUNE PANCREATITIS AND OBSTRUCTIVE
JAUNDICE A CHALLENGING DIAGNOSIS
Malladi, S.V. Subramanyam1; Malladi, S.V. Subramanyam1; Chang, Yeon-
Jeen1; Mittal, Vijay1; Maas, Luis2; Jacobs, Michael1
1Providence Hospital and Medical Centers, Surgery, Southfield, United
States; 2Providence Hospital and Medical Centers, Gastroenterology, South-
field, United States
Background. Autoimmune pancreatitis is a chronic inflammatory condition
of the pancreas constituting one quarter of Whipple resections performed for
benign conditions in North America. Autoimmune pancreatitis is a steroid
responsive disease. Awareness of its existence helps to avoid unnecessary
resections.
Objective. We report a case of autoimmune pancreatitis associated with a
pancreatic head mass that was successfully managed without a pancreatico-
duodenectomy.
Methods and Results. A 50 year-old Ukrainian women with a history of
Sjo¨grens syndrome presented with epigastric pain, jaundice and weight loss
for 6 weeks. She received Imuran and prednisone for 7 years. Tumor markers
were negative. Ultrasound (US) revealed an enlarged pancreas and dilated
intra and extra hepatic biliary ducts. Computer tomography scan showed
similar findings with a possible distal duct stone. Endoscopic Retrograde
Cholangiopancreatography showed dilated biliary ducts with tapering of the
distal third of the common bile duct (CBD), which was suspicious for
extrinsic compression from an enlarged pancreatic head. A biliary stent was
placed. Endoscopic US demonstrated a pancreatic head lesion with coarse
borders. Surgical intervention was advised. Intraoperatively, the pancreas was
diffusely indurated without acute inflammation. A 1.5-cm nodule was found
at the junction of intra and extra pancreatic bile ducts. Intraoperative US
confirmed previous findings, however, multiple transduodenal core biopsies
were negative for malignancy. CBD resection and hepaticoenterostomy were
performed due to the occlusive distal CBD lesion. The patient had an
uncomplicated postoperative course. Histopathology of the pancreas showed
autoimmune pancreatitis. CBD showed intense chronic inflammation with
fibrosis.
Conclusion. Despite the significant understanding of autoimmune pancrea-
titis, preoperative diagnosis remains a challenge. Surgery may be necessary to
establish the diagnosis and correct peripancreatic pathology such as benign
biliary strictures.
PP 17.01
PANCREATICODU0DENECTOMY FOR BENIGN DISEASE FAIL-
URES OF A DIAGNOSTIC WORK-UP ARE THERE ANY LEARN-
ING POINT?
Manzia, Tommaso Maria; Cherian, Thomas; Toti, Luca; Attia, Magdy;
Coldham, Chris; Buckels, John; Mayer, David; Bramhall, Simon; Wigmore,
Stephen; Mirza, Darius
Queen Elizabeth Hospital/University of Birmingham, Liver Unit, Birming-
ham, United Kingdom
Background. It is well recognised that a small percentage of patients who
undergo a pancreaticoduodenectomy (PD) for suspected malignancy will
turn out to have benign pathology. We sought to audit our series, and access
the incidence and outcome of benign conditions in patients who underwent a
PD. We specifically attempted to analyse 2 subgroups: one, those in whom
PD was performed for benign disease i.e. no malignancy suspected
preoperatively, and two, those who underwent PD for strong suspicion of
malignancy but had negative histology.
Patients and Methods. Between January 1997 and April 2006, 499 pts
(457 for suspected cancer, 42 for suspected benign disease) underwent PD at
the Queen Elizabeth Hospital. Prospectively collected data was reviewed and
analysed.
Results. Overall 78 (15.6%) patients were negative for malignant disease on
the basis of the final histological report. Our median follow up was 35 months
(1113 months). The pathology was chronic pancreatitis in 35 (7%), benign
cystoadenomas in 19 (3.8%), inflammatory biliary strictures in 10 (2%) and
other benign conditions in 14 patients (2.8%) respectively. Five year overall
survival rate in these patients was 83.3%, with no survival difference between
patients with chronic pancreatitis and those with other benign diseases. Of
the 41 patients with a preoperative diagnosis of benign pathology, we found
12 cases (27%) of malignancy.
Conclusion. This study confirms previous reports that benign diseases
represent approximately 10% of the PD performed for suspected malignancy.
More importantly, it shows that in a third of the patients in whom PD is
carried out for suspected benign disease such as chronic pancreatitis, there is
an underlying malignancy.
PP 17.02
DOUBLE CANCER; ARISING IN GASTRIC HETEROTOPIC PAN-
CREAS AND PANCREAS TAIL
Sanada, Takahiro1; Iwasaki, Yoshiaki2; Goro, Honda3; Koji, Tsuruta3
1Ohkubo Hospital, Surgery, Tokyo, Japan; 2Komagome Hospital, gastric
surgery, Tokyo, Japan; 3Komagome Hospital, Hepato-Biliary-Pancreatic
surgery, Tokyo, Japan
Introduction. A heterotopic pancreas in the gastric wall is a relatively
common congenital condition, but its malignant transformation is extremely
rare. Here we report a very rare case of 61-year-old Japanese woman with
double cancer arising in gastric heterotopic pancreas and pancreas tail.
Patient. 61-year-old Japanese woman admitted to our hospital, complaining
of epigastric discomfort.
Radiological Studies. Computed tomography and magnetic resonance
imaging showed a cystic lesion of gastric wall and irregular change of main
pancreatic duct with pseudocyst at the proximal site of the main pancreatic
duct. Upper gastrointestinal endoscopy revealed a submucosal tumor in the
antrum along the greater curvature, and a biopsy specimen confirmed this
submucosal cystic tumor included heterotopic pancreatic tissue.
Blood Examination. CA19-9 was elevated to 167.3U/ml.
Operation. We found liver metastasis and a lot of disseminations on the
abdominal wall, mesocolon, and mesojejunum. So she underwent distal
gastrectomy only.
Discussion. Adenocarcinoma arising within ectopic pancreas is a rare
occurrence with fewer than 40 well-documented cases reported in the world
literature to our knowledge, but it should be noted that the malignant
transformation of ectopic pancreas could occur.
PP 17.04
LAPAROSCOPY IN PATIENTS WITH LOCALLY ADVANCED
PANCREATIC TUMOURS.
Morak, Marjolein J.M.1; Smeenk, Hans1; Mast, Jay1; Hermans, John J.2;
Kazemier, Geert1; van Eijck, Casper H.J.1
1Erasmus Medical Center, Surgery, Rotterdam, Netherlands; 2Erasmus
Medical Center, Radiology, Rotterdam, Netherlands
Background. In pancreatic cancer, differentiating between resectable,
locally advanced and metastasized tumours is of pivotal importance for
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optimal treatment. In patients with locally advanced pancreatic cancer
locoregional chemoradiation is the treatment of choice.
Aim. To investigate the role of diagnostic laparoscopy in patients with locally
advanced pancreatic cancer.Method.: In a retrospective study 82 patients
with locally advanced pancreatic cancer were classified based on CT scan
according to Phoa criteria. All patients underwent laparoscopy and in case of
metastases, these were all proven histologically. In the non-metastasized
patients histology was obtained with percutaneous biopsy, endoscopic
ultrasound or based on Ca 19.9 levels of250kU/l.
Results. Metastases were found during laparoscopy in 34 (41%) of patients.
The mean survival in these patients was 6.8 months. Overall survival in the
locally advanced patients was 14.7 months. Twenty eight of these patients
received chemoradiation, with a mean survival of 20.2 months. Twenty two
patients either refused or were not eligible for chemoradiation and their
survival was 8.9 months.
Conclusion. In 41% of patients with locally advanced pancreatic cancer
metastases were detected during laparoscopy, which were not visualised by
CT- scanning. In these accurate staged patients, chemoradiation might
improve survival.
PP 17.05
CT APPEARANCES OF SOLID PSEUDO-PAPILLARY NEO-
PLASMS OF THE PANCREAS
Eapen, Anu1; Suzy Cherian, Rekha1; Lorence Vyas, Frederick2; Kurian,
Susy3; Sitaram, Venkatramani2
1Christian Medical College, Department of Radiology, Vellore, India;
2Christian Medical College, Department of Hepato-biliary surgery, Vellore,
India; 3Christian Medical College‘, Department of Pathology, Vellore, India
Background. Solid pseudo-papillary neoplasm of the pancreas is a rare, low
grade malignant tumor seen in young women. Recognition of this entity on
imaging is important, as it is potentially curable after resection.
Aim. To describe CT features of solid pseudo-papillary neoplasm of the
pancreas.
Methods. We retrospectively analyzed CT features of solid pseudo-papillary
neoplasm of the pancreas in 10 patients who underwent surgical resection.
Pancreatic tumors were analyzed with respect to location, size, attenuation
{solid or cystic}, encapsulation, hemorrhage and calcification, features of
malignancy (infiltration, adenopathy and liver metastasis), associated find-
ings (duct dilatation, atrophy of gland and venous thrombosis).
Results. All 10 patients were women between the ages of 10 -36 years,
(mean: 24 years). Tumor involved the body or tail of pancreas in 8. Four of
these were large masses, involving both body and tail. The maximum
transverse diameter of the tumor on CT varied from 3.2 to 13 cm. The
lesions were solid masses (5), solid with areas of cystic change/necrosis (4)
and cystic with thick enhancing wall (1). Punctate calcification within the
mass was present in 3 patients. All lesions were well encapsulated with no
peri-tumoral infiltration. In one patient with a previous history of pancrea-
titis, tumor was partly adherent to stomach. Significant adenopathy or liver
metastases were not seen. Pancreatic duct dilatation upstream was present in
2 patients with lesions in the head, and atrophy of the gland was observed in 2
patients. Splenic vein thrombosis was a feature in 3 patients.
Conclusion. The CT diagnosis of solid pseudopapillary neoplasm of the
pancreas should be considered when a well encapsulated, solid or partially
cystic lesion is seen in young women. Punctate calcification may be present.
Cystic degeneration is a common feature. Presence of peri-tumoral infiltra-
tion, adenopathy and metastasis are atypical.
PP 17.06
PANCREATICOGASTROSTOMY FOR PANCREATIC RECON-
STRUCTION AFTER PANCREATICODUODENECTOMY
Pai, Madhava1; Damrah, Oasama2; Abulkhir, Adel2; Lauretta, Andrea2;
Raychaudhari, Prasenjit2; Healey, Andrew2; Habib, Nagy2; Jiao, Long2
1Hammersmith Hospital, Imperial College, Hepatobiliary Surgery, Du Cane
Road, London, United Kingdom; 2Hammersmith Hospital, Imperial Col-
lege, Hepatobiliary Surgery, London, United Kingdom
Background. Postoperative morbidity after pancreaticoduodenectomy has
been associated mainly with the development of pancreatic fistula. The aim of
the present study was to investigate the postoperative morbidity in a series of
pancreaticoduodenectomies with pancreaticogastrostomies.
Methods. Retrospective review of a prospectively collected database at a
tertiary care university hospital. A total of 60 consecutive patients underwent
pancreaticogastrostomy (PG) following pancreaticoduodenectomy (PD)
between 2003 and 2006. Preoperative risk factors, intraoperative and
postoperative variables, and postoperative complications along with mortality
were analysed.
Results. The 4 most common indications for surgery were pancreatic
adenocarcinoma (48.3%), ampullary carcinoma (8.3%), duodenal carcinoma
(6.7%), and chronic pancreatitis (5%). The median operating time was 7
hours. Median blood loss was 465 ml. The median intraoperative blood
transfusion was 0 U. The median postoperative length of stay was 17.5 days.
Postoperative mortality was 5% (n3). The most common complications
were wound infection (20%) followed by abdominal collection/ abscess
(16.7%). Two patients had delayed arterial haemorrhage 1 of which was the
cause of 1 of 3 mortalities in this series. There was no incidence of pancreatic
fistula.
Conclusion. Pancreaticogastrostomy is a safe operation associated with low
mortality and morbidity rates. It should be considered as a suitable
alternative for management of the pancreatic remnant after pancreaticoduo-
denectomy.
PP 17.07
EXTENDED DUODENOPANCREATECTOMY FOR NONPER-
IAMPULARY TUMORS
Albagli, Rafael1; Albagli, Rafael2; Mali Jr, Jorge3; Stoduto, Gustavo4
1National Cancer Institute-Brazil, Abdominal Surgery, Rio de Janeiro, Brazil;
2; 3Cancer Hospital, Londrina, Brazil; 4National Cancer Institute- Brazil, Rio
de Janeiro, Brazil
Introduction. To evaluate the surgical morbimortality and the evolution of
the patients submitted to extended duodenopancreatectomy (DP) for
nonperiampulary tumors.
Methods. It were analised retrospectivaly 15 patients submitted to DP for
nonperiampulary tumors, in the abdominal-pelvic surgery service of National
Cancer Institute- Brazil, from 1990 to 2005.
Results. The histologic kinds of primary tumors included the adenocarci-
noma of colon (n9), gastric adenocarcinoma (n3), gastrointestinal
stromal tumors (n2) and renal carcinoma (n1). The average internation
time was 13,5 days (6 to 36), the average operation time was 360 minutes, the
hemotransfusion average was 307 ml, the ressected limph nodes average was
19, where 3 patients had positive limph nodes, the average size of the tumor
was 7,8cm (2,5 to 24), the surgical morbidity was 60%, the operative
mortality was 6,6% (1/15) and the global survival average was 38 months.
Conclusion. The duodenopancreatectomy for nonperiampulary tumors is
an exception procedure and it must be considered only for selected patients.
PP 17.08
EFFECT OF BLOOD TRANSFUSION ON OUTCOME AFTER
PANCREATICODUODENECTOMY: A CASE-MATCH STUDY
Pai, Madhava1; Abulkhir, Adel2; Damrah, Osama2; Limongelli, Paolo2;
Habib, Nagy2; Williamson, Robin2; Jiao, Long2
1Hammersmith Hospital, Imperial College, Hepatobiliary Surgery, Du Cane
Road, London, United Kingdom; 2Hammersmith Hospital, Imperial Col-
lege, Hepatobiliary Surgery, London, United Kingdom
Background. Although blood transfusions have allowed surgeons increased
latitude in resecting pancreatic cancers, they can cause significant morbidity.
Potential side effects may include transmission of infection and immunosup-
pression. The aims of this study were to examine the effect of blood
transfusion on morbidity and mortality in association with pancreaticoduo-
denectomy (PD).
Methods. 102 patients underwent PD in our institution between 2002 and
2006. Patients were matched for age, sex, and histology and divided into two
groups of 32 patients each, one group had received blood transfusion (BT)
and the other had no blood transfusion (NBT). Their clinical data,
transfusion records, postoperative outcome including morbidity and mortal-
ity were analysed.
Results. 20 patients had pancreatic ductal adenocarcinoma and 12 had
ampullary adenocarcinoma in each group. The median age was 67.5 (40
82years) and 68 (3681years) in BT and NBT groups (p0.7). Intraopera-
tive blood loss (pB0.001) and operative time (pB0.0001) were significantly
higher in the BT group. However there was no difference in intensive care
unit (ICU)(p0.08) or hospital stay (p0.4). The two groups had no
statistically significant difference in relaparotomy, overall morbidity or
postoperative mortality.
Conclusion. Intraoperative blood loss and operative time are the two
important factors influencing BT. Although BT is not shown to affect the
short-term results after PD in this study, its effect on the overall survival and
disease recurrence needs to be further evaluated.
PP 17.09
RARE PRIMARY PANCREATIC MALIGNANCIES- PRESENTA-
TION AND OUTCOME.
Cherian, Thomas1; Manzia, T2; Coldham, C2; Toti, L2; Bramhall, SR2;
Mayer, D2; Buckels, JAC2; Wigmore, SJ2; Mirza, DF2
1University Hospital, Birmingham; 2
Background. Non-ductal adenocarcinomas and non neuroendocrine tu-
mours are unusual in the Pancreas and exhibit diverse biological behaviour.
We reviewed our experience of these rare pancreatic malignancies (RPM)
accumulated over 10 years.
Method. We conducted a retrospective review of all cases of RPM from Jan
1997 to 2007, from our prospectively collected database of 1551 pancreatic
tumours. We discuss the clinical course, diagnosis, and treatment of these less
common neoplasms of the pancreas. Pancreatic lymphomas and neuroendo-
crine tumours being separate, homogenous entities, merit dedicated analysis
and were excluded from this study.
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Results. There were 89 cases of RPM (incidence 5.6% of pancreatic
tumours); 49 females; median age 61years (range 1786); median follow-
up 18 months. Histologically, 39 (45%) were cystadenocarcinomas, 15
IPMN (18%), 8 pseudopapillary tumours, 7 adenosquamous carcinomas, 4
paragangliomas, 4 acinar cell carcinomas, 3 osteclastomas and 7 other
miscellaneous neoplasms. Fifty-nine patients (70%) had resectional surgery-
12 total pancreaticoduodenectomy, 33 partial pancreaticoduodenectomy
(Whipples), 14 distal pancreatectomy. Among the 15 IPMNs, 4 had
carcinoma in situ and 9 invasive cancer. There was no statically significant
survival difference between the various subgroups within this diverse cohort,
however their overall 5-year survival was 30% compared to 5% from ductal
adenocarcinomas in our institution. PB0.05. Three-year survival rates for
cystadenocarcinomas were particularly poor (33%), in contrast to the
cystadenomas (52%), which often appear similar on imaging. Conclusion
Rare pancreatic malignancy although fewer than ductal adenocarcinomas,
form a significant part of our pancreatic cancer workload (5.6%). As
awareness of the entity increases, adenocarcinomas arising from IPMN
seems to form a sizeable percentage. The prognosis of these RPM appear to
be better than ductal adenocarcinomas making histological confirmation
essential, especially if tumours appear inoperable.
PP 17.10
PANCREATICO-DUODENECTOMY WITH ARTERIAL RESEC-
TION FOR PANCREATIC ADENOCARCINOMA
Jaeck, Daniel; Bachellier, Philippe; Rosso, Edoardo; Tracey, Jacky; Oussoult-
zoglou, Elie; Pessaux, Patrick
Hopital de Hautepierre, Centre de Chirurgie Visce´rale et Transplantation,
Strasbourg, France
Hypothesis: Arterial resection associated with pancreaticooduodenectomy for
adenocarcinoma of the pancreas is feasible and does not impair final
outcome. Patients: From January 1990 to December 2005 nine patients
underwent a R0 pancreaticoduodenectomy associated with an arterial
resection for adenocarcinoma of the pancreas. Their records were reviewed
for perioperative outcome and long term survival. Main Outcome Measures:
The postoperative mortality was nil while the postoperative morbidity was
66%. Complications were of grade III in 33% of the patients. Eight patients
underwent a simultaneous portal vein resection. No postoperative arterial or
venous thrombosis occurred. Final pathology showed regional lymph nodes
metastases in eight patients. The median survival was 10 months. The actual
1- and 2-years survival rates for all 9 patients were 33% and 13%,
respectively. One patients is alive 76 months after surgery without recurrence.
Conclusions. Pancreaticoduodenectomy with AR and/ or combined venous
resection for locally advanced adenocarcinoma of the pancreas can be
performed safely in selected patients, whenever the arterial resection
represents the only obstacle to a curative resection. Long term survival is
similar to that of less extensive surgery for locally advanced adenocarcinoma
of the pancreas. Whenever R0 resection cannot be achieved pancreaticoduo-
denectomy with arterial resection is not indicated.
PP 18.01
LEVELS OF TUMOUR MARKERS MEASURING BIOLOGICAL
ACTIVITY DURING AND AFTER LIVER METASTASE RESEC-
TION
Lipska, Ludmila1; Visokai, Vladimir2; Vrzalova, Jindra3; Topolcan, Ondrej4;
Levy, Miroslav5; Holubec, Lubos6
1Thomayer Tcheaching Hospital, Department of Surgery, Praque 4, Czech
Republic; 2Thomayer Teaching Hospital, Department of Surgery, Praque 4,
Czech Republic; 3University Hospital Pilsen, Department of Nuclear
Medicine, Pilsen, Czech Republic; 4Immunoanalytic laboratory, Department
of Nuclear Medicine, Plzen, Czech Republic; 5Thomayer Teaching Hospital,
Department of Surgery, Prague, Czech Republic; 6Immunoanalytical labora-
tory, Department of Nuclear Medicine, Plzen, Czech Republic
Background. Postoperative monitoring of tumour markers biological
activity is important for the consideration of the effect of surgical treatment
and the success of hepatic tissue regeneration.
Aims. To monitor the changes in blood levels of selected growth factors,
interleukins and tumour markers during and immediately after resection of
liver metastase.
Methods. Blood samples were obtained regulary from 8 patients during
surgical procedure, 24 hours after the operation and day, two days and one
week after the operation. Serum levels of interleukin (IL) 6, IL 8 and
hepatocyte growth factor (HGF) were assessed by multiplex immunoassay
and carcinoembryonal antigen (CEA), thymidinkinase (TK), insulin like
growth factor I (IGFI), carbohydrate antigen (CA) 242 and tissue specific
polypeptide antigen (TPS) using routin immunoassays.
Results. The results are presented as individual case reports and imply that:
HGF levels increase during 24 hours and the first day after the operation and
then drop gradually, IL 6 levels increase in the first 24 hours and then drop
slowly, TPS levels increase rapidly from the beginning of an operation and
drop rapidly during the first 24 hours after an operation, IL8 levels are
elevated after an operation but not with the characteristic peak visible for e.g.
HGF. TK is elevated one week after the operation but not earlier, probably as
a marker of rash DNA synthesis during tissue reparation. CA 242, CEA and
IGFI do not show any striking changes.
Conclusions. Our study shows the necessity of proper timing for post-
operative monitoring of tumour markers biological activity. However, for the
standardization of monitoring it is necessary to perform a study on a larger
group of patients. This study was supported by the research project VZ MSM
0021620819.
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RADIOFREQENCY ASSITED LIVER RESECTION FOR COLOR-
ECTAL CANCER METASTASES PREVENTS SURGICAL MARGIN
RECURRENCE
Bulajic, Predrag; Milicevic, Miroslav; Basaric, Dragan; Galun, Danijel
First surgical clinic, Clinical center of Serbia, Belgrade, Serbia and
Montenegro
Introduction. Liver resection for colorectal liver metastases is the only
potentially curable treatment available today. Numerous independent pre-
dictors of survival after curative surgery have been reported. The one factor
most consistently related to prognosis after liver resection is surgical margine
status and it is the only predictor that can be influenced by surgeons. There is
no definitive evidence regarding the width of the surgical margin during
hepatectomy, needed to avoid reccurence.
Objective. To evaluate the influence of radiofrequent assited liver resection
technique on surgical margine recurrence.
Methods. From December 2001 to December 2006 101 patient were
operated for liver only colorectal cancer metastases and 123 liver resections
were performed using radiofrequency assisted technique. The technique
consist of diseccation of healthy liver parenchyma using radiofrequency
energy and consequent transection by scalpel through diseccated area.
Multiple desiccation and cutting sequences are performed to gradually
achieve transection plane through the liver parenchyma. Follow up included
regular CT and tumor markers investigations and histological examination of
the superficial scars on the liver when re-resection was performed.
Results. In the majority of patients a non anatomical liver resection was
performed. The width of surgical margin was 0 mm in 47 patients. At a
median follow-up of 23 months, 76 patients had developed a recurrence
within the liver. 17 patient underwent liver re-resections. Histology of the
removed surfical scar on the liver during reresection did not reveal local
(surgical margine) recurrence in any of the patients (10 patints with 0 mm
and 7 patients with 1 mm or more wide margin). There were no CT
detectable surgical margin-related recurrences in the patients who were not
reoperated.
Conclusion. Ablations of the healthy liver parenchyma in close proximity of
the liver metastases can prevent surgical margin recurrence.
PP 18.03
RESECTION OF HEPATIC AND PULMONARY COLORECTAL
METASTASES: WHICH IS FIRST?
Damrah, Osama1; Raychaudhuri, Prasenjit1; Pai, Madhava1; Shah, Amit1;
Anderson, Jon2; Jiao, Long1; Canelo, Ruben1; Habib, Nagy1
1Hammersmith Hospital, Imperial College, Hepatobiliary Surgery, London,
United Kingdom; 2Hammersmith Hospital, Imperial College, Cardiothor-
acic Surgery, London, United Kingdom
Introduction. Among patients undergoing curative resection for colorectal
carcinoma, lung and liver metastases develops in 40% of cases. Treatment in
the form of surgical resection or radiofrequency ablation (RFA) is thought to
benefit a selected group of patients. The outcome of patients who had
surgical intervention first for the lung was compared to those who had
surgical intervention for the liver in the first instance.
Methods. Database on 218 consecutive patients who underwent hepatic
resection for colorectal liver metastases between January 2002 and December
2006 at our centre were reviewed. Of these, 51 patients had synchronous
hepatic and pulmonary metastases. Patient demographics, operative inter-
ventions, and overall survival were analyzed.
Results. 11 patients with a mean age of 58 years had resection/RFA of both
pulmonary and hepatic metastases. The median number of lung lesions was 2
(range 15) whereas that of liver lesions was 3(range14). Lung lesions were
unilateral in 73% while liver lesions were unilobar in 45% of patients. 5
patients had lung resection before liver resection, while 6 patients had lung
resection after liver resection. Overall there were 14 resections and 4 RFA for
liver lesions and 8 resections and 4 RFA for lung lesions. Median survival of
patients who underwent liver intervention first was 46 months while patients
undergoing lung intervention first had median survival of 25 months. Overall
median survival was 38 months.
Conclusion. Surgical resection and/or RFA of both hepatic and pulmonary
colorectal metastases provides survival advantage in selected patients.
PP 18.04
LIVER SURGERY FOR ELDERLY: IS IT FEASIBLE?
Stoot, Jan; Van Dam, Ronald; van der Poll, Marcel; Olde Damink, Steven;
Bemelmans, Marc; Dejong, Kees
University Hospital maastricht, Department of Surgery, Maastricht, Nether-
lands
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Background. Hepatic resections for primary and metastatic tumours are
performed with increasing frequency and the limits extending. However, the
safety and feasibility of liver surgery in elderly patients is still under debate.
Aim. The aim of this study was to evaluate the feasibility and outcome of
liver resections in the elderly (70 years and older).
Methods. Between January 1, 1997 and January 1, 2007 a consecutive series
of 194 patients underwent 214 liver resections. The group of patients under
70 years served as control group (paediatric patients were excluded). Primary
outcome was mortality. Secondary outcomes were complications, hospital
length of stay and readmissions.
Results. Forty six elderly patients with a median age of 75 years (range 70
88) underwent partial liver resection. Both groups matched for gender and
major/minor resections. Mortality rate was higher in the elderly group
compared to the control group [2/46 (4 per cent) versus 1/166 (0.6 per
cent)] but within the range reported in literature. Also, complications rates
were higher in the elderly [19/46 (41 per cent) versus 50/166 (30 per cent)].
The median length of hospital stay was 9 days (range 482) in the elderly
versus 8 days (range 381) in the control group. There were 4 re-admissions
(9 per cent) in the elderly group compared to 27 (16 per cent) in the control
group. None of these differences between the groups were statistically
significant.
Conclusion. Hepatic resection can be performed in elderly patients of 70
years and older with an acceptable morbidity and mortality.
PP 18.05
IS THE ‘5050 CRITERIA’ USEFUL FOR THE PREDICTION OF
HEPATIC FAILURE AND MORTALITY FOLLOWING RESECTION
OF COLORECTAL LIVER METASTASES
Morris-Stiff, Gareth; Gomez, Dhanwant; Bonney, Glenn K; Toogood, Giles
J; Lodge, J. Peter A.; Prasad, Rajendra
Leeds Teaching Hospitals NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom
Background. The ‘5050 criteria’ on day 5 has recently been advocated as
means of predicting the development of liver failure and death following
hepatectomy. A wide spectrum of pathologies were included in the analysis
but with only 21% of resections being performed for colorectal liver
metastases (CRLM), the commonest indication for hepatic resection in
Western populations.
Aims. To validate the role of ‘5050 criteria’ in a contemporaneous cohort of
patients undergoing liver resection for CRLM, including subgroup analysis of
patients with hepatic parenchymal damage.
Patients and Methods. All patients undergoing resection of colorectal liver
metastases from 20002005 were identified from a prospectively maintained
database. Data collected included: peri-operative factors (extent and com-
plexity of resection, blood/plasma transfusion); histopathological factors
(degree of steatosis/fibrosis); post-operative (morbidity rate, ICU stay,
mortality).
Results. During the period of the study 386 patients (246 Male and 140
females) with a mean age of 65.9 years, 268 of which were aged60 years,
underwent resection. Only 28/386 (7.3%) of patients fulfilled the criteria.
The ‘5050 criteria’ was not related to any of the peri- or post-operative
factors and did not predict liver failure or death in patients undergoing
resection of CRLM. Furthermore, subgroup analysis did not identify a
predictive role for the criteria even when there was histological evidence of
steatosis or fibrosis in the background parenchyma.
Conclusions. The results show that the ‘5050 criteria’ are not there able to
accurately predict outcome in patients undergoing resection of CRLM.
Despite significant improvements in perioperative care, hepatic failure and
mortality remain potential risks in particular when extended resections are
performed and thus the search for an accurate predictive biomarker must
continue.
PP 18.06
THROMBOTIC COMPLICATIONS FOLLOWING LIVER RESEC-
TION FOR COLORECTAL METASTASES ARE PREVENTABLE
White, Alan; Morris-Stiff, Gareth; Gomez, Dhanwant; Toogood, Giles;
Lodge, J. Peter A.; Prasad, Rajendra
Leeds Teaching Hospital NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom
Background. Surgery for colorectal liver metastases may be expected to be
associated with a significant rate of thrombotic complications due to the
performance of long-duration procedures often with dissection close to the
vena cava in patients aged 60 years or over. As a result all patients received
low molecular weigh heparin, thromboembolic deterrent stockings and
intermittent calf compression perioperatively.
Aims. The aim of this study was to determine the prevalence of clinically
significant thrombotic complications including deep venous thrombosis
(DVT) and pulmonary embolus (PE) in a contemporary series of patients
undergoing resection of colorectal liver metastases.
Methods. All patients undergoing resection of colorectal liver metastases
from 20002005 were identified from a prospectively maintained database
with particular reference to thrombotic complications. In addition, the
radiology department database was reviewed to confirm that clinically
suspicious thromboses had been confirmed radiologically by ultrasound in
the case of DVT or CT for PEs.
Results. During the period of the study 386 patients (246 Male and 140
females) with a mean age of 65.9 years, 268 of which were aged60 years,
underwent resection. More than 4 segments were excised in 245 of the
patients. One or more complications were seen in 39.4% of patients.
Thrombotic complications were seen in 8 (2%) patients: DVT alone (n3)
and PE (n5). Six of 8 thrombotic complications occurred in patients
undergoing resection of 4 or more segments, 4 of which were trisectionec-
tomies. Patients were anti-coagulated and there were no mortalities.
Conclusions. The symptomatic thrombotic complication rate was lower in
this cohort than may be expected in patients undergoing non-hepatic
abdominal surgery. It is uncertain as to whether this is related to s in this
cohort was low. It is uncertain whether this is due entirely to effective
prophylaxis or a combination of treatment and a natural anti-coagulant state
following hepatic resection.
PP 18.07
LONG TERM DISEASE-FREE SURVIVAL AND PROGNOSTIC
FACTORS FOLLOWING HEPATIC RESECTION FOR COLOR-
ECTAL LIVER METASTASES
Gomez, Dhanwant; Morris-Stiff, Gareth; Toogood, Giles J; Lodge, J. Peter
A.; Prasad, Rajendra
Leeds Teaching Hospital NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom
Background. To date, there is limited data available on prognostic factors
that influence long term disease-free survival following hepatic resection for
colorectal liver metastasis (CRLM). The aim of the current study was to
analyse prognostic factors of patients developing recurrent disease within 5-
years following hepatic resection compared to patients that have been disease-
free for 5-years or more.
Methods. Patients undergoing resection for CRLM from January 1993 to
March 2007 were identified from the hepatobiliary database. Data analyzed
included demographics, laboratory results, operative findings and histo-
pathological data.
Results. 705 primary hepatic resections were performed of which 434
patients developed recurrent disease during the follow-up period and 67
patients were disease-free more than 5-years. 204 patients were excluded (25
post-op deaths and 179 patients who are currently under follow-up and
disease-free forB5 years). There was a significant association between
inflammatory response to tumour (IRT  raised neutrophil to lymphocyte
ratio and/or C-reactive protein), blood transfusion, 2 tumours and
resection margin involvement with developing recurrence during the 5-year
follow-up period. On multi-variate analysis, three independent predictors for
recurrent disease within the 5-year follow-up were identified: pre-operative
raised IRT; blood transfusion requirement; and status of resection margin.
Overall survival was significantly lower in patients with raised IRT, blood
transfusion and involved resection margin.
Conclusion. Pre-operative low IRT, absence of requirement for blood
transfusion and a clear resection margin are associated with long term disease
free survival.
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PERI-OPERATIVE OUTCOME FOLLOWING CURATIVE RESEC-
TION FOR COLORECTAL LIVER METASTASES IN PATIENTS
WITH SINUSOIDAL OBSTRUCTION SYNDROME
Gomez, Dhanwant1; Morris-Stiff, Gareth1; Wyatt, Judy2; Ward, Janice3;
Robinson, Paul3; Guthrie, Ashley3; Sheridan, Maria3; Toogood, Giles J1;
Lodge, J. Peter A.1; Prasad, Rajendra1
1Leeds Teaching Hospitals NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom; 2Leeds Teaching Hospitals NHS Trust,
Department of Histopathology, Leeds, United Kingdom; 3Leeds Teaching
Hospitals NHS Trust, Department of Radiology, Leeds, United Kingdom
Aims. To determine the peri-operative outcome following hepatic resection
for colorectal liver metastasis (CRLM) in patients with sinusoidal obstruction
syndrome (SOS).
Methods. Patients undergoing curative resection for CRLM with SOS on
histology from January 2005 to March 2007 were identified from the
Pathology database. Data analysed included demographics, extent of hepatic
resection and histopathology data.
Results. 20 patients were identified with a median age of 62 (38  79) years
and equal gender distribution. All patients underwent neo-adjuvant oxalo-
platin-based chemotherapy. 7 patients had at least one co-morbid condition.
13 patients underwent major hepatic resections (hemi-hepatectomy or
trisectionectomy). Only one patient required blood transfusion post-surgery
(2 units). Overall morbidity was 30% and no mortality was recorded in these
patients. The median hospital stay was 8 (7  22) days. In this group of
patients, age, gender, severity of steatosis and the presence of fibrosis were
not associated with higher morbidity. Although not statistically significant,
there was a trend for higher morbidity in patients with SOS that had major
hepatic resections (46%; p0.051).
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Conclusion. Patients with SOS in this study had a morbidity rate of 30%.
Extent of hepatic resection could potentially affect the post-operative
outcome in these patients. Further analysis in a larger sample of patients is
required to determine the effect of SOS on morbidity and mortality following
hepatic resection.
PP 18.09
STEATOSIS AND STEATOHEPATITIS IN PATIENTS UNDER-
GOING LIVER RESECTIONS-DOES IT MATTER AND IS CHE-
MOTHERAPY TO BLAME?
Al Momani, Hazeem1; Gilmour, JP1; Johnson, SC2; Boyles, TH3; Williams,
GT2; Kumar, N1
1University Hospital of Wales, Cardiff Liver Unit, Cardiff, United Kingdom;
2University Hospital of Wales, Department of Pathology, Cardiff, United
Kingdom; 3University Hospital of Wales, Department of Medicine, Cardiff,
United Kingdom
Objectives. The aim of our study was to find (a) the post-surgical outcome
of patients with histologically verified steatohepatitis and (b) any association
between preoperative chemotherapy and steatohepatitis.
Methods. Histological specimens from patients who had elective liver
resection under the care of a single surgeon over three years were reviewed
by a pathologist, who was blinded to the clinical details. Steatohepatitis(SH)
was defined as a Brunt score of ¡Y´4. Steatosis was quantified using a
computer assisted method which was developed and validated locally. The
results were correlated with the clinical data.
Results. There were 72 patients. SH was present in 19 patients. There was
no significant difference in age, sex, weight, presence of diabetes, proportion
of major resections, and alcohol consumption in patients with and without
SH. Only body weight and histological steatosis were significantly associated
with SH (p0.001). There was no difference in the mortality, ITU stay or
hospital stay between the two groups. Chemotherapy (FOLFOX) was given
to 32 patients and none to 40 patients. There was no significant difference in
the degree of steatosis or SH between the two groups. Liver resection was
performed at a mean of 151 days (48783) from completion of chemother-
apy. There was no difference in the frequency or the degree of steatohepatitis
between patients undergoing liver resection less than, or more than, 100 days
from chemotherapy.
Conclusion. We conclude that there is no apparent increase in morbidity or
mortality in patients undergoing liver resections in the presence of steatohe-
patitis. Oxaliplatin based chemotherapy is not associated with steatohepatitis.
PP 18.10
OUTCOMES OF HEPATIC RESECTION FOR COLORECTAL
METASTASIS
Cho, Eung-ho1; Kang, Kyang-Taeae1; Mun, Sun-Mi1; Choi, Dong-Wook2;
Mun, Nan-Mo1; Hwang, Dae-Yong1; Kim, Sang Bum1
1KIRAMS, Surgery, seoul, Korea, Republic of; 2Samsung medical center,
Surgery, Seoul, Korea, Republic of
Purpose. Colorectal cancer remains one of the most common cancers, but
liver metastases will develop in more than one-third of patients. Among
various treatment modalities, hepatic resection is generally accepted as the
only potential for cure in patients with colorectal metastases confined to the
liver. The aim of this study was to evaluate the short- and long-term results of
patients who underwent hepatectomies for colorectal liver metastases.
Patients and methods. From September 1993 to November 2006, patients
underwent the consecutive liver resection for colorectal metastases. Clin-
icopathologic, operative, and perioperative data were reviewed to evaluate
perioperative outcomes. Median follow up period was 23.5 months (0.7165
month).
Results. The population of this study consisted of 100 patients undergoing
consecutive hepatic resection. Median age was 61 year-old (2784) and there
were 66 male and 34 female patients. Preoperative PET was performed in 54
cases and positive rate was 96.3%. Simultaneous hepatic resection was
performed in 70 cases including 15 two-stage operations. The number of
synchronous and metachronous metastasis were 76 and 24 cases respectively.
Major resection was performed in 47 cases. Intraoperative transfusion was
done in 24 cases and median hospital stay was 14 day (2100). The mean size
and number of tumor were 3.13¡341.99 centimeter and 1.64¡
3
41.08. In 4 cases
resection margin were involved microscopically. In-hospital mortality rate
was 1% (1cases) and the cause of death was myocardial infarction. Overall
morbidity rate was 32.4% but major complication rates were 6.1%. During
the follow up recurrence occurred in 62 cases and most common site of
recurrence were liver and lung. 5 year survival rate and disease free survival
rate was 33.1% and 25.7% respectively.
Conclusion. Hepatic resection was safe and effective treatment option for
patients with colorectal liver metastases.
PP 19.01
INITIAL POOR FUNCTION DOES NOT AFFECT PATIENT AND
GRAFT SURVIVAL FOLLOWING LIVER TRANSPLANTATION
Bonney, Glenn K1; Kalyanaraman, Aarti1; Attia, Magdy2; Pollard, Stephen
G2; Toogood, Giles J1; Lodge, J Peter A1; Prasad, K Rajendra1
1St James’ University Hospital, Department of Hepatobiliary and Tranp-
slantation Su, Leeds, United Kingdom; 2St James’ University Hospital,
Department of Hepatobiliary and Tranpslantation Su, Leeds
Background. Initial Poor Function (IPF) has been thought to predispose to
primary non-function following liver transplantation. IPF has been described
using a number of biochemical and haematological criteria. The aim of this
study was to analyse the effect of 3 of these definitions on patient and graft
survival following liver transplantationMethods. A prospectively collected
database of 661 liver transplants performed between 1998 and 2005 was used
for the analysis. Biochemical and graft and patient survival data was used for
the analysis. The effect of IPF, using three different published criteria was
analysed. Criteria 1: Alanine Transaminase 1500 within the first 3 days of
transplantation. Criteria 2: Alanine Transaminase 2500 in day 1 of
transplantation. Criteria 3: Alanine Transaminase 2500 within 3 days of
transplantation.
Results The IPF rate using criteria 1,2 and 3 was 14.2%, 2.6% and 3.7%
respectively. IPF using and of the three definitions resulted in similar patient
and graft survival when compared to non-IPF recipients. Futhermore, the
occurrence of IPF, using any of the three definitions was not associated with
Primary Non-Function.
Conclusion. In this study, IPF as defined by transaminitis with three
different definitions here did not result in poorer patient and graft survival.
Furthermore, with these definitions, it was not associated with the occur-
rence of Primary Non-Function. There remains a need for more robust,
biochemical, clinical and pathological definitions of IPF particularly in
association with the later occurrence of Primary Non-Function
PP 19.02
MANAGEMENT OF HEPATIC ARTERY PSEUDOANEURYSM
AFTER LIVER TRANSPLANTATION: ONE CENTER’S EXPERI-
ENCE
McHugh, Patrick P; Johnston, Thomas D; Jeon, Hoonbae; Gedaly, Roberto;
Ranjan, Dinesh
Transplant Center, University of Kentucky, Surgery, Lexington, Kentucky,
United States
Background. Hepatic artery (HA) pseudoaneurysm is a rare complication
that can occur after orthotopic liver transplantation (OLT), particularly those
with postoperative bile leak or intraabdominal infection. While HA pseu-
doaneurysms typically present with hemorrhage, they can also present
nonspecifically, making prompt diagnosis challenging. Various treatment
options exist to manage this complication.
Objective. To present our experience diagnosing and managing HA
pseudoaneurysm after OLT.
Methods. Between July 1995 and July 2007 we performed 386 OLT
procedures in 378 patients. Of these, three patients (0.79%) developed HA
pseudoaneurysm.
Results. In all three patients the HA pseudoaneurysm was symptomatic: two
presented with bleeding (hemobilia and gastrointestinal), while the third
complained of vague abdominal pain. Both patients with bleeding had
antecedent bile leak and local infection, but the third had no apparent cause.
Diagnosis was made in all patients by screening Doppler ultrasound followed
by CT scan with angiography. Two patients underwent successful pseudoa-
neurysm resection with cadaveric vessel bypass. In the other patient, surgical
repair was unsuccessful due to hepatic hilar inflammation and friable tissues.
However, the HA was successfully embolized angiographically. Followup
studies in this patient have shown extensive arterial collateralization in the
liver hilum. All three patients have subsequently done well, and none has
evidence of biliary or hepatic ischemia.
Conclusions. Although rare, HA pseudoaneurysms are serious vascular
complications that can follow OLT. A high index of suspicion, especially in
patients with gastrointestinal hemorrhage or a history of hepatic hilar
infection, is necessary for early diagnosis and successful therapy. Angio-
graphic embolization may be an alternative if surgery is unsuccessful, as the
development of arterial collaterals may be sufficient to prevent ischemic
complications.
PP 19.03
FEASIBILITY OF VENA CAVA PRESERVATION DURING LIVER
TRANSPLANTATION FOR POLYCYSTIC LIVER DISEASE
Sommacale, Danie`le1; Andraus, Wellington1; Donde´ro, Fe´de´rica1; Sauvanet,
Alain1; Durand, Franc¸ois2; Francoz, Claire2; Goasguen, Nicolas1; Farges,
Olivier1; Belghiti, Jacques1
1Hospital Beaujon, HPB Surgery, Clichy, France; 2Hospital Beaujon,
Hepatology, Clichy, France
Background. Liver transplantation (LT) for polycystic liver disease (PLD) is
indicated in case of hepatomegaly. Total hepatectomy with caval-preservation
during LT for PLD is technically difficult because the liver often surrounds
the inferior vena cava (IVC). The increasing use of partial grafts inspired our
group to preserve the IVC.
Methods. From 1992 to 2007, 26 patients underwent LT for PLD. There
were 4 men and 22 women (mean age 55 yrs). Nineteen patients underwent
LT associated with renal transplant. Previous treatments for PLD were
performed in 8 (4 cyst fenestrations, 4 hepatic resection). To facilitate the
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IVC approach during LT procedure included cyst fenestrations, portocaval
anastomosis in all cases and in two cases a partial hepatectomy were
performed. Full grafts were used in 23 and partial grafts in 3 (2 split grafts
and 1 living donor).
Results. IVC preservation was possible in 24 (92%) patients. Failure to
preserve the IVC occurred in 2, one case of difficult dissection due to a
previous liver resection and one case of intraoperative death from massive
bleeding due to IVC injury. Total hepatectomy time ranged from 130 to 540
min with a mean blood loss of 3506 mL and blood transfusion rate of 9.2U.
Total IVC clamping during hepatectomy was required in 7 (26%), including
5 cases of poor hemodynamic tolerance. Venovenous bypass was used in 4
(IVC preservation was always possible). Total hepatectomy duration and
bloss were significantly higher in patients who had undergone previous liver
resection respectively: 327976.2 vs 243955.2 min (p0.036) and 80009
2743 vs 105091891 cc (p0.013). Postoperative mortality was of 11.5% (3
patients), from septic complications (pulmonary, colonic perforation and
multiorgan failure).
Conclusion. IVC preservation was feasible in 93% of LT for PLD and could
be facilitated by venovenous bypass, extensive cyst fenestrations and partial
liver resection. IVC preservation should be expected to be more difficult in
case of previous hepatectomy.
PP 19.04
PERI-OPERATIVE OUTCOME FOLLOWING PAEDIATRIC LI-
VER TRANSPLANTATION FROM A MODERN SERIES
Gomez, Dhanwant1; Morris-Stiff, Gareth1; McClain, Paddy2; Stringer, Mark
D.2; Prasad, Rajendra1
1Leeds Teaching Hospital NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom; 2Leeds Teaching Hospital NHS Trust,
Paediatric Transplantation Unit, Leeds, United Kingdom
Background. As a result of a number of developments including: surgical
techniques; immunosuppression therapy; patient selection criteria; and organ
preservation, peri-operative outcomes following orthotopic paediatric liver
transplantation (OPLTx) have improved significantly over recent years. The
aim of this study was to report peri-operative outcomes following primary
OPLTx and analyse donor, recipient and operative factors that affect post-
operative outcomes in a relative new paediatric centre.
Methods. Patients undergoing primary OPLTx from January 2000 to July
2007 were identified from the transplantation database. Data analyzed
included: demographic factors; donor and recipient characteristics; and
operative data.
Results. 102 OPLTx were performed, of which 91 patients were primary
OPLTx with a median age of 4.8 (0.05  17.2) years. Biliary atresia (n27,
30%) was the most common indication. Patients underwent 34 whole size
grafts, 14 reduced size and 43 split-liver transplants. Overall mortality was
3% (n3). Morbidity was reported in 50 patients (55%). Four patients (4%)
developed hepatic artery (HA) thrombosis and six patients (7%) had HA
stenosis. Both biliary complications and primary non-function was reported
in 5 patients (5%). Infection-related complications were noted in 16 patients
(18%). Recipient variables including demographics and Paediatric End-Stage
Liver Disease (PELD) did not influence morbidity. With respect to operative
factors, blood transfusion was significantly associated with morbidity follow-
ing OPLTx. Donor gender also significantly influenced post-operative
morbidity. Multi-variate analysis did not reveal an independent predictor of
morbidity.
Conclusion. Despite technically challenging, excellent peri-operative out-
comes could be achieved in a new program. Minimizing blood loss may
influence overall morbidity.
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IMPACT OF GRAFT TYPE ON OUTCOME FOLLOWING LIVER
TRANSPLANTATION IN PAEDIATRIC PATIENTS
Gomez, Dhanwant1; Morris-Stiff, Gareth1; McClain, Paddy2; Stringer, Mark
D.2; Prasad, Rajendra1
1Leeds Teaching Hospital NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom; 2Leeds Teaching Hospital NHS Trust,
Paediatric Transplantation Unit, Leeds, United Kingdom
Background. The aim of the study was to analyse prognostic factors that
influence graft and overall survival following orthotopic paediatric liver
transplantation (OPLTx) based on graft type.
Methods. Patients undergoing OPLTx from January 2000 to July 2007 were
identified from the Transplantation database. Data analyzed included
demographics, donor, recipient and operative data. Patients were divided
into three groups; whole, reduced-size and split-liver transplantation.
Results. 102 OPLTx were performed in 92 patients during the study period.
Patients underwent 36 (35%) whole size, 18 (18%) reduced size and 48
(47%) split-liver transplantation. Patients B12 months were more likely to
have a split-liver transplant compared to patients 12 months (pB0.001).
The split-liver transplant group were more likely to have a longer cold
ischaemia time (p0.004) and shorter warm ischaemia time (p0.033)
compared to the other groups. Graft survival at 1, 3 and 5-year was 88%,
88% and 84% in the whole-liver group, 83%, 83% and 83% in the reduced-
size group and 85%, 78% and 73% in the split-liver transplantation group
(p0.624). The 1, 3 and 5-year overall survival in the whole, reduced-size
and split-liver groups were 88%, 88% and 84%, 89%, 89% and 74% and
92%, 81% and 71%, respectively (p0.663). Warm ischaemia time was the
only variable that significantly affected graft and overall survival on univariate
analysis.
Conclusion. The graft and overall survival is not affected by type of graft
used. Warm ischaemia time does affect graft and overall survival.
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LIVER TRANSPLANTATION FOR POLYCYSTIC LIVER DISEASE
Bhatt, Anand N; Oniscu, Gabriel C; Gunson, Bridget; Coldham, Christo-
pher; Mayer, David; Mirza, Darius F; Buckels, John AC; Bramhall, Simon R
Queen Elizabeth Hospital, The Liver and Hepatobiliary Surgery Unit,
Birmingham, United Kingdom
Background. Orthotopic liver transplantation (OLT) offers a curative
option for diffuse polycystic liver disease (PLD) unlike aspiration, fenestra-
tion or resection.
Aim. To examine the role of OLT in patients with PLD.
Methods. Demographic, transplant and surgical data were retrieved from the
unit’s prospective database as well as patients’ medical records.
Results. 22 patients (1 male/ 21 female) who had a liver transplant for PLD
were identified among the 3000 transplants carried out between 1982 and
2007. Median age was 50 years (range 3459). The indications for OLT were
massive hepatomegaly resulting in pain and severe physical handicap (n
21), malnutrition (n6) and chronically infected cysts following marsupia-
lisation (n1). 6 patients (27%) had other interventions prior to OLT (3
aspirations, 2 de-roofing, 1 marsupialisation). The primary cyst pattern was
multiple bi-lobar disease. Eight patients had kidney transplants (5 simulta-
neous, 2 sequential and 1 prior to OLT). The median weight of the explanted
livers was 3555 grams (largest being 16kg). The hepatectomy time was 137
minutes (range 51225 min) and this was comparable with OLT for other
indications. The mean hospital stay was 14 days. The transplant complica-
tions are shown in the table below. 5-year patient and graft survival rates were
83% and 95% respectively (follow-up 3 months-17 years). Three patients
died during the follow-up period (1 pancreatic cancer, 1 lung cancer and 1
heart attack, at 3, 6 & 11 years post OLT, respectively).
Conclusion. In patients with diffuse PLD with significant impairment of
quality of life, OLT is the optimal treatment option with low complication
rates and excellent survival.
Complications
Biliary leak 3
Biliary stricture 3
Hepatic artery thrombosis 1
Renal Failure 7 (5 requiring haemodialysis)
Pneumonia 4
Tracheotomy 2
Pleural effusions 4
Cardiac complications 3
Post transplant diabetes 4
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POSITIVE EMISSION TOMOGRAPHY WITH FLUORINE-18-
FLUORODEOXYGLUCOSE IS USEFUL FOR PREDICTING THE
PROGNOSIS OF LT PATIENTS WITH HEPATOCELLULAR CAR-
CINOMA
Ryu, Je-Ho; Lee, sung-kyu; Kim, kwan-Woo; Ko, keung-Hoon; Choi, Nam-
Kyu
Asan Medical Center/University of Ulsan College of Medicine, department
of surgery, seoul, Korea, Republic of
Backgrounds and aims. Positive Emission Tomography with Fluorine-18-
fluorodeoxyglucose(FDG-PET) has established itself as a useful diagnostic
imaging for metastatic liver tumors. However, in case of hepatocellular
carcinoma(HCC), several investigators have reported controversial results
and have an inadequate sensitivity of PET(5055%). Nevertheless, a high
positive rate of FDG accumulation has been reported in patients with high-
grade HCC. We retrospectively reviewed 110 HCC cases that received liver
transplantation(LT) at our center between Jan 2003 and December 2005 and
underwent whole-body PET imaging.
Methods. FDG uptake was accessed in the liver, and its prognostic factors
was investigated. Of 110 patients enrolled, 34 patients had positive PET
scans for liver tumor.
Results. When we analyzed the association between tumor factors and
PET(greater PET lesion uptake)in the liver, vascular invasion, number of
tumors(3nodules), and tumor size(5cm) were found to be significantly
associated with PET(PB0.001, P0.004, and PB0.001, retrospectively).
However, the preoperative AFP level and histological grade was not
significantly associated with PET(P0.418 and P0.064). The 2-year
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recurrence-free survival rate of PET- patients was significantly higher than
that of PETpatients(89.2% vs. 61.7%)(P0.0005). Of 18 PET patients
who did not meet the Milan criteria, 12 patients(66.7%) had recurrence, but
14 PET- patients who did not meet the Milan criteria, 5 patients(35%) had
recurrence.
Conclusions. PET imging is useful for predicting the post-LT risk of tumor
recurrence, because vascular invasion and histological grade cannot be
determined preoperatively. The tumor recurrence could be highly anticipated
for PETHCC patients who do not meet Milan criteria. PET HCC
patients could be considered seriously for LT.
PP 19.08
TECHNICAL INNOVATIONS IN PEDIATRIC LIVING DONOR
LIVER TRANSPLANTATION
Sood, Disha1; Kakodkar, Rahul1; Kumaran, Vinay1; Mohan, Neelam2;
Nundy, Samiran1; Soin, A.S1
1Sir Ganga Ram Hospital, Surgical Gastroenterology & Liver transplanta-
tion, New Delhi, India; 2Sir Ganga Ram Hospital, Paediatrics, New Delhi,
India
Background. Advancements in surgical technique, immunosuppression,
and pre and postoperative management of patients have dramatically
improved survival after pediatric living donor liver transplantation (LDLT).
Aim. To study the surgical innovations used in pediatric LDLT and their
outcome.
Methods. Of the 164 patients who received LDLTs at our centre since 2004,
16 were children. Their intraoperative surgical problems, techniques used
and outcome were reviewed. Graft procurement was done with ultrasonic
aspirator without vascular clamping. Post transplant immunosuppression was
Tacrolimus or Neoral † based in 13 and 3 cases respectively.
Results. There were 10 males and 6 females, 1 to 15 years of age. The grafts
included 4 left lateral segments, 10 left lobes, 1 right lobe and 1 reduced left
lateral segment. Intraoperative surgical innovations/deviation from standard
procedure were required in 6 patients. 2 needed cavoportal transposition due
to complete portomesenteric thrombosis (1) and portal vein stenosis in (1).
One left lateral segment that proved too large and had patchy reperfusion due
to poor portal vein flow was removed, reflushed with HTK solution, reduced
on the bench. One left lobe with 2 hepatic arteries needed microvascular
reconstruction of both due to inadequate collaterals between the two. One
graft had a short, separate segment 2 hepatic vein draining into cava that was
extended using a cryopreserved vein graft, and then joined by a venoplasty to
the middle and left hepatic veins to make a single outflow channel. The
patient with right lobe graft had primary hyperoxaluria and also required a
simultaneous kidney graft from another living donor. The patient and graft
survival at a mean follow up of 23 months (244) was 100%. All donors are
currently well.
Conclusion. To obtain good results in pediatric LDLT, surgical innovations
are often required to deal with the challenges posed by portal vein
thrombosis, donor vascular anomalies and large for size grafts.
PP 19.09
LIVER TRANSPLANTIONS AT A CENTER IN SOUTH INDIA
Sharma, Supriya1; Sharma, Supriya2; Jayaram, Murali2; S, Sudhindran2;
Dhar, Puneet2; OV, Sudheer2; VG, Prasad2
1Amrita Institute of Medical Sciences and Reserce Center, Dept. of Gastro-
Intestinal Surgery, Amrita Lane, Elamakkara PO, KOCHI, India; 2Amrita
Institute of Medical Sciences and Research Center, Dept. of Gastro-
Intestinal Surgery, KOCHI, India
Introduction. Liver transplantation (LT) has become established as the
standard of care for a large number of end stage liver diseases.
Objective. To analyze the initial experience with LT at a South Indian
centre.
Materials and Methods. Retrospective analysis of the medical records of
nine LT performed at our centre (one cadaveric and eight living donor) from
June 2004  Aug 2007 was done to evaluate our experience.
Results. The first cadaveric transplantation was performed in 2004 June for
hepatitis B related cirrhosis. He died 3 years later due to recurrent Fibrosing
Cholestatic Hepatitis B. All 8 Living Donor LT (LDLT) have been
performed over 10 months from 2006. Two were paediatric transplantations
receiving left lobes from the mother and 7 were adults receiving right lobes
with the middle hepatic vein from first degree related donors. Three
transplantations were done on an emergency basis for Acute Liver Failure.
There were 3 perioperative deaths (33%). The median times for the donor
and recipient surgeries were 510 minutes (Range: 420600minutes) and
780minutes (Range: 720  960 minutes) respectively. The median ICU stay
and hospital stays for recipients were 10 days (Range: 8  14 days) and 24
days (Range: 8  31 days) respectively. Our chief complication in the recipient
has been biliary leak in 2 patients, both subsequent to hepatic artery
thrombosis. The median hospital stay for the donor was 11 days (Range: 7
 15 days). Apart from mild chest infection in 2 donors, all had uninterrupted
recovery. The average charge for the transplant was Rs 10,00000 (3,00,000 to
12,00,000). The entire team for transplant has been in-house, with only two
surgeons being trained abroad.
Conclusions. It is possible to perform liver transplantation in experienced
hepatobiliary centres without a very precipitous learning curve and with a
practical price tag. The referral to our transplantation center occurs at an
advanced stage of liver failure, probably accounting for the modest success
rate.
PP 19.10
PORTAL VEIN RECONSTRUCTION USING RECIPIENT OWN
RIGHT HEPATIC VEIN AS A INTERPOSITION GRAFT IN LIVING
DONOR LIVER TRANSPLANTATION
Niitsu, Hiroaki1; Tashiro, Hirotaka2; Itamoto, Toshiyuki2; Amano, Hiro-
nobu2; Ohdan, Hideki2; Asahara, Toshimasa2
1Hiroshima Unversity, Surgery, Hiroshima, Japan; 2Hiroshima University,
Surgery, Hiroshima, Japan
Background. Portal vein reconstruction is a key factor of successful living
donor liver transplantation when portal vein stenosis or thrombosis has been
observed. In such a case, portal vein is reconstructed using interposition vein
graft consisting of recipient internal jugular vein or external iliac vein graft,
but recipient requires additional surgery. We have recently reported that the
middle hepatic vein tributaries draining segments V (V5) and VIII (V8) of a
right lobe graft are reconstructed with the recipientIfs own middle hepatic
vein or right hepatic vein which was harvested ex vivo from recipient liver.
Here, we report that portal vein was reconstructed using interposition vein
graft consisting of recipient right hepatic vein which was harvested ex vivo
from recipient liver.
Method. 33 year old female suffered from biliary atresia. Preoperative CT
revealed complete obstruction of portal vein trunk and huge splenorenal
shunt. She underwent living donor right liver transplantation. After total
hepatectomy, right hepatic vein graft with 5 cm length was harvested from
recipient liver at back-table. The right hepatic vein graft was anastomosed to
the recipientIfs superior mesenteric-splenic vein confluence, and then the
graft portal vein was anastomosed to the right hepatic vein graft.
Result. The postoperative course was uneventful. Postoperative ultrasonogr-
phy and CT showed good inflow of portal vein.
Conclusion. The use of the recipientIfs own right hepatic vein is a suitable
option for reconstructing portal vein in right-liver living donor transplanta-
tion. This method does not require an additional surgery for the patient.
PP 20.01
THE ROLE OF DYNAMIC POSITRON EMISSION TOMOGRAPHY
TO DIFFERENTIATE INTRAHEPATIC CHOLANGIOCARIC-
NOMA AND PULMONARY INFLAMMATORY DISORDER
Liao, Chieh-Hung; Yeh, Ta-Sen; Jan, Yi-Yin; Chen, Miin-Fu
Chang Gung Memorial Hospital, Chang Gung University, Department of
General Surgery, Taipei, Taiwan
Backgrounds. Intrahepatic cholangiocarcinoma (ICC) is associated with a
dismal prognosis because of early intrahepatic and distant metastasis. It is
mandatory to exclude the presence of occult distant metastasis before subject
to surgical resection. We herein tested the efficacy of positron dynamic
positron emission tomography (PET) to differentiate ICC and pulmonary
inflammatory disorder.
Materials and Methods. Murine cholangiocarcinoma and pulmonary
inflammatory model was established using Sprague-Dawly rats fed thioace-
tamide for 30 weeks. The experimental animals underwent FDG-PET-CT
examination at week 30. Standardized uptake value (SUV) and retention
indices (RI) of experimental animals were calculated. Expression of glucose
transporter 1 and hexokinase II in liver and lung tissues were determined
using immunohistochemistry.
Results. Of 26 rats fed thioacetamide for 30 weeks, 22 developed ICC while
the remaining four did not. Of 22 ICC rats, 9 (41%) developed non-bacterial
bronchopneumonia. In contrast, none of shamed controls (n4) and those
fed thioacetamide but without ICC (n4) had bronchopneumonia. All nine
ICC rats associated with bronchopneumonia displayed strong PET signals at
their liver and lung fields, 13 ICC rats without bronchopneumonia displayed
strong PET signals at liver field alone, while the remaining four rats fed
thioacetamide but without ICC did not displayed PET signal at their liver
and lung fields. Furthermore, the mean RI of lung lesions and liver lesions
were 0.058¡O´0.013 and ¡V0.082¡O´0.019, respectively (p0.0008). Expres-
sion of glucose transporter 1 in liver and lung lesions of ICC rats were weakly
and moderately positive respectively, while the expression of hexokinase II in
liver and lung lesions of ICC rats were moderately and strongly positive,
respectively.
Conclusions. PET might disclose ICC and pulmonary inflammatory disease
with an acceptable sensitivity. Dynamic PET further helped to differentiate
these two diseases.
PP 20.02
THALIDOMIDE ATTENUATES TUMOR GROWTH AND PRE-
SERVES FAST-TWITCH SKELETAL MUSCLE FIBERS OF CHO-
LANGIOCARCINOMA RAT
Ouyang, Chun-Hsiang; Yeh, Ta-Sen; Jan, Yi-Yin; Chen, Miin-Fu
Chang Gung Memorial Hospital, Chang Gung University, Department of
General Surgery, Taipei, Taiwan
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Background. We present a rat model of cholangiocarcinoma cachexia and
demonstrate that thalidomide attenuates tumor growth and improves
cachexia.
Methods. A cholangiocarcinoma cachectic model was established using
Sprague-Dawley rats fed thioacetamide for 40 weeks. Cholangiocarcinoma
cachectic rats were treated using either thalidomide for eight weeks. Tumor
growth and weight were recorded for all animals. The expression of CD31,
VEGF, eIF4E, and apoptosis of cholangiocarcinoma were also determined.
Further, Fas- mediated apoptosis genes of cholangiocarcinoma were deter-
mined. The distribution of fast-twitch soleus skeletal-muscle fibers and the
expression of TNFa and TGFb1 were analyzed.
Results. The mean weight of saline- and thalidomide-treated rats was 24%
and 19%, respectively, less than that of sham group. The mean tumor volume
of thalidomide-treated rats was 1.9¡O´0.4 cm2 compared to 4.6¡O´1.3 cm2 for
saline-treated rats. The expression of CD31, eIF4E and VEGF was lower for
thalidomide-treated rats than for saline-treated rats. The expression of Fas,
caspase-3 and Bax mRNA of thalidomide-treated rats was greater than for
saline-treated rats. The mean number of fast-twitch skeletal-muscle fibers of
sham group, saline- and thalidomide-treated rats was respectively 43¡O´6,
14¡O´3, and 41¡O´8. The expression of TNFa and TGFb1 from soleus muscles
for thalidomide-treated rats was lower than that for saline-treated rats.
Conclusion. Using our rat cholangiocarcinoma cachectic rat model, we
demonstrated that thalidomide inhibited tumor growth and was associated
with a reduced eIF4E and VEGF expression, and that thalidomide preserved
fast-twitch skeletal-muscle fibers, which was associated with reduced TNFa
and TGFb1 expression.
PP 20.03
PATTERNS OF RECURRENCE OF INTRAHEPATIC AND HILAR
CHOLANGIOCARCINOMA
Morris-Stiff, Gareth; Gomez, Dhanwant; Murphy, Laura; Toogood, Giles J;
Lodge, J. Peter A.; Prasad, Rajendra
Leeds Teaching Hospital NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom
Background. Surgical resection is the treatment of choice for intrahepatic
(IHC) and hilar cholangiocarcinomas (HC). Recurrence rates following
resection are high but the interval and distribution of recurrences in Western
populations have not yet been defined.
Aims. To determine the patterns of recurrence following curative resection
of IHC and HC.
Methods. Patients undergoing resection of either IHC or HC were identified
from the database. Only patients in whom an R0 resection was obtained, and
who survived the perioperative period were included. Patterns of recurrence
were based upon findings of protocol-based cross-sectional imaging using
CT, with radiology results being reviewed to determine distribution of
recurrences. The database was interrogated to determine the management
and outcome of recurrent disease.
Results. During the study period, 52 patients (27 IHC and 25 HC) achieved
an R0 resection of which 46 were enrolled in the screening program (26 IHC
and 20 HC). In the IHC group, recurrence occurred in 21 of 26 (88.5%) at a
median time of 10.5 months. Recurrence was most common in the remnant
liver (n14), followed by peritoneum (n10), lung (n6), lymph nodes
(n2), bone (n1). 20 of the recurrences occurred within 24 months of
resection. None of the patients were suitable for resection. 20 of 21 patients
with recurrence have died with a median interval between diagnosis and
death was 3.5 months. In the HC group, recurrence occurred later at a
median of 15 months and was seen in 11 of 20 (55%) of resections. The
peritoneum (n6) was the commonest site for recurrence, followed by liver
(n5), lung (n2) and lymph nodes (n1). 78% (8 of 11) recurrences
occurred within 24 months. 9 of 11 patients with recurrence have died with a
median interval of 3.5 months following diagnosis.
Conclusions. Recurrence is common following resection of HC and IHC
with similar patterns of dissemination. Although the interval between
resection and recurrence is longer for HC, the time from resection to death
is idental.
PP 20.04
PATTERNS OF FIRST FAILURE AFTER MANAGEMENT OF
HILAR CHOLANGIOCARCINOMA
Lee, Keon-Young; Bang, Tae-Jun; Ahn, Seung-Ik; Hong, Kee-Chun
Inha University College of Medicine, Surgery, Incheon, Korea, Republic of
Background. The pattern of recurrence after management of hilar
cholangiocarcinoma is still unclear.
Aims. To evaluate the patterns of disease progression after either resection or
palliative management of hilar cholangiocarcinoma and to clarify the polarity
of the resection margin.
Methods. The medical records of 78 hilar cholangiocarcinoma patients who
admitted at the Inha University Hospital from June, 1996 to May, 2006 were
retrospectively reviewed. Pattern of recurrence was compared between the
margin positive, margin negative and the palliative management groups.
Factors influencing recurrence and survival were analyzed using Cox
proportional hazard model.
Results. 56 patients (71.8%) were identified to have recurred after initial
treatment and the median progression free survival (PFS) was 10.1 months.
The 3-yr estimates of overall relapse, the median PFS were 90.7%, 17
months in resection group (n32) and 100%, 7 months in palliative group
(n46), respectively (p0.045). There was no significant difference of the
3-yr estimates of overall disease progression, the median PFS according to
the margin positivity or resection.
Methods. In the analysis of disease progression pattern, there was no
significant difference between the groups. The survival analysis showed that
resection with curative intent increased survival compared to the palliative
management group (p0.001). Adjuvant chemotherapy or radiotherapy did
not affect the recurrence or the survival. Poor differentiation was the only
significant prognostic factor for survival.
Conclusion. Considering the absence of difference in the pattern of disease
progression, aggressive surgical resection should be attempted to prevent
recurrence and to increase survival even in cases with suspicious positive
resection margin.
PP 20.05
PROGNOSTIC ANALYSIS OF SURGICAL TREATMENT OF PER-
IPHERAL CHOLANGIOCARCIOMA:THREE DECADES OF EX-
PERIENCE AT CHANG GUNG MEMORIAL HOSPITAL
Jan, Yi-Yin; Chen, Miin-Fu
Chang Gung Memorial Hospital, Chang Gung University, Department of
General Surgery, Taipei, Taiwan
Aim. to analyze the prognostic factors influencing the overall survival of
peripheral cholangiocarcinoma (PCC) patients undergoing surgical treat-
ment during 30 years at a single institution.
Methods. This study retrospectively reviewed prospectively collection data
about 433 patients with histologically proven PCC who underwent surgical
treatment between 1977 and 2006.
Results. Four hundred and thirty-three PCC patients (188 men and 245
women) underwent surgical treatments from 1977 to 2006. Among them,
228 PCC patients underwent hepatectomy and 137 had curative resection.
The follow-up duration ranged from 0.10 to 169.0 mo(mean/median15.2/
7.2mo). Overall cumulative survival rates at 1,3 and 5 years were
38.1%,14.2%,7.8%, respectively. Univariate log-rank analysis identified the
following as adverse influences on overall survival: presence of symptoms,
presence of physical findings, absence of mucobilia, elevated CEA and CA19-
9 levels, non-papillary tumor type, receiving non-hepatectomy, advanced
tumor staging, lack of post-operative chemotherapy and radiotherapy.
Meanwhile, multivariate Cox¡js proportional hazard analysis demonstrated
that presence of symptoms, non-papillary tumor type, advanced tumor
staging, non-hepatectomy and lack of post-operative chemotherapy were the
five independent prognostic factors that adversely affected overall survival.
Conclusion. Favorable overall survival of PCC patients undergoing surgical
treatment depends on early tumor stage, absence of symptoms, papillary
tumor type, hepatic resection and post-operative chemotherapy.
PP 20.06
TREATMENT WITH GEMCITABINE FOR ADVANCED OR RE-
CURRENT EXTRAHEPATIC BILE DUCT CANCER
Onuki, Manabu1; Nakayama, Mao2; Takahashi, Tetsu2; Fukuda, Koji2;
Akashi, Tatsuru2; Ando, Hideaki2; Tanaka, Yuichi2; Hanaoka, Takao2
1Nakadori General Hospital, Akita city, Japan; 2Nakadori General Hospital,
Division of Surgery, Akita city, Japan
Background. Extrahepatic bile duct cancer has a bad prognosis and there
was no standard chemotherapy for advanced and recurrence cases. Recently,
Gemcitabine(GEM) was applied for biliary tract cancer, so this study shows
the effectiveness of GEM for extrahepatic bile duct cancer.
Patients and Methods. Between 2003 to 2006, 18 patients were treated
with GEM. These patients were 10 advanced cases(more than Stage III by
UICC criteria) and 8 recurrence cases. Effectiveness of GEM treatment was
comparison with non-randomized 22 cases, treated with biliary drainage
without any chemotherapy. Endpoint of this study was survival ratio which
were compared using Kaplan-Meier survival curves. GEM(1,000mg/m2) was
administrated through a vein, within thirty minutes and once a week for three
weeks in a row, followed by a week without treatment.
Result. There was no adverse event over Grade IV with GEM treatment.
GEM treatment was one to 32 times, average 13 times/case, administrated by
case, and during 224 days by average. Main reason of change of the dosing
regime was cholangitis. Response rate was 25%; NE 2 cases, CR 1, PR 1, SD
9, PD 5. Survival rates in without GEM at 6 and 12 months were 82% and
45%, survival rates in GEM therapy at 6, 12 were 94%, 94%.
Conclusion. GEM therapy was useful for advanced and recurrent extra-
hepatic bile duct cancer without any severe adverse events.
PP 20.07
ANALYSIS OF CLINICAL OUTCOME AND PROGNOSTIC FAC-
TORS IN PATIENTS WITH HILAR CHOLANGIOCARCINOMA
Kim, Dong-Goo; Lee, Kyung-Keun; Kim, Sae June
KangNam St. Mary’s HospitaL, Surgery, Seoul, Korea, Republic of
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Introduction. The aim of the present study was to find the proper treatment
for improving the survival of patients with hilar cholangiocarcinoma by
analyzing many factors affecting the patients’ survival.
Methods. Between January 1991 and April 2006, 152 patients with hilar
cholangiocarcinoma and who underwent surgery were reviewed. One
hundred fifteen patients underwent attemped curative resections and 37
patients had findings that precluded any further intervention. Of the 115
patients who underwent concomitant hepatectomy. The clinicopathogical
data of these patients was analyzed.
Results. The 3 year overall survival and disease-free survival rates were
41.2% and 52.5%, respectively. The overall recurrence rate was 40.9%(47/
115) and of patients with recurrence, those who had been treated aggresslvely
survived longer than those who had been treated conservatively(P.039). Of
the patients’ factors that affected survival, only preoperative weight loss was
meaningful(P.024). Of the histologic factors, tumor cell
differentiation(P.048) and the presence of lymph node metastasis(P
.028) were associated with survival. Of the perioperative factors, only
achivement of complete tumor resection affected survival. On comparing
between resection of the extrahepatic bile duct only and concomitant partial
hepatectomy, the latter achived more definitely negative histologic mar-
gins(63.6% vs 39.5%, respectively, P.037) at the expense of a more
prolonged operation time and hospital stay and greater complications.
Conclusions. Preoperative weight loss, poor differentiation, lymph node
metastasis and a positive hitoligic margin could be included in the poor
prognostic factors affecting survival. Concomitant liver serection could be
rationalized in that it could attain a more negative histologic margin for
treating resectable hilar cholangiocarcinoma, but it could increase mortality
and morbidity rates.
PP 20.08
MODIFIED LIVER HANGING MANEUVER TO FACILITATE LEFT
HEPATECTOMY AND CAUDATE LOBECTOMY FOR HILAR
BILE DUCT CANCER
Hwang, Shin; Lee, Sung-Gyu; Lee, Young-Joo; Ha, Tae-Yong; Ko, Kyoung-
Hoon; Kim, Kwan-Woo; Choi, Nam-Kyu
Asan Medical Center, University of Ulsan, Department of Surgery, Seoul,
Korea, Republic of
Background. The liver hanging maneuver (LHM) is a useful technique
enabling a safe anterior approach, but it has several technical limitations for
resection of the hepatic paracaval portion.
Patients and Method. We present a modified LHM that facilitates
concurrent resection of the paracaval portion, a technique applicable to left
liver resection for hilar bile duct (HBD) cancers. During 6 months from
December 2006 to May 2007, 6 of 20 HBD cancer patients underwent
curative left liver resection using the modified LHM. This method included
initial partial transection of the caudal paracaval portion. Thus, subsequent
blind tunneling over the retrohepatic inferior vena cava can become as short
as 23 cm in length, resulting in effective prevention of short hepatic vein
injury. The parenchyma transection plane was tailored to remove most of the
paracaval portion.
Results. This modified LHM technique was safely and effectively applied to
all 6 patients, resulting in a shorter time for caudate lobe isolation. No
significant bleeding occurred during retrohepatic tunneling. The final
parenchymal transection plane after left liver resection using modified
LHM was the same as that following conventional surgical technique for
HBD cancers.
Conclusion. This modified LHM was an effective, technically simpler
procedure for left liver resection in HBD patients.
PP 20.09
GTREATMENT STRATEGY FOR HILAR CHOLANGIOCARCINO-
MAH: A SPECIAL REFERENCE TO OUR NEW TREATMENT FOR
NON-CURATIVE AND UNRESECTABLE CASES
Morine, Yuji; Mistuo, Shimada; Imura, Satoru; Ikegami, Toru; Kanemura,
Hirohumi; Mori, Hiroki; Arakawa, Yusuke; Kanamoto, Mami; Hanaoka, Jun;
Tokunaga, Takuya; Sugimoto, Kouji
The University of Tokushima, Japan., Department of Surgery, Tokushima,
Japan
Introduction. Hilar cholangiocarcima have poor prognosis even though with
radical resection. Furthermore, the effective adjuvant therapy has not been
established yet. This study was conducted to identify the validity of surgical
treatment, and to clarify the effectiveness of GFP chemotherapy (Gemcita-
bine combined with CDDP and 5FU) for hilar cholangiocarcinoma.
Patients and Methods. A retrospective analysis was conducted for 59
patients with hilar cholangiocarcinoma. Of these 40 patients underwent
surgical treatment (67.8%). We investigated the prognostic clinicopathor-
ogical variables after surgery using univariate analysis. GFP chemotherapy
applied to advanced hilar chorangiocarcinoma (non-curative: n3, unre-
sectable: n3). 4-week cycle GFP chemotherapy regimen as follows:
Gemcitabine at 1000mg/m2 on days 1,8,15, and 22. 5-FU at 250mg/m2
and CDDP at 3mg/m2 on days 1 to 5, 8 to 12, 15 to 19 and 22 to 26.
Results. In operable cases, 36 of 40 patients (90%) received radical
hepatectomy combined with caudate lobectomy and lymphadenectomy.
Actual 3- and 5-year survival rate in operable cases were 52.3 and 30.5%,
respectively. In unresectable cases (n19), no survival cases over 2-years
have been observed. Univariate analysis revealed that surgical curability and
lymph nodes metastasis were the independent prognostic factors. In non-
curative cases with GFP chemotherapy (n3), all patients survived over 1-
year without tumor progression. Furthermore, in unresectable cases with
GFP chemotherapy (n3), median survival time was 12 months and
prognosis was improved compared with other treatment cases (n16)
Conclusions: Surgical resection is an effective treatment for hilar cholangio-
carcinoma, even if non-curative treatment. Furthermore, GFP chemotherapy
is promising to improve the prognosis of non-curative and unresectable
cases.
PP 20.10
HILAR CHOLANGIOCARCINOMA AND LYMPH NODE REAC-
TION TO PORTAL VEIN EMBOLISATION: A CASE REPORT
Fuks, David; Chatelain, Denis; Brehant, Olivier; Dumont, Frederic; Sab-
bagh, Charles; Yzet, Thierry; Delcenserie, Richard; Regimbeau, Jean-Marc
CHU Nord Amiens, Federation Digestive Diseases, Amiens, France
Background. Only surgery with R0 resection can improve survival in hilar
cholangiocarcinoma. Presence of lymph nodes discovered on CT-scan is
unrare. We report the case of a 59-year-old woman with para-aortic lymph
nodes on pre-operative staging of a hilar cholangiocarcinoma. After portal
vein embolisation, several new lymphs nodes appeared.
Discussion Right lobectomy with extended lymph node resection was
performed and histological analysis did not find malignant infiltration of
the 10 lymph nodes resected. Only mineral oil lipidosis were found in these
lymph nodes. This case emphasizes that radical surgery should be discussed
for patients with resectable cholangiocarcinoma even in case of lymph node
on CT-scan.
Conclusion. CT is not accurate for the prediction of nodal involvement.
Lymph node reaction to radiopaque oils should be known after portal vein
embolisation.
PP 21.01
PROSPECTIVE STUDY OF BIOCHEMICAL PARAMETRES IN
ESTIMATION OF ETIOLOGY AND TREATMENT OF OBSTRUC-
TIVE JAUNDICE
Zajic, Sasa; Jovanovic, Milan; Zdravkovic, Rade; Milojevic, Vladeta
Health Centre Krusevac, Surgery department, Krusevac, Serbia and Mon-
tenegro
In the period from 01.05.2006. till 01.03.2007., this prospective study
encompassed the patients with obstructive jaundice. During this period the
total number of 87 patients were analysed, out of which 39 women (42,83%),
and 48 (55,17%) men, average age 64,72 years (the youngest 27, the oldest
83 years old). The analysed parametres on the basis of which the type of
obstruction was estimated, besides standard biochemical parametres, were
also alkaline phosphatase and bilirubin. Among the patients included in this
study there were 60 (68,97%) benign obstructions and 27 (31,03%) malign
obstructions. In cases of malign obstructions the level of the abovementioned
parametre of total bilirubin was between 127,8 and 789,5 mmol/L (average
274,76 mmol/L). Level of alkaline phosphatase in malign obstructions was
from 236 till 3066 U/L (average 815,04 U/L). In cases of benign obstructions
level of total bilirubin was between 22,1 and 347,1 mmol/L (average 117,9
mmol/L), and the level of alkaline phosphatase from 79 till 1666 U/L
(average 361,35 U/L). On the basis of the compared parametres the etiology
of the type of obstruction was estimated, and the optimal type of treatment of
the patients was determined. Compared laboratory values of alkaline
phosphatase and total bilirubin are in relation with clinical picture of both
benign and malign obstruction. On the basis of compared parametres it is
possible to estimate pre-surgically with high certainty level whether it is a case
of benign or malign obstruction.
PP 21.02
EFFECT OF PREOPERATIVE ENDOSCOPIC BILIARY DRAI-
NAGE AND STENTING ON POSTOPERATIVE INFECTION AND
THE OUTCOME OF SURGERY FOR BENIGN OBSTRUCTIVE
JAUNDICE.
Elsebae, Magdy1; Ezzat, Hussin1; Helmy, Ahmed Hazem1; Fakhry, Sameh2
1Theodore Bilharz Medical Research Institute, General Surgery, Cairo,
Egypt; 2Theodore Bilharz Medical Research Institute, Tropical Medicine,
Cairo, Egypt
Introduction. Obstructive jaundice (OJ) patients come to the care of the
endoscopist, before going to surgery. (ERCP) and stent insertion preopera-
tively became the routine in our institute. no study was found that specifically
identify the organisms present in bile in patients with benign obstructive
Jaundice before endoscopic biliary stent insertion and after it at the beginning
of surgical procedure. The aim of this study: was to evaluate the effect of
preoperative endoscopic biliary drainage on the outcome of surgery for
patients presenting with benign obstructive jaundice.
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Materials and Methods. The study involved 79 of patients with surgically
corrected benign obstructive jaundice at TBRI. Preoperative (ERCP) was
done for all of the patients and stent insertion was made in 60 of them. Bile
specimens were obtained by flushing technique and intra-operatively by
puncture before incising the common bile duct. Bile samples were analyzed
for their bacterial spectrum and sensitivity to antibiotics. Concomitant
postoperative septic complications such as wound infection and cholangitis
were also assessed.
Results. Bile culture of intra-operatively obtained specimens was positive in
39/60 (65.0%) of the patients in Group II (ERCP biliary stent), a
significantly higher incidence than that observed in group I (ERCP only),
in which 7/19 (36.8%) of the patients presented positive cultures (p0.001).
There was no significant difference in general postoperative morbidity
between groups. When infective complications (cholangitis, pneumonia,
wound infection) were analyzed separately, a higher incidence, although
without significance, was found in Group II than in Group I.
Conclusion. Preoperative biliary drainage using the endoscopic retrograde
cholangiopancreatography (ERCP) and stent insertion in patients subjected
to surgery for benign obstructive jaundice could provokes biliary bacterial
colonization with a possible appearance of infective complications during the
postoperative pe
PP 21.03
RUPTURE OF THE RIGHT HEPATIC DUCT INTO AN ECHINO-
COCCAL CYST DUE TO CHOLEDOCHOLITHIASIS
Sapalidis, Kostantinos1; Michalopoulos, Antonios2; Michalopoulos, Niko-
laos1; Papavramidis, Theodossis S.2; Souleimanis, Christos1; Fyllosoglou,
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1A.H.E.P.A University Hospital of Thessaloniki, Aristotle’s University of
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University Hospital of Thessaloniki, Aristotle’s University of Thessaloniki,
1st Propedeutic Surgical Department, Thessaloniki, Greece; 3A.H.E.P.A
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Background. Echinococcal cyst is typically an asymptomatic mass. In rare
cases, the cyst may rupture into the biliary tree and show symptoms. The
present case is extremely rare because choledocholithiasis increased biliary
tree pressure and rupture of the right hepatic duct into the echinococcal cyst
occurred.
Case Report. A 60 years-old female patient presented to the emergency
department with right upper quadrant pain and jaundice. She had a known
cholelithiasis and an echinococcal cyst in the liver. The biochemical and
hematological screening revealed leucocytosis with elevated PMNs, transa-
minasemia and hyperbilirubinemia. Ultrasonography revealed multiple
echinococcal cysts of the liver, distended bile ducts and cholelithiasis. CT
described the presence of a large multisegmented echinococcal cyst occupy-
ing the segments V, VI and VIII. The patient was treated conservatively for
the acute cholelithiasis, was scheduled for cholecystectomy and discharged.
Ten days after the discharge, she revisited us with jaundice. Two day after the
reentry, an acute fall of the hyperbilirubinemia occurred. MRCP proved
communication between the echinococcal cyst and the right hepatic duct,
while the common hepatic duct and the common bile duct were full with
material. Emergency operative management included cholecystectomy with
exploration of the common bile duct, excision of the echinococcal cyst and
removal of pigmented gallstones from the cyst. The intra-operative cholan-
giography revealed communication of the echinococcal cyst with the right
hepatic duct. The right hepatic duct was ligated; a T-tube was put in the
common bile duct and drainages placed.
Conclusion. Typically the echinococcal cyst ruptures into the biliary tree
and biliary colic, jaundice or anaphylaxis occurs. In the present case the
reverse course seemed to occurred since the increased intrabiliary pressure
lead to a rupture of the right hepatic duct into the cyst.
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ENDOSCOPIC REMOVAL OF COMMON BILE DUCT STONES
USING DOUBLEIjBALLOON ENTEROSCOPE AFTER TOTAL
GASTRECTOMY WITH ROUXIjENIjY RECONSTRUCTION
Takahata, Shunichi; Sadakari, Yoshihiko; Ienaga, Jun; Tanabe, Reiko;
Tanaka, Masao
Graduate School of Medical Sciences, Kyushu University, Department of
Surgery and Oncology, Fukuoka, Japan
Background. Bile duct stones sometimes occurs, after total gastrectomy;
however, Roux-en-Y reconstruction used to have excluded the biliary
diseases from endoscopic procedures. Recent developed double-balloon
enteroscope (DBE) facilitates endoscopic exploration of the afferent Roux-
en-Y jejunal limb and enable to treat bile duct stones.
Patients.We experienced 3 patients with common bile duct stones who had
previously undergone total gastrectomy for gastric cancer followed by Roux-
en-Y reconstruction.I@They are 2 male and 1 female, with a mean age of
75.0(6285). Fujinon EC450BI5 (Fujinon Corporation, Saitama-Shi, Sai-
tama, Japan) were employed for DBE. Needle type sphincterotome was used
for endoscopic sphincterotomy.
Results. All the patients were successfully cured by endoscopic sphincter-
otomy and extraction of stones. Endoscopic cholangiogram revealed 1 or 2
stone for each patients. Mean size of stones was 10.4mm (715) in maximum
diameter. 2.7(24) endoscopic interventions were required for complete
stone removal. No major complication was observed. Placement of biliary
tube stent prior to sphincterotomy was useful.
Conclusion. DBE-sphincterotomy and stone extraction is safe and useful
technique for management of common bile duct stone in patients after Roux-
en-Y reconstruction.
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LONG CYSTIC DUCT STUMP WITH CALCULI CAUSING RE-
CURRENT CHOLANGITIS
Khare, Ritu1; Raja, Kaiser2; Shetty, Sukrith3; Kumar, Ashok4
1New Medical Centre Hospital, Laparoscopic Surgery, Abu Dhabi, United
Arab Emirates; 2New Medical Centre Hospital, Gastroenterology, Abu
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Background. Post cholecystectomy biliary pain can occure in 610% of
cases. It has a variable etiology (CBD stones, biliary stricture, cystic duct
stump syndrome, SOD, dyspepsia). However recurrent cholangitis is
uncommon in the absence of stones or stricture in the common bile duct.
We present a case of multiple calculi in unusually long cystic duct stump
presenting as reccurent upper abbominal pain and fever.
Case Report. A 46-year-old lady presented 12 years after cholecystectomy
with recurrent episodes of right uppper quadrant pain and fever. Initial
investigations done during an episode of pain revealed leukocytosis and raised
C-reactive protein. Liver enzymes were minimally elevated (twice normal)
without any hyperbilirubinemia. Abdominal ultrasound did not reveal any
obvious calculi or dilation of the common bile duct. However, a CTabdomen
was suggestive of multiple calculi in the common bile duct. At ERCP, no
calculi were detected in the CBD. A long remnant, unusually low inserted
cystic duct (just above the papilla) with multiple filling defects was visualized.
Repeated attempts at endsocopic extraction of cystic duct calculi did not
relieve her pain despite extraction of several calculi on more than one
occasion. The patient eventually underwent excision of the cystic duct stump
with choledocho-duodenostomy. Two residual calculi were found impacted
in the proximal end of the stump. The patient bacame symptom free after the
surgery.
Conclusion. Long remnant cystic duct stump with retained/recurrent calculi
can be a cause of recurent pain/cholangitis after cholecystectomy in the
absence of pathology in the common bile duct. Endoscopic extraction of
impacted cystic duct calculi may not always be successful.
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LAPAROSCOPY ASSISTED ERCP IN FAILED PRE OPERATIVE
ERCP
Kota, Venugopal; Varma Gunturi, Surya Ramchandra; Peshwe, Harish;
Kona, Lakshmi Kumari; Cherukuri, Anil Kumar; Ravindranath, K.
Global Hospitals, Hyderabad, India
Introduction. Laparoscopic Cholecystectomy (LC) is the gold standard for
the management of symptomatic gallstones in the present era. A minority
have accompanying choledocholithiasis. Therapeutic Endoscopic Retrograde
Cholangio Pancreatography (ERCP) is successful over 90% of patients in
experienced hands in extracting common bile duct (CBD) stones failing
which surgical intervention either laparoscopically, if amenable or open is
required. We hereby describe laparoscopy assisted ERCP in the operation
theatre to manage choledocholithiasis where pre operative ERCP in extract-
ing the CBD stones was unsuccessful.
Methods. Four patients underwent LC and Laparoscopy Assisted ERCP in
our hospital over last 2 years. The reasons of failure of preoperative ERCP
were: Location of papilla in or adjacent to a large duodenal diverticulum (n
3) and Malrotation(n1). The age group ranged from 2975 years, 2 Males
and 2 Females. A 5 F ureteric catheter was passed through cystic duct and
CBD into duodenum. Using this as an aid, the CBD was accessed
endoscopically.
Results. All 4 patients had a successful CBD stones clearance.
Conclusion. Laparoscopic Cholecystectomy with Laparoscopy Assisted
ERCP can be a option for failed preoperative ERCP, enabling to do both
of them in a single stage and when successful, avoids CBD exploration and its
accompanying risks.
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LAPAROSCOPIC CBD STONE MANAGEMENT
Sinha, Rajeev
MLB Medical College, General surgery, Jhansi, India
Background. The CBD stone management is again undergoing a change.
The accepted routine of ERCP followed by Laparoscopic cholecystecto-
my(Lap Chole) is being challenged by laparoscopic transcystic or transductal
CBD exploration at the same sitting along with Lap Chole.
Aim. The advantages of this same sitting surgery although obvious to some
extent, need to be more clearly defined.
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Methods. We have operated on 32 patients of CBD stone by laparoscopic
transductal choledocholithotomy using a 4 mm urethroscope and later a
17FG nephroscope for stone visualization and complete visualization of the
proximal extrahepatic biliary channels and distally upto the duodenum.
Dilatation of ampulla was carried out using a urethral dilator in patients with
tight ampullary opening. T tube intubation was optional. CBD closure was
by intracorporeal suturing.
Results. Five ports were used 10mm(2) and 5 mm (3). The operating time
varied from 45 minutes to 105 minutes. T tube was used in only 7 patients
with doubtful clearance or closure. Closure was with intra corporeal
continous 30 monocryl suturing. Morrison’s pouch drain was used in all
patients. Discharge time was 4 days. PeriT tube bile leakage persisted for 4
days in one patient, port site infection was seen in 2 patients. Retained stones
were recorded in 2 patients. Conversion to open surgery was carried out in 5
patients.
Conclusion. Lap CBD exploration gives results equal to open exploration
and because it can be done in the same sitting as Lap Chole the morbidity is
less than that of ERCP followed by Lap Chole. But it requires training and
expertise in intracorporeal suturing.
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PROPOSED PATHWAY FOR MANAGEMENT OF CHOLEDO-
CHOLITHIASIS TO REDUCE THE INCIDENCE OF NEGATIVE
ERCP
Al-Jiffry, Bilal Omar1; El-Fateh, Abdeen2; Saleem, Absher2
1Al-Hada Armed Forces Hospital, General Surgery, Taif, Saudi Arabia; 2
Objective. We propose a less-invasive pathway in managing choledocho-
lithiasis.
Background. There is no consensus up to date on the diagnosis and
treatment of choledocholithiasis. Though ERCP is the most effective, it has
complications up to 10%, mortality less than 1%, and can be negative in 75%
when selection is based on an abnormal liver function test (LFT). MRCP can
detect CBD stones. However, the capital expense and running cost limit’s
widespread availability. Also, normal duct size can be a source of false-
positive stone detection.
Method. All patients from November 06 to August 07 with proven gallstones
and abnormal LFTand/or abnormal ultrasound became eligible. We consider
the US to be abnormal if CBD was dilated (] 7mm) or stones were detected.
If both tests were abnormal the patient had an ERCP followed by surgery
with intra-operative cholangiogram (IOC). However, if the US was normal,
MRCP was done and an ERCP was reserved for abnormal tests only followed
by surgery and IOC.
Results. Total NO was 49. 22 (45%) abnormal LFT, 2 (4%) abnormal US
and 25 (51%) both abnormal (LFT and US). The 22 had MRCP, 14 tests
normal (64%), 6 stones (27%) and failed to have the test in 2 (9%). ERCP
done for 6 (positive MRCP) and stones found in 4 (67%) and negative in 2
(33%). 27 had abnormal US, 6 stones (22%), 11 CBD dilatation (41%) and
10 (37%) both (dilatation and stone). All 16 with stones on US were proven
to have CBD stones by ERCP. 7 out of the 10 with dilatation had stones
(70%), 2 from 3 w/o stones (dilatation group) had a normal LFT. So, 1 out of
25 with abnormal LFT and US did not have CBD stones. Total 33 ERCP
done with 28 patients with stones and 5 negative ERCP (15%). The
incidence of stones was 96% when both tests were abnormal and 17% if
any of the tests was normal.
Conclusion. Patients with an abnormal LFT and US have a high incidence
of CBD stones and ERCP is indicated and the coast of MRCP is not
warranted. However, if any of the tests are normal MRCP is indicated to
decrease the NO of negative ERCP
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REFRACTORY CHOLEDOCHOLITHIASIS AND CHOLANGITIS
AFTER CHOLEDOCHOJEJUNOSTOMY BY TWISTED ROUX-
EN-Y JEJUNUM LIMB
Ienaga, Jun; Takahata, Shunichi; Sadakari, Yoshihiko; Tanabe, Reiko; Toma,
Hiroki; Yamaguchi, Koji; Tanaka, Masao
Graduate School of Medical Sciences, Kyushu University, Department of
Surgery and Oncology, Fukuoka, Japan
Background. Anastomotic stenosis is well known as major complication of
choledochojejunostomy and cause of cholangitis. However, there are a few
reports of cholangitis due to stenotic Roux-en-Y jejunal limb. We report a
case of refractory choledocholithiasis and cholangitis associated with twisted
jejunum limb after choledochojejunostomy and propose a hypothesis of its
etiology.
Case Report. The patient was a 77-year-old Japanese woman who had
undergone a side-to-side choledochojejunostomy for choledocholithiasis 25
years previously. After the surgery, choledocholithiasis and cholangitis were
repeated and endoscopic lithotomy had been required each time. Cholangio-
gram suggested disruption of jejunal limb and we decided to have a surgical
treatment. Laparotomy revealed that the jejunal limb was twisted and
stenotic. The site of side-to-side choledochojejunostomy including the
twisted limb was resected and a new end-to-end anastomosis was made.
After the operation, the patient did not have any complaint. Neither
malignancy nor specific inflammation was found in the resected specimen
by pathologic exploration.
Discussion. The repeated choledocholithiasis was caused by torsion of the
Roux-en-Y limb. The obstructed jejunum became a blind pouch producing
intestinal juice. Bile stasis and bacterial infection in the jejunum should form
the recurrent stones.
Conclusion. Twisted Roux-en-Y jejunal limb after choledochojejunostomy
could cause refractory choledocholithiasis and cholangitis. Surgical operation
is recommended for the condition.
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SURGICAL OUTCOME IN BENIGN BILIARY DISORDERS
Singh, Rajinder1; Adhikari, Devbrata2; Patil, Bhushan2; Bhange, Snehal2;
Shetty, Tilakdas2; Joshi, Rajeev2
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Background. Bile duct pathologies present a formidable challenge with
varying management protocols and long term Results. Despite the emergence
of therapeutic endoscopy surgery continues to play a major role.
Objective. To evaluate the outcome following surgeries done for benign
biliary disorders.Method.: Analysis of 160 cases (81 bile duct injuries, 55
choledocholithiasis, 16 choledochal cysts, 5 Mirizzi’s syndrome and 3 post H-
Jstomy strictures), surgically treated from February 1999 to July 2007.
Result. H-Jstomy was done in 69 cases of biliary injury, choledochoduode-
nostomy (CD) in 7, T-tube placement and bilio-biliary anastomosis in 4 and
1 case respectively. For choledocholithiasis, CD was performed in 48 cases,
H-Jstomy in 3 and T-tube placements in 4 cases.16 choledochal cysts were
completely excised. Choledochoplasty in 3 cases, partial cholecystectomy and
T-tube placement in 1 case each, was done for Mirizzi’s syndrome. Revision
H-J was done in 3 post H-Jstomy strictures. Complications (16.88%),
included wound infection (6.25%), bile leak (5%), adhesive obstruction,
anastomotic stenosis and intra-abdominal sepsis.1 patient of H-Jstomy
expired due to biliary peritonitis. 3 patients developed anastomotic stenosis
by 32 months, 2 were treated with balloon dilatation and 1 with revision
surgery.
Discussion. Though not routinely performed, we found PTBD useful in
patients with biliary injuries detected postoperatively. It helped in controlling
sepsis, intraoperative identification of anatomy and decompression of
anastomosis. Predictors of adverse outcome are well known. 3 patients who
restenosed had proximal stricture, prior attempt at repair and end to end
biliary anastomosis.
Conclusion. Despite the emergence of therapeutic endoscopy and interven-
tional radiology, surgical intervention is mandatory in select benign biliary
disorders, and if appropriately timed and well performed has shown best long
term results in biliary injuries.
PP 21.11
MANAGEMENT OF IATROGENIC BILE DUCT INJURY:A STUDY
OF 30 CASES
Trivedi, Dilip1; Trivedi, Mayuri2; Shetty, Arun3
1Sir H.N Hospital, Mumbai, India; 2Mumbai, India; 3Hiranandani Hospital,
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Background. The aim of the study was to assess the use of hepaticoduo-
denostomy in Bismuth I type of common bile duct (cbd) injury and study the
results of other Bismuth type cbd injury retrospectively. This study of cbd
injury was carried out in Sir H N Hospital, Mumbai, India in a single surgical
unit.
Method. 30 cases of cbd injury are retrospectively analyzed. Majority of the
patients were managed primarily. However three patients were reconstructed
secondarily after the failure of the primary surgery at other centers. The
procedures carried out were roux en y hepaticojejunostomy in majority of the
patients. However in Bismuth type I injury where available duct length was
more than 2 cms. Hepaticoduodenostomy was performed after mobilizing
duodenum to achieve tension free anastomosis.
Results These patients were operated and they were followed up for a period
of three years regularly. The longest follow up is for 14 years.
Conclusion. Hepatico duodenostomy is the operation of choice in Bismuth
type I injury. The advantage is that the anastomosis is available for
manipulation endoscopically in case of complications like stenosis or
recurrent cbd stones at a later date. Hepatico jejunostomy is the operation
of choice for other Bismuth type of cbd injuries. Best results are obtained in
the tertiary care centers where experienced surgeon as well as good backup is
available for the investigations and the postoperative management. If
expertise is not available at the time of first surgery, it is advisable to drain
the bile duct and send the patient to tertiary care centre for further
management. The long term results of the surgery are definitely better
when the patients were treated at the tertiary care centre.
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THE ROLE OF SURGERY IN THE LIVER METASTASES OF
OVARIAN CARCINOMA
Saribeyoglu, Kaya1; Pekmezci, Salih1; Arvas, Macit2; Demirkiran, Fuat2;
Aytac, Erman1
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Introduction. Surgery plays an important role in ovarian carcinoma
metastases as most of the patients benefit from tumor debulking which is
chemosensitive. However the management strategy of liver metastases of this
tumor was seldom reported. Removal of all macroscopic tumor is crucial in
this type of tumor and it is only achievable by liver resections. This study
includes a series of patients who had ovarian carcinoma metastases to the
liver and underwent liver resection.
Methods. The patients who underwent surgical resection of ovarian
carcinoma metastases were included. Demographic features, technical de-
tails, surgical outcome and prognosis were evaluated.
Results. Eight patients underwent surgical management of liver metastases
related to ovarian carcinoma between March 2003  May 2007. Operations
included right hepatectomies, left lateral segmentectomy and tumor resec-
tions. Extended lymphadenectomy was performed in a patient where
pathological paraaortic lymph nodes were present. In another patient
additional visceral resection was necessary. There was neither surgery related
morbidity nor mortality. The operations was resulted with complete removal
of all macroscopic tumors.
Conclusion. Liver resection is feasible and useful in ovarian carcinoma
metastases. Larger series including long term follow-up are needed for an
ultimate conclusion.
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RADIOFREQUENCY THERMAL ABLATION AS A PALIATION
METHOD IN PATIENTS WITH CARCINOID SYNDROME DUE
TO LIVER METASTASES
Zadrozny, Dariusz1; Sledzinski, Zbigniew1; Studniarek, Michal2; Adamonis,
Walenty1; Gorycki, Tomasz2
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Background. Liver metastases from carcinoid tumors are often a cause for
carcinoid syndrome. The syndrome results from vasoactive substances
(serotonin, bradykinin, histamine, prostaglandins, polypeptide hormones)
secreted by the tumor and is characterized by cutaneous flushing, abdominal
cramps, and diarrhea. The symptoms may be reduced by octreotide or
somatostatin administration, but this treatment is very expensive. Tumor
excision or destruction may result in complete relief of symptoms.
Material. Between 2001 and 2006 five patients (3M, 2F) aged 4668 years
(mean 56,3) were treated in our institution for to carcinoid syndrome. In 3
cases liver metastases from carcinoid tumor of appendix and in 2  from
jejunum were the cause of symptoms. All patients were scanned for the
possibility of radionuclide treatment and treated with standard chemotherapy
with rapid progression. Octreotide was administered in all patients for 35
months and rejected. Patients were referred for percutaneous radiofrequency
thermal ablation of liver metastases after disqualification from liver resection.
At the admission time mean 7 (410) tumors 18 cm (av. 3,7) in diameter
were found in the liver.
Results. No complication of RFTA occured in this group of patients. Mean
observation time is 2,4 years (14), all patients are alive. Formation of new
tumors was found in 4 of 5 patients (80%), in one patient the disease is stable
after one RFTA session. Overall number of ablation sessions was 15 (19,
mean 3 per patient). After each ablation relief of symptoms was observed, the
effect was stable for 45 months. Relapse of syndroms was the indication for
subsequent ablation of local recurrence or new foci. The patient’s quality of
life is good.
Conclusion. Radiofrequency thermal ablation can used as a paliative
treatment in patients with carcinoid syndrome resistant to other therapy
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ANATOMIC VARIATIONS OF EXTRA-HEPATIC BILIARY TRACT
AND HEPAITC VASCULATURE;A REVEIW OF LITERATURE
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Anatomic variations of extra-hepatic biliary tree and hepatic vasculature are
so common that it is difficult to find an individual patient with completely
orthodox hepatobiliary system. Healey and Schroy, Bowden championed
research in this field in 1950s. Literature has reported anatomical variations
to the tune of 38% for biliary system (n300), 20% for portal venous
branching (n507) and 45% for hepatic artery branching (n200). Be it
for a general surgeon, hepatobiliary surgeon, endoscopist, or radiologist, it
becomes imperative to have the thorough knowledge of these anomalies,
especially in this era of liver transplantation and laparoscopic surgery. Apart
from the biliary tract, Gall bladder anomalies can be divided as variations of
formation, number and position. Seven gross variations in biliary tree
branching have been described. Its knowledge is essential for the safe
conduct of hepatobiliary procedures. While doing hepatic resection and
surgeries at porta, it becomes absolutely essential to have sound knowledge
of about ten variations in hepatic artery branching and six variations in
portal vein branching. More importantly, vascular and biliary anatomic
variations do not correlate with each other. With advances in the imaging
technologies, especially MRCP, preoperative identification of anomalies
looks possible, so that surgical strategies can be designed accordingly. Thus,
in this important aspect of hepatobiliary surgery, more in depth research is
needed in the fields of diagnostics, clinical implication and surgical
innovations.
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ANATOMICAL VARIATION OF SEGMENT IV HEPATIC ARTERY
YU, HEE-CHUL; Jin, Guang Yu; Cho, Baik-Hwan
Chonbuk National University Medical School, Surgery, Jeonju, Korea,
Republic of
Background. Anatomical complications of split and living donor liver
transplantation (LDLT) have promoted comprehensive understanding of
liver anatomy and embryology in greater depth and encouraged to view the
matter from many different perspectives than ever before.
Objective. To investigate the points of origin of segment IV artery (A4) of
the liver.
Methods. Meticulous dissection of livers (n62) to study the types and the
prevalence of the anatomical variation found in the principal A4.
Results. A4 was found to be extra- or intra-hepatic branches of the right, left
or proper hepatic arteries. We classified and characterized four different types
of A4 according to their origin in the livers (n46) without aberrant left
hepatic artery (abLHA). The RHA type, originated from the right or right
anterior hepatic artery, was identified in 24 cases (52.2%) in our series. Based
on our dissection study, we developed what we called a ¡8sliding model¡9 of
stemming of A4 roots that originated from either the RHA or the LHA. The
A4 roots (n19) had a strong tendency of stemming from the RHA (n12)
rather than from the abLHA (n5) even in the livers with abLHA(n16).
Conclusions. According to our dissection study RHA type is the
most prevalent type of variation which is found in the principle A4. In
the era of LDLT using extended right lobe, comprehensive knowledge
paying particular attention to the point of origin of A4 is prerequisite in
planning surgery.
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ERYTHROPOIETIN STRONGLY PROTECTS THE LIVER FROM
ISCHEMIA REPERFUSION INJURY IN A PIG MODEL
Shimoda, Mitsugi; Sawada, Tokihiko; Iwasaki, Yoshimi; Kijima, Hiroaki;
Okada, ,s,I,‘‘,ﬄ,, . . .; Kubota, Keiichi
Dokkyo University School of Medicine, Second Department of Sugery,
Mibu, Japan
Background. Erythropoietin (EPO) has various extrahematopoietic effects.
We investigated the protective effect of EPO against liver ischemia reperfu-
sion (IR) injury in a pig model.
Methods. Partial hepatic ischemia for 60 min was created in pigs. Pigs were
allocated to 2 groups (n5 each): Vehicle; IR injury, EPO group; IR injury
with three injections of EPO at 5000 IU/kg. In the EPO group, EPO was
injected 10 min before and 30 min and 60 min after the ischemia.
Results. At 3 h after IR injury, liver function test and histological evaluation
were significantly better in EPO-treated groups than those in the Vehicle
group. Apoptotic indices in the Vehicle and EPO groups 3 h after IR injury
were 2.4090.93, 1.3690.12 (P0.036), respectively. The apoptotic idex of
EPO group was significantly lower than that of the Vehicle group.
Conclusions. EPO treatment significantly ameliorated liver IR injury by
inhibiting apoptosis.
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ASSESSMENT OF HIP/PAP1 EFFECT ON COLORECTAL CELL
PROLIFERATION: Results OF IN VITRO AND IN VIVO STUDY ON
RAT.
VIBERT, Eric1; CAM, Laurence2; MONIAUX, Nicolas1; SAMUEL,
Didier3; AMOUYAL, Pierre1; AMOUYAL, Gilles1; BRECHOT, Christian1;
FAIVRE, Jamila1
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Introduction. Human Hepatocarcinoma-Intestine-Pancreas/Pancreatic As-
sociated Protein 1 (HIP/PAP1 or HIP), is an hepatic growth factor presenting
mitogenic and anti-apoptotic activities in primary hepatocytes in vitro and in
vivo. It is also a promising candidate for stimulating liver regeneration post-
hepatectomy
Objective. To evaluate whether or not the recombinant HIP protein exhibits
an oncogenic effect on colorectal cells (CC) in vitro and in a model of liver
metastasis (LM) in BDIX rats.
Methods. The DHDK12 CC line was cultured in 96-well microplates in a
DMEM medium containing 1% or 5% fetal calf serum (FCS). The CC were
incubated every day with a fresh medium containing 0, 0.5, 1 or 2 mg/mL of
the HIP recombinant protein or the buffer (control cells). Cell counting and
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viability were performed at 5 time points post-incubation (H24, H48, H72
and H96) using the WST-1 assay. The colorectal LM model was made by
injecting 20106 DHDK12 CC through the portal vein of BDIX rats (n
12). At day 8, the recombinant HIP protein (200 mg) diluted in 1 mL of saline
buffer (n6) was injected via the portal vein during a second laparotomy,
and compared with the control groupe (n6) injected with 1 mL of buffer.
At day 14, all animals were sacrificied for examination.
Results. The cell viability was similar in HIP-treated and in control CC at
the different time points whatever the concentration of FCS. There is no
difference of cell viability depending of the HIP concentration. The mean
number of LM was of 22914 and 19915 in HIP-treated and in control
group, respectively (p0.76). The mean volume of LM was of 6.598 mm3
and 4.794.3 mm3 in HIP-treated and in control group, respectively (p
0.65). Histological features were similar in the 2 groups.
Conclusion. HIP has no deleterous effect on CC proliferation in vitro and
does not stimulate tumor growth of LM in vivo. The effects of HIP in the
colorectal LM rat model followed hepatectomy are ongoing to make sure that
the recombinant HIP protein has interest in liver surgery
PP 22.09
IDENTIFYING POTENTIAL MOLECULAR MARKERS FOR HCV-
POSITIVE, HBV-POSITIVE AND NON VIRAL HEPATOCELLU-
LAR CARCINOMA
Privato, Marta; Kubrusly, Marcia S; Stefano, Jose T; Oliveira, Andre C;
Bacchella, Telesforo; Machado, Marcel C.C
Sao Paulo University, Department of Gastroenterology, Sao Paulo, Brazil
Introduction. Hepatocellular carcinoma (HCC) is a multi-step process
associated with changes in gene expression. Chronic hepatitis B virus (HBV)
and hepatitis C virus (HCV) infections are the most important factors
associated with HCC. Some individuals who develop HCC are neither
infected with HBV nor HCV. Molecular analysis by gene expression in this
rare type of HCC, may allow the determination of molecular signature that
would help to distinguish genetic events and pathways involved in carcino-
genesis of these three HCC types.
Aim. To gain insights into regarding the similarities and differences in
mRNA abundances between non viral (NV-HCC) and viral HCC (HBV-
HCC or HCV-HCC) using microarray.
Methods. Tumor samples obtained from 9 patients (3 HBV-HCC, 3 HCV-
HCC and 3 NV-HCC) were evaluated for differentially expressed mRNAs by
using CodeLinkTM Human Whole Genome Bioarrays with 57,000 tran-
scripts.
Results. Using filtering criteria of 2.0-fold-change in expression and t-test (p
B0.05), different transcriptional levels of genes were found for the
comparisons: 1671 for HBV vs NV-HCC, 2257 for HBV/HCV vs NV-
HCC, 1141 for HBV vs HCV and 1584 for HCV vs NV-HCC. Using Gene
Ontology software no common pathways with differentially expressed genes
were found comparing all groups. Specific pathways were identified in HBV-
HCC vs NV-HCC (2,4-Dichlorobenzoate degradation, Ascorbate and
aldarate metabolism, Coumarine and phenylpropanoid biosynthesis, Fatty
acid biosynthesis, Glycosaminoglycan degradation, Heparan sulfate bio-
synthesis), HBV/HCV-HCC vs NV-HCC (Amyotrophic lateral sclerosis-
ALS), HBV-HCC vs HCV-HCC (Alkaloid biosynthesis I, Novobiocin
biosynthesis, O-Glycan biosynthesis) and HCV vs NV-HCC (Glyoxylate
and dicarboxylate metabolism, Nicotinate and nicotinamide metabolism).
Conclusion. This study reveals a difference in molecular signature between
NV-HCC and viral HCC. Further studies by tissue microarray will be
addressed to confirm our findings. Supported by FAPESP 06/56127-5.
PP 23.01
TREATMENT OF HEPATOCELLULAR CARCINOMA IN NON-
CIRRHOTIC LIVER
Ardiles, Victoria; Bregante, Mariano; Salceda, Juan; Fernandez, Diego; Juan,
Pekolj; de Santiban˜es, Eduardo
Hospital Italiano de Buenos Aires, HPB Surgery and Liver Transplant Unit,
Buenos Aires, Argentina
Background. Presentation, treatment and prognosis of hepatocellular
carcinoma depend on presence or absence of cirrhosis. There are few studies
of hepatocellular carcinoma in non-cirrhotic livers.
Objective. To analyse a cohort of patients operated on for hepatocellular
carcinoma in non-cirrhotic liver identifying prognostic factors of recurrence
and long- term survival.
Material and Methods. Fifty-one patients were operated on between 1990
and 2006. A retrospective database until 2001 and a prospective database as
from the same year were created. Data was gathered from the pre, intra and
postoperative period. Univariate and multivariate analyses were carried out to
identify the factors associated with recurrence and long- term survival.
Results. Thirty-three male patients (mean age: 49.8 years). A major
hepatectomy was carried out in 72%. Intraoperative mortality and morbidity
were 0% and 43%, respectively. One-, 2-, 3-year survival rates were 90%,
75% and 67%, respectively. One-, 2-, 3-year disease-free survival rates were
65%, 41% and 37%, respectively. Vascular invasion and positive nodes were
statistically significant for survival in univariate analysis. Neither of them were
statistically significant for survival in multivariate analysis.
Conclusion. Major hepatic resection is a safe procedure for the treatment of
hepatocellular carcinoma in non-cirrhotic liver. Vascular invasion and
positive nodes were identified as independent prognostic factors of survival.
PP 23.02
OUTCOMES OF HEPATECTOMY FOR HEPATOCELLULAR
CARCNOMA MEETING MILAN CRITERIA WITH PRESERVED
LIVER FUNCTION
Park, SH; Lee, DS; Yun, SS; Kim, HJ
Yeungnam University Hospital, Surgery, Daegu, Korea, Republic of
Background Hepatic resection and liver transplantation are surgical
therapeutic option for small-sized HCC. But, patients with single tumors
and preserved liver function present a therapeutic dilemma.
Purpose. In this study, we examined the outcomes of surgical resection for
HCC patients meeting Milan criteria with preserved liver function and
rationale of hepatic resection as the initial treatment for HCC meeting Milan
Criteria.
Material. Between 1990 and 2005, 248 patients with HCC underwent
Keratectomy. In 158 primary HCC patients meeting Milan criteria (Group
M) and in 90 patients beyond Milan criteria (Group N). Median age were
54.5 years in group M and 52.4 years in group N.
Results. Most of patients have A of Child -Pugh scores, bur 4 patient in
group M and 1 patient in group N have B of CPS. The tumor size, mean
survival months, level of AFP, E-S grade and vascular invasion rate were
significantly different between two groups. 67 patients in group M and 22
patients in group N have intrahepatic recurrence after primary hepatectomy.
The 1, 3, and 5 years disease-free survival rate were 86.7%, 59.6% and
40.2% in group M and 67.1%, 52.3%, and 50.5% in group N, respectively.
The cumulative 1, 3, and 5 year survival rates were 86.0%, 68.2%, and
54.7% in group M after primary hepatectomy and 62.2%, 45.5%, and 29.4%
in group N, respectively.
Conclusion. Because of high survival rate and long-term survival after
adequate treatment of recurrence, primary hepatectomy is resonable option
as first-line treatment for HCC meeting Milan criteria with preserved liver
function
PP 23.03
A Case of Huge Hepatocellular Carcinoma With Aplastic Anemia in
Young Aged Man
Won, Yong Sung1; Cho, Jin Bum2; KIM, Jung Ah3
1St. Vincent hospital, Surgery, 93-6 Ji-dong Paldal-gu, Suwon, Korea,
Republic of; 2St. Vincent hospital, Surgery, Suwon, Korea, Republic of;
3St. Vincent hospital, Hematology, Suwon, Korea, Republic of
Aplastic anemia is a disease that characterized by the pancytopenia and bone
marrow suppression. Generally, the diagnosis is performed by bone marrow
biopsy and hematopoietic stem cell transplantation is regarded as curative
treatment. We experiended one case of aplastic anemia with hepatocellular
carcinomoa and complete response for the aplastic anemia had been
documented without hematopoietic stem cell transplantation after Rt hepatic
lobectomy for hepatocellular carcinoma. 28 years old male visted our
hospital. He complained Rt upper quadrant pain and epigatric pain. he was
diagnosed with hepatocellular carcinoma of the hepatic 8th segment ( 17
1210 cm) 3 months ago, and then he received three cycles of TACE. The
operation for Hepatocellular carcinoma was scheduled. At the admission, we
checked complete blood cell counts which showed pancytopenia ( Hemoglo-
bin level was 8.7g/dl, platelet count was 10,000/mm6, White blood cell count
was 1,870/mm6). We perfromed bone marrow biopsy and bone marrow
suppression was confirmed ( ceullarity 1020%), So we could diagnosed
aplastic anemia and considered Hematopoietic stem cell transplantation or
immunosuppresive treatment, but the progression of the hepaticoellular
carcinoma was expected. Furthermore, the patient was Hepatitis B carrier, so
when immunosuppression, aggravation of the infection could be foresighted.
We transfused Packed red cell and platelete concentration and injected
granulocyte stimulating factor preoperatively. Then Rt. hepatic lobectomy
was performed.(2005.8.2) After the surgery, complete blood cell counts were
recoveryed spontaneously without specific treatment. ( On postoperative
10th day, hemoglobin count was 11.1g/dl, white blood cell count was 6110/
mm3, platelet count was 100,800/mm6), Now, two yeara later, there is no
evidence of relapse of the hepatocelular carcinoma and aplastic anemia.
PP 23.04
EVALUATION OF THE USE OF HABIB-4X SEALER DURING
LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC PATIENTS
Ibrahiem, Tarek; Soliman, Hossam Eldeen; Soliman, Bassem; Marwan,
Ibrahiem
National Liver Institute, Menoufia University, Department of Hepatobiliary
and Liver Transplantat, Egypt
Background. Hepatocellular carcinoma is a common tumor in patients with
liver cirrhosis. Bleeding tendency, portal hypertension and the general status
of the patient are important factor in planning therapeutic option. Habib-4x
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sealer has emerged a simple and safe tool during liver resection in those
patients.
Aims. Evaluation of the use of this tool during liver resection in cirrhotic
patients especially as regards safety, and outcomes.
Patients and Methods. We had performed 30 consecutive liver resections in
cirrhotic patients in the department of Surgery, National Liver institute,
Menoufia University since the first of August 2006 to the end of July 2007
using this device. Patients were Child class A with equal sex distribution and
with single hepatic focal lesions (mean diameter 8.593 cm). All the patients
had HCC with no other forms of therapy before or during the procedure.
Five cases had formal resections, 12 had bisegmentectomy and 13 had non-
anatomical resections. We collected the preoperative tumor characteristics,
patient’s operative data, postoperative details including hospital stay, the in-
hospital complications and early follow for two postoperative months.
Results. There were no operative or in-hospital mortality. The operative
time was 1209 30 minutes; blood loss was less than 100 cc in most of the
cases. Hospital stay was 592 days. Complications included ascites produc-
tion and leak in 4 cases, wound infections in 3 cases and pleural effusion in 3
cases.
Conclusions. Although the Habib-4x Sealer is a safe, fast technique that
reduces operative time hospital stay and costs but this technique must be
performed by well trained hepatobiliary surgeons especially in formal
resections and in lesions near the major vessels especially the hepatic veins.
PP 23.05
HIGH PREOPERATIVE C-REACTIVE PROTEIN LEVEL AF-
FECTS UNFAVORABLY THE PROGNOSIS OF PATIENTS WITH
HEPATICELLULAR CARCINOMA AFTER CURATIVE RESEC-
TION
Hwang, Yoon Jin1; Kim, Jong Yeol1; Chang, Su Kurn1; Lee, Sun Gi2; Kee, Se
Kook3; Chun, Jae Min4; Kim, Sang Geol1; Kim, Yang Il5
1Kyungpook National University Hospital, Surgery, Daegu, Korea, Republic
of; 2Andong Sungso Hospital, Surgery, Andong, Korea, Republic of; 3Kumi
Cha Hospital, Surgery, Kumi, Korea, Republic of; 4Samsung Medical
Center, Surgery, Seoul, Korea, Republic of; 5Japan
Background. The prognosis of the patients with hepatocellular carcinoma
(HCC) is unfavorable even after curative resection. Host responses to tumor
such as local and systemic inflammatory responses and immune reactions as
well as tumor factors and liver function status may affect the overall survival.
C-reactive protein (CRP) has been reported to affect the prognosis of various
gastrointestinal and hematological malignancies.
Methods. We reviewed 82 patients who underwent curative resection for
HCC retrospectively. Correlation between preoperative CRP level and
clinical factors was analyzed. The clinical factors, overall survival, and
disease free survival of high CRP group (10 mg/L, n18) and normal
CRP group (B10 mg/L, n64) were compared. Univariate and multivariate
analysis was performed to identify the prognostic factors.
Results. 72 patients were male and 10 patients were female. The mean age
was 53.9 years old. All patients except only one patient of Child B stage were
in Child A stage. The median size of tumors and level of serum AFP were
60.3mm and 599.92ng/ml respectively. The mean serum albumin was
4.1¡340.45 mg/dl. Vascular invasion of tumor was present in 36.6%. The
median preoperative CRP was 8.8 mg/L. The CRP level was inversely
correlated with serum albumin level (r-0.382; pB0.001), Patients of high
CRP group (n18) had lager mean size of tumors, lower mean level of
albumin, higher incidence of stage 3, and higher incidence of vascular
invasion compared to the patients of normal CRP group. In high CRP group,
1 and 3 year overall survival rate was 61.1% and 25.5%, whereas 1, 3, and 5
year overall survival rate was 87.5%, 72.9%, and 60.1% in normal CRP
group (pB0.001). Multivariate analysis revealed that preoperative CRP level
and vascular invasion are independent prognostic factors of survival and
recurrence after curative resection.
Conclusion. This study showed preoperative CRP level in addition to the
presence of vascular invasion is an independent and significant prognostic
factor.
PP 23.06
PERCUTANEOUS ABLATION FOR SMALL HEPATOCELLULAR
CARCINOMA EQUAL TO OR LESS THAN 2 CM IN DIAMETER
Kuang, Ming1; Xu, Zuo F2; Lu, Ming D1; Liang, Li J1; Peng, Bao G1; Xie,
Xiao Y2
1The First Affiliated Hospital of Sun Yat-Sen University, Department of
Hepatobiliary Surgery, Guangzhou, China; 2The First Affiliated Hospital of
Sun Yat-Sen University, Department of Medical Ultrasonics, Guangzhou,
China
Objective. To investigate the thereapeutic effects of percutaneous ablation
for hepatocellular carcinoma (HCC)? 2 cm in diameter.
Methods. Thirty-three cases of pathologically conformed HCC sized up to 2
cm were treated with percutaneous microwave ablation (MWA) or percuta-
neous ethanol injection (PEI) using a multi-pronged needle. All patients
signed written informed consent before the treatment. Follow-up ranged
from 3 to 37 months (mean, 18 months99). Patients were observed for
progression of the treated tumors and for appearance of new lesions in the
liver. Primary aims were disease-free survival rates and overall survival rates.
Risk factors to the local effectiveness, and survival were assessed with Chi-
square test, univariate and multivariate analysis.
Results. The complete ablation rate was 93.9%, the local recurrence and
distant recurrence rates were 9.1% and 33.3%, respectively. One, 2-, and 3-
year disease-free survival rates were 62.6%?62.6%?62.6%, respectively.
Overall survival rates were 84.0%?74.5%?63.9%, respectively. Of all 16
variables assessed by univariate analysis, only pre-ablation?-fetoprotein
(AFP) level was significantly related to recurrence-free survival, while AFP
level and distant recurrece were significantly related to overall survival. In
multivariate analysis, AFP level and distant recurrece were independent risk
factors to overall survival.
Conclusions. Percutaneous ablation is capable of eradicating HCC? 2 cm in
size. Pre-ablation AFP level and post-treatment distant recurrence are
significantly related to prognosis.
PP 23.07
LOCO-REGIONAL MANAGEMENT OF LIVER TUMORS
Kantharia, Chetan1; Prabhu, Ramkrishna2; Bapat, Ravindra2; Supe, Avi-
nash2
1Kem Hosital & Seth Gs Medical College, Surgical Gastroenterology,
Mumbai, India; 2Kem Hospital & Seth Gs Medical College, Clinical
Pharmacology, Mumbai, India
Introduction and Aim. Liver cancer causes death in 75 percent of patients
within a year of diagnosis. Other than conventional surgical treatment, loco-
regional treatment modalities like radiofrequency ablation, Trans arterial
Chemo-embolization and chemotherapy, are used. This study determines the
role of loco-regional modalities in management of Liver Malignancy.
Method: 38 patients of Liver Tumors (31M: 7 F, age range: 4578 years)
presented from 20032006. Of these, 27 were of Primary Liver Malignancy
(8 cirrhotic), 3 recurrence and 8 were metastatic- (colorectal). Although
preoperative investigations revealed feasibility of resection in 13 cases, on
exploration only 12 patients were found to resectable. Resection done were
segmental resection (segment III)-3 patient, Right Hepatic resection 6
patients, Left hepatic resection 2 patients and Extended Right in 1 patients.
In 4 patients no therapy was given in view of extensive disease, all of whom
died within 6 months. Of the remaining 22 patients, 8 patients were subjected
to RFA, 3 patients to TACE, 9 patients to a combination of RFA and TACE
and 2 patients to chemo-infusion, and. The average follow up was for 18
months. Their survival and The Quality of Life (Modified SF-36 score) was
assessed.
Results.
GROUP MEAN SURVIVAL IN MONTHS AVERAGE QOL
Resected group 18 (132) 7.42
Group left alone 2.5 (14) 2.75
RFA 12 6
TACE 12 (1113) 4
TACE RFA 20.5 (1625) 6.5
Chemotherapy 6 4
Conclusion. Loco-regional treatment has a definite role in the management
of Liver tumor, with the patient leading a good quality of life.
PP 23.08
STEROETACTIC RADIOSURGICAL ABLATION USING CYBER-
KNIFE IS A SAFE METHOD FOR PROVIDING EFFECTIVE
TREATMENT FOR UNRESECTABLE HEPATIC MALIGNANCIES
Stephenson, G. Robert; Grabbe, Kelly; Sorgen, Stephen D.; Buchanan, Sam
W.; La Nasa, Peter
Harris Methodist Fort Worth Hospital, Fort Worth, United States
Introduction. The Cyberknife radiosurgical ablation system with precision
can deliver high dose radiation to essentially any site in the body. There are
many patients with malignant liver tumors who are not candidates for the
standard local therapies (e.g. surgical resection, radiofrequency ablation, or
transplantation).
Objective. The aim of this retrospective chart review is to determine whether
radiosurgery may be able to safely provide effective local control for
malignant liver tumors.
Methods. Between July 2006 and June 2007, 15 patients with primary or
secondary hepatic malignancies underwent radiosurgery using the Cyberknife
system. Seven patients had primary liver tumors (5 hepatocellular carcinoma;
1 intrahepatic cholangiocarcinoma) and nine had liver metastases from a
variety of primary sites. All patients were not candidates for standard local
therapy. The average tumor size was 5.9 cm (range 2.614 cm). Patients
received an average dose of 3.8 Gy in 3 or 4 fractions.
Results. None of the patients was admitted to hospital for either short or
long term toxicity related to treatment. There was no treatment related
mortality. Half of the patients noted mild, self-limiting treatment related
symptoms. The overall response rate was 87%. The one year actuarial
survival rate was 73%. One patient with a 14 cm hepatocellular carcinoma
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was subsequently able to undergo resection nine months after radiosurgery.
The patient’s tumor had decreased to a diameter of 7 cm and the resected
tumor was 70% necrotic on final pathology.
Conclusion. In summary, this early experience indicates that radiosurgical
ablation using Cyberknife is a remarkably safe treatment that can produce a
high rate of biological response in patients with hepatic malignancies who are
not candidates for standard local therapies and may also have a role in
downstaging patients with large unresectable tumors in order to make them
resectable.
PP 23.09
LAPAROSCOPIC RADIO FREQUENCY ABLATION OF LIVER
TUMORS
Chinnusamy, Palanivelu; Palanisamy, Senthilnathan; Ramakrishnan, Partha-
sarathi; Palanivelu, Praveen Raj; Rangasamy, Senthilkumar
Gem Hospital, GI Surgery, Coimbatore, India
Introduction. Resection is the best modality of treatment for liver tumors as
they have prolonged survival following resections. But still only 25% of these
tumors are amenable for resection due to various factors. Radio-frequency
thermal ablation is one of the most promising minimally invasive techniques
for the treatment of unresectable hepatic tumors.
Objective. To evaluate the use of laparoscopic radiofrequency ablation for
liver tumors and the potential advantages over other modalities.
Methods. Between April 2004 and July 2007, we have performed 37
laparoscopic radiofrequency ablations mainly for hepatoma and liver
secondaries. We performed a diagnostic laparoscopy and laparoscopic
ultrasonogram for localization of the lesion and detecting additional lesions.
Under ultrasonic guidance radio frequency ablation is done using RITA
system. The process of ablation is monitored by real time ultrasound. Follow
up CT’s are taken after 2 months to assess the completeness of ablation.Re-
sults. The average size of the lesions was 3.7 cm (2to 5.5 cm). Out of 37
lesions in 31patients, 29 have resolved completely and in the remaining 8
patients we performed reablation. The lesions that were inadequately ablated
were more than 4.5 cm. The lesions were distributed throughout the liver. We
have not applied Pringle maneuver in any of our patients. There were no
detectable changes in hemoglobin levels, platelets counts and liver biochem-
istry in any of our patients. The mean hospital stay was 3 days. Over a period
of 3 year follow-up, we had 4 recurrences.
Conclusion. Laparoscopic RFA for management of liver tumors results in
decreased morbidity and quicker recovery especially in the background of
cirrhosis.
PP 24.01
LAPAROSCOPIC MANAGEMENT OF BENIGN CYSTIC LESIONS
OF THE LIVER
Varma Gunturi, Surya Ramachandra; Kota, Venugopal; Kona, Lakshmi
Kumari; Ravindranath, K.
Global Hospitals, Hyderabad, India
Introduction. The widespread success of Laparoscopic Cholecystectomy
worldwide, enabled by advances in technology has prompted surgeons to
explore the role of laparoscopy in other surgical conditions including liver
diseases. Laparoscopic management of cystic lesions of the liver has been
described to be a safe approach. We describe our experience in laparoscopic
management of benign cystic lesions of the liver in a tertiary care center.
Materials and Methods. 56 Patients over last 7 years underwent Laparo-
scopic Liver Surgery for symptomatic benign cystic lesions. Indications were:
Simple Cysts (n33), Polycystic Liver Disease (n1) and Hydatid Cysts
(n22). Data was collected prospectively and retrospectively. Deroofing9
Omental packing was the preferred treatment in simple and polycystic liver
disease. In Hydatid cysts, puncture and aspiration, scolicidal injection and
reaspiration followed by deroofingomental packing was performed.
Results. In 55 patients, the procedures were completed laparoscopically.
Conversion to Laparotomy was needed in 1. Complications were seen in 3
patients: Anaphylaxis (n1), bilioma (n2) which were managed success-
fully non surgically. There was no mortality. Follow up period ranged from 3
60 months.
Conclusions. Laparoscopic management of benign liver cysts in selected
patients is safe in experienced hands.
PP 24.02
GIANT HEPATIC CYSTS-THE FEASIBILITY OF LAPAROSCOPIC
SURGERY
Seah, Melanie; Kow, Alfred; Chan, Chung Yip; Ho, Choon Kiat; Liau, Kui
Hin
Tan Tock Seng Hospital, General Surgery, Singapore, Singapore
Background. Selected patients with symptomatic giant hepatic cysts stand
to benefit the many advantages that come with laparoscopic surgery.
Aim. The objective of this study is to review our experience and the surgical
outcome of laparoscopic management of giant hepatic cysts (8cm) in a
tertiary institution.
Methods. From January 2002 to December 2006, seven patients underwent
surgery by the hepatobiliary team for symptomatic giant hepatic cysts (
8cm). The demographic and operative data were collected and analyzed.
Results. There were 4 males and 3 females with the median age of 64 (50 to
78) years. The median size of the cyst by radiological measure is 18 (9 to 30)
cm. Partial cystectomy leaving behind the cyst wall adjacent to liver
parenchyma was performed for all patients. Six underwent laparoscopic
surgery with one conversion to open surgery due to dense adhesions and a
posteriorly sited cyst in segment VI. One patient underwent open surgery due
to the pre-operative suspicion of hydatid cyst. The median length of surgery
was 200 (105 to 230) minutes for patients managed laparoscopically
compared to 225 minutes for those managed with open surgery. Post-
operatively, one patient who was managed laparoscopically had deep vein
thrombosis while one patient who underwent open surgery had pleural
effusion. There was no mortality. The median length of stay was 3 (1 to 12)
days for those who were managed laparoscopically compared to 9 days for
those with open surgery.
Conclusions. Laparoscopic partial cystectomy for giant hepatic cysts is safe
and effective. It can be performed within reasonable time limits with minimal
morbidity. Patients recover faster and enjoy a shorter hospital stay.
PP 24.03
LAPAROSCOPIC DRAINAGE AND PARTIAL CYSTECTOMY FOR
LIVER HYDATID DISEASE.
Tepetes, Konstantinos; Spyridakis, Michael; Baloyannis, John; Christodou-
lidis, Gregory; Hatzitheofilou, Constantine
University Hospital of Larissa, Surgery, Larissa, Greece, Greece
Laparoscopic and percutaneous minimal invasive techniques have been
recently used for the management of hepatic hydatid disease with results
similar to those following open conventional methods, regarding safety and
efficacy. We present our laparoscopic technique for draining and excising liver
hydatid disease. The safety of our method is based on the appropriate
mobilization and isolation of the involved liver segment and the use of a 18
mm trocar for the aspiration of the cyst contents [fluid, daughter cysts, inner
layer]
PP 24.04
RADIOFREQUENCY ASSISTED LAPAROSCOPIC LIVER RESEC-
TION IN A WOMAN WITH BENIGN LIVER TUMOUR; A NOVELL,
SAFE AND RELIABLE TECHNIQUE
Mir, Jose1; Redondo Cano, Carlos R.2; Bruna Esteban, Marcos1; Artigues,
Enrique1; Fabra, Ricardo1
1Hospital general Universitario de Valencia, Hepatic surgery, Valencia, Spain;
2Hospital general Universitario de Valencia, General and digestive surgery
department, Valencia, Spain
Background. The hepatic surgery has developed fast in the last years.
Nowadays, the progress in the surgical technique and the evolution
parenchymal transection systems; has improved the results in patients
submitted to hepatic resections. The radiofrequency assisted hepatic resec-
tion has proved to be a very safe transection method, decreasing the surgical
times, and the complications rate. Laparoscopic access for the hepatic
resection is growing in acceptance; many authors support its good Results.
Clinical Case: A 33 years-old woman, who refers an history of recurrent
abdominal pain, mainly in epigastrium and both hypochondriums, there were
no fever, icterus, or nausea, the blood tests results were normal. A magnetic
resonance was accomplished, discovering a big liver lesion located in the left
lobule, which displaces the gastric cavity, this lesion does not infiltrate
adjacent structures. The radiologic aspect suggests a liver angyoma.
Methods. The patient underwent a resection of the left lateral segment,
accessing the abdomen trough 4 Throcars; the parenchymal transection was
performed using the Habibtm 4x laparoscopic device with RITA 1500X RF
Generator and software (RITA Medical Systems, Inc. 46421 Fremont, CA
94538 USA), There was no needing for blood transfusions after the surgery;
the patient was discharged on the fifth postoperative day without complica-
tions.
Discussion: The implement of laparoscopic in hepatic surgery has demon-
strate to be beneficial, permitting less discharge times of patients, the us of
radiofrequency for the laparoscopic transection of hepatic parenchyma helps
to improve results, allowing a faster, safer and reliable surgery, as well as
decrease the needing of blood transfusions.
PP 24.05
THE EFFICACY AND SAFETY OF RADIOFREQUENCY ABLA-
TION THERAPY UNDER SMALL THORCOTOMY FOR HEPATO-
CELLULAR CARCINOMAS.
Uchida, Shinji; Horiuchi, Hiroyuki; Hisaka, Toru; Kawashima, Yusuke;
Fujishita, Manami; Kinoshita, Hisafumi; Shirouzu, Kazuo
Kurume University Hospital, Surgery, KURUME, Japan
Background; We have performed radiofrequency ablation therapy(RFA) for
hepatocellular carcinomas(HCC). At that time, we often meet some difficult
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cases to introduce under ultrasound guidance cause of lung and lib. We could
performe RFA in safety through the diaphragm under ultrasound guidance
after small thoracotomy. So we examined the efficacy and safety of RFA
under the thoracotomy for HCC patients. Patient and Method; We perform
RFA at the 13 HCC patients under thoracotomy. If we cannot detect the
tumor, we marked the point of thoracotomy before surgery. After thoracot-
omy, an electrode cannula was introduced into the tumor through diaphragm
under ultrasound guidance, which was then ablated at 40w to 90w under
ultrasound imaging monitoring, using a RFA device at the frequency of
460kHz. The efficacy of this RFA therapy was evaluated by intraoperative
enhanced ultrasound, perioperative and follow-up CT scans. Results; The
RFA effectively ablated in all tumor(100%). Complications included inter-
costals neuralgia; however, there was no serious mobidity such as pleural
effusion and bleeding. Conclusions; The present study has demonstrated that
the RFA under small thoracotomy is able to provide a safe and effective
means in controlling HCC.
PP 24.06
SAFETY AND RESULTS OF LIVER RESECTION AT A NEW
SPECIALIST UNIT IN INDIA.
Philip, Sujith1; Doctor, Nilesh2; Nagral, Sanjay2
1Jaslok Hospital and Research Centre, GI Surgey, Mumbai, India; 2Jaslok
Hospital and Research Centre, GI Surgery, Mumbai, India
Introduction. Liver surgery is a blossoming field in India. But data on
results are scarce. We present an experience of 111 hepatic resections over an
8year period at a specialist unit.
Objectives. Safety and outcome of liver resections at a new HPB unit in
India.
Methods. A retrospective analysis was done of 111 liver resections between
1999 to 2007 focusing on patient details and outcome. Resections were done
with intermittent porta clamping except in living donor. The liver was divided
with an ultrasonic dissector. Intraoperative ultrasound was used.
Results. Patients included 68 males, 43 females with a mean age of 47 yrs
(range 6 months to 74 years). Indications included Hepatocellular carcinoma
in 27, Carcinoma GallBladder 12, Hepatoblastoma 11, Cholangiocarcinoma
17, Haemangioma 11, Metastases 9, Donor Living Liver Transplant 7 &
others 17. Procedures included Right Hepatectomy 33, Right Extended
Hepatectomy 10, Right Lateral Segmentectomy 2, Left Hepatectomy 14,
Left Lateral Segmentectomy 12, Segmental Resections 24, Non anatomical
resections 16. There were 6 postoperative deaths giving a mortality rate of
5.4%. All deaths were in patients with malignancy. Post operative morbidity
included Post Hepatectomy Liver Failure in 11, bile leak or bilioma in 18
(stenting in 8), re-bleeding in 2 and prolonged cholestasis in 1. The overall
major morbidity rate is 28.82% and was influenced by ASA Score and extent
of resection. Both were less in latter half of the series. The mean follow up is
52 months (range 284). 17 patients are lost to followup. All patients with
benign indications are well at last follow up. The mean survival for patients
with HCC is 11 months, cholangiocarcinoma 33 months &metastases
25months.
Conclusions. Although ours is a new unit in a developing country the
morbidity and mortality of liver resections compare favourably with literature
from developed countries.
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R.F. ASSISTED HEPATECTOMY Results OF 50 LIVER RESEC-
TION R Pellicci, A. Percivale, A. Gandini, S Baldo S. Corona
Hospital, Italy
Pellicci, Riccardo
Santa Corona Hospital, Pietra Ligure, Italy
Introduction. Surgical resection remains the best treatment for liver tumors.
A new technique first described by Habib using radiofrequency has
increasingly been utilised in the past years: this new procedure, employs
the heat produced by a radiofrequency needle electrode to obtain a previous
coagulation of the tissue before cutting it and to perform a liver resection.
Methods. From June 2002 to September 2005 fifty patients underwent liver
resection with the Habib technique (21 HCC and 29 ColonRectal metas-
tasis) with the evaluations of recurrences on the surgical margins, blood loss
and blood transfusion requirement, ICU admission and technical related
complications. Patients were enrolled in to 3 groups looking for margin of
resection: Group A enrolled 9 patients: no margin; Group B: 19 patients:B1
cm and Group C: 22 patients1 cm. Six patients receive blood transfusion
with a mean of 2,791,5 units of red blood cells. Two patients required fresh
frozen plasma. The mean overall operative time was 210980 minutes: the
mean resection time was 65943 minutes.
Results. Cumulative survival rates were calculated with the Kaplan Meier
method Factors found to be significant predictors of survival and disease free
survival on univariate analysis were subjected to multivariate analysis using
the Cox’s proporzional hazard mode. At a median follow up of 50 months 31
patients were alive and 19 died. No recurrence on the line of resection was
diagnosed. Thirty patients experienced recurrence in the remnant liver:
extrahepatic recurrence occurred in 7 patients.
Conclusion. Although this study was not designed to compare Habib
technique with other resection technique, we can say that this new technical
monopolar and bipolar devices used to perform hepatic resection seems to be
effective in order to decrease the transfusion requirement intraoperative
blood loss and ICU admission. Moreover the margin of necrosis induced by
the coagulative necrosis is adequate for a complete sterilization of the
resection site.
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REPORT OF AN IN VIVO ON PIG LIVER STUDY OF LAPARO-
SCOPIC BLOOD-SAVING LIVER RESECTION USING A NEW RF-
ASSISTED DEVICE
Navarro, Ana Cristina1; Burdio, Fernando2; Berjano, Enrique3; Gu¨emes,
Antonio4; Sousa, Ramon5; Rufas, Maria4; Subira, Jorge6; Burdio, Jose
Miguel7; Castiella, Tomas8; Tejero, Eloy4; De Gregorio, Miguel Angel9;
Grande, Luis2; Lozano, Ricardo4; Gonzalez, Ana10
1HCU Lozano Blesa and FH Calahorra, Department of Surgery, Zaragoza
and Calahorra, La Rioja, Spain; 2Hospital del Mar, Department of Surgery,
Barcelona, Spain; 3University of Valencia, Dept of Electric Engineering and
Communications, Valencia, Spain; 4HCU Lozano Blesa, Department of
Surgery, Zaragoza, Spain; 5HCU Lozano Blesa, Department of Surgery,
Zaragoza; 6HCU Lozano Blesa, Department of Urology, Zaragoza, Spain;
7University of Zaragoza, Dept of Electric Engineering and Communications,
Zaragoza, Spain; 8HCU Lozano Blesa, department of payhology, Zaragoza;
9HCU Lozano Blesa, Depertment of interventional Radiology, Zaragoza,
Spain; 10Veterinary Faculty, University of Zaragoza, Department of Animal
Pathology and Surgery, Zaragoza, Spain.
Introduction. The aim of any device designed for liver resection is to allow
blood-saving and quick resections, this may be optimized using minimally-
invasive approach. In this article we describe a radiofrequency-assisted
device, combining a cooled blunt tip electrode with a sharp blade on one
side, on an in vivo preliminary study using hand-assisted laparoscopy to
perform partial hepatectomies.
Methods. A total of 8 partial hepatectomies were performed on pigs through
hand-assisted laparoscopy, using the radiofrecuency-assisted device as only
method for transection and hemostasia. Main outcome measures were:
transection time, blood loss, transection area, transection speed, blood loss
per transection area and tissue coagulation depth. Risk of biliar leak was also
assessed using methylene blue test.
Results. Transection time of 1397 min for a mean transected area of 34911
cm2. Mean total blood loss was 26934 cc. Mean transection speed was 391
cm2/min, and blood loss per transection area was 191 ml/cm2. Abdominal
examination showed no complications in nearby organs. One biliar leak was
indentified in one case using methylene blue test. Transection surface was
34911 cm2. Mean tissue coagulation depth was 992 mm. The inviability of
the coagulated surface was assessed by NADH staining.
Conclusion. The RF-assisted device has demonstrated in a laparoscopic
approach that it can perform liver resections quicker and with less blood loss
than other commercial devices, using a single device in a minimally invasive
approach without vascular control, while results have no significant differ-
ences with the same device used in open approach.
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ISOLATED TOTAL CAUDAL LOBECTOMY
Kotenko, Oleg
Institute surgery and transplantology, Department of the liver transplantation
and surger, Kiev, Ukraine
Introduction. The caudate lobe of the liver lies deep between the hepatic
hilus and the inferior vena cava. Isolated total caudal lobectomy usefull for
treatment different tumor of the liver.
Aim. Aim was to present surgical techniques of isolated total caudate
lobectomy.
Materials and Methods. Three techniques have been reported for isolated
total caudate lobectomy: the anterior approach by Yamamoto, the posterior
approach with or without total hepatic vascular exclusion by Yanaga and
Takayama, and the left lateral approach by Colonna. A lot of surgeons used
left lateral approach. We would like to demonstrate technique anterior
transhepatic approach and the posterior approach for caudate lobectomy.
The anterior transhepatic approach provides a safe procedure for an isolated
caudate lobectomy. The opening of the hepatic parenchyma overlying the
caudate lobe exposed the major hepatic veins and the hilar plate to direct
view, facilitating control of venous bleeding and interruption of the ascending
paracaval portal branches along the hilar plate. Its especially important for
surgery Klatskin tumor Bismuth II. We are demonstrating technique of
isolated total caudate lobectomy in case with Klatskin tumor by anterior
transhepatic approach. In another case huge benign tumor of the caudate
lobe we used right posterolateral approach. The division of the ascending
paracaval portal branches, originating from the craniodorsal aspects of the
hilar plate, and the control of the bleeding from the hepatic venous branches
are formidable work, especially when the tumor is large. We don’t use
counterstaining technique to separate margin caudate lobe because upper
anterior wall were hepatic veins. Liberation of the liver, securing the major
hepatic veins, and complicated liver transaction requires a considerable
amount of time, a shortcoming of this procedure.
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Conclusion. Thus isolated total caudal lobectomy is parenchyma saving
procedure for treatment local tumor of the liver different etiology.
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COMPARISON BETWEEN THE MINIMUM MARGIN DEFINED
ON PREOPERATIVE IMAGING AND THE FINAL SURGICAL
MARGIN AFTER HEPATECTOMY FOR CANCER. HOW TO
MANAGE IT?
Elias, Dominique1; Bonnet, Ste´phane1; Honore´, Charles1; Kohneh-Shahri,
Niaz1; Tomasic, Gorana2; Lassau, Nathalie3; Dromain, Clarisse3; Goe´re´,
Diane1
1Institut Gustave Roussy, Surgical Oncology, Villejuif, France; 2Institut
Gustave Roussy, Pathology, Villejuif, France; 3Institut Gustave Roussy,
Radiology, Villejuif, France
Background. The liver surgeon’s decision to operate is based on imaging.
However, no clear practical guidelines are available enabling surgeons to
safely predict tumor-free margins after a partial hepatectomy. The aim of our
study was to compare the preoperative margin measured on imaging to the
final histological margin measured on the specimen, and to propose to the
liver surgeon some simple practical guidelines to manage this surgical margin.
Patients and methods. Forty patients with liver metastases, who underwent
an anatomical right or left hepatectomy, passing along the median hepatic
vein, were selected for this study. The radiological margin was measured on 2
liver imaging and defined as the smallest distance between the LM and the
median hepatic vein. Liver transection was always performed by parenchyma
crushing.
Results.The median tumor-free excision margin was 5 mm at pathological
analysis, significantly different (pB0.0001) from the tumor-free margin
measured on preoperative imaging (15 mm). The mean difference between
these two measurements was 1094 mm (median 9). This difference was
partly due to the technique of transection, and partly due to technical
deviations in relation to the ideal resection line. Conclusion the liver surgeon
must consider that roughly a 5 to 8 mm tumor-free margin will disappear
during hepatectomy when comparing measurements based on preoperative
imaging versus tumor-free specimen margins. If the histologically assessed
minimum 2-mm tumor-free margin is added, the surgeon must plan to have a
7 to 10 mm tumor-free margin on preoperative imaging.
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ELECTIVE LIVER RESECTION-A MULTIVARIATE ANALYSIS OF
PARAMETERS DETERMINING THE POSTOPERATIVE OUT-
COME
Scho¨n, Michael R.1; Wiegel, Natalie M.1; Kaps, Maria2; Hauss, Johann P.2;
Scholz, Markus3; Zaatar, Mohamed1
1Klinikum Karlsruhe, Surgery, Karlsruhe, Germany; 2Universtiy of Leipzig,
Surgery, Leipzig, Germany; 3Universtiy of Leipzig, Medical Informatics and
Statistics, Leipzig, Germany
Introduction. Postoperative morbidity and mortality after liver resection has
been reduced significantly over the past years. To further improve upon the
postoperative outcome we analyzed a series of patients undergoing elective
liver surgery.
Methods. Out of 200 patients, 152 underwent liver resection for malignancy
and 48 for benign lesions. Procedures performed were extended right-
hepatectomy (n35), right- (n58), extended left- (n2), left (n24), left
lateral- (n18), and segmental-hepatectomy (n63). More than 150 pre-
and intraoperative parameters of every patient were registered and statisti-
cally correlated with the postoperative outcome. For univariate analysis, the
t-Test, Mann-Whitney-U-Test, Chi-Quadrate-Test and Fisher-Exact-Test
were applied and for multivariate analysis, a binary logistic regression model.
Results. In 130 patients no complications occurred and in 37 patients
complications were considered as minor (pleural effusions, superficial wound
infections). 27 patients suffered from severe complications such as pulmon-
ary embolism, sepsis, liver dysfunction. The 30 day hospital mortality was 3%
(n6). Preoperative parameters such as age, diabetes, ASA classification and
fibrosis and intraoperative factors such as duration, transfusion and simulta-
neous procedures were correlated with postoperative morbidity and mortal-
ity. Multivariate analysis revealed that diabetic patients and liver resection
with simultaneous procedures were both correlated with high morbidity and
mortality. The correlation for diabetes and simultaneous procedures with a
poor clinical outcome was even stronger than i.e. for cirrhosis and age.
Conclusion. Considering that this group of 200 patients undergoing elective
liver surgery already was selected for well established exclusion criteria and
considering that simultaneous procedures often are not a matter of choice we
suggest that focusing more on diabetes and its treatment in the selection
process will result in a further improvement of the clinical outcome.
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EMERGENCY LAPAROSCOPIC CHOLECYSTECTOMY FOR
ACUTE CHOLECYSTITIS: THE DELAY BEYOND 72 HOURS
DOSE NOT INCREASE OPERATIVE DIFFICULTY OR RISK.
Darwish, Ammar1; Al-Hourani, SA2; Ammori, Basil2
1Manchester Royal Infirmary, General Surgery, Oxford Street, Manchester,
United Kingdom; 2Manchester Royal Infirmary, General Surgery, Manche-
ster, United Kingdom
Background. There is reluctance to perform emergency laparoscopic
cholecystectomy (LC) in patients with acute cholecystitis (AC) if surgery is
delayed beyond 72 hours in fear of increased operative difficulty, morbidity
and conversion to open surgery.
Aims. To evaluate the safety and feasibility of delayed urgent LC, Methods.
We adopted a policy of offering an emergency LC to patients with AC
regardless of the delay incurred while awaiting access to the CEPOD theatre.
The outcomes of surgery in patients operated on within 72 hours of
admission (Group I) were compared with those who underwent delayed
emergency LC (Group II).
Results. Between 2001 and 2006, 75 patients underwent emergency LC for
AC (Group I, n22; Group II, n53). There was no difference between the
groups with regard to age, sex distribution, ASA score and frequency of
previous abdominal surgery. The interval between admission and surgery was
significantly shorter in Group I (median, 2 vs. 7 days, pB0.001). There were
no conversions to open surgery. No differences were observed between the
groups in the frequency of gangrene of gallbladder (9% vs. 6%, p0.627),
operating time (median, 80 vs. 80 minutes, p0.456), postoperative
morbidity (4.5% vs. 7.5%, p0.664) and mortality (4.5% vs. 1.9%, p
0.503), or postoperative hospital stay (median, 2 vs. 2 days, p0.403). There
were no bile duct injuries.
Conclusions. The delay in performing emergency LC for AC beyond 72
hours does not increase operative difficulty or risk of operative morbidity.
Patients with AC should not be denied an emergency LC if access to theatre
was delayed.
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EFFICACY OF PERCUTANEOUS CHOLECYSTOSTOMY FOR
PATIENTS WITH ACUTE CHOLECYSTITIS and ASA CLASSIFI-
CATION MORE THAN 3
Yun, Sung Su1; Lee, Dong Shick1; Kim, Hong Jin2
1Yeungnam University Hospital, Department of Surgery, Taegu, Kuwait;
2Yeungnam University Hospital, Department of Surgery, Taegu, Korea,
Republic of
Background/AIMS:Percutaneous Cholecystostomy(PC) has been proposed
as an effective bridge procedure before elective cholecystectomy for acute
cholecystitis. But many centers have different indications of PC including old
age, comorbidity, sepsis and liver function abnormality etc. Among them, we
designed this study to evaluate the efficacy of PC in patients with acute
cholecystitis and ASA classification more than 3.Method.: For recent 3 years,
we did PC in 29 patients with acute cholecystitis and ASA classification more
than 3. We did PC as a bridge procedure before elective cholecystecto-
my(bridge group) in 20 patients and as a palliation of symptom in 9
patients(palliation group). We evaluated patients characteristics, complica-
tion rate after PC, ASA classification change before and after PC, resumption
of oral intake after PC and success rate of laparoscopic cholecystectomy(LC)
etc.
Results. Mean age of bridge group and palliation group were 72.7 ¡34
9.7(Mean ¡34 S.D.) and 75.3 ¡
3
4 8.5 years old, respectively. Mean ASA
classification before and after PC were 3.7 ¡34 0.5, 2.3 ¡
3
4 0.8 and 4.0 ¡
3
4 0.8,
3.4 ¡34 0.7, respectively in both group. There was only one complication after
PC(peritonitis after PC, 3.4%), who is one of two mortality cases in palliation
group(22.2%). Resumption of oral intake was possible 3.2 ¡34 2.1 days after
PC in bridge group and 3.0 ¡34 2.4 days in palliation group except two
mortalities due to underlying diseases. We tried 12 LC and one failed due to
bile duct injury (success rate was 91.6%). Mean operation time for LC was
106.8 ¡34 32.5 which is a little bit longer than our elective LC. The
postoperative course of all patients received LC and open cholecystectomy
were uneventful.
Conclusion. PC is a good procedure for bridge procedure before elective LC
and palliation of symptom in patients with acute cholecystitis and ASA
classification more than 3.
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THREE-PORT-CHOLECYSTECTOMY AS A ROUTINE PROCE-
DURE IN ACUTE CHOLECYSTITIS
Riesener, Klaus-Peter; Wichary-Janoschka, Claudia; Roth, Marcus
Marien-Hospital Marl, Department of General and Visceral Surgery, Marl,
Germany
Background. During recent decades laparoscopic cholecystectomy has been
established as the procedure of choice for the treatment of acute cholecystitis.
The four-trocar technique can been regarded as the standard procedure. The
aim of the study was to show the feasibility and safety of a three-trocar-
technique as the routine procedure in acute cholecystitis.
Methods. Between January 1st, 2002 and December 31st, 2005, 380
consecutive patients underwent cholecystectomy for gallstone disease. Of
these 106 patients presented with acute cholecystitis. 96 patients were
selected for laparoscopic cholecystectomy, in 10 cases primary open
cholecystectomy was performed. Any laparoscopy was started using the
three-trocar technique.
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Results. The three-trocar-technique was feasible in 77 patients with acute
cholecystitis. A fourth trocar was added in 5 additional patients. The
insertion of the fourth trocar was mainly performed due to poor visualization
of the structures of Calot‘s triangle. In 14 further patients laparoscopy was
converted to open cholecystectomy. There were no postoperative deaths and
no major operative complications.
Conclusion. The three-port technique for laparoscopic cholecystectomy is
safe and feasible in the majority of patients with acute cholecystitis. Extension
towards a four-trocar technique is useful in selected cases. Early conversion
towards open cholecystectomy in patients with poor identification of the
Calot‘s triangle keeps the rate of complications reasonable and avoids lesions
of adjacent structures. The main advantages of the three-port technique are
that it is less expensive, it can be performed by a single surgeon under the
assistence of a nurse, and it leaves fewer scars.
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LAPAROSCOPIC SUBTOTAL CHOLECYSTECTOMY-OUR
TECHNIQUE AND A NEW CLASSIFICATION PROPOSAL
Chinnusamy, Palanivelu; P.S, Rajan; Palanisamy, Senthilnathan; M.V,
Madan Kumar; K, Sendhilkumar
Gem Hospital, Gi Surgery, Coimbatore, India
Background. Laparoscopic cholecystectomies for acute cholecystitis are
being performed commonly. We are presenting our surgical experience over
the past 16 years (July 1991 to Jan 2007) in the management of the acute
cholecystitis.
MATERIALS AND Methods. Total numbers of cases were 458 with 297
male and 161 female patients. Age group ranges from 34 years to 80 years.
Duration of symptoms ranged from 1 to 5 days. 357 patients presented with
pain abdomen. 234 patients had co morbid illness diabetes mellitus being the
commonest one. 138 patients had right hypochondrial mass on clinical
examination. Laparoscopic subtotal cholecystectomy (LSC) was performed
in all patients (LSC I and LSC II) LSC I is the technique of leaving behind
the posterior muscular wall of the GB which is adherent to the liver bed. LSC
II includes the division of the GB at the infundibulam and suturing, after
stripping of the mucosa.
Results. Out of 458 patients, 21 patients were converted to open
cholecystectomy to complete the procedure. The mean operating time was
55 minutes for laparoscopic subtotal cholecystectomy and 132 minutes for
open cholecystectomy. Mean blood loss was 67 ml. Hospital stay was 2.8
days.
Conclusion. Laparoscopy has a great role to play in the surgical manage-
ment of the acute cholecystitis with excellent outcome and minimal
morbidity. LSC offers all the benefits of minimally invasive surgery to the
patients with very low conversion rate.
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LAPAROSCOPIC CHOLECYSTECTOMY FOR ACUTE CHOLE-
CYSTITIS PERFORMED AFTER WORKING HOURS IS ASSOI-
CATED WITH A POORER OUTCOME?
Chong, Charing C.N.; Teoh, Anthony Y.B.; Wong, John; Lee, K.F.; Lai, Paul
B.S.
Prince of Wales Hospital/ The Chinese University of Hong Kong, Surgery,
Shatin, New Territories, Hong Kong
Background. Performing laparoscopic cholecystectomy LC for acute
cholecystitis at night is challenging and is supposed to be associated with
suboptimal performance and a higher conversion rate. Data on this aspect are
lacking. OBJECTIVE To determine whether LC performed after working
hours (nine am to five pm) was associated with increased rate of conversion in
patients with acute cholecystitis.
Patients and Methods. Medical records of patients admitted for acute
cholecystitis with emergency LC performed between July 1997 and June
2004 were reviewed. Clinical outcomes of patients who received the
operation during and after working hours were compared.
Results A total of 158 patients were included. Eighty nine (56.3%) patients
were operated before five pm and sixty-nine (43.7%) patients were operated
after five pm. There were no significant differences in demographics between
the two groups. Patients operated during normal working hours had to wait
significantly longer for the operation (3.7 days vs 3.1 days, P0.026) [Table
1] while those operated during after hours were associated with a significantly
higher conversion rate (29.2% vs 22.9%, P0.042). There were no
significant differences in operative time, hospital stay, complication rate,
percentage of operation performed by trainees and mortality rate. [Table 2].
Discussion and Conclusion. Laparoscopic cholecystectomy performed
after working hours was associated with a higher conversion rate. These
operations should be performed during normal working hours provided the
patient remains stable and theatre lists are available.
During working
hours
After working
hours
P
N (%) 89 (56.3) 69 (43.7)
Age * 58.0 (15.2) 57.7 (15.1) 0.898
Table (Continued)
During working
hours
After working
hours
P
Duration of onset of
symptoms (days) *
3.7 (2.1) 3.1 (1.9) 0.026
During working
hours
After working
hours
P
N (%) 89 (56.3) 69 (43.7)
Operative time (minutes)
*
101.6 (51.9) 111.9 (54.9) 0.121
Hospital stay (days) * 7.7 (3.5) 7.4 (2.5) 0.986
Complication rate (%) 16.9 15.9 0.879
Operation performed by
trainees (%)
30.0 21.7 0.226
Mortality (%) 0 0
Conversion rate (%) 29.2 44.9 0.042
* Data presented as mean (S.D.)
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PERCUTANEOUS CHOLECYSTOSTOMY FOR ACUTE CHOLE-
CYSTITIS IN HIGH RISK PATIENTS: A RISING STANDARD?
Melloul, Emmanuel1; Denys, Alban2; Demartines, Nicolas1; Calmes, Jean
Marie1
1CHU Vaudois, Visceral Surgery, Lausanne, Switzerland; 2CHU Vaudois,
Radiology, Lausanne, Switzerland
Background. As percutaneous cholecystostomy (PC) is an alternative
treatment to surgery in some cases of acute calculous/acalculous cholecystitis
(ACC/AAC), we aimed to evaluate in a standardized high risk population PC
procedure and its impact on both 30 days morbidity and mortality.Method.:
Patients presenting ACC and AAC treated by PC or surgery were reviewed.
Previous comorbid conditions at admissions were evaluated by the Simplified
Acute Physiology Score II (SAPS). Complications after surgery and PC were
classified using the Clavien and al. and SIR classifications, respectively.
Cholecystitis was diagnosed by clinical signs, blood sampling and ultrasound
(US) or CT scan. PC was performed by approach throughout the liver
parenchyma under CT or US guidance after 2 to 4 days of broadspectrum IV
antibiotics trial. Surgery was performed by laparoscopic or conventional
cholecystectomy. All hydrocholecystitis or choledocolithiasis were excluded.
Results. Seventy nine percent (68/86) of patients underwent surgery and
21% (18/86) PC. The median SAPS score was 38 (1571) for PC group and
18.5 (037) for SG group (pB0.05) with a Predicted Death Rate (PDR) of
21% and 3%, respectively (pB0.05). The overall 30 days mortality observed
after PC and SG was 22% and 0%, respectively. The mortality rate was
neither related to cholecystitis nor to PC procedure. The respective 42% (3/
7) and 9% (1/11) mortality rate observed after PC in the AAC and ACC
subgroups was only related to the severity of patients critical state (SAPS
score of 56.5 and 33.5, respectively (pB0.05)). PC resolved 94% of the acute
episode. One patient required emergency cholecystectomy. Major complica-
tions rate after PC and surgery was of 0% and 3%, respectively (p0.05).
Conclusions. PC allows resolution of AC with a low procedure related
morbidity and mortality and should be proposed to high risks patients. Early
morbidity and mortality is related to patient’s comorbidities rather than AC
or PC.
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CASE STUDY OF XANTHOGRANULOMATOUS CHOLECYSTI-
TIS MIMICKING GALLBLADDER CANCER WITH METASTASIS-
B@OF THE LIVER
Okano, Yusuke; Kotera, Yosihito; Katagiri, Satoshi; Ariizumi, Shun-ichi;
Takahashi, Yutaka; Yamamoto, Masakazu
Tokyo women’s medical university, institute of gastroenterology, Tokyo,
Japan
Xanthogranulomatous cholecystitis can often be difficult to preoperatively
differentiate from the gallbladder cancer, as the peripheral organ tends to
show a symptom of inflammatory infiltration. In recent years, however, the
diagnostic imaging system has enabled preoperative identification of xantho-
granulomatous cholecystitis in many cases. This paper reports a case of
xanthogranulomatous cholecystitis with tumor of the liver, which was
unidentifiable with gallbladder cancer with metastasis of the liver. The
patient, 62 year-old male, had abdominal pain on the right side as well as
emesis with fever after meal in April 2007, and visited local hospital. The
Ultrasonography, CT, and MRI exposed a sign of gallbladder cancer, and the
patient was referred to our institute for further check and treatment. The
patient showed no symptom when hospitalized except for high figures in
AST, ALT and bile tube-related enzyme. Markers for jaundice or tumor and
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inflammatory reaction were all normal while ICG was 7.2%. CT shows high
thickening of the gallbladder wall and poorly-demarcated mass. We also
found a viable lesion 15mm in diameter, which is suspected of hepatic
metastasis. ERCP also shows two stones in the common bile duct, but there
was no clear indication of stenosis. The cytology on the bile detected only up
to class III a, but we decided to carry out the operation for gallbladder cancer
with hepatic metastasis on June 5. The operation found scattered nodules in
the liver, which we suspected to be a sign of hepatic metastasis. The
gallbladder suffered adhesion to the peripheral tissues and could not be
decorticated. We performed anterior segmentectomy, resection of Segment 4
of the liver, together with duodenum, and extra bile duct resection and
choledochojejunostomy. The pathological test concluded the case was
xanthogranulomatous cholecystitis with no malignancy. The tumor on the
right hepatic lobe, which was also removed in the operation, had a similar
sign of granulomatous lesion.
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TOTAL EXCISION OF THE EXTRAHEPATIC BILIARY TREE FOR
CHRONIC BILIARY PAIN: IMPLICATIONS FOR OUR UNDER-
STANDING OF SUCH PAIN.
Stubbs, Richard
Wakefield Hospital, The Wakefield Clinic, Wellington, New Zealand
Background. Chronic acalculous biliary pain is generally thought of as being
either gallbladder in origin (acalculous gallbladder pain) or related to
sphincter of Oddi dysfunction (SOD). The former is generally resolved by
cholecystectomy and the latter may be resolved by sphincter division.
However, many patients suffering from the condition have ongoing pain
and disability following both cholecystectomy and sphincterotomy.
Aim. Does our current thinking on this condition fail to recognise other
mechanisms for chronic biliary pain?
Methods. We present the case histories of two patients who were seriously
disabled by narcotic dependent chronic acalculous biliary-type pain, who had
previously been treated with cholecystectomy and sphincter division (even
repeated) with temporary or no relief. Both patients had experienced
continual problems for a number of years and both had abnormalities of
biliary dynamics as demonstrated by quantitative HIDA scanning. As a last
resort, and after much discussion, both underwent excision of the extra-
hepatic, suprapancreatic bile duct with reconstruction by Roux Y hepatico-
jejunostomy.
Results. Both patients were immediately relieved of their chronic narcotic
dependent pain and have returned to normal life. Freedom from pain has
now persisted for over 18 months in both cases. No histological abnormality
was noted in the resected bile duct.
Conclusion. There is good reason to believe we do not yet have a clear
enough understanding of the mechanism of chronic acalculous biliary pain,
to be confident of the range of treatment options that can or should be offered
for this condition. Failure to recognise this may leave a proportion of patients
with disabling chronic pain and symptoms in the long term.
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EFFECTIVENESS OF A SUBCUTANEOUS LOOP IN BILIO-EN-
TERIC ANASTOMOSIS
Carrillo-Maciel, Vicente; Carrillo-Maciel, Jose Evaristo; Acosta-Saludado,
Alma Leticia; Silva-Vasquez, Rene; Ramos-Linaje, Samuel
IMSS UMAE 134, Surgery, Torreon, Mexico
Background. At the end of the XIX century the first cholecystectomy was
performed, also setting the beginning of biliary duct injuries. Approximately
95% of the injuries are benign. Treatment for these types of injuries is bilio-
enteric anastomosis. The most common problem that we face is post-
operative strictures, with a frequency of 13 -30% of the cases. Postoperative
strictures cause an increase in morbidity and mortality subduing the patient
to more invasive and complex procedures. Roux en Y reconstruction is the
recommended procedure. A modification of this technique includes the
employment of the proximal end-loop in a subcutaneous fashion, which
permits access to the anastmosis with endoscopic equipment. This permits
dilatation of strictures as many times as it is required.
Objective. Demonstrate the effectiveness of a subcutaneous loop in bilio-
enteric anastomosis.
Materials and Methods. 50 patients with benign biliary duct injuries in the
last ten years were revised. The patients were divided into two groups. Group
I: Traditional reconstruction and Group II: Subcutaneous loop.
Results. 41 patients in group I and 9 patients in group II. Group I: One
patient deceased. Group II had two patients with strictures treated with
hydrostatic dilatation and three post-incisional hernias.
Discussion. The subcutaneous loop was helpful in two of nine patients in
which postoperative strictures were present. These patients were reinstated to
productive life faster once the problem was resolved.
Conclusions. We recommend the subcutaneous loop in young patients and
Bismuth injuries 2, 3, and 4.
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’EMPYEMA NECESSITATIS’: A RARE COMPLICATION OF
GALLBLADDER DISEASE
Madhok, Brijesh1; Gunasekaran, Thenral2; Cooper, Michelle2; Capozzi,
Patrizia2; Blower, Anthony2
1Royal Albert Edward Infirmary, General Surgery, WWL NHS Trust,
Wigan, United Kingdom; 2Royal Albert Edward Infirmary, Wigan, United
Kingdom
Background. The term ‘empyema necessitatis’ essentially means a ‘burrow-
ing abscess’ of the abdominal wall as a result of chronic gallbladder
inflammation i.e. cholecystocutaneous abscess. The early use of modern
diagnostic tools, antibiotics and early surgical intervention has greatly
reduced its incidence with less than 20 case reports in the last 50 years. We
report a case of an abdominal wall abscess, which was diagnosed as a
cholecystocutaneous abscess intra-operatively not being diagnosed upon
initial investigations.
Aims. This case highlights the need to have a high degree of suspicion of this
rare entity in all cases of abdominal wall suppuration or cellulitis.
Methods. A 76-year-old female presented with a mass in right hypochon-
drium. On examination the patient looked well and was not jaundiced. A
1010 cm mass was found in the right hypochondrium. An ultrasound scan
of the abdomen revealed a large hypoechoic mass in the right upper quadrant.
A CT scan confirmed a 128 cm loculated cystic collection in the abdominal
wall deep to the external oblique muscle. The gallbladder was contracted
with its fundus in close proximity to the collection. However, no definite
communication between the gallbladder and the collection was identified.
Results. On incision and drainage the abscess was found to be commu-
nicating with the gall-bladder resulting into open cholecystectomy and on-
table cholangiogram. External biliary abscess or fistula may result from
intrahepatic abscess, calculous cholecystitis or other inflammatory process
involving the biliary tree. Now it is most common following hepatobiliary
surgery or trauma.
DISCUSSION. This case highlights that in all cases of abdominal wall
suppuration or cellulitis, a high degree of suspicion should be maintained in
regards to this rare entity and a CT scan should be considered in all cases.
Two different approaches of management have been described. In the near
future a laparoscopic one-stage approach may become the treatment of
choice
PP 25.11
XANTHOGRANULOMATOUS INFLAMMATORY STRICTURES
OF EXTRAHEPATIC BILIARY TREE: PRESENTATION AND
SURGICAL MANAGEMENT
Ravula, Phani Krishna1; Kumar, ashok2; Singh, Rajneesh kumar2; Saxena,
Rajan2; Kapoor, Vinay K2
1Sanjay gandhi post graduate institute of medical sciences, Surgical gastro-
enterology, Lucknow, India; 2
Introduction. Xanthogranulomatous cholecystitis (XGC) is variant of
chronic cholecystitis characterized by intense inflammation and occasionally,
invasion of adjacent organs. Invasion of common bile duct (CBD), termed as
xanthogranulomatous choledochitis may present with jaundice and mimic
malignancy.
Aim. We describe clinico-pathological features and management of four
patients with xanthogranulomatous inflammatory biliary strictures.
Methods. Review of a prospectively maintained database for XGC.
Results. Out of 6150 cholecystectomies performed, we had 10% incidence
of XGC (n620). 4 patients had xanthogranulomatous choledochitis
causing biliary stricture. All four presented with jaundice and 3 out of
4(75%) had history of cholangitis. All patients had associated gallstones with
thick-walled gallbladder. Two patients had hilar stricture (Bismuth type-III
and IV), one patient each had mid-CBD stricture and lower-CBD stricture
with a dilated pancreatic duct. All four patients had a preoperative diagnosis
of malignancy. Operative findings revealed extensive subhepatic adhesions,
pericholedochitis and thick-walled gallbladder in all four patients. Three
patients underwent resection of the stricture- CBD excision for mid-CBD
stricture, pancreaticoduodenectomy for lower-end stricture and Right
hepatectomy with hilar excision for hilar stricture with atrophy-hypertrophy.
In one patient hilar stricture was unresectable due to encasement of the
common-hepatic artery. Therefore hepaticojejunostomy was performed after
obtaining intraoperative hilar tissue biopsy. All 4 patients are asymptomatic at
1 to 3 year follow-up.
Conlusions. Xanthogranulomatous pericholedochitis can involve any part
of the biliary tree. It may be suspected in the presence of a thick walled
gallbladder and gallstones especially in areas where XGC is common.
However imaging and cytology are unreliable in ruling out malignancy.
Therefore resection of the stricture should be performed whenever possible.
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QUANTIFICATION OF LIVER CELL VIABILITY AFTER ISCHE-
MIA AND REPERFUSION INJURY IN RAT LIVER
Yun, Sung Su; Lee, Dong Shick; Kim, Hong Jin; Park, Sang Hwan
Yeungnam University Hospital, Department of Surgery, Taegu, Korea,
Republic of
Background/Aims. Liver cell damage after ischemia and reperfusion injury
has been a major cause of death after liver surgery. But there has been no
exact and practical guideline for liver cell damage after ischemia and
reperfusion injury. The aim of this study was to quantify liver cell viability
after ischemia and reperfusion injury.
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Methods. Seventy percent partial liver occlusion model with Spraque
Dawley Rats was used. ATP content of liver tissue, palmitic acid metabolic
rate and histologic change(H/E, TUNEL stain) were measured to assess liver
cell viability during 120 minutes ischemia by 30 minutes interval. At 24 hours
reperfusion after 30, 60 and 120 minutes ischemia, the same parameters and
AST/ALT level in the blood were measured.
Results. ATP content was decreased below 20% compared to normal liver
after ischemia, but there were no significant change in histology and palmitic
acid metabolic rate during 120 minutes ischemia. At 24 hours reperfusion
after 30, 60 and 120 minutes ischemia, ATP content were decreased around
50% in all groups and palmitic acid metabolic rate were decreased 90.9¡342.4,
80.0¡345.3 and 79.1¡
3
47.7%, repectively, compared to control liver. But
histologic change was not as much as in change in ATP content and palmitic
acid metabolic rate.
Conclusion. With these results, liver had relatively well tolerance during
ischemia but after reperfusion, liver had damage depending on duration of
ischemia. This study might be very helpful as a guide line of liver damage
after ischemia and reperfuion in clinical practice and basic reserach.
PP 26.02
SIGNIFICANCE OF BIOELECTRICAL IMPEDANCE AND LIVER
CELLl VIABILITY DURING ISCHEMIA-REPERFUSION INJURY
IN THE RAT LIVER
Yun, Sung Su1; Lee, Dong Shick2; Kim, Hong Jin2; Choi, Mi Lan3; Ahn,
Hyun Soo3; Shin, Hyoun Jin3
1Yeungnam University Hospital, Department of Surgery, 317-1 Daemyung
Dong, Nam Gu, Taegu, Korea, Republic of; 2Yeungnam University Hospital,
Department of Surgery, Taegu, Korea, Republic of; 3Yeungnam University,
Institute of Biomedical Engineering, Taegu, Korea, Republic of
Background/Aims. During liver resection and liver transplantation, liver is
damaged by ischemia-reperfusion injury. Until now, there is no approved
method to measure or predict the extent of liver injury during the operation.:
This is the preliminary study to make the real time monitoring system by
quantification of bioelectrical impedance and ischemia-reperfusion injury in
liver.Method.: Male Spraque-Dawley rats, weighting 250300g were used.
We applied different periods of 70% partial hepatic ischemia(30, 60, 90 and
120minutes) and 24 hours reperfusion. Liver tissue bioelectrical impedance
were measured at various frequency(120 Hz-100 KHz) every five minutes
interval with LCR meter (GS-4311B, ANDO, Japan). Cell viability was
assessed by metabolic capacity of palmitic acid metabolic rate, ATP content
and histological examination(H&E and TUNEL staining) at every 30
minutes interval during ischemia.
Results. Bioelectrical impedance was changed significantly (pB0.05) during
ischemia in lower frequency compared to higher frequency. Liver tissue
bioelectrical impedance(120 Hz) increased after ischemia but had tendency
to maintain plateau after 1 hour. ATP content was decreased below 20%
compared to normal liver after ischemia, but there were no significant change
in histology and palmitic acid metabolic rate during 120 minutes ischemia. At
24 hours reperfusion after 30, 60 and 120 minutes ischemia, ATP content
were decreased around 50% in all groups and palmitic acid metabolic rate
were decreased 90.9¡342.4, 80.0¡
3
45.3 and 79.1¡
3
47.7%, repectively, compared to
control liver. But histologic change was not as much as in change in ATP
content and palmitic acid metabolic rate.
Conclusion. We found the possible role of bioimpedance to measure and
predict the extent of ischemia-reperfusion injury in liver. But we need further
study to clarify the relationship between bioimpedance and ischemia-
reperfusion injury.
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PREVALANCE OF OCCULT HBV INFECTION IN THE LIVER OF
HBsAg NEGATIVE GALL BLADDER CANCER PATIENTS
Bose, Sujoy1; Kazim, S. N.2; Agarwal, Anil1; Sakhuja, Puja1; Ramakrishna,
Gayatri3; Sarin, S. K.1
1G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India; 2Centre for Interdisciplinary Research in Basic
Sciences, Jamia Millia Islamia, New Delhi, India; 3Lab for Cancer Biology,
Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India
Background. HBV infection is common in India. Magnitude of Occult HBV
infection, defined as presence of HBV genome in hepatitis B surface antigen
(HBsAg)-negative individuals (HBV DNA and/or anti HBc positive) is not
known.
Aim. A retrospective study was undertaken to estimate the prevalence of
occult HBV infection in patients of Gall bladder cancer (GBC) managed
surgically.
Methods. 50 operated GBC patients (2001- 2005) were studied. Total
hepatic tissue DNA was isolated from stored liver biopsies. Basal core
promoter/precore/core and X-region of HBV genome were PCR amplified in
two separate reactions. Subsequently direct DNA sequencing was done
where PCR amplification was there. HBV genotyping was done with the help
of multiplex PCR. HBsAg, anti HCV and anti HIV status was also obtained.
Results. All patients (n50) were serologically negative for HBsAg and anti
HCV. Presence of occult HBV infection was found in 5/50 (10%). None of
these 5 patients had a history of blood transfusion. Genotypically 3/5 (60%)
was Genotype D and 2/5 (40%) was AD mixed genotype. Presence of
mutations at 1762/1764 was observed in 2/5 occult cases. In one patient
mutations at 1762/1764 and major deletions in the basal core promoter,
precore and the core region of HBV genome was also observed. Liver biopsy
showed the features of histological inflammation and moderate fibrosis.
Conclusion. The prevalence of HBV infection was 10% (5/50) in this
cohort, with a negative test for HBsAg (0/50). There is a significant incidence
of occult HBV infection HBV prevalence area, India. The study emphasizes
that conventional HBsAg screening alone is not adequate for pre-vaccination
screening for hepatitis B infection or in high-risk population, patients
undergoing surgery and medical personnel.
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IMPACT OF PRINGLE MANEUVER IN HEPATOCELLULAR
FUNCTION IN THE MURINE MODEL WITH NORMAL LIVER
Tralhao, Jose1; Abrantes, Ana2; Laranjo, Mafalda2; Portela, Ivan1; Gon-
calves, Cristina3; Figueirinha, Rita4; Cardoso, Dulce5; Sarmento-Ribeiro,
Ana B3; Ponciano, Emanuel4; Botelho, Maria F4; Castro Sousa, Francisco6
1Coimbra University Hospitals, Surgery/Biophysics Biomathematics Faculty
Medicine, Coimbra, Portugal; 2CIMAGO, IBILI-Faculti of Medicine,
Biophysics/Biomathematics Institute, Coimbra, Portugal; 3CIMAGO, Fa-
culty of Medicine, Biochemistry Institute, Coimbra, Portugal; 4CIMAGO,
IBILI-Faculty of Medicine, Biophysics Biomathematics Institute, Coimbra,
Portugal; 5Coimbra University Hospitals, Nuclear Medicine, Coimbra,
Portugal; 6Coimbra University Hospitals/Faculty of Medicine, Surgery,
Coimbra, Portugal
Pringle maneuver (PM) is used to prevent bleeding during transection of the
hepatic parenchyma. However, PM itself causes ischemia and reperfusion
injury. This experimental study aimed to estimate the impact of PM in
hepatocyte (H) function, viability and the longest safe duration of PM. Three
groups of male Wistar rats were subjected to a total liver ischemia period for
60 min: group A (n15)-a continuous inflow occlusion; group B (n16)-
intermittent clamping (IC) for 30 min with 5 min of reperfusion; group C
(n16)-IC for 15 min with 5 min of reperfusion. The group D (n16)-no
PM. A partial hepatectomy was doing at the end of ischemia period. The
degree of tissue injury was evaluated using: 1) blood markers: AST, ALT, AF,
GGT, TB, LDHI´ and hepatic extraction fraction (HEF) by radioisotopic
methods 3 days before laparotomy and after reperfusion; 2) HE staining; 3)
apoptosis, necrosis and oxidative stress were investigated after collagenase H
isolation by flow-cytometry using the followed probes: propidium-iodide,
annexin-V, DCFH2-DA and JC-1. Statistical analysis-variance analysis and,
if applicable, post-hoc comparisons by Turkey-test were performed (pB
0.05). The results are: 1) ALT (pB0.001), AST (pB0.001), GGT (pB
0.006), TB (pB0.013) and LDH (pB0.011) show values in groups A and B;
2) no time dependence is observed for HEF however, the time increases
significantly with time dependence (pB0.006), being the signification the
differences groups A and B (pB0.03); 3) decrease of viability associated with
an increase of H death preferentially by necrosis in groups A and B; these
results agree with increase of ROS production and change on mitochondrial
membrane potential in the same groups; 4) statistically increased of mortality
between group A and C (p0.03) and D (pB0.001).
Conclusions. intermittent PM 15 min cycles is highly protective of
hepatocellular function. This data, if confirmed in humans, may represent
a change in the knowledge of current practice of hepatic surgery.
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HEPATOBILIARY SCINTIGRAPHY FOR EVALUATION OF LIVER
FUNCTION IN A RAT MODEL OF HEPATIC ISCHEMIA REPER-
FUSION INJURY WITH PARTIAL LIVER RESECTION
de Graaf, Wilmar1; Spruijt, Onno1; Maas, Adrie1; de Bruin, Cora2; Bennink,
Roelof J.2; Gulik, Thomas M.1
1Academic Medical Center, Department of Surgery/Surgical Laboratory,
Amsterdam, Netherlands; 2Academic Medical Center, Department of
Nuclear Medicine, Amsterdam, Netherlands
Background. A rodent model of 70% partial hepatic ischemia and
reperfusion (I/R) injury is commonly used to study the mechanisms under-
lying I/R injury. A clinically more relevant model is the combination of I/R
injury with a partial liver resection. I/R injury and outcome of interventions
are usually assessed by biochemical (ALT, AST) and histological parench-
ymal damage parameters. Functional recovery, however, is determined by
both liver regeneration and hepatocellular damage. Indocyanine green (ICG)
clearance is a valuable quantitative liver function test, however it requires
repeated blood samples and is therefore difficult to apply in rodents.99mTc-
mebrofenin hepatobiliary scintigraphy (HBS) has been introduced for non-
invasive assessment of liver function.
Aim. To evaluate functional recovery after hepatic I/R injury combined with
partial resection using 99mTc-mebrofenin HBS and ICG clearance.
Methods. A rat model of 70% partial liver I/R was combined with resection
of the non-ischemic lobes (30%). Different ischemia times were used
including 0, 15, 30, 45 and 60min (n7 per group). A group undergoing
no operation served as control. At 24 hour reperfusion, ALT, AST
prothrombin time (PT, synthetic liver function), ICG clearance test and
99mTc-mebrofenin HBS were performed.
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Results. Correlation between 99mTc-mebrofenin HBS and ICG clearance
test (Pearson r0.93) as well as PT(r0.83) was strong and significant.
Partial liver resection (30%) alone resulted in a significant increase of ALT
and AST levels, while no significant decrease in liver function (HBS, ICG
and PT) was observed. ALT and AST increased with longer ischemia times.
HBS was significantly impaired only after 30 (79.6%), 45 (40.6%) and
60min (27.8% of baseline) of ischemia.
Conclusion. Conventional biochemical damage parameters do not provide
sufficient information on functional recovery after hepatic I/R injury
combined with partial resection. 99mTc-mebrofenin HBS is a valuable
alternative for the assessment of postoperative liver function.
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NON OPERATIVE MANAGEMENT OF BLUNT HEPATIC
TRAUMA REQUIRES INVASIVE PROCEDURES
Mulieri, Giacco; Fuks, David; Yzet, Thierry; Loyer, Arnaud; Robert, Brice;
Dumont, Frederic; Brasseur, Aline; Frigerri, Arnaud; Dupont, Herve´;
Verhaeghe, Pierre; Regimbeau, Jean-Marc
CHU Nord Amiens, Federation Digestive Diseases, Amiens, France
Background. Non operative management (NOM) of blunt hepatic injuries
has become a standard of care with more than 80% of success. The aim of our
study was to analyse prospectively management of blunt hepatic trauma in
our center.
Methods. 43 consecutive patients were managed in Amiens Universitary
Hospital during 30 months (February 2005  July 2007). In hemodynami-
cally stable patients with blunt hepatic injury, NOM was treatment of choice
with under close surveillance in intensive care unit. Surgery was performed in
case of hemodynamically instable patients or failure of NOM. We analysed
morbidity, mortality, additional interventional procedures of this strategy.
Results There were 28 men and 15 women with a mean age of 34 (1684).
Mean Injury Severity Score was 32 (475). Hepatic injury was associated
with others multiples injuries in 72% of cases. 58% of patients had high-grade
hepatic injuries (AASTII). There were 14 patients with AAST III, 7 with
AAST IV and 4 with AAST V. 6 patients underwent initial surgery in
emergency for hemodynamic instability with blood transfusion more than 4
units. NOM was realised in 37 (74%) of all patients and was successful in 30
(81%) patients. Surgery (packing with damage control n2, hemostasis n
4, drainage n5) was necessary in 7 (18%) patients with failure of NOM
(AAST III n4, AAST IV n3). Overall mortality rate was 4% (hemor-
rhagic shock n2). Complications occurred in 37% (haemorrhage n14,
hemobilia n4, biliary fistula-biloma n5, abscess n1). Among patients
managed by NOM, mortality was 0%, selective embolisation was performed
in 8 (16%) patients and successful in 5 patients (62%). Endoscopic
retrograde cholangiopancreaticography was realised in 13% (intrahepatic
biliary stenting and nasobiliary drainage). Median length of stay was 27 days.
Conclusion. NOM of hepatic injuries can be safely accomplished with low
mortality. However, to obtain high rate of success, this strategy requires
additional invasive procedures with a multidisciplinary management.
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ANALISIS OF LIVER HEPATIC TRAUMA IN A REFFERAL HOS-
PITAL CENTER
Paterna, Sandra; Serrablo, Alejandro; Cebollero, Pilar; Ruiz-Montoya, Jaime;
Cerdan, Rafael; Esarte, Jesus
Miguel Servet University Hospital, HPB Surgical Unit, Zaragoza, Spain
Introduction. Hepatic trauma occurs in approximately 5% of all admision in
emergency rooms and it is the main cause of death by abdominal severe
trauma (1015% of mortality rate). In the last decades, there has been a
increasing interest in the conservative management even in the severe liver
injury if the patient is clinically stable.
Aim. To evaluate all liver trauma charge in the emergency room in a refferal
hospital Materials and Methods. Retrospetic analisis of all liver trauma
treated in our hospital from January 2000 to June 2006. We analized the
following variables: age, cause, clinical characteristic, severity status (AAST),
intra and extraabdominal injuries, management and outcome.
Results. 57 patients (46 male and 11 female) were treated by liver trauma.
The mean age was 32.08 years old. The road traffic accidents, falled from the
top and knife injuries were the most important causes of trauma, 64.9, 21 and
14%, respectively. The main clinical symptons and signs were abdominal
pain, abdominal wall defense, breath insufficiency and cutaneus-mucosa
paleness. The CTand ultrasonography were the more frecuent diagnostic test
(40.3 and 35%) The liver trauma score accoding to AAST were: 42% of II
grade, 33 of III, 14 of I and 11% of IV and V grade. 54% of patients were
treated by conservative management. In 12% of patients treated by operative
management, the extrahepatic injury was the principal cause. (Table 1) The
mean of length of ICU and hospital stay were 8.1 and 17 days, respectively.
The mortality rate was 17.5%.
Conclusions. Nowadays, the conservative management is goal standar in
liver trauma with regards to clinical status. In spite of refferal hospital the
mortality rate in severe liver trauma was high although 60% of death was
caused by extrahepatic injuries.
Grade
CONSERVATIVE
MANAGEMENT
SURGICAL
MANAGEMENT
I 6 2
II 13 11
III 8 11
IV 3 1
V 1 1
PP 26.08
ERCP IN THE MANAGEMENT OF BILE LEAKS FOLLOWING
HEPATIC TRAUMA
Kochhar, Rakesh1; srinivasan, Thiagarajan2; nagi, birender1; dutta, Usha1;
sinha, saroj k1; Gupta, Rajesh2; yadav, Thakur D2; kalra, naveen3; singh,
kartar1; Wig, Jai D2
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Chandigarh, India, radiodiagnosis, chandigarh, India
Background.: Biliary leaks following liver laceration are difficult to manage
AIMS: Retrospective analysis of therapeutic ERCP done in patients with bile
leak following trauma to liver.
Material and Methods. Data on all patients of hepatic trauma referred to us
for ERCP over the last 10 years were analysed for indications, results and
outcome of the procedure.
Results. A total of 16 patients (age 1348 yr, 14 males, 2 females) with
hepatic trauma and biliary leak were seen by us. Two patients had stab injury,
one had gunshot injury and 13 had blunt injury to abdomen following road
side accident. Indications for ERCP were persistent bile leak and biloma after
surgery (n11) or after conservative treatment (n5). On ERCP localized
leak was seen from right hepatic duct in 11 patients, left hepatic duct in 1, at
porta hepatis in 1 and from multiple sites in right ductal system in 3 patients.
Three patients had broncho-biliary fistula. 4 patients had liver abscess. A
nasobiliary drain (NED) was placed in the desired ductal system in 14
patients, and a biliary stent was placed in two patients. 7 patients underwent
sphincterotomy as well. Pig tail catheter drainage was carried out in 6
patients. All patients benefited from the therapeutic procedure with resolu-
tion of biliary leak over 4 to 12 weeks. Only in one patient ERCP was
repeated to replace a non functioning (NBD). Two patients having hepatic
artery aneurysm received embolization.
Conclusions. ERCP and placement of NBD/biliary stent and sphincter-
otomy are uniformly successful in managing biliary leaks following traumatic
injury to the liver.
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IDIOPATIC LIVER ABSCESSES-Results OF PROSPECTIVE EVA-
LUATION AND TREATMENT
Otto, Wlodzimierz; Cieœlak, Bartosz; Najnigier, Bogdan; Mackiewicz, Anna;
Krawczyk, Marek
Medical University of Warsaw, General, Transplantation & Liver Surgery,
Warsaw, Poland
Background. Idiopathic liver abscess is the pathology of the liver arising
without any apparent cause. The aim of study conducted from 1998 to 2007
was to evaluate the results of treatment according to the prospective
protocol.
Material and Methods. There were 128 patients (m.77, f.51, m.a.50)
presented with abdominal pain and hectic fever in 100% of cases but with
right hydrothorax and jaundice in 35% and 19% of cases, respectively.
Ultrasound and CT scans were the main diagnostic tools and enabled to
establish the single abscess in 97 patients (76%) and the multiloculated or
multiple abscesses in 31 patients (24%). The primary treatment included of
antibiotic therapy alone for the abscessesB6cm in size in 36 patients,
percutaneous aspiration for the single abscess6cm in size in 48 patients and
the open drainage and/or liver resection for multiloculated or multiple
abscesses in 44 patients. In the case of failure patients were treated with
additional drainage procedures and/or liver resection.
Results:Out of 36 patients treated with antibiotics alone 20 (55%) required
percutaneous drainage;12 (60%) of them required additionally open surgical
drainage and 3 (15%) liver resection. Out of 48 patients treated with
percutaneous aspiration 32 (66.6%) required open drainage or liver resec-
tion;4 (8%) of them developed complications and 1 (2%) die due to sepsis.
Out of 44 patients treated primarily with open drainage 8 (18%) developed
complications that required percutaneous drainage in 3 (7%) and open
drainage or liver resection in 5 (11%);3 (6.8%) of them die due to sepsis.
Culture of the pus obtained from 112 patients (except 16 patients treated
successfully with antibiotics) was positive for Staphylococcus (28%),
Enterococcus (19%), Escherichia coli (16%), Klebsiella (14%), Serratia
(6%), Acinetobacter (5%), other (12%).
Conclusions. Antibiotic therapy, percutaneous aspiration and the open
surgical drainage are the complementary methods of treatment. The results
are dependent upon the peculiarity of the abscess itself.
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IMPAIRED LIVER REGENERATION IN DIABETIC RATS FOL-
LOWING PORTAL VEIN LIGATION
Yeh, Ta-Sen; Jan, Yi-Yin; Chen, Miin-Fu
Chang Gung Memorial Hospital, Chang Gung University, Department of
General Surgery, Taipei, Taiwan
Background. Percutaneous transhepatic portal vein embolization has been
widely applied prior to major hepatic resection. The aim of this study was to
audit impaired liver regeneration in diabetic subject following portal vein
embolization.
Material and Methods. Male Sprague-Dawley rats weighing 250¡O´50 gm
were used. Diabetic rats were created by streptozotocin injection. Portal vein
ligation (PVL) (branches of median lobe and left lobe) was performed. The
animals were thereafter sacrificed at day 1, 3, 5 and 7. The regeneration index
was quantified using the formula: weight of non-ligated lobes/ weight of
whole liver. The experimental animals underwent sulfur colloid and DISIDA
test using NanoSPECT/CT to represent their liver volume and bile-secretion
function, respectively. DNA synthesis was evaluated using BrdU assay.
mRNA of cell cycle genes and apoptosis-related genes were determined
using quantitative PCR.
Results. Regeneration index of normal rats was greater than diabetic rats
(80.5¡O´3.9% versus 69.8¡O´5.2%, pB .01). which was in match with that
detected by sulfur colloid scan. Bile secretion function detected by DISIDA
scan predominantly took place at the non-ligated lobes. Paradoxically, DNA
synthesis in diabetic rats was greater than normal rats following PVL. mRNA
expression of cyclin D1, cyclin A2, PCNA, cyclin B1 and BclXL of normal
rats were increased compared to those of diabetic rats; while the mRNA
expression of Bax, DAXX and JNK of normal rats were decreased compared
to those of diabetic rats.
Conclusion. Liver regeneration was attenuated in diabetic rats following
PVL, with 10% discrepancy compared to normal rats. Blockade of cell cycle
at synthesis phase and increased proapoptotic genes expression in diabetic
rats might explain their disturbed liver regeneration.
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PELIOID HEPATOCELLULAR CARCINOMA MIMICKING LIVER
HEMANGIOMA
Shah, Sudeep1; Desai, Devendra2; Deshpande, Ramesh3
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Background. Asymptomatic liver hemangiomas may be conserved. MR is a
good modality to diagnose these lesions. However, the MR appearance may
be misleading in certain cases, which the clinician needs to be aware of.
Case Report. A 55 year old lady with no co-morbid illnesses presented with
an asymptomatic liver lesion, detected on ultrasonography. This was
evaluated by CT scan and MR angiography and was diagnosed to be a liver
hemangioma. Her tumour markers were negative and she was HbsAg and
anti-HCV negative. The lesion increased in size over a year following which
she was re-evaluated. A repeat MR angiography was performed and the
same diagnosis was provided. In view of the progressive increase in size, she
was referred for surgery. CT chest and bone scan ewere negative. An initial
diagnostic laparoscopy revealed a large solid, non compressible lesion
in the right lobe of the liver, the remaining liver was non cirrhotic. She
proceeded to have a right extended hepatectomy. The histology from the
resection specimen confirmed a pelioid variant of hepatocellular cancer. The
large vascular lakes within the tumour were responsible for the appearance on
the MR study. The patient is recurrence free on follow up one year after
surgery.
Conclusion. Rarely, vascular tumours mimic hemangioma of the liver.
Rapid increase in size should be an indication for surgical resection
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RESULTS OF 5 YEARS EXPERIENCE OF LIVER SECONDARIES
TREATED BY RADIOFREQUENCY ABLATION
Singh, Vikrant1; Jaiswal, rashmi2; mishra, prateek2; singh, mandeep2;
sharma, sandesh2; naik, saleem2; purohit, dipak2; varshney, subodh2;
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bhopal, India
Introduction. Radiofrequency ablation (RFA) is a new percutaneous
tissue ablative therapy. Role of RFA in treating liver secondaries is not
widely studied. We present our 5 years experience of RFA of liver
secondaries.
Material and Method. Using Berchtold (Tuttlingan, Germany) RF
generator (5060 watt output), 15002000 watts energy/cc tumour was
delivered according to the volume of liver secondaries. Inclusion criterias
were: lesion B5cm in size, Non-invasion of portal vein, no proximity to large
vessel or duct technically feasible. Exclusion criterias were: extra-hepatic
disease not being treated by chemotherapy, diminished hepatic function (eg.
Child Pugh Class C), refractory coagulopathy, massive ascites. Between
February 2001 and October 2006, 81 patients (52 males and 29 females),
aged 39 to 72 years (mean 56 years) had RFA of 252 liver secondaries from
gall bladder22, colorectal36, breast14, carcinoid or neuroendocrine
5, stomach4 cancers. Lesions were sized B3 cm in 69, 34 cm in 118 and
4 cm in 65. RF needle was placed, US guided in 76, CT guided in 1 and at
an open surgery in 4 patients. Follow up was done by contrast enhanced CT
scan between 14 weeks after the procedure.
Results. There was no procedure related mortality. All patients were
discharged within 24 hours except two. There was no major morbidity.
There were 10/81 (8%) minor morbidity (self limiting ascites3, severe
abdominal pain3, self limiting pleural effusion4). EFFICACY: Com-
plete necrosis was seen in all (100%,) of lesion up to 3 cm size and (40.6%,)
of lesion 34 cm in size. None of the lesion 4 cm had complete necrosis.
Recurrence at completely treated site at mean follow up of 12 months was
(8.54%). On more than 12 months follow up, (63%) patients developed new
hepatic or systemic recurrence. SURVIVAL: One year survival was 59% and
2 year survival was 24% of whole group.
Conclusion. RFA is safe and effective local tissue ablative method for liver
secondaries. More randomized trials are required to ascertain efficacy
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PRIMARY HEPATIC GLOMUS TUMOR OF UNCERTAIN MALIG-
NANT POTENTIAL-A CASE REPORT
Lee, JungNam; Kim, KeonKuk; Song, SeulGee; Choi, SangTae; Choi,
MyungMin; Park, YeonHo
Gil Medical Center, Gachon University of Medicine and Science, Depart-
ment of Surgery, INCHEON, Korea, Republic of
Glomus tumors are small, benign tumor that mostly occur in the peripheral
soft tissues. However, they have also been reported in the deep soft tissue,
bone, lungs, and gastrointestinal tract. It has recently been proposed that
deep-seated glomus tumors, especially if larger than 2.0 cm, need a close
follow-up due to uncertain malignant potential. To date, only two cases of
primary hepatic glomangioma have previously been reported. We present a
case of a glomus tumor primarily arising in the liver of a 70-year-old woman
who presented with dyspepsia of several months’ duration. Ultrasonography
and CT scan reveals 4.5cm sized mass that centrally located between segment
VII and VIII of liver. US-guided biopsy showed a primary glomus tumor of
liver. Immunostains showed the tumor cells to be diffusely positive for and
smooth muscle actin and to be focally positive for CD34. Owing to possibility
of malignant potential of glomus tumor, we conducted right hemihepatect-
omy. Further histological evaluation of the tumor did not reveal malignancy.
The patient had an unremarkable postoperative course. In conclusion, we
have reported an unusual case of primary glomus tumor of the liver with
uncertain malignant potential.
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A CASE OF CURATIVE RESECTION FOR ANGIOSARCOMA OF
LIVER
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Rew, Jong Sun2; Jeong, Yong Yeon3; Shin, Sang Soo3; Lee, Jae Hyuk4
1Chonnam National University Medical School, Surgery, Gwangju, Korea,
Republic of; 2Chonnam National University Medical School, Internal
Medicine, Gwangju, Korea, Republic of; 3Chonnam National University
Medical School, Radiology, Gwangju, Korea, Republic of; 4Chonnam
National University Medical School, Pathology, Gwangju, Korea, Republic
of
Background. The primary angiosarcoma of liver(PAL) is a rare malignant
tumor with a incidence of 2% of all primary hepatic tumor. The PAL is
aggressive tumor and the prognosis is very poor with a median survival of only
6 months. In one large review only 3% of patients survived more than 2 years.
Surgical resection is usually unsuccessful because most patients present with
advanced tumors with huge size or multiple lesion in both lobes. Hepatic
resection is feasible in only an extremely small number of patients.
Aim/Methods. We present a patient who underwent hepatic resection for
incidentally detected hepatic tumor which was confirmed PAL pathologically.
A 62 year-old-male was admitted for incidentally detected liver mass. CT
scan and MRI of abdomen showed 2.72.2 cm sized peripheral enhancing,
low attenuated lesion with enhancement of mosaic pattern in hepatic dome
area. The laboratory findings including tumor markers were non-specific. In
operation, there was 22 cm sized soft mass in superficial portion of the
segment 7 and resection of segment 7 was performed.
Results. In gross finding of specimen, 21.5 cm sized white to red colored
mass lesion with hemorrhagic foci was observed in cut surface. In micro-
scopic exmination, the specimen showed numerous, irregular, anastomosing
vascular space lined by variably pleomorphic, hyperchromatic endothelial
cells showing multilayering and papillary formation. The results of immu-
nohistochemical staning were as follow; CK(-), Vimentin(), CD34(),
Factor VIII(), HSA(-), AFP(-), c-kit(). Histopathological diagnosis was
consistent with angiosarcoma of liver. The postoperative course was
unremarkable and no adjuvant therapy was administered. The patient is
well alived without evidence of recurrence in a 3 year follow up evaluation.
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Conclusions. We report a case of incidentally detected primary angiosar-
coma of liver with unusually small size which was treated with curative
hepatic resection.
PP 27.03
LEIOMYOSARCOMA OF THE FALCIFORM LIGAMENT
Shah, Sudeep1; Shah, Shrenik1; Desai, Devendra2; Bhaduri, Anita3
1PD Hinduja Hospital, GI Surgery, Mumbai, India; 2PD Hinduja Hospital,
Gastroenterology, Mumbai, India; 3PD Hinduja Hospital, Pathology, Mum-
bai, India
Background. Tumours of the falciform ligament are unusual. We present
one such case excised surgically.
Methods. A 40 year old male was found to have a mass in his falciform
ligament on sonography investigating abdominal pain. CT scan showed a 4
cm vascular lesion at the root of the falciform ligament, overlying the
umbilical portion of the portal vein. He was subjected to a left hepatectomy as
the segment III and IV venous branches were adjacent to the tumour.
Histology revealed a poorly differentiated lieomyosarcoma. Immunohisto-
chemistry for c-kit receptors was negative and the adjacent liver parenchyma
was uninvolved. The patient is well on follow up of 3 months.
DISCUSSION: Tumours of the falciform ligament are rare in literature.
Unusual forms such as myomelanocytic tumours occur at this site. Only
solitary case reports exist for lieomyosarcomas at this location. Surgical
resection is the therapeutic modality of choice.
PP 27.04
ANTENATALLY DIAGNOSED HEPATOBLASTOMA: SUCCESS-
FUL TREATMENT BY CHEMOTHERAPY AND SURGERY
Shah, Sudeep1; Almel, Sachin2; Motiwale, Sandeep3
1PD Hinduja Hospital, GI Surgery, Mumbai, India; 2PD Hinduja Hospital
and MRC, Oncology, Mumbai, India; 3PD Hinduja Hospital and MRC,
Pediatric Surgery, Mumbai, India
Background. Hepatoblastomas are rare tumours occurring in young
children. Isolated cases of antenatal diagnosis of liver tumours have been
reported the outcome in these cases has been poor. We report a case of
antenatally diagnosed hepatoblastoma which has successfully been treated
with combination chemotherapy and surgery.
Case report. A 34 week foetus was found to have a 5 cm liver lesion on
ultrasonography. The previous USG had been at 12 weeks and was normal.
The mother delivered soon after. A biopsy showed hepatoblastoma and
chemotherapy was commenced in the first month. The lesion remained the
same size and was subsequently excised by performing a left extended
hepatectomy. The child is now 18 months old, fit and well, with normal AFP
levels.
Conclusion. With appropriate pro-active management, antenatally diag-
nosed hepatoblatoma can be successfully treated.
PP 27.05
HEPATOBLASTOMA: Successes and Pitfalls of therapy.
Dastidar, Arindam; Sen, Sudipta; Chacko, Jacob; Karl, Sampath; Kumar,
Jyotish
Christian Medical College and Hospital, Department of Paediatric Surgery,
Vellore, India
Background. Hepatoblastoma is a common primary hepatic malignancy in
pediatric age group. The aim of this study is to analyze the outcome of
treatment in patients with Hepatoblastoma.
Material and Method. 26 Children with primary hepatic malignancy were
seen in the period 20002007; of these 21 were hepatoblastoma (14 males 7
females, age range 884 months). Initial diagnosis was achieved by Ultra-
sonography, CT scan, Chest X-ray, Serum AFP and True-cut biopsy. Serum
AFP was raised in all and beta-hCG in one child. Another child had
concomitant thoracic Neuroblastoma. PRETEXT Staging was as follows; I:
4, II: 5, III: 10, IV: 2, two patients had pulmonary metastasis at presentation.
Results. Among these 21 children, 5 either refused or discontinued
chemotherapy, 2 died during chemotherapy, while 14 underwent hepatic
resections. There were no operative or perioperative deaths. Four ultimately
died of disease recurrence while one is alive with recurrent disease for the past
four years.10 children are alive with out disease.
Conclusion. Disease free survival in our series of Operated children was
64%, while overall disease free survival was 43%.
PP 27.06
Right Trisectionectomy with Caudate Lobectomy, Portal vein Resec-
tion and Anastomosis for Intrahepatic Malignant Paraganglioma; a
case report
Lee, Heuy Seong; Paik, Kwang Yeol; Ryu, Dong Do; Lee, Hyung Geun;
Heo, Jin Seok; Choi, Seong Ho; Choi, Dong Wook
Samsung Medical Center, Surgery, Seoul, Korea, Republic of
Paragangliomas are unusual neoplasms embryologically derived from neural
crest cells. The most common location of these neoplasms is the adrenal
medulla, where they are known as pheochromocytomas. Approximately 10%
of these neoplasms occur in extraadrenal sites, most commonly in the
retroperitoneum. Isolated cases have been reported in a variety of unusual
locations, including the carotid body, orbit, mediastinum, larynx, mesentery,
lung, stomach, and urinary system. The unusual presentation of a para-
ganglioma in the intrahepatic duct, has not, to our knowledge, been
previously reported. A 56 year-old man was referred to Samsung Medical
Center for evaluation of huge liver mass. She had been admitted in an outside
hospital for jaundice and during work-up for the origin of the jaundice, an
abdominal CT was done and the liver mass detected in right lobe. Total
bilirubin was 7.7mg/dl and CA19-9 was 56.3U/dl. Abdominal CT showed
9cm sized irregular mass in the liver right lobe. Surgical exploration was done
and right trisectionectomy with caudate lobectomy, portal vein resection and
anastomosis was carried out. Macroscopically, the cut surface of the tumor
showed a white solid mass. Histopathological findings showed nests of
polygonal cells and immunohistochemistry showed S-100 and Ki67 strong
positive tumor cells. The final pathological report was malignant paragan-
glioma of the intrahepatic duct. We describe the clinical and pathologic
findings and therapeutic approach in this unusual case.
PP 27.07
DIAGNOSIS AND TREATMENT OF FOCAL NODULAR HYPER-
PLASIA AND HEPATOCELLULAR ADENOMA; A REAPPRAISAL
Esschert van den, Jacomina W1; Erdogan, Deha1; Phoa, Saffire SKS2;
Delden van, Otto M2; Bennink, Roelof J3; Busch, Olivier RC4; Kate ten,
Fiebo JW5; Gouma, Dirk J4; Gulik van, Thomas M1
1Academic Medical Center Amsterdam, Surgical Laboratory, Amsterdam,
Netherlands; 2Academic Medical Center Amsterdam, Radiology, Amster-
dam, Netherlands; 3Academic Medical Center Amsterdam, Nuclear Medi-
cine, Amsterdam, Netherlands; 4Academic Medical Center Amsterdam,
Surgery, Amsterdam, Netherlands; 5Academic Medical Center Amsterdam,
Pathology, Amsterdam, Netherlands
Background. Hepatocellular adenoma (HCA) and focal nodular hyperpla-
sia (FNH) are benign liver lesions which may give rise to diagnostic problems
due to common features on imaging studies.
Objective. To evaluate the features of FNH and HCA on US and CT
imaging studies and to assess the additional value of liver scintigraphy. An
algorithm for diagnosis and treatment is proposed.
Methods. Retrospective analysis of 81 patients with radiological suspicion on
and/or histologically proven HCA or FNH.
Results. FNH was diagnosed in 45 patients and HCA in 36 patients, of
whom 27 presented with spontaneous bleeding. On US, FNH was
hypoechoic in 49%, isoechoic in 29% or hyperechoic in 17% of patients,
compared to respectively 43%, 29% and 29% in case of HCA. On non-
enhanced CT, FNH was hypodense in 67%, isodense in 21% and hyperdense
in 13% of patients, compared to hypodense in 75% and isodense in 25% in
case of HCA. A central scar was seen in 13% of patients with FNH on US,
compared to 37% on CT imaging. The HIDA-scan showed normal uptake
with normal excretion into the common bile duct in 71% and normal uptake
with decreased excretion in 29% of the patients with FNH. In case of HCA it
showed normal uptake and biliary excretion in 67% and no uptake in 33% of
patients. Resection was undertaken in 18 patients with abdominal bleeding, 8
specimens showed remnants of HCA. In 22 patients without bleeding, 18
resection specimen were histologically diagnosed as FNH and 4 as HCA.
Conclusion. Differentiation of HCA and FNH is difficult based on imaging
studies. A central scar is characteristic for FNH. Scintigraphy has limited
value and should only be used when radiological imaging is inconclusive.
Surgical treatment is indicated for FNH in case of symptoms or when
differentiation from HCA is uncertain for lesions5 cm. In case of HCA,
oral contraceptive use should be discontinued and surgical resection is
indicated when size exceeds 5 cm.
PP 27.08
HEPATIC RESECTION FOR LIVER CYSTIC LESIONS
CHOUILLARD, ELIE1; ata, toufic2; de jonghue, bernard3; outin, herve´3;
cherqui, daniel4
1CENTRE HOSPITALIER INTERCOMMUNAL, GENERAL AND LI-
VER SURGERY, POISSY, France; 2Centre Hospitalier, general and liver
surgery, poissy, France; 3Centre Hospitalier, intensive care, poissy, France;
4hopital henri mondor, general and liver surgery, creteil, France
Background. Up to 5% of the population has one or more liver cysts 90% of
which are simple biliary cysts, usually asymptomatic with no specific
treatment required (i.e., laparoscopic deroofing). Other cystic lesions require
appropriate treatments including, drainage, cystic resection or even liver
resection. Design. We assessed our experience in the management of liver
cystic lesions requiring liver resection emphasizing results as well as manage-
ment guidelines. Setting. A retrospective review of hepatic resections for
liver cystic lesions performed between 1992 and 2006 in one university
hospital and one general hospital affiliated to a university program.
PATIENTS: 33 patients who underwent 39 liver resections were included.
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Results. 24 women and 9 men had 39 liver resections (14 left lobectomies,
12 right hemihepatectomies, 7 left hemi-hepatectomies and 6 segmentec-
tomies). Final diagnoses included hydatid cyst (30%), cystadenoma (18%),
simple cysts (18%), Caroli’s disease (12%), cystadenocarcinoma (9%) and
miscellaneous (12%). No mortality and a 15% overall postoperative
morbidity rate were encountered.
Conclusions. Hepatic resection for a presumed non-biliary cystic lesion is a
safe procedure which provides satisfactory long-term symptom control in
benign disease and may provide cure in case of malignancy. Almost 50% of
such lesions were simple cysts or hydatid cysts. It is legitimate to perform en-
bloc liver resection for every liver cystic lesion which it is neither typically
parasitic nor bearing features of a simple cyst.
PP 27.09
CYSTOJEJUNOSTOMY IN THE SURGICAL MANAGEMENT OF
THE LIVER HYDATID CYST
Simon, Ioan1; Cebotari, Oleg2; Cazacu, Mircea2
1Surgical Clinic, General Surgery, Cluj-Napoca, Romania; 2University of
Medicine and Pharmacy, General Surgery, Cluj-Napoca, Romania
Even if radical methods are considered to be ideal operations for liver hydatid
cysts, they are feasible in only 10% of the cases. The major problem of the
conservative procedures is the surgical management of the residual cavity.
Observing the frequent complications after external drainage or obliteration
of the cyst cavity, we decided to evaluate the results of internal drainage by
cystojejunostomy. Between January 2004 and December 2006, 8 patients
with liver cystic hydatidosis were included in ths study. The 8 patients had 9
hydatid cyst: 5 protruding on the upper surface, 3 on the inferior surface and
1 on both surfaces of the liver. In 5 patients the cysts were complicated. The
surgical procedure performed in all cases was the Roux en Y cystojejunost-
omy. The common bile duct was approached twice. The postoperative course
was uneventfull in 7 cases and complicated once. We registered no mortality.
We can conclude that cystojejunostomy constitute a valuable treatment
method for both simple and complicated cysts. Obviously this procedure is
more advantageous in cysts with large biliary fistulae avoiding complications
that usually occure in other surgical techniques.
PP 28.01
ISCHEMIC ACUTE PANCREATITIS: CLINICAL FEATURES, DI-
AGNOSIS, THERAPY AND OUTCOME.
Hackert, Thilo1; Hartwig, Werner2; Schneider, Lutz2; Strobel, Oliver2;
Buechler, Markus2; Werner, Jens2
1Department of Surgery, University of Heidelberg, Heidelberg, Germany;
2Department of Surgery, Heidelberg, Germany
Background. Acute pancreatitis (AP) can be caused by various triggers.
Besides alcohol excess and gallstones, pancreatic ischemia can cause AP.
Although this entity is poorly defined clinically or radiologically, it should be
considered when no other obvious reasons can be defined. Aim of this study
is to define ischemic AP with regard to its pathophysiological, radiological
and clinical conditions.
Methods. Eleven patients suffered from acute pancreatitis caused by
mesenteric hypoperfusion of different origin. Course, severity and outcome
of the disease as well as diagnostic and therapeutic measures are presented. In
addition, a special focus is put on the differentiation between acute
pancreatitis and elevated pancreatic enzyme levels, which can often be
observed in ICU patients without further clinical complications.
Results. Acute ischemia-induced pancreatitis was either caused by hemor-
rhage and hypotension (7 patients) or mesenteric macrovessel occlusion (4
patients). Therapy of the patients was conservative in 4 patients and operative
with surgical hemostasis, necrosectomy and drainage in the other 7 patients.
Seven of the patients died within 38 days after the onset of AP, 4 patients
recovered completely.
Conclusion. Ischemia is an important etiology of acute pancreatitis.
Different causes of ischemia lead to a hypoperfusion of the pancreas with
consecutive induction of an inflammatory response. Severity of the disease
can range from moderate edematous affections up to severe courses with fatal
outcome. However, the indication for surgical intervention in ischemia
induced AP is more aggressive, diagnostic and conservative therapeutic
procedures are similar compared to those performed in AP of other etiologies.
PP 28.02
CLINICAL CHARACTERISTICS AND MANAGEMENT OF PA-
TIENTS WITH ACUTE PANCREATITIS: EXPERIENCE FROM A
SINGLE CENTER
Dulundu, Ender; Erkan, Ozkan; Kayahan, Munire; Ozel, Yahya; Akyuz,
Cebrail; Topaloglu, Umit
Haydarpasa Numune Education and Research Hospital, 5th Department of
Surgery, Istanbul, Turkey
Introduction and Aim. In our city acute pancreatitis (AP) is an important
cause of morbidity. The current study reviews our department’s experience
which is situated in one of the largest teaching and reference Hospital in the
Asian side of Istanbul.
Patients and Methods. Consecutive patients admitted with AP between
December 2003 and June 2007 were identified and retrospectively analyzed.
Patients in whom pancreatitis was related to malignant disease were excluded
from the survey.
Results. We identified 80 patients, of whom 55 (69%) were woman. The
mean age was 50 years. In 60 (75%) of cases AP was associated with biliary
illness followed by alcohol abuse in 6 (7.5%) of patients. Abdominal pain was
the most common symptom at onset 97.5%. High serum amylase level
(87.5%), followed by leukocytosis (75%) was the most abnormal laboratory
test. Hospital stay varied between 4 to 43 days, mean hospital stay was 8 days.
Ranson’s criteria was used as a prognostic evaluation and ultrasonography
and computed tomography was used for the morphologic evaluation of the
pancreas. There was only one hospital mortality.
Conclusion. Majority of the patient of acute pancreatitis requiring hospi-
talization at our hospital was biliary pancreatitis. The correct and rapid
clinical diagnosis of acute pancreatitis with an appropriate treatment it does
not increase the morbidity and mortality.
PP 28.03
EFFECTS OF HYPERBARIC OXYGENATION AS A COMPONENT
OF INTENSIVE CARE (IC) IN PATIENTS WITH ACUTE PAN-
CREATITIS (AP) ON OXIDATIVE STRESS (OS).
Pavars, Maris1; Lisagors, Ilans2; Sondore, Antonina3; Schesters, Andrejs4;
Jaunalksne, Inta5; Silova, Alise4; Eklona, Anete6; Pronkova, Anastasia7;
Gormalova, Jelena7; Porina, Ieva6
1Paul Stradins University Hospital, Surgery, Riga, Latvia; 2Riga Stradins
University, Anaesthesiology and Intensive Care, Riga, Latvia; 3Rigas Stradins
university, Anaesthesiology and Intensive Care, Riga, Latvia; 4Rigas Stradins
University, Laboratory of biochemistry, Riga, Latvia; 5Rigas Stradins Uni-
vertsity, Center of immunology, Riga, Latvia; 6Paul Stradins University
Hospital, Anaesthesiology and Intensive Care, Riga, Latvia; 7Rigas Stradins
University, Riga, Latvia
Background. Presence of local ischemia and global hypoxia in the
pathogenesis of AP suggests potentially positive effects of HBO as addition
to the standardized therapy. At the same time little is known about the pro-
oxidative effects of hyperbaric oxygenation AIM of the study was to
determine the impact of HBO as an additive treatment of AP and its effects
on OS.
Methods. A prospective case-controlled study was performed on 16 patients
(pts.) with AP. 8 pts. were in HBO group (gr.), 8-in the control gr. (C gr.).
HBO course (c) of 6 sessions (s), once a day (d), under 1,7 ATA in a
monoplace chamber was initiated within 24 h after admission. Pts. were
assessed using APACHE II, SOFA, Ransons scores and biochemical analyses.
Global and splanchnic hypoxia were evaluated during 6 days after admission,
by arterial blood gases (ABG), lactate, gastric tonometry (GT); intensity of
OS; by the plasma level malondialdehyde (MDA), lucinogen induced
hemiluminescence (HCL); activity of anti-oxidative system-by plasma total
antioxidant capacity (TAC), level of selenium (Se), superoxiddismutase
(SOD), vitamin E.
Results The demographics and severity of SAP were similar in both gr.
SOFA score improved faster in HBO gr. Blood glucose decreased for 1, 5  2,
4 mmo/l after each HBOT s. (mean 1,85 mmol/l). There was low level of O2
in 40% of pts. of HBO gr., 50% in C gr., mucosal acidosis was noted in 40%
of pts. of both gr. on admission. In HBO gr. MDA decreased for 41.69%, for
66.46% in C gr., luminol-enhanced chemiluminescence (h) for 25,12% and
21,14%. Vit. E increased for 32,64% in HBO gr. and did not change in C gr.
An early low plasma Se was established in 8 p. (100%) (67 ngr/ml). It wasn’t
affected by HBOT c. SOD increased in 5 pts. for 14.8% in HBO gr. TAC was
within the norm in both gr.
Conclusion. Applied regimens of HBO to the standard IC of AP alleviated
lipid peroxidation and improve course of the disease, possibly by improving
oxygenation and tissue metabolism
PP 28.04
PANCREATITIS IN PREGNANCY: LITERATURE REVIEW AND
PROPOSED CLINICAL GUIDELINES
Dhingra, Vandana1; Chin, Kirk2
1Birmingham Womens Hospital, Obstetrics & Gynaecology, Mitchley park
road, Edgbaston, Birmingham, United Kingdom; 2Staffordshire general
Hospital, Obstetrics & Gynaecology, Stafford, United Kingdom
Pregnant women frequently present with abdominal pains of varying severity
during pregnancy. The aetiology may be pregnancy-specific; however, non-
obstetric causes can and do occur. The dynamic changes of pregnancy can
hinder a prompt diagnosis, especially when abdominal complaints persist
ABSTRACT Acute pancreatitis complicating pregnancy can be a life-
threatening emergency. Reported mortality is 20%higher in pregnant than
non-pregnant women of the same age. It is also associated with a high
perinatal mortality 38% The incidence of pancreatitis ranges from 1 in 1066
live births to 1 in 3333 pregnancies. Pancreatitis can occur during any stage of
pregnancy with the highest incidence in the third trimester and in multi-
parous women. The common misdiagnosis of pancreatitis in the first
trimester is hyperemesis gravidarum. The most common predisposing cause
is cholelithiasis and hypertriglyceridaemia. This results from the increased
estrogen effect and the familial tendency for some women toward high
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triglyceride levels. Pregnancy per se does not adversely affect the prognosis of
pancreatitis thus termination of pregnancy is unnecessary unless severe fetal
compromise ensues during the course of the illness Various treatment options
are available to manage pancreatitis in pregnancy;conservative medical
management, ERCP, endoscopic sphincterotomy or surgical management;
surgical management of symptomatic cholelithiasis in pregnancy is safe,
decreases hospitalisation and reduces the rate of induction of labour and
preterm deliveries. The relapse rate for gallstone-related pancreatitis is higher
up to 70% with conservative treatment only This case presents the surgical
management (with video clip) of a 36 year old woman in her second trimester
of pregnancy, who was admitted several times with pancreatitis secondary to
cholelithiasis. We will also discuss the literature review of acute pancreatitis
complicating pregnancy and suggest guidelines for the management of
pancreatitis specifically debating the use of ERCP in pregnancy
PP 28.05
TREATMENT OF SEPTIC SUPPURATIVE COMPLICATIONS OF
NECROTIZING PANCREATITIS
Petrushenko, Viktoria
Vinnitsa national medical university, Department of surgery, Vinnitsa,
Ukraine
Introduction. Diagnostics and treatment of necrotizing pancretatitis still
constitutes the issue of the day in abdominal surgery. Correct timing of
appropriate surgical access to the area of destructive changes is still at
discussion.
Methods. Our study is dedicated to the analysis of 88 cases of surgical
treatment of patients with various forms of acute pancreatitis at the stage of
septic suppurative complications. Treatments were performed in the period
2002 to 2007. Severity of each case was determined according to SAPS scale.
There were 39 females and 49 males in the total number of cases.
Results. 35 patients had phlegmon of retroperitoneal space (unlimited septic
suppurative process, duration since the beginning of the disease:15,492.1
days), in 53 patients para-pancreatic abscess was diagnosed. There were 32
cases of late abscess and 21 cases of early abscess. Various types of surgeries
have been performed, depending on the type of suppurative complication.
Drainage under control by ultrasonic method has been performed in 15
patients with abscess of omental bursa. Two drainages for flow lavage were
implemented in 7 cases. Abscess volume varied from 50 to 300 ml. Patients
underwent fractional lavage of cavity by antiseptics. Dynamic fistulograms
and bacteriological test of punctuate were used to monitor whether adequate
response is obtained by application of drainages and by therapeutic procedure
in general. Duration of drainages varied from one (1) to four (4) weeks,
depending on dimensions of nidus of suppuration and development of
destructive process. 17 patients underwent middle laparotomy with drainage
of necrotic suppurative nidi and abdominal cavity with subsequent elective
relaparotomy. 21 patients underwent laparotomy with selective drainage of
abscess by application of stoma of retroperitoneal space and subsequent mini-
invasive sanation.
Conclusions. The present results emphasize that mini-invasive methods are
required by practical reasons and extensive laparotomy is an induced
measure.
PP 28.06
PANCREATICOPLEURAL FISTULA AS A COMPLICATION OF
THE CHRONIC PANCREATITIS. HOW I DO IT.
Sabol, Martin1; Straka, Martin2; Sabol, Martin2; Straka, Vladimı´r2
1St. Elisabeth Oncological Institute, Department of Oncological Surgery,
Heydukova 10, Bratislava, Slovakia; 2St. Elisabeth Oncological Institute,
Department of Oncological Surgery, Bratislava, Slovakia
Background. Pancreaticopleural fistulas are rare, typical internal pancreatic
fistulas arising most of all during an acute exacerbation of underlying chronic
alcohol- associated pancreatitis. In posterior disruption of pancreatic ducts
leaking pancreatic juice may track through the esophageal and aortic hiatus to
the mediastinum.
Methods. Clinical data of 6 patients with chronic alcohol-associated
pancreatitis were analyzed in whom pancreaticopleural fistula arised always
with left-sided pleural cavity.
Results. In all patients we confirmed pancreaticopleural fistula with
disruption of panreatic duct by means of ERCP and/or CT and perioperative
fistulography. Visualisation of anatomy and location of pancreatic duct
obstruction is important. In one patient with proximal pancreatic duct
obstruction successful duodenopancreatic drainage was performed by endo-
scopic stent placement. Five patients were operated on after initial con-
servative treatment failure. In 2 patients we created latero-lateral
fistulopancreaticojejunostomy Roux-en-Y. In one patient we made segmen-
tal(central) resection of the proximal part of pancreas body and termino-
terminal pancreaticojejunostomy Roux-en-Y. Two patients with communi-
cating pancreatic pseudocyst were solved by pseudocysto-gastrostomy. Post-
operative course in all patients was complications free. Postoperative
mortality was 0.0%. During the follow-up after 5, 6, 7 and 9 years there
was no exacerbation of pancreatitis.
Conclusion. Initial way of treatment is short-term conservative practice. In
the case of its failure invasive approach on the basis of imaged pancreatic duct
anatomy should proceed. Fistula is caused by an obstructed pancreatic duct
followed by its disruption. The aim is to provide the outflow of the pancreatic
duct or its part that possessed impaired drainage. In the case of suitable
pathomorphologic finding we prefer an early surgical intervention without
worthless delay.
PP 28.07
SPLANCHNIC ARTERY PSEUDOANEURYSMS IN CHRONIC
PANCREATITIS: IS THERE A ROLE FOR SURGICAL MANAGE-
MENT?
Kumar, Santosh; Rajkumar, K.; Agarwal, Shaleen; Singh, Shivendra; Tyagi,
Sanjay; Agarwal, Anil
G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India
Background/Aims. Splanchnic artery pseudo aneurysms are an unusual but
often serious complication of chronic pancreatitis. The treatment modalities
for this entity include transcatheter arterial embolization and surgery. In this
study we reviewed our experience of management of splanchnic artery
pseudo aneurysms associated with chronic pancreatitis.
Methods. Prospectively collected data of 14 patients of chronic pancreatitis
with splanchnic artery pseudo aneurysms, managed at our centre between
January 1996 and December 2005 was analyzed retrospectively.
Results. The incidence of splanchnic artery pseudo aneurysm in patients
with chronic pancreatitis was 9%( 14/157 patients). Splenic artery was
involved most often (n10, 71%) followed by gastro duodenal artery in two
patients (14%). Emergency angioembolization of pseudo aneurysm was
performed in 5 patients (36%). Two patients who underwent angioemboliza-
tion had rebleeding after the procedure and required emergency surgery for
control of bleeding. Pseudo aneurysms were managed surgically in 11
patients (79%). There was no rebleeding in any of the patients managed
surgically.
Conclusion. Surgery is safe and highly effective in life threatening
circumstances such as hemodyanamically unstable patients, after failed
angioembolization and patients of chronic pancreatitis with incidentally
detected pseudoaneurysm requiring surgery for the management of under-
lying pancreatic pathology.
PP 28.08
SIGNIFICANCE OF SPLENIC VEIN THROMBOSIS IN CHRONIC
PANCREATITIS
Agarwal, Shaleen; Rajkumar, K.; Singh, Shivendra; Agarwal, Anil
G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India
Background & Aim: Splenic vein thrombosis leading to sinistral portal
hypertension and variceal bleeding is a complication of chronic pancreatitis.
The management of these patients without variceal bleed remains contro-
versial.
Methods. A total of 157 patients of chronic pancreatitis were managed
consecutively in our center during the period of Jan 1996-Dec 2005. Thirty
four patients with chronic pancreatitis were diagnosed to have splenic vein
thrombosis.
Results. The incidence of splenic vein thrombosis in patients with chronic
pancreatitis was 22%. 15% of patients with chronic pancreatitis and splenic
vein thrombosis presented with gastro esophageal variceal bleed. Nine
patients underwent splenectomy along with pancreatic procedures and 21
patients underwent pancreatic procedures only. Adding splenectomy with the
pancreatic procedure did not lead to increased morbidity or mortality.
Conclusion. Splenectomy should also be added to the pancreatic procedure
in patients who have evidence of portal hypertension on preoperative
evaluation, especially if gastric varices are found
PP 28.09
SURGICAL MANAGEMENT OF PANCREATIC ASCITES
Varma Gunturi, Surya Ramachandra; Kota, Venugopal; Reddy, G. Sambi;
Narayana Rao, D.V.L.; Prabhakar, B.; Hasan, Ibrahim; Malleshwara Rao,
G.L.N.
Osmania Government General Hospital, Hyderabad, India
Introduction. Pancreatic ascites is exudative ascites caused by non
malignant pancreatic disease, characterized by very high fluid amylase levels
over 1000 U/L and protein concentrations3 gm/dl. Surgical management is
needed when conservative methods including endoscopic approaches fail.
This study describes our results in the management of pancreatic ascites.
Methods. This is a combined retrospective and prospective study of 14
patients diagnosed and treated as pancreatic ascites with chronic pancreatitis
in a tertiary referral government health centre over a period of 4 years.
Patients were initially conservatively managed with ascitic fluid drainage,
octreotide and nutrition in the form of either TPN (Total Parenteral
Nutrition) or nasojejunal feeding with blenderized diet for 3 weeks. Failures
were taken up for surgical intervention. The type of surgery depended on the
site of leak and associated pancreatic pathology as demonstrated by ERCP
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(Endoscopic Retrograde Cholangiopancreatography) and Contrast En-
hanced Computerized Tomography (CECT) scan of abdomen.
Results. Nine patients needed surgical intervention: Distal Pancreatectomy
(n7), Longitudinal Pancreaticojejunostomy (n1) and Pancreatic Cysto-
jejunostomy (n1). All had successful resolution of pancreatic ascites
postoperatively. One patient had a secondary hemorrhage, which responded
to conservative management.
Conclusion. ERCP is the road map to determine the pathology of pancreatic
duct and to determine upon the type of surgery needed. Nasojejunal
blenderized feeds are an alternative form of nutrition, especially helpful in
developing countries. Surgery provides definitive treatment in pancreatic
ascites where conservative methods fail.
PP 28.10
PREVALENCE OF TROPICAL CHRONIC PANCREATITIS IN
ORISSA & SURGICAL OUT COME AFTER DRAINAGE PROCE-
DURE.
Mihir k Mohapatra, Mihir
S C B Medical college., Surgical Gastroenterology., Cuttack, Cuttack, India
Introduction. Tropical chronic pancreatitis (TCP) is common in orissa.
Two third of our patients are being managed conservatively and one third
have required operative management, the leading indications being intract-
able pain & complications like pseudocyst & obstructive jaundice. Frey’s
procudere has offered the most satisfactory Results.
Methods. During the period from April 1997 to Aug 2007, 227 patients of
chronic Pancreatitis were treated in the Dept. of Surgical Gastroenterology,
SCB Medical college, Cuttack, Orissa, out of which 117(75%) were male &
57(25%) were female. Most of the patients (127,56%) were with in 2140
years. These patients were worked up for history of pain, diabetes&
malnutrition & pancreatic structural changes. Glucose tolerance test, serum
amylase&lipase, calcium&phosphate, X-ray abdomen & Ultrasound was
done in all cases.68 patients had surgery, the main indication being
intractable pain followed by pseudocyst(11) & obstructive jaundice(9).
Pancreatic calcification& calculi was found in all cases. MPD was in range
of 418 mm in 67 patients.43(63%)patientswere offered drainage procedur-
e(Frey’s procedure in 29(43%) & Patrington & Rochelle procedure in
13(19%), Izbicki’sprocedure in 1(1.4%). Whipple procedure in2(2.8%),
Cystogastrostomy & cystoduodenostomy in 11(16%), Cholecystojejunost-
omy in 5(7%) and other procedure in 7(10%) patients.
Results. Pain relief was excellent in 28(98.5%) patients after Frey procedure
& in 11(84%) after Patrington & Rochelle procedure. There was no further
worsening of endocrine & exocrine function in any of the patients undergoing
the above drainage procedures. Nutritional status & quality of life have
improve in all patients after drainage procedure. There was no mortality &
majore complication like haemorrhage or pancreatic fistula after Frey or
Patrington/Rochelle procedure.
Conclusion. Surgical out come(pain relief&improved diabetic & nutritional
status)after an adequate drainage is excellent in TCP.
PP 29.01
ANTE SITUM LIVER RESECTION UNDER TOTAL VASCULAR
EXCLUSION AND VENOVENOUS BYPASS WITH HYPOTERMIC
PERFUSION
Chu, Chong-Woo1; Kim, Hyung-Chul2
1Soon Chun Hyang University Hospital, Surgery, Bucheon, Korea, Republic
of; 2
We present a case of a recurrent rectal cancer liver metastasis that was
managed with ante situm liver resection under total vascular exclusion (TVE)
and venovenous bypass with hypothermic perfusion. A 58-year-old man had
been transferred to our hospital with a rectal cancer liver metastasis in
January 2006. Left lateral sectionectomy had been performed. A recurrent
lesion developed in segment I, IV, and VIII one year after the first
hepatectomy. It was involved in the origin site of middle hepatic vein and
retro-hepatic vena cava. The tumor size was 5 cm. The authors thought that
incomplete tumor free margin and massive bleeding were expected under
conventional liver resection. Moreover, vena cava reconstruction was
expected. Therefore, we planned ante situm liver resection under TVE and
venovenous bypass with hypothermic perfusion. After adhesiolysis, hilar
dissection was carried out. Inflow of medial segment was interrupted. And
then liver and IVC were fully mobilized. During short hepatic vein control,
we found adhesion of hepatocaval portion. So, Venovenous bypass was
performed and suprahepatic IVC transection underwent. Long conduit of V5
was preserved during hepatic parenchymal dissection. Paracaval portion of
caudate lobe was easily detached from IVC. Suprahepatic IVC reconstruction
was performed after V5 reconstruction with saphenous vein. And then portal
vein anastomosis was carried out. After reperfusion, end to side anastomosis
was performed between saphenous vein and IVC. Finally, roux-en-Y HJ was
carried out. The patient remains well without recurrence 7 months after
operation.
PP 29.02
LIVER RESECTIONS FOR COLORECTAL METASTASIS IN MEL-
BOURNE
Choi, Julian; Beitner, Sarah; Usatoff, Val; Haydon, Andrew; Evans, Peter
Alfred Hospital, Melbourne, Australia
Introduction. Colorectal cancer is a major health problem in Australia. 1 in
20 Australia will develop the disease in their life times and 5060% of them
will develop liver metastases. Liver resection is the treatment of choice for the
colorectal liver metastases when appropriate. There is limited data published
on Australian experience of liver resection for colorectal metastases.
OBJECTIVES. The aims of this study are; to identify our operative morbidity
and mortality for liver resection; to determine overall and disease free survival
rates after liver resection; to examine if pre-operative biopsy of liver lesions
affect overall and disease free survival.
Methods. A retrospective review of 135 consecutive liver resections done
over 11 years (Jan 1995 Dec 2005) at the Alfred and Cabrini hospitals was
performed. Patients’ demographics, clinical data, 30 days morbidity and
mortality, overall and disease free survival data were collected. Pre-operative
biopsy results were also noted with their impact on overall and disease free
survival.
Results. 135 consecutive liver resections have been performed during this
11-year period with operative morbidity and mortality rates of 1.5% and
33.7% respectively. The 5 years overall and intra-hepatic disease free survival
was 52% and 36% respectively. 38 patients required pre-operative biopsy of
their liver lesion, which did not result in difference of their overall or intra-
hepatic disease free survival.
Conclusions. This is an important study representing Australian experience
of liver resection for colorectal liver metastases. Our operative morbidity,
mortality and overall survival rates are comparable to other published series.
Selective use of pre-operative biopsy in our series did not affect overall or
disease free survival.
PP 29.03
PUSHING THE ‘‘BOUNDARIES’’  IMPACT OF RESECTION
MARGIN AND TUMOUR BIOLOGY ON OUTCOME FOLLOWING
HEPATIC RESECTION FOR COLORECTAL METASTASES
Gomez, Dhanwant; Morris-Stiff, Gareth; Toogood, Giles J; Lodge, J. Peter
A.; Prasad, Rajendra
Leeds Teaching Hospitals NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom
Background. The evolution of hepatic resection for patients with colorectal
liver metastasis (CRLM) has lead to expansion of conventional selection
criteria, in particular tumour size and number. The aim of the study was to
analyse prognostic factors and outcome of patients based on a selection
criteria based on tumour number and size.
Methods. Patients undergoing resection for CRLM from January 1993 to
March 2007 were identified from the hepatobiliary database. Patients were
divided into 3 groups: Conventional criteria (B3 met and/or B3cm),
extended criteria (47mets and/or 3-B5cm) and hard-line criteria (8
mets and/or 5cm).
Results. 705 patients that underwent primary resection were included.
There were 154, 262 and 289 patients in the conventional, extended and
hard-line group respectively. The 5-year disease-free (pB0.001) and overall
(pB0.001) survival were significantly different between the groups. Inflam-
matory response to tumour [IRT-raised neutrophil to lymphocyte ratio
(NLR) and/or C-reactive protein, pB0.001], extent of resection (pB
0.001) and resection margin status (pB0.001) were significantly different
between the groups. Sub-group analysis revealed that IRT was the only
adverse predictor for poorer disease-free and overall survival in the conven-
tional group. In the extended group, IRT was the only predictor of poorer
disease-free survival on multi-variate analysis. In addition, IRT also predicted
poorer overall survival in this group. For patients in the hard-line criteria
group, resection margin and blood transfusion were independent predictors
of poorer disease-free survival. On multi-variate analysis, age, resection
margin and IRT were independent predictors of overall survival in this
cohort.
Conclusion. By extending the selection criteria, resection margin influence
the long term outcome of patients within the hard-line criteria group, hence
the importance of achieving good clearance in these patients. IRT signifi-
cantly influences the outcome of patients with less aggressive disease.
PP 29.04
IMPACT OF SYSTEMIC NEUTROPHIL TO LYMPHOCYTE RA-
TIO IN HISTOPATHOLOGICAL FEATURES OF COLORECTAL
LIVER METASTASES
Gomez, Dhanwant1; Prasad, P2; Wyatt, J2; Morris-Stiff, Gareth1; Toogood,
Giles J1; Lodge, J. Peter A.1; Prasad, Rajendra1
1Leeds Teaching Hospital NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom; 2Leeds Teaching Hospital NHS Trust,
Department of Pathology, Leeds, United Kingdom
Aims. An elevated pre-operative neutrophil to lymphocyte ratio (NLR) has
been implicated as a poor prognostic factor in patients udergoing hepatic
resection for colorectal liver metastasis (CRLM). The aim of this study was to
determine whether systemic NLR correlates with degree of tumour lympho-
cytic infiltration in CRLM.
Methods. Patients undergoing curative resection for CRLM were identified
from the pathology and hepatobiliary databases. The histopathological slides
were reviewed by a single pathologist. NLR was calculated by dividing the
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absolute value of neutrophils to the value of lymphocytes. NLR5 was
considered elevated.
Results. 151 patients were included, of which 27 patients had a raised NLR.
Of these 27 patients, 24 patients (89%) had no lymphocytic infiltration and 3
patients (11%) had mild infiltration. No patients showed either moderate to
severe lymphocytic infiltration. The degree of lymphocytic infiltration in
patients with a NLR B5 was: none 77% (n95); mild 16% (n20); and
moderate to severe 7% (n9) respectively (p0.253). There was no
significant difference between patients with a NLR 5 compared to B5 in
terms of tumour number, tumour size, biliary invasion, satellite nodules or
capsular infiltration. However, patients with a high NLR exhibited a
significantly higher rate of vascular invasion (p0.029).
Conclusion. The systemic NLR does not represent the degree of tumour
lymphocytic infiltration in cases of CRLM.
PP 29.05
RESULTS OF RFTA TREATMENT IN PATIENTS WITH INOPER-
ABLE COLORECTAL CANCER LIVER METASTASES ON STAN-
DARD (5-FUFOLINIC ACID) CHEMOTHERAPY REGIMEN.
Zadrozny, Dariusz1; Sledzinski, Zbigniew1; Studniarek, Michal2; Gorycki,
Tomasz2; Adamonis, Walenty1
1Medical University of Gdansk, Poland, Dept of General, Endocrine and
Transplant Surgery, Gdansk, Poland; 2Medical University of Gdansk,
Poland, Dept of Radiology, Gdansk, Poland
Background. Liver metastasis from colorectal cancer (CRC), when inoper-
able, are connected with poor prognosis. On standard’’ chemotherapy (5-
FluorouracilFolinic Acid) the median survival time from metastasis
discovery is short 612 months. Radiofrequency thermal ablation (RFTA)
seems to be an option of treatment for these patients.
Material. 195 patients with inoperable liver metastases from CRC were
treated using percutaneous RFTA between 2001 and 2007. Ninety five of
them (48,7%, 65 M and 30 F) were on standard’’ chemotherapy. Mean age in
this group was 65,7 (3885) years. 186 ablation session were performed (17
per patient, average 1,97). At the start of treatment 237 lesions were
recognised as RFTA targets (17 mean 2,5 per patient), but due to disease
progression overall 347 tumors were destroyed (112, av. 3,65 per patient and
1,87 per intervention).
Methods. Ultrasound-guided percutaneous thermal ablation under total
intravenous anesthesia was performed in all patients. The Cool-Tip (Radio-
nics, Burlington, USA) equipment was used.
Early Results. There were no perioperative deaths. In one patient early
complication (liver abscess and colon perforation) occured (1%). In all
except one patient hospital stay was shorter than 72 hours.
Late Results. Median survival time was 18,48 months from the first thermal
ablation and 24,0 months from the discovery of liver metastases. The
computed 5-year surviwal is 18%. There were no differences in survival in
patients with synchronic vs metachronic lesions, neither between patients
with single and multiple lesions. The CEA level, sum of lesions diameters,
chemotherapy response and team experience have significant impact on
patients survival.
Conclusion. Percutaneous RFTA is safe and efficient method of treatment
for inoperable colorectal cancer liver metastases. 18% 5-years survival may be
achieved even in patients treated with old school’’ chemotherapy.ts
PP 29.06
PATTERN OF INTRA-HEPATIC RECURRENCE FOLLOWING
NON ANATOMIC FIRST HEPATECTOMY IN PATIENTS WITH
COLORECTAL LIVER METASTASES
Yeluri, Sashidhar1; Malik, HZ2; Gomez, Dhanwant2; Cluskey, S2; Toogood,
GJ2; Lodge, J Peter A2; Prasad, K Rajendra2
1St. James’s University Hospital, Department of HPB and Transplant
Surgery, Beckett Street, Leeds, United Kingdom; 2St. James’s University
Hospital, Department of HPB and Transplant Surgery, Leeds, United
Kingdom
Background. Non anatomical liver resections (NALR) have become
common place in the management of colorectal liver metastases (CRLM).
The purpose of the present study was to determine the pattern of intra
hepatic tumour recurrence in NALR.
Methods. A prospectively maintained database was used to identify 100
patients with CRLM who underwent primary NALR in the period between
1995 and 2006. Data analyzed included demographics, hepatic metastases
site pre-NALR, and patterns of intrahepatic recurrence.
Results. The median age of patient was 68 years (S.D 9.8). There were 65
males and 40 patients presented with synchronous disease. The median
metastases size was 28 mm with 15 patients having multiple (4 or more)
metastases. There were 35 intrahepatic recurrences. Analysis suggested that
in 28 of these 35 patients an initial anatomical resection would have
prevented subsequent intra-hepatic recurrence within the same sector. The
only clinico-pathological factor preoperatively that predicted for recurrence
in the same hepatic sector was the presence of multiple metastases (p
0.003).
Conclusion. Non-anatomical resection remains an acceptable option for the
management of CRLM. However, the presence of multiple metastases
preoperatively may predict the need for an initial anatomical resection.
PP 29.07
INTERMITTENT PRINGLE MANOEUVRE IS NOT ASSOCIATED
WITH ADVERSE LONG TERM PROGNOSIS
Wong, Vincent KH; Hamady, Zaed ZR; Malik, Hassan Z; Prasad, K
Rajendra; Lodge, J Peter; Toogood, Giles J
St. James University Hospital, Hepatopancreatobiliary & Transplant Surgery,
Leeds, United Kingdom
Background. Intermittent clamping of the porta-hepatis (IPM) is often used
for inflow control during parenchymal liver transection. However, IPM
remains controversial with risk of ischaemic-reperfusion injury. A recent
murine study showed that ischaemic-reperfusion injury accelerated the
outgrowth of hepatic colorectal liver metastases.
Objective. The aim of this study is to analyse whether IPM is associated with
any adverse long-term outcome following liver resection for colorectal liver
metastases (CRLM).
Methods. All patients undergoing resection for CRLM between 1993 and
2006, in which data on IPM was recorded were included in this study. A total
of 563 patients were available for analysis.
Results. 51.3% of patients undergoing resection had an IPM performed.
The duration of IPM ranged from 2 to 104 minutes (median 22). There were
no differences in clinico-pathological features between the two groups.
Furthermore, there was no difference in post-operative morbidity between
the IPM and no- IPM groups. There was no difference in intra-hepatic
recurrence between the 2 groups with the median survival for those
undergoing IPM was 55.6 months compared to 48.9 months for those not
having an IPM, p0.406. Similarly, there was no difference in disease-free
survival between the two groups, 0.199.
Conclusion. IPM is not associated with adverse long-term prognosis.
PP 29.08
RADIOFREQUENCY ABLATION OF COLORECTAL LIVER ME-
TATSTASES DOWNSTAGED BY CHEMOTHERAPY
Knudsen, Anders1; Kannerup, Anne-Sofie1; Mortensen, Frank Viborg1;
Sørensen, Steen Mellerup2; Nielsen, Dennis Tønner2
1Aarhus University Hospital, Department of Surgery L, Aarhus, Denmark;
2Aarhus University Hospital, Department of Radiology R, Aarhus, Denmark
Aim. To evaluate the long-term survival in patients treated by radiofrequency
ablation (RFA) for colorectal liver metastases after downstaging by systemic
chemotherapy.
Methods. Forty-three patients with colorectal liver metastases initially
unsuitable for local treatment were downstaged by chemotherapy and treated
by RFA. All patients were managed in a single institution during a nine year
period from 1998 to 2007. Chemotherapy mainly consisted of 5-fluorouracil
and leucovorin combined to oxaliplatin or irinotecan. Multinodularity, size of
tumours or limited hepatic reserve was the main cause of patients being
unsuitable for local treatment. Patients with extrahepatic disease were
excluded from RFA treatment. Pre  and posttreatment evaluation was
performed with contrast-enhanced computed tomography.
Results. Twenty-three men and twenty women with a median age of 65 years
(4779) were treated with RFA after being downstaged by chemotherapy.
Thirty-two patients had a colon cancer as a primary cancer. The five-year
overall survival rate was 37% (1958), with a median survival of 47 months.
Conclusion. Patients with unresectable liver metastases from colorectal
cancer can, after being downstaged by systemic chemotherapy, be treated by
radiofrequency ablation with an excepted 5-year survival rate on 37%.
PP 29.09
COMBINED LIVER RESECTION AND RADIOFREQUENCY AB-
LATION FOR COLORECTAL LIVER METASTASES
Kannerup, Anne-Sofie1; Nielsen, Dennis Tønner2; Sørensen, Steen Mel-
lerup2; Mortensen, Frank Viborg3
1Aarhus University Hospital, Aarhus, Department of Surgery L, Aarhus,
Denmark; 2Aarhus University Hospital, Department of Radiology R, Aarhus,
Denmark; 3Aarhus University Hospital, Department of Surgery L, Aarhus,
Denmark
Aim. Liver resection in combination with radiofrequency ablation (RFA) is a
novel approach in patients with colorectal liver metastases who are otherwise
untreatable with resection. The aim of this study was to evaluate the results of
the combined treatment.
Methods. Eighteen patients with colorectal liver metastases were treated
with surgical resection combined with RFA. All patients were followed
prospectively with CT-scanning of thorax and abdomen during a five-year
period: one, four, eight and 12 months after treatment and every six months
thereafter for the next four years. Main outcome were recurrence and
survival.
Results. Eleven men and seven female patients with a median age of 65 years
(4377) were treated with combined surgery and RFA. Seventy-six metas-
tases were treated, 34 of these with resection. Median survival rate in the
entire group were 35 months. The estimated 1-, 2- and 3-year overall survival
rates were 100%, 87% and 45%, respectively. Five-years overall survival was
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33.7%. Twelve patients had recurrence. Four of these developed hepatic
recurrence while eight patients developed extrahepatic disease, primarily in
the lungs.
Conclusion. The combination of surgery and radiofrequency ablation
augments the number of patients with colorectal liver metastases who can
be treated surgically and seems to increase long-term survival when
compared to chemotherapy.
PP 29.10
CONTRAST ENHANCED INTRAOPERATIVE ULTRASOUND
HELPS IN THE DETECTION OF ADDITIONAL COLORECTAL
LIVER METASTASES AND CHARACTERISATION OF FOCAL
LESIONS
Shah, Ankur1; Pope, IM1; Callaway, Mark2; Finch-Jones, Meg D1
1Bristol Royal Infirmary, HPB surgery, Bristol, United Kingdom; 2Bristol
Royal Infirmary, Radiology, Bristol, United Kingdom
Background. Intraoperative ultrasound (IOUS) is the standard intra-
operative investigation for assessing liver metastases prior to a resection.
However, small and iso-echoic lesions may be missed due to size or poor
characterization.
Aims. To determine whether Contrast enhanced ultrasound (CE-IOUS)
detects additional metastases and improves the assessment of liver lesions as
compared to B-mode IOUS prior to liver resection.
Methods. This prospective cohort study had ethical approval. All patients for
a liver resection for colorectal metastases were invited to participate in this
study. Pre-operative staging was performed with multi-slice CTscan plus
MRI and/or Laparoscopic ultrasound. A standard protocol was followed for
IOUS and contrast. Following surgical exploration, IOUS was performed. All
lesions were characterized and mapped. CE-IOUS was then performed with
an intravenous injection of sulphur hexafluoride microbubbles (Sonovue†),
and the characteristics, number, size and position of lesions were recorded.
Any additional lesions/changes with reference to the non-enhanced IOUS
findings were documented. Any alteration in the surgical management was
recorded. Finally, the resected specimen was correlated with the findings.
Results. Our preliminary data is based on 23 consecutive patients. 3 patients
were inoperable on initial laparotomy and excluded. The total number of
lesions detected in 20 patients by IOUS was 30 (out of the 36) as compared
to 35 (out of 36) with CE-IOUS. 1 lesion was missed by both the modalities.
CE-IOUS made one cancer inoperable by detecting multiple bilobar
metastases and altered the operative plan in another patient. The accuracy
of CE-IOUS was 97.2% compared to 83% for IOUS. In summary, CE-IOUS
picked up 17% additional lesions and changed management in 10% of
patients.
Conclusion. Our preliminary results suggest that CE-IOUS helps to detect
additional metastases and characterize lesions better. CE-IOUS can be useful
as an added tool prior to a resection for colorectal metastases.
PP 30.01
ROLE OF SPIRAL CT SCAN AND EUS IN DIAGNOSIS OF PERI-
AMPULLARY TUMOURS.
Hegab, Bassem1; El-Kased, Ahmed2; Okasha, Hussein3; Fawzi, May4; El-
Badry, Ahmed5; Korayem, Enas2
1National Liver Institute, University of menoufiya., Menoufiya, Egypt;
2Egypt; 3Cairo University, Egypt, Egypt; 4Cairo University, Egypt5
Introduction. Pancreatic cancer is associated with an extremely poor
prognosis with less than 5% of patients surviving 5 years after the diagnosis.
Current preoperative staging modalities include various cross-sectional
imaging techniques, including spiral CT and endoscopic ultrasound (EUS).
Aim of the work: demonstrating the role of spiral CT and endoscopic
ultrasonography in early diagnosis and staging of periampullary tumors.
Patients and Methods. Sixty-two patients with periampullary tumors were
included in this study. All cases were subjected to abdominal ultrasound,
Spiral CT, ERCP, EUS and operative interference. Surgical findings were
considered the gold standard for assessing the sensitivity of spiral CT and
EUS in diagnosing, staging and estimating resectability of periampullary
tumors.
Results. Endoscopic Ultrasonography was very sensitive in detecting
periampullary masses (93.5%) especially masses smaller than 20mm while
the sensitivity of spiral CT was 71%. EUS was also very sensitive in detecting
ampullary masses (100%) in contrast to spiral CT that missed the diagnosis
of the 14 ampullary masses found in our work. EUS was more sensitive than
Spiral CT in detecting malignant vascular invasion (95% versus 75%) while it
was slightly less specific than spiral CT in that context (74 versus 80%). The
predictive value of spiral CT was 60% for tumor resectability while is was
100% for tumor unresectability. The predictive value of EUS was 73.5% for
tumor resectability while it was 96.4% for tumor unresectability. When
combining both techniques the predictive value for tumor resectability was
65% while it was 100% for tumor unresectability. No complications were
encountered in both techniques.
Conclusions. EUS is more sensitive than spiral CT in detection and staging
of periampullary masses. Also, the non-invasive spiral CT and the minimally
invasive EUS are very valuable tools in predicting unresectability of
periampullary masses while EUS is slightly more valuable in detecting tumor
resectability.
PP 30.02
EUS EVALUATION OF CYSTIC TUMOURS OF THE PANCREAS-
STRENGTHS AND PITFALLS.
Winkles, C; Cherian, PT; Taniere, P; Hejmadi, RK; Mahon, Brin
University Hosptial, Birmingham, United Kingdom
Background. Awareness of the malignant potential of cystic lesions of the
pancreas and increased availability of EUS has lead to increased use of this
modality in their evaluation. We reviewed our practice, especially with regards
to size, morphology, and analysis of aspirates from EUS to identify learning
points. Method: A retrospective review of consecutive patients referred to us
for evaluation of cystic tumours between May 2005 and Feb 2007 using
hospital records.
Results. 87 patients were reviewed. Presenting complaints ranged from being
incidental (26.4%) to pain, jaundice, weight loss, chronic pancreatitis and
cyst surveillance. Mean cyst size varied with presenting features. Of the 87
samples, 27 were positive for mucin, of whom 13(48.1%) had definite or
suspected malignancy on cytology. An attempt at aspirate CEA levels was
made. EUS morphology of these 27 patients were complex/multi-septated
(18), simple/benign (7) and not described (2). Only in 10 of the 13 malignant
cases was morphology suggestive of malignancy. Of the 7 in whom
morphology was considered benign, one was mucin positive. Among the 23
‘incidental’ patients, 7 were mucin positive and 2 mucin positive and
malignant. Sixteen cysts had amylase levels 1000 and were probably
pseudocysts, of whom only 68.8% had history or EUS findings suggestive of
pancreatitis.
Conclusions. In the evaluation of cystic pancreatic lesions, neither history
nor EUS morphology is reliable for diagnosis, and aspirate analysis is crucial.
Presence of mucin is an indicator for malignancy with almost 50% of them
being malignant if present. A combination of history, high amylase levels and
typical EUS morphology allows separation of benign pseudocysts in most
cases.
PP 30.03
SURGICAL CHOICE IN PANCREATIC HEAD MASS WITH UN-
CERTAIN DIAGNOSIS. CASE REPORT.
La Greca, Gaetano; Sofia, Maria; Lombardo, Rosario; Barbagallo, Fran-
cesco; Chisari, Andrea; Gagliardo, Salvatrice; Russello, Domenico
University of Catania, catania, Italy
Background. Because of its silent course, late clinical manifestation and
rapid growth, pancreatic adenocarcinoma is been considered as a silent killer.
Differential diagnosis for pancreatic head mass includes malignant tumor,
ampullary carcinomas, neuroendocrine tumors, acute and chronic pancrea-
titis and at least autoimmune pancreatitis (AIP). We report a case of
pancreatic head mass in which differential diagnosis has led to resolve
some questions about diagnostical and therapeutical choice.
Case Report. C.G., male 52 years old, was admitted in our department due
to abdominal pain. Laboratory bloody test showed acute pancreatitis. An
abdominal ultrasonography identified a pancreatic head mass. The abdomen
CT was then performed, confirming the mass that involved the superior
mesenteric vessels. Bloody tumoral makers levels were normal. Suspecting a
malignant neoplasm, a EUS with FNA was performed, but it revealed a
chronic pancreatitis. The patient was discharged with a EUS follow-up at 2
months, but after 2 weeks he came back due to abdominal pain and jaundice.
An explorative laparotomy was performed. The intraoperative incisional
biopsy was suspected for neoplasm. Due to the unresectability of the mass a
coledoco- jejunal anastomosis was performed and the patient was led to the
oncologist for adjuvant chemotherapy. The definitive istological result of the
incisionale biopsy, reveal a chronic pancreatitis. After 3 months of
chemotherapy the pancreatic mass was disappeared, and an AIP was
suspected in this patient, but until now not confirmed.
Conclusions. Not all pancreatic head mass are malignant tumor, the 9.2% of
Whipple resection are performed for benign but clinically suspected for
malignant mass of the pancreas. The most common benign etiology in this
case is the AIP. Preoperative diagnosis of this disease is very rare but in
patients responders to risk factor for AIP, serum level of IgG4 should be
performed. This screening may avoid unnecessary surgery and chemotherapy
in future case.
PP 30.04
ACUTE PANCREATITIS AS FIRST SIGN OF PANCREATIC CAN-
CER
Massani, Marco
Regional Hospital, IV Dpt Surgery, Treviso, Italy
Background. Pancreatic cancer is the fourth cause of death in eastern
country, with an incidence increased twofold during last 40 years. Approxi-
mately 95% arise from exocrine cells and two thirds occur in the pancreatic
head. Initial symptoms are various and insidious and relatively non specific.
This may delay diagnosis. Acute pancreatitis as first sign of pancreatic cancer
is rare and sometime the diagnosis could be difficult.
Methods. In a cohort of 1026 patients with proven acute pancreatitis we
retrospectively reviewed our experience. In a group of five patients we have
considered 2 patients (0,19%) with recurrent, non chronic, pancreatitis. Both
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where referred to our institution with diagnosis of idiopathic pancreatitis
after, at least, two acute episodes. We reviewed images with our dedicated
radiologist and we discovered in both patient a small cephalic lesion, present
since the beginning of the history of pancreatitis, probably explained as focal
pancreatitis or small necrotic component of the inflammation. The two
patients required a duodenopancreatectomy and definitive specimen showed
a pancreatic adenocarcinoma.
Conclusion. Our experience confirms that acute pancreatitis as first sign
of pancreatic cancer is an uncommon event but confirms also that all
patients with diagnosis of idiopathic pancreatitis need an accurate evaluation
and follow up. In presence of a small lesion is mandatory to obtain a
diagnosis.
PP 30.05
GROOVE PANCREATITIS MIMICKING PANCREATIC MALIG-
NANCY: A REPORT OF FOUR CASES
Gandhi, Vidhyachandra1; Varma, Vibha2; Bheerappa, Nagari2; Regulagadda,
Adikesava Sastry2
1Nizams Institute of Medical Sciences, Surgical Gastroenterology, Panja-
gutta, Hyderabad, India; 2Nizams Institute of Medical Sciences, Surgical
Gastroenterology, Hyderabad, India
Background. Groove pancreatitis is a rare form of segmental chronic
pancreatitis characterized by a focal lesion confined to the groove between
the duodenum, pancreatic head and bile duct with Brunner gland hyperpla-
sia, cystic areas in the duodenum, dilated pancreatic ductules with mucinous
plugs within. Despite all advances in imaging technologies, differentiating it
from pancreatic malignancy has remained a persistent problem.
Aim. It is a study of four cases of pancreatic head mass with diagnostic
dilemma treated in our unit for their presentation, investigation and
management.
Material & Methods. Four middle aged patients, 3 males (chronic
alcoholic) and 1 female, presented with chronic upper abdominal pain and
vomiting. One patient presented with duodenal obstruction and upper
gastrointestinal endoscopy confirmed obstruction due to a submucosal
mass. Two other patients had mural thickening of the medial wall of
duodenum. One patient presented with recurrent episodes of jaundice.
Results. Abdominal computed tomography in all the patients showed a mass
lesion in the groove between duodenum and pancreatic head with duodenal
wall thickening and cystic areas within. Pancreatic malignancy could not be
ruled out despite multiple biopsies and estimation of CA 19-9. Pancreatico-
duodenectomy was done in three cases, while one case was deemed
inoperable due to vascular encasement (anomalous common hepatic artery
arising from superior mesenteric artery). Frozen biopsy from the lesion was
reported as chronic pancreatitis. Histology confirmed groove pancreatitis in
all four cases and was corroborated by imaging.
Conclusion. Groove pancreatitis is difficult to differentiate from malignancy
and pancreaticoduodenectomy is the commonest procedure performed for
such cases. Follow-up and conservative management is offered if diagnosis is
made on imaging and clinical features.
PP 30.06
Screening in Familial and Hereditary Pancreatic Cancer
Erdmann, Joris1; Poley, Jan Werner2; Van Eijck, Casper H. J.3; Kuipers, Ernst
J.4
1Erasmus MC, Surgery, Rotterdam; 2Erasmus MC, Gastroenterology and
Hepatology, Rotterdam; 3Erasmus MC, Surgery, Rotterdam, Netherlands;
4Erasmus MC, Gastroenterology and Hepatology, Rotterdam, Netherlands
Pancreatic cancer (PC) has a poor prognosis. Early detection of pre-
malignant lesions (IPMN, PanIN) or small asymptomatic tumors could
improve outcomes. Since pancreatic cancer is relatively rare, screening of the
general population is unfeasible. However, 515% of all PC is considered to
be familial or hereditary in origin. By using endoscopic ultrasound (EUS) it is
possible to examine both pancreatic parenchyma and pancreatic duct in
detail. Furthermore, cytological specimens can be obtained.
Methods. Since 2005 patients with familial or hereditary PC were offered
EUS screening. Procedures were carried out under conscious sedation and
performed by an experienced endoscopist. When abnormalities were found,
EUS was followed by CT and/or MRI.
Results. 20 patients from 14 families (M/F 10/10) were screened. Genetic
background was diverse: patients with at least two first-degree relatives with
PC (familial PC, n8), patients with familial PC and/or familial atypical
multiple mole melanoma syndrome (FAMMM) with unclassified variants
(UV) in the p16 gene (n5), Peutz-Jeghers syndrome (n2), genetically
proven FAMMM syndrome (n4)and one carrier of a pathogenic BRCA2
mutation in a family with familial PC. No procedure related complications
occurred. Significant pathology was found in three patients (15%): in a
patient with a p16 UV multifocal side-branch intraductal papillary mucinous
neoplasms (IPMN) were found, all less than 1,5 cm in size. In a patient with
familial PC one side-branch IPMN of 5 mm was found. Furthermore, one
small solid lesion in the pancreatic tail (22 mm) in an asymptomatic BRCA2
carrier was found. This patient underwent a resection of the pancreatic tail
without complications. Histopathological examination confirmed an adeno-
carcinoma.
Conclusions. EUS screening has a significant yield in selected asymptomatic
high-risk patients and may lead to resections. Whether this improves outcome
in these patients remains to be proven.
PP 30.07
PANCREATIC CARCINOMA OCCURRING IN CHRONIC CALCI-
FIC PANCREATITIS OF TROPICS
Iype, Satheesh1; SubhaLal, N2; Kuruvilla, A P2; M L, Arun Kumar2;
Anandakumar, M3; Kocher, H M1
1Royal London Hospital, HPB Surgery, London, United Kingdom; 2Medical
College Hospital, Dept. Of Surgical Gastroenterology, Trivandrum, India;
3Medical College Hospital, Retd. Dept. Of Surgical Gastroenterology,
Trivandrum, India
Introduction. Chronic calcific pancreatitis of tropics(CCPT) is a juvenile
form of chronic calcific non-alcoholic pancreatitis prevalent almost exclu-
sively in the tropical countries. Kerala, the southwestern state of India has
found to be one of the ‘hot spots’ with high incidence of CCPT. The
characteristics of this disease have been described as ‘‘pain in childhood,
diabetes in adolescence and death at the prime of life.’’ Carcinoma developing
in chronic calcific pancreatitis of tropics has been hypothesized since last 3
decades without adequate cohort studies to define the clinical presentation of
the disease or its assessment in comparison to pancreatic cancer occurring de
novo.
Methods. We reviewed 2 cohorts of patients in a single tertiary referral
centre: CCPT with malignancy (n90) and de novo pancreatic ductal
adenocarcinoma (n195) during a 9-year period from March 1998 to
October 2006.
Results. Salient clinical difference in the two groups are listed in table
De novo Pancreatic
cancer
Ca in CCPT
Age (median, range) 62 (4381) years 42 (2677) years
M:F 140:55 (2.54:1) 66:24 (2.75:1)
Symptoms
Jaundice 89.23% 73.33%
Pain 7.36% 95.55%
Loss of weight 35.38% 81%
Diabetes Mellitus 11.28% 78.50%
Median size(cm) 3.72 4.11
Histology for resected
WDAC 43 (56%) 14 (37%)
MDAC 21 (26%) 15 (41%)
PDAC 15 (18%) 8 (22%)
Histology for unresected
WDAC 12 (67%) 5 (20%)
MDAC 3 (16.5%) 10 (38%)
PDAC 3 (16.5%) 11 (42%)
Location of tumour
Head 88.22% 74.70%
Body 10.25% 22.80%
Tail 1.53% 2.50%
Operation types
Biliary bypass 20 (10.3%) 19 (21.2%)
Biliary bypassGJ9Other
procedures
87 (44.6%) 13 (14.4%)
Classical Whipple 21 (10.7%) 4 (4.4%)
PPPD (Pylorus Preserving
Pancreatoduodenectomy)
45 (23.1%) 28 (31.2%)
Distal pancreatectomy 9 (4.6%) 4 (4.4%)
Others 13 (6.7%) 22 (24.4%)
Conclusion. Carcinoma occur at younger age in CCPT patients, as
compared to de novo pancreatic cancer suggesting the pre-malignant state
of the CCPT. Also Ca in CCPT tended to occur twice more commonly in the
head and generally tumours were of the worse grade and less likely to be
resectable.
PP 30.08
BBILIARY BYPASS FOR PALLIATION
Dariwala, Shekhar
NRS Medical College Hospital, Kolkata, India
Holbrook and colleagues (January 1990 JRSM, p 12) report the results of
biliary bypass surgery in patients with pancreatic cancer. They pose the
question whether a gastroenterostomy is necessary at the time of primary
surgery. They note that 48 of 165 (29%) patients underwent a gastroenter-
ostomy either to prevent gastric outlet obstruction or to treat it. They note a
much higher mortality following biliary bypass with gastroenterostomy (10 of
37, 27%) compared with biliary bypass alone (18 of 128, 14%).
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ADENOSQUAMOUS CARCINOMA ORIGINATING FROM PA-
PILLA OF VATER
Ozkan, Erkan1; Dulundu, Ender1; Ozel, Yahya1; Kayahan, Munire1; Gunes,
Pembegul Binbir2; Topaloglu, Umit1
1Haydarpasa Numune Education and Research Hospital, 5th Department of
Surgery, Istanbul, Turkey; 2Haydarpasa Numune Education and Research
Hospital, Department of Pathology, Istanbul, Turkey
Introduction. Adenosquamous carcinoma of the pancreas is a rare agressive
subtype of exocrine pancreatic neoplasms. Clinical features and course of the
tumor is similar to those of pancreatic adenocarcinomas. A patient is
presented here that was operated for periampullary tumor and that the
pathological examination of the specimen resulted in adenosquamous
carcinoma. We aimed to discuss the histopathological and clinical character-
istics of the neoplasm in the light of literature.
Material and Method. A 58-year-old woman was admitted to hospital with
the complaints of abdominal pain and jaundice lasting for one month. On
computerized tomography of the abdomen common bile duct was dilated
with an irregular contour and a blind end and the density changed in that
localization. A 10-mm polipoid lesion of soft tissue density was observed
proximal to the transvers part of duodenum as an area with contrast defect.
Total bilirubin level was increased to 23.9mg/dl (N: 0.40.8mg) and CA 19-9
level to 69.8U/ml (N: B35U/ml). On laparotomy we removed the tumor via
Whipple operation. Histopathological examination of the tumor showed that
the localization was on the papilla of Vater and that the patology was
moderately differentiated adenosquamous carcinoma. Tumor was reported to
have invaded choleduct and pancreas and metastasized to common hepatic
duct, small intestines and peripancreatic lymph nodes. She left hospital
without any complications and started to have oncologic treatment.
Conclusion. Adenosquamous carcinoma is the type with the worst prognosis
among ductal carcinomas of the pancreas. It originates in the duct following
mutation of K-ras oncogene. Adenosquamous carcinoma of the pancreas is
presented in literature as sporadic and small series. Survival is less than one
year in spite of surgical treatment in most patients. Adenosquamous
carcinoma should be kept in mind in the differential diagnosis of a mass
localized at the head of the pancreas.
PP 30.10
CONTINUOUS VERSUS INTERRUPTED PANCREATIC ANASTO-
MOTIC TECHNIQUES IN WHIPPLE’S PANCREATO DUODE-
NECTOMY
Patil, Vrishali; Low, Jee K; Manu, Mangta; Vadeyar, Hemant; Sherlock,
David
North Manchester General Hospital, Surgery, Manchester, United Kingdom
Introduction. Interrupted pancreatic anastomosis is the commonly per-
formed anastomotic technique in Whipple’s pancreatoduodenectomies. The
pancreatic-jejunal anastomosis may be done using interrupted two layers or
continuous two layered method. OBJECTIVE To compare the leak rate of
continuous versus interrupted methods of pancreatic anastomosis in Whip-
ple’s surgery.
Methods. A review was undertaken for 50 patients who underwent
pancreato-jejunal anastomosis during Whipple’s pancreatico-duodenectomy
between 2006 and 2007 at a tertiary HPB referral centre. Indication for the
operation, age group, gender, operative set up, post operative care, clinical
outcomes, histological grade were assessed for the occurrence of anastomotic
leaks.
Results. 23 patients underwent interrupted pancreatic jejunal anstomosis
using absorbable sutures and telescoping the pancreas.27 patients underwent
continuous anastomosis using identical Methods. Pancreatic leak rate was
4.3% in the interrupted group and 3.7% in the continuous group. There is no
statistically significant difference in the leak rates and the post operative
morbidity in both study groups.
Conclusion. It is safe to perform continuous pancreatic-jejunal anastomosis
and there are no added disadvantages over interrupted techniques.
PP 31.01
SURGERY IN MALIGNANT OBSTRUCTIVE JAUNDICE: PROG-
NOSTIC INDICATORS OF MORBIDITY AND MORTALITY
Bhange, Snehal1; Patil, Bhushan2; Adhikari, Devbrata2; Singh, Rajinder2;
Shetty, Tilakdas2; Joshi, Rajeev2
1T.N. Medical College & B.Y.L. Nair Ch. Hospital, General Surgery,
A.L.Nair Road, Mumbai, India; 2T.N. Medical College & B.Y.L. Nair Ch.
Hospital, General Surgery, Mumbai, India
Background. Pancreatico-duodenectomy although a formidable operative
procedure is been increasingly performed and palliative bypass procedures do
have a role despite the emergence of endoscopic palliation.
Objective. Analyse factors contributing to morbidity and mortality following
curative and palliative procedures and identify prognostic indicators.-
Method.: 218 patients (126 pancreatico-duodenectomy, 7 Klatskin tumour
resections and 85 palliative bypass procedures) were analysed from February
1999 to July 2007.
Results. Morbidity and mortality following curative surgeries were 50.37%
and 7.51% respectively and 31.76% and 4.7% respectively following bypass
procedures. On univariate analysis in the curative surgery group, higher post-
operative morbidity and mortality was associated with hemoglobin B9gm% (
pB0.055), WBC counts 11,000/cumm (pB0.078), and low albumin B
2.2mg/dl (pB 0.051). Pre-operative endobiliary drainage although associated
with the same was not statistically significant. On multivariate analysis, values
of hemoglobin, alkaline phosphatase and bilirubin taken together improved
the predictability of outcome in the patients. On univariate analysis in the
palliative group, a significant association was seen between alkaline phos-
phatase 650 U/L and higher post-operative morbidity and mortality (pB
0.026). On multivariate analysis values of hemoglobin, albumin and bilirubin
taken together, improved the predictability of outcome.
Conclusion. Mortality rate of 7.51% after curative surgery is encouraging in
Indian context as most of our patients are anaemic or hypoproteinemic with
fairly advanced disease. Complications decrease with gain in experience,
dedicated peri-operative management and team approach. In the palliative
surgery group higher mortality and morbidity was seen in patients with low
hemoglobin and albumin and high bilirubin. Even in the presence of
these adverse factors the surgical option needs to be exercised if endoscopy
fails.
PP 31.02
PANCREATICODUODENECTOMY IN ELDERLY PATIENTS
Ito, Takaaki; Hiramatsu, Kiyoshi; Kato, Kenji
Kiryu Kosei General Hospital, Surgery, Kiryu, Japan
Background./Aims. Due to long life expectancy, a case of resectable
pancreatic cancer or bile duct cancer in the periampullary lesion are
increasing among elderly patients. They may need to undergo pancreatico-
duodenectomy (PD) for the curative therapy. PD is a procedure with
relatively high rate of mortality and morbidity as compared with the other
digestive surgery. The risk and benefit of PD in elderly patients is still unclear.
Therefore, the aim of this study was to investigate the safety of the PD in
elderly patients over 75 years old.
OBJECTIVES. Between 1992 and 2007, One-hundred and forty-nine PDs
were performed at Department of Surgery, Kiryu Kosei General Hospital.
These consecutive cases were divided into two groups by age 75. Fifty
patients were 75-year-old or older (elderly-patient-group: EP). Ninety-nine
patients were under 75-year-old (younger-patient-group: YP). We evaluated
morbidity and mortality in these groups.
Results. Morbidity: These two groups were statistically similar with respect
to sex, intraoperative blood loss, and operative time. Preoperative comorbid-
ity rate was 32.0% (17/50) in EP and 24.2% (24/99) in YP. Complications
associated with surgical techniques, such as pancreatic fistula, anastomotic
leakage, delayed gastric emptying, wound infection etc., occurred in and 32
cases (64%) in EP (p0.323, N.S.) and 55 cases (55.6%) in YP. Mean
length of hospital stay was 47.8 days in EP and 45.5 days in YP. (p0.420,
N.S.) Mortality: Four patients died within 30 days of operation. The three of
them (6.0%) were in EP and one of them (1.0%) was in YP (p0.075, N.S.).
Conclusions. Although high aged patients have trend of high rate of
preoperative comorbidity, PD for elderly patients is as safe as for younger
patients. We conclude that careful selection of the patients can keep safety of
pancreaticoduodenectomy even in the elderly patients.
PP 31.03
PANCREAS-SPARING DUODENECTOMY FOR ADVANCED
DUODENAL CARCINOMA WITHOUT LYMPH-NODE METASTA-
SIS AND PANCREATIC INVASION
Arimitsu, Hidehito1; Cho, Akihiro2; Yamamoto, Hiroshi2; Nagata, Matsuo2;
Kainuma, Osamu2; Takiguchi, Nobuhiro2; Souda, Hiroaki2; Gunji, Hisashi2;
Miyazaki, Akinari2; Matsumoto, Ikuko2; Ikeda, Atsushi2; Nagao, Yoshiko2;
Ryu, Munemasa2
1Chiba Cancer Center Hospital, Division of Gastroenterological Surgery,
Chiba, Japan; 2
Pancreatoduodenectomy (PD) is often required to obtain curative surgical
resection for advanced duodenal carcinoma. However, leakage from pan-
creaticoenteric anastomoses after PD remain associated with intra-abdominal
hemorrhage and subsequent high mortality rates, especially in high-risk
patients. In contrast, recent advances in diagnostic imaging and the surgical
anatomy of the pancreatoduodenal region have made limited resections of the
periampullary area possible. Pancreas sparing-duodenectomy (PSD) has
emerged during the last few years as an alternative to PD and is becoming
increasingly accepted as a technique for the treatment of benign diseases and
low-grade malignancies, such as familial adenomatous polyposis syndrome,
villous adenoma, and duodenal trauma. We successfully performed supra-
ampullary PSD for two high-risk patients of advanced duodenal carcinoma
without lymph-node metastasis and pancreatic direct invasion. Although our
experience is limited and appropriate indications must await future studies,
we believe that supra-ampullary PSD can be feasible and safe in highly
selected patient. This report describes an operative procedure of supra-
ampullary pancreas-sparing duodenectomy.
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THE JUSTIFICATION OF PERFORMING A WHIPPLE?S PROCE-
DURE IN CIRRHOTIC PATIENTS
Pereira, Jorge; Duarte, Emanuel Vigia; Coelho, Joa˜o; Pereira, Jose´ Anto´nio;
Marques, Hugo; Mira, Paulo; Martins, Ame´rico; Barroso, Eduardo
Hospital de Curry Cabral, Centro Hepatobiliopancrea´tico e de Transplanta-
c¸a˜o, Lisboa, Portugal
Background. Pancreatoduodenectomy (PD) is a major surgical procedure
only justified in fit patients that might benefict from such an unavoidable
dissection with a low morbimortality. The coexistence of cirrhosis adds a new
risk to the procedure, increasing the probabilities of major morbimortality.
Aims. to prove that cirrhotic patients with periampulary tumors are still
candidates to major pancreatic resections.
Methods. since 2003, 97 PDs were performed for periampulary tumors.
Among these, 3 patients had cirrhosis:2 male (65 and 62 years old) with
alcoholic cirrhosis and 1 female (69 years old) with criptogenic cirrhosis;all
CHILD A desease and one with coexistent 2 CHC nodes (B 3 cm); they all
were submited to Whipple’s operation (same surgical team). Alcoholization
was performed simultaneously in the CHC case as a bridge to eventual
further liver transplantation.
Results. histology revealed an ampuloma in one case (pT1N0Mx) and a 4
and 5 cm IPMN of the pancreatic head in the other two. All the 3 operations
were performed by the same surgical technique (ligasure dissection, 2 units of
red blood cells in one case).There was no mortality;Morbidity:ascitic fluid
infection followed by reoperation at post-op day 7 (one case);biliary fistula
was detected by the drainage treated conservatively. In all 3 patients, major
ascitis was present for some weeks, complicating pos-operative period with
important hidroelectrolitic imbalance. Patients were discharged at days 18,
25 and 30, uneventfully.
Conclusions. we conclude, from our experience, that Whipple’s
procedure may be indicated in cirrhotic patients with periampulary tumors,
provided they are CHILD A and fit for a potential curative pancreatic
resection.
PP 31.05
HEPATIC ARTERY RECONSTRUCTION IN PANCREATICODUO-
DENECTOMY BY DIRECT ANASTOMOSIS UTILIZING PAN-
CREATICODUODENAL ARTERY.
Hoshino, Takanobu; Ishida, Takashi; Hashimoto, Daijo
Saitama Medical University, Medical Center, Hepato-pancreato-biliary
Surgery, Kawagoe-city, Japan
OBJECTIVE. To present technical aspects and advantages of hepatic artery
(HA) reconstruction by direct anastomosis utilizing pancreaticoduodenal
artery (PDA) as a useful option in pancreaticoduodenectomy.
Methods. Pancreaticoduodenectomy was performed in a patient with
complete obstruction of celiac trunk. A 69-year-old female patient, com-
plaining of jaundice, was admitted with diagnosis of cancer of either pancreas
head or CBD. Angiography demonstrated complete obstruction of celiac
trunk, because of arteriosclerosis, and marked dilation of the arcade between
inferior and superior PDAs. Blood flow of HA turned out to be supplied only
from superior mesenteric artery (SMA) via arcades of PDAs. Therefore, it
was mandatory to perform HA reconstruction to safely complete pancrea-
ticoduodenectomy. OPERATION: Intraoperative findings revealed no tumor
exposure on the surface of pancreas or CBD. There was no tumor invasion to
adjacent tissue and no lymph node swelling, either. Therefore, we decided to
utilize the arcade of PDAs for HA reconstruction. Anterior arcade of inferior
and superior PDAs was carefully dissected and freed, first, by ligating and
dividing small branches communicating to pancreas head. Following
complete dissection of the anterior arcade of PDAs, we performed recon-
struction of HA by end-to-end anastomosis between gastroduodenal artery
and dilated anterior inferior PDA (4 mm in diameters for both arteries). After
adequate blood flow of HA (through this vascular anastomosis) was
confirmed, the rest of pancreaticoduodenal resection followed by biliary
and alimentary tract anastomoses were completed in usual fashion.
Results. Postoperative course was uneventful, and no complication, includ-
ing vascular problems such as anastomotic occlusion or leakage, was
observed. This patient is still alive, free of disease, at four years three months
following surgery.
Conclusion. HA reconstruction utilizing PDAs appears to be one of the
useful options when adequate diameters of the arteries are available.
PP 31.06
REFERRAL PATTERNS AND MANAGEMENT OF PANCREATIC
CANCERS AT A SINGLE, LARGE REFERRAL CENTRE IN THE
UK.
Sethi, Harsheet1; Madanur, Mansoor1; Deshpande, Rahul2; Heaton, Nigel3;
Rela, Mohamed3
1Kings College Hospital, Hepatobiliary surgery, London, United Kingdom;
2Royal Marsden Hospital, Hepatobiliary surgery, London, United Kingdom;
3Kings College Hospital, Hepatobiliary surgery and Transplantation, Lon-
don, United Kingdom
Background. The NHS Cancer plan recommends that specialist assessment
and interventions for patients with pancreatic cancer should be provided by a
multidisciplinary team based at a Regional Pancreas cancer centre serving
populations of 24 million. This was implemented in 2005 aiming to increase
resection rates and reduce hospital morbidity and mortality. We present
management of patients at the regional centre of the South-east England
cancer network since centralisation.
Methods. A retrospective analysis of all pancreatic cancer referrals to the
Multidisciplinary meeting at the regional cancer centre from 2005 till 2007
was carried out. Of the total number of referrals (557), 511 were for
suspected cancer, and 426 were characterized as malignant disease. Pre-
operative staging indicated metastatic disease in 93, locally advanced in 114
and operable tumour in 182 patients. The resectability rates, post-operative
morbidity and mortality were analysed.
Results. 145 patients (29.6%) underwent surgery for pancreatic cancer with
114 pancreatico-duodenectomies, including 3 laparoscopic and 18 vascular
resections. 71% of the resections were for tumours in the head, 22% peri-
ampullary and 5.5% for cystic tumours in body and tail of pancreas. Post-op
morbidity was 32.5%, with pancreatic leak rate of 8.7%. The post-operative
mortality was 2.4%, with a 30-day mortality of 1.2%.
Conclusions. This initial audit of the working of a specialised cancer unit
has provided encouraging data to back-up the role of centralisation in
improving outcomes in pancreatic cancer. Studies focussing on long-term
survival benefits and Quality of life assessment are underway.
PP 31.07
SURGICAL RESECTION FOR MANAGEMENT OF PANCREATIC
CANCER IN OCTOGENARIANS.
Sethi, Harsheet1; Marangoni, Gabriele1; Bartlett, Adam1; Rela, Mohamed1;
Heaton, Nigel2
1Kings College Hospital, Hepatobiliary surgery, London, United Kingdom;
2Kings College Hospital, Hepatobiliary surgery and Transplantation, Lon-
don, United Kingdom
Background. We live in a rapidly aging society with the highest demographic
growth in the very elderly group, over the age of 80 years. Incidence of
pancreatic cancer peaks after the 7th decade. We present management of
pancreatic cancer in octogenarians at a tertiary referral centre.
Methods. A review of departmental data bases of pancreatic cancer referrals
from 2005 to 2007 identified 64 patients over the age of 80 years. Pre-
operative staging included assessment of performance status and discussion
at the multidisciplinary meeting. At initial assessment, 9 patients had
metastases, 27 with locally advanced disease and 28 had resectable tumours.
12 patients were found unfit for surgery, 4 refused surgery, and 12 underwent
surgery. We evaluated peri-operative morbidity, mortality and 6 month
follow-up in these patients.
Results. The surgeries include pancreatico-duodenectomy in 9 patients
including 2 laparoscopic resections, 1 laparoscopic distal pancreatectomy,
and 1 bypass for irresectable tumour found at laparotomy. The tumour was
located in the ampulla and head of pancreas in 5 patients each. The median
duration of surgery was 320 minutes (range 150  660). The median HDU
stay was 1 day (range 16) and the median post-operative hospital stay was 15
days (range 248). The post-operative morbidity of 50% did not include any
pancreatic leak. One patient died on POD2 following a myocardial infarct.
Follow-up at 6 months demonstrated a disease free survival of 92%.
Conclusion. Surgery for pancreatic cancer in octogenarians can be carried
out in a safe and effective manner and chronologic age alone cannot be
considered a contraindication to radical surgery.
PP 31.08
PREOPERATIVE STAGING AND EVALUATION OF PANCREATIC
CANCER PROGNOSTIC FACTORS
Kubyshkin, Valeriy1; Kochatkov, Alexander1; Kriger, Andrei1; Karmaza-
novsky, Grigory2; Gurevich, Larisa3; Stepanova, Yuliya2; Zborovskaya, Irina4
1A.V. Vishnevsky Institute of Surgery, abdominal surgery department,
Moscow, Russian Federation; 2A.V. Vishnevsky Institute of Surgery, radi-
ology department, Moscow, Russian Federation; 3MONIKI, Moscow,
Russian Federation; 4N.N. Blikhina RONC, Moscow, Russian Federation
Background. We assessed the surgical value of staging and molecular factors
in predicting resectability and survival rates of patients with pancreatic head
cancer (PHC).
Methods. 92 patients with PHC were grouped into three classes of
resectability: 1  resectable (55.44%), 2  questionably resectable
(22.82%), and 3  non-resectable (21.74%). We investigated DNA ploidy,
mutations in the K-ras and ð53 genes, LOH of ð16INK4a/15INK4b, DPC-
4, expression of E-cadherin, matrix metalloproteinases-2 (MMP-2), ð53 and
Ki-67 as possible prognostic factors.
Results. Tumor DNA content was aneuploid in 73.9% pts and in 92.3% G3
tumors. Mutations in the K-ras oncogene occurred in 76% tumors. We did’t
find any correlations between K-ras mutation and cancer stage. Mutations in
273 codon of ð53 gene were found in 35.8% tumors. We found a significant
correlation between Ki-67 index and DNA tumor content. Ki-67 index was
27.297 and 1392.8 in aneuploid and diploid tumors (p0.017). Expres-
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sion of MMP-2 was found in 63% tumors. The mean overall survival was
11.5499.27 months. The survival for R0 and R2 patients was 14.8910.7
and 5.592.8 months; and for patients of the 1st, 2nd and 3rd groups was
16.198.3, 8.6594.0, 5.492.9 months respectively. The mean survival of
patients with diploid and aneuploid tumors was 28.8916.34 and 11.698.8
months (ð0.006). Molecular Alteration Index (MAI) did’t have any
correlations to the stage of PHC and tumor grade (ð0.75, ð0.36). For
patients who were alive for less than a year, for less than 2 years and for more
than 3 years mean values of MAI were 77.2795.56%, 45.7598.34% and
34.699.6%, (ð0.006). MAI was a significant prognostic factor in PHC.
The lower the MAI the better was long-term outcome.
Conclusions. The worst PHC prognostic factors are partial or complete
circumscription of the vessels, with or without hepatic metastasis, as well as
tumor cell aneuploidy, high level of Ki-67 index, 273 codon p53 gene
mutations and expression of MMP2.
PP 31.09
EIGHTY CONSECUTIVE PANCREATICODUODENECTOMIES
WITHOUT MORTALITY.
Tank, Avinash Kumar; Singh, Rajneesh Kumar; Behari, Anu; Ashok Kumar,;
Saxena, Rajan; Kapoor, Vinay Kumar
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Surgical
Gastroenterology, Lucknow, India
Introduction. Pancreaticoduodenectomy (PD) is an operation that has
conventionally been associated with a high morbidity (3060%) and mortality
(128%). Recent results from high volume centers report a significant
lowering of mortality and morbidity. However there are only a few published
reports of PD without any mortality.Method.:Eighty consecutive patients
underwent PD without any mortality (from July 2005 to May 2007) and were
analyzed from a prospectively maintained database with regard to presenta-
tion and outcome.
Results. The median age was 53 (range 1782) years. The commonest
presenting symptoms were jaundice 70 (88%), weight loss 71 (88%) and
cholangitis 44 (55%). The mean hemoglobin was 11.4 gm/dl, mean serum
albumin was 3.5 gm/dl and 27 (33%) patients had maximum bilirubin15
mg/dl. Fifty-two (65%) patients underwent preoperative biliary drainage.
Pylorus preserving PD was done in 39 (49%) patients and classical Whipples’
PD was done in 41 (52%) patients. The mean operation time was 7 (range
3.5 to 11) hours and the mean blood loss was 568 (range 100 to 2000) ml, 45
(56%) patients did not require peri-operative blood transfusion. The
pathology of the resected specimen showed ampullary carcinoma in 52
(65%) patients, cholangio-carcinoma in 9 (11%), pancreatic head adeno-
carcinoma in 7 (9%), duodenal carcinoma in 5 (6%) and no malignancy in 7
(9%) patients. Major postoperative morbidity was seen in 35 (44%) patients:
this included bleeding 12 (15%), pneumonia 11 (14%), pancreatico-jejunal
anastomotic leak 11 (14%), hepatico-jejunostomy anastomotic leak 6 (8%),
intra-abdominal abscess 7 (8%), and duodeno-jejunal or gastro-jejunal
anastomotic leak 2 (4%). Re-operation was required in 6 (8%) patients.
There was no mortality. The median post-operative hospital stay was 15
(range 741) days.
Conclusion. Though the morbidity of PD still remains high, it is possible to
achieve a nil operative mortality with improved postoperative care and better
understanding of the postoperative complications
PP 31.10
SURGICAL OUTCOME IN ADENOCARCINOMA OF PANCREA-
TIC HEAD AND UNCINATE PROCESS WITH SMV-PV RESEC-
TION.
K, Dilip Chakravarty1; Hwang, Tsann-Long2; Liu, Keng-Hao2; Yeh, Chun-
Nan2; Yeh, Ta-Sen2; Jan, Yi-Yin2; Chen, Miin-Fu2
1Chang Gung Memorial Hospital, Fellow in HPB Surgery, Dept. of General
Surgery, Taipei, Taiwan; 2Chang Gung Memorial Hospital, Department of
General Surgery, Taipei, Taiwan
Introduction. Adenocarcinoma accounts for more than 80% of all pancrea-
tic malignancies. 5 yr survival is 15 to 25% in most series. The recent
approach towards early diagnosis and aggressive resectability has some
impact on the surgical outcome.
Objective. This is retrospective study carried out from 1996 to 2006 in
Chang Gung Memorial Hospital, Taipei, Taiwan to study the surgical
outcome in patients undergoing surgery for pancreatic head and uncinate
process malignancies with encasement of SMV-Portal vein.
Methods. Only stage II and III adenocarcinoma involving head and uncinate
process were included. Stage I, IV and adenocarcinoma involving pancreatic
neck, body and tail were excluded. Total 87 cases in stage II and III
undergone curative resection. Whipple with PV-SMV resection 12 cases
(13.8%), Whipple without SMV-PV resection 57 cases (65.5%) and PPPD
without SMV-PV resection18 cases (20.7%). 20 cases patients received
palliative treatment in the form of surgery, CTand RT. The factors taken into
consideration are pre-operative staging of tumor, histological type, lymph
node status, tumor size, tumor markers, type of surgery, complications,
adjuvant chemoradiotherapy.
Results. The surgical outcome in terms of mortality, morbidity and survival
rate is compared with PPPD and Whipple procedure with/without SMV-PV
resection. The overall cumulative survival rate in 2 yrs and 4 yrs in patients of
whipple and PPPD is 22.7%,11.3% and those with PV-SMV resection
18.8%,18.8% respectively. 1 yr and 2 yr survival in those with PV-SMV
resection is 50.0% and 31.3% and those patients who undergo palliative
resection/CT, RT is 25.0% and 6.3% respectively.
Conclusion. Pancreatic head and uncinate process adenocarcinoma with
encasement of PV-SMV does not preclude operability and should not be
regarded as a contraindication for radical resection. SMV-PV resection can be
performed safely, without increase in the morbidity and mortality in carefully
selected patients.
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INFECTIOUS COMPLICATIONS IN LIVING DONOR LIVER
TRANSPLANT RECIPIENTS ARE A MAJOR RISK FACTOR OF
EARLY MORTALITY
van den Broek, Maartje1; Saner, Fuat2; Olde Damink, Steven W.M.1; Rath,
Paul3; Paul, Andreas2; Nadalin, Silvio2; Broelsch, Christoph E.2; Malago´,
Massimo4
1University hospital Maastricht, Department of Surgery, Maastricht, Nether-
lands; 2University hospital Essen, Dept. of General, Visceral and Transplant
Surgery, Essen, Germany; 3University hospital Essen, Institute of Medical
Microbiology, Essen, Germany; 4University College London, Department of
Surgery, London, United Kingdom
Background. Living donor liver transplantation (LDLTx) has gained
increasing acceptance for patients with end-stage liver disease. Despite
advances in graft preservation, operating techniques and post-transplant
care, recipient morbidity and mortality remain considerably high.
Objective. We analyzed the influence of post-transplant clinically significant
infections (CSI) on recipient survival after LDLTx.
Methods. All adult LDLTx recipients transplanted in our Unit between
2004 and 2007 were studied. Patients were treated in a single ICU, applying
standardized care consisting of triple immunosuppression, antimicrobial
prophylaxis and selective digestive decontamination. CSI were defined as
pulmonary, intra-abdominal or blood stream infections proven by culture
with accompanying symptoms that reacted to therapy. The influence of CSI
on recipient survival was analysed using Fisher?s exact test. PB0.05 was
considered significant.
Results. Sixty patients constituting of 35 males and 25 females with a mean
age of 49.3911.6 years, underwent LDLTx during the study period. Mean
MELD score was 1497.7. Indications for LDLTx were cirrhosis associated
HCCs (18), viral hepatitis (11), cholestatic liver disease (7), alcoholic liver
disease (5), autoimmune hepatitis (4), acute liver failure (4) and other (11).
CSI arose in 26 (43%) recipients, consisting of 8 pulmonary, 14 intra-
abdominal and 14 blood stream infections. Sixteen (27%) recipients died
during their hospital stay after a median of 18 (069) days and the main cause
of recipient death was septic multi-organ failure in 10 (63%). The risk of
mortality was 5.7 times increased when a clinical significant infection
occurred (p0.0008).
Conclusion. CSI in LDLTx recipients confer a major risk of early post-
transplant mortality. Prevention of such infections is crucial to achieve higher
post-transplant survival rates. Therefore, active identification of graft and
recipient related risk factors is of key importance to improve LDLTx
outcomes.
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TREATMENT OF PORTAL VEIN STENOSIS AFTER LIVING
DONOR LIVER TRANSPLANTATION USING INTERVENTIONAL
RADIOGRAPHY
Amano, Hironobu1; Hirotaka, Tashiro2; Itamoto, Toshiyuki3; Oshita, Aki-
hiko2; Ohdan, Hideki2; Toyota, Naoyuki4; Asahara, Toshimasa5
1Hiroshima University Hospital, Hiroshima, Japan; 2Hiroshima University
Hospital, Surgery, Hiroshima, Japan; 3Hiroshima University Hospital,
Surgery, Hiroshima; 4Hiroshima University Hospital, Radology, Hiroshima,
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Background. Portal vein stenosis is significant factors leading to graft loss
after liver transplantation. However, surgical treatment for this complication
is sometimes very difficult and too much invasive for patients. Recently,
interventional radiography (IVR) technique was developed and applied to
treat this complication. We evaluate IVR as a therapeutic strategy for
postoperative portal vein stenosis based on our experience.
Methods and Results. We have performed 102 cases of living donor liver
transplantation and applied IVR procedure to 3 cases to treat portal vein
stenosis after transplantation. These patients showed clinical signs such as
ascites, jaundice, and liver dysfunction after transplantation, and Doppler US
were useful to diagnose these complications. Three-dimensional computed
tomography (3D-CT) was used to confirm the indications for IVR. Both of 2
patients suffering from portal vein stenosis were treated by percutaneous
transhepatic approach using metallic stent following balloon dilatation, and
showed excellent long-term patency after stenting. On the other hand, one
patient suffering from stenosis of anterior and posterior branches of portal
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vein was treated by jejunal vein approach using metallic stents, and also
showed exellent long-term patency after stenting. We experienced no
complications with these IVR procedures.
Conclusions. IVR can be safely and successfully applied to the treatment of
portal vein stenosis before graft dysfunction becomes irreversible.
PP 32.03
INTRAOPERATIVE PORTAL VEIN STENTING: A SIMPLE
METHOD FOR SEVERE PORTAL VEIN STENOSIS IN LIVING
DONOR LIVER TRANSPLANATION
Ahn, ChulSoo; Lee, SungGyu; Hwang, Shin; Kim, KiHun; Moon, Deok-
Bok; Ha, TaeYong; Song, Giwon; Jung, Donghwan; Lee, HyoJun; Park,
JeongIk; Ryu, JeHo
Asan Medical Center, Surgery, Seoul, Korea, Republic of
In cirrhotic liver, portal thrombosis or stricture is not uncommon due to the
portal hypertension. But maintaining the adequate portal flow is essential for
initial graft function and its regeneration after living donor liver transplanta-
tion(LDLT). Usually thrombectomy or venoplasty is applied to improve
portal flow. But it may be insufficient if the luminal narrowing is located more
proximally. We used the intraoperative portal vein stent to solve this problem.
After the explantation of diseased liver, we examined the portal stump, if the
lumen was narrowed we have performed thrombectomy or venoplasty. Direct
portogram was taken through inferior mesenteric vein just after the
anstomosis and reperfusion of the graft and intraportal stents was inserted.
We applied balloon dilatation when the lumen was not fully expanded after
stenting. Some of collaterals of portal vein were also embolized during
portogram, to prevent portal flow steal. From Jan.2004 to Nov.2006, 615
adult to adult living donor liver transplantations were performed in Asan
Medical Center. In 114 cases(18.5%), portal vein thrombosis or stricture
were detected. We did direct portograms in 20 cases(3.2%). The patients
were 14 men and 6 women. The underlined disease were hepatitis B
associated cirrhosis in 14, alcoholic cirrhosis in 3, others in 3, and 8 of
them had hepatomas. In three cases, we did only portogram without stenting,
and we inserted 20 stents(metallic stent diameter 1cm, length 48cm) in 17
cases. Balloon venoplasty was applied in 6 cases, which showed severe
narrowing after stent insertion. Coil embolization of coronary vein was
performed in one case. The median follow up period was 20 months(134
months), and all patients has good portal flow until now except one case who
expired at postoperative10 month due to the intracranial hemorrhage. In
conclusion, in the case of severe portal vein stenosis, intraoperative stent
insertion can be a simple and good solution to get sufficient portal flow to the
transplanted graft.
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ACUTE PANCREATITIS WITH PSEUDOANEURYSM RUPTURE
AFTER LIVING DONOR LIVER TRANSPLANTATION
Hyo-Jun, Lee1; Sung-Gyu, Lee2; Shin, Hwang2; Ki-Hun, Kim2; Chul-Soo,
Ahn2
1Asan Medical Center, University of Ulsan College of Medicine, Division of
Hepato-Biliary Surgery and Liver trans, Seoul, Korea, Republic of; 2Asan
Medical Center, Seoul, Korea, Republic of
Background. Acute Pancreatitis(AP) is a rare life-threatening complication
occurring 3% to 4% after liver transplantion(LT). It has been described
mainly after orthotopic liver transplantation(OLT) or pediatric OLT in some
cases. It is associated with a mortality rate of more than 50%. (OBJECT)
Herein we report a immediate postoperative acute pancreatitis case with
pseudoaneurysm rupture after adult living donor liver transplanta-
tion(LDLT).
Method. A 37-year-old man who had undergone LDLT, right
graft(750gram) for fulminent hepatitis due to hepatitis A virus infection
developed fatal acute pancreatitis. Donor was his cousin, 37-year-old male.
Preoperatively mental status was comatous. Child-Pough score is 12(Class
C). MELD scrore is 37. UNOS status is 1.
Result. On preoperative CT scan, he underwent panreatitis with peripan-
creatic fluid collection and swelling. Immediate postoperatively pancreatitis
was markly subsided with decreased serum amylase/lipase level. But On
Postoperative 40th day, he underwent emergent reoperation(bleeding control
with gauze packing & external drainage) due to pseudoaneurysm rupture of
peripancreatic vessels with fatal acute pancreatitis. After bleeding control he
was successfully managed with another percutanous drainage, supportive
care with feeding tube through the directly jejunum. Although the patient
repeatedly had gotten into septic condition(pneumonia, peritonitis, bactre-
mia), he have the luck to discharge with recovery at postoperative 289th day.
Conclusion. In conclusion, although AP with pseudoaneurysm rupture after
LDLT is very rare and sereous complication, it is possible to save a life as a
adequetly supportive care.
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SAFETY OF LIVING DONOR LIVER TRANSPLANTATION IN
ELDERLY PATIENTS
Singh, Amanjeet1; Kakodkar, Rahul2; Kumaran, Vinay1; Nundy, Samiran1;
Saigal, Sanjiv1; Saraf, Neeraj1; Soin, Arvinder1
1Sir Ganga Ram Hospital, Surgical Gastroenterology and Liver Transplant,
New Delhi, India; 2Sir Ganga Ram Hospital, Surgical Gastroenterology and
Liver Transplant, New Delhi, India
Background. With advancement in perioperative care and better surgical
techniques, similar graft survival can be achieved with liver transplantation in
patients older than 60 years of age. As living liver donation is relatively new,
there is insufficient data to prove safety of living donor liver transplants in
elderly patients. AIM To assess the safety and efficacy of living donor liver
transplants in elderly patients.
Material and Methods. A retrospective analysis of prospectively collected
data was performed. The preoperative workup, intraoperative course and the
posttransplant outcome of elderly patients (more than 60 years age) was
analysed.
Results. From Jan 2005 to July 2007, of the 150 patients who received living
donor liver transplants at our centre, 13 were aged 60 years or more. There
were 10 males and 3 females with a mean age of 63.5 years (6069 years).
The indications for transplant were Hepatitis C with HCC (5), cryptogenic
(3), alcoholic (2), primary biliary (2) and Hepatitis B cirrhosis (1). 9 patients
received right lobes, 3 left lobes and one had a dual lobe transplant (a right
and a left lobe graft each from two donors). Postoperatively, 2 patients had de
novo cardiac problems, recovered with conservative management. 3 patients
had re-explorations, 2 were for bile leaks and one for drain site bleed. There
was no perioperative mortality. The mean ICU stay was 9.3 days (5  40
days) with a mean hospital stay of 20.4 days (10  47days). Two patients lost
their grafts, died at 7 and 14 months after transplant due to non-compliance.
Rest are alive at a median follow up of 6.2 months (1  21 months).
Conclusion. In our experience, elderly patients did well after liver transplant
in the short and medium term. This may be explained by the extensive
preoperative evaluation done for these patients to rule out age related risk
factors. With rigorous preoperative screening and meticulous perioperative
care, chronological age per se is not a barrier to living donor liver
transplantation.
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RIGHT ANTERIOR SECTORIAL DUCT JOINING THE CYSTIC
DUCT. A REPORT OF THE CASE OF DONOR SURGERY OF THE
LIVING DONOR LIVER TRANSPLANTATION.
Ishiguro, Yasunao; Hyodo, Masanobu; Fujiwara, Takehito; Sakuma, Yasu-
naru; Hojo, Nobuyuki; Kawarasaki, Hideo; Yasuda, Yoshikazu
Jichi Medical University, Surgery, Tochigi, Japan
The donor was a 35 year old lady who had a second son suffered from biliary
atresia followed by biliary cirrhosis. The donor surgery was planed to take the
left lateral segment for the liver graft. Preoperative examination revealed no
abnormal findings except congenital absence of the right kidney. The
intraoperative cholangiography is routinely performed to demonstrate the
biliary system before dissecting the hepatoduodenal ligament. During the
cholangiography through the incision of the cystic duct, the catheter was
easily inserted into the right anterior sectorial duct (RASD) because of it was
joined to the cystic duct with the right posterior sectorial duct joined to the
left hepatic duct. The incision of the cystic duct was carefully closed not to
make biliary stenosis. After harvesting the left lateral segment, the final
cholangiography was performed through the stump of the left hepatic duct to
confirm the appearance of the confluence of the RASD and the cystic duct.
Postoperative course was uneventful. Although the biliary anatomical
variation is frequently encountered, this case is a rare anomalous biliary
connection different from the past reports described as the cystohepatic
ducts. If the RASD is injured, the repair might be difficult because of the thin
duct without dilatation. MRCP is still unsatisfied to demonstrate small biliary
branches especially in the case of donor surgery. We recommend the careful
intraoperative cholangiography through the incision of Hartmann pouch
instead of the cystic duct before dissection of the hepatoduodenal ligament
for the safety of donor surgery.
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BILIARY COMPLICATIONS AFTER LIVE DONOR LIVER
TRANSPLANTATION-A SINGLE CENTRE EXPERIENCE
Yadav, Thakur Deen1; Chawda, Hitesh2; Kangho, Lee2; Tan, K C2
1PGIMER, Chandigarh, India, General Surgery, Chandigarh, India; 2Asian
centre for liverdiseases and transplantation, Singapore, Singapore
Aim: To analyze the biliary complications after live donor liver transplanta-
tion(LDLT) and to assess the recipient’s morbidity related to the overall
biliary complications, and their management.
Patients and Methods. From April 2002 to June 2007 we performed 93
right hemiliver transplants from living donors. There were 73 male
recepients. Liver size and vascular anatomy were assessed by multislice
computed tomography (MSCT) scan with vascular reconstruction. Biliary
anatomy was investigated using an intraoperative cholangiography. Right lobe
transplantation was performed excluding the middle hepatic vein in all cases.
The prospectively kept Data of the patients with short and long term
complications have been analysed.
Results. Biliary complications occurred in 20(21.5%) patients. In 10 cases
we found a single right biliary duct (50%) and in 7 we found two right biliary
ducts (35%), small subsegmental ducts in two(10%) and three right ducts in
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one patient(5%). We performed single biliary anastomosis in 14 cases (70%)
and double anastomosis in the remaining six (30%) cases. Arterial anatomy
was normal in 15(75%) patients. The following biliary complications were
observed: External biliary fistula15, intra abdominal collection/ abscess-12,
late anastomotic strictures6, peritonitis 5. Five patients with biliary
complications died with the mortality rate of 25%. Two patients required
laparotomy to control the sepsis and the rest were managed with non
operative measures.
Conclusions. In conclusion biliary complications affected our series of
ALDLT with a high percentage. Most of the biliary complications were
successfully treated without surgery by interventional radiologists or by
endoscopic interventions. Sometimes the patients who developed a biliary
complication needed multiple treatment and consequent short hospital
readmissions.
PP 32.08
THE VENOUS RECONSTRUCTION AT LIVING RELATED LIVER
TRANSPLANTATION
Kotenko, Oleg; Popov, Alexey; Korshak, Alexandr; Gusev, Andrey; Gri-
nenko, Alexandr; Fedorov, Denis
Institute surgery and transplantology, Department of the liver transplantation
and surger, Kiev, Ukraine
INTRODUCTION. Transplantation of a part of a liver from the alive donor
allows expanding opportunities of cadaveric transplantation and to lower
mortality in a waiting list. Feature of living related liver transplantation
(LRLT) is deficiency of functional weight of a graft in adult and autovenous a
plastic material for performance of vascular reconstruction.
Aim. Aim was studying efficiency of venous reconstruction at LRLT.Mater-
ials and Methods. 51 patients with end stage liver diseases received LRLT
from August 2003 till March 2007, there were 26 adults (51%) and 25 (49%)
patients in the pediatric age group. From 22 patients with biliary atresia in 1
case took place agenesis of the portal vein, in 1  congenital fibrosis of the
portal vein.
Results. From 51 LRLT venous reconstruction was made at 40 patients.
From 7 patients with a portal vein thrombosis at right lobe LRLT in 5 cases
has executed thrombectomy with the subsequent imposing portoportal
anastomosis. In 2 cases due to degenerate changes of a wall portal vein it
was resected and reconstructed. At 1 case dual LRLT portal vein resection
and the subsequent Y-shaped autovenous plasty portal vein has made due to
portal vein thrombosis. At left lateral section LRLT in 2 cases with congenital
portal vein fibrosis portal vein reconstruction in recipient has made with
donor’s left ovarian vein. In other 2 cases cavaportal transposition was made.
For this purpose suprarenal part of inferior vena cava was anastomosed with
left portal vein of a graft. Cavaportal transposition used in one case of right
lobe LRLTat the patient with viral liver cirrhosis and total portal veins system
thrombosis. In 8 cases adults LRLT right lobe harvested with middle hepatic
vein.
Conclusion. Venous reconstructions of a grafts allows to expand indications
to donation parts of a liver from the alive donor, to made LRLT of patients
with a portal vein thrombosis which were considered unpromising earlier and
to provide adequate graft function.
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LONG-TERM OUTCOME OF HEPATIC ARTERY ANASTOMOSIS
USING CONTINUOUS SUTURE TECHNIQUE IN LIVING DONOR
LIVER TRANSPLANTATION
Yi, Nam-Joon; Suh, Kyung-Suk; Lee, Hae Won; Shin, Woo Young; Kim,
Juhyun; Lee, Kuhn Uk
Seoul National University College of Medicine, Surgery, Seoul, Korea,
Republic of
Background. In living donor liver transplantation (LDLT), hepatic arterial
anastomosis (HAA) requires interrupted suture technique (IST) under a
microscope. Continuous suture technique (CST) is simple and time-saving
procedure, but there has been no report HAA using CST in LDLT.
Patients and Methods. From Jan. to Dec. 2005, 7 recipients underwent
HAA using CST in LDLT. Six patients were male, and mean age was 44 (35
62) years. The original liver diseases were viral hepatitis in 6 and primary
sclerosing liver cirrhosis in 1. Although 3 patients had hepatocellular
carcinoma, there was no history of transarterial chemoembolization. The
indications of CST in HAA were large graft hepatic artery (internal
diameter2.0mm) and good quality of recipient hepatic artery. HAA was
performed under microscope using Nylon 80 in an end-to-end fashion.
Patency of arterial flow was followed-up using a US doppler for 5 days and
then using a liver dynamic CT scan 1, 4, and 12 months after surgery. The
mean follow-up period was 23 (21.625.8) months.
Results. All grafts were right livers. The internal diameter of hepatic artery
was 2.2 (2.02.5) mm. The used recipient artery was the right hepatic artery
in 6 and the proper hepatic artery in 1. The mean time of HAA was 28 (20
42) minutes; it was significantly shorter than that of matched historical
control group who underwent HAA using IST (48 minutes) (pB0.05).
There was no mortality and no complication in HAA during follow-up
period. There were 2 biliary strictures at the anastomosis site resolved by
non-surgical method. A 34-year-old male patient suffered multiple post-
operative complications; atrial fibrillation, pneumonia, intrapeirtoneal bleed-
ing, ascites associated with portal vein stenosis resolved with non-surgical
treatment, and mitral regurgitation corrected by surgical valve replacement.
Conclusion. In LDLT, HAA using CST was feasible and saved operation
time for HAA compared with conventional HAA using IST. In addition, it
may guarantee long-term safety.
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VARIATIONS IN BILIARY ANATOMY AND MODIFICATIONS OF
RECONSTRUCTION IN 62 LIVING DONOR LIVER TRANS-
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Background. Biliary complications are common after live donor liver
transplant (LDLT) due to frequent variations in biliary anatomy neccessitat-
ing technical modifications.
Aim. Study the influence of variations in biliary anatomy on incidence,
morbidity and mortality of biliary complications.
Methods. We studied 62 consecutive LDLTs from November 19th 2006 to
July 31st 2007. Biliary anatomy, reconstructive technique, complications and
their management were analyzed.
Results. Of the 62 patients, 48 received right, 12 left, 1 left lateral and 1 dual
lobe grafts. All the left lobe grafts had a single bile duct. 10 had duct-to-duct
(DD) reconstruction and 2 had hepaticojejunostomy (HJ). Of the right lobe
grafts, 41 had single ducts, 6 had 2 ducts and 1 had 3. In the grafts with single
ducts, 37 had DD reconstruction and 4 had HJ due to primary sclerosing
cholangitis (2) or unsuitable recipient duct (2). Of the grafts with 2 ducts, 3
had a common sheath. 2 had DD reconstruction while 1 had HJ. Of the other
3, 2 had a HJ and DD reconstruction to one duct each and 1 had 2 DD
anastomoses. The patient with 3 ducts had a HJ. In the dual lobe transplant,
the right lobe had a DD reconstruction and the left lobe had a HJ. There were
5 bile leaks (8%) and 2 strictures (3%). 2 of the bile leaks were in left lobe
recipients while 3 were in right lobes. None resulted in mortality. Both left
lobe recipients with leaks were explored and found to have cut surface leaks, 1
of which was sealed with fibrin glue while the other was sutured. Of the 3
leaks in right lobe grafts, 1 was explored and a leak from the cut surface was
sealed with fibrin glue. An anastomotic leak was managed with endoscopic
stenting and a biloma was drained percutaneously with resolution of the leak.
The two strictures were managed by percutaneous balloon dilatation and
stenting.
Conclusion. Modifications in the technique of biliary reconstruction can
minimize the rate of biliary complications despite frequent variations in
biliary anatomy in LDLT
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THROMBOPHILIA IN PATIENTS WITH NON-CIRRHOTIC POR-
TAL VEIN THROMBOSIS AND BUDD-CHIARI SYNDROME
Shah, Sudeep1; Abraham, Philip2; Joshi, Anand2; Desai, Devendra2; Das-
Gupta, Amar3
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Background. Thrombophilia is thought to be responsible for non-cirrhotic
portal vein thrombosis (PVT) and the Budd-Chiari syndrome. The sig-
nificance of multiple co-existant conditions has not been well studied.
AIMS: To determine thrombophilias in patients with PVT and BCS with
normal synthetic liver function and compare this with matched controls and
patients developing deep vein thrombosis (DVT)
Methods. Over a 3 year period, 33 patients of PVT and 4 with BCS were
evaluated, after excluding patients with liver dysfunction and secondary
causes of PVT (eg tumour. pancreatitis). Thrombophilia screen was
performed. The incidence of thrombophilia was compared with 18 patients
developing de-novo DVT following joint surgery and 50 healthy controls.
Results. Of the thrombophilias, Protein C deficiency was the most prevalent
(n13), followed by Protein S (n10) and Antithrombin (n8). Antic-
ardiolipin antibody syndrome, lupus anticoagulant, Factor VIII elevation and
hyperhomocysteinemia were rare. Factor V Leiden mutation was seen in 3
patients. Overall, thrombophilias were seen in 22 patients with PVT and 2
with BCS- both having polycythemia rubra vera. In contrast to patients with
DVT where only one of the patients had more than one thrombophilia, 10 of
those in the study group had multiple thrombophilia (p0.08, Fisher’s exact
test).
Discussion. Thrombophilias were present in the majority of patients with
PVT. Patients with BCS were difficult to recruit as few had normal synthetic
liver function. Factor V Leiden mutations were less common as compared to
the West. Multiple thrombophilic states were seen in 30% of PVT patients
and this was more common than in patients with DVT.
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LOW INCIDENCE OF THROMBOEMBOLIC EVENTS AND
SAFETY OF LOW MOLECULAR WEIGHT HEPARIN THROMBO-
PROPHYLAXIS IN LIVER RESECTION-10 YEAR CAMBRIDGE
EXPERIENCE
Kan, Yuk-Man; Jah, Asif; Paulvannan, Subramanian; Sadat, Umar; Gibbs,
Paul; Praseedom, Raaj K; Jamieson, Neville V; Huguet, Emmanuel L
Addenbrooke’s Hospital, Hepatobiliary and Transplant Surgery, Cambridge,
United Kingdom
Introduction. Thromboembolic events are a recognised complication in
patients undergoing major surgery but the incidence post liver resection has
never been reported. Prophylactic anticoagulation with low molecular
heparin in this group of patient is controversial and world wide practice
varies. This study is the first to document the incidence of thromboembolic
events and the safety of clexane use in patients undergoing major liver
resection.
Methods. Over a 10 year period between 1997 to 2007, 301 major liver
resections were undertaken for malignancy of the liver or biliary tract. Mean
age was 56.8 years. All received thromboprophylaxis with clexane, compres-
sion stockings and intra-operative pneumatic calf compression. Resections
were undertaken by open technique except for one which was performed
laparoscopically. Operative, post op clinical, biochemical and haematological
outcome parameters were recorded with particular reference to coagulation
related complications.
Results. Mean operative time was 167 minutes; mean blood loss was 500mls
and mean blood transfusion 200mls. Only 3 patients (1%) developed a
thromboembolic event with radiologically proven pulmonary emboli. There
was a 25% drop in platelets levels immediately post operatively from day 0 to
3 but this returned to pre-operative levels by day 7. Only one case of heparin
induced thrombocytopenia was identified and one patient returned to theatre
for haemorrhage. There were no epidural related complication.
Conclusions. Thromboembolic events are a rare event in our institution
following major liver resection for malignancy. This may in part be due to the
antithrombotic strategies we employ but the observed post operative
derangement in the clotting profile and our findings of falling platelets in
these patients may also contribute. The use of prophylactic clexane appears
to be safe in these patients.
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EVIDENCE BASED LIVER SURGERY: IS IT FEASIBLE?
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Background. Evidence based guidelines are the gold standard in patient
care. However, the evidence base of surgical practice in hepatobiliary surgery
is low since only a small number of randomized controlled trials (RCT) have
been performed.
Objective. To determine the feasibility of conducting an RCT in hepato-
biliary surgery.
Methods. A structured literature search retrieved all descriptive English
articles published in the last decade using mortality or morbidity after partial
hepatectomy as endpoint. The sample size (a0.05 and b0.1) for a
hypothetical RCT aiming to show a reduction in mortality or morbidity by a
third or one half was calculated using 25% trimmed mean incidence rates.
Results. Out of 892 studies, eighteen studies were included comprising
7,499 patients (7,704 resections). Thirty day and in-hospital mortality were
2.8% (90.3) and 4.4% (90.9), respectively. Total morbidity rate was 37.2%
(9 8.0) and the incidence rates of the clinically most relevant complications
were pneumonia (6.0%), bile leakage (5.5%), intra-abdominal abscess
(5.5%), wound infection (5.3%), sepsis (4.0%) and post-resectional liver
failure (3.7%). The smallest numbers of patients necessary to enrol in an
RCT aiming to show a 33% reduction of in-hospital mortality and the
clinically relevant complications bile leakage and post-resectional liver failure
were 6892, 5448 or 8298 or to show a 50% reduction were 2766, 2188 or
3328, respectively.
Conclusion. The conductance of an RCT in liver surgery seems hardly
feasible, since it would imply extreme multi-centre collaborations or
exceptionally long inclusion periods given the required sample size. However,
studies designed with fewer patients are underpowered and should be
interpreted with care. Therefore, surrogate endpoints represented by highly
specific and sensitive biomarkers should be developed and considered as
primary outcome parameters for RCTs.
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OXIDATIVE STRESS IN PORTAL VEIN EMBOLIZATION; FACT
OR FICTION?
Makay, Ozer1; Firat, Ozgur1; Gurcu, Baris1; Gokce, Goksel2; Sapaz, Nazli1;
Zeytunlu, Murat1; Yenisey, Cigdem3; Coker, Ahmet1
1Ege University Hospital, General Surgery, Izmir, Turkey; 2Ege University,
Pharmocology, Izmir, Turkey; 3Adnan Menderes University Hospital,
Chemistry, Aydin, Turkey
Background. Whether liver failure develops after hepatectomy depends on
how well the remnant liver functions after resection. Preoperative treatment
with portal vein embolization (PVE) has been reported to increase resect-
ability and to reduce posthepatectomy complications. The evidence that
oxidative stress has any impact on complications and hepatic regeneration is
weak. This study was conducted to investigate the role of reactive oxygen
radicals in the pathogenesis of PVE.
Methods. Rats were divided into three groups that underwent (1) lapar-
otomy only (control group); (2) right portal vein ligation (RPL) group 
sacrificed postoperative 72nd hour; (3) RPL  sacrificed postoperative 15th
day. Serum levels of AST, ALT, GGT and cholesterol were measured for
determining hepatic reserve and levels of oxidative stress markers like
malondialdehyde (MDA), nitric oxide (NO), glutathione (GSH), catalase
(CAT), superoxide dismutase (SOD) and gluthatione peroxidase (GPx) were
determined.
Results. When compared to group 1, the mean MDA and NO levels were
higher, while GSH, CAT, SOD and GPx were lower in group 2 and group 3
(pB0.01). Differences of all assessed oxidative stress markers between group
2 and 3 reached no significance (p0.05). Moreover, serum AST, ALT and
GGT levels were significantly higher in group 2 and 3, compared to group 1
(pB0.05). There was also a significant difference between groups in means of
cholesterol levels (pB0.05).
Conclusion. These data collectively support that oxidative stress is a critical
step in PVE related injury in the acute and the late phase, and suggest that
antioxidant strategies designed to either inhibit free radical formation or to
scavenge free radicals may provide protection during hepatic regeneration.
PP 33.05
ROLE OF ERCP IN COMPLICATED HYDATID DISEASE OF
LIVER
Kochhar, Rakesh1; Dutta, Usha1; puri, pankaj1; nadkarni, Nikhil1; Kochhar,
s2; sinha, saroj k1; sriram, PVJ2; nagi, birender1; wig, Jai D3; singh, kartar1
1PGIMER, Chandigarh, India, Gastroenterology, chandigarh, India; 2PGI-
MER, Chandigarh, India, radiodiagnosis, chandigarh, India; 3PGIMER,
Chandigarh, India, General Surgery, chandigarh, India
Background.: ERCP has emerged as an effective form of management in
biliary rupture of hepatic hydatid cysts.
Aims. Retrospective analysis of outcome of therapeutic ERCP in patients
with complicated hydatid cysts of liver.
Material and Methods. Records of all patients of complicated hydatid cysts
(HC) of liver seen by us between 1993 and 2007 were retrieved and analysed
for clinical presentation, radiological features, endoscopic procedures done
and outcome.
Results. A total of 24 patients (13 males, age 1350 yr) had presented to us
with cholangitis (n16), pain and jaundice (n3) and post-operative biliary
fistula (n4). 17 patients had a single cyst, 4 had two and 3 had three cysts,
19 patients had cysts in the right lobe, 2 in left lobe and 3 in both the lobes.
ERCP revealed intrabiliary rupture of HC in 18, a fistula in 5 (cystobiliary in
4, brocho-cysto-biliary in 1) and dilated CBD with daughter cysts/mem-
branes in 12. 12 patients underwent sphincterotomy, 22 underwent
nasobiliary drainage (NBD) (into cyst cavity in 5, in hepatic duct in 17),
CBD stent placement in 3 and extraction of daughter cysts/membranes in 12.
16/16 patients with cholangitis had resolution, 4/5 with biliary leak resolved,
with NBD/stent placement for 612 weeks. 18 patients were subsequently
operated upon, while 7 patients did not need any surgery. One patient with
broncho biliary fistula died post operatively.
Conclusion. ERCP will nasobiliary drainage/stenting helps resolve
cholangitis in patients with ruptured HC, and is also effective in management
of post-operative biliary fistula in such patients, avoiding surgery in the
latter.
PP 33.06
ETIOLOGICAL PROFILE OF PEDIATRIC PORTAL HYPERTEN-
SION IN SOUTH INDIA
Simon, Ebby; Joseph, A J; George, Biju; Zachariah, Uday; Eapen, C E;
Chandy, George; Ramakrishna, B S; Kurian, George; Chacko, Ashok
Christian Medical College, Dept of GI Sciences, Vellore, India
Introduction. Causes of portal hypertension in children are different from
those in adults. Extrahepatic portal vein obstruction (EHPVO) is the most
common cause of upper GI bleed in childrenObjective. To study the
etiological profile of pediatric portal hypertension in our centre.
Methods. Retrospective analysis of patientsB16 years old, who had upper
GI endoscopy and abdominal imaging for portal hypertension in our
institution between May 2000 and April 2007.
Results. Of 724 pediatric patients who had upper GI endoscopy, 171(24%)
had portal hypertension (male: female ratio 2.8:1 and mean age 9.2(SD 3.4)
years). 63(38%) were from West Bengal and 56(34%) were from Tamil
Nadu. The etiology of portal hypertension was as follows: EHPVO -
113(66%), intrahepatic causes-56(33%) and Budd Chiari-2(1%). Among
the intrahepatic causes, 38(66%) had cirrhosis, 6(11%) had NCPF, 1(2%)
had Caroli’s syndrome and 11(19%) were unclassified. Among those with
cirrhosis, 21(55%) had Wilson’s disease, 4(10%) had autoimmune hepatitis,
156 Abstracts
2(5%) were HBV related, 1(3%) had biliary atresia, 1(3%) had primary
sclerosing cholangitis and 9(24%) were cryptogenic.
Conclusion. In our centre, the commonest causes of pediatric portal
hypertension were EHPVO and cirrhosis. Wilson’s disease was the most
common cause of cirrhosis in this series.
PP 33.07
FIBRIN-COATED COLLAGEN FLEECE PATCHES OR LIQUID
FIBRIN GLUE? CLINICAL OUTCOME AND COST EFFECTIVE-
NESS IN LIVER RESECTION
Scho¨n, Michael R.1; Zaatar, Mohamed1; Kaps, Maria2; Hauss, Johann P.2;
Wiegel, Natalie1
1Klinikum Karlsruhe, Surgery, Karlsruhe, Germany; 2University of Leipzig,
Surgery, Leipzig, Germany
Background. Improved dissection techniques and sealing of the resection
surface with fibrin glue are essential to reduce blood losses in liver surgery.
Fibrin glues are available in the form of fibrin-coated collagen fleece patches
that are fitted to suit the resected area, and also as liquid fibrin sealant for
spray application.
Objective. This study compares the postoperative outcome and cost
effectiveness of both fibrin products in patients undergoing liver resection.
Methods. Liver resection was carried out in 50 patients. In group 1 fibrin-
coated collagen fleece patch (Tachocomb, n25) was used as a sealant. In
group 2 a liquid fibrin glue (Quixil, n25) was used by spray application.
Both groups were matched for age, sex, type of pathology, American Society
of Anesthesiologists (ASA) classification, operation time and resection extent.
Transfused blood/plasma, ICU-/hospital stay and cost per segment/patient
were analysed.
Results. Differences in number and weight of resected segments, transfusion
requirements, complications, ICU and hospital stay were not significant
between both groups (pB0,05). The median costs of haemostatic agents per
patient were 583 Euros in group 1 and 316 Euros in group 2 (p0.014). For
a better comparison costs spent for haemostatic agents per resected liver
segment were calculated. In group 1 the median costs were 146 Euros per
resected segment and 105 Euros in group 2 (p0,019).
Conclusion. Fibrin-coated collagen fleece patches (Tachocomb) and liquid
fibrin glue (Quixil) have comparable hemostatic properties. There are no
significant differences in the postoperative outcome of the patients in both
groups. However, application of liquid fibrin glue has a financial advantage
over fibrin-coated collagen fleece patches.
PP 33.08
GADOXETIC ACID (PRIMOVIST) IMPROVES THE SPECIFICITY
OF MRI FOR MALIGNANT LIVER LESIONS COMPARED TO
GADOLINIUM/SUPRAMAGNETIC IRON OXIDE(RESOVIST)
patel, bhavik1; Pring, Christopher2; Ko, Hyun3; Tesar, Paul3; O’rourke,
Nicholas3
1royal brisbane and womans hospital, brisbane, Australia; 2royal brisbane and
womans hospital, Australia; 3Australia
Background. Distuinguishing benign and malignant liver lesions on MRI
scanning remains a challenge. The introduction of contrast agent gadoxetic
acid(Primovist), which functions by hepatocyte uptake, should improve the
specificity of MRI scanning, which compared to gadolinium plus supramag-
netic iron oxide (Resovist), which functions by Kupffer cell uptake. AIM To
assess the improved diagnostic accuracy of primovist over Resovist in
determining benign and malignant liver lesions.
Methods. We have performed a retrospective cohort analysis of all patients in
our unit who had a liver resection, between January 2005-September
2007.We analysed the MRI images and the final histology, to assess the
specificity of Primovist and Resovist in determinig benign and malignant
lesions.
Results We performed approximately 90 liver resections over the study
period. 15 of these had preoperative MRI imaging with Primovist and 25 had
preoperative imaging with gadolinium and Resovist. 40%of the resections
were benign lesions in the Primovist group and 52% were for benign lesions
in the Resovist group.
Conclusions. This small retrospective study, which indicates that the new
agent Primovist may have higher specificity for malignant lesion than
Resovist.
PP 33.09
CONSERVATIVE TREATMENT OF BLUNT ABDOMINAL
TRAUMA INVOLVING THE LIVER AND AT LEAST ANOTHER
SOLID ABDOMINAL ORGAN
Papavramidis, Theodossis S.1; Kartalis, Nick2; Potsi, Stamatia2; Michalo-
poulos, Antonis1; Papadopoulos, Vassilis N.1; Paramythiotis, Daniel1; Duros,
Vassilios1; Kouskouras, Konstantinos2; Dimitriadis, Athanasios2; Harlaftis,
Nikolaos1
1A.H.E.P.A. University Hospital, Aristotle’s University of Thessaloniki,
Macedonia, Greece, 1st Propedeutic Department of Surgery, Thessaloniki,
Greece; 2A.H.E.P.A. University Hospital, Aristotle’s University of Thessalo-
niki, Department of Radiology, Thessaloniki, Greece
Background. The diagnosis of blunt abdominal trauma is suspected on the
basis of the mechanism of injury and the presence of associated injuries. In
trauma centers, ultrasonographic examination elucidates many aspects of the
trauma; nevertheless CT scanning is necessary in grading blunt abdominal
trauma. The present study aims to evaluate the conservative treatment when
multiple solid organs are implied in blunt abdominal trauma.
Material. Between 1/1/2003 and 31/12/2006 43 patients (among 1866
trauma patients) with blunt abdominal trauma involving the liver and at least
another solid organ were treated our clinic. There were 36 men and 7 women
with average age of 42.72y (range: 1880yrs, SD 20.32yrs). The liver injuries
were combined in 15 patients (34.9%) with splenic injury, in 16 (37.2%) with
kidney injury, and in 12 (27.9%) with both splenic and kidney injury.
According to AAST the patients had the following types of injuries: (i) Liver:
Grade I 2 patients, Grade II 15 patients, Grade III 9 patients, Grade IV 15
patients, Grade V 2 patients; (ii) Spleen: Grade I 4 patients, Grade II 11
patients, Grade III 8 patients, Grade IV 2 patients, Grade V 2 patients; (iii)
Kidney: Grade I 5 patients, Grade II 9 patients, Grade III 7 patients, Grade
IV 7 patients. 15 patients had hemodynamic instability and necessitated
surgery, while 28 were treated conservatively.
Results. The mean hospitalization was 60.2 days for the surgically treated
patients, while it was 12.3 days for the conservatively treated patients. The
overall mortality rate for the surgically treated patients was 53.3%, while for
the conservatively treated patients it was 10.7%.
Conclusion. Liver trauma is a difficult problem in emergency surgery. When
radiological imaging associates liver trauma with other solid abdominal organ
injuries conservative treatment is not common practice. The present study
demonstrates that the non-operative treatment has to be considered when
hemodynamic stability is present even in multi-organ injured patients.
PP 33.10
MANAGEMENT OF BUDD-CHIARI SYNDROME-SINGLE CEN-
TRE EXPERIENCE
Khan, Abdaal; Dafallah, Mutasim; El-Sarraj, Ibrahim; Sabra, Bilal; Al-Baiz,
Khuloud; Nafea, Osama; Al-Abdulkareem, Abdulmajeed
KING ABDULAZIZ MEDICAL CITY, HEPATO-BILIARY SCIENCES,
RIYADH, Saudi Arabia
Background. Budd Chiari Syndrome (BCS) is a rare hepatic disorder,
which results from obstruction of hepatic venous outflow tract. With the
advent of transjugular intrahepatic portal systemic shunt (TIPS), surgical
shunts are less commonly performed.
Methods. We retrospectively reviewed the experience of management of this
syndrome by medical treatment alone, surgical shunt, TIPS (since 1998) and
liver transplantation over the last 15 years at King Abdulaziz Medical City,
Riyadh, Saudi Arabia.
Results. A total of 25 cases were reviewed. There were 17 males. Mean age at
diagnosis was 29.6 (10.4) years. Presentation was fulminant in 3, acute in 14
and chronic in 8 patients. The etiology was confirmed for 40% of cases and
included 16% with myeloproliferative disorders, and Behcet’s syndrome
12%. The site of block was restricted to the hepatic veins in 60% while 32%
had hepatic venous obstruction combined with inferior vena cava (IVC)
involvement. Majority presented with ascites (88%) and hepatomegaly
(68%). Best medical treatment was given to 11 patients of whom 4 died in
hospital. A surgical shunt was performed in 9. TIPS were scheduled in 8
patients. There was complete blockage of IVC in 3 patients. TIPS were
successfully placed in 4 of 5 patients. TIPS revision was required in 3
patients. The 5- year survival (Kaplan-Meier) was 45.44%. Hospital
mortality was 24%. Median follow-up of survivors was 12 months (Range
1- 120 m). One patient underwent liver transplantation.
Conclusions. TIPS has supplanted surgical shunts in the management of
BCS in selected patients.
PP 33.11
MANAGEMENT OF IATROGENIC BILIARY INJURIES IN A RE-
FERRAL CENTER: ANALYSIS OF 54 PATIENTS
gurcu, baris; uguz, alper; aydin, unal; firat, ozgur; parildar, mustafa; memis,
ahmet; ersoz, galip; tekesin, oktay; zeytunlu, murat; kilic, murat; coker,
ahmetege university school of medicine hospital, HPB working group, izmir,
Turkey
Background. To evalute the changes in the pattern of iatrogenic biliary
injury and consequential effects on treatment stategy and outcome.
Methods. Fy`fty four patients treated for iatrogenic biliary injury (IBI)
between 2003 July 2007 May at a tertiary care center in izmir, turkey were
retrospectively analysed.
Results. Underlying diseases were; missed tumo¨r (n:2%3,7)biliary surgery
(n:47%87) and hydatic disease (n:3%5,5) in recent years with a gradual
increase in the availability of endoscopic and radiologial expertise the
majority of patients underwent extensive preoperative diagnostic and
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therapeutic procodures including endoscopic retrograd panceratography
(n:17%31,4) and percutaneus transhepatic cholangiography (n:29 53,7).
definitive surgery was performed in all patients. roux en y hepaticojejunost-
omy was the reconstruction most frequently performed (n:28%51,8) there
was only one (% 1,85) hospital mortality. restenosis developped in two
patient (%2,9) and was reoperated. percutaneus baloon dilatation was failed
in three patients as a first treatment option. none of patients died of disease
related causes during the follow up period.
Conclusion. Increased experinece in laparoscopic biliary surgery might
be caused to attempt more challenging cases and increased bilary tract
injuries.
PP 34.01
PERIOPERATIVE USE OF THE LIMON METHOD OF INDOCYA-
NINE GREEN ELIMINATION MEASUREMENT TO DETECT
POST-HEPATECTOMY LIVER FAILURE
de Liguori Carino, Nicola; O’Reilly, Derek A.; Wong, Chang; Ghaneh, Paula;
Poston, Graeme J.; Wu, Andrew
University Hospital Aintree, Supra-Regional Hepato-Biliary Unit, Liverpool,
United Kingdom
Introduction. There are few practical and reliable tests for the estimation of
hepatic functional reserve in patients being assessed for hepatic resection.
Recently, a non-invasive liver function monitoring system, the LiMON
(Pulsion Medical Systems, Munich, Germany), has been developed that
measures indocyanine green (ICG) elimination by pulse spectrophotometry.
The aim of this study was to assess the utility of the LiMon system in the
prediction and early detection of liver failure post-hepatectomy.
Methods. Indocyanine green elimination, using the LiMON system, serum
liver function tests and Child-Pugh score were assessed in 31 patients
undergoing major liver resection (50%) pre-operatively and at days 1, 5
and 10 post-operatively. Post-operative course, complications and final
outcome were recorded.
Results. There were 22 men and 9 women with a median age of 67 years
(range 3977). Linear regression using Sperman’s rank correlation shows that
there is a significant correlation between ICG Plasma Disappearance Rate
(PDR%/min) value as measured on post-operative day 1 and Bilirubin levels
at post-operative days 1, 5 and 10, pB0.001, B0.001, B0.001 respectively.
Albumin levels at post-operative days 5 and 10 are significantly correlated
(pB0.006, B0.001) to ICG Plasma Disappearance Rate (PDR%/min) as
measured on post operative day 1. There is no significant relationship
between pre-operative PDR value and Bilirubin levels at post-operative days
1, 5 and 10, p0.67,0.79,0.35, respectively.
Conclusions. LiMON ICG elimination by pulse spectophotometry
is a quick, non-invasive and reliable liver function test in patients undergoing
liver resection that aids in the early identification of post-hepatectomy liver
failure.
PP 34.02
LIVER REGENERATION AFTER HEPATECTOMY IN HGFA DE-
FICIENT MICE
Uchiyama, Shuichiro1; Nagaike, Koki1; Chijiiwa, Kazuo1; Tanaka, Hir-
oyuki2; Fukushima, Tsuyoshi2; Kataoka, Hiroaki2
1Miyazaki University School of Medicine, Surgical Oncology and Regulation
of Organ Function, Miyazaki, Japan; 2Miyazaki University School of
Medicine, Section of oncopathology and regenerative biology, Miyazaki,
Japan
Background.: Hepatocyte growth factor activator (HGFA) is a serum
protease that is responsible for proteolytic activation of the precursor form
of hepatocyte growth factor (HGF) in injured tissues. HGFI@functions as a
mitogen, morphogen,I@motogen, and angiogenic factor for various cells
through MET receptor tyrosine kinase. HGFA is strongly detected in the
liver, which has been thought to be the major source of HGFA. We generated
mice deficient in HGFA, and we have previously demonstrated that HGFA
deficient mice were viable and fertile without obvious abnormalities, and that
regeneration of injured intestinal mucosa was impaired in HGFA-deficient
mice.
Aim. To investigate the precise role of HGFA in the mechanisms of HGF
activation during liver regeneration, we performed a 70% hepatectomy in
wild type mice and HGFA-deficient mice.I@ Expression of Hepsin and
matriptase-2, hepatic transmembrane serine protease expressed in the liver,
was also analyzed by using RT-PCR analysis.
Results. Both wild type and HGFA deficient mice were all alive for a week
after hepatectomy, and there was no significant difference in the regenerated
liver weight between the two groups. Hepsin and matriptase-2 were
significantly upregulated in HGFA-deficient mice compared with wild type
mice.
Conclusion. The results suggest that loss of HGFA is compensated for other
functionally related serine protease gene products.
PP 34.03
DOES THE REMNANT LEFT LIVER SEGMENTAL REGENERA-
TION AFTER RIGHT HEPATECTOMY DEPEND ON MIDDLE
HEPATIC VEIN ANATOMY?
FAITOT, Franc¸ois1; VIBERT, Eric1; KOSKAS, Franck2; AZOULAY,
Daniel1; ADAM, Rene´1; BELLIN, Marie-France2; CASTAING, Denis3
1Paul Brousse hospital (AP/HP), Centre Hepato Biliaire, VILLEJUIF,
France; 2Paul Brousse hospital (AP/HP), Radiology department, VILLE-
JUIF, France; 3Paul Brousse hospital (AP/HP), Centre Hepato Biliaire,
94804, France
Introduction. Hepatic surgery is based on liver anatomy but few anatomic
studies have been conducted on operated livers. The aim of this study was to
describe and assess segmental volumetric variations and their anatomic
determinants focusing on middle hepatic vein (MHV) anatomy. Material and
method: Pre- and 1-month post-operative CT scan of 9 patients with normal
liver operated of a right hepatectomy (RH) with conservation of MHV (living
donors (n6), HCC (n1), cholangiocarcinoma (n1) and colo-rectal
cancer metastasis (n1)) were analysed. Left liver segments, their propor-
tions to the left liver and spleen volumes were calculated. They were
compared one to each other using a Student t-test. MHV anatomy before
RH was analysed using the depth of middle hepatic vein confluence and
Nakamura’s classification of inter-segmental area. We looked for correlation
between MHV anatomy and regeneration rate of left lobe (LL) and segment 4
(S4).
Results. Before RH, whole liver, segment 1, LL, S4 and spleen volumes were
respectively 14829246cc, 27919cc, 2579121cc, 224980cc and 2419
104cc. After RH, these volumes were respectively 11259235cc, 36927cc,
7729181cc, 313969cc and 3469170cc. Liver regeneration are more
important for LL than for S4 (p0.001). There was no difference of whole
liver regeneration rate according to MHV anatomy whatever classification
was used. There was no difference neither for LL nor for S4 between the
groups using Nakamura’s classification (respectively p0.21 and 0.51).
There was a significant difference of proportion variation of S4 and LL
between the groups using depth of confluence: a later confluence of the
segment 4a branch was associated with significantly lower regeneration of
segment 4 (p0.0002) and a significantly higher LL regeneration (p
0.0012) than an early confluence.
Conclusion. After RH, remnant liver regeneration seems to be more due to
left lobe growth than to S4 growth. The depth of MHV confluence before RH
plays a role in this inhomogeneous regeneration.
PP 34.04
Safety and Liver Regeneration following Hepatic Trisectionectomy
for Hepato-Biliary Malignancies
Paik, Kwang Yeol1; Chung, Jun Chul2; Lee, Hyung Geun1; Ryu, Dong Do1;
Heo, Jin Seok1; Choi, Seong Ho1; Choi, Dong Wook1
1Samsung Medical Center, Surgery, Seoul, Korea, Republic of; 2Soon Chun
Hyang Bucheon Hospital, Surgery, Bucheon, Korea, Republic of
Extensive liver resections such as right or left trisectionectomy ( RTS or LTS)
are required more frequently for pathologically curative resection for various
hepato-bilary malignancies. This study was conducted to evaluate the safety
and to identify the factors to affect liver regeneration. Retrospective analysis
of prospectively collected data for 12 patients who underwent RTS or LTS
from May 2005 through June 2006 in Samsung Medical Center was
performed. Preoperative portal vein embolization was applied if the future
remnant volume will be less than 20%. In case of cholestatic liver, surgery
was carried out if bilirubin level was below 3 mg/dl. Liver regeneration was
estimated with volumetry by serially checked MDCT scan. There were 7
male and 5 female patients, whose median age was 54.8. 3 RTS, 7 RTS plus
caudate lobectomy and 2 LTS plus caudate lobectomy were performed for 7
hilar cholangiocarcinoma, 2 intrahepatic cholangiocarcinoma and 3 others
with 2 portal vein resection. Average operation time was 430 min and hospital
stay was 18.3 days. 8 patients developed various complications including 1
biliary leakage without liver failure or mortality. Fortunately, we could
achieve pathological curability for all cases. Average remnant liver volume
was 32.7%, which increased to 46.9%, 61.7%, 76.0%, 76.5% and 76.6%
after 1 week, 1 month, 3 months, 6 months and 12 months. Age and body
surface area were statistically significant factors affecting postoperative
liver regeneration. Conclusion; Further study should be followed to
investigate the limit of maximal liver resection rate for advanced hepato-
biliary malignancies.
PP 34.05
SEQUENTIAL RIGHT HEPATIC VEIN EMBOLIZATION AFTER
RIGHT PORTAL VEIN EMBOLIZATION TO INDUCE LEFT LIVER
HYPERTROPHY IN HILAR BILE DUCT CANCER PATIENTS
Hwang, Shin1; Lee, Sung-Gyu1; Ko, Gi-Young2; Ha, Tae-Yong1; Song, Gi-
Won1; Lee, Kwang1; Ryu, Je-Ho1
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Korea, Republic of; 2Asan Medical Center, University of Ulsan, Department
of Radiology, Seoul, Korea, Republic of
Background. Preoperative right portal vein (RPV) embolization has been
performed to induce contralateral hypertrophy for right liver resection, but
the effect of ipsilateral atrophy-contralateral hypertrophy was not definite in a
small proportion of our 500 patients.
Patients and Methods. We prospectively performed sequential right hepatic
vein (RHV) embolization after right portal vein embolization to accelerate left
liver hypertrophy in 6 hilar bile duct cancer patients undergoing right
lobectomy. The indication of RHV embolization was insufficient regeneration
of the left lobe (B 40% of whole liver volume after RPV embolization) and/or
high operative risk (age65 years, major co-morbidity, low hepatic func-
tional reserve and concurrent pancreatoduodenectomy).
Result. RHV emolization was performed after determination of interlobar
liver volumes using 2-week computed tomography volumetry after RPV
embolization. RHV embolization was performed through internal jugular
vein approach. Before RPV embolization, mean left lobe volume proportion
to the whole liver volume was 34%; after 2 weeks, it increased to 39%; and 2
weeks after RHV embolization, it became 43%. No procedure-related
complication occurred. All patients successfully underwent right
lobectomy, caudate lobectomy and bile duct resection, and concurrent
pancreatoduodenectomy was performed in 1 patient. All patients recovered
uneventfully. Immunohistochemical studies revealed that apoptosis was
definitely increased in the area of RPV and RHV embolization; proliferative
index was higher in the left liver comparing with only RPV embolization
group.
Conclusion. Sequential RPV-RHVembolization is a safe and effective tool to
induce contralateral hypertrophy. The underlying mechanism of RHV
embolization seems to be complete blockage of portal flow through
interference of intrahepatic arterio-portal collateral flows.
PP 34.06
Effects of Simultaneous Colonic Resection on Liver Function and
Regeneration: An Experimental Study in Rats
Sasanuma, Hideki1; Viborg Mortensen, Frank1; Okada, Masaki1; Yasuda,
Yoshikazu1; Funch-Jensen, Peter2; Nagai, Hideo1
1Jichi Medical School Hospital, Department of Surgery, Shimotsuke, Japan;
2Aarhus University Hospital, Department of Surgical Gastroenterology L,
Aarhus, Denmark
Background. and AIMS: The surgical strategy for the treatment of color-
ectal cancer and synchronous liver metastases remains controversial. The
effects of simultaneous colectomy on liver function and regeneration have yet
to be identified. The aim of the present study was to investigate the effects of
colonic resection on the liver function and regeneration in rat model.
Methods. One hundred-and-eight Sprague-Dawley rats were block-rando-
mized into 6 groups: Group I had a laparotomy performed. Group II had 1
cm of the left sided colon resected and anastomosed. Additionally, 40% or
70% of the liver was resected in Group IV and VI, respectively. Group III had
40% of the liver resected. Group V had 70% of the liver resected. Body
weight was recorded on POD 0, 3, 5 and 7. Rats were sacrificed on
postoperative day 7 by rapid collection of blood from the inferior vena cava
(IVC), and endotoxin levels were measured. Remnant liver function was
evaluated by means of the rate of branched amino acids to tyrosine ratio
(BTR). Liver regeneration was evaluated using hepatic regeneration rate
(RR).
Results: Body weight changes were significantly affected by the colectomy.
Higher plasma endotoxin levels of the IVC were found in simultaneous
colectomy groups. BTR was significantly lower and RR was significantly
higher in simultaneous colectomy groups.
Conclusions. Simultaneous colectomy induced a higher degree of endotox-
emia and hepatic regeneration. Body weight changes and BTR were
negatively affected by colectomy.
PP 34.07
ERYTHROPOIETIN IN LIVER SURGERY AND TRANSPLANTA-
TION-TISSUE PROTECTION AND ENHANCED REGENERA-
TION
Schmeding, Maximilian; Rademacher, Sebastian; Boas-Knoop, Sabine;
Neuhaus, Peter; Neumann, Ulf
Charite´ University Hospital, General and Transplantation Surgery, Berlin,
Germany
Background. It has been proven in various animal studies that recombinant
human erythropoietin (rHuEPO) protects kidney and heart tissue from
ischemia, and promotes regeneration of adult CNS neurons. Recently
protective effects of rHuEPO could be demonstrated in ischemia-reperfusion
of the liver.
Aim. Regarding the limitations of hepatic surgery by impaired regeneration
capacity of the remnant tissue after major liver resection we investigated the
influence of pre- and perioperative rHuEPO treatment on liver regeneration.
Furthermore the tissue-protective capacities of rHuEPO were evaluated in a
small animal liver transplantation (LT) model.
Methods. Wistar rats undergoing 70% or 90% hepatectomy received an
intraportalvenous administration (i.p.) of rHuEPO prior to resection or a
subcutaneous injection (s.c.) for 3 days postoperatively, control animals were
treated with surgery and saline injection only. Regeneration capacity of
remnant livers was studied over 7 days by histology and immunohistochem-
istry (Ki67, PCNA). PCR was performed to measure TGF-ß, HIF, STAT-3
and VEGF. In a second study liver transplantation was performed in rats after
18 hours of cold ischemia, rats and transplanted grafts were either pre-treated
with rHuEPO or saline injection. Liver enzyme levels were measured,
apoptosis and necrosis rates as well as survival were evaluated (TUNEL,
H/E).
Results. 10-day survival in rats undergoing 90% hepatectomy significantly
increased in i.p. pretreated animals. After 70% hepatectomy the mitotic index
was significantly increased in both rHuEPO treated groups, PCNA and Ki-
67 expression displayed sign. enhancement in rHuEPO treated groups 24 h
and 2 days after liver resection. After LT liver enzyme levels were significantly
reduced in rHuEPO pre-treated animals with substantially lower rates of
apoptosis and necrosis.
Conclusion. rHuEPO effectively enhances hepatic regeneration in rats after
major liver resection. In LT rHuEPO contributes to minimalize ischemia-
reperfusion injury and optimize initial graft function
PP 34.08
EXTENT OF HISTOLOGIC LIVER DISEASE IN HBEAG NEGA-
TIVE CHRONIC HEPATITIS B PATIENTS WITH PERSISTENTLY
NORMAL SERUM ALT AND LOW HBV DNA
Mahtab, Mamun1; Rahman, Salimur1; Khan, Mobin1; Kamal, Mohammad2;
Ahmed, Faroque1; Hussain, Fawaz1; Podder, Provat1
1Bangabandhu Sheikh Mujib Medical University, Department of Hepatol-
ogy, Dhaka, Bangladesh; 2Bangabandhu Sheikh Mujib Medical University,
Department of Pathology, Dhaka, Bangladesh
Background. It is not uncommon in our practice to come across patients
with chronic hepatitis B (CHB) having persistently normal serum transami-
nase (ALT) and low HBV DNA level. The aim of this study is to see the
Knodell and HAI scores in these patients to assess the severity of liver injury
in them.
Methods. We did percutaneous liver biopsies of 42 consecutive CHB
patients with persistently normal ALT and low HBV DNA (B100,000
copies/ml).
Results. 15/42 (35.7%) patients had mild to moderate chronic hepatitis
(CH) (HAI score 412). Fibrosis score was 2 in 8/42 (19%) patients.
Conclusion. The study shows that pre-core/core promoter mutant CHB
with persistently normal ALT and low HBV DNA produces significant
histologic liver disease in a good proportion of patients.
PP 34.09
MEDICINE SPECIALISTS ARE LESS SUSCEPTIBLE TO HCV
INFECTION COMPARED TO OTHER HEALTH CARE PERSON-
NEL IN BANGLADESH
Mahtab, Mamun
Bangabandhu Sheikh Mujib Medical University, Hepatology, Dhaka, Ban-
gladesh
Introduction. Hepatitis C virus is not frequent in Bangladesh. The
prevalence has been estimated at 0.8% in the general population (Mahtab
et. al. unpublished data). Studies have shown that the prevalence of HCV in
health care personnel in this country is 1.4% (Alam et. al. 2007). Since
medicine specialists are less involved with invasive producers compared to
surgeons or nurses, the aim of this study was to see whether they are less
likely to be exposed to HCV.
Methods. Medicine specialists attending the 18th Annual Conference of the
Association of Physicians of Bangladesh volunteered to get anti-HCV tests
done during the conference. In all 400 medicine specialists from all over
Bangladesh participated in the study.
Results. None of the 400 medicine specialists (0%) tested positive for anti-
HCV.
Conclusion. The study shows that medicine specialists are much less
susceptible to HCV infection compared to other health care personnel.
PP 34.10
REACTIVATION OF HBV VIRAL REPLICATION AFTER HEPATIC
RESECTION
Lee, Hae Won; Suh, Kyung-Suk; Kim, Joohyun; Shin, Woo Young; Yi, Nam-
Joon; Lee, Kuhn Uk
Seoul National University College of Medicine, Department of Surgery,
Seoul, Korea, Republic of
Background. It has been reported that viral replication could accelerate after
hepatic resection in HBV-positive patients. Reactivation of viral replication
may be one of the significant prognostic factors in HBV-positive patients
because it can aggravate hepatitis and cirrhosis. In this study, we investigated
actual changing pattern of serum HBV DNA levels during the early
postoperative period after hepatic resection.
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Methods. Among HBV-positive patients who underwent hepatic resection
for hepatocellular carcinoma at Seoul National University Hospital between
February and July 2007, 26 patients who had available postoperative serum
HBV DNA levels were enrolled. Eight patients underwent tumorectomy and
the others underwent major resection more than segmentectomy.
Results. The mean preoperative serum HBV DNA level was 5.37¡340.37
Log10copies/mL. The DNA levels slightly decreased in 72% of patients on
postoperative day (POD) 2 and the mean DNA level was 5.29¡340.33
Log10copies/mL although it was not significant change (p0.174). How-
ever, DNA level on POD 7 was 5.69¡340.35 Log10copies/mL, which was
significantly increased level than on POD 2 (pB0.001). This increasing
pattern of DNA level was constant irrespective of resection type or
preoperative DNA levels. At postoperative 1 month, DNA level slightly
decreased again to 5.35¡340.38 Log10copies/mL (p0.447). Five (33%) of 15
patients who had DNA level more than 6 Log10copies/mL between
postoperative 1 week and 1 month showed alanine aminotransferase (ALT)
level elevation by more than two times of normal range although the others
showed no elevation of ALT.
Conclusion. The early acceleration of HBV replication after hepatic
resection, especially within 1 week, was a universal event and high DNA
level affected postoperative hepatic function. Therefore, it might be necessary
to check postoperative serum HBV DNA levels after hepatic resection in
HBV-positive patients and early antiviral therapy should be considered if the
DNA levels are high.
PP 35.01
MANAGEMENT OF BLEEDING PSEUDOANEURYSMS IN PA-
TIENTS WITH PANCREATITIS
venu, thummanims, hyderbad, India
Background. Bleeding pseudoaneurysm is a rare but frequently fatal
complication in patients with pancreatitis Methods. The details of 9 patients
who presented with pseudoaneurysm associated with pancreatitis between
2000 to 2006 were reviewed.
Results. Five patients had pseudoaneurysms associated with acute pancrea-
titis, and four with chronic pancreatitis. The splenic artery was involved in
seven cases, and the gastroduodenal artery in two cases. Four patients had
prior intervention pigtail(2), cytogastrostomy(1), necrosectomy(1). Evidence
of haemorrhage(2 with bloody drain,3 with UGI bleed) was present on
admission in all patients with acute pancreatitis.2 of 4 patients with chronic
pancreatitis presented with haemosuccus pancreaticus. Angiography was
done in eight patients. One patient underwent surgery without previous
arteriography because of haemodynamic unstability. Angiogram was done
during the episode of bleed and could localize the lesion in all the patients.
Doppler could localize the lesion in only 1 of 4 patients. Two of four patients
with chronic pancreatitis underwent primary surgery(distal pancreatectomy
and splenectomy) one as an emergency and one within 48 hrs of bleed. The
remaining patients had transcatheter arterial embolization with microcoils.
Control of bleeding was successful in all patients treated by surgery, but one
patient treated by embolization required a second intervention (splenectomy,
distal pancreatectomy and necrosectomy) in acute pancreatitis group.
There was one mortality in chronic pancreatitis group (patient with
alcoholic cirrhosis with portal hypertension and splenic artery aneurysm
developed renal failure and sepsis post embolisation) Conclusion: CT is not
accurate in the diagnosis of pseudoaneurysms complicating acute pancrea-
titis. Primary resection of the pseudoaneurysm, which frequently requires
pancreatic resection, is the treatment of choice in patients with chronic
pancreatitis.
PP 35.02
ENDOSCOPIC PANCREATIC SPHINCTEROTOMY FOR PRO-
LONGED PANCREATIC FISTULA AFTER DISTAL PANCREATIC
SURGERY
Goasguen, Nicolas1; Lesurtel, Mickae¨l1; Bourrier, Anne2; Ponsot, Philippe3;
Prat, Fre´de´ric2; Dousset, Bertrand4; Sauvanet, Alain1; Belghiti, Jacques1
1Hospital Beaujon, HPB Surgery, Clichy, France; 2Hospital Cochin,
Gastroenterology, Paris, France; 3Hospital Beaujon, Gastroenterology, Cli-
chy, France; 4Hospital Cochin, Digestive Surgery, Paris, France
Background. Pancreatic fistula (PF) is a frequent complication of distal
pancreatectomy (DP) or enucleation (E). Usually, PF closes spontaneously
but complete healing can need several weeks with a mean time for PF closure
ranging from 21 to 35 days. Preoperative endoscopic pancreatic sphincter-
otomy (EPS) has been proposed to prevent PF before DP but its routine use
is debatable due to its own morbidity. We report herein 8 consecutive patients
who were successfully treated by EPS for a prolonged PF following DP or E.
STUDY DESIGN: From 2004 to 2006, 8 patients with intraductal papillary
mucinous tumor (n5), endocrine tumor (n2) and corticosurrenaloma
invading the distal pancreas (n1), treated by DP (n4), medial pancrea-
tectomy (n2, with PF from the cephalic remnant) and E (n2),
experienced prolonged PF. All 8 underwent attempt to EPS for PF ongoing
for a mean delay of 35 days (range: 19114). Median PF daily output was 80
ml (range, 50250).
Results. EPS was performed in all patients and was associated with
pancreatic stent insertion in 3. No additional mortality or morbidity was
observed. PF healed within a median delay of 4 days (range, 112) after EPS,
including one patient who had a second endoscopic procedure for stent
malposition. No patients developed any abscess nor recurrent PF, including 2
who susbsequently stent removal. All patients were discharged within a
median delay of 13 days (range, 815) after EPS.
Conclusions. These encouraging results suggest that EPS should be
performed in patients with prolonged PF following DP or E. In this
indication, EPS seems highly feasible, allows to shorten the duration of PF
healing, and do not induce a specific morbidity.
PP 35.03
RISK OF PANCREATITIS AFTER ERCP AND EBD
Matsubayashi, Hiroyuki1; Ono, Hiroyuki1; Fukutomi, Akira2; Otake, Yo-
suke1; Yamaguchi, Yuichiro1; Hasuike, Noriaki1; Ikehara, Hisatomo1; Taki-
zawa, Kohei1; Uesaka, Katsuhiko3; Maeda, Atsuyuki3; Matsunaga, Kazuya3;
Kanemoto, Hideyuki3
1Shizuoka Cancer Center, Division of Endoscopy, Suntogun, Shizuoka,
Japan; 2Shizuoka Cancer Center, Division of GI Oncology, Suntogun,
Shizuoka, Japan; 3Shizuoka Cancer Center, Division of Hepatopancreato-
biliary Surgery, Suntogun, Shizuoka, Japan
Background. Pancreatitis is a complication, which occurs in 515% after
ERCP. EBD (endoscopic biliary drainage) is a therapeutic technique for the
obstructive jaundice before surgery or during chemotherapy. So far, several
risk factors of post-ERCP pancreatitis had been assessed, however not on
post-EBD pancreatitis.
Aim and Method. During 2002, Oct.-2007. April, 654 consecutive patients
who underwent ERCP associated procedures at Shizuoka Cancer Center
were entered and analyzed for the risk factors of post-ERCP and -EBD
pancreatitis. For biliary drainage, we used 710 French (Fr.) of EBD and 5
7.2 Fr. of ENBD (naso-biliary drain). For the initial drainage, we chose 8.5
Fr. or smaller in more than 80% of cases to prevent the obstruction of
pancreatic juice exclusion, but after second time, 10 Fr. in more than 60% of
cases. CottonO˜s criteria were used for diagnosis of pancreatitis.
Results. Of 654 ERCP procedures, 406 were with drainage and 165 were for
diagnostic examination using at least one of the following modalities: biopsy
or brushing of the duct, IDUS, and POPS or POCS. Overall incidence of
post-ERCP pancreatitis was 4.0% (26/654). There was a modest trend of
higher rate in female (6.3%) than in male (3.0%)(P0.055), but no trend by
age. Incidence of pancreatitis was similar between cases with (3.7%) or
without (4.4%) drainage, but was significantly higher in initial drainage
(6.7%) than in 32nd time (0.5%)(P0.001). Six cases of EBD-pancreatitis
recovered after replacement with downsized drain or additional EST.
Pancreatitis was recognized more often in examination group (9.1%) to
compare with the rest of group (2.2%)(P0.0001). No pancreatitis occurred
after therapeutic procedures such as papillectomy and choledocal stone
removal, or with EPD (pancreatic duct drainage) insertion after ERCP.
Conclusion. Not only diagnostic examination, but also biliary drainage may
occasionally cause pancreatitis. Endoscopists have to keep in mind of the risk
and management for post-ERCP and post-EBD pancreatitis.
PP 35.04
8 CASES OF LIVING DONOR PANCREAS TRANSPLANTATION
IN KOREA
Han, Duckjong; Park, Kwan Tae; Shin, Haengchul; Kim, Songchul
Asan Medical Center, Surgery, Seoul, Korea, Republic of
Introduction. Cadaveric pancreas transplantation(PT) has become a widely
accepted treatment option for the type 1 DM patients. But the living donor
pancreas transplantation(LD PT), an attractive alternative that can give
recipients the benefits of better immunologic match, reduced ischemic time,
better timing of transplantation, has not been done widely. So, the purpose of
this study is to report our experiences of eight LD PT.
Methods. From August of 2005 to July of 2007, 5 PTA(pancreas transplant
alone) and 3 SPK(simultaneous pancreas kidney transplant) from living
donors were performed in Asan Medican Center. Donors underwent
standardized metabolic workup such as insulin secretion test, HgbA1C,
glucose tolerance test and abdominal CT. Distal pancreatectomy at the level
of superior mesenteric vein with splenectomy was done for organ procure-
ment. Also, functionally inferior kidney was harvested together in case of
SPK. Seven doses of thymoglobulin induction therapies and tacrolimus and
mycophenolate mofetil maintenance were used. Six doses of steroid were
administrated and eliminated in early postoperative days.
Results. Five patients were female and three were male. Median age was 31
(2046) and all the donors were family members (mother:3, siblings:3,
spouse:2). Exocrine bladder drainages were done for 5 PTA and 2 SPK and
enteric drainage for 1 SPK. One patient had graft thrombosis at the 5th day
and the graft was removed. In 2 SPK recipient, solitary pancreas rejection
was developed and one of them was successfully rescued by steroid pulse and
thymoglobulin. Another 1 PTA patient lost pancreatic function from
incompliance to tacrolimus. Finally, 5 out of 8 recipients are doing well
and euglycemic without insulin. All the donor are also doing well and had no
postoperative DM.
Conclusions. LD PT can be done safely and effectively as an alternative to
cadaveric PT with strict selection of donors. To prevent graft thrombosis in
LD PT, anticoagulation should be used cautiously.
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EXTRAPERITONEAL PANCREAS TRANSPLANTATION WITH
SYSTEMIC-ENTERIC DRAINAGE: EARLY SURGICAL COMPLI-
CATIONS AND OUTCOME
Kocik, Matej1; Lipar, Kvetoslav1; Adamec, Milos1; Saudek, Frantisek2;
Boucek, Petr2
1Institute for Clinical and Experimental Medicine, Transplant Surgery
Department, Prague, Czech Republic; 2Institute for Clinical and Experi-
mental Medicine, Diabetes Center, Prague, Czech Republic
Background. A variety of techniques for pancreas transplantation (PTx) is
used in different centers and intraperitoneal placement of the graft has
remained a cornerstone of the operation technique. Despite improving results
over the last years, there is still a significant number of surgical complications.
We describe a single center experience with extraperitoneal placement with
systemic venous and enteric exocrine drainage of the pancreas graft. The aim
of this study was to evaluate early surgical complications and outcome in the
first 3 months after PTx.
Methods. Between March 2001 and May 2007, a total of 126 PTx were
performed in our institution of which 17.5% as an isolated PTx. In all
transplants pancreas graft was placed extraperitoneally in the right iliac fossa
and the vessels of the graft were joined to iliac vessels of the patient.
Duodenum was joined in a side-to-side fashion to an adjacent small bowel
loop after an incision of the peritoneum.
Results. A total of 39 patients (31%) had a surgical complication reguiring
repeat laparotomy. Indications were: bleeding (7.9%), venous thrombosis
(6.3%), duodenal anastomotic leak (1.6%), bowel obstruction (0.8%),
peripancreatic abscess (1.6%), impaired wound healing with fluid secretion
(12.7%). 3-months patient and pancreas graft survival rates were 96.8% and
86.5%. Indications for graft removal were: portal vein thrombosis (6.3%),
otherwise uncontrollable bleeding (1.6%) and duodenal anastomotic leak
(1.6%).
Conclusions. Our data confirm that PTx with extraperitoneal placement
and systemic  enteric drainage brings comparable results with other
techniques when pancreas graft is placed intraperitoneally. Extraperitoneal
placement eliminates intraperitoneal infection and bleeding and allows easy
ultrasound examination of the graft including its biopsy and early rehabilita-
tion and oral nutrition. A drawback is more frequent incidence of impaired
wound healing above the pancreas. It may lead to prolonged hospital stay but
has no effect on long term survival.
PP 35.06
COMPARISON OF PANCREAS TRANSPLANTATION OUT-
COMES BY DRAINAGE TYPE: A SINGLE CENTER’S EXPERI-
ENCE
McHugh, Patrick P; Johnston, Thomas D; Jeon, Hoonbae; Gedaly, Roberto;
Ranjan, Dinesh
Transplant Center, University of Kentucky, Surgery, Lexington, Kentucky,
United States
Background. Pancreas allografts are transplanted by anastomosing donor
duodenum to recipient urinary bladder or jejunum, facilitating exocrine
drainage. Enteric drainage (ED) is more common, thus avoiding local
complications associated with bladder drainage (BD). However, we observed
a higher rate of major complications at our center, especially allograft venous
thrombosis, using ED. After performing only ED since early 1998, we
returned to using only BD in February 2005.
Objective. To compare outcomes in pancreas transplants at our center, by
drainage method used.
Methods. We reviewed outcomes in patients who received simultaneous
pancreas-kidney (SPK) or pancreas-after-kidney (PAK) transplant, or
pancreas transplant alone (PTA) at our center.
Results. Between January 1996 and July 2007, we performed 104 SPK, 13
PAK, and one PTA, in 112 patients; since return to BD in February 2005, 12
SPK and 5 PAK have been performed. None of 27 total BD-SPK allografts
has thrombosed, compared to 12 of 77 ED-SPK (p0.02). Among 14 PAK/
PTA cases, one BD graft and 2 ED grafts thrombosed (pn/s). All
thrombosed grafts required emergent pancreatectomy. Of all BD-SPK, one
patient developed bowel ischemia with survival of allograft function. 5 ED-
SPK patients had major complications such as graft leak, necrosis,
hemorrhage, jejunal volvulus, and bladder fistula; 2 required pancreatectomy.
BD-related complications such as severe acidosis (9 total patients), cystitis (5
patients), and reflux pancreatitis (3 patients) occurred but were successfully
managed, though 6 BD-SPK required ED-conversion, 2 of which within 1
year.
Conclusion. BD-SPK appears superior to ED-SPK performed at our center,
with fewer major technical complications. A similar trend exists among PAK/
PTA, but the small number of patients limits statistical analysis. Complica-
tions unique to BD are comparatively minor and rarely compromise long
term allograft survival  overall an acceptable tradeoff for fewer postoperative
thromboses.
PP 35.07
PANCREAS ISLET AUTOTRANSPLANTATION-AN UNCOMMON
SOLUTION FOR SEVERE PANCREATIC FISTULA POST HEMI-
PANCREATODUODENECTOMY
OLIVERIUS, Martin1; Girman, Peter2; Adamec, Milos1; Saudek, Frantisek3
1Institute for Clinical and Experimental Medicine, Transplant Surgery
Department, Prague, Czech Republic; 2Institute for Clinical and Experi-
mental Medicine, Department of Diabetology, Prague; 3Institute for Clinical
and Experimental Medicine, Department of Diabetology, Prague, Czech
Republic
Background. pancreatic leak represents the most serious complication of
pancreatosurgery. Some of those cases can be solved conservatively but some
of them need a surgical treatment with total pancreatectomy.
AIM(S)/OBJECTIVE(S): The major morbidity following total pancreatect-
omy is diabetes mellitus with its associated complications. Islet autotrans-
plantation can be considered as a useful therapeutic option serving to prevent
the occurrence of surgically-induced diabetes.
Methods. in a series of the 87 hemipancreatoduodenectomies with a total of
9, 1% leaks during 2004/2007 two patients underwent a total pancreatectomy
with islet autotransplantation for severe leak. Islets were prepared in
laboratory by digestion of the excised pancreas, and infused unpurified into
the portal vein through an operatively placed catheter during one procedure.
Results: postoperative course was uneventful in both cases and their C
protein was positive during the follow up. Owing to the moderate fasting
hyperglycemia, postoperative exogenous low dose insulin therapy was
necessary. During follow-up the fasting C-peptide level was positive, and
an oral glucose tolerance test and an intravenous glucagon stimulation
showed functioning engrafted islets.
Discussion. total pancreatectomy is mutilating procedure with lifelong
defect of the exo- and endocrine functions. While the first one could be
easily substitute the second one results of serious instable diabetes. Pancreas
islet autotransplantation usually does not achieve insulin independence but
improved control of glycated HbA1c. Reduced risk of recurrent hypoglyce-
mia is a great benefit. The procedure is now associated with low morbidity
and mortality.
Conclusion. In our opinion, islet autotransplantation should be offered to
any patient needing to undergo total pancreatectomy for severe leak. In cases
in which insulin independence is not achieved, the potential beneficial effects
of C-peptide make the procedure worthwhile.
PP 35.08
TECHNICAL PROCEDURES OF PANCREAS TRANSPLANTA-
TION
Sabino, Gustavo B.; Brabo, Janaina L.; Iida, Diego F.; Ribeiro Junior,
Marcelo A. F.; Subero, Lı´dia L.; Saad, William A.
Universidade Cidade de Sa˜o Paulo-UNICID, Sa˜o Paulo, Brazil
Introduction. Due to the evolution in the surgical techniques as well as the
imunosuppression drugs, the pancreas transplantation (PT) has been
increased for the treatment of the Diabetes Mellitus (DM) throughout the
world. The Simultaneous Kidney and Pancreas Transplantation (SKPT), is
the modality of transplant more used in the entire world following by
Pancreas Transplantation after Kidney (PTAK). This last one, is indicated to
patients who had made the renal transplant from a living donor and are still
waiting the pancreas from a deceased donor to get the benefits of the glicemia
levels. Normally the PTAK is carried through after the stabilization of the
graft kidney. The Isolated Pancreas Transplantation (IPT) is the less
common modality, corresponding 5% of the transplants. It is indicated for
severe metabolic disturbance.
Objective. A review of the literature about the subject.
Methods. Research of articles and specialized books from the English and
Portuguese literature.
Results. It can be verified that, despite the survival of the patient to be
similar in all the categories of receivers, the functional graft’s result after one
year is significantly superior in the SKPT when compared with PTAK and
IPT (P0.0001). However, recently the group of Minnesota has demon-
strated that, following some guidelines, they could get similar results of
survival grafts in these two last categories of patients when compared with the
SKPT.
Conclusion. According to the reviewed literature, the final results of the PT
depends of a lot of factors, mainly related of the receivers and technical
procedures. Evidences in literature suggest a beneficial effect of the PTon the
metabolic disturbance and the evolution of the secondary complications of
the illness.
PP 35.09
PANCREAS TRANSPLANTATION: BLADDER VS. ENTERIC
DRAINAGE.
Brabo, Janaina L.; Sabino, Gustavo B.; Iida, Diego F.; Ribeiro Junior,
Marcelo A.F.
Universidade Cidade de Sa˜o Paulo-UNICID, Sa˜o Paulo, Brazil
Introduction. Several series have compared bladder drainage (BD) versus
enteric drainage (ED) of pancreas secretions for differences in long-term
survival. The most recent UNOS/IPTR registry reports no difference in
patient, kidney graft or pancreas graft survival between the techniques.
Objective. A review of literature about the subject.
Methods. Research of articles and specialized books in English and
Portuguese literature.
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Results. Recent individual center reports demonstrate no difference in long-
term survival between the techniques. This is in contrast to reports from the
early 1990’s that reported increased infections (mainly intra-abdominal),
increased technical failure, and worse graft outcome for ED compared to BD.
Sollinger et al. demonstrated no difference if graft survival in BD versus ED.
However, of the 388 BD grafts, 62.5% had urinary tract infection (UTI),
17.7% had hematuria, 15.4% had duodenal segment/bladder leak, 2.8% had
urethral stricture and 2.5% had urethral disruption. By comparison, only 8%
of the ED grafts suffered from leak and only 11.7% had urinary tract
infections.
Conclusion. With current techniques and immunosuppression, patient and
graft survival appears equal with either BD grafts or ED grafts. However, BD
grafts appear to have a higher incidence of metabolic abnormalities, urologic
complications, and infectious complications. The latter may play a role in the
increased death from infectious causes in pancreas recipients. ED grafts
appear to have a higher rate of intra-abdominal infections and hypertension.
BD pancreas patients need to be monitored long-term for infections,
metabolic abnormalities, and urologic complications including tumors.
Patients who develop these manifestations may safely undergo conversion
to ED without compromising graft or patient survival.
PP 35.10
LAPAROSCOPIC CHOLECYSTECOMY USING FLEXIBLE GAS-
TROSCOPE-THE FIRST STEP ON THE WAY TO NOTES
Starkov, Yury1; Shishin, Kirill1; Solodinina, Elena2; Alekseev, Konstantin2
1A.V.Vishnevsky Institute of Surgery, Surgical Endoscopy, Moscow, Russian
Federation; 2A.V.Vishnevsky Institute of Surgery, Endoscopic Surgery,
Moscow, Russian Federation
Introduction. Natural Orifice Translumenal Surgery is the latest trend of
endoscopic surgery. Availability of this kind of surgical approach in treatment
of different surgical diseases, e.g. calculous cholecystitis, was shown by good
results of experimental operations in animals. Hybrid operations with using of
flexible and laparoscopic endoscopy are transitional stage of application
NOTES to clinical practice.
Methods. 30/05/07 a 46-years-old man, with clinically and instrumentally
confirmed diagnosis of chronic calculous cholecystitis was operated with
using of combined surgical approach. Gastroscope was inserted into
abdominal cavity after creation of the pneumoperitoneum in umbilical point.
Further during the operation pneumoperitoneum was maintained through
trocar 5 mm inserted in the right hypohondrium region in the mid axillary
line. Consecutive dissection of the cystic duct and cystic artery was made
with the using of hot biopsy forceps and coagulation probe. Cystic duct and
cystic artery were cut after clipping with endoscopic clips (2 clips were left on
cystic duct stump and 2  on cystic artery stump). Following evacuation of
gall-stone gall-bladder was dissected with the help of coagulation probe and
IT-knife and removed from abdominal cavity. Gall-bladder bed was coagu-
lated. The operation time was 2 hours 15 minutes. There was no hemorrhage
during the operation. Postoperative period was without any complications.
Abdominal ultrasound did not reveal any pathological changes. The patient
was discharged two days after operation, his status was satisfactory. Follow-
up for three month after operation did not reveal any peculiarities of the
postoperative period.
Conclusion. This case report shows the ability of cholecystectomy perfor-
mance with the instruments conducted through the gastroscope channels. It
is our first step on the way to translumenal endoscopic surgery  the next
stage of minimally invasive surgery development.
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THREE CASES OF ISOLATED SPLENIC METASTASIS
Cho, Chol Kyoon1; Koh, Yang Seok1; Kim, Hyun Jong1; Kim, Jung Chul1;
Hur, Young Hoi1; Lee, Wan Sik2; Park, Chang Hwan2; Choi, Sung Kyu2;
Kim, Seok Mo3; Jeong, Yong Yeon4; Shin, Sang Soo4; Lee, Jae Hyuk5
1Chonnam National University Medical School, Surgery, Gwangju, Korea,
Republic of; 2Chonnam National University Medical School, Internal
Medicine, Gwangju, Korea, Republic of; 3Chonnam National University
Medical School, Gynecology, Gwangju, Korea, Republic of; 4Chonnam
National University Medical School, Radiology, Gwangju, Korea, Republic
of; 5Chonnam National University Medical School, Pathology, Gwangju,
Korea, Republic of
Background. Splenic metastases from solid tumors are unusual and
detected with a state of multiple metastasis of many organs in far advanced
stage. Cancers of ovary, lung, breast, stomach, colon and skin are known to
metastasize to spleen. Isolated splenic metastasis without a evidence of
metastasis to other organ is very rare and the exact pathomechanism of
metastasis remains unknown even though hematogenous metastasis sup-
posed to be related.
Aim/Bbjective. We present three cases of splenectomy for isolated splenic
metastasis and evaluate the significance of splenectomy in such clinical
situation.
Methods. The first case is a 36-year-old female who underwent left
oophorectomy for ovarian mucinous cancer. Follow up CT 1 year after
operation showed 9¡¿8 cm sized multi-septated cystic lesion with internal
calcification in spleen. The second case is a 47-year-old female who has been
treated with chemo-radiotherapy for endocervical cancer. Follow up CT after
10 months showed 2.3¡¿1.9 cm sized low attenuated mass in spleen. The
third case is a 55-year-old female who received a chemo-radiotherapy for
cervix cancer. Follow up CT after 10 months showed 2¡¿1.1 cm sized low
attenuated mass in spleen. All cases were treated with splenectomy by open
method in the first case and by laparoscopically in the other cases.
Results. In microscopic examination of the resected specimen, the first case
was metastatic mucinous cystadenocarcinoma from ovary, and the second
case was metastatic adenocarcinoma from cervix, and the third case was
squamous cell carcinoma from cervix. All three cases recieved chemotherapy
or chemo-radiotherapy after splenectomy and are alived without a evidence of
recurrence in follow up periods of 7 years, 21 months and 26 months
respectively.
Discussion. Splenectomy appears to be an appropriate therapy and confers a
substantial survival benefit to patients with isolated splenic metastasis.
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SAFETY OF GASTROGRAFIN IN THE EFFECTIVE MANAGE-
MENT OF ADHESIVE SMALL BOWEL OBSTRUCTION
Dash, Nihar Ranjan1; Sharma, Aribam D2; Kulkarni, Mukund1; Pal, Sujoy1;
Sahni, Peush1; Chattopadhyay, Tushar Kanti1
1AIIMS, GI Surgery and LTx, New Delhi, India; 2
Background. Adhesive small bowel obstruction (ASBO) is a problem
following abdominal surgeries including the HPB. Gastrografin is being
increasingly advocated in the diagnosis as well as therapy despite the concerns
over its use.
Objective. To asses the effectivity and safety of Gastrografin in the
management of ASBO.
Patients and Methods. During Feb04 to Nov05, all patients of clinically
and radiologically diagnosed cases of uncomplicated ASBO, who failed to
improve by bowel rest regimen, were prospectively studied. 100ml of
undiluted Gastrografin was administered either through oral or enteral route.
Abdominal X rays Were taken at 8 hrs and 24 hrs.
Result. Thirty patients were studied. The median age was 37.5 years. (11
74). Majority(13/30) of them were following colorectal surgeries (43%).Six
(20%) were following HPB surgery.10% ASBO occurred during first week
and 40% within 3 weeks following surgery. Complete relief occurred in
25(83%) cases. Median time for passage of flatus was 24 hours (4120
hours).Median time for oral intake was 1 day (1to 8 days).Five (17%) cases
required surgery in the form of adhesiolysis. None had strangulation. Only
one had a localized small perforation at an anastomosis site. The median
hospital stay following Gastrografin was 5 days (340).There was no
mortality. Recurrence occurred in 13%( 3/25) cases with in 6 months. All
were managed conservatively The presence of contrast at the stoma (at 8 hrs)
or in the rectum (24 hrs) correlated significantly with the need for surgery.
The sensitivity, specificity, overall accuracy, PPV and NPV for continuation
of non operative management in stoma patients were 100% each. No patient
had allergic or anaphylactic reaction. None had any problem like nausea
abdominal pain; vomiting or aspiration following contrast ingestion. There
was no deterioration in the renal parameters.
Conclusion. Gastrografin is safe to use in the effective evaluation and
therapy of post operative ASBO after other causes of obstruction have been
reasonably ruled out.
PP 36.03
COMPARISON OF GASTRIC ACIDITY BETWEEN PANCREATI-
COGASTROSTOMY AND PANCREATICOJEJUNOSTOMY FOL-
LOWING PYLORUS-PRESERVING PANCREATICODUO-
DENECTOMY
Shinchi, Hiroyuki1; Takao, Sonshin2; Maemura, Kosei1; Noma, Hidetoshi1;
Mataki, Yukou1; Kurahara, Hiroshi1; Maeda, Shinichi1; Ueno, Shinichi1;
Sakoda, Masahiko1; Kubo, Fumitake1; Aikou, Takashi1
1Kagoshima University Graduate School, Department of HBP Surg,
Kagoshima, Japan; 2Kagoshima University Graduate School, Frontier
Science Research Center, Kagoshima, Japan
Background. In general, pancreaticojejunostomy (PJ) or pancreaticogas-
trostomy (PG) has been performed after Whipple resection or pylorus-
preserving pancreaticoduodenectomy (PPPD). Although the physiologic
alteration in the stomach is important for the correlation between gastric
and pancreatic functions, the actual intragastric pH profile after PG or PJ is
still unclear. This study was conducted to investigate the physiologic changes
in gastric pH and serum gastrin and secretin levels before and after PPPD
reconstructed with PG or PJ in humans.
Methods. Twenty-four hour continuous intragastric pH and serum gastrin
and secretin levels in the fasting state were examined in 13 patients who had
undergone PG and 10 patients with PJ.
Results. No peptic ulcer was detected in either group after the operation.
After PPPD, in both PG and PJ patients, median pH and percentages of time
that the gastric pH was less than 4 (% pHB4) and more than 6 (% pH6)
did not change in comparison with preoperative data, and circadian pH
patterns also remained unchanged. Each data showed no significant
differences between PG and PJ patients. Serum gastrin and secretin levels
in the fasting state were also unchanged in both groups.
162 Abstracts
Conclusions. These results suggest that both PPPD-PG and PJ present no
problem to the intragastric pH milieu and that the neurohumoral relation
between the stomach, duodenum, and pancreas is preserved, which seems to
be due to the preservation of the antrum and duodenal bulb.
PP 36.04
PRESENTATION, MANAGEMENT AND OUTCOME OF PAN-
CREATICO-BILIARY TUBERCULOSIS
Jain, Sundeep1; Kalla, Komal2; Kalla, Mukesh3; Sharma, Jayant4; Sharma,
Shyam Sunder5
1S.K.Soni Hospital, Gastrointestinal & Laparoscopic Surgery, Sector 5,
Vidhyadhar Nagar, Jaipur, India; 2S.R.Kalla Memorial Hospital, Pathology,
Jaipur, India; 3S.R.Kalla Memorial Hospital, Gastroenterology, Jaipur, India;
4S.K.Soni Hospital, Gastroenterology, Jaipur, India; 5S.M.S. Hospital,
Gastroenterology, Jaipur, India
Introduction. Isolated pancreatico-biliary involvement with tuberculosis
(TB) is a rare entity. Its clinical, biochemical, radiological and endoscopic
presentation mimics that of pancreatico-biliary malignancy. OBJECTIVE
The aim of the present study was to evaluate the clinical, biochemical,
radiological and endoscopic presentation, management and outcome in
patients with histologically confirmed pancreatico-biliary TB.
Methods. We retrospectively analyzed the records of 5 patients managed for
biliary obstruction and/or pancreatic mass due to TB, during January 2002 to
July 2007.
Results The clinical presentation was with jaundice, cholestasis, pain
abdomen and anorexia. Three patients had LFTs suggestive of biliary
obstruction. On radiological and endoscopic evaluation, 1/5 had hilar block,
2/5 had lower CBD stricture with peripancreatic lymphadenopathy and 2/5
had pancreatic head mass with peripancreatic lymphadenopathy. Histopatho-
logically, 4/5 patients revealed caseating granulomas and 1/5 patient had acid
fast bacilli. Patient with hilar block underwent laparotomy with the diagnosis
of hilar cholangiocarcinoma, however intraoperative histopathology of the
hilar lymph-nodes revealed caseating granulomas. He was treated by Roux-
en-y hepatico-jejunostomy and antitubercular treatment (ATT). Patients
with lower CBD stricture were treated with CBD stenting and ATT. Two
patients with pancreatic head mass responded to ATT and on imaging
showed significant reduction in size. The total follow-up of 4/5 patients is 3
months to 5 years. One patient was lost to follow-up.
Conclusions. There should be high index of suspicion for pancreatico-
biliary TB in patients residing in endemic areas. If the diagnosis is confirmed
histopathologically it can be treated without surgery. In case of doubt surgical
exploration should be performed.
PP 36.05
NON-NEOPLASTIC CYSTIC AND CYST LIKE LESION OF PAN-
CREAS
Vyas, Frederick1; Joseph, Philip2; Sanghi, Ravish2; Eapen, Anu3; Sitaram,
Venkatramani2
1Christian Medical College Hospital, Department of General Surgery, Ida
Scudder road, Vellore, India; 2Christian Medical College Hospital, Depart-
ment of General Surgery, Vellore, India; 3CHristian Medical College
Hospital, Department of Radiodiagnosis, Vellore, India
Background. Because of increasing use of cross sectional imaging, cystic
lesions of pancreas are increasingly diagnosed. Many patients with cystic
lesions of pancreas are asymptomatic. Pancreatic pseudocysts and cystic
neoplasms are common. Non neoplastic pancreatic cystic and cyst like lesions
are extremely rare.
Methods. Medical records of all patients who underwent surgical exploration
for excision of cystic lesions of pancreas were retrospectively reviewed. Five
patients had a final diagnosis of non neoplastic pancreatic cystic or cyst like
lesion. These five patients are the focus of this study.
Results. There were 4 females and 1 male with a median age of 38 years
(range 2847). Three patients presented with abdominal pain and epigastric
fullness. One patient presented with a discharging sinus following percuta-
neous drainage of hydatid cyst of liver in another hospital when he was also
detected to have multiple cystic lesions in the tail of pancreas. One patient
was asymptomatic. Two patients had palpable mass. Pre-operative radiolo-
gical diagnosis included mucinous cystadenoma, pseudopancreatic cyst (2),
hydatid cyst and dermoid cyst. Surgical procedures performed were
pancreaticoduodenectomy (1), distal pancreatectomy with splenectomy (2),
and excision of cyst (2). The final diagnoses on histopathology were
lymphangioma, hydatid cyst of pancreas, mature cystic teratoma, benign
epithelial cyst and degenerated parasitic cyst. Over a median follow up of 28
months, all patients are alive and well without any evidence of recurrent
disease. Though 3 patients would have required surgery on the basis of signs
and symptoms, there were 2 patients in whom surgical treatment could have
been avoided.
Conclusion. Non-neoplastic, non-inflammatory lesions of pancreas are
generally benign and do not require surgical treatment when asymptomatic.
The pre-operative diagnosis is often unreliable. The challenge is to diagnose
these lesions pre-operatively and avoid unnecessary operations.
PP 36.06
LYMPHOEPITHELIAL CYST OF THE PANCREAS *A RARE
CYSTIC LESION THAT MIMICS CARCINOMA
Langan, Russell1; Paragi, Prakash1; Danieu, Linda2; Chamberlain, Ronald1
1Saint Barnabas Medical Center, Department of Surgery, Livingston, United
States; 2Saint Barnabas Medical Center, Department of Oncology, Living-
ston, United States
Background. Lymphoepithelial cysts of the pancreas are rare lesions that
mimic other cystic lesions such as pancreatic cystadenoma, cystadenocarci-
noma and pseudocysts. Histogenesis of this lesion is not implicit, and
differentiation from other cystic lesions of the pancreas is necessary to tailor
the treatment.
Aim. We report a 59 year old male with lymphoepithelial cyst of the
pancreas. A review of literature encompassing clinical presentation, diagnosis
and management is presented.
Methods. An asymptomatic patient with a cystic lesion of the pancreas
detected on routine workup was evaluated. Work up revealed a multi-cystic
lesion in the head of the pancreas with no pancreatic insufficiency.
Preoperative histopathology was inconclusive. Endoscopic ultrasound and
fine needle aspiration revealed a non-serous, thick, yellow fluid with rare
cellular atypia. No malignant cells were seen. Computer tomography revealed
a 5.05.2cm multi-loculated cystic mass in the head of the pancreas
extending into the uncinate process.
Results. The patient underwent a conventional Whipple procedure and
pathological sections revealed a multi-loculated cyst lined by squamous
epithelium and underlying lymphoid tissue consistent with a lymphoepithelial
cyst.
Conclusion. True pancreatic cysts, which are distinguished by their
epithelial lining, are the rarest form of cystic pancreatic lesions. The
lymphoepithelial cyst of the pancreas is an extremely rare benign neoplasm
of unknown etiology, and should be considered in the differential diagnosis of
cystic lesions of the pancreas.
PP 36.07
TUBERCULOSIS OF PERIPANCREATIC LYMPH NODES CAN
BE ASSOCIATED WITH OTHER PANCREATIC LESIONS- A
RETROSPECTIVE STUDY
OV, Sudheer; Menon, Ramachandra; S, Sudhindran; Dhar, Puneet
Amrita Institute of Medical Sciences, Gastrointestinal Surgery, Kochi, India
Background. Peripancreatic lymph nodes with tuberculosis is not very rare
where the disease is prevalent. This has importance in suspected pancreatic
malignancy where the disease may be over staged by CT scan.
Materials and Methods. The cases of peripancreatic lymph nodes affected
with tuberculosis during the period 20002006 were analyzed retrospectively
from hospital data.
Results. During this period 10 cases of peripancreatic tuberculosis of lymph
nodes were identified. The age group was 28 to 74 years. 5 out of the 10
patients were immunocompromised. (Diabetes mellitus 3, HIV positive 2) 5
cases were identified on evaluation of malignant obstructive jaundice. (2 in
preoperative FNAC and 3 in Whipple’s specimen associated with malig-
nancy). 3 cases were found to have tuberculosis of peripancreatic lymph
nodes associated with chronic calcific pancreatitis. Peripancreatic tubercu-
losis of lymph nodes was identified in one patient operated for solid and cystic
tumour of pancreas. FNAC showed tuberculosis in another patient presented
with anorexia, weight loss and peripancreatic lymph nodular mass on CT
scan. In 5 out of 10 cases CT showed lymph nodes with central necrosis.
FNAC was positive for tuberculosis in 5 out of 6 cases where it was done. All
the 10 patients were treated with antitubercular treatment.
Conclusion. Peripancreatic lymph nodes with tuberculosis can be associated
with other diseases. Large nodes with central necrosis in CT scan should
raise a suspicion of tuberculosis. FNAC can give a diagnosis in majority of
cases.
PP 36.08
Intra-abdominal pressure variations after large pancreatic pseudo-
cyst transcutaneous drainage
Papavramidis, Theodossis S.; Duros, Vassilios; Michalopoulos, Antonios;
Papadopoulos, Vassilios N.; Paramythiotis, Daniel; Netta, Smaro; Harlaftis,
Nikolaos
A.H.E.P.A. University Hospital, Aristotle’s University of Thessaloniki, 1st
Propedeutic Department of Surgery, Thessaloniki, Greece
Background. The intra-abdominal pressure (IAP) is the pressure existing in
the abdominal cavity. The present study aims to investigate the IAP variations
after large pancreatic pseudocyst transcutaneous drainage.
Material. In the present study participated 9 patients (6 males and 3
females) with large pancreatic pseudocysts that fulfilled the inclusion criteria:
(i) volume greater than 1l, (ii) no signs of chronic pancreatitis, and (iii) no
signs of acute pancreatitis for the last 2 months. The mean age of the patients
was 72.2y (range 64 to 78y). The mean age was of 72.2 years. The BMI
averaged 27.15 kg/m2. The mean volume of the initial pseudocyst fluid was
2300ml.
In order to measure IAP a Foley catheter was inserted into the urinary
bladder using a standard sterile technique 6 hours before the transcutaneous
drainage, with the patient at supine position. The measurements were taken 6
hours before the drainage and at 8 o’clock in the morning every morning for
the 7 days following the drainage.
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Results. The mean pre-drainage IAP was 12.6 cmH2O, while the first post-
drainage day (PDD) it was 6.9 cmH2O. The second PDD IAP was 7.6
cmH2O, the third 8.7 cmH2O, the fourth 9.4 cmH2O, the fifth 10.8
cmH2O, the sixth 11.2 cmH2O, and finally the seventh 11.2 cmH2O.
Paired student’s T-test showed statistically significant IAP differences
between the pre- and all the post-drainage values. Furthermore, it is
important to notice that IAPs seem to stabilize after the 5th post-drainage
day since no statistical difference appears between 5th, 6th an 7th PDD.
Conclusion. The present study demonstrates that the drainage of large
pancreatic pseudocyst reduces the intra-abdominal pressure both in an acute
and in a chronic basis. Moreover, the IAP seems to rise shortly after the
drainage again in a way that it remains at all time inferior to the initial value.
More chronic changes to the IAP are related to abdominal cavity’s properties
which need more time to be altered, and have to be further studied.
PP 36.10
Large pancreatic pseudocysts alter the intra-abdominal pressure in a
chronic basis.
Papavramidis, Theodossis S.1; Kotidis, Eustathios2; Duros, Vassilios1;
Michalopoulos, Antonios1; Papadopoulos, Vassilios N.1; Paramythiotis,
Daniel1; Papavramidis, Spiros T.2
1A.H.E.P.A. University Hospital, Aristotle’s University of Thessaloniki, 1st
Propedeutic Department of Surgery, Thessaloniki, Greece; 2A.H.E.P.A.
University Hospital, Aristotle’s University of Thessaloniki, 3rd Department
of Surgery, Thessaloniki, Greece
Background. Intra-abdominal pressure (IAP) is the pressure existing in the
abdominal cavity. There is vast literature on the abdominal compartment
syndrome and the different techniques for measuring the pressure. The
present study aims to investigate whether the large pancreatic pseudocysts
alter the IAP.
Methods. Two groups were formed. Group A consisted of 9 patients (6
males and 3 females) with pancreatic pseudocysts that fulfilled the inclusion
criteria: (i) volume greater than 1l, (ii) no signs of chronic pancreatitis, and
(iii) no signs of acute pancreatitis for the last 2 months. The mean age of the
patients was 72.2y (range 64 to 78y). Group B consisted of 40 patients with
type II, after Nyhus, inguinal hernia. The only condition that had to be
fulfilled in forming this group was that the age of the patients had to be in the
age range of Group A.
A Foley catheter was inserted into the urinary bladder of all patients using a
standard sterile technique. The bladder was filled with 50 mL of saline using
a previously described closed-system technique. The measurements were
taken in the morning.
Results. BMI averaged 27.15 kg/m2 and 26.95 kg/m2 for groups A and B
respectively. The mean IAP while supine was 12.6 cmH2O (range, 917
cmH2O) for group A, while for group B it was 11.1 cmH2O (range, 912.5
cmH2O). Student’s T-test showed a statistically significant IAP difference
between the two groups (p0.05).
Conclusions. The formation of the pseudocysts limits the abdominal
volume occupied by the pancreatic fluids, and the exposure of the adjacent
organs from the erosion of the pancreatic fluids. This study demonstrates that
the presence of large pseudocyst sustains the IAP slightly elevated. This may
have an effect mainly in pancreatic irrigation, but also other organs irrigation.
Therefore, when large pancreatic pseudocysts are present, drainage of the
cyst may importantly improve the condition of the pancreas, as well as the
general condition of the patients.
PP 37.01
GASTRIC AND DUODENAL ULCERS IN PATIENTS WITH CIR-
RHOSIS AND NON- CIRRHOTIC PORTAL HYPERTENSION
Sinha, S K1; Mehta, V K1; Nada, R2; Prasad, K K1; Rana, S V1; Bhasin, D
K1; Singh, K1
1Post Graduate Institute of Medical Education & Research, Department of
Gastroenterology, Chandigarh, India; 2Post Graduate Institute of Medical
Education & Research, Department of Histopathology, Chandigarh, India
Introduction. Patients with cirrhosis have higher risk of peptic ulcer than
general population. This may be related to either portal hypertension or
hepatocellular dysfunction. The risk of peptic ulcer in non-cirrhotic portal
hypertension (NCPHT) is not clearly defined. Comparing the risk in the two
groups may also help in understanding the pathogenesis of these ulcers.
Aims & objectives. To study the prevalence of gastric and duodenal ulcer in
patients with cirrhosis and NCPHT, and assess their relation with H. pylori.
Methods. This prospective study was conducted on following three groups of
patients: 84 patients with cirrhosis, 37 patiens with NCPHT (7 patients with
non-cirrhotic portal fibrosis-NCPF and 30 patients with extrahepatic portal
vein obstruction-EHPVO), and 50 patients with non-ulcer dyspepsia.
Cirrhosis, EHPVO and NCPF were diagnosed on the basis of clinical,
imaging and endoscopic findings. Informed consent was obtained from each
patient. All patients underwent esophagogastroduodenoscopy and findings
were recorded. Biopsies were obtained from gastric antrum and body for
rapid urease test and histopathological examination to look for presence of H
pylori.
Results. Out of 84 patients with cirrhosis (mean age 45.711.5 years),
29(34.5%) patients had evidence of peptic ulcer ( duodenal ulcer in 20,
gastric ulcer in 7 and both in 2). Out of 37 patients with non-cirrhotic portal
hypertension (mean age30.116.7 years), four (10.8%) patients had
evidence of peptic ulcer (all duodenal ulcer). The difference in prevalence
of ulcers was significant (pB0.05). Helicobacter pylori was present in 12 out
of 50 (24%) patients with non-ulcer dyspepsia (mean age 45.313.8 years),
16 out of 29 (55.1%) patients with peptic ulcer and cirrhosis and two out of
four (50%) patients with peptic ulcer and non-cirrhotic portal hypertension.
Conclusion. Prevalence of peptic ulcer was significantly higher in patients
with cirrhosis as compared to non-cirrhotic portal hypertension.
PP 37.02
LIVER FAILURE AFTER HEPATECTOMY: PREDICTIVE FAC-
TORS OF MORTALITY
Vigano’, Luca1; Vellone, Maria2; Ferrero, Alessandro1; Giuliante, Felice2;
Nuzzo, Gennaro2; Capussotti, Lorenzo1
1Ospedale Mauriziano ‘‘Umberto I’’, Surgery, Torino, Italy; 2Policlinico ‘‘A.
Gemelli’’, Surgery, Roma, Italy
Background. Liver failure is the first cause of death after hepatectomy. Few
therapies are available with poor benefits.
Aim. To analyze predictive factors of mortality in patients with liver failure in
order to define therapeutic suggestions.
Methods. Patients undergoing liver resection in Ospedale Mauriziano
‘‘Umberto I’’ in Turin and in Policlinico ‘‘A. Gemelli’’ in Rome between
1998 and 2006. Characteristics of patients with postoperative liver failure
were analyzed as predictive factors of mortality.
Results. 1271 hepatectomies in 1153 patients were performed. Operative
mortality was 1.7% (21). In 76.2% of cases mortality was associated with
liver failure. Liver failure occurred in 57/1271 hepatectomies (4.5%), its
related mortality was 28.1%. Four patients with liver failure due to vascular
thrombosis were excluded from analysis. Mortality was significantively
increased in patients with cirrhosis and diagnosis of HCC (54.5% vs
14.3%, p0.0045; 46.2% vs 15%, p0.020); it was decreased in case of
colorectal liver metastases (0% vs 34.3%, p0.0044). Among postoperative
data, sepsis and reoperation increased risk of mortality (46.7% vs 13.2%, p
0.0087; 50.0% vs 14.6%, p0.010). Two independent risk factors of
mortality were identified at multivariate analysis: cirrhosis (p0.0053) and
sepsis (p0.0079). Fifteen patients with liver failure developed associated
sepsis and their mortality rate was 46.7%. Comparing septic to non-septic
patients, median bilirubin values were significantively higher only after sepsis
onset.
Conclusions. Strict preoperative selection is mandatory in cirrhotic patients.
Sepsis is often associated to liver failure and it has a key-role in its evolution
toward death. Its early detection and aggressive treatment could reduce liver
failure-related mortality.
PP 37.03
PREDISPOSING FACTORS AND SURGICAL OUTCOME OF
COMPLICATED LIVER HYDATID CYSTS
Akcan, Alper1; Sozuer, Erdogan1; Akyildiz, Hizir1; Yilmaz, Namik1; Ozturk,
Ahmet2; Yilmaz, Zeki1
1Erciyes University School of Medicine, Department of General Surgery,
Kayseri, Turkey; 2Erciyes University School of Medicine, Departments of
Biostatistics, Kayseri, Turkey
Background. The management and surgical outcome of complicated liver
hydatid cysts remains controversial. The aim of this study was to evaluate the
predisposing factors for peritoneal perforation and intrabiliary rupture and
the effects of these complications on surgical outcome in liver hydatid disease.
Methods. A total of 372 patients with liver hydatid cysts who had undergone
surgical treatment were evaluated retrospectively. Twenty eight patients with
peritoneal perforation, 93 patients with spontaneous intrabiliary perforation,
and 251 patients with noncomplicated hydatid cysts were treated in our
clinics.
Results. Age and cyst diameter are important predisposing factors for both
complications. Although complication rates were significantly different,
recurrence, length of hospital stay, and mortality were not significantly
different among the groups.
Conclusion. Our preferred surgical technique for liver hydatid cysts in
complicated and noncomplicated patients is partial pericystectomy and
drainage. In peritoneal perforated and intrabiliary ruptured cysts, the most
important steps are irrigation of the peritoneal cavity with a sufficient amount
of scolicidal agents, removal of all cystic contents from the peritoneum, and
clearance of the cystic material from the biliary tree. Morbidity rates
significantly increased in peritoneally perforated and intrabiliary ruptured
cases.
PP 37.04
OPERATIVE APPROACH TO EXTENSIVE LIVER TRAUMA
Djukic, vladimir; Stepic, D.; Bumbasirevic, V.; Vujovic, S.; Jovanovic, B;
Loncar, Z.; Popovic, N.; Karamarkovic, A.
KCS Belgrade, HPB and Emergency Surgery, Belgrade, Serbia and
Montenegro
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Background. Surgical strategy in the treatment of blunt and penetrating
liver trauma has been dramatically redesigned since CT scan was applied in
l981 tovards non operative. Extensive liver trauma grade IV and V with
challenging juxtahepatic injuries are still matter of dramatic surgery with high
comlication and mortality rate up to 65% Even liver transplant should be
consider as an option of extreme surgery.
Material and Methods. 26 patients were operated in Emergency Centre
Clinical Centre of Serbia Belgrade in a period ranging 01.01.2002
31.12.2006 Grade IV 18 patients and grade V remaining 8.Various surgical
procedures and vascular isolation techniques were applied in order to achieve
better results 1 atriocaval shunt completed with frormal right hepatectomy, 3
TVE total vascular exclusion/2 right hepatectomies and 1 patient right
hepatectimy and suttures of left liver/, 4 left sectorectomies S 2,3, 6 patients
wirh infrahepatic IVC repair,2 patients with caval repair and liver resection of
3 segments and more and nephrectomy, 3 patients with common bile duct
and portal vein reconstruction, 6 atypical mayor liver resection/more than
four segments/and 1 patient treated with perihepatic liver packing and
modified Damage control surgey. Owerall mortality was 57% DISCUSSION
High mortality rate and fatal triade as hypothermia, coagulopathy and
acidosis due to severe haemorrhage in multiple injuried patients with bad
prognostic ISS, TRISS, APACHE II an GLasgow Comma scale is reported
in many Pub Med citated series from USA Canada and Europe. Unfortu-
natelly there is no magic alternative to demanding surgery with poor results in
liver trauma grade IV and V Damage control surgery since Rotondo 1993
might be good initial option for bleeding problem but liver cell injury is still
fatal
PP 37.05
LIVER TRAUMA
Frena, Antonio; Marinello, Peter; Ciola, Michele; Imperiale, Sandro;
Ferrara, Roberto; Polato, Romano; Schellner, Michael Gerd; La Guardia,
Giuseppe; Martin, Federico
Central Hospital of Bolzano, General Surgery, Bolzano, Italy
Background. liver injuries are the most frequent cause of death in the field
of abdominal traumas. The increase in road accidents and sports injuries
makes discussion of the treatment modalities increasingly relevant in this
area.
Aim. In recent years we have witnessed an evolution in the therapeutic
management of such injuries with the increasingly frequent use of non-
operative procedures for the management of non-complex lesions.
Methods. a retrospective study was conducted in 111 cases of liver injuries
observed in our department over a 20-year period (19852005). The mean
age of the patients was 31 years. The most frequent causes were road
accidents (48%), followed by sports injuries (23%) and occupational
accidents (11%).
Results. 82 patients (74%) were treated surgically and 29 conservatively. In
58 cases (35 of which treated surgically), the liver injury was isolated, while in
the other 53 cases lesions were also present in other abdominal organs. The
liver injuries, classified according to the AAST, were grade I in 47 cases,
grade II in 30 cases, grade III in 19 cases, grade IV in 5 cases, and grade V in
10 cases. Thirty-five percent of grade I-II lesions were treated conservatively,
while 94% of grade III-IV-V lesions received surgical treatment. The overall
operative mortality was 12.5%.
Conclusions. the evolution of the management of liver injuries has witnessed
an increase in conservative treatment, particularly for grade I and II lesions.
There is no alternative to surgical treatment when the injury involves the
major hepatic vessels or substantial amounts of parenchyma. The mortality
rate is high compared to that of elective liver surgery, but this is due to the
frequent associated lesions in other organs and apparatuses.
PP 37.06
SPONTANEOUS CUTANEOUS FISTULA OF A LIVER HYDATID
CYST: A RARE COMPLICATION OF HYDATID DISEASE
Martin-Perez, Elena; Go´mez, Joaquı´n; Rubio, Ine´s; Rodrı´guez, Ana; Larra-
n˜aga, Eduardo
La Princesa Hospital, Dpt. of Hepatobiliopancreatic Surgery, Madrid, Spain
Background. Common sites of rupture of hepatic hydatid cyst are into the
bile duct, bronchi, peritoneal and pleural cavity, and the gastrointestinal
tract. However, rupture into the subcutaneous space is extremely rare.
Objectives. We report an unusual case of spontaneous cutaneous fistula into
the abdominal wall of a hepatic hydatid cyst.
Case Report. An 87-year-old man presented to the emergency department
with a slowly growing painless mass in his right hypochondrium for the past
four years, without history of fever or jaundice. On physical examination, a
well-defined and irreducible mass over the right flank was observed. A
computed tomography (CT) scan revealed an 187 cm hypodense, well-
defined cystic mass located in segment VIII of the liver causing compression
of the left lobe to the midline. The lesion was seen to communicate with
another cystic mass in the subcutaneous tissue through intercostal muscles.
The patient refused to undergo surgery, and oral albendazole treatment was
suggested as medical therapy. Ten months later he noticed a swelling in the
abdominal wall over the right hypochondrium and a fistula draining a
yellowish gelatinous material and whitish wrinkled cystic elements. At
operation, the subcutaneous cystic lesion was totally resected and the liver
cyst was treated by partial cystectomy. The residual cystic cavity was cleared
of its contents, irrigated with diluted povidone iodine solution, and drained
by a closed suction system. The postoperative course was uneventful. Follow-
up abdominal CT scans showed no evidence of relapse.
Conclusion. Spontaneous cutaneous fistulization complicating liver hydatid
disease is an extremely rare complication and is sparsely described in the
literature. CT scan, in addition to clinical presentation, is essential for
diagnosis. Surgery is usually required to achieve complete evacuation of the
cyst contents. This pathology should be included in the differential diagnosis
of an abdominal mass in endemic areas.
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HEPATIC TUBERCULOMA: A RARE MASS LESION OF LIVER
Pandey, Anshuman; Singh, Rajneesh K; Kapoor, Vinay K
Sanjay Gandhi Post Graduate Institute Of Medical Sciences, Surgical
Gastroenterology, Lucknow, India
Background. Hepatic tuberculosis usually presents as miliary tuberculosis
or granulomatous hepatitis. Hepatic tuberculoma presenting as a mass lesion
is rare. We present a case of hepatic tuberculoma and the problems of
diagnosis and management. Methods A middle aged female patient presented
with low grade fever for 6 years. CT scan of the liver (picture for poster)
showed a heterogeneously enhancing mass lesion of the left lobe of liver. The
serum tumour markers (AFP, CEA, CA19-9) were within normal limits and
preoperative FNAC was inconclusive. The routine LFT, chest X-ray and
esophago-gastroscopy did not show any abnormality. At laparotomy there
was a hard mass lesion in the left lobe of the liver with soft fleshy lymph nodes
in the hepatoduodenal ligament. Frozen section of the nodes revealed
granulomatous inflammation. The left lobe of the liver was resected along
with the mass lesion (picture for poster). Histopathology showed multiple
large epitheloid cell granulomas and was diagnostic of a tuberculoma of the
liver.
Results. The patients did well after the surgery and the fever resolved.
Thereafter she was given a 9 month course of 4 drug anti-tubercular therapy.
Discussion. Hepatic tuberculosis may present as one of three forms  (most
common) diffuse miliary tuberculosis, diffuse hepatic infiltration (granulo-
matous hepatitis) or (the rarest) hepatic tuberculoma or abscess. Fever,
weight loss and hepatomegaly are the common presenting symptoms. A
raised ESR and mild derangement of LFT may be seen. CECT shows large
discerete hypodense lesions with no pathognomonic features. MRI is of no
added benefit. The final diagnosis rests on the histopathological evidence of
caseating granulomas or demonstration of acid fast bacilli (AFB) on smear or
culture of the specimen. The cornerstone of management is standard
antitubercular drug treatment.
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RADIOFREQUENCY THERMAL ABLATION OF LIVER CARCI-
NOMA. PROSPECTIVE STUDY OF 82 LESIONS.
Lermite, Emilie1; MUCCI, Ste´phanie2; TEYSSEDOU, Carlos2; BRA-
CHET, Dorothe´e2; HAMY, Antoine2; AUBE, Christophe3; ARNAUD,
Jean-Pierre2
1Chirurgie visce´rale. CHU, Angers, France; 2CHU, chirurgie visce´rale,
Angers, France; 3CHU, Radiologie, Angers, France
Objectives: The aim of this prospective study was to evaluate the feasibility
of radiofrequency ablation of hepatic tumors. We studied the rates of
mortality, morbidity, and recurrence and recorded overall and disease-free
survival.
Methods. All patients aged over 18 years with histologically proven
malignant liver disease inaccessible to surgical treatment (one to four tumor
localizations) were eligible for inclusion in the study. Child-Pugh scoreB9,
platelets count 3 cm was correlated significantly with recurrence (P0.03).
Actuarial 1-, 2- and 3-year survival rates in the hepatocarcinoma group (N
31) were 84.7%, 57.7% and 34.6% respectively. Actuarial 1-, 2- and 3-year
survival rates in the metastasis from colorectal adenocarcinoma group (N
14) were 90%, 54% and 54% respectively (P0.72).
Conclusion. Radiofrequency thermal ablation is an effective treatment for
hepatic tumors measuring less than 3 cm. There is a low risk of complications
and open surgery can be associated. However in the absence of randomized
studies comparing radiofrequency and surgery, respective indications cannot
be defined in detail.
PP 37.09
BILE LEAKAGE AND ABDOMINAL BLEEDING AFTER HEPATIC
RESECTION WITH BILIARY RECONSTRUCTION
Ferrero, Alessandro; Russolillo, Nadia; Vigano’, Luca; Sgotto, Enrico; Lo
Tesoriere, Roberto; Ribero, Dario; Amisano, Marco; Capussotti, Lorenzo
Ospedale Mauriziano- Umberto I, Department of Surgery, Torino, Italy
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Background. Risks of conservative management of bile leakage after
hepatectomy with cholangio-jejunostomy are not well defined.Aim. To
evaluate the outcome of conservative treatment of bile leakage after liver
resection with biliary reconstruction.
Patients and Methods. Prospectively collected clinical data of 1034
consecutive patients who underwent liver resection were reviewed. Bile
leakage occurred in 25 out of 119 patients (21.0%) who underwent
hepatectomy with biliary reconstruction (Group 1) and in 42 out of 915
patients (4.6%) without biliary anastomosis (Group 2) (pB0.001). Serum
albumin and bilirubin levels were the only factors significantly different
between the two groups.Results. Mortality rates were similar in the two
groups (4% vs 2.3%). One or more postoperative complications occurred in
68% in Group 1 and in 40.4% in Group 2 (p 0.029). The incidence of sepsis
(32% vs 7.1%, p 0.01), intra abdominal abscess (12% vs 0, p 0.04) and
abdominal bleeding (28% vs 0, p 0.006) was significantly higher in Group1.
Bile leak spontaneously healed in 52% of patients in Group 1 vs 76.2% in
Group 2 (p 0.04). In order to identify independent predictive factors for
abdominal bleeding we compared clinical data of patients with (7 patients)
and without (18 patients) abdominal bleeding after hepatectomy and biliary
reconstruction. The following variables were considered for multivariate
analysis: arterial hypertension, cholangiojejunostomy on 3 ducts, left
hepatectomy 9Sg1, intraoperative blood loss 300 mL and duration of
postoperative bile leakage 10 days. Stepwise logistic regression analysis
identified cholangiojejunostomy on 3 ducts as independent predictive factor
of abdominal bleeding (p 0.02).
Conclusions. Conservative management of bile leakage after liver resection
with biliary reconstruction is associated with higher rates of morbidity. The
most severe complication is abdominal bleeding, which occurs more
frequently after reconstruction of three ducts.
PP 37.10
PERI-OPERATIVE INDOCYANINE GREEN CLEARANCE IN LI-
VER RESECTION PATIENTS
Low, Jee1; Mackillop, Andrew2; Clark, Debbie1; Vadeyar, Hemant1; Sher-
lock, David1
1North Manchester General Hospital, Surgery, Manchester, United King-
dom; 2North Manchester General Hospital, Anaesthesia, Manchester,
United Kingdom
Introduction. Elimination of indocyanine green (ICG) from blood can be
used to determine peri-operative hepatic function.
Aim. This technique was used to monitor the hepatic function of patients
undergoing any form of liver resection.
Method. Sixteen patients scheduled for hepatic resection were studied. We
used transcutaneous pulse densitometry for the assessment of liver function
by measuring ICG plasma clearance (Limon †). After an intravenous
injection of 0.25mg/kg of ICG, we observed plasma disappearance rate
(PDR) and retention rate extrapolated to 15 minutes (R15).
Results. Sixteen patients were studied, nine male and five female. The mean
PDR before operation of all sixteen patients was 26.7%/min (19.340.2), on
the first post-operative day 23.8%/min (7.940.1), one week later 23.4%/min
(4.531.4) and beyond six weeks 21.0%/min (9.030.3) respectively. Of the
six patients who underwent right hepatectomy, they had mean PDR of
29.8%/min, 13.9%/min, 17.3%/min and 18.9%/min respectively. The seven
patients who underwent segmentectomy, had a mean PDR of 26.6%/min,
31.5%/min, 28.0%/min and 25.0%/min respectively. Three patients who had
re-do hepatectomy had a mean PDR of 20.7 C, 25.4%/min, 24.8%/min and
19.9%/min respectively.
Conclusion. Measuring ICG clearance using Limon is practical, easy to use
and a useful way of estimating hepatic dysfunction after surgery. There were
clear differences in PDR between those patients who had right hepatectomy
and those with segmentectomy
PP 38.01
THE EXPRESSION OF P15 AND P16 PROTEINS IN GALLBLAD-
DER CANCER AND ITS CLINICAL SIGNIFICANCE
Sui, Chen-guang1; Han, Yue2; Ren, Hong2; Ma, Qing-yong2; Shi, Jing-sen2
1First Hospital of Xi¡*an Jiao Tong University£Xi¡*an 710061£China,
Department of Oncology, Xi An; 2
Introduction. The gallbladder cancer is the most common malignant tumor
in biliary tract system and its incidence takes the fifth or sixth position in all
alimentary tract tumors in China. Gallbladder cancer is confirmed uneasily
and with a poor prognosis. OBJECTIVE£8To evaluate the role of p15 and
p16 in the occurrence and progression of gallbladder cancer and to make a
understanding of their relationship and clinical significance.
Methods. Immunohistochemical techniques was applied on 30 cases of
gallbladder cancer and 10 cases of cholecystolithiasis in order to detect the
expression of p15 and p16 proteins.
Results. The expression of p15, p16 was correlated with clinical pathological
stage, matastsis and prognosis in gallbladder cancer (PB0.05). The p15
expression was positive correlation to p16 expression in gallbladder cancer
(PB0.05).
Conclusion. The reduced expression of p15 and p16 may participate in the
occurrence and progression of the gallbladder cancer. Examination of
expression of these two proteins may be helpful to judge biological behavior
and prognosis of gallbladder cancer.
PP 38.02
INAPPARENT CARCINOMA GALLBLADDER: INAPPARENT OR
INAPPROPRIATELY MANAGED?
Singhal, Dinesh; Chaudhary, Adarsh
Sir Ganga Ram Hospital, Surgical Gastroenterology, New Delhi, India
Background. Early gallbladder cancer (GBC) is difficult to differentiate
from chronic cholecystitis on preoperative imaging and is often diagnosed at
histopathology examination of the cholecystectomy specimen (‘inapparent
GBC’). Our experience in the management of these patients indicated that all
lesions might not have been truly inapparent. Hence we systematically
investigated inapparent GBC patients for probable errors in the management
and the lessons learnt.
Method. From 2003 2007, 21 patients [13 females and 8 males, median age
of 50 years (range 30  67 years)] referred to us for further management of
‘inapparent GBC’ were retrospectively analyzed for demography, presenta-
tion, preoperative imaging and surgical management. These characteristics
were compared with those of 51 other patients managed by us as GBC during
the same duration.
Results. Inapparent GBC patients were significantly younger than those with
gallbladder mass lesions managed as GBC (50 versus 58 years, P0.017).
Three patterns of management errors were identified: 1. Planning of
laparoscopic cholecystectomy (LC) despite imaging suggestive of GBC (8
patients) 2. Persistence with LC in this group leading to bile leak in 5 patients
and bleeding in 1 patient 3. Inappropriate postoperative management
delaying definitive surgery (3 patients).
Conclusions. Mass lesions of gallbladder are more likely to be misinter-
preted as benign in younger patients. Errors in the management of such
patients are often avoidable.
PP 38.03
PRIMARY ADENOCARCINOMA OF GALLBLADDER WITH SO-
LITARY INTRAABDOMINAL METASTASIS FROM COLONIC
ADENOCARCINOMA
Jacobs, Michael1; Kansakar, Erina2; Chang, Jennifer2
1Providence Hospital-St John Health System, Surgery, Southfield, United
States; 2Providence Hospital, Surgery, Southfield, United States
Background. Carcinoma of the colon is one of the most common
malignancies in the Western world; however, isolated peritoneal recurrence
is rare. Primary gallbladder adenocarcinoma is also rare. OBJECTIVE The
occurrence of primary adenocarcinoma of the gallbladder with a solitary
intraabdominal metastasis from the colon is unusual and forms the basis of
this report.
Methods and Results A 90-year old man presented with jaundice and
bloody stools five-years after surgery for colon cancer. The physical exam
demonstrated jaundice with a microcytic anemia on complete blood count.
The CEA and CA 19-9 were abnormal. A CT scan of the abdomen showed a
right-sided mass anterior to Gerota’s fascia free from adjacent organs and a
mass in the neck of the gallbladder adjacent to the common bile duct.
Colonoscopy revealed an intact ileocolonic anastomosis and no additional
lesions. An ERCP showed a non-lithogenic filling defect at the junction of the
CBD and cystic duct. Intraoperatively, the peritoneal mass was identified in
Morrison’s Pouch and was not attached to adjacent organs. A tumor was also
seen in the infundibulum/cystic duct of the gallbladder with hemobilia.
Intraoperative frozen section showed tumor free margins in the resected
CBD. The patent underwent resection of the mass and common duct,
cholecystectomy, and hepaticoduodenostomy. The histopathology was in-
vasive poorly-differentiated adenocarcinoma of gallbladder (R0) and meta-
static peritoneal moderately-differentiated adenocarcinoma of colonic origin.
The patient did well postoperatively and was discharged after seven days.
Conclusion. Primary gallbladder cancer and isolated metastatic colorectal
carcinoma is a unique rarity. Surgery offers both cure and palliation of
jaundice and should be considered even at the extremes of age.
PP 38.04
STAGING LAPAROSCOPY PLAYS A DEFINITE ROLE IN THE
PREOPERATIVE STAGING OF PATIENTS WITH RESECTABLE
PROXIMAL BILIARY DUCT CANCERS
Hariharan, Deepak1; Bhattacharya, Satyajit2; Abraham, Ajit2; Kocher,
Hemant2
1Barts & the London School of Medicine & Dentistry, Institute of Cancer,
London, United Kingdom; 2The Royal London Hospital, Barts and the
London HPB Centre, London, United Kingdom
Background. There exists a high incidence of occult metastases in patients
diagnosed with proximal bile duct malignancies (gall bladder carcinoma,
intra-hepatic carcinomas and hilar cholangiocarcinomas) despite extensive
preoperative staging.
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Aim. To determine the role of staging laparoscopy (SL) in association with
laparoscopic ultrasound (LUS) in the management of patients with proximal
biliary malignancies.
Methods. Studies using contemporary staging techniques and assessing the
effect of SL/LUS in patients with potentially resectable proximal biliary
malignancies with respect to alteration in surgical management were
included. Surgical evaluation was considered the gold standard for staging
and laparoscopy only, when obvious metastatic lesions were detected which
precluded surgical exploration. Overall test characteristics and yield of SL/
LUS in preventing unnecessary laparotomy was calculated.
Results. A total of 5 studies satisfied our inclusion criteria and 420 patients
were assessed laparoscopically. In 7 patients the laparoscopic assessment was
incomplete due to adhesions. Additional metastatic disease precluding
curative resection was identified in 170 patients. The sensitivity of SL/LUS
for diagnosing unresectability was 57.2%, specificity 100%, positive pre-
dictive value of 100%, and negative predictive value of 49.2%. The true yield
of SL/LUS in identifying inoperable disease was determined to be 41.1%.
Conclusion. Staging laparoscopy is a useful tool in predicting unresectability
in patients with proximal bile duct malignancies, especially gall bladder
carcinomas.
PP 38.05
NEUROENDOCRINE TUMOUR OF THE GALLBLADDER MI-
MICKING ADENOCARCINOMA
Shah, Sudeep1; Deshpande, Ramesh2
1PD Hinduja Hospital and MRC, GI Surgery, Mumbai, India; 2PD Hinduja
Hospital and MRC, Pathology, Mumbai, India
Background. Carcinoma gallbladder is common in India and has a poor
prognosis if there is extensive liver infiltration. Carcinoid tumour of the
gallbladder is extremely unusual and presents in a similar fashion. As the
prognosis is much better, this condition should not be overlooked.
Case Report. A 67 year old gentleman was incidentally detected to have a
gallbladder mass on sonography, performed to evaluate prostatic symptoms.
On subsequent CT, an 1187 cm mass was seen engulfing the
gallbladder, extensively infiltrating segments IVB, V and VI of the liver.
There was no vascular or nodal involvement. CT chest and bone scan were
negative. CA 19-9 was normal. The patient underwent resection of segment
IVB, V and VI with the gallbladder and regional nodal clearance. Histo-
pathology revealed neuroendocrine tumour. Nodes and margin was negative.
The patient is asymptomatic 4 months after surgery
Discussion. Neuroendocrine tumours of the gallbladder are very rare and
may mimic adenocarcinoma. Surgery should be offered for these as the
prognosis is excellent.
PP 38.06
RESECTABILITY AND SURVIVAL IN CARCINOMA GALL BLAD-
DER-OUR EXPERIENCE
KAPOOR, SANJAY1; N, Kannan2; Gupta, Samir3
1ARMY HOSPITAL, SURGICAL ONCOLOGY, (RESEARCH & RE-
FERRAL), DELHI, India; 2Command Hospital(WC), Surgical Oncology,
Chandigarh, India; 3Army Hospital (Research and Referal), Surgical
Oncology, Delhi, India
Background. Cancer of the Gallbladder is very common in North India
along the Ganges planes and majority of the cases present in advanced stage
with obstructive jaundice and are inoperable. AIMS To study the impact of
neoadjuvant chemotherapy in improving the possibility of resectability and
the impact of neoadjuvant chemotherapy on improving survival.
Methods. All patients diagnosed as Carcinoma gallbladder were investigated
for staging and to asses operability. Non metastatic cases were included in the
study. Patients found operable were undertaken for Radical Cholecystectomy.
Patients detected to have Cancer gall bladder after cholecystectomy for
benign causes underwent completion radical cholecystectomy, after staging.
Patients who were jaundiced but operable, were operated after biliary stenting
Patients found to be inoperable were offered neoadjuvant chemotherapy.
Those who had jaundice were stented before starting chemotherapy. These
patients were evaluated after three cycles of chemotherapy and if found fit for
surgery, they underwent radical cholecystectomy. If the desease was still
unresectable, patients were given three more cycles of chemo therapy and
then evaluated for operability, and those who responded underwent surgery
at this stage. Chemotherapy was terminated if there was disease progression
during chemotherapy. Patients who underwent surgery primarily or after
three cycles of neoadjuvant chemotherapy were given adjuvant chemother-
apy. More chemotherapy was given to patients who were found to have
residual disease on surgery after six cycles of chemotherapy.
Results 124 patients were included in the study. Neoadjuvant Chemotherapy
increased the number of resectabilty. Nodal metastasis was found in one case,
who underwent completion radical cholecystectomy. Residual disease was
found in all cases after three cycles, and in few cases after six cycles of
chemotherapy.
Conclusion. Aggressive surgery with Neoadjuvant and Adjuvant chemother-
apy can change the dismissal scenario of gall bladder cancer
PP 38.07
Clinicopathological study according to depth of subserosal invasion in
patients with pT2 gallbladder carcinoma
Yuko, Mataki; Hiroyuki, shinchi; Noma, Hidetoshi; Maemura, Kousei;
Kurahara, Hiroshi; Maeda, Shinichi; Ueno, Shinichi; Sakoda, Masahiko;
Kubo, Fumitake; Takao, Sonshin; Aikou, Takashi
Kagoshima University, Surgical Oncology, Kagoshima, Japan
Background. We examined whether depth of subserosal cancer invasion
survival in gallbladder carcinoma (GBC) patients with pathological subser-
osal invasion (pT2).
Methods. Between 1987 and 2007, a total of 49 patients with GBC
underwent a curative surgery at our department in Kagoshima University.
Of these, subjects comprised 28 patients with pT2 GBC. We divided
subserosal invasion into two categories corresponding to invasion of the
shallower layer, ss1(n15) and deeper layer, ss2(n13). Relationships
between subserosal classification, histopathological factors, and prognosis
were examined.
Results. Positive rates of histopathologic findings, such as lymph node
metastasis, lymphatic invasion, venous invasion, perineural invasion, hepatic
invasion, and biliary infiltration, in ss1 GBC were lower than those in ss2
GBC(p0.26, pB0.001, p0.006, p0.055, p0.06, p0.11, respec-
tively). Overall five-year survival rate in pT2 GBC was 63.8%. The five-year
survival of patients with ss1 GBC was significantly better than those with ss2
GBC(p0.033). Various hepatectomy for ss GBC was selected, such as
cholecystectomy (n7), resection of hepatic bed (n14), S4aS5 resection
(n5), extended right lobectomy (n2). There was no significant difference
in five-year survival among 4 types of hepatic resection. Only cholecystect-
omy provides five-year survival for 2 cases with ss1 GBC. Meanwhile,
hepatectomy greater than gallbladder bed resection provides five-year
survival for 4 cases with ss2 GBC. Recurrence of hepatic metastasis occurred
in 6 cases. In two cases among them, S4a, S5 hepatic metastases occurred in
half-year after first resection, and by additional resection of hepatic
metastases they could get five-year survival.
Conclusions. In compliance with the extent of depth of subserosal invasion
in ss GBC, hepatectomy should be selected.
PP 38.08
A RETROSPECTIVE ANALYSIS OF GALLBLADDER CANCER
WITH SUBSEROUS INVASION (PT2) TREATED WITH SURGI-
CAL RESECTION
Katagiri, Hiroyuki1; Yoshida, Muneki2; Ishii, Kenichiro1; Itabashi, Kouichi1;
Takahashi, Yoshihito1; Furuta, Kazunori1; Watanabe, Masahiko1
1Kitasato university, School of Medicine, Department of Surgery, Sagami-
hara, Japan; 2Sagamino Hospital, Department of Surgery, Sagamihara, Japan
Background. An appropriate procedure improves the outcome of long-term
survival of patients of gallbladder cancer with subserous invasion (pT2). We
had conducted the liver lobectomy, the central inferior (S4aS5) hepatic
subsegmentectomy, the gallbladder bed resection and the simple cholecys-
tectomy in various cases of the pT2 cancer. Also such fundamental procedure
has been done with regional lymphadenectomy, with or without extra hepatic
bile duct resection. The prognosis of pT2 patients and the appearance of the
recurrence were different among the procedure.
Aim. This study investigated which was most suitable procedure for pT2
cancer.
Methods. 34 patients with pT2 cancer who underwent the surgical treatment
were reviewed. Prognostic factors of patients were evaluated by single or
multivariate analysis.
Results. 14 patients had been underwent the radical operation (HPD).
Seven patients, who had either pN0 disease and no infiltration of the cancer
cells into the hepatoduodenal ligament, survived longer than 5 years.
However the mean survival time (MST) of the other seven patients, who
had carcinomatous invasion in the hepatoduodenal ligament, was only 7
months. Also patients with paraaortic lymphnodes metastasis, have not been
survived beyond 12 months. In all cases of pT2 patients, that a tumor
presented in the gallbladder neck (and/or extend to the cystic duct), the
carcinomatous invasion in hepatoduodenal ligament were confirmed. Ad-
jacent hepatic recurrence was most frequent mode in the case of the patients
who underwent the simple cholecystectomy.
Conclusion. A radical surgery may not achieve a good outcome for all, and
must be carefully considered to avoid surgical risk. Our results suggest that
the gallbladder bed resection, combined with regional lymphadenectomy, is
the most appropriate, and that the extra bile duct resection is reasonable for
the tumor located on the gall-neck (and/or extend to cystic duct).
PP 38.09
GEMCITABINE BASED CHEMOTHERAPY IN GALLBLADDER
CANCER
Kim, Hyungchul
Soonchunhyang University College of Medicine, Surgery, Bucheon, Korea,
Republic of
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Background. Gallbladder cancer is the most common malignancy of the
biliary tract and the fifth most common gastrointestinal cancer. Unfortu-
nately, patients with gallbladder cancer have advanced, unresectable tumor at
the time of presentation and face a dismal prognosis in the absence of a
standard chemotherapy regimen. This study was performed to evaluate the
outcome of patients with gallbladder cancer who received postoperative
chemotherapy. Methods and Materials: From 2001 through 2007, 23
patients with gallbladder cancer underwent surgical treatment in our
institution. Most of patients were treated with a 3-week cycle gemcitabine
(1000mg/m2) and 5-fluorouracil (200mg/m2) on day 1, 8, 15, 22, 29, 36,
and 43. 4 patients with advanced gallbladder cancer (T3, T4) were treated
with a 3-week cycle gemcitabine (1000mg/m2) on day 1, 8 and 5-fluorouracil
(200mg/m2) on day 1.
Results. There were 1, 3, 13, 4, and 2 patients with T1a, T1b, T2, T3, and
T4 disease, respectively. Radical cholecystectomy was the standard treatment
of the respectable gallbladder cancer except T1a disease. The mean survival
for the entire group was 36 months, and the overall 5-year survival rate was
62.5%, respectively. Results of survival analysis for patients who received
chemotherapy for gallbladder cancer were 84.6% at 5 years postoperatively
(p0.042).
Conclusions. Patients with completely resected (negative margins) gall-
bladder followed by adjuvant gemcitabine based chemotherapy had a
relatively favorable prognosis, with a 5-year survival rate of 84.6%. This
regimen warrants further evaluation in a phase II study including larger
numbers of patients.
PP 38.10
DELAY IN GASTRIC EMPTYING IN CARCINOMA GALLBLAD-
DER-A SCINTIGRAPHIC STUDY
pitchai, rajapandi; Yadav, THAKUR D; Wig, Jai D; Kudari, ashwinikumar;
doley, rudra p; Gupta, rajesh; srinivasan, thiagarajan
PGIMER, Chandigarh, India, General Surgery, chandigarh, India
Background. AND AIM: Gastrtoparesis is characterized by delayed gastric
emptying in the absence of mechanical gastric outlet obstruction. There is a
strong association of gastroparesis with carcinoma gall bladder. About one
third of patients with carcinoma gallbladder present with symptoms and signs
suggestive of gastric stasis. The aim of this study is to find the incidence of
delayed gastric emptying in carcinoma gallbladder without mechanical gastric
outlet obstruction and its correlation with symptoms, stage of the disease.
Methods. Thirty patients diagnosed with carcinoma gallbladder and 20
normal controls were enrolled in this study. Patients with mechanical gastric
outflow obstruction were excluded from the study. All patients underwent
CECT abdomen & radiolabelled solid meal gastric emptying scintigraphy
study. The upper limit of normal gastric emptying time was defined from the
control group as mean2 SD. This value was applied to the study group to
find out the delayed emptying in patients.
Results. Age and sex were comparable between the two groups. Upper limit
of normal gastric emptying time is 55.09 (40.5314.56) minutes. In our
study, 5 (15.6%) patients of carcinoma gallbladder had symptoms suggestive
of gastric stasis and 16 (53.3%) patients had delayed gastric emptying. The
range is 23127 (mean 66.72) minutes. Among the later 16 patients, only 2
(12.5%) patients had symptoms of gastric stasis. Other factors like age, sex,
symptoms, duration of symptoms, associated gallstones, serum bilirubin and
stage of the disease were also studied but these factors were found to have no
affect on gastric emptying.
Conclusion. Significant percentage of patients with carcinoma gallbladder
have delayed gastric emptying sub clinically. This delay does not correlate
with symptoms and stage of the disease and not affected by associated
gallstones or lymph nodal status.
PP 38.11
INCIDENTAL CARCINOMA OF THE GALL BLADDER- TO RE-
OPERATE OR TO LEAVE ALONE?
IRPATGIRE, RAVINDRA1; KANTHARIA, CHETAN2; PRABHU,
RAMKRISHNA2; BAPAT, RAVINDRA2; SUPE, AVINASH2
1KEM HOSPITAL & SETH GS MEDICAL COLLEGE, SURGICAL
GASTROENTEROLOGY, PAREL, MUMBAI, India; 2KEM HOSPITAL
& SETH GS MEDICAL COLLEGE, SURGICAL GASTROENTEROL-
OGY, MUMBAI, India
Department of Surgical Gastroenterology, Seth GS Medical College &
KEMH, Parel
Background. Though the management of Ca GB is well established, ideal
management of Incidental Ca GB still remains to be protocolised. The
present study is to determine the whether patients with Incidental Ca GB
need to be re-operated.
Methods. 48 cases of Ca GB were identified from our database, in last three
years (20032006). 11 of these (8 females, age range; 2980 years, median -
54 years.) had Incidental Ca GB. All the 11 patients had undergone
laparoscopic cholecystectomy. Following HP diagnosis of Ca GB, the
patients were subjected to CECT Scan for staging. Two patients with liver
infiltration and five with Lymphadenopathy without liver infiltration were
detected. They were subjected to surgery. The median time from cholecys-
tectomy to re-resection was 18 days. At the time of re-resection, wedge
resection with LN clearance (three), tri-segmentectomy (two) and peridochal
lymp node clearance (two) was performed. 4 were left alone and kept under
surveillance. Pathology of the re-resection specimen noted residual disease in
all 7. Specifically, carcinoma was found in the liver bed (4), lymph nodes (3).
All the patients were monitored by doing USG and CT scan. The F/U ranged
from 6 to 33 months. QOL (based on SF-36 criteria) and survival was
assessed Results:
Median Survival in
months
QOL
Wedge resection with LN
clearance (3)
30 (1830) 8 (78)
segmental resection (2) 20 (1426) 7 (68)
Peridochal LN exicision(2) 27 (2430) 7 (68)
Left alone 12 (1114) 5.5 (56)
Conclusions: Re-resection for incidental gallbladder carcinoma is warranted
as the majority of patients have residual disease. They have acceptable
mortality and offers better QOL.
PP 39.01
ROLE OF SPECT-CT ’’FUSION IMAGING’’ IN NEUROENDO-
CRINE TUMOURS
Kumari, Saumya1; Krishna, B. A.2; Ghule, Shwetal2
1P. D. Hinduja National Hospital, Nuclear Medicine, and Medical Research
Centre, Mumbai, India; 2P. D. Hinduja National Hospital, Nuclear
Medicine, Mumbai, India
Background. The fusion imaging (CT and nuclear imaging) has enhanced
the sensitivity of nuclear imaging in oncology practice. In the context of
neuroendocrine tumours, the wholebody octreotide imaging is conventionally
used pre and post operatively. However, lack of anatomical details reduced
the clinical impact. The recently introduced fusion imaging technique  CT-
SPECT- has enhanced its role in the treatment decision making process.
Aim. To demonstrate the improved localization and higher sensitivity of the
SPECT-CT fusion imaging over planar or SPECT imaging alone in patients
of neuroendocrine tumours.
Methods. Totally 13 patients with pathologically proven diagnosis of
neuroendocrine tumours were included in this study. All patients were
subjected to 111 Indium Octreotide imaging. Both whole body planar and
CT-SPECT images were acquired.
Results. In 10/13 patients, the SPECT demonstrated additional lesions over
the planar images and SPECT-CT further enhanced the spatial localization in
8 out of these 10 patients.
Conclusion. SPECT-CT fusion imaging using 111 Indium Octreotide is a
sensitive and specific modality for the diagnosis and localization of the
disease, thereby guiding the optimal management of these patients. The
SPECT imaging diagnosed additional lesions in 77% of the patients and the
SPECT-CT fusion imaging further enhanced the localization in 80% of these
patients.
PP 39.02
IMPACT OF PREOPERATIVE POSITRON EMISSION TOMO-
GRAPHY ON PATIENT SURVIVAL IN COLORECTAL LIVER
METASTASIS-10 YEAR CAMBRIDGE EXPERIENCE
Sadat, Umar; Jah, Asif; Kan, Yuk-Man; Paulvannan, Subramanian; Gibbs,
Paul; Praseedom, Raaj K; Jamieson, Neville V; Huguet, Emmanuel L
Addenbrooke’s Hospital, Hepatobiliary and Transplant Surgery, Cambridge,
United Kingdom
Introduction. Postoperative survival after liver resection for colorectal liver
metastases depends on good patient selection. PET scan is a useful
radiological tool which increases the accuracy of preoperative disease staging.
Aim. To assess the impact of preoperative PET imaging on the survival of
patients with colorectal liver metastasis.
Methods. All patients undergoing liver resection for colorectal liver
metastases since 1997 were included, and divided into three groups: group
1, patients who had liver resection after PET scan, group 2 who had resection
without PET and group 3 who were deemed inoperable on PET findings.
Kaplan-Meier survival estimates and Log rank/Wilcoxin tests were used to
quantify the median survival time, hazard ratio and equivalence of death rates
respectively. The correlation between number of lesions on PET, CT scan
and histology in operated cases was determined by Spearman’s rank
correlation.
Results. In the ten year period, 157 patients underwent liver resections for
colorectal liver metastases (mean age: 61.5 yrs97.3), males being predomi-
nant (36% females). 149 patients were included for analysis (8 records
missing, 86 patients in group 1, 63 in group 2, and 30 patients in group 3).
The median survival for the three groups was 2651 vs. 1338 (95%CI895
1729) vs. 679 days (95%CI6761916) respectively (hazard ratio (95%
CI):1.69 (0.85 -3.36) group1 vs. group 2, 0.44 (0.121.63) group 1 vs. group
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3 and 0.26 (0.070.88) group 2 vs. group 3, equivalence of death rates:15.22,
P0.0005). There was good correlation between findings on PET, CT and
histology in the extent of intrahepatic disease (liver histology vs. liver CT:
0.55, liver histology vs. liver PET: 0.46, liver PET vs. liver CT: 0.58, PB
0.0001), but PET was more sensitive in the detection of extrahepatic disease.
Conclusions. As a result of detection of occult extrahepatic disease,
preoperative PET scanning is associated with significantly improved patient
survival, and thereby allows futile liver resections to be avoided.
PP 39.03
THE CLINICAL ROLE OF 18F-FDG PET-CT FOR PRIMARY
EXTRAHEPATIC BILE DUCT CANCER
Jeong, Seok1; Lee, Don Haeng1; Kang, Hyo Seung2; Lee, Chung Hwon3
1Inha University College of Medicine, Incheon, Korea, Republic of; 2Incheon
Christian Hospital, Internal Medicine, Incheon, Korea, Republic of; 3Dong-
suwon General Hospital, Internal Medicine, Suwon, Korea, Republic of
Background. In the primary extrahepatic bile duct (EHD) cancer, pre-
operative evaluation is important because only surgical excision is associated
with improvement in 5-year survival. However, morphological imaging
techniques, including CT, are still insufficient for accurate diagnosis and
staging. We evaluate the sensitivity and specificity of PET-CT using 18F-
FDG for diagnosis, differential diagnosis and staging of the primary EHD
cancer.
Subjects and Methods. Abdominal CT and PET-CT studies were
performed on 27 patients (21 men, 6 women; mean age ¡34 SD, 65 ¡
3
4 10 y)
with suspicious malignant EHD strictures on abdominal CT, MRI, endo-
scopic retrograde cholangiography, or percutaneous cholangiography. The
final diagnosis of EHD cancer was made by pathologic exam after surgical
resection or bile cytology, or by regular clinical and radiological follow-up for
12 months or more. The SUVmax was measured on the primary lesion.
Results. Final diagnosis was histologically or clinically proven to the primary
EHD cancer in 22 cases and benign stricture in 5 cases. The sensitivity and
specificity of FDG PET-CT for diagnosing the primary EHD cancer was
84% (21/25) and 50% (1/2), respectively. The sensitivity and specificity of
FDG PET-CT for nodal staging in 12 patients who were surgically confirmed
as the primary EHD cancer, was 40% (2/5) and 71% (5/7), respectively. The
probability of localization of PET-CT for the primary EHD cancer was 100%
(21/21). The SUVmax was 4.38 ¡34 2.38 (range, 1.6911.1) in primary EHD
cancer group, compared with 2.64 ¡34 0.42 (range, 2.033.2) in benign EHD
stricture group (P0.029). The optimal cutoff value of SUVmax for
detecting the primary EHD cancer (area under the curve 0.851, pB0.029)
was 3.22, obtained from analysis of receiver operator characteristics curve.
Conclusions. We suggest that 18FDG PET-CT may have some clinical roles
in differential diagnosis of both the primary EHD cancer and benign
stricture, and localization of the primary lesion.
PP 39.04
EVALUATION OF RESPONSE TO 90-YTTRIUM MICROSPHERE
TREATMENT FOR COLORECTAL LIVER METASTASES USING
FDG-PET SCAN: HISTOLOGICAL CORRELATION
Sommerville, Craig1; Pai, Madhava2; Damrah, Osama2; Stamp, Gordon3;
Jackson, James4; Tait, Paul4; Al- Nahas, Adel5; Habib, Nagy2; Jiao, Long2
1Hammersmith Hospital, Imperial College, Hepatobiliary Surgery, Du Cane
Road, London, United Kingdom; 2Hammersmith Hospital, Imperial Col-
lege, Hepatobiliary Surgery, London, United Kingdom; 3Hammersmith
Hospital, Imperial College, Histopathology, London, United Kingdom;
4Hammersmith Hospital, Imperial College, Radiology, London, United
Kingdom; 5Hammersmith Hospital, Imperial College, Nuclear Medicine,
London, United Kingdom
Introduction. Selective Internal Radiation Therapy (SIRT) with 90Yttrium
microspheres has emerged as a treatment option for patients with colorectal
liver metastases. Positron emmision tomography (PET)has recently been
advocated as an early metabolic marker of disease response to SIRT.
Methods. Two patients with colorectal liver metastases underwent surgery
following successful downstaging therapy with SIRT. At surgery one patient
had portal hypertension and the planned resection of a PET non-responsive
metastasis was abandoned after a biopsy. The second patient underwent
resection of the PET non-responsive metastasis and an excisional biopsy of a
metastasis that had responded on PET imaging.
Results. The histological response was a central fibrovascular core contain-
ing microspheres with fibrosis, hyalinization and a reduction of viable tumour
cells in the two patients. The biopsy of patient 1 showed a histological
response to SIRT compared to his previous hepatectomy specimen and in
patient 2 there was no difference between the metastases that had and had
not shown a PET response although both had evidence of a histological
response to the therapy. The result does demonstrate a pathological response
to SIRT however the PET imaging does not correlate with the pathological
response.
Conclusion. The imaging response to best assess response to treatment is
not known and requires further investigation.
PP 39.05
EVALUATION OF MRI IN DIAGNOSING FOCAL HEPATIC LE-
SIONS AND SUSPECTED CANCER: ITS CLINICAL UTILITY.
Shah, Ankur J1; Parsons, Brian2; Callaway, Mark3; Finch-Jones, Meg1;
Finch-Jones, Meg1; Thomas, Michael G2
1Bristol Royal Infirmary, HPB surgery, Bristol, United Kingdom; 2Bristol
Royal Infirmary, Surgery, Bristol, United Kingdom; 3Bristol Royal Infirmary,
Radiology, Bristol, United Kingdom
Background. Detection and characterization of focal liver lesions (FHL)
remains a challenge. MRI is frequently used for evaluation of focal hepatic
lesions that are indeterminate with other imaging modalities.
Aims. To explore the clinical utility of contrast enhanced MRI in the
characterization of FHL and to find out if it made a change in the staging of
cancer.
Methods. This retrospective study looked at the results of 122 consecutive
MRI scans over the last 2 years. This was compared to the previous
radiological examination (Ultrasound-USS or multislice CT scan).The
results were evaluated on the basis of utility of MRI to add/ confirm /negate
the findings of the previous USS/CT scan for all lesions and specifically
whether it changed the staging in suspected cancer.
Results. Out of the 122 patients who had a MRI; 86 had previous USS and
40 had a CT scan. For all FHL, MRI made a difference in 72% (62/86) of
patients who had an USS. As compared to a CT scan, MRI made a difference
in 47.5% (19/40) of patients. A cancer was suspected in 63 patients. MRI
changed the diagnosis in 64% (23/36) of patients who had an USS only;
whereas it altered the management in 44% (12/27) of patients who had a CT
scan. In summary, MRI made a significant change in 55.5% of patients in
whom a cancer was suspected.
Conclusions. MRI is superior to other non-invasive imaging modalities for
lesion identification and characterization. It made a significant difference in
the diagnosis and management of suspected cancer. This study supports the
routine use of contrast enhanced MRI for undiagnosed focal liver lesions.
PP 39.07
A CASE OF AN OBSTRUCTING DUODENAL EMBRYONAL
CARCINOMA
Smith, Marty; Abraham, Ajit
Royal London Hospital, HPB Surgery, London, United Kingdom
We present a case report of an embryonal cell carcinoma originating in the
second part of the duodenum, mimicking a primary duodenal carcinoma and
causing obstruction. The patient was a 39 year old man who was otherwise fit
and well but under investigation epigastric pain, vomiting and weight loss.
There was no history of a mass or back pain. He underwent upper GI
endoscopy which revealed a circumferential tumor, biopies were consistent
with a poorly differentiated adenocarcinoma of duodenal or pancreatic origin.
Staging CT revealed a bulky tumor without vascular involvement but local
lymphadenopathy particularly a large nodal mass in the aorto-caval groove.
PET scans confirmed no other focii of FDG avid disease. An aggressive
approach of surgery followed by chemotherapy was set upon and a Whipples
Pancreato-duodenectomy with clearance of regional lymph nodes was
performed. The patients recovery was complicated by a pancreato-jejunost-
omy leak but has made a good recovery and is now receiving chemotherapy.
Histo-pathological examination of the specimen has revealed a completely
resected Embryonal Cell Carcinoma. This was supported by immunohis-
tochemistry; MNF 116, CD 30, PLAP and AFP positive, CD 31, CD 117,
CD 56, Chromogranin and Desmin negative. Of the resected lymph nodes
one of fifteen (from the aorto-caval groove) was involved The retroperito-
neum is the second most common site for Extra-Gonadal Germ Cell Tumors
(EGGCT) that are known to arise at any point in the midline between pineal
gland and sacro-coccyx. Most of these are metastatic with a testicular primary
however a diligent search revealed no primary site hence we conclude that
this has originated in or immediately around the duodenum. The usual mode
of presentation for these tumors in the adult is back pain, a mass or bleeding,
an advanced tumor causing gastric outlet obstruction in an adult has not
previously been reported.
PP 39.08
CHOLEDOCHAL CYST IN NEONATES
paraian, ioan1; budusan, anca2; ordeanu, calin2
1University of medicine, surgery, cluj-napoca, Romania; 2university of
medicine, cluj-napoca, Romania
Aim. Choledochal cyst is an uncommon cause of neonatal jaundice and a
rare biliary disease mostly presenting during childhood. The aim of this study
is to present our experience in diagnosis and treatment of choledochal cyst in
neonates.
Material and Methods. We retrospectively analysed files of the patients
admitted in our clinic between 2000 and 2007. During a seven years period 4
children were diagnosed and treated with choledochal cysts in our clinic. The
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patients were newborns, 2 girls and 2 boys. They presented with prolonged
jaundice after birth. Laboratory findings revealed elevated levels of serum
transaminases and direct bilirubin. Ultrasound revealed a cystic mass close to
gall-bladder.Results All patients underwent surgery and dilatation of the
common bile duct with distal obstruction was noted during surgery in all
cases. We performed cyst excision with Roux-en-Y hepaticojejunostomy and
cholecystectomy. The postoperative course was uneventful with administra-
tion of antibiotics.
Conclusions. early diagnosis and treatment oc choledochal cyst in neonates
are important for preventing serious complications of biliary obstruction 
progressive damage to the bile ducts and to the liver parenchyma. Ultrasound
of the abdomen should be performed in cases of prolongued jaundice in all
neonates.
PP 39.09
COMPOSITE LARGE CELL NEUROENDOCRINE CARCINOMA
AND ADENOCARCINOMA OF THE AMPULLA OF VATER
Lee, Keun Ho; Lee, Jin A; Park, Il Young
The Catholic Univ of Korea, SURGERY, Seoul, Korea, Republic of
Neuroendocrine tumor of the ampulla of Vater is rare, and large cell
neuroendocrine carcinoma (LCNEC) is extremely rare among neuroendo-
crine tumors. This report dercribes composite LCNEC and adenocarcinoma
of the ampulla of Vater. A 60-year-old man presented with fever, chill and
jaundice. We found a periampullary ulcerative lesion and performed radical
pancreatoduodenectomy. Histopathologically the tumor consists of a
LCNEC component and a poorly differentiated adenocarcinoma compo-
nent. Immunohistochemical stain showed the tumor cells are reactive for
chromogranin, synaptophysin, neuron-specific endolase and CD56. Five
months after operation, the patient underwent PET-CT scan and it showed
multiple metastatic lymphadenopathy. He received radiation therapy.
LCNEC is very rare in this location and highly aggressive with a poor
prognosis.
PP 39.10
CLINOCOPATHOLOGICAL ANALYSIS OF LYMPH NODE ME-
TASTASES IN CASES OF THE CANCER OF THE MAJOR DUO-
DENAL PAPILLA
Nagaike, Koki; Chijiiwa, Kazuo; Uchiyama, Shuichiro; Nagano, Motoaki;
Hiyoshi, Masahide; Ohuchida, Jiro; Kai, Masahiro; Kondo, Kazuhiro
MIyazaki University, School of Medicine, Surgical Oncology and Regulation
of Organ Function, Miyazaki, Japan
Background. Pancreaticoduodenectomy or pylorus preserving pancreatico-
duodenectomy has been applied for cancer of the major duodenal papilla as a
standard surgical approach. Although the less invasive surgery such as
ampullectomy including endoscopic approach is sometimes chosen for early
ampullary cancer, its indication is still vague.
Aim. To clarify the suitable surgical procedure, we performed clinocopatho-
logical analysis of the patients with ampullary cancer treated by curative
resection.
Methods. Between 1986 and 2006, twenty-two patients (eight women and
fourteen men, range 4385 years old)with ampullary cancer were treated.
The survival rates with respect to various clinicopathologic factors were
analyzed retrospectively.
Results. The overall rate of lymph node metastases was 36.4%, and all
metastases were located at the regional lymph nodes. Cases without lymph
node metastasis showed better prognosis than those with lymph node
metastases statistically (pB0.05). The analysis of lymph node metastases
with respect to the depth of tumor invasion revealed that when tumor was
limited in the mucosal layer, no lymph node metastasis was observed. One of
five cases (20%) with invasion into the sphincter of Oddi showed lymph node
metastasis, and this case also showed intraductal spreading into the lower bile
duct. However, in cases with invasion over the sphincter of Oddi, 46.1% (7/
15) showed lymph node metatases. The 3-year survival rates of the patients
limited to the mucosal layer or the sphincter of Oddi were significantly higher
(100%) than those with invasion over the sphincter of Oddi (45.4%).
Conclusions. When the tumor is limited to the mucosal layer, ampullectomy
can be applied. Pancreaticoduodenectomy with lymph nodes dissection is
required in cases with invasion over the sphincter of Oddi.
PP 39.11
CLINICOPATHOLOGICAL ANALYSIS OF AMPULLARY LESIONS
TREATED BY WIDE AMPULLECTOMY
Uchiyama, Shuichiro; Chijiiwa, Kazuo; Hiyoshi, Masahide; Imamura,
Naoya; Nagano, Motoaki; Ohuchida, Jiro; Nagaike, Koki; Kai, Masahiro;
Kondo, Kazuhiro
Miyazaki University School of Medicine, Surgical Oncology and Regulation
of Organ Function, Miyazaki, Japan
Background.: Although benign and malignant tumors of the major
duodenal papilla can be detected endoscopically, definitive diagnosis of
cancer by histologic examination using biopsy specimens and of the depth of
invasion are sometimes difficult. If apparent invasive growth is observed by
imaging modalities including endoscopic ultrasonography and intraductal
ultrasonography, pancreaticoduodenectomy is chosen as the standard treat-
ment. We have applied wide ampullectomy to only the patients who have
been diagnosed as high grade adenoma or suspicious of a small focus of
malignancy.
Aim. To clarify the significance of wide ampullectomy in such patients, we
performed clinicopathological analysis of the cases treated by wide ampul-
lectomy.
Results. From 1995 to 2007, six cases were treated by wide ampullectomy.
Among them, four were diagnosed as adenomas, and two as carcinoma in
adenoma. Among the latter 2 cases, one showed a small focus of carcinoma
and carcinoma in adenoma was diagnosed, but the resected edges were free
from cancer cells and neither vessel nor lymphatic peameation was seen. In
another one case, intraductal spreading into the lower common bile duct was
observed at the resected edge, and pancreaticoduodenectomy was added
later. In all cases, there was no severe crash damage, and precise histologic
diagnosis could be easily performed. All cases were alive without recurrence.
Conclusion. Wide ampullectomy is an adequate treatment in cases of high-
grade adenomas or high-grade adenoma with a small focus of carcinoma.
PP 40.01
LAPAROSCOPIC CHOLECYSTECTOMY FOR GALLBLADDER
LESIONS IN PATIENTS WITH CARDIOVASCULAR DISEASE
Lee, Chen-Fang; Yeh, Chun-Nan; Jan, Yi-Yin; Chen, Miin-Fu
Chang Gung Memorial Hospital, Chang Gung University, Department of
General Surgery, Taipei, Taiwan
Background. Cardiovascular disease (CVD) and gallstone are reported
strongly associated because both diseases are frequently involved as part of
the metabolic syndrome. Laparoscopic cholecystectomy (LC) has become
them standard treatment for gallbladder lesions over the world. CVD is
considered as an absolute or relative contraindication to LC, however, clinical
information on LC for gallbladder lesions in patients with CVD is lacking.
This study aims to assess feasibility of LC for gallbladder lesions in CVD
patients.
Method. From 1996 to 2005, the medical records of 66 CVD patients
(including valvular heart disease, ischemic heart disease, and heart failure)
with gallbladder lesions undergoing LC (CVD-group) were retrospectively
reviewed. Furthermore, the clinical features and outcomes of 8834 patients
with gallbladder lesions without CVD undergoing LC (NCVD-group) were
also summarized for comparison.
Results. Of 8900 patients with gallbladder lesions that had undergone LC,
66 (0.74%) had CVD. Overall, CVD patients undergoing LC clearly
exhibited older age, male predominance, higher BUN level, and longer
hospital stay when compared with those without CVD. Longer hospital stay
and higher percentage of acute cholecystitis and chronic cholecystitis were
the independent factors to differentiate between patients with open heart
surgery and NCVD-group patients. Anticoagulant adjustment not post-
operative complications contribute to longer hospital stay. Older age and
male predominance were the independent factors to differentiate between
patients with ischemic heart disease with intervention.
Conclusions. LC is a feasible procedure for selected CVD patients with
gallbladder lesions. Applying LC to treat selected CVD patients with
gallbladder lesions could achieve similar operative morbidity and mortality
rate to patients with gallbladder lesions without CVD. Appropriate pre-
operative preparations and experienced operative techniques are still man-
datory.
PP 40.02
USE OF PEROPERATIVE CHOLEDOCHOSCOPY IN MANAGING
CHOLEDOCHOLITHIASIS
Damodaram, Srikumari1; Naganath Babu O L, 1; Selvaraj T, 1; Raghumani P,
1; Berty A, 2; Lakshmanan, Anand3
1Govt. General Hospital, Dept. of SGE, MMC, Chennai., chennai; 2;
3Madras Medical college, Dept. of Surgical Gastroenterology, Chennai
Introduction. Common bile duct exploration is an important surgical
intervention when endoscopic retrograde pancreatography fails to extract
calculi. Direct visualization of biliary tree using choledochoscopy reduces the
incidence of retained biliary calculi and is an opportunity to detect other
pathologies missed during initial evaluation. AIM To assess the value of
choledochoscopy in lowering the incidence of retained stones in the common
bile duct following choledocholithotomy.
Methods. From July 2004 to May 2007,44 patients underwent exploration
of common bile duct specifically for calculous disease at the Department of
Surgical Gasteroenterology, Madras Medical College. 6 patients had prior
cholecystectomy, hence underwent common bile duct exploration alone.38
patients underwent cholecystectomy with common bile duct exploration.
Choledochoscopy was done for all the cases.
Results. In 20.5% (9/44) patients stones which had been missed by
preoperative evaluation was detected. In 2 patients (5.45%) intrahepatic
calculus was detected and extracted using choledochoscopy. The distal CBD
stones were removed by Dormia basket and in one patient the stone was
pushed into the duodenum. Primary closure of choledochotomy was done in
36 patients(81.8%).T Tube drainage was done in 2 patients(4.55%).5
patients (11.4%)underwent choledochoduodenostomy 1 patient(2.3%) un-
derwent choledochojejunostomy. In 2 cases stricture was detected. Biopsy
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revealed inflammatory fibrous disease. There was no mortality or morbidity
in this series.
Conclusion. Per-operative choledochoscopy is an effective method in
preventing retained ductal stones during common bile duct exploration and
should be used in patients with suspected choledocholithiasis, to ensure
removal of all calculi.
PP 40.03
ADVANTAGES OF LAPAROSCOPIC CHOLECYSTECTOMY FOR
CEREBROVASCULAR ACCIDENT PATIENTS WITH GALLBLAD-
DER LESIONS
Lee, Hsiang-Lin; Yeh, Chun-Nan; Liu, Yu-Yin; Chen, Miin-Fu; Jan, Yi-Yin
Chang Gung Memorial Hospital Chang Gung University, Department of
General Surgery, Taipei, Taiwan
Background. Since 1987, laparoscopic cholecystectomy (LC) has become
the treatment of choice for gallbladder lesions over the world. However, no
information is reported on gallbladder lesions in patients with cerebrovas-
cular accident (CVA). This study aims to assess feasibility of LC when
compared with open cholecystectomy (OC) in CVA patients with gallbladder
lesions.
Method. From January 1994 to June 2005, 104205 CVA patients treated at
our hospital, among them, 696 (0.67%) had gallbladder lesions. 172 of the
696 CVA patients (24.7%) with gallbladder lesions undergoing cholecys-
tectomy were reviewed. Among them, 100 patients undergoing LC were
classified as LC-CVA group, while the remaining 72 patients receiving OC
were classified as OC-CVA-group. The clinical features and outcomes
between LC-CVA and OC-CVA group patients were compared. Result:
Gallbladder stone with acute cholecystitis was the most common cause for
CVA patients undergoing cholecystectomy (78/172; 45.3%). The LC-CVA
group patients had similar demographic and laboratory data to OC-CVA
patients. However, LC-CVA patients experienced less blood loss, shorter
operation time, and shorter hospital stay. Applying LC or OC to treat CVA
patients with gallbladder lesions could achieve similar operative morbidity
and mortality rate.
Conclusions. Gallbladder lesions seem to be uncommon in the CVA
patients, however, gallbladder stone with acute cholecystitis is the most
common cause for CVA patients undergoing cholecystectomy either by open
or laparoscopic approach. Applying LC or OC to treat CVA patients with
gallbladder lesions could achieve similar operative morbidity and mortality
rate. LC had significant advantages for CVA patients with gallbladder lesions
with less blood loss, shorter operation time, and shorter hospital stay.
Appropriate preoperative preparations and experienced operative techniques
are still required to prevent morbidity and mortality in the specific subtype of
patients.
PP 40.04
A REVIEW OF AMBULATORY LAPAROSCOPIC CHOLECYS-
TECTOMY IN A SINGAPORE TEACHING INSTITUTION: ARE
WE READY FOR DAY-CASE LAPAROSCOPIC CHOLECYSTECT-
OMY
Kow, Alfred Wei-Chieh1; Ho, Choon-Kiat1; Tan, Amanda Pei-En1; Chan,
Siew-Pang2; Lee, Sow-Fong3
1Dept of General Surgery, Tan Tock Seng Hospital, Center for Advanced
Laparoscopic Surgery, Singapore, Singapore; 2Tan Tock Seng Hospital,
Clinical Research Unit, Singapore; 3Tan Tock Seng Hospital, Operating
Theatre Management, Singapore
Background. Day-Case laparoscopic cholecystectomy (LC) is practiced in
many countries. However, this has yet been accepted in Singapore.
Aim. This study aims to determine the potential success rate of day-case LC
in our institution and hence the feasibility of starting this programme locally.
Patient and Methods. We retrospectively assessed the proportion of our
Ambulatory Surgery 23 hour (AS23) LC patients that met discharge criteria.
Our porposed same-day discharge criteria include minimal pain, ability to
tolerate feeds, ambulate independently and void spontaneously after 68
hours of monitoring.
Results. From 2005 to 2006, of 405 patients listed for elective LC, 339
patients were admitted to our AS23 ward. The other 66 were admitted as
inpatient. Of these, 41 patients were admitted because of conversion to open
surgery. A history of cholecystitis or cholangitis was a significant predictor of
conversion to open surgery (OR5.73 and 5.74 respectively, PB0.001).
However, if the gallbladder of such patients can be successfully removed
laparoscopically, then these patients have an equal chance of fulfilling all the
discharge criteria as those who had no past history of cholecystitis or
cholangitis. Of the 339 patients, 221 of them fulfilled all 4 criteria by the 8th
hour of monitoring. Therefore, based on an intention-to-treat analysis,
51.2% fulfilled all 4 criteria and could potentially be discharged the same day
if we had day-case LC. No predictor for failure was identified, including
presence of co-morbidities, duration of operation, surgeon’s grade and
additional procedures like laparoscopic common bile duct exploration.
Conclusion. We can expect a potential success rate of at least 50% if we offer
day-case LC. With the attendant advantages of cost-savings and reduced
resource utilization, it is therefore worthwhile to start it in Singapore.
PP 40.05
MULTIPLE LINEAR REGRESSION ANALYSIS OF HOSPITAL
CHARGE IN ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY
Chuang, Shih-Chang; Lee, King-Teh
Kaohsiung Medical University Hospital, Surgery, Kaohsiung, Taiwan
Background. Laparoscopic cholecystectomy is the standard method in the
surgical treatment of gallbladder stone and becomes an item of case payment
system in many developed countries. The aim of this study is to delineate the
impact of clinical factors on the total hospital charge.
Methods. The patients who underwent elective laparoscopic cholecystect-
omy were retrospectively studied during January 2003 to April 2006 at
Kaohsiung Medical University Hospital. Clinical and economic information
were abstracted from medical charts and the financial division, that included
the demographics (age, gender), clinical manifestations (acute inflamma-
tion), admission status, age adjusted Charlson comorbidity index, pre-
operative waiting days, operative time, complications and length of hospital
stay.
Results. Nine hundred and twenty-one consecutive patients include 555
man and 366 women, mean age 52.8 ¡O´ 12.9 years old. The mean length of
hospital stay was 4.7 days, and the mean total hospital charge was USD
1,526. From multiple linear regression analysis, the length of hospital stay,
acute inflammation, operation time, admission status, age (PB0.001) and
complication (P0.035) was associated with significantly cost. While, the
age adjusted Charlson comorbidity index did not significantly influence total
hospital charge. As a result, we created the linear regression formulas:
THC18013 3654(length of stay)5142(acute inflammation)
49(operative time)3966(admission status)82(age)4578(com-
plication) Conclusions: This study demonstrates that multi-factors affect the
total hospital charge, while length of hospital stay plays the most important
role.
PP 40.06
A CASE OF BILOMA FORMATION IN THE INTRAMUSCULAR
LAYER AFTER LAPAROSCOPIC CHOLECYSTECTOMY
Lee, Daesung
Sunlin Hospital, Pohang, Korea, Republic of
Symptomatic bile leak and biloma formation occur sometimes after laparo-
scopic cholecystectomy. Localized collection of bile occurring usually after
postcholecystectomy is intraperitoneal cavity. I experienced a rare case of
intramuscular biloma formation after laparoscopic cholecystectomy through
barovac drain. Case: A 58-year-old male was admitted to our hospital with a
history of intermittent right upper quadrant pain from 1 year. Ultrasound
showed diffuse gallbladder wall-thickening with stones. I performed laparo-
scopic cholecystectomy with infrahepatic drainage for treatment. Only diffuse
thickening of the gallbladder was seen during the operation. Multiple dark
colored stones were in the gallbladder. Unusual abdominal pain was present
in the postoperative 2nd day. I didn’t detect bile discharge from an
infrahepatic drain, so I performed immediate computer tomography on
him. I detected large biloma in the intramuscular layer on the computer
tomography. Biloma resolved and bile leakage was treated by replacement of
a drain. On the postoperative 15th day, he showed no event of bile leakage
and had normal finding on the cholescintigraphy. On the postoperative 22th
day, he was discharged without any other problems. I report a rare case of
intramuscular biloma occurred by a drain after laparoscopic cholecystectomy
with infrahepatic drainage.
PP 40.07
XANTHOGRANULOMATOUS CHOLECYSTITIS: P53 AND PCNA
EXPRESSION IN COMPARISON TO CHRONIC CHOLECYSTITIS
AND GALLBLADDER CANCER
Ghosh, Mila1; Sakhuja, Puja2; Singh, S.1; Agarwal, Anil1
1G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India; 2G. B. Pant Hospital and Maulana Azad Medical
College, Pathology, New Delhi, India
Background. Xanthogranulomatous cholecystitis (XGC) is an uncommon
variant of chronic cholecystitis which often mimics a gallbladder carcinoma.
Pre-operative and intra-operative diagnosis is usually difficult and it may
coexist with GBC and lead to diagnostic dilemma. Furthermore the
premalignant nature of this entity is controversial.
Aim. To study the p53 and PCNA expression in XGC in comparison to
gallbladder cancer and chronic inflammation.
Materials and Methods. Sections were obtained from paraffin embedded
blocks of surgically resected specimens of gallbladder cancer (29 cases), XGC
(44 cases), chronic cholecystitis (16 cases), Normal gall bladder (10 cases).
Immunohistochemistry with the monoclonal antibody p53 (DakoCytoma-
tion), and monoclonal antibody PCNA(Diagnostic Biosystem) was per-
formed in all cases. The results were scored semiquantitavely and statistical
analysis performed. p53 expression was scored as percentage of the nuclei
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stained. PCNA expression was scored as the product of percentage of nuclei
(0100) stained and intensity of the staining(13). Thus a maximum Quick
score of 300 can be obtained. A cut off value 30 for Quick score was taken
as a positive result. Result: p53 mutation was positive in 82% (24 out of 29)
GBC cases. p53 expression was positive in 9% (4 out of 44) in XGC cases,
6%( 1 out of 16) in chronic cholecystitis, and 0%( 0 out of 10) in normal
cases. p53 expression in XGC was significantly lower than in GBC (pB
0.0001). But there was no significant difference of p53 expression in XGC
with chronic cholecystitis and normal gallbladder. PCNA expression was
97%(28 out of 29 cases) in GBC, 27% (12 of 44) in XGC, 6%(1 of 16 cases)
in chronic cholecystitis, and 0% (0/10) in normal. PCNA expression was
significantly higher in GBC than XGC (p0.004)but there was no
significant difference in PCNA expression in XGC in comparison to chronic
cholecystitis and normal gallbladder.
Conclusion. There is significant less expression of p53 and PCNA in XGC
than in GBC but statistically no difference with chronic inflammation. This
result supports the inflammatory nature of XGC and does not support a
premalignant nature of the disease.
PP 40.08
HOW TO AVOID BILIARY DISASTERS IN LAPAROSCOPY-SIN-
GLE SURGEON’S EXPERIENCE
Singh, Kuldip; Ohri, Ashish
Dayanand Medical College, Department of Surgery, Ludhiana, India
In the era of laparoscopy when laparoscopic cholecystectomy has become the
‘gold standard’ for the treatment of gallstone disease, the incidence of bile
duct injuries is still higher than open cholecystectomy. These biliary disasters
entail a great morbidity for the patient and also put excessive burden on the
health service providers. The subgroup of patients which are more prone to
these disasters are patients having undergone previous abdominal surgery
with gallstone disease, patients having complicated cholecystitis like em-
pyema GB, gangrenous GB, cholecystoenteric fistula and patients having
abnormal anatomy like mirizzi syndrome. For patients with suspected
adhesions like those undergone upper abdominal surgery, one should have
a pre-operative evaluation with CT scan of abdomen and choose a safe option
while creating pneumoperitoneum like insertion of veress needle in the left
hypochondrium, use of open technique with Hasson canula or use of Endotip
or optiview to make a safe entry into the peritoneal cavity. In cases of
anomalous anatomy or complicated disease, adherence to the basic rules of
surgery and step by step dissection following the landmarks like staying close
to the liver margin, defining the gall bladder neck, defining the junction of
gall bladder with cystic duct, identifying the cystic lymph node, displaying the
calot’s triangle, staying antero-superior to the Rouviere’s sulcus can make
most of the difficult situations possible laparoscopically. In our own
experience of 6780 cases, we had to convert 31 patients to open surgery
with a conversion rate of 0.45% and the most common complication was a
bile duct injury which lead to four conversions. All the converted cases were
complicated. From our experience, we emphasize that the experience of the
surgeon and meticulous technique are the most important factors to achieve a
low complication rate.
PP 40.09
POST CHOLECYSTECTOMY SECTORAL BILE DUCT INJURY
Yadav, Abhishek; Gupta, Vishal; Singh, Shivendra; Agarwal, S.; Agarwal,
Anil
G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India
Background. Sectoral duct injury/Type 5 benign biliary strictures (BBS) are
uncommon bile duct injury sustained after cholecystectomy. The manage-
ment and outcome of this subgroup of patients are reviewed.
Methods. Retrospective analysis of the records of patients referred to a
tertiary care center for the management of post cholecystectomy bile duct
injury from January 2000 to December 2006.
Results. Total 302 patients of bile duct injury were treated during this
period, including 183 patients who underwent surgical repair. Nine patients
had sectoral duct injury constituting 3% of total cases. Median age was 28
years (range 1855 years) with most (6/9) injuries sustained after open
cholecystectomy. Two patients presented with biliary peritonitis and were
managed with laparotomy lavage and drainage while remaining 7 patients
underwent surgical repair of stricture, hepaticojejunostomy. Liver resection
was not required in any case. Right anterior sectoral duct injury was seen in 4
patients while remaining 3 patients had right posterior sectoral duct injury.
Atrophy was seen in 3 patients. Median hepaticojejunostomy stoma size was
28 mm (range: 2533mm). Access loop was constructed in 5 patients while
stented anastomosis was performed in 5 patients. Postoperative mortality was
none and no major morbidity was seen. Median postoperative hospital stay
was 7 days (range 513 days).
Conclusion. Type 5 BBS/ sectoral duct injury are an uncommon and
complex biliary injury. Successful repair, however, can be achieved in
specialized center with minimal morbidity and mortality.
PP 40.10
MIRIZZI SYNDROME TYPE II  LAPAROSCOPIC APPROACH.
Bregante, Mariano; Ardiles, Victoria; Salceda, Juan; Fernandez, Diego;
Pfaffen, Guillermo; Pekolj, Juan; de Santiban˜es, Eduardo
Hospital Italiano de Buenos Aires, HPB Surgery and Liver Transplant Unit,
Buenos Aires, Argentina
Background. Common hepatic duct obstruction secondary to compression
by gallstones impacted at the gallbladder neck or cystic duct could induce a
cholecystobiliary fistula or ‘‘Mirizzi Syndrome’’ (MS) type II which is a rare
complication of prolonged cholelithiasis. Its laparoscopic treatment seems
controversial at present.
Aim. To show a health center experience in HPB surgery and laparoscopic
treatment for MS type II Design: Retrospective analysis. Material and
method: Between November 1999 and December 2004, 6107 laparoscopic
cholecystectomies for gallstones were performed. Estimated biliary fistula
incidence, in particular cholecystobiliary fistula(MS type II), its laparoscopic
treatment, conversion incidence, resolution, morbidity and mortality were
assessed. All the patients underwent preoperative laboratory test and two or
more imaging studies. Intraoperative cholangiography was perfomed in all
cases.
Results. Biliary fistula, 38 patients (0.6%); MS type II,0.2% with common
hepatic duct gallstones in 58.3%. Female patients:76.3%, mean age: 68
years. Laparoscopic treatment resolution in MS type II: 66.7%. Conversion
rate:33.3%. Morbidity: 25%. Mortality: 0%.
Conclusion. Mirizzi Syndrome is a rare and major complication of
prolonged cholelithiasis. The use of the laparoscopic or the open approach
depends on the surgeon’s experience. Its diagnostic presumption is an
important issue regarding its resolution, since patients’referral to specialized
centres has resulted in lower short-term and long-term morbidity and
mortality rates
PP 40.11
SEVERITY AND OUTCOME OF MANAGEMENT OF GALLSTONE
DISEASE IN ELDERLY PATIENTS
Jain, Sundeep1; Sharma, Jayant2; Kalla, Mukesh3; Sharma, Bharat4; Sharma,
Shyam Sunder5
1S.K. Soni Hospital, Gastrointestinal & Laparoscopic surgery, sector-5,
Vidhyadhar Nagar, Jaipur, India; 2S.K. Soni Hospital, Gastroenterology,
Jaipur, India; 3S.R. Kalla Memorial Hospital, Gastroenterology, Jaipur,
India; 4S.K. Soni Hospital, Gastrointestinal & Laparoscopic Surgery, Jaipur,
India; 5S.M.S. Hospital, Gastroenterology, Jaipur, India
Introduction. Gallstone disease in elderly population is associated with
higher perioperative morbidity and mortality. OBJECTIVE This study was
undertaken to determine the relationship between the age of the patients,
severity of the disease, and the outcome of treatment in these patients.
Methods. The study was prospectively conducted in 150 patients during
August 2005 to July 2007. All patients were divided into three groups. Group
I- age B50yrs, Group II- age 5069yrs, and Group III- age 70 yr. A
comparative analysis was done between them in terms of clinical presenta-
tion, presence of gallstone related complications, comorbid conditions, and
overall outcome of treatment.
Results The three groups had 80, 54, and 16 patients respectively. The
incidence of CBD stones was maximum in the IIIrd group (37.5%), with the
successful endoscopic CBD clearance rate of 100%, 71.4% & 0% in the three
respective groups. Laparoscopic surgery was successful in only 37.5%
patients in group III. All of the group III patients had comorbid conditions
in comparison to 38.8% and 6.25% in group II & I patients. Group III
patients had maximum postoperative complications (18.7%) and mortality
(18.7%). All 3 patients who died in group III were having CBD stones along
with the stent. The median hospital and ICU stay in the three groups were 1
0, 10 & 55 days, respectively.
Conclusions. Gallstone disease in elderly population is associated with
higher perioperative morbidity and mortality due to the presence of more
comorbid conditions, and septic complications. Higher incidence of gallstone
related complications in them are an important determinant of conversion of
laparoscopic procedure into an open surgery. Elderly patients are more
commonly associated with CBD stones which are multiple and big in size
making their endoscopic removal difficult.
PP 41.01
ROLE OF MULTIDETECTOR ROW CT IN ASSESSING RESECT-
ABILITY OF PERIAMPULLARY CARCINOMA
yadav, Thakur D1; venkatesan, ragavendran1; Kang, Mandeep2; Wig, Jaidev1
1PGIMER, Chandigarh, India, department of general surgery, chandigarh,
India; 2PGIMER, Chandigarh, India, department of radiodiagnosis, chandi-
garh, India
Objective. Periampullary carcinoma exhibit poor prognosis due to early
spread to surrounding vessels and organs. Proper assessment of resectability
is important to avoid unnecessary laparotomy. We tried to evaluate the
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accuracy of Multidetector row helical CT angiography in assessing the
resectability of periampullary carcinoma and defining vascular anomalies.
Methods. Thirty three patients with clinical features and imaging suggestive
of periampullary carcinoma were studied prospectively. All of them under-
went MDCT preoperatively while 24 patients underwent surgery. Intrao-
perative findings were correlated with preoperative CT findings with respect
to tumour, vascular invasion and vascular anomalies.
Results. Thirty three patients were studied, 23 were male and 10 were
females. Mean age was 52 years. Twenty four patients underwent surgical
exploration, 17 had curative resection and 7 had palliative surgery. MDCT
yielded sensitivity, specificity, PPV, NPV and accuracy of 100%, 75%, 98.9%,
100% and 98.97% respectively for determining resectability with respect to
vascular invasion. For predicting resectability, a sensitivity, specificity, PPV,
NPV and accuracy were 94.1%, 71.4%, 88.8%, 83.3% and 87.5%. Of the
eighteen patients (n18) concluded by CT as resectable, on surgery 16
patients were found to be resectable (n16) and two patients were
unresectable (n2). The causes of unresectability were Grade III vascular
invasion in one case (n1) and liver metastases in one case (n1). Vascular
anomalies were detected in seven patients and were confirmed in five patients
who underwent surgery.
Conclusion. MDCT significantly improves the prediction of resectability of
periampullary carcinoma and also provides an adequate overview of vascular
anatomy.
PP 41.02
INDICATION FOR ORGAN-PRESERVING SURGERY FOR
TREATMENT OF INTRADUCTAL PAPILLARY MUCINOUS NEO-
PLASMS (IPMN) OF THE PANCREAS: AN INSTITUTIONAL
EXPERIENCE
Vashist, Yogesh; Link, Bjoern; Schurr, Paulus; Bogoevski, Dean; Gawad,
Karim; Reichelt, Uta; Izbicki, Jakob; Yekebas, Emre
University Clinic Hamburg-Eppendorf, General, Visceral and Thoracic
Surgery, Hamburg, Germany
Objective. Surgical management of intraductal papillary mucinous neo-
plasms (IPMN) remains a topic of considerable dispute. Background.
IPMN are divided into adenomas (IPM-A), borderline tumors (IPM-B),
non-invasive and invasive carcinomas (IPM-C). In non-invasive IPMN,
reported 5-year survival rates range from 77100%. Surgical procedures vary
considerably between different institutions.
Methods. 32 patients with pancreatic IPMN were included into this
institutional study between 1997 and 2004. Re-classification of specimens
was performed based on the WHO nomenclature (2002). Surgical technique,
tumor-staging and pattern of recurrence were related to survival.
Results. 22 non-invasive IPMN (4 IPM-A, 15 IPM-B, 3 non-invasive IPM-
C) and 10 invasive IPM-C (all of the colloidal non-cystic type) were
identified. Median disease-specific survival for invasive IPM-C and non-
invasive IPMN was 12 and 46 months, respectively (pB0.001). All patients
with invasive IPM-C (n10) were treated by radical pancreaticoduodenect-
omy. Out of 19 patients with IPM-A and IPM-B, 9 were treated with
duodenum-preserving pancreatic resection (DPPR) and 9 with radical
pancreaticoduodenectomy. The remaining patient with IPM-A in which a
diagnostic laparoscopy was performed, died perioperatively. In type A and B
lesions, except one patient, no tumor relapse was observed. In 2 out of 3
patients with non-invasive IPM-C treated by DPPR, local recurrence
occurred after 46 and 49 months, respectively. The remaining patient was
treated by left splenopancreatectomy and is still relapse-free since 56 month.
Conclusion. Radical resection is indicated in IPM-C irrespective of
invasiveness. Organ-preserving surgery such as DPPR is the surgery of
choice in IPM-A and IPM-B.
PP 41.03
OUTCOMES IN ELDERLY PATIENTS WITH A PANCREATIC
ANASTOMOTIC LEAK
Mukherjee, Samrat; Hutchins, Robert R; Bhattacharya, Satyajit; Kocher,
Hemant M; Abraham, Ajit T
Barts and the London HPB Centre, London, United Kingdom
Background. Major pancreatic resections can be performed for the elderly
with acceptable outcomes. However, pancreatic anastomotic leak remains the
major cause of morbidity and mortality in patients undergoing pancreatico-
duodenectomy (PD).
Aims. To evaluate the incidence and outcome of pancreatic anastomotic leak
in elderly patients undergoing PD.
Methods. Patients undergoing PD were extracted from a prospectively
maintained pancreatic database. Data was analysed for patients aged 70 years
and above versus those less than 70 years, in terms of the incidence of
pancreatic leaks and related mortality.
Results. From 1999 to 2007, 49 patients aged 70 or above (median, 75
(range 7084) years) underwent a PD as compared with the 117 patients
aged less than 70 (median 59 (range 3169). 3 patients (6.1%) in the elderly
group developed a pancreatic anastomotic leak, of whom 2 died as a
consequence compared to 12 patients (10.2%) in the younger group of
whom 1 patient died as a consequence. (Fisher’s exact test, p0.55 for
likelihood of leak: p0.08 for the likelihood of mortality following a
pancreatic leak).
Conclusion. Following PD in the elderly, their likelihood of developing a
pancreatic leak or dying as a consequence is not significantly different from a
younger sub-group of patients.
PP 41.04
PANCREATIC FISTULA AFTER PANCREATICODUODENECT-
OMY: IS THE INTERNATIONAL STUDY GROUP OF PANCREA-
TIC FISTULA (ISGPF) DEFINITION USEFUL?
Martin-Perez, Elena; Go´mez, Joaquı´n; Bermejo, Elena; Garcı´a, Rube´n;
Martin-Alvarez, Jose´ Luis; Larran˜aga, Eduardo
La Princesa Hospital, Dpt. of Hepatobiliopancreatic Surgery, Madrid, Spain
Background. One of the most common complications of pancreaticoduo-
denectomy (PD) is pancreatic fistula (PF) with a reported rate highly variable
(from 2% to 30%). This variability depends on the lack of consensus on the
definition of this complication.
Objectives. To validate the International Study Group of Pancreatic Fistula
(ISGPF) definition and analyze the risk factors for PF in a group of patients
undergoing PD.
Methods. Between November 2001 and March 2007, 50 consecutive
patients with periampullary neoplasms underwent PD. PF was defined by
ISGPF criteria. Patients were divided into four categories: no fistula, grades
A, B, and C. Collected data included: pathological diagnosis, diameter of
pancreatic duct, texture of the remnant pancreas, amylase levels from drains,
symptoms, therapeutic and diagnostic strategies, incidence and type of
complications, readmission, reoperation, and mortality.
Results. There were 32 men and 18 women, with a mean age of 66,614,26
years (range 41 to 84 years). Final pathology: adenocarcinoma: 43 (86%);
cystic neoplasms: 2 (4%); neuroendocrine: 2 (4%); GIST: 1 (2%); other: 2
(4%). Pancreatico-jejunal anastomosis: end-to-side with ductal stent: 39
(78%); end-to-end: 11 (22%). 32 patients (64%) had no evidence of fistula.
There were 8 (16%) grade A fistulas, 6 (12%) grade B fistulas, and 4 (8%)
grade C fistulas. Pancreatic duct size and texture of the remnant pancreas are
risk factors influencing pancreatic leakage after PD. Clinical outcomes of the
main features of each fistula grade are presented.
Conclusions. This classification can provide comparison of surgical out-
comes among different centres and treatments. Biochemical fistulas (grade
A) have no clinical significance, but grade B and C fistulas negatively impact
patients with higher rates of complications, hospital stays and costs. Further
studies are warranted in large well controlled trials to definitively validate this
definition.
PP 41.05
AMYLASE CONCENTRATION OF DRAINAGE FLUID AFTER
PANCREATICODUODENECTOMY AS PREDICTIVE FACTOR
OF PANCREATIC FISTULA
Martin-Perez, Elena; Go´mez, Joaquı´n; Zapata, Camilo; Martin-Alvarez, Jose´
Luis; Sa´nchez-Urdazpal, Luis; Larran˜aga, Eduardo
La Princesa Hospital, Dpt. of Hepatobiliopancreatic Surgery, Madrid, Spain
Background. Pancreatic fistula (PF) is a serious complication of pancrea-
ticoduodenectomy (PD). The correlation of the amylase value in drains with
the development of PF is still unclear.
Objectives. The aim of this study was to assess if the volume and amylase
content of the effluent from surgical drains predict PF after PD and to
determine the factors affecting the drainage amylase level.
Methods. From November 2001 to March 2007, 50 consecutive patients
underwent PD. Data included age, gender, diagnosis, type of anastomosis,
complications, mortality, length of stay, need for postoperative percutaneous
drainage, reoperation, and readmission. The consistency of the pancreas and
the diameter of the pancreatic duct were also evaluated. The volume and
amylase concentration of the drainage fluid were measured from post-
operative day (POD) 3 and POD 7. The upper limit of normal of the serum
amylase value in our hospital is 110 U/L. The criteria for leak were met if 
50 ml/day of drainage was observed and if that drainage contained an
amylase-rich fluid (greater than 3 times the upper limit of normal of the
serum amylase value) on or after POD7.
Results. Data were compared between patients with no fistula (n39) and
with fistula (n11). On POD 3, the drainage fluid amylase was more than
three times the normal serum amylase in 52%, with a median of 548 U/L
(range 3016.363 U/L). On POD 7 the median drainage fluid amylase was
136 U/L but ranged from 30 to 26000 U/L, with 22% with amylase greater
than 3 times the upper limit of normal of the serum amylase value. Soft
pancreatic parenchyma and a nondilated pancreatic duct were significantly
associated with higher drainage amylase levels.
Conclusion. Although determination of volume and drainage fluid amylase
levels may be useful for early detection of a leak that will have clinical impact
and to plan appropriate management, other factors such as consistency of the
pancreas and diameter of the pancreatic duct must be evaluated.
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GRANULOCYTIC SARCOMA OF THE PANCREAS
Martin-Perez, Elena; Go´mez, Joaquı´n; Martin-Alvarez, Jose´ Luis; Rodrı´guez,
Ana; Rubio, Ine´s; Larran˜aga, Eduardo
La Princesa Hospital, Dpt. of Hepatobiliopancreatic Surgery, Madrid, Spain
Background. Granulocytic sarcoma (GS) is a rare extramedullary soft-tissue
tumour that is composed of immature cells of the myeloid series. It
commonly presents as bone, soft tissue, or lymph node tumours.
Objectives. To describe a case a GS of the pancreas, who presented initially
with obstructive jaundice without evidence of bone marrow disease.
Case report. A 41-year-old man presented with a 6-month history of
painless jaundice and 5 kg weight loss. Computed tomography scan showed
dilated intrahepatic bile ducts with no masses in the pancreas. Magnetic
resonance cholangiopancreatography revealed an irregular narrowing of the
distal common hepatic duct suggestive of a cholangiocarcinoma or pancreatic
carcinoma. The patient underwent surgery and frozen section biopsy speci-
men showed a malignant tumour, compatible with poorly differentiated
carcinoma. A duodenopancreatectomy was performed. However, histological
examination of the resected specimen revealed that the tumour was
characterized by an extensive infiltrate of polimorphic cells with irregular
nuclear contours, vesicular chromatin, prominent nucleoli and various stages
of maduration with characteristic eosinophilic granules consistent with GS.
Immunohistochemical examination: positive for myeloperoxidase, murami-
dasa, CD34 and CD68, and negative for CD3, UCHL-1, and CD56, a profil
consistent with a myeloid phenotype. A bone marrow biopsy was normal.
The patient received combination therapy (idarubicin and AraC). Ten
months after operation the patient remained well and had not developed
acute myelogenous leukaemia.
Conclusion. In patients who develop GS before leukaemia, the diagnosis is
difficult to make by radiographic examination only, and it may be confused
with adenocarcinoma or lymphoma because of the non-specific necrotic
nature of the tumour. The presence of GS is associated with a poorer
outcome and a shorter overall survival. An early and intensive chemotherapy
may improve the prognosis and avoid systemic involvement.
PP 41.07
PYLORUS-PRESERVING PANCREATODUODENECTOMY WITH
GASTROINTESTINAL RECONSTRUCTION BY THE IMANAGA
METHOD
Kitago, Minoru1; Matsui, Junichi2; Omagari, Kenji1; Matsubara, Kentaro1;
Akiyama, Yoshinobu1; Hattori, Hiroaki1; Yamamoto, Tatsuya1; Suzuki,
fumio1; Otaka, Hitoshi1; Ogata, Yoshiro3
1Kyosai Tachikawa Hospital, Surgery, Tachikawa, Tokyo, Japan; 2Saitama
city hospital, Surgery, Saitama, Saitama, Japan; 3Tochigi Cancer Center,
Surgery, Utsunomiya, Tochigi, Japan
Background. Pylorus-preserving pancreatoduodenectomy (PPPD) have
been performed for disorders of the pancreatic head and periampullary
region. The most commonly used reconstructive technique anastomose the
duodenum end-to-side to the jejunum, with pancreatic and biliary anasto-
moses placed proximally to the end-to-side duodenojejunostomy. In contrast,
we have favored PPPD with gastrointestinal reconstruction by the Imanaga
method (PPPD-Imanaga), which consists of end-to-end duodenojejunost-
omy, end-to-side pancreatojejunostomy, and choledochojejunostomy, per-
formed in that order, because the PPPD-Imanaga provides a physiologic
mixture of food, pancreatic juice, and bile in the upper portion of the jejunum
and pancreatojejunostomy and choledochojejunostomy are observed by
endoscopy after PPPD-Imanaga. We present our PPPD-Imanaga and
evaluate anastomoses of pancreatojejunostomy and choledochojejunostomy
by endoscopy.
Methods. From April 2007, 2 patients underwent PPPD-Imanaga at
Tachikawa Hospital. As part of the PPPD-Imanaga, the pancreatic duct
was sewn directly to the jejunal mucosa and lost tube stent was inserted.
Outer layer sutures were placed between the pancreas and seromuscular layer
of the jejunum after spraying of fibrin glue on the pancreatic stump.
Choledochojejunostomy was done with single layer sutures without biliary
drainage tube. End-to-end duodenojejunostomy was anastomosed by layer-
to-layer anastomosis.
Results. No complication correlated with PPPD-Imanaga was shown in
pancreatic head cancer patient(TNM Stage%V) and cholangiocarcinoma
patient(TNM-Stage%UA). The average duration of hospital stay after
operation was 25 days. Follow-up endoscopic examination in 3 months since
operation showed pancreatojejunostomy and choledochojejunostomy were
opened and stent tube was lost. ConclusionIFImanaga method is a
favorable complement to PPPD.
PP 41.08
MESENTERICOPORTAL VEIN RESECTION FOR PANCREATIC
HEAD CARCINOMA
Kostov, Daniel; Ivanov, Valkan
Naval Hospital, Clinic of General Surgery, Varna, Bulgaria
Introduction. Long-term survival in patients with cancer of the pancreatic
head is disappointing. Surgery is the only curative therapy. However, this
procedure can only be performed in a few cases due to presentation of the
tumor in advanced stages.
Objective. An aggressive surgical approach remains the best palliation and
chance for five-year survival in the treatment of locally advanced pancreatic
cancer. Increasingly this approach has involved partial or total resection of
the portal vein (PV) or superior mesenteric vein (SMV) in combination with
pancreaticoduodenectomy.
Methods. We are presenting three patients with pancreatic head carcinoma,
operated by different types of techniques, different resection volume and
mesentericoportal vein reconstruction. One of the patients with two-third of
cross-sectional circumference of the lower PV or SMV resection, and a SMV
diameter of 0.5 cm will result with primary venous re-anastomosis, primary
closure is preferred technique of reconstruction. When a large amount of the
cross-sectional venous diameter was resected we use of an on-lay patch or
interposition graph of autogenous vein  used in the second patient. The third
patient was put under total resection of the portal-mesenterial venous
confluence along 2 cm, which allowed termino-terminal venous anastomosis.
Results. In our series all patients underwent partial or total vein resection
with minimal additional blood loss, operative time, or post-operative
complications including pancreatic fistulae. Postoperative portography had
showed preserved anatomical relationship of the vessels, without kink or
rotation of the portal-mesenteric confluence.
Conclusion. Pancreatic resection is currently the only treatment offering the
possibility of long-term survival for patients with pancreatic cancer.
Mesentericoportal vein involvement used to be considered a contraindication
to pancreatic resection, but recent advances in vascular surgery have
gradually extended the indications of curative pancreatic resection in such
cases.
PP 42.01
CHOLANGIOCELLULAR CARCINOMA PRESENTING AS
BUDD-CHIARI SYNDROME: A CASE REPORT AND LITERA-
TURE REVIEW
Korita, Pavel1; Wakai, Toshifumi1; Shirai, Yoshio1; Sakata, Jun1; Muneoka,
Katsuki2; Hatakeyama, Katsuyoshi1
1Niigata University Graduate School of Medical and Dental Sciences,
Division of Digestive and General Surgery, Niigata City, Japan; 2Niitsu
Medical Center Hospital, Department of Surgery, Niigata City, Japan
We herein report the case of a patient with cholangiocellular carcinoma
presenting as Budd-Chiari syndrome. A 63-year-old man presented with
shortness of breath and abdominal distention. Thoraco-abdominal CT and
inferior vena cavography revealed the obstruction of the inferior vena cava,
and Budd-Chiari syndrome was diagnosed. As it could not be denied that soft
tissue density around the obstruction on CT showed a malignant tumor,
exploratory laparotomy was performed, which revealed a tumor measuring 5
cm arising in the segment VIII of the liver with direct invasion to the inferior
vena cava. Histologic examination of excisional biopsy specimen revealed
moderately to poorly differentiated adenocarcinoma. It was considered that
extrahepatic stromal invasion involved the inferior vena cava led to Budd-
Chiari syndrome. Radical resection was abandoned because of distant nodal
disease and peritoneal metastases. Immunohistochemical study confirmed a
diagnosis of cholangiocellular carcinoma, because the tumor cells were
diffusely positive for cytokeratin 7, which is a marker for biliary epithelium.
He received systemic chemotherapy with gemcitabine (250mg/m2/day) and
irinotecan (25mg/m2/day). No adverse effects were noted. Eight months after
the initiation of chemotherapy, he died of disease. In the literature, we found
only 5 cases (including the present case) of cholangiocellular carcinoma
presenting as Budd-Chiari syndrome. This case and a review of the literature
suggest that patient with cholangiocellular carcinoma arising in the liver
adjacent to the inferior vena cava may present as Budd-Chiari syndrome and
clinicians should take it into consideration in differential diagnosis of a cause
disorder of Budd-Chiari syndrome.
PP 42.02
PANCREATIC AND DUODENAL INVASION IN DISTAL BILE
DUCT CANCER: PARADOX IN THE TUMOR CLASSIFICATION
OF THE AMERICAN JOINT COMMITTIEE ON CANCER
EBATA, Tomoki; NISHIO, Hideki; IGAMI, Tsuyoshi; YOKOYAMA,
Yukihiro; NIMURA, Yuji; NAGINO, Masato
Nagoya University Graduate School of Medicine, Disision of Surgical
Oncology, Nagoya, Japan
Background. Distal bile duct cancer often invades the pancreas and/or
duodenum; invasion of the pancreas is defined as a T3 and that of the
duodenum as a T4 tumor, in the T classification of the American Joint
Committee on Cancer (AJCC).
Objective. The aim of this study was to assess whether this T classification is
rational from the viewpoint of prognostic power.Method.: Ninety-five
patients with distal bile duct cancer were retrospectively analyzed, according
to the current T classification of the AJCC.
Results. The main determinant of pT3 (n32) and pT4 (n30) was
pancreatic and duodenal invasion, respectively, and the survival for patients
with pT3 and pT4 are similar (P0.595). Duodenal invasion was present in
39% of the patients with pancreatic invasion, whereas pancreatic invasion was
observed in 86% of those with duodenal invasion. The survival for patients
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with pancreatic invasion was not significantly different (P0.283) whether or
not there was concomitant duodenal invasion (n19 and n37, respec-
tively). Multivariate analysis identified venous invasion, distant metastasis,
histologic grade, and pancreatic invasion as independent prognostic factors.
Conclusion. Although duodenal invasion usually occurs after pancreatic
invasion, it is not a significant prognostic factor while pancreatic invasion is.
The current T classification should be revised since it expresses tumor
extension but does not reflect a survival in distal bile duct cancer.
PP 42.03
AGGRESSIVE INDICATION OF LOBAR HEPATIC RESECTION
AND VASCULAR RESECTION FOR HILAR CHOLANGIOCARCI-
NOMA
Tanaka, Eiichi; Hirano, Satoshi; Suzuki, On; Sagawa, Noriaki; Ichimura,
Tatsunosuke; Hashida, Hideaki; Suzuoki, Masato; Kondo, Satoshi
Hokkaido University Graduate School of Medicine, Surgical Oncology,
Sapporo, Japan
Background. Hemihepatectomy combined with portal and/or hepatic
arterial resection and reconstruction for hilar cholangiocarcinoma (HC) is
a challenging issue, in both technical aspects and safety. Large amount of
hepatic resection may result in negative hepatic ductal margin, however,
increased risk in postoperative hepatic failure. Vascular resection, especially
hepatic arterial resection has a serious risk of postoperative remnant liver
ischemia and liver abscess. Introduction. Standard operative procedure for
HC except Bismuth type IIIb in our department is right hemihepatectomy
with caudate lobectomy and extrahepatic bile duct resection in the condition
of adequate remnant liver functional reserve. In addition, vascular resection
such as portal and/or hepatic arterial resection is concomitantly performed
with or without liver resection to keep surgical separation margin free.
Recently, portal vein resection and reconstruction is routinely performed with
right hemihepatectomy for en bloc resection of HC.
Materials and Methods. We experienced 100 surgically resected cases in
our department since 1999, of which age are 68(4581) on average, gender
M/F81/19, and Bismuth classification I/II/III/IV18/20/31/31. Hepatic
arterial resection (N18) was performed in the presence of temporal arterio-
portal shunting and no direct arterial reconstruction in 17 patients, preserved
left hepatic artery originated from left gastric artery and no arterial
reconstruction in 1 patient.
Results. Respectability of our 100 cases are; R0/R1/R288/10/2. Cumula-
tive 3 and 5 year survival rate on Kaplan-Meier method is; 49% and 29% in
the case of portal vein resection(N39), 34% and 13% in arterial
resection(N18), 51% and 34% in simultaneous arterial and portal vein
resection(N9), respectively. There is no postoperative mortality in the case
of combined arterial resection.
Conclusion. We believe lobar hepatic resection with vascular resection(s) is a
safe and potent surgical procedure to improve surgical outcome of HC.
PP 42.04
HILAR CHOLANGIOCARCINOMA: SURGICAL TREATMENT
Mega, Raquel; Oliveira, Paulo; Nobre, Ana Marta; Rocha, Vitorino; Coelho,
Joa˜o; Moniz, Luisa; Pereira, Jose´ A.; P. Marques, Hugo; Filipe, Edite; Mira,
Paulo; P. Pereira, Jorge; Martins, Ame´rico; Barroso, Eduardo
H. de Curry Cabral, Centro Hepatobiliopancrea´tico e de Transplantac¸a˜o,
Lisboa, Portugal
Background. Hilar cholangiocarcinoma is a frequent cause of obstructive
jaundice. Curative treatment is only possible with complete resection, which
sometimes demands large hepatic resections. This treatment should be done
in hospitals with large experience in hepatic surgery and with possibility of
multidisciplinary approach.
Objectives. To study patients who underwent surgery for carcinoma at the
hilar confluence of the hepatic ducts. To define age, sex, type of tumor, pre-
operative drainage, type of surgery, complications, pos-operative mortality,
staging and presence of positive nodes, margins of resection, survival rates
and disease-free survival rates. To study prognostic factors to survival and
disease-free survival rates.
Methods. Retrospective study, with consultation of clinical process. Survival
analysis by Kaplan-Meyer Curves, and prognostic factors with Long-Rank
test.
Results. From 2004 to June 2007, 39 patients (71,8% male, aged 3581,
average 63,25) underwent surgery, in our HBP center. Curative resection was
possible in 64% of the cases, either local or hepatic resection. About 50%
involved the left or right hepatic duct (Bismuth type IIIa or IIIb). The
pathological classification showed 40% of IIa tumors by the TMN staging. In
8 patients lymph node involvement was present. The 33 months survival rates
for 25 patients undergoing curative resection were 25%.
Conclusion. Surgery is the only curative treatment for cholangiocarcinoma.
When resection with free margins is possible, the results are better in long
term survival, with a relatively low complications rate.
PP 42.05
TRENDS IN SURGICAL MANAGEMENT OF NO-KLATSKIN BILE
DUCT CANCER
Frena, Antonio
Central Hospital of Bolzano, General Surgery, Bolzano, Italy
Introduction. carcinoma of the mid or distal third of the common bile duct
is a fairly rare nosological entity in the West, accounting for 1323% of
tumours of the extrahepatic bile ducts. The surgical treatment varies in
relation to the site: in the case of carcinomas of the distal common bile duct
the operation of choice is duodeno-pancreatectomy, whereas for tumours of
the mid common bile duct there is still no unanimous consensus of opinion
regarding the type of surgery.
Aim. The prognosis of these tumours is better than that of carcinomas of the
proximal choledochus.
Methods. we retrospectively assessed 37 patients with non-hilar extra-
hepatic bile duct tumours observed in our department from 1985 to 2005.
The presenting symptom was jaundice in 95% of cases. In 23 cases the
carcinoma affected the distal common bile duct and in 14 cases the mid
common bile duct.
Results. 15 patients were treated with a radial intent by either duodenopan-
createctomy (13 cases) or by resection of the common bile duct (2 cases).
Twenty-two patients with local inoperability or liver metastases were treated
with a palliative operation or endoscopically. Postoperative staging identified
1 patient as stage Ia, 2 patients as stage Ib, 8 patients as stage IIa, 3 patients as
stage IIb, and 1 patient as stage III according to the new TNM classification.
There was no operative mortality. Survival at 1, 2 and 5 years was 51%, 27%
and 14%, respectively.
Conclusions. carcinoma of the mid or distal portion of the common bile
duct is a tumour that offers fairly good prospects of survival. Surgical
radicality is achieved by obtaining ductal and radial margins which are free of
microscopic infiltration and by means of a thorough lymphadenectomy.
These conditions can be achieved more easily in carcinomas of the distal
portion of the duct owing to the extent of duodeno-pancreatectomy they
require. In carcinomas of the mid common bile duct the anatomical
contiguity with the portal vein is responsible for a lower resectability rate
PP 42.06
SURGICAL TREATMENT OF HILAR BILE DUCT CARCINOMA –
MY PERSONAL EXPERIENCE WITH 25 CONSECUTIVE HEPA-
TECTOMIES–
Kawarada, Y1; Tabata, M2; Taoka, H2; Isaji, S3
1Mie University School of Medicine, 1st Department of Surgery, Tsu-City,
Japan; 2; 3Mie University School of Medicine, Department of Surgery(
Hepatobiliary pancreas), Tsu, Japan
Background.To evaluate our recent surgical policy regrding hilar bile duct
carcinoma, we evaluated 62 cases treated between 1976 and 1993, and 25
cases treated between 1944 and 2000. Hepatectomy was performed in a totl
of 65 (74.7%) of the 87patients. 40(64.5%) in the early period, and all 25 in
the late period, and thus 100 percentage of patients treated by hepatectomy
was significantly highr in the late period. Hepatectomy ı¨¿½{total caudate
lobectomy that included the paracaval portion (S1ı¨¿½{S9) were performed in
all patients in the late period. Also, S4aı¨¿½{S5ı¨¿½{S1 (so called Taj Mahal
hepatectomy) hepatectomies were performed in old patients and patients
with poor liver function, and only in the late period. The curative resection
rate was significantly higher in the late period. We reported 3-and 5-year
survival rates in the late period of 59.9% and 49.9%, respectively, compared
with 27.1% and 20.2%, respectively, in the early period in 2001 in the J.
Gastrointestinal Surgery (2002). However, some may feel that 2001 was too
early to judge our data for the late period or to evaluate the 3-year and 5-year
survival rates.BAimI retired from Mie University School of Medicine but
continued to follow up my 25 cases until the end of 2006.BResultsAt the
end of 2006, the 3-and 5-year survival rates in the late period (my cases) were
59.1% and 46.4%, respectively. Also, seven of the 25 patients had survived
recurrence-free for more than 5 years after surgery.BConclusionBetween
1994 and 2000, I performed 25 hepatectomies for hilar bile duct carcinoma.
After I retired, but continued to follow up my 25 cases for 6 years between
2001 and 2006. The small number in this study may explain the number of
positive Results. However, my data revealed good results and proved the
effectiveness of our procedures for hilar bile duct carcinoma.
PP 42.07
DIFFERENTIATION OF MALIGNANT AND BENIGN PROXIMAL
BILE DUCT STRICTURES
Kloek, Jaap1; van Delden, OM2; Erdogan, Deha1; ten Kate, Fibo3; Rauws,
Eric1; Busch, Olivier1; Gouma, Dirk1; van Gulik, Thomas1
1Academic Medical Center, Department of Surgery, Amsterdam, Nether-
lands; 2Academic Medical Center, Department of Radiology, Amsterdam,
Netherlands; 3Academic Medical Center, Department of Pathology, Am-
sterdam, Netherlands
Background. The main etiology of proximal bile duct strictures is hilar
cholangiocarcinoma (HCCA). However, the differentiation of benign and
malignant strictures at the liver hilum remains difficult despite extensive
diagnostic work-up. The aim of this study was to assess whether preoperative
criteria were able to differentiate HCCA from benign proximal bile duct
strictures.
Methods. A total of 68 patients underwent resection on the suspicion of
HCCA between 1998 and Jan 2007. In these patients, collected data
included laboratory investigations, combination of imaging studies (including
cholangiography, CT, MRCP and duplex ultrasound) and brush cytology.
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These findings were analyzed in regard with the final histopathological
outcome.
Results. Histopathological examination of the resection specimens con-
firmed HCCA in 58 patients (85%, group I) whereas 10 patients (15%,
group II) were diagnosed with benign strictures. Benign strictures mainly
consisted of sclerosing cholangitis (including autoimmune cholangitis) and
chronic fibrosing inflammation. The most common presenting symptom was
obstructive jaundice in 77% of patients (79% in group I vs. 60% in group II,
respectively, P0.23). Laboratory findings showed significantly elevated
transaminase levels in group I compared to group II (PB0.05). The various
imaging modalities showed a higher incidence of a mass lesion in group I
(97% in group I vs. 70% in group II, respectively, PB0.05). Vascular
involvement was exclusively found in group I (36% PB0.05). Brush cytology
was positive for malignant cells in 50% of the patients in group I, whereas
none in group II showed malignant cells (PB0.05).
Conclusions. Despite improved imaging techniques, the differentiation of
HCCA from benign proximal bile duct strictures remains difficult. Although
specific features, such as vascular involvement and the presence of a mass
lesion support malignancy, these findings are inconclusive. Therefore, in case
of a suspicious lesion in the liver hilum, surgical excision should be pursued.
PP 42.08
POSTOPERATIVE LIVER FAILURE RATE AFTER LIVER RESEC-
TION FOR HILAR CHOLANGIOCARCINOMA IN THE ABSENCE
OF PREOPERATIVE BILIARY DRAINAGE
Rajan, Ramesh; Natesh, Bonny; Kumar, Arun; R S, Sindhu; A, Sylesh; N,
Subhalal; A P, Kuruvilla
Medical College Hospital, Surgical Gastroenterology, Trivandrum, India
Background. Meta-analyses of controlled trials have not shown preoperative
biliary drainage to be beneficial in malignant lower biliary obstruction
although isolated reports have shown benefit. However, resection of
malignant hilar obstruction often involves resection of cholestatic liver with
higher rates of postoperative liver dysfunction/failure. The role of preopera-
tive drainage in this setting is less clear.
Objective. To assess the postoperative liver failure rate after liver resection
for hilar cholangiocarcinoma in the absence of preoperative biliary drainage.
Materials and Methods. Operative morbidity and mortality was evaluated
from a prospectively held database in patients undergoing liver resection for
hilar cholangiocarcinoma over a four year period from July 2003 to June
2007. Preoperative biliary drainage was performed in none.
Results. There were 12 resections in all out of a total of 38 patients with hilar
cholangiocarcinoma. 9 patients needed liver resections. There were 5 (L)
hepatectomies, 3 ( R) hepatectomies and 1 Parenchyma conserving liver
resection. Morbidities noted were minor bile leaks (3), major bile leak with
biliary peritonitis (1), ascitic leak (3), hemobilia (1), pleural effusion needing
paracentesis (1). Postoperative liver failure occurred in none although there
was reversible liver dysfunction in 3. There was 1 mortality due to sepsis from
biliary peritonitis. The median preoperative Total Bilirubin level in those who
underwent liver resection was 18 mg/dl.
Conclusion. Absence of preoperative biliary drainage is not necessarily
associated with a high postoperative liver failure rate in liver resections for
hilar cholangiocarcinoma.
PP 42.09
IS THE LEVEL OF TOTAL BILIRUBIN IN THE BILE A SIMPLE
INDICATOR FOR EVALUATION OF FUNCTIONAL LIVER RE-
SERVE IN OBSTRUCTIVE JAUNDICE PATIENTS?
Ota, Takehiro1; Araida, Tatsuo2; Hamano, Mie1; Takeshita, Nobuhiro1;
Yazawa, Takehisa1; Tezuka, Tohru3; Yagawa, Yohsuke3; Yasuda, Hideki3;
Yamamoto, Masakazu1; Higuchi, Ryota4
1Tokyo women’s Medical University, Surgery, Tokyo, Japan; 2Tokyo Wome-
nIfs Medical University Yachiyo Medical Center, Surgery, Chiba, Japan;
3Teikyo University Chiba Medical Center, Surgery, Chiba, Japan; 4Tokyo
Women’s Medical University, Teikyo University Chiba Medical Center,
Surgery, Tokyo, Japan
Objective. This prospective study was performed to investigate whether
monitoring the level of total bilirubin in the bile from a predicted remnant
liver (LTB) can assist in predicting functional liver reserve in obstructive
jaundice patients undergoing major hepatectomy. Summary Background
Data: Accurate evaluation of functional liver reserve before hepatectomy in
patients with obstructive jaundice is sometimes difficult. Method: In 118
patients (45 hilar bile duct and 73 gallbladder cancer) who underwent
surgery in our institution, 24 consecutive patients with jaundice scheduled to
receive major hepatectomy, in whom all bile from the predicted remnant liver
could be collected were included in this study. We measured bile volume,
density and LTB preoperatively from the predicted remnant liver. We judged
the safe zone to be over 80 mg/day, and the risky zone, from 60 to 80 mg/day.
Results. Mean bile volume, total bilirubin density and LTB from the
predicted remnant liver were 3.4I}1.7dl, 51I}26 mg/dl and 153I}72 mg/
day, respectively. Of 21 patients with LTB over 60 mg/dl, who underwent
major hepatectomy as planned preoperatively, one died of liver infarction,
sepsis and DIC from obstruction of the reconstructed hepatic artery, but no
patient died of liver failure from hepatic insufficiency. Two patients whose
LTB was under 60 mg/dl barely tolerated major hepatectomy, and long
postoperative management was needed because of postoperative liver failure.
Conclusion. LTB is a simple indicator for evaluation of functional liver
reserve in obstructive jaundice patients who are candidates for major
hepatectomy.
PP 42.10
HORIZONTAL EXTENT OF EXTRAHEPATIC BILE DUCT CAN-
CER ACCURATELY DIAGNOSED BY INTRADUCTAL ULTRA-
SONOGRAPHY: A CASE REPORT
Sadakari, Yoshihiko1; Ienaga, Jun2; Tanabe, Reiko2; Nakamura, Masahumi2;
Yamaguchi, Koji2; Tanaka, Masao2
1Graduate School of Medical Sciences, Department of Surgery and
Oncology, Kyushu University, Fukuoka City, Japan; 2
Background. Bile duct cancer often extends intraluminally. The proper
diagnosis concerning about the horizontal extent is important to determine
the treatment strategy. We report bile duct cancer of which extent diagnosed
correctly using intraductal ultrasonography (IDUS).
CASE REPORT. A 59-year-old Japanese man consulted his personal doctor
for jaundice. Serum chemistry suggested obstructive jaundice and ultrasono-
graphy revealed dilatated intrahepatic bile ducts. Therefore, the patient was
referred to our hospital for the further examination and treatment.
Computed tomography, magnetic resonance imaging and endoscopic retro-
grade cholangiography detected bile duct tumor localized in the extrahepatic
bile duct below primary confluence, and diagnosed bilateral hepatic ducts
were intact. However IDUS only revealed the papillary change in the left
hepatic duct and intrahepatic duct which suggested cancer invasion.
Extended left lobectomy with caudate lobectomy and pylorus-preserving
pancreatoduodenectomy were performed. The resected specimen showed
that the tumor extended to the left hepatic duct and surgical margin was free.
18 months after the operation, the patient is alive without recurrence.
Conclusion. IDUS is one of the useful modalities to determine horizontal
extent of bile duct cancer in some cases.
PP 42.11
CARCINOMA OF THE PROXIMAL AND MID BILE DUCT: IS
BILE DUCT SEGMENTAL RESECTION AND LYMPH NODE
DISSECTION APPROPRIATE?
Lee, Hyung geun1; Choi, Sung-Ho2
1Samsung Medical Center, Sungkyunkwan University School of Medicine,
seoul, Korea, Democratic People’s Republic of; 2Samsung Medical Center,
seoul, Korea, Republic of
Background/aims. Bile duct segmental resection with lymph node dissec-
tion (radical BDSR) is a procedure done for the Bismuth type I of proximal
bile duct cancer (PBD-1) and mid bile duct cancer (MBD) when proximal
and distal resection margins are negative and there is no local invasion to
surrounding vascular structures, duodenum, pancreas or liver. Although
BDSR is performed by many surgeons in select cases, clinical studies on the
adequacy of this procedure is scarce. In this study, clinical observation and
prognostic factor analysis is done for patients receiving radical BDSR for
PBD-1 or MBD. To validate the adequacy of radical BDSR for PBD-1 or
MBD, comparison of survival and postoperative complication and hospital
stay is made between radical BDSR for PBD-1 or MBD and pancreatico-
duodenectomy (PD) for distal bile duct cancer (DBD). Result: Retrospective
analysis was conducted for 45 cases of radical BDSR for PBD-1 or MBD and
149 cases of PD for DBD. 3- and 5-year survivals were 51.7% and 36.6% for
the radical BDSR group. T-stage and lymph node invasion were significant
prognostic factors. 3- and 5-year survivals of patients in the PD group were
55.7% and 34.2%, respectively. Radical BDSR group and PD group did not
show significant difference in survival when adjusted for TNM stage.
Postoperative complications were significantly less in the radical BDSR
group (20.0% vs. 40.9%, p0.01). Postoperative hospital stay was sig-
nificantly shorter in the radical BDSR group (mean 16.62 vs. 28.39 days, p
0.035).
Conclusions. Bile duct segmental resection with lymph node dissection is
justified as a radical operation for PBD-1 or MBD when there is minimal
local invasion and negative bile duct resection margin and radial margin is
ensured.
PP 43. 03
LAPAROSCOPIC RIGHT HEPATECTOMY PRESERVING MID-
DLE HEPATIC VEIN TRIBUTARIES IN ADULT-TO-ADULT LIV-
ING DONOR LIVER TRANSPLANTATION
Yi, Nam-Joon1; Suh, Kyung-Suk1; Kim, Juhyun1; Shin, Woo Young2; Lee,
Hae Won1; Lee, Kuhn Uk1
1Seoul National University College of Medicine, Surgery, Seoul, Korea,
Republic of; 2
This is the first report of a totally laparoscopic right hepatectomy preserving
middle hepatic vein tributaries in a live donor. A 25-year-old lady volunteered
to be a live donor to her farther who has suffered from recurrent hepatic
encephalopathy associated with hepatitis B related liver cirrhosis and
hepatocellular carcinoma. A totally laparoscopic procedure was performed
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using a hand port device and additional 5 ports. The hepatic parenchyma was
dissected using laparoscopic ultrasonic aspirator under pneumoperitoneum.
After then, the right bile duct stump was intracorporeally over-sewn using 6
0 prolene. The right hepatic artery, right portal vein, and middle hepatic vein
tributaries were divided using hem-o-lock clips. The right hepatic vein was
divided using endovascular GIA stapler. The operation time of the donor was
765 minutes including 218 minutes for parenchymal transaction and 150
minutes for meticulous wound closure. She was discharged on postoperative
day (POD) 10 without complication. The recipient recovered well but
unfortunately experienced cerebral infarction on POD 10. He was discharged
POD 32 after recovery from sequela of cerebral infarction. In this case, a
totally laparoscopic modified right hepatectomy was technically feasible and
may improve the quality of life of live liver donors as well as cosmetic effect.
PP 43.01
LIVING DONOR LIVER TRANSPLANTATION FOR HEPATOCEL-
LULAR CARCINOMA IN PATIENTS BEYOND THE MILAN BUT
WITHIN THE UCSF CRITERIA
Park, Jeong-Ik; Lee, Sung-Gyu; Hwang, Shin; Kim, Ki-Hun; Ahn, Chul-
Soo; Moon, Deok-bog; Ha, Tae-Yong; Song, Gi-Won; Jung, dong-hwan
University of Ulsan College of Medicine and Asan Medical Center,
Department of Surgery, Seoul, Korea, Republic of
Background. Liver transplantation is accepted as one of the curative
treatments for patients with the diagnosis of hepatocellular carcinoma(HCC).
The Milan criteria have remained the standard inclusion criteria for over a
decade. Nevertheless, no much is known regarding the results of liver
transplantation in patients with tumors outside of the Milan criteria. The aim
of this study was to analyze the patient¡*s survival and post-transplant
disease-free survival comparing HCC meeting the Milan and meeting the
UCSF but exceeding the Milan criteria.
Patients and Methods. Between February 2000 and June 2006, 329 cases of
living donor liver transplantation(LDLT) for patients with HCC were
performed at Asan medical center. We excluded 13 hospital mortalities and
17 salvage LDLT. Among the patients, 15 patients exceeding the Milan but
meeting the UCSF criteria and 226 patients meeting the Milan criteria were
identified. Male to female sex ratio was 245/54 and mean age was 52.3 years
old.
Results: The overall 1- and 3-year survival rates of patients who meeting the
Milan criteria were 95.1%, 86.7%, respectively, whereas those of patients
who exceeding the Milan but meeting the UCSF criteria were 93.3%, 74.7%,
respectively. The 1- and 3-year disease-free survival rates of patients who
fulfilled the Milan criteria were 94.7%, 89.0%, respectively, whereas those of
patients who exceeded the Milan but meeting the UCSF criteria were 86.7%,
71.1%, respectively.
Conclusions: This study shows that the 3-year survival and disease free
survival rate was lower in the beyond Milan-within UCSF criteria compared
to within the Milan criteria patients. However, only small percentage of
transplanted HCC patients can be classified as beyond Milan within UCSF
criteria, so more large volume patients¡* study is needed.
PP 43.02
LIVING-DONOR LIVER TRANSPLANTATION WITH SIDE-TO-
END RENO-PORTAL ANASTOMOSIS FOR PATIENTS WITH
OBLITERATED PORTAL VEIN AND LARGE SPLENORENAL
SHUNTS
Moon, Deok-Bog; Lee, Sung-Gyu; Ahn, Chul-Soo; Kim, Ki-Hun; Hwang,
Shin; Park, Kwang-Min; Kim, Kwan-Woo; Ko, Kyoung-Hoon; Choi, Nam-
Kyu; Ha, Tae-Yong
Asan Medical Center, Seoul, Hepato-Biliary Surgery & Liver Transplanta-
tion, Seoul, Korea, Republic of
Background. End-stage liver disease patients with obliterated portal
vein(PV) and large spontaneous splenorenal shunts(SRS) often need
renoportal anastomosis(RP-A) during liver transplantation as one of the
solutions. At our institution, RP-A in living-donor liver transplanta-
tion(LDLT) was successfully performed by using different method from
the previous end-to-end anastomosis.
Methods. We performed four LDLT with RP-A for the treatment of
obliterated PV and large spontaneous SRS between 2005 and 2006. We
reviewed the two different methods of RP-A, and also evaluated outcomes of
RP-A.
Results. End-to-end RP-A was performed in one patient by interposing
cadaveric iliac vein graft between native renal vein and graft portal vein. It
had several problems causing difficult and insecure anastomosis. Other three
patients underwent side-to-end RP-A that could make us to perform easy and
secure anastomosis. Except one patients who died from cerebral hemorrhage,
other three patients who underwent LDLTs with RP-A are alive with normal
graft function and a patent RP-A.
Conclusion. LDLT with side-to-end RP-A for the treatment of obliterated
PV and large spontaneous SRS in patients with end-stage liver disease is an
easy and safe life-saving portal reconstruction technique.
PP 43.04
TEMPORARY PORTO-CAVAL SHUNT(TPCS) DURING LIVING
DONOR LIVER TRANSPLANTATION(LDLT)
Goja, Sanjay; Kakodkar, Rahul; Kumaran, Vinay; Nundy, S; Soin, Arvinder
Sir Ganga Ram Hospital, Gyan Burman Liver Surgery Unit, New Delhi,
India
Background. Temporary porto-caval shunt can resolve the problems
associated with portal vein clamping during the anhepatic phase of liver
transplantation. Its advantages include avoidance of bowel edema, reduction
in transfusion requirements and avoidance of fluid overload which in turn
may translate into reduction in artificial ventilation time and the shorter
intensive care and posttransplant hospital stay. AIM To study the indications
and utility of temporary porto-caval shunt in our series of LDLT.
Methods. All the 148 LDLTs performed between Jan 2002 to July 2007
were analysed. An end-to side TPCS was done in 13 patients with one or
more of the following: a) Fulminant liver failure or patients who had no
spontaneous portocaval shunts (5) b) Benching time unexpectedly prolonged
(4) c) Excessive portal hypertensive bleeding during hepatectomy (6) d)
Variceal bleeding during recipient hepatectomy (1).
Results. Among the TPCS patients, 10 were males and 3 females. Their age
ranged from 17 to 58years (mean 39.7). Three patients had FHF, 2 HCV
induced cirrhosis, 4 cryptogenic cirrhosis,1 PSC, 1 Hepatitis B induced
cirrhosis, 1 alcoholic cirrhosis and 1 autoimmune cirrhosis. Their MELD
scores were between 22 to 38 (mean 28). The average time taken for the
TPCS was 5 minutes and there was no loss of portal vein length in any
patient. Portal vein clamping time was 64104 minutes in FHF patients and
80201 minutes in the others. There was appreciable decrease in blood loss
after TPCS in all patients. In one patient intra-operative variceal bleeding was
immediately controlled with TPCS. In this high risk group of patients, 10 out
of 13 (77%) survived and are currently well 138 months after transplant.
Our overall current (last 100 patients) patient and graft survival rate at 1 year
is 92%.
Conclusion. In selected high risk patients, temporary TPCS is an easy and
efficacious method of reducing problems due to portal vein clamping during
the anhepatic phase of living donor liver transplantation.
PP 43.05
EFFECTS OF ISCHEMIC PRECONDITIONING OF THE GRAFT
IN ADULT LIVING RELATED LIVER TRANSPLANTATION
azoulay, DANIEL; castaing, denis; andreani, paola
APHP hopital paul brousse, cHB, Villejuif, France
Background. Ischemic preconditioning of the liver graft in the donor has not
yet been studied in clinical adult to adult living related right liver
transplantation (LRRLT). OBJECTIVE To compare the results of LRRLT
with and without ischemic preconditioning of the graft in the donor.
Patients and Methods. Alternate patients were transplanted with right liver
grafts from living donor that had (n22, Group Precond) or had not (n22,
Group Control) been subjected to IPC of the graft in the donor. Liver
ischemia-reperfusion injury, liver and kidney function, morbidity and
mortality were compared in the two groups of recipients. Predictive factors
of the peak AST level and the minimum value of prothrombin time were
assessed by uni-and multivariate analysis. The outcome of the two groups of
donors were compared.
Results In the recipients, the postoperative peaks of AST (IU/L) and ALT
(IU/L) were similar (307189 and 437302, p0.8, vs 290146 and
496343, p0.6, respectively) in Group Precond and Group Control. In
univariate analysis, only the preoperative value of AST in the recipient was
significantly associated with the postoperative peak of AST. The rate of
technical morbidity and the incidence of acute rejection were similar in both
groups. Primary non function occured in 1 and 0 case of Group Precond and
Group Control respectively (p0.9). In multivariate analysis, the graft to
recipient weight ratio (p0.003) and the preoperative value of bilirubin (p
0.004) were significantly predictive of the post-transplant minimum value of
PT. Hospital mortality rates were similar in the two groups. IPC had no
impact in the donor on postoperative peak of AST, liver and kidney function
tests, morbidity and duration of hospital stay.
Conclusion. Compared to standard LRRLT, ischemic preconditioning of
the liver graft in the donor does not trigger any benefit neither for the
recipient nor for the donor. Until further studies are available, the clinical
value of preconditioning liver grafts remains uncertain.
PP 43.06
Results OF HEPATIC ARTERY ANASTOMOSIS USING LOUPE
MAGNIFICATION IN LIVING DONOR LIVER TRANSPLANTA-
TION
Goyal, Neerav; Vij, Vivek; Sahani, Riti; Wadhawan, Manav; Srivastava,
Ajitabh; Kumar, Abhay; Gupta, Subash
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Indraprastha Apollo Hospital, Liver Transplant and Surgical Gastroenterol-
ogy, New Delhi, India
Background. Hepatic artery thrombosis (HAT) occurs in 1.6 to 8% of Liver
recipients and has high morbidity and mortality. Amongst other factors, using
operating microscope is said to decrease incidence of HAT, but it prolongs
operative time. We use 3.5x loupe for our hepatic arterial anastomosis (HAA)
and describe our center’s experience with it.
Material and Methods. Seventy patients underwent Living Donor Liver
Transplantation from January 2004 to August 2007 with Right lobe grafts in
63 and Left lobe in 7 patients. Donors had preoperative evaluation by
MDCT Angiography. HAA was carried out with 70 prolene, using 3.5x
Loupe. Recipient’s post transplant vascular perfusion was evaluated per-
operatively with Doppler Ultrasonography (DU) by a single ultrasonologist.
Post operatively, DU was done for five consecutive days and then as required.
Hepatic arterial peak flow velocity, type of flow and resistive indices were
evaluated. Hemoglobin was keptB10gm%, patients with INRB1.7 received
low molecular weight heparin, and Ecosprin once platelet count rose to
30,000/cumm. Diagnosis of HAT was made on basis of DU and confirmed by
MDCT Angiography.
Results. Mean diameter of hepatic artery in 70 patients was 2.8mm. Redo
HAA was done in 4 patients for unsatisfactory flow at per-operative DU. One
patient developed HAT on post operative day 3. Redo anastomosis with an
arterial conduit was attempted because of intimal dissection of hepatic artery,
but was unsuccessful. Another patient had late HAT due to persisting bile
leak. Incidence and mortality due to HAT was 2/70 (1.4%). Overall survival
was 59/70 (81.9%).
Conclusion. A meticulously done Hepatic arterial anastomosis under loupe
magnification, avoiding kinking, looping or twisting of anastomosis, can keep
the incidence of HAT low. Hepatic arterial anastomosis should be redone
unless a satisfactory per-operative DU result is achieved, which goes a long
way in reducing incidence of post operative HAT.
PP 43.07
TIPS FOR TRANSPLANT IN LIVING DONOR LIVER TRANS-
PLANT-ROLE IN DECREASING PERIOPERATIVE RISK
Wadhawan, Manav1; Vij, Vivek2; Kumar, Ajay1; Gupta, Subash2; Gupta,
Subash2
1Indraprastha Apollo Hospital, Gastroenterology & Hepatology, Liver
Transplant, New Delhi, India; 2Indraprastha Apollo Hospital, Liver Trans-
plantation and Surg Gastro, New Delhi, India
Background. Role of TIPS to reduce perioperative risk in liver transplant is
controversial. Anecdotal studies have reported decreased intraoperative
blood loss if TIPS is done prior to transplant, but evidence is equivocal.
We report a very high-risk case for transplant that had multiple abdominal
surgeries in the past and underwent successful liver transplant after a TIPS
procedure.
Case report. A 55 yr old lady, suffering from HCV related end stage liver
disease, presented to us in grade IV encephalopathy for consideration of liver
transplant. She had a history of multiple abdominal surgeries in the past 
Tubal ligation in 1985, open cholecystectomy in 1992, incisional hernia
repair in 1992 and repeat repair of incisional hernia in 2002. After initial
stabilization, TIPS procedure was performed on her prior to the transplant.
She tolerated the procedure well, had no encephalopathy post TIPS and
ascites disappeared. She underwent a right lobe LDLT 10 days after TIPS.
There were dense adhesions between the liver, stomach, duodenum and
colon, which took 3.5 hours to separate. Despite extensive adhesions due to
previous surgeries, patient had minimal blood loss and required only 2
packed red cell transfusions. Of this one unit was transfused during
reperfusion, where we flush the liver with portal blood and suck this out
through an IVC vent. It was relatively simple to retrieve the stent at operation
by dividing the stent with scissors at the right portal vein level. She had an
uneventful postoperative recovery and was discharged on 20th post op day.
Conclusion. TIPS may have a role before transplant to reduce blood loss
during surgery. TIPS does not hinder surgery or postoperative survival and
may reduce morbidity and mortality in sick patients for liver transplant with a
high risk of intraoperative bleeding.
PP 43.08
HEPATIC ARTERY RECONSTRUCTION IN LEFT LOBE LIVER
TRANSPLANTATION: DIFFICULTIES AND OUTCOMES
Soliman, Hossam Eldeen; Ibrahiem, Tarek; Soliman, Bassem; Hegazy,
Osama; Marwan, Ibrahiem
National liver institute, Menoufia University, Department of Hepatobiliary
and liver transplantat, Egypt
Background. Hepatic artery reconstruction is an essential step during liver
transplantation. The use of micro9surgical techniques had minimized the rate
of hepatic artery complications to below 2%. Left lobe grafts are commonly
used in pediatric transplants and less commonly in adults.
Aims. We present our experience in in hepatic artery reconstruction in a
mixed pediatric and adult living donor transplantation governmental
program in Egypt. mes.
Patients and Methods. We had performed 16 left lobe livibg donor liver
transplantation for pediatric patients that will be compared to 23 right lobe
grafts for adults in the department of Surgery, National Liver institute,
Menoufia University starting from 28th of April 2003 to the end of
September 2007. We reviewed the preoperative patients data, graft char-
acteristics, operative data, postoperative details including hospital stay, the in-
hospital complications and early follow.
Results. There were no cases of Hepatic artery thrombosis in left lobe grafts
compared to two cases in the adult series. Hepatic artery steal phenomena
occurred in each group. The operative time was 609 30 minutes for left lobe
grafts while 45910 in Right lobe grafts. What is unique in our series is that
reconstruction of hepatic arteries arising from the left gastric artery was done
in 3 cases and was associated with more operative time and all has biliary
complications and leak. All died later from these biliary complication.
Conclusions. Hepatic artery reconstruction for left lobe grafts is technically
more difficult but with low thrombosis rate. We don’t recommend recon-
struction of accessory arteries arising from the left gastric artery because of
the high rate of biliary complications in theses cases in our series.
PP 43.09
USE OF THE NATIVE LIVER VEINS AS A SOURCE FOR VEIN
GRAFTS IN LIVING DONOR LIVER TRANSPLANTATION: TECH-
NIQUE, DIFFICULTIES AND COMPLICATIONS
Soliman, Hossam Eldeen; Ibrahiem, Tarek; Soliman, Bassem; Hegazy,
Osama; Marwan, Ibrahiem
National liver institute, Menoufia University, Department of Hepatobiliary
and liver transplantat, Egypt
Background. LIVING DONOR liver transplantation is a good alternative in
areas where cadaveric transplants. Variation of the hepatic veins and portal
vein are important factor in determining suitability of grafts for living
donation especially as regard donor safety and difficulty in outflow
reconstruction due to the lack of suitable vein grafts.
Aims. We present our experience in vascular reconstruction of living donor
transplants using vein grafts from the native liver of the recipient.
Patients and Methods. We had performed 39 living donor liver transplan-
tation in the department of Surgery, National Liver institute, Menoufia
University starting from 28th of April 2003 to the end of September 2007.
They 16 pediatric patients and 23 adult patients. We reviewed the
preoperative patients data, graft characteristics, operative data, postoperative
details including hospital stay, the in-hospital complications and early follow.
And accordingly, we excluded 7 patients with tumors and two patients with
portal vein thrombosis.
Results. There were one case of use of portal confluence for reconstruction
of double portal veins in left lobe group graft in pediatric cases. While in right
lobe grafts we used vein grafts in 13 out of 16 patients. We tried to minimize
the number of hepatic veins to a maximum of two anastomsies by this
technique. Long grafts were obtained from the portal system and the hepatic
veins in reconstruction of V5 in 4 patients, V8 in 2 cases, middle hepatic vein
in 5 cases, inferior hepatic vein in 2 cases and anterior patch for the right
hepatic vein in 8 cases. In one case we used a canalized umbilical vein to
reconstruct two inferior veins in one patient. In one case the long grafts were
thrombosed postoperatively but the rest were functioning postoperatively.
Conclusions. The native liver of the recipient is a good source for vein grafts
in livind donor liver transplants in absence of portal vein thrombosis and
malignancy.
PP 43.10
EXTENDED LEFT HEPATECTOMY INCLUDING MIDDLE HE-
PATIC VEIN ACCOMPANIED BY V5 AND V8 RECONSTRUCTION
FOR A LIVING-RELATED DONOR
Hyodo, Masanobu; Yasuda, Yoshikazu; Fujiwara, Takehito; Sakuma, Yasu-
naru
Jichi Medical University Hospital, Department of Surgery, Shimotsuke,
Japan
Background. In case of extended left hepatectomy including middle hepatic
vein (MHV), anterior segment is subject to congestion due to dissection of
V5 and V8.Aim. We have introduced V5 and V8 reconstruction in extended
left hepatectomy for a living-related donor to prevent anterior segment from
congestion.
Methods. We expose suprahepatic vena cava (IVC) distinctly. After left
hepatic artery and portal vein are secured, we transect liver parenchyma along
right side of MHV intermittently clamping anterior segment portal pedicle,
taking care of preserving V5 and V8. After the confluence of MHV and IVC is
completely exposed, V8-IVC anastomosis is performed at first, and V5-IVC
anastomosis is made by interposed a 34cm venous graft. If the surgical space
is too small, we dissected left hepatic duct and hilar plate prior to venous
reconstruction. Finally, we take out the graft after dissection of left hepatic
duct, artery, portal vein, and both middle and left hepatic vein.
Results. We have performed this procedure for living-related donor
operationI@in three cases without any complications.
Conclusions. Left extended hepatectomy accompanied by V5, V8 recon-
struction is a feasible procedure for a safe living-related donor operation to
preserve functional liver volume as much as possible.
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HEPATOPULMONARY SYNDROME ASSOCIATED WITH EX-
TRAHEPATIC PORTOSYSTEMIC SHUNT IMPROVES AFTER
RADIOLOGICAL CLOSURE
Zachariah, Uday1; Shyamkumar, NK2; Surendra Babu, SRN2; Moses,
Vinu2; Eapen, C E1; Kurian, George1; Sitaram, V3
1Christian Medical College, GI Sciences, Vellore, India; 2Christian Medical
College, Radiodiagnosis, Vellore, India; 3Christian Medical College, Hepa-
topancreatobiliary Surgery, Vellore, India
Background. Hepatopulmonary syndrome (HPS) secondary to extrahepatic
portosystemic shunt (EPS) is rare. Congenital EPS can be Type I or Type II
depending on the absence or presence of a patent portal vein (PV). Of only 2
reported cases of EPS with HPS, both below 5 years of age, one had surgical
shunt ligation. We report a case of HPS associated with a mesocaval shunt in
an adult male, with significant improvement after radiological intervention.
Case report. A 41 year old male was evaluated for progressive exertional
dysnoea and cyanosis over 5 years. He had a normal chest radiograph,
echocardiogram, CT thorax and pulmonary angiogram with blood gases
demonstrating orthodeoxia and contrast echo suggesting an extra cardiac
shunt. CT abdomen revealed a small, symmetric liver, small caliber PV
(6mm) and the superior mesenteric vein draining into infrarenal inferior vena
cava via a large collateral vein. He had normal liver function. A diagnosis of
HPS possibly secondary to EPS was made. Treatment options considered
were liver transplantation, surgical ligation and radiological shunt closure.
Following temporary balloon occlusion of the shunt, radiological coil
embolization was planned at a later date. Meanwhile, he noticed marked
improvement in his effort tolerance. Doppler and CT abdomen revealed
shunt thrombosis with increase in PV caliber (12.6mm). Follow up at 2
months confirmed improvement in his oxygenation.
Discussion. EPS must be considered in any patient presenting with HPS
without hepatic dysfunction. Portal venous blood may contain gut derived
pro-angiogenic factors that are modified by hepatic anti-angiogenic factors.
Any extrahepatic shunt may therefore contribute to pulmonary arteriolar
proliferation and HPS. We believe spontaneous shunt thrombosis was
precipitated by endothelial injury during balloon occlusion.
Conclusion. In this case of Type II EPS, shunt closure after radiological
intervention resulted in improvement of HPS.
PP 44.02
HEPATOPANCREATIC TUBERCULOSIS MASQUERADING MA-
LIGNANCY
Varma, Vibha1; Gandhi, Vidhyachandra2; Nagari, Bheerappa3; Regulagadda,
Adikesava Sastry4
1Nizam’s Institute of Medical Sciences, Department of Surgical Gastro-
enterology, Panjagutta, Hyderbad, India; 2Nizam’s Institute of Medical
Sciences, Department of Surgical Gastroenterology, Hyderbad, India;
3Nizam’s Institute of Medical Sciences, Department of Surgical Gastro-
enterlogy, Hyderabad, India; 4Nizam’s Institute of Medical Sciences,
Department of Surgical Gastroenterology, Hyderabad, India
Background. Hepatopancreatic tuberculosis, a curable disease can have
protean manifestations. It may mimic malignancy on clinical and radiological
grounds.
Objective. We present our experience of this rare entity in five patients.
Methods. Between June 2000 -2007, we treated three patients of hepatic
tuberculosis and two of pancreatic tuberculosis. Their demographic details,
clinical presentation and management were studied.
Results. Four patients were males and one female with age range of 1658
years. Presentation of hepatic tuberculosis was in the form of obstructive
jaundice in two patients and hepatomegaly with an abdominal lump in the
other. Imaging revealed dilated intra and extrahepatic biliary system with a
mass lesion in bile duct (1), periampullary lesion (1) and a space-occupying
lesion (SOL) in the liver (1). All were explored for suspected malignancy.
Bilobar SOL’s in liver with pericholedochal lymphadenopathy (1), with
periampullary lesion (1) and large SOL in right lobe with omental nodules &
abdominal lymphadenopathy (1) was found at laparotomy. Whipple’s with
metastatectomy was performed for periampullary carcinoid, other two had
biopsy from liver and omental nodules. Histology confirmed tuberculosis.
Periampullary carcinoid had associated hepatic tuberculosis. Presentation of
pancreatic tuberculosis was with obstructive jaundice and pancreatic head
mass in both. One patient had para-aortic lymphadenopathy and image
guided cytology from head mass confirmed the diagnosis. Second patient
underwent Whipple’s procedure for suspected head malignancy. Histology
confirmed tuberculosis. All four responded dramatically to antituberculous
chemotherapeutic regimen.
Conclusion. Hepatopancreatic tuberculosis, a rare and curable entity should
be thought of as a differential diagnosis in mass lesion of liver and pancreas,
in endemic areas. Laparotomy may be required to confirm the diagnosis,
although targeted fine needle aspiration cytology may avoid laparotomy in
some.
PP 44.03
LEIOMYOSARCOMA OF THE INFERIOR VENA CAVA (IVC): THE
EXTENDED ROLE OF THE HPB SURGEON
Sitaram, Venkatramani1; Joseph, Philip2; Vyas, Frederick2; Sanghi, Ravish2;
Cherian, Verghese3; Eapen, Anu4; Thomas, Susanna5; Samuel, Rekha5
1Christian Medical College Hospital, Department of General Surgery, Ida
Scudder Road, Vellore, India; 2Christian Medical College Hospital, Depart-
ment of General Surgery, Vellore, India; 3Christian Medical College
Hospital, Department of Anaesthesia, Vellore, India; 4Christian Medical
College Hospital, Department of Radiodiagnosis, Vellore, India; 5Christian
Medical College Hospital, Department of Pathology, Vellore, India
Background. Leiomyosarcoma of the IVC is a rare malignant tumor.
Though rare it is still the most common tumor of the IVC. The experience
worldwide is limited. The HPB surgeon is ideally suited to manage these
patients.
Objective. To share our experience of 8 patients with leiomyosarcoma of the
IVC during the period 200307.
Methods. The case records of 8 patients with leiomyosarcoma of the IVC
seen in our unit from January 2003 to date were analyzed.
Results. Eight patients (6 females and 2 males) were diagnosed to have IVC
leiomyosarcoma. Their mean age was 48.4 years (range 3858). The
commonest symptom was right upper abdominal pain (6); two patients had
back pain. The duration of symptoms ranged from 176 months (mean 19.6
months, median 6 months). An abdominal mass was palpable in 4 of them.
None of the patients had symptoms or signs of IVC obstruction. Seven
patients were diagnosed by computed tomography and one by magnetic
resonance imaging. One patient with type III IVC tumor refused treatment.
Complete excision of the tumor was done in 7 patients with type II IVC tumor.
A prosthetic graft was used in 5 patients to reconstruct the excised IVC. Of
these, one patient underwent autotransplantation of the liver. One patient had
local excision and primary closure of the IVC and another had patch closure of
the IVC defect. Five patients needed renal vein reconstruction. Postoperative
complications include transient renal failure (5), graft thrombosis (1),
systemic inflammatory response syndrome (3), ventilator associated pneu-
monia (1), fungal septicemia (1). There was one perioperative death. Two
patients are lost to follow-up. One patient died during follow-up.
Conclusion. Although these tumors appear formidable at the time of
presentation, an attempt at complete excision should be made. Radical
excision still remains the major therapeutic option in the treatment of
leiomyosarcoma of the IVC.
PP 44.05
LIVER LESIONS IN A GENERAL HOPSITAL: AN AUDIT
Patil, Bhushan; Bhange, Snehal; Adhikari, Devbrata; Singh, Rajinder; Shetty,
Tilakdas; Joshi, Rajeev
T.N. Medical College & B.Y.L. Nair Ch. Hospital, General Surgery,
Mumbai, India
Background. Liver lesions often pose a diagnostic and therapeutic dilemma.
Some rare lesions of the liver mimic common clinical conditions, adding to
the confusion.
Objective. To profile liver lesions, to diagnose them accurately after a proper
clinico-radiologico-pathological co-relation, to assess the lesions amenable to
surgical intervention and to formulate a diagnostic and therapeutic algorithm.
Methods. 604 patients were analysed from February 1999 to July 2007.
Diagnosis was based on clinical assessment, USG, CT scan, biochemical
investigations, FNAC and MRI in select cases. The lesions were classified as
solid and cystic. Of the 324 cystic lesions seen, 248 were amoebic liver
abscesses, 34 parasitic cysts, 27 pyogenic abscesses, 7 simple hepatic cysts, 5
hepaticolithiasis, 2 polycystic liver disease and one each of biliary cystade-
noma, embryonal sarcoma and cystic cholangiocarcinoma. Of the 228 solid
lesions, 116 were metastases, 68 were HCC, 34 hemangiomas, 6 focal
nodular hyperplasia and 4 hepatic adenomas.
Results. A few uncommon liver pathologies masquerading as some common
clinical entities led to confusion. Majority of the cystic lesions of the liver were
amoebic or pyogenic abscesses. 4 patients with amoebic abscesses and 1 with
pyogenic abscesses required exploration. 24 patients of hydatid cysts, 1 with
simple cyst and 1 with biliary cystadenoma were subjected to surgery. All 5
patients of hepaticolithiasis underwent hepatic resection. Only six of the
HCC patients could be resected while 10 underwent chemo-embolisation.
One case of hemangioma underwent liver resection in view of rapid increase
in size. All the remaining cases were managed conservatively.
Conclusion. Amoebic abscesses are common among the lower socio-
economic strata and pyogenic abscesses are showing an increasing incidence,
related to the increasing incidence of HIV. Majority of the HCC cases present
late in the course of the disease and hence are not amenable to surgery.
PP 44.07
SPONTANEOUS HAEMORRHAGE OF THE LIVER; A MANAGE-
MENT ALGORITHM
Silva, Michael A1; Mehat, Manjit2; Pissanou, Theodora2; Coldham, Chris-
topher2; Mayer, David2; Bramhall, Simon R2; Buckels, John A C2; Mirza,
Darius F2
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1University Hospital Birmingham NHS Trust-Queen Elizabeth, The Liver
Unit, Edgbaston, Birmingham, United Kingdom; 2University Hospital
Birmingham NHS Trust-Queen Elizabeth, The Liver Unit, Birmingham,
United Kingdom
Background. Spontaneous liver bleeds (SLB) are relatively uncommon. We
review the management of SLB referred to a single centre in the UK.
Methods. Review of a prospectively recorded database, between 1995 and
April 2007. The majority of patients were stabilised with transfusions and
optimization of clotting at the referral centre. Those requiring transfer were
then managed at our centre.
Results. 52 patients (37 female), median age 47(2184) years. Bleeding into
a liver adenoma (n15), focal nodular hyperplasia (n4), hepatoma (n
11), simple cyst (n1), HELLP syndrome of pregnancy (n3) were
underlying causes for 34 (65%). In 18 (35%) patients no aetiology was
found. 37 (71%) presented with abdominal pain, 5 (10%) in haemodynamic
collapse. Sixteen (31%) had intraperitoneal bleeds, the remainder subcap-
sular haematomas. 6 were explored at the local hospital with two procedures
attended by one of our surgeons. Three of these required packing. 43 (83%)
were transferred to our centre in the acute phase or following MDT review.
Two were operated acutely for rupture following pregnancy which was
packed the other a ruptured hepatoma requiring liver resection. Both died
along with another patient with HELLP syndrome. 16 underwent re-imaging
at our centre. 5 required angiography and embolization for continued
bleeding at our centre. 44 (85%) were managed non operatively following
the acute bleed. 21 (40%) underwent surgery for underlying lesions6
weeks later. 6 patients with hepatoma died during follow up. Aetiology and
intraperitoneal bleeding was not correlated to requirement for interventional
radiology or surgery (P0.05;NS) Conclusion: Resuscitation and correction
of clotting deficit is paramount with cross-sectional imaging and liaising with
a HPB centre. Majority can be managed non operatively in the acute phase
followed by further imaging, with interval resections where indicated.
Surgery in the acute phase has a high mortality. In a significant proportion
(35%), cause for the bleed remains elusive.
PP 44.09
OUR RESULTS IN BILIARY ATRESIA-A REALISTIC ASSESS-
MENT
Kannaiyan, Lavanya; Sen, Sudipta; Chacko, Jacob; Thomas, Gordon; Karl,
Sampath; Kumar, Jyothish
Christian Medical College and Hospital, Paediatric Surgery, Vellore, India
Background. Results of Biliary Atresia leave much to be desired. Outcome
depends on how early the patients are operated. We present our results.
Aim. To study the outcome of Kasai’s Procedure in patients with Biliary
Atresia.
Materials and Methods. Retrospective Study of the patients with Biliary
Atresia who underwent Kasai’s Procedure at CMC, Vellore.
Results. A total of 44 patients underwent Kasai’s Procedure from 1995
2005. The average age of presentation was 74 days. 17 females and 27
males.13 patients had liver cell failure at the time of presentation. 4 patients
had Biliary Splenic Malformation Syndrome. The mean age of surgery was at
87 days. 13 patients underwent surgery beyond 100 days of age. The average
follow up was 180 days. 9 patients are lost to follow up. 20 patients had follow
of at least 3 months (ranging from 3 months to 5 years). Of the patients with
adequate follow up, 3 patients have expired, 3 patients with worsening liver
failure refused further treatment. 8 pts have serum bilirubin less than 2 mg%.
(40% have successful outcome).
Conclusion. The results appear to correlate to reported success of Kasai’s.
And with Liver transplant being increasingly available for children, Kasai’s
can act a bridge till the pt is old enough to under go liver transplantation,
PP 44.10
UNUSUAL CAUSES OF EXTRAHEPATIC BILIARY OBSTRUC-
TION IN CHILDREN- A SINGLE CENTER EXPERIENCE
Ravula, Phani Krishna1; Lal, Richa2; Sikora, Sadiq S2; Yacha, Surender K3;
Pal, Lily4
1Sanjay gandhi post graduate institute of medical sciences, Surgical gastro-
enterology, Lucknow, India; 2Sanjay gandhi postgraduate institute of medical
sciences, Surgical gastroenterology, Lucknow, India; 3Pediatric gastroenter-
ology; 4Pathology
Background. While biliary atresia and choledochal cyst are the two most
common causes of surgical obstructive jaundice in children, other rare causes
of biliary obstruction are infrequently reported in literature.
Aim. This paper highlights the etiology, diagnosis, management and
outcome in 9’rare’ cases of extrahepatic biliary obstruction in children.
Methods. Retrospective review of medical records of patients managed
between March 2000 and March 2007 at the reporting centre.
Results. Extrahepatic biliary atresia and choledochal cyst constituted 93%
(127/136) of all pediatric surgical biliary disorders However, 9 children (aged
1.515 years) presented with uncommon causes of biliary obstruction. These
were: i) idiopathic benign non-traumatic inflammatory stricture (n3), ii)
idiopathic fibrosing chronic pancreatitis (n2), iii) post cholecystectomy
type benign biliary stricture (n1), iv) post acute pancreatitis pseudo cyst of
pancreas (n1), v) non-Hodgkin’s lymphoma (NHL) with extramural
common bile duct compression and gall bladder perforation (n1) and vi)
Langerhan cell histiocytosis (LCH, n1). The clinical features and the
diagnostic work up of each group are discussed. A preoperative endoscopic/
percutaneous biliary drainage was required in 4 children because of
cholangitis at presentation. A biliary-enteric anastomosis was performed for
all 7 children in groups (i) to (iv). The patients with NHL and LCH were
referred for chemotherapy after establishing tissue diagnosis at laparotomy.
With a follow up period of 3 months-7 years, 7 children (with the exception
of patients with NHL and LCH) are currently anicteric.
Conclusion. This paper draws attention to some infrequently discussed
causes of extrahepatic biliary obstruction in children. The management
entails a carefully planned combination of endoscopic interventions, inter-
ventional radiology and surgery. The outcome in benign cases is usually
satisfactory.
PP 45.01
RUPTURED HEPATOCELLULAR CARCINOMA: AGGRESSIVE
MANAGEMENT FOR INITIAL SURVIVORS
Leung, Kam Fung; Cheung, Chin Cheung; Lau, Kwok Wai
Tuen Mun Hospital, Hepatobiliary Surgery, Tuen Mun, Hong Kong
Background. Ruptured hepatocellular carcinoma (HCC) is a life-threaten-
ing disease associated with high mortality of 50%. It has been labeled as
terminal event with malignant dissemination. AIM We want to study whether
the recent advance in interventional radiology and liver resection can befit the
patients who survive after the incident of rupture.
Method. We retrieve the patients with spontaneous rupture of HCC from
hospital database in the past 4 years and study the survival outcome after
intervention. We exclude those with in-hospital mortality because of terminal
malignancy and decompensated liver function.
Results. There were 11 patients (9 men and 2 women; average age 51, range
39 76) who responded well to transcatheter arterial embolization (TAE) and
they were worked up for subsequent management. 6 patients were deemed
inoperable and they received a series of transcatheter arterial chemoembo-
lization with average overall survival of 7 months (range 38 months). 5
patients underwent operation (3 resection, 2 open radiofrequency ablation)
with average survival of 32 months (range 12 48 months; 2 still alive in 32
and 36 months). DISCUSSION We show that patients who recovered from
rupture of HCC could be benefited by aggressive treatment. One half had
survival benefit of about 7 months with TAE alone while the other half had
much better survival of about 32 months by surgical resection or ablation.
Conclusion. It is worthwhile to workup for aggressive radiological or surgical
intervention for patients who recover from the rupture of HCC.
PP 45.02
A CASE OF HEPATOCELLULAR CARCINOMA WITH REPEATED
BILE DUCT METASTASIS.
Takahashi, Yutaka; Yamamoto, Masakazu; Katagiri, Satoshi; Kotera, Yoshi-
hito; Ariizumi, Shun-ichi; Okano, Yusuke
Tokyo WomenIfs Medical University, Dept. of Surgery, The Institute of
Gastroenterolog, Tokyo, Japan
The patient is a 73-year-old man with hepatocellular carcinoma (HCC). He
underwent transarterial chemoembolizationIiTACEIjfor HCC twice. He
presented with tarry stool and upper abdominal pain. Total bilirubin was
5.0mg/dl. Upon admission, he underwent endoscopic retrograde biliary
drainage (ERBD). During the ERBD a hemorrhage and an impacted tumor
thrombus were seen macroscopically on endoscopy. Ultrasonography and CT
scan revealed a tumor about 25 mm in diameter in segment 8. Cholangio-
graphy did not show the bile duct of the anterior segment of the liver, and
showed a filling defect in the common bile duct. Angiography showed tumor
stains in segment 8 and 4. We diagnosed of HCC with bile duct tumor
thrombus and we performed central bisegmentectomy of the liver in
December 2004. The result of pathology revealed moderately differrentiated
HCC (vp1, vv0, b3, fc(), fc inf()). After surgery in August 2005, he had
jaundice and fever. He admitted to our emergency department due to acute
cholangitis and obstructive jaundice. Cholangiography showed a filling defect
in the common bile duct. Based on a diagnosis of recurrence of HCC into the
bile duct, we performed endoscopic retrograde cholangiography (ERC). The
tumor was removed by endoscopic balloon catheter. After discharge, the
tumor thrombus recurred 3 times and was removed repeatedly by endoscopy
in the same way. We suspected that the tumor thrombus was growing out of
the choledochal mucosa of the anterior bile duct stump, and the performed
radiation therapy (total 50 Gry). After radiation therapy, the tumor maker
AFP decreased and the tumor thrombus disappeared in June 2006.
PP 45.04
HEPATOCELLULAR CARCINOMA AND COMPENSATED CIR-
RHOSIS: RESECTION AS A SELECTION TOOL FOR LIVER
TRANSPLANTATION
Scatton, Olivier1; Zalinski, Ste´phane1; Terris, Benoit2; Lefevre, Jeremie1;
Cassali, Alessandra1; Massault, Pierre-Philippe1; Conti, Filomena1; Calmus,
Yvon1; Soubrane, Olivier1
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1Hoˆpital Cochin, hepato biliary surgery and liver transplantation, Paris,
France; 2Hoˆpital Cochin, pathology, Paris, France
Objective. To evaluate histological profile obtained from primary resection
of hepatocellular carcinoma as a selection tool for LT.
Background. Experience of resection prior to LT has been reported with
conflicting results. Interestingly, histological data of the primary tumor and
its recurrence have never been compared.
Methods. Between 1987 and 2006, 20 patients underwent a resection prior
to LT. Feasibility, morbidity and mortality of LT following primary resection
were analysed. Long term survival of these 20 patients was compared to the
survival of 73 patients who underwent primary LT. Histological features of
the resected specimen were compared to those of the recurrences.
Results. mortality and morbidity of LT following resection were 10% and
55%. Mean operation time was 892 hours. After a mean follow up of 3.89
4.4 years and 2.794.5 years from resection and LT respectively, 6 patients
died; 4 from recurrence, 1 from severe cholangitis and 1 from HCV
recurrence. Mean -1, -3, -5, -10 years overall survival rates in patients
treated with transplantation and resection prior transplantation were 71%,
61%, 55%, 45% and 74%, 66%, 66%, 40%, respectively (ns). Fourteen
patients had a recurrence at the time of LT. For two patients histological
study of the recurrent tumors was not possible due to complete necrosis of
the lesion. For 9 patients (75%), histological features of the recurrent tumor
were exactly similar to those of the initial nodule. Four patients experienced
recurrence following LT, in each case primary and recurrent nodules shared
the same histological markers of poor prognosis.
Conclusion. Primary resection before LT seems feasible and has no
deleterious consequence in term of morbidity, mortality and survival of LT.
In addition, we showed for the first time that the primary resected tumor and
its recurrence share the same histological profile in most of the cases. The
histological features obtained from the primary resected specimen may be
used as a selection tool for LT.
PP 45.05
HEPATOCELLULAR CARCINOMA ARISING FROM AUTOIM-
MUNE HEPATITIS
Abe, Akihito; Kubota, Keiichi
Dokkyo University Hospital, Department of Gastroenterological Surgery,
Tochigi, Japan
Autoimmune hepatitis (AIH) is a disorder of unknown etiology, which often
progresses to cirrhosis and carries a high mortality, even though its treatment
with corticosteroids has become common. Hepatocellular carcinoma (HCC)
has been reported as a rare complication of AIH. We describe an operative
case of a 70-year-old woman with HCC associated with AIH during a 15-year
follow-up. She took steroid therapy (predonin 5mg/day) after AIH diagnosis.
In 2006, Alpha-1-fetoprotein (AFP) was elevated and abdominal CT, US,
Angiogram revealed a 3.5cm in diameter lesion in the S7. We diagnosed as a
primary HCC in an AIH. We performed subsegmentectomy of the S7.
Histological examination showed that tumor was a moderately differentiated
HCC and liver tissue was an AIH. Post operative couse was an eventful and
she was doing well without any reccurence. Patients with AIH were not
recognized to be a high-risk group for developing HCC because HCC
occasionally occurred even in patients with long-standing cirrhosis in the
absence of hepatitis B virus and hepatitis C virus infection.
PP 45.06
FATE OF REMAINED FLOATING BILE DUCT TUMOR DEBRIS
AFTER CURATIVE RESECTION IN HEPATOCELLULAR CARCI-
NOMA WITH BILE DUCT TUMOR THROMBOSIS
Yun, Sung Su1; Lee, Dong Shick2; Kim, Hong Jin2
1Yeungnam University Hospital, Department of Surgery, 3171 Daemyung
Dong, Nam-Gu, Taegu, Korea, Republic of; 2Yeungnam University Hospital,
Department of Surgery, Taegu, Korea, Republic of
Background./AIMS: Eventhough common causes of jaundice in patients
with hepatocellular carcinoma(HCC) are underlying liver cirrhosis and/or
extensive parenchymal destruction, occasionally, jaundice can be caused by
bile duct tumor thrombi. We can have good outcome after curative
hepatectomy with extrahepatic bile duct resection if the disease is still
localized. But we do not know the fate of remained floating tumor debris after
curative resection, whether it is viable or not. We reviewed our treatment
experience of floating bile duct tumor debris in patients with HCC with bile
duct tumor thrombosis to clarify the viability of floating tumor debris.
Methods. We experienced 17 cases of HCC with bile duct tumor thrombi for
recent two decades. Among them, we had 8 patients with floating bile duct
tumor debris remote from main bile duct tumor thrombus. We performed
curative hepatectomy with extrahepatic bile duct resection in these 5 patients
and reviewed recurrence pattern.
Results. Two patient are alive until now and 2 patients had recurrence in
their liver those were not different from usual recurrence pattern of HCC.
One patient had recurrence in remnant intrapancreatic bile duct. The patient
was 46 years old female who had 9 cm HCC in the left lobe of liver with
tumor thrombus extended to main confluence of hepatic duct. We did left
lobectomy and extrahepatic bile duct resection and Roux-en-Y hepaticoje-
junostomy. Careful review revealed that, at the time of surgery, we did not
remove all of the floating bile duct tumor debris in remnant intrapancreatic
bile duct. Two year later, we found recurrence in remnant intrapancreatic bile
duct and consequently the patient was dead due to multiple tumor recurrence
29 months after operation.
Conclusion. We think that floating bile duct tumor debris is viable and can
be source of recurrence, unless we remove it completely.
PP 45.07
SIGNIFICANCE OF SURGICAL TREATMENT FOR PATIENTS
WITH HEPATOCELLULAR CARCINOMA EXCEEDING MILAN
CRITERI
Amano, Hironobu1; Itamoto, Toshiyuki2; Oshita, Akihiko2; Tanimoto,
Yoshisato2; Ushitora, Yuichirou2; Ohdan, Hideki2; Tashiro, Hirotaka2;
Asahara, Toshimasa3
1Hiroshima University Hospital, Surgery, Hiroshiam, Japan; 2Hiroshima
University Hospital, Surgery, Hiroshima, Japan; 3Hiroshima University
Hospital, Surgery, Japan
Background. The appropriate treatment strategy for patients with hepato-
cellular carcinoma (HCC) exceeding Milan criteria (MC) is not unclear. The
aim of this study is to clarify the significance of the surgical treatment for
those patients.
Methods. From January 1990 to December 2006, 134 patients with HCC
diagnosed as exceeding MC underwent curative surgical treatment. Survival
rates and prognostic factors were analyzed retrospectively.
Results. The overall 5-year and disease-free survival rates of the patients with
platelet counts of more than 100.000 /mm,R(n100) were 65% and 38%,
whereas those with platelet counts of less than 100.000 /mm,R(n34), were
26% and 6%, respectively. These results suggest that platelet counts can be
significant prognostic factor for better overall and disease-free survival.
Moreover, among patients with platelet counts of more than 100.000/
mm,R, 57% (57 of 100 cases) of the case revealed recurrence with median
interval of 15.7 months (range 1144), although in 25% (19 of 57 cases) of
the cases, recurrent pattern showed within MC, indicating those patients can
be rescued by following liver transplantation.
Conclusions. Among HCC patients diagnosed exceeding MC, platelet
count of more than 100.000 /mm,R can be good prognostic factor after
operation both in overall and disease-free survival. In these patients
hepatectomy may contribute to suboptimal patient selection for liver
transplantation.
PP 45.08
CLINICOPATHOLOGICAL CHARACTERISTICS OF HEPATO-
CELLULAR CARCINOMA WITH BILE DUCT INFILTRATION
Ikenaga, Naoki; Chijiiwa, Kazuo; Otani, Kazuhiro; Uchiyama, Shuichirou;
Kondo, Kazuhiro
Miyazaki University, Surgery Oncology and Regulation of Organ Function,
Miyazaki, Japan
Introduction. Although vascular invasion in hepatocellular carcinoma
(HCC) has been well documented, characteristics of HCC involving bile
duct are not clear.
Objective. To reveal clinicopathological characteristics of HCC with bile
duct infiltration.
Methods. From 1990 to 2006, 271 patients with HCC were surgically
treated at our institute. Macroscopic or microscopic bile duct infiltration was
found in 15 cases (5.5%). We compared these 15 cases (b group) with the
other 256 without bile duct infiltration (b- group).
Results. In the b group, 27% of patients showed obstructive jaundice and
dilated intrahepatic bile duct was detected in 47%. The levels of serum
bilirubin (2.39 mg/dl vs. 0.78 mg/dl, pB0.0001) and serum alkaline
phosphatasehigher (478 IU/l vs. 291 IU/l, p0.001) were significantly
higher in the b group than those in the b- group. With respect to the
macroscopic type, confluent multinodular type (40% vs. 12%) and infiltrative
type (20% vs. 5%) were predominant in the b group (p0.002).
Microscopically, infiltration of tumor capsule was found in all cases of b
group (100% vs. 73% in b- group, p0.0399). The portal vein infiltration
was significantly associated in the b group (86% vs. 44%, pB0.004);
however, the frequency of hepatic vein invasion was similar (p0.0956). The
median survival after surgery was significantly shorter in the b group than
b- group (11.4 months vs. 56.1 months, p0.0022) and the main recurrence
site was the remnant liver.
Conclusion. HCC with bile duct infiltration has its own characteristics
resulting in the poor outcome.
PP 45.09
LIVER TRANSPLANTATION VS RESECTION FOR PATIENTS
WITH HCC WITHIN MILAN CRITERIA.
Luigi, Lupo1; Carbotta, Giuseppe2; Panzera, Piercarmine2; Memeo, Ric-
cardo3; Tandoi, Francesco2; Tedeschi, Michele2; Vittore, Francesco2; De
Blasi, Vito2; Memeo, Vincenzo3
1Policlinico Universitario, Emergency and organ translantation, Bari, Italy;
2Policlinico, Emergency and Organ transplant, Bari, Italy; 3Policlinico,
Emergency and organ transplantation, Bari, Italy
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Background. Debate is going on the optimal strategy of the management of
HCC balancing resources and results. Resection allows only short term good
results but it’s followed by recurrence. Liver transplantation allows long term
result but is limited by shortage of organ. Aim To compare results of Liver
resection (Res) and liver transplantation (LTx) in a cohort of patients with
HCC within Milan criteria in a single centre.
Patients and Methods. Between 2001 and 2007 58 patients ( Age median
54, range:48  64, M 53, F 59 with HCC within the Milan Criteria ( Mc),
underwent LTx (29) or Res ( 29). The two groups had similar distribution by
cancer stage, [n81 (13) vs 3 ( 15)] and size [2.8 (24.5) vs 2.8 ( 25)] and
liver disease etiology ( HBV: HCV: ALD: 10:16:3 vs 9:18:2), but at different
stage ( C-P: A:B:C: 3, 15,11 vs 12,13,4; pB0.001).Data were compared with
parametric and non parametric tests; Survival and DFS were analyzed by life
tables and log rank test. Results Two deaths occurred only in the LTx group.
The overall survival (OS) at the 1st, 3rd and 5th year after LTx and Res was
respectively: 80%, 72.2% and 72.2% and 88.9%, 72.7% and 57%. The
disease free survival (DFS) in the LTx group at the 1st year was 92% and
remains stable for the following four years and was statistically longer than in
the Res ( 88.9% at the 1st year, 72.7% at the 3rd y and 57% at the 5th y (PB
0.01) Transplanted patients seem to have better 5 year survival rate even if it
was not statistically validated because of the shortage of the cohort of
patients. Conclusion Liver transplantation offers better results than Liver
resection in the treatment of HCC within Milan criteria. Considering good
results of liver resection in the short term, and according to Markow analysis
of Majno and Sarasin, liver resection may be offered as first option and liver
transplantation as rescue therapy.
PP 45.10
Preoperative TACE and PVE plus RFA extend limits of surgical
management of large HCC on cirrhosis
Lupo, Luigi; Panzera, Piercarmine; Carbotta, Giuseppe; Tedeschi, Michele;
De Blasi, Vito; Vittore, Francesco; Bizzoca, Cinzia; Memeo, Vincenzo
Policlinico universitario, Emergency and organ transplantation, Bari, Italy
Background. Liver Resection (Res)and transplantation (LTx) currently
offer the optimal therapy for HCC but are limited by the extension of cancer
and/or the poor liver function. Aim A prospective study was undertaken to
evaluate the impact of arterial chemioembolization (TACE), portal vein
embolization plus radio frequency ablation (PVERFA) before surgery, on
improving suitability for surgical treatment of large HCC on cirrhosis.
Patients and Methods. From Sept 2002 to June 2007 14 patients (Age
median 62 range 52 78; with HCC (n8 median 1, range 14; median
diameter 7cm, range 312)) on cirrhosis (HBV 5, HCV 8, ALD 1; CP: A8,
B6) underwent sequential TACE and PVERFA 46 weeks later. fp
determination. Results AfteraPatients were followed up by US and CT
scan and TACE and PVERFA no deaths but 3 abscesses occurred. Eight
patients underwent Res after controlateral hypertrophy and 1 LTx at an
internal of 28 months. Three patients did not require further treatment and
survived without evidence of cancer 30, 38 and 46 months, but 2 experienced
rapidly progression of cancer disease and died. Histology of surgical speci-
mens revealed residual cancer or new lesions on 6/9. During follow up 4
patients died in the Res group from liver failure (2) and cancer (2) at an
interval ] 3 years. Conclusion This limited experience shows that combined
TACE, PVERFA allow surgical treatment of advanced HCC with
improved outcome.
PP 46.01
LAPAROSCOPIC MANAGEMENT OF SYMPTOMATIC CONGE-
NITAL LIVER CYSTS
Daskalakis, Kritolaos1; Daskalaki, Despoina2; Paraskakis, Stefanos2; Anasta-
siou, Anastasios2
1General Hospital of Rethymno, Surgery Clinic, Rethymno, Greece; 2
Background. Laparoscopic management is the gold standard for treating
selected symptomatic congenital liver cysts ( CLC). In contrast, the
laparoscopic approach is not indicated for patients suffering from adult
polycystic liver disease (APLD) except for APLD type I with large multiple
cysts of the liver.
AIM. The aim of this study is to evaluate the advandages using laparoscopic
approach in the management of symptomatic congenital hepatic cysts.
MATERIAL: During the period 2004  2006, 5 patients with symptomatic
congenital hepatic cysts treated laparoscopically in our institution. There
were 3 patients with CLC and 2 ( brother and sister) with APLD type I. One
was male and 4 females, mean age 68,5 years ( range 56  86 years). The wide
fenestration technique by deroofing the cyst wall was applied in all patients.
Cholecystectomy was added in 4 patients, in 2 for gallstones and in 2 because
of proximity of the hepatic cyst with gallbladder. Drainage of the residual
cavity/ies was inserted in all patients.
Results. There were no intraoperative complications ( haemorrhage, bile
leakage, hepatic or biliary injury etc) and no conversions. Mortality was nil.
There were no postoperative complications. Mean hospital stay: 3,9 days.
Follow  up range from 4 to 31 months. Clinical observation, laboratory
investigations and abdominal ultrasound (every six months) confirmed the
absence of both the symptomatology and the relapse of the disease. The
histological results on the segments of the excised cystic wall, established the
diagnosis of CLC.
Conclusion. Laparoscopic approach can be considered as a safe and
efficacious method in the management of symptomatic CLC and APLD
type I.
PP 46.02
LAPAROSCOPIC TREATMENT OF BILE PERITONITIS FOL-
LOWING BLUNT HEPATIC TRAUMA
Pilgrim, Charles1; Usatoff, Val2; Evans, Peter2; Burton, Paul2
1The Alfred Hospital, Commercial Road, Melbourne, Australia; 2The Alfred
Hospital, Melbourne, Australia
Minimally invasive techniques have gained widespread acceptance and are
indeed standard of care for many hepatobiliary problems. Their application
in the trauma setting remains to be defined so clearly. Conservative
management of blunt hepatic trauma has become mainstream and is
successful in avoiding laparotomy in most cases. As a result however, biliary
tree injuries are not being recognised or repaired until later in the hospital
admission. Delayed presentation bile leak in this setting is well treated with
laparoscopic washout and drainage, and we present four cases successfully
managed in this manner. This technique sits along side endoscopic and
percutaneous drainage, but offers advantages over both, and should be
considered part of the armamentarium for surgeons dealing with hepatobili-
ary trauma.
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RADIOFREQUENCY ABLATION OF HEPATIC METASTASES:
OWN EXPERIENCE.
Shabunin, Alexey1; Bedin, Vladivir2; Tavobilov, Michael1; Lukin, Andrey1;
Grekov, Dmitryi1; Shikov, Dmitryi1
1Botkin, s Memorial Hospital, HPB-surgery, Moscow, Russian Federation;
2Botkin, s Memorial Hospital, Cief of HPB-surgery, Moscow, Russian
Federation
Background./AIMS: Radiofrequency ablation (RFA) has been shown to be
one of the promising new modalities to treat or to palliate metastatic liver
tumors.Method. OLOGY: We present a series of 19 patients, 5 females and
14 males with a age ranging from 43 to 78 years, treated since October 2006
to July 2007, the RFA has been used either by laparotomy (3 patients) or
percutaneously (16 patients) to treat 32 lesions. There were 15 patients with
metastases of colorectal cancer, 2 patients with metastasis of pancreastic
cancer and the other 2 had a breast cancer metastasis. The RFA was
performed after the primary tumor resection was done. Pre- and post-
treatment evaluation was performed with contrast-enhanced computed
tomography, ultrasonography (US) and fine-needle biopsy.
Results. The total number of lesions treated were 32 with a size range of 18
to 49 mm. Two patients had 4 and 5 lesions, accordingly. All lesions were
treated by 21 RFA procedures (from 12 to 28 min. long). Three patients had
a postablative complications such as fatigue, flabbiness, fever and hepatic
enzymes elevation. All complications were managed by intravenous infusion
therapy in three days period. None of the patients died. Long-term results
(up to 9 months) showed 0% morbidity rate and lowered level of contrast
intake in RFA underwent lesions.
Conclusion. RFA is an effective method to treat liver metastases. Survival is
improved and the rate of complications is low.
PP 46.04
GLYCINE PROTECTS LIVERS FROM REPERFUSION INJURY
DUE TO PNEUMOPERITONEUM
Al-Saeedi, Mohammed1; Nickkholgh, Arash1; Flechtenmacher, Christa2;
Zorn, Markus3; Liang, Rui1; Buechler, Markus W1; Gutt, Carsten N1;
Schemmer, Peter1
1Ruprecht-Karls University, Dept. of General Surgery, Heidelberg, Ger-
many; 2Ruprecht-Karls University, Dept. of Pathology, Heidelberg, Ger-
many; 3Ruprecht-Karls University, Central Laboratory, Heidelberg,
Germany
Background. Experimental pneumoperitoneum induces ischemia/reperfu-
sion injury (IRI) in liver most likely via activation of Kupffer cells. Glycine
has been shown to ameliorate reperfusion injury in various animal models.
Thus, this study was performed to assess the effects of glycine to liver tissue
after pneumoperitoneum.
Materials and Methods. Sprague-Dawley rats (200230 g) underwent CO2
pneumoperitoneum (12 mmHg) for 90 minutes. Some rats received i.v.
glycine (1.5 ml, 300 mM) 10 min before pneumoperitoneum. Controls were
given the same volume of Ringer’s solution. Subsequently, transaminases,
hepatic microcirculation, and latex beads phagocytosis to index both liver
injury and Kupffer cell activation were investigated. Analysis of variance
(ANOVA) followed by t test or ?2 (or Fisher’s exact) test were performed as
appropriate. Results are presented as mean9SEM.
Results. Glycine significantly decreased AST, ALT, and LDH at 1 hr after
desufflation from 145919 U/L, 5395 U/L, and 500958 U/L in controls to
9494 U/L, 4092 U/L, and 334927 U/L, respectively (pB0.05). In parallel,
glycine significantly blunted the permanent adherence of leukocytes to the
endothelium by up to 35% of controls (pB0.05). Furthermore, glycine
decreased the rate of phagocytosis significantly more than 50%.
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Conclusion. Glycine decreased IRI after CO2 pneumoperitoneum most
likely via inactivation of Kupffer cells and an improved hepatic microperfu-
sion.
PP 46.05
SECURE AND RAPID PROCEDURE ON IMPLANTATION OF
DENVER PERITONEOVENOUS SHUNT
Oida, Takatsugu1; Mimatsu, Kenji1; Kawasaki, Atsushi2; Aramaki, Osamu1;
Kuboi, Youichi1; Kanou, Hisao1; Miyake, Hiroshi3; Amano, Sadao4
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Social Insurance Yokohana Central Hospital, Surgery, Yokohama, Japan;
3Kasukabe Municipal Hospital, Surgery, Kasukabe, Japan; 4Nihon Univer-
sity School of Medicine, Surgery, Tokyo, Japan
Background./AIM. Ascites often contributes to patient morbidity and
discomfort. Peritoneovenous shunt is a suitable alternative treatment,
obviating both the problem of fluid intraperitoneal accumulation and
continuous loss of proteins. Denver peritoneovenous shunt is one of the
treatments for refractory ascites. The purpose of this study was to analyze our
technique of implant of Denver shunt.
Patients and Methods. Fourteen shunts (Denver-PAK, Denver Biomater-
ials Inc.) were implanted in 14 patients with hepatic failure-related ascites. All
the procedures were performed in the operating suite under general
anesthesia with the patients laying supine. In all patients the shunts were
percutaneously placed through the left subclavian vein under digital fluoro-
scopic guide. Ultrasound (US)-guided puncture of peritoneal cavity ipsilat-
eral to side of venous puncture (left side). The ascitic fluid is slowly drained in
order to avoid that a great amount of fluid reverses into the circulatory system
the shunt is operating. A subcutaneous pocket, lateral to the nipple line on
the costal border, is then made by cutaneous incision. The venous access is
obtained by percutaneous US-guided approach to left subclavian vein. The
introducer and the wire are removed, and the venous end of the Denver
shunt, which has been cut to the proper length, is passed through the sheath,
which is then stripped away. Once the vein and peritoneal cavity have been
accessed and the pump chamber pocket fashioned, the subcutaneous tunnels
are created.
Results. No complications directly related to the procedure occurred. The
shunt was successfully positioned in all patients in 44 min average time.
Conculusions. Denver peritoneovenous shunt is a useful in resolution of
refractory ascites, reducing symptoms, and allowing effective palliation. Left
subclavian approach is a relatively easy, rapid, and secure procedure on
implant of Denver shunt.
PP 46.06
SURGICAL CORRECTION OF PORTAL HYPERTENSION BY
METHOD OF HEPATIC TUNNELING IN COMBINATION WITH
ENDOSCOPIC LIGATION OF ESOPHAGEAL VARICOSE VEINS
Mugatarov, Ildar1; Zarivchatskiy, Mikhail2; Ishenin, Yuriy1; Mugatarov,
Ildar1; Kamenskikh, Ekaterina3; Smolentsev, Sergey1; Smetanin, Denis1
1Center of Hepatology, Medicosanitary Hospital N1, Perm, Russian Federa-
tion; 2Center of Hepatology, Medicosanitary Hospital N1, Academy of
Medicine named after Acad. E. Wagner, Perm, Russian Federation;
3Academy of Medicine named after Acad. E. Wagner, Perm, Russian
Federation
Introduction. Prophylaxis of varicose veins hemorrhage of cardioesophageal
zone in patients with cirrhosis promotes introduction of new methods of
portal hypertension correction.
Objective. Intrahepatic portosystem shunting by tunneling method accord-
ing to Ishenin was used from May 2005 up to July 2007 in 10 patients aged
43  62 suffering from cirrhosis with 24 times esophageal hemorrhage in
anamnesis. Among them there were 7 (70%) females and 3 (30%) males.
Triple tunneling of liver was fulfilled in 60% of cases, only double tunneling-
in 20%, single tunneling-in 20%.
Results. Intraoperative hemorrhage was equal to 150  2500 ml. Two
patients died: 1  from thrombohemorrhagic syndrome, 1  from hepatic
deficiency. Endoscopic ligation of esophageal varicose veins was fulfilled to 5
patients. Degree of varicose veins was equal to F3.
Results. Stenosis of portal vein from 1820 mm up to 912 mm in 7 patients
and up to 14 mm  in 1 patient was observed 13612 months after the
operation in sonography of liver. Blood flow in tunnels remains. Increase of
blood flow volume in portal vein from 287914 ml/min to 970911 ml/min
(normal blood flow is equal to 850 ml/min) was observed in duplex scanning.
Hepatic encephalopathy doesn’t increase, patients are able to work, no
relapses were fixed. Results of endoscopic picture are rated as good in 3
patients (form of veins F2), as excellent (form of veins F1-F0)  in 2 patients.
Conclusion. The methods permitted to decrease pressure in portal vein and
increase its volume blood flow, they decreased risk of hemorrhage relapses.
PP 46.07
CENTRAL HEPATECTOMY-AN ALTERNATIVE TO EXTENSIVE
LIVER RESECTIONS IN SELECTED CASES
Govil, Sanjay; Chepudira, Vikram Belliappa
Narayana Hrudayala Institute of Medical Sciences, Surgical Gastroentrology,
Bangalore, India
Introduction. Many tumors due to their central location will require
extensive resections. In few patients a central hepatectomy is a viable option
to get adequate clearance and save functioning liver parenchyma.
Methods. At our center two patients underwent central hepatectomies for
centrally located hepatocellular carcinomas. One patient had a background of
cirrhosis. In both cases hepatic veins were controlled extra-hepatically.
Intermittent inflow occlusion was used in one case. Transection of the liver
parenchyma was done using crushing technique with a hemostat clamp.
Resection of segments 4, 5 and 8 was carried out in both patients.
Results. The mean postoperative stay in hospital was ten days. The patient
with background cirrhosis required two units of blood transfusion. Both
patients had postoperative ascitis which resolved on conservative measures.
Both patients had resected margins which were free of tumor.
Conclusion. Central hepatectomies are a viable alternative to extensive liver
resections in selected patients. These resections help in preserving maximum
amount of functional liver tissue and prevent postoperative liver failure in
patients with background liver disease.
PP 46.08
MANAGEMENT OF EXCLUDED BILE DUCT LEAKAGE AFTER
HEPATIC RESECTION. REPORT OF FOUR CASES.
HONORE, Charles; VIBERT, Eric; AZOULAY, Daniel; ADAM, Rene´;
CASTAING, Denis
Paul Brousse Hospital, Centre Hepato Biliaire, 94804, France
Background. Post-operative bile leakage is a common complication after
hepatic surgery. Nagano and al. classified this situation in four different sub-
types. Leakage due to bile duct exclusion is the rarest and remains
problematic for two reasons: difficult diagnosis and unclear treatment. The
aim of this study was to report our management of this situation.
Methods. We reviewed 2254 hepatectomies performed between April 1992
and June 2007. Four presented an excluded bile duct fistula following a right
hepatectomy for patient 1 and 3, a right hepatectomy extended to segment 4
for patient 2 and a right hepatectomy extended to the segments 1, 5 and 8 for
patient 4.
Results. Symptoms were permanent bilious leak or recurring abdominal
bilious collection for which multiple percutaneous drainages were required. A
preoperative vascular embolization was tried in one but was only able to
decrease the drainage. Definitive treatment consisted in a resection of the
right half of segment 4, resection with a new bilio-digestive anastomosis for
patient 1, a removal of the incomplete remains of segment 6 for patient 2 and
the completion of segment 8 and 5 resection for patient 3. Patient 4 has not
been operated yet. Patient 3 evolved uneventfully. Patient 1 developed a
biliary fistula on the bilio-digestive anastomosis which eventually closed after
3 months of drainage. Patient 2’s initial evolution was initially satisfactory but
he later developed a main bile duct stenosis which required a percutaneous
trans-stenotic drain. Patient 4 is being prepared for surgery.
Conclusion. operative treatment of excluded segmental bile leakage is
efficient. In our experience, conservative treatment was deceptive because
incomplete.
PP 46.09
SYSTEMATIC EXTENDED RIGHT LATERAL SECTIONECT-
OMY: AN ALTERNATIVE TO RIGHT HEPATECTOMY
Donadon, Matteo; Marconi, Matteo; Botea, Florin; Palmisano, Angela; Del
Fabbro, Daniele; Procopio, Fabio; Montorsi, Marco; Torzilli, Guido
University of Milan, Istituto Clinico Humanitas IRCCS, Third Department
of General Surgery, Rozzano (MI), Italy
Background. A surgical approach based on ultrasound-guided hepatectomy
might minimize the need for major resection, whose rates of morbidity and
mortality are not negligible. Right hepatectomy (RH) is traditionally
performed in cases of vascular invasion of the right hepatic vein (RHV)
with multiple tumors in the right lateral section, and/or of the right lateral
portal branch (P67) with tumor in contact with right paramedian portal
branch (P58). We herein describe an alternative approach to RH consisting
in ultrasound-guided systematic extended right lateral hepatic sectionectomy
(SERLS).
Methods. Among 207 consecutive hepatectomies, 21 (10%) underwent
SERLS. Median age was 67 years (range 4879). There were 13 men and 8
women. Ten (48%) patients had HCC; 11 (52%) had colorectal liver
metastases. Median tumor number was 2 (range 115); median tumor size
was 4.5 cm (range 2.520). Ten (48%) patients had cirrhosis, 8 (38%) had
steatosis, and 3 (16%) had normal liver. Surgical strategy was based on
tumor-vessels relationship at intraoperative ultrasonography (IOUS) and on
findings at color-Doppler IOUS.
Results. In-hospital and 90-days mortality were nil. Major and minor
morbidity occurred in 3 (14%) and 2 (9.5%) patients respectively. No
patients were reoperated because of complications. Blood transfusions were
given to 2 (9.5%) patients. After a median follow-up of 21 months no local
recurrence was observed.
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Conclusions. IOUS guided SERLS is feasible, safe, and effective. It should
be applied whenever possible as alternative resection to RH to maximize liver
parenchymal sparing
PP 46.10
TWO-HUNDRED HEPATECTOMIES WITHOUT MAJOR MOR-
BIDITY: THE 50-7 RULE
Del Fabbro, Daniele; Marconi, Matteo; Donadon, Matteo; Botea, Florin;
Palmisano, Angela; Spinelli, Antonino; Montorsi, Marco; Torzilli, Guido
University of Milan, Istituto Clinico Humanitas IRCCS, Rozzano, Milan,
Italy, Third Department of General Surgery, Rozzano (MI), Italy
Objectives. Reoperation for major morbidity, and bile leakage are two
factors which still impair results of liver surgery. To limit their occurrence, we
adopt a well established policy comprehensive of careful intraoperative
control of the liver cut surface, and of the long-term drain maintenance.
The aim of this study was to validate this policy on a large series of
consecutive patients.
Materials and Methods. A prospective cohort study enrolling 200
consecutive patients with liver tumors has been carried out. All patients
underwent liver resection. Wound closure was never started prior to 50
minutes since resection was ended, and abdominal drains were always
positioned and maintained for at least 7 postoperative days (pod). Intrao-
perative cholangiography was never carried out. The bilirubin concentration
in serum and drain discharge was sampled on the 3rd, 5th and 7th pod.
Results. Peroperative mortality was 0.5%, and no reoperation were carried
out. Drains were removed in 7th pod in all but 2 patients in whom were
removed in 12th pod. The median bilirubin level in drain discharge was
significantly higher on the 5th postoperative day than on the 3rd and 7th pod.
Percutaneous drainages of fluid collections were never needed.
Conclusions. The policy summarized in the two rules of 50 minutes of liver
cut surface control and 7 days postoperative drain maintenance proved to be
effective in limiting morbidity and in particular biliary fistulas after
hepatectomies in a large series of consecutive patients.
PP 47.01
DONOR SPLENIC VEIN GRAFT TO IMPROVE THE PATENCY OF
PORTAL VEIN IN PEDIATRIC LIVER TRANSPLANTATION
Sakuma, Yasunaru; Fujiwara, Taketo; Hyodo, Masanobu; Mizuta, Koichi;
Kawano, Yoichi; Egami, Satoshi; Hishikawa, Shuji; Kawarasaki, Hideo;
Yasuda, Yoshikazu
Jichi Medical University, Department of surgery, Shimotsuke, Japan
In pediatric living donor liver transplantation (LDLT), the patientsIf portal
veins (PV) are sometimes complicated by sclerosis or stenosis due to
cholangitis or previous laparotomies. The liver grafts from adult donors
have larger vessel compared with those of small pediatric patients, and the
size mismatch of PV and short pedicles demands the usage of vein grafts. In
addition, the option to obtain vessel grafts is limited, and gonadal vein,
inferior mesenteric vein, and colic vein are commonly used. These veins were
too small in some cases, and therefore the donor splenic vein (SV) was
introduced to adjust them in three cases. Case 1) One yr old girl who
diagnosed as congenital absence of portal vein received LDLT. The SV graft
from her paternal donor was 4014mm in diameter and interposed between
the donor PV and native superior mesenteric vein (SMV). Case 2) Ten month
old boy who diagnosed as congenital biliary atresis had narrowing PV (3mm)
and received LDLT. The SV graft from her paternal donor was 3012mm in
diameter, and anastomosed to the confluence of SMV and SV. Case 3) Ten
month old boy who diagnosed as congenital biliary atresis had narrowing PV
(3mm) and received LDLT. The SV graft from his maternal donor was 35
10mm in diameter, and anastomosed to the confluence of SMV and SV. All
SV grafts were taken out from the distal side of the union of SV and SMV. No
complication was observed in donors, and the post operative courses of the
recipients were fine. There was no need of radiological and/or surgical
intervention after transplantation. Here, we introduced the method of donor
splenic vein graft especially from the point of donor harvest and recipient
portal reconstruction.
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POST-TRANSPLANT PULMONARY ARTERY EMBOLIZATION IN
A PATIENT WITH SEVERE HEPATOPULMONARY SYNDROME
Lee, Hae Won; Suh, Kyung-Suk; Kim, Joohyun; Shin, Woo Young; Yi, Nam-
Joon; Lee, Kuhn Uk
Seoul National University College of Medicine, Department of Surgery,
Seoul, Korea, Republic of
Background. Hepatopulmonary syndrome (HPS), one of the most serious
complications of the liver disease may be improved after liver transplantation
(LT). However, post-transplant mortality has been reported to be much
higher in patients with severe HPS than in patients without HPS. The
purpose of this report was to introduce our experience of post-transplant
pulmonary artery embolization (PAE) performed in a patient who had
suffered from sustained dyspnea after LT.
Methods. A 10-year-old male patient who had undergone Kasai operation
for biliary atresia at 3 months after birth was referred for LT. He had
recurrent variceal bleeding and severe HPS. His arterial O2 pressure (PaO2)
and saturation (SaO2) was only 40mmHg and 7075% in room air. A diffuse
pulmonary ateriovenous shunt was identified by saline contrast echocardio-
graphy and pulmonary arteriography. The calculated amount of the shunt
fraction was 63% on macroaggregated albumin scan. He received extended
left liver graft including middle hepatic vein from his father.
Results. Hypoxemia and dyspnea remained and he was still bed-ridden till
post-LT one month. We performed PAE for tortuous and dilated vascularity
in left upper lung field on post-LT 30th day. The abnormal vascularity
markedly decreased and oxygen saturation increased by about 10% right after
PAE. The second PAE was performed in right lower lung field on 37th day.
His activity got better and better and he showed some active movements such
as wheel-chair ambulation at the time of discharge, 40th day. His PaO2 and
SaO2 increased up to 65mmHg and 93% 3 months after LT and he showed
the same activity as children in his age group.
Conclusion. A patient with severe HPS may suffer from sustained
hypoxemic symptoms for a long time even after LT. We found that PAE
improved these symptoms by reducing the amount of the shunt. Therefore,
we think that post-transplant PAE might be useful to reduce the risk of
postoperative mortality and morbidity and to accelerate the recovery in a
patient with severe HPS.
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HISTORY OF LIVER TRANSPLANTATION;ITS EVOLUTION AND
PRESENT SCENARIO.
Shah, Niraj1; Dhumane, Parag1; Mansukhani, verushka1; Bharucha, Manoj2
1LILAVATI HOSPITAL, General Surgery., Mumbai, India; 2LILAVATI
HOSPITAL, G I Surgery, Mumbai, India
Introduction. History of transplantation goes way back in 12th century
B.C., power of lord shiva who xenotransplanted head of an elephant over a
boy to produce an Indian God, ‘‘Ganesha’’. Egyptian and Greco-Roman
mythology provides us with countless examples of metamorphoses sung by
Homer and Ovid. History of Transplantation: Liver has been the organ of life
from time immemorial-Leber in German, derived from verb to live.
Replacing a diseased organ with a healthy one from another individual,
dead or alive, to enable a human to survive, considered most stirring event in
field of medicine. Welch (1955) and Cannon (1956) attempted liver
transplantation in dogs. Starzl (Denver) performed first liver transplant in
humans (1/03/1963). 3 year child with biliary atresia, received liver from child
who died from brain tumour & survived for five hours, succumbing to
complications of coagulation and haemostasis. 2nd liver transplantation
performed (May 5, 1963), was more successful. Patient died on 22nd
postoperative day from pulmonary embolism, with a normal liver. Starzl
achieved first long-term survival in 1967. (19601970) one year patient
survival only 35%. In 1980’s immunosuppressive therapies helped to increase
graft and patient survival by treating acute and chronic rejection effectively.
Survival rose from 47% (19681988) to 67% (19881996). Further advance
was improvement of liver preservation by the introduction of Viaspan
solution (1987). Present scenario:Research in Domino transplant, lab grown
(stem cell) liver transplant, xenotrnsplant and advances in transplant
immunology assure of promising future.
PP 47.04
PATIENTS ECONOMIC IMPACT OF ORTHOTOPIC LIVER
TRANSPLANT IN ATLANTIC CANADA
Molinari, Michele; Gillis, Amy; Walsh, Mark
Dalhousie University, Surgery, Halifax, Canada
Background. Data on the impact of OLT on the patients’ and their families’
financial status are lacking. Primary aim of this study was to assess the
personal and familiar annual income changes occurring after OLT.
Methods. From September 2006 to January 2007, a cross sectional study
was performed using a validated Societal Reintegration Questionnaire.
Participants were interviewed by phone or during follow-up visits and were
adults at least 3 years post OLT, without communication impairments. All
data were prospectively collected. Chi-Square was used to analyze categorical
data and Student’s t test for continuous variables; P valuesB0.05 with two
tail distribution were considered significant.
Results. Among 158 eligible patients, 47 were randomly selected. 45 (95%)
participated and 2 declined for personal reasons. 15 patients (33%) were full
time employed and 12 (52%) were employed in the same position as before
OLT. 13 individuals (28%) were on disability while the remaining were
students or housekeepers. 11 patients (24%) had retired. The overall annual
personal income of patients undergoing OLT decresed from $ 28,300 to
26,500 (pns) and the houshold annual income from $ 44,000 to 43,700
(pns) despite the expected 3% national discount rate. 35 individuals (77%,
pB0.05) reported that OLT had a negative impact on their personal and
familiar finances due to the increased expenses for medical therapy and 12
(26%) had to borrow money for medicine costs or travel expenses related to
OLT. Among them 42% had to interrupt immunosuppression medications
against medical advice because of financial restriction.
Conclusion. Although OLT provides better survival and quality of life to
patients with liver failure, the financial impact of this procedure on patients
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and their families is significant. For low income patients, better financial
support should be considered to prevent suboptimal care and risks of chronic
graft rejection.
PP 47.05
BILE DUCT INJURIES AND LIVER TRANSPLANTATION
Ardiles, Victoria; Bregante, Mariano; Pekolj, Juan; Ciardullo, Miguel Angel;
de Santiban˜es, Eduardo
Hospital Italiano de Buenos Aires, HPB Surgery and Liver Transplant Unit,
Buenos Aires, Argentina
Background. Bile duct injuries constitute a severe complication during the
treatment of a benign disease. Several surgical, endoscopic and percutaneous
procedures are required to repair the lesion and to treat concomitant
complications. In spite of the procedures applied, a significant percentage
of cases develop end-stage liver disease and liver transplant arises as the sole
solution.
Objective. To analyse the indications and results of liver transplant as a
treatment bile duct injuries. DESIGN: Retrospective cohort study.
Materials and Method. Twenty patients on liver transplant waiting list
between January 1988 and April 2003 with end-stage liver disease secondary
to a bile duct injury. Retrospective charts and office visits analysis. Survival
was estimated with Kapplan Meir test.
Results. Four patients died on the waiting list and 16 were transplanted. The
lesion occurred during a cholecystectomy in 81% of patients. Lesion
mechanism included resection in 4 patients, burn in 3, ligature in 3, section
in 6, post T-tube placement stenosis in 2 and formol injection in 1. All
patients had undergone previous repair attempts of the lesion. Transplant was
performed with cadaveric donor in all patients. Intraoperative mortality was
0%. Hospital morbidity and mortality were 12.5% and 56.2%, respectively.
Follow-up ranged between 24 and 152 months. One, 5 and 10-year survival
rates were 81%; 75% and 50%, respectively.
Conclusions. Complex bile duct injuries and those with previous repair
attempts can lead to- end stage liver disease. In these cases, liver transplant
provides good quality of life and long- term survival.
PP 47.06
LOWASPARTATE TO ALANINE AMINOTRANSFERASE RATIO IS
AN INDICATOR OF LATE CELLULAR REJECTION IN PEDIA-
TRIC LIVER TRANSPLANTATION PATIENTS.
Kim, Joohyun1; Suh, Kyung-Suk2; Yi, Nam-Joon2; Lee, Hae Won2; Shin,
Woo Young2; Lee, Kuhn Uk2
1Seoul National Universiy College of Medicine, Surgery, Seoul, Korea,
Republic of; 2Seoul National Universiy Hospital, Surgery, Seoul, Korea,
Republic of
Background. Some serum markers have been proven to be indicators of the
fibrosis in adult liver diseases, but their role in the pediatric liver
transplantation patients were not have been determined. Because invasive-
ness and longterm-safety are particularly concerned in this age group, it is
important to identify high-risk groups for appropriate management.
OBJECTIVE. To evaluate simple serum tests as predictors for the
pathologic results of the pediatric liver transplantation patients.
Methods. Seventy consecutive pediatric liver transplantation patients under-
going a liver biopsy between October 1999 and July 2006 were retrospectively
reviewed, and pathologic findings of the liver biopsy was systemically re-
interpreted. Nine patients underwent deceased liver transplantation
(DDLT), and 61 patients underwent living donor liver transplantation
(LDLT).
Results. LDLT patients showed a tendency of the lower AAR (P0.056).
Twenty-one (30%) of 70 patients had early cellular rejections during follow
up, and 10 (14%) patients showed late cellular rejections. Aspartate to
alanine aminotransferase ratio (AAR) of the late cellular rejection patients
during the first postoperative year was significantly lower than those of the
early rejection patients (P0.045). Moreover, the patients who had fibrosis
in their liver biopsy specimen showed a tendency of higher AAR (P0.057).
Conclusions. Simple, noninvasive serum tests including AAR might be a
valid predictor for late cellular rejections in pediatric liver transplantation
patients, and some pathologic backgrounds of them could be identified.
PP 47.07
GUILLAIN-BARRE´ SYNDROME AFTER LIVER TRASPLANTA-
TION: A CASE REPORT
Bilbao, Itxarone1; Sapisochin, Gonzalo1; Dopazo, Cristina1; Len, Oscar2;
Escartin, Alfredo1; Castells, Luis3; Lazaro, Jose Luis4; Lopez, In˜igo4;
Balsells, Joaquin4
1Hospital Vall d?Hebron, Surgery Department, Barcelona, Spain; 2Hospital
Vall d?Hebron, Infectious Service, Barcelona, Spain; 3Hospital Vall
d?Hebron, Hepatology Department, Barcelona, Spain; 4
Background. Guillain-Barre´ syndrome (GBS) is characterized by acute
paralysis and ascending neuropathy. Although its pathogenesis is not fully
established it is well known its association to cytomegalovirus (CMV) and
Campylobacter jejuni infection.
AIMS To asses a single case experience of a GBS after liver transplantation
(LT). CASE: A 61 years old man received a LT for hepatocarcinoma and
hepatitis C (HCV). Initial immunosuppressive therapy consisted in Tacro-
limus (Tac) and mofetil mycofenolate (MMF). Both donor and recipient
were CMV negative and the patient did not receive prophylaxis with
ganciclovir. One and a half months later, he was admitted with a history of
fever and diarrhea; pp65 antigenemia and polimerase reaction chain (PCR)
for CMV were positive. He was diagnosed of disseminated CMV infection
and was treated with ganciclovir (5mg/kg/12h) for 17 days and afterwards
with valganciclovir (900mg/12h) for 4 days. MMF was stopped and Tac
decreased to through levels between 35 ng/ml. Both, antigenemia and PCR
became negative. Fifteen days later, he developed bilateral symmetric leg
weakness. Neurological examination revealed absence of muscle stretch
reflexes in all extremities. Cerebrospinal fluid (CSF) showed absence of cells
and a total protein concentration of 103mg/dl. Shortly after readmission he
developed acute respiratory failure and was admitted in intensive care unit.
Treatment with intravenous immunoglobulin (0,4mg/kg/day) was started for
5 days. Tac was stopped and everolimus was initiated in monotherapy at low
dose to reach levels around 3. Antigenemia and PCR for CMV were negative.
He was discharged from hospital 10 days after the treatment was started.
Conclusions. GBS has been associated to CMV infection in non-transplant
population. Evidence of CMV in our patient suggests that CMV may have a
role in triggering this illness. However Tacrolimus with its known neurotoxi-
city may also be involved. In such case everolimus (m-Tor inhibitor) may be
useful to protect the patient from rejection.
PP 47.08
OUTCOME OF LIVER TRANSPLANTATION FOR HEPATITIS C
IN HAEMOPHILIC PATIENTS CO-INFECTED WITH HIV
Sapisochin, Gonzalo1; Bilbao, Itxarone1; Escartin, Alfredo1; Dopazo, Cris-
tina1; Castells, Luis1; Lazaro, Jose Luis1; Altisent, Carmen2; Balsells,
Joaquin1
1Hospital Vall D?Hebron, HBP and Liver Transplantation Unit, Barcelona,
Spain; 2Hospital Vall D?Hebron, Haemphilia Unit, Barcelona, Spain
Background. Prior to the introduction of hepatitis C virus (HCV) screening,
many patients with haemophilia developed chronic viral hepatitis due to
transfusion and some of them progressed to cirrhosis and hepatocarcinoma.
AIMS: To assess our experience in liver transplantation for HCV cirrhosis in
haemophilic patients co-infected with HIV.
Results. We present two patients with haemophilia A co-infected with
hepatitis C and HIV, with end stage liver disease, who received liver
transplantation. Both of them received transfusion in their childhood, before
1980. One patient was diagnosed of severe haemophilia (factor VIIIB1%)
and the other, mild haemophilia (factor VIII 7%). At the time of surgery one
patient was 26 years old and the other was 37. Perioperatively factor
concentrate replacement was administrated using continuous infusion regi-
men following initial bolus dosing. Postoperatively clotting factor levels were
normalized and concentrate infusion discontinued 55 hours post transplant
in both cases. Transfusion requirements during surgery and the immediate
post-transplant period were similar to non-haemophilic transplanted patients;
4 red blood cells (RBC) units and 13 plasma units in the mild haemophilia
and 8 RBC units, 14 plasma units and 15 platelet units in the severe case. No
complications were seen. Antiretroviral treatment was started on day 7 after
LT and patients received the same HAART regimen administered before LT.
HIV viremia remained negative and CD4 levels were above 200 cells/mL.
Actually, both patients have developed a HCV recurrence, and received early
treatment with interferon and ribavirin with no response and have developed
liver cirrhosis after a mean follow-up of 24 months. Actually their clotting
factors and coagulation is completely normal.
Conclusions. Liver transplantation can be considered as definitive therapy
for haemophilic patients with transfusion-related cirrhosis and is associated
with similar morbidity than patients with no clotting factor disorders.
PP 47.09
GRAFT VERSUS HOST AFTER LIVER TRANSPLANTATION
Bilbao, Itxarone1; Dopazo, Cristina1; Len, Oscar2; Castells, Luis3; Lazaro,
Jose Luis1; Lopez, In˜igo1; Escartin, Alfredo1; Sapisochin, Gonzalo1; Balsells,
Joaquin1
1Hospital Vall d?Hebron, Surgery Department, Barcelona, Spain; 2Hospital
Vall d?Hebron, Infectious Service, Barcelona, Spain; 3Hospital Vall
d?Hebron, Hepatology Department, Barcelona, Spain
Introduction. Graft versus host disease (GVHD) is extremely rare after liver
transplantation (LT). Management and treatment is not stablished.
Aim. To present a single case experience of a GVHD after LT. CASE. A 56
years old male, submitted to renal transplant 20 years previously, was taken
inmunosuppression with azatioprina and steroids. He was operated 3 years
ago for hepatocellular carcinoma in cirrhosis HBV and HCV positive. He was
submitted to liver transplantation on April 2007 due to multifocal recurrence
of HCC (segments IV, VII, VIII). He received triple therapy with Tacrolimus
(around 8ng/ml), MMF and steroids. During the second week post-
transplant, he presented high fever without focality (toraco-abdominal
scan, ultrasound, urine and blood culture, CMV, Epstein-Barr and Herpes
virus negative). In the third week post-trasplant a maculopapular cutaneous
rush involving palms and soles, appeared. Skin biopsy revealed graft versus
Abstracts 185
host. Therapy with steroid pulses was started, MMF was stopped and
tacrolimus was converted to everolimus. Donor lymphocyte chimerism
reached 12%. Patient ameliorated and was discharged on steroids 30 mg/
day and everolimus (3 ng/ml). Fifteen days later he was readmitted with fever
and cutaneous rush. Ebstein-barr, CMV and herpes virus 6 were positive.
Everolimus was stopped and steroids tappered to cero. He was treated with
IV ganciclovir. Peak chimerism increased to 15%. After 4 weeks of treatment
he was discharged, but 15 days later he has been readmitted for fever,
pancitopenia, and extreme astenia. A bone marrow biopsy revealed medular
aplasia. The patient is currently under teatment with Basiliximab.
Conclusion. There are conflicting opinions on wether to increase or
decrease immunosuppression in the face of GVHD. In the first episode we
increased immunosuppression, in the second episode we chose to withdraw
therapy in order to allow patient?s immune system to fight against infections,
but now in a last attempt to resolve the situation we have decided to
administer Basiliximab.
PP 47.10
EXPRESSION AND INDUCTION OF CYTOCHROME P450 AC-
TIVITY IN CRYOPRESERVED PORCINE HEPATOCYTES
Cursio, Raffaele1; Baldini, Edoardo1; De Sousa, Georges2; Margara,
Andrea1; Honiger, Jiri3; Saint-Paul, Marie-Christine4; Bayer, Pascale1;
Raimondi, Vincent1; Rahmani, Roger2; Mouiel, Jean1; Gugenheim, Jean1
1Univ. de Nice Sophia Antipolis, Laboratoire de Recherches Chirurgicales,
Nice, France; 2INRA, Lab. Pharma-Toxicologie Cellulaire, Antibes, France;
3Univ. de Paris V, INSERM U420, Paris, France; 4Univ. de Nice Sophia
Antipolis, Service d’Anatomo-Pathologie, Nice, France
Background./AIMS: Hepatocyte transplantation may be useful as a bridge
for patients to whole organ transplantation, and it may provide metabolic
support during liver failure. However, the availability of human hepatocytes is
limited and the maintenance of primary culture is possible for only a few
weeks. Cryopreservation may be a way to preserve hepatocytes for a longer
periode, but the isolation may modify their function represented by
cytochrome P450 enzyme activity. The aim of this study was to assess the
cytochrome P450 enzyme activity and the effects of its induction in long-term
cryopreserved porcine hepatocytes.
Methods. Isolated porcine hepatocytes were cryopreserved for 1 month,
thawed and cultured for 3 days. During medium culture, the hepatocytes
were exposed to the following cytochrome P450 inducers: dimethyl sulph-
oxide, rifampicin, phenobarbital, 3-methylcholantrene and dexamethasone.
Cytochrome P450 enzyme activities were determined by immunoblotting
and EROD assay.
Results. Basal expression of Cytochrome P450 activity was maintained in
cryopreserved porcine hepatocytes. CYP1A2 protein levels were significantly
increased in cryopreserved porcine hepatocytes when exposed to 3-methyl-
cholantrene compared to other cytochrome P450 inducers. CYP34A protein
levels were significantly increased by rifampicin and phenobarbital, whereas
no cytochrome P450 inducer modified CYP2E1 protein levels. EROD
activity was significantly increased in cryopreserved porcine hepatocytes
when exposed to phenobarbital and 3-methylcholantrene compared to other
cytochrome P450 inducers.
Conclusions. Cytochrome P450 activity in long-term cryopreserved porcine
hepatocytes was maintained and could be increased when exposed to several
cytochrome P450 inducers.
PP 48.01
REMOTE ISCHEMIC PRE-CONDITIONING IMPROVES HEPA-
TIC TISSUE OXYGENATION AND ACIDOSIS FOLLOWING LI-
VER ISCHEMIA REPERFUSION INJURY
Kanoria, Sanjeev1; Jalan, Rajiv2; Davies, Nathan A.3; Fusai, Giuseppe4;
Quaglia, Alberto4; Seifalian, Alexander M.4; Williams, Roger2; Davidson,
Brian4
1Royal Free Hospital and RFUCSM, Pond Street, London, United King-
dom; 2The UCL Institute of Hepatology, Division of Medicine, London,
United Kingdom; 3The UCL Institute of Hepatology, Division of Medicine,
Londoan, United Kingdom; 4Royal Free Hospital and RFUCSM, London,
United Kingdom
Introduction. Hepatic ischemia reperfusion injury (IRI) lowers hepatic
oxygenation and induces hepatic tissue acidosis affecting the outcome of
major liver surgery. Remote ischemic pre-conditioning (RIPC) has been
shown to reduce the adverse systemic and local effects of liver IRI.Objective.
This is the first study to investigate the effect of RIPC on improving liver
tissue oxygenation and acidosis following liver IRI non-invasively through
near infra-red spectroscopy (NIRS).
Methods. 24 New Zealand rabbits were grouped into four groups: sham,
RIPC, IRI alone, RIPCIRI. RIPC was induced through 3 cycles of 10
minute ischemia and reperfusion to the limb. Total hepatic ischemia was
produced by complete portal inflow occlusion for 25 minutes. Serum
transaminases, bicarbonate and hepatic venous nitrite/nitrate (NOx) levels
were measured 2 hours post-reperfusion. Hepatic oxygenation was monitored
with NIRS.
Results. At 2 hours post reperfusion, IRI alone resulted in reduced
mitochondrial oxygenation (CytOx CuA Redox), serum bicarbonate, hepatic
venous NOx and an increase in serum transaminases and hepatic deoxyhe-
moglobin levels. RIPC before IRI caused significant improvement in
mitochondrial oxygenation (P0.01), increased serum bicarbonate (P
0.02), hepatic venous NOx (P0.025) levels and a decrease in serum
transaminases (P0.04) and hepatic deoxyhemoglobin levels (P0.03).
There was a positive correlation (P0.02) between hepatic venous NOx
levels and mitochondrial oxygenation.
Conclusion. RIPC before IRI reduces hepatic injury, acidosis and improves
mitochondrial oxygenation. This is associated with increased Nitric Oxide
bioavailability in the liver. RIPC has potential for clinical application in
reducing the adverse effects of liver IRI following major liver surgery.
PP 48.02
CYTOKINES IN THE PIG LIVER DURING WARM ISCHEMIA,
PRECONDITIONING AND REPERFUSION
Kannerup, Anne-Sofie1; Grønbæk, Henning2; Jørgensen, Rasmus Lange-
lund1; Funch-Jensen, Peter1; Tønnesen, Else3; Mortensen, Frank Viborg1
1Aarhus University Hospital, Department of Surgery L, Aarhus, Denmark;
2Aarhus University Hospital, Department of Medicine V, Aarhus, Denmark;
3Aarhus University Hospital, Dept. of Anesthesiology Medicine, Aarhus,
Denmark
Aim: Hepatic ischemia-reperfusion injury induced by Pringles manoeuvre
during liver surgery is a well known cause of morbidity and mortality. The
aim of this study was to monitor serum interleukins (IL-6, IL-8 and IL-10)
and tumor necrosis factor (TNF) during warm ischemia, preconditioning
and reperfusion in the pig liver.
Methods. Sixteen landrace pigs (60 kilos), eight in each group, underwent
laparotomy followed by 60 minutes of total ischemia with or without prior
ischemic preconditioning (10 minutes of ischemia followed by 10 minutes of
reperfusion) followed by 3 hours of reperfusion. Before ischemia, at the end
of ischemia and during reperfusion serum interleukins (IL-6, IL-8 and IL-10)
and TNF were measured as well as serum alanine aminotransferase.
Results. Before ischemia and during the following 60 minutes of total
ischemia no differences in pro- and anti-inflammatory cytokines (IL-6, IL-8,
IL-10 and TNF) were observed. Thirty minutes after reperfusion all three
cytokines started to increase in both groups, especially IL-6. TNF increased
only in the ischemic group. IL-6 increased significantly in the group with
ischemic preconditioning compared with the non-preconditioned group. IL-8
and IL-10 increased more in the ischemic group compared with the
preconditioned group. A minor increase in alanine aminotransferase was
observed.
Conclusion. Warm liver ischemia with or without ischemic preconditioning
activates the pro- and anti-inflammatory cytokines. Especially IL-6 increased
when the liver was exposed to preconditioning.
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Efficacy of Heat Shock Protein to RFA for liver
KAWASHIMA, YUSUKE; UCHIDA, SHINJI; SHIROUZU, KAZUO
KURUME University Hospital, Surgery, KURUME, Japan
Background. In order to reduce postoperative complication, preservation of
liver function and reduction of operative stress are important in treatment of
hepatocellular carcinoma(HCC). Therefore, liver radiofrequency ablation
therapy (RFA) is prevailing as the local treatment in Japan. HSP is composed
quickly to fever and various kinds of stress in cytoplasm. HSP control quality
of protein in cytoplasm and has strongly resistance to stress. Geranylger-
anylacetone:GGA(Esai Co. Ltd Tokyo Japan) is a antiulcer drug that protects
gastric mucosa without affecting gastric acid or pepsin secretin. It make clear
that GGA guides HSP70(molecular weight 72kDa) selectively by activation
of transcriptase of HSP70.
Purpose. Using rats RFA model, we confirm a state of liver damage after
liver RFA and review the influence of GGA.
Methods. Using Wistar rats (male 10weeks 300g), we divide into three
groups:GGA treated group (NG ), non-treated group(NGI[) and GGA
Quercetin(an inhibitor of HSP70) treated group(GQ). GGA were given at a
dose of 200mg/kg body weight in 24 and4 hours before RFA. Quercetin were
given at a dose of 100mg/kg body weight in4 hours before RFA.I@RFA
were performed about 15% of liver under general anesthesia with diethy-
lether.I@We measured ALT, AST, TB, LDH, TNFa, IL -6 by ELISA
method at preoperation, 6, 12, 24, 48 hours after RFA. We measured
expression of HSP70 in the liver using western blotting.
Results. AST, ALT, TB, LDH peak occurred within 6hours after RFA.
GGA treated group had a significantry lower peak compared with non-
treated group and GGAQuercetin treated group.I@TNF-a, IL -6 peak
occurred within 6 and12hours after RFA too, and GGA treated group had a
significantry lower the peak. GGA treated group showed high expression of
HSP70 compared with non-treated group until 48 hours after RFA. Western
Blotting showed inhibition of HSP70 by medication of Quercetin.
Conclusion. Administration of GGA induce HSP70 and HSP70 relived
liver damage.
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DECREASED SERUM INSULIN-LIKE GROWTH FACTOR I (IGF-
I) IN HEPATOCELLULAR CARCINOMA: A CORRELATION
STUDY WITH CLINICAL DATA
Wang, Shen-Nien1; Lee, King-Teh2
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Background. Experimental studies have demonstrated that deregulated
serum IGF- I levels play an important role in hepatocarcinogenesis. Our
study aims to explore the correlation of clinical data with serum IGF- I levels
in patients with hepatocellular carcinoma (HCC).
Methods. A radioimmunoassay was used to determine serum IGF- I levels in
60 HCC patients and 160 healthy subjects. The data was further correlated
with their clinical and biochemical characteristics.
Results. The mean IGF- I level was significantly decreased in HCC patients
in comparison with healthy subjects (158.46¡O´105.07 vs. 247.63¡O´149.96
ng/mL; P B0.001). Homeostasis model assessment-insulin resistance
(HOMA-IR) index of HCC patients was significantly higher than that of
healthy subjects (5.35¡O´8.82 vs. 2.53¡O´6.90; P0.027). Moreover, the
positive correlation of HOMA-IR with serum IGF- I, which appeared in
healthy subjects, was not noted in HCC patients. Intriguingly, in HCC
patients, the mean IGF- I level of HCV subgroup was significantly reduced
than that of HBV subgroup (113.14 ¡O´71.28 vs. 180.14 ¡O´105.10 ng/mL,
P0.006).
Conclusion. Serum IGF- I level is reduced in HCC patients. Insulin
resistance and HCV infection may play some important roles in this
deregulation.
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FROM SIMPLE STEATOSIS TO NASH-RELATED HEPATOCEL-
LULAR CARCINOMA (HCC): AN UPDATE ON THE MOLECU-
LAR GENETICS
Stefano, Jose T1; Oliveira, Claudia Cpm2; Correa-Giannella, Maria Lucia3;
Kubrusly, Marcia S2; Privato, Marta2; Mello, Evandro S4; Alves, Venancio
AF4; Bacchella, Telesforo2; Machado, Marcel C C2; Carrilho, Flair J2
1School Of Medicine Sa˜o Paulo University, Department of Gastroenterology,
Sa˜o Paulo, Brazil; 2School of Medicine University of Sa˜o Paulo, Department
of Gastroenterology, Sa˜o Paulo, Brazil; 3School of Medicine University of
Sa˜o Paulo, Departament of Endocrinology, Sa˜o Paulo, Brazil; 4School of
Medicine University of Sa˜o Paulo, Department of Pathology, Sa˜o Paulo,
Brazil
Introduction. Although the risk factors for nonalcoholic fatty liver disease
(NAFLD) are well established, its natural history is still uncertain. Studies
suggest that the progression from one stage to the next can be triggered by
genetic and environmental factors alone and also through their interaction.
Aim. To identify molecular processes involved in NAFLD progression, from
simple hepatic steatosis to NASH-related hepatocellular carcinoma (HCC)
using microarray analysis.
Methods. Liver tissues from 12 patients with NAFLD diagnosis [3 affected
by simple steatosis grade II (STEAT), 3 NASH grade I (NASH), 3 NASH-
related cirrhosis (CIR) and 3 NASH-related HCC (HCC)] and 3 non-
diseased tissues (CTRL) were evaluated for differentially expressed mRNAs
by using CodeLinkTM Human Whole Genome Bioarrays with 57,000
human transcripts. Data were analyzed by MAPPFinder, which works with
the annotations from GO to identify global biological trends in gene
expression data and biological pathways.
Results. Using filtering criteria of 2.0-fold-change in expression and a t-test
where pB0.05, the number of differentially expressed genes among all
conditions is shown on Table 1. Considering the 866 genes modulated at least
in one NAFLD-related condition, the pathways identified as significantly
disturbed included: Fatty acid beta oxidation, Synthesis and degradation of
ketone bodies, Fatty acid biosynthesis; Triacylglyceride synthesis; Steroid
biosynthesis; Inositol metabolism; Heme biosynthesis; Eicosanoid synthesis;
Translation factors; Acyltransferase activity; Complement and coagulation
cascades; Alpha6-Beta4-Integrin NetPath; Oxidative Stress; Prostaglandin
synthesis regulation; Inflammatory response pathway; p38 MAPK signaling
pathway and TGF beta signaling pathway.
Conclusions. This study reveals significant gene expression alterations in
key biological process and the pathways modulated between the different
stages of progression of NAFLD were identified. Table 1. Differentially
expressed genes among all conditions
COMPARISON GENES
UP-
REGULATED
DOWN-
REGULATED
CIRCTRL 91 39 52
NASHCTRL 248 30 218
HCCCTRL 249 20 229
STEATCTRL 113 24 89
NASHCIR 220 32 188
HCCCIR 181 4 177
STEATCIR 107 8 99
HCCNASH 452 53 399
STEATNASH 237 113 124
HCCSTEAT 305 33 272
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TRANS-PAPILLARY PANCREATIC DUCTAL STENT PLACE-
MENT IN THE THERAPY OF PANCREATIC DUCT DISRUPTION
Carter, R; McKay, C.J.; Murray, W.R.; Imrie, Clem
Glasgow Royal Infirmary, Department of Surgery, Glasgow, Scotland,
United Kingdom
Introduction. Pancreatic duct(PD)disruption usually presents as a conse-
quence of chronic (CP)or acute pancreatitis(AP)in the form of a pseudocyst
or ascites. Traditional therapy involves surgical or endoscopic pseudocyst
drainage. We describe our experience with PD stenting as part of a multi-
modality management algorithm for pancreatic pseudocyst and ascites.
Methods. A prospectively collated database of endoscopic findings was
supplemented by retrospective record review. Between April 1996 and
November 2006, 9485 ERCP’s were performed, 818 procedures were on
416(4.5%) patients for the investigation of ‘‘cysts’’. A median of 2.36 (range
1 4) procedures were performed per patient. In 182(1.9%) patients a
radiological PD disruption was identified. This occurred in 125 male and 57
female patients, median age 51(range 1082)).Only 14(8%) had ascites or a
pancreatico-pleural fistula. The disruption was in the pancreatic head in
35(19%), neck 58(32%), body 35(19%) and tail 54(30%). CP was present in
97(54%), AP in 79(43%) and 6(3%)involved trauma/ tumour/auto immune
pancreatitis. Treatment success was defined as radiological resolution of the
fistula, and any associated cyst. The median follow-up 55 months (range 1
118).
Results. Trans-papillary stenting was technically successful in 162/182
patients (89%). Presence of a PD stricture significantly reduced the
likelihood of initial stent placement (16/98 vs. 4/84;p0.03). Of 162
successful stents, treatment is ongoing in 6, leaving 156 on which to assess
the short/medium term success of therapy. Overall resolution occurred in
68%(119/176) of all disruptions and 76% (119/156) of those with success-
fully placed stents. Resolution was unaffected (p0.05) by the site of the
disruption (head 25/32(78%)), neck (36/47(77%)), body (18/28(64%)) and
tail (40/49(82%)); etiology (AP-58/71(82%)); CP- 58/60(73%)); stent
diameter (5FG  47/61(77%)); 7FG- 72/95(76%)); or whether the stent
crossed the disruption (44/6172%); was short of the disruption 66/86(77%)
or into the cyst 9/9 (100%). The presence of an established duct stricture
significantly reduced the success of treatment (44/79(58%) vs. 73/77(95%)
pB0.05).
Conclusion. Trans-papillary PD stenting is effective in controlling duct
disruption. Pancreatic duct stricture adversely affects outcome.
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PYLORIC EXCLUSION IN THE MANAGENET OF BLUNT DUO-
DENAL TRAUMA.
Morales, Dieter1; Garcia de Polavieja, Manuel2; Casanova, Daniel2; Seco,
Isabel2; Ortega, Carlos2; Marton, Paula2; Naranjo, Angel2
1University Hospital ‘‘Marque´s de Valdecilla’’, Department of Surgery,
Santander, Spain; 2
Introduction. Blunt injuries to the duodenum are uncommon and pre-
operative diagnosis is difficult. We report the case of a blunt duodenal trauma
successfully managed with pyloric.
Case Report. 47 year old white man with history of alcoholism and gastric
surgery due foreing body swallowing. He was admitted at hospital drunk.
Clinical exploration showed pain and tenderness at right hemiabdomen.
Laboratory examination showed leucocytosis with normal amylasa. Ultra-
sonography showed free fluid at Douglas and CT scan showed retro-
peritoneal free air (Fig. 1). A median laparotomy was performed. There
was a perforation at second part of duodenum (grade III) and biliary
peritonitis. A pyloric exclusion, vagotomy and gastrojejunostomy were
performed (iconography). The postoperative period was uneventful.
Conclusions. 1.- Preoperative diagnosis of duodenal perforations is diffi-
cult.2.- Pyloric exclusion provides an valuable alternative of management of
this injuries in order to shorten the operative time and make the procedure
reversible.3.- To practise vagotomy remain controversial.
PP 48.08
INTERRUPTED HORIZONTAL MATTRESS SUTURES PLUS
CROSS DOUBLE ‘‘U’’ PANCREATICOJEJUNAL ANASTOMOSIS
PREVENT PANCREATIC FISTULAS
Chen, Yifa; Chen, Xiaoping
Tongji Hospital, Hepatic Surgery Centre, Wuhan, China
Background. Pancreaticoduodenectomy(PD) has become an increasingly
common and safe operation for most patients with benign and malignant
periampullary tumors. However pancreatic fistula (PF) is still the most
problematic common complication after PD. Especially the pancreaticojeju-
nal anastomostic leakage is a major cause of morbidity and mortality post-
pancreaticoduodenectomy.
Methods. We designed a new technique of pancreaticojejunal anastomosis to
prevent the development of pancreatic Fistulas. The procedures of this new
technique included pancreatic remnant interrupted horizontal mattress
sutures(see figure1) and cross double ‘‘U’’ pancreaticojejunal anastomo-
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sis(two sutures)(see fugure2). Mattress sutures shoud avoid main pancrea
duct ligament and the double cross ‘‘U’’ pancreaticojejunal anastomosis
made the pancreatic remnant in the jejunal lumen sheath at least 3 cm.
Results. From May 2006 to May 2007, a total of 52 periampullary malignant
tumor patients were operatived with this type of pancreaticojejunostomy,
None of the patients developed pancreatic fistulas.
Conclusion. Pancreatic remnant interrupted horizontal mattress sutures
plus cross double ‘‘U’’ pancreaticojejunal anastomosis can prevent pancreatic
fistulas after pancreaticoduodenectomy.
PP 48.09
CHRONIC VENTRAL PANCREATITIS WITH PANCREAS DIVI-
SUM
Tanabe, Reiko1; Takahata, Syunichi2; Konomi, Hiroyuki3; Sadakari, Yoshi-
hiko2; Ienaga, Jun2; Yamaguchi, Koji2; Tanaka, Masao2
1Kyushu University Hospital, Department of Surgery and Oncology,
Fukuoka, Japan; 2Graduate School of Medical Sciences of Kyushu Uni-
versity, Department of Surgery and Oncology, Fukuoka, Japan; 3Kitakyushu
Municipal Medical Center, Kitakyushu, Japan
Background. Pancreas divisum is one of the anatomical variant, results from
the deficiency of fusion of the dorsal and ventral pancreatic duct. Sometimes
it causes dorsal pancreatitis because of the insufficient drainage via minor
papilla but scarcely ventral pancreatitis. We report a case of chronic ventral
pancreatitis with pancreas divisum successfully treated by pancreas head
resection. CASE: A 57 year old woman had abdominal pain after drinking.
Computed tomography showed the stone of pancreas head. First she was
treated by medication, but the pain wasnIft improved. ERCP studies could
not show the Wirsung duct but showed the dilation of dorsal pancreatic ducts
and branches. We performed EST and stenting for dorsal pancreatic duct via
minor papilla. However, the pain slowly emerged two years later, she
underwent pancreaticoduodenectomy. The resected specimen showed
chronic pancreatitis localized to the ventral pancreas and there is no
connection dorsal and ventral pancreatic duct. After the operation, she
recovered from the pain.
Conclusion. Pancreas divisum is found about 3% in Japan, and known to
bring about chronic dorsal pancreatitis. This case, however, was seemed to be
caused by insufficient drainage of ventral pancreas induced by drinking, and
was cured by pancreaticoduodenectomy. There is possibility to be a ventral
pancreatitis in pancreas divisum, and if it were, it was effective to resect the
ventral pancreas such as pancreaticoduodenectomy.
PP 48.10
ANALYSIS OF CHEMORADIATION THRAPY FOR UNRESECT-
ABLE STAGE IV PANCREATIC CANCER
Otani, Satoshi; Takeda, Shin; Yamada, Suguru; Sugimoto, Hiroyuki;
Nomoto, shuji; Kasuya, Hideki; Kanazumi, Naohito; Nakao, Akimasa
Nagoya university graduate school of medicine, Surgery II, Nagoya, Japan
Background. Pancreatic cancer has an extremely poor prognosis. The
benefit of chemotherapy, radiotherapy or both as a palliative treatment of
unresectable pancreatic cancer is uncertain. OBJECTIVE To assess the
effects of chemotherapy (CHT) and/or intraoperative radiotherapy (IORT)
in the management of unresectable pancreatic cancer. SUBJECTS AND
Methods. Between October 1981 and August 2007, 167 patients with
unresectable pancreatic cancer were treated at our institution. According to
the treatment modality, the study population was classified by (with/without)
IORT, CHT, locally advanced and/or distant metastasis. We evaluated
median survival and the 0.5 and 1-year survival rates of the each group
retrospectively. Kaplan-Meier analysis was used to calculate the actuarial rate
of the overall survival (OS) rate. Results Median survival of the 0.5-year (and
1.0-year) survival rates in the group with CHTIORT (n39), with IORT
alone (n55), with CHT alone (n18) and no treated (n55) were 6.7
months, 52.6(23)%, 6.6months, 55.6(20.4)%, 8.1 months, 72.1(19%),
3.2months, 24.1(3.7)%, respectively. In the 39 patients with chemoradiation,
the median survival in the GEM-based group (n18) were significantly
better than in the other agents-based group (n21) (P0.02). Median
survival amounted to 3.16 months (95% CI: 2.24.1 months) for the patients
without CHT (n110) while it was prolonged to 6.6 months (95% CI: 5.4
Ij7.9 months) for undergoing IORT.
Conclusions. Prolongation of the survival period was shown by concomitant
IORT and administration of GEM for unresectable pancreatic cancer. Thus,
attempting to combine chemotherapy with IORT and giving additional
consideration to the administration method was shown to provide adjuvant
therapy that can be expected to be effective against stage IV unresectable
pancreatic cancer.
PP 49.01
KRUKENBERG?S TUMOR AS A FIRST MANIFESTATION OF
FIBROLAMELLAR HEPATOCARCINOMA
Bilbao, Itxarone1; Vilallonga, Ramon1; Dopazo, Cristina1; Allende, Elena2;
Viladomiu, Luis3; Quiroga, Sergi4; Margarit, Carlos1
1Hospital Vall d?Hebron, Surgery Department, Barcelona, Spain; 2Hospital
Vall d?Hebron, Pathology Department, Barcelona; 3Hospital Vall d?Hebron,
Hepatology Department, Barcelona; 4Hospital Vall d?Hebron, Radiodiag-
nostic Department, Barcelona
Introduction. Fibrolamellar carcinoma (FL-HCC) is a rare subtype of
hepatocellular carcinoma (HCC) with distinctive clinical and histological
features and better prognosis than HCC.
Aim. To present a single case experience of a Krukenberg?s tumor as a first
manifestation of FL-HCC. CASE. A 45 years old woman presented inferior
abdominal pain and swelling during the last 5 months. Abdominal explora-
tion revealed left hepatomegaly and masses in both iliac fossa. Ultrasound
and CTscan revealed an 812 cm mass in left hepatic lobe, bilateral ovarian
masses and peritoneal implants in great omentum, perihepatic, right
parietocolic and minor pelvis peritoneum. Citology by ovarian PAAF was
positive for malignant cells of hepatic morphology. Inmunohistochemistry
was positive for keratine A7 and negative for keratine AE1 /AE3, alpha
fetoprotein, citokeratine 20, HMB-45 and plap. Liver enzymes revealed:
AST163 UI/L, ALT80UI/L, Alkaline phosphatase888UI/L GGT
177UI/L. HBV and HCV serology were negatives. Left hepatectomy with
doble anexectomy, omentectomy and partial peritonectomy was done.
Histopathologic characteristics showed a well diferentiated FL-HCC (pT2,
N1, M1). Postoperative course was uneventful and she was discharged 12
days after surgery. She received chemotherapy with gemcitabine 1000 mg/m2
the first day followed by oxaliplatino 100 mg/m2 the second day, each two
weeks. She received a total of 4 cycles, with bad tolerance and respond. Six
months after operation an abdominal TAC revealed peritoneal recurrence.
Two years after surgery she is still alive with bad general status and palliative
treatment.
Conclusion. FL-HCC is variety of hepatocallular carcinoma appearing more
frequently in young adults. The presentation as a Krukenber tumour is very
rare but has been previously reported. The best treatment is surgical
resection. In cases of diseminated disease, citoreduction can be tried in order
to prolonge survival.
PP 49.02
LAPAROSCOPIOC HEPATECTOMY FOR CILIATED HEPATIC
FOREGUT CYST
Kawasaki, Atsushi1; Oida, Takastugu1; Mimatsu, Kenji1; Aramaki, Osamu1;
Kuboi, Youichi1; Kanou, Hisao1; Inami, Makiko2; Mtsuoka, Shun-ichi2;
Fijikawa, Hirotoshi3; Amano, Sadao4
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Social Insurance Yokohama Central Hospital, Gastroenterology, Yokohama,
Japan; 3Social insurance Yokohama Central Hospital, Gastroenterology,
Japan; 4Nihon University School of Medicine, Surgery, Tokyo, Japan
Background. Ciliated hepatic foregut cyst (CHFC) is rare benign, solitary
cyst consisting of ciliated pseudostratified columnar epithelium, subepithelial
connective tissue, smooth muscle layer, and an outer fibrous capsule.
However, ciliated cysts commonly arise from the tracheal bronchial tree
and esophagus, they could also be found in the liver with rare incidence.
Therefore, we present a case of 57-year-old woman who underwent
laparoscopic hepatectomy for CHFC.
Case Report. A-57-year-old woman with a liver tumor was admitted to our
hospital. The tumor was cystic with calcification. Fine needle aspiration
biopsy underwent for the cystic lesion, and diagnosed CHFC. The cystic
tumor slightly enlarged at 7 months later after the diagnosed. We performed a
laparoscopic hepatectomy. The HE-stained sections showed an epithelial
lining of ciliated pseudostratified columnar cells with occasional goblet cells.
Niether signs of squamous metaplasia nor signs of malignancy could be
pbserved in the epithelium.
Conclusion. When squamous epithelium is identified in a liver cyst, an
extensive sampling is recommended to identify possible foci of squamous
carcinoma and to classify more precisely the histological type of the lesion.
Laparoscopic surgical removal of the lesion may be appropriated as a
minimally invasive procedure.
PP 49.03
SMALL CELL CARCINOMA LIVER  A CASE REPORT
Kanchustambam, subba rao; Darmender, MS
Apollo health city, HPB & Liver transplant surgery, hyderabad, India
Introduction. Small cell carcinoma is one of the commonest malignant
tumors of Lung. Extra pulmonary primary small cell carcinoma is rare. We
herein report a case of small cell carcinoma of Liver CASE HISTORY The
patient is a 73 yr old female presented with right upper quadrant pain with
fever 6 months following Lap cholecystectomy. CT abdomen showed well
defined hypo dense lesion at the junction of segment 5 and 4 whose FNA
(thought to be abscess) suggested Hepatoma. Her AFP was 24ng/ml. The
other tumor markers CEA, Ca 19-9 were normal. She has no underlying liver
disease. She underwent Diagnostic laparoscpy followed by segment 4 and 5
resection. Recovery was uneventful. HISTOLOGY Histopathology revealed
small cell carcinoma (High grade endocrine tumor) of liver. The resected
margin is free. Adjoining liver and omentum are free of tumor. On immuno
histochemistry, tumor cells show diffuse and strong positivity for NSE and
negative for CYTOK-7&CYTOK-20. DISCUSSION: Extra pulmonary
Small cell carcinoma (EPSCC) is an entity different from that of lung. Of
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all EPSCC, one third is from uterine origin. EPSCC other than uterus are
usually aggressive. The median survival from the time of diagnosis is about 9
to 14 months. The prognosis is dependent on the stage and primary location
of the tumor. Multimodal treatment improves survival both in local and
extensive disease.
PP 49.04
DIAGNOSIS OF INFLAMMATORY PSEUDOTUMOR OF THE
LIVER
Kuboi, Youichi1; Oida, Takatsugu1; Mimatsu, Kenji1; Kawasaki, Atsushi1;
Aramaki, Osamu1; Kanou, Hisao1; Miyake, Hiroshi2; Amano, Sadao3
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Kasukabe Municipal Hospital, Surgery, Kasukabe, Japan; 3Nihon Univer-
sity School of Medicine, Surgery, Tokyo, Japan
Background and Aim. Inflammatory pseudotumors are uncommon mass
lesions arising most typically in the lungs of young adults. Hepatic
inflammatory pseudotumors (HIPT) are rare focal lesions of the parench-
yma, accompanied by fever, malaise, abdominal pain and mass effect, and
therefore are commonly misdiagnosed as malignant tumors or liver abscesses.
Routine imaging techniques are not specific and do not reach a definitive
preoperative diagnosis between a benign and a malignant tumor. We studied
three patients with HIPT to determine what examination can aid in its
diagnosis.
Patients and Method. One patient underwent lateral hepatic segmentect-
omy as a cholangiocellular carcinoma. We performed repeat ultrasonography
in one patient, and diagnosed as a hepatocellular carcinoma. One patient
underwent ultrasonography-guided percutaneous liver biopsy because of
difficulty in definitive preoperative diagnosis, and the histological finding was
consistent with HIPT.
Results and Conclusion. Repeat US findings are useful to diagnosis as
HCC or HIPT, however, in the difficulty of preoperative diagnosis,
preoperative histological confirmation is necessary to avoid unnecessary
surgery.
PP 49.05
FIBROLAMELLAR HEPATOCELLULAR CARCINOMA AND
LARGE FOCAL NODULAR HYPERPLASIA: A CASE REPORT
AND REVIEW OF THE LITERATURE.
Sapisochin, Gonzalo; Dopazo, Cristina; Escartin, Alfredo; Lazaro, Jose Luis;
Bilbao, Itxarone; Balsells, Joaquin
Hospital Vall D?Hebron, HBP Surgery and Liver Transplant, Barcelona,
Spain
Introduction. Focal nodular hyperplasia (FNH) is the second most common
benign liver tumor after hemangioma. The potential for malignant transfor-
mation has not been demonstrated, however some authors have suggested a
direct link between FNH and fibrolamellar hepatocarcinoma (FL-HCC).
OBJETIVES. To describe a case report of a liver tumor that was a FNH
with focus of FL-HCC.
CASE. A 47-year-old man was referred to our outpatient clinic in April 2003
with mild abdominal pain and fatigue. An abdominal ultrasound was then
performed and revealed a 65 cm liver mass in the left lobe. A CT scan
showed this mass with a central scar and was described as a FNH, which was
confirmed with a fine needle biopsy that didn’t show atypical cells, and an
MRI that showed a typical FNH image. From July 2003 to December 2006
the patient was controlled in the clinic and different image examinations were
done revealing a progressive increase in the size of the mass but with the same
FNH characteristics. Laboratory exams were normal. The patient referred
increase in the pain. A new CT scan was repeated and showed that the liver
mass had a 10 cm diameter now, and still had FNH characteristics. Due of
the great increase of pain and the increase in size, the patient was operated on
March 2007. The surgical procedure involved a left hepatectomy. Macro-
scopically it had a yellowwhite cut surface and a central scar. Microscopic
examination revealed a FNH with focus of FL-HCC. The postoperative
period was uneventful. Actually, 6 months after surgery the patient is
asymptomatic and free of disease.
Conclusions. FL-HCC have a relatively indolent tumor biology and it may
be difficult to differentiate it from a FNH with imaging techniques. To find an
association between FNH and FL-HCC is rare, and so, it becomes difficult to
draw conclusions for both the pathology of this tumor and the optimal
management of these patients.
PP 49.06
The benefitial effect of ICK(Inchin-ko-to) in large volume hepatect-
omy in an icteric liver with hilar cholangiocarcinoma: Report of a
clinical case
Nishi, Masaaki; Ikegami, Toru; Imura, Satoru; Morine, Yuji; Kanemura,
Hirofumi; Arakawa, Yusuke; Mori, Hiroki; Shimada, Mitsuo
The University of Tokushima, Department of Surgery, Tokushima, Japan
Background. ICK (inchin-ko-to), an herbal medicine, is known to have
various hepatotrophic effects including hepatocytes protection, prevention of
hepatic fibrosis, and promoted bile excretion by hepatocytes. Therefore,
possible improvement in liver functions of an icteric liver is anticipated, even
in a surgical setting. We herein report a case with hilar cholangiocarcinoma
(HC). With the aid of ICK, the patients underwent extended right lobectomy
with complete caudate lobectomy. A case report. The case was a female
patients aged 70’s. She admitted in our ward for HC with prominent jaundice
and malaise. The radiological works-ups showed that the invasive tumor was
located on the confluence of hepatic ducts, with dilatation of the intrahepatic
bile ducts in the both lobes. Liver function test were as follows; Total
bilirubin(T-bil) 17.3mg/dl, direct bilirubin 13.1mg/dl, type?collagen 241ng/
ml, hyaluronic acid 119ng/ml, CEA1.0ng/ml and CA199 733U/ml. The
plan for curative resection was extended right lobectomy with complete
caudate lobectomy followed by bile duct reconstruction. The patient under-
went percutaneous trans-hepatic biliary drainage through the B3, followed by
the administration of daily ICK. Two weeks later, T-bil was still 4.9mg/dl with
ICG15 value of 32%. The volumemetry analysis showed that the expected
remnant liver was 29.2% of her total liver volume after the planned surgery.
The planned curative surgery was conducted under continuous administra-
tion of ICK. Although she had some signs of hepatic failure with elevated
total bilirubin of 10.4mg/dl, her condition improved within 10days, followed
by the discharge on 44days after surgery.
Conclusion. We reported a case with a successful large-volume hepatectomy
under administration of ICK, even though the hepatic icterus was not fully
ameliorated. ICK may prevent hepatic failure in large volume hepatectomy in
a marginally icteric liver.
PP 49.07
HEPATECTOMIES FOR NON-MALIGNANT AND NON-INFEC-
TIOUS LIVER MASSES.
Sapisochin, Gonzalo; Dopazo, Cristina; Bilbao, Itxarone; Escartin, Alfredo;
Lazaro, Jose Luis; Balsells, Joaquin
Hospital Vall D?Hebron, HBP Surgery and Liver Transplant, Barcelona,
Spain
Introduction. Non-malignant and non-infectious liver masses, are increas-
ingly being recognized with the widespread of better and more accurate
imaging techniques. Hepatectomies are usually performed with suspicion of
malignancy or because patients become symptomatic.
Aim. To describe our experience on hepatectomies for these masses.
Results. Between 19892006, 695 hepatectomies have been performed in
our unit, 68 (9,8%) for these masses. Mean age of patients was 50 years (r
2280); 46% males and 54% females. The majority of these masses were
cavernous hemangioma 15 (22%) and focal nodular hyperplasia 13 (19%)
while the rest of the diagnosis were a miscellanea. Fifteen percent were
cirrhotic patients of whom 50% were HCV positive and 10% HBV positive.
There was a unique mass in 80% of the cases and more than one in 20%, and
were located on the left lobe in 53%, 42% on the right lobe and 5% were
bilobar. Mean size of the biggest mass was 6 cm (r 0,418), 58% were
encapsulated. Indications for treatment were the suspicion of malignancy,
size or symptoms. Surgical procedures included 18 left lateral segmentec-
tomies (26,5%), 14 segmentectomies (20,5%), 14 tumorectomies (20,5%),
10 right hepatectomies (14,7%), 6 left hepatectomies (8,8%), 3 amplified left
hepatectomies (4,4%), 2 right lateral hepatectomies (2,9%) and 1 central
hepatectomy (1,5%); mean time for surgery was 154968 minutes with need
of blood transfusion in 24%. There was 1 case (1,5%) of postoperative
mortality due to acute liver failure. Morbidity was observed in 18%; 15%
infections, 7,4% biliary leak, 8,8% acute liver failure and 1,5% re-laparotomy
for hemoperitoneum. Patients were followed-up a minimum of 6 months and
no mortality was observed.
Conclusions. Non-malignant and non-infectious liver masses may be
resected with safety by expert liver surgeons and it is associated with a low
mortality and morbidity. We think that surgery is feasible and needed in cases
were the non-malignant nature of the mass cannot be confirmed or when
symptoms appear.
PP 49.08
RESULTS FOLLOWING SURGICAL RESECTION FOR PERIPH-
ERAL CHOLANGIOCARCINOMA
Pissanou, Theodora; Silva, Michael A; Attia, Magdy S; Manzia, Tomasso;
Coldham, Christopher; Mayer, David; Bramhall, Simon R; Buckels, John A
C; Mirza, Darius F
University Hospital Birmingham NHS Trust-Queen Elizabeth, The Liver
Unit, Birmingham, United Kingdom
Background. Peripheral cholangiocarcinoma (PC) is the second most
common primary bile duct cancer and constitutes 10% of primary liver
malignancies. Surgical resection presently offers the only prospect of long
term survival. We present the experience of managing PC at a tertiary referral
centre in the UK.
Methods. This is a retrospective analysis of a prospectively maintained
database from 1988 to January 2007. Patients with peri-hilar lesions and gall
bladder cancer were excluded.
Results. There were 103 patients (58 female), median age 64 (4181) years;
42 (41%) underwent surgical exploration with 29 (28%) undergoing curative
resection including portal lymph node clearance. All these patients presented
late with vague symptoms without jaundice. Postoperative morbidity and 30
Abstracts 189
day mortality were 52% and 10% respectively. R0 clearance was achieved in
22 (76% of resected) with 4 having R1 clearance. The median survival
following R0 resection was 16.4 (0.298) months and for R1 was 1.5 (0.332)
months respectively (P0.001). The median survival of non resectable and
those managed non operatively was 4.8 (056) months (P0.001). Tumour
size 5cm, vascular and lymph node invasion were significantly associated
with for tumor recurrence post resection and survival (PB0.05). R0 resection
of tumours classified as advanced according to UICC staging however
achieved longer survival compared to in operable and those managed non
operatively.
Conclusions. R0 resection resulted in significantly prolonged survival, with
tumour size, vascular and lymph node invasion being prognostic factors for
tumor recurrence and survival. R0 resection can provide prolonged survival,
even in patients with advanced PC.
PP 49.09
RUPTURED HEPATIC ANGIOSARCOMA: A CASE REPORT
Sonawane, Rajendra
Medical Trust Hspital, Surgical Gastroenterology, M G Road, Cochin, India
Introduction. Rupture is a common and fatal complication of Hepatic
Angiosarcoma (HA). Management of ruptured HA is addressed in anecdotal
reports worldwide. Hitherto it is unreported from India. CASE REPORT: A
65 year old male with 6 cm tumor in segment II and III was referred to us for
liver resection with histological diagnosis of hemangioendothelioma. The
patient opted for alternative medicine and was lost to follow up. Four months
later he was readmitted with hypovolemic shock and acute abdomen. On
assessment he was found to have hemoglobin of 4 gm%, hemoperitoneum
and 16 cm mass in liver. After resuscitation and transfusion of activated
factor VIIa, triphasic CT was done which revealed multiple space occupying
lesions in right lobe besides an exophytic 16 cm. mass from the left lobe. Left
lateral segmentectomy and partial caudate lobe resection was performed 48
hours after admission. Barring transient nonoligouric renal failure the
recovery was uneventful. Patient was discharged on 14th day. Histology
revealed HA. At 8 month follow up patient is alive and asymptomatic with
disease in right lobe.
Conclusion. This case report highlights aggressive nature of HA. Resection
is feasible in ruptured HA after optimization. Critical risk/benefit assessment
should be done, as resection is often non-curative. Angiographic emboliza-
tion has been reported either as an alternative modality or as an adjunct to
surgery. Role of factor VIIa in such situations is evolving and randomized
trials do not support its routine application yet.
PP 50.01
FLEXIBLE APPROACH IN MANAGEMENT OF NECROTIZING
PANCREATITIS
Shabunin, Alexey1; Bedin, Vladimir2; Shikov, Dmitryi3; Tavobilov, Michael3;
Lukin, Andrey3; Grekov, Dmitryi3
1Botkin, s Memorial Hospital, Prof. The cief surgeon, Moscow, Russian
Federation; 2Botkin, s Memorial Hospital, The cief of HPB-surgery,
Moscow, Russian Federation; 3Botkin, s Memorial Hospital, HPB-surgery,
Moscow, Russian Federation
Background. It’s obvious that degree of pancreas gland and parapancreatic
fat damage plays the leading role in determination of surgical approach,
which cosequently influences on the outcome.
AIM. to assess the role of Dynamic Contrast Enhancement Computed
Tomography (DCECT) in combination with ultrasound (US) monitoring
and MR-tomography in defining the surgical management. MATERIALS/
Methods. 277 patients with NP, which were presented of two groups, have
been analyzed during 2002 to 2006. All patients had the same clinical data
(Ranson3, APACHE9) on admission. Group 1125 patients (2002
2003), group 2  152(20042006). In group 1 the main role in diagnostic
algorythm were US monitoring and native CT. All patients from group 2
underwhent CECTon 35 days from the onset of desease or on the admission
case of delay hospitalization with following CECT monitoring and MRT to
detect latest complications. The choice of way and kind of surgery based on
clinical data and results of CECTor MRT. Patients which had CT index of C
and D and volume of necrosis (VN)B30% were underwent endoscopic
surgery and US guided percutaneus drain, in cases with peripancreatic fluid
collections50 ml. In some cases these methods were performed like a first
step with following open surgery. If CT index was grade E (VN  3050%, 
50%) such patients were mainly underwent open surgery.
Results. Endoscopic surgery and US-guided drain were performed as a first
and final stage of treatment in 41 (32,8%) cases of group 1 and in 106
(69,7%) of group 2. Endoscopic surgery and US-guided drain with following
open surgery were performed in 39 (31,1%) cases of group 1 and in 32
(21,1%) cases of group 2. Open surgery, as a single surgical method, was
performed In 45 (36,1%) cases of group 1 and in 14(9,2%) cases of group 2.
The mortality range in group 1 was 35,2% and 16,4%-in group 2 (p0.005).
Conclusion. DCECT and MRTare the most effective diagnostic methods in
management of necrotizing pancreatitis.
PP 50.02
THE ANTIOXIDANT STATUS OF AN INFLAMMATORY DISEASE
AS MEASURED BY CYCLIC VOLTAMMETRY: A RODENT
STUDY TO ASSESS THE SEVERITY OF ACUTE PANCREATITIS
Anubhav, Mittal1; Flint, Richard2; Fanous, Medhat3; Delahunt, Brett3;
Killmartin, Paul3; Cooper, Garth JS3; Windsor, John A1; Phillips, Anthony4
1University of Auckland, Surgery, Auckland, New Zealand; 2University of
Auckland, Surgery, Auckland; 3; 4University of Auckland, Surgery
Objective.To determine whether serum antioxidant capacity measured by
the electrochemical technique of cyclic voltammetry (CV) could resolve
differences in severity of the inflammatory disease acute pancreatitis.
Methods. Experimental animal study using male Wistar rats. Rats from 5
groups were studied. Group 1 (baseline), immediate euthanasia with no
surgical interventions; Group 2 (sham), identical surgical procedures to the
pancreatitis groups but no intraductal infusion; Groups 3  5, acute
pancreatitis induced by intraductal infusion of 3%, 4% or 5% sodium
taurocholate respectively. Terminal blood and pancreatic tissue samples for
CV, biochemistry and histology were collected at 12 h (Groups 25).
Results.There was a significant positive correlation of the first serum cyclic
voltametric peak current maxima (CVi1) with pancreatic histological severity
(Spearman r0.51, p0.007) as well as with a number of other markers of
systemic disease severity, notably bicarbonate (r0.57, p0.002), base
excess (r0.65, p B0.001) urea (r0.68, pB0.001) and calcium (r
0.60, p0.008). Uric acid and ascorbic acid, two circulating low
molecular weight antioxidants, were calculated to contribute a maximum of
57912% and 1994% respectively, to the serum CVi1 peak current. CVi1
was superior at indicating the severity of the disease state compared to a
standard method of total antioxidant capacity measurement (ABTS. based
assay).
Conclusions. CV was found to be a simple, technique that could
differentiate between the physiological and histological severities of acute
pancreatitis. Further clinical studies are now justified to determine if point-
of-care CV offers prognostic and treatment-monitoring advantages for severe
acute pancreatitis within the critical care setting.
PP 50.03
Experience of the treatment of emphysematous necrotizing pancrea-
titis.
Ðileikis, Audrius; Beiða, Virgilijus; Jurevie`ius, Saulius; Zdanyte¨, Elena;
Strupas, Kæstutis
Vilnius University hospital Santariðkiø klinikos, Abdominal surgery depart-
ment, Vilnius, Lithuania
Background. Emphysematous pancreatitis is a life-threatening condition
that ordinarily requires surgical management. Four cases of emphysematous
pancreatitis including successful medical treatment without any surgical
interventions are described in this article.
Methods. Retrospective review of case records of patients with emphysema-
tous pancreatitis, who have been treated by different methods.
Results. Four patients had pancreatic necrosis with retroperitoneal and
intrapancreatic gas trapping for more than 3 years. Retroperitoneal and
intrapancreatic gas trapping was found for all of them during the first week of
their illness. Two of them underwent immediate surgery after the confirma-
tion of the diagnosis (necrosectomy and open packing), the third patient was
operated (necrosectomy and closed lavage) on the 9th day after medical
treatment, and the fourth patient recovered after conservative treatment
without any surgery.
Conclusions. If the patient’s condition is stable antibiotic treatment could be
undertaken without any surgical intervention despite the evidence of
pancreatic infection. General physical condition of the patient is an important
factor for choosing a treatment rather than bacteriological or radiological
findings of the infection.
PP 50.04
ALCOHOL-METABOLIZING ENZYME GENE POLYMORPHISMS
AND ALCOHOL CHRONIC PANCREATITIS AMONG POLISH
INDIVIDUALS
Lach, Halina; Celin˜ski, Krzysztof; S3omka, Maria
Medical University of Lublin, Department of Gastroenterology, Lublin,
Poland
Background. Chronic pancreatitis develops in 510% of alcohol-addicts. In
developed societies alcohol is the cause of chronic pancreatitis, at least in 70
80%. Genetic polymorphism of enzymes involved in alcohol metabolism
plays relevant role in etiopathogenesis of chronic pancreatitis.
Aim. The aim of the study was to find, in the Polish population, the ADH,
ALDH2 and CYP2E1 alleles and genotypes that are likely to be responsible
for higher susceptibility to chronic alcohol pancreatitis.
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Methods. We determined the allele and genotype of ADH2, ADH3, ALDH2
and CYP2E1 in 141 subjects: 44 with alcohol chronic pancreatitis, 43
‘‘healthy alcoholics’’ and 54 healthy nondrinkers as the controls. Genotyping
was performed using PCR-RELP methods on white cell DNA.
Results. ADH2*1, ADH3*1 alleles and ADH2*1/*1, ADH3*1/*1 genotypes
were statistically more frequent among the patients with alcohol chronic
pancreatitis in comparison to the controls. ADH3*2/*2 genotype was more
frequent among ‘‘healthy alcoholics’’ and in the controls than among those
with alcohol chronic pancreatitis. In the studied group only ALDH2*1 allele
was detected, all patients were ALDH2*1/*1 homozygotic. Differences in the
CYP2E1 allele and genotype distribution in the examined groups were not
significant.
Conclusion. In the Polish population examined ADH3*1, ADH2*1 allele
may be risk factors for developing alcoholism. ADH3*2/*2 genotype may
confer protection against alcohol chronic pancreatitis. CYP2E1 gene poly-
morphisms are not related to alcoholism and alcohol chronic pancreatitis.
Examined Polish population is ALDH2*1/*1 homozygotic.
PP 50.05
GROOVE PANCREATITIS SUCCESSFULLY TREATED BY PAN-
CREATICODUODENECTOMY
DeOliveira, Michelle L.1; Benini, Ba´rbara2; Trivin˜o, Marcelo2; Apodaca-
Torrez, Franz R.2; Artigiani-Neto, Ricardo3; Trivin˜o, Tarcisio2
1University Federal of Sao Paulo-Division of Gastrointestinal Surgery,
Surgery, Sao Paulo, Brazil; 2University Federal of Sao Paulo-Division of,
Surgery, Sao Paulo, Brazil; 3University Federal of Sao Paulo, Pathology, Sao
Paulo, Brazil
Background. Groove pancreatitis is a rare subtype of chronic pancreatitis
where the fibrotic tissue involves the groove between the pancreatic head and
duodenum, and common bile duct. It is a tumor-like lesion that often mimics
pancreatic carcinoma. There are different choices of treatment for groove
pancreatitis described in the literature, mainly due complications from such
uncommon disease.
Aim. The aim of this study was to report three cases of groove pancreatitis
with duodenal stenosis.
Methods. Three male patients with an average age of 49 years, presenting
severe upper abdominal pain, post-prandial vomiting and weight loss
associated to remarkable history of alcohol abuse were evaluated.
Results. All patients underwent pancreaticoduodenectomy (with pylorus
preserving in two cases and partial gastrectomy in one case). After surgical
treatment, there was no related mortality and patients evolved with symptoms
relief and weight gain. The final diagnosis was confirmed by histological
findings.
Conclusion. These cases illustrate pancreaticoduonectomy as favorable
treatment choice for groove pancreatitis leading to duodenal stenosis.
PP 50.06
FREY’S PROCEDURE-EXPERIENCE OF A TERTIARY CARE
CENTER
Yadav, Thakur Deen; Wig, Jai Dev
PGIMER, General Surgery, Chandigarh, India
Background. Debilitating abdominal pain remains the most common
indication for surgery in patients with chronic pancreatitis. In 1987 Frey
and Smith described a new procedure designed to decompress a hypertensive
ductal system more completely in patients with chronic pancreatitis. The aim
of this study is to evaluate the safety and outcome of Frey’s procedure.
Patients and Methods. All patients of chronic pancreatitis where Frey’s
procedure was offered; were included in this study. The study period was
from June 2003 to May 2007.
Results. During this period, 28 patients affected by chronic pancreatitis were
subjected to the Frey’s procedure. Seventeen patients were male and etiology
included alcohol abuse in 12, idiopathic in 10 patients. Pancreas divisum was
found in 2 patients. Preoperative selection criteria included confirmed
diagnosis of chronic pancreatitis. Preoperative pain was present in 27 cases,
7 patients were diabetic, left sided portal hypertension was found in 4
patients. Frey’s procedure was done in 24 patients, Frey’s procedure with
hepaticojejunostomy in one patient, Frey’s with gastrojejunostomy in two
patient and Izbicki’s procedure in one patient. Postoperative gastrointestinal
and intraabdominal bleed occurred in one patient and small leak from the
pancreaticojejeunal anastomosis in one patient. Both these patients were
successfully managed on conservative line using octreotide in both. Mortality
was nil. All patients were pain free in the immediate post operative period.
After surgery, in two patients the diabetes stabilized and the insulin
requirement decreased. None of the patients developed diabetes in the post
operative period. The body mass index and quality of life showed significant
improvements in the follow up.
Conclusion. With limited follow up, the outcomes confirm that Frey’s
procedure is a safe procedure in experienced hands.
PP 50.07
SURGICAL CONSIDERATIONS IN THE MANAGEMENT OF
FAILED PANCREATIC ENDOTHERAPY (PANCREATIC STENT-
ING) IN CHRONIC PANCREATITIS
Joshi, Mukund
Joshi Clinic, Janardan Sadan, 1194/23, Ghole Road, Pune, India
Introduction. Endoscopic pancreatic stenting is quite commonly practiced
in cases of chronic Pancreatitis. Often it is followed by Pancreatic lithotripsy
for easier extraction. We have presented 14 cases in which pancreatic
endotherapy was advocated which failed on various accounts and needed
surgical exploration. The paper contains illustrations with intra-operative
photographs.
Methods. We selected cases of chronic pancreatitis who had undergone
pancreatic endotherapy, who presented with abdominal pain, sepsis or
Jaundice. 4/14 cases had undergone pancreatic stenting alone, 8/14 had
undergone stenting with Lithotripsy, 2/14 had undergone ERCP where
stenting had failed. All patients underwent CT scan evaluation, biochemical
work up and were started on IV antibiotics 24 hours prior to surgery.
Results. All cases underwent Laparotomy. Identification of pancreatic duct
was found to be difficult secondary to ‘‘Edematous Fibrotic pancreas’’. In
majority of cases stones were seen around the stent and 10/12 stents were all
blocked. All patients underwent PJ after successful removal of stent. Average
blood loss was 650cc. Requiring Blood transfusions. Average time was
4.30hrs. There was no mortality. DISCUSSION: Surgical exploration of
pancreas becomes difficult due to edematous pancreas which spreads to
nearby tissues making the dissection difficult. Stent could never be palpable
on the surface of pancreas due to edematous pancreas. One needs to be
extremely gentle while performing pancreatic anastomosis as sutures can give
way secondary to pancreatic tissue edema. Stents need careful pulling as it
can lead to severe bleeding and duodenal injury.
Conclusions. Pancreatic endotherapy is not without complications. Litho-
tripsy does not necessarily lead to duct clearance. Careful dissection is
priority. Adequate blood transfusions should be reserved. Overall post-
operative recovery appeared delayed as compared to Pancreatico-jejunos-
tomies done without pre-operative pancreatic endotherapy.
PP 50.08
ROLE OF FREY’S PROCEDURE FOR CHRONIC PANCREATITIS
IN INDIAN SCENARIO  INITIAL RESULTS
Joshi, Mukund1; Dadu, Anurag2; Dube, Sudhir2; Jamkar, Arun2; Joshi,
Manohar2
1Joshi Clinic, Janardan Sadan, 1194/23, Ghole Road, Pune, India; 2
Introduction. In India we have a mixed spectrum of tropical calcific
Pancreatitis & Alcoholic Pancreatitis. We selected Frey’s head coring
procedure for the patients with predominant disease in head of Pancreas.
Methods. Frey’s procedure was performed in 32/46 cases since Feb. 2002.
Frey’s procedure involves coring of the pancreatic head along with laying
open of the pancreatic duct & lateral anastomosis. Male to female ratio was
3:1. Age group ranged from 9 to 60 years. The main complaint was epigastric
pain referred to back, and significant weight loss, for over 5 years. 10/32 cases
were those of Tropical calcific pancreatitis (TCP)with no history of
Alcoholism, while the rest (22/32) gave h/o alcoholism ranging from 5 to
11 years. Out of these 22 cases, 15 patients had features of tropical calcific
pancreatitis. Six patients were diagnosed to have diabetes. & six were known
diabetics. Ultrasonography and CT scan were performed in all patients. 21/
46 cases were shown to have complicated disease in the head. Selection of
patients was made by radiological assessment ( 21/46) & by intra-operative
assessment (11/46). Average blood loss is around 350cc. Mean operation
time was 4:30 hrs.
Results. There was no mortality. 2 patients had superficial wound infections.
Two patients experienced malaena for 6 days. Mean post-operative hospital
stay was 9 days. 24/36 patients had excellent pain relief in the early post-
operative period. Pain relief was greater in the alcoholic group. DISCUS-
SION: The Frey’s procedure is more elaborate than classical lateral
pancreatico-jejunostomy. Pain relief in the alcoholic group was remarkable.
The diabetic status remained unchanged.
Conclusion. Frey’s procedure offered better pain relief than with lateral
pancreatico-jejunostomy alone and appears less cumbersome than Beger’s
procedure. Advantage of Frey’s procedure in the TCP group of patients
needs to be assessed further. Frey’s Procedure seems ideal for the disease
predominantly in the head of pancreas with H/O alcoholism.
PP 50.09
COMMON BILE DUCT (RE)STENOSIS AFTER SURGERY FOR
CHRONIC PANCREATITIS
Van der Gaag, Niels A; Boermeester, Marja A; Hemmes, Sabrine; Busch,
Olivier RC; Van Gulik, Thomas M; Gouma, Dirk J
Academic Medical Center, Surgery, Amsterdam, Netherlands
Background. Controversy exists whether surgical drainage alone (pancrea-
ticojejunostomy) treats chronic pancreatitis (CP) sufficiently or should always
be combined with (limited) resection (Frey/Beger procedure), to decrease the
risk of local symptoms such as common bile duct (CBD) stenosis.
Aim. To evaluate in patients with CP the occurrence of benign symptomatic
CBD stenosis after surgical drainage alone or after combined drainage/
resection.
Methods. Records of 146 drainage and 46 drainage/resection patients with
CP, operated between Jan-1992 and Sep-2006 for intractable pain, were
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reviewed to assess symptomatic CBD stenosis rate. Rates were compared
with the results after pure resection procedures, i.e. tail resection (38
patients) and pancreatoduodenectomy (PD) (68 patients; including 63 CP
patients operated for a mass lesion). Treatment of stenosis was also evaluated.
Results. 2 patients died postoperatively, 4 were lost to follow-up. Median
follow-up was 60 months. Symptomatic CBD stenosis occurred significantly
less after drainage compared to drainage/resection: 8% (12/144) vs. 24% (11/
45), respectively (P0.004). Concomitant biliodigestive anastomosis re-
duced symptomatic CBD stenosis to 3% (1/35) after drainage (P0.29) and
to 6% (1/18) after drainage/resection (P0.031). After pure resection
procedures symptomatic CBD stenosis rate was 5% (2/38) for tail resection
and 6% (4/67) for PD. Overall, patients received conservative treatment in
14%, endoscopy/PTC in 75% and reoperation in 41% (NS different among
procedures).
Conclusion. Symptomatic CBD (re)stenosis rate was higher after drainage/
resection for CP than after drainage alone, showing that, in the absence of
pancreatic head involvement in CP, surgical drainage alone carries no
increased risk of CBD stenosis.
PP 50.10
MESENTERIC INFLAMMATORY PROCESS IN EXPERIMENTAL
ACUTE PANCREATITIS: ROLE OF TNF-ALPHA IN
LEUKOCYTEENDOTHELIUM INTERACTION
Matheus, Andre S.1; Jukemura, Jose1; Coelho, Ana Maria M.1; Sannomiya,
Paulina2; Nakagawa, Naomi K.2; Machado, Marcel C.C.1; Cunha, Jose
Eduardo M.1
1University of Sao Paulo, Dept. of Gastroenterology, Sao Paulo, Brazil;
2University of Sao Paulo, Research Division-Heart Institute (InCor)
Background. Leukocyteendothelium interaction is known to be a remark-
able event at the beginning of systemic inflammatory response syndrome.
Leukocyte activation and infiltration are believed to be critical steps in the
progression from mild to severe pancreatitis and responsible for many of its
systemic complications. The aim of this study was to evaluate leukocyte
endothelium interactions in mesenteric postcapillary venules and cytokines
serum levels in experimental acute pancreatitis followed by inhibition of
TNF-a´ prodution.
Methods. Severe pancreatitis was induced in Wistar rats with a injection of
0.5ml of 2.5% sodium taurocholate into the pancreatic duct. Eighteen rats
were divided in 3 groups: Sham (surgical procedure without AP induction),
Pancreatitis (AP Induction), and Pentoxifylline (AP induction plus admin-
istration of 25 mg/kg pentoxifylline). Intravital microscopy was used to
observe inflammatory leukocyte rolling, adhesion, and transendothelial
migration in small venules in vivo (venule diameter, 1525 ı`m). TNF-a´,
IL-6, and IL-10 levels were measured by ELISA.
Results. Inhibition of TNF-a´ by pentoxifylline shows beneficial effects in this
experimental model. The Pentoxifylline group had a statistically significant
reduction of leukocyte rolling, adhesion, and transendothelial migration in
vivo and a statistically significant reduction of inflammatory cytokines levels
(IL-6, IL-10, and TNF-a´).
Conclusion. Inhibition of TNF-a´ reduced systemic inflammatory response
in this experimental model. Moreover, our data suggest that TNF-a´ induce
accumulation (adhesion, and transendothelial migration) of leukocytes in
acute pancreatitis.
PP 51.01
IS LIVER RESECTION FOR COLORECTAL LIVER METASTASES
SAFE AND FEASIBLE IN THE ELDERLY?
de Liguori Carino, Nicola1; van Leeuwen, Barbara2; Wu, Andrew1; Ghaneh,
Paula1; Audisio, Riccardo A.2; Poston, Graeme J.1
1University Hospital Aintree, Supra-Regional Hepato-Biliary Unit, Liver-
pool, United Kingdom; 2St. Helens & Knowsley Hospitals Trust, Prescot,
United Kingdom
Introduction. Among all patients with a newly diagnosed colorectal tumour
76% are between 65 and 85 years old. A substantial proportion will develop
colorectal liver metastases, for which resection is the only cure. This study
was conducted to investigate the feasibility, short and long terms outcomes of
liver resection for colorectal liver metastases in elderly patients.
Methods. Between 1990 and April 2007 data were prospectively collected on
patients over 70 years old who underwent a liver resection for colorectal liver
metastases in the Hepato Billiary Unit at the University Hospital Aintree,
Liverpool, UK.
Results. 181 liver resections were performed in 178 consecutive patients.
Median age was 74 years. 34 patients (18,8%) received neoadjuvant
chemotherapy(FOLFOX) prior to liver surgery and a majority (57,5%) of
liver resections involved more than three Couinaud’s segments. Median in
hospital stay was 13 days, 70 (38,5%) patients had perioperative complica-
tions and overall in hospital mortality was 4,9% (9 patients). Median follow-
up was 17,5 months (range 1120). Overall- and disease free survival rates at
1, 3 and 5 years were 86,1%, 43,2% and 31,5%, and 65,8%, 26% and 16%
respectively. Neoadjuvant chemotherapy and hepatic pedicle clamping did
not significantly influence overall and disease free median survival(p0.05).
In multivariate analysis only the occurrence of postoperative complications
was predictive of overall and disease free survival.
Conclusions. Liver resection for colorectal liver metastases in elderly
patients is safe and may offer long time survival to a substantial percentage
of patients. We strongly recommend considering senior patients for surgical
treatment whenever possible.
PP 51.02
GROWTH FACTOR EXPRESSION FOLLOWING THERMAL AB-
LATION OF COLORECTAL LIVER METASTATIC TUMORS.
Fifis, Theodora; Amidjojo, Jason; Anggono, Beatrice; Malcontenti-Wilson,
Caterina; Muralidharan, Vijayaragavan; Christophi, Christopher
University of Melbourne, Austin Health, Department of Surgery, Heidelberg
3084, Australia
Background. Thermal ablation is an alternative treatment for colorectal
liver metastases in patients not eligible for liver resection. While some studies
report lower tumor recurrence after thermal ablation compared to liver
resection, recurrence still occurs in large number of patients. Growth factors
which are upregulated during liver regeneration following hepatectomy, may
also be upregulated after thermal ablation resulting in tumor recurrence.
AIM: To investigate changes in growth factor expression after thermal
ablation Methods. A murine colorectal liver tumor metastasis model was
used. Thermal ablation of selected tumors was performed 21 days after
tumor induction. Expression of EGF, HGF, TGF-b, VEGF and bFGF was
assessed by immunohistochemistry and ELISA in thermal ablation and sham
treated livers and tumors at the time of treatment and at several time points,
for up to seven days after. Growth factors were also measured in livers of un-
induced mice.
Results. The baseline expression of VEGF and TGF-b were significantly
elevated in tumor bearing livers compared to that of un-induced livers. HGF
was also increased but did not reach significance. No changes in EGF
expression were observed. Expression of all growth factors decreased in the
ablated tumour following treatment. In the liver tissue and at distant non
ablated tumors VEGF and HGF showed a decreasing trend, while EGF
showed a small increase and TGF-b showed a significant increase at the later
time points.
Conclusion. The decrease in growth factors in the ablated tumors may be
responsible for the reported lower tumor recurrence compared to resection.
However the increases in EGF and TGFb in liver and untreated tumors of
the treated animals may contribute to tumor recurrence. Inhibition of these
factors in combination with thermal ablation may improve the outcome for
patients with unresectable liver metastases.
PP 51.03
DOES VASCULAR CLAMPING AFFECT LONG-TERM SURVIVAL
FOLLOWING LIVER RESECTION FOR COLORECTAL METAS-
TASES?
Nuzzo, Gennaro; Giuliante, Felice; Ardito, Francesco; Vellone, Maria;
Giordano, Marco; Ranucci, Giuseppina; Giovannini, Ivo
Catholic University-School of Medicine, Hepato-Biliary and Digestive
Surgery Unit, Rome, Italy
Background. Liver resection for colorectal metastases offers good long-term
outcome. A controversial issue is that hepatic ischemia/reperfusion injury
from vascular clamping might accelerate the outgrowth of residual micro-
metastases.
Objective. To evaluate the impact of liver ischemia on long-term outcome
after hepatectomy.
Methods. Between 1992 and 2006, 216 patients had primary curative
hepatectomy for metastases (colon/rectum 151/65; synchronous/metachro-
nous 85/131; single/multiple 116/100). Outcomes were analyzed according to
clinico-pathologic variables.
Results. There were 122 major and 94 minor resections, with hepatic pedicle
clamping in 163 cases (in 78 with continuous clamping30 min or
intermittent clamping60 min). Mortality was 0.9%, morbidity 24.3%,
blood transfusion requirement 26.4%. Clamping vs. no clamping was
associated with a higher rate of transfusion (39.6% vs. 22.1%, p0.02)
and transfused units/patient. At a mean follow-up of 39 months, 117 patients
(117/214, 54.7%) had recurrence, involving hepatic recurrence in 59
(27.6%). At univariate analysis, transfusion requirement, small surgical
margin, preoperative CEA, primary tumor nodal status, synchronous
metastases, R1-resection, major resection, number, bilobarity and size of
metastases (p from B0.001 to 0.03) were associated with lower disease-free
survival. Five-year disease-free survival was higher in patients who underwent
clamping (31.2 vs. 17.4%, p0.04). Liver-free survival was unrelated to
clamping and to its duration. At multivariate analysis, transfusion require-
ment and surgical margin remained the strongest predictors of lower disease-
free and overall survival (pB0.002 for all), with clamping weakly associated
with higher survival.
Conclusions. Blood transfusion and small surgical margin are powerful
predictors of poor long-term outcome, with no similar impact of clamping,
which indeed is protective against transfusion requirement.
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Prognostic factors in Hepatic Resections for the Colorectal cancer
metastases
Karamarkovic, Aleksandar1; Blazic, Ivan2; Ivancevic, Nenad2; Mihailovic,
Vojin2; Doklestic, Krstina3
1University Center for Emergency Surgery, School of Medicine Belgrade,
Surgiocal Dpt. III, Belgrade, Serbia and Montenegro; 2University Center for
Emergency Surgery, School of Medicine Belgrade, Surgical Dpt. III,
Belgrade, Serbia and Montenegro; 3University Center for Emergency
Surgery, School of Medicine Belgrade, Surgical Dpt. III, Belgrade
Background. Liver resection currently serves as the only one curative
therapy for liver metastases from colorectal carcinoma. Appropriate criteria
for surgical resection are controversial.
Aim. The aim of this study was to determine the caracteristics of the disease
which affected prognosis. Methodology: Between March 2002 and Decem-
ber 2006, 135 patients with hepatic metastases from colorectal carcinoma
underwent anatomical liver resection at our institution. There were 77 men
and 58 women, with a mean age of 56.9 years (range 2274). The follow-up
period ranged from 2 to 69 months. The survival rate was estimated by the
Kaplan-Meier method and compared by log-rank test.
Results. 76 of the primary lesions were located in the colon and 59 in the
rectum. There were 42 Dukes B, 54Dukes C and 39 Dukes D. Liver
metastases were detected synchronously in 45 and metachronously in 90
patients at the time of diagnosis. The operative mortality rate within 30
postoperative days was 3.1%. During the follow-up period we registered
tumor recurrence rate of 14.1%. The overall 5-year survival rate was 31.8%.
Multivariate analysis shows a significant correlation between 5-year survival
and solitary (pB0.05) and unilobar (pB0.01) metastases. The survival rate
did not significantly correlate with gender, age, location of primary tumor,
Dukes classification, time of diagnosis or CEA level.
Conclusions. According to our results, number and localization of meta-
static liver lesions represents the prognostic factors of significant importance.
Without an effective therapeutic alternative, liver resection is still recom-
mended and represent a ‘‘gold’’ standard in the treatment of colorectal liver
metastases.
PP 51.05
INTRA-OPERATIVE MEASUREMENT OF CARCINOEMBRYO-
NIC ANTIGEN IN GALLBLADDER BILE AS A MARKER OF
OCCULT HEPATIC METASTASIS IN COLORECTAL CANCER.
Hathurusinghe, Harsha; Holt, Adrian; Siriwardena, Ajith
Manchester Royal Infirmary, Hepatobiliary Surgery Unit, Manchester,
United Kingdom
Aims. Carcinoembryonic antigen (CEA)  a 200,000 kilodalton glycoprotein
has a high specificity for colon cancer and is used in post-resection
surveillance. In patients with hepatic metastases, CEA is concentrated in
bile and measurement of biliary CEA is reported to help predict metastases.
This study undertakes a pooled analysis evaluating intra-operative measure-
ment of biliary CEA during bowel cancer resection in order to ascertain
optimum cut-offs and predictive values (sensitivity and specificity) for
subsequent detection of hepatic metastases.
Methods. A computerized search of MEDLINE from January 1996 to June
2006 using the MeSH headings ‘‘carcinoembryonic antigen’’, ‘‘Bile’’ and
‘‘colorectal-neoplasms’’ was undertaken. Only articles with original data were
recruited. Pooled data were available on 203 patients with known hepatic
metastases at the time of bowel resection and a further 602 undergoing
colectomy without hepatic metastases. In all cases biliary CEA was obtained
by intra-operative gallbladder aspiration.
Results. There were no reports of procedure-related complications. Paired
(biliary CEA compared to serum CEA) data were retrieved for 203 patients.
All studies report higher levels of CEA in bile than in serum. Modal biliary
CEA in patients with known colorectal metastases was 612 ng/mL compared
to a modal serum CEA of 89 ng/mL in matched series. Raised biliary CEA
(with a cut-off set at 5 ng/mL) has a sensitivity of 75100% and a specificity
of 3895% for prediction of subsequent development of liver metastases.
Several studies report a correlation between hepatic tumour burden and
biliary CEA (R 0.80.91) with linear regression demonstrating that metas-
tases as small as 1 cm could be determined with raised biliary CEA.
Conclusion. There is evidence of a consistent trend that intra-operative
measurement of biliary CEA during bowel cancer resection and the finding of
elevated values helps in the identification of a subset of patients at risk for
subsequent development of hepatic metastasis.
PP 51.06
A PRELIMINARY ANALYSIS OF COMBINED LIVER RESECTION
AND NEW CHEMOTHERAPEUTIC AGENTS FOR SYNCHRO-
NOUS COLORECTAL LIVER METASTASIS
Ng, Wilson WC; Lee, KF; Wong, John; Fok, KL; Ng, Nancy; Lo, Xina; Mak,
OS; Ling, Eva; Lai, Paul BS
Prince of Wales Hospital, The Chinese University of Hong Kong, Depart-
ment of Surgery, Hong Kong SAR, Hong Kong
Background. Liver resection in combination of new chemotherapy for
colorectal liver metastasis can potentially prolong survival.
Aim. To evaluate the benefit of liver resection in combination with new
chemotherapy (oxaliplatin, irinotecan, capecitabine, bevacizumab or cetux-
imab) for patients with synchronous colorectal liver metastasis.
Methods. Patients who followed the management strategy were retro-
spectively studied.
Results. Over a four-year period (20022006), we had 30 patients with
synchronous colorectal liver metastasis (Dukes¡j D) undergoing hepatectomy.
Twelve patients (40%) were initially unresectable either due to local extend of
the disease or extrahepatic disease. Out of these 30 patients, 8 (26.7%) had
received palliative liver resection. Concomitant intra-operative radiofre-
quency ablation (RFA) and pre-hepatectomy RFA was used in 5 and 2
patients respectively. Fifteen patients (50%) had received pre-hepatectomy
chemotherapy (60% down-staging & 40% neoadjuvant) while 21 patients
(70%) had post-hepatectomy chemotherapy (57.1% palliative & 42.9%
adjuvant). Three patients (10%) developed post-operative complications
but there was no in-hospital mortality. The median minimal histological
tumor free margin was 10 mm. The median duration of follow up was
24.5months. Two patients (9.1%) developed recurrent liver metastasis after
curative liver resection. The median overall survival and disease free survival
were 33.8 and 7.3 months. The overall one- and two-year survival rates were
96.7% and 66.6% while those for disease-free survival rates were 45.6% and
28.1% respectively.
Conclusions. For patients with synchronous colorectal liver metastasis, liver
resection in combination with new chemotherapy demonstrates satisfactory
response rate and short-term survival outcome.
PP 51.07
CHEMOTHERAPY-ASSOCIATED HEPATOTOXICITY: IMPACT
ON THE SURGERY FOR COLORECTAL LIVER METASTASES
Polishchuk, Lilia; Kozmin, Leonid; Sekatcheva, Marina; Skipenko, Oleg
Russian Research Center of Surgery, Moscow, Russian Federation
Background. Preoperative prolonged chemotherapy lead to liver resection in
up to 1013% of the patients with initially unrespectable disease. But the
clinical effects of chemotherapy are associated with the chemotherapy-related
hepatic injuries. Damages of parenchyma can lead to increase of post-
operative morbidity and mortality.
Objective. To investigate the influence of chemotherapy on liver parench-
yma.
Patients and Methods. 40 patients (24 received preoperative chemother-
apy: C group; and 16 were without chemotherapy: C- group) were selected
for detailed pathologic analyses. Histologic review of the nontumorous liver
was performed using established criteria for steatosis, fibrosis, vascular
lesions and surgical necrosis. The effect of different regimens of chemother-
apy and associated liver injury on perioperative outcomes was analyzed.
Results. Chemotherapy consisted of 5-FU-based regimens: alone, 2 patients;
plus irinotecan, 2 patients; plus oxaliplatin, 7 patients; hepatic arterial
infusion with 5-FU, 2 patients; and other therapy, 3 patients. Clinical and
operative factors were similar in both groups. On histological analysis,
moderate and severe grade of steatosis had 11 cases, sinusoidal vasodilatation
 12, fibrosis  7 cases. Necrotic lesions possibly induced by operative
manipulation on liver were detected in 14 cases. There was no postoperative
mortality. In 7 from 16 post-chemotherapy patients, peliosis developed but
there was no correlation between postoperative morbidity and intraoperative
RBC transfusion requirement. The rate of moderate to severe steatosis was
similar (C group, 5; C- group, 6; p0,39). Fibrosis revealed more often in
C group (1 in C- group vs. 6 in C group, p0,025), but it was not
associated with increase of postoperative morbidity.
Conclusion. The main hepatic lesion induced by chemotherapy in patients
with colorectal liver metastasis is moderate and severe forms of fibrosis. Even
after prolonged chemotherapy, major liver resection could be performed
without mortality
PP 51.08
SPLENIC METASTASES FROM COLORECTAL CANCER: TWO
CASES
Bracco, Ricardo1; Grondona, Jorge2; Moreno, Adria´n3; Lo Veci, Juan4;
Moreno, Adria´n5
1Clinica Pueyrredo´n, HPB unit, Mar del Plata, Argentina; 2Centro Me´dico
Martı´n y Omar, HPB unit, San Isidro, Argentina; 3Clı´nica Pueyrredo´n, HPB
fellow; 4Centro Me´dico Martı´n y Omar, HPB fellow, San Isidro, Argentina;
5Clı´nica Pueyrredo´n, HPB fellow, Mar del Plata, Argentina
Background. splenic metastases from colorectal cancer are very rare and
there are only 13 cases reported in the English literature so far. Most cases are
asymptomatic and the diagnosis is usually made by imaging studies during
the evaluation of rising CEA level postoperatively.
Aim. to describe two cases of splenic metastases from colorectal cancer.
Methods. case 1: a 74 year old male patient underwent right hemicolectomy
for a right colon cancer 27 months before that an elevation of the CEA level
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was observed. At the same time a ct-scan showed a 6 cm in diameter tumor in
contact with the inferior part of the the spleen with no other evidence of
metastasic disease. At laparotomy a tumor located in an accesory spleen was
recognized. Splenectomy and remotion of the tumor was carried out and the
patient survived for 3 years and 3 months. Case 2: a 72 year old female
patient underwent a right hemicolectomy for a right colon carcinoma with 4
syncronous liver metastases. After a 6 months period of sistemic chemother-
apy she was operated on again to treat the liver tumors. Beside this lesions a
very small tumor of 0.5 cm on the small bowell wall and a cluster of small
tumors at the anterosuperior edge of the spleen were founded also. A left
hepatectomy, an atipical resection of the right liver, a wedge resection of the
small bowell and a splenectomy were performed. Eighteen months later the
patient died with cancer progression on lungs and bones.
Conclusions. splenic metastases are a very rare finding in the follow up of
colorectal cancer patients and long term survival can be achieved with
splenectomy.
PP 51.09
SYNCHRONOUS LIVER METASTASES RESECTED TOGETHER
WITH PRIMARY COLORECTAL CANCER
Lipska, Ludmila; Visokai, Vladimir; Levy, Miroslav
Thomayer Teaching Hospital, Surgical Department, Prague 4, Czech
Republic
Objectives: To review a single institution experience with simultaneous
resections of primary colorectal carcinoma and liver metastases.
Background. Surgery remains the only option for curative radical treatment
for liver metastases from colorectal carcinoma. The strategy for resection of
synchronous liver metastases from colorectal carcinoma is still a question for
discussion.
Methods. Aim of this lecture is to present our experience with simultaneous
resections of synchronous liver metastases in one stage procedure with
resection of colon or rectum. Since the year 1996 till 2006, 47 patient
undewent such operation in our surgery. The primary tumor was located in
colon in 27 patients (58%) and in 20 patients (42%) it was a rectal
carcinoma. In 2 patients the subtotal colectomy was performed due to acute
colon obstruction. Radical lymphadenectomy of the resected colorectal
primary up to apical nodes was obligatory. Lymphadenectomy of the
hepatoduodenal ligamnet was optional. Alltogether 90 metastatic lesions
were removed, 2 right hepatectomies, 2 left hepatectomies, 1 extended right
hepatectomy, 2 bisegmentectomies, 3 segmentectomies and 40 nonanatomi-
cal resections were performed. Two patients were operated urgently due to
large bowel obstruction.
Results. The mean blood loss was 600 ml, postoperative morbidity was 25%
and mortality 2,5%. Median survival was 2,4 year, median follow up 1,9 year,
3 year overall survival was 42% and 5 year overall survival was 30%.
Multivariate analysis was done and the most important prognostic factor was
N2 nodal status of primary colon or rectal cancer.
Conclusion. Simultaneous liver and colorectal resections are feasible. The
benefit for patient is only one operation. In our institution we prefere
nonanatomical parenchyma sparing resections.
PP 51.10
THE EFFECT OF MICROWAVE RADIATION (MWR) TREAT-
MENT ON THE SUBCELLULAR ANATOMY OF NORMAL LIVER
IN THE TREATMENT OF COLORECTAL LIVER METASTASES
(CLM)
Pathak, Samir1; Verghese, Miriam2; Poston, Graeme J1; Foster, Christopher
S3
1Royal Liverpool University Hospital, Dept of Surgery, Liverpool, United
Kingdom; 2Royal Liverpool University Hospital, Surgery, Liverpool, United
Kingdom; 3Royal Liverpool University Hospital, Dept of Patholgy, Liver-
pool, United Kingdom
Background. Hepatectomy is the gold-standard treatment for CLM and
should be achieved with 1cm margin because of the risk of satellite
tumours. Destructive therapies are being used increasingly to treat CLM,
particularly as not all patients are suitable for major, open surgery. Recent
interest has focussed on the use of MWR. Little is known about the
penetration depth of MWR beyond the visible macroscopic burn (B) in
human liver OBJECTIVES-To investigate the effect of MWR on adjacent
liver in patients undergoing evaluation of MWR for CLM.
Methods. Biopsies taken after MWR treatment (100W/120seconds, 3 cm
diameter CLM) at edge of B, 1cm, 2cm, 3 cm and distant from B for light
(H&E)(LE) and electron (osmium tetroxide fixation)(EM) microscopy.
Observers were blinded to sample site.
Results.
Discussion. The limited changes seen on LM may in fact be due to the
‘‘freezing’’ effect of the microwave radiation, immediately after use. These
cells do probably undergo severe damage as illustrated by EM. Future studies
to confirm this would be ethically challenging as one would need to biopsy
the same patient a few months post-operatively to ascertain the true extent of
the burn. It remains to be proven whether MWR treatment is safe or effective
when treating CLM. Our observations suggest that in normal human liver,
the effect of MWR, at the dose tested, will be measurable up to 2cm beyond
visible TB, which may be equivalent to the 1cm margin of conventional liver
surgery. Long-term follow up of these patients is needed to determine the
effectiveness of MWR as an alternative treatment to open hepatectomy.
PP 52.01
OUTCOME OF R1 RESECTION IN PATIENTS UNDERGOING
PANCREATODUODENECTOMY FOR PANCREATIC CANCER
Fusai, Giuseppe1; Pamecha, Viniyendra1; Warnaar, Nienke1; Sabin, Caro-
line2; Archibong, Samuel1; Davidson, Brian1
1Royal Free Hospital, Liver Transplantation & Hepatobiliary Unit, London,
United Kingdom; 2Royal Free and University College Medical School,
Primary Care & Population Sciences, London, United Kingdom
Background. Pancreatico-duodenectomy (PD) is the only potentially
curative treatment for cancer of the head of the pancreas. Its role is well
established if complete tumour clearance is anticipated. However, with the
decrease in perioperative morbidity and mortality, there might be a role for
palliative resection in selected cases. AIMS: To define the outcome for
microscopically incomplete PD in patients with pancreatic cancer.
Methods. 106 consecutive patients with pancreatic head cancer underwent
exploratory laparotomy with the intention to perform PD. 67 patients were
resected and 32 underwent palliative bypass (PSB) because of locally
advanced disease. Perioperative status and complications were recorded
and compared between the two groups. Survival was analysed between
patients undergoing microscopically complete (R0) PD, incomplete (R1) PD
and PSB.
Results. Groups were similar with regard to demographic and preoperative
state. Of the 67 PD, 27 were classified as R0 and 40 as R1. Median survival
for R0, R1 and PSB were 24, 18 and 9 months respectively. Survival in the
PSB group was 34% at 1 year and 0% at 2 years. 1, 2 and 5 year survival in
the R0 and R1 group was 79% and 70%, 48.3% and 39.1%, 21.5% and 9.9%
respectively. There was a significant difference between the mortality curves
in the three groups (p0.0002, log-rank test). Compared to those under-
going PSB, both other groups were less likely to die over follow-up (R0: Risk
Hazard (RH) 0.29, 95% CI [0.15055] p0.0002; R1: RH 0.41 [0.23
0.72], p0.002). Mortality was not different between the R0 and R1 groups
(RH 1.52 [0.792.92], p0.21). Perioperative complications and hospital
mortality were similar in the PD and PSB groups (29.9% and 3.0% vs 31.3
and 3.1% respectively, p1.00).
Conclusions. A better survival in the R1 PD than in the PSB group and a
similar perioperative risk would support the decision to perform a PD even
when there is the possibility of incomplete microscopic clearance.
PP 52.02
TUMOR INVASIVENESS IS THE STRONGEST PREDICTOR OF
SURVIVAL FOLLOWING RESECTION FOR AMPULLARY ADE-
NOCARCINOMA
Barauskas, Giedrius1; Gulbinas, Antanas2; Sileikis, Audrius3; Pundzius,
Juozas1; Strupas, Kestutis3
1Kaunas University of Medicine, Dept. of Surgery, Kaunas, Lithuania;
2Kaunas University of Medicine, Institute for Biomedical Research, Kaunas,
Lithuania; 3Vilnius University Hospital Santariskiu Klinikos, Centre of
Abdominal Surgery, Vilnius, Lithuania
Background. Adenocarcinoma is the most common malignant tumor of
ampulla, but in general it is still rare. Therefore there are discordant data on
factors affecting prognosis in in ampulla of Vater adenocarcinoma AIM. To
evaluate long-term survival of patients surgically treated for pancreatic
adenocarcinoma and to determine independent factors influencing survival.
Site LM EM
B edge 10% necrosis Granulomatous cytoplasm, complete loss of intracellular architecture
1cm B Scattered 10% necrosis Significant mitochondria loss in all cells and loss of intracellular lipids
2cm B Normal intracellular architecture Variable mitochondria and intracellular lipid loss, endoplasmic reticulum undamaged
3cm B Normal intracellular architecture Random loss of intracellular architecture, decreased mitochondria inB5% cells
Distant Normal intracellular architecture Normal intracellular architecture
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Methods. We have prospectively investigated 52 consecutive patients with
adenocarcinoma of the papilla of Vater at two HPB centers performing the
vast majority pancreatic resections in Lithuania. Preoperative clinical data,
pathology reports, UICC tumor stage and long-term follow-up results were
evaluated.
Results. Overall 1-, 3-, and 5-year actuarial survival rates after resection were
83.2, 67.7, and 67.7 per cent respectively with mean survival time of 71
months (95% CI: 5983) after resection. The survival rates of patients with
stage III tumor was significantly better than with stage IIIIV disease.
Patients with T1T2 and/or N negative tumors had significantly better
survival comparing with patients with T3T4 and/or N positive tumors.
Patients who had ampullary tumors with high or moderate differentiation of
cells (G1 and G2) survived better than patients with poor cell differentiation
(G3). Presence of lymphatic invasion and blood vessel infiltration by
malignant cells significantly worsened survival rates, whereas another tumour
related factor  neural invasion had no significant influence to overall survival
rates. Multivariate analysis revealed that lymphonode positivity ( Hazard ratio
for N1-5.8) and blood vessel infiltration (Hazard ratio for V1  7,1) are the
strongest independent predictors of survival.
Conclusion. Tumor invasiveness is the main predictor of survival after
resection for ampullary adenocarcinoma.
PP 52.03
POPULATION-BASED STUDY ON SURVIVAL DETERMINANTS
FOLLOWING PANCREATODUODENECTOMY FOR PANCREA-
TIC CANCER
Barauskas, Giedrius1; Gulbinas, Antanas2; Sileikis, Audrius3; Jurevicius,
Saulius3; Strupas, Kestutis3; Pundzius, Juozas1
1Kaunas University of Medicine, Dept. of Surgery, Kaunas, Lithuania;
2Kaunas University of Medicine, Institute for Biomedical Research, Kaunas,
Lithuania; 3Vilnius University Hospital Santariskiu Klinikos, Center of
Abdominal Surgery, Vilnius, Lithuania
Background. Majority of studies that have analyzed the determinants of
long-term survival in post resection pancreatic cancer patients, have been
single-institutional chart reviews yielding inconsistent results. Therefore
factors, influencing survival following radical operations due to pancreatic
adenocarcinoma are still ill defined.Objective. To analyze prognostic factors
influencing pancreatic cancer survival following curative resection, using
prospectively collected population-based data.
Methods. Data was prospectively collected from 199 consecutive patients
being resected for pancreatic adenocarcinoma at two HPB centers perform-
ing the vast majority of pancreatic resections in Lithuania. Overall survival
probabilities were calculated using Kaplan-Meier method. All factors likely to
be predictive of survival after pancreatic resection were evaluated by
univariate analysis (Log-rank test). Multivariate analysis using Cox model
was completed for all factors with p value B0.1 at univariate analysis.
Results. Median survival of the patients was 15 months. Overall 1, 3- and 5-
year actuarial survival rates after resection for pancreatic adenocarcinoma
were 56.3, 22.3 and 12.8 percent respectively with mean survival time of 26
months (95%CI: 2131). Univariate analysis revealed that stage of the
disease including T-stage and lymphnode positivity (N1), tumor differentia-
tion grade and curative (R0) resection were main factors influencing survival
for pancreatic cancer. Multivariate analyses through Cox proportional
hazards survival analysis indicated that strongest predictors of survival were
differentiation grade of the tumor (Hazard ratio 1.7 for less differentiated
G3G4 tumors) and curative resection (Hazard ratio 1.5 for R1).
Conclusion. Although biologic characteristics remain important predictors
of survival for patients with resected pancreatic cancer the survival rate could
be determined by the radicality of resection
pp 52.04
PANCREATICO-DUODENECTOMY WITH RADICAL LYMPHA-
DENECTOMY IN PATIENTS WITH ESTABLISHED CHRONIC
LIVER DISEASE AND PORTAL HYPERTENSION
Sethi, Harsheet; Marangoni, Gabriele; Srinivasan, Parthi; Prachalias, An-
dreas; Heaton, Nigel; Rela, Mohamed
Kings College Hospital, HPB Surgery and Liver Transplantation, London,
United Kingdom
Background. Chronic liver disease has been considered a contraindication
to radical surgery for intra-abdominal tumours because of the risk of
decompensation. There are no established guidelines for the management
of operable pancreatic tumours in patients with cirrhosis and portal
hypertension.
Methods. A retrospective analysis of all patients undergoing pancreatico-
duodenectomy for cancer from January 2000 to December 2006 at our centre
identified 4 patients with operable pancreatic tumours and well-compensated
chronic liver disease. Pre-operative staging, decompression of the biliary tree,
liver biopsy and assessment of the Childs-Pugh and MELD scores was
performed in all patients.
Results. All patients had successful pancreatico-duodenectomy with minimal
blood loss, and no peri-operative blood transfusions or liver decompensation.
There was no post-operative mortality. Two patients received adjuvant
chemotherapy. One patient died with recurrent disease at 18 months, one
is alive with disease at 22 months, and two patients are alive and disease free 8
and 11 months after surgery.
Conclusion. Patients with pancreatic cancer and well-compensated chronic
liver disease should routinely be considered for radical surgery.
PP 52.05
A VERTICAL STOMACH RECONSTRUCTION AFTER MODI-
FIED SUBTOTAL-STOMACH PRESERVING PANCREATICO-
DUODENECTOMY PREVENTING FOR DELAYED GASTRIC
EMPTYING
Oida, Takatsugu1; Mimatsu, Kenji2; Kawasaki, Atsushi1; Aramaki, Osamu1;
Kuboi, Youichi1; Kanou, Hisao1; Miyake, Hiroshi3; Amano, Sadao4
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan; 2;
3Kasukabe Municipal Hospital, Surgery, Kasukabe, Japan; 4Nihon Univer-
sity School of Medicine, Surgery, Tokyo, Japan
Background. AND AIM: Pylorus-preserving panpancreaticoduodenectomy
(PPPD) has better results in operative mortality and morbidity and post-
operative nutritional state than that of Whipple procedure. However, delayed
gastric emptying (DGE) comprises one of the most troublesome complica-
tions of this procedure. Subtotal stomach preserving pancreaticoduodenect-
omy (SSPPD), in which duodenum and pylorus ring were removed, has been
performed for the patients of periampullary and pancreas head tumors of
malignancy.I@While a comparison between PPPD and Whipple procedure
has been often reported, SSPPD has been evaluated as an alternative to
PPPD only few. The aim of this study was to create a reconstruction method
which preventing DGE with modified SSPPD.
Patients and Method. Eight patients (3 female, 5I@male) underwent
SS,oPD. The mean age was 64 years (56I@to 78). The diagnosis was
carcinoma of the pancreatic head in 3 patients, carcinoma of the ampulla of
Vater in 3 patients, carcinoma of the lower bile duct in 2 patients.
Gstrointestinal reconstruction after modified SSPPD was as followed.
Modified pancreaticogastrostomy, end-to-side choledocojejunostomy, and
end-to- side gastrojejunostomy have been performed, in that order. The
major modification of our technique was as retrocolic reconstruction and
setting the transverse colon between pancreaticogastrostomy and gastrojeju-
nostomy.
Results. Hospital mortality was none. Postoperative morbidity was 12.5%.
DGE and pancreatic leakage were observed in 12.5% and 0%, respectively.
Nasogastric suction was required for 2.6I} 1.0 (2 to 5) days, and 11.8I}3.4
(9 to 20) postoperative days were needed until a solid diet was tolerated
orally.
Conclusion. We consider that our reconstruction as one of the
most favorable procedure in patients who undergone pancreaticoduodenec-
tomy.
PP 52.06
DOES BILE CONTAMINATION DURING PANCREATICODUO-
DENECTOMY INCREASE POSTOPERATIVE SEPTIC COMPLI-
CATIONS?
Fuks, David; Mirre, Frantz; Riboulot, Michel; Moquet, Olivier; Delmas,
Jerome; Delcenserie, Richard; Yzet, Thierry; Dupont, Herve´; Regimbeau,
Jean-Marc
CHU Nord Amiens, Federation of Digestive Diseases, AMIENS, France
Background. Thirty percent of postoperative complications after pancrea-
ticoduodenectomy (PD) are septic. This study aimed to determine if bile
contamination during PD is an independent risk factor of postoperative
septic complications (PSC).
Methods. We reviewed data of 51 patients with PD with pancreaticogas-
trostomy performed from 2002 to 2006. We distinguished patients with bile
contamination (B) and patients with sterile bile culture (B). Among
patients with B with PSC, we compared isolated microorganisms. Clinical,
preoperative and PSC data were analysed using Mann-Whitney U-test and
Pearson chi(2) tests.
Results. 51 patients were included. Age (66915 years old vs 63916),
ASA3 (27% versus 20%), operative time (455960min vs 450997) and
blood loss (6509500 ml versus 6009387) were similar in group B and
B. Median length of stay (30917 days versus 21918), ICU stay (293
versus 293), overall mortality (3% versus 0%) and pancreatic fistula (42%
versus 48%; benign fistula 80%) were similar in both groups. 28 (55%)
patients had one or more PSC: 15 (58%) patients were B and 13 (52%)
were B (p0,68). 16 patients (31%) had local PSC: 10 (38%) were in B
group and 6 (24%) were in B group (p0,26). 35 (67%) patients had
distant PSC: 17 (65%) were in B group and 18 (72%) were in B group
(p0,61). 80% of local PSC were caused by same microorganism than in
bile versus 47% in distant PSC. In B group, 17 patients had preoperative
biliary drainage versus none in B group ((pB0.0001). We compared
antibiotic prophylaxis (with or without enterococci coverage) by amoxicillin/
clavulanic acid versus cephalosporin use. 8% of local PSC occurred with
amoxicillin/clavulanic acid use versus 39% with cephalosporin use (p0.07).
Conclusion. Bile contamination during PD doesn’t seem to increase PSC.
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Preoperative biliary drainage is a major risk factor of bile contamination.
The use of prophylactic antibiotics with amoxicillin seems to decrease local
PSC.
PP 52.08
Neoadjuvant radiochemotherapy for resectable adenocarcinoma of
the pancreas: hope and disappointment
Turrini, Olivier institut paoli calmettes, surgical oncology, marseille, France
Objective. To determine the real impact of neoadjuvant radiochemotherapy
(RCT) on survival of patients with pancreatic adenocarcinoma (PA).
Methods. From 1996 to 2005, 114 patients were diagnosed with resectable
PA. 82 patients received neoadjuvant RCT and 40 were resected (group 1)
after restaging (49%). 32 patients underwent primary surgery and 25 (group
2) had curative resection (78%).
Results. a) Intend-to-treat survival: median survival of patients receiving
neoadjuvant RCT (n82) or not (n32) was respectively 15 months and 14
months (p0.8); 5 year global survival was respectively 8%19% (p0.01).
b) Survival of resected patients: median survival for group 1 was 23 months
compared with 14 months for group 2 (P0.04). 5 year survival of group 1
and group 2 was respectively 14% and 21% (p0.16). c) Disease-free
survival: median disease-free survival for group 1 was 15 months compared
with 10 months for Group 2 (p0.03). Disease-free survival of group 1and
group 2 at 1, 3 and 5 years was respectively 57% and 47%; 27% and 18%;
and 14% and 18% (p0.04). Local recurrences occurred in 2 patients (5%)
in group 1 and 6 patients (24%) in group 2 (p0.02). General metastasis or
carcinomatosis occurred in 26 patients (65%) in group 1 and 10 patients
(40%) in group 2 (p0.04).
Conclusion. Impact on survival of neoadjuvant RCT is disappointing.
However, we concluded that abandoning the use of preoperative radiotherapy
is unjustified because it improves local control of the disease. Association with
systemic chemotherapy should improve survival, controlling the metastatic
part of the disease.
PP 52.09
Post Pancreaticoduodenectomy Hemorrhage: Risk factors and Man-
agement Options
Rajarathinam, G.; Vimalraj, V.; Jeswanth, S.; Ravichandran, P.; Rajendran,
S.; Balachandar, T.G.; Kannan, D.; Surendran, R.
Government Stanley Medical College and Hospital, Department of Surgical
Gastroenterology, Chennai, India
OBJECTIVE. The aim of the present study was to analyse the presentation
and management and risk factors of postoperative haemorrhage after
pancreaticoduodenectomy in a single institution during the last ten years.
MATERIAL AND Methods. Between Jan 1997 and Dec 2006 a total of 458
patients underwent Whipple’s pancreaticoduodenectomy in our department
were analyzed with regard to postoperative bleeding complications.
Results. Postoperative haemorrhagic complications occurred in 14 patients
(3.1%) with a range of interval from 1 to 40 days after pancreaticoduode-
nectomy. Early haemorrhage was recorded in 5 (36%) patients, and delayed
haemorrhage in 9 (64%) patients. Luminal bleed occurred in 6(43%) and
intraabdominal bleeding in 8(57%) patients, 8 (57%) had sentinel bleeding,
bleeding site identified in 13 (93%) patients. In 7 (50%) patients hemorrhage
developed from pseudoaneurysms of the peripancreatic major arteries, 5
(36%) from pancreatic stump, 1(7%) at anastomotic site. Hemostasis was
attempted by surgery in 10 (71%) patients; angioembolization was successful
in 2 (14%) and endotherapy in 1(7%)patient. Overall, mortality is 36%(n
5). Intraoperative vascular injury, pancreatic leak and sepsis were associated
with increased risk of massive bleeding.
Conclusion. The surgeon should seriously consider the possibility of
imminent massive hemorrhage in patients who had intraoperative vascular
injury, pancreatic leak and sepsis. Emergency angiography and embolization
is the recommended treatment fails which surgery indicated. Identification of
risk factors for massive bleeding and close observation postoperative leak and
sepsis might prompt earlier diagnosis.
PP 53.01
A NEW RECONSTRUCTION USING DOUBLE INTESTINAL SEG-
MENT AFTER PANCREATICODUODENECTOMY
Oida, Takatsugu1; Mimatsu, Kenji1; Kawasaki, Atsushi1; Aramaki, Osamu1;
Kuboi, Youichi1; Kanou, Hisao2; Miyake, Hiroshi3; Amano, Sadao4
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Social insurance Yokohama Central Hospital, Surgery, Japan; 3Kasukabe
Municipal Hospital, Surgery, Kasukabe, Japan; 4Nihon University School-
I@,l . . .,,,Z, . . ., Surgery, ,s,I,TM,I, Japan
Background./AIM. Pancreaticoduodenectomy (PD) is commonly used for
the surgical treatment of malignancies of the ampulla of Vater, duodenum,
head of pancreas, and distal common bile duct. We have performed PD with
pancreaticogastrostomy (PG) since 1999, no revealed pancreatic leakage,
however, delayed gastric empting (DGE) occurred in 40% of all patients
undergoing PD with PG. In this study we inroduced and evaluated our new
surgical technique, modified ChildIfs reconstruction with double intestinal
segment and with PG to prevent DGE after PD. SURGICAL TECHNI-
QUE: PG implanted the pancreatic stump into the upper area of the stomach
via a anterior gastrostomy. Interrupted sutures were placed circumferentially
around 1 cm below from the stump of the pancreas and a full thickness of the
posterior gastric wall through an anterior gastrostomy. The pacreatic duct
tube was brought out through the upper anterior gastric wall. A double
intestinal segment was prepared by means of an automatic instrument for
enteroanastomosis. An opening was made in the jejunum and a double
intestinal segment was produced by inserting the automatic instrument into
the jejunum through the opening. The double intestinal segment was
anastomosed to remnant stomach by side to end.
Results. No complications directly related to the procedure occurred. The
smooth passage to the double intestinal segment was observed, and the DGE
was short.
Conclusions. Modified ChildIfs reconstruction with double intestinal
segment and with PG useful procedure to prevent DGE without pancreatic
leakage.
PP 53.02
LAPAROSCOPIC VERSUS OPEN APPROACH TO NEUROLYTIC
CELIAC PLEXUS BLOCK IN INOPERABLE PANCREATIC CAN-
CER
Tsimoyiannis, E.C.1; Zikos, N.2; Pappas-Gogos, G.1; Tsimogiannis, K.E.1;
Benetatos, N.1; Tsimogiannis, K.J.1
1G. Hatzikosta General Hospital, Surgery, Ioannina, Greece; 2Filiates
General Hospital, Surgery, Filiates, Thesprotia, Greenland
Background. The cancer of pancreatic body and tail tends to be diagnosed at
a relatively late stage of the disease when curative resection is precluded.
Neurolytic celiac plexus block (NCPB) is an effective method of palliative
pain control in such cases, while the diagnostic laparoscopy prevents aimless
laparotomies in these severe ill patients.
Aim. We study the feasibility and effectiveness of the laparoscopic NCPB
guided by laparoscopic ultrasound (LUS) versus open approach.
Methods. Eight patients (Group A) with cancer of the pancreatic body and
tail underwent in diagnostic laparoscopy which revealed an inoperable
pancreatic cancer. After tru-cut needle biopsy, under LUS guidance 40 ml
of solution (20 ml of 95% ethanol mixed with 20 nl of xylocaine) was injected
into either side of the para-aortic soft tissue, on the level of the celiac artery,
via a percutaneously placed 18-gauge long length needle. The same solution
was injected and in ten patients (Group B), with inoperable pancreatic cancer
(body and tail) diagnosed during a laparotomy, under intraoperative
ultrasound.
Results. There were no intraoperative or postoperative, NCPB related,
complications. From the early postoperative period the patients in both
groups, reported significant pain relief. Using the visual analogue scale
preoperatively, in the 2nd postoperative day, 1st and 3rd postoperative
month, in Group A the score was 3.9, 1.0, 1.5, and 2.3 respectively, and in
Group B, 4.1, 0.8, 1.7 and 3.0 respectively (N.S. difference). In Groups A
and B the mean hospital stay was 2.1 vs 5.2 days (PB0.05) and the mean
survival 8.4 vs 7.6 months (N.S.).
Conclusions. The NCPB is feasible under laparoscopic approach, during
the diagnostic laparoscopy, and its effectiveness is about same as in open
approach. The laparoscopic NCPB gives a shorter hospital stay than the open
NCPB procedure.
PP 53.03
RISK FACTORS AFFECTING PANCREATIC FISTULA AFTER
PANCREATICODUODENECTOMY
Jang, Yongsun; Lee, Joung-Bum; Ahn, Seung-Ik; Lee, Keon-Young; Oh,
Cheong-Ah; Choi, Yun-Mee; Choi, Sun-Keun; Hur, Yoon-Seok; Kim, Sei-
Joong; Cho, Young-Up; Hong, Kee-Chun; Shin, Seok-Hwan; Kim, Kyung-
Rae; Woo, Ze-Hong
College of Medicine, In-ha University, Department of Surgery, Incheon,
Korea, Democratic People’s Republic of
Background. Pancreacticoduodenectomy is a procedure of choice for
managing periampullary malignancy. But pancreatojejunostomy site leakage
is so important and critical complication because of hardship of leakage
prevention. Objective. To analyze the risk factors of pancreatic leakage after
pancreaticoduodenectomy.
Methods. 172 consecutive patients were reviewed who had received
pancreaticoduodenectomy at Inha University Hospital between Apr. 1996
and Mar. 2006. We analyzed pancreatic leakage rates according to clinical
characteristics, pathologic findings, laboratory findings, and anastomosis
methods retrospectively.
Results. There were differences in the mean age and pathologic findings
between the two groups. Patients older than 60 years were 115 (66.9%) while
other 57 patients (33.1%) were younger than 60 years. The incidence of
developing pancreatic fistula in patients older than 60 years was 21.7% (25/
115) while 8.8% (5/57) in younger patients, showing a significant difference
regarding age(p0.03). The patients with dilated pancreatic duct showed
lesser post-operative pancreatic fistula rate than the patients with non-dilated
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duct(p0.001). Other factors including anastomosis method and pathologic
diagnosis dose not show any difference of statistical significance. According
to the pathologic diagnosis, patients with pancreatitis and stomach cancer
revealed pancreatic fistula to a smaller extent; among all cases- pancreatitis: 6
(3.5%), stomach cancer: 22 (12.8%). Among pancreatic fistula cases-
pancreatitis: 0 (0%), stomach cancer: 2 (6.7%) But the difference was not
statistically significant.
Conclusion. Our study demonstrated that pancreatic fistula is related to age
and dilated pancreatic duct. Surgeon must take these risk factors into
consideration when operating pancreaticoduodenectomy. We recommend
surgeons to use oneself skilful technique to prevent pancreatic fistula.
pp 53.04
CELIAC AXIS STENOSIS AND LETHAL LIVER ISCHEMIA
AFTER PANCREATICODUODENECTOMY
Visokai, Vladimir; Lipska, Ludmila; Trubac, Miroslav
Thomayer Teaching Hospital, Surgical Department, Prague 4, Czech
Republic
Celiac axis stenosis can lead to a fatal hepatic ischemia after pancreatico-
duodenectomy unless a simmultaneous revascularisation of the celiac
circulation is performed. We report three cases of celiac axis stenosis, all of
which had histologically confirmed periampullary cancer. Case 1: a 50-year-
old male with a history of myocardial infarction and liver steatosis; visceral
arteriography prior to the surgery demonstrated a celiac axis stenosis.
Whipple operation was performed. After removing the specimen no signs
of liver ischemia were found (liver was cholestatic) and pulsation of the
hepatic artery was strong. Patient died on the second postoperative day after
an abrupt irreversible cardiac arrest. Autopsy proved acute severe hepatic
ischemia. Case2: a 64-year-old female. Preoperative visceral angiography
showed significant celiac axis stenosis. As a first step of surgery the root of the
celiac trunk was exposed, a fibrotic ring around it was divided. Standard D1
pylorus preserving pancreaticoduodenectomy was performed. Case 3: a 58-
year-old female without preoperative angiography, indicated for surgery.
After occlusion test of the gastroduodenal artery liver became ischemic.
Division of the fibrotic ring around celiac axis was performed together with a
standard D1 pylorus preserving pancreaticoduodenectomy. No postoperative
complications were reported in both case 2 and 3. Our presentation is based
on our background of experience and on study of literature. Few published
articles on this topic what we found is in contradiction with frequence of this
phenomenon and its potential danger of acute liver ischemia after pancrea-
ticoduodenectomy.
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CONTINUOUS SUCTION DRAINAGE OF PANCREATIC JUICE
AFTER PANCREATICODUODENECTOMY WITH SOFT PAN-
CREAS
Oida, Takatsugu1; Aramaki, Osamu1; Mimatsu, Kenji2; Kawasaki, Atsushi3;
Kuboi, Youichi2; Kanou, Hisao2; Miyake, Hiroshi4; Amano, Sadao5
1Socil Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
3Social Insurance Yokohma Central Hospital, Surgery, Yokohama, Japan;
4Kasukabe Municipal Hospital, Surgery, Kasukabe, Japan; 5Nihon Univer-
sity School of Medicine, Surgery, Tokyo, Japan
Background./AIM. Pancreaticoduodenectomy (PD) is commonly used for
the surgical treatment of malignancies of the ampulla of Vater, duodenum,
head of pancreas, and distal common bile duct, however, leakage from
pancreatic anastomosis still occurs and a serious problem. It has been
proposed that a soft, friable, and normal pancreas with a normal size and
thin-walled main pancreatic duct increases the risk of anastomotic leakage
because of difficulties in anastomosis and the high output of pancreatic juice.
To prevent the pancreatic leakage, the high output of pancreatic juice from
soft remnent pancreas was contineous suction drainaged externally.
Patients and Method. Ten patients with soft pancreas underwent a PD. All
patients had pancreaticogastrostomy with pancreatic duct tube (Sumitomo
Bakelite Medical, Tokyo, Japan) connected to 200cc Silicone Bulb
Evacuator† (Bard Medical Division, Georgia, U.S.A), which drained
externally. The contineous suction pressure of Evacuator† is 20
30mmHg. The daily pancreatic juice output was measured for 7 days after
the surgery by using a pancreatic duct tube connected to Evacuator†.
Drainage fluid amylase from the drainage tube near the pancreatic
amnastomisis was measured on POD7. Anastomotic leakage was identified
radiological by using contrast medium.
Results. The mean daily pancreatic juice output was 84923 ml on POD1,
109932 ml on POD 2, 152949 ml on POD3, 180959 ml on POD4, 2079
44 ml on POD5, 250961 ml on POD6, 275975ml on POD7. The mean
levels of drainage fluid amylase was 80922 U/L. Pancreatic leakage and
fistula were no revealed. CONCULUSIONS: Total external drainage with
continuous suction of the pancreatic juice is useful to prevent pancreatic
leakage in patients with a soft pancreas.
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MANAGEMENT OF TRAUMATIC PANCREATIC TRANSECTION,
EXPERIENCE OF 6 CASES
Borgaonkar, Vijay, Seth Nandlal Dhoot Hospital, Surgery, A-1 Midc
Chikalthana, Jalna Road, Aurangabad, India
Introduction. Traumatic transection of pancreas is relatively uncommon,
but carries high morbidity & mortality if not treated appropriately. Pancreatic
injuries are often missed on first clinical examination & need high index of
suspicion & early diagnostic studies for diagnosis & proper treatment.
Materials. From the year 2002 to 2006, 6 patients of pancreatic transection
following vehicular trauma were admitted in our institute. All were male
patients, youngest 3 years & eldest 45 years. 2 presented within 2 hours of
injury, one within 24 hours, 2 within 48 hours & 1 presented delayed 7 days.
In all these cases diagnosis was established on computed tomography. 4 cases
had pancreatic transection at midbody, 1 had transection at neck & 1 was
with incomplete disruption of duct. Surgical management was performed in 5
patients & endoscopic management (pancreatic stenting) performed in 1.
Out of these 6, 5 recovered well, 1 succumbed to ARDS on 15th post-
operative day. This patient who succumbed had associated major injuries like
# shaft femur, multiple # ribs & # pelvis. Amongst surgical options, distal
pancreatojejunostomy Roux En Y anastomoses performed in 2. Distal
pancreactectomysplenectomy in 1, spleen preserving distal pancreactect-
omy & open drainage in 1 was performed. 1 patient had incomplete
disruption of the duct & was managed by pancreatic stenting. In all these
patients, peri- & post-operatively octeotrides were used. All patients treated
surgically had feeding jejunostomy for enteral nutrition. Intensive surgical
care & use of suitable antibiotic contributed for better results.
Conclusions. CT Scan is valuable imaging modality; MRCP is possible only
in select patients, ERCP is often not possible due to acute morbid condition.
Patients should be explored as early as possible, aims of exploration being
assessment of injury, peritoneal toilet with drainage, whenever feasible
perform definitive reconstructive procedure. In situations of high volume
drainage, ERCP & Pancreatic Stenting is useful.
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PANCREATIC TRAUMA: AN INSTITUTIONAL EXPERIENCE
Nagari, Bheerappa1; Regulagadda, Adikesava sastry2
1Nizam’s Institute of Medical Sciences, Surgical gastroenterology, Panja-
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Background. Diagnosis of blunt pancreatic trauma can be difficult. Delay in
diagnosis may lead to high morbidity and mortality. AIM: To evaluate the
investigative modalities, treatment options and their outcome following
Pancreatic trauma.
Methods. 48 consecutive patients with Pancreatic trauma were treated
between Jan.1990 and May 2007, of whom 33 had isolated pancreatic
trauma.
Results. There were 46 males and 2 females with age range of 855 years.
Grades of Injury were (AAST grading): Grade I- 6 patients, II  8, III  24, IV
 10. US Abdomen had poor correlation (9.3%) whereas CECT done in 38
patients had good operative correlation (80.7%). Out of 16 patients that
presented early (less than 48 hrs), 13 underwent surgery (Laporotomy and
drainage-6, distal Pancreatectomy-4, Pancreatic ductal drainage-2 for grade
IV as a part of two stage procedure and Laporotomy and debridement-1). 32
patients presented late and 23 underwent surgery (10 Pancreatic necrosect-
omy, 6 Laporotomy and drainage, 2 distal pancreatectomy, 2 Cysto
gastrostomy, 2 Pancreatico jejunostomy and one Whipples procedure.). Six
had percutaneous drainage for fluid collection and 3 were managed
conservatively. Ductal stenting was unsuccessful in 4 attempts in the late
group. Two patients with grade IV injury had an innovative external ductal
drainage initially followed by internal drainage three months later with good
result. All the six deaths were in the late group (19.3%). Seven patients had
complications-transient pancreatic fistula in two, bleeding, pancreatic ascites,
subphrenic collection, colonic perforation and sepsis with multiorgan failure
in one each.
Conclusion. Management should be individualized depending up on the
grade of injury, timing of presentation and presence of associated injuries.
Based on our experience we recommend conservative surgery that could be
staged even in grade IV injuries.
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SPECTRUM AND OUTCOME OF PANCREATIC TRAUMA
Prabhu, Ramkrishna1; Kantharia, Chetan2; Bapat, Ravindra3; Supe, Avi-
nash3
1Kem Hospital & Seth Gs Medical College, Surgical Gastroenterology,
Mumbai; 2Kem Hospital & Seth Gs Medical College, Surgiacl Gastroenter-
ology, Mumbai, India; 3Kem Hospital & Seth Gs Medical College, Surgical
Gastroenterology, Mumbai, India
Abstracts 197
Introduction. Pancreatic trauma is associated with high morbidity and
mortality. Its diagnosis is difficult, posing a formidable challenge.
Methods. Prospective analysis of data of 17 patients of pancreatic trauma
was done with respect to the mode of injury, diagnostic modalities, associated
injuries, grade of pancreatic trauma and its management. Pancreatic Trauma
was graded as per Modified Lucas classification.
Results. Median age: 39 years (range 1961). Etiology of pancreatic trauma
was blunt trauma -14 and penetrating injury-3 cases. Bowel injury in 4 cases
(3 penetrating injury and 1 blunt trauma) and one had associated vascular
injury. Pancreatic Trauma graded as (Grade I- 5, Grade II- 3, Grade III- 7
and Grade IV -2). CECT scan was done for diagnosis in all patients with
blunt trauma. Immediate diagnosis could be reached only in 4 (28.57%).
Seven patients responded to only conservative treatment. Of ten patients
operated, 6 required surgery for pancreas and duodenum. (distal pancrea-
tectomy with splenectomy -3, PPPD -1, debridement with external drainage-
1, associated injuries -duodenum -1). Pancreatic fistula, recurrent pancrea-
titis and pseudo-cyst formation was seen in 3 (17.05%), 2 (11.7%) and 1
(5.4%) patients respectively. Mortality was in 4 cases (23.52%), Grade IV-2,
Grade III- 2.
Conclusions. CECT scans are useful in diagnosing and grading pancreatic
trauma and in treatment and follow up of these patients. A repeat scan is
indicated at times for evolving pancreatic injury. Though majority responds
to conservative treatment, patients with penetrating trauma, higher grade
pancreatic trauma and associated injuries require surgical interventions which
carry higher morbidity and mortality.
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MULTIPLE ORGAN INJURIES WORSE OUTCOME IN
PANCREATIC TRAUMA
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Background. Traumatic injury to the pancreas is uncommon with a
reported prevalence of only one out of 250,000 trauma admissions. Both
the diagnosis and treatment of most pancreatic trauma represent major
challenges for the surgeons. The most important determinant guiding
management is the integrity of the main pancreatic duct. Because of the
low prevalence, few surgeons or institutions have gathered sufficient
experience to address the diagnostic and therapeutic issues.Objective. The
aim of this study was to evaluate in a single large trauma center the
management, severity, and complications of pancreatic injuries.
Methods. We performed a retrospective analysis of 50 consecutive patients
with pancreatic injuries admitted to a single trauma center over a 20-year
period focusing on diagnosis, therapy and prognostic factors.
Results. The median age was 32 years and 84% of the patients were male.
The mechanisms of injury were blunt trauma in 20 (40%) patients, gunshot
wound in 22 (44%) and stab wound in 8 patients (15%). Injury to the
pancreas was isolated in only 4 cases and combined with other organ injuries
the other 46 patients. Accordingly to the Pancreas Injury Severity Score
Criteria (AAST), there were 6 injuries Grade I, 21 Grade II, 17 Grade III, 5
Grade IV and one Grade V. The majority (66%) of pancreatic injuries was
managed by drainage with or without suturing. Distal pancreatectomy was
performed in 16 patients (%), and a Whipple procedure in one patient.
Complications were graded according to a standardized severity grading
system. Overall complications occurred in 70% of the cases and pancreas-
related complications occurred in 56%. The overall mortality rate in this
series was 34%, which closely correlated to the presence and number of
extrapancreatic injuries. Mortality was also higher in gunshot and blunt
trauma injury group.
Conclusion. Pancreatic trauma is associated with a high morbidity and
mortality mostly due to associated injuries.
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PREDICTORS OF MORTALITY IN INJURIES TO THE PANCREA-
TICO-DUODENAL COMPLEX
Gupta, Rajesh; Wig, Jai D; Kudari, Ashwini K; Doley, Rudra P; Ravella,
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Background. Injuries to the pancreatico-duodenal complex are rare with
high mortality.Objective. To identify predictors of mortality in these difficult
to manage injuries.
Patients and Methods. In this retrospective study, we analysed the results of
management of these injuries at our Gastrointestinal Surgery unit.
Results. There were 37 cases of injury to pancreatico-duodenal complex
(pancreatic 21, duodenal 11 and both 5) i.e., total of 26 pancreatic and 16
duodenal injuries. There were 35 males with mean age of 32.9 years. Blunt
trauma accounted for 27 and penetrating in10. Nineteen patients arrived
24 hours later. Associated intra-abdominal injuries were present in 62.1%
and extra-abdominal injuries in 32.4%. Mortality was 10/37 (pancreatic
23.8%; duodenal 27.2%; combined 40%). Pancreatic injury group: Admis-
sion factors with significantly higher odds for mortality were age, hypoten-
sion, and hyperuremia. Tachypnea for48 hours postoperative and
multiorgan failure had significantly higher odds. Duodenal injury group:
Admission hypotension, associated chest abnormality and postoperative
hypotension had nearly significant odds. Whole Cohort: Significantly higher
odds were noted for age, associated chest injuries, hypotension, hypoxia, and
hyperuremia amongst the admission parameters. Leucocytosis at admission
had significantly lower odds. Postoperatively significantly higher odds were
noted with systemic complications, tachycardia, tachypnea and hypotension.
Conclusions. AAST grade of organ injury and location of pancreatic or
duodenal injury and the operative procedure were not significant factors
affecting mortality. In pancreatic injury group, age, admission hypotension,
hyperuremia, postoperative tachypnea and multiorgan failure had signifi-
cantly higher odds. In duodenal injury, hypotension and associated chest
trauma had nearly significant higher odds.
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MODIFIED RECONSTRUCTION OF MIDDLE HEPATIC VEIN
OUTFLOW IN RIGHT LOBE LIVER TRANSPLANT WITHOUT
INTERPOSITION GRAFT
Vij, Vivek1; Srivastav, Ajitab1; Goyal, Neerav1; Govil, Deepak1; Gupta,
Subash2
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Background. Middle hepatic vein (MHV) outflow reconstruction with
interposition graft in Right lobe liver transplant is a tedious and time taking
process. Retrieval of MHV requires preserving the segment 4a branch in
order to prevent congestion of remnant liver. Quite often this will require
lengthening of MHV at the back table by an interposition graft obtained from
recipient portal vein. This leads to prolonged cold ischemic time, anhepatic
phase, portal clamping time leading to congestion of bowel and overall
prolonged operative time for the recipient. To avoid these, we join the MHV
of right lobe directly with carefully retrieved intrahepatic portion of the MHV
of the recipient.
Methods. From January 2004 to August 2007, a total of 70 live donor liver
transplants were done. 42 (60%) right lobes were retrieved with full or partial
MHV. New technique was used in last 10 consecutive patients. Operative
time was compared in 32/42 patients without this technique (group A) and
10/42 patients with this technique. During the terminal phase of recipient
hepatectomy (after dividing portal structures and right hepatic vein) the long
length of MHV was retrieved after splitting the liver parenchyma at the root
of MHV. This stump of MHV was carefully checked and any holes were
closed. MHV of the graft was directly joined to this stump maintaining a
specific orientation.
Results. Anastomosis was technically successful in all the ten cases as
documented on intraoperative Doppler study. None of the anastomosis
required revision. The average time saved was 2.45 hours when compared to
the group A. This led to shorter cold ischemia time, shorter anhepatic phase
and shorter portal clamping time. The routine protocol Doppler’s on first five
days confirmed the triphasic flow and patency of MHV.
Conclusion. The technique of directly joining the MHV of the right lobe
graft with carefully preserved MHV of the recipient is feasible & saves overall
operative time. It also shortens cold ischemic time, portal clamping time &
anhepatic phase.
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INFERIOR VENA CAVAL MOBILITY AND VENOUS OUTFLOW IN
LIVING DONOR LIVER TRANSPLANT
Vij, Vivek; Goyal, Neerav; Srivastav, Ajitab; Gupta, Subash
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Background. Proper venous outflow in living donor liver transplant is the
key to avoid congestion and resultant graft dysfunction. Venous outflow is
very sensitive to positional (rotation) changes of the graft as the graft swells
up after reperfusion and may obstruct hepatic venous outflow. Further, the
right hepatic vein- caval anastomosis is sometimes difficult due to less
mobility of the posterior edge of the common orifice of right hepatic vein and
IVC. We report a new technique to facilitate this anastomosis and prevent the
effect of graft rotation after reperfusion. In this new technique, we completely
free the cranial end of the IVC from the diaphragm by tying off the phrenic
branches of the IVC.
Methods. From January 2004 to August 2007, a total of 70 live donor liver
transplants were done. 63/70 (89%) of patients underwent right lobe liver
transplant. The cranial side of the IVC was freed in the last 30 cases. After
recipient hepatectomy without caval clamping, the phrenic veins draining
into IVC were ligated and divided. IVC was then mobilized carefully
circumferentially for a length of about 1.52.0 cm above the opening of the
right hepatic vein. All the hepatic venous-caval anastomosis was done after
cross clamping the supra and infra hepatic IVC.
Results. Freeing the IVC resulted in easier anastomosis as the IVC could be
easily lifted up during the anastomosis. The analysis of waveforms of the
Doppler USG after reperfusion of the graft revealed an interesting finding.
28/30 (100%) patients with this technique revealed triphasic waveform of
outflow veins. None of the patients required positional adjustment of the graft
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after reperfusion. 5/33 (15%) of patients required major graft positional
adjustments after reperfusion before adopting this technique and only 18/33
(55%) revealed triphasic flow in outflow veins and biphasic flow in the
remaining.
Conclusion. This new technique helps in easing the anastomosis and leads
to good outflow as documented by triphasic waveform on doppler examina-
tion.
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Introduction. Liver transplantation is indicated in patients with end-stage
liver disease due to neonatal hepatitis.
Objective. We present our institutional experience with living donor liver
transplantation in children with neonatal hepatitis.
Patients and Methods. 310 patients underwent LDLT at our institution
from June 1994 to May 2007. Ten children (5 male, 5 female) were
diagnosed with neonatal hepatitis. We reviewed and analyzed the clinical
records of these patients retrospectively.
Results. The median age at the time of transplantation was 1.5 years (range
0.666). The mean Child-Turcotte-Pugh score was 9 (S.D. 91.89), and the
mean PELD score was 15.6 (S.D. 97.60). All patients presented with
hyperbilirubinemia and/or complications from end-stage liver disease. 5
patients had undergone prior exploratory laparotomy to investigate the cause
of neonatal jaundice. Hepatitis B and C were negative in all patients. Nine
patients received left lateral segment grafts and one patient received an
extended left lateral segment graft. The mean graft-to-recipient weight ratio
was 2.92 (S.D. 90.86). One patient with a primary duct-duct anastomosis
developed biliary stricture that required conversion to a Roux-en-Y hepati-
cojejunostomy. Another patient developed intestinal B cell lymphoma with
bone marrow metastasis which required small bowel resection and che-
motherapy. There was one perioperative mortality from liver graft infarction
secondary to portal vein occlusion. Another patient died at 15 months post
transplantation from sepsis secondary to pneumonia. The mean follow-up
was 59.89 months (S.D. 922.34 months). Only 1 patient had an episode of
acute cellular rejection. Liver function was normal in all surviving patients.
The 6-month, 1-year and 5-year recipient survival rates were 90%, 80% and
80% respectively.
Conclusion. LDLT is a viable option for pediatric patients with end-stage
liver disease secondary to neonatal hepatitis. Long-term follow up after liver
transplantation shows excellent graft and patient survival.
PP 54.04
APPLICATION OF CRYOPRESERVED VEIN GRAFTS TO RE-
CONSTRUCT PORTAL FLOW IN ADULT LIVING LIVER TRANS-
PLANTATION
Wu, Tsung-Han; Chou, Hong-Shiue; Wu, Ting-Jun; Lee, Wei-Chen; Jan, Yi-
Yin; Chen, Miin-Fu
Chang-Gung Memorial Hospital, Department of General Surgery, Taipei,
Taiwan
Introduction. Adult-to-adult living donor liver transplantation is not only an
alternative but also the only way to solve shortage of liver donation for adult
patients in Asia countries. When transplant candidates have portal vein
thrombosis/fibrosis, living donor liver transplantation is relatively contra-
indicated because portal veins in the grafts are short and vein grafts may not
be available to reconstruct portal vein. MATERIAL&Methods. From June
2003 and May 2007, 82 adult living donor liver transplantations were
performed at Chang-Gung Memorial Hospital, and three of them having
portal veins thrombosis/fibrosis were accepted to have living donor liver
transplantation. Cryopreserved vein grafts were applied to reconstruct portal
flow from engorged coronary vein to graft portal.
Results. Following Doppler ultrasound and computed tomography showed
vein grafts are patent in 12, 12 and 3 months, respectively, after transplanta-
tion. All three patients are well and have normal liver function at present.
Conclusion. Portal vein thrombosis/ fibrosis increases surgical complexity of
liver transplantation. When cryopreserved vein grafts are available, adult
living donor liver transplantation can be successfully performed for the
patients with portal vein thrombosis/fibrosis. A shortcut from engorged
coronary veins to graft portal vein is preferred for portal vein reconstruction,
which is short and may decrease re-thrombosis incidence of venous conduits.
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A COMPARATIVE STUDY ON THE PREDICTABILITY OF CT
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Backgrounds. Accurate prediction of the functional mass of both graft and
remnant livers is essential for proper donor selection and optimal recipient
outcome in adult living donor liver transplantation (LDLT). The objectives
of this study is to evaluate accuracy for determining lobar liver volumes using
a multi-detector CT scanner in potential donors undergoing LDLT and to
compare predictability of CT volumetry between right and left lobe.
Methods. During the period from January 2005 to December 2006, 472
donors who underwent hepatectomy for LDLT in our center were included
this study. 359 patients underwent right lobectomy and 113 patients
underwent extended left lobectomy. Multi-detector CT was preoperatively
performed all patients. The estimated volume of the grafts in two-demen-
sional image was compared with actual graft weight.
Results. In right lobectomy group, preoperatively measured right lobe
volume was 779?133 mL and actual graft weight was 692?107 g. There
was significant agreement between preoperatively measured right lobe
volume and actual graft weight at surgery in right lobectomy group (r
0.838). In extended left lobectomy group, preoperatively measured left lobe
volume was 372?92 mL and actual graft weight was 384?82 g. There was
significant agreement between preoperatively measured left lobe volume and
actual graft weight at surgery in extended left lobectomy group (r0.841).
Error ratio B(estimated liver volume?actual graft weight)/actual graft
weight * 100 was 12.9?10.3% and?2.7?11.6% for right lobe graft and
extended left lobe graft, respectively.
Conclusions. The relationship between the estimated CT volume and actual
graft weight was linear. The preoperatively measured volume of right lobe is
substantially larger than the intraoperative actual graft weight. The pre-
operatively measured volume of left lobe is smaller than the intraoperative
actual graft weight.
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Aim. To asses our experience with the use and management of m-TOR after
liver transplantation (LT).
Material: From 1988 to 2007, 783 LT has been performed in 725 patients.
Fifty one patients (7%) received immunosuppression with m-TOR: Rapa-
micine 36 and everolimus 15. Mean age was 54.8 y (r:2470). Indication of
use, time between LT and introduction of m-TOR, eficacy, side effects and
survival were analysed.
Results. Indications were: refractory rejection in the context of renal
insufficiency 20 (39%), renal insufficiency 5 (10%), other side effects of
CNI 6 (12%), extended HCC in the explanted live 7 (14%), HCC
recurrence in the follow-up 7 (14%) and the novo tumour 3 (6%). Mean
time between LT and m-TOR were 18929 months; median 3 months (r:10
days-122months). Mean follow-up after conversion was 12 months (r: 165),
with a median of 7. Half of the patients converted for refractory rejection,
resolved the event; 4 required re-LT; 3 progressed to chronic rejection and 3
died due to non resolved rejection, overimmunosuppression and sepsis. Of 19
patients with renal insufficiency at time of conversion, 10 (52%) resolved.
Three out of 7 patients with extended HCC, died and 4 out of 7 patients with
recurrent HCC, died. The 3 the novo tumour were operated and are perfectly
healthy. Half of the patients presented side effects related to m-TOR:
diarrhea in 4 (8%), hematologic complications in 5 (10%), dyslipemia in
22 (43%), and infection in 8 (16%). Ten patients (20%) developed acute
rejection after conversion. Nineteen patients (33%) discontinued drug: 9 due
to ineficacy, 4 due to resolution of the cause, 3 due to intercurrent surgery
and 3 due to advers event. Actuarial survival postconversion is 55% and 15%
at 1y and 3y.
Conclusion. m-TOR are indicated in critical and sometimes irreversible
situations where other immunosuppressants have failed. In the early period
for refractory rejection or as prophylaxis for recurrence of extended tumors.
In the late period for patients with serious CNI side effects
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BASILIXIMAB INDUCTION IN ORTHOTOPIC LIVER TRANS-
PLANT RECIPIENTS FOR DELAYED TACROLIMUS INITIATION
AND RENAL PROTECTION
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Thomas D3; Jeon, Hoonbae3; Gedaly, Roberto3; Ranjan, Dinesh3
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Background. Tacrolimus, a calcinuerin inhibitor (CNI), is a mainstay of
current immunosuppression, although its use is complicated by nephrotoxi-
city. CNI-sparing regimens, often with basiliximab induction, are sometimes
used in renal transplant patients, but there is scant data in orthotopic liver
transplant (OLT) patients. We hypothesized that using basiliximab for
induction after OLT in patients with renal dysfunction provides adequate
immunosuppression and allows delay of CNI initiation. OBJECTIVES: To
evaluate if: 1. basiliximab induction coupled with delayed CNI initiation will
favorably affect renal function (up to 3 months); 2. delaying CNI will result in
increased incidence of acute rejection episodes.
Methods. We reviewed charts of all patients who underwent OLT since April
2005 who had elevated creatinine and/or oliguria postoperatively and
received basiliximab induction with subsequent delay in CNI initiation.
Patients were divided by serum creatinine: 1.5mg/dL (group A) and
¡U¨1.5mg/dL (group B).
Results. There were 12 patients in group A, and 11 in group B. Mean
creatinine in group A at 1 day, 1 week, 1 and 3 months postoperatively was
2.2, 1.8, 1.6, and 1.4 mg/dL, and 1.3, 1.0, 1.2, and 1.3 mg/dL in group B,
respectively. One patient (in group A) underwent treatment for acute
rejection, which in retrospect was recurrent hepatitis C. Timing of the first
basiliximab dose varied slightly but was postoperative day 1 on average (range
03). Mean times to CNI initiation were 4.5 days in group A and 4.1 in
group B.
Conclusion. While improvement in postoperative renal function may be
multifactorial and not only related to delayed CNI therapy, our data show no
detrimental effect of basiliximab induction and delay of CNI initiation after
OLT, particularly in patients with greater renal impairment (serum creatinine
1.5mg/dL). The degree of mild renal insufficiency at which optimal benefit
is obtained with this regimen remains uncertain.
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DETERIORATION OF MITOCHONDRIAL FUNCTION IS THE
KEY MECHANISM RESPONSIBLE FOR HEPATIC INJURY IN
NON-HEART-BEATING DONOR LIVERS.
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Introduction. Non-heart-beating-donor (NHBD) livers are extremely
susceptible to ischaemia-reperfusion injury. Mitochondria play a central
role in hepatic ischaemia reperfusion injury due to its role in reactive oxygen
species (ROS) formation and apoptotic cell death. We have investigated the
mitochondrial functional changes during ischaemia-reperfusion and its
relationship with hepatocellular injury in NHBD livers.
Methods. Porcine livers (Group IR, n5) were subjected to 60 minutes of
ischaemia and then connected to an extracorporeal perfusion circuit for 24
hours for assessment of viability. Group C (Control, n5) did not receive
ischaemic injury. Both groups were subjected to transient cooling during the
bench work prior to reperfusion. Sequential liver biopsies were analysed for
ATP content and mitochondrial function (respiratory control ratio (RCR),
cytochrome c release and caspase activation). The perfusate was analysed for
serum transaminase, bile production and base deficit.
Results. 60 minutes of warm ischaemia did not alter mitochondrial function
significantly (p0.128). However, subsequent cold preservation produced
significant decline in mitochondrial function (RCR 3.9790.43 vs. 2.459
0.21 pB0.001). Mitochondrial function did not recover during reperfusion
with oxygenated blood. ATP energetics mirrored the changes in mitochon-
drial function. Mitochondrial damage was associated with cytochrome c
release and caspase activation and increased hepatocellular damage as
evidenced by raised transaminase release (pB0.05) in the perfusate. By
comparison, Control livers (without warm ischaemia) maintained normal
mitochondrial function during cold preservation and subsequent reperfusion
with minimal hepatocellular damage.
Conclusions. Our data suggest that alteration of mitochondrial function is a
critical event leading to cellular energetic failure and cell death in NHBD
livers. This may have important implications in developing novel therapeutic
strategies for resuscitation of NHBD livers.
PP 55.01
SURGICAL TREATMENT OF HYDATID LIVER DISEASE
Karamarkovic, Aleksandar1; Ivancevic, Nenad2; Blazic, Ivan2; Doklestic,
Krstina2; Mihailovic, Vojin2; Radenkovic, Dejan2
1University Center for Emergency Surgery, School of Medicine Belgrade,
Surgical Dpt. III, Belgrade, Serbia and Montenegro; 2University Center for
Emergency Surgery, School of Medicine Belgrade, Surgical Dpt. III,
Belgrade
Background. Surgery remains the main treatment modality of hydatid liver
disease. There still debate about the best approach, conservative surgery
(marsupialization, drainage, partial cystectomy) has opposed to radical
surgery in which the cyst is totally removed including the pericyst by total
pericystectomy or partial hepatectomy.
Aim. This study aims to show that radical surgery resection of the hepatic
hydatid cysts is a safe and effective technique.
Patients and Methods. A series of 49 consecutive patients operated on for
liver hydatid disease between January 2003 and December 2006 was
analyzed. The most common compliant were pain (62%), hepatomegaly
and abdominal mass ( 39%). Diagnostic assessment was obtained with
serology (ELISA) and radiology (US and CT scan). Surgery comprised
conservative methods like partial cystopericystectomy with intracavitary
placed drainage and omentoplasty of residual cavity (21 pt.), and radical
surgical methods like total cystopericystectomy (5 pts.) and liver resection
(segmentectomy, lobectomy, hemihepatectomy) (23 pts.).
Results. In the entire series, morbidity was 19% of which 28% was seen with
conservative surgery and 11% with radical methods (pB0.05). Biliary fistula
was more frequent complication in both groups: 15.9% vs. 4.2% (pB0.01) in
patients that underwent conservative methods and radical methods, respec-
tively. There was no operative and postoperative mortality in our studied
group. Long-term follow-up showed that hydatid disease relapsed frequently
in patients who underwent conservative treatment than in those who
underwent radical surgical approach: 4 pts. Vs. 0 pts.
Conclusion. According to our results, radical surgery of the hydatid liver
disease represents the method of choice over others such as partial
pericystectomy.
PP 55.02
INFECTIVE AND BILIARY COMPLICATIONS IN COMPLEX
HEPATIC INJURIES  A TEN YEAR PERSPECTIVE
Srinivasan, Thiagarajan1; Wig, Jai D1; Gupta, Rajesh1; Yadav, Thakur D1;
Doley, Rudra P1; Kudari, Ashwinikumar1; Kochhar, Rakesh2
1PGIMER, Chandigarh, India, General Surgery, chandigarh, India; 2PGI-
MER, Chandigarh, India, Gastroenterology, chandigarh, India
Background. Nonoperative management is being increasingly employed in
the management of bile leaks and infective complications in patients with
blunt hepatic injury. AIM AND Methods. Patients with complex hepatic
injuries with biliary and infective complications over a period of 10 years
(1996  2006) were analyzed.
Results. 208 patients with blunt hepatic injury were admitted and 103
patients had complex liver injuries. The mortality and morbidity in this series
was 10.7% and 56.4% respectively. 26.2% patients had biliary complications
and seventeen patients had intra-abdominal collections. The grade of the
injury was proportional to the increased incidence of biliary and infective
complications. The infective complications were significantly higher in the
surgical group (37.5%) than the conservative group (10%). 4.8% patients
had liver abscesses, eleven patients had bilomas, two had external biliary
fistulas and two had bilioplueral fistulas. Endoscopic management for bile
leaks was performed in five with nasobiliary drains initially and replaced with
stents in 3 patients. Image guided pig-tail drainage was done for liver
abscesses in 3 patients and bilomas in 8 patients. 43% (7/16) of patients with
biliary and infective complications required surgery. Five patients underwent
T-tube drainage for bile duct injuries and two patients underwent delayed
surgery for evacuation of liver abscess. One patient underwent hepaticojeju-
nostomy for delayed left hepatic duct stricture.
Conclusions. Biliary leaks and infective complications in complex liver
injuries are the major causes of increased morbidity which can be managed
successfully with multimodality treatment. Surgery is reserved for selected
indications.
PP 55.03
SURGICAL TREATMENT OF HEPATIC INJURIES
Karamarkovic, Aleksandar1; Ivancevic, Nenad2; Blazic, Ivan2; Radenkovic,
Dejan2; Mihailovic, Vojin2
1University Center for Emergency Surgery, School of Medicine Belgrade,
Surgical Dpt. III, Belgrade, Serbia and Montenegro; 2University Center for
Emergency Surgery, School of Medicine Belgrade, Surgical Dpt. III,
Belgrade
Background/Aims. Aim of study was to analyse the results of the surgical
treatment of 238 cases of hepatic injuries during the last six years (2001
2006).
Patients and Methods. 214 patients underwent surgical intervention, while
24 patients ith blunt liver trauma were treated conservatively.
Results. 89 patients (41.6%) had one or more associate abdominal injuries
and more than 20% sustained extraabdominal lesions. The mean ISS was
35.9 According to the OIS, surgicaly treated patients presented lesions of
grade I, II, III, IV and V in 11%, 25%, 41%, 19%, 4% of patients,
respectively. The most common surgical procedure was hepatorrhapy with-
out or with viable omental packing. Anatomical resection (segmentectomy,
hepatectomy) was done in 17 pts (7.9%), while atypical resection performed
in 5.1% cases. In 5.6% was necessary to perform a perihepatic packing and
Staged Injury Repair (STIR), with multiple re-explorations and delayed
definitive repair, utilizing a glider (ETIZIP) for temporary abdominal
closure. Operative treatment also included Pringle manoeuvre or total
vascular exclusion (TVE), cholecystectomy, vascular sutures of the inflow
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hepatic circulation, hepatic veins and VCI, and also bile duct reconstruction.
The observed mortality in our series was 16% (34 patients). In the group of
the most severe hepatic injuries (grade III, IV and V) the overall mortality
rates were 10, 49 and 67%. The main causes of death were sepsis syndrome
associated with DIC, ARDS and MODS. The most common specific
complications in patients, after surgical treatment, were intraabdominal
abscess (6.5%), late haemorrhage (4.2%), biliary fistula and peritonitis
(8.8%).
Conclusions. There is the significant correlation between injury grade and
mortality rate. Careful clinical assessment and close radiological monitoring
of the patients with minor hepatic injuries, may prevent from unnecessary
laparotomies. From that point of view, diagnostic laparoscopy play an
important role.
PP 55.04
HEPATICODUODENOSTOMY AFTER EXCISION OF CHOLE-
DOCHAL CYST-A STUDY IN 43 PATIENTS
Dastidar, Arindam; Sen, Sudipta; Chacko, Jacob; Karl, Sampath; Kumar,
Jyotish
Christian Medical College and Hospital, Department of Paediatric Surgery,
Vellore, India
Background. Hepaticoduodenostomy is a controversial option in the
management of Choledochal cyst.
Aim. The aim of this study is to analyze the outcome of Hepaticoduode-
nostomy (HD) in patient with Choledochal Cyst.
Materials and Methods. 72 patients with Choledochal cyst were operated
over past 7 years. Among them 43 underwent HD after cyst excision. Most
common complaint in these patients at presentation was abdominal pain with
one or more episodes of jaundice. One patient was antenatally detected to
have Choledochal cyst. 26 among these 43 patients were girls; average age of
presentation was 6.8 years (Range 1year  15 years). Average duration of
admission was for 7 days with nasogastric drainage for 4 days and nil per oral
for 5 days. All HD was done below the hilum to first part of duodenum.
Duodenum was kocherised to form a tension free anastomosis. Suture line
was further reinforced with an omental wrap.
Results. No major complications namely cholangitis, calculi encountered in
any of our patient during follow up. Duration of follow up ranged from 6
months  24 months (mean 15 months). Follow up was done in OPD with
Liver Function Test, Ultrasound and HIDA scan.
Conclusion. Hepaticoduodenostomy is a physiological technique of recon-
struction after cyst excision. It offers many advantages over other techniques,
by limiting the operative field to the supra colic compartment and a single
anastmoses. Apart from this it allows access to the biliary tree via an
endoscope in the event of calculi or anastomotic stricture. Despite the
controversy regarding this procedure in literature, we find HD a safe option
in the treatment of Choledochal cyst
PP 55.05
A COMPARATIVE EXPERIMENT OF NEW HIGH-SPEED RADIO-
FREQUENCY SYSTEM WITH CONVENTIONAL MONOPOLAR
RADIOFREQUENCY DEVICE
Yao, Peng; Akhter, Javed; Daniel, Steve; Morris, David
University of New South Wales, Department of Surgery, Sydney, Australia
Background. Radiofrequency (RF) is a safe and effective minimally invasive
procedure in the treatment of liver and other organs neoplastic lesions. We
have developed a new high speed radiofrequency system (HSRFS).
Aim. We sought to compare the efficacy of HSRFS with conventional
monoporlar RF device on ex vivo perfused bovine liver.
Methods. Bovine livers were obtained from the local abattoir, then were
preserved by HTK solution in accordance with the protocol for liver
transplantation and brought back to our lab. Portal vein was cannulated
and connected to a MasterFlex pump (Barnant Co, Barrrington, IL, USA).
RFA was conducted with the RITA 1500 generator (RITA Medical systems,
Mountain View, CA, USA). HSRFS and RITA StarBurst were tested in this
study.
Results. We applied two different power setting: 100 watts5 min and 150
watts10 min. In the no perfusion setting, there was no significant difference
between two devices. However there was significant difference in the
perfusion model (both 500 ml/min and 1000 ml/min).
Conclusion. New HSRFS could create larger lesions than that of monopolar
RFA device under perfusion.
PP 55.06
CONFLUENT HEPATIC FIBROSIS MIMICKING MASS LESION
IN A PATIENT WITH BACKGROUND HEPATITIS B ON SCREEN-
ING ULTRASONOGRAPHY
Lai, Bo San Paul1; Wong, John2; Ng, Wilson W C2; Lee, K F2
1Prince of Wales Hospital, Chinese University of Hong Kong, Surgery, Hong
Kong, Hong Kong; 2Prince of Wales Hospital, Surgery, Hong Kong
Introduction. Confluent hepatic fibrosis is an uncommon condition, even in
patients with advanced cirrhosis. CASE REPORT: A 78-year-old gentleman
was referred to our Joint Hepatoma Clinic for a mass lesion detected on
screening USG done as part of a community health check program. He was
also found to be a carrier of hepatitis B surface antigen and his liver function
was normal. Clinically, he is Child¡js A. USG found a 14cm nodule
occupying almost the whole right lobe of the liver with background cirrhosis.
CT scan was then arranged for the patient which confirmed that he did not
have liver cancer. Instead, CT reconstruction disgnosed that the liver was
badly distorted and there was no mass lesion within the liver parenchyma.
DISCUSSION: Confluent hepatic fibrosis (CHF) causes severe changes in
the liver architecture as a result of regneration nodules formation together
with capsular retraction during the process of cirrhosis. The shape of the liver
can change so much that it does not look like a liver at all on imagings. It is
also rare to have normal liver function in patients having CHF. Because of the
distortion in the shape of hepatic lobes, the pseudolesions may mimic
malignant lesions in the background of cirrhosis. In our patients, the
radiologist doing the USG misread the dominant nodule on the right lobe
as a mass lesion and CT scan together with 3D-reconstruction was required
to reveal the correct diagnosis.
PP 55.07
HEPATECTOMY FOR RECURRENT PYOGENIC CHOLANGITIS
Wong, John; Lee, Kit Fai; Ng, Wilson Wing Chi; Ling, Eva; Fok, Ka Lung;
Ng, Nancy; Lo, Xina; Mak, Oi Sze; Lai, Paul Bo San
The Chinese University of Hong Kong, Department of Surgery, Hong Kong,
China
Background. Recurrent pyogenic cholangitis (RPC) is a common disease in
Southeast Asia and is prevalent in Hong Kong. It is characterized by repeated
attacks of cholangitis due to intrahepatic ductal stones. Management of RPC
is multidisciplinary, aiming at retrieval of biliary stones, drainage of the biliary
system and resection of the non-functioning liver segments.
Methods. A retrospective review of RPC patients requiring formal hepa-
tectomy in a single centre between 2002 and 2007 was performed. Nature of
operation, requirement of concomitant procedures, morbidity and mortality
rates, specimen pathology and residual symptoms were analyzed.
Results. During the study period, 24 patients (9 males, 15 females) received
hepatectomy, with a median age of 62.5 years (range 3574 years). Median
follow-up period was 12.4 months (range 1.2¡V55.7 months). Extent of
hepatic resection included left lateral sectionectomy (segments II & III) (n
19), left hepatectomy (n2) and right hepatectomy (n3). Choledocho-
scopy was performed at the same time for stone clearance in 19 patients. Four
patients required a hepatico-jejunostomy for biliary drainage. Three patients
(12.5%) had incidental finding of malignancy confirmed in specimen
pathology: cholangiocarcinoma (n1), hepatocellular carcinoma (n1)
and papillary adenocarcinoma (n1). There was no operative mortality.
Surgical related morbidities included wound infection (n8), abdominal
collection (n1), bile leak (n1) and left lung collapse (n1). No patient
developed recurrent biliary tree stone or cholangitis subsequently. Survival at
1 and 2 years were both 87%. DISCUSSION: Hepatectomy is a safe and
definitive treatment for RPC. Left lateral sectionectomy is performed in 79%
of cases. Stone clearance can be ascertained by choledochoscopy. The most
commonly encountered complication is wound sepsis. The malignant
potential of this disease should not be overlooked.
PP 55.08
A TEN-YEAR STUDY OF EARLY OUTCOMES FOLLOWING
HEPATIC RESECTION IN A HIGH-VOLUME TERTIARY REFER-
RAL UNIT.
Lordan, Jeffrey T.; Karanjia, Nariman D; Fawcett, William J.; Worthington,
Tim R.; Quiney, Nail; Remington, Jacky
Royal Surrey County Hospital, Guildford, United Kingdom
Background. Centres with high volumes of high-risk surgery have signifi-
cantly better outcomes than low-volume centres for pancreatic resection,
oesophagectomy and pelvic exenteration. However, this has not to date been
conclusively demonstrated for hepatic resection.
Patients and Methods. Data regarding 381 consecutive liver resections
were prospectively recorded and retrospectively analysed in a high-volume
tertiary referral unit over a 10 year period. Patients’ demographics, operative
mortality and morbidity were analysed.
Results. Operative mortality was 1.6% and the morbidity rate was 24.1%.
Bile leak was the most common complication followed by severe sepsis.
Median intra-operative blood loss was 250ml and 13 patients received intra-
operative blood transfusions.
Conclusion. This article conclusively demonstrates that high-volume
centres are the safest environment for hepatic resection.
PP 55.09
OPERATIVE MANAGEMENT OF EXTENSIVE LIVER TRAUMA V.
DJUKIC D.
Stepic, Z Loncar, S. Mijatovic, P Savic V. Bumbasirevic, A. Karamarkovic
KCS Belgrade-Serbia Djukic, Vladimir.
KCS Belgrade, HPB and Emergency Surgery, Belgrade, Serbia and
Montenegro
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Background. Surgical, operative management of extensive blunt or pene-
trating injuries to the liver remains a significant challenge with a certainly
high morbidity of 50% and mortality up to 80%Historicaly concept of
surgical management has been tremedously shift towards non operative
approach since CT implementation in 1981 Extensive liver trauma grade III
an IV and V are still surgical and multidisciplinary task and hypotremia,
acidosis and coagulopathy as fatal triade has to be solved in order to achieve
better results THE AIME of the study is to eveluate the role of precondition-
ing and Pringle manuever in liver resection in patients with severe
haemodynamic schock I
Methods and Results. The results of 20 patients who underwent different
life saving procedures in Emergency Centre Belgrade Serbia 01012002 
30.05.2007 were analyzed 3 TVE total vascular exclusion, 1 atriocaval shunt,
1 IVC repair with graf repair,6 infrahepatic IVC repair,4 formal right
hepatectomies,4 bisegmentectomies S 6,7, 2 segmentectomies S5with
cholecystectomy, and 3 left sectorectomies S 2,3 Blood loss was 2340
7800ml, bile leak 35% Mortality rate was extremely high 60%.
Discussion. The authors report such a unsatifactory results because all of
our patients had multiple organ injuries with dominant abdominal and bad
AAST, TRISS ISS and Glasgow Comma Scale.
Conclussion. Vascular inflow control with preconditioning still has no
alternative in allready hypoperfused and exsanguinated patients Surgeons has
to be encourraged to apply Damage Control procedure widely in order to
reduse high mortality rate
PP 55.10
INTRAARTERIAL CHEMOTHERAPHY OF LIVER METASTASES
Djukic, Vladimir; Stepic, D; Loncar, Z; Mijatovic, S.; Bumbasirevic, V.;
Djurovic, M.; Culafic Dj, Radenkovic; Karamarkovic, A.
KCS Belgrade, HPB and Emergency Surgery, Belgrade, Serbia and
Montenegro
Background. Regional hepatic arterial chemotherapy was proposed as a
rational approach to intensify therapy based on pharmacological and
anatomical approach.
The Aime. of the study was to evaluate retrospectively the effects of
intraarterial chemotherapy for liver metastases of various origin.
The Resultsof 40 patients treated with implantable catheter HAI hepatic
artery infusion for nonresectable metastic disease. Colorectal 24, pancreatic 6
breast 8 and gynecol 2. Liver replacement by tumor was 35% in our series
measured by CTand NMR. Administered dose was 1 gr of 5 FU 6 cycles of 5
days per month. Assessment of response to treatment was based on CT and
tumor markers C 199, CEA We had no single patient with complete
response, partial response 50% of tumor volume CT control had 4 (10%)
partial 25% of tumor size 10 (25%), 8 (20%) patients had very limited
response. Unfortunately 18 (45%) patients had rapid tumor progression.
Intraoperative mortality, was 0%. Total morbidity was 10%: port side
infection in 2 (5%) 1(2,5%) perforation and thrombosis of the catheter in
1 (2,5%) three and five months after the implantation. The median survival
was 12 months. The maximum of 34 months survived lady operated for
colorectal adenocarcinoma with synchronous liver secondary tumor. After
successful down stage period of six months we resected segments 6 and 7.
Discussion. Results of our study are disappointing comparing to Memorial
Sloan Kettering Cancer Center. Fong et al of Mayo Clinic with response
rate following HAI of 48% or French multicentric 49%. with 2 year survival
rate of 22% for HAI.
Concusion. Patients with hepatic replacement by tumor30% and con-
comitant extrahepatic metastatic disease are throught to be inappropriate
candidates for hepatic artery chemotherapy
PP 55.11
POST CHOLECYSTECTOMY BILE DUCT STRICTURE WITH
PORTAL HYPERTENSION: PRELIMINARY PORTOSYSTEMIC
SHUNTING UNNECESSARY
Vyas, Frederick1; Joseph, Philip2; Sanghi, Ravish2; Sitaram, Venkatramani2
1Christian Medical College Hospital, Department of General Surgery, Ida
Scudder Road, Vellore, India; 2Christian Medical College Hospital, Depart-
ment of General Surgery, Vellore, India
Introduction. Portal hypertension develops in 1520% of patients with
benign bile duct stricture as a result of secondary hepatic fibrosis or direct
damage to the portal vein. The outcome of patients with biliary stricture and
portal hypertension is poor with an in hospital mortality rate of 2540%.
Aim. To analyze our experience in managing these patients.
Methods. Case records of all patients with post cholecystectomy benign
biliary stricture and portal hypertension between 1992 and 2007 were
analyzed.
Results. Twenty three patients were available for review. All patients had
developed biliary stricture after cholecystectomy and had evidence of portal
hypertension on oesophago-gastroduodenoscopy. There were 10 males and
13 females with a mean age of 38 years. Median duration of symptoms before
presentation was 42 months. Cholangitis was present in 16 patients and all 23
patients were jaundiced. Five patients had previous attempts at repair and
three patients had multiple endoscopic interventions. There were 7 Bismuth
type II, 13 type III and 3 type IV strictures. One patient had a preliminary
interposition mesocaval shunt and one patient had an attempted shunt. All
the other underwent hepaticojejunostomy without a preliminary shunt. There
were 5 peri-operative deaths. The patient with mesocaval shunt died of
progressive liver failure six months after surgery. One patient was lost to
follow up. Follow up was available on 16 patients. Median duration of follow
up was 38 months. Two patients needed dilatation of anastomosis; one for
raised alkaline phosphatase levels and one for recurrent cholangitis. The
other 14 patients are symptom free with an excellent outcome.
Conclusion. Satisfactory repair with acceptable morbidity and mortality is
possible in patients with bile duct strictures and secondary portal hyperten-
sion. Portosystemic shunting is not necessary. Patients with complex injuries
and borderline liver function should be considered for liver transplantation
PP 56.01
AVOIDING TOTAL PANCREATECTOMY IN A SUSPECTED MUL-
TIFOCAL IPMT. A CASE REPORT
Guerra, Juan Francisco; Martı´nez, Jorge; Guzma´n, Sergio; Jarufe, Nicola´s
Pontificia Universidad Cato´lica de Chile, Digestive Surgery, Santiago, Chile
Introduction. Parenchyma-sparing resections have been described in order
to reduce endocrine and exocrine postoperative insufficiency after pancreatic
surgery. A patient with a suspected mutifocal IPMT who underwent a
pancreatoduodenectomy plus a distal resection of the pancreatic remnant is
presented. Case Report. A 47 year-old male was admitted with a medical
history of 12 episodes of acute pancreatitis, within the last 8 years. Abdominal
US, CT Scan and MRI demonstrated a dilated main pancreatic duct, with a
deformation in the pancreatic head, uncinate process and the tail of the
gland, suggesting an Intraductal Papillary Mucinous Tumor (IPMT). The
gallbladder and the bile duct were normal. ERCP showed a bulking papilla.
Regarding radiologic findings, a Total Pancreatectomy was recomended, but
the patient refused this kind of surgery, because the need of lifetime insuline
use. A parenchyma-sparing resection, leaving a central segment of pancreatic
parenchyma was planned. At surgery, a 443cm cystic appearence mass
was adverted at the uncinate process and a smaller cystic mass was evident in
the pancreatic tail. A Pancreatoduodenectomy, with pancreatojejunostomy
reconstruction and a distal pancreatectomy and splenectomy was performed.
A central portion of well irrigated pancreatic parenchyma was preserved. A
well tolerated, low flow pancreatic fistula was the only surgical complication.
Histology showed a main duct IPMT at the uncinate process. In the distal
portion of the gland a sclerosing chronic pancreatitis was found, with no
tumor evidence. After 24 months the patient has no exocrine insufficiency
with normoglycemic status under oral antidiabetic therapy
PP 56.02
AMYLASE LEVEL IN ABDOMINAL DRAIN AFTER DUODENO-
PANCREATECTOMY: A SIGNIFICANT RISK FACTORS FOR
PANCREATIC FISTULA
Matheus, Andre S.; Montagnini, Andre L.; Jukemura, Jose; Jureidini,
Ricardo; Perini, Marcos V.; Haddad, Luciana B.P.; Abe, Emerson K.;
Cecconello, Ivan; Cunha, Jose Eduardo M.
University of Sao Paulo, Dept. of Gastroenterology, Sao Paulo, Brazil
Operative mortality rates after pancreaticoduodenectomy (PD) have de-
creased dramatically over the past 3 decades and recent series have reported
very low mortality. Nevertheless pancreatic fistula (PF) remains the major
cause of morbidity. A significant fraction of patients undergoing PD develop a
postoperative pancreaticocutaneous leak.
Methods. Sixty five patients who underwent PD at our hospital were
prospectively investigated. Standard PD was performed for 10 cases and
pylorus-preserving PD for 55 cases. A duct-to-mucosa pancreaticojejunost-
omy was performed in all patients and a transanastomotic stent was placed in
patients with soft pancreas and non-dilated duct. Octreotide was not used
after surgery. Four preoperative, two intraoperative, and five postoperative
risk factors with potential to affect the incidence of pancreatic fistula were
analyzed. PF was defined and graded in accordance with the International
Study Group on PF.
Results. Of the 65 patients, 11 (16.9%) were identified as having pancreatic
leakage after operation. The hospital mortality in this series was 3.07%, and
the mortality associated with pancreatic fistula was 0% (0/37). General risk
factors including patient age, gender, history of jaundice, preoperative
nutrition, and pathological diagnosis didn’t have any relation with pancreatic
fistula occurrence. Intraoperative risk factor, texture of the remnant pancreas,
was not found to be significantly associated with pancreatic leakage. Blood
loss, type of resection, and serum amylase level on postoperative day 1 did not
have significantly relation with pancreatic fistula. The incidence of pancreatic
leakage was 81.9% (9/11) in those patients with abdominal drain amylase
level1000UI/dL on postoperative day 1, it was the only risk factor with
significantly relation with pancreatic fistula (pB0.05).
Conclusion. Amylase level1000UI/dL in the abdominal drain on
postoperative day 1 is the only significant predictive factor of PF develop-
ment.
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PANCREATIC FISTULA AFTER PANCREATICODUODENECT-
OMY: THE CHOICE OF CONSERVATIVE TREATMENT
Haddad, Luciana B P; Scatton, Olivier; Randone, Bruto; Andraus, Well-
ington; Massault, Pierre-Philippe; Dousset, Bertrand; Soubrane, Olivier
Cochin Hospital, Liver Department, Paris, France
Background. Pancreatic fistula (PF) is the most common complication after
pancreaticoduodenectomy (PD), and its reported incidence varies from 2 to
28%. The aim of the present study is to analyze the treatment of complicated
pancreatic fistula comparing the surgical approach to conservative techni-
ques.
Methods. From January 2000 through August 2006, 121 patients were
submitted to PD. There were 70 men and 47 women, with a median age of 60
years (SD912). The main indications for PD was pancreatic duct carcinoma
in 52 patients (44.5%), ampullary carcinoma or adenoma in 18 (15.4%) and
islet cell tumor in 11 (9.4%). Reconstruction by pancreatogastrostomy was
performed in 65 patients (55.6%) and by pancreatojejunostomy in 52
patients (44%).
Results. Thirty five patients (30%) developed pancreatic fistula. Amongst
these, 20 were managed conservatively and 14 were reoperated. These two
groups of patients were compared with patients without PF for analysis.
There was no significant difference in the mean age, the sex ratio, ASA
classification, surgical time and blood replacement, number of associated
procedure, vascular resection and type of reconstruction between the three
groups. There were 5 postoperative deaths (4.2%), three patients (21.4%) in
the surgical treatment group (pB0.01). Mean total number of complications
(p0.02) and mean length of hospital stay (pB0.001) were greater in the
surgical group. The medium delay between the pancreatic resection and the
reoperation was 10 days (range, 332 days). Completion splenopancreatect-
omy was required in 5 patients while conservative treatment including
debridement and drainage was applied in 9 patients.
Conclusion. Surgical approach of PF is associated with a higher mortality
and morbidity. There is no advantage in performing completion pancrea-
tectomy instead of extensive drainage due to the same mortality and
morbidity rates and the risk of endocrine insufficiency. In cases of
complicated PF, radiological or surgical conservative treatment is recom-
mended.
PP 56.04
PIGMENTED EXTRA-ADRENAL PARAGANGLIOMA PRESENT-
ING AS A MULTICYSTIC PANCREATIC TUMOR
Pace, Ronald F1; Cummings, Brian2; Husien, Mohamed1
1Grand River Hospital, Surgery, Kitchener, Canada; 2Grand River Hospital,
Pathology, Kitchener, Canada
Cystic pancreatic tumors frequently present as large pancreatic masses with
few symptoms, and have a characteristic appearance on CT scanning. We
present a case of a massive multicystic tumor apparrently arising in the tail of
the pancreas which proved to be an extra-adrenal paraganglioma after
histologic review. A 32 year old female of Vietnamese origin presented with
occasional sharp pains in the left upper quadrant. An ultrasound and
subsequent CT scan disclosed the presence of an 18.911.78 cm. solid
mass with multiple cystic spaces which seemed to arise from the tail of the
pancreas. She had no past medical illnesses, and had minimal left upper
quadrant fullness as the only physical finding. She was taken to the operating
room and an extensive evaluation showed no evidence of metastatic disease.
The tumor seemed to arise from the tail of the pancreas, and infiltrated the
mesentery of the splenic flexure of the colon. An enblock resection of the
tumor was performed, including the tail of the pancreas, spleen, and splenic
flexure of the colon. She had a smooth post-operative course. Histologic
evaluation of the excised tumor proved it to be a Pigmented Extra-Adrenal
Paraganglioma originating from the retroperitoneum and pressing on, but not
invading the pancreatic tail. Although angioinvasion was identified histolo-
gically, there was no evidence of lymph node metastases. Urinary catecho-
lamine levels are normal, and the patient has remained well clinically.
Retroperitoneal tumors, such as Extra-Adrenal Paragangliomas may mimic
pancreatic tumors on CT scanning, and should be considered when assessing
patients for surgical intervention.
PP 56.05
MORPHOLOGICAL CLASSIFICATION OF SEROUS CYSTIC TU-
MOR SCT OF THE PANCREAS
Lee, Seung Eun; Lee, Seung Eun; Jang, Jin-Young; Kwon, Yujin; Kim,
Young-Hoon; Hwang, Dae Wook; Hwang, Dae Wook; Lee, Kuhn Uk; Kim,
Sun-Whe
Seoul National University College of Medicine, Department of Surgery,
Seoul, Korea, Republic of
Background. Although honeycomb microcystic type is common and typical
for serous cystic tumor (SCT), clinical and radiological features of SCT show
diversely according to subtype. However, standard classification of subtype is
not well established. The purpose of this study is to classify subtype of SCT
and to clarify its clinicopathological characteristics.
Methods. From 1992 to 2006, clinical data from 52 patients with
pathologically confirmed SCT were prospectively collected in standard data
form. Radiologic finding and differential diagnosis were reviewed by one GI
specific radiologist. According to cyst size and multiplicity on gross and
radiologic feature, when every cyst was smaller than 2cm, SCT was classified
as microcystic and if there were cysts larger than 2cm, SCT was classified as
macrocystic. Then, microcystic tumors were subdivided into honeycomb and
compact type, while macrocystic tumors were subdivided into unilocular and
multilocular according to number of cyst. The cilicopathologic features of
four subtypes were compared.
Results. Mean age was 50(2573) years. 22 cases were microcystic SCT
which were subclassified into honeycomb (n21) and compact type (n1),
while 30 cases were macrocystic SCT which were subclassified into multi-
locular (n16) and unilocular (n14). There were no differences between
four subtypes in gender, tumor location, and size. Preoperative diagnostic
accuracy of unilocular macrocystic SCT was only 35.7%, while that of
honeycomb microcystic and multilocular macrocystic SCT were 81% and
87.5% respectively, and there was significant difference(P0.005).
Conclusion. Microcystic and multilocular macrocystic SCT can be accu-
rately diagnosed at preoperative stage, so conservative treatment and
observation is possible. However, unilocular macrocystic SCT is difficult to
differentiate from other pancreatic cystic tumors with malignant potential, so
resection must be considered cautiously. Our classification of SCT is
linguistically clear and well reflect characteristic of subtypes of SCT.
PP 56.06
DIVERSE CLINICAL FEATURE AND OUTCOME OF SOLID
PSEUDOPAPILLARY NEOPLASM: ANY DIFFERENCE BE-
TWEEN ADULT AND CHILDREN?
Lee, Seung Eun; Jang, Jin-Young; Park, Kwi-Won; Lee, Seong-Cheol; Jung,
Sung-Eun; Hwang, Dae Wook; Lee, Kuhn Uk; Kim, Sun-Whe
Seoul National University College of Medicine, Department of Surgery,
Seoul, Korea, Republic of
Background. The purpose of this study was to delineate clinical and
pathological characteristics of solid pseudopapillary neoplasm (SPN) in
adults and children, to determine predictive features suggesting malignant
potential and to evaluate long-term outcome by examining a single
institution¡*s experience.
Methods. Between 1985 and 2006, 62 consecutive patients who underwent
surgery for pathologically confirmed SPN were retrospectively reviewed. The
patient demographic information and clinical presentation, radiological
details, surgical data, pathology, postoperative course, and long-term survival
were evaluated. The outcomes of clinical and pathological characteristics of
adults and children were compared.
Results. Among 62 patients, 47 patients were adults (mean age, 36, range,
1863 years) and 15 patients were children (mean age, 12, range, 813 years).
A palpable mass was the most common presenting symptom (9/15, 60%) in
children and an incidentally detected pancreatic mass (18/47, 38.3%) in
adults(P0.001). The mean tumor size in children was significantly lager
than in adults(8.0 vs. 6.0 cm, PB0.028). In children, the tumor was located
in head of pancreas (10/15, 66.7%), and in adults, in body or tail (38/47,
80.9%)(P0.001). Nine patients (14.5%) had malignant SPN. Deep
pancreatic invasion or perineural invasion were the most common patholo-
gical findings. There was no significant clinical factor suggesting malignant
potential. Follow-up ranged from 5 months to 20 years (mean 47.5 months).
Two patients had a tumor recurrence. They were still alive after debulking
surgery. There were no tumor-related deaths and all the patients are currently
still alive.
Conclusion. SPN had different clinical features in adults and children.
Further study is required to elucidate pathophysiology of these differences.
Because long-term survival can be achieved, even with the synchronous or
metachronous metastatic lesions, SPN should be treated aggressively, with
complete resection, even if this requires metastatectomy.
PP 56.07
PANCREAS INVOLVEMENT IN VON HIPPEL-LINDAU DISEASE:
TWO CASES
PARK, IL YOUNG; CHO, CHEONG EUN
Holy Family Hospital, Catholic University of Korea, Dept. of Surgery,
Bucheon, Korea, Republic of
Von Hippel-Lindau(VHL) disease is an autosomal dominant multicancer
syndrome caused by the germline mutation of a tumor suppressor gene. The
affected patients developed cancers of central nervous system, renal cell
carcinoma, pheochoromocytoma and cysts or benign tumors in pancreas. We
report two cases of patients presenting with pancreatic cyst who had showed a
mass in the cerebellum which was removed and hispathologically diagnosed
as hemangioblastoma. The first patient was 47-year-old woman and the
second case was 18-year-old daughter. Computed Tomography(CT) sacn
showed multiple cysts in the pancreas. In VHL disease, pancreas involvement
is frequent. Yearly follow up examinations were needed including abdominal
CT scan, Magnetic Resonance Imaging in craniospinal axis, opthalmoscopy
and plasma catecholamine and metanephrine determinations.
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DUODENOPANCREATECTOMY FOR CYSTIC DYSTROPHY IN
HETEROTOPIC PANCREAS OF THE DUODENAL WALL.
ARNAUD, Jean-Pierre; BRIENNON, Xavier; ALABEIDI ALZAHRANI,
Fahad; HAMY, Antoine; POUGET, Yael; LERMITE, Emilie
CHU, Chirurgie visce´rale, Angers, France
Aim of the study. Cystic dystrophy in heterotopic pancreas (CDHP) is rare.
The aim of this study was to evaluate the diagnosis, management, and follow-
up of the CDHP.
Patients and Methods. Between August 1990 and March 2004, 12 patients
with CDHP underwent a duodenopancreatectomy. The patients were retro-
spectively reviewed.
Results. There were 11 men and 1 woman with a mean age of 42.4 years
(range: 3454 years). Nine patients (75%) were alcoholic and 8 patients had
chronic pancreatitis. The diagnosis of CDHP was performed in 8 patients
(66.6%) after the preoperative workup. Seven patient had a medical
treatment with octreotid and endoscopic cystic ponction (N3) or cystic
fenestration (N1). Recurrence of pain was noted after a mean period of 5
months. Three patients had recurrent acute pancreatitis. Duodenopancrea-
tectomy was performed in all cases. The mortality and morbidity rate were
respectively 8.3% (N1) and 25% (N3). Mean follow-up was 64 months
(ranges: 6158 months). One patient was seen 70 months later with epigastric
pain and features of acute pancreatitis of the pancreatic stump due to
anastomotic stenosis. The other patients were asymptomatic.
Conclusions. Diagnosis of CDHP is difficult. After failure of medical
treatment, duodenopancreatectomy can be proposed.
PP 56.09
TWO CASES OF METASTATIC PANCREAS TUMORS OF RENAL
CELL CARCINOMA
Takamatsu, Susumu; Iseki, Hideaki; Kawai, Shigeo; Maruo, Hirotoshi;
Kume, Shinichiro
Toshiba Hospital, Surgery, Tokyo, Japan
We experienced relatively rare two cases of metastases of renal cell carcinoma
(RCC) to pancreas. Case 1: The patient was a 68 year-old-male and received
left nephrectomy with lymphadenoctomy for the left RCC in 2002 at another
hospital. The detail of the renal cell tumor was unknown. In follow up period,
a hypervascular tumor of 2cm in diameter was detected in pancreas head and
there were no abnormal findings in other organs on the enhanced abdominal
computed tomography (CT). He had no symptoms and all laboratory data of
endocrine function associated with pancreas was within normal limits. The
hypervascular tumor was suspected a nonfunctional endocrine tumor of the
pancreas preoperatively. We performed enuclation of the tumor in March
2007 and postoperative course was uneventful. In resected specimen, the
tumor was diagnosed pancreatic metastasis of RCC in histologically. He has
been still alive without recurrence. Case 2: The patient was a 47 year-old-
female and received right nephrectomy with lymphadenoctomy for the right
RCC in 2001 at another hospital. The RCC was diagnosed pT1b on TNM
classification. In 2006, two hypoechoic mass were detected in pancreas body
on abdominal ultrasonography and these tumors were hypervascular on
enhanced CT. On magnetic resonance imaging, these tumors were shown low
intensity on T1WI and high intensity on T2WI. We diagnosed as two
metastatic tumors of RCC of the pancreas body and performed distal
pancreatectomy in July 2007. The postoperative course was uneventful and
pathological diagnosis of these tumors was metastatic tumor of RCC. She has
been still alive with no recurrence. In conclusion, metastatic tumor of renal
cell carcinoma of the pancreas is relatively rare and it is hypervascular.
Therefore, the hypervascular tumor of the pancreas should be diagnosed
carefully if the patient who had been resected renal cell carcinoma.
PP 56.10
THE INCIDENCE OF PANCREATIC LEAKS FOLLOWING PAN-
CREATODUODENECTOMY FOR ‘NON-PANCREATIC CANCER’
PERIAMPULLARY LESIONS
Spalding, Duncan1; Hutchins, Robert2
1Hammersmith Hospital, HPB Surgery, Du Cane Road, London, United
Kingdom; 2The Royal London Hospital, HPB Surgery, London, United
Kingdom
Introduction. The literature reports 410% mortality, 3060% morbidity
and 929% anastomotic leak rates after a Whipples and its variant a pylorus
preserving proximal pancreatoduodenectomy (PPPP) performed for periam-
pullary tumours. These results often fail to distinguish between pancreatic
cancers, which commonly have a dilated main pancreatic duct (MPD) and
fibrosed pancreas, and ‘non-pancreatic cancer periampullary lesions whose
MPDs are often small and pancreatic texture soft. The aim of this study was
to assess the outcomes of Whipples and PPPP for ‘non-pancreatic’ cancer
periampullary lesions based on the experience of two pancreatic units in
affiliated university hospitals.
Methods. Between 20032006, 47 patients had a Whipples or PPPP for
‘non-pancreatic’ cancer periampullary lesions. The type of pancreatojeju-
nostomy performed was determined by the pancreatic texture and MPD size
(end-to-side duct-to-mucosa if a hard pancreas and dilated duct, end-to-end
invaginating if a soft pancreas and normal duct). All patients received peri-
operative octreotide. Their histology, operations and clinical outcome were
reviewed retrospectively.
Results. There were 34 malignant neoplasms (ampullary adenocarcinoma
17, duodenal carcinoma 7, cholangiocarcinoma 6, stromal tumour 1, IPMT
1, lung and colorectal metastases 1 each), and 13 benign neoplasms (chronic
pancreatitis 7, ampullary adenoma 3, duodenal polyposis 1, autoimmune
pancreatitis 1, chronic duodenal sinus 1). Thirty seven patients had a PPPP
and 10 had a Whipples. Post-operative mortality was 4.2% (PV thrombosis 1,
non-occlusive small bowel necrosis 1). Overall morbidity was 53% (25
patients). The pancreatic leak rate was 10.6% (5 patients), all were
successfully treated conservatively with drainage, octreotide and jejunal
feeding.
Conclusions. The overall pancreatic leak rate in this series is low. Altering
the type of pancreatojejunostomy performed at the time of operation
depending on the pancreatic texture and MPD size may reduce the
pancreatic leak rate.
PP 57.01
IS CYSTOPERICYSTECTOMY GOLD STANDARD IN THE MAN-
AGEMENT OF HYDATID CYSTS OF LIVER?
Singh, Rana
Dr R M L Hospital, General Surgery, New Delhi, India
Background. Hydatid cyst of liver has been a global health problem because
of its endemic nature. Multiplicity of treatment options available is a clear
reflection of the fact that no available modality is close to the ideal.
Aims and Objectives. To evaluate the position of Cystopericystectomy in
the era of multiple conservative methods available for managing hydatid
disease of the liver.
Methods. We have got modest experience of managing nine consecutive
cases of liver hydatid cysts by Cystopericystectomy. Eight patients had
solitary cysts while one patient had three cysts in the liver and one in the right
lung. In this patient one cyst replaced the whole of segment I and two other
cysts appeared to be fused with the right and the middle hepatic veins on
CECT of the abdomen. In at least three other patients hydatid cyst appeared
fused with one of the hepatic veins in the CECT. It was always possible to
dissect them off from these veins using CUSA. The CECT appearance was
rather fallacious because they appeared fused with the veins due to
compression rather than true adherence.
Results. There was no spillage of cystic fluid in any of the patients. Small
amount of serobilious drainage in the immediate post operative period was
almost universal but we did not encounter even a single case of biloma or
wound infection. On a mean follow up of 2 years we are yet to see a
recurrence. Diagnosis and planning of the surgery was done by CECT of the
abdomen but in the follow up we used Ultrasound of the belly to demonstrate
possible recurrence.
Conclusions. Following factors make Cystopericystectomy procedure of
choice for liver hydatidosis i. No need to use intracystic scolicidal agent hence
no fear of sclerosing cholangitis. ii. Lack of spillage of cystic fluid, brood
capsules or daughter cysts in the abdomen. iii. Striking the cystobiliary
communication away from pericyst provides practical immunity against
major post operative bile leak or biloma formation. iv. It is always possible
to separate hydatid cyst from major hepatic vessels.
PP 57.02
PORTAL VEIN ARTERIALISATION AS A SALAVAGE PROCE-
DURE DURING LEFT HEPATIC TRISECTIONECTOMY FOR
HILAR CHOLANGIOCARCINOMA
Young, Alastair L; Abu-Hilal, Mohammed; Khan, Aamir Z; Malik, Hassan
Z; Lodge, J Peter A
St James’s University Hospital, Hepatobiliary and Transplant Surgery, Leeds,
United Kingdom
Background. Surgical resection for Hilar Cholangiocarcinoma remains a
technical challenge. Several authors have emphasised the need to combine
standard bile duct resection with additional hepatic resection to obtain
improved oncological clearance. More recently portal vein resection with
reconstruction has become increasingly accepted as a way to further increase
the number of patients who could be offered resection with long term
survival. Hepatic artery resection remains controversial because of the
difficulties of reconstruction.
Aims. We applied a technique of portal vein arterialisation in a case of very
major liver resection where arterial reconstruction failed. This technique may
increase the number of patients with Hilar Cholangiocarcinoma who can be
offered surgical resection.
Methods. We present a case of Left Hepatic Trisectionectomy for Hilar
Cholangiocarcinoma in a 54 year old man in January 2006 which utilised the
technique of portal vein arterialisation. We also review the potential for this
procedure as a possible way to expand the number of operable candidates
Results. A Left Hepatic Trisectionectomy was planned with curative intent.
At operation a large hilar mass was removed en-bloc with only the right
posterior sectional portal vein identified as clear of tumour. Following
parenchymal transection arterial reconstruction was not possible and so after
a failed venous conduit, the gastroduodenal artery was anastomosed to the
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right posterior portal vein. Technically this procedure was successful. A
transient period of hyperbilirubinaemia persisted for several months following
the operation but this settled. The patient has had no intra-abdominal
recurrence although he has needed a thoracotomy to remove two lung
nodules.
Conclusion. Our report shows that the successful use of portal vein
arterialisation during major hepatic resections can safely further extend the
boundaries of liver surgery thus increasing the number of patients who may
benefit from a surgical resection
PP 57.03
COMPLICATIONS OF INTRAOPERATIVE RADIOFREQUENCY
ABLATIONS OF LIVER METASTASES.
EVRARD, Serge1; ISAMBERT, Mile`ne1; LALET, Caroline2; BROUSTE,
Ve´ronique2; MATHOULIN-PELISSIER, Simone2
1Institut BERGONIE, Digestive Tumours Unit, BORDEAUX, France;
2Institut BERGONIE, Department of Biostatistics, BORDEAUX, France
Background. Intraoperative use of radiofrequency ablation (IRFA) is
gaining more and more acceptance to achieve R0 treatment in complement
of parenchymal resection. It is now well established than indications and
efficiencies of IRFA and percutaneous applications (PRFA) are very different
and may not be confused together. Complications of PRFA have been well
documented.
Aim. The aim of this study was to analyse retrospectively our complications
with IRFA.
Method. Until June 2007, 200 patients have been referred in our tertiary
care centre to be treated for colorectal (70%) and noncolorectal (30%) liver
metastases. Patients observations were prospectively entered in a computed
database. Among them 172 patients could be analysed. They underwent 207
laparotomies, 102 for liver resections only (group 1), 60 for IRFA only (group
2) and 45 for IRFA plus resection (group 3). Respective indications of
resection or IRFA were established on size, topography and number of the
mets: small size, solitariness, closeness from biliary ducts, paravascular
location were in favour of IRFA; large size, closed together and numerous,
closed to biliary ducts were in favour of resection. Necessity to spare liver
functions lead to use IRFA probably avoiding to use atropho-hypertrophy
techniques by portal embolisation.
Results. Mortality was 2 patients by liver failure, 1 treated by IRFA alone
and 1 by resection alone. Morbidity was 12.1%; 12.7% for group 1, 13.3%
for group 2 and 8.9% for group 3. Complications were respectively for group
1, 2 and 3: 1) abscess: 3, 2, 0. 2) perihepatic collection: 7, 3, 1. 3) pleural
effusion: 2, 1, 1. 4) haemorrhage: 1, 0, 1. 5) portal thrombosis: 0, 1, 0. No
symptomatic biliary stenoses were observed. Reoperations were 6, 2 and 1.
Conclusion. IRFA indicated on lesion size, topography, number as well as
hepatocytes reserve lead in our hands to very few complications. Pattern of
complications seams also to be different from those published for PRFA.
PP 57.04
ARE THE TECHNOLOGICAL DEVICES USEFUL FOR PAR-
ENCHIMAL TRANSECTION DURING HEPATIC RESECTION?
Di Carlo, Isidoro1; Sparatore, Francesca2; Primo, Stefano3; Pulvirenti, Elia3;
Toro, Adriana3
1Cannizzaro Hospital University of Catania, Dep of Surg Sciences OT AT,
Catania, Italy; 2Cannizzaro Hospital University of Catania, Dep of Surgical
Sciences OT AT, Catania, Italy; 3
Are The Technological Devices Useful For Parenchimal Transection During
Hepatic Resection? I. Di Carlo, F. Sparatore, S. Primo, E. Pulvirenti, A. Toro
Department of Surgical Science, Organs Trasplantation and Advanced
Technologies University of Catania. Cannizzaro Hospital. Catania. Italy.
Bleeding is the most important complication in patients submitted to hepatic
surgery, and many devices have recently been developed to avoid intraopera-
tive blood loss. Moreover these devices became essential for laparoscopic
hepatic resections. Aim of this study is to analyze retrospectively our results in
hepatic resections using the Tissuelink† Monopolar Dissecting Sealer in
order to estimate their usefulness. From 2003 to 2006, 55 patients, who
underwent hepatic surgery, have been studied. Sex, age, type of disease and
type of surgical procedure in association with the duration of the surgical
procedure, type of parenchimal transection, blood loss, use of vascular
camping of the liver, length of hospital stay, morbidity and mortality have
been analyzed. Thirty-one males and 23 females, aged from 32 to 79 years,
affected by hepatocarcinoma (15), liver metastasis (18) and miscellaneous
(22) have been submitted to 4 major liver resections, 7 sectoriectomy, 20
segmentectomy, 17 limited resection and 7 total cistectomy, 37 using only
Kellyclasia (group A) and 18 using technological devices (group B) for
parenchimal transection. Average blood loss was 1001000 ml for group A
and 50600 ml for group B. The operative time was longer for the group B.
Pringle maneuver was used in 31 patients of group A. In group B one Pringle
manouver and one total vascular exclusion have been used. Hospital stay was
from 4 to15 days. Morbidity consisted of one ascites and one infected
haematoma. Mortality in one patient (1,8%). Technological devices are safe
instruments for hepatic resections and are useful for hepatic surgery, on the
opposite they are mandatory for laparoscopic surgery.
PP 57.05
BILIOBRONCHIAL FISTULA ASYMPTOMATIC FOR 20 YEARS
Di Carlo, Isidoro1; Sparatore, Francesca2; Primo, Stefano2; Pulvirenti, Elia2;
Toro, Adriana2
1Cannizzaro Hospital University of Catania, Dep of Surgical Sciences OT
AT, Catania, Italy; 2
BILIOBRONCHIAL FISTULA ASYMPTOMATIC FOR 20 YEARS I. Di
Carlo, F. Sparatore, S. Primo, E. Pulvirenti, A. Toro Department of Surgical
Science, Organs Trasplantation and Advanced Technologies University of
Catania. Cannizzaro Hospital. Catania. Italy. We report the case of a patient
affected by biliobronchial fistula presented sudden bilioptisis, fever, and
weight loss 20 years after surgery for hepatic hydatid disease. CT scan
demonstrated a subphrenic cystic mass, engaging segments 6 and 7 and most
of segments 5 and 8 of the right hepatic lobe, in the same location as a past
hydatid cyst. In the thoracic cavity, there was a pleural empyema and
atelectasis of the right inferior lobe. A fibrobroncoscopy performed pre-
operatively showed bile. Through thoracophrenolaparotomy, right inferior
lobectomy of the lung, partial cistectomy of the hepatic cyst and partial
resection of the diaphragm have been performed. As the preoperative
examination had not revealed disease in the biliary tracts, air was injected
through the cystic duct and the ensuing air bubbles identified the holes of
leakages. These were sutured and thereafter the diaphragm was repaired by
separated sutures. The surgical procedure resolved the symptoms because the
patient is disease free eight months later. However, we do not have an
explanation for the long asymptomatic period from the past surgical
procedure to the actual disease.
PP 57.06
MANAGEMENT IN PATIENTS WITH LIVER CIRRHOSIS AND AN
UMBILICAL HERNIA
Marsman, Hendrik A1; Heisterkamp, Joos2; Halm, Jens A2; Tilanus, Hugo
W2; Metselaar, Herold J2; Kazemier, Geert2
1Academic Medical Center, Surgery, Amsterdam; 2Erasmus Medical Center,
Surgery, Rotterdam, Netherlands
Background. Patients with liver cirrhosis and ascites are at high risk of
developing an umbilical hernia. The expectance that surgical management in
these patients is associated with high morbidity and mortality often leads to
avoidance of operative treatment. However, conservative management can
ultimately lead to serious complications as well.
Objective. To retrospectively compare the outcome in our series of operative
versus conservative treatment of patients with an umbilical hernia in the
presence of liver cirrhosis and ascites.
Methods. In the period between 1990 and 2004, 34 patients with an
umbilical hernia combined with liver cirrhosis and ascites were identified
from our hospital database. 21 patients underwent elective hernia repair, and
13 were initially managed conservatively.
Results. MELD (Model of End Stage Liver Disease) scores and mean age
were not significantly different between the two groups. Elective hernia repair
was successful in 16 out of 21 patients (76%). Complications occurred in 3 of
these 21 patients (14%), consisting of wound related problems (infection,
necrosis and haematoma) and hernia recurrence in 5 out 21 (24%). Success
rate of the initial conservative management was only 23%; hospital
admittance due to incarcerations occurred in 10 of 13 patients (77%) of
which six patients required hernia repair in an emergency setting. Two
patients of the initially conservative managed group died due to complica-
tions of the umbilical hernia. The complication rates between conservative
management and elective surgical management (77% and 14% respectively)
were significantly different, p0.0002.
Conclusions. Conservative management of umbilical hernias in patients
with liver cirrhosis and ascites leads to a high rate of incarcerations with
subsequent hernia repair in an emergency setting whereas elective repair can
be performed with less morbidity and is therefore advocated.
PP 57.07
POST OPERATIVE COURSE AFTER LIVER RESECTION IS NOT
INFLUENCED BY THE USE OF PORTAL INFLOW COMPRES-
SION (PRINGLE’S MANOEUVRE)
Patil, Vrishali; Riyad, Kallingal; Vadeyar, Hemant; Sherlock, David
North Manchester General Hospital, Surgery, Manchester, United Kingdom
Introduction. Portal inflow compression (PIC) is used to reduce blood loss
at the time of parenchymal transection though hepatic ischaemia with
reperfusion injury has been a theoretical possibility. Emerging evidence
seems to indicate intermittent PIC may precondition the liver to tolerate
ischaemia with some hepatoprotection. Our aim was to compare the post
operative recovery and outcome of patients who had PIC at the time of major
liver resection (2 segments) with those who did not.
Methods. The biochemical and haematological data of patients were
recovered from our prospectively maintained database for the period from
January 2004 to June 2005. All patients who had undergone a major liver
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resection were included in our study. The change in haemoglobin concentra-
tion, the perioperative blood transfusion, liver function test and coagulation
profile was all compared between the two groups along with length of hospital
stay.
Results. A total of 102 (81 with no PIC vs. 21 with PIC) were included in the
study. The two groups were similar in age and sex distribution and type of
liver resection. The post operative course did not show any statistically
significant difference in peak elevation of liver function tests, change in
haemoglobin concentration, post operative morbidity and length of hospital
stay. The blood product transfusion rates were similar in both group with no
statistically significant difference.
Conclusion. PIC does not seem to influence the post operative recovery of
patients undergoing liver resection and can be safely used without fear of post
operative hepatic dysfunction. However there seems to be no difference in the
perioperative blood usage in both groups.
PP 57.08
SURGICAL SITE INFECTION AFTER HEPATECTOMY: ITS
CAUSE AND STRATEGY FOR PREVENTION
Abe, Tomoyuki1; Shirabe, ken2; Kondo, Jyunnya1; Tsujita, Eiji1; Kajiyama,
Kiyoshi1; Nagaie, Takashi1
1Aso-Iizuka Hospital, Department of surgery, Iizuka city, Japan; 2Aso-Iizuka
Hospital, Department of Hepatogastroenterology, Iizuka city, Japan
Background. S: Surgical site infection (SSI) remains a common complica-
tion after hepatectomy, and was reported to prolong the hospital stay and can
be fatal.
Aim. To investigate the risk factors for surgical site infection (SSI) and to
clarify the strategy for prevention SSI after hepatectomy, according to the
outcome of 301 hepatectomized patients in a single center.
Patients and Methods. Between June 2002 and June 2007, three hundreds
and one hepatectomized patients were enrolled into this study. For preven-
tion of organ SSI, we started bile leakage test on August 2004. And to prevent
the contamination during surgery, we start to wear double gloves and
exchange every three hours on July 2006. These patients were divided into
three groups, based on these procedures. Group I: (n101) No bile leakage
test nor exchange of doubly weared gloves during surgery between June 2002
and July 2004, group II (n136) bile leakage test was performed, but no
glove exchanges between August 2004 and June 2006, group III (n64) bile
leakage test and glove exchange was performed between July 2006 and June
2007. The risk factors for superficial incisional SSI and organ SSI were
investigated in group I. Incidence of superficial and organ SSI were compared
among three groups.
Results. The incidence of superficial and organ SSI was 8.6% and 9.3% in
all 301 patients. The most of bacteria isolated were skin bacteria in superficial
SSI and those were gut bacteria in organ SSI. The significant risk factors for
superficial SSI was operation time and those for organ SSI were bile leakage,
blood loss, and blood transfusion in group I. The incidence of superficial SSI
was 7%, 11%, and 3% in group I, II and III. The incidence of organ SSI was
14%, 8% and 5% in group I, II and III.
Conclusion. Doubly weared gloves and exchange every three hours reduced
superficial SSI. This policy may prevent the contamination during surgery.
Bile leakage was strongly related to organ SSI. Bile leakage test for prevention
of bile leakage prevented the organ SSI.
PP 57.09
PORTAL TRIAD CLAMPING IN HEPATIC RESECTION-A SYS-
TEMATIC REVIEW AND META-ANALYSIS
Wente, Moritz N1; Rahbari, Nuh N1; Schemmer, Peter1; Diener, Markus K1;
Hoffmann, Katrin1; Motschall, Edith2; Schmidt, Jan1; Weitz, Ju¨rgen1;
Bu¨chler, Markus W1
1University of Heidelberg, Heidelberg, Germany; 2University of Freiburg,
Freiburg, Germany
Background. To determine the impact of portal triad clamping on
perioperative outcome of patients undergoing hepatic resection.
Methods. A systematic literature search (Medline, Embase, The Cochrane
Library database Clinical Trials, Science Citation Index) was conducted to
detect randomized controlled trials assessing effectiveness and safety of portal
trial clamping alone and with ischemic preconditioning of the liver. Studies
on clamping of the inferior vena cava or hepatic veins were excluded. Meta-
analyses were performed using a random-effects model.
Results. Nine randomized controlled trials comprising a total of 630 patients
were eligible for final analysis. Study design of identified studies varied
considerably. Analyses of postoperative morbidity, mortality, intraoperative
blood loss, and blood transfusion revealed no difference between intermittent
portal triad clamping and no portal triad clamping. Continuous but not
intermittent portal triad clamping resulted in significantly increased post-
operative alanine aminotransferase levels. Meta-analyses of studies on portal
triad clamping with and without previous ischemic preconditioning showed
no differences either; however postoperative transaminases were significantly
lower in patients with ischemic preconditioning.
Conclusion. Based on current best available evidence, routine use of portal
triad clamping does not offer any benefits in perioperative outcome to
patients undergoing liver resection and can therefore not be recommended as
a standard procedure.
PP 57.10
TOTAL CYSTO-PERICYSTECTOMY FOR HYDATID DISEASE
OF LIVER  IS IT THE BEST CHOICE?
Joshi, Mukund1; Joshi, Manohar J2; Pande, Eknath3; Jamkar, Arun3
1B.J. Medical College & Sassoon General Hospital, Pune, India; 2India; 3
Introduction. This is a retrospective analysis of 16 cases, surgically treated
over a period of five years. This study attempts to analyze the treatment of
choice depending upon the size of the cyst, location & type of presentation.
Methods. There were 13 males & 4 females. Average age was 39 years. 15
cases were electively operated & 2 presented as infective complications.
Decision of which procedure to be done was taken intra-operatively only.
Various surgical treatments like marsupilzation with omental pack(OM)(2)
hepatic resection(1), Total pericystectomy(8), Pericysto-jejunostomy(PJ)(5)
& external drainage(ED)(1) were performed.
Results. There was no mortality. 2 patients developed transient biliary leaks
& were managed conservatively. Blood loss was restricted to less than 250 cc
in cases of ED, PJ &MO where as blood loss in total pericystectomy was 400
cc & hepatic resection was 850cc.
Discussion. Biliary leaks were observed in cases of hepatic resection,
external drainage & marsupilization with omental pack. Least blood loss
was noticed in Pericysto-jejunostomy & just external drainage was the
quickest. All the different procedures had advantages & disadvantages.
However we observed that total pericystectomy had two major advantages
1) complete excision was feasible without peritoneal contamination 2) less
cumbersome than hepatic resection with lesser blood loss. External drainage
appears to have a major possibility of biliary leak. Hepatic resection appeared
over-treatment for the benign disease.
Conclusions. From the study it appeared that the total pericystectmy &
pericysto-jejunostomy appeared to be the procedures of choice with less
morbidity & minimal complication rate. We would advice total pericystect-
omy whenever possible, especially when the cysts are located at the periphery.
For those placed centrally, pericysto-enterostomy or marsupilization with
omental pack appeared better considering the difficulty in excision.
PP 58.01
Carcinoid of the gallbladder; a case report.
Koizumi, Masaru; Sata, Naohiro; Kasahara, Naoya; Hyodo, Masanobu;
Yasuda, Yoshikazu
Jichi Medical University, Surgery, Shimotsuke, Japan
We report a rare case of carcinoid of the gallbladder. The case was 45-year-
old obese man. Annual abdominal ultrasonography (US) incidentally pointed
out a polyp of the gallbladder. Endoscopic US detected an 18 mm protruding
lesion in the neck of the gallbladder in Jichi Medical University Hospital. CT
showed slight enhancement of the tumor. Tumor markers, such as CEA and
CA199, were within normal limits. Laparoscopic cholecystectomy was
performed under preoperative diagnosis of benign tumor (e.g. cholesterol
polyp). However the lesion was histopathologically diagnosed as carcinoid of
the gallbladder by the findings of funicular and tubular cells in lamia propria
mucosa, homogeneous nuclei, basophilic cytoplasm, and positive staining of
Chromogranin A, Synaptophysin, S-100 and CD56. The patient discharged
on the fourth postoperative day uneventfully and showed no recurrence for
six months after surgery. Generally, carcinoid of the gallbladder shows
favorable postoperative outcomes. As far as we searched, there were 35 case
reports in Japan and 42 case reports in Western countries. Many of these case
reports confused the conception of carcinoid and were contaminated by
neuroendocrine cell carcinomas of the gallbladder, which show distinctively
different histological form and natural history. Carcinoid should be discussed
separately from neuroendocrine cell carcinoma. Herein, we report a case and
literature review.
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The role of open cholecystectomy in the era of laparoscopic surgery
Oniscu, Gabriel C; Coldham, Chris; Buckles, John AC; Mirza, Darius;
Mayer, David; Bramhall, Simon R
The Queen Elizabeth Hospital, The Liver and Hepatobiliary Unit, Birming-
ham, United Kingdom
Background. Laparoscopic cholecystectomy is the standard treatment for
gallstone disease. However, some patients require an open procedure AIM:
To examine the indications and the role of open cholecystectomy in the
laparoscopic era in a tertiary referral hepatobiliary unit.
Methods. 1012 patients who had a cholecystectomy between 1998 and 2007
in the unit were identified. Referral data, demographic, diagnostic and
surgical details were obtained from a prospective database. Logistic regres-
sion was used to determine the factors associated with an indication for
primary open cholecystectomy.
Results. 777 patients (77%) were referred directly to the unit, whilst 193
cases were referred from other surgical units. 679 cases (67.1%) were
completed laparoscopically, 265 (26.2%) were primary open whilst 68
(6.7%) were converted open cholecystectomies. The differences in the
indications for surgery between the groups are shown in the table. Open
procedures (52.3%) were more common in the cohort referred from other
units compared to primary referrals (19.3%, pB0.001). Open cholecystect-
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omy was carried out in older patients (median age 61 vs. 51 years, pB0.001),
more likely men and who had previous upper abdominal surgery. The
morbidity and peri-operative mortality (30 days) were significantly higher
following open procedures compared to laparoscopic ones as shown in the
table. The indication for primary open cholecystectomy is associated with
patient’s gender, age at referral, the presence of previous abdominal surgery
and the indication for bile duct exploration. Similarly, conversion is
associated with previous surgery and male gender.
Conclusion. Open cholecystectomy accounts for a significant proportion of
the cholecystectomies performed in a hepatobiliary unit. This may be due to
a high number of secondary referrals due to suspicion of sinister or complex
biliary pathology. These cases offer the training experience in open procedure
that lacks in other general surgical units.
Laparoscopic Primary
open
Converted
open
Gallstone disease 65.4% 28.4% 45.6%
CBD stone 6.9% 21.2% 11.8%
Acute cholecystitis 12.1% 15.9% 19.1%
Gallbladder cancer 0.3% 5.3% 1.5%
Acute pancreatitis 9% 9.8% 11.8%
Perioperative mor-
tality
0.7% 9.1% 1.5%
PP 58.03
AUDIT ON 3 PORT LAPAROSCOPIC CHOLECYSTECTOMY:
PIONEER SRI LANKAN EXPERIANCCE
Ganesaratnam, M1; Liyanage, Chandika2
1National Hospital of Sri Lanka, Surgery, Colombo, Sri Lanka; 2Faculty of
medicine, University of Kelaniya, Surgery, Ragama, Sri Lanka
Background. Laparoscopic choecystectomy is the commonest laparoscopic
surgical operation performed in Sri Lanka. Many approach it with 4 port
technique. We have found that 3 port technique is quicker, less cumbersome
and reduced ‘‘sword fighting’’ during surgery. Other Sri Lankan surgeons are
also catching up with this technique. Objectives: To analyze the the
complications and the effectiveness of 3 port approach to cholecystectomy
by a single team.
Methods. Retrospective anlysis of laparoscopic cholecystectomies done from
October 2003 to March 2007. For this whole series the operating surgeon,
the camera holding surgeon and the anaesthetist team were the same. The
operative details, the complications and the outcome were recorded and
analyzed.
Results. 374 laparoscopic cholecystectomies were performed during this
period. All had Hassan technique of creation of pneumoperitoneum and had
only 3 ports against the traditional 4 port technique. None of the patients had
nasogastric suction or catheterization. 4 required (1.06%) conversion to open
cholecystectomy. None required an insertion of an additional port. There
were 2 (0.5%) common bile duct injuries and there was one (0.2%) mortality
due to pulmonary embolism. The duration for surgery ranged from 20
minutes to 90 minutes. There were no significant wound infections or port
site herniae. Average hospital stay was one day. Discussion: 3 port technique
did not give rise to operative difficulties and maneuvering instruements
appeared to be easier. The conversion rate was comparable and there was no
procedure related mortality. The operating team required only the surgeon
the camera surgeon and one scrub nurse. We conclude that 3 port approach is
convienent, less cumbersome, safe and an efficient technique in laparoscopic
cholecystectomy
PP 58.04
LAPAROSCOPIC APPROACH FOR TECHNICALLY DIFFICULT
GALL BLADDER STONE DISEASE: THE ROLE OF LAPARO-
SCOPIC SUBTOTAL CHOLECYSTECTOMY
ELSEBAE, MAGDY; Nasr, Magid M.A; Ezzat, Hussin
Theodore Bilharz Medical Research Institute, General Surgery, Cairo, Egypt
A total of 531 consecutive patients were operated upon by laparoscopic
cholecystectomy for symptomatic gallbladder stone disease in our institute
over the last five years. Technical difficulty was encountered in 55 of them
(10.36%). Parameters of difficulty at laparoscopic cholecystectomy in our
study involved obscured anatomy of the Calot’s triangle, absence of a
dissection plane between the gallbladder and the liver bed or the occurrence
of intraoperative complication. The operation was concluded by either
standard laparoscopic technique, laparoscopic subtotal cholecystectomy or
converted to open cholecystectomy. Technically Difficult laparoscopic
cholecystectomy could be completed in 13 of the 55 patients (23.63%). In
twenty-four of the patients conversion to open cholecystectomy was required
(43.63%). Laparoscopic subtotal cholecystectomy was performed for 18 of
patients (32.72%) who constituted 3.39% of the laparoscopic cholecystec-
tomies performed at the same time period. There was no operative mortality.
Two only of the eighteen patients operated upon by laparoscopic subtotal
cholecystectomy have had postoperative local complications in the form of
bile leak (11.1%). None of the patients who underwent laparoscopic subtotal
cholecystectomy developed symptoms attributed to biliary disease or post-
cholecystectomy syndrome at a mean follow-up period of 28 (range 640)
months. Laparoscopic subtotal cholecystectomy LSC is a safe and definitive
operation to treat diseases of the gallbladder, whenever there are major
difficulties in dissection. It prevents bile duct injuries and allows removal of a
difficult gallbladder without the need for conversion to open procedure. Key
words: Subtotal cholecystectomy; Laparoscopic, Open.
PP 58.05
PHANTOM GALLBLADDER: THE FIRST CASE REPORT OF
REACTIVE NODULAR FIBROUS PSEUDOTUMOR FOUND AT
GALLBLADDER FOSSA AFTER CHOLECYSTECTOMY
Mak, Oi Sze1; Lai, Chris K.C.2; Lee, K.F.1; Wong, John1; Ng, Wilson W.C.1;
Ng, Nancy C.1; Fok, K.L.1; Lo, Xina1; Lai, Paul B.S.1
1The Chinese University of Hong Kong, Surgery, Hong Kong, Hong Kong;
2The Chinese University of Hong Kong, Anatomical and Cellular Pathology,
Hong Kong, Hong Kong
Introduction. Reactive Nodular Fibrous Pseudotumors (RNFP) are un-
common fibroinflammatory lesions that mimic primary bowel neoplasm or
intraabdominal fibromatosis. Total 16 cases were reported since 2003 and
most arose from serosa of intestine. We reported the first case of RNFP
located in gallbladder fossa 12 years after cholecystectomy. CASE REPORT:
A 54-year old lady underwent laparoscopic cholecystectomy 12 years ago for
symptomatic gallstone. She presented to us with right upper quadrant pain.
Ultrasonography and computed tomography showed a 3cm heterogeneous
mass at porta hepatic area. Endoscopic ultrasonography revealed a globular
mass containing sludge and small stones, which raised the suspicious of a
gallbladder remnant. Surgical exploration was performed and a 4cm solid
mass at the gallbladder fossa was found. The lesion was completely excised,
and histological examination confirmed RNFP. DISCUSSION: All RNFP
reported behave in benign manner. However, they often mimic neoplasms
like gastrointestinal stromal tumor (GIST), which require more aggressive
treatment. Differentiation by clinical, morphological and immunohistochem-
ical features would facilitate the correct diagnosis. More than half of the
reported cases of RNFP have a preceding history of surgery, trauma, or
underlying pathology. Histologically, RNFP are usually hypocellular, with
bland spindled and stellate cells arranged in short or haphazardly fascicles.
They showed minimal nuclear atypia with low to absent mitotic activity.
Immunohistochemicaly, most of the RNFP showed immunoreactivity
towards SMA and/or MSA but conflicting result to c-kit & AE1/AE3 in
reported literature.
PP 58.06
DOES CRITICAL VIEW AT LAPAROSCOPIC CHOLECYSTECT-
OMY REDUCE MAJOR DUCT INJURY: ANALYSIS OF 1010 CASES
UNDERTAKEN BY A SINGLE FIRM?
Velchuru, Vamsi R; Atkins, Chris; Lameris, Madeleine; Walker, Cathryn;
Kamat, Sachin; Studley, John G N
James Paget University Hospital, Upper GI surgery, Great Yarmouth, United
Kingdom
Background. Duct injury at laparoscopic cholecystectomy is a devastating
injury to the patient and also a medico-legal nightmare to the surgeon.
Various methods have been used to identify ductal anatomy, including intra-
operative cholangiography, infundibular technique, and critical view techni-
que.
Aim. The purpose of the study was to evaluate whether critical view
dissection during laparoscopic cholecystectomy reduces major duct injury. A
secondary outcome measure was to identify its impact on conversion rates.
Methods. Data was collected from elective laparoscopic cholecystectomies
performed by a single firm over a period of 14 years. All operations were
performed by the critical view technique either by the main author or trained
registrars on the firm under supervision. If the anatomy could not be
displayed satisfactorily, open surgery was undertaken. Data was collected on
indications for surgery, conversion rates, reasons for conversion and
complications.
Results. Sample population (19922006) was 1010 after exclusions. On
initial analysis of 289 cases there was no major duct injury and none had their
procedures converted to an open procedure. Gallstones were the commonest
indication (98%) and the rest were for gall bladder polyps. Two patients had
port site bleeding and one patient had bile leak. Final analysis (1010 patients)
will be presented in the meeting.
Conclusions. Critical view dissection during laparoscopic cholecystectomy
resulted in no bile duct injury in this series.
PP 58.07
MEDICOLEGAL IMPLICATIONS OF BILE DUCT INJURIES FOL-
LOWING LAPAROSCOPIC CHOLECYSTECTOMY.
Roy, Pankaj1; Soonawalla, Zahir2; Grant, Hugh3
1John Radcliffe Hospital, Surgery, Oxford, United Kingdom; 2John Radcliffe
Hospital, Hepato-biliary Surgery, Oxford, United Kingdom; 3John Radcliffe
Hospital, Pediatric Surgery, Oxford, United Kingdom
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Background. When successfully performed, laparoscopic cholecystectomy
(LC) significantly reduces post-operative pain, shortens hospital stay and
hastens post-operative recovery when compared with open cholecystectomy
(OC). However, LC results in higher incidence of biliary, bowel and vascular
injuries than with OC, and is associated with increased litigation.
Methods. This is a retrospective review of the claims reported to the NHS
Litigation Authority (NHSLA) for England from 20002005 relating to LC.
The data was analysed with respect to the type of injury, delay in recognition
of the injury, mortality, and litigation costs. This was compared to previously
published data from the USA.
Results. A total of 166 claims following laparoscopic procedures in general
surgery were reported in England, of which 111 (67%) were for complica-
tions relating to LC. Bile duct injuries accounted for the majority (72%) of
the LC claims, others being due to bowel injury (9%), bleeding (4%),
vascular damage (3%), and miscellaneous problems (11%). Only 17 out of
80 (21%) bile duct injuries were recognized during surgery, while the
majority were not noticed at the time of surgery resulting in late diagnosis,
necessitating an additional intervention. The mortality rate amongst the
claimants was 8.7% following biliary injuries. The LC claims resulted in
payments of £6m (average of £54,054 per claim), of which £4.3m was paid
out for bile duct injuries. The average cost was higher in patients who
suffered a delay in diagnosis.
Conclusion. Litigation is more common after LC than OC. Bile duct, bowel
and vascular injuries following LC remain a serious hazard for patients,
despite improvements in training and instrumentation. Those resulting in
litigation are a huge financial drain on the healthcare system. Delayed
recognition appears to correlate with an increased risk of litigation. A low
threshold for conversion to open surgery may decrease the risk of litigation.
PP 58.08
WORLDWIDE EPIDEMIOLOGY OF GALLBLADDER CANCER
Saied, Abdouslam; Hariharan, Deepak; Patel, Bijendra; Kocher, Hemant
Barts & the London School of Medicine & Dentistry, Institute of Cancer,
London, United Kingdom
Background. Ethnic background and geographical location play an im-
portant role in the incidence of gallbladder carcinoma leading to variable
mortality rate across the world.
Methods. Age-Standardized mortality rate [ASR (W)] were extracted
separately for males and females from a data base maintained by Interna-
tional Agency for Research on Cancer for 50 countries across the world
(Europe-32 countries, Americas-8 countries and Asia-10 countries) and
compared for the period 1960 2002. Further in-depth analysis over 10 years
(19922002) was conducted by empirically dividing ASR (W) /B 2 in
2002 and /B 3.5 in 1992. RESULT: From 19602002, the ASR (W) in
majority of countries the world over showed no change barring Netherlands,
Germany, USA and Canada, which showed a decrease (range 4 to 0.6) while
Italy and Japan, demonstrated an increase (range 0.9 to 8.5). Imposing the
ASR (W) /B 2 in 2002 and /B 3.5 in 1992 for the 10 year period (1992
2002) most countries remained static; Germany, Sweden Slovenia, Czech,
Hungary, Japan, USA and Canada showed a decline in mortality (range 7.8
to 0.6). In 2002 applying ASR (W) /B 2, Korea showed an increase in
mortality [male (6 to 7), female (3.2 to 4.5)] and in 1992 using ASR (W) /
B 3.5 as cut off Israel showed a downward trend [male (1.4 to 0.5), female
(2.4 to 0.8)].
Conclusion. Overall there was a decline in ASR (W) for gall bladder cancer.
Better diagnostic modalities resulting in appropriate staging of gall bladder/
biliary cancers as well as changes in ICD classification and perhaps better
hygiene/awareness have contributed to these trends
PP 58.09
AN EVALUATION OF NOVEL ELECTROSURGICAL DEVICES IN
BILIARY TRACT SURGERY
Hope, William; Newcomb, William; Schmelzer, Thomas; Heath, Jessica;
Lincourt, Amy; Heniford, B. Todd; Iannitti, David
Carolinas Medical Center, Department of Surgery, Charlotte, United States
Traditionally, metallic clips have been used for ligation of the cystic duct
during laparoscopic cholecystectomy. The purpose of this study was to
evaluate two novel electrosurgical devices in biliary tract surgery. Porcine
common bile ducts were sealed with two electrosurgical devices, an
electrothermal bipolar vessel sealing (EBVS) device and ultrasonic coagula-
tion shears (HS). Metallic clips were used for control. Half the animals
underwent bile duct ligation followed by immediate burst pressure testing
and histologic evaluation. The remaining halves underwent bile duct ligation
and were survived for one week or until signs of sepsis. Proximal bile duct
pressures were documented. The study included 23 pigs that underwent bile
duct ligation, 11 acute and 12 chronic. Seal failure rate for the acute study
was 50% for both electrosurgical devices. There were no seal failures for the
metallic clip. Acutely, the clip had significantly higher burst pressures than
the EBVS (6469282 mmHg vs. 73986mmHg, p0.002) and HS (6469
282 mmHg vs. 72989mmHg, p0.002). No difference in burst pressure
was noted between the EBVS and HS (73986mmHg vs. 72989mmHg, p
NS) acutely. In the chronic study, obvious bile leaks were noted in 2 animals
(50%) in the HS group and 1 animal (25%) in the EBVS group. There were
no obvious bile leaks noted in the clip group. Burst pressures were unable to
be obtained for the bile ducts ligated with HS and EBVS secondary to
disruption of the seal with minimal dissection. Average chronic burst pressure
for the clip was 10889922. The average proximal bile duct pressure from
seven animals was 16.194mmHg. The novel electrosurgical instruments
studied cannot be recommended for routine use in sealing biliary structures
secondary to the failure rate associated with the seals. The porcine common
bile ducts sealed in this study may not be an ideal surrogate for the human
cystic duct.
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GALLBLADDER PERFORATION DUE TO GALLSTONES FOL-
LOWING BLUNT INJURY ABDOMEN
Rajasekar, Arthanari
Sri Gokulam Hospital, Surgical Gastroenterology, 3/60 Meyyanur Road,
Salem, India
Background. Gallbladder injuries secondary to abdominal trauma are
extremely rare. We present a case of isolated gallbladder perforation due to
gallstones following blunt injury abdomen Case Presentation: Sixty-two years
old patient presented after having been involved in a motorcycle accident. He
gave a history of blunt injury of the abdomen due to the motorcycle handle
bar. On presentation he was haemodynamically stable and had features of
peritonitis. He did not have any other injury. Ultrasonography of the
abdomen showed free fluid in the abdomen. With the clinical and
ultrasongraphy diagnosis of probably bowel perforation, laparotomy was
done. Laparotomy revealed bile peritonitis with multiple gallstones lying
freely in the peritoneal cavity around the gall bladder with perforation of the
gallbladder in the neck. Cholecystectomy was done and patient recovered
without any complication. Discussion: A review of the English literature
shows a total of 104 patients with gallbladder injuries secondary to blunt
trauma. The most commonly reported injury was perforation. The diagnosis
of gallbladder in most of the cases was made during surgical intervention.
Other gallbadder injuries reported following blunt injury abdomen are
gallbladder contusions and avulsions. Cholecystectomy is the preferred
surgical treatment and Cholecystostomy should be reserved for patients in
moribund conditions due to other associated injuries.
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CLINICAL FACTORS AND PRE OPERATIVE QUALITY OF LIFE
AS PREDICTORS OF SURVIVAL IN PATIENTS WITH COLOR-
ECTAL LIVER METASTASES UNDERGOING LIVER RESECTION
Dasgupta, Dowmitra1; Needham, Paul2; Bedford, Matthew3; Prasad, K
Rajendra1; Toogood, Giles J3; Lodge, J Peter A3
1St James’s University Hospital, HPPB and Transplant Surgery, Leeds,
United Kingdom; 2St James’s University Hospital, HPB and Transplant
Surgery, Leeds, United Kingdom; 3
Aim: Pre operative quality of life (QOL) has been shown to have prognostic
value for survival in certain malignancies. Clinical status has been shown to
influence quality of life and survival. There is no data analysing the
relationship between preoperative QOL, preoperative clinical data and
survival in patients with colorectal liver metastases (CRM) undergoing liver
resections.
Methods. All patients with CRM undergoing liver resection between July
2002 and July 2003 completed the QOL questionnaire EORTC QLQ C30
preoperatively. Pre-operative clinical, operative and pathological data were
recorded. Follow up was complete until July 2006. Univariate and multi-
variate survival analysis was performed using Cox regression.
Results. 73 patients (mean age 62.2 years, 66% male) underwent hepatic
resection. In univariate analysis platelet count under 220 (p0.007) and age
over 70 (p0.018); but no QOL domains were significant survival
predictors. In multivariate analysis of QOL domains higher cognitive
functioning, reduced diarrhoea and increased fatigue were predictive of
improved survival (pB0.05). When clinical factors and QOL domains were
all entered into a Cox proportional hazards model the clinical factors
remained robust survival predictors, but QOL domains were not predictive
of survival. Pain (p0.008) and nausea (p0.038) were significantly higher
in females, age was inversely correlated with financial difficulties (r
0.387, p0.001), and albumin was positively correlated with global QOL
(r0.270, p0.021).
Conclusions. There are significant associations between certain pre-opera-
tive QOL domains and clinical data, but pre-operative QOL is not a
prognostic factor for survival in patients undergoing liver resection for CRM.
PP 59.02
RELATIONSHIP BETWEEN QUALITY OF LIFE AND IMMUNE
FUNCTION IN PATIENTS UNDERGOING RESECTION OF COL-
ORECTAL LIVER METASTASES
Morris-Stiff, Gareth1; Dasgupta, Dowmitra2; Gomez, Dhanwant1; Need-
ham, Paul1; Bedford, Matthew1; Toogood, Giles J1; Prasad, K Rajendra1;
Lodge, J Peter A1
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1St James’s University Hospital, HPB and Transplant Surgery, Leeds, United
Kingdom; 2
Background. There is increasing evidence as to the intricate relationship
that exists between the immune system and behaviour characteristics of
malignant tumours. The influence of quality of life (QOL) on immune-
function has been well investigated in many disease states but there is little
data in hepatobiliary disease, and in particular patients with colorectal cancer
metastases. Aims: To evaluate the relationship between baseline quality of life
in patients undergoing resection for colorectal liver metastases (CRLM) and
immune function as determined by the neutrophile/lymphocyte ratio
(NLR).Patients and Methods. The EORTC QLQ C30 cancer specific
QOL questionnaire was prospectively administered to 74 consecutive
patients with CRLM undergoing liver resection. The NLR was calculated
on the basis of immediate pre-operative blood counts. Peri- and post-
operative data was collected prospectively.
Results. The cohort consisted of 51 males and 74 females. The NLR was
elevated5 in 8/74 (10.8%). There was no relationship between mean scores
for any of the functional domains or the global QOL domain and immune
function as assessed by NLR. Neither was the NLR related to any of the
symptom domainsof the EORTC QLQ C30 questionnaire test.
Conclusions. In this small cohort, the immune function did not appear to be
related to any of the QOL parameters measured. Further evaluation using
larger numbers using a hepatobiliary-specific QOL questionnaire is planned.
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SIGNIFICANCE OF INDETERMINATE LUNG NODULES IN HE-
PATO-PANCREATICO-BILIARY MALIGNANCY
Pamecha, Viniyendra1; Elaffandy, Ahemed2; Waleed, Al-Obaydi2; Yu,
Dominic3; Davidson, Brian2; Sharma, Dinesh2
1Royal Free Hospital, University College Medical School, HPB AND LIVER
TRANSPLANTATION, Pond Street, Hampstead, LONDON, United
Kingdom; 2Royal Free Hospital, University College Medical School, HPB
AND LIVER TRANSPLANTATION, LONDON, United Kingdom; 3Royal
Free Hospital, University College Medical School, Department of Radiology,
LONDON, United Kingdom
Background. Chest CT (Computed Tomography) is routinely used as a part
of staging protocol for Hepao-Pancreatico-Biliary malignancy. About 20% of
patients are found to have lung nodules on routine CT chest. If there are no
definite benign or malignant morphological features, the pulmonary nodules
are classified as indeterminate. A number of pulmonary nodules are difficult
to characterize and 25%39% of nodules are inaccurately classified after
radiological assessment of size, margins, contour, and internal characteristics.
Objective. To know the incidence of indeterminate lung nodules and there
evolution over time with follow up scans.
Methods. Prospectively collected data on patients undergoing CT chest as
part of staging for HPB malignancy over 2 years. Evolution of indeterminate
nodules with at least one three monthly scan was assessed. Demographic,
clinical and details of nature of primary malignancy and treatment were
noted.
Results. Of two hundred patients over a period of 2 years, 71 patients were
found to have pulmonary nodules (35%). Thirteen patients had benign, 16
had malignant and 42(21%) had indeterminate pulmonary nodules. On
follow up scan, out of 42 patients with indeterminate nodules 5(11%)
patients had increase in the size of nodules and were characterized as
malignant on subsequent scans.
Conclusion. Indeterminate lung nodules are common on routine chest scan
for HPB malignancy. Most indeterminate nodules are benign but a
proportion of them can be malignant and a high degree of suspicion is
needed in order not to miss malignant nodules.
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COLONIC LESIONS IN PATIENTS WITH AMEBIC LIVER AB-
SCESS
Sinha, S K1; Kochhar, R1; Lal, A2; Sehagal, R3; Dutta, U1; Rana, S S1;
Bhasin, D K1; Singh, K1
1Post Graduate Institute Of Medical Education & Research, Department of
Gastroenterology, Chandigarh, India; 2Post Graduate Institute Of Medical
Education & Research, Department of Radiodiagnosis, Chandigarh, India;
3Post Graduate Institute Of Medical Education & Research, Department of
Parasitology, Chandigarh, India
Introduction. Amebic liver abscesses (ALA) occur secondary to amebic
colitis but history of diarrhea is uncommon in these patients. Prevalence of
active amebic ulcers in colon among patients with ALA is not clearly defined.
Objective. To study the frequency of active amebic colitis in patients
presenting with ALA.
Methods. This prospective study was conducted from November 2003 to
July 2006 and included patients presenting with ALA. ALA was diagnosed on
the basis of history, imaging findings, serology, microscopy and culture of
aspirated pus. Each patient underwent full length colonoscopy within five
days of presentation to our hospital. Bowel was prepared with polyethylene
glycol lavage solution. Following patients were not subjected to colonoscopy:
those unwilling to undergo colonoscopy, history of anti-amebic therapy for 
5days prior to presenting in our hospital, hemodynamically unstable and
ruptured liver abscess.
Results. A total of 47 patients (45males, 2 females, age 37.811.68 years)
with amebic liver abscess were seen during the study period. Ten patients
were not subjected to colonoscopy because they fulfilled the exclusion
criteria. Out of 37 patients who underwent colonoscopy (36 males, 1 female,
mean age 38.811.0 years), 27 had ulcers in colon. Distribution of ulcers
was as follows: cecum and ascending colon in 25, transverse colon in 1and
rectosigmoid in 1 patient. Biopsy from these lesions showed acute inflamma-
tion in all, ameba could be demonstrated in only two patients. History of
recent episode of diarrhea was present in 9 out of 47 patients with ALA and 8
out of 37 patients who underwent colonoscopy. When the group with colonic
ulcers was compared with the group without ulcers, there was no significant
difference with respect to age, duration of fever, duration of pain, frequency
of diarrhea, serum albumin level, number and size of liver abscesses.
Conclusion. Active amebic colitis is common in patients presenting with
ALA. These ulcers are most commonly present in cecum and ascending
colon.
PP 59.05
RECURRENT CHOLANGITIS AFTER ERCP IN PRIMARY
SCLEROSING CHOLANGITIS
Andraus, Wellington1; Haddad, Luciana B P1; Moura, Fabio2; Bachella,
Tele´sforo1
1University of Sa˜o Paulo School of Medicine, Department of Gastroenter-
ology, Sa˜o Paulo, Brazil; 2
Introduction. Diagnosis of primary sclerosing cholangitis (PSC) is a
challenge. Confirmation with an imaging exam is often necessary. ERCP is
considered the gold standard; however it is an invasive method with its
inherent risks. Magnetic Resonance (MR) appeared as a good option in such
cases. OBJECTIVES: Report the risk of ERCP in PSC patients and compare
two diagnostic methods (ERCP and MR) for this disease.
Methods. We report two cases of patients with PSC who developed recurrent
cholangitis after ERCP. A review of literature was performed in a mesh
database on MEDLINE in the last 15 years.
Results. The first case was 39 years old female, presenting high levels of
canaliculare liver enzymes, underwent a ERCP for investigation. She had
never experienced cholangitis before, and after ERCP procedure she started
presenting recurrent biliary infections. The diagnosis of PSC was confirmed,
however, for that reason, antibiotic profilaxy is permanently required. The
second one, a 51 years old male, had the diagnosis of intestinal inflammatory
disease. During a investigation of upper abdominal pain and hepatic enzymes
alteration, he underwent a MR that showed irregularities in intrahepatic
biliary tree. The diagnosis of PSC was already made, even though a ERCP
was performed for complete investigation. The patient presented multiple
hepatic abscesses after the procedure, with long period of hospitalization and
antibiotic therapy. In the outcome he presented recurrent cholangitis. The
literature reports cholangitis as a possible procedure complication. PSC is a
rare disease and there is no data of recurrent cholangitis after ERCP. We
report two cases of recurrent cholangitis after papilotomy, and they are in the
waiting list of liver transplantation. Moreover, many authors showed the
equivalency of MR and ERCP in diagnosis of PSC.
Conclusions. We recommend MR for diagnostic confirmation in PSC, and
avoiding ERCP in such cases because of the recurrent cholangitis risk with
this exam.
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MANAGEMENT OF HEPATIC TRAUMA IN ADULTS- A SINGLE-
CENTRE EXPERIENCE
Akolekar, Deepika1; Dhiya, Luay2; Hidalgo, Ernest2; Powell, James2;
Ravindran, Ravi2; Wigmore, Steve J2; Garden, O James2; Parks, Rowan W2
1Royal Infirmary of Edinburgh, Department of Clinical and Surgical
Sciences, 51, Little France Crescent, Edinburgh, United Kingdom; 2Royal
Infirmary of Edinburgh, Department of Clinical and Surgical Sciences,
Edinburgh, United Kingdom
Background. Liver trauma is associated with significant mortality and
morbidity. AIMS The aim of this study was to assess the management of
patients with liver trauma and to assess factors that influence outcome in a
specialist hepatobiliary centre.
Methods. All patients treated for liver trauma from 1995 to 2006 were
identified from the prospectively collected Lothian Surgical Audit database
and details regarding demographics, operative management and outcome
were analysed.
Results. A total of 92 patients (73 males, 19 females) with a median age of 29
years were treated for liver trauma over this period. Thirty three patients
(36%) were transferred to this unit from other hospitals. Blunt trauma
especially road traffic accidents accounted for 41% of the injuries. Liver
trauma with associated injures of other organs was noted in 64 (70%)
patients. Fifty nine liver injuries (64%) were of low severity (grades I and II),
while 33 (36%) were of high severity (grade III, IV and V). Thirty eight
patients (41.3%) were haemodynamically unstable (systolic BP 5 90
mmHg) at presentation. 52.5% of the patients with low grade injuries were
managed conservatively. Three of the 38 patients with liver trauma initially
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considered for conservative management required surgery due to bile leak or
haemorrhage. Operative management was undertaken in 57 patients (62%).
The overall mortality was 12%.The mortality rate was higher patients with
haemodynamically instability (p0.009) and increasing severity of liver
injury (p0.007).
Conclusion. Low grade liver injuries can be managed nonoperatively with
excellent results. Associated injuries are common. Grade of injury and
haemodynamic instability are associated with higher mortality.
PP 59.07
WHAT IS A MAJOR HEPATIC RESECTION IN 2007?
Morris-Stiff, Gareth; Gomez, Dhanwant; Toogood, Giles J.; Lodge, J. Peter
A.; Prasad, Rajendra
Leeds Teaching Hospital NHS Trust, Hepatobiliary and Transplantation
Unit, Leeds, United Kingdom
Background. A major hepatic resection is currently defined as the resection
of 3 or more Couinaud segments. With advances in perioperative techniques,
the safety of liver resection has improved in terms of both morbidity and 30-
day mortality allowing removal of larger volumes of hepatic parenchyma
without significant impairment of synthetic function thus raising the question
as to whether the classification of liver resections should now be modified.
Aims: To determine the preoperative morbidity and mortality of hepatic
resection in relation to removal of 12, 34 or 56 hepatic segments.
Patients and Methods. All patients undergoing resection of colorectal liver
metastases from 20002005 were identified from a prospectively maintained
database. Data collected included: morbidity rate; number of patients
experiencing morbidity; prevalence of hepatic failure; and 30-day mortality.
Results. During the period of the study 386 patients (246 Male and 140
females) with a mean age of 65.9 years, 268 of which were aged60 years,
underwent resection. There were significant differences in both the number
of patients experiencing morbidity and the overall morbidity rates for all 3
groups and significant differences in both the hepatic failure and mortality
rates between the 12/34 and the 56 segment groups. When the 12 and 3
4 groups were combined there were clear differences between the combined
group and those undergoing extended resections of 56 segments in all
parameters examined.
Conclusions. The results show that there are clear differences in relation to
the number of segments excised and morbidity allowing division into: Minor
(12); Moderate (34); and Major (56) segments. Alternatively, as the major
concerns are hepatic failure and death, the resections could be classified as 2
groups: Minor (14) and Major 56) Couinaud segments. Further work is
required to confirm these results and to sub-analyse in relation to
chemotherapy-associated hepatic parenchymal damage as this may lead to
‘group migration’.
PP 59.08
A CASE OF HEPATOCELLULAR CARCINOMA ACCOMPANIED
WITH DUBIN-JOHNSON SYNDROME
Katagiri, Satoshi; Kotera, Yoshihito; Ariizumi, Shun-ichi; Takahashi, Yutaka;
Okano, Shunsuke; Yamamoto, Masakazu
Institute of Gastroenterology, Tokyo Women‘s Medical University, Dept.
Surgery, Tokyo, Japan
A 77-year-old man was admitted to our hospital because of liver tumor by
screening ultrasonography at medical checkups. He had been pointed out
slightly jaundice thirty years ago. Abdominal computed tomography showed
a strong enhanced tumor of 3cm in diameter identified at the segment 7 and
the tumor had a corona. The preoperative total bilirubin was 2.7 mg/dl and
direct bilirubin was 2.0 mg/dl, but other hepatic functional reserves were kept
in normal limits. Virus markers were not detected. He was diagnosed as
having Hepatocellular Carcinoma (HCC) accompanied with Dubin-Johnson
syndrome (DJS) without chronic hepatitis. On June 2007, Segment 7
resection of the liver was performed. Intraoperative findings showed a black
liver without liver fibrosis. Histopathologically, the hepatic tumor was a
moderately differentiated HCC without intrahepatic metastasis and portal
invasion. The liver parenchyma was a rough brown granule. The total
bilirubin level rose up to 9.4 mg/dl after operation but it gradually decreased.
So, HCC accompanied with DJS in which hepatic resection was performed
were rare report.
PP 59.09
FDG-PET IN THE STAGING AND SURVEILLANCE FOR PA-
TIENTS WITH CHOLANGIOCARCINOMA
Rath, Siddhartha; Byrnes, Kerry; Shokouh-Amiri, Hosein; Lilian, David;
Johnson, Lester; Johnson, Lester; Turnage, Richard; Zibari, Gazi
Louisiana State University Health Sciences Center, Surgery, Shreveport,
United States
Purpose. FDG PET is a valuable tool in both staging and surveillance of
multiple malignancies. Cholangiocarcinoma is rare and frequently presents
late. Computed tomography has become the gold standard in staging
cholangiocarcinoma, however it has its weaknesses. The purpose of this
study is to assess the value of conventional FDG-PET in both the staging and
surveillance of patients with cholangiocarcinoma.
Methods. All patients with a diagnosis of cholangiocarcinoma from 1999
2004 were identified and reviewed retrospectively. Patients who underwent
PET scanning as part of their staging preoperative workup and surveillance
were selected. Concomitant computed tomography scans were reviewed
when available. Pathology reports and operative findings were reviewed in
detail. The sensitivity of both PET imaging and computed tomography was
determined.
Results. Thirteen patients with cholangiocarcinoma who underwent FDG-
PET scanning were identified. A total of 19 PET scans were obtained of
which eight were performed as part of pre-operative staging; the remaining
eleven underwent PET for surveillance. All patients who had pre-operative
PET scans underwent surgery, (7 laparotomies, 1 laparoscopy), and in all
cholangiocarcinoma was confirmed by histology. The sensitivity of PET in
detecting primary disease was 100%. In two patients distant disease existed
and PET scan accurately identified one of these. Eleven surveillance (post-
operative) PET and CT scans were performed in seven patients. The
sensitivity of PET in detecting recurrence was 100%. In comparison,
computed tomography detected recurrence with a sensitivity of 33%.
Conclusion. PET scan is a valuable tool for pre-operative staging of
cholangiocarcinoma and compares favorably to conventional computed
tomography as a surveillance tool.
PP 59.10
THE CLINICAL VALUE OF REPEAT FOLLOW-UP IMAGING
STUDIES IN PATIENTS WITH BLUNT HEPATIC TRAUMA.
Lee, Minjae1; Evans, Peter1; Usatoff, Val1; Atkin, Chris2
1The Alfred Hospital, Commercial Road, Department of Surgery, Monash
University, Melbourne, Australia; 2The Alfred Hospital, Commercial Road,
Department of Trauma Surgery, Melbourne, Australia
Background. There has recently been much controversy surrounding
follow-up management of patients with blunt hepatic trauma, in particular
whether repeat imaging is routinely required in asymptomatic patients after
livery injury. Currently there are conflicting recommendations in the
literature. AIMS: To test the hypothesis that blunt hepatic trauma patients
who receive follow-up imaging studies have the same outcomes as patients
who do not receive follow-up imaging studies.
Methods. A 6 year retrospective review was conducted on consecutive cases
of blunt hepatic trauma at a level 1 trauma centre. Repeated Computed
Tomography and Ultrasound scans during the follow-up period were
reviewed together with detailed analysis of patients’ medical records. With
each of the repeated imaging studies, chronological correlations were made
with the medical records to observe for changes in clinical management as a
consequence of these imaging studies.
Results. Over the period from 2001 to 2007, 386 patients were admitted
with blunt hepatic trauma at a level 1 trauma centre. Mean age at time of
trauma was 38 years of age. There were 262 (68%) grade I and II, 59 (15%)
grade III, 47 (12%) grade IV, 16 (4%) grade V and 2 (1%) grade VI hepatic
injuries. Repeated Computed Tomography or Ultrasound scans during the
follow-up period were shown to have minimal impact in clinical management
of patients after blunt hepatic trauma.
Conclusion. Routine use of Computed Tomography scans in follow-up
management of patients is not warranted in most cases of blunt hepatic
trauma, with limited impact on subsequent clinical management of these
patients. Use of Ultrasound as a follow-up imaging modality is an alternative
to Computed Tomography for patients who may be at high risk of developing
complications from blunt hepatic trauma.
PP 59.11
CONGENITAL ABNORMALITIES OF THE INTRA AND EXTRA-
HEPATIC BILIARY TREE IN ADULTS.
Bracco, Ricardo1; Grondona, Jorge2; Moreno, Adria´n3; Lo Veci, Juan4
1Clinica Pueyrredo´n, HPB unit, Mar del Plata, Argentina; 2Centro me´dico
martı´n y Omar, HPB unit, San isidro, Argentina; 3Clinica Pueyrredo´n, HPB
fellow, Mar del Plata, Argentina; 4Centro me´dico Martı´n y Omar, HPB
fellow, San Isidro, Argentina
Background. congenital abnormalities of the intra and extrahepatic biliary
tree are characterized by cystic and/or diffuse dilatations and usually present
pancreatobiliary maljunction with potential risk of malignant transformation.
Aim. to describe a 16 year period experience in the treatment of congenital
biliary tree dilatations in adults.
Methods. out of 20 patients with congenital biliary tree dilatations, 18
females(90%) and 2 males(10%) were observed. Most frequent lesions
treated were Type I and IV A of Todani-Watanabe classification. In 7
patients(35%) a pancreatobiliary maljunction was detected. Out of 20, in 8
cases the whole extrahepatic biliary tract, including the convergence of both
left and right hepatic ducts were resected. In addition, 8 liver resections were
performed: 4 sectionectomies and 4 hepatectomies.
Results. no postoperative mortality was observed. A neumopathy, a bile leak,
a subphrenic abscess and a biliary peritonitis were the complications
registered. The last two were treated succesfully by laparoscopic and
laparotomic approach respectively. Thorough follow up was achieved in 19
patients(95%).
Conclusions. congenital abnormalities of the intra and extrahepatic biliary
tree in adults can be diagnosed by modern imaging techniques for
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hepatopancreatobiliary diseases. Surgical approach consist of removing
pathological extrahepatic cystic areas. Liver resections should be carried
out according to the presence of stenosis, biliary stasis and/or intrahepatic
stones. The surgical technique must be accurate in extension and meticulous
when performed.
PP 60.01
THE ROLE OF MRCP IN THE PREOPERATIVE ASSESSMENT
OF CHOLEDOCHAL CYSTS IN CHILDREN.
Hegab, Bassem; Korayem, Enas; El Araby, Hanaa
National Liver Institute, University of Menoufiya, Menoufiya, Egypt
Aims. To assess the preoperative diagnostic value of MRCP versus
intraoperative cholangiography and surgery in children with choledochal
cysts.
Patients and Methods. Twelve children who were initially diagnosed with
choledochal cyst by ultrasonography were included in this study. All the
patients performed preoperative MRCP and intraoperative cholangiography
before cyst excision. The type of choledochal cyst, anomalous pancreatico-
biliary ductal union (APBDU), and associated pathology were characterized
on the basis of MRCP findings and were compared with those findings of
intraoperative cholangiography and surgery. All patients underwent cyst
excision and hepaticojejunostomy Roux-en-Y anastomosis except five
patients with associated biliary atresia who underwent Kasai’s portoenter-
ostomy operation.
Results. There were 12 patients, with median age of 3.19 (2months-13
years) years, of whom 9 were girls and 3 were boys. The commonest
presenting symptom was jaundice in 9 (75%) patients, followed by
abdominal pain in 7 (58.3%) patients, abdominal mass in 4 patients
(33.3%), cholangitis in 2 (16.7%) patients and acute pancreatitis in 2
(16.7%) patients. Only 2 (16.7%) patients presented with the classical triad
of abdominal mass, pain, and jaundice. MRCP depicted a diagnosis of
choledochal cyst in all patients, characterized the type of cyst (2 Type Ia, 2
Type Ib, 5 Type Ic, 1 Type II, and 2 Type IVa). MRCP findings were
confirmed by surgery and intraoperative cholangiography in all patients.
APBDU was detected by MRCP and intraoperative cholangiography in 5
(41.6%) and 3 (25%) of 12 patients, respectively, all of them were of type B
anomaly. Biliary stones were found in three patients (25%). Associated
pathology with choledochal cyst included 5 (41.7%) patients with biliary
atresia.
Conclusion. MRCP appears to be a reliable, non invasive and safe method
in the diagnosis, specifying type and determining the extent of the
choledochal cyst as well as diagnosis of associated pathology and duct
anomalies.
PP 60.02
BILE DUCT INJURIES: CAUSES AND MANAGEMENT
Kantharia, Chetan1; Prabhu, Ramkrishna2; Dalvi, Abhay2; Bapat, Ravindra2;
Supe, Avinash2
1Kemh & Seth Gs Medical College, Surgical Gastroenterology, Parel,
Mumbai, India; 2Kem Hospital & Seth Gs Medical College, Clinical
Pharmacology, Mumbai, India
Background. Cholecystectomy is associated with bile duct injury (BDI). We
review our experience of BDI with attention to the cause and treatment.
Material and Methods. From 2003 to 2006, 27 patients of BDI were
referred. 21 (14 females; age range 2568 years) were following elective
Laparoscopic cholecystectomy (LC) and six (4 females; age range 2472
years), were following elective open cholecystectomy (OC). BDI classified as
per Strasberg classification BDI following LC: Type A (n1), type B, C (n
1), type D (n3), type E1 (n5), type E2 (n3), type E3 (n6), type E4
(n1) and type E5 (n1). BDI following OC: Type E2 (n3), E3 (n1)
and type E4 (n2). Reasons leading to the BDI were assessed.
Results. The reasons for BDI in LC group was Difficult anatomy (11pts),
Bleeding with excessive clip applications 94 pts), sub-optimal facilities and
assistance (11 patients) and visual perception defect (2 pts). In OC group, it
was difficult anatomy (2 patients) and sub-optimal facilities and assistance
(2 patients). All the 21 LC were operated by experienced laparoscopic
surgeons. BDI was identified at the time of occurrence in 9 patients. 7
patients underwent further surgery\procedures before referral. None of the
BDI following OC were detected on table. The post referral treatment was: In
OC group  Hepaticodocho Jejunostomy in all six patients, In LC group:
Hepaticojejunostomy (11) T-tube drainage (3), operative drainage of biloma
(1), ERCP/stent (4), percutaneous transhepatic stenting (2). There was no
mortality in the open group but 5 in the LC group (3 patients were referred
late with multi-organ failure, and 2 patients had severe cholangitis). The
median F /U was 45 months (range 1104).
Conclusions. The common causes of causes of BDI in both groups were
difficult anatomy and sub-optimal facilities and assistance.
2) The learning curve excuse does not hold true in the present study.
3) The recent trend towards the referral to specialist HPB unit, of what
ultimately turn out to be minor injuries is encouraging.
PP 60.03
UNUSUAL CAUSES OF OBSTRUCTIVE JAUNDICE
Gawade, Sandesh; Prabhu, Ramkrishna; Kantharia, Chetan; Supe, Avinash;
Bapat, Ravindra
Kem Hospital & Seth Gs Medical College, Surgiacl Gastroenterology,
Mumbai, India
We present four rare presentations of OJ with review of literature. 38 year old
lady presenting with cholangitis, underwent stenting, followed by Open
cholecystectomy with CBD exploration. Intra operatively diagnosed to have a
CBD mass and subjected to cholecystectomy with T- tube insertion. Biopsy
revealed endocrine tumor of pancreas. CT scan showed mass at confluence.
She had two subsequent stent changes. On presentation she was subjected to
MRCP showed CBD mass and was followed by PTCD. Complete excision of
tumour with high hepaticodochojejunostomy done. HP confirmed Extra-
Hepatic Carinoid tumour. Case 2: 54 year patient with h/o recurrent
cholangitis since last 11/2 years and OJ since 1 month. H/O undergone
open cholecystectomy with CBD exploration 2years back for cholecystitis
with choledocholithiasis. She was non-diabetic and HbSAg and HIV
negative.USG and CT-Scan done revealed dilated IHBR and dilated CBD.
Subjected to PTBD to alleviate her rising bilirubin. It revealed characteristic
pattern suggestive of mucormycosis. Bile culture was positive for Mucormy-
cosis. She was started on antifungal, but she succumbed.Case3: 54 year man
who had undergone choledochojejunostomy after choledochal cyst excision,
developed ischemic stricture of the Roux-en-Y loop intestinal loop and
recurrent cholangitis. The stricturous intestinal loop was excised with re-
anastomosis with new Roux-en-Y loop. Case 4: 24-year lady presented with
bilious expectoration and H/O OJ, following open cholecystectomy. Pleur-
ocentesis, followed by intercostals drainage done, which drained about 300
ml bilious fluid per day for a month. Her symptoms were relieved. A pleuro-
biliary fistula was demonstrated by percutaneous transhepatic cholangio-
gram, HIDA scan and ERCP, showed complete cut-off at the lower end. The
patient underwent bilio-enteric bypass with gastric access loop, with complete
healing of the pleuro-biliary fistula.
PP 60.04
CHOLEDOCHAL CYST IN ADULTS: A SINGLE CENTER EX-
PERIENCE
Penteado, Sonia1; Perini, Marcus Vinicius2; Cunha, Jose Eduardo2; Jureidini,
Ricardo3; Jukemura, Jose4
1University of S.Paulo, Department of Gastroentrology, S.Paulo, Brazil;
2Department of Gastroenterology, S.Paulo, Brazil; 3University of S.Paulo,
Department of Gastroenterology, Brazil; 4Department of Gastroenterology
Background. The low incidence of choledochal cysts in Western adults has
resulted in little information about results of surgical treatment of these
patients.
AIM. to analyze long term results of surgical excision of choledochal cysts
diagnosed after childhood.
Methods. retrospective review of patients presenting with extrahepatic
choledocal cysts from 1987 on, excluding Caroli’s disease. Data included
demographics, symptoms, surgical procedure, surgical pathology results,
morbidity, mortality and follow-up. Cysts were grouped according to
Todani’s classification by imaging techniques, surgical findings and intra-
operative cholangiogram.
Results. Thirty patients, 20 women and 10 men, ages from 14 to 77 years
(mean 33.6), were treated since 1987. Symptoms were pain in 96% and
jaundice 56%, prior cholangitis 56% and acute pancreatitis 13%, none had
palpable mass. Prior treatments were endoscopic papillotomy in seven
(23%), biliary stenting in one, 14 patients underwent previous laparotomy
(27,5%), including cholecystectomy 24,1% (8/29), cystenterostomy 10,3%
(3/29), pancreatic pseudocyst drainage (1/29), splenectomy (1/29), lapar-
otomy (1/29). The cysts were resected distally as far as the biliopancreatic
junction, however a dome like segment of about 0.5 was left in the biliary
confluence to avoid anastomotic stricture.Twenty seven patients underwent
excision, one had only a biopsy because of carcinomatosis, and two (type II
and III) refused operation. Type I cists were more frequent, 70%, type IV
23%, type II 3.3% as type III,3.3%. No postoperative deaths were observed.
Mean follow up was 51 months; one had recurrence of cholangitis and was
submitted to left hepatectomy. None had biliary strictures and so far none
presented with cholangiocarcinoma.
Conclusion. The technique for excision prevented strictures, but the fate of
the small remnant mucosa is a major concern.
PP 60.05
NON TRAUMATIC INFLAMMATORY STRICTURES OF THE
BILE DUCT
Vyas, Frederick1; Joseph, Philip2; Sanghi, Ravish2; Eapen, Anu3; Sitaram,
Venkatramani2
1Christian Medical College Hospital, Department of General Surgery,
Ida Scudder Road, Vellore, India; 2Christian Medical College Hospital,
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Department of General Surgery, Vellore, India; 3Christian Medical College
Hospital, Department of Radiodiagnosis, Vellore 632004, India
Background. Non traumatic inflammatory strictures of bile duct are
uncommon. Strictures occurring within common hepatic duct and common
bile duct without a history of prior surgery in that region or stone disease are
usually thought to be due to cholangiocarcinoma unless proved otherwise. It
is often impossible to distinguish between benign and malignant strictures
before laparotomy.
Aim. To examine the clinical and pathological features of benign idiopathic
strictures of the bile duct.
Methods. From February 2002 to January 2007, 76 patients with benign bile
duct strictures were operated upon. Ten patients had a final diagnosis of non
traumatic benign stricture. We reviewed these patients retrospectively and
they are the focus of this study.
Results. There were 10 patients (7 male, 3 female) with a mean age of 36
years (range 1465). Presenting symptoms included jaundice (8), abdominal
pain (6), fever (5) and weight loss (4). Their mean bilirubin and alkaline
phosphatase levels were 6.21 mg/dl and 430u/dl respectively. Pre-operative
imaging was consistent with cholangiocarcinoma in all patients (9 MRCP, 1
ERCP). None of them had evidence of stone disease on pre-operative
imaging. CA 19.9 levels were normal in all patients except 2. There were 7
proximal and 3 mid bile duct strictures. Nine patients underwent cholecys-
tectomy with biliary enteric bypass and 1 patient underwent double bypass
for suspicion of advanced malignancy. Based on operative and histopatho-
logical reports, the causes were congenital (1), tuberculosis (3) and non
specific fibrosis/inflammation (7). Major morbidity occurred in 2 patients but
none died.
Conclusion. Differentiating benign from malignant biliary strictures is often
difficult. Surgical resection is the treatment of choice. However, benign
etiology should be considered when younger patients present with bile duct
strictures
PP 60.06
POST CHOLECYSTECTOMY BILIARY COMPLICATIONS: PRE-
SENTATION AND MANAGEMENT.
Virk, Satpal1; Babra, Ravinder Pal Singh2; Ahuja, Ashish1
1Dayanand Medical College & Hospital, Dept of Surgery, Ludhiana Punjab,
India; 2Dayanand Medical College & Hospital, Dept Of Surgery, Ludhiana
Punjab, India
Background.Cholecystectomy is associated with bile duct injury, incidence
of which has doubled since the introduction of laparoscopic cholecystectomy.
This study reviews the presentation and management of bile duct injury in a
tertiary care centre.
Methods. From 2003 to 2007, 37 patients (28 females) of median age 42
years (range 2570)were referred to this centre with bile duct injury following
open and laparoscopic cholecystectomy.
Results. Patients were referred after a median of 30 (range 03650) days
after cholecystectomy. Patients with laparoscopic cholecystectomy (40.54%)
had median of 7(0425) days while patients with open cholecystectomy
(59.45%) had median of 46 (13650) days. Management before surgical
referral included definitive reconstruction [hepaticojejunostomy (1) and T
tube drainage (1)], drainage of abcess (6), ERCP (3). Management after
referral included definitive surgical reconstruction (29) laparotomy/laparo-
scopic drainage (4) ERCP with stent insertion (3) and stump closure (2).
Definitive surgical reconstruction comprised of Roux-en-Y hepaticojejunost-
omy (Hepp-Couinard technique) for Bismuth type of striture which included
TypeI(7) TypeII(15) TypeIII (3) TypeIV(2) TypeV(2). Two patients died,
who had undergone laparotomy and drainage for biliary peritonitis at our
centre. They had median inpatient stay following referral of 6 days.
Conclusion.: Bile duct injury following cholecystectomy is a complex
management problem and results in significant postoperative morbidity.
Most patients reffered required reconstructive surgery and patients with
complex high injuries had a risk of long term morbidity.
PP 60.07
CHOLEDOCHAL CYSTS  A RETROSPECTIVE ANALYSIS
Khandelwal, Manish1; Kumar, Bindey2; Khandelwal, Chiranjiva2
1Aberdeen Royal Infirmary, Aberdeen, United Kingdom; 2Indira Gandhi
Institute of Medical Sciences, Patna, India
Background. Choledochal cysts are congenital anomalies of the bile ducts.
They consist of cystic dilatations of the extra-hepatic biliary tree, intrahepatic
biliary radicals, or both. It poses a considerable challenge in terms of
diagnosis & management.
Objective. We analysed the sixty four cases that presented to us over the last
17 years in terms of age of presentation, clinical features, type of cyst &
perioperative complications.
Methods. Retrospective analysis of 64 cases over the last 17 years.
Results. Sixty Four patients with Choledochal cyst were treated over a
period of 17 years. Thirty three (52%) patients were under 12 year’s age.
Forty two (66%) of patients were females. Upper abdominal pain was the
most common presenting symptom (66%) followed by jaundice & fever
(28%). Investigations included Ultrasonography in all cases, Endoscopic
Retrograde Cholangio Pancreatogram (ERCP) in most (60%), Percutaneous
Transhepatic Cholangiogram (PTC) & Intra-operative Cholangiogram in
two cases each. Commonest type was Todani Type I (77%). Complete
excision was possible in 55(86%) cases (Type I & II) & excision of extra
hepatic cyst with wide drainage of intra hepatic cyst in 6(9%) cases (Type
IVA). Submucosal excision of cyst (Lilly’s technique) was done in 2 cases &
internal bypass in one. Overall we had only one (2%) perioperative mortality.
48% of our patients were adults but cholangitis and hepatitis was more
common in children (24%).No patient had cholangiocarcinoma.
Discussion. Choledochal cyst, though are congenital anomalies may not
present until adulthood. If presented in childhood, patients tend to have
serious Hepato-biliary complications (cholangitis, hepatitis & cirrhosis) more
commonly as compared to their adult counterparts.Choledochal cysts should
be treated by early surgical intervention. With experience most Choledochal
cysts can be excised safely.
PP 60.08
PORTAL BILIOPATHY- A STUDY OF 39 SURGICALLY TREATED
PATIENTS
Sharma, D1; Girish, S.P.1; Singh, Shivendra1; Agarwal, S.1; Chaudhary, A.1;
Sakhuja, Puja2; Agarwal, Anil1
1G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India; 2G. B. Pant Hospital and Maulana Azad Medical
College, Pathology, New Delhi, India
Background. Portal biliopathy denotes intrahepatic and extra hepatic biliary
ductal abnormalities in portal hypertension. It is usually associated with extra
hepatic portal vein obstruction (EHPVO).
Methods. Retrospective analysis of prospectively collected data of surgically
managed portal biliopathy patients between 1996 to 2007 was performed for
presentation, clinical features, imaging and the results of surgery. All patients
were taken up with plan of decompressive shunt surgery in the first stage and
biliary drainage procedure in second stage 68 weeks later if required.
Results. 39 patients (27 males, mean age 29.57 years) of symptomatic portal
biliopathy were surgically managed. Jaundice was the commonest symptom
followed by right upper quadrant pain and recurrent cholangitis. The first
stage surgery included proximal splenorenal shunt (37), esophago-gastric
devascularization with simultaneous hepaticojejunostomy (1 patient with
peroperatively found nodular liver), and hepaticojejunosotmy alone (1 patient
found to have splenic vein thrombosis in preoperative workup). During follow
up, clinical and biochemical improvement was monitored. Those with
persistent symptoms underwent Doppler and MRCP examination. Thirteen
patients underwent second stage surgery-12 required biliary drainage
procedures (Hepaticojejunostomy-11, Choledochoduodenostomy-1). These
patients had dominant strictures and choledocholithiasis. One patient had
successful endoscopic clearance of CBD stones after first stage and required
only cholecystectomy in second stage for gall stones. Average blood
transfusion requirement at second surgery was 0.92 unit, post-op complica-
tions were minimal with no mortality. Over a follow up of 548 months the
patients are asymptomatic and well.
Conclusion. Symptomatic portal biliopathy needs intervention. Surgical
decompressive shunt followed by biliary drainage is the best possible
treatment. While for most of the early biliary changes shunt alone is effective,
patients with dominant stricture will need a second stage biliary drainage
procedure.
PP 60.09
THE ROLE OF STAGING LAPAROSCOPY IN EXTRA HEPATIC
PROXIMAL BILIARY TRACT MALIGNANCIES
Basu, A K; Singh, R P; Mandal, Sanjoy; Singh, Shivendra; Agarwal, Anil
G. B. Pant Hospital and Maulana Azad Medical College, Department of GI
Surgery, New Delhi, India
The staging laparoscopy of Extra hepatic proximal biliary tract malignancies
has a potential to identify intra-abdominal metastasis and thereby avoid
laparotomy in unresectable cases. This prospective study evaluates the role of
staging laparoscopy in Extra hepatic proximal biliary tract malignancies in a
tertiary referral centre.
Methods. a total of 130 cases of Extra hepatic proximal biliary tract
malignancies that were deemed resectable by preoperative imaging were
included in this study. There were 115 cases of Gallbladder Cancer (GBC)
44 with biliary obstruction (SOJ) (n44); and 71 cases without. 15 cases
were of cholangiocarcinoma (Cholangio Ca). All patients were subjected to
staging laparoscopy prior to laparotomy.
Results. laparoscopy spared laparotomy for metastatic disease in 43 cases of
GBC and 6 cases of cholangioCa. Laparoscopy failure rate was in 14 cases of
GBC SOJ (11.27%) and 3 cases of cholangioCa. Overall, staging laparoscopy
spared 44.61% of patient from unnecessary laparotomy. Patients with
unresectable disease that were not detected by laparoscopy most often had
locally advanced tumors. The average hospital stay was shorter in the only
staging laporoscopy group.
Conclusion. Laparoscopy avoided laparotomy in 43 of 115 cases and 6 of
15 cases of cholangiocarcinoma., Laparoscopy thus significantly reduces
the morbidity, and cost of hospitalization by avoiding unnecessary lapar-
otomy.
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PP 60.10
BILIARY TRACT INJURIES AFTER CHOLECISTECTOMIES:
FIVE CASES REPORT
Ribeiro, Marcelo; Condi, GA; Jurado, MM; Albuquerque, JR MS; Saad, WA
Medical Sciences College, Pontifical Catholic University, Department of
Hepatic Surgery, Sao Paulo, Brazil
Introduction. Due to the continuous increasing of the diagnostic methods
for gallblader disease colelithiasis, an increasing of the number of cholecis-
tectomies has been also achieved, including open or laparoscopic approach-
ings. Biliary tract stenosis ranges from 0,16% to 2,35% (Duca et al., 2003,
Ahrendt et al., 2005). Consequently, the biliary tract injury incidence should
not be underestimated, once it affects patients morbidity and mortality rates.
Objective. Report of five uncommon cases of biliary tract injuries during
conventional or laparoscopic cholecistectomies and the appropriate treatment
for each patient, by using clinical history and subsidiary exams.
Report. Case 1: KCVM, 28 years, female, submitted to conventional
procedure, presented ascitis one week later. At the second surgery, there
were found common bile duct perforation and section of right hepatic artery.
Case 2: RBS, 34 years, female, presented bile leak during laparoscopic
surgery. After that, intra-operative colangiography was not performed. Three
months later, a cholangio MR demonstrated hepatic ducts junction stenosis
(Bismuth IV). Case 3: MAVF, 40 years, female, presented jaundice and
chronic colangitis after laparoscopic cholecistectomy. Case 4: EFR, 35 years,
male, presented recurrent jaundice after the same procedure, with Bismuth
II/III injury. Case 5:SAS, 30 years, female, presented at laparoscopic surgery
complete biliary tract section. Discussion: When Y-Roux hepaticojejunost-
omy is used for such lesions, the results success rate in the literature are
between 80% and 90% (Csendes et al., 1992, Bergmann et al., 1996). In the
first four cases, complete section of the biliary tract was identified and
according to that the patients underwent Y-Roux technique. In one case, the
lesion was found intra-operatively, and the proposed treatment at that
moment was end-to-end anastomosis of the bile duct. All patients presented
satisfactory post-operative clinical recover, which was possible because of the
appropriate Y-Roux hepaticojejunostomy anastomosis.
Conclusions. The biliary tract is a common site for complications when it is
not handle with great care and high index of suspicious. Nevertheless, the
early recognition of the injuries constitutes an important factor for reducing
patients morbidity.
PP 60.11
CHOLEDOCHAL CYST, EMERGING PATTERNS OF PRESENTA-
TION
Joseph, Philip; Vyas, Frederick; Raju, Ravish Sanghi; Sitaram, Venkatramani
CMC Hospital, Hepatobiliary Unit (Surgery Unit 4), Vellore, India
Background. Choledochal cyst is an uncommon anomaly which is more
common in the Asian population. It usually presents in childhood and there is
a female preponderance. Excellent results have been achieved with timely
management. However in a developing country like India, this disease may
present in adults. Complications including malignancy seen in the adult
population continue to remain a challenge.
Methods. The hospital records of all adult patients who underwent surgical
treatment for choledochal cyst in a single centre during 2001 07 were
analysed.
Results. There were a total of 56 adult patients. Abdominal pain was the
commonest presenting symptom, the next being cholangitis. Type 1
choledochal cyst (69%) was the commonest type. Malignancy was seen in
3 patients (1 male, 2 females). Nineteen patients had undergone a previous
operative procedure (cholecystectomy, cyst enteric bypass, t-tube drainage,
partial excision and Roux en y bypass) before they presented to us. Major
morbidity included bile leak, bleeding, intra-abdominal collection, wound
infection and was seen in 14 patients. There was no increase in the morbidity
or mortality from the definitive operation, in patients who had undergone
previous biliary enteric bypass or other operative procedure. Three patients
died (intra-operative bleeding 1, post-operative bleeding 1, post-operative
sepsis 1).
Conclusion. The female preponderance is different from quoted literature in
adults. Abdominal pain and cholangitis are common presenting symptoms in
adults. When diagnosed in adults complete excision must be offered as they
have an increased risk of developing malignancy.
PP 61.01
CXCL16, CXCR6 AND A DINSINTEGRIN AND MATRIX METAL-
LOPROTEINASE (ADAM10)  AN INTERPLAY LEADING TO
PROGRESSION OF PANCREATIC CANCER?
Gaida, Matthias M1; Haag, Natascha1; Mayer, Christine1; Giese, Thomas1;
Felix, Klaus1; Bergmann, Frank1; Giese, Nathalia A1; Friess, Helmut2;
Bu¨chler, Markus W1; Wente, Moritz N1
1University of Heidelberg, Heidelberg, Germany; 2Technical University of
Munich, Munich, Germany
Background. Regulated shedding of transmembrane chemokines by disin-
tegrin and metalloproteinases (ADAMs) facilitates detachment of adherent
leukocytes. Tumor cells are known to appropriate chemokine pathways to
promote own dissemination. The chemokine CXCL16 was implicated to
play a role in pancreatic cancer (PaCa) through yet unknown mechanisms. In
leukocytes, CXCL16 processing is regulated by ADAM10. We investigated
whether ADAM10 is expressed in PaCa cells and influences balance between
soluble and membrane-bound CXCL16 forms.
Methods. Expression of CXCL16, its receptor CXCR6 and ADAM10 was
determined by quantitative RT-PCR (qPCR) and immunohistochemistry
(IHC) in pancreata of PaCa patients and healthy donors and human PaCa
cell lines. To evaluate the size of soluble CXCL16 detected in patient sera by
ELISA, mass spectrometry (MS) analysis was performed using SELDI-TOF.
Soluble CXCL16 was also measured in supernatants of ADAM10-siRNA
transfected PaCa cell lines (BxPC-3, Colo-357).
Results. PaCa cell lines expressed ADAM10, CXCL16 and CXCR6, with
ADAM10 being strikingly high. In cancerous compared to normal pancreata,
qPCR showed 6.4, 6.8, and 1.4 fold increase of CXCL16, CXCR6 and
ADAM10, respectively. IHC revealed a heterogeneous expression pattern of
investigated targets: CXCL16 was strongly expressed in most precancerous
lesions and CXCR6 was detected in tumor cells in all specimen. MS revealed
significant peaks obtained from the profiled spectra, confirmed by ELISA,
showing a 2.0 fold increase of CXCL16 in PaCa patient sera vs. controls.
Silencing ADAM10 in PaCa cells caused a decrease of soluble CXCL16
proven by ELISA.
Conclusion. In PaCa cells, abundantly expressed ADAM10 may augment
processing of overexpressed transmembrane CXCL16 to its soluble form,
therefore intensifying detachment of tumor cells and promoting dissemina-
tion. Increased ectodomain shedding may create a gradient of soluble
CXCL16 which will attract CXCR6-positive leukocytes and further aggra-
vate cancer-associated inflammation in pancreatic cancer.
PP 61.02
CEACAM1 Expression in intraductal papillary mucinous neoplasms
(IPMNs) of the pancreas: A factor of prognostic significance in
invasive IPM-Carcinomas
Vashist, Yogesh; Link, Bjoern; Reichelt, Uta; Bogoevski, Dean; Liebl, Lena;
Gawad, Karim; Izbicki, Jakob; Yekebas, Emre
University Clinic Hamburg-Eppendorf, General, Visceral and Thoracic
Surgery, Hamburg, Germany
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is
a member of the carcinoembryonic antigen (CEA) family and is involved in
intercellular adhesion, signal transduction and tumor cell growth regulation.
Aim of the study was to correlate CEACAM1 expression with outcome in
intraductal papillary mucinous neoplasms (IPMNs). By immunohistochem-
istry CEACAM1 expression was evaluated in 32 IPMNs of the pancreas (4
IPM-Adenomas (A), 15 IPM-Borderlines (B), 2 non-invasive IPM-Carcino-
mas (C), 11 invasive IPM-C). There are several distinctive staining pattern:
cytoplasmatic and apical negative (), apical positive (), moderate
cytoplasmatic and apical positive (), strong cytoplasmatic and apical
positive (). Kaplan-Meier analysis were performed with an up to 80
month follow-up to assess the prognostic relevance of CEACAM1 expres-
sion. 27 tumors (84%) were classified as CEACAM1 positive. In IPM-A and
-IPMN-B a weak apical staining () was observed in 50% and 80%
respectively. Median follow-up in IPM-A was 58 month, in IPM-B 49
month. No patient died of tumor-relapse. Non-invasive IPM-C showed both
cytoplasmatic and apical positive staining (). One patient died of tumor
recurrence 49 month after initial diagnosis, the other patient is still disease-
free after 56 month. The strongest CEACAM1 expression was observed in
invasive IPM-C of relapse-free survivors (1x, 3x). The median
follow-up for relapse-free survivors was 39 month. In patients with tumor
related death (median tumor related follow-up 12 month) the CEACAM1
expression was significantly lower (4x, 1x). Kaplan-Meier analysis
revealed a highly significant association between CEACAM1 overexpression
and long-term survival (pB0,033) in invasive IPMN-C. Moderate to high
cytoplasmatic and apical expression of CEACAM1 in invasive IPM-C of the
pancreas is highly associated with a long-term survival (pB0.033). This
raises the possibility to stratify patients with invasive IPM-C into low-risk and
high-risk groups.
PP 61.03
DETECTION OF K-RAS GENE MUTATIONS AT CODON 12 AND
CODON 13 IN PANCREATIC CANCER AND CHRONIC PAN-
CREATITIS PATIENTS IN NORTH INDIAN POPULATION
Polipalli, Sunil1; Agarwal, Anil2; Gondal, Ranjana3; Husain, Syed Akhtar4;
Medhi, S.1; Kar, P.1
1Maulana Azad Medical College, University of Delhi, PCR- Hepatitis
Laboratory, Dept. of Medicine, New Delhi, India; 2G. B. Pant Hospital
and Maulana Azad Medical College, Department of GI Surgery, New Delhi,
India; 3G. B. Pant Hospital and Maulana Azad Medical College, Pathology,
New Delhi, India; 4Jamia Millia Islamia University, Department of Bios-
ciences, New Delhi, India
Background & Aim. To clarify the sensitivity and the validity of K-ras point
mutational analysis at codon 12 and codon 13 in North Indian patients with
pancreatic malignancy & chronic pancreatitis, and the possible correlation
between the presence of the mutation and the histopathological findings.
Abstracts 213
Methods. 45 patients with pancreatic ductal adenocarcinoma, and chronic
pancreatitis were enrolled in this study. 15 female (33.3%) & 30 male patients
(66.7%) with an average age of 48.09912.11 years for carcinoma (22 70
years), 279 12.21 years for chronic pancreatitis (2255 years). DNA
extracted from 10 normal human pancreas was utilized as a control. Codon
12 K-ras mutations were examined using the two step polymerase chain
reaction (PCR) combined with restriction enzyme digestion, followed by
nonradioisotopic single-strand conformation polymorphism (SSCP) analysis
and by means of automated DNA sequencing.
Results. The sensitivity of K-ras mutational analysis in surgically resected
tissue samples of the pancreatic carcinoma was 80%( 24/30) while in the
chronic pancreatitis, it was 33% (5/15) (PB0.01). The mutation pattern of
Kras codon 12 and codon 13 observed in pancreatic carcinoma was GGT?
GGA and GGC ? GGG and this was identical in patients of chronic
pancreatitis also. K-ras mutation rate was progressively increased from
normal duct at the tumor free resection margin to pancreatic carcinoma.
Conclusion. The presence of similar mutation pattern of K ras in chronic
pancreatitis in 33% of our study group may be an indicator of the malignat
potential of chronic pancreatitis. The value of K-ras gene mutation for the
detection of early pancreatic cancer and differentiation of pancreatic cancer
from chronic pancreatitis remains uncertain in clinical practice. However, if
this mutation is identified in large number of established chronic pancreatitis
cases progressing to PC, it could be a useful as a molecular marker for early
diagnosis of pancreatic cancer.
PP 61.04
DENSITY AND SIZE OF LYMPHATIC VESSELS ARE REDUCED
IN CANCER OF THE PANCREATIC HEAD DESPITE EXPRES-
SION OF VEGF-C AND -D
Cartland, Sarah J1; Menon, Krishna V2; Rahman, Sakhawat H3; Verbeke,
Caroline S4
1The Leeds Teaching Hospitals NHS Trust, Deparment of Histopathology,
Leeds, United Kingdom; 2The Leeds Teaching Hospitals NHS Trust,
Deparment of Surgery, Leeds, United Kingdom; 3The Leeds Teaching
Hospitals NHS Trust, Department of Surgery, Leeds, United Kingdom;
4The Leeds Teaching Hospitals NHS Trust, Department of Histopathology,
Leeds, United Kingdom
Background. Lymph node metastasis is common in pancreatic head cancer
and adversely affects prognosis. AIMS: To determine if pancreatic head
cancers are associated with lymphangiogenesis, and whether this correlates
with VEGF-C/-D expression by the tumours.
Methods. Paraffin-embedded tissue from normal pancreas, ampulla, com-
mon bile duct (CBD) and each 15 cases of adenocarcinoma of the pancreas
(PC), ampulla (AC) and distal common bile duct (CC) was immunostained
with D240 (lymphatic endothelial marker), VEGF-C and -D antibodies.
Lymphatic vessel size (vascular area), shape (largest/smallest diameter) and
lymphatic vessel density (LVD) in the centre and at the periphery of each
tumour were assessed on digitized images.
Results. LVD was higher (p5.02) and vessel size smaller (pB.001) in
normal ampulla and CBD compared to pancreas. LVD in the centre and
periphery of PC did not differ from the low LVD found in normal tissue. In
CC, central and peripheral LVD were similar to that in PC, and significantly
lower than in normal CBD (p.03). LVD in AC was higher than in PC and
CC (p5.03), but significantly reduced compared to that in normal ampulla
(pB.001). In AC, central LVD was lower than peripheral LVD (p.04), but
no such difference was seen in PC or CC. LVD was inhomogeneous in
individual tumours and highest where cancer infiltrated the ampulla and
duodenum. In all cases, lymphatics were of similar size in normal tissue and
tumour periphery, but significantly smaller in the tumor centre (pB.001).
No difference in vessel shape existed between cancers and normal tissue.
Immunolabeling for VEGF-C was stronger than for VEGF-D, and expres-
sion of both factors was higher in AC than PC or CC (p5.05) but did not
correlate with LVD.
Conclusions. Rather than inducing lymphangiogenesis, pancreatic head
cancers seem to destroy and constrict lymphatic channels, despite expression
of VEGF-C and -D. LVD varies within individual tumours, reflecting
differences in LVD of the normal tissue compartments within the pancreatic
head.
PP 61.05
CLINICAL IMPACT OF MIDKINE EXPRESSION IN PANCREATIC
HEAD CANCER
Maeda, Shinichi1; Shinchi, Hiroyuki1; Maemura, Kousei1; Noma, Hide-
toshi1; Mataki, Yuko1; Kurahara, Hiroshi1; Ueno, Shinichi1; Sakoda,
Masahiko1; Kubo, Fumitake1; Aikou, Takashi1; Takao, Sonshin2
1Kagoshima University, Surgical Oncology and Digestive Surgery, Ka-
goshima, Japan; 2Kagoshima University, Frontier Science Research Center,
Kagoshima, Japan
Background. Midkine (MK) is a heparin-binding growth factor and a
product of a retinoic acid-responsive gene. MK is overexpressed in many
carcinomas and thought to play an important role in carcinogenesis.
However, no studies have been focussed on the role of MK in pancreatic
carcinoma. This study sought to evaluate the clinical significance of MK
expression in pancreatic head carcinoma, including the relationship between
immunohistochemical expression and clinicopathologic factors.
Methods. Immunohistochemical expression of MK and CD34 was evalu-
ated in pancreatic head carcinoma specimens from 75 patients who under-
went surgical resection.
Results. MK was expressed in 53.3% of patients. MK expression was
significantly correlated with venous invasion, microvessel density, and liver
metastasis (P0.0063, 0.0025 and 0.0153, respectively). The 5-year survival
rate was significantly lower for patients positive for MK versus patients
negative for MK (P0.0073). Multivariate analysis revealed that MK
expression was an independent prognostic factor (P0.0033).
Conclusions. This is the first report of an association between MK
expression and pancreatic head carcinoma. MK may play an important role
in the progression of pancreatic head carcinoma, and evaluation of MK
expression is useful for predicting malignant properties of pancreatic head
carcinoma.
PP 61.06
SURGICAL PROCEDURES IN BENIGN PANCREATIC PATHOL-
OGIES: ANALYSIS OF RESULTS
Patil, Bhushan; Bhange, Snehal; Singh, Rajinder; Adhikari, Devbrata; Shetty,
Tilakdas; Joshi, Rajeev
TNMC & BYL Nair Ch. Hospital, General Surgery, Mumbai, India
Background. Surgical procedures for various benign pancreatic pathologies
have of late been ignored because of the emergence of sophisticated
endoscopic and radiological alternatives. Although these surgeries are
technically demanding they may yet be the most efficacious therapeutic
option.Objective. To analyse the outcome of surgical procedures for various
benign pancreatic disorders with respect to alleviation of symptoms,
morbidity and mortality.
Methods. 135 patients treated in a referral unit from February 1999 to July
2007, were analysed. Diagnosis was based on clinico-radiologico-pathological
co-relation. The cases included 55 pseudocysts, 50 chronic pancreatitis, 12
solid cystic pancreatic neoplasms, 5 insulinomas, 3 carcinoids, 4 acute
necrotising pancreatitis,4 pancreatic injuries and 2 pseudoaneurysms.
Results. Significant pain relief after surgery was seen in 78% of patients with
chronic pancreatitis. In previously diabetic patients with chronic pancreatitis,
the insulin requirements decreased in 70% patients whereas 15% patients
were rendered non-diabetic after the surgery. Significant pancreatic leak was
seen in 1 patient following necrosectomy who succumbed and in 1 patient
following insulinoma enucleation who was successively managed conserva-
tively. Trivial leaks were seen in 3 patients post distal pancreatectomies and in
1 patient following Puestow’s procedure. These were managed conserva-
tively. Overall 2 patients succumbed. The morbidity rate was 17.03% and the
mortality rate was 1.48%.
Conclusion. Surgical intervention remains a relevant and important
component in management of benign pancreatic pathologies, being a one
off procedure as opposed to repetitive endoscopic or radiologic interventions.
Relief of symptoms following surgery as seen in our series re emphasizes the
role of surgery as an efficacious and viable option.
PP 61.07
GERMLINE GENETIC ALTERATION IN THE PATIENTS WITH
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM AND AS-
SOCIATED EXTRAPANCREATIC TUMORS.
Ahn, Young Joon
Seoul National University Boramae hospital, General surgery, Seoul, Korea,
Republic of
Background/Aim. IPMN is frequently reported in combination with a
variety of extrapancreatic tumors. The IPMN in these patients might
represent the phenotype of genes associated with the multiple tumor
syndrome. The purpose of this study was to confirm the presence of germline
mutations in the p53, MLH2, MSH2, BRCA1/2, and CDH-1 genes known
to be associated with gastrointestinal malignancies in hereditary tumor
syndromes such as Li-Fraumani syndrome, HNPCC (Hereditary Nonpoly-
posis colon cancer), Hereditary Breast/Ovarian cancer, and Hereditary
diffuse gastric cancer.
Methods. 14 patients with IPMN and extrapancreatic tumors who under-
went resection between 1996 and 2003 were enrolled in this study. The
extrapancreatic tumors included 6 gastric cancers (early 4, advanced 2), 5
colorectal malignancies, 1 gastric GIST, 2 hepatocellular carcinomas and 1
ampulla of Vater cancer. We performed conventional PCR and direct
sequencing analysis for the following genes: p53, MLH1, MSH2 and
CDH-1 in addition, multiplex PCR, fluorescent CSGE and direct sequen-
cing was performed for BRCA1/2 genes.
Results. We identified 2 novel mutations in the p53 gene (exon 1, codon 31,
GTC CTC, Glu–Gln) and the CDH1 gene (exon 14, codon 2218,
CCC TCC, Pro–Ser). In addition, we identified 11 identical coding
SNP (exon 11, codon 3232, AAGAGG, Glu–Gly) among 13 patients
with a high allele frequency (46.1%) compared with the allele frequency of
30.1% reported in Korean breast cancer patients. For BRCA2, we identified
a coding SNP with an allele frequency of 2.6% (exon 11-2, codon 2578,
AAGAGG, Met–Val).
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Conclusion. Germline alterations of the p53 and CDH-1 genes in IPMN
patients with extrapancreatic cancer suggest that IPMN may be a manifesta-
tion of the multiple tumor syndrome. The large difference in allele frequency
between BRCA1 gene findings in this study and the Korean breast cancer
database, and the low allele frequency in the SNP of the BRCA2 gene suggest
the possible existence of a disease-causing process.
PP 61.08
ALTERATION OF THE LANGERHANS ISLETS IN PANCREATIC
CANCER
Iki, Katsumichi1; Iki, Katsumichi1; Urakami, Atsushi1; Nagatsuyka, Ryou-
suke1; Pour, PM2; Tsunoda, Tsukasa1
1Kawasaki Medical School, Gastroentelorogical Surgery, Kurashiki, Japan;
2University of Nebraska Medical Center, UNMC Eppley Cancer Center,
Omaha, United States
Background and Aims. Previous studies have shown a significant alteration
of pancreatic islets in disarrangement in endothelial cells and the expression
of ductal and cancer cell markers. However, it could not be found whether
these alterations are restricted to cancer areas or are global. To clarify this
issue, we extended our studies by using tumor-free tissues adjacent to cancer
and a series of antibodies.
Material and Methods. Five normal pancreatic tissue from donors and 21
surgical pancreatic cancer of different degree of differentiation and the
adjacent tumor free areas were examined by immunohistochemistry. Anti-
bodies to all four islet hormones were used. In each specimen the number of
the reactive islet cells was counted.
Results. Compared to control specimens, alteration in immunoreactivity for
all antibodies was found in 15 out of 21 specimens in both pancreatic cancer
and in tumor-free tissues. The number of insulin cells was reduced but the
number of glucagon, somatostatin and PP cells was increased significantly. In
one case, a remarkable tumor-like proliferatin of somatostain cells was
identified in the periductal area in one of the tumor-free specimens.
Conclusion. The result of the current and previous studies highlights
alteration of islets in morphological and biological pattern in pancreatic
cancer. The occurrence of these alteration in both cancer tissue and tumor-
free area support our view that the observed changes of islet cells in
pancreatic cancer is a primary effect and unrelated to the presence of cancer.
These changes could well explain the altered glucose tolerance and diabetes
in most pancreatic cancer patients.
PP 61.09
THE PROTEOME OF RODENT MESENTERIC LYMPH IN
FASTED AND FED STATES
Mittal, Anubhav1; Middleditch, Martin2; Ruggiero, Katya3; Buchanan,
Christina M2; Jullig, Maria2; Loveday, Benjamin4; Cooper, Garth JS3;
Windsor, John A4; Phillips, Anthony RJ3
1University of Auckland, Surgery, Auckland, New Zealand; 2University of
Auckland, Maurice Wilkins Centre for Molecular Biodiscovery; 3University
of Auckland, School of Biological Sciences; 4University of Auckland, Surgery
Background. Mesenteric lymph contributes to the pathogenesis of multiple
organ dysfunction syndrome. We have previously shown that ischaemia
conditioned mesenteric lymph adversely affects acute pancreatitis. Despite
this growing interest in mesenteric lymph, there is no description in the
literature of the normal mesenteric lymph proteome.
Aims. The aim of this study was to define the proteome of normal rodent
mesenteric lymph in the fasted and fed states.
Methods. Eight male Wistar rats fed a standard rodent diet were randomised
to 2 groups. Group 1 (’fasted’, n4) were fasted for 24 hours prior to
anaesthetised collection of mesenteric lymph. Group 2 (’fed’, n4) had no
intervention prior to collection. Mesenteric lymph was subjected to proteo-
mic analysis using iTRAQTM with liquid chromatographytandem mass
spectrometry.
Results. 150 proteins, including 26 hypothetical proteins were identified in
this study. All were identified in both the fasted and fed states, but differences
were found in the relative abundance of some proteins between the two
states. The relative abundance of proteins in the mesenteric lymph differed
significantly from that reported for serum. The largest functional protein
classes identified were protease inhibitors (16%) and proteins related to
innate immunity (12%).
Conclusion. This is the first comprehensive description of the normal
mesenteric lymph proteome in the fed and fasted states. Mesenteric lymph
contains a wide spectrum of known protein classes. These differ from
previously reported proteomic studies of plasma and between the fasted and
fed states in their relative distribution. This approach can now be used to
determine how different diseases, including acute pancreatitis and hypovo-
laemic shock, alters the ML proteome.
PP 61.10
INTRATUMORAL LYMPHANGIOGENESIS CORRELATES WITH
LYMPHATIC INVASION, NODAL STATUS, AND VASCULAR EN-
DOTHELIAL GROWTH FACTOR (VEGF)-C IN PANCREATIC
CANCER
Kurahara, Hiroshi1; Takao, SonShin2; Shinchi, Hiroyuki1; Aikou, Takashi1
1Kagoshima university graduate school, Surgical oncology and digestive
surgery, Kagoshima city, Japan; 2Kagoshima university graduate school,
Frontier science research center, Kagoshima city, Japan
Background. Lymph node metastasis is a major prognostic factor in
pancreatic cancer. Identifying characteristics of the primary tumor that
may predict nodal metastasis and understanding the mechanisms of
lymphatic metastasis are, therefore, essential for the development and
selection of better treatment strategies for pancreatic cancer. OBJECTIVES:
The aim of this study was to elucidate the relationships between lymphan-
giogenesis and lymphatic metastasis and prognosis in pancreatic cancer.
Methods. Formalin-fixed, paraffin-embedded blocks were obtained from 75
patients with pancreatic cancer. All patients underwent a curative resection.
To evaluate the lymphangiogenesis, we measured the density of lymph vessels
as assessed with the marker D2-40 in non-cancerous pancreatic tissues
resected with pancreatic cancer and cancerous pancreatic tissues. Expression
of VEGF-C was evaluated by immunohistochemical staining. When over
25I‘‘ of the tumor cells showed distinct staining, the tumor was judged as
having high expression of VEGF-C.
Results. Lymphatic vessel density (LVD) in pancreatic cancer was signifi-
cantly increased compared with the non-cancerous pancreatic tissues (PB
0.0001). In pancreatic cancer, node-positive group exhibited significantly
higher LVD compared with the node-negative group (P0.0208). Further-
more, high expression of VEGF-C was clearly associated with increased LVD
in pancreatic cancer (P0.0001). Interestingly, tumor cells invading
lymphatic vessels expressed more VEGF-C than other tumor cells of the
primary tumors (P0.0074). The 5-year survival rate of patients with high
LVD was significantly lower than that of patients with low LVD (P0.0414).
Conclusion. Lymphangiogensis in pancreatic cancer was significantly
associated with VEGF-C expression and lymphatic metastasis and poor
prognosis.
PP 62.01
BROKEN DORMIA IN BILIARY SYSTEM: UNUSUAL CASE RE-
PORT
Anand, Kaushal; Saxena, Rajan; Kapoor, V.K.; Kumar, A; Richa, L; Behari,
A; Singh, R; Prakash, A
SGPGIMS, Surgical gastroenterology, lucknow, India
Introduction. This a 3rd case reported in the literature with history of
broken dormia basket retained during ERCP clearance of large CBD stone.
extended indications for endoscopist to clear large and impacted stones with
dormia may invite such complication in the future, needs a serious measures.
A case history: 73 yr, male with pain in right hypochondrium for the 1 month
not associated with fever, jaundice or vomiting.examination unremarkable.
ultrasound showed cholelithiasis with multiple large CBD stones.
Biochemistry s. bilirubin T: 0.1 mg%, SGOT/ SGPT: 14/13 U/L,
SAP.103 IU/L, TLC: 6.5 cells/cmm. Patient underwent ERCP- EPT,
cholangiogram -3 large stones impacted in lower part of CBD. One 12mm
stone crushed with mechanical lithotripter and failed to extract the stone,
plastic stent placed. Patient remained asymptomatic 1 year readmitted march
2007. ultrasonography showed no stones in the CBD with stent in situ and
dilated CBD at the upper part. MRCP before the laparoscopic cholecys-
tectomy  large artifact coming at the hilum- forced to withheld the study.
Patient remained stable. Radiologist opinion s/o metal artifact within CBD.
In view to previous failed attempt by dormia, digital X ray AP view of
abdomen(Image 1) confirmed broken dormia basket at hilum. After
consultation with medical gastroenterologist endoscopic attempt done. At
cholangiogram, no stones were present within CBD and dormia visualized in
the CHD. A new dormia basket inserted and broken dormia held within it
and gently removed without injury to the duct wall. Completion cholangio-
gram showed cleared CBD. Post procedure patient remained stable and on
next day he underwent laparoscopic cholecystectomy with uneventful post
operative course.
Discussion. Endoscopic management remains a gold standard for the CBD
stones in the present era. With the increased experience of medical
gastroenterologist and extention of indications may invite such complica-
tions.
PP 62.02
ROLE OF ENDOSCOPIC ULTRASOUND IN OBSCURE LOWER
BILIARY TRACT OBSTRUCTION: A PROSPECTIVE STUDY
Kumar, Pavan1; Bhatia, Vikram2; Dash, Nihar Ranjan1; Pal, Sujoy1; Sahani,
Peush1; Chattopadhyay, T.K.1; Garg, Pramod2
1AIIMS, Gastrointestinal surgery, New Delhi, India; 2AIIMS, Dept. of
Gastroenterology, New Delhi, India
Background. Confirmatory diagnosis of lower biliary tract obstruction
(LBT) continues to elude diagnostic modalities like CECT, MRCP and side
viewing endoscopy (SVE) in a few proportion of patients. Endosonography
(EUS) has the potential to assess the LBT from a close range.Objective. To
assess (i) the diagnostic accuracy of EUS in obscure lower biliary obstruction
(OLBO) and (ii) its impact on management.
Methods. Fifty-five patients with a dilated common bile duct (CBD8
mm); the cause of which could not be ascertained by CT, MRCP and SVE
were included in the study. By using a radial echoendoscope, CBD was
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evaluated. The result was correlated with surgicopathological/ ERCP
findings/ clinical behaviour on long term (6 months) follow-up.
Results. Patients were studied in 2 groups, Gr I (suspected benign, n24)
and Gr II (suspected malignant n31). The sensitivity, specificity and
accuracy of EUS in detecting the cause of obstruction were 93.3%, 100%,
and 95.8% respectively in Gr I and 92.3%, 100%, and 92.8% respectively
(likelihood ratio 25 & 14.2) in Gr II. EUS correctly identified the cause of
obstruction in 14 and 27 patients respectively in Gr I and II and ruled out
obstruction in 9 and 2 patients. EUS helped avoid a diagnostic ERCP in
41.6% and 22.5% in Gr I and II. It also avoided surgery in 9 patients in Gr I.
In Gr II, EUS avoided surgery in 8 patients, simplified in one and
strengthened indication for surgery in 8. EUS helped patient counseling
regarding the nature of further management in 95.8% and 93.5% in the
respective groups.
Discussion and Conclusion. EUS is a sensitive, specific and accurate
method for evaluation of OLBO. It has an impact on management by
avoiding ERCP and unnecessary surgery. It is useful in counseling prior to
therapeutic interventions, especially in the present scenario of medico-legal
litigation. However in our study EUS missed a 0.9 mm sized ampullary
tumor and malignancy associated with a case of chronic pancreatitis.
Operator dependence is also a limitation to EUS.
PP 62.03
NOTES IN PEG ASSISTED TRANSGASTRIC CHOLECYSTECT-
OMY BY DOUBLE CHANNEL FLEXIBLE ENDOSCOPY
Sugimoto, Maki; Yasuda, Hideki; Koda, Keiji; Yamazaki, Masato; Tezuka,
Tohru; Kosugi, Chhiro; Higuchi, Ryota; Yagawa, Yousuke; Suzuki, Masato
Teikyo University Chiba Medical Center, Department of surgery, 3426-3
Anesaki Ichihara Chiba, Japan
Background. Natural orifice transluminal endoscopic surgery (NOTES) is a
novel concept that combines aspects of laparoscopic with flexible endoscopic
surgery. This might offer advantages over open and laparoscopic surger-
y.Objective. We develop novel advanced technologies specifically for
NOTES to overcome the limitations of isolated transgastric surgery using
percutaneous endoscopic gastrostomy (PEG) assisted double channel flexible
endoscopy.
Methods. Transgastric cholecystectomy was performed in five survival
porcine studies. A flexible double channel endoscope was inserted perorally
and PEG was replaced under infusion of carbon dioxide. Endoscope-induced
pneumoperitoneum through the abdominal and stomach wall was applied,
the endoscope was advanced into the peritoneal cavity over the PEG. Via the
endoscopic double channel, a grasping instrument and a knife with an
isolated tip were inserted for gallbladder traction to facilitate exposure of the
cystic duct and artery assisted with a percutaneous needle grasper. Both the
cystic duct and artery were identified, clipped, and transected. The
gallbladder itself was then dissected and retracted through the mouth, and
the gastric wall incision was safely closed with endoscopic clips.
Results. The time for transgastric removal of the gallbladder was within 60
minutes. The PEG could allowed the safe performance of a controlled gastric
perforation and shorten the procedure time. Percutaneous gallbladder
grasping and manipulation by needle grasper through the PED insertion,
proved to be particularly valuable to enhance gastroscope-guided counter-
traction and dissection. These approaches increased safety of initial gastric
puncture and gastric wall incision.
Conclusions. Blending the use of a flexible endoscope and PEG approach
might potentially overcome multiple intraperitoneal limitations in NOTES,
and simplifies peroral transgastric cholecystectomy, could be used to decrease
invasiveness.
PP 62.04
BILE DUCT INJURY AFTER LAPAROSCOPIC CHOLECYSTECT-
OMY, THE VALUE OF ENDOSCOPIC RETROGRADE CHOLAN-
GIOPANCREATOGRAPHY
Cheung, Chin Cheung1; Leung, Kam Fung2; Wong, Wai Man2
1Tuen Mun Hospital, Department of Surgery, Tuen Mun, New Territories,
Hong Kong; 2Tuen Mun Hospital, Department of Surgery, New Territories,
Hong Kong
Introduction and Aims. This study describes the value of endoscopic
retrograde cholangiopancreatography (ERCP) in patients with bile duct
injury after laparoscopic cholecystectomy(LC).
Method. and Results. 24 consecutive patients were studied over 4 year
period (20022006) with ERCP done after bile duct injury from LC. The
median age is 55 year old (31 to 77) with no gender difference. ERCP was
performed after median of 14 days post-operatively (3 to 90 days). They
presented with fever (20/24), pain (15/24) and cholestasis (4/24). Most of
them had ultrasonography done with fluid collection around the Morrison
pouch. In all patients, the biliary tree was visualised with ERCP. Two of them
had complete bile duct obstruction with proximal hepaticojejunostomy
performed; another two had incomplete obstruction at cystic duct area;
while the remaining patients with leakage was detected at variable sites: 10
out of 24 leak over cystic duct stump; 3 leak over common hepatic duct; 3
leak over common bile duct; 3 leak over right intrahepatic duct and 3 leak
over gall baldder bed. They all treated by endoscopic sphincterotomy and
subsequent stent placement. One patient died of uncontrolled sepsis after
ERCP.
Conclusion. Two patients with complete obstruction presented with a
relatively prolonged symptom free period before diagnosis (1 month and 3
months). When patients do not recover uneventfully after lap cholecystect-
omy, even without cholestasis or jaundice, early ERCP is recommended as a
safe and valuable method to detect bile duct injury and to suggest treatment.
Subsequently, most of such patients can be treated endoscopically. Extended
follow up is needed to evaluate the long term results.
PP 62.05
LAPAROSCOPIC ULTRASONOGRAPHY DURING LAPARO-
SCOPIC SURGERY IN HEPATOBILIARY DISEASE
PARK, IL YOUNG; KIM, SEONG AH
Holy Family Hospital, Catholic University of Korea, Surgery, Bucheon,
Korea, Republic of
Introduction. With the increasing minimal invasive surgery, laparoscopic
ultrasonograpy(LUS) has become more important. In laparoscopic surgery,
surgeon can not palpate intra-abdominal and retroperitoneal structures. But
by using the LUS, the surgeon is able to overcome some of this limitation.
Methods. Between August 2005 and July 2007, we underwent 52 patients
consisting of gallbladder and common bile duct stones (38), malignancy
staging (2), hepatobiliary mass (9) pancreatic mass (2). We use 7.5 MHz
flexible tip ultrasound probe. LUS probe is passed through the umbilical or
epigastric port. This probe has the capability of Doppler ultrasound including
color flow-imaging. LUS is used in many procedures, including the
examination of the common bile duct during laparoscopic cholecystectomy,
the examination of the liver for primary and metastatic tumors, and the
staging of hepatobiliary and pancreatic carcinomas. After learning the LUS
technique, surgeons are able to provide optimal care for their patients by
using the LUS.
Conclusions. We conclude that the use of LUS is a minimal, less time
consuming and highly accurate method during laparoscopic surgery
PP 62.06
REVIEW OF BILIARY STENTINGS
Nakamura, Takayuki1; Tagaya, Ranko2; Nogawa, Hideyuki2; Kon, Yoichi2;
Fukai, Yasuyuki1; Haga, Norihiro1; Kawano, Noriaki1; Sawada, Toshio1
1Gunma Prefectural Cancer Center, Surgical oncology, Ota, Gunma, Japan;
2Gunma Prefectural Cancer Center, Gastroenterology, Ota, Gunma, Japan
Introduction. Obstructive jaundice is one of the major complications in
biliary malignancy. It causes hepatic dysfunction and sometimes biliary
infections. Patients suffered general fatigue, anorexia, and insomnia duo to
itchiness. That does not only disturb anticancer treatment but also interfere
with quality of life. Biliary stenting brings a chance to recanalize stenotic
biliary tracts. Two different approaches are available to place the biliary stent
these days. One is percutaneous transhepatic route and another is endosco-
pical.
Aims. Benefits and problems are analyzed for the biliary stenting.
Methods. We reviewed all cases with biliary metallic stents in Gunma
Prefectural Cancer Center from April 2006 to August 2007.
Results. Forty three patients (24 males and 19 females) were placed biliary
metallic stents for their biliary obstructions or stenoses. Mean age was 69.2
years old. All of those stenoses and obstructions in biliary tracts were made by
malignancy. Twenty one cases were bile duct carcinoma that was the leading
causes. Pancreas cancer was the second and made fifteen cases. We chose the
endoscopical approach for twenty six patients and the percutaneous
transhepatic route for seventeen patients. Three patients had cholecystitis,
that was the top of the early complications after biliary stenting. Eleven cases
had stent malfunction. We experienced one case of stent migration and an
interesting complication of intussuscepted stent. Median duration of the
patency after stenting was sixty five days. Five patients couldnIft leave
hospital until the end of their lives after stenting. One of them took cerebro-
vascular accident and other four cases had uncontrolled advances of their
cancers.
Conclusions. Biliary stenting is safe and could improve quality of patientIfs
life. The stenting devices are expected to have much longer biliary patency for
the near future.
PP 62.07
SELECTION AND PLACEMENT OF STENTS IN A MALIGNANT
NARROWING OF THE BILE DUCT
OGATA, KENJI; MAESHIRO, KENSEI; YAMASHITA, YUICHI;
IKEDA, SEIYO
Fukuoka University School of Medicine, Gastroenterological Surgery,
Fukuoka, Japan
Background. In bile duct cancer, the placement of multiple stents may be
required, so the selection, placement, and patency period become issues.
Objectives. By April 2006, stent treatment (EMS: 57; TS: 60; no stent: 4)
was performed for 121 cases of non-resected bile duct cancer. Problems in
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stent treatment were compared according to placement pathway, stent type,
and treatment method, and countermeasures were discussed.
Results. 1. Placement pathway: Papillary placement of multiple TS or EMS
was possible but difficult in the procedures, and cholangitis frequently
occurred as a complication, so treatment in cases of reocclusion after EMS
placement was difficult. 2. Stent types: TS has advantages in that it is
inexpensive and easily converted and replaced, but the bore diameter and
number that can be used is limited. The 50% patency rate of stents was 12
months in EMS and 3.5 months in TS, and particularly in cases of occlusion
in the hepatic hilum, EMS was significantly superior. 3. Effects and
complications of localized treatment: Tumor morphology is closely involved
with reocclusion of stents. In histological types with a strong tendency of
hemorrhagic necrosis filling the lumen of the bile duct or with large mucus
production, early occlusion and dysfunction of stents frequently occur. For
these cases, localized treatment from the lumen of the bile duct was effective
(no stents in four cases). In addition, localized treatment not only prolonged
the patency period of the stent but also contributed to prolongation of
survival time. In localized treatment cases, internal drainage from a single
route was possible in all cases.
Conclusion. In stent treatment for non-resected bile duct cancer, it is
necessary to determine the placement pathway and the type of stent while
taking the indications and particulars of localized treatment carefully into
account.
PP 62.08
LONG-TERM RESULTS OF HEPATICO-JEJUNOSTOMY FOL-
LOWING BILIARY INJURY DURING CHOLECYSTECTOMY
Goihman, Yaakov1; Kori, Issac2; Nakache, Richard1; Klausner, Joseph1; Ben-
Haim, Menahem1
1Tel-Aviv Sourasky Medical Center, Surgery B and Transplantation, Tel-
Aviv, Israel; 2Tel-Aviv Sourasky Medical Center, Interventional Radiology,
Tel-Aviv, Israel
Introduction. The long-term outcome of hepatico-jejunostomy (H-J) to
repair biliary injury during cholecystectomy is inadequately defined.
Metods. Retrospective analysis of data. Reconstructions by H-J were
performed ‘‘immediately’’, if diagnosed so; ‘‘delayed’’, if diagnosed within
2472 hours or electively (68 weeks) if diagnosed later. In the ‘‘elective’’
group, the anatomy of injury was studied and biliary drainage was achieved
by percutaneous trans-hepatic cholangiography (PTC). Outcome was
defined as ‘‘good’’, if there was no need for any further intervention;
‘‘Fair’’, if strictures were managed successfully by interventional radiology
(IR) or ‘‘poor’’ if there was a need for surgical revision following failure of IR
procedures.
Results. 24 patients were referred (20037). Injuries were at laparoscopic
cholecystectomy in 18 and at open in 6 and included complete transaction of
CHD (16), RHD (3), RPHD (2) and of more than 1 major duct (3). Original
repairs were ‘‘immediate’’ in 10, ‘‘delayed’’ in 6 or ‘‘elective’’ in 8. Strictures
developed in 7/10 (70%), 6/6 (100%) and 1/8 (12.5%) of H-J’s, respectively.
When compared by timing of repair, end-results were ‘‘good’’ in 3/10, 0/6
and 7/8; ‘‘fair’’ in 2/10, 3/6 and 1/8 and ‘‘poor’’ 5/10, 3/6 and 0/8, respectively
(pB0.05). Original H-J repairs were done by a HPB surgeon in 18 or by a
general surgeon in 6. End-results were ‘‘good’’ in 10/18 vs. 0/6, ‘‘fair’’ in 5/18
vs. 0/6 and ‘‘poor’’ in 3/18 vs. 6/6 when compared accordingly (pB0.05).
Interval to clinical presentation of a stricture was 224 months and 5 years in
one case.
Conclusions. The incidence of H-J stricture following biliary injury is higher
than reported and long term follow-up is mandatory. Timing of definitive
repair and surgeon’s expertise are significant risk factors.
PP 62.09
BILIOBRONCHIAL FISTULA AFTER LIVER SURGERY FOR
GIANT HYDATID CYST
Loinaz, Carmelo1; Herna´ndez, Teresa2; Martı´n, Jaime3; Pacheco, Pedro3;
Ochando, Federico3; Ferna´ndez, Beatriz3; Herna´ndez, Pilar3; Garcı´a, Ce´sar3;
Rueda, Jose´ A3; Ramos, Marı´a3; Jime´nez, Pedro3; Vorwald, Peter3; Ferna´n-
dez, Jose Marı´a3; Quinta´ns, Antonio3
1Fundacio´n Hospital Alcorco´n, Surgery, Alcorco´n (Madrid), Spain; 2Funda-
cio´n Hospital Alcorco´n, Radiology, Alcorco´n (Spain), Spain; 3Fundacio´n
Hospital Alcorco´n, Surgery, Alcorco´n (Spain), Spain
Background. Biliobronchial fistula (BBF) is a rare complication in the
natural history of liver hydatid disease by E. granulosus. We present a case of
BBF after resection of a giant liver hydatid cyst in a 72 years old woman.
Methods. A total cyst-pericystectomy was done, leaving only the left lateral
section, that was fixed to the diaphragm at the end of the operation. She
developed a postoperative biliary fistula and obstructive jaundice. An ERCP
showed an ‘‘stop’’ at hte junction of the left biliary duct and the main biliary
duct, and contrast leak. At reoperation the main duct showed a torsion at its
longitudinal axis and the tissue seemed ischemic. A hepatotomy was done at
the hilar plate and a biliary duct (1cm) was dissected to anastomose to a Roux
en Y jejunal loop. She was discharge without complications.
Results. Five months later she developed a bout of cholangitis and was
successfully treated with antibiotics. After repeated respiratory infections she
was admitted four months later with fever, cough, right lower lobe
pneumonia and bilioptisis. the doagnosis of BBF was confirmed with
HIDA. At transhepatic cholangiography an important bile duct dilation
was seen, with a bilio-thoracic leak. A stenosis of the bilio-jejunal anastomosis
was dilated and an external-internal catheter was left in place. Repeated
controls showed nor fistula neither stenosis and the catheter was retrieved 3
1/2 months later. One year later the patient is in very good condition.
Conclusion. An indirect treatment of the BBF by dilation of the biliary
stenosis avoided a more invasive treatment
PP 62.10
ONLY PERCUTANEOUS DRAINAGE PROCEDURES WITHOUT
ENDOSCOPIC INTERVENTION AS THE TREATMENT OF BILE
LEAK AFTER LAPAROSCOPIC CHOLECYSTECTOMY
Lee, Daesung; Kim, Hyuntae
Sunlin hospital, Pohang, Korea, Republic of
Background. Bile leak is a potential complication after laparoscopic
cholecystectomy. Early diagnosis and treatment are very important to
decrease the morbidity and mortality related to bile leak. Objective.
Endoscopic intervention is widely accepted as a choice of diagnosis and
treatment in patients who are decided to be treated non-operatively today.
But, we treated symptomatic bile leak only by drainage procedures without
endoscopic modalities.
Methods. From July 2004 to May 2007, 207 patients underwent laparo-
scopic cholecystectomy at Sunlin hospital by a single surgeon. Patient records
and radiologic findings were reviewed. A bile leak was identified in 4 patients.
Three patients were mananged non-operatively and one was reoperated by
primary suture on right hepatic duct for a severe bile peritonitis. We analysed
3 patients underwent a non-operative management.
Results. The male-to-female ratio was 2:1. All was dignosted gallbladder
stone with cholecystitis in preoperative ultrasound. All were operated with
infrahepatic drainage tube. We detected bile leaks through postsurgical
drainage tubes in all patients. We performed a computer tomography and a
hepatobiliary scintigraphy. One patient could be successfully managed
without any other modalities. Two patients were managed with percuta-
neously drainage procedure without endoscopic intervention. External biliary
drains were removed at postoperative 20 or 82 days, respectively. All patients
were asymptomatic at a mean follow-up of 15 months.
Conclusion. A infrahepatic drain insertion may be usefully by a case-by-case
basis for the early detection of bile leaks. Bile leaks can be successfully treated
by Only percutaneous drainage procedures without endoscopic intervention.
PP 62.11
A CASE OF NEUROENDOCRINE CARCINOMA OF COMMON
BILE DUCT
Cho, Chol Kyoon1; Koh, Yang Seok1; Kim, Hyun Jong1; Kim, Jung Chul1;
Hur, Yong Hoi1; Park, Chang Hwan2; Lee, Wan Sik2; Choi, Sung Kyu2; Rew,
Jong Sun2; Jung, Yong Yeon3; Shin, Sang Soo3; Lee, Jae Hyuk4
1Chonnam National University Medical School, Surgery, Gwangju, Korea,
Republic of; 2Chonnam National University Medical School, Internal
Medicine, Gwangju, Korea, Republic of; 3Chonnam National University
Medical School, Radiology, Gwangju, Korea, Republic of; 4Chonnam
National University Medical School, Pathology, Gwangju, Korea, Republic
of
Background/Aim. Neoplasm derived from neuroendocrine(NE) system
comprise a large and heterogenous spectrum with a range of benign NE
tumor or carcinoid to NE carcinoma. The ability to differentiate between NE
carcinoma and benign NE tumor is based on histologic, cytologic, and
immunohistochemical differences. NE carcinoma of extrahepatic bile duc-
t(EHBD) is extremely rare and accounts for 0.22% of all gastrointestinal NE
tumor. The biological behavior of NE carcinoma of EHBD is aggressive and
is associated with a significantly shorter survival time than carcinoma with
exocrine differentiation. Herein we present a case of NE carcinoma of
common bile duct(CBD) with evaluation of clinical course.
Methods. The patient was 57 year-old-female and abdominal CT and MRI
showed 2.5X2.0 cm sized well-enhancing polypoid mass at distal CBD with
dilatation of intra and extrahepatic bile duct. The laboratory findings
including tumor markers were non-specific except the findings of obstructive
jaundice. In operation, there was 3X3 cm sized hard mass at distal CBD and
pylorus preserving pancreaticoduodenectomy with lymphnode dissection was
performed.
Results. In gross finding, there was 2.6X2.2 cm sized well defined white
mass at distal CBD obstructing the lumen. In microscopic examination, the
tumor was mixed tumor of ductal adenocarcinoma and NE carcinoma. The
results of immunohistochemical study were as follow; p53 (), Ki67 (),
Topoisomerase II (), CK7 (), CK 20(, focal), E-cadherin (),
Vimentin(), Chrmogranin (), Synaptophysin (), CD56 (), Insulin
(), Glucagon (), Pancreatic polypeptide (). The TNM staging was
T2N0M0. The postoperative course was unremarkable and adjuvant
chemotherapy with Gemcitabine and 5-FU was administered. In the follow
up evaluation, multiple hepatic metastasis were detected 3 months after
operation and the patient received conservative treatment.
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Conclusions. We report a case of NE carcinoma of CBD which is extremely
rare and is very aggressive in clinical course.
PP 63.01
VASCULAR RESECTIONS DURING PANCREATODUODENECT-
OMY FOR PERI-AMPULAR TUMORS
Vigia Duarte, Emanuel; Pereira, Jorge; Coelho, Joa˜o; Pereira, Jose´ Anto´nio;
Marques, Hugo; Mira, Paulo; Martins, Ame´rico; Barroso, Eduardo
Hospital de Curry Cabral, Centro Hepatobiliopancrea´tico e de Transplanta-
c¸a˜o, Lisboa, Portugal
Background.Nowadays, vascular resection during pancreatoduodenectomy
(PD) for peri-ampular tumors (PAT) is feaseble and can lead to a survival
similar to the one found in patients without vascular invasion.
Aims. To prove that in 8 cases of vascular resection during PD for PAT of 97
patients, prognosis and survival were similar to those patients without
vascular invasion.
Methods. 97 PD between 2003 and 2007; 8 patients (4 male and 4 female)
with vascular invasion: Vena cava (1); Portal Vein (3); Superior mesenteric
artery (1); Right hepatic artery (2); Superior mesenteric vein (1). Surgical
procedures: 7 Whipple’s PD and 1 Traverso-Longmire PD. One case: Gore-
Tex prothesis due to superior mesenteric artery resection (intra-operatively
arterial invasion finding).
Results. Mortality: 1 case of sepsis in the peri-operative period; Morbidity:
ascitic fluid infection leadind to reoperation at day 5 (1 case); Post-operative
fever (2 cases); Outcome: 2 patients died (7 months and 12 months); Median
follow-up: 15 months (532 months) all without relapse.
Conclusions. Outcome of patients with PAT with vascular invasion
(excluding superior mesenteric artery) is comparable to the one of patients
without it, inespective of tumor stage, extent of wall invasion and extent of
vascular resection. Surgical resection of a PAT with vascular invasion must
always be considered as a valuable technique in these patients.
PP 63.02
IS STAGE AND LONG-TERM SURVIVAL OF PANCREATIC CAN-
CER PATIENTS UNDERGOING A WHIPPLE’S PROCEDURE
PREDICTED BY PREOPERATIVE BODY COMPOSITION?
Smith, Ross C1; Aslani, Alireza2; Cooper, Bruce A3
1Royal North Shore Hospital, Department of Surgery, Sydney, Australia;
2Royal North Shore Hospital, Department of Nuclear Medicine, Sydney,
Australia; 3Royal North Shore Hospital, Department of Renal Medicine,
Sydney, Australia
Background. The status of the resection margins for pancreatic cancer is a
significant predictor of survival but it could also be important to determine
the influence of nutritional status on this outcome.
Aims/Objectives. The aim of this study was to determine the difference in
survival between patients undergoing Whipple’s Procedure (WP) and
receiving a Clear Margins (CM) and the patients receiving an Unclear
Margins (UCM). In addition, the predictive value of different body
composition (BC) measurement parameters were assessed and investigated.
Methods. WP was performed on 31 patients, 17 males and 14 females (age
range: 42 to 81y; mean: 67y; median 69y), with pancreatic cancer. Detailed
preoperative BC measurements included: Total Body Nitrogen (TBN) using
In Vivo Neutron Capture Analysis (IVNCA), Nitrogen Index (NI), Total
Body Water (TBW) by Bioelectrical Impedance Analysis (BIA), percentage
body fat (%BFat) from skin-folds and BIA.
Results. Patients with involved margins at the time of resection were
significantly more likely to be males (7/11 v 10/20), with a lower Body
Mass Index (22.0 v 24.9 m/kg2), Body Fat (13.6 v 22.9 kg), and total body
potassium to height ratio (0.58 v 0.63 g/m) (Binary Logistic Analysis). Cox’s
backwards stepwise regression analysis demonstrated survival to be predicted
by margins and presentation values for age, fat mass, Lean body mass and
Total Body Potassium (TBK).
Conclusions. When patients with resectable cancers of the head of the
pancreas have involved surgical margins they are also likely to have
preoperative nutritional deficits compared to those without resectable
margins. Further more these nutritional deficits appear to have an impact
on the patient’s long term survival.
PP 63.03
CARCINOMA OF THE AMPULLA OF VATER: EARLY AND LATE
RESULTS OF PATIENTS UNDERGOING RADICAL RESECTION
Haddad, Luciana B P1; Almeida, Jose´ L J1; Jukemura, Jose´1; Andraus,
Wellington1; Montagnini, Andre´1; Penteado, Soˆnia1; Abdo, Emilio1; Jurei-
dini, Ricardo1; Matheus, Andre´ S1; Perini, Marcos2; Bachella, Tele´sforo1;
Machado, Marcel C C1; Cecconello, Ivan1; da Cunha, Jose´ E M1
1University of Sa˜o Paulo School of Medicine, Department of Gastroenter-
ology, Sa˜o Paulo, Brazil; 2
Background. Ampullary tumors consist a rare clinical entity and have a
better prognosis than others periampullary tumors. The aim of this study was
to analyze presenting clinical features, surgical outcome and predictive
survival factors in a single institution series.
Patients and Methods. From January 1985 through December 2006, 106
patients underwent pancreaticoduodenectomy for ampullary adenocarci-
noma at Hospital das Clı´nicas of Sa˜o Paulo University School of Medicine.
The correlation between clinicopathologic variables and survival was tested
by Kaplan-Meier method and log-rank test.
Results. There were 64 men (60.4%) and 42 women with a mean (s.d.) age
of 59.3 (11) years. Jaundice (81.6%), weight loss (68.6%) and abdominal
pain (60.7%) were the most common presenting symptoms. Sixty-one
(57.6%) patients were submitted to pylorus-preserving pancreaticoduode-
nectomy and 45 (42.4%) to a Whipple resection. Median operative time was
5819126 minutes. The surgical morbidity rate was 56.6%. Delayed gastric
emptying (27.4) and pancreatic fistula (21%) were the most frequent
complications. Thirty-day mortality was 2.9% (3 of 106 patients). Median
follow-up was 54 months (range 6156 months). Median survival was 108
months. The overall 5-year survival was 54.7%, and 30,7% in node-positive
patients. Survival was found to be significantly affected by pre operative
jaundice (0.001), serum albumin levels lower than 3g/dL (p0.011), blood
transfusion (p0.024), tumor grade (p0.011) and nodal status (p
0,003). In multivariable analysis, jaundice, tumor grade and lymph node
status were related with worse survival rates.
Conclusion. Pancreatoduodenectomy is the treatment of choice for ampul-
lary carcinoma, but despite the low mortality, there is still a high morbidity
associated with this procedure. Preoperative jaundice, tumor grade and
lymph node status showed to be important survival factors.
PP 63.04
WHITE CELL COUNT AND ALBUMIN PREDICTS THE INCI-
DENCE OF POST-OPERATIVE COMPLICATIONS FOLLOWING
PANCREATIC SURGERY.
Wijeyekoon, Sanjaya1; Fusai, Giuseppe2; Ramamoorthy, Rajarajan2; Sra,
Harminder3; Davidson, Brian R2
1The Royal Free Hospital, Hepato-Pancreato-Biliary & Liver TransplantSur-
gery, Pond Street, London, United Kingdom; 2The Royal Free Hospital,
Hepato-Pancreato-Biliary & Liver TransplantSurgery, London, United King-
dom; 3University College London, London, United Kingdom
Background. Pancreatic surgery has a high complication rate, early
detection of which potentially reduces mortality. Inflammatory markers
have traditionally been used to predict development of complications in a
non-quantitative way. Several studies have identified a prognostic role for
IL6, IL8 and IL10, procalcitonin, body mass index, obesity, patient age and
extended resections. We evaluated the utility of simple inflammatory markers
such as white cell count (WCC), Platelet count (PLT), C-reactive protein
(CRP) and albumin (ALB) to quantitatively predict the development of post-
operative complications after pancreatic surgery.
Method. A retrospective cohort of 123 consecutive pancreatic resections
performed between 20042007 was analysed. Serial inflammatory markers
between day 015 were evaluated for their association with ‘‘In-hospital
complications’’, the out-come measure. Analyses were performed with
logistic regression.
Results. 34.1% experienced a complication. Only WCC (p0.013) and
ALB (p0.05) on the 5th post-operative day were significantly and
independently associated with the outcome. The risk model based on
WCC & ALB had an ROC0.65, sensitivity of 69.1%, specificity 54.3%,
positive predictive value 43.9% and negative predictive value of 77.2%.
Patients with a combination of ALB on day 5 B25 and WCC ]11 had 7.6
(2.0 * 28.8) times the risk, along with a probability of 63% of developing a
complication.
Conclusion. WCC and ALB on the fifth post-operative day only were
significantly and independently related to the development of in-hospital
complications. CRP and PLT showed no association with complications. A
combination of WCC ]11 and ALB B25 resulted in the highest risk. The
nomogram we have developed could be used at the bedside to predict a given
patient’s probability of developing complications after the 5th post-operative
day.
PP 63.05
TREATMENT OF PERIAMPULLARY AND PANCREAS TUMORS:
A SINGLE CENTER EXPERIENCE
uguz, alper1; gurcu, baris2; aydin, unal2; nart, deniz2; ersoz, galip2; ozutemiz,
omer2; tekesin, oktay2; elmas, nevra2; goker, erdem2; ozkok, serdar2; yilmaz,
funda2; zeytunlu, murat2; coker, ahmet2
1ege university school of medicine hospital, HPB working group, izmir,
Turkey; 2ege university school of medicine hospital, HBP working group,
izmir, Turkey
Purpose. our purpose is to study mortality and morbidity and survival of the
pancreatic and periampullary tumors which has diagnosed, treated in Ege
University School of Medicine Department of General Surgery.
Methods. findings in new 143 cases between the dates of June 2003 and
December 2006 were retrospectively analyzed according to diagnosis, tumor
regions, surgical and adjuvant therapy, mortality and morbidity and survivals.
We perform standart pancreaticoduodenctomy to periampullary tumors and
distal standart pancreatectomy to pancreas body tumors as surgigal treat-
ment. The patients received gemcitabine and combined gemcitabine-radio-
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therapy as adjuvant therapy. Kaplan-meier proportions used in survival
analysis.
Results. forty cases had radiological vascular invasion and only 18 of them
had vascular invasion. Diabetes and/or hipertension were the most common
systemic diseases. Mean ASA(american society of anesthesiologists) scores
was two and mean CA199 was 229. preop biliary stent insertion was
performed to 45 cases. Twenty six cases were not operated. Fifteen cases had
perioperative major complication. Surgical procedures performed on
77(%57) cases for periampullary tumors, 37(%27) cases for pancreatic
body masses. Four (%3) of them was chronic pancreatitis. Seventyone of
them were adenocancer, and 43 was the other types. Perioperative mortality
was 3(%0,65), and major mobidity(leakage, GY´ bleeding) was 5(%1,38).
Median survival rates of pancreas head and distal bile duct cancers were
19.6291,42 months, pancreatic body tumors were 12,3291,11 tumors of
the papilla were 20,3691,41 months.
Conclusion. this study demonstrates that surgery can be performed safely in
an experienced department on HPB. The results are acceptable. The major
aim must be to continue performing a standart surgery and giving a treatment
chance to the patients with adjuvant therapies.
PP 63.06
SIMULTANEOUS HEPATIC RESECTION WITH PANCREATO-
DUODENECTOMY AND PORTAL VEIN RESECTION FOR META-
STATIC PANCREATIC CANCER: A CASE REPORT
Dulundu, Ender; Ozel, Yahya; Ozkan, Erkan; Kayahan, Munire; Topaloglu,
Umit
Haydarpasa Numune Education and Research Hospital, 5th Department of
Surgery, Istanbul, Turkey
Introduction. Pancreatic cancer is a common gastrointestinal cancer with
one of the worst prognostic malignancy. Despite recent advances in the field
of medical and radiation oncology, surgery remains the single most important
modality for the treatment of pancreatic cancer. On the other hand most
patients are diagnosed at an advanced and unresectable stage. Generally,
metastatic liver tumors from pancreatic cancer are not indicated for surgical
treatment in most of the center, and simultaneous liver and pancreatic
resection was recently considered to be a safe operation.
Case Report. A case of simultaneous hepatic resection with pancreatoduo-
denectomy and portal vein resection for metastatic pancreatic cancer, in a 66
year- old man who obtain relatively long survival, is presented. Patient
presented to our clinic with jaundice and loss of appetite. A computed
tomography examination showed a 2025 mm mass lesion on the pancreatic
head which was also invaded the portal vein. As the patient agreed to
operation, he was admitted to the operation theatre. During the exploration
of the abdominal cavity a 1.5 cm metastatic tumor was found in the right
anterior segment of the liver. Pancreatoduodenectomy with portal vein
resection and hepatectomy was performed. Patient is still alive after two
years of the operation, without any metastases and recurrences.
Conclusion. Hepatectomy with pancreatoduodenectomy might offer a
prolonged survival in highly selected patient with metastatic liver disease
from a pancreatic cancer.
PP 63.07
EFFECT OF SURGICAL MARGINS ON LONG TERM BODY
COMPOSITION CHANGES AFTER A WHIPPLES PROCEDURE
Smith, Ross1; Aslani, Alireza2
1Royal North Shore Hospital, Department of HPB and Upper GI Surgery, 5/
5 North Shore Private Hospital, St.Leonards, Australia; 2Royal North SHore
hospital, Body Composition, StLeonards, Australia
Recovery following a Whipple’s Procedure may be determined by the
patient’s nutritional status. Recovery of protein and fat losses should improve
patient’s response to adjuvant therapy which is mandatory when margins are
involved. It is important to study the effect of margin involvement on long
term nutritional status through detailed body composition measurements.
Aim. The aim of this study was to describe the detailed body composition
changes that occur during the first 6 months after a Whipples Procedure for
pancreatic cancer and to determine the differences in patients with clear
(CM) and Unclear margins (UCM).
Methods. 31 consecutive patients undergoing a Whipples Procedure (WP)
for pancreatic cancer were invited to undergo detailed nutritional assessment
at time points -1 and 2, 5, 14, and 26 weeks after surgery. Nutritional
assessment included measures of body weight, protein using in vivo neutron
capture (TBP), fat skin folds (TBF), water by bioimpedance (TBW) and
potassium shielded chamber (TBK).
Results. 11 were reported by the pathologist to have UCM while 20 had
CM. All patients were studied at -1, 2 and 5 week time points, while 3/11
UCM v 3/20 CM patients could not attend at 14 weeks and 8/11 UCM v 5/
20 CM patients could not attended at 26 weeks because of progressive
disease or chemotherapy. Although the UCM patients had lower fat stores
prior to surgery these were maintained at 5 and 14 weeks after surgery
similarly to those with CM. The patients with CM gained a mean of 0.83 kg
protein by 14 weeks (P0.04) while those with UCM maintained discharge
TBP values during this period. TBK and Fat free mass were maintained
equally well in UCM and CM groups during the first 14 weeks after surgery.
Conclusions. It is concluded that patients maintain their discharge body
composition for the first 14 weeks after surgery even when the pathological
margins are involved but the rapid drop off rate in those with UCM implies
that disease progression with many patients after that time point.
PP 63.08
RE-ADMISSIONS AFTER PANCREATICODUODENECTOMY:
CAUSES AND OUTCOME.
Tank, Avinash Kumar; Tank, Avinash Kumar; Singh, Rajneesh Kumar;
Behari, Anu; Kumar, Ashok; Saxena, Rajan; Kapoor, Vinay Kumar
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Surgical
Gastroenterology, Lucknow, India
Introduction. Postoperative morbidity following pancreaticoduodenectomy
(PD) has been highlighted in several reports, there are however very few
published series of re-admissions after PD.
Method. Between 1989 and 2006, 338 patients underwent PD and 307 were
available for follow-up (31 died in the post operative period). Sixty four
patients (19%) required readmissions. Prospectively maintained database
was analyzed with regards to presentation, treatment and outcome.
Results. There were 106 re-admissions of 64 patients; 64 (60%) re-
admissions were related to complications of index surgery, 38 (36%) re-
admissions were related to tumor recurrence and 4 (4%) re-admissions were
related to post-radiotherapy complications. Forty-two re-admissions were
within 1 year following index surgery and 64 were beyond 1 year. The major
causes of re-admissions related to complications of index surgery were-small
bowel obstruction (n9), stent or T-tube related re-admission (n8).
Seventeen (16%) re-admissions required surgery, 23 (22%) were treated
with percutaneous/ endoscopic interventions and 66 (63%) were managed
conservatively. The overall outcome of re-admissions (n106) was complete
recovery in 32 (30%), partial recovery in 39 (37%), problem persisted in 7
(6%) and 28 (27%) re-admissions showed gradual deterioration, including
hospital death of 2 patients. There was no statistical difference in survival in
the readmitted Vs not readmitted group (median survival 30 months Vs 20
months respectively). On comparison of two groups, postoperative intra-
abdominal abscess (p0.021) was predictive of subsequent readmission.
Conclusion. Re-admission is frequently required after PD for reasons
related to complications of index surgery, tumor recurrence and post-
radiotherapy complications. Most patients with index surgery related re-
admissions could be managed successfully while tumor recurrence related re-
admission has a low success rate. Re-admissions did not adversely impact the
overall survival of patients.
PP 63.09
CLINICAL AND PATHOLOGICAL PROGNOSTIC FACTORS
AFTER RESECTION FOR PANCREATIC CANCER
Perini, Marcus Vinicius1; Montagnini, Andre Luiz1; Penteado, Sonia1;
Jukemura, Jose1; Patzina, Roseli1; Cunha, Jose Eduardo2; Cecconello, Ivan3
1University of S.Paulo, Department of Gastroenterology, S.Paulo, Brazil;
2University of S.Paulo, Department of Gastroenterology, Brazil; 3Brazil
Background. -Pancreatic cancer one of the main causes of cancer related
deaths, surgical resection is currently the only established therapeutic option
with curative potential for this disease.
AIM. to correlate clinical and pathological parameters with survival in
patients submitted to pancreatic resection for pancreatic adenocarcinoma.
Methods. Surgical resection with curative intent was performed in sixty five
patients with pancreatic cancer between 1990 and 2006. The results of
surgical treatment were retrospectively analyzed and compared to the
clinicopathological features of these patients.
Results. Pylorus preserving pancreatoduodenectomy was performed in
56.9%, Whipple resection in 35.4%, distal pancreatectomy in 4.6% and
total pancreatectomy in 3.6%. Postoperative complications occurred in 28
patients (43.1%) Mean survival and 5-year survival rate after surgical
resection were 27.17 months and 7.0%, respectively. Sex, TNM stage,
tumor differentiation, neural invasion, tumor size and resection margin
involvement were the significant prognostic factors.
Conclusion. Pancreatic cancer patients, even those with poor prognostic
factors should be given the opportunity of surgical resection with curative
intent.
PP 63.10
BINDING PANCREATO-JEJUNOSTOMY, A NEW TECHNIQUE
FOR SAFER PANCREATODUODENECTOMY
Verma, G.R.
PGIMER, Surgery, Chandigarh, India
Background.Pancreato duodenectomy is a formidable procedure associated
with sizable morbidity and mortality up to 5%. Major morbidity is due to
disruption of pancreato enteric anstomosis. The anastomotic leakage related
mortality accounts for 4050%. A number of procedures and modifications
have been described in the literature to curtail the incidence of PJ Leak
following pancreato duodencetomy. However, the leak rate still hovers
around 720%.
Methods.Pancreato duodenectomy was performed by a single surgeon in
fifteen patients of periampullary or pancreatic tumors in the preceding three
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and half years (200307) at PGI Chandigarh, a tertiary referral hospital in
northern India. Ten patients were male and five females. The age varied from
2765 years (mean 48.6 years). In ten patients, a standard Whipple’s while in
five, pylorus preserving Pancreato duodenectomy was performed. Pancreto-
jejunal anastomosis was done with a new technique called ‘‘Binding
pancreato jejunostomy’’. Technical detail shall be discussed.
Results. Drain fluid amount and amylase values were estimated up to ten
days after surgery. Octreotide was not given to any patient. Mean post
operative stay was 16.8 days (1138 days). Morbidity was observed in 36.3%
(6/14). However, none of the patients except one developed PJ leak, due to
avoidable technical reason. One patient died from Post operative bleed due to
uncontrolled hypertension. The remaining fourteen patients were followed
up from 340 months (mean- 15.9 months). Twelve are alive and free of
disease. Two died after twelve and fourteen months of surgery from
disseminated disease.
Conclusion. It may be concluded that Binding Pancreato Jejunostomy is a
safe and efficient technique to prevent PJ leak following pancreato duode-
nectomy.
PP 64.01
STEREOTACTIC RADIATION THERAPY WITH BODY FRAME
(SBF) IN HEAPTICO-PANCREATICO-BILIARY (HPB) TUMORS
Mahantshetty, Umesh1; Patil, Nikhilesh1; Jamema, SV2; Engineer, Reena1;
Shrivastava, SK1; Mohandas, KM3; Shukla, PJ4; Shrikande, SV4; Dinshaw,
KA5
1Tata Memorial Hospital, Radiation Oncology, Mumbai, India; 2Tata
Memorial Hospital, Medical Physics, Mumbai, India; 3Tata Memorial
Hospital, Digestive Diseases and Nutrition, Mumbai, India; 4Tata Memorial
Hospital, GI Surgical Oncology, Mumbai, India; 5Tata Memorial Centre,
Radiation Oncology, Mumbai, India
Background and Rationale. Unresectable HPB tumors have dismal
outcome with a median survival of 6 months. Various treatment modalities
like, bypass surgeries, palliative resections, stenting, embolisation, che-
motherapy and radiation therapy have been tried. Recent reports have
demonstrated that the stereotactic technique using a body frame is safe and
with hypo-fractionated regimens could be efficacious for palliation. At Tata
Memorial Hospital, Stereotactic irradiation of extracranial targets was
initiated in 1998 adopting the method from Karolinska Hospital, Stockholm.
With an aim to evaluate the feasibility, toxicities and treatment results of
extracranial stereotactic radiotherapy (ESRT) for palliation in extra cranial
targets mainly HPB lesions, we undertook this retrospective analysis.
Material and Methods. Patients with locally advanced/unresectable HPB
tumors less then 3 in number and none more than 4cm were offered palliative
radiation with stereotactic radiotherapy. All patients underwent stringent
planning process which requires 57 days.
Results. With a mean age of 44 (3065) years, thirty-one (HPB: 15; Hepatic
mets: 4; Cholangiocarcinomas: 5) patients treated with stereotactic radio-
therapy using body frame between 19982006. Out of 31, Partial response 10
(33%), stable disease15 (48%) and remaining 6 (19%) had progressive
disease. Few patients also received palliative chemotherapy. With a median
follow-up of 27 months (332 months), 21 patients achieved good palliation.
One patient developed duodenal ulceration at 10 months post treatment, but
improved with conservative treatment only.
Conclusions. Our initial experience with extracranial stereotactic radio-
therapy in hepato-biliary cancers and non-colorectal hepatic metastasis is
enterprising.
PP 64.02
OVERLAY NAVIGATION SYSTEM OF CARBON DIOXIDE MDCT
CHOLANGIO-PANCREATOGRAPHY GENERATED BY OSIRIX
PROVIDE ACCURATE 3D IMAGE GUIDED HEPATO-PAN-
CREATO-BILI
Sugimoto, Maki1; Yasuda, Hideki1; Koda, Keij1; Yamazaki, Masato1; Tezuka,
Tohru1; Kosugi, Chihiro1; Higuchi, Ryota1; Yagawa, Yohsuke1; Suzuki,
Masato2
1Teikyo University Chiba Medical Center, Surgery, 34263 Anesaki Ichihara
Chiba, Japan; 2
Background/Aim. The application of virtual reality (VR) surgical assis-
tance, in which medical images are processed to provide reference images for
preoperative surgical planning or during surgery, is being evaluated. Overlay
technique is a most recent VR navigation system. We describe a new overlay
navigation system with carbon dioxide MDCT cholangio-pancreatography
(CMCP) enables synchronous visualization of HPB anatomy overlaid on the
real operative field provides real time image-guided 3D navigation for HPB
surgery.
Methods. 16-slice MDCT was performed in 70 HPB patients under trans-
papillary infusion of carbon dioxide and synchronously contrast material
administered intravenously. Virtual CMCP angiography (CMCPA) was
generated by DICOM viewer OsiriX. 3D reconstruction (volume rendering)
were incorporated and overlaid on the patient body surface and operative
field from the projector during surgery. Capability of the intra-operative
virtual navigation was evaluated.
Results. Overlay of CMCPA, superimposed on the actual space in front of
the surgical operator on the patientIfs operative field or the surface of the
abdomen, provided accurate information for localizing the target lesions of
HPB and GI anatomy with its relationship to the surrounding vessels. This
could help acquiring better hand-eye coordination to decrease the intrao-
perative complications and avoide organ injuries by accurate augmentation.
Disscusions/Conclusions. When a surgeon consults an image displayed on
a monitor, there is a distance arising from the actual view of the operative
field, hence, a technology for dynamic 3D images that fuses together the
actual space and the virtual space became necessary. Our overlaid image
guided navigation system demonstrated its clinical usefulness in reproducing
detailed planning simulation in complex HPB surgeries. It makes it possible
to perform detailed HPB surgeries easily and accurately by providing
accurate intraoperative real time 3D navigation.
PP 64.03
SHORT  TERM RESULTS OF ROBOTICALLY ASSISTED LA-
PAROSCOPIC TREATMENT OF HEPATIC CYSTS
Langer, Daniel; Ryska, Miroslav; Dolezel, Radek; Pudil, Jiri
Surgery Department, 2nd Faculty of Medicine, Charles University and
Central Military Hospital Prague, Prague, Czech Republic
Background. Hepatic cysts do not fall into common disease group in the
middle Europe. There are non-parasitic cystical lesions in nearly all of the
cases. Only minor part of patients with cystical liver masses suffer from
clinical disorders and vindicate surgery treatment. The authors intention is a
short-period results presentation of robot-assisted liver cyst surgery.
Method. Group evaluation of 8 patients, who underwent minimally invasive
operative treatment for symptomatic liver cyst disease in our surgery
department since the 1.4.2006 till 31.5.2007.
Results. Group of our patient was composed of 7 women (88%) and one
man (12%), average aged 61.1 years, in range of 42 to 72 years. All operative
procedures were finished in laparoscopic way. Operation duration time
averaged 105 minutes. There were only solitary cyst masses in our group,
localized in the right hepatic lobe in one half of cases. Cholecystectomy was
accomplished in one patient simultaneously. We did not record any early
complications nor deaths in evaluated patients. Blood losses were negligible
with no need of any blood transfusion product substitution. We revealed just
one recurrence 12 months after operation in one of our patients. The average
follow-up time was 5 months (in range of 2 to 12 months).
Conclusion. Our laparoscopic liver cyst (polycystosis excepted) surgery
experience supports and advocates laparoscopic treatment to be useful
modality with minimal morbidity and mortality in concordance with
literature conclusions. Da Vinci robotic system has notably assisted in less
accessible hepatic segments. Presented results of our group are comparable
with other published conclusions. We rate our results as temporary
considering short term trial.
PP 64.04
MUCINOUS CYSTIC NEOPLASM OF THE PANCREAS: CLINI-
COPATHOLOGIC MARKER THAT MIGHT SUGGEST MAL-
lGNANT POTENTIAL
Yang, Sung Hoon
Seoul National University College of Medicine, Department of Surgery,
Seoul, Korea, Republic of
Background & Aims. Mucinous cystic neoplasm (MCN) of the pancreas
could have a malignant potential. But, we would be difficult to differentiate
between benign and malignant lesion of MCN. Our aims were to investigate
the clinicopathologic marker that might suggest malignant potential of MCN.
Methods. In this retrospective study, we enrolled 56 MCN patients who
received the resection of the MCN at our center between 1991.8.1 and
2006.8.30. Medical records of the MCN patients were reviewed to obtain
clinico-pathologic data.
Results. Patients with MCN were almost exclusively (n55, 98.2%)
women; we identified 1 man with benign MCN. The mean (9SD) age at
resection was 49914 years (82.5%B60 y). Abdominal pain was the most
common presenting symptom; 32.1% (n18) were asymptomatic. Most
MCN (n52, 92.9%) were in the pancreatic body/tail region. Their median
size was 5 cm (range: 1.520 cm, 55.4%or5 cm). Histologically, 32
(57.1%) were benign MCNs, 18 (32.1%) were borderline MCNs, 4 (7.1%)
were non-invasive MCNs, and 2 (3.6%) had invasive cancer. Among the 40
MCN patients who the pathologic review could be performed, 36 (90%) had
the ovarian stroma. All 4 MCNs without the ovarian stroma were benign or
borderline. The 2 invasive MCNs had 5 and 11 cm-sized tumors,
respectively. The 4 non-invasive MCNs had 1.5, 2.5, 3, 6.5 cm-sized tumors,
respectively. The tumor sizes of benign and borderline MCNs were very
various from 1.5 cm to 20 cm. The average ages of non-invasive or invasive
MCN patients and benign or borderline MCN patients were 48.5 and 48.9
years, respectively. One female patient with a 4 cm-sized benign MCN of the
pancreas had a metastatic MCN of the liver.
Conclusions. In this study, no clinicopathologic marker that might suggest
malignant potential could not be found. Further study would be needed to
determine the malignant marker in the MCN of the pancreas.
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PANCREATICO-DUODENECTOMY FOR BENIGN PANCREATIC
LESIONS IN A UK SPECIALIST HPB CENTRE
Mukherjee, Samrat; Adansi-Pipim, Yaw; Smith, Marty; Bhattacharya,
Satyajit; Hutchins, Robert R; Abraham, Ajit T; Kocher, Hemant M
Barts and the London HPB Centre, London, United Kingdom
Background. Over the last 25 years, pancreatico-duodenectomy (PD) has
gained increasing acceptance as an effective and safe method for treating
malignant neoplasm of the pancreas. Increasingly PD is done for benign
diseases in the peri-ampullary region. AIMS: To evaluate clinical experience
with patients undergoing a PD, with a benign histological diagnosis, in a UK
specialist HPB centre.
Methods. Patients with pancreatic pathologies undergoing resection at our
institution from 1999 to 2007 were identified and those with benign histology
were extracted. We analysed the outcomes with respect to mortality,
morbidity and length of stay.
Results. Of 166 patients undergoing a PD, 27 (16.2%) patients had a benign
histology [Chronic pancreatitis (n11), endocrine tumours (n7), intra-
papillary mucinous neoplasm (n3), duodenal adenoma (n3) and others
(n3)]. Median age was 51 (range 31 to 82) years. There was no mortality
and the overall morbidity was 12 (44.4%). The most frequent and severe
complication was a pancreatic anastomotic leak (n4, 14.8%) of which 2
patients (7.4%) underwent a re-laparotomy. The median length of stay was
18 (range 9  316) days.
Conclusions. PD performed for benign pancreatic lesions have satisfactory
outcomes in a specialist centres.
PP 64.06
MANAGEMENT OF PANCREATIC TRAUMA AT A TERTIARY
CENTRE
Singh, A; Choubey, R P
Army Hospital (R&R), GI Surgery, New Delhi, India
Intoduction. Pancreatic trauma is relatively uncommon, but it has high
morbidity and usually detected late and usually missed if urgent laparotomy is
done for hamodynamically unstable patient.
Methods. A total of 9 cases of pancreatic injury were treated during a 2 year
period at a tertiary center were reviewed retrospectively. Diagnosis and
assessment of injury severity were based on imaging studies and peroperative
findings as most of patient had laparotomy before referral to this centre.
Results. Of the 09 patients, 01 underwent distal pancreatectomy with
splenectomy, 3 received a pancreatic duct stent, with the remaining 5
individuals underwent drainage alone. The 3 patients developed psudocyst
and 2 patients had necrotizing pancreatitis.All the patients with stent
developed complications.
Conclusion. All 9 cases were managed without any mortality and Magnetic
resonance pancreatography was found to be unreliable early after injury.
Treatment has to be tailored to the individual situation with prolonged in
hospital treatment.
PP 64.07
LYMPHO EPITHELIAL CYST OF PANCREAS: A RARE CASE
REPORT.
Sharma, Sandesh1; Naik, Saleem1; Sewkani, Ajit1; Varshney, Subodh2;
Maudar, K.K2
1Bhopal Memorial Hospital Bhopal, Dept.Of Surgical gastroenterology and
Clinical Nut, Bhopal, India; 2
Background. Lymph epithelial cysts are rare pancreatic lesions of unde-
termined pathogenesis. The literature on this entity is limited to case reports
or small series. 0BJECTIVE-To present a rare case report of pancreatic
Lympepitheleal cystand discuss its management.
Method. We describe a case of 66 year male, incidentally diagnosed as lymph
epithelial cyst of pancreas. To our knowledge this is the first case report of
lymph epithelial cyst of pancreas from India.
Result. Our patient had high CA 19.9 levels preoperatively and CT scan was
suggestive of a large cystic mass arising from head of pancreas. We performed
total Enucletion of the cyst from the head of pancreas. The biopsy of the cyst
was consistent with the lymphoepitheal cyst of the pancreas without
squamous metaplasia. One year postoperative patient is well with normal-
ization of the CA-19.9 levels and no recurrence of the cyst on ultrasound
imaging.
Discussion. An extensive Medline search was carried out for lymphoepithe-
lial cyst of pancreas. Total of 81 cases were identified in available English
literature. These 82 cases (including our case) were analyzed. Lymphoe-
pithelial cyst of the pancreas is a rare and distinct lesion mostly found in
adolescent male. Majority of patients present with non-specific symptoms
making preoperative diagnosis difficult it is mostly seen in the tail region of
pancreas with male preponderance. Because of the cystic appearance on
imaging it should be considered in the differential diagnosis of the cystic
neoplasm of the pancreas. It is not associated with the clinical syndromes that
are seen with their analogues in the salivary glands. Eneucleation from the
head or distal pancreatectomy is the recommended surgery for such lesions.
Conclusion. Lymph epithelial cyst of the pancreas is a rare benign lesion,
which is difficult to diagnose preoperatively. High index of suspicion and
preoperative fine needle aspiration cytology may help in making diagnosis
and avoiding surgery in asymptomatic patients.
PP 64.08
DISTAL PANCREATECTOMY- INDICATIONS AND OUTCOME
IN A TERTIARY CARE CENTER
Yalakanti, Raghavendra Babu1; Singh, Rajneesh Kumar2; Behari, Anu2; Lal,
Richa2; Kumar, Ashok2; Saxena, Rajan2; Kapoor, Vinay Kumar2
1Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Gastro
Surgery, LUCKNOW, India; 2Sanjay Gandhi Post Graduate Institute Of
Medical Sciences, Gastrosurgery, Lucknow, India
Background. Distal pancreatectomy (DP) may have significant post-
operative morbidity including pancreatic fistula and diabetes. We present
our experience with DP at a tertiary care referral center.
Methods. Sixty three patients underwent DP at our institution between Jan
1989 Dec 2006. Retrospective analysis of indications, mortality, morbidity,
factors affecting morbidity (e.g. firmness of pancreatic parenchyma, extent of
resection, and method of stump/ duct management and outcome) was done.
Results. The indications of DP were pancreatic diseases in 34 (54%)
patients (chronic pancreatitis in 21, pancreatic tumours in 8 and others in 5)
and extra-pancreatic diseases in 29 (46%) patients (tumours involving
pancreas). The overall operative mortality was 4 (6.3%), the morbidity was
29 patients (46%) and was similar in the two groups. The major post-
operative complications in the two groups (pancreatic and extra-pancreatic
diseases) were: new-onset diabetes (22% and 4%), pancreatic fistula (15%
and 10%), and intra-abdominal abscess (12% and 28%) respectively. Re-
operation was required in 6 patients (14.7% and 3.4% respectively). The
overall incidence of post-operative pancreatic fistula was 8 (13%) patients.
Upon statistical analysis it was found that the intra-operative pancreatic duct
identification was the only significant factor predicting pancreatic fistula (p
0.023). The overall incidence of new-onset diabetes was 6 (12%) patients.
There was no difference in the incidence of diabetes if the resection line was
at the neck (12 patients) or in the distal body (37 patients). Spleen was
preserved in 9 patients and the results (morbidity, intra-operative blood loss,
operative time, and length of stay) were similar to those in whom splenectomy
was done.
Conclusion. We conclude that intra-operative pancreatic duct identification
decreases the incidence of pancreatic fistula and the extent of pancreatic
resection did not influence the incidence of new-onset diabetes. Spleen
preserving DP is a safe and feasible procedure.
PP 64.09
HEPATIC RESECTION WITH PANCREATODUODENECTOMY:
BE AWARE OF THE PANCREAS
Melloul, Emmanuel; Chirica, Mircea; Kianmanesh, Re´za; Sauvanet, Alain;
Belghiti, Jacques
Hospital Beaujon, HPB Surgery, Clichy, France
Background. Liver resections associated with pancreatoduodenectomy
(PD) is a procedure which is indicated for some biliary cancers. However
this intervention is rarely performed because of its high risk. We aimed to
present in this study the first homogenous western series.
Patients and Methods. From year 2001 to 2006, 10 patients with a median
age of 53 years (range 3470) underwent liver resection with PD for stage IV
gallbladder carcinoma (n7), neuroendocrine tumor of the pancreas (n1),
GIST (n1), and main bile duct carcinoma (n1), respectively. All patients
had a PD associated with major hepatectomy in 4, which was prepared by
portal vein embolization (PVE) and biliary drainage in all cases and with
minor hepatectomy consisted of bisegmentectomy IV-V in 6.
Results. Mean operative time was 480 minutes (range 345720) and
operative blood loss 850 mL (range 1501700). The mortality rate was nil.
Only one patient experienced major liver morbidity with episodes of
angiocholitis due to biliary anastomosis stenosis. There was no postoperative
liver failure. Pancreatic complications included fistulas in half of patients,
requiring pancreatico-jejunal anastomosis refection in one. The pancreatic
fistula rate was 75% after major hepatic resection. The mean ICU/hospital
stay after PD with major and minor hepatectomy was 18/56 and 7/27 days,
respectively.
Conclusions. Liver resection with PD is a procedure which can be
performed safely, providing that major hepatectomy is prepared by both
biliary drainage and PVE. Results of this study showed that pancreatic
complications are underestimated with a high rate of fistulas.
PP 64.10
CHOLEDOCHOLITIASIS DURING PREGNANCY SUCCESS-
FULLY TREATED WITH ERCP.
Morales, Dieter1; Mellado, MJ2; de La Pen˜a, J2; Silvan, M2; Martin-Oviedo,
J2; Yagu¨e, E2; Naranjo, A2; de Miguel, JR2
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1University Hospital ‘‘Marque´s de Valdecilla’’, Department of Surgery,
Santander, Spain; 2
Introduction. Choledocholithiasis is an uncommon complication of gall-
stone disease during pregnancy. Therapeutic approach of choledocholithiasis
during pregnancy has maternal and fetal riks and remain controversial. We
present a case of choledocholithiasis during the third trimester successfully
treated with ERCP and recorder laparoscopic cholecystectomy.
Case Report. A previously healthy 35-yr-old white female presented at 28-
wk gestation was addressed to our hospital with sudden right upper quadrant
pain radiate through to the back. Obstetric and abdominal exploration were
normal. Four days after, the pain remains and the patient present jaundice.
White cell count and serum amylase level were normal. Liver function test
showed high levels of alkaline fosfatase and transaminases Ultrasonography
showed normal liver, gallbladder with stones, CBD diameter increased and a
single stone at the end of CBD. Pancreas was normal (figure 1). Therapeutic
ERCP with sphincterotomy was performed with sedation and two seconds X-
ray and the calculi was removed with Dormia basket without problems
(Figure 2). Patient recovered unevenfull. and the birth was at 35-wk with
Caesarean operation without complications. One month after the birth,
laparoscopic cholecystectomy was performed and patient is asymtomatic.
Conclusions. 1.- ERCP at third trimester and recorder laparoscopic
cholecystectomy after birth is a safe therapheutic option for mother and
feto. 2.- Cholecystectomy, cholangiography and common bile duct explora-
tion during third trimester carry a relatively low maternal morbidity and
mortality but the evidence of fetal wastage may be quite high with open
surgery, and laparoscopic approach remain controversial.
PP 65.01
HUMAN HEPATOCYTE ISOLATION FOR CELL TRANSPLANTA-
TION: THE ST GEORGE EXPERIENCE
Yao, Peng1; Akhter, Javed2; Johnson, Loreena2; Morris, David2
1University Of New South Wales, Sydney, Australia; 2UNiversity of New
South Wales, Department of Surgery, Sydney, Australia
Background. Isolated hepatocytes can be an attractive therapeutic alter-
native to the patients who are waiting for orthotopic liver transplantation.
However, the availability of healthy human livers for cell isolation is limited.
Currently the isolated human hepatocytes are mainly from livers unsuitable
for transplantation, surgical waste materials for split-liver transplantation and
resected tissues from partial hepatectomy.
Aim. Our group has sought to use liver resection materials from cancer
patients.
Methods. Study was approved by local authority. Between Jul 2004 to Jan
2007, 54 patients who giving consent were eligible for the study. The tumour
was dissected with at least 1 cm margin from the resected liver specimen, the
liver was then cannulated and perfused by modified two step collagenase
digestion technique. Isolated hepatocytes were functionally tested using
attachment rate, albumin secretion, urea secretion and diazepam metabo-
lism.
Results. Hepatocyte isolation was performed in the designed lab. The mean
weight of specimen was 211 g, mean digestion rate was 40%, mean viability
was 56%, mean viable cell per isolation was 1,080 millions. There was no
correlation between warm ischaemic time and yield and viability of isolated
hepatocytes, but there was correlation between cold ischaemic time and yield
and viability. Age did impact the yield of hepatocytes.
Conclusion. Isolated hepatocytes from liver resection materials maintain
good functions, and can be a good source for hepatocyte transplantation.
PP 65.02
MITOCHONDRIAL FUNCTIONAL CHANGES IN NON-HEART-
BEATING DONOR LIVERS: ADVERSE EFFECT OF COOLING
Roy, Debabrata1; Ashley, Neil2; Southerland, Andrew3; Elker, Doruk3;
Morovat, Reza4; Coussios, Constantin5; Friend, Peter J3
1John Radcliffe Hospital, Nuffield Department of Surgery, oxford; 2John
Radcliffe Hospital, Nuffield Department of Obstetric and Gynaecology,
oxford, United Kingdom; 3John Radcliffe Hospital, Nuffield Department of
Surgery, oxford, United Kingdom; 4John Radcliffe Hospital, Nuffield
Department of Biochemistry, oxford, United Kingdom; 5University of
Oxford, Department of Bioengeenering, oxford, United Kingdom
Introduction. The use of livers from non-heart-beating-donors (NHBD)
has been restricted because the liver does not tolerate prolonged warm
ischaemia followed by cold preservation. The purpose of this study is to
investigate the kinetics of energy metabolism and mitochondrial function
during ischaemia and its relationship with increased hepatocellular injury in
non-heart-beating donor livers.
Methods. After 60 minutes of warm ischaemia, porcine livers (n5) were
cold preserved for 60 minutes in University of Wisconsin solution and then
connected to an extracorporeal perfusion circuit for 24 hours for functional
assessment. Sequential liver biopsies were analysed for ATP content and
mitochondrial functions (respiratory control ratio (RCR), cytochrome c
release and caspase activation). The perfusate was analyzed for serum
transaminases, bile production, and base deficit. Apoptotic and necrotic
changes after reperfusion were examined by TUNEL and haematoxylin
staining respectively.
Results. Although cellular ATP levels declined sharply during 60 minutes of
warm ischaemia (pB0.01), mitochondrial function was maintained. How-
ever, subsequent cold preservation produced significant decline in mitochon-
drial function (RCR 3.8390.16 vs. 2.0490.11, pB0.01). Reperfusion with
oxygenated blood led to further loss of mitochondrial function (pB0.01),
ATP energetics (pB0.05), initiation of apoptosis through cytochrome c
release and the caspase activation. This was associated with increased
hepatocellular (pB0.01) damage with apoptosis, necrosis and destruction
of architecture on histology. These features not seen in livers subjected to
warm ischaemia without cold preservation.
Conclusions. Combination of warm ischaemia and cold preservation
produces significant hepatocellular injury due to its profound effects on
cellular energetics and mitochondrial function. This may have important
implications in developing novel therapeutic strategies for resuscitation of
NHBD livers
PP 65.03
PROTECTIVE EFFECT OF ANTIOXIDANT N2-MERCAPTOPRO-
PIONYLGLICYNE IN EXPERIMENTAL ISCHEMIA/REPERFU-
SION OF LIVERS
Abdo, Emilio; Jureidini, Ricardo; Ali Taha, Mohamed; Penteado, Sonia
University of S.Paulo, Department of Gastroenterology, S.Paulo, Brazil
N2-mercaptopropionylglycine (N2-MPG), a simple thiol, among other
properties, is a powerful superoxide synthesis inhibitor and was tested as a
preventive agent of metabolic and structural damage of several organs, in the
ischemia/reperfusion process.
Aim. To evaluate the effect of the thiol N2-MPG on modulation of some
biochemical and histological aspects of animal livers.
Methods. Twenty-two rats and twenty-two dogs were divided into four
groups: Group I: rats that received I.V. saline 0.9%; Group II: rats that
received I.V. 100mg/kg of N2-MPG; Group III: dogs that received saline I.V.
0.9% and Group IV: dogs that received IV 100mg/kg N2-MPG. Ten minutes
after the saline or drug administration, each group was submitted to left lobe
liver ischemia for 25 minutes followed by reperfusion.
Results. Biochemical studies 24 hours after reperfusion revealed a significant
decrease of transaminases in animals of groups G-II (AST2719182;
ALT2619161) and G-IV (AST101945; ALT123989) when com-
pared to the controls G-I (AST21449966; ALT186991040 00) and G-
III (AST182976.51; ALT2779219) respectively (pB0,001). All the
results are expressed in IU/dl. Histology study showed a significant minor
aggression to animals of G-II and G-IV when compared to G-I and G-III
respectively (pB0,05).
Conclusion. These results suggest an actual and significant release of free
radicals of oxygen in the isquemia/reperfusion process of the liver and that
N2-MPG may have a significant protective effect on its parenchyma
PP 65.04
LIVER APOPTOSIS FOLLOWING NORMOTHERMIC ISCHEMIA-
REPERFUSION: IN VIVO DETERMINATION OF CASPASE AC-
TIVITIES BY FLIVO ASSAY
Cursio, Raffaele1; Colosetti, Pascal2; Auberger, Patrick2; Gugenheim, Jean1
1Univ. de Nice Sophia Antipolis, Laboratoire de Recherches Chirurgicales,
Nice, France; 2Univ. de Nice Sophia Antipolis, INSERM U526, IFR50,
C3M, Nice, France
Background/Aim. The mode of cell death after liver ischemia-reperfusion
(I-R) is considered to be necrotic, but there is increasing evidence that
apoptosis plays also a role. The aim of this study was to determine in vivo
caspase activities during normothermic liver I-R-induced apoptosis.
Methods. In rats a segmental normothermic ischemia of the liver was
induced for 120 minutes. After intravenous injection of green probe
FLIVOTM, in vivo caspase -3 and -7 specific activity was determined, by
fluorescence microscopy, in non-ischemic and ischemic liver lobes, 3 and 6 h
after reperfusion. Liver apoptosis was assessed by the TUNEL assay.
Results. Fluorescence microscopy showed that liver apoptosis and in vivo
caspase -3 and -7 specific activity were increased in ischemic lobes after 3 and
6 h of reperfusion, compared to non-ischemic liver lobes (pB0.005).
Quantitative analysis of apoptotic cells showed that more than 35 per cent
of the cells were TUNEL-positive in ischemic lobes 3 and 6 h after
reperfusion, compared with less than 1 per cent in non-ischemic liver lobes
(pB0.005).
Conclusions. Normothermic liver I-R resulted in increased in vivo caspase -
3 and -7 specific activity and in liver apoptosis.
PP 65.05
CURCUMIN ENHANCES LIVER HYPOTHERMIC PRESERVA-
TION AND DECREASES APOPTOSIS IN AN EX-VIVO PERFU-
SION MODEL
Chen, Changguo; Johnston, Thomas D; Jeon, Hoonbae; Gedaly, Roberto;
Mchugh, Patrick; Wu, Guanghan; Ranjan, Dinesh
University of Kentucky, College of Medicine, Surgery, Lexington, Kentucky,
United States
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Background. Curcumin (Cur), a component of the spice turmeric, has
antioxidant and anti-inflammatory properties and has been used as a wound
healing agent.Objective. To assess the effect of Cur on liver hypothermic
preservation in an isolated perfusion model.
Methods. Sprague-Dawley rat livers were flushed with different preservation
solutions of phosphate buffered saline (PBS), Euro-Collins solution (EC),
University of Wisconsin solution (UW) with or without Cur (25200 mM)
and stored at 48C for 2448h. The livers were then perfused for 120 min via
the portal vein with oxygenated Krebs-Henseleit bicarbonate buffer (pH 7.4,
378C) at a pressure of 18 cm H2O in a perfusion apparatus. The livers in the
normal (NL) group were flushed with PBS, EC or UW, then immediately
perfused (zero preservation time).
Results. We found that Cur at optimal concentration (100 mM) significantly
(pB0.05, n10) increased portal vein flow rate and bile production and
significantly decreased the release of liver enzymes (alanine aminotransferase,
aspartate aminotransferase, and lactate dehydrogenase) to the perfusate in
the ECCur and PBSCur preserved livers as compared to the EC or PBS
preserved livers. Comparing UW Cur vs. UW, there was no difference in
these parameters after 24h preservation; however, after 36h and 48 h of
preservation, the portal vein flow rate and bile production were significantly
higher in the UWCur livers than in the UW livers. Histological analysis
after perfusion indicated that the mean number of apoptotic bodies per field
was 0.1690.05 in NL group, 0.0990.04 in ECCur group, 0.2490.05 in
EC group. The number of apoptotic bodies in the EC group was significantly
higher than in the ECCur and NL groups (pB0.05, n10).
Conclusions. Cur has inherent organ preservation property as it improves
liver preservation which may be related to reduced apoptosis in the Cur
preserved livers.
PP 65.06
PERITONEAL IMPLANTATION OF CRYOPRESERVED ENCAP-
SULATED PORCINE HEPATOCYTES IN RATS WITHOUT IM-
MUNOSUPPRESSION: VIABILITY AND FUNCTION
Cursio, Raffaele1; Baldini, Edoardo1; De Sousa, Georges2; Margara,
Andrea1; Honiger, Jiri3; Saint-Paul, Marie-Christine4; Bayer, Pascale1;
Raimondi, Vincent1; Rahmani, Roger2; Mouiel, Jean1; Gugenheim, Jean1
1Univ. de Nice Sophia Antipolis, Laboratoire de Recherches Chirurgicales,
Nice, France; 2INRA, Lab. Pharma-Toxicologie Cellulaire, Antibes, France;
3Univ. de Paris V, INSERM U420, Paris, France; 4Univ. de Nice Sophia
Antipolis, Service d’Anatomo-Pathologie, Nice, France
Background/Aim. Encapsulated hepatocyte transplantation is a promising
approach to cell transplantation without immunosuppression as an alter-
native to whole organ liver transplantation. The aim of this study was to
assess viability and function of cryopreserved encapsulated porcine hepato-
cytes implanted intraperitoneally in rats without immunosuppression.
Methods. Isolated porcine hepatocytes were cryopreserved at -196 degrees
Celsius for 1 month. Thereafter they were thawed and encapsulated in hollow
fibers (AN69 polymer). Four groups were created: Group 1 (n10), freshly
encapsulated porcine hepatocytes cultured in albumin-free medium for 10
days; Group 2 (n10), freshly encapsulated porcine hepatocytes implanted
in rat peritoneum without immunosuppression for 1 month, and cultured for
10 days after explantation; Group 3 (n10), cryopreserved encapsulated
porcine hepatocytes cultured for 10 days; Group 4 (n10), cryopreserved
encapsulated porcine hepatocytes implanted in rat peritoneum without
immunosuppression for 1 month and cultured for 10 days after explantation.
Hepatocyte viability, liver enzyme release, urea and albumin production were
assessed.
Results. There was no significant difference in urea synthesis between the
groups. Albumin synthesis was significantly decreased in group 4 compared
to the other groups (pB0.01). There was no significant difference in AST,
ALT and LDH levels in culture medium (p0.05). Encapsulated cryopre-
served porcine hepatocytes explanted from rat peritoneum after 1 month
appeared morphologically viable and their ultrastructure was preserved.
Conclusions. Long-term cryopreservation of porcine hepatocytes resulted in
retention of their biological activity and in significant viability when
transplanted into rat peritoneum without immunosuppression.
PP 65.07
SUCCESSFUL LIVE DONOR LIVER TRANSPLANT FROM A
DONOR WITH UNUSUAL BILIARY ANATOMY
Srivastava, Ajitabh1; Vij, Vivek2
1Indraprastha Apollo Hospital, Surgical Gastroenterology and Liver Trans-
plant, New Delhi, India; 2Successful Live Donor Liver transplant from a
donor with unusual biliary anatomy Ajitabh Srivastava, Vivek Vij, Neerav
Goyal, Manav Wadhawan, Ashish Singhal, Subash Gupta Department of
Surgical Gastroenterology and Liver Transplantation Indraprastha Apollo
Hospital, Sarita Vihar, New Delhi
Background. Preoperative magnetic resonance cholangiography (MRC) is
used to screen donors for LDLT. As living donors are scarce, donors should
not be rejected unless there is a risk to donor or recipient. Complicated biliary
anatomy must be correctly interpreted in order to ensure smooth donor and
recipient recovery. We present a case of an unusual biliary anatomy on MRC
which we operated successfully.
Patients and Materials. A 44 year old, healthy female was evaluated for
right lobe donation to her brother. MRC during evaluation revealed a dilated
right hepatic duct draining into the cystic duct, with multiple anomalous
intrahepatic communications between left and right ductal system. Findings
were confirmed on intraoperative cholangiogram, and hepatectomy in the
ischemic plane yielded a single RHD for anastomosis. The anomalous
connections were ligated and divided. Post transection cholangiogram
showed complete drainage of the left lobe.
Results.The donor had an uneventful recovery except for minor bile leak
which stopped after 7 days. The recipient post operative recovery was marked
by high ascitic output for two weeks and later developed a small bile
collection which required pigtail drainage which gradually settled.
Conclusion. Right hepatic duct insertion into the cystic duct is very
uncommon. However if it is recognized on intraoperative cholangiogram
successful liver transplantation is possible.
PP 65.08
DEVELOPMENT OF A NEW EXTRACORPOREAL PORCINE
LIVER PERFUSION MODEL WITH A HOLLOW FIBRE FILTER
Bikhchandani, Jai1; Metcalfe, Matthew1; Illouz, Severine1; Nicholson,
Michael2; Dennison, Ashley R1
1University Hospitals of Leicester NHS Trust, Department of Hepatopan-
creatobiliary Surgery, Leicester, United Kingdom; 2University Hospitals of
Leicester NHS Trust, Department of Transplant Surgery, Leicester, United
Kingdom
Background and Aims. Liver transplantation is the only effective treatment
of acute liver failure, but a large proportion of patients die while on the
waiting lists. Arguably, there is a need for a liver support device that can act as
a bridge to transplantation. An isolated porcine liver perfused with patients’
blood has shown good results as a support system but with concerns about
the possible transfection of porcine retroviruses. A separating membrane (or
filter) between the patient and porcine liver could potentially block the
transfer of these viruses. The current study was aimed to design a liver
perfusion model with a hollow fibre filter and to test its efficacy in providing
hepatic function.
Methods. Normothermic ECMO based perfusion of porcine liver was
carried out using a circuit including a haemofilter unit Evaclio-EC4A, pore
size 30 nm. A reservoir of blood with high ammonia levels was used as a
‘‘surrogate-patient’’ of acute liver failure. Viability of liver was assessed by bile
outflow and 15 min retention of indocyanine green (ICGR15). Ammonia
clearance and galactose elimination from the ‘‘surrogate’’ patient circuit were
used as measures of hepatic function.
Results. Mean oxygen consumption of 56.128.6 ul/min/gram of hepatic
tissue, bile production of 74.2 ml/hour and ICGR15 22.59.7% con-
firmed optimum hepatic perfusion (n10). More than 75% of ammonia
(1000 mg) was cleared from the ‘‘surrogate-patient’’ blood in 15 minutes.
Galactose-elimination rate (Vmax) of 128  51.9 mg/min/Kg liver was
seen.
Conclusion. We have shown that in an experimental set up it is possible to
provide reliable hepatic function across a hollow fibre filter using this liver
perfusion system. The next step would be to test this system in a live animal
model of acute liver failure.
PP 65.09
A PROSPECTIVE STUDY OF ABDOMINAL PAIN AND FUNC-
TIONAL SYMPTOMS IN LIVING LIVER DONORS AFTER PAR-
TIAL LIVER DONATION AND GALLBLADDER REMOVAL
Søndenaa, Karl1; Royaie, Sasan2; Emre, Sukru3; Goldman, Jody S3;
Gondolesi, Gabriel3; Hausken, Trygve4; Schwartz, Myron E3
1Haraldsplass Deaconal Hospital, Department of Surgery, University of
Bergen, Bergen, Norway; 2; 3Recanati/Miller Transplantation Institute/
Mount Sinai Hospital, Liver Transplantation& Hepatobiliary Surgery, New
York, United States; 4University of Bergen, Institute of Medicine, Bergen,
Norway
Introduction. Abdominal complaints occur fairly frequently after removal of
the gallbladder in gallstone disease but the cause of this disorder has not been
ascertained. We wanted to examine the nature of possible abdominal
complaints after removal of the gallbladder and part of the liver in living
donors.
Objective. Twelve patients referred for live donor operations were enrolled
in the study during a three-year period and followed up a 6 and 12 months.
There were nine men, aged 1845 years, and three women, aged 3246 years.
Ethnicity was mixed with caucasian (n7), hispanic (n3), asian and afro-
american origin. Patients filled out questionnaires including questions
pertaining to typical gallstone symptoms and functional abdominal com-
plaints (FAC) using a recognised questionnaire, Rome II.
Reuslts. Abdominal pain occurred in 8 patients at 6 months but was reduced
to 5 patients at one year and FAC in 11 and 9, respectively. Pain was
accompanied by FAC in all instances, with the exception that 2 patients had
FAC but no abdominal pain at one year. A pain attack pattern only vaguely
similar to typical gallstone pain was only found consistently in one patient at
each follow-up. Irritable bowel syndrome (IBS) was found in the majority of
patients but functional dyspepsia (FD) was also observed. Dyspepsia
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appeared de novo in all but one patient at the two follow-ups including those
two patients thought to have symptoms reminiscent of a gallstone pain
pattern.
Conclusion. Pain and FAC was fairly common after living liver donation but
pain waned with time during a one-year follow-up. Pain and FAC seemed to
indicate a general postoperative disorder, perhaps influenced by psychoso-
matic factors not evaluated further in this study, and not connected with
removal of the gallbladder in particular.
PP 65.10
FORMULA FOR CALCULATING STANDARD LIVER VOLUME
(SLV) IN INDIANS
Chandramohan, Anuradha1; Venkatramani, Sitaram2
1Christian Medical College and Hospital, Department of Radiology, Vellore,
India; 2Christian Medical College, Department of Hepatobiliary and
Pancreatic Surgery, Vellore, India
Aim. To assess the formula described by Johnson (2005) to calculate SLV in
Indians, and to compare it with formulae derived from Indian, Korean and
Chinese populations.
Materials and Methods. This is a retrospective study of 398 cadavers with
normal liver at autopsy between 1999 and 2005. Patient’s height, weight and
liver weight were obtained from autopsy records. Density of formalin
preserved liver was estimated using water displacement method. Volume of
liver was calculated from liver weight and density. Body surface area (BSA)
was calculated using Mosteller’s formula. Liver volume obtained from
autopsy record was compared with liver volume estimated from the formulae.
The best formula to estimate SLV in Indians was obtained by applying Akaike
information criteria, ICC and paired t-test to the formulae.
Results. There were 281 males and 117 females, median age 45 years (8
70). The mean BSA was 1.57 square meter (0.672.18); liver volume was
1204.67 cc (310.9 2089). The density of the liver was found to be 1.158kg/l.
There was good agreement between the total liver volume (TLV) and SLV
estimated by formulae derived from the Indians (ICC0.39, pB0.001),
Koreans (ICC0.41, pB0.001) and the Johnson model (0.41, pB0.001).
However the correlation was less good with the gender based formula derived
from the Chinese population (ICC0.27, pB0.001). Mean difference
between the TLV and formula estimated SLV was least with the Johnson
model (27.7 cc, p0.003) and maximum with the Chinese formula (205.7
cc, pB0.001). The difference obtained using Indian formula was (47.1 cc,
pB0.001). Akaike information criteria (AIC) supported the above. Gender
had no significant effect on liver volume.
Conclusions. The Johnson model is the best available formula for estimating
SLV in Indians. However the formula derived from Indian population
(Anuradha model) can be used in view of its close AIC value and its
simplicity.
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WRAPPING OF ANASTOMOTIC SITE OF PANCREATICOGAS-
TROSTOMY USING THE FALCIFORM LIGAMENT AND THE
GREATER OMENTUM IN PANCREATICODUODENECTOMY
Mimatsu, Kenji1; Oida, Takatsugu1; Kawasaki, Atsushi1; Aramaki, Osamu1;
Kuboi, Youichi1; Kanou, Hisao1; Miyake, Hiroshi2; Amano, Sadao3
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Kasukabe Municipal Hospital, Surgery, Kaskabe, Japan; 3Nihon University
School of Medicine, Surgery, Tokyo, Japan
Background. A leakage of pancreatic juice at the anastomotic site of
pancteaticojejunostomy or pancreaticogastrostomy (PG) is a major cause of
morbidity in patients undergoing pancreaticoduodenectomy (PD). A pan-
creatic fistula may expose skeltonized vessels directly to pancreatic juice,
causing delayed intra-abdominal bleeding. Also, it may cause to the intra-
abdominal abscess due to melting tissue around surgical site by pancreatic
juice. With the aim of protecting vessels and anastomotic site, we have
adopted an operative technique by which these vessels and anastomotic site
are wrapped using a pedicled falciform ligament and fixation of greater
omentum.
Methods. After PD with lymph node dissection, Child or Cattell reconstruc-
tion with PG was performed. The pedicle falciform ligament and greater
omentum is spread out widely on major vessels including portal vein, hepatic
artery and stump of gastroduodenal artery, and protected anastomotic site of
PG. Between April 2005 and July 2007, PD with PG was undergone 11
patients in periampullary caner. We reviewed the 11 patients who underwent
PD with these procedures.
Results. The mobilization of the falciform ligament and the greater
omentum and wrapping of the anastomotic site of PG was successfully
performed without any operative complications. The amount of drain
amylase had become below 10000 U/l until 3.7 days, and drain removed
until 9.1 days after operation. Wound infection was occurred in 1 patient,
although, major complication such as pancreatic fistula and delayed intra-
abdominal bleeding was not occurred in any of the patients.
Conclusions. The wrapping of the falciform ligament and fixation of the
greater omentum was convenient and safe technique, and may be reduce
major complication including pancreatic fistula and delayed intra-abdominal
bleeding.
PP 66.02
RECONSTRUCTION METHOD FOLLOWING PANCREATICO-
DUODENECTOMY IN PERIAMPULLARY CANCER PATIENTS
AFTER BILLROTH-I GASTRECTOMY
Mimatsu, Kenji1; Oida, Takatsugu1; Kawasaki, Atsushi1; Aramaki, Osamu1;
Kuboi, Youichi1; Kanou, Hisao1; Miyake, Hiroshi2; Amano, Sadao3
1Social Insurance Yokohama Central Hospital, Surgery, Yokohama, Japan;
2Kasukabe Municipal Hospital, Surgery, Kasukabe, Japan; 3Nihon Univer-
sity School of Medicine, Surgery, Tokyo, Japan
Background. With recent aging, we have often experienced pancreatico-
duodenectomy (PD) for periampullary cancer patients after gastrectomy.
Billroth-I is major reconstruction after gastrectomy for gactric ulcer and
gastric cancer. There are many methods of reconstruction following PD,
however, the reconstruction following PD after Billroth-I gasterctomy is
unclear. We elucidated reconstruction following PD after Billroth-I gastrect-
omy, retrospectively.
Methods. Between 1997 and 2007, nine patients underwent PD after
Billroth-I gastrectomy with the Billroth I type (Imanaga and Cattell method:
n3) and Billroth II trype (Modified Child method: n6). We reviewed
nine patients who underwent PD after Billroth-I gastrectomy, and compared
with duration until removal of nasogastric tube, duration until oral taking and
complications between the two groups.
Results. Although leakage of pancreaticojejunostomy was one case of
Billroth-II type (Modified Child method), the incidences of other complica-
tions was not significant different between two groups. Duration until
removal of naso-gastric tube and oral taking was significantly shorter
Billroth-II than Billroth-I type. Postoperative roenterography showed stasis
into the residual stomach in Billroth-I (Cattell method) type, however, it
showed smooth passage to jejunum in Billroth-II (Modified Child method)
type.
Conclusions. Billroth-II type reconstruction of modified Child method may
prevent gastric stasis following PD in periampullary cancer patients after
Billroth-I gastrectomy.
PP 66.03
IS ISOLATED ROUX LOOP PANCREATICOJEJUNOSTOMY
SUPERIOR TO CONVENTIONAL PANCREATICOJEJUNOST-
OMY?-A COMPARATIVE STUDY
Perwaiz, Azhar; Singhal, Dinesh; Chaudhary, Adarsh
Sir Ganga Ram Hospital, Surgical Gastroenterology, New Delhi, India
Introduction. Pancreatic fistula (PF) predicts mortality and morbidity in
patients undergoing pancreaticoduodenectomy (PD). Though there is no
comparative study, proponents of isolated Roux loop pancreaticojejunostomy
(IPJ) believe in its superiority over conventional pancreaticojejunostomy
(CPJ).
Objective. To assess whether isolated Roux loop reconstruction is superior
to conventional PJ.
Methods. Between September 2003 to July 2007, we performed 108
pancreaticoduodenectomies. All patients underwent conventional PD with
pancreaticojejunostomy (PJ). Patients were divided into two groups. Group I-
IPJ and group II- CPJ. A retrospective analysis of prospectively collected data
was performed. Primary end points were PF, duration of surgery, length of
hospital stay, over all complications and operative mortality.
Results. There were 81 males and 27 females with median age of 54.3 years
(1880). There were 53 patients in group I and 55 in group II. Over all
incidence of PF was 10.1% (n11). No statistically significant difference in
the incidence of PF was noted in the two groups (5 in group I versus 6 in
group II). Clinically significant PF was noted in 6 out of 11 patients (3 in
each group). The outcome of patients with clinically significant PF was no
different in the two groups (2 patient died in each group). Overall
complications, mortality and length of hospital stay were similar in the two
groups, however duration of surgery was higher in group I (442 minutes
versus 370 minutes).
Conclusion. Isolated pancreaticojejunostomy is not superior to conventional
PJ; instead it increases the duration of surgery.
PP 66.04
IMPACT OF CLINICAL PATHWAY FOR PANCREATICODUODE-
NECTOMY(PD) AT A TERTIARY CARE CENTRE
Goja, Sanjay; Singhal, Dinesh; Chaudhary, Adarsh
Sir Ganga Ram Hospital, Surgical Gastroenterology, New Delhi, India
Introduction. Pancreaticoduodenectomy has evolved to be safe procedure in
high volume centers. Comprehensive perioperative clinical pathway has
improved outcomes and reduced length of hospital stay. Clinical pathway is
sequence of treatment related events with daily goals to provide quality and
efficient care.
Aim. To assess impact of application of clinical pathway in PD in improving
outcomes at our institution.
Methods. Prospectively collected data of 108 consecutive pancreaticoduo-
denectomies, performed between September 2003 to July 2007 at our centre,
was analyzed. Clinical pathway was applied in last 50 patients(GroupI).First
58 patients in whom no clinical pathway was used were put in Group II.
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Pathway execution started preoperatively with patient counseling about
surgery, followed in immediate post operative period and continued in
subsequent days. Protocol included early removal of nasogastric tube and
ambulation on POD (postoperative day) 1, orally liquids, removal of urinary
catheter and drain fluid amylase on POD2, drain removal on POD3, stopping
I/V fluids and switching to oral medication on POD4, USG abdomen on
POD5 and discharge on POD 5 or 6. Out comes analyzed were perioperative
complications, mortality, length of postoperative hospital stay and read-
mission.
Results. Out of 108 patients 81 were male and 27 female with median age of
54.3 years (1880). Mean hospital stay in group I was 6.7 days (522)
compared to 11.01 days (527days) in group II Pancreatic fistula developed
10.3%( n6) in group II compared to 10%(n5) in group I. Overall
mortality was 3.7% with 4% in group I compared to 3.4% in group II, not
statistically significant. Overall 6 patients were readmitted, 4 in group II and 2
in group I. Commonest reason for readmission was delayed gastric emptying
(about 50%)
Conclusion. Implementation of clinical pathway in pancreaticoduodenect-
omy results in earlier discharge of patients from hospital and thus better
hospital resource utilization without any detrimental effect on patient care
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ADENOSQUAMOUS CARCINOMA OF THE PANCREAS
Hsu, Jun-Te; Yeh, Chun-Nan; Yeh, Ta-Sen; Hwang, Tsann-Long; Jan, Yi-
Yin; Chen, Miin-Fu
Chang Gung Memorial Hospital, Chang Gung Univeristy, Department of
General Surgery, Taipei, Taiwan
Introduction. Primary adenosquamous carcinoma of the pancreas (ASC) is
a rare pancreatic malignancy subtype, which is identified to have two
histological patterns of ductal adenocarcinoma and squamous carcinoma
for the same tumor. This study investigated the clinicopathological features
of 12 cases of ASC.
Method. From January 1993 to December 2006, 12 patients (5 men and 7
women; age range, 32 to 79 years; median, 71 years) diagnosed with ASC
undergoing surgical treatment at Chang Gung Memorial Hospital were
retrospectively reviewed. Survival rate was calculated using the Kaplan-Meier
method.
Results. Symptoms of ASC were as follows: abdominal pain (91.7%), body
weight loss (83.3%), anorexia (41.7%) and jaundice (25.0%). The tumors
were located at the head of the pancreas in 5 (41.7%) patients, at the tail in 5
(41.7%), and at the body in 4 (33.3%). Anemia was identified in 9 patients
(75.0%). Nine (75.0%) patients had elevated serum CEA and CA 19-9
levels, respectively. Surgical resections were performed on 7 patients
including 5 curative resections, bypass surgery on 3, and exploratory
laparotomy on 2. The median tumor size was 6.3 cm, ranging from 3.5 to
8 cm. Two patients underwent intraoperative radiotherapy and 7 received
postoperative chemotherapy. No surgical mortality or morbidity occurred.
Seven (58.3%) and 11 (91.7%) patients died within 6 and 12 months after
surgery, respectively. Median survival of 12 patients was 4.92 months,
ranging from 1.12 to 22.42 months. Five patients receiving curative
resections had median survival of 4.08 months (range, 2.50 to 10.82
months).
Conclusions. Symptoms of patients with ASC are similar to those of
adenocarcinoma of the pancreas reported in the literature. Distribution of
ASC is even in the pancreas, and the tumor size is big at the time of diagnosis.
In this limited cases study, patients with ASC seemingly show dismal
outcomes despite aggressive surgery.
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TUMOUR LOCATION AND NUMBER OF POSITIVE LYMPH
NODES ARE INDEPENDENT PROGNOSTIC FACTORS IN DIS-
TAL BILE DUCT CANCER
Gomez, Dhanwant1; Menon, Krishna V1; Smith, Andrew M1; Verbeke,
Caroline S2
1The Leeds Teaching Hospitals NHS Trust, Department of Surgery, Leeds,
United Kingdom; 2The Leeds Teaching Hospitals NHS Trust, Department
of Histopathology, Leeds, United Kingdom
Background. To date, clinicopathological data on distal bile duct (DBD)
cancer are limited, and the factors that influence survival following curative
resection remain inconclusive. AIMS: To identify prognostic factors in a
series of DBD cancers that underwent fully standardized pathological
examination, including exact mapping of the tumour extension.
Methods. Patients undergoing potentially curative resection (pancreatico-
duodenectomy) for DBD adenocarcinoma between January 2000 and April
2007 were identified from the Pathology database. Demographics, histo-
pathology and survival data were analysed.
Results. 50 patients were identified with a median age of 61 (range: 37  86)
years. Over 75% of cases were stage pT3 and associated with multiple adverse
factors, including nodal metastasis, lymphovascular and perineural invasion.
Margin involvement was found in 70%, whereby the R1 rate differed
significantly between tumours that involved the very distal part of the DBD
and were entirely intrapancreatic (40%), and those located more proximally,
towards the superior border of the pancreas, with or without encroachment
on the extrapancreatic DBD stump (60%; p0.012). Overall, the 1, 3 and 5
year survival was 77%, 30% and 20%, respectively. Vascular invasion was an
adverse prognostic factor (p0.018) on univariate analysis only. Indepen-
dent predictors of poorer overall survival on multivariate analysis were
involvement of the DBD at the superior border of the pancreas (p0.039),
and3 positive lymph nodes (p0.033). Age, sex, lymphatic or perineural
invasion, lymph node positivity rate, differentiation, tumour size and
resection margin status did not have an impact on overall survival.
Conclusion. DBD cancer is a locoregionally advanced cancer with a high R1
rate. Tumour involvement of the proximal end of the DBD close to the
superior pancreatic border, and more than 3 positive lymph nodes are
independent prognostic factors of poorer overall survival after curative
resection.
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EXTENDED EXTRAHEPATIC BILE DUCT RESECTION TO
AVOID PERFORMING PANCREATODUDENECTOMY IN PA-
TIENTS WITH MID BILE DUCT CANCER
Hwang, Shin; Lee, Sung-Gyu; Kim, Ki-Hun; Ahn, Chul-Soo; Moon, Deog-
Bok; Ha, Tae-Yong
Asan Medical Center, University of Ulsan, Department of Surgery, Seoul,
Korea, Republic of
Background. Since mid bile duct cancers often involve the proximal part of
intrapancreatic bile duct (IPBD), resection of the extrahepatic bile duct
(EHBD) results in a tumor-positive distal resection margin. We developed a
surgical procedure to obtain a tumor-free distal resection margin during
EHBD resection, in which R0 resection can be achieved without performing
pancreatoduodenectomy.
Patients and Method. Based on preparatory pathologic analyses, the extent
of IPBD excavation was designed to resemble a 2 cm-long funnel. The
surgical procedure was a combination of usual EHBD resection and funnel-
shaped excavation of the proximal IPBD. This unique procedure, which we
named extended EHBD resection, was performed in 3 patients over 70 years
old with mid bile duct cancer.
Results. Deep IPBD excavation per se required about 1 hour. Tumor-free
IPBD resection margin was obtained in all 3 patients. Only minor complica-
tions occurred, and all patients have been doing well for 1016 months
without tumor recurrence.
Conclusion. Extended EHBD resection can benefit some mid bile duct
cancer patients in whom pancreatoduodenectomy has a high operative risk,
by achieving R0 resection.
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LAPAROSCOPY-ASSISTED PANCREATODUODENECTOMY
Nagao, Yoshiko1; Cho, Akihiro2; Yamamoto, Hiroshi2; Nagata, Matsuo2;
Kainuma, Osamu2; Takiguchi, Nobuhiro2; Soda, Hiroaki2; Gunji, Hisashi2;
Miyazaki, Akinari2; Ikeda, Atsushi2; Matsumoto, Ikuko2; Arimitsu, Hide-
hito2; Ryu, Munemasa2
1Chiba Cancer Center Hospital, Division of Gastroenterological Surgery,
Chiba, Japan; 2
Minimally invasive surgery has been accepted widely as a superior alternative
to conventional surgery in many gastrointestinal fields, and laparoscopic
procedures of the pancreas have rapidly emerged as good alternatives to open
surgery. However, major laparoscopic resections of the pancreas, including
pancreatoduodenectomy (PD), are still highly specialized field because
laparoscopic pancreatic surgery presents severe technical difficulties, and
leakage from pancreaticoenteric anastomoses after PD remain associated with
intra-abdominal hemorrhage and subsequent high mortality rates. The recent
rapid development of technological innovation, improvements in surgical
skills, and extensive experiences of surgeons have proved the feasibility and
safety of a laparoscopic approach for properly selected patients. We
successfully performed laparoscopy-assisted PD (the resection was per-
formed laparoscopically, with the reconstruction performed through a small
midline incision) for patients with IPMN. Although our experience is limited
and appropriate indications must await future studies, we believe that
laparoscopy-assisted PD can be feasible and safe in highly selected patient.
This report describes an operative procedure of laparoscopy-assisted PD.
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SURGICAL TREATMENT OF THE PANCREATIC CANCER
Bilanovic, Dragoljub1; Randjelovic, Tomislav1; Zdravkovic, Darko1; Tosko-
vic, Borislav1; Dikic, Srdjan1; Stanisavljevic, Natasa2
1University Medical Center Bezanijska Kosa, Department of Surgery,
Belgrade, Serbia and Montenegro; 2University Medical Center Bezanijska
Kosa, Department of Hematology, Belgrade, Serbia and Montenegro
Background. Pancreatic cancer is a highly lethal disease and the most
frequent histology is adenocarcinoma. The advances in therapy do not
improve the prognosis significantly. The new methods of exploration have not
improved its detection at an earlier stage of the disease
Method. The authors analyzed the resectability rate, treatment, morbidity,
mortality and follow up of 196 pts (118 male and 78 female) with pancreatic
cancer treated and prospectively monitored at the Medical Centre ‘‘Beza-
nijska kosa’’ from January 2000 to December 2005.
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Results. Radical (potentially curative) procedure was performed in 63 cases
(32.1%) and 133 palliative procedures (67.9%). In the group of patients that
underwent potential curative resection there were 39 cephalic duodenopan-
createctomies, 8 total duodenopancreatectomies, 13 distal, 2 central, 1 near
total pancreatectomies. Portal vein (PV) resection was performed in 2 pts and
lateral PV excision in 3 pts. The operative treatment of pancreatic head
cancer in the group of patients that underwent palliative procedures in most
cases (97 pts) involved biliary enteric bypassing (hepaticojejunostomy) and
prophylactic or therapeutic GEA as a standard procedure. Operative
mortality in radically treated was 5 pts (7.9%). In the group of patients
that were subjected to palliative procedures mortality was 8 pts (6%). The
average survival in the group that underwent palliative treatment was 13.5
months. In the group of radically treated pts 23 have died to date and their
average survival time was 26 months.
Conclusion. Although surgical resection is not efficient in the long-term, it is
currently the only procedure for extending the lifetime and provide with the
hope of total cure. The quality of life can be significantly improved within the
group of patients with non-resectable tumors with adequate palliative
procedures (biliodigestive bypass and GEA).
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